ccopy_reg
_reconstructor
p0
(cnetworkx.classes.graph
Graph
p1
cdill.dill
_load_type
p2
(S'ObjectType'
p3
tp4
Rp5
Ntp6
Rp7
(dp8
S'node'
p9
(dp10
VPosterior Pituitary Lobe Hormones
p11
(dp12
S'type'
p13
S'category'
p14
sS'Id'
p15
V/categories/DBCAT002109
p16
ssVVitamins
p17
(dp18
g13
g14
sg15
V/categories/DBCAT000230
p19
ssVProstacyclin Analogues
p20
(dp21
g13
g14
sg15
V/categories/DBCAT002688
p22
ssS'Pseudoephedrine Hydrochloride'
p23
(dp24
g13
S'drug'
p25
sg15
S'0310000N0'
p26
ssVUGT1A1 Substrates
p27
(dp28
g13
g14
sg15
V/categories/DBCAT003871
p29
ssS'Clindamycin/Tretinoin'
p30
(dp31
g13
g25
sg15
S'1306010AB'
p32
ssVLactates
p33
(dp34
g13
g14
sg15
V/categories/DBCAT001522
p35
ssVCaffeine
p36
(dp37
g13
g14
sg15
V/categories/DBCAT004728
p38
ssVBCRP/ABCG2 Inhibitors
p39
(dp40
g13
g14
sg15
V/categories/DBCAT002662
p41
ssS'Oxycodone Hydrochloride'
p42
(dp43
g13
g25
sg15
S'0407020AD'
p44
ssVBenzoquinones
p45
(dp46
g13
g14
sg15
V/categories/DBCAT001600
p47
ssS'Floxuridine'
p48
(dp49
g13
g25
sg15
S'0801030G0'
p50
ssVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p51
(dp52
g13
g14
sg15
V/categories/DBCAT004517
p53
ssVCalculi Dissolution Agent
p54
(dp55
g13
g14
sg15
V/categories/DBCAT003446
p56
ssVDeoxycytidine
p57
(dp58
g13
g14
sg15
V/categories/DBCAT001087
p59
ssVHistamine H2 Antagonists
p60
(dp61
g13
g14
sg15
V/categories/DBCAT000933
p62
ssVBreast Cancer Resistance Protein Inhibitors
p63
(dp64
g13
g14
sg15
V/categories/DBCAT004102
p65
ssVPeripheral Opioid Receptor Antagonists
p66
(dp67
g13
g14
sg15
V/categories/DBCAT002566
p68
ssS'Chlorzoxazone'
p69
(dp70
g13
g25
sg15
S'1002020E0'
p71
ssS'Fenoprofen'
p72
(dp73
g13
g25
sg15
S'1001010G0'
p74
ssVThiazide-like Diuretic
p75
(dp76
g13
g14
sg15
V/categories/DBCAT003322
p77
ssS'Osimertinib'
p78
(dp79
g13
g25
sg15
S'0801050CG'
p80
ssVHIV Antigens
p81
(dp82
g13
g14
sg15
V/categories/DBCAT002887
p83
ssVMicrotubule Inhibition
p84
(dp85
g13
g14
sg15
V/categories/DBCAT004205
p86
ssS'Capecitabine'
p87
(dp88
g13
g25
sg15
S'0801030V0'
p89
ssVArsenicals
p90
(dp91
g13
g14
sg15
V/categories/DBCAT001515
p92
ssVPhosphinic Acids
p93
(dp94
g13
g14
sg15
V/categories/DBCAT000924
p95
ssVAntihistamines for Systemic Use
p96
(dp97
g13
g14
sg15
V/categories/DBCAT002287
p98
ssVHydroxyquinolines
p99
(dp100
g13
g14
sg15
V/categories/DBCAT001262
p101
ssS'Oxymetholone'
p102
(dp103
g13
g25
sg15
S'0901030H0'
p104
ssVCytochrome P450 3A4 Inhibitors
p105
(dp106
g13
g14
sg15
V/categories/DBCAT004087
p107
ssVVinca Alkaloids
p108
(dp109
g13
g14
sg15
V/categories/DBCAT000714
p110
ssVOCT1 substrates
p111
(dp112
g13
g14
sg15
V/categories/DBCAT004550
p113
ssVInsecticides and Repellents
p114
(dp115
g13
g14
sg15
V/categories/DBCAT002606
p116
ssVPhosphoramide Mustards
p117
(dp118
g13
g14
sg15
V/categories/DBCAT000951
p119
ssVGABA Agonists
p120
(dp121
g13
g14
sg15
V/categories/DBCAT000427
p122
ssVOAT3/SLC22A8 Substrates
p123
(dp124
g13
g14
sg15
V/categories/DBCAT002661
p125
ssS'Piperacillin Sodium/Tazobactam Sodium'
p126
(dp127
g13
g25
sg15
S'0501014S0'
p128
ssS'Calcium Gluconate'
p129
(dp130
g13
g25
sg15
S'1902070G0'
p131
ssS'Gliclazide'
p132
(dp133
g13
g25
sg15
S'0601021M0'
p134
ssS'Cefoxitin Sodium'
p135
(dp136
g13
g25
sg15
S'0501021E0'
p137
ssS'Mexiletine Hydrochloride'
p138
(dp139
g13
g25
sg15
S'0203020P0'
p140
ssS'Capsaicin'
p141
(dp142
g13
g25
sg15
S'1003020AA'
p143
ssVCytochrome P-450 CYP3A Inhibitors (strong)
p144
(dp145
g13
g14
sg15
V/categories/DBCAT003815
p146
ssS'Tamoxifen Citrate'
p147
(dp148
g13
g25
sg15
S'0803041S0'
p149
ssVAcetic Acid
p150
(dp151
g13
g25
sg15
S'1201010B0'
p152
ssVLipopeptide Antibacterial
p153
(dp154
g13
g14
sg15
V/categories/DBCAT003272
p155
ssVSclerosing Activity
p156
(dp157
g13
g14
sg15
V/categories/DBCAT004100
p158
ssVNicotinic Acid and Derivatives
p159
(dp160
g13
g14
sg15
V/categories/DBCAT002431
p161
ssVPegylated agents
p162
(dp163
g13
g14
sg15
V/categories/DBCAT004540
p164
ssS'Cholic Acid'
p165
(dp166
g13
g25
sg15
S'0109010H0'
p167
ssS'Amfetamine Sulfate'
p168
(dp169
g13
g25
sg15
S'0404000A0'
p170
ssS'Choline Magnesium Trisalicylate'
p171
(dp172
g13
g25
sg15
S'1001010M0'
p173
ssVCytochrome P-450 CYP2D6 Inhibitors (strong)
p174
(dp175
g13
g14
sg15
V/categories/DBCAT002624
p176
ssVProtein-Lysine 6-Oxidase, antagonists & inhibitors
p177
(dp178
g13
g14
sg15
V/categories/DBCAT001009
p179
ssVGrowth Inhibitors
p180
(dp181
g13
g14
sg15
V/categories/DBCAT000221
p182
ssS'Phenobarbital'
p183
(dp184
g13
g25
sg15
S'0408010N0'
p185
ssVInsulin, Short-Acting
p186
(dp187
g13
g14
sg15
V/categories/DBCAT000135
p188
ssVCytochrome P-450 CYP2C9 Inducers (weak)
p189
(dp190
g13
g14
sg15
V/categories/DBCAT003039
p191
ssVErythropoiesis-Stimulating Agents
p192
(dp193
g13
g14
sg15
V/categories/DBCAT002721
p194
ssS'Aliskiren'
p195
(dp196
g13
g25
sg15
S'0205053A0'
p197
ssVTopical Products for Joint and Muscular Pain
p198
(dp199
g13
g14
sg15
V/categories/DBCAT002314
p200
ssVCalcium Chelating Activity
p201
(dp202
g13
g14
sg15
V/categories/DBCAT004168
p203
ssS'Acetazolamide Sodium'
p204
(dp205
g13
g25
sg15
S'1106000C0'
p206
ssVAdamantanes
p207
(dp208
g13
g14
sg15
V/categories/DBCAT003739
p209
ssS'Naphazoline Hydrochloride'
p210
(dp211
g13
g25
sg15
S'1104020R0'
p212
ssS'Lisinopril'
p213
(dp214
g13
g25
sg15
S'0205051L0'
p215
ssVBunolol
p216
(dp217
g13
g14
sg15
V/categories/DBCAT001298
p218
ssS'Metformin Hydrochloride/Rosiglitazone'
p219
(dp220
g13
g25
sg15
S'0601023V0'
p221
ssVAntimalarials
p222
(dp223
g13
g14
sg15
V/categories/DBCAT000524
p224
ssVAdrenergic alpha-1 Receptor Antagonists
p225
(dp226
g13
g14
sg15
V/categories/DBCAT000777
p227
ssVProto-Oncogene Proteins c-sis
p228
(dp229
g13
g14
sg15
V/categories/DBCAT004971
p230
ssVCytochrome P-450 2C18 Inducers
p231
(dp232
g13
g14
sg15
V/categories/DBCAT004670
p233
ssVi.v. Solutions
p234
(dp235
g13
g14
sg15
V/categories/DBCAT002460
p236
ssVHydrocortisone and derivatives
p237
(dp238
g13
g14
sg15
V/categories/DBCAT001067
p239
ssS'Zuclopenthixol Acetate'
p240
(dp241
g13
g25
sg15
S'040201010'
p242
ssVDopamine Agents
p243
(dp244
g13
g14
sg15
V/categories/DBCAT000436
p245
ssVDrugs for Treatment of Bone Diseases
p246
(dp247
g13
g14
sg15
V/categories/DBCAT002166
p248
ssVLipids
p249
(dp250
g13
g14
sg15
V/categories/DBCAT000178
p251
ssVGlucagon-Like Peptides
p252
(dp253
g13
g14
sg15
V/categories/DBCAT001826
p254
ssS'Isoprenaline Hydrochloride'
p255
(dp256
g13
g25
sg15
S'0301040P0'
p257
ssVBoric Acids
p258
(dp259
g13
g14
sg15
V/categories/DBCAT003149
p260
ssVSerotonin 5-HT1 Receptor Antagonists
p261
(dp262
g13
g14
sg15
V/categories/DBCAT001739
p263
ssVSympathomimetics, Plain
p264
(dp265
g13
g14
sg15
V/categories/DBCAT002348
p266
ssVNitrogen Mustard Compounds
p267
(dp268
g13
g14
sg15
V/categories/DBCAT000680
p269
ssVSucrose-specific Enzyme
p270
(dp271
g13
g14
sg15
V/categories/DBCAT003477
p272
ssVFenamates
p273
(dp274
g13
g14
sg15
V/categories/DBCAT001132
p275
ssVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p276
(dp277
g13
g14
sg15
V/categories/DBCAT002376
p278
ssS'Tenofovir Disoproxil'
p279
(dp280
g13
g25
sg15
S'0503010H0'
p281
ssS'Pimozide'
p282
(dp283
g13
g25
sg15
S'0402010R0'
p284
ssS'Apixaban'
p285
(dp286
g13
g25
sg15
S'0208020Z0'
p287
ssS'Safinamide'
p288
(dp289
g13
g25
sg15
S'0409010AA'
p290
ssVHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor
p291
(dp292
g13
g14
sg15
V/categories/DBCAT003484
p293
ssS'Codeine Phosphate'
p294
(dp295
g13
g25
sg15
S'0309010C0'
p296
ssVTooth Bleaching
p297
(dp298
g13
g14
sg15
V/categories/DBCAT003164
p299
ssVLincomycin
p300
(dp301
g13
g14
sg15
V/categories/DBCAT001291
p302
ssVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p303
(dp304
g13
g14
sg15
V/categories/DBCAT004496
p305
ssVExcitatory Amino Acid Agents
p306
(dp307
g13
g14
sg15
V/categories/DBCAT000939
p308
ssVHypertension, Pulmonary
p309
(dp310
g13
g14
sg15
V/categories/DBCAT001796
p311
ssVFused-Ring Compounds
p312
(dp313
g13
g14
sg15
V/categories/DBCAT004974
p314
ssVSubstituted Ethylene Diamines
p315
(dp316
g13
g14
sg15
V/categories/DBCAT002468
p317
ssS'Dolutegravir/Rilpivirine'
p318
(dp319
g13
g25
sg15
S'0503010AP'
p320
ssVOCT2 Substrates
p321
(dp322
g13
g14
sg15
V/categories/DBCAT002657
p323
ssVLocal Anesthesia
p324
(dp325
g13
g14
sg15
V/categories/DBCAT004115
p326
ssVNon Potassium Sparing Diuretics
p327
(dp328
g13
g14
sg15
V/categories/DBCAT003863
p329
ssVResins, Plant
p330
(dp331
g13
g14
sg15
V/categories/DBCAT002033
p332
ssVCytochrome P-450 CYP1A2 Inhibitors
p333
(dp334
g13
g14
sg15
V/categories/DBCAT000402
p335
ssS'Ibuprofen'
p336
(dp337
g13
g25
sg15
S'1001010J0'
p338
ssS'Linagliptin'
p339
(dp340
g13
g25
sg15
S'0601023AE'
p341
ssVPolyunsaturated Alkamides
p342
(dp343
g13
g14
sg15
V/categories/DBCAT001691
p344
ssS'Levomilnacipran'
p345
(dp346
g13
g25
sg15
S'0403040AA'
p347
ssVFurocoumarins
p348
(dp349
g13
g14
sg15
V/categories/DBCAT000968
p350
ssS'Azelaic Acid'
p351
(dp352
g13
g25
sg15
S'1306010B0'
p353
ssS'Minocycline Hydrochloride'
p354
(dp355
g13
g25
sg15
S'0501030P0'
p356
ssS'Lipegfilgrastim'
p357
(dp358
g13
g25
sg15
S'0901060Q0'
p359
ssVSerotonin 3 Receptor Antagonists
p360
(dp361
g13
g14
sg15
V/categories/DBCAT004178
p362
ssVCyclosporins
p363
(dp364
g13
g14
sg15
V/categories/DBCAT000198
p365
ssVAdrenergic beta-Antagonists
p366
(dp367
g13
g14
sg15
V/categories/DBCAT000456
p368
ssVBenzamides and benzamide derivatives
p369
(dp370
g13
g14
sg15
V/categories/DBCAT000775
p371
ssS'Epoetin Beta'
p372
(dp373
g13
g25
sg15
S'0901030E0'
p374
ssS'Methyldopate Hydrochloride'
p375
(dp376
g13
g25
sg15
S'0205020J0'
p377
ssVPharmaceutical Solutions
p378
(dp379
g13
g14
sg15
V/categories/DBCAT000894
p380
ssVNon-Nucleoside Reverse Transcriptase Inhibitors
p381
(dp382
g13
g14
sg15
V/categories/DBCAT002245
p383
ssVAntidepressive Agents
p384
(dp385
g13
g14
sg15
V/categories/DBCAT000345
p386
ssS'Nortriptyline'
p387
(dp388
g13
g25
sg15
S'0403010V0'
p389
ssVMethylprednisolone
p390
(dp391
g13
g14
sg15
V/categories/DBCAT001203
p392
ssVButanols
p393
(dp394
g13
g14
sg15
V/categories/DBCAT002059
p395
ssS'Potassium Iodide'
p396
(dp397
g13
g14
sg15
V/categories/DBCAT004827
p398
ssVAlcohol Deterrents
p399
(dp400
g13
g14
sg15
V/categories/DBCAT001048
p401
ssS'Lanreotide'
p402
(dp403
g13
g25
sg15
S'0803043P0'
p404
ssS'Alimemazine Tartrate'
p405
(dp406
g13
g25
sg15
S'0304010Y0'
p407
ssVImmune Sera
p408
(dp409
g13
g14
sg15
V/categories/DBCAT002881
p410
ssVPituitary Hormones
p411
(dp412
g13
g14
sg15
V/categories/DBCAT000096
p413
ssS'Thioridazine'
p414
(dp415
g13
g25
sg15
S'0402010W0'
p416
ssVOrganothiophosphorus Compounds
p417
(dp418
g13
g14
sg15
V/categories/DBCAT001124
p419
ssS'Ammonium Chloride/Diphenhydramine HCl'
p420
(dp421
g13
g25
sg15
S'0309020AH'
p422
ssVTrimethyl Ammonium Compounds
p423
(dp424
g13
g14
sg15
V/categories/DBCAT000264
p425
ssS'Diazepam'
p426
(dp427
g13
g25
sg15
S'0401020K0'
p428
ssVChorionic Gonadotropin
p429
(dp430
g13
g14
sg15
V/categories/DBCAT001930
p431
ssVBenzomorphan Derivatives
p432
(dp433
g13
g14
sg15
V/categories/DBCAT002436
p434
ssVAnti-Parkinson Drugs
p435
(dp436
g13
g14
sg15
V/categories/DBCAT002254
p437
ssS'Daclatasvir'
p438
(dp439
g13
g25
sg15
S'0503032E0'
p440
ssVGABA Agents
p441
(dp442
g13
g14
sg15
V/categories/DBCAT000428
p443
ssS'Levothyroxine Sodium'
p444
(dp445
g13
g25
sg15
S'0602010V0'
p446
ssS'Daclizumab'
p447
(dp448
g13
g25
sg15
S'0802020V0'
p449
ssS'Tapentadol Hydrochloride'
p450
(dp451
g13
g25
sg15
S'0407020AG'
p452
ssVTaurine
p453
(dp454
g13
g14
sg15
V/categories/DBCAT001584
p455
ssS'Bosutinib'
p456
(dp457
g13
g25
sg15
S'0801050BL'
p458
ssVThiazines
p459
(dp460
g13
g14
sg15
V/categories/DBCAT000573
p461
ssVInterleukin-5
p462
(dp463
g13
g14
sg15
V/categories/DBCAT005013
p464
ssS'Bupropion Hydrochloride'
p465
(dp466
g13
g25
sg15
S'0403040B0'
p467
ssVDrugs Affecting Bone Structure and Mineralization
p468
(dp469
g13
g14
sg15
V/categories/DBCAT002165
p470
ssVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p471
(dp472
g13
g14
sg15
V/categories/DBCAT004527
p473
ssS'Decitabine'
p474
(dp475
g13
g25
sg15
S'0801030AE'
p476
ssS'Mercaptopurine'
p477
(dp478
g13
g25
sg15
S'0801030L0'
p479
ssVPhenoxyacetates
p480
(dp481
g13
g14
sg15
V/categories/DBCAT001185
p482
ssVAntifoaming Agents
p483
(dp484
g13
g14
sg15
V/categories/DBCAT001607
p485
ssS'Fluphenazine Decanoate'
p486
(dp487
g13
g25
sg15
S'0402020L0'
p488
ssVIncretin Mimetics
p489
(dp490
g13
g14
sg15
V/categories/DBCAT003758
p491
ssVWolman Disease, drug therapy
p492
(dp493
g13
g14
sg15
V/categories/DBCAT002076
p494
ssS'Propantheline Bromide'
p495
(dp496
g13
g25
sg15
S'0102000Y0'
p497
ssVPotassium
p498
(dp499
g13
g14
sg15
V/categories/DBCAT002463
p500
ssS'Sevelamer'
p501
(dp502
g13
g25
sg15
S'0905022S0'
p503
ssVAlkalinizing Activity
p504
(dp505
g13
g14
sg15
V/categories/DBCAT004224
p506
ssS'Norethisterone Acetate'
p507
(dp508
g13
g25
sg15
S'0803020Q0'
p509
ssVCytochrome P450 1A2 Inhibitors
p510
(dp511
g13
g14
sg15
V/categories/DBCAT004161
p512
ssVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p513
(dp514
g13
g14
sg15
V/categories/DBCAT002283
p515
ssS'Domperidone'
p516
(dp517
g13
g25
sg15
S'0406000J0'
p518
ssVAntibodies, Monoclonal, Murine-Derived
p519
(dp520
g13
g14
sg15
V/categories/DBCAT000172
p521
ssVMacrolides
p522
(dp523
g13
g14
sg15
V/categories/DBCAT000496
p524
ssVNandrolone and esters
p525
(dp526
g13
g14
sg15
V/categories/DBCAT002677
p527
ssS'Toremifene Citrate'
p528
(dp529
g13
g25
sg15
S'0803041U0'
p530
ssVAndrostenols
p531
(dp532
g13
g14
sg15
V/categories/DBCAT001013
p533
ssS'Nabilone'
p534
(dp535
g13
g25
sg15
S'0406000R0'
p536
ssS'Morphine Hydrochloride'
p537
(dp538
g13
g25
sg15
S'0407020P0'
p539
ssVVascular Endothelial Growth Factor Receptor 2 Antagonist
p540
(dp541
g13
g14
sg15
V/categories/DBCAT003458
p542
ssS'Testosterone'
p543
(dp544
g13
g25
sg15
S'0604020K0'
p545
ssS'Nalmefene'
p546
(dp547
g13
g25
sg15
S'0410010D0'
p548
ssVAcyclovir
p549
(dp550
g13
g14
sg15
V/categories/DBCAT004570
p551
ssVMiscellaneous Antimycobacterials
p552
(dp553
g13
g14
sg15
V/categories/DBCAT003644
p554
ssVDermatologicals
p555
(dp556
g13
g14
sg15
V/categories/DBCAT002135
p557
ssVLaxatives
p558
(dp559
g13
g14
sg15
V/categories/DBCAT001927
p560
ssS'Tiopronin'
p561
(dp562
g13
g25
sg15
S'1001030Q0'
p563
ssS'Moclobemide'
p564
(dp565
g13
g25
sg15
S'0403020K0'
p566
ssVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p567
(dp568
g13
g14
sg15
V/categories/DBCAT004504
p569
ssS'Propiverine Hydrochloride'
p570
(dp571
g13
g25
sg15
S'0704020P0'
p572
ssS'Nelfinavir Mesilate'
p573
(dp574
g13
g25
sg15
S'0503010C0'
p575
ssVEstrogen Receptor Modulators
p576
(dp577
g13
g14
sg15
V/categories/DBCAT000917
p578
ssVIsoindoles
p579
(dp580
g13
g14
sg15
V/categories/DBCAT000724
p581
ssS'Nitrazepam'
p582
(dp583
g13
g25
sg15
S'0401010R0'
p584
ssVMelatonin, agonists
p585
(dp586
g13
g14
sg15
V/categories/DBCAT001822
p587
ssVBenzodiazepine hypnotics and sedatives
p588
(dp589
g13
g14
sg15
V/categories/DBCAT003883
p590
ssVSphingosine 1-phosphate Receptor Modulator
p591
(dp592
g13
g14
sg15
V/categories/DBCAT003491
p593
ssVSpermatocidal Agents
p594
(dp595
g13
g14
sg15
V/categories/DBCAT001608
p596
ssVHypoglycemia-Associated Agents
p597
(dp598
g13
g14
sg15
V/categories/DBCAT002695
p599
ssS'Mebendazole'
p600
(dp601
g13
g25
sg15
S'0505010D0'
p602
ssS'Tolcapone'
p603
(dp604
g13
g25
sg15
S'0409010S0'
p605
ssVCitrates
p606
(dp607
g13
g14
sg15
V/categories/DBCAT001578
p608
ssS'Octreotide Acetate'
p609
(dp610
g13
g25
sg15
S'0803043N0'
p611
ssS'Ephedrine Sulfate'
p612
(dp613
g13
g25
sg15
S'0301040J0'
p614
ssVRespiratory Smooth Muscle Relaxants
p615
(dp616
g13
g14
sg15
V/categories/DBCAT003651
p617
ssVDrugs Used in Opioid Dependence
p618
(dp619
g13
g14
sg15
V/categories/DBCAT002315
p620
ssS'Erlotinib'
p621
(dp622
g13
g25
sg15
S'0801050AE'
p623
ssVInterferon Inducers
p624
(dp625
g13
g14
sg15
V/categories/DBCAT001094
p626
ssVDecreased Platelet Production
p627
(dp628
g13
g14
sg15
V/categories/DBCAT004381
p629
ssS'Flupentixol Decanoate'
p630
(dp631
g13
g25
sg15
S'0402020G0'
p632
ssS'Frovatriptan'
p633
(dp634
g13
g25
sg15
S'0407041AB'
p635
ssVSolutions Producing Osmotic Diuresis
p636
(dp637
g13
g14
sg15
V/categories/DBCAT002459
p638
ssVortho-Aminobenzoates
p639
(dp640
g13
g14
sg15
V/categories/DBCAT001133
p641
ssVAngiotensin II receptor blockers (ARBs) and diuretics
p642
(dp643
g13
g14
sg15
V/categories/DBCAT004593
p644
ssS'Ethanolamine Oleate'
p645
(dp646
g13
g25
sg15
S'0213000F0'
p647
ssVHydroxy Acids
p648
(dp649
g13
g14
sg15
V/categories/DBCAT000581
p650
ssVCytochrome P-450 CYP2C9 Inhibitors
p651
(dp652
g13
g14
sg15
V/categories/DBCAT000489
p653
ssS'Degarelix'
p654
(dp655
g13
g25
sg15
S'0803042R0'
p656
ssS'Magnesium Sulphate'
p657
(dp658
g13
g25
sg15
S'0101010T0'
p659
ssVProgesterone Receptor Modulators
p660
(dp661
g13
g14
sg15
V/categories/DBCAT002473
p662
ssVDitiocarb
p663
(dp664
g13
g14
sg15
V/categories/DBCAT001149
p665
ssVCytochrome P-450 CYP2D6 Inhibitors (weak)
p666
(dp667
g13
g14
sg15
V/categories/DBCAT002726
p668
ssS'Avelumab'
p669
(dp670
g13
g25
sg15
S'0801050CF'
p671
ssVPyrimidine Analogues
p672
(dp673
g13
g14
sg15
V/categories/DBCAT002372
p674
ssVPurine Derivatives
p675
(dp676
g13
g14
sg15
V/categories/DBCAT002469
p677
ssVTumor Necrosis Factor Receptor Blocking Activity
p678
(dp679
g13
g14
sg15
V/categories/DBCAT004095
p680
ssVOxytocin and Analogues
p681
(dp682
g13
g14
sg15
V/categories/DBCAT002139
p683
ssS'Nimodipine'
p684
(dp685
g13
g25
sg15
S'0206020M0'
p686
ssS'Hyoscyamine Sulfate'
p687
(dp688
g13
g25
sg15
S'0102000AB'
p689
ssS'Erythromycin Ethylsuccinate'
p690
(dp691
g13
g25
sg15
S'0501050H0'
p692
ssVGlycoside Hydrolases
p693
(dp694
g13
g14
sg15
V/categories/DBCAT000166
p695
ssS'Clozapine'
p696
(dp697
g13
g25
sg15
S'0402010C0'
p698
ssVAluminium Compounds
p699
(dp700
g13
g14
sg15
V/categories/DBCAT002569
p701
ssS'Tiagabine'
p702
(dp703
g13
g25
sg15
S'0408010AB'
p704
ssVReproductive Control Agents
p705
(dp706
g13
g14
sg15
V/categories/DBCAT000061
p707
ssVCholine Esters
p708
(dp709
g13
g14
sg15
V/categories/DBCAT002364
p710
ssVCytochrome P-450 CYP3A4 Inducers
p711
(dp712
g13
g14
sg15
V/categories/DBCAT003896
p713
ssS'Dronabinol/Cannabidiol'
p714
(dp715
g13
g25
sg15
S'1002020Y0'
p716
ssS'Tranexamic Acid'
p717
(dp718
g13
g25
sg15
S'0211000P0'
p719
ssVHydroxides
p720
(dp721
g13
g14
sg15
V/categories/DBCAT001847
p722
ssS'Indacaterol/Glycopyrronium'
p723
(dp724
g13
g25
sg15
S'0301040Y0'
p725
ssVImino Sugars
p726
(dp727
g13
g14
sg15
V/categories/DBCAT001529
p728
ssVTetrazoles
p729
(dp730
g13
g14
sg15
V/categories/DBCAT000407
p731
ssVCatecholamines
p732
(dp733
g13
g14
sg15
V/categories/DBCAT000467
p734
ssS'Ibandronic Acid'
p735
(dp736
g13
g25
sg15
S'0606020W0'
p737
ssVVerapamil and analogues
p738
(dp739
g13
g14
sg15
V/categories/DBCAT002850
p740
ssVCholestanes
p741
(dp742
g13
g14
sg15
V/categories/DBCAT000308
p743
ssVReceptor, ErbB-2, antagonists & inhibitors
p744
(dp745
g13
g14
sg15
V/categories/DBCAT001652
p746
ssVFatty Acid Synthesis Inhibitors
p747
(dp748
g13
g14
sg15
V/categories/DBCAT001001
p749
ssVGlobulins
p750
(dp751
g13
g14
sg15
V/categories/DBCAT000022
p752
ssS'Edrophonium Chloride'
p753
(dp754
g13
g25
sg15
S'1002010H0'
p755
ssVUGT1A3 Inhibitors
p756
(dp757
g13
g14
sg15
V/categories/DBCAT004454
p758
ssVSmoothened Receptor Antagonists
p759
(dp760
g13
g14
sg15
V/categories/DBCAT004411
p761
ssS'Lutropin Alfa'
p762
(dp763
g13
g25
sg15
S'0605010Y0'
p764
ssVProstaglandin analogs reducing intraocular pressure (IOP)
p765
(dp766
g13
g14
sg15
V/categories/DBCAT004677
p767
ssVSelective Beta 3-adrenergic Agonists
p768
(dp769
g13
g14
sg15
V/categories/DBCAT003777
p770
ssS'Bortezomib'
p771
(dp772
g13
g25
sg15
S'0801050AC'
p773
ssVEnzyme Activators
p774
(dp775
g13
g14
sg15
V/categories/DBCAT003063
p776
ssVAminoalkyl Ethers
p777
(dp778
g13
g14
sg15
V/categories/DBCAT002286
p779
ssS'Paliperidone'
p780
(dp781
g13
g25
sg15
S'0402010AE'
p782
ssVAlkaloids
p783
(dp784
g13
g14
sg15
V/categories/DBCAT000443
p785
ssVGonadotropin-releasing Hormone Antagonists
p786
(dp787
g13
g14
sg15
V/categories/DBCAT003613
p788
ssS'Tegaserod Maleate'
p789
(dp790
g13
g25
sg15
S'0102000AG'
p791
ssVHerbs and Natural Products
p792
(dp793
g13
g14
sg15
V/categories/DBCAT003727
p794
ssVProstaglandins
p795
(dp796
g13
g14
sg15
V/categories/DBCAT000353
p797
ssVCytochrome P-450 CYP3A4 Inducers (weak)
p798
(dp799
g13
g14
sg15
V/categories/DBCAT002718
p800
ssS'Exenatide'
p801
(dp802
g13
g25
sg15
S'0601023Y0'
p803
ssVEndocrine Therapy
p804
(dp805
g13
g14
sg15
V/categories/DBCAT002090
p806
ssVHydrocarbons, Acyclic
p807
(dp808
g13
g14
sg15
V/categories/DBCAT000365
p809
ssVSex Hormones and Modulators of the Genital System
p810
(dp811
g13
g14
sg15
V/categories/DBCAT002113
p812
ssVBiocompatible Materials
p813
(dp814
g13
g14
sg15
V/categories/DBCAT000985
p815
ssS'Mifepristone/Misoprostol'
p816
(dp817
g13
g25
sg15
S'0701021A0'
p818
ssS'Atazanavir & Cobicistat'
p819
(dp820
g13
g25
sg15
S'0503010AL'
p821
ssS'Pipotiazine Palmitate'
p822
(dp823
g13
g25
sg15
S'0402020V0'
p824
ssVPlatelet Activating Factor, antagonists & inhibitors
p825
(dp826
g13
g14
sg15
V/categories/DBCAT002084
p827
ssS'Alprazolam'
p828
(dp829
g13
g25
sg15
S'0401020A0'
p830
ssS'Dutasteride'
p831
(dp832
g13
g25
sg15
S'0604020B0'
p833
ssS'Clomifene Citrate'
p834
(dp835
g13
g25
sg15
S'0605010G0'
p836
ssS'Propylthiouracil'
p837
(dp838
g13
g25
sg15
S'0602020N0'
p839
ssS'Alectinib'
p840
(dp841
g13
g25
sg15
S'0801050CD'
p842
ssVElectrolyte Solutions
p843
(dp844
g13
g14
sg15
V/categories/DBCAT002438
p845
ssVCytochrome P-450 CYP2C9 Inducers
p846
(dp847
g13
g14
sg15
V/categories/DBCAT001245
p848
ssS'Norethisterone'
p849
(dp850
g13
g25
sg15
S'0703021N0'
p851
ssVCalcium Channel Blockers (Dihydropyridine)
p852
(dp853
g13
g14
sg15
V/categories/DBCAT003977
p854
ssVIncretins
p855
(dp856
g13
g14
sg15
V/categories/DBCAT001316
p857
ssS'Idarubicin Hydrochloride'
p858
(dp859
g13
g25
sg15
S'0801020P0'
p860
ssVButyrophenone Derivatives
p861
(dp862
g13
g14
sg15
V/categories/DBCAT002383
p863
ssVPhthalimides
p864
(dp865
g13
g14
sg15
V/categories/DBCAT000722
p866
ssVAzole Antifungals
p867
(dp868
g13
g14
sg15
V/categories/DBCAT003230
p869
ssVPeptide Hormones
p870
(dp871
g13
g14
sg15
V/categories/DBCAT000055
p872
ssVNeuromuscular Agents
p873
(dp874
g13
g14
sg15
V/categories/DBCAT000187
p875
ssVAntihypertensive Agents
p876
(dp877
g13
g14
sg15
V/categories/DBCAT000410
p878
ssS'Bumetanide'
p879
(dp880
g13
g25
sg15
S'0202020D0'
p881
ssVDimethylamines
p882
(dp883
g13
g14
sg15
V/categories/DBCAT000477
p884
ssVBlood Substitutes
p885
(dp886
g13
g14
sg15
V/categories/DBCAT001950
p887
ssS'Carbamazepine'
p888
(dp889
g13
g14
sg15
V/categories/DBCAT004984
p890
ssS'Nepafenac'
p891
(dp892
g13
g25
sg15
S'1108020AF'
p893
ssVGuanylate Cyclase Activators
p894
(dp895
g13
g14
sg15
V/categories/DBCAT004134
p896
ssVEpinephrine and similars
p897
(dp898
g13
g14
sg15
V/categories/DBCAT000798
p899
ssVMedicated Dressings
p900
(dp901
g13
g14
sg15
V/categories/DBCAT002321
p902
ssVEthylamines
p903
(dp904
g13
g14
sg15
V/categories/DBCAT000433
p905
ssVCarbamoyl Phosphate Synthetase 1 Activator
p906
(dp907
g13
g14
sg15
V/categories/DBCAT003479
p908
ssS'Timolol & Brimonidine'
p909
(dp910
g13
g25
sg15
S'1106000AG'
p911
ssVFatty Acid Derivatives
p912
(dp913
g13
g14
sg15
V/categories/DBCAT002301
p914
ssS'Fentanyl Citrate'
p915
(dp916
g13
g25
sg15
S'1501043F0'
p917
ssS'Tegafur'
p918
(dp919
g13
g25
sg15
S'0801030S0'
p920
ssVDeoxyribonucleases
p921
(dp922
g13
g14
sg15
V/categories/DBCAT002873
p923
ssVNicotine, antagonists & inhibitors
p924
(dp925
g13
g14
sg15
V/categories/DBCAT001935
p926
ssVDrugs Used in Erectile Dysfunction
p927
(dp928
g13
g14
sg15
V/categories/DBCAT002206
p929
ssVSpecific Antirheumatic Agents
p930
(dp931
g13
g14
sg15
V/categories/DBCAT002476
p932
ssS'Almotriptan'
p933
(dp934
g13
g25
sg15
S'0407041B0'
p935
ssVNitrofuran Derivatives
p936
(dp937
g13
g14
sg15
V/categories/DBCAT002318
p938
ssVPhenoxypropanolamines
p939
(dp940
g13
g14
sg15
V/categories/DBCAT000482
p941
ssVAntiarrhythmics, Class Ic
p942
(dp943
g13
g14
sg15
V/categories/DBCAT002518
p944
ssS'Desloratadine'
p945
(dp946
g13
g25
sg15
S'0304010AB'
p947
ssVAntibiotics, Antitubercular
p948
(dp949
g13
g14
sg15
V/categories/DBCAT000630
p950
ssVCytochrome P-450 CYP2C18 Substrates
p951
(dp952
g13
g14
sg15
V/categories/DBCAT004664
p953
ssVNitroimidazole Antimicrobial
p954
(dp955
g13
g14
sg15
V/categories/DBCAT003414
p956
ssVChlorobenzenes
p957
(dp958
g13
g14
sg15
V/categories/DBCAT001112
p959
ssVThionucleosides
p960
(dp961
g13
g14
sg15
V/categories/DBCAT001221
p962
ssS'Naproxen Sodium'
p963
(dp964
g13
g25
sg15
S'100101070'
p965
ssS'Eplerenone'
p966
(dp967
g13
g25
sg15
S'0202030X0'
p968
ssS'Methyl Salicylate/Levomenthol'
p969
(dp970
g13
g25
sg15
S'1003020AE'
p971
ssS'Cefazolin Sodium'
p972
(dp973
g13
g25
sg15
S'0501020V0'
p974
ssVNeprilysin Inhibitor
p975
(dp976
g13
g14
sg15
V/categories/DBCAT004016
p977
ssS'Bumetanide/Amiloride Hydrochloride'
p978
(dp979
g13
g25
sg15
S'0202080D0'
p980
ssVDopamine D2 Receptor Agonists
p981
(dp982
g13
g14
sg15
V/categories/DBCAT000838
p983
ssVBone Anabolic Agents
p984
(dp985
g13
g14
sg15
V/categories/DBCAT004660
p986
ssVInterleukin-17
p987
(dp988
g13
g14
sg15
V/categories/DBCAT005031
p989
ssVIncreased Epithelial Proliferation
p990
(dp991
g13
g14
sg15
V/categories/DBCAT004461
p992
ssVZalcitabine
p993
(dp994
g13
g14
sg15
V/categories/DBCAT004749
p995
ssVProgrammed Death Receptor-1 Blocking Antibody
p996
(dp997
g13
g14
sg15
V/categories/DBCAT003510
p998
ssVLeprostatic Agents
p999
(dp1000
g13
g14
sg15
V/categories/DBCAT000611
p1001
ssVChemically-Induced Disorders
p1002
(dp1003
g13
g14
sg15
V/categories/DBCAT000397
p1004
ssVPotassium Channel Openers
p1005
(dp1006
g13
g14
sg15
V/categories/DBCAT004293
p1007
ssS'Morphine Tartrate & Cyclizine Tartrate'
p1008
(dp1009
g13
g25
sg15
S'040702020'
p1010
ssVPhotosensitizing Agents
p1011
(dp1012
g13
g14
sg15
V/categories/DBCAT000335
p1013
ssS'Phenylbutyric Acid'
p1014
(dp1015
g13
g25
sg15
S'0908010X0'
p1016
ssVProkinetic Agents
p1017
(dp1018
g13
g14
sg15
V/categories/DBCAT003753
p1019
ssVUDP Glucuronosyltransferases Inhibitors
p1020
(dp1021
g13
g14
sg15
V/categories/DBCAT004220
p1022
ssVBenzylammonium Compounds
p1023
(dp1024
g13
g14
sg15
V/categories/DBCAT001273
p1025
ssVImmunoglobulin Fragments
p1026
(dp1027
g13
g14
sg15
V/categories/DBCAT001915
p1028
ssVUGT2B15 Inhibitors
p1029
(dp1030
g13
g14
sg15
V/categories/DBCAT004457
p1031
ssVCyclophosphamide
p1032
(dp1033
g13
g25
sg15
S'0801010H0'
p1034
ssS'Menthol'
p1035
(dp1036
g13
g25
sg15
S'0308000M0'
p1037
ssS'Iloprost'
p1038
(dp1039
g13
g25
sg15
S'0205010V0'
p1040
ssS'Bisacodyl'
p1041
(dp1042
g13
g25
sg15
S'0106020C0'
p1043
ssS'Pindolol'
p1044
(dp1045
g13
g25
sg15
S'0204000P0'
p1046
ssS'Itraconazole'
p1047
(dp1048
g13
g25
sg15
S'0502010C0'
p1049
ssS'Fluconazole'
p1050
(dp1051
g13
g25
sg15
S'0502010B0'
p1052
ssVPhysiological Phenomena
p1053
(dp1054
g13
g14
sg15
V/categories/DBCAT000235
p1055
ssVFluoresceins
p1056
(dp1057
g13
g14
sg15
V/categories/DBCAT001073
p1058
ssS'Ziconotide Acetate'
p1059
(dp1060
g13
g25
sg15
S'1502010X0'
p1061
ssS'Pioglitazone Hydrochloride'
p1062
(dp1063
g13
g25
sg15
S'0601023B0'
p1064
ssVVinyl Compounds
p1065
(dp1066
g13
g14
sg15
V/categories/DBCAT001871
p1067
ssVAluminum Complex
p1068
(dp1069
g13
g14
sg15
V/categories/DBCAT003337
p1070
ssVPigments, Biological
p1071
(dp1072
g13
g14
sg15
V/categories/DBCAT000332
p1073
ssVDibenzoxepins
p1074
(dp1075
g13
g14
sg15
V/categories/DBCAT001120
p1076
ssVIncreased Coagulation Factor VIII Activity
p1077
(dp1078
g13
g14
sg15
V/categories/DBCAT004437
p1079
ssVGanciclovir
p1080
(dp1081
g13
g14
sg15
V/categories/DBCAT004762
p1082
ssVGlucocorticoids
p1083
(dp1084
g13
g14
sg15
V/categories/DBCAT000557
p1085
ssVPhosphate Binder
p1086
(dp1087
g13
g14
sg15
V/categories/DBCAT003309
p1088
ssVGaucher Disease
p1089
(dp1090
g13
g14
sg15
V/categories/DBCAT000146
p1091
ssS'Dimenhydrinate/Cinnarizine'
p1092
(dp1093
g13
g25
sg15
S'0406000AC'
p1094
ssVCD22-directed Immunoconjugate
p1095
(dp1096
g13
g14
sg15
V/categories/DBCAT003836
p1097
ssS'Brigatinib'
p1098
(dp1099
g13
g25
sg15
S'0801050CP'
p1100
ssS'Emtricitabine & Tenofovir Alafenamide'
p1101
(dp1102
g13
g25
sg15
S'0503010AM'
p1103
ssS'Chlorphenesin'
p1104
(dp1105
g13
g25
sg15
S'1310020G0'
p1106
ssVDrug Carriers
p1107
(dp1108
g13
g14
sg15
V/categories/DBCAT000064
p1109
ssS'Nitrofurantoin'
p1110
(dp1111
g13
g25
sg15
S'0501130R0'
p1112
ssS'Ethanol'
p1113
(dp1114
g13
g14
sg15
V/categories/DBCAT000273
p1115
ssVPolymers
p1116
(dp1117
g13
g14
sg15
V/categories/DBCAT000805
p1118
ssVSalt Solutions
p1119
(dp1120
g13
g14
sg15
V/categories/DBCAT002528
p1121
ssVOnium Compounds
p1122
(dp1123
g13
g14
sg15
V/categories/DBCAT000267
p1124
ssVPhosphoramides
p1125
(dp1126
g13
g14
sg15
V/categories/DBCAT000952
p1127
ssVLactams
p1128
(dp1129
g13
g14
sg15
V/categories/DBCAT000570
p1130
ssVMethylphenidate and isomer
p1131
(dp1132
g13
g14
sg15
V/categories/DBCAT004580
p1133
ssS'Palonosetron Hydrochloride'
p1134
(dp1135
g13
g25
sg15
S'0406000AB'
p1136
ssVCyclohexanols
p1137
(dp1138
g13
g14
sg15
V/categories/DBCAT000474
p1139
ssS'Midostaurin'
p1140
(dp1141
g13
g25
sg15
S'0801050CK'
p1142
ssVCytochrome P-450 CYP3A Inducers (strong)
p1143
(dp1144
g13
g14
sg15
V/categories/DBCAT003816
p1145
ssS'Domiphen Bromide'
p1146
(dp1147
g13
g25
sg15
S'1203030H0'
p1148
ssS'Pegaspargase'
p1149
(dp1150
g13
g25
sg15
S'0801050BA'
p1151
ssS'Benznidazole'
p1152
(dp1153
g13
g25
sg15
S'0504060B0'
p1154
ssVPolyethylene Glycols
p1155
(dp1156
g13
g14
sg15
V/categories/DBCAT001605
p1157
ssVEndodeoxyribonucleases
p1158
(dp1159
g13
g14
sg15
V/categories/DBCAT002871
p1160
ssVAntimycobacterials
p1161
(dp1162
g13
g14
sg15
V/categories/DBCAT002244
p1163
ssS'Zinc Oxide'
p1164
(dp1165
g13
g25
sg15
S'0107010Z0'
p1166
ssVAngiotensin II receptor blockers (ARBs), plain
p1167
(dp1168
g13
g14
sg15
V/categories/DBCAT004594
p1169
ssVCell Death Inducer
p1170
(dp1171
g13
g14
sg15
V/categories/DBCAT003452
p1172
ssS'Flucytosine'
p1173
(dp1174
g13
g25
sg15
S'0502050A0'
p1175
ssS'Benethamine Penicillin/Benzylpenicillin'
p1176
(dp1177
g13
g25
sg15
S'0501011W0'
p1178
ssVAmrinone
p1179
(dp1180
g13
g14
sg15
V/categories/DBCAT000587
p1181
ssVEpidermal Growth Factor Receptor Antagonist
p1182
(dp1183
g13
g14
sg15
V/categories/DBCAT003244
p1184
ssS'Rosiglitazone'
p1185
(dp1186
g13
g25
sg15
S'0601023S0'
p1187
ssS'Mepyramine Maleate'
p1188
(dp1189
g13
g25
sg15
S'0304010R0'
p1190
ssVImmunomodulatory Agents
p1191
(dp1192
g13
g14
sg15
V/categories/DBCAT003615
p1193
ssS'Loxapine Succinate'
p1194
(dp1195
g13
g25
sg15
S'0402010M0'
p1196
ssVProstaglandin Antagonists
p1197
(dp1198
g13
g14
sg15
V/categories/DBCAT001397
p1199
ssVCalcium Homeostasis
p1200
(dp1201
g13
g14
sg15
V/categories/DBCAT002102
p1202
ssVBlood Viscosity Reducer
p1203
(dp1204
g13
g14
sg15
V/categories/DBCAT003405
p1205
ssVFibrin Modulating Agents
p1206
(dp1207
g13
g14
sg15
V/categories/DBCAT000011
p1208
ssS'Ingenol Mebutate'
p1209
(dp1210
g13
g25
sg15
S'1308010Z0'
p1211
ssVLuteolytic Agents
p1212
(dp1213
g13
g14
sg15
V/categories/DBCAT001156
p1214
ssVCD52-directed Cytolytic Antibody
p1215
(dp1216
g13
g14
sg15
V/categories/DBCAT003274
p1217
ssVAlkanesulfonates
p1218
(dp1219
g13
g14
sg15
V/categories/DBCAT000889
p1220
ssVIncreased T Lymphocyte Destruction
p1221
(dp1222
g13
g14
sg15
V/categories/DBCAT004394
p1223
ssVHydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
p1224
(dp1225
g13
g14
sg15
V/categories/DBCAT003279
p1226
ssVLoxapine
p1227
(dp1228
g13
g14
sg15
V/categories/DBCAT000960
p1229
ssVCytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index
p1230
(dp1231
g13
g14
sg15
V/categories/DBCAT004032
p1232
ssVDiet, Food, and Nutrition
p1233
(dp1234
g13
g14
sg15
V/categories/DBCAT000234
p1235
ssVXanthines and Adrenergics
p1236
(dp1237
g13
g14
sg15
V/categories/DBCAT002274
p1238
ssS'Metronidazole'
p1239
(dp1240
g13
g25
sg15
S'0501110C0'
p1241
ssVAntipsoriatics for Topical Use
p1242
(dp1243
g13
g14
sg15
V/categories/DBCAT002153
p1244
ssS'Halcinonide'
p1245
(dp1246
g13
g25
sg15
S'1304000U0'
p1247
ssS'Hydroxyzine Hydrochloride'
p1248
(dp1249
g13
g25
sg15
S'0304010J0'
p1250
ssVHemostatics
p1251
(dp1252
g13
g14
sg15
V/categories/DBCAT000115
p1253
ssVCytochrome P-450 CYP3A4 Inducers (strong)
p1254
(dp1255
g13
g14
sg15
V/categories/DBCAT002649
p1256
ssVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p1257
(dp1258
g13
g14
sg15
V/categories/DBCAT004479
p1259
ssS'Ipratropium Bromide'
p1260
(dp1261
g13
g25
sg15
S'0301020I0'
p1262
ssS'Rasagiline Mesilate'
p1263
(dp1264
g13
g25
sg15
S'0409010Y0'
p1265
ssS'Etanercept'
p1266
(dp1267
g13
g25
sg15
S'1001030D0'
p1268
ssVIncreased Myeloid Cell Production
p1269
(dp1270
g13
g14
sg15
V/categories/DBCAT004143
p1271
ssVMedicated Shampoos
p1272
(dp1273
g13
g14
sg15
V/categories/DBCAT002574
p1274
ssS'Trifluridine/Tipiracil'
p1275
(dp1276
g13
g25
sg15
S'0801030AF'
p1277
ssS'Benzathine Penicillin'
p1278
(dp1279
g13
g25
sg15
S'0501011F0'
p1280
ssS'Hydromorphone Hydrochloride'
p1281
(dp1282
g13
g25
sg15
S'040702050'
p1283
ssVIncreased Medullary Respiratory Drive
p1284
(dp1285
g13
g14
sg15
V/categories/DBCAT004082
p1286
ssVIon Exchange Resins
p1287
(dp1288
g13
g14
sg15
V/categories/DBCAT000810
p1289
ssVAniline Compounds
p1290
(dp1291
g13
g14
sg15
V/categories/DBCAT000637
p1292
ssVAntimetabolites, Antineoplastic
p1293
(dp1294
g13
g14
sg15
V/categories/DBCAT000685
p1295
ssVLignans
p1296
(dp1297
g13
g14
sg15
V/categories/DBCAT000416
p1298
ssVDecreased Central Nervous System Disorganized Electrical Activity
p1299
(dp1300
g13
g14
sg15
V/categories/DBCAT004152
p1301
ssVNatural Opium Alkaloids
p1302
(dp1303
g13
g14
sg15
V/categories/DBCAT002292
p1304
ssVIsotopes
p1305
(dp1306
g13
g14
sg15
V/categories/DBCAT002980
p1307
ssVMATE 1 Substrates
p1308
(dp1309
g13
g14
sg15
V/categories/DBCAT003951
p1310
ssS'Ceftazidime'
p1311
(dp1312
g13
g25
sg15
S'1103010A0'
p1313
ssVOxazolidinones
p1314
(dp1315
g13
g14
sg15
V/categories/DBCAT000625
p1316
ssVMiscellaneous GI Drugs
p1317
(dp1318
g13
g14
sg15
V/categories/DBCAT003746
p1319
ssVCell-mediated Immunity
p1320
(dp1321
g13
g14
sg15
V/categories/DBCAT004059
p1322
ssVSelective Immunosuppressants
p1323
(dp1324
g13
g14
sg15
V/categories/DBCAT002129
p1325
ssS'Dimethyl Sulfoxide'
p1326
(dp1327
g13
g14
sg15
V/categories/DBCAT004769
p1328
ssVInflammation Mediators
p1329
(dp1330
g13
g14
sg15
V/categories/DBCAT000352
p1331
ssS'Cidofovir'
p1332
(dp1333
g13
g25
sg15
S'0503022C0'
p1334
ssVAgents used to treat hypothyroidism
p1335
(dp1336
g13
g14
sg15
V/categories/DBCAT004965
p1337
ssVVasodilating Agents
p1338
(dp1339
g13
g14
sg15
V/categories/DBCAT003676
p1340
ssVLiposomes
p1341
(dp1342
g13
g14
sg15
V/categories/DBCAT001064
p1343
ssVDigoxin, antagonists & inhibitors
p1344
(dp1345
g13
g14
sg15
V/categories/DBCAT004735
p1346
ssVAntiseptics and Disinfectants
p1347
(dp1348
g13
g14
sg15
V/categories/DBCAT002319
p1349
ssVRifamycin Antimycobacterial
p1350
(dp1351
g13
g14
sg15
V/categories/DBCAT003383
p1352
ssVAlimentary Tract and Metabolism
p1353
(dp1354
g13
g14
sg15
V/categories/DBCAT002118
p1355
ssS'Tafluprost'
p1356
(dp1357
g13
g25
sg15
S'1106000AK'
p1358
ssVQuinolones
p1359
(dp1360
g13
g14
sg15
V/categories/DBCAT000903
p1361
ssVUGT1A9 Substrates
p1362
(dp1363
g13
g14
sg15
V/categories/DBCAT003966
p1364
ssS'Trabectedin'
p1365
(dp1366
g13
g25
sg15
S'0801050AV'
p1367
ssVGranulocyte Colony-Stimulating Factor
p1368
(dp1369
g13
g14
sg15
V/categories/DBCAT000207
p1370
ssS'Dabrafenib'
p1371
(dp1372
g13
g25
sg15
S'0802040AI'
p1373
ssVPlant Oils
p1374
(dp1375
g13
g14
sg15
V/categories/DBCAT001209
p1376
ssVEnzyme Preparations
p1377
(dp1378
g13
g14
sg15
V/categories/DBCAT003135
p1379
ssVPituitary Hormones, Anterior
p1380
(dp1381
g13
g14
sg15
V/categories/DBCAT000095
p1382
ssS'Fludroxycortide'
p1383
(dp1384
g13
g25
sg15
S'1304000T0'
p1385
ssVCytochrome P450 1A Inducers
p1386
(dp1387
g13
g14
sg15
V/categories/DBCAT004391
p1388
ssVCytochrome P-450 CYP2C8 Inhibitors (weak)
p1389
(dp1390
g13
g14
sg15
V/categories/DBCAT003042
p1391
ssVAntirheumatic Agents
p1392
(dp1393
g13
g14
sg15
V/categories/DBCAT000045
p1394
ssVOrganic Acids
p1395
(dp1396
g13
g14
sg15
V/categories/DBCAT002544
p1397
ssVHormone Antagonists
p1398
(dp1399
g13
g14
sg15
V/categories/DBCAT000144
p1400
ssS'Vigabatrin'
p1401
(dp1402
g13
g25
sg15
S'0408010X0'
p1403
ssVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p1404
(dp1405
g13
g14
sg15
V/categories/DBCAT000887
p1406
ssVMATE 2 Substrates with a Narrow Therapeutic Index
p1407
(dp1408
g13
g14
sg15
V/categories/DBCAT004526
p1409
ssVTriamcinolone
p1410
(dp1411
g13
g14
sg15
V/categories/DBCAT001008
p1412
ssS'Levorphanol Tartrate'
p1413
(dp1414
g13
g25
sg15
S'0407020J0'
p1415
ssVAnticholinergic Agents
p1416
(dp1417
g13
g14
sg15
V/categories/DBCAT000533
p1418
ssVHydralazine
p1419
(dp1420
g13
g14
sg15
V/categories/DBCAT002851
p1421
ssVBCRP/ABCG2 Inducers
p1422
(dp1423
g13
g14
sg15
V/categories/DBCAT003986
p1424
ssS'Perphenazine'
p1425
(dp1426
g13
g25
sg15
S'0402010Q0'
p1427
ssVKinase Inhibitor
p1428
(dp1429
g13
g14
sg15
V/categories/DBCAT003325
p1430
ssVErgolines
p1431
(dp1432
g13
g14
sg15
V/categories/DBCAT000605
p1433
ssS'Methadone Hydrochloride'
p1434
(dp1435
g13
g25
sg15
S'0407020M0'
p1436
ssVBotulinum Toxins, Type A
p1437
(dp1438
g13
g14
sg15
V/categories/DBCAT004699
p1439
ssVAnesthetics, General
p1440
(dp1441
g13
g14
sg15
V/categories/DBCAT000563
p1442
ssVMilnacipran
p1443
(dp1444
g13
g14
sg15
V/categories/DBCAT005019
p1445
ssVSelective T Cell Costimulation Blocker
p1446
(dp1447
g13
g14
sg15
V/categories/DBCAT003474
p1448
ssVDrugs Used in Addictive Disorders
p1449
(dp1450
g13
g14
sg15
V/categories/DBCAT002183
p1451
ssS'Sodium Cromoglicate'
p1452
(dp1453
g13
g25
sg15
S'1202010P0'
p1454
ssVRenal Agents
p1455
(dp1456
g13
g14
sg15
V/categories/DBCAT000629
p1457
ssVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p1458
(dp1459
g13
g14
sg15
V/categories/DBCAT004498
p1460
ssS'Warfarin Sodium'
p1461
(dp1462
g13
g25
sg15
S'0208020V0'
p1463
ssS'Emedastine'
p1464
(dp1465
g13
g25
sg15
S'1104020X0'
p1466
ssVSelective Calcium Channel Blockers With Direct Cardiac Effects
p1467
(dp1468
g13
g14
sg15
V/categories/DBCAT002327
p1469
ssS'Dienogest'
p1470
(dp1471
g13
g25
sg15
S'0604012W0'
p1472
ssS'Axitinib'
p1473
(dp1474
g13
g25
sg15
S'0801050BJ'
p1475
ssVBiphenyl Compounds
p1476
(dp1477
g13
g14
sg15
V/categories/DBCAT001053
p1478
ssVThiocarbamates
p1479
(dp1480
g13
g14
sg15
V/categories/DBCAT000949
p1481
ssS'Cytomegalovirus Immunoglobulin'
p1482
(dp1483
g13
g25
sg15
S'1405000M0'
p1484
ssVParathyroid Hormones and Analogues
p1485
(dp1486
g13
g14
sg15
V/categories/DBCAT002565
p1487
ssVEnzyme Inducing Antiepileptic Drugs
p1488
(dp1489
g13
g14
sg15
V/categories/DBCAT003860
p1490
ssS'Lidocaine'
p1491
(dp1492
g13
g25
sg15
S'1303000N0'
p1493
ssVHydrazides
p1494
(dp1495
g13
g14
sg15
V/categories/DBCAT002487
p1496
ssVThiomalates
p1497
(dp1498
g13
g14
sg15
V/categories/DBCAT001972
p1499
ssVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p1500
(dp1501
g13
g14
sg15
V/categories/DBCAT004484
p1502
ssS'Posaconazole'
p1503
(dp1504
g13
g25
sg15
S'0502010A0'
p1505
ssVBiguanides
p1506
(dp1507
g13
g14
sg15
V/categories/DBCAT000761
p1508
ssVAcrylates
p1509
(dp1510
g13
g14
sg15
V/categories/DBCAT001443
p1511
ssVGlyoxylates
p1512
(dp1513
g13
g14
sg15
V/categories/DBCAT001559
p1514
ssVSelenium Compounds
p1515
(dp1516
g13
g14
sg15
V/categories/DBCAT002602
p1517
ssVAnti-Infective Agents, Urinary
p1518
(dp1519
g13
g14
sg15
V/categories/DBCAT000631
p1520
ssVHydroxymethylglutaryl-CoA Reductase Inhibitors
p1521
(dp1522
g13
g14
sg15
V/categories/DBCAT000391
p1523
ssVIsobutyrates
p1524
(dp1525
g13
g14
sg15
V/categories/DBCAT001019
p1526
ssS'Abacavir'
p1527
(dp1528
g13
g25
sg15
S'0503010E0'
p1529
ssVGlucosylceramide Synthase Inhibitor
p1530
(dp1531
g13
g14
sg15
V/categories/DBCAT003346
p1532
ssVSulfuric Acids
p1533
(dp1534
g13
g14
sg15
V/categories/DBCAT001037
p1535
ssVVesicular Monoamine Transporter 2 Inhibitors
p1536
(dp1537
g13
g14
sg15
V/categories/DBCAT004435
p1538
ssS'Azithromycin'
p1539
(dp1540
g13
g25
sg15
S'0501050A0'
p1541
ssVStereoisomerism
p1542
(dp1543
g13
g14
sg15
V/categories/DBCAT001189
p1544
ssVAgents Acting on the Renin-Angiotensin System
p1545
(dp1546
g13
g14
sg15
V/categories/DBCAT002171
p1547
ssS'Bisoprolol Fumarate'
p1548
(dp1549
g13
g25
sg15
S'0204000H0'
p1550
ssVIntercellular Signaling Peptides and Proteins
p1551
(dp1552
g13
g14
sg15
V/categories/DBCAT000080
p1553
ssVLow-Ceiling Diuretics and Potassium-Sparing Agents
p1554
(dp1555
g13
g14
sg15
V/categories/DBCAT002300
p1556
ssVMiscellaneous Antiretrovirals*
p1557
(dp1558
g13
g14
sg15
V/categories/DBCAT003994
p1559
ssVAcids, Acyclic
p1560
(dp1561
g13
g14
sg15
V/categories/DBCAT000328
p1562
ssS'Pertuzumab'
p1563
(dp1564
g13
g25
sg15
S'0801050BK'
p1565
ssVCytochrome P-450 CYP2C19 Inducers
p1566
(dp1567
g13
g14
sg15
V/categories/DBCAT001246
p1568
ssVMethemoglobinemia Associated Agents
p1569
(dp1570
g13
g14
sg15
V/categories/DBCAT002719
p1571
ssVAnti-Parkinson Agents (Dopamine Agonist)
p1572
(dp1573
g13
g14
sg15
V/categories/DBCAT002867
p1574
ssVOcular Vascular Disorder Agents
p1575
(dp1576
g13
g14
sg15
V/categories/DBCAT002390
p1577
ssS'Sodium Salicylate'
p1578
(dp1579
g13
g25
sg15
S'1001010W0'
p1580
ssS'Phytomenadione'
p1581
(dp1582
g13
g25
sg15
S'0906060Q0'
p1583
ssVCytochrome P-450 CYP3A7 Inducers (weak)
p1584
(dp1585
g13
g14
sg15
V/categories/DBCAT004501
p1586
ssValpha-Hydroxy Acid
p1587
(dp1588
g13
g14
sg15
V/categories/DBCAT003478
p1589
ssVBlood and Related Products
p1590
(dp1591
g13
g14
sg15
V/categories/DBCAT002592
p1592
ssVMiscellaneous Cardiac Drugs
p1593
(dp1594
g13
g14
sg15
V/categories/DBCAT003708
p1595
ssVCTLA-4-directed Blocking Antibody
p1596
(dp1597
g13
g14
sg15
V/categories/DBCAT003464
p1598
ssS'Imiquimod'
p1599
(dp1600
g13
g25
sg15
S'1307000V0'
p1601
ssVAntihypertensives for Pulmonary Arterial Hypertension
p1602
(dp1603
g13
g14
sg15
V/categories/DBCAT002410
p1604
ssS'Diethylpropion Hydrochloride'
p1605
(dp1606
g13
g25
sg15
S'0405020E0'
p1607
ssVFormyltetrahydrofolates
p1608
(dp1609
g13
g14
sg15
V/categories/DBCAT004981
p1610
ssS'Isotretinoin'
p1611
(dp1612
g13
g25
sg15
S'1306010M0'
p1613
ssS'Triamcinolone Hexacetonide'
p1614
(dp1615
g13
g25
sg15
S'1001022Y0'
p1616
ssVClass IV Antiarrythmics
p1617
(dp1618
g13
g14
sg15
V/categories/DBCAT003978
p1619
ssVFluorides
p1620
(dp1621
g13
g14
sg15
V/categories/DBCAT001983
p1622
ssVParenteral Nutrition Solutions
p1623
(dp1624
g13
g14
sg15
V/categories/DBCAT001774
p1625
ssS'Solifenacin'
p1626
(dp1627
g13
g25
sg15
S'0704020AB'
p1628
ssS'Sodium Tetradecyl Sulphate'
p1629
(dp1630
g13
g25
sg15
S'0213000T0'
p1631
ssVBotulinum Toxins
p1632
(dp1633
g13
g14
sg15
V/categories/DBCAT000183
p1634
ssS'Dopamine Hydrochloride'
p1635
(dp1636
g13
g25
sg15
S'0207010F0'
p1637
ssVHydroxylamines
p1638
(dp1639
g13
g14
sg15
V/categories/DBCAT000393
p1640
ssVUric Acid-specific Enzyme
p1641
(dp1642
g13
g14
sg15
V/categories/DBCAT003259
p1643
ssVRenin-Inhibitors
p1644
(dp1645
g13
g14
sg15
V/categories/DBCAT002219
p1646
ssVGlycosaminoglycans
p1647
(dp1648
g13
g14
sg15
V/categories/DBCAT001272
p1649
ssS'Bicalutamide'
p1650
(dp1651
g13
g25
sg15
S'0803042A0'
p1652
ssVAlpha-and Beta-adrenergic Agonists
p1653
(dp1654
g13
g14
sg15
V/categories/DBCAT003674
p1655
ssS'Rifaximin'
p1656
(dp1657
g13
g25
sg15
S'0501070X0'
p1658
ssS'Metformin Hydrochloride/Sitagliptin'
p1659
(dp1660
g13
g25
sg15
S'0601023AD'
p1661
ssVLincosamides
p1662
(dp1663
g13
g14
sg15
V/categories/DBCAT001292
p1664
ssVIncreased Platelet Production
p1665
(dp1666
g13
g14
sg15
V/categories/DBCAT004194
p1667
ssS'Eletriptan'
p1668
(dp1669
g13
g25
sg15
S'0407041AA'
p1670
ssVFibrinolytic Agents
p1671
(dp1672
g13
g14
sg15
V/categories/DBCAT000013
p1673
ssS'Fluorouracil/Glucose'
p1674
(dp1675
g13
g25
sg15
S'0801030J0'
p1676
ssVAmiodarone
p1677
(dp1678
g13
g14
sg15
V/categories/DBCAT005004
p1679
ssVLyases
p1680
(dp1681
g13
g14
sg15
V/categories/DBCAT000169
p1682
ssS'Dabigatran Etexilate'
p1683
(dp1684
g13
g25
sg15
S'0208020X0'
p1685
ssS'Temoporfin'
p1686
(dp1687
g13
g25
sg15
S'0801050AK'
p1688
ssVCaffeine and Caffeine Containing Products
p1689
(dp1690
g13
g14
sg15
V/categories/DBCAT002675
p1691
ssVAnalgesics
p1692
(dp1693
g13
g14
sg15
V/categories/DBCAT000041
p1694
ssVSodium Potassium Chloride Symporter Inhibitors
p1695
(dp1696
g13
g14
sg15
V/categories/DBCAT000543
p1697
ssVGuanylate Cyclase-C Agonist
p1698
(dp1699
g13
g14
sg15
V/categories/DBCAT003498
p1700
ssVCardiovascular Agents
p1701
(dp1702
g13
g14
sg15
V/categories/DBCAT000010
p1703
ssS'Rizatriptan'
p1704
(dp1705
g13
g25
sg15
S'0407041R0'
p1706
ssS'Droperidol'
p1707
(dp1708
g13
g25
sg15
S'0402010G0'
p1709
ssVFactor VIII Activator
p1710
(dp1711
g13
g14
sg15
V/categories/DBCAT003252
p1712
ssVNucleoside Analog Antifungal
p1713
(dp1714
g13
g14
sg15
V/categories/DBCAT003428
p1715
ssVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p1716
(dp1717
g13
g14
sg15
V/categories/DBCAT004030
p1718
ssS'Levobunolol Hydrochloride'
p1719
(dp1720
g13
g25
sg15
S'1106000T0'
p1721
ssVOripavine Derivatives
p1722
(dp1723
g13
g14
sg15
V/categories/DBCAT002486
p1724
ssVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p1725
(dp1726
g13
g14
sg15
V/categories/DBCAT004493
p1727
ssV4-Quinolones
p1728
(dp1729
g13
g14
sg15
V/categories/DBCAT001093
p1730
ssVPenem Antibacterial
p1731
(dp1732
g13
g14
sg15
V/categories/DBCAT003321
p1733
ssVFood Ingredients
p1734
(dp1735
g13
g14
sg15
V/categories/DBCAT004977
p1736
ssS'Ipilimumab'
p1737
(dp1738
g13
g25
sg15
S'0801050BC'
p1739
ssVBasic Lotions and Liniments
p1740
(dp1741
g13
g14
sg15
V/categories/DBCAT003726
p1742
ssVNeuraminic Acids
p1743
(dp1744
g13
g14
sg15
V/categories/DBCAT000970
p1745
ssS'Amifostine'
p1746
(dp1747
g13
g25
sg15
S'0801000V0'
p1748
ssVTests for Diabetes
p1749
(dp1750
g13
g14
sg15
V/categories/DBCAT002510
p1751
ssVAluminum and magnesium containing antacids
p1752
(dp1753
g13
g14
sg15
V/categories/DBCAT004681
p1754
ssVBenzodiazepine Antagonist
p1755
(dp1756
g13
g14
sg15
V/categories/DBCAT003432
p1757
ssVJanus Kinases, antagonists & inhibitors
p1758
(dp1759
g13
g14
sg15
V/categories/DBCAT001908
p1760
ssS'Gentamicin Sulfate'
p1761
(dp1762
g13
g25
sg15
S'1310012I0'
p1763
ssVMonoamine Oxidase B Inhibitors
p1764
(dp1765
g13
g14
sg15
V/categories/DBCAT002494
p1766
ssS'Amiloride Hydrochloride'
p1767
(dp1768
g13
g25
sg15
S'0202030C0'
p1769
ssS'Benzocaine'
p1770
(dp1771
g13
g14
sg15
V/categories/DBCAT004767
p1772
ssVEstradiol, agonists
p1773
(dp1774
g13
g14
sg15
V/categories/DBCAT004753
p1775
ssS'Glucagon'
p1776
(dp1777
g13
g14
sg15
V/categories/DBCAT004689
p1778
ssVAndrogen Receptor Antagonists
p1779
(dp1780
g13
g14
sg15
V/categories/DBCAT004226
p1781
ssS'Neomycin Sulfate'
p1782
(dp1783
g13
g25
sg15
S'1202010N0'
p1784
ssS'Tegafur/Gimeracil/Oteracil'
p1785
(dp1786
g13
g25
sg15
S'0801030AD'
p1787
ssVEthers, Chemically Close to Antihistamines
p1788
(dp1789
g13
g14
sg15
V/categories/DBCAT002516
p1790
ssS'Tretinoin'
p1791
(dp1792
g13
g14
sg15
V/categories/DBCAT004751
p1793
ssVAmino Acids, Cyclic
p1794
(dp1795
g13
g14
sg15
V/categories/DBCAT000244
p1796
ssVShort-Acting Sulfonamides
p1797
(dp1798
g13
g14
sg15
V/categories/DBCAT002262
p1799
ssS'Fluorometholone'
p1800
(dp1801
g13
g25
sg15
S'1104010K0'
p1802
ssS'Tiotropium'
p1803
(dp1804
g13
g25
sg15
S'0301020Q0'
p1805
ssVAntiinflammatory Products for Vaginal Administration
p1806
(dp1807
g13
g14
sg15
V/categories/DBCAT002467
p1808
ssS'Oxycodone HCl/Naloxone HCl'
p1809
(dp1810
g13
g25
sg15
S'0407020AF'
p1811
ssS'Zinc Acetate'
p1812
(dp1813
g13
g25
sg15
S'0908010AJ'
p1814
ssVSubstance P/Neurokinin-1 Receptor Antagonist
p1815
(dp1816
g13
g14
sg15
V/categories/DBCAT003389
p1817
ssVEstradiol
p1818
(dp1819
g13
g14
sg15
V/categories/DBCAT001293
p1820
ssVBile Therapy
p1821
(dp1822
g13
g14
sg15
V/categories/DBCAT002535
p1823
ssVCytochrome P-450 CYP3A5 Inhibitors (weak)
p1824
(dp1825
g13
g14
sg15
V/categories/DBCAT004488
p1826
ssVEthers
p1827
(dp1828
g13
g14
sg15
V/categories/DBCAT000562
p1829
ssVCytochrome P-450 CYP2E1 Inducers
p1830
(dp1831
g13
g14
sg15
V/categories/DBCAT002632
p1832
ssVAppetite Depressants
p1833
(dp1834
g13
g14
sg15
V/categories/DBCAT000473
p1835
ssVSalicylates
p1836
(dp1837
g13
g14
sg15
V/categories/DBCAT000579
p1838
ssVReplacement Preparations
p1839
(dp1840
g13
g14
sg15
V/categories/DBCAT003709
p1841
ssS'Magaldrate'
p1842
(dp1843
g13
g25
sg15
S'0101010M0'
p1844
ssVDiagnostic Dye
p1845
(dp1846
g13
g14
sg15
V/categories/DBCAT003392
p1847
ssVFatty Acids, Monounsaturated
p1848
(dp1849
g13
g14
sg15
V/categories/DBCAT001122
p1850
ssVOxides
p1851
(dp1852
g13
g14
sg15
V/categories/DBCAT000860
p1853
ssVDetergents
p1854
(dp1855
g13
g14
sg15
V/categories/DBCAT001419
p1856
ssS'Nisoldipine'
p1857
(dp1858
g13
g25
sg15
S'0206020W0'
p1859
ssVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p1860
(dp1861
g13
g14
sg15
V/categories/DBCAT002611
p1862
ssS'Famciclovir'
p1863
(dp1864
g13
g25
sg15
S'0503021E0'
p1865
ssS'Rasburicase'
p1866
(dp1867
g13
g25
sg15
S'1001040U0'
p1868
ssS'Levetiracetam'
p1869
(dp1870
g13
g25
sg15
S'0408010A0'
p1871
ssS'Amoxicillin'
p1872
(dp1873
g13
g25
sg15
S'0501013B0'
p1874
ssS'Sodium Thiosulfate'
p1875
(dp1876
g13
g25
sg15
S'1902070S0'
p1877
ssVPenicillamine and Similar Agents
p1878
(dp1879
g13
g14
sg15
V/categories/DBCAT002475
p1880
ssS'Ranolazine'
p1881
(dp1882
g13
g25
sg15
S'0206030Z0'
p1883
ssVChlorides
p1884
(dp1885
g13
g14
sg15
V/categories/DBCAT001114
p1886
ssVAnabolic Steroids
p1887
(dp1888
g13
g14
sg15
V/categories/DBCAT002427
p1889
ssS'Rivastigmine'
p1890
(dp1891
g13
g25
sg15
S'0411000E0'
p1892
ssVPyrethrins
p1893
(dp1894
g13
g14
sg15
V/categories/DBCAT001640
p1895
ssVProstaglandins, Synthetic
p1896
(dp1897
g13
g14
sg15
V/categories/DBCAT000677
p1898
ssS'Voriconazole'
p1899
(dp1900
g13
g25
sg15
S'0502010D0'
p1901
ssVCytochrome P-450 CYP3A7 Inducers (moderate)
p1902
(dp1903
g13
g14
sg15
V/categories/DBCAT003899
p1904
ssVCytochrome P-450 Enzyme Inducers
p1905
(dp1906
g13
g14
sg15
V/categories/DBCAT000491
p1907
ssS'Paroxetine Hydrochloride'
p1908
(dp1909
g13
g25
sg15
S'0403030P0'
p1910
ssS'Loperamide Hydrochloride'
p1911
(dp1912
g13
g25
sg15
S'0104020L0'
p1913
ssS'Ketorolac Trometamol'
p1914
(dp1915
g13
g25
sg15
S'110802070'
p1916
ssS'Alitretinoin'
p1917
(dp1918
g13
g25
sg15
S'0801050Z0'
p1919
ssS'Tofacitinib'
p1920
(dp1921
g13
g25
sg15
S'1001030AB'
p1922
ssVPro-Opiomelanocortin
p1923
(dp1924
g13
g14
sg15
V/categories/DBCAT001333
p1925
ssVSuccinimides
p1926
(dp1927
g13
g14
sg15
V/categories/DBCAT000987
p1928
ssVCD52-directed Antibody Interactions
p1929
(dp1930
g13
g14
sg15
V/categories/DBCAT004258
p1931
ssVIonophores
p1932
(dp1933
g13
g14
sg15
V/categories/DBCAT001029
p1934
ssVOATP1B3 substrates
p1935
(dp1936
g13
g14
sg15
V/categories/DBCAT004563
p1937
ssS'Flumazenil'
p1938
(dp1939
g13
g25
sg15
S'1501070F0'
p1940
ssS'Furosemide'
p1941
(dp1942
g13
g25
sg15
S'0202020L0'
p1943
ssVUGT2B7 substrates
p1944
(dp1945
g13
g14
sg15
V/categories/DBCAT004610
p1946
ssS'Cilostazol'
p1947
(dp1948
g13
g25
sg15
S'0206040X0'
p1949
ssVCholinergic Agents
p1950
(dp1951
g13
g14
sg15
V/categories/DBCAT000126
p1952
ssVMeglitinides
p1953
(dp1954
g13
g14
sg15
V/categories/DBCAT003738
p1955
ssVPhenylurea Compounds
p1956
(dp1957
g13
g14
sg15
V/categories/DBCAT001627
p1958
ssVPregnenes
p1959
(dp1960
g13
g14
sg15
V/categories/DBCAT000828
p1961
ssVArylsulfatases
p1962
(dp1963
g13
g14
sg15
V/categories/DBCAT002905
p1964
ssVLincosamide Antibacterial
p1965
(dp1966
g13
g14
sg15
V/categories/DBCAT003431
p1967
ssVBornanes
p1968
(dp1969
g13
g14
sg15
V/categories/DBCAT001420
p1970
ssVOther Miscellaneous Therapeutic Agents
p1971
(dp1972
g13
g14
sg15
V/categories/DBCAT003610
p1973
ssVGold Preparations
p1974
(dp1975
g13
g14
sg15
V/categories/DBCAT002492
p1976
ssVOpiate Partial Agonists
p1977
(dp1978
g13
g14
sg15
V/categories/DBCAT003704
p1979
ssS'Risedronate Sodium'
p1980
(dp1981
g13
g25
sg15
S'0606020R0'
p1982
ssVMycobacterium tuberculosis
p1983
(dp1984
g13
g14
sg15
V/categories/DBCAT001913
p1985
ssVAcetic Acid Derivatives and Related Substances
p1986
(dp1987
g13
g14
sg15
V/categories/DBCAT002310
p1988
ssVXanthine derivatives
p1989
(dp1990
g13
g14
sg15
V/categories/DBCAT001034
p1991
ssVOsmotic Activity
p1992
(dp1993
g13
g14
sg15
V/categories/DBCAT004090
p1994
ssVCytochrome P-450 CYP2C9 Inhibitors (strong)
p1995
(dp1996
g13
g14
sg15
V/categories/DBCAT002635
p1997
ssVAndrogens and Estrogens
p1998
(dp1999
g13
g14
sg15
V/categories/DBCAT002429
p2000
ssVCaloric Agents
p2001
(dp2002
g13
g14
sg15
V/categories/DBCAT003625
p2003
ssVSuccinimide Derivatives
p2004
(dp2005
g13
g14
sg15
V/categories/DBCAT002417
p2006
ssS'Leuprorelin Acetate'
p2007
(dp2008
g13
g25
sg15
S'0803042N0'
p2009
ssVDrugs Used in Nicotine Dependence
p2010
(dp2011
g13
g14
sg15
V/categories/DBCAT002182
p2012
ssS'Cyclizine Lactate'
p2013
(dp2014
g13
g25
sg15
S'0406000G0'
p2015
ssVHuman Immunoglobulin G
p2016
(dp2017
g13
g14
sg15
V/categories/DBCAT003547
p2018
ssVReverse Transcriptase Inhibitors
p2019
(dp2020
g13
g14
sg15
V/categories/DBCAT000594
p2021
ssVEmollients Demulcents and Protectants
p2022
(dp2023
g13
g14
sg15
V/categories/DBCAT003784
p2024
ssVThyroid Products
p2025
(dp2026
g13
g14
sg15
V/categories/DBCAT002707
p2027
ssVDrugs for Urinary Frequency and Incontinence
p2028
(dp2029
g13
g14
sg15
V/categories/DBCAT002216
p2030
ssVMustard Compounds
p2031
(dp2032
g13
g14
sg15
V/categories/DBCAT000681
p2033
ssS'Dasatinib'
p2034
(dp2035
g13
g25
sg15
S'0801050AN'
p2036
ssVAnion Exchange Resins
p2037
(dp2038
g13
g14
sg15
V/categories/DBCAT000811
p2039
ssVNeoplasm Proteins
p2040
(dp2041
g13
g14
sg15
V/categories/DBCAT000212
p2042
ssS'Exemestane'
p2043
(dp2044
g13
g25
sg15
S'0803041C0'
p2045
ssS'Tetracycline'
p2046
(dp2047
g13
g25
sg15
S'0501030V0'
p2048
ssV17-alpha-Hydroxyprogesterone
p2049
(dp2050
g13
g14
sg15
V/categories/DBCAT005016
p2051
ssVTests for Bile Duct Patency
p2052
(dp2053
g13
g14
sg15
V/categories/DBCAT002361
p2054
ssVCardiac Stimulants Excl. Cardiac Glycosides
p2055
(dp2056
g13
g14
sg15
V/categories/DBCAT002218
p2057
ssS'Aminocaproic Acid'
p2058
(dp2059
g13
g25
sg15
S'0211000B0'
p2060
ssVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p2061
(dp2062
g13
g14
sg15
V/categories/DBCAT003973
p2063
ssVTricyclics and Other Norepinephrine-reuptake Inhibitors
p2064
(dp2065
g13
g14
sg15
V/categories/DBCAT003664
p2066
ssS'Ephedrine HCl/Ipecacuanha'
p2067
(dp2068
g13
g25
sg15
S'0309020AE'
p2069
ssVOCT2 substrates with narrow therapeutic index
p2070
(dp2071
g13
g14
sg15
V/categories/DBCAT004582
p2072
ssVCytochrome P-450 CYP2C9 Substrates
p2073
(dp2074
g13
g14
sg15
V/categories/DBCAT002634
p2075
ssVCarbazoles
p2076
(dp2077
g13
g14
sg15
V/categories/DBCAT001187
p2078
ssS'Pemetrexed'
p2079
(dp2080
g13
g25
sg15
S'0801030Y0'
p2081
ssVFirst Generation Antihistamines
p2082
(dp2083
g13
g14
sg15
V/categories/DBCAT003748
p2084
ssVMutagens
p2085
(dp2086
g13
g14
sg15
V/categories/DBCAT000955
p2087
ssS'Celecoxib'
p2088
(dp2089
g13
g25
sg15
S'1001010AH'
p2090
ssVPregnenediones
p2091
(dp2092
g13
g14
sg15
V/categories/DBCAT000827
p2093
ssS'Ixazomib'
p2094
(dp2095
g13
g25
sg15
S'0801050CC'
p2096
ssVAdrenal Cortex Hormones
p2097
(dp2098
g13
g14
sg15
V/categories/DBCAT000556
p2099
ssVSpiro Compounds
p2100
(dp2101
g13
g14
sg15
V/categories/DBCAT000923
p2102
ssVLanthanum
p2103
(dp2104
g13
g14
sg15
V/categories/DBCAT004830
p2105
ssVAntifungals for Dermatological Use
p2106
(dp2107
g13
g14
sg15
V/categories/DBCAT002197
p2108
ssS'Diclofenac Sodium'
p2109
(dp2110
g13
g25
sg15
S'1003020U0'
p2111
ssS'Cantharidin'
p2112
(dp2113
g13
g25
sg15
S'1003020E0'
p2114
ssS'Encorafenib'
p2115
(dp2116
g13
g25
sg15
S'0801050CM'
p2117
ssS'Agalsidase Beta'
p2118
(dp2119
g13
g25
sg15
S'0908010AE'
p2120
ssVStreptogramins
p2121
(dp2122
g13
g14
sg15
V/categories/DBCAT001412
p2123
ssVPyrrolidinones
p2124
(dp2125
g13
g14
sg15
V/categories/DBCAT000973
p2126
ssS'Etynodiol Diacetate'
p2127
(dp2128
g13
g25
sg15
S'0703021C0'
p2129
ssVDiuretics, Osmotic
p2130
(dp2131
g13
g14
sg15
V/categories/DBCAT001104
p2132
ssS'Levonorgestrel'
p2133
(dp2134
g13
g25
sg15
S'0703023L0'
p2135
ssVHeavy Metal Antagonists
p2136
(dp2137
g13
g14
sg15
V/categories/DBCAT003716
p2138
ssVKeto Acids
p2139
(dp2140
g13
g14
sg15
V/categories/DBCAT000260
p2141
ssS'Ivermectin'
p2142
(dp2143
g13
g25
sg15
S'1306030B0'
p2144
ssVNitroferricyanide Derivatives
p2145
(dp2146
g13
g14
sg15
V/categories/DBCAT002306
p2147
ssVBenzoates
p2148
(dp2149
g13
g14
sg15
V/categories/DBCAT000582
p2150
ssVAngiotensin II Antagonists and Diuretics
p2151
(dp2152
g13
g14
sg15
V/categories/DBCAT002172
p2153
ssVAntibiotics, Antineoplastic
p2154
(dp2155
g13
g14
sg15
V/categories/DBCAT000679
p2156
ssVQuinoline Derivatives and Related Substances
p2157
(dp2158
g13
g14
sg15
V/categories/DBCAT002495
p2159
ssVAntiviral Agents
p2160
(dp2161
g13
g14
sg15
V/categories/DBCAT000066
p2162
ssVPotassium Salt
p2163
(dp2164
g13
g14
sg15
V/categories/DBCAT003554
p2165
ssVSchizophrenia
p2166
(dp2167
g13
g14
sg15
V/categories/DBCAT001645
p2168
ssVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p2169
(dp2170
g13
g14
sg15
V/categories/DBCAT003809
p2171
ssS'Saxagliptin'
p2172
(dp2173
g13
g25
sg15
S'0601023AC'
p2174
ssVCytochrome P-450 CYP1A2 Inhibitors (weak)
p2175
(dp2176
g13
g14
sg15
V/categories/DBCAT002870
p2177
ssVAntivaricose Therapy
p2178
(dp2179
g13
g14
sg15
V/categories/DBCAT002393
p2180
ssVCholelitholytic Agents
p2181
(dp2182
g13
g14
sg15
V/categories/DBCAT003763
p2183
ssVpara-Aminobenzoates
p2184
(dp2185
g13
g14
sg15
V/categories/DBCAT000584
p2186
ssVAmmonium Compounds
p2187
(dp2188
g13
g14
sg15
V/categories/DBCAT000268
p2189
ssVAntiparasitic Products, Insecticides and Repellents
p2190
(dp2191
g13
g14
sg15
V/categories/DBCAT002212
p2192
ssVCyclopropanes
p2193
(dp2194
g13
g14
sg15
V/categories/DBCAT001393
p2195
ssS'Nilotinib'
p2196
(dp2197
g13
g25
sg15
S'0801050AS'
p2198
ssS'Dextromethorphan Hydrobromide'
p2199
(dp2200
g13
g25
sg15
S'0309010L0'
p2201
ssVRecombinant Human Deoxyribonuclease 1
p2202
(dp2203
g13
g14
sg15
V/categories/DBCAT003546
p2204
ssVGlycogenolytic Hormones
p2205
(dp2206
g13
g14
sg15
V/categories/DBCAT002111
p2207
ssVCarbamic Acid Esters
p2208
(dp2209
g13
g14
sg15
V/categories/DBCAT002357
p2210
ssS'Cabozantinib'
p2211
(dp2212
g13
g25
sg15
S'0801050BR'
p2213
ssVAlkenes
p2214
(dp2215
g13
g14
sg15
V/categories/DBCAT000364
p2216
ssVCentral Nervous System Stimulation
p2217
(dp2218
g13
g14
sg15
V/categories/DBCAT004212
p2219
ssVProgrammed Cell Death 1 Receptor
p2220
(dp2221
g13
g14
sg15
V/categories/DBCAT005020
p2222
ssVAromatase Inhibitors
p2223
(dp2224
g13
g14
sg15
V/categories/DBCAT000787
p2225
ssS'Desonide'
p2226
(dp2227
g13
g25
sg15
S'1304000I0'
p2228
ssVPoly(ADP-ribose) Polymerase Inhibitors
p2229
(dp2230
g13
g14
sg15
V/categories/DBCAT001523
p2231
ssVCorticosteroids, Very Potent (Group IV)
p2232
(dp2233
g13
g14
sg15
V/categories/DBCAT002571
p2234
ssVHydrolytic Lysosomal Glycogen-specific Enzyme
p2235
(dp2236
g13
g14
sg15
V/categories/DBCAT003435
p2237
ssVKetosteroids
p2238
(dp2239
g13
g14
sg15
V/categories/DBCAT001041
p2240
ssVTyrosine Kinase Inhibitors
p2241
(dp2242
g13
g14
sg15
V/categories/DBCAT001447
p2243
ssVBenzyl Compounds
p2244
(dp2245
g13
g14
sg15
V/categories/DBCAT000417
p2246
ssVBodily Secretions
p2247
(dp2248
g13
g14
sg15
V/categories/DBCAT001367
p2249
ssS'Tenofovir Alafenamide'
p2250
(dp2251
g13
g25
sg15
S'0503031D0'
p2252
ssS'Insulin Glulisine'
p2253
(dp2254
g13
g25
sg15
S'0601011P0'
p2255
ssS'Tafluprost & Timolol'
p2256
(dp2257
g13
g25
sg15
S'1106000AM'
p2258
ssVMultidrug and Toxin Extrusion Transporter 1 Inhibitors
p2259
(dp2260
g13
g14
sg15
V/categories/DBCAT004367
p2261
ssS'Guanfacine'
p2262
(dp2263
g13
g25
sg15
S'0404000V0'
p2264
ssS'Tiotixene'
p2265
(dp2266
g13
g25
sg15
S'040201020'
p2267
ssVAntivirals for treatment of HCV infections
p2268
(dp2269
g13
g14
sg15
V/categories/DBCAT004597
p2270
ssVCombination Contraceptives (with Estrogen and derivatives)
p2271
(dp2272
g13
g14
sg15
V/categories/DBCAT003872
p2273
ssS'Glecaprevir/Pibrentasvir'
p2274
(dp2275
g13
g25
sg15
S'0503032K0'
p2276
ssS'Neostigmine Bromide'
p2277
(dp2278
g13
g25
sg15
S'1002010M0'
p2279
ssVAmphibian Venoms
p2280
(dp2281
g13
g14
sg15
V/categories/DBCAT001366
p2282
ssS'Carbetocin'
p2283
(dp2284
g13
g25
sg15
S'0701010W0'
p2285
ssS'Nandrolone Decanoate'
p2286
(dp2287
g13
g25
sg15
S'0901030C0'
p2288
ssS'Atomoxetine Hydrochloride'
p2289
(dp2290
g13
g25
sg15
S'0404000S0'
p2291
ssVAntimuscarinics Antispasmodics
p2292
(dp2293
g13
g14
sg15
V/categories/DBCAT003668
p2294
ssVEstrogens, Conjugated (USP)
p2295
(dp2296
g13
g14
sg15
V/categories/DBCAT001131
p2297
ssVNorbornanes
p2298
(dp2299
g13
g14
sg15
V/categories/DBCAT001045
p2300
ssVAzepines
p2301
(dp2302
g13
g14
sg15
V/categories/DBCAT001304
p2303
ssS'Esmolol Hydrochloride'
p2304
(dp2305
g13
g25
sg15
S'020400070'
p2306
ssVProton-pump Inhibitors
p2307
(dp2308
g13
g14
sg15
V/categories/DBCAT003638
p2309
ssVCytochrome P-450 CYP3A7 Inhibitors (weak)
p2310
(dp2311
g13
g14
sg15
V/categories/DBCAT004497
p2312
ssVChondroitin
p2313
(dp2314
g13
g14
sg15
V/categories/DBCAT001976
p2315
ssS'Eluxadoline'
p2316
(dp2317
g13
g25
sg15
S'0102000AK'
p2318
ssVTertiary amine tricyclic antidepressants
p2319
(dp2320
g13
g14
sg15
V/categories/DBCAT004609
p2321
ssVArabinonucleotides
p2322
(dp2323
g13
g14
sg15
V/categories/DBCAT002900
p2324
ssVIncreased Glutathione Concentration
p2325
(dp2326
g13
g14
sg15
V/categories/DBCAT004189
p2327
ssVPancreatic Extracts
p2328
(dp2329
g13
g14
sg15
V/categories/DBCAT000191
p2330
ssVBenzopyrans
p2331
(dp2332
g13
g14
sg15
V/categories/DBCAT000370
p2333
ssV2-Chloroadenosine
p2334
(dp2335
g13
g14
sg15
V/categories/DBCAT000595
p2336
ssVAntiarrhythmics, Class V
p2337
(dp2338
g13
g14
sg15
V/categories/DBCAT003707
p2339
ssVRecombinant Human Growth Hormone
p2340
(dp2341
g13
g14
sg15
V/categories/DBCAT003261
p2342
ssS'Alglucosidase Alfa'
p2343
(dp2344
g13
g25
sg15
S'0908010AH'
p2345
ssS'Vemurafenib'
p2346
(dp2347
g13
g25
sg15
S'0801050BD'
p2348
ssVGanglion Blockers
p2349
(dp2350
g13
g14
sg15
V/categories/DBCAT001047
p2351
ssVCytochrome P-450 CYP2C19 Inducers (strong)
p2352
(dp2353
g13
g14
sg15
V/categories/DBCAT002641
p2354
ssS'Tolazamide'
p2355
(dp2356
g13
g25
sg15
S'0601021V0'
p2357
ssS'Midazolam Hydrochloride'
p2358
(dp2359
g13
g25
sg15
S'0408020W0'
p2360
ssVMusculo-Skeletal System
p2361
(dp2362
g13
g14
sg15
V/categories/DBCAT002122
p2363
ssVSerine Proteases
p2364
(dp2365
g13
g14
sg15
V/categories/DBCAT000073
p2366
ssVInterleukin Antagonists
p2367
(dp2368
g13
g14
sg15
V/categories/DBCAT003773
p2369
ssVNorpregnanes
p2370
(dp2371
g13
g14
sg15
V/categories/DBCAT000705
p2372
ssS'Beclometasone Dipropionate'
p2373
(dp2374
g13
g25
sg15
S'0302000C0'
p2375
ssVCoenzymes
p2376
(dp2377
g13
g14
sg15
V/categories/DBCAT000223
p2378
ssVBasic Powders and Demulcents
p2379
(dp2380
g13
g14
sg15
V/categories/DBCAT003789
p2381
ssVAntineovascularisation Agents
p2382
(dp2383
g13
g14
sg15
V/categories/DBCAT002389
p2384
ssVDiphenylbutylpiperidine Derivatives
p2385
(dp2386
g13
g14
sg15
V/categories/DBCAT002501
p2387
ssS'Clobetasone Butyrate'
p2388
(dp2389
g13
g25
sg15
S'1304000H0'
p2390
ssS'Sulfasalazine'
p2391
(dp2392
g13
g25
sg15
S'0105010E0'
p2393
ssVCorticosteroids for Systemic Use, Plain
p2394
(dp2395
g13
g14
sg15
V/categories/DBCAT002377
p2396
ssS'Miglitol'
p2397
(dp2398
g13
g25
sg15
S'0601023M0'
p2399
ssVUGT1A3 substrates
p2400
(dp2401
g13
g14
sg15
V/categories/DBCAT004554
p2402
ssS'Ethosuximide'
p2403
(dp2404
g13
g25
sg15
S'0408010I0'
p2405
ssVAntipruritics and Local Anesthetics
p2406
(dp2407
g13
g14
sg15
V/categories/DBCAT003654
p2408
ssVP-glycoprotein inducers
p2409
(dp2410
g13
g14
sg15
V/categories/DBCAT003895
p2411
ssVSelective Alfa-1-adrenergic Blocking Agents
p2412
(dp2413
g13
g14
sg15
V/categories/DBCAT003670
p2414
ssVgamma-Aminobutyric Acid
p2415
(dp2416
g13
g14
sg15
V/categories/DBCAT000423
p2417
ssS'Linezolid'
p2418
(dp2419
g13
g25
sg15
S'0501070W0'
p2420
ssVAnthracyclines
p2421
(dp2422
g13
g14
sg15
V/categories/DBCAT000874
p2423
ssS'Acetarsol'
p2424
(dp2425
g13
g25
sg15
S'0702020C0'
p2426
ssS'Desipramine Hydrochloride'
p2427
(dp2428
g13
g25
sg15
S'0403010H0'
p2429
ssS'Flurazepam Hydrochloride'
p2430
(dp2431
g13
g25
sg15
S'0401010L0'
p2432
ssS'Bupivacaine Hydrochloride & Fentanyl Cit'
p2433
(dp2434
g13
g25
sg15
S'1502010Z0'
p2435
ssS'Cefuroxime Sodium'
p2436
(dp2437
g13
g25
sg15
S'1103010T0'
p2438
ssVPotassium Compounds
p2439
(dp2440
g13
g14
sg15
V/categories/DBCAT001113
p2441
ssVAntihelminthic
p2442
(dp2443
g13
g14
sg15
V/categories/DBCAT003367
p2444
ssVPhenylalanine Hydroxylase Activators
p2445
(dp2446
g13
g14
sg15
V/categories/DBCAT004298
p2447
ssVHER2 Receptor Antagonist
p2448
(dp2449
g13
g14
sg15
V/categories/DBCAT003268
p2450
ssS'Raltitrexed'
p2451
(dp2452
g13
g25
sg15
S'0801030Z0'
p2453
ssVOpioids
p2454
(dp2455
g13
g14
sg15
V/categories/DBCAT000480
p2456
ssVSilicates
p2457
(dp2458
g13
g14
sg15
V/categories/DBCAT001373
p2459
ssS'Cobicistat'
p2460
(dp2461
g13
g25
sg15
S'0503010AI'
p2462
ssVAdrenergic Uptake Inhibitors
p2463
(dp2464
g13
g14
sg15
V/categories/DBCAT000439
p2465
ssS'Mitomycin'
p2466
(dp2467
g13
g25
sg15
S'0801020Q0'
p2468
ssVIncreased Cellular Death
p2469
(dp2470
g13
g14
sg15
V/categories/DBCAT004375
p2471
ssVMethylating Activity
p2472
(dp2473
g13
g14
sg15
V/categories/DBCAT004227
p2474
ssVCalcium Channel Blockers and Diuretics
p2475
(dp2476
g13
g14
sg15
V/categories/DBCAT002343
p2477
ssVAntimigraine Preparations
p2478
(dp2479
g13
g14
sg15
V/categories/DBCAT002225
p2480
ssS'Levofloxacin'
p2481
(dp2482
g13
g25
sg15
S'1103010AG'
p2483
ssVAdenosine
p2484
(dp2485
g13
g14
sg15
V/categories/DBCAT000251
p2486
ssVAntibacterials for Systemic Use
p2487
(dp2488
g13
g14
sg15
V/categories/DBCAT002130
p2489
ssVNeuraxial Anesthetics
p2490
(dp2491
g13
g14
sg15
V/categories/DBCAT004617
p2492
ssS'Vandetanib'
p2493
(dp2494
g13
g25
sg15
S'0801050BG'
p2495
ssVMorphinan Derivatives
p2496
(dp2497
g13
g14
sg15
V/categories/DBCAT002424
p2498
ssVInsulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting
p2499
(dp2500
g13
g14
sg15
V/categories/DBCAT002119
p2501
ssVAgents to Treat Airway Disease
p2502
(dp2503
g13
g14
sg15
V/categories/DBCAT002866
p2504
ssS'Arachis Oil'
p2505
(dp2506
g13
g25
sg15
S'1302010G0'
p2507
ssVAmino Alcohols
p2508
(dp2509
g13
g14
sg15
V/categories/DBCAT000271
p2510
ssVMAP Kinase Kinase 1, antagonists & inhibitors
p2511
(dp2512
g13
g14
sg15
V/categories/DBCAT001678
p2513
ssVAntiglaucoma Agents
p2514
(dp2515
g13
g14
sg15
V/categories/DBCAT003725
p2516
ssVMiscellaneous Antiprotozoals
p2517
(dp2518
g13
g14
sg15
V/categories/DBCAT003714
p2519
ssVPeripheral alpha-1 blockers
p2520
(dp2521
g13
g14
sg15
V/categories/DBCAT004614
p2522
ssS'Pentazocine Hydrochloride'
p2523
(dp2524
g13
g25
sg15
S'0407020T0'
p2525
ssVAlkanesulfonic Acids
p2526
(dp2527
g13
g14
sg15
V/categories/DBCAT000890
p2528
ssVEpithelial Sodium Channel Blockers
p2529
(dp2530
g13
g14
sg15
V/categories/DBCAT000817
p2531
ssVTopoisomerase I Inhibitors
p2532
(dp2533
g13
g14
sg15
V/categories/DBCAT001116
p2534
ssVCyclooxygenase Inhibitors
p2535
(dp2536
g13
g14
sg15
V/categories/DBCAT003910
p2537
ssS'Eslicarbazepine Acetate'
p2538
(dp2539
g13
g25
sg15
S'0408010AI'
p2540
ssVProgrammed Death Ligand-1-directed Antibody Interactions
p2541
(dp2542
g13
g14
sg15
V/categories/DBCAT004243
p2543
ssVPhenanthrenes
p2544
(dp2545
g13
g14
sg15
V/categories/DBCAT000691
p2546
ssVTopoisomerase Inhibitors
p2547
(dp2548
g13
g14
sg15
V/categories/DBCAT000548
p2549
ssVPyridazines
p2550
(dp2551
g13
g14
sg15
V/categories/DBCAT001326
p2552
ssS'Magnesium Carbonate'
p2553
(dp2554
g13
g25
sg15
S'0101010F0'
p2555
ssVAntisickling Agents
p2556
(dp2557
g13
g14
sg15
V/categories/DBCAT001227
p2558
ssS'Selegiline Hydrochloride'
p2559
(dp2560
g13
g25
sg15
S'0409010T0'
p2561
ssVLeukotriene Antagonists
p2562
(dp2563
g13
g14
sg15
V/categories/DBCAT000910
p2564
ssVAcyclovir and prodrug
p2565
(dp2566
g13
g14
sg15
V/categories/DBCAT002686
p2567
ssVViral Proteins
p2568
(dp2569
g13
g14
sg15
V/categories/DBCAT002892
p2570
ssVCytochrome P-450 CYP2B6 Substrates
p2571
(dp2572
g13
g14
sg15
V/categories/DBCAT002619
p2573
ssVMagnesium Compounds
p2574
(dp2575
g13
g14
sg15
V/categories/DBCAT001038
p2576
ssVDeoxyribonucleosides
p2577
(dp2578
g13
g14
sg15
V/categories/DBCAT000597
p2579
ssVMonoamine Oxidase A Inhibitors
p2580
(dp2581
g13
g14
sg15
V/categories/DBCAT002515
p2582
ssS'Carbidopa'
p2583
(dp2584
g13
g25
sg15
S'0409010D0'
p2585
ssVAntimicrobial Cationic Peptides
p2586
(dp2587
g13
g14
sg15
V/categories/DBCAT001130
p2588
ssVThiazolidinediones
p2589
(dp2590
g13
g14
sg15
V/categories/DBCAT002198
p2591
ssVOcular Disorders
p2592
(dp2593
g13
g14
sg15
V/categories/DBCAT003712
p2594
ssVOligosaccharides
p2595
(dp2596
g13
g14
sg15
V/categories/DBCAT000668
p2597
ssS'Metformin Hydrochloride/Pioglitazone'
p2598
(dp2599
g13
g25
sg15
S'0601023W0'
p2600
ssVLymphocyte Growth Factor
p2601
(dp2602
g13
g14
sg15
V/categories/DBCAT003255
p2603
ssVAntimetabolite Immunosuppressant
p2604
(dp2605
g13
g14
sg15
V/categories/DBCAT003391
p2606
ssVEnzymes, Immobilized
p2607
(dp2608
g13
g14
sg15
V/categories/DBCAT000159
p2609
ssVCytosine Nucleotides
p2610
(dp2611
g13
g14
sg15
V/categories/DBCAT000912
p2612
ssVTocolytic Agents
p2613
(dp2614
g13
g14
sg15
V/categories/DBCAT000759
p2615
ssS'Metoprolol Tartrate'
p2616
(dp2617
g13
g25
sg15
S'0204000K0'
p2618
ssVDisinfectants
p2619
(dp2620
g13
g14
sg15
V/categories/DBCAT001171
p2621
ssVSensitizers Used in Photodynamic/radiation Therapy
p2622
(dp2623
g13
g14
sg15
V/categories/DBCAT002451
p2624
ssVMacrolides, Lincosamides and Streptogramins
p2625
(dp2626
g13
g14
sg15
V/categories/DBCAT002202
p2627
ssVOxazoles
p2628
(dp2629
g13
g14
sg15
V/categories/DBCAT000626
p2630
ssVPsycholeptics
p2631
(dp2632
g13
g14
sg15
V/categories/DBCAT002185
p2633
ssVChlorine Compounds
p2634
(dp2635
g13
g14
sg15
V/categories/DBCAT000942
p2636
ssVNorepinephrine Uptake Inhibitors
p2637
(dp2638
g13
g14
sg15
V/categories/DBCAT004068
p2639
ssVAlpha and Beta Blocking Agents
p2640
(dp2641
g13
g14
sg15
V/categories/DBCAT002420
p2642
ssVPsoralens for Topical Use
p2643
(dp2644
g13
g14
sg15
V/categories/DBCAT002407
p2645
ssVCyclohexanes
p2646
(dp2647
g13
g14
sg15
V/categories/DBCAT000358
p2648
ssVCorpus Luteum Hormones
p2649
(dp2650
g13
g14
sg15
V/categories/DBCAT000829
p2651
ssS'Paritaprevir/Ritonavir/Ombitasvir'
p2652
(dp2653
g13
g25
sg15
S'0503032G0'
p2654
ssVThrombocytosis
p2655
(dp2656
g13
g14
sg15
V/categories/DBCAT000632
p2657
ssS'Metoclopramide Hydrochloride'
p2658
(dp2659
g13
g25
sg15
S'0406000P0'
p2660
ssVRibonucleotide Reductases, antagonists & inhibitors
p2661
(dp2662
g13
g14
sg15
V/categories/DBCAT000869
p2663
ssS'Quetiapine'
p2664
(dp2665
g13
g25
sg15
S'0402010AB'
p2666
ssS'Dapsone'
p2667
(dp2668
g13
g25
sg15
S'0501100H0'
p2669
ssVAnabolic Agents
p2670
(dp2671
g13
g14
sg15
V/categories/DBCAT001012
p2672
ssVgamma-Aminobutyric Acid A Receptor Agonist
p2673
(dp2674
g13
g14
sg15
V/categories/DBCAT003556
p2675
ssS'Eliglustat'
p2676
(dp2677
g13
g25
sg15
S'0908010AR'
p2678
ssVConotoxins
p2679
(dp2680
g13
g14
sg15
V/categories/DBCAT002963
p2681
ssVGonadal Hormones
p2682
(dp2683
g13
g14
sg15
V/categories/DBCAT000674
p2684
ssVMitosis Modulators
p2685
(dp2686
g13
g14
sg15
V/categories/DBCAT000716
p2687
ssS'Quinine Sulfate'
p2688
(dp2689
g13
g25
sg15
S'0504010Y0'
p2690
ssVAppetite Stimulants
p2691
(dp2692
g13
g14
sg15
V/categories/DBCAT000780
p2693
ssVLipopeptides
p2694
(dp2695
g13
g14
sg15
V/categories/DBCAT000177
p2696
ssVAntivertigo Preparations
p2697
(dp2698
g13
g14
sg15
V/categories/DBCAT002412
p2699
ssVN-Calcium Channel Receptor Antagonists
p2700
(dp2701
g13
g14
sg15
V/categories/DBCAT004414
p2702
ssS'Cinacalcet Hydrochloride'
p2703
(dp2704
g13
g25
sg15
S'0905012I0'
p2705
ssS'Mafenide'
p2706
(dp2707
g13
g25
sg15
S'1310011K0'
p2708
ssVOATP1B1/SLCO1B1 Inducers
p2709
(dp2710
g13
g14
sg15
V/categories/DBCAT003933
p2711
ssVIndazoles
p2712
(dp2713
g13
g14
sg15
V/categories/DBCAT001180
p2714
ssS'Mycophenolate Mofetil'
p2715
(dp2716
g13
g25
sg15
S'0802010M0'
p2717
ssVTriptans
p2718
(dp2719
g13
g14
sg15
V/categories/DBCAT003231
p2720
ssVMacromolecular Substances
p2721
(dp2722
g13
g14
sg15
V/categories/DBCAT000809
p2723
ssVTubulin Modulators
p2724
(dp2725
g13
g14
sg15
V/categories/DBCAT000718
p2726
ssVVascular Sclerosing Activity
p2727
(dp2728
g13
g14
sg15
V/categories/DBCAT004101
p2729
ssS'Rufinamide'
p2730
(dp2731
g13
g25
sg15
S'0408010AF'
p2732
ssS'Ketotifen Fumarate'
p2733
(dp2734
g13
g25
sg15
S'1104020Y0'
p2735
ssS'Methoxsalen'
p2736
(dp2737
g13
g25
sg15
S'1305020L0'
p2738
ssS'Clindamycin/Hydrocortisone'
p2739
(dp2740
g13
g25
sg15
S'1306010AA'
p2741
ssVNitriles
p2742
(dp2743
g13
g14
sg15
V/categories/DBCAT000545
p2744
ssVArteriolar Vasodilation
p2745
(dp2746
g13
g14
sg15
V/categories/DBCAT004240
p2747
ssVInsulins and Analogues for Inhalation
p2748
(dp2749
g13
g14
sg15
V/categories/DBCAT003127
p2750
ssVSugar Alcohols
p2751
(dp2752
g13
g14
sg15
V/categories/DBCAT000648
p2753
ssS'Bevacizumab'
p2754
(dp2755
g13
g25
sg15
S'0801050AP'
p2756
ssVHypotensive Agents
p2757
(dp2758
g13
g14
sg15
V/categories/DBCAT002696
p2759
ssVNasal Decongestants for Systemic Use
p2760
(dp2761
g13
g14
sg15
V/categories/DBCAT002351
p2762
ssS'Flutamide'
p2763
(dp2764
g13
g25
sg15
S'0803042H0'
p2765
ssVCosmetics
p2766
(dp2767
g13
g14
sg15
V/categories/DBCAT001169
p2768
ssS'Ranitidine Bismuth Citrate'
p2769
(dp2770
g13
g25
sg15
S'0103010S0'
p2771
ssVPenicillin G
p2772
(dp2773
g13
g14
sg15
V/categories/DBCAT000740
p2774
ssVSmoking Cessation Agents
p2775
(dp2776
g13
g14
sg15
V/categories/DBCAT004978
p2777
ssVNonnucleoside Reverse Transcriptase Inhibitors
p2778
(dp2779
g13
g14
sg15
V/categories/DBCAT003641
p2780
ssVHeparin Group
p2781
(dp2782
g13
g14
sg15
V/categories/DBCAT002505
p2783
ssS'Naloxegol'
p2784
(dp2785
g13
g25
sg15
S'0106060B0'
p2786
ssS'Griseofulvin'
p2787
(dp2788
g13
g25
sg15
S'1310020Q0'
p2789
ssVPhenylacetates
p2790
(dp2791
g13
g14
sg15
V/categories/DBCAT000845
p2792
ssVAprepitant and Prodrugs
p2793
(dp2794
g13
g14
sg15
V/categories/DBCAT003971
p2795
ssVCytochrome P-450 CYP1A2 Inducers (strong)
p2796
(dp2797
g13
g14
sg15
V/categories/DBCAT002612
p2798
ssVTrimethoprim and Derivatives
p2799
(dp2800
g13
g14
sg15
V/categories/DBCAT002375
p2801
ssVCD80-directed Antibody Interactions
p2802
(dp2803
g13
g14
sg15
V/categories/DBCAT004361
p2804
ssS'Turpentine Oil'
p2805
(dp2806
g13
g25
sg15
S'1003020V0'
p2807
ssS'Penciclovir'
p2808
(dp2809
g13
g25
sg15
S'1310030L0'
p2810
ssVAndrostadienes
p2811
(dp2812
g13
g14
sg15
V/categories/DBCAT000979
p2813
ssS'Buspirone Hydrochloride'
p2814
(dp2815
g13
g25
sg15
S'0401020B0'
p2816
ssS'Buserelin'
p2817
(dp2818
g13
g25
sg15
S'0803042B0'
p2819
ssVSerotonin 5-HT1 Receptor Agonists
p2820
(dp2821
g13
g14
sg15
V/categories/DBCAT000734
p2822
ssVRetroviridae Proteins
p2823
(dp2824
g13
g14
sg15
V/categories/DBCAT002891
p2825
ssS'Ergocalciferol'
p2826
(dp2827
g13
g25
sg15
S'0906040N0'
p2828
ssS'Everolimus'
p2829
(dp2830
g13
g25
sg15
S'0801050AX'
p2831
ssS'Progesterone'
p2832
(dp2833
g13
g25
sg15
S'0604012S0'
p2834
ssS'Cilazapril'
p2835
(dp2836
g13
g25
sg15
S'0205051E0'
p2837
ssS'Norfloxacin'
p2838
(dp2839
g13
g25
sg15
S'0501120Q0'
p2840
ssS'Cyproheptadine Hydrochloride'
p2841
(dp2842
g13
g25
sg15
S'0304010K0'
p2843
ssS'Dipyridamole & Aspirin'
p2844
(dp2845
g13
g25
sg15
S'0209000V0'
p2846
ssVP-glycoprotein/ABCB1 Substrates
p2847
(dp2848
g13
g14
sg15
V/categories/DBCAT002668
p2849
ssS'Ambrisentan'
p2850
(dp2851
g13
g25
sg15
S'0205010X0'
p2852
ssVCytochrome P-450 CYP2A6 Substrates
p2853
(dp2854
g13
g14
sg15
V/categories/DBCAT002613
p2855
ssVGlycolates
p2856
(dp2857
g13
g14
sg15
V/categories/DBCAT001186
p2858
ssVDecreased Cholesterol Absorption
p2859
(dp2860
g13
g14
sg15
V/categories/DBCAT004477
p2861
ssS'Alendronic Acid'
p2862
(dp2863
g13
g25
sg15
S'0606020A0'
p2864
ssVmTOR Inhibitors
p2865
(dp2866
g13
g14
sg15
V/categories/DBCAT004158
p2867
ssVCytosine
p2868
(dp2869
g13
g14
sg15
V/categories/DBCAT001267
p2870
ssVOphthalmologicals
p2871
(dp2872
g13
g14
sg15
V/categories/DBCAT002091
p2873
ssVIncreased Intravascular Volume
p2874
(dp2875
g13
g14
sg15
V/categories/DBCAT004214
p2876
ssVAminopenicillins
p2877
(dp2878
g13
g14
sg15
V/categories/DBCAT003682
p2879
ssVAmino Acids, Essential
p2880
(dp2881
g13
g14
sg15
V/categories/DBCAT000242
p2882
ssVInterleukin-1beta, antagonists & inhibitors
p2883
(dp2884
g13
g14
sg15
V/categories/DBCAT001766
p2885
ssS'Argipressin'
p2886
(dp2887
g13
g25
sg15
S'0605020W0'
p2888
ssVTriose Sugar Alcohols
p2889
(dp2890
g13
g14
sg15
V/categories/DBCAT004975
p2891
ssVDaunorubicin
p2892
(dp2893
g13
g14
sg15
V/categories/DBCAT000873
p2894
ssS'Chloramphenicol'
p2895
(dp2896
g13
g14
sg15
V/categories/DBCAT001884
p2897
ssVTaxoids
p2898
(dp2899
g13
g14
sg15
V/categories/DBCAT001309
p2900
ssS'Carbomer 974P'
p2901
(dp2902
g13
g25
sg15
S'1108010Z0'
p2903
ssVSerine Endopeptidases
p2904
(dp2905
g13
g14
sg15
V/categories/DBCAT000067
p2906
ssVBile Acids and Salts
p2907
(dp2908
g13
g14
sg15
V/categories/DBCAT001384
p2909
ssS'Citalopram Hydrobromide'
p2910
(dp2911
g13
g25
sg15
S'0403030D0'
p2912
ssS'Sulconazole Nitrate'
p2913
(dp2914
g13
g25
sg15
S'1310020X0'
p2915
ssVCytochrome P-450 CYP2C18 Inhibitors (strength unknown)
p2916
(dp2917
g13
g14
sg15
V/categories/DBCAT004669
p2918
ssVCiprofloxacin and isotope
p2919
(dp2920
g13
g14
sg15
V/categories/DBCAT001596
p2921
ssVPhenytoin and Prodrugs
p2922
(dp2923
g13
g14
sg15
V/categories/DBCAT002678
p2924
ssVDecreased DNA Replication
p2925
(dp2926
g13
g14
sg15
V/categories/DBCAT004416
p2927
ssS'Chlorquinaldol'
p2928
(dp2929
g13
g25
sg15
S'1310050L0'
p2930
ssVGuanylyl Cyclase C Agonists
p2931
(dp2932
g13
g14
sg15
V/categories/DBCAT005018
p2933
ssVAnti-Anxiety Agents
p2934
(dp2935
g13
g14
sg15
V/categories/DBCAT000404
p2936
ssVSerotonin Receptor Antagonists
p2937
(dp2938
g13
g14
sg15
V/categories/DBCAT000604
p2939
ssS'Polymyxin B Sulphate'
p2940
(dp2941
g13
g25
sg15
S'1103010Q0'
p2942
ssS'Fluvastatin Sodium'
p2943
(dp2944
g13
g25
sg15
S'0212000M0'
p2945
ssS'Pantoprazole'
p2946
(dp2947
g13
g25
sg15
S'0103050R0'
p2948
ssVCytochrome P-450 CYP2C8 Inducers (weak)
p2949
(dp2950
g13
g14
sg15
V/categories/DBCAT003898
p2951
ssVAntiandrogens and Estrogens
p2952
(dp2953
g13
g14
sg15
V/categories/DBCAT002464
p2954
ssVProline
p2955
(dp2956
g13
g14
sg15
V/categories/DBCAT000927
p2957
ssVNorepinephrine Reuptake Inhibitor
p2958
(dp2959
g13
g14
sg15
V/categories/DBCAT003318
p2960
ssVHighest Risk QTc-Prolonging Agents
p2961
(dp2962
g13
g14
sg15
V/categories/DBCAT002689
p2963
ssVVasoconstrictor Agents
p2964
(dp2965
g13
g14
sg15
V/categories/DBCAT000165
p2966
ssVCholestadienes
p2967
(dp2968
g13
g14
sg15
V/categories/DBCAT001504
p2969
ssVInterleukin 1 Receptor Antagonists
p2970
(dp2971
g13
g14
sg15
V/categories/DBCAT004385
p2972
ssVStarch
p2973
(dp2974
g13
g14
sg15
V/categories/DBCAT001021
p2975
ssVOpioids, Anilidopiperidine
p2976
(dp2977
g13
g14
sg15
V/categories/DBCAT003009
p2978
ssVMorpholines
p2979
(dp2980
g13
g14
sg15
V/categories/DBCAT000802
p2981
ssVPhosphonoacetic Acid
p2982
(dp2983
g13
g14
sg15
V/categories/DBCAT000950
p2984
ssS'Sodium Chloride'
p2985
(dp2986
g13
g25
sg15
S'1108010K0'
p2987
ssVParasympatholytics
p2988
(dp2989
g13
g14
sg15
V/categories/DBCAT000535
p2990
ssS'Adefovir Dipivoxil'
p2991
(dp2992
g13
g25
sg15
S'0503031A0'
p2993
ssVErgot-derivative Dopamine Receptor Agonists
p2994
(dp2995
g13
g14
sg15
V/categories/DBCAT003643
p2996
ssVOral Hypoglycemics
p2997
(dp2998
g13
g14
sg15
V/categories/DBCAT003861
p2999
ssS'Sodium Aurothiomalate'
p3000
(dp3001
g13
g25
sg15
S'1001030J0'
p3002
ssVDiphenylpropylamine Derivatives
p3003
(dp3004
g13
g14
sg15
V/categories/DBCAT002316
p3005
ssVDecreased DNA Integrity
p3006
(dp3007
g13
g14
sg15
V/categories/DBCAT004407
p3008
ssS'Praziquantel'
p3009
(dp3010
g13
g25
sg15
S'0505050P0'
p3011
ssV4-Hydroxyphenylpyruvate Dioxygenase, antagonists & inhibitors
p3012
(dp3013
g13
g14
sg15
V/categories/DBCAT000778
p3014
ssS'Gemcitabine'
p3015
(dp3016
g13
g25
sg15
S'0801030X0'
p3017
ssS'Levodopa/Carbidopa/Entacapone'
p3018
(dp3019
g13
g25
sg15
S'0409010X0'
p3020
ssS'Erythromycin Stearate'
p3021
(dp3022
g13
g25
sg15
S'0501050N0'
p3023
ssS'Clotrimazole'
p3024
(dp3025
g13
g25
sg15
S'1310020H0'
p3026
ssS'Paclitaxel'
p3027
(dp3028
g13
g25
sg15
S'0801050V0'
p3029
ssVIron Compounds
p3030
(dp3031
g13
g14
sg15
V/categories/DBCAT000754
p3032
ssVMicrotubule Inhibitors
p3033
(dp3034
g13
g14
sg15
V/categories/DBCAT002734
p3035
ssS'Labetalol Hydrochloride'
p3036
(dp3037
g13
g25
sg15
S'0204000I0'
p3038
ssVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p3039
(dp3040
g13
g14
sg15
V/categories/DBCAT004029
p3041
ssVSolvents
p3042
(dp3043
g13
g14
sg15
V/categories/DBCAT001183
p3044
ssVPropionates
p3045
(dp3046
g13
g14
sg15
V/categories/DBCAT001030
p3047
ssS'Benserazide Hydrochloride'
p3048
(dp3049
g13
g25
sg15
S'0409010C0'
p3050
ssVAnti-Asthmatic Agents
p3051
(dp3052
g13
g14
sg15
V/categories/DBCAT000134
p3053
ssVCapsaicin and Similar Agents
p3054
(dp3055
g13
g14
sg15
V/categories/DBCAT002570
p3056
ssVBenzoxazoles
p3057
(dp3058
g13
g14
sg15
V/categories/DBCAT000783
p3059
ssVUGT1A9 substrates with narrow therapeutic index
p3060
(dp3061
g13
g14
sg15
V/categories/DBCAT004544
p3062
ssVCytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index
p3063
(dp3064
g13
g14
sg15
V/categories/DBCAT004675
p3065
ssVAntiglaucoma Preparations and Miotics
p3066
(dp3067
g13
g14
sg15
V/categories/DBCAT002192
p3068
ssVJanus Kinase Inhibitors
p3069
(dp3070
g13
g14
sg15
V/categories/DBCAT004108
p3071
ssS'Telmisartan'
p3072
(dp3073
g13
g25
sg15
S'0205052Q0'
p3074
ssVHemodialysis Solution
p3075
(dp3076
g13
g14
sg15
V/categories/DBCAT003718
p3077
ssVBiomimetic Materials
p3078
(dp3079
g13
g14
sg15
V/categories/DBCAT001054
p3080
ssVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p3081
(dp3082
g13
g14
sg15
V/categories/DBCAT004031
p3083
ssVVascular Endothelial Growth Factor Inhibitor
p3084
(dp3085
g13
g14
sg15
V/categories/DBCAT003817
p3086
ssS'Olsalazine Sodium'
p3087
(dp3088
g13
g25
sg15
S'0105010C0'
p3089
ssS'Colistin Sulphate'
p3090
(dp3091
g13
g25
sg15
S'1201010M0'
p3092
ssVChondroitinsulfatases
p3093
(dp3094
g13
g14
sg15
V/categories/DBCAT002906
p3095
ssVPhosphorus Compounds
p3096
(dp3097
g13
g14
sg15
V/categories/DBCAT000926
p3098
ssS'Ferrous Gluconate'
p3099
(dp3100
g13
g25
sg15
S'0901011H0'
p3101
ssVCarboxylic Ester Hydrolases
p3102
(dp3103
g13
g14
sg15
V/categories/DBCAT000189
p3104
ssS'Nicotinic Acid/Laropiprant'
p3105
(dp3106
g13
g25
sg15
S'0212000AE'
p3107
ssVSalicylic Acid and Derivatives
p3108
(dp3109
g13
g14
sg15
V/categories/DBCAT002147
p3110
ssS'Entacapone'
p3111
(dp3112
g13
g25
sg15
S'0409010V0'
p3113
ssS'Timolol & Bimatoprost'
p3114
(dp3115
g13
g25
sg15
S'1106000AI'
p3116
ssS'Megestrol Acetate'
p3117
(dp3118
g13
g25
sg15
S'0803020L0'
p3119
ssVPolyene Antifungal
p3120
(dp3121
g13
g14
sg15
V/categories/DBCAT003385
p3122
ssVIncreased Lymphocyte Activation
p3123
(dp3124
g13
g14
sg15
V/categories/DBCAT004234
p3125
ssS'Asparaginase'
p3126
(dp3127
g13
g14
sg15
V/categories/DBCAT004271
p3128
ssVCCR5 Co-receptor Antagonist
p3129
(dp3130
g13
g14
sg15
V/categories/DBCAT003447
p3131
ssS'Tipranavir'
p3132
(dp3133
g13
g25
sg15
S'0503010AB'
p3134
ssVBile and Liver Therapy
p3135
(dp3136
g13
g14
sg15
V/categories/DBCAT002536
p3137
ssVKetoses
p3138
(dp3139
g13
g14
sg15
V/categories/DBCAT001421
p3140
ssS'Tetracycline Hydrochloride'
p3141
(dp3142
g13
g25
sg15
S'1310012P0'
p3143
ssS'Acetylcysteine'
p3144
(dp3145
g13
g25
sg15
S'1902070A0'
p3146
ssS'Omalizumab'
p3147
(dp3148
g13
g25
sg15
S'0304020X0'
p3149
ssVToothpastes
p3150
(dp3151
g13
g14
sg15
V/categories/DBCAT001999
p3152
ssVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p3153
(dp3154
g13
g14
sg15
V/categories/DBCAT002261
p3155
ssS'Apomorphine Hydrochloride'
p3156
(dp3157
g13
g25
sg15
S'0704050G0'
p3158
ssVTissue Plasminogen Activator
p3159
(dp3160
g13
g14
sg15
V/categories/DBCAT004683
p3161
ssVIMP Dehydrogenase, antagonists & inhibitors
p3162
(dp3163
g13
g14
sg15
V/categories/DBCAT001071
p3164
ssVViral Fusion Protein Inhibitors
p3165
(dp3166
g13
g14
sg15
V/categories/DBCAT000219
p3167
ssVI.V. Solution Additives
p3168
(dp3169
g13
g14
sg15
V/categories/DBCAT002149
p3170
ssVCicatrizants
p3171
(dp3172
g13
g14
sg15
V/categories/DBCAT002133
p3173
ssS'Clindamycin'
p3174
(dp3175
g13
g25
sg15
S'1306010E0'
p3176
ssS'Pinaverium Bromide'
p3177
(dp3178
g13
g25
sg15
S'0102000AD'
p3179
ssVInfluenza A M2 Protein Inhibitor
p3180
(dp3181
g13
g14
sg15
V/categories/DBCAT003356
p3182
ssS'Epoetin Zeta'
p3183
(dp3184
g13
g25
sg15
S'0901030Q0'
p3185
ssVGenitourinary Arterial Vasodilation
p3186
(dp3187
g13
g14
sg15
V/categories/DBCAT004182
p3188
ssVAdrenals
p3189
(dp3190
g13
g14
sg15
V/categories/DBCAT003629
p3191
ssVMuscle Relaxants, Centrally Acting Agents
p3192
(dp3193
g13
g14
sg15
V/categories/DBCAT002177
p3194
ssVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p3195
(dp3196
g13
g14
sg15
V/categories/DBCAT004034
p3197
ssVGlycogen Storage Disease Type II
p3198
(dp3199
g13
g14
sg15
V/categories/DBCAT001324
p3200
ssVSodium Compounds
p3201
(dp3202
g13
g14
sg15
V/categories/DBCAT001355
p3203
ssS'Chlordiazepoxide'
p3204
(dp3205
g13
g25
sg15
S'0401020D0'
p3206
ssS'Kanamycin'
p3207
(dp3208
g13
g14
sg15
V/categories/DBCAT000915
p3209
ssVenv Gene Products, Human Immunodeficiency Virus
p3210
(dp3211
g13
g14
sg15
V/categories/DBCAT002889
p3212
ssVPropanolamines
p3213
(dp3214
g13
g14
sg15
V/categories/DBCAT000483
p3215
ssS'Zoledronic Acid'
p3216
(dp3217
g13
g25
sg15
S'0606020V0'
p3218
ssS'Fluocinonide'
p3219
(dp3220
g13
g25
sg15
S'1304000P0'
p3221
ssS'Primaquine'
p3222
(dp3223
g13
g25
sg15
S'0504010K0'
p3224
ssValpha-Galactosidase, antagonists & inhibitors
p3225
(dp3226
g13
g14
sg15
V/categories/DBCAT001655
p3227
ssVReceptors, Tumor Necrosis Factor
p3228
(dp3229
g13
g14
sg15
V/categories/DBCAT000027
p3230
ssS'Indapamide'
p3231
(dp3232
g13
g25
sg15
S'0202010P0'
p3233
ssVAdjuvants, Pharmaceutic
p3234
(dp3235
g13
g14
sg15
V/categories/DBCAT001242
p3236
ssVCystine Disulfide Reduction
p3237
(dp3238
g13
g14
sg15
V/categories/DBCAT004371
p3239
ssS'Propranolol Hydrochloride'
p3240
(dp3241
g13
g25
sg15
S'0204000R0'
p3242
ssVPropiophenones
p3243
(dp3244
g13
g14
sg15
V/categories/DBCAT001282
p3245
ssS'Thymol'
p3246
(dp3247
g13
g25
sg15
S'1203030V0'
p3248
ssS'Calcipotriol'
p3249
(dp3250
g13
g25
sg15
S'1305020D0'
p3251
ssVEicosanoids
p3252
(dp3253
g13
g14
sg15
V/categories/DBCAT000350
p3254
ssVAbortifacient Agents
p3255
(dp3256
g13
g14
sg15
V/categories/DBCAT000854
p3257
ssS'Temozolomide'
p3258
(dp3259
g13
g25
sg15
S'0801050Y0'
p3260
ssS'Binimetinib'
p3261
(dp3262
g13
g25
sg15
S'0801050CN'
p3263
ssS'Pentostatin'
p3264
(dp3265
g13
g25
sg15
S'0801050S0'
p3266
ssS'Cloxacillin'
p3267
(dp3268
g13
g25
sg15
S'0501012D0'
p3269
ssVReduction Activity
p3270
(dp3271
g13
g14
sg15
V/categories/DBCAT004190
p3272
ssVLocal Hemostatics
p3273
(dp3274
g13
g14
sg15
V/categories/DBCAT002444
p3275
ssVCTLA-4-directed Antibody Interactions
p3276
(dp3277
g13
g14
sg15
V/categories/DBCAT004286
p3278
ssS'Sulindac'
p3279
(dp3280
g13
g25
sg15
S'1001010S0'
p3281
ssVAgents that produce neuromuscular block (indirect)
p3282
(dp3283
g13
g14
sg15
V/categories/DBCAT003930
p3284
ssVTiclopidine
p3285
(dp3286
g13
g14
sg15
V/categories/DBCAT004983
p3287
ssVHuman Platelet-derived Growth Factor
p3288
(dp3289
g13
g14
sg15
V/categories/DBCAT003278
p3290
ssS'Cefepime'
p3291
(dp3292
g13
g25
sg15
S'0501020AD'
p3293
ssVHerbs (Hypotensive Properties)
p3294
(dp3295
g13
g14
sg15
V/categories/DBCAT002708
p3296
ssS'Tinzaparin Sodium'
p3297
(dp3298
g13
g25
sg15
S'0208010W0'
p3299
ssVDipeptides
p3300
(dp3301
g13
g14
sg15
V/categories/DBCAT000375
p3302
ssVDirect Acting Antivirals
p3303
(dp3304
g13
g14
sg15
V/categories/DBCAT002140
p3305
ssVBiological Factors
p3306
(dp3307
g13
g14
sg15
V/categories/DBCAT000036
p3308
ssVNS3/4A Protease Inhibitors
p3309
(dp3310
g13
g14
sg15
V/categories/DBCAT002768
p3311
ssS'Sodium Dihydrogen Phosphate Dihydrate'
p3312
(dp3313
g13
g25
sg15
S'0905021L0'
p3314
ssVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p3315
(dp3316
g13
g14
sg15
V/categories/DBCAT003359
p3317
ssS'Isosorbide Dinitrate'
p3318
(dp3319
g13
g25
sg15
S'0206010I0'
p3320
ssS'Apremilast'
p3321
(dp3322
g13
g25
sg15
S'1001030AA'
p3323
ssVAnorexigenic Agents & Respiratory and CNS Stimulants
p3324
(dp3325
g13
g14
sg15
V/categories/DBCAT003635
p3326
ssVIncreased IgG Production
p3327
(dp3328
g13
g14
sg15
V/categories/DBCAT004060
p3329
ssVPartial Opioid Agonist/Antagonist
p3330
(dp3331
g13
g14
sg15
V/categories/DBCAT003387
p3332
ssS'Epoetin Delta'
p3333
(dp3334
g13
g25
sg15
S'0901030L0'
p3335
ssVNorethindrone
p3336
(dp3337
g13
g14
sg15
V/categories/DBCAT004982
p3338
ssVGeneral Nutrients
p3339
(dp3340
g13
g14
sg15
V/categories/DBCAT002545
p3341
ssVCoordination Complexes
p3342
(dp3343
g13
g14
sg15
V/categories/DBCAT004979
p3344
ssVSelective Beta 1-adrenergic Agonists
p3345
(dp3346
g13
g14
sg15
V/categories/DBCAT003733
p3347
ssVUrological Agents
p3348
(dp3349
g13
g14
sg15
V/categories/DBCAT000517
p3350
ssVMineral Supplements
p3351
(dp3352
g13
g14
sg15
V/categories/DBCAT002308
p3353
ssVColouring Agents
p3354
(dp3355
g13
g14
sg15
V/categories/DBCAT002449
p3356
ssVAnti-Bacterial Agents
p3357
(dp3358
g13
g14
sg15
V/categories/DBCAT000104
p3359
ssVVEGFR2 Inhibitors
p3360
(dp3361
g13
g14
sg15
V/categories/DBCAT004246
p3362
ssS'Phentermine'
p3363
(dp3364
g13
g25
sg15
S'0405020R0'
p3365
ssVHIV Integrase
p3366
(dp3367
g13
g14
sg15
V/categories/DBCAT001732
p3368
ssVLipase Inhibitors
p3369
(dp3370
g13
g14
sg15
V/categories/DBCAT004196
p3371
ssVReceptors, Somatotropin, antagonists & inhibitors
p3372
(dp3373
g13
g14
sg15
V/categories/DBCAT000181
p3374
ssVCytoprotective Agent
p3375
(dp3376
g13
g14
sg15
V/categories/DBCAT003319
p3377
ssVIgE-directed Antibody Interactions
p3378
(dp3379
g13
g14
sg15
V/categories/DBCAT004420
p3380
ssS'Protriptyline Hydrochloride'
p3381
(dp3382
g13
g25
sg15
S'0403010W0'
p3383
ssVGlycopeptides
p3384
(dp3385
g13
g14
sg15
V/categories/DBCAT000678
p3386
ssVUGT1A6 substrate
p3387
(dp3388
g13
g14
sg15
V/categories/DBCAT004045
p3389
ssVHistamine H1 Antagonists, Non-Sedating
p3390
(dp3391
g13
g14
sg15
V/categories/DBCAT000772
p3392
ssS'Methylprednisolone Acetate'
p3393
(dp3394
g13
g25
sg15
S'1001022K0'
p3395
ssVOximes
p3396
(dp3397
g13
g14
sg15
V/categories/DBCAT000392
p3398
ssS'Procainamide Hydrochloride'
p3399
(dp3400
g13
g25
sg15
S'0203020S0'
p3401
ssVOxytocin, analogs & derivatives
p3402
(dp3403
g13
g14
sg15
V/categories/DBCAT004704
p3404
ssVAurothioglucose
p3405
(dp3406
g13
g14
sg15
V/categories/DBCAT001222
p3407
ssS'Flurbiprofen Sodium'
p3408
(dp3409
g13
g25
sg15
S'1104020G0'
p3410
ssVEstren Derivatives
p3411
(dp3412
g13
g14
sg15
V/categories/DBCAT002454
p3413
ssVPyridones
p3414
(dp3415
g13
g14
sg15
V/categories/DBCAT001044
p3416
ssVBeta Blocking Agents, Non-Selective
p3417
(dp3418
g13
g14
sg15
V/categories/DBCAT002338
p3419
ssVIncreased Coagulation Factor VIII Concentration
p3420
(dp3421
g13
g14
sg15
V/categories/DBCAT004438
p3422
ssVPeripherally Acting Antiobesity Products
p3423
(dp3424
g13
g14
sg15
V/categories/DBCAT002499
p3425
ssS'Perindopril Arginine'
p3426
(dp3427
g13
g25
sg15
S'0205051Y0'
p3428
ssVPurine Nucleosides
p3429
(dp3430
g13
g14
sg15
V/categories/DBCAT000252
p3431
ssS'Lumacaftor/Ivacaftor'
p3432
(dp3433
g13
g25
sg15
S'0307000T0'
p3434
ssVUterotonic agents
p3435
(dp3436
g13
g14
sg15
V/categories/DBCAT000218
p3437
ssVNucleoside Reverse Transcriptase Inhibitors
p3438
(dp3439
g13
g14
sg15
V/categories/DBCAT002755
p3440
ssVTransition Elements
p3441
(dp3442
g13
g14
sg15
V/categories/DBCAT001388
p3443
ssS'Guanfacine Hydrochloride'
p3444
(dp3445
g13
g25
sg15
S'0205020G0'
p3446
ssS'Lidocaine Hydrochloride Anhydrous'
p3447
(dp3448
g13
g25
sg15
S'0203020M0'
p3449
ssVPhotosensitizing Activity
p3450
(dp3451
g13
g14
sg15
V/categories/DBCAT004155
p3452
ssVProto-Oncogene Proteins
p3453
(dp3454
g13
g14
sg15
V/categories/DBCAT000210
p3455
ssVProgesterone, antagonists & inhibitors
p3456
(dp3457
g13
g14
sg15
V/categories/DBCAT004736
p3458
ssVGrowth Hormone, metabolism
p3459
(dp3460
g13
g14
sg15
V/categories/DBCAT004968
p3461
ssVPyrethrines, Incl. Synthetic Compounds
p3462
(dp3463
g13
g14
sg15
V/categories/DBCAT002555
p3464
ssVBeta Blocking Agents, Non-Selective, and Thiazides
p3465
(dp3466
g13
g14
sg15
V/categories/DBCAT002339
p3467
ssVNitrogen Compounds
p3468
(dp3469
g13
g14
sg15
V/categories/DBCAT000269
p3470
ssVAntihistamines for Topical Use
p3471
(dp3472
g13
g14
sg15
V/categories/DBCAT002285
p3473
ssVAvermectines
p3474
(dp3475
g13
g14
sg15
V/categories/DBCAT002421
p3476
ssVFertility Agents, Female
p3477
(dp3478
g13
g14
sg15
V/categories/DBCAT000062
p3479
ssVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p3480
(dp3481
g13
g14
sg15
V/categories/DBCAT004600
p3482
ssVPhosphodiesterase 3 Inhibitors
p3483
(dp3484
g13
g14
sg15
V/categories/DBCAT000590
p3485
ssVPurinergic P2 Receptor Antagonists
p3486
(dp3487
g13
g14
sg15
V/categories/DBCAT000531
p3488
ssVCytochrome P-450 CYP3A7 Inducers
p3489
(dp3490
g13
g14
sg15
V/categories/DBCAT004499
p3491
ssVGABA Modulators
p3492
(dp3493
g13
g14
sg15
V/categories/DBCAT000453
p3494
ssS'Palifermin'
p3495
(dp3496
g13
g25
sg15
S'0801000W0'
p3497
ssVSelective Serotonin Reuptake Inhibitors
p3498
(dp3499
g13
g14
sg15
V/categories/DBCAT002772
p3500
ssVAntifungal Agents (Vaginal)
p3501
(dp3502
g13
g14
sg15
V/categories/DBCAT002682
p3503
ssS'Acetohydroxamic Acid'
p3504
(dp3505
g13
g25
sg15
S'0704030A0'
p3506
ssVNucleosides and Nucleotides
p3507
(dp3508
g13
g14
sg15
V/categories/DBCAT003686
p3509
ssVN-substituted Glycines
p3510
(dp3511
g13
g14
sg15
V/categories/DBCAT001454
p3512
ssVCytochrome P-450 CYP2B6 Inducers
p3513
(dp3514
g13
g14
sg15
V/categories/DBCAT001015
p3515
ssS'Paracetamol & Codeine Phosphate'
p3516
(dp3517
g13
g25
sg15
S'0407010V0'
p3518
ssS'Glimepiride'
p3519
(dp3520
g13
g25
sg15
S'0601021A0'
p3521
ssVThiadiazoles
p3522
(dp3523
g13
g14
sg15
V/categories/DBCAT000804
p3524
ssVAntifungals for Topical Use
p3525
(dp3526
g13
g14
sg15
V/categories/DBCAT002196
p3527
ssVUGT1A1 Inducers
p3528
(dp3529
g13
g14
sg15
V/categories/DBCAT003925
p3530
ssS'Sotalol Hydrochloride'
p3531
(dp3532
g13
g25
sg15
S'0204000T0'
p3533
ssVUrea Cycle Disorder Agents
p3534
(dp3535
g13
g14
sg15
V/categories/DBCAT002683
p3536
ssS'Ammonium Lactate'
p3537
(dp3538
g13
g25
sg15
S'1302010L0'
p3539
ssVCarbon Compounds, Inorganic
p3540
(dp3541
g13
g14
sg15
V/categories/DBCAT001345
p3542
ssS'Ethinylestradiol'
p3543
(dp3544
g13
g25
sg15
S'0702010E0'
p3545
ssS'Lapatinib'
p3546
(dp3547
g13
g25
sg15
S'0801050AT'
p3548
ssVGonadotropins, Pituitary
p3549
(dp3550
g13
g14
sg15
V/categories/DBCAT000106
p3551
ssVEthylene Imines
p3552
(dp3553
g13
g14
sg15
V/categories/DBCAT002548
p3554
ssVIncreased Uterine Smooth Muscle Contraction or Tone
p3555
(dp3556
g13
g14
sg15
V/categories/DBCAT004294
p3557
ssVChlorobenzoates
p3558
(dp3559
g13
g14
sg15
V/categories/DBCAT000995
p3560
ssVCytochrome P-450 CYP2A6 Inducers
p3561
(dp3562
g13
g14
sg15
V/categories/DBCAT002617
p3563
ssVAdjuvants, Immunologic
p3564
(dp3565
g13
g14
sg15
V/categories/DBCAT000090
p3566
ssVLeukocyte Growth Factor
p3567
(dp3568
g13
g14
sg15
V/categories/DBCAT003248
p3569
ssS'Haloperidol'
p3570
(dp3571
g13
g25
sg15
S'0402010J0'
p3572
ssS'Ixekizumab'
p3573
(dp3574
g13
g25
sg15
S'1305030G0'
p3575
ssS'Didanosine'
p3576
(dp3577
g13
g25
sg15
S'0503010N0'
p3578
ssVAllylamine Antifungal
p3579
(dp3580
g13
g14
sg15
V/categories/DBCAT003396
p3581
ssVAndrostenediols
p3582
(dp3583
g13
g14
sg15
V/categories/DBCAT001287
p3584
ssVArabinonucleosides
p3585
(dp3586
g13
g14
sg15
V/categories/DBCAT000481
p3587
ssS'Ramucirumab'
p3588
(dp3589
g13
g25
sg15
S'0801050BZ'
p3590
ssVDantrolene and Derivatives
p3591
(dp3592
g13
g14
sg15
V/categories/DBCAT002520
p3593
ssVInsulins and Analogues for Injection, Long-Acting
p3594
(dp3595
g13
g14
sg15
V/categories/DBCAT002121
p3596
ssS'Brinzolamide/Brimonidine'
p3597
(dp3598
g13
g25
sg15
S'1106000AL'
p3599
ssVMetals, Rare Earth
p3600
(dp3601
g13
g14
sg15
V/categories/DBCAT001863
p3602
ssVProgesterone and Derivatives
p3603
(dp3604
g13
g14
sg15
V/categories/DBCAT000992
p3605
ssVAromatic Amino Acid Decarboxylase Inhibitors
p3606
(dp3607
g13
g14
sg15
V/categories/DBCAT000471
p3608
ssS'Fludarabine Phosphate'
p3609
(dp3610
g13
g25
sg15
S'0801030W0'
p3611
ssVAntineoplastic and Immunomodulating Agents
p3612
(dp3613
g13
g14
sg15
V/categories/DBCAT002086
p3614
ssVAntiobesity Preparations, Excl. Diet Products
p3615
(dp3616
g13
g14
sg15
V/categories/DBCAT002189
p3617
ssVBlood Proteins
p3618
(dp3619
g13
g14
sg15
V/categories/DBCAT000019
p3620
ssVPurinergic Agonists
p3621
(dp3622
g13
g14
sg15
V/categories/DBCAT001024
p3623
ssS'Dorzolamide'
p3624
(dp3625
g13
g25
sg15
S'1106000P0'
p3626
ssS'Levothyroxine Sodium & Liothyronine'
p3627
(dp3628
g13
g25
sg15
S'0602010Z0'
p3629
ssVBetamethasone
p3630
(dp3631
g13
g14
sg15
V/categories/DBCAT000870
p3632
ssS'Olaparib'
p3633
(dp3634
g13
g25
sg15
S'0801050BY'
p3635
ssVCromolyn Sodium
p3636
(dp3637
g13
g14
sg15
V/categories/DBCAT004761
p3638
ssS'Crotamiton'
p3639
(dp3640
g13
g25
sg15
S'1303000I0'
p3641
ssVInterleukin-6 Receptor Antagonist
p3642
(dp3643
g13
g14
sg15
V/categories/DBCAT003466
p3644
ssVInsecticides
p3645
(dp3646
g13
g14
sg15
V/categories/DBCAT000857
p3647
ssVDecreased GI Motility
p3648
(dp3649
g13
g14
sg15
V/categories/DBCAT004427
p3650
ssS'Paracetamol & Phenylephrine HCl'
p3651
(dp3652
g13
g25
sg15
S'0407010AB'
p3653
ssVPituitary Hormone-Releasing Hormones
p3654
(dp3655
g13
g14
sg15
V/categories/DBCAT000053
p3656
ssS'Natamycin'
p3657
(dp3658
g13
g25
sg15
S'1103010P0'
p3659
ssVHuman Growth Hormone, antagonists & inhibitors
p3660
(dp3661
g13
g14
sg15
V/categories/DBCAT004693
p3662
ssVSigma-1 Receptor Agonists
p3663
(dp3664
g13
g14
sg15
V/categories/DBCAT004207
p3665
ssVHER2/Neu/cerbB2 Antagonists
p3666
(dp3667
g13
g14
sg15
V/categories/DBCAT004073
p3668
ssVNuclear Proteins
p3669
(dp3670
g13
g14
sg15
V/categories/DBCAT001958
p3671
ssVVitamin D and Analogues
p3672
(dp3673
g13
g14
sg15
V/categories/DBCAT002152
p3674
ssVDiazepines, Oxazepines, Thiazepines and Oxepines
p3675
(dp3676
g13
g14
sg15
V/categories/DBCAT002317
p3677
ssVAporphines
p3678
(dp3679
g13
g14
sg15
V/categories/DBCAT001090
p3680
ssVLanthanoid Series Elements
p3681
(dp3682
g13
g14
sg15
V/categories/DBCAT001862
p3683
ssS'Hyoscine Butylbromide'
p3684
(dp3685
g13
g25
sg15
S'0102000N0'
p3686
ssVVerapamil
p3687
(dp3688
g13
g14
sg15
V/categories/DBCAT004529
p3689
ssVGluconates
p3690
(dp3691
g13
g14
sg15
V/categories/DBCAT001733
p3692
ssVThiopurine Analogs
p3693
(dp3694
g13
g14
sg15
V/categories/DBCAT002714
p3695
ssS'Amlodipine'
p3696
(dp3697
g13
g25
sg15
S'0206020A0'
p3698
ssS'Iron & Folic Acid'
p3699
(dp3700
g13
g25
sg15
S'0901011Q0'
p3701
ssVCytochrome P-450 CYP2A6 Inducers (moderate)
p3702
(dp3703
g13
g14
sg15
V/categories/DBCAT003105
p3704
ssVBone Density Conservation Agents
p3705
(dp3706
g13
g14
sg15
V/categories/DBCAT000089
p3707
ssS'Atenolol'
p3708
(dp3709
g13
g25
sg15
S'0204000E0'
p3710
ssS'Salicylic Acid'
p3711
(dp3712
g13
g14
sg15
V/categories/DBCAT001197
p3713
ssVChelating Activity
p3714
(dp3715
g13
g14
sg15
V/categories/DBCAT004260
p3716
ssVNaphthacenes
p3717
(dp3718
g13
g14
sg15
V/categories/DBCAT000617
p3719
ssVVascular Endothelial Growth Factor-directed Antibody Interactions
p3720
(dp3721
g13
g14
sg15
V/categories/DBCAT004233
p3722
ssVNatriuretic Agents
p3723
(dp3724
g13
g14
sg15
V/categories/DBCAT000114
p3725
ssVPhosphoric Monoester Hydrolases
p3726
(dp3727
g13
g14
sg15
V/categories/DBCAT001744
p3728
ssVHallucinogens
p3729
(dp3730
g13
g14
sg15
V/categories/DBCAT000908
p3731
ssS'Cetirizine Hydrochloride'
p3732
(dp3733
g13
g25
sg15
S'0304010I0'
p3734
ssVCatecholamine Synthesis Inhibitor
p3735
(dp3736
g13
g14
sg15
V/categories/DBCAT003401
p3737
ssVLipid Modifying Agents
p3738
(dp3739
g13
g14
sg15
V/categories/DBCAT002168
p3740
ssVPolyamines
p3741
(dp3742
g13
g14
sg15
V/categories/DBCAT000281
p3743
ssVHistone Deacetylase Inhibitors
p3744
(dp3745
g13
g14
sg15
V/categories/DBCAT001486
p3746
ssVAcids
p3747
(dp3748
g13
g14
sg15
V/categories/DBCAT000322
p3749
ssVPhenyl Ethers
p3750
(dp3751
g13
g14
sg15
V/categories/DBCAT000812
p3752
ssS'Pyrimethamine'
p3753
(dp3754
g13
g25
sg15
S'0504010N0'
p3755
ssVTopoisomerase II Inhibitors
p3756
(dp3757
g13
g14
sg15
V/categories/DBCAT000549
p3758
ssVAntiparasitic Agents
p3759
(dp3760
g13
g14
sg15
V/categories/DBCAT000522
p3761
ssVEchinocandin Antifungal
p3762
(dp3763
g13
g14
sg15
V/categories/DBCAT003336
p3764
ssVSensory Organs
p3765
(dp3766
g13
g14
sg15
V/categories/DBCAT002092
p3767
ssVHistamine H1 Antagonists
p3768
(dp3769
g13
g14
sg15
V/categories/DBCAT000665
p3770
ssVMetal cations
p3771
(dp3772
g13
g14
sg15
V/categories/DBCAT004585
p3773
ssVMiscellaneous Anxiolytics Sedatives and Hypnotics
p3774
(dp3775
g13
g14
sg15
V/categories/DBCAT003678
p3776
ssS'Galsulfase'
p3777
(dp3778
g13
g25
sg15
S'0908010AG'
p3779
ssVEENT Drugs, Miscellaneous
p3780
(dp3781
g13
g14
sg15
V/categories/DBCAT003675
p3782
ssS'Cyproterone Acetate'
p3783
(dp3784
g13
g25
sg15
S'0803042E0'
p3785
ssVFluids and Secretions
p3786
(dp3787
g13
g14
sg15
V/categories/DBCAT001368
p3788
ssVVoltage-Gated Sodium Channel Blockers
p3789
(dp3790
g13
g14
sg15
V/categories/DBCAT000615
p3791
ssVMetaproterenol
p3792
(dp3793
g13
g14
sg15
V/categories/DBCAT001334
p3794
ssS'Valganciclovir Hydrochloride'
p3795
(dp3796
g13
g25
sg15
S'0503022B0'
p3797
ssVLipoglycopeptide Antibacterial
p3798
(dp3799
g13
g14
sg15
V/categories/DBCAT003450
p3800
ssS'Alemtuzumab'
p3801
(dp3802
g13
g25
sg15
S'0802030E0'
p3803
ssVSubstituted Alkylamines
p3804
(dp3805
g13
g14
sg15
V/categories/DBCAT002362
p3806
ssVGastrointestinal Hormones
p3807
(dp3808
g13
g14
sg15
V/categories/DBCAT000091
p3809
ssVChromones
p3810
(dp3811
g13
g14
sg15
V/categories/DBCAT001225
p3812
ssVCholinergic Agonists
p3813
(dp3814
g13
g14
sg15
V/categories/DBCAT000444
p3815
ssVIncreased Diuresis
p3816
(dp3817
g13
g14
sg15
V/categories/DBCAT004080
p3818
ssVBile acids and derivatives
p3819
(dp3820
g13
g14
sg15
V/categories/DBCAT004599
p3821
ssVThyroid Hormone Synthesis Inhibitor
p3822
(dp3823
g13
g14
sg15
V/categories/DBCAT003370
p3824
ssS'Magnesium Citrate'
p3825
(dp3826
g13
g25
sg15
S'0106050M0'
p3827
ssVGlucosides
p3828
(dp3829
g13
g14
sg15
V/categories/DBCAT000871
p3830
ssVFlavonoids
p3831
(dp3832
g13
g14
sg15
V/categories/DBCAT001281
p3833
ssVUGT1A4 substrates
p3834
(dp3835
g13
g14
sg15
V/categories/DBCAT004564
p3836
ssVMineralocorticoid (Aldosterone) Receptor Antagonists
p3837
(dp3838
g13
g14
sg15
V/categories/DBCAT003684
p3839
ssVThyroid Hormone Synthesis Inhibitors
p3840
(dp3841
g13
g14
sg15
V/categories/DBCAT004343
p3842
ssVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p3843
(dp3844
g13
g14
sg15
V/categories/DBCAT002625
p3845
ssS'Lansoprazole'
p3846
(dp3847
g13
g25
sg15
S'0103050L0'
p3848
ssS'Ethambutol Hydrochloride'
p3849
(dp3850
g13
g25
sg15
S'0501090H0'
p3851
ssVAntihypoglycemic Agent
p3852
(dp3853
g13
g14
sg15
V/categories/DBCAT003548
p3854
ssVPiperidones
p3855
(dp3856
g13
g14
sg15
V/categories/DBCAT000785
p3857
ssS'Simvastatin & Ezetimibe'
p3858
(dp3859
g13
g25
sg15
S'0212000AC'
p3860
ssS'Estrone'
p3861
(dp3862
g13
g14
sg15
V/categories/DBCAT004748
p3863
ssVCalcium Channel Blockers
p3864
(dp3865
g13
g14
sg15
V/categories/DBCAT000574
p3866
ssS'Rivaroxaban'
p3867
(dp3868
g13
g25
sg15
S'0208020Y0'
p3869
ssVIrrigating Solutions
p3870
(dp3871
g13
g14
sg15
V/categories/DBCAT002155
p3872
ssVPotassium Channel Opener
p3873
(dp3874
g13
g14
sg15
V/categories/DBCAT003451
p3875
ssVIncreased T Lymphocyte Activation
p3876
(dp3877
g13
g14
sg15
V/categories/DBCAT004287
p3878
ssVVasoprotectives
p3879
(dp3880
g13
g14
sg15
V/categories/DBCAT002284
p3881
ssS'Benralizumab'
p3882
(dp3883
g13
g25
sg15
S'0304020AA'
p3884
ssS'Disopyramide'
p3885
(dp3886
g13
g25
sg15
S'0203020F0'
p3887
ssVHeparin Antagonists
p3888
(dp3889
g13
g14
sg15
V/categories/DBCAT001959
p3890
ssS'Sacrosidase'
p3891
(dp3892
g13
g25
sg15
S'0908010Y0'
p3893
ssVDiketopiperazines
p3894
(dp3895
g13
g14
sg15
V/categories/DBCAT000814
p3896
ssVAcetaldehyde Dehydrogenase Inhibitors
p3897
(dp3898
g13
g14
sg15
V/categories/DBCAT001150
p3899
ssS'Terazosin Hydrochloride'
p3900
(dp3901
g13
g25
sg15
S'0704010T0'
p3902
ssVImmunoglobulins
p3903
(dp3904
g13
g14
sg15
V/categories/DBCAT000017
p3905
ssVAcids, Carbocyclic
p3906
(dp3907
g13
g14
sg15
V/categories/DBCAT000583
p3908
ssVFluorescent Dyes
p3909
(dp3910
g13
g14
sg15
V/categories/DBCAT001077
p3911
ssS'Elbasvir/Grazoprevir'
p3912
(dp3913
g13
g25
sg15
S'0503032I0'
p3914
ssVFertility Agents
p3915
(dp3916
g13
g14
sg15
V/categories/DBCAT000060
p3917
ssVDihydroxyphenylalanine
p3918
(dp3919
g13
g14
sg15
V/categories/DBCAT000464
p3920
ssVCholinesterase substrates
p3921
(dp3922
g13
g14
sg15
V/categories/DBCAT004572
p3923
ssVKidney Failure, Chronic
p3924
(dp3925
g13
g14
sg15
V/categories/DBCAT001864
p3926
ssVAntiemetics and Antinauseants
p3927
(dp3928
g13
g14
sg15
V/categories/DBCAT002342
p3929
ssS'Procarbazine Hydrochloride'
p3930
(dp3931
g13
g25
sg15
S'0801050U0'
p3932
ssVParenteral Iron Replacement
p3933
(dp3934
g13
g14
sg15
V/categories/DBCAT003555
p3935
ssVAdrenergic Agents
p3936
(dp3937
g13
g14
sg15
V/categories/DBCAT000435
p3938
ssVCytochrome P-450 CYP3A5 Inducers
p3939
(dp3940
g13
g14
sg15
V/categories/DBCAT004489
p3941
ssVBasic Ointments and Protectants
p3942
(dp3943
g13
g14
sg15
V/categories/DBCAT003627
p3944
ssVPolysaccharides
p3945
(dp3946
g13
g14
sg15
V/categories/DBCAT000669
p3947
ssVSupplements
p3948
(dp3949
g13
g14
sg15
V/categories/DBCAT002729
p3950
ssVUGT1A1 substrates with narrow therapeutic index
p3951
(dp3952
g13
g14
sg15
V/categories/DBCAT004530
p3953
ssVHematoporphyrin Derivative
p3954
(dp3955
g13
g14
sg15
V/categories/DBCAT001082
p3956
ssVPhthalazines
p3957
(dp3958
g13
g14
sg15
V/categories/DBCAT001325
p3959
ssVNorgestrel
p3960
(dp3961
g13
g25
sg15
S'0703021P0'
p3962
ssS'Tacrolimus'
p3963
(dp3964
g13
g14
sg15
V/categories/DBCAT004756
p3965
ssVMicrosomal Triglyceride Transfer Protein Inhibitor
p3966
(dp3967
g13
g14
sg15
V/categories/DBCAT003488
p3968
ssVArginine Vasopressin, analogs & derivatives
p3969
(dp3970
g13
g14
sg15
V/categories/DBCAT004696
p3971
ssVCytochrome P-450 CYP2C9 Inhibitors (weak)
p3972
(dp3973
g13
g14
sg15
V/categories/DBCAT003038
p3974
ssS'Brompheniramine Maleate'
p3975
(dp3976
g13
g25
sg15
S'0304010F0'
p3977
ssS'Trazodone Hydrochloride'
p3978
(dp3979
g13
g25
sg15
S'0403010X0'
p3980
ssS'Framycetin Sulfate'
p3981
(dp3982
g13
g25
sg15
S'1201010P0'
p3983
ssVBoron Compounds
p3984
(dp3985
g13
g14
sg15
V/categories/DBCAT000461
p3986
ssVBCRP/ABCG2 Substrates
p3987
(dp3988
g13
g14
sg15
V/categories/DBCAT002663
p3989
ssS'Benzoyl Peroxide'
p3990
(dp3991
g13
g25
sg15
S'1306010C0'
p3992
ssVDigoxin and derivatives
p3993
(dp3994
g13
g14
sg15
V/categories/DBCAT003177
p3995
ssVLymphokines
p3996
(dp3997
g13
g14
sg15
V/categories/DBCAT002874
p3998
ssVBarbiturates and Derivatives
p3999
(dp4000
g13
g14
sg15
V/categories/DBCAT002391
p4001
ssS'Amsacrine'
p4002
(dp4003
g13
g25
sg15
S'0801050C0'
p4004
ssS'Cefalexin'
p4005
(dp4006
g13
g25
sg15
S'0501021L0'
p4007
ssS'Migalastat'
p4008
(dp4009
g13
g25
sg15
S'0908010AQ'
p4010
ssVTetrahydronaphthalenes
p4011
(dp4012
g13
g14
sg15
V/categories/DBCAT001127
p4013
ssS'Busulfan'
p4014
(dp4015
g13
g25
sg15
S'0801010B0'
p4016
ssS'Isoniazid'
p4017
(dp4018
g13
g25
sg15
S'0501090K0'
p4019
ssVAngiotensin II Antagonists and Calcium Channel Blockers
p4020
(dp4021
g13
g14
sg15
V/categories/DBCAT002170
p4022
ssS'Colchicine'
p4023
(dp4024
g13
g25
sg15
S'1001040G0'
p4025
ssVCytochrome P-450 CYP2C9 Inducers (strong)
p4026
(dp4027
g13
g14
sg15
V/categories/DBCAT002637
p4028
ssVImmunologic Factors
p4029
(dp4030
g13
g14
sg15
V/categories/DBCAT000038
p4031
ssVAntacids
p4032
(dp4033
g13
g14
sg15
V/categories/DBCAT001353
p4034
ssS'Hyoscine'
p4035
(dp4036
g13
g25
sg15
S'0406000A0'
p4037
ssVOCT2 Inhibitors
p4038
(dp4039
g13
g14
sg15
V/categories/DBCAT003948
p4040
ssVGrowth Hormone Receptor Antagonists
p4041
(dp4042
g13
g14
sg15
V/categories/DBCAT004283
p4043
ssVAzirines
p4044
(dp4045
g13
g14
sg15
V/categories/DBCAT000711
p4046
ssVMembrane Fusion Proteins
p4047
(dp4048
g13
g14
sg15
V/categories/DBCAT002898
p4049
ssVDrugs for Obstructive Airway Diseases
p4050
(dp4051
g13
g14
sg15
V/categories/DBCAT002112
p4052
ssS'Insulin Degludec'
p4053
(dp4054
g13
g25
sg15
S'0601012Z0'
p4055
ssS'Metipranolol'
p4056
(dp4057
g13
g25
sg15
S'1106000U0'
p4058
ssVFolate Analog
p4059
(dp4060
g13
g14
sg15
V/categories/DBCAT004536
p4061
ssS'Furosemide/Potassium'
p4062
(dp4063
g13
g25
sg15
S'0202080K0'
p4064
ssVAmines
p4065
(dp4066
g13
g14
sg15
V/categories/DBCAT000266
p4067
ssS'Clofarabine'
p4068
(dp4069
g13
g25
sg15
S'0801030AA'
p4070
ssVFentanyl and fentanyl analogues
p4071
(dp4072
g13
g14
sg15
V/categories/DBCAT001085
p4073
ssVNootropic Agents
p4074
(dp4075
g13
g14
sg15
V/categories/DBCAT000278
p4076
ssS'Lovastatin'
p4077
(dp4078
g13
g25
sg15
S'0212000R0'
p4079
ssVEstrogens, agonists
p4080
(dp4081
g13
g14
sg15
V/categories/DBCAT004754
p4082
ssVCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
p4083
(dp4084
g13
g14
sg15
V/categories/DBCAT003339
p4085
ssVDecreased Sebaceous Gland Activity
p4086
(dp4087
g13
g14
sg15
V/categories/DBCAT004079
p4088
ssS'Deflazacort'
p4089
(dp4090
g13
g25
sg15
S'0603020I0'
p4091
ssVOxacillin
p4092
(dp4093
g13
g14
sg15
V/categories/DBCAT000701
p4094
ssVFolic Acid
p4095
(dp4096
g13
g14
sg15
V/categories/DBCAT004537
p4097
ssVPeptide Hydrolases
p4098
(dp4099
g13
g14
sg15
V/categories/DBCAT000069
p4100
ssS'Dihydrocodeine Tartrate'
p4101
(dp4102
g13
g25
sg15
S'0407020G0'
p4103
ssVCytochrome P450 3A5 Inhibitors
p4104
(dp4105
g13
g14
sg15
V/categories/DBCAT004187
p4106
ssVAdrenergic beta-Agonists
p4107
(dp4108
g13
g14
sg15
V/categories/DBCAT000553
p4109
ssVBelladonna and Derivatives, Plain
p4110
(dp4111
g13
g14
sg15
V/categories/DBCAT002368
p4112
ssS'Prednisolone Acetate'
p4113
(dp4114
g13
g25
sg15
S'1001022N0'
p4115
ssVProgestins
p4116
(dp4117
g13
g14
sg15
V/categories/DBCAT000708
p4118
ssVCytochrome P-450 CYP2E1 Inhibitors (strong)
p4119
(dp4120
g13
g14
sg15
V/categories/DBCAT002630
p4121
ssVAmino Acids
p4122
(dp4123
g13
g14
sg15
V/categories/DBCAT000243
p4124
ssVMiscellaneous Analgesics and Antipyretics
p4125
(dp4126
g13
g14
sg15
V/categories/DBCAT003661
p4127
ssVVirus Neutralization
p4128
(dp4129
g13
g14
sg15
V/categories/DBCAT004071
p4130
ssVNitrogen Mustard Analogues
p4131
(dp4132
g13
g14
sg15
V/categories/DBCAT002289
p4133
ssVBenzylidene Compounds
p4134
(dp4135
g13
g14
sg15
V/categories/DBCAT000619
p4136
ssVBoronic Acids
p4137
(dp4138
g13
g14
sg15
V/categories/DBCAT000460
p4139
ssVPurinergic P1 Receptor Agonists
p4140
(dp4141
g13
g14
sg15
V/categories/DBCAT001025
p4142
ssS'Somatropin'
p4143
(dp4144
g13
g25
sg15
S'0605010S0'
p4145
ssVMedicated Dressings With Antiinfectives
p4146
(dp4147
g13
g14
sg15
V/categories/DBCAT002320
p4148
ssVAdrenergics, Inhalants
p4149
(dp4150
g13
g14
sg15
V/categories/DBCAT002231
p4151
ssVAnesthetics for Topical Use
p4152
(dp4153
g13
g14
sg15
V/categories/DBCAT002279
p4154
ssS'Phenobarbital & Phenytoin'
p4155
(dp4156
g13
g25
sg15
S'0408010S0'
p4157
ssV4-Hydroxycoumarins
p4158
(dp4159
g13
g14
sg15
V/categories/DBCAT000640
p4160
ssVAnthracycline Topoisomerase Inhibitor
p4161
(dp4162
g13
g14
sg15
V/categories/DBCAT003352
p4163
ssS'Efavirenz/Emtricitabine/Tenofovir Disop'
p4164
(dp4165
g13
g25
sg15
S'0503010AN'
p4166
ssVQuaternary Ammonium Compounds
p4167
(dp4168
g13
g14
sg15
V/categories/DBCAT000265
p4169
ssS'Urofollitropin'
p4170
(dp4171
g13
g25
sg15
S'0605010M0'
p4172
ssS'Tetrabenazine'
p4173
(dp4174
g13
g25
sg15
S'0409030C0'
p4175
ssVMarine Toxins
p4176
(dp4177
g13
g14
sg15
V/categories/DBCAT001494
p4178
ssVDicarboxylic Acids
p4179
(dp4180
g13
g14
sg15
V/categories/DBCAT000327
p4181
ssVHistamine Antagonists
p4182
(dp4183
g13
g14
sg15
V/categories/DBCAT000664
p4184
ssS'Trastuzumab'
p4185
(dp4186
g13
g25
sg15
S'0801050AD'
p4187
ssVGentamicins
p4188
(dp4189
g13
g14
sg15
V/categories/DBCAT001201
p4190
ssVHistamine H1 Inhibitors
p4191
(dp4192
g13
g14
sg15
V/categories/DBCAT003399
p4193
ssVNMDA Receptor Antagonists
p4194
(dp4195
g13
g14
sg15
V/categories/DBCAT002723
p4196
ssS'Dexrazoxane'
p4197
(dp4198
g13
g25
sg15
S'0801000Y0'
p4199
ssS'Belatacept'
p4200
(dp4201
g13
g25
sg15
S'0802020Y0'
p4202
ssVFlavoring Agents
p4203
(dp4204
g13
g14
sg15
V/categories/DBCAT000376
p4205
ssVVarious Alimentary Tract and Metabolism Products
p4206
(dp4207
g13
g14
sg15
V/categories/DBCAT002164
p4208
ssVCOMT Substrates
p4209
(dp4210
g13
g14
sg15
V/categories/DBCAT002654
p4211
ssVAgents causing hyperkalemia
p4212
(dp4213
g13
g14
sg15
V/categories/DBCAT003960
p4214
ssVEstrogen Antagonists
p4215
(dp4216
g13
g14
sg15
V/categories/DBCAT000786
p4217
ssVPreparations With No Effect on Uric Acid Metabolism
p4218
(dp4219
g13
g14
sg15
V/categories/DBCAT002529
p4220
ssVCycloparaffins
p4221
(dp4222
g13
g14
sg15
V/categories/DBCAT000359
p4223
ssVM2 Protein Inhibitors
p4224
(dp4225
g13
g14
sg15
V/categories/DBCAT004305
p4226
ssVSelective Estrogen Receptor Modulators
p4227
(dp4228
g13
g14
sg15
V/categories/DBCAT000918
p4229
ssVCytochrome P-450 CYP2A6 Inducers (strong)
p4230
(dp4231
g13
g14
sg15
V/categories/DBCAT002618
p4232
ssVHumanized Monoclonal Antibody Fragment
p4233
(dp4234
g13
g14
sg15
V/categories/DBCAT003522
p4235
ssS'Methyltestosterone'
p4236
(dp4237
g13
g25
sg15
S'0604020H0'
p4238
ssVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p4239
(dp4240
g13
g14
sg15
V/categories/DBCAT004049
p4241
ssVAndrostan Derivatives
p4242
(dp4243
g13
g14
sg15
V/categories/DBCAT002426
p4244
ssVHexoses
p4245
(dp4246
g13
g14
sg15
V/categories/DBCAT001567
p4247
ssVTertiary Amines
p4248
(dp4249
g13
g14
sg15
V/categories/DBCAT002324
p4250
ssVAcid Reducers
p4251
(dp4252
g13
g14
sg15
V/categories/DBCAT003864
p4253
ssVDrugs that are Mainly Renally Excreted
p4254
(dp4255
g13
g14
sg15
V/categories/DBCAT003987
p4256
ssS'Chenodeoxycholic Acid'
p4257
(dp4258
g13
g25
sg15
S'0109010G0'
p4259
ssS'Etodolac'
p4260
(dp4261
g13
g25
sg15
S'1001010E0'
p4262
ssS'Clopidogrel'
p4263
(dp4264
g13
g25
sg15
S'0209000C0'
p4265
ssS'Isocarboxazid'
p4266
(dp4267
g13
g25
sg15
S'0403020H0'
p4268
ssVSympatholytic (Adrenergic Blocking) Agents
p4269
(dp4270
g13
g14
sg15
V/categories/DBCAT003663
p4271
ssS'Auranofin'
p4272
(dp4273
g13
g25
sg15
S'1001030A0'
p4274
ssVImidazolines
p4275
(dp4276
g13
g14
sg15
V/categories/DBCAT000977
p4277
ssS'Alogliptin/Metformin'
p4278
(dp4279
g13
g25
sg15
S'0601023AJ'
p4280
ssVDesipramine
p4281
(dp4282
g13
g14
sg15
V/categories/DBCAT004770
p4283
ssVAmides
p4284
(dp4285
g13
g14
sg15
V/categories/DBCAT000494
p4286
ssS'Topiramate'
p4287
(dp4288
g13
g25
sg15
S'040801050'
p4289
ssVEphedrine
p4290
(dp4291
g13
g14
sg15
V/categories/DBCAT004776
p4292
ssVEctoparasiticides, Incl. Scabicides, Insecticides and Repellents
p4293
(dp4294
g13
g14
sg15
V/categories/DBCAT002371
p4295
ssVContrast Media
p4296
(dp4297
g13
g14
sg15
V/categories/DBCAT000560
p4298
ssS'Elvitegravir'
p4299
(dp4300
g13
g25
sg15
S'0503010AJ'
p4301
ssS'Swabs'
p4302
(dp4303
g13
g25
sg15
S'2012'
p4304
ssVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p4305
(dp4306
g13
g14
sg15
V/categories/DBCAT004480
p4307
ssVLipotropic Agents
p4308
(dp4309
g13
g14
sg15
V/categories/DBCAT000277
p4310
ssVSecosteroids
p4311
(dp4312
g13
g14
sg15
V/categories/DBCAT000311
p4313
ssVGlucagon-like Peptide-1 (GLP-1) Agonists
p4314
(dp4315
g13
g14
sg15
V/categories/DBCAT004144
p4316
ssVMATE 2 Substrates
p4317
(dp4318
g13
g14
sg15
V/categories/DBCAT003954
p4319
ssS'Latanoprost & Timolol'
p4320
(dp4321
g13
g25
sg15
S'1106000AD'
p4322
ssVCytochrome P-450 CYP2C19 Inhibitors (strong)
p4323
(dp4324
g13
g14
sg15
V/categories/DBCAT002639
p4325
ssVHigh-Ceiling Diuretics and Potassium-Sparing Agents
p4326
(dp4327
g13
g14
sg15
V/categories/DBCAT002450
p4328
ssVFluoropyrimidines
p4329
(dp4330
g13
g14
sg15
V/categories/DBCAT003851
p4331
ssVInducers of Drug Clearance
p4332
(dp4333
g13
g14
sg15
V/categories/DBCAT002722
p4334
ssVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p4335
(dp4336
g13
g14
sg15
V/categories/DBCAT004516
p4337
ssS'Insulin Lispro'
p4338
(dp4339
g13
g25
sg15
S'0601011L0'
p4340
ssS'Etacrynic Acid'
p4341
(dp4342
g13
g25
sg15
S'0202020H0'
p4343
ssS'Mirtazapine'
p4344
(dp4345
g13
g25
sg15
S'0403040X0'
p4346
ssVCytochrome P450 2D6 Inducers
p4347
(dp4348
g13
g14
sg15
V/categories/DBCAT004282
p4349
ssVMineralocorticoid Receptor Antagonists
p4350
(dp4351
g13
g14
sg15
V/categories/DBCAT000844
p4352
ssVAdenine Nucleotides
p4353
(dp4354
g13
g14
sg15
V/categories/DBCAT000290
p4355
ssS'Glatiramer Acetate'
p4356
(dp4357
g13
g25
sg15
S'0802040U0'
p4358
ssVThird-Generation Cephalosporins
p4359
(dp4360
g13
g14
sg15
V/categories/DBCAT002268
p4361
ssVBiomedical and Dental Materials
p4362
(dp4363
g13
g14
sg15
V/categories/DBCAT000806
p4364
ssS'Insulin Detemir'
p4365
(dp4366
g13
g25
sg15
S'0601012X0'
p4367
ssVPotassium Channel Blockers
p4368
(dp4369
g13
g14
sg15
V/categories/DBCAT000519
p4370
ssVBile Acid Preparations
p4371
(dp4372
g13
g14
sg15
V/categories/DBCAT002534
p4373
ssVReceptors, AMPA, antagonists & inhibitors
p4374
(dp4375
g13
g14
sg15
V/categories/DBCAT001477
p4376
ssS'Acitretin'
p4377
(dp4378
g13
g14
sg15
V/categories/DBCAT004740
p4379
ssVStandardized Chemical Allergen
p4380
(dp4381
g13
g14
sg15
V/categories/DBCAT003420
p4382
ssVImmunoglobulin G
p4383
(dp4384
g13
g14
sg15
V/categories/DBCAT000025
p4385
ssVMicrosomal Triglyceride Transfer Protein Inhibitors
p4386
(dp4387
g13
g14
sg15
V/categories/DBCAT004347
p4388
ssVBenzothiadiazines
p4389
(dp4390
g13
g14
sg15
V/categories/DBCAT000575
p4391
ssVAntidepressive Agents, Tetracyclic
p4392
(dp4393
g13
g14
sg15
V/categories/DBCAT003850
p4394
ssVAminosalicylic Acids
p4395
(dp4396
g13
g14
sg15
V/categories/DBCAT000578
p4397
ssS'Sodium Fluoride'
p4398
(dp4399
g13
g25
sg15
S'0905030G0'
p4400
ssS'Phenazopyridine Hydrochloride'
p4401
(dp4402
g13
g25
sg15
S'0704030E0'
p4403
ssVBicarbonates
p4404
(dp4405
g13
g14
sg15
V/categories/DBCAT001354
p4406
ssVPodophyllotoxin Derivatives
p4407
(dp4408
g13
g14
sg15
V/categories/DBCAT002380
p4409
ssVNatural Penicillins
p4410
(dp4411
g13
g14
sg15
V/categories/DBCAT003683
p4412
ssVNitroimidazoles
p4413
(dp4414
g13
g14
sg15
V/categories/DBCAT001188
p4415
ssVCoccidiostats
p4416
(dp4417
g13
g14
sg15
V/categories/DBCAT000789
p4418
ssS'Bretylium Tosilate'
p4419
(dp4420
g13
g25
sg15
S'0203020E0'
p4421
ssVDNA Terminase Complex Inhibitors
p4422
(dp4423
g13
g14
sg15
V/categories/DBCAT004445
p4424
ssS'Ibuprofen/Pseudoephed HCl'
p4425
(dp4426
g13
g25
sg15
S'0309020AA'
p4427
ssVIsoquinolines
p4428
(dp4429
g13
g14
sg15
V/categories/DBCAT000551
p4430
ssVCytochrome P-450 CYP3A Substrates
p4431
(dp4432
g13
g14
sg15
V/categories/DBCAT003919
p4433
ssVSulfanilamides
p4434
(dp4435
g13
g14
sg15
V/categories/DBCAT000636
p4436
ssS'Rolapitant'
p4437
(dp4438
g13
g25
sg15
S'0406000AH'
p4439
ssS'Lodoxamide Trometamol'
p4440
(dp4441
g13
g25
sg15
S'1104020M0'
p4442
ssVEpoxide Hydrolase Inhibitors
p4443
(dp4444
g13
g14
sg15
V/categories/DBCAT004334
p4445
ssS'Brinzolamide & Timolol'
p4446
(dp4447
g13
g25
sg15
S'1106000AJ'
p4448
ssS'Vardenafil'
p4449
(dp4450
g13
g25
sg15
S'0704050AA'
p4451
ssS'Felodipine'
p4452
(dp4453
g13
g25
sg15
S'0206020F0'
p4454
ssVVascular Endothelial Growth Factor Inhibitors
p4455
(dp4456
g13
g14
sg15
V/categories/DBCAT004320
p4457
ssS'Morphine'
p4458
(dp4459
g13
g25
sg15
S'0407020N0'
p4460
ssVCarbamates
p4461
(dp4462
g13
g14
sg15
V/categories/DBCAT000800
p4463
ssVAnthelmintics
p4464
(dp4465
g13
g14
sg15
V/categories/DBCAT000944
p4466
ssS'Sacubitril/Valsartan'
p4467
(dp4468
g13
g25
sg15
S'0205052AE'
p4469
ssVProtein Synthesis Inhibitors
p4470
(dp4471
g13
g14
sg15
V/categories/DBCAT000501
p4472
ssVCytochrome P-450 CYP1A2 Substrates
p4473
(dp4474
g13
g14
sg15
V/categories/DBCAT002609
p4475
ssS'Loteprednol Etabonate'
p4476
(dp4477
g13
g25
sg15
S'1104010W0'
p4478
ssS'Erythromycin Lactobionate'
p4479
(dp4480
g13
g25
sg15
S'0501050K0'
p4481
ssVSulfides
p4482
(dp4483
g13
g14
sg15
V/categories/DBCAT000318
p4484
ssVDiphenylmethane Derivatives
p4485
(dp4486
g13
g14
sg15
V/categories/DBCAT002409
p4487
ssS'Adrenaline'
p4488
(dp4489
g13
g25
sg15
S'0207030A0'
p4490
ssS'Colestyramine'
p4491
(dp4492
g13
g25
sg15
S'1303000E0'
p4493
ssVErythromycins
p4494
(dp4495
g13
g14
sg15
V/categories/DBCAT003634
p4496
ssVCytochrome P-450 CYP2A6 Inhibitors (strong)
p4497
(dp4498
g13
g14
sg15
V/categories/DBCAT002615
p4499
ssVThiouracil
p4500
(dp4501
g13
g14
sg15
V/categories/DBCAT000964
p4502
ssVFree Radical Scavengers
p4503
(dp4504
g13
g14
sg15
V/categories/DBCAT000864
p4505
ssVImidazoline Receptor Agonists
p4506
(dp4507
g13
g14
sg15
V/categories/DBCAT002413
p4508
ssVScopolamine Derivatives
p4509
(dp4510
g13
g14
sg15
V/categories/DBCAT000888
p4511
ssVAgents that reduce seizure threshold
p4512
(dp4513
g13
g14
sg15
V/categories/DBCAT004553
p4514
ssS'Nafarelin Acetate'
p4515
(dp4516
g13
g25
sg15
S'0607020P0'
p4517
ssVCytochrome P-450 CYP2B6 Inhibitors
p4518
(dp4519
g13
g14
sg15
V/categories/DBCAT001285
p4520
ssS'Azacitidine'
p4521
(dp4522
g13
g14
sg15
V/categories/DBCAT004993
p4523
ssVEstrogen Contraceptives
p4524
(dp4525
g13
g14
sg15
V/categories/DBCAT003006
p4526
ssVHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
p4527
(dp4528
g13
g14
sg15
V/categories/DBCAT003302
p4529
ssVOphthalmic Solutions
p4530
(dp4531
g13
g14
sg15
V/categories/DBCAT001236
p4532
ssVImidazolidines
p4533
(dp4534
g13
g14
sg15
V/categories/DBCAT000613
p4535
ssVAngiotensin II
p4536
(dp4537
g13
g14
sg15
V/categories/DBCAT001238
p4538
ssS'Erythromycin'
p4539
(dp4540
g13
g25
sg15
S'1306010I0'
p4541
ssS'Hydroxychloroquine Sulfate'
p4542
(dp4543
g13
g25
sg15
S'1001030C0'
p4544
ssVAntifibrinolytic Agents
p4545
(dp4546
g13
g14
sg15
V/categories/DBCAT000387
p4547
ssVAntifibrotic Agents
p4548
(dp4549
g13
g14
sg15
V/categories/DBCAT003767
p4550
ssS'Inotuzumab'
p4551
(dp4552
g13
g25
sg15
S'0801050CE'
p4553
ssVGrowth Substances
p4554
(dp4555
g13
g14
sg15
V/categories/DBCAT000214
p4556
ssS'Chalk'
p4557
(dp4558
g13
g25
sg15
S'0104010D0'
p4559
ssVDecreased B Lymphocyte Activation
p4560
(dp4561
g13
g14
sg15
V/categories/DBCAT004412
p4562
ssVIntestinal Lipase Inhibitor
p4563
(dp4564
g13
g14
sg15
V/categories/DBCAT003425
p4565
ssVAminobenzoates
p4566
(dp4567
g13
g14
sg15
V/categories/DBCAT000585
p4568
ssVGlycine
p4569
(dp4570
g13
g14
sg15
V/categories/DBCAT001455
p4571
ssVCyclic Lipopeptides
p4572
(dp4573
g13
g14
sg15
V/categories/DBCAT003619
p4574
ssVMuscle Relaxants, Peripherally Acting Agents
p4575
(dp4576
g13
g14
sg15
V/categories/DBCAT002205
p4577
ssVAlkylating Activity
p4578
(dp4579
g13
g14
sg15
V/categories/DBCAT004116
p4580
ssS'Lactulose'
p4581
(dp4582
g13
g25
sg15
S'0106040G0'
p4583
ssVReceptor Protein-Tyrosine Kinases, antagonists & inhibitors
p4584
(dp4585
g13
g14
sg15
V/categories/DBCAT001758
p4586
ssVPlant Exudates
p4587
(dp4588
g13
g14
sg15
V/categories/DBCAT002021
p4589
ssVGlutamates
p4590
(dp4591
g13
g14
sg15
V/categories/DBCAT000339
p4592
ssVPeripheral Vasodilators
p4593
(dp4594
g13
g14
sg15
V/categories/DBCAT002432
p4595
ssS'Paracetamol'
p4596
(dp4597
g13
g25
sg15
S'0407010H0'
p4598
ssVSodium-Glucose Transporter 2 Inhibitors
p4599
(dp4600
g13
g14
sg15
V/categories/DBCAT004076
p4601
ssVPolymyxins
p4602
(dp4603
g13
g14
sg15
V/categories/DBCAT001129
p4604
ssVBeta-Lactam Antibacterials
p4605
(dp4606
g13
g14
sg15
V/categories/DBCAT002295
p4607
ssVAntiplatelet agents
p4608
(dp4609
g13
g14
sg15
V/categories/DBCAT000149
p4610
ssVN-methyl-D-aspartate Receptor Antagonist
p4611
(dp4612
g13
g14
sg15
V/categories/DBCAT003424
p4613
ssVNitrofuran Antibacterial
p4614
(dp4615
g13
g14
sg15
V/categories/DBCAT003393
p4616
ssVCytochrome P-450 CYP2C8 Inhibitors (strong)
p4617
(dp4618
g13
g14
sg15
V/categories/DBCAT002643
p4619
ssS'Ciclesonide'
p4620
(dp4621
g13
g25
sg15
S'0302000U0'
p4622
ssS'Orciprenaline Sulfate'
p4623
(dp4624
g13
g25
sg15
S'0701030N0'
p4625
ssVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p4626
(dp4627
g13
g14
sg15
V/categories/DBCAT002636
p4628
ssS'Simeticone'
p4629
(dp4630
g13
g25
sg15
S'0101010R0'
p4631
ssVOpiate Agonists
p4632
(dp4633
g13
g14
sg15
V/categories/DBCAT003632
p4634
ssS'Lidocaine & Tetracaine'
p4635
(dp4636
g13
g25
sg15
S'1502010Y0'
p4637
ssS'Roflumilast'
p4638
(dp4639
g13
g25
sg15
S'0303030B0'
p4640
ssVAcid Sensing Ion Channel Blockers
p4641
(dp4642
g13
g14
sg15
V/categories/DBCAT000988
p4643
ssVCitric Acid
p4644
(dp4645
g13
g14
sg15
V/categories/DBCAT001953
p4646
ssS'Midodrine Hydrochloride'
p4647
(dp4648
g13
g25
sg15
S'0207020Y0'
p4649
ssS'Bezafibrate'
p4650
(dp4651
g13
g25
sg15
S'0212000D0'
p4652
ssS'Dexamethasone Phosphate'
p4653
(dp4654
g13
g25
sg15
S'0603020AA'
p4655
ssS'Hydrochlorothiazide/Potassium'
p4656
(dp4657
g13
g25
sg15
S'0202080M0'
p4658
ssVPregnen (4) Derivatives
p4659
(dp4660
g13
g14
sg15
V/categories/DBCAT002358
p4661
ssVAminosalicylic Acid and Derivatives
p4662
(dp4663
g13
g14
sg15
V/categories/DBCAT002242
p4664
ssVHexanols
p4665
(dp4666
g13
g14
sg15
V/categories/DBCAT000475
p4667
ssVAdrenergic beta-1 Receptor Antagonists
p4668
(dp4669
g13
g14
sg15
V/categories/DBCAT000458
p4670
ssVEnzyme Replacement Therapy
p4671
(dp4672
g13
g14
sg15
V/categories/DBCAT000147
p4673
ssVCytochrome P-450 CYP2E1 Inhibitors
p4674
(dp4675
g13
g14
sg15
V/categories/DBCAT002629
p4676
ssVRibonucleotides
p4677
(dp4678
g13
g14
sg15
V/categories/DBCAT000291
p4679
ssS'Estradiol Valerate'
p4680
(dp4681
g13
g25
sg15
S'0604011K0'
p4682
ssS'Choline Theophyllinate'
p4683
(dp4684
g13
g25
sg15
S'0301030H0'
p4685
ssVAdrenergic alpha-2 Receptor Antagonists
p4686
(dp4687
g13
g14
sg15
V/categories/DBCAT001356
p4688
ssVPropulsives
p4689
(dp4690
g13
g14
sg15
V/categories/DBCAT002422
p4691
ssVJanus Kinase Inhibitor
p4692
(dp4693
g13
g14
sg15
V/categories/DBCAT003500
p4694
ssVAllyl Compounds
p4695
(dp4696
g13
g14
sg15
V/categories/DBCAT001195
p4697
ssVDisulfides
p4698
(dp4699
g13
g14
sg15
V/categories/DBCAT000317
p4700
ssVOxygen Compounds
p4701
(dp4702
g13
g14
sg15
V/categories/DBCAT000861
p4703
ssVDibenzothiazepines
p4704
(dp4705
g13
g14
sg15
V/categories/DBCAT001302
p4706
ssS'Zanamivir'
p4707
(dp4708
g13
g25
sg15
S'0503040A0'
p4709
ssS'Ceftibuten'
p4710
(dp4711
g13
g25
sg15
S'0501020U0'
p4712
ssS'Idarucizumab'
p4713
(dp4714
g13
g25
sg15
S'0208040A0'
p4715
ssS'Ketoprofen'
p4716
(dp4717
g13
g25
sg15
S'100302010'
p4718
ssVAntituberculosis Agents
p4719
(dp4720
g13
g14
sg15
V/categories/DBCAT003667
p4721
ssVNucleic Acids, Nucleotides, and Nucleosides
p4722
(dp4723
g13
g14
sg15
V/categories/DBCAT000256
p4724
ssS'Titanium Dioxide'
p4725
(dp4726
g13
g25
sg15
S'1308010U0'
p4727
ssVIron Trivalent, Oral Preparations
p4728
(dp4729
g13
g14
sg15
V/categories/DBCAT002587
p4730
ssVDietary Fats, Unsaturated
p4731
(dp4732
g13
g14
sg15
V/categories/DBCAT000295
p4733
ssVPeptides
p4734
(dp4735
g13
g14
sg15
V/categories/DBCAT000052
p4736
ssS'Laureth 9'
p4737
(dp4738
g13
g25
sg15
S'0213000D0'
p4739
ssVSympathomimetic-like Agent
p4740
(dp4741
g13
g14
sg15
V/categories/DBCAT003397
p4742
ssVAngiogenesis Inducing Agents
p4743
(dp4744
g13
g14
sg15
V/categories/DBCAT000215
p4745
ssS'Dantrolene Sodium'
p4746
(dp4747
g13
g25
sg15
S'1501080B0'
p4748
ssVDecreased Striated Muscle Tone
p4749
(dp4750
g13
g14
sg15
V/categories/DBCAT004297
p4751
ssS'Edoxaban'
p4752
(dp4753
g13
g25
sg15
S'0208020AA'
p4754
ssVDietary Carbohydrates
p4755
(dp4756
g13
g14
sg15
V/categories/DBCAT004980
p4757
ssVInterleukin-5 Receptor alpha-directed Cytolytic Antibody
p4758
(dp4759
g13
g14
sg15
V/categories/DBCAT003992
p4760
ssVAmino Acids, Peptides, and Proteins
p4761
(dp4762
g13
g14
sg15
V/categories/DBCAT000021
p4763
ssVBeta Blocking Agents and Thiazides
p4764
(dp4765
g13
g14
sg15
V/categories/DBCAT002266
p4766
ssVMydriatics and Cycloplegics
p4767
(dp4768
g13
g14
sg15
V/categories/DBCAT002350
p4769
ssS'Magnesium Trisilicate'
p4770
(dp4771
g13
g25
sg15
S'0101010J0'
p4772
ssS'Bedaquiline'
p4773
(dp4774
g13
g25
sg15
S'0501090V0'
p4775
ssVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p4776
(dp4777
g13
g14
sg15
V/categories/DBCAT004033
p4778
ssVAgents for Dermatitis, Excluding Corticosteroids
p4779
(dp4780
g13
g14
sg15
V/categories/DBCAT002323
p4781
ssS'Doxycycline Hyclate'
p4782
(dp4783
g13
g25
sg15
S'1203010U0'
p4784
ssVProglucagon
p4785
(dp4786
g13
g14
sg15
V/categories/DBCAT000120
p4787
ssS'Meloxicam'
p4788
(dp4789
g13
g25
sg15
S'1001010AA'
p4790
ssVAcids, Aldehydic
p4791
(dp4792
g13
g14
sg15
V/categories/DBCAT001527
p4793
ssVNitrosoureas
p4794
(dp4795
g13
g14
sg15
V/categories/DBCAT002264
p4796
ssVCytomegalovirus
p4797
(dp4798
g13
g14
sg15
V/categories/DBCAT003852
p4799
ssVNon-selective Beta-adrenergic Agonists
p4800
(dp4801
g13
g14
sg15
V/categories/DBCAT003747
p4802
ssS'Naproxen'
p4803
(dp4804
g13
g25
sg15
S'1001010P0'
p4805
ssS'Glyceryl Trinitrate'
p4806
(dp4807
g13
g25
sg15
S'0107040A0'
p4808
ssVPyrimidines
p4809
(dp4810
g13
g14
sg15
V/categories/DBCAT000349
p4811
ssVAcetylcholine Releasing Agent
p4812
(dp4813
g13
g14
sg15
V/categories/DBCAT003369
p4814
ssVEthers, Cyclic
p4815
(dp4816
g13
g14
sg15
V/categories/DBCAT000835
p4817
ssVMembrane Lipids
p4818
(dp4819
g13
g14
sg15
V/categories/DBCAT000313
p4820
ssS'Insulin Human'
p4821
(dp4822
g13
g25
sg15
S'0601011R0'
p4823
ssVKetolide Antibacterial
p4824
(dp4825
g13
g14
sg15
V/categories/DBCAT003419
p4826
ssS'Ivabradine'
p4827
(dp4828
g13
g25
sg15
S'0206030Y0'
p4829
ssS'Sulfadiazine'
p4830
(dp4831
g13
g14
sg15
V/categories/DBCAT001680
p4832
ssVDecreased GI Smooth Muscle Tone
p4833
(dp4834
g13
g14
sg15
V/categories/DBCAT004426
p4835
ssVNitrosourea Compounds
p4836
(dp4837
g13
g14
sg15
V/categories/DBCAT000633
p4838
ssVIndium Radioisotopes
p4839
(dp4840
g13
g14
sg15
V/categories/DBCAT000194
p4841
ssVTriazoles
p4842
(dp4843
g13
g14
sg15
V/categories/DBCAT000486
p4844
ssS'Danaparoid Sodium'
p4845
(dp4846
g13
g25
sg15
S'0208010C0'
p4847
ssVBiologics for Rheumatoid Arthritis Treatment
p4848
(dp4849
g13
g14
sg15
V/categories/DBCAT003020
p4850
ssVPhenylalkylamine Derivatives
p4851
(dp4852
g13
g14
sg15
V/categories/DBCAT002442
p4853
ssVKinase Inhibitors
p4854
(dp4855
g13
g14
sg15
V/categories/DBCAT004244
p4856
ssS'Moxifloxacin'
p4857
(dp4858
g13
g25
sg15
S'0501120Y0'
p4859
ssS'Mercaptamine'
p4860
(dp4861
g13
g25
sg15
S'0908010E0'
p4862
ssS'Fluorouracil'
p4863
(dp4864
g13
g25
sg15
S'1307000U0'
p4865
ssVColony-Stimulating Factors
p4866
(dp4867
g13
g14
sg15
V/categories/DBCAT000082
p4868
ssVTromethamine
p4869
(dp4870
g13
g14
sg15
V/categories/DBCAT002676
p4871
ssS'Amoxicillin Sodium'
p4872
(dp4873
g13
g25
sg15
S'0501013C0'
p4874
ssS'Desoximetasone'
p4875
(dp4876
g13
g25
sg15
S'1304000J0'
p4877
ssVCellulose
p4878
(dp4879
g13
g14
sg15
V/categories/DBCAT001448
p4880
ssS'Pyrazinamide'
p4881
(dp4882
g13
g25
sg15
S'0501090N0'
p4883
ssS'Laronidase'
p4884
(dp4885
g13
g25
sg15
S'0908010AB'
p4886
ssS'Methazolamide'
p4887
(dp4888
g13
g25
sg15
S'110600030'
p4889
ssS'Empagliflozin'
p4890
(dp4891
g13
g25
sg15
S'0601023AN'
p4892
ssVSorbitol
p4893
(dp4894
g13
g14
sg15
V/categories/DBCAT000647
p4895
ssVHistamine Receptor Antagonists
p4896
(dp4897
g13
g14
sg15
V/categories/DBCAT004215
p4898
ssVPurinones
p4899
(dp4900
g13
g14
sg15
V/categories/DBCAT000504
p4901
ssS'Triclosan'
p4902
(dp4903
g13
g14
sg15
V/categories/DBCAT004833
p4904
ssS'Golimumab'
p4905
(dp4906
g13
g25
sg15
S'1001030X0'
p4907
ssVIncreased Glycogenolysis
p4908
(dp4909
g13
g14
sg15
V/categories/DBCAT004425
p4910
ssS'Rifampicin'
p4911
(dp4912
g13
g25
sg15
S'0501090R0'
p4913
ssVPsoriasis
p4914
(dp4915
g13
g14
sg15
V/categories/DBCAT000201
p4916
ssS'Altretamine'
p4917
(dp4918
g13
g25
sg15
S'0801050A0'
p4919
ssS'Telithromycin'
p4920
(dp4921
g13
g25
sg15
S'0501050T0'
p4922
ssVTetrahydrofolates
p4923
(dp4924
g13
g14
sg15
V/categories/DBCAT004542
p4925
ssS'Fenofibrate'
p4926
(dp4927
g13
g25
sg15
S'0212000P0'
p4928
ssS'Dichlorobenzyl Alcohol'
p4929
(dp4930
g13
g25
sg15
S'1203030Z0'
p4931
ssVGrowth Hormone Receptor Antagonist
p4932
(dp4933
g13
g14
sg15
V/categories/DBCAT003273
p4934
ssS'Parathyroid Hormone'
p4935
(dp4936
g13
g25
sg15
S'0606010V0'
p4937
ssVSurface-Active Agents
p4938
(dp4939
g13
g14
sg15
V/categories/DBCAT000898
p4940
ssVProteasome Inhibitors
p4941
(dp4942
g13
g14
sg15
V/categories/DBCAT003056
p4943
ssVOther Cold and Cough Preparations
p4944
(dp4945
g13
g14
sg15
V/categories/DBCAT003729
p4946
ssVNaphthoquinones
p4947
(dp4948
g13
g14
sg15
V/categories/DBCAT000382
p4949
ssVPolyketides
p4950
(dp4951
g13
g14
sg15
V/categories/DBCAT000497
p4952
ssS'Abacavir/Lamivudine/Zidovudine'
p4953
(dp4954
g13
g25
sg15
S'0503010F0'
p4955
ssVTriazole Derivatives
p4956
(dp4957
g13
g14
sg15
V/categories/DBCAT002193
p4958
ssS'Gabapentin'
p4959
(dp4960
g13
g25
sg15
S'0408010G0'
p4961
ssVPyrimidine Nucleotides
p4962
(dp4963
g13
g14
sg15
V/categories/DBCAT000913
p4964
ssVImmune Sera and Immunoglobulins
p4965
(dp4966
g13
g14
sg15
V/categories/DBCAT002143
p4967
ssVCytochrome P-450 CYP2A6 Inhibitors
p4968
(dp4969
g13
g14
sg15
V/categories/DBCAT002614
p4970
ssVPhytol
p4971
(dp4972
g13
g14
sg15
V/categories/DBCAT000380
p4973
ssS'Mefenamic Acid'
p4974
(dp4975
g13
g25
sg15
S'1001010N0'
p4976
ssS'Alirocumab'
p4977
(dp4978
g13
g25
sg15
S'0212000AI'
p4979
ssVTamoxifen
p4980
(dp4981
g13
g14
sg15
V/categories/DBCAT000916
p4982
ssVDibenzazepines
p4983
(dp4984
g13
g14
sg15
V/categories/DBCAT000792
p4985
ssVTestosterone Congeners
p4986
(dp4987
g13
g14
sg15
V/categories/DBCAT001014
p4988
ssVMetals
p4989
(dp4990
g13
g14
sg15
V/categories/DBCAT001341
p4991
ssVXanthenes
p4992
(dp4993
g13
g14
sg15
V/categories/DBCAT001074
p4994
ssVCaproates
p4995
(dp4996
g13
g14
sg15
V/categories/DBCAT000938
p4997
ssVFerrous Compounds
p4998
(dp4999
g13
g14
sg15
V/categories/DBCAT001773
p5000
ssVRecombinant Antithrombin
p5001
(dp5002
g13
g14
sg15
V/categories/DBCAT003597
p5003
ssVPeptoids
p5004
(dp5005
g13
g14
sg15
V/categories/DBCAT001456
p5006
ssS'Olmesartan Medoxomil/Amlodipine'
p5007
(dp5008
g13
g25
sg15
S'0205052AB'
p5009
ssVSleep Initiation and Maintenance Disorders
p5010
(dp5011
g13
g14
sg15
V/categories/DBCAT001294
p5012
ssVBismuth containing drugs
p5013
(dp5014
g13
g14
sg15
V/categories/DBCAT003915
p5015
ssVDideoxynucleosides
p5016
(dp5017
g13
g14
sg15
V/categories/DBCAT000928
p5018
ssVNucleic Acid Synthesis Inhibitors
p5019
(dp5020
g13
g14
sg15
V/categories/DBCAT000593
p5021
ssVLymphocyte Function Alteration
p5022
(dp5023
g13
g14
sg15
V/categories/DBCAT004393
p5024
ssS'Calcium Acetate'
p5025
(dp5026
g13
g25
sg15
S'0905022C0'
p5027
ssS'Ospemifene'
p5028
(dp5029
g13
g25
sg15
S'0702010M0'
p5030
ssVSympathomimetics
p5031
(dp5032
g13
g14
sg15
V/categories/DBCAT000438
p5033
ssVGABA-A Receptor Agonists
p5034
(dp5035
g13
g14
sg15
V/categories/DBCAT000850
p5036
ssVRetinoids
p5037
(dp5038
g13
g14
sg15
V/categories/DBCAT000355
p5039
ssVCarbonic Acid
p5040
(dp5041
g13
g14
sg15
V/categories/DBCAT001344
p5042
ssVCorticosteroids for Systemic Use
p5043
(dp5044
g13
g14
sg15
V/categories/DBCAT002378
p5045
ssVBradykinin B2 Receptor Antagonists
p5046
(dp5047
g13
g14
sg15
V/categories/DBCAT001770
p5048
ssVMuscarinic Antagonists
p5049
(dp5050
g13
g14
sg15
V/categories/DBCAT000534
p5051
ssVQuinuclidines
p5052
(dp5053
g13
g14
sg15
V/categories/DBCAT000905
p5054
ssVDiterpenes
p5055
(dp5056
g13
g14
sg15
V/categories/DBCAT000381
p5057
ssVHydroxybutyrates
p5058
(dp5059
g13
g14
sg15
V/categories/DBCAT001363
p5060
ssVl-Triiodothyronine
p5061
(dp5062
g13
g14
sg15
V/categories/DBCAT003316
p5063
ssS'Clonazepam'
p5064
(dp5065
g13
g25
sg15
S'0408020D0'
p5066
ssS'Pentobarbital Sodium'
p5067
(dp5068
g13
g25
sg15
S'0401030Q0'
p5069
ssVRetinoids for Topical Use in Acne
p5070
(dp5071
g13
g14
sg15
V/categories/DBCAT002161
p5072
ssS'Pegfilgrastim'
p5073
(dp5074
g13
g25
sg15
S'0901060P0'
p5075
ssVErgot Alkaloids and Derivatives
p5076
(dp5077
g13
g14
sg15
V/categories/DBCAT000606
p5078
ssVThrombopoietin Receptor Agonist
p5079
(dp5080
g13
g14
sg15
V/categories/DBCAT003455
p5081
ssS'Demeclocycline Hydrochloride'
p5082
(dp5083
g13
g25
sg15
S'0501030F0'
p5084
ssS'Glycerol'
p5085
(dp5086
g13
g25
sg15
S'1203040H0'
p5087
ssVCardanolides
p5088
(dp5089
g13
g14
sg15
V/categories/DBCAT000822
p5090
ssVCephalosporins
p5091
(dp5092
g13
g14
sg15
V/categories/DBCAT000568
p5093
ssS'Canagliflozin/Metformin'
p5094
(dp5095
g13
g25
sg15
S'0601023AP'
p5096
ssVDibenzocycloheptenes
p5097
(dp5098
g13
g14
sg15
V/categories/DBCAT000742
p5099
ssVAzasteroids
p5100
(dp5101
g13
g14
sg15
V/categories/DBCAT001274
p5102
ssVIons
p5103
(dp5104
g13
g14
sg15
V/categories/DBCAT000324
p5105
ssVThiazoles
p5106
(dp5107
g13
g14
sg15
V/categories/DBCAT000348
p5108
ssVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p5109
(dp5110
g13
g14
sg15
V/categories/DBCAT004027
p5111
ssS'Nateglinide'
p5112
(dp5113
g13
g25
sg15
S'0601023U0'
p5114
ssVAntitrematodals
p5115
(dp5116
g13
g14
sg15
V/categories/DBCAT002496
p5117
ssVBenzocycloheptenes
p5118
(dp5119
g13
g14
sg15
V/categories/DBCAT000743
p5120
ssVErythromycin and similars
p5121
(dp5122
g13
g14
sg15
V/categories/DBCAT000499
p5123
ssVMydriatics
p5124
(dp5125
g13
g14
sg15
V/categories/DBCAT000550
p5126
ssS'Pazopanib'
p5127
(dp5128
g13
g25
sg15
S'0801050AZ'
p5129
ssVExpectorants
p5130
(dp5131
g13
g14
sg15
V/categories/DBCAT000852
p5132
ssS'Secobarbital Sodium'
p5133
(dp5134
g13
g25
sg15
S'0401030T0'
p5135
ssVAnti-Dementia Drugs
p5136
(dp5137
g13
g14
sg15
V/categories/DBCAT002344
p5138
ssVNucleotides
p5139
(dp5140
g13
g14
sg15
V/categories/DBCAT000292
p5141
ssVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p5142
(dp5143
g13
g14
sg15
V/categories/DBCAT004503
p5144
ssS'Brivaracetam'
p5145
(dp5146
g13
g25
sg15
S'0408010AL'
p5147
ssVInterleukin-5 Antagonists
p5148
(dp5149
g13
g14
sg15
V/categories/DBCAT004230
p5150
ssVToxic Actions
p5151
(dp5152
g13
g14
sg15
V/categories/DBCAT000151
p5153
ssVDopamine D2 Receptor Antagonists
p5154
(dp5155
g13
g14
sg15
V/categories/DBCAT000879
p5156
ssS'Sodium Lactate'
p5157
(dp5158
g13
g25
sg15
S'1108010U0'
p5159
ssVBlood Substitutes and Perfusion Solutions
p5160
(dp5161
g13
g14
sg15
V/categories/DBCAT002150
p5162
ssVNucleosides
p5163
(dp5164
g13
g14
sg15
V/categories/DBCAT000255
p5165
ssVBSEP/ABCB11 Substrates with Narrow Therapeutic Index
p5166
(dp5167
g13
g14
sg15
V/categories/DBCAT003984
p5168
ssS'Amoxapine'
p5169
(dp5170
g13
g25
sg15
S'0403010C0'
p5171
ssVCannabinoid Receptor Agonists
p5172
(dp5173
g13
g14
sg15
V/categories/DBCAT000909
p5174
ssVNutritional Support
p5175
(dp5176
g13
g14
sg15
V/categories/DBCAT002733
p5177
ssVHyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
p5178
(dp5179
g13
g14
sg15
V/categories/DBCAT004369
p5180
ssS'Parecoxib Sodium'
p5181
(dp5182
g13
g25
sg15
S'1501042H0'
p5183
ssVBelladonna Alkaloids
p5184
(dp5185
g13
g14
sg15
V/categories/DBCAT000763
p5186
ssVDeoxycholic Acid
p5187
(dp5188
g13
g14
sg15
V/categories/DBCAT001381
p5189
ssVDecreased IgE Activity
p5190
(dp5191
g13
g14
sg15
V/categories/DBCAT004419
p5192
ssS'Malathion'
p5193
(dp5194
g13
g25
sg15
S'1310040M0'
p5195
ssVSerum Globulins
p5196
(dp5197
g13
g14
sg15
V/categories/DBCAT000018
p5198
ssS'Enalapril Maleate'
p5199
(dp5200
g13
g25
sg15
S'0205051I0'
p5201
ssVEstrogens
p5202
(dp5203
g13
g14
sg15
V/categories/DBCAT000620
p5204
ssVThiepins
p5205
(dp5206
g13
g14
sg15
V/categories/DBCAT001305
p5207
ssS'Doxycycline Monohydrate'
p5208
(dp5209
g13
g25
sg15
S'0501030Z0'
p5210
ssVAnalgesics and Anesthetics
p5211
(dp5212
g13
g14
sg15
V/categories/DBCAT002281
p5213
ssVAntidepressive Agents, Second-Generation
p5214
(dp5215
g13
g14
sg15
V/categories/DBCAT000347
p5216
ssVInterleukin Inhibitors
p5217
(dp5218
g13
g14
sg15
V/categories/DBCAT002105
p5219
ssVEstradiol Congeners
p5220
(dp5221
g13
g14
sg15
V/categories/DBCAT000672
p5222
ssVRestless Legs Syndrome
p5223
(dp5224
g13
g14
sg15
V/categories/DBCAT000840
p5225
ssS'Lanthanum Carbonate'
p5226
(dp5227
g13
g25
sg15
S'0905022T0'
p5228
ssS'Eprosartan'
p5229
(dp5230
g13
g25
sg15
S'0205052W0'
p5231
ssVHemic and Immune Systems
p5232
(dp5233
g13
g14
sg15
V/categories/DBCAT002885
p5234
ssS'Zonisamide'
p5235
(dp5236
g13
g25
sg15
S'0408010AD'
p5237
ssS'Spironolactone'
p5238
(dp5239
g13
g25
sg15
S'0202030S0'
p5240
ssVT-Lymphocytes, Helper-Inducer, immunology
p5241
(dp5242
g13
g14
sg15
V/categories/DBCAT003911
p5243
ssVCytochrome P-450 CYP2C19 Inhibitors (weak)
p5244
(dp5245
g13
g14
sg15
V/categories/DBCAT003040
p5246
ssS'Ropinirole Hydrochloride'
p5247
(dp5248
g13
g25
sg15
S'0409010H0'
p5249
ssS'Indometacin'
p5250
(dp5251
g13
g25
sg15
S'1001010K0'
p5252
ssVQuinolizines
p5253
(dp5254
g13
g14
sg15
V/categories/DBCAT001626
p5255
ssS'Valproic Acid'
p5256
(dp5257
g13
g25
sg15
S'0402030Q0'
p5258
ssVHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
p5259
(dp5260
g13
g14
sg15
V/categories/DBCAT003347
p5261
ssVInterleukin 6 Receptor Antagonists
p5262
(dp5263
g13
g14
sg15
V/categories/DBCAT004312
p5264
ssVAdrenocortical Insufficiency
p5265
(dp5266
g13
g14
sg15
V/categories/DBCAT003759
p5267
ssS'Podophyllotoxin'
p5268
(dp5269
g13
g14
sg15
V/categories/DBCAT001126
p5270
ssS'Guanidine Hydrochloride'
p5271
(dp5272
g13
g25
sg15
S'1002010K0'
p5273
ssVCytochrome P-450 CYP3A4 Substrates (moderate)
p5274
(dp5275
g13
g14
sg15
V/categories/DBCAT003889
p5276
ssVPenicillinase-resistant Penicillins
p5277
(dp5278
g13
g14
sg15
V/categories/DBCAT003750
p5279
ssVCytotoxic Antibiotics and Related Substances
p5280
(dp5281
g13
g14
sg15
V/categories/DBCAT002288
p5282
ssS'Crystal Violet'
p5283
(dp5284
g13
g25
sg15
S'1311060E0'
p5285
ssS'Macrogol 3350'
p5286
(dp5287
g13
g25
sg15
S'0106040M0'
p5288
ssS'Verapamil Hydrochloride'
p5289
(dp5290
g13
g25
sg15
S'0206020T0'
p5291
ssVAcid Preparations
p5292
(dp5293
g13
g14
sg15
V/categories/DBCAT002546
p5294
ssS'Moxifloxacin Hydrochloride'
p5295
(dp5296
g13
g25
sg15
S'1108020U0'
p5297
ssVColoring Agents
p5298
(dp5299
g13
g14
sg15
V/categories/DBCAT001075
p5300
ssVCentrally Acting Antiobesity Products
p5301
(dp5302
g13
g14
sg15
V/categories/DBCAT002188
p5303
ssVNitrobenzenes
p5304
(dp5305
g13
g14
sg15
V/categories/DBCAT000875
p5306
ssVResins, Synthetic
p5307
(dp5308
g13
g14
sg15
V/categories/DBCAT002940
p5309
ssVThiazide Derivatives
p5310
(dp5311
g13
g14
sg15
V/categories/DBCAT002509
p5312
ssS'Glibenclamide'
p5313
(dp5314
g13
g25
sg15
S'0601021H0'
p5315
ssS'Chloroquine Sulfate'
p5316
(dp5317
g13
g25
sg15
S'0504010G0'
p5318
ssVAnti-Dyskinesia Agents
p5319
(dp5320
g13
g14
sg15
V/categories/DBCAT000129
p5321
ssVFluoroquinolones
p5322
(dp5323
g13
g14
sg15
V/categories/DBCAT002228
p5324
ssVReceptors, Immunologic
p5325
(dp5326
g13
g14
sg15
V/categories/DBCAT000029
p5327
ssVNitrate Vasodilator
p5328
(dp5329
g13
g14
sg15
V/categories/DBCAT003394
p5330
ssVNicotinic Acids
p5331
(dp5332
g13
g14
sg15
V/categories/DBCAT000824
p5333
ssS'Camphor'
p5334
(dp5335
g13
g25
sg15
S'1003020G0'
p5336
ssVNeurokinin 1 Antagonists
p5337
(dp5338
g13
g14
sg15
V/categories/DBCAT004213
p5339
ssVMiscellaneous Antilipemic Agents
p5340
(dp5341
g13
g14
sg15
V/categories/DBCAT003706
p5342
ssVHIV Envelope Protein gp41
p5343
(dp5344
g13
g14
sg15
V/categories/DBCAT004972
p5345
ssVEndothelin Receptor Antagonists
p5346
(dp5347
g13
g14
sg15
V/categories/DBCAT000972
p5348
ssVDiamines
p5349
(dp5350
g13
g14
sg15
V/categories/DBCAT000286
p5351
ssVNarrow Therapeutic Index Drugs
p5352
(dp5353
g13
g14
sg15
V/categories/DBCAT003972
p5354
ssVAntiarrhythmics, Class Ib
p5355
(dp5356
g13
g14
sg15
V/categories/DBCAT002278
p5357
ssVAnticholesteremic Agents
p5358
(dp5359
g13
g14
sg15
V/categories/DBCAT000390
p5360
ssVBenzothiazepine Derivatives
p5361
(dp5362
g13
g14
sg15
V/categories/DBCAT002326
p5363
ssS'Mometasone Furoate'
p5364
(dp5365
g13
g25
sg15
S'1304000Y0'
p5366
ssVAnti-Allergic Agents
p5367
(dp5368
g13
g14
sg15
V/categories/DBCAT000133
p5369
ssS'Zafirlukast'
p5370
(dp5371
g13
g25
sg15
S'0303020Z0'
p5372
ssVAdjuvants
p5373
(dp5374
g13
g14
sg15
V/categories/DBCAT002735
p5375
ssVMAP Kinase Kinase 2, antagonists & inhibitors
p5376
(dp5377
g13
g14
sg15
V/categories/DBCAT001917
p5378
ssVPiperazine Derivatives
p5379
(dp5380
g13
g14
sg15
V/categories/DBCAT002325
p5381
ssS'Epoetin Theta'
p5382
(dp5383
g13
g25
sg15
S'0901030S0'
p5384
ssVAgents producing tachycardia
p5385
(dp5386
g13
g14
sg15
V/categories/DBCAT004571
p5387
ssVEstranes
p5388
(dp5389
g13
g14
sg15
V/categories/DBCAT001043
p5390
ssVPropylamine Derivatives
p5391
(dp5392
g13
g14
sg15
V/categories/DBCAT003731
p5393
ssS'Diflunisal'
p5394
(dp5395
g13
g25
sg15
S'1001010D0'
p5396
ssVFourth-Generation Cephalosporins
p5397
(dp5398
g13
g14
sg15
V/categories/DBCAT002531
p5399
ssS'Factor VIII Inhibitor Bypassing Fraction'
p5400
(dp5401
g13
g25
sg15
S'0211000Y0'
p5402
ssVUGT1A9 Inducers
p5403
(dp5404
g13
g14
sg15
V/categories/DBCAT003967
p5405
ssVCefotaxime
p5406
(dp5407
g13
g14
sg15
V/categories/DBCAT000566
p5408
ssS'Pegvisomant'
p5409
(dp5410
g13
g25
sg15
S'0605010Z0'
p5411
ssVHeparins or Heparinoids for Topical Use
p5412
(dp5413
g13
g14
sg15
V/categories/DBCAT002447
p5414
ssS'Magnesium Hydroxide'
p5415
(dp5416
g13
g14
sg15
V/categories/DBCAT004845
p5417
ssVAntiinflammatory and Antirheumatic Products, Non-Steroids
p5418
(dp5419
g13
g14
sg15
V/categories/DBCAT002311
p5420
ssVSerotonin and Noradrenaline Reuptake Inhibitors
p5421
(dp5422
g13
g14
sg15
V/categories/DBCAT002715
p5423
ssVKetones
p5424
(dp5425
g13
g14
sg15
V/categories/DBCAT000720
p5426
ssS'Olodaterol'
p5427
(dp5428
g13
g25
sg15
S'0301011Z0'
p5429
ssVGases
p5430
(dp5431
g13
g14
sg15
V/categories/DBCAT000320
p5432
ssS'Estradiol & Nomegestrol'
p5433
(dp5434
g13
g25
sg15
S'0703010S0'
p5435
ssVProtease Inhibitors
p5436
(dp5437
g13
g14
sg15
V/categories/DBCAT000002
p5438
ssVAdrenergic and Dopaminergic Agents
p5439
(dp5440
g13
g14
sg15
V/categories/DBCAT002217
p5441
ssVReversed Anticoagulation Activity
p5442
(dp5443
g13
g14
sg15
V/categories/DBCAT004198
p5444
ssVVascular Endothelial Growth Factor A
p5445
(dp5446
g13
g14
sg15
V/categories/DBCAT001633
p5447
ssS'Stannous Fluoride'
p5448
(dp5449
g13
g25
sg15
S'0905030M0'
p5450
ssVCalcium Compounds
p5451
(dp5452
g13
g14
sg15
V/categories/DBCAT001284
p5453
ssS'Vinblastine Sulfate'
p5454
(dp5455
g13
g25
sg15
S'0801040H0'
p5456
ssS'Potassium Citrate'
p5457
(dp5458
g13
g25
sg15
S'0704030G0'
p5459
ssS'Brinzolamide'
p5460
(dp5461
g13
g25
sg15
S'1106000AC'
p5462
ssS'Dulaglutide'
p5463
(dp5464
g13
g25
sg15
S'0601023AQ'
p5465
ssVSclerosing Agents for Local Injection
p5466
(dp5467
g13
g14
sg15
V/categories/DBCAT002392
p5468
ssS'Ursodeoxycholic Acid'
p5469
(dp5470
g13
g25
sg15
S'0109010U0'
p5471
ssS'Tolvaptan'
p5472
(dp5473
g13
g25
sg15
S'0605020Y0'
p5474
ssVSympathomimetics in Glaucoma Therapy
p5475
(dp5476
g13
g14
sg15
V/categories/DBCAT002382
p5477
ssVCorticosteroids, Dermatological Preparations
p5478
(dp5479
g13
g14
sg15
V/categories/DBCAT002236
p5480
ssVBarbiturates
p5481
(dp5482
g13
g14
sg15
V/categories/DBCAT000728
p5483
ssVSecologanin Tryptamine Alkaloids
p5484
(dp5485
g13
g14
sg15
V/categories/DBCAT000526
p5486
ssS'Naltrexone Hydrochloride'
p5487
(dp5488
g13
g25
sg15
S'0410030E0'
p5489
ssVPheniramine
p5490
(dp5491
g13
g14
sg15
V/categories/DBCAT001157
p5492
ssVToxins, Biological
p5493
(dp5494
g13
g14
sg15
V/categories/DBCAT000185
p5495
ssVPolyenes
p5496
(dp5497
g13
g14
sg15
V/categories/DBCAT000363
p5498
ssS'Mirabegron'
p5499
(dp5500
g13
g25
sg15
S'0704020AE'
p5501
ssVCentral Nervous System Stimulants
p5502
(dp5503
g13
g14
sg15
V/categories/DBCAT000437
p5504
ssVBeta Blocking Agents, Selective
p5505
(dp5506
g13
g14
sg15
V/categories/DBCAT002186
p5507
ssVMetals, Alkaline Earth
p5508
(dp5509
g13
g14
sg15
V/categories/DBCAT001352
p5510
ssS'Sodium Citrate'
p5511
(dp5512
g13
g25
sg15
S'110802050'
p5513
ssS'Semaglutide'
p5514
(dp5515
g13
g25
sg15
S'0601023AW'
p5516
ssVNitro Compounds
p5517
(dp5518
g13
g14
sg15
V/categories/DBCAT000765
p5519
ssS'Abacavir & Lamivudine'
p5520
(dp5521
g13
g25
sg15
S'0503010Z0'
p5522
ssVAnthracyclines and Related Substances
p5523
(dp5524
g13
g14
sg15
V/categories/DBCAT002347
p5525
ssS'Terbinafine Hydrochloride'
p5526
(dp5527
g13
g25
sg15
S'0502050C0'
p5528
ssVAnesthetics
p5529
(dp5530
g13
g14
sg15
V/categories/DBCAT000564
p5531
ssS'Ferumoxytol'
p5532
(dp5533
g13
g25
sg15
S'0901012Q0'
p5534
ssS'Fluphenazine Hydrochloride'
p5535
(dp5536
g13
g25
sg15
S'0402010I0'
p5537
ssVVitamin K Antagonists
p5538
(dp5539
g13
g14
sg15
V/categories/DBCAT002267
p5540
ssVReceptor Tyrosine Kinase Inhibitors
p5541
(dp5542
g13
g14
sg15
V/categories/DBCAT004052
p5543
ssVCytochrome P-450 CYP2B6 Inhibitors (weak)
p5544
(dp5545
g13
g14
sg15
V/categories/DBCAT003033
p5546
ssVAntidiuretic Hormone Receptor Antagonists
p5547
(dp5548
g13
g14
sg15
V/categories/DBCAT001166
p5549
ssVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p5550
(dp5551
g13
g14
sg15
V/categories/DBCAT002190
p5552
ssVProgestin Contraceptives
p5553
(dp5554
g13
g14
sg15
V/categories/DBCAT003003
p5555
ssS'Colecalciferol'
p5556
(dp5557
g13
g25
sg15
S'0906040G0'
p5558
ssVPolymyxin-class Antibacterial
p5559
(dp5560
g13
g14
sg15
V/categories/DBCAT003403
p5561
ssVGlucans
p5562
(dp5563
g13
g14
sg15
V/categories/DBCAT001022
p5564
ssVImidazole and Triazole Derivatives
p5565
(dp5566
g13
g14
sg15
V/categories/DBCAT002195
p5567
ssVBretylium Compounds
p5568
(dp5569
g13
g14
sg15
V/categories/DBCAT001283
p5570
ssS'Chlorpropamide'
p5571
(dp5572
g13
g25
sg15
S'0601021E0'
p5573
ssS'Metolazone'
p5574
(dp5575
g13
g25
sg15
S'0202010V0'
p5576
ssS'Erythropoietin'
p5577
(dp5578
g13
g14
sg15
V/categories/DBCAT000081
p5579
ssS'Betaxolol Hydrochloride'
p5580
(dp5581
g13
g25
sg15
S'0204000G0'
p5582
ssVCyproterone
p5583
(dp5584
g13
g14
sg15
V/categories/DBCAT001625
p5585
ssVViral Structural Proteins
p5586
(dp5587
g13
g14
sg15
V/categories/DBCAT002894
p5588
ssS'Aspirin & Caffeine'
p5589
(dp5590
g13
g25
sg15
S'0407010AA'
p5591
ssVTenofovir and prodrugs
p5592
(dp5593
g13
g14
sg15
V/categories/DBCAT003858
p5594
ssS'Captopril'
p5595
(dp5596
g13
g25
sg15
S'0205051F0'
p5597
ssS'Phenylephrine HCl & Tropicamide'
p5598
(dp5599
g13
g25
sg15
S'1105000T0'
p5600
ssVAntipsychotic Agents (Second Generation [Atypical])
p5601
(dp5602
g13
g14
sg15
V/categories/DBCAT002673
p5603
ssVBeta Blocking Agents, Selective, and Thiazides
p5604
(dp5605
g13
g14
sg15
V/categories/DBCAT002265
p5606
ssVCytochrome P-450 CYP3A4 Inhibitors (weak)
p5607
(dp5608
g13
g14
sg15
V/categories/DBCAT002713
p5609
ssVPreparations Increasing Uric Acid Excretion
p5610
(dp5611
g13
g14
sg15
V/categories/DBCAT002493
p5612
ssVAntiheparin Agents
p5613
(dp5614
g13
g14
sg15
V/categories/DBCAT003785
p5615
ssVCytochrome P-450 CYP2D6 Substrates
p5616
(dp5617
g13
g14
sg15
V/categories/DBCAT002623
p5618
ssS'Trandolapril'
p5619
(dp5620
g13
g25
sg15
S'0205051U0'
p5621
ssS'Tenecteplase'
p5622
(dp5623
g13
g25
sg15
S'0210020U0'
p5624
ssVParathyroid Agents
p5625
(dp5626
g13
g14
sg15
V/categories/DBCAT004661
p5627
ssVCardenolides
p5628
(dp5629
g13
g14
sg15
V/categories/DBCAT000823
p5630
ssVBSEP/ABCB11 inducers
p5631
(dp5632
g13
g14
sg15
V/categories/DBCAT003980
p5633
ssVAdrenergic Antagonists
p5634
(dp5635
g13
g14
sg15
V/categories/DBCAT000457
p5636
ssVCholine
p5637
(dp5638
g13
g14
sg15
V/categories/DBCAT000510
p5639
ssVProdrugs
p5640
(dp5641
g13
g14
sg15
V/categories/DBCAT000851
p5642
ssVSecond-Generation Cephalosporins
p5643
(dp5644
g13
g14
sg15
V/categories/DBCAT002239
p5645
ssS'Abemaciclib'
p5646
(dp5647
g13
g25
sg15
S'0801050CL'
p5648
ssVUrease Inhibitors
p5649
(dp5650
g13
g14
sg15
V/categories/DBCAT004222
p5651
ssS'Pirfenidone'
p5652
(dp5653
g13
g25
sg15
S'0311010B0'
p5654
ssVMembrane Proteins
p5655
(dp5656
g13
g14
sg15
V/categories/DBCAT000031
p5657
ssVNeurotransmitter Uptake Inhibitors
p5658
(dp5659
g13
g14
sg15
V/categories/DBCAT000400
p5660
ssVQuinine and Derivatives
p5661
(dp5662
g13
g14
sg15
V/categories/DBCAT002394
p5663
ssVMalates
p5664
(dp5665
g13
g14
sg15
V/categories/DBCAT001973
p5666
ssVAntigonadotropins and Similar Agents
p5667
(dp5668
g13
g14
sg15
V/categories/DBCAT002530
p5669
ssVHydroxyzine
p5670
(dp5671
g13
g14
sg15
V/categories/DBCAT000771
p5672
ssVElectrolytes
p5673
(dp5674
g13
g14
sg15
V/categories/DBCAT000325
p5675
ssVAntigens
p5676
(dp5677
g13
g14
sg15
V/categories/DBCAT000035
p5678
ssVImmunoglobulin Fc Fragments
p5679
(dp5680
g13
g14
sg15
V/categories/DBCAT002951
p5681
ssVTumor Necrosis Factor Blocker
p5682
(dp5683
g13
g14
sg15
V/categories/DBCAT003245
p5684
ssS'Sulfacetamide Sodium'
p5685
(dp5686
g13
g25
sg15
S'1310011X0'
p5687
ssVAntigens, CD20
p5688
(dp5689
g13
g14
sg15
V/categories/DBCAT000175
p5690
ssS'Chlordiazepoxide Hydrochloride'
p5691
(dp5692
g13
g25
sg15
S'0401020E0'
p5693
ssS'Haloperidol Decanoate'
p5694
(dp5695
g13
g25
sg15
S'0402020T0'
p5696
ssVMinerals
p5697
(dp5698
g13
g14
sg15
V/categories/DBCAT001376
p5699
ssVDiphenylacetic Acids
p5700
(dp5701
g13
g14
sg15
V/categories/DBCAT001929
p5702
ssVDexamethasone
p5703
(dp5704
g13
g14
sg15
V/categories/DBCAT000963
p5705
ssVMATE 2 Inhibitors
p5706
(dp5707
g13
g14
sg15
V/categories/DBCAT003953
p5708
ssVAmino Acids, Neutral
p5709
(dp5710
g13
g14
sg15
V/categories/DBCAT000246
p5711
ssVSulfonamide Antibacterial
p5712
(dp5713
g13
g14
sg15
V/categories/DBCAT003334
p5714
ssVAminoglycoside Antibacterials
p5715
(dp5716
g13
g14
sg15
V/categories/DBCAT000853
p5717
ssVProteins
p5718
(dp5719
g13
g14
sg15
V/categories/DBCAT000020
p5720
ssVSelective Serotonin 5-HT1 Receptor Agonists
p5721
(dp5722
g13
g14
sg15
V/categories/DBCAT002224
p5723
ssVmeta-Aminobenzoates
p5724
(dp5725
g13
g14
sg15
V/categories/DBCAT000601
p5726
ssS'Allopurinol'
p5727
(dp5728
g13
g25
sg15
S'1001040C0'
p5729
ssVThioglycosides
p5730
(dp5731
g13
g14
sg15
V/categories/DBCAT000796
p5732
ssVBile-acid Binding Activity
p5733
(dp5734
g13
g14
sg15
V/categories/DBCAT004184
p5735
ssS'Meropenem'
p5736
(dp5737
g13
g25
sg15
S'0501022A0'
p5738
ssS'Naloxone Hydrochloride'
p5739
(dp5740
g13
g25
sg15
S'1902070Q0'
p5741
ssVPenicillins
p5742
(dp5743
g13
g14
sg15
V/categories/DBCAT000702
p5744
ssVUGT1A6 substrate with narrow therapeutic index
p5745
(dp5746
g13
g14
sg15
V/categories/DBCAT004531
p5747
ssVSulfates
p5748
(dp5749
g13
g14
sg15
V/categories/DBCAT001036
p5750
ssV11-Hydroxycorticosteroids
p5751
(dp5752
g13
g14
sg15
V/categories/DBCAT001068
p5753
ssVHIV Fusion Inhibitors
p5754
(dp5755
g13
g14
sg15
V/categories/DBCAT000220
p5756
ssS'Deferasirox'
p5757
(dp5758
g13
g25
sg15
S'0901030K0'
p5759
ssVCarbamoyl Phosphate Synthetase 1 Activators
p5760
(dp5761
g13
g14
sg15
V/categories/DBCAT004135
p5762
ssVPlasminogen Activators
p5763
(dp5764
g13
g14
sg15
V/categories/DBCAT000074
p5765
ssS'Hydrocortisone'
p5766
(dp5767
g13
g25
sg15
S'1304000V0'
p5768
ssS'Oxazepam'
p5769
(dp5770
g13
g25
sg15
S'0401020T0'
p5771
ssVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p5772
(dp5773
g13
g14
sg15
V/categories/DBCAT004505
p5774
ssVImmunization, Passive
p5775
(dp5776
g13
g14
sg15
V/categories/DBCAT001686
p5777
ssVSolutions
p5778
(dp5779
g13
g14
sg15
V/categories/DBCAT000895
p5780
ssS'Pentazocine Lactate'
p5781
(dp5782
g13
g25
sg15
S'0407020U0'
p5783
ssVHormones, Hormone Substitutes, and Hormone Antagonists
p5784
(dp5785
g13
g14
sg15
V/categories/DBCAT000057
p5786
ssVBenzophenones
p5787
(dp5788
g13
g14
sg15
V/categories/DBCAT000719
p5789
ssVMegestrol
p5790
(dp5791
g13
g14
sg15
V/categories/DBCAT000779
p5792
ssS'Anagrelide Hydrochloride'
p5793
(dp5794
g13
g25
sg15
S'0901040A0'
p5795
ssS'Indacaterol Maleate'
p5796
(dp5797
g13
g25
sg15
S'0301011X0'
p5798
ssVThymidylate Synthase, antagonists & inhibitors
p5799
(dp5800
g13
g14
sg15
V/categories/DBCAT000684
p5801
ssVHemorrheologic Agents
p5802
(dp5803
g13
g14
sg15
V/categories/DBCAT003722
p5804
ssS'Propafenone Hydrochloride'
p5805
(dp5806
g13
g25
sg15
S'0203020R0'
p5807
ssVProgrammed Death Ligand-1 Antagonists
p5808
(dp5809
g13
g14
sg15
V/categories/DBCAT004242
p5810
ssVInterleukin-17A Antagonists
p5811
(dp5812
g13
g14
sg15
V/categories/DBCAT004179
p5813
ssVGuanylate Cyclase
p5814
(dp5815
g13
g14
sg15
V/categories/DBCAT002760
p5816
ssS'Afatinib'
p5817
(dp5818
g13
g25
sg15
S'0801050BP'
p5819
ssVDrugs for Constipation
p5820
(dp5821
g13
g14
sg15
V/categories/DBCAT002415
p5822
ssVKinins
p5823
(dp5824
g13
g14
sg15
V/categories/DBCAT001752
p5825
ssVImino Pyranoses
p5826
(dp5827
g13
g14
sg15
V/categories/DBCAT001528
p5828
ssS'Bisoprolol Fumarate/Aspirin'
p5829
(dp5830
g13
g25
sg15
S'0204000AC'
p5831
ssS'Omeprazole'
p5832
(dp5833
g13
g14
sg15
V/categories/DBCAT001099
p5834
ssS'Coal Tar & Corticosteroid Preparations'
p5835
(dp5836
g13
g25
sg15
S'1305020I0'
p5837
ssVAnesthetics, Local
p5838
(dp5839
g13
g14
sg15
V/categories/DBCAT000661
p5840
ssVMiscellaneous Anticonvulsants
p5841
(dp5842
g13
g14
sg15
V/categories/DBCAT003640
p5843
ssVFerric Compounds
p5844
(dp5845
g13
g14
sg15
V/categories/DBCAT000753
p5846
ssS'Enfuvirtide'
p5847
(dp5848
g13
g25
sg15
S'0503010J0'
p5849
ssVFusion Protein Inhibitors
p5850
(dp5851
g13
g14
sg15
V/categories/DBCAT004232
p5852
ssS'Clobazam'
p5853
(dp5854
g13
g25
sg15
S'040801060'
p5855
ssVImmunoglobulin Constant Regions
p5856
(dp5857
g13
g14
sg15
V/categories/DBCAT002952
p5858
ssVUGT2B7 Inhibitors
p5859
(dp5860
g13
g14
sg15
V/categories/DBCAT004456
p5861
ssVAnthracenes
p5862
(dp5863
g13
g14
sg15
V/categories/DBCAT001196
p5864
ssS'Clindamycin Phosphate'
p5865
(dp5866
g13
g25
sg15
S'1306010F0'
p5867
ssVAnticestodal Agents
p5868
(dp5869
g13
g14
sg15
V/categories/DBCAT000945
p5870
ssS'Entecavir'
p5871
(dp5872
g13
g25
sg15
S'0503031B0'
p5873
ssVCytochrome P-450 CYP2A6 Inhibitors (weak)
p5874
(dp5875
g13
g14
sg15
V/categories/DBCAT003897
p5876
ssS'Buprenorphine Hydrochloride'
p5877
(dp5878
g13
g25
sg15
S'0410030A0'
p5879
ssS'Tioguanine'
p5880
(dp5881
g13
g25
sg15
S'0801030T0'
p5882
ssVDopamine Antagonists
p5883
(dp5884
g13
g14
sg15
V/categories/DBCAT000603
p5885
ssVPsychostimulants, Agents Used for Adhd and Nootropics
p5886
(dp5887
g13
g14
sg15
V/categories/DBCAT002180
p5888
ssS'Acarbose'
p5889
(dp5890
g13
g25
sg15
S'0601023A0'
p5891
ssVCytochrome P450 3A4 Inducers
p5892
(dp5893
g13
g14
sg15
V/categories/DBCAT004170
p5894
ssS'Betamethasone Valerate'
p5895
(dp5896
g13
g25
sg15
S'0603020D0'
p5897
ssVPCSK9 Inhibitor
p5898
(dp5899
g13
g14
sg15
V/categories/DBCAT003524
p5900
ssVPharmaceutical Preparations
p5901
(dp5902
g13
g14
sg15
V/categories/DBCAT000896
p5903
ssVCytochrome P-450 CYP2C19 Substrates
p5904
(dp5905
g13
g14
sg15
V/categories/DBCAT002638
p5906
ssVBlood and Blood Forming Organs
p5907
(dp5908
g13
g14
sg15
V/categories/DBCAT002085
p5909
ssVDNA (Cytosine-5-)-Methyltransferases, antagonists & inhibitors
p5910
(dp5911
g13
g14
sg15
V/categories/DBCAT004992
p5912
ssVVesicular Monoamine Transporter 2 Inhibitor
p5913
(dp5914
g13
g14
sg15
V/categories/DBCAT003448
p5915
ssVThioxanthene Derivatives
p5916
(dp5917
g13
g14
sg15
V/categories/DBCAT002478
p5918
ssS'Sumatriptan Succinate'
p5919
(dp5920
g13
g25
sg15
S'0407041T0'
p5921
ssS'Doxapram Hydrochloride'
p5922
(dp5923
g13
g25
sg15
S'0305010W0'
p5924
ssVFructose
p5925
(dp5926
g13
g14
sg15
V/categories/DBCAT004805
p5927
ssS'Nedocromil Sodium'
p5928
(dp5929
g13
g25
sg15
S'1202010Q0'
p5930
ssVReceptors, Opioid, delta, antagonists & inhibitors
p5931
(dp5932
g13
g14
sg15
V/categories/DBCAT001971
p5933
ssS'Chlortalidone'
p5934
(dp5935
g13
g25
sg15
S'0202010F0'
p5936
ssVHistamine Agonists
p5937
(dp5938
g13
g14
sg15
V/categories/DBCAT000652
p5939
ssVMembrane Transport Modulators
p5940
(dp5941
g13
g14
sg15
V/categories/DBCAT000128
p5942
ssVBenzomorphans
p5943
(dp5944
g13
g14
sg15
V/categories/DBCAT001035
p5945
ssS'Eptifibatide'
p5946
(dp5947
g13
g25
sg15
S'0209000X0'
p5948
ssVGuaiacol
p5949
(dp5950
g13
g14
sg15
V/categories/DBCAT000847
p5951
ssVAdrenergic beta-3 Receptor Agonists
p5952
(dp5953
g13
g14
sg15
V/categories/DBCAT001740
p5954
ssVXanthine Oxidase Inhibitors
p5955
(dp5956
g13
g14
sg15
V/categories/DBCAT002773
p5957
ssVMiscellaneous Anti-infectives
p5958
(dp5959
g13
g14
sg15
V/categories/DBCAT003735
p5960
ssVOrganosilicon Compounds
p5961
(dp5962
g13
g14
sg15
V/categories/DBCAT002007
p5963
ssVSigma-1 Agonist
p5964
(dp5965
g13
g14
sg15
V/categories/DBCAT003364
p5966
ssVAcids, Noncarboxylic
p5967
(dp5968
g13
g14
sg15
V/categories/DBCAT000321
p5969
ssS'Zopiclone'
p5970
(dp5971
g13
g25
sg15
S'0401010Z0'
p5972
ssS'Ciclopirox Olamine'
p5973
(dp5974
g13
g25
sg15
S'1310020I0'
p5975
ssVCytochrome P450 3A Inhibitors
p5976
(dp5977
g13
g14
sg15
V/categories/DBCAT004051
p5978
ssVSteroids, Chlorinated
p5979
(dp5980
g13
g14
sg15
V/categories/DBCAT000825
p5981
ssVCephaloridine
p5982
(dp5983
g13
g14
sg15
V/categories/DBCAT000867
p5984
ssVPituitary Hormone Release Inhibiting Hormones
p5985
(dp5986
g13
g14
sg15
V/categories/DBCAT001948
p5987
ssVBenzimidazole Derivatives
p5988
(dp5989
g13
g14
sg15
V/categories/DBCAT002403
p5990
ssVErythema
p5991
(dp5992
g13
g14
sg15
V/categories/DBCAT003234
p5993
ssVUGT2B7 inducers
p5994
(dp5995
g13
g14
sg15
V/categories/DBCAT004611
p5996
ssVSerum
p5997
(dp5998
g13
g14
sg15
V/categories/DBCAT002882
p5999
ssS'Valsartan/Amlodipine'
p6000
(dp6001
g13
g25
sg15
S'0206020Z0'
p6002
ssVBacterial Proteins
p6003
(dp6004
g13
g14
sg15
V/categories/DBCAT000186
p6005
ssVSulfhydryl Compounds
p6006
(dp6007
g13
g14
sg15
V/categories/DBCAT000316
p6008
ssS'Chlorambucil'
p6009
(dp6010
g13
g25
sg15
S'0801010F0'
p6011
ssS'Levocabastine'
p6012
(dp6013
g13
g25
sg15
S'1104020P0'
p6014
ssS'Insulin Glargine'
p6015
(dp6016
g13
g25
sg15
S'0601012V0'
p6017
ssVPolysaccharide-Lyases
p6018
(dp6019
g13
g14
sg15
V/categories/DBCAT000167
p6020
ssVHedgehog Pathway Inhibitor
p6021
(dp6022
g13
g14
sg15
V/categories/DBCAT003489
p6023
ssS'Aspirin & Paracetamol'
p6024
(dp6025
g13
g25
sg15
S'0407010S0'
p6026
ssVChlorohydrins
p6027
(dp6028
g13
g14
sg15
V/categories/DBCAT000462
p6029
ssVOrganophosphates
p6030
(dp6031
g13
g14
sg15
V/categories/DBCAT001125
p6032
ssS'Simvastatin'
p6033
(dp6034
g13
g25
sg15
S'0212000Y0'
p6035
ssVAnti-Infective Agents
p6036
(dp6037
g13
g14
sg15
V/categories/DBCAT000065
p6038
ssVCalcium Salts
p6039
(dp6040
g13
g14
sg15
V/categories/DBCAT000758
p6041
ssVInterleukins
p6042
(dp6043
g13
g14
sg15
V/categories/DBCAT000118
p6044
ssS'Dexamethasone Sodium Phosphate'
p6045
(dp6046
g13
g25
sg15
S'0603020H0'
p6047
ssS'Montelukast'
p6048
(dp6049
g13
g25
sg15
S'0303020G0'
p6050
ssS'Tamsulosin Hydrochloride'
p6051
(dp6052
g13
g25
sg15
S'0704010U0'
p6053
ssVProstaglandins F, Synthetic
p6054
(dp6055
g13
g14
sg15
V/categories/DBCAT000676
p6056
ssVAntioxidants
p6057
(dp6058
g13
g14
sg15
V/categories/DBCAT000368
p6059
ssVCorticosteroids Acting Locally
p6060
(dp6061
g13
g14
sg15
V/categories/DBCAT002356
p6062
ssVOrganothiophosphates
p6063
(dp6064
g13
g14
sg15
V/categories/DBCAT001123
p6065
ssVNitrofurans
p6066
(dp6067
g13
g14
sg15
V/categories/DBCAT000764
p6068
ssS'Alfuzosin Hydrochloride'
p6069
(dp6070
g13
g25
sg15
S'0704010A0'
p6071
ssVCoumarins
p6072
(dp6073
g13
g14
sg15
V/categories/DBCAT000641
p6074
ssS'Nevirapine'
p6075
(dp6076
g13
g25
sg15
S'0503010B0'
p6077
ssVAmmonia Detoxicants
p6078
(dp6079
g13
g14
sg15
V/categories/DBCAT003702
p6080
ssVIndoleacetic Acids
p6081
(dp6082
g13
g14
sg15
V/categories/DBCAT001109
p6083
ssVFatty Alcohols
p6084
(dp6085
g13
g14
sg15
V/categories/DBCAT000476
p6086
ssVVitamin B Complex
p6087
(dp6088
g13
g14
sg15
V/categories/DBCAT000236
p6089
ssS'Ticagrelor'
p6090
(dp6091
g13
g25
sg15
S'0209000Z0'
p6092
ssS'Sodium Phenylbutyrate'
p6093
(dp6094
g13
g25
sg15
S'0908010P0'
p6095
ssVHydrazinophthalazine Derivatives and Diuretics
p6096
(dp6097
g13
g14
sg15
V/categories/DBCAT002525
p6098
ssVCytochrome P-450 CYP2C8 Inhibitors
p6099
(dp6100
g13
g14
sg15
V/categories/DBCAT000868
p6101
ssS'Aminophylline'
p6102
(dp6103
g13
g25
sg15
S'0301030B0'
p6104
ssVBenzothiazoles
p6105
(dp6106
g13
g14
sg15
V/categories/DBCAT000726
p6107
ssVSialic Acids
p6108
(dp6109
g13
g14
sg15
V/categories/DBCAT000969
p6110
ssVNasal Decongestants
p6111
(dp6112
g13
g14
sg15
V/categories/DBCAT000818
p6113
ssVDeoxyadenosines
p6114
(dp6115
g13
g14
sg15
V/categories/DBCAT000596
p6116
ssVIncreased Histamine Release
p6117
(dp6118
g13
g14
sg15
V/categories/DBCAT004058
p6119
ssVAminoquinolines
p6120
(dp6121
g13
g14
sg15
V/categories/DBCAT000997
p6122
ssS'Oxandrolone'
p6123
(dp6124
g13
g25
sg15
S'0604030P0'
p6125
ssVHepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor
p6126
(dp6127
g13
g14
sg15
V/categories/DBCAT003521
p6128
ssVCell Stimulants and Proliferants
p6129
(dp6130
g13
g14
sg15
V/categories/DBCAT003717
p6131
ssVGlycols
p6132
(dp6133
g13
g14
sg15
V/categories/DBCAT000877
p6134
ssVThioxanthenes
p6135
(dp6136
g13
g14
sg15
V/categories/DBCAT001167
p6137
ssVPeroxisome Proliferator-activated Receptor alpha Agonists
p6138
(dp6139
g13
g14
sg15
V/categories/DBCAT004318
p6140
ssVThiocarbamide Derivatives
p6141
(dp6142
g13
g14
sg15
V/categories/DBCAT002423
p6143
ssVHydrogen Sulfide
p6144
(dp6145
g13
g14
sg15
V/categories/DBCAT000319
p6146
ssVDrugs for Acid Related Disorders
p6147
(dp6148
g13
g14
sg15
V/categories/DBCAT002221
p6149
ssS'Hetastarch'
p6150
(dp6151
g13
g25
sg15
S'0902022K0'
p6152
ssVDirect-acting Skeletal Muscle Relaxants
p6153
(dp6154
g13
g14
sg15
V/categories/DBCAT003756
p6155
ssS'Granisetron Hydrochloride'
p6156
(dp6157
g13
g25
sg15
S'0406000M0'
p6158
ssVAldehyde Dehydrogenase Inhibitor
p6159
(dp6160
g13
g14
sg15
V/categories/DBCAT003406
p6161
ssS'Benzydamine Hydrochloride'
p6162
(dp6163
g13
g25
sg15
S'1003020F0'
p6164
ssVAminoacridines
p6165
(dp6166
g13
g14
sg15
V/categories/DBCAT000655
p6167
ssVTranquilizing Agents
p6168
(dp6169
g13
g14
sg15
V/categories/DBCAT000398
p6170
ssS'Bleomycin'
p6171
(dp6172
g13
g14
sg15
V/categories/DBCAT004732
p6173
ssVCytochrome P-450 CYP3A5 Inhibitors
p6174
(dp6175
g13
g14
sg15
V/categories/DBCAT003893
p6176
ssVAgents Causing Muscle Toxicity
p6177
(dp6178
g13
g14
sg15
V/categories/DBCAT003935
p6179
ssS'Triptorelin'
p6180
(dp6181
g13
g25
sg15
S'0607020T0'
p6182
ssS'Cefpodoxime'
p6183
(dp6184
g13
g25
sg15
S'0501021F0'
p6185
ssS'Orphenadrine Citrate'
p6186
(dp6187
g13
g25
sg15
S'1002020V0'
p6188
ssVIncreased Prostaglandin Activity
p6189
(dp6190
g13
g14
sg15
V/categories/DBCAT004146
p6191
ssS'Hydroxycarbamide'
p6192
(dp6193
g13
g25
sg15
S'0901030R0'
p6194
ssVDecreased Protein Synthesis
p6195
(dp6196
g13
g14
sg15
V/categories/DBCAT004151
p6197
ssVCOX-1 Inhibitors
p6198
(dp6199
g13
g14
sg15
V/categories/DBCAT003907
p6200
ssVReceptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
p6201
(dp6202
g13
g14
sg15
V/categories/DBCAT001819
p6203
ssS'Cefadroxil'
p6204
(dp6205
g13
g25
sg15
S'0501021B0'
p6206
ssS'Carisoprodol'
p6207
(dp6208
g13
g25
sg15
S'1002020G0'
p6209
ssVAminosalicylate
p6210
(dp6211
g13
g14
sg15
V/categories/DBCAT003404
p6212
ssS'Denosumab'
p6213
(dp6214
g13
g25
sg15
S'0606020Z0'
p6215
ssS'Siltuximab'
p6216
(dp6217
g13
g25
sg15
S'0802040AM'
p6218
ssVHormones
p6219
(dp6220
g13
g14
sg15
V/categories/DBCAT000056
p6221
ssVP-Glycoprotein Interactions
p6222
(dp6223
g13
g14
sg15
V/categories/DBCAT004339
p6224
ssVCyclooxygenase-2 (COX-2) Inhibitors
p6225
(dp6226
g13
g14
sg15
V/categories/DBCAT003912
p6227
ssS'Chorionic Gonadotrophin'
p6228
(dp6229
g13
g25
sg15
S'0605010D0'
p6230
ssS'Valaciclovir'
p6231
(dp6232
g13
g25
sg15
S'0503021A0'
p6233
ssVDopamine, metabolism
p6234
(dp6235
g13
g14
sg15
V/categories/DBCAT004760
p6236
ssVAntiadrenergic Agents, Peripherally Acting
p6237
(dp6238
g13
g14
sg15
V/categories/DBCAT002227
p6239
ssS'Lincomycin Hydrochloride'
p6240
(dp6241
g13
g25
sg15
S'0501060J0'
p6242
ssVHydroxycorticosteroids
p6243
(dp6244
g13
g14
sg15
V/categories/DBCAT001069
p6245
ssS'Calcium Polystyrene Sulfonate'
p6246
(dp6247
g13
g25
sg15
S'0902011L0'
p6248
ssVVasopressin Analog
p6249
(dp6250
g13
g14
sg15
V/categories/DBCAT003253
p6251
ssVPropylene Glycols
p6252
(dp6253
g13
g14
sg15
V/categories/DBCAT000876
p6254
ssVAntineoplastic Agents, Phytogenic
p6255
(dp6256
g13
g14
sg15
V/categories/DBCAT000717
p6257
ssVPotassium-Sparing Agents
p6258
(dp6259
g13
g14
sg15
V/categories/DBCAT002346
p6260
ssS'Naltrexone/Bupropion'
p6261
(dp6262
g13
g25
sg15
S'0405020U0'
p6263
ssVAdjuvants, Anesthesia
p6264
(dp6265
g13
g14
sg15
V/categories/DBCAT000730
p6266
ssS'Triamterene'
p6267
(dp6268
g13
g25
sg15
S'0202030W0'
p6269
ssVPharmaceutical Vehicles
p6270
(dp6271
g13
g14
sg15
V/categories/DBCAT001429
p6272
ssS'Dichlorobenzyl Alcohol/Amylmetacresol'
p6273
(dp6274
g13
g25
sg15
S'1203030AA'
p6275
ssVSodium Chloride Symporter Inhibitors
p6276
(dp6277
g13
g14
sg15
V/categories/DBCAT000577
p6278
ssS'Miconazole'
p6279
(dp6280
g13
g25
sg15
S'0502020B0'
p6281
ssVCardiac Glycosides
p6282
(dp6283
g13
g14
sg15
V/categories/DBCAT000821
p6284
ssVMelatonin Receptor Agonists
p6285
(dp6286
g13
g14
sg15
V/categories/DBCAT002489
p6287
ssVVITAMIN B12 AND FOLIC ACID
p6288
(dp6289
g13
g14
sg15
V/categories/DBCAT004535
p6290
ssS'Olmesartan Medoxomil/Hydrochlorothiazide'
p6291
(dp6292
g13
g25
sg15
S'0205052Y0'
p6293
ssVUrinary Acidifying Agents
p6294
(dp6295
g13
g14
sg15
V/categories/DBCAT002710
p6296
ssVDrugs for Treatment of Hypoglycemia
p6297
(dp6298
g13
g14
sg15
V/categories/DBCAT002508
p6299
ssVHeterocyclic Compounds, Fused-Ring
p6300
(dp6301
g13
g14
sg15
V/categories/DBCAT004973
p6302
ssS'Olanzapine'
p6303
(dp6304
g13
g25
sg15
S'040201060'
p6305
ssVBetaine
p6306
(dp6307
g13
g14
sg15
V/categories/DBCAT004828
p6308
ssVCD20-directed Cytolytic Antibody
p6309
(dp6310
g13
g14
sg15
V/categories/DBCAT003269
p6311
ssS'Minoxidil'
p6312
(dp6313
g13
g25
sg15
S'1309000H0'
p6314
ssS'Dronedarone Hydrochloride'
p6315
(dp6316
g13
g25
sg15
S'0203020X0'
p6317
ssS'Chlorpromazine Hydrochloride'
p6318
(dp6319
g13
g25
sg15
S'0402010D0'
p6320
ssVOpioid Anesthetics
p6321
(dp6322
g13
g14
sg15
V/categories/DBCAT002452
p6323
ssVSteroids
p6324
(dp6325
g13
g14
sg15
V/categories/DBCAT000309
p6326
ssVCorticosteroids, Potent (Group III)
p6327
(dp6328
g13
g14
sg15
V/categories/DBCAT002234
p6329
ssVNaphthaleneacetic Acids
p6330
(dp6331
g13
g14
sg15
V/categories/DBCAT001137
p6332
ssS'Enzalutamide'
p6333
(dp6334
g13
g25
sg15
S'0803042U0'
p6335
ssS'Bosentan'
p6336
(dp6337
g13
g25
sg15
S'0205010U0'
p6338
ssVPropanols
p6339
(dp6340
g13
g14
sg15
V/categories/DBCAT000484
p6341
ssVIncreased Dopamine Activity
p6342
(dp6343
g13
g14
sg15
V/categories/DBCAT004066
p6344
ssS'Triamcinolone Acetonide'
p6345
(dp6346
g13
g14
sg15
V/categories/DBCAT004743
p6347
ssS'Sulphafurazole'
p6348
(dp6349
g13
g25
sg15
S'0501080Q0'
p6350
ssVFluocinolone Acetonide
p6351
(dp6352
g13
g25
sg15
S'1304000N0'
p6353
ssVDihydropyridine Derivatives
p6354
(dp6355
g13
g14
sg15
V/categories/DBCAT002270
p6356
ssVIron Bivalent, Oral Preparations
p6357
(dp6358
g13
g14
sg15
V/categories/DBCAT002537
p6359
ssS'Tetracosactide'
p6360
(dp6361
g13
g25
sg15
S'0605010T0'
p6362
ssVCholanes
p6363
(dp6364
g13
g14
sg15
V/categories/DBCAT001383
p6365
ssVSulfoxides
p6366
(dp6367
g13
g14
sg15
V/categories/DBCAT000769
p6368
ssVHIV Integrase Inhibitors
p6369
(dp6370
g13
g14
sg15
V/categories/DBCAT001873
p6371
ssVSulfonic Acids
p6372
(dp6373
g13
g14
sg15
V/categories/DBCAT000891
p6374
ssVAminobutyrates
p6375
(dp6376
g13
g14
sg15
V/categories/DBCAT000424
p6377
ssVDopamine Agonists
p6378
(dp6379
g13
g14
sg15
V/categories/DBCAT000607
p6380
ssS'Carbachol'
p6381
(dp6382
g13
g25
sg15
S'0704010F0'
p6383
ssVAntiinflammatory and Antirheumatic Products
p6384
(dp6385
g13
g14
sg15
V/categories/DBCAT002312
p6386
ssVNucleoside Analog Antiviral
p6387
(dp6388
g13
g14
sg15
V/categories/DBCAT003306
p6389
ssVMetals, Light
p6390
(dp6391
g13
g14
sg15
V/categories/DBCAT001339
p6392
ssS'Sulfur'
p6393
(dp6394
g13
g14
sg15
V/categories/DBCAT004849
p6395
ssVUrinary Alkalinisers
p6396
(dp6397
g13
g14
sg15
V/categories/DBCAT003862
p6398
ssVFluorobenzenes
p6399
(dp6400
g13
g14
sg15
V/categories/DBCAT001265
p6401
ssV17-Ketosteroids
p6402
(dp6403
g13
g14
sg15
V/categories/DBCAT001040
p6404
ssVSympatholytics
p6405
(dp6406
g13
g14
sg15
V/categories/DBCAT000485
p6407
ssS'Prazosin Hydrochloride'
p6408
(dp6409
g13
g25
sg15
S'0205040S0'
p6410
ssS'Bupivacaine Hydrochloride'
p6411
(dp6412
g13
g25
sg15
S'1502010C0'
p6413
ssVGrowth Hormone, antagonists & inhibitors
p6414
(dp6415
g13
g14
sg15
V/categories/DBCAT004692
p6416
ssVAnalgesics, Non-Narcotic
p6417
(dp6418
g13
g14
sg15
V/categories/DBCAT000040
p6419
ssVMethylphenidate
p6420
(dp6421
g13
g14
sg15
V/categories/DBCAT001839
p6422
ssVCytochrome P-450 CYP2C19 Inhibitors (moderate)
p6423
(dp6424
g13
g14
sg15
V/categories/DBCAT002640
p6425
ssVFribic Acid Derivatives
p6426
(dp6427
g13
g14
sg15
V/categories/DBCAT003745
p6428
ssVChlorophenols
p6429
(dp6430
g13
g14
sg15
V/categories/DBCAT001111
p6431
ssS'Piperacillin Sodium'
p6432
(dp6433
g13
g25
sg15
S'0501014M0'
p6434
ssS'Darunavir'
p6435
(dp6436
g13
g25
sg15
S'0503010AC'
p6437
ssVQuinazolinones
p6438
(dp6439
g13
g14
sg15
V/categories/DBCAT000948
p6440
ssVTryptamines
p6441
(dp6442
g13
g14
sg15
V/categories/DBCAT001049
p6443
ssVPenicillins With Extended Spectrum
p6444
(dp6445
g13
g14
sg15
V/categories/DBCAT002304
p6446
ssS'Dapagliflozin/Metformin'
p6447
(dp6448
g13
g25
sg15
S'0601023AL'
p6449
ssVButylene Glycols
p6450
(dp6451
g13
g14
sg15
V/categories/DBCAT001228
p6452
ssVCytochrome P450 2C19 Inducers
p6453
(dp6454
g13
g14
sg15
V/categories/DBCAT004173
p6455
ssVChlorine Containing Products
p6456
(dp6457
g13
g14
sg15
V/categories/DBCAT002369
p6458
ssVGlucosidases
p6459
(dp6460
g13
g14
sg15
V/categories/DBCAT001323
p6461
ssVHematoporphyrins
p6462
(dp6463
g13
g14
sg15
V/categories/DBCAT001083
p6464
ssVCentral alpha-2 Adrenergic Agonist
p6465
(dp6466
g13
g14
sg15
V/categories/DBCAT003378
p6467
ssS'Nefazodone Hydrochloride'
p6468
(dp6469
g13
g25
sg15
S'0403040T0'
p6470
ssS'Bimatoprost'
p6471
(dp6472
g13
g25
sg15
S'1106000AF'
p6473
ssS'Misoprostol'
p6474
(dp6475
g13
g25
sg15
S'0103040M0'
p6476
ssVDisease-modifying Antirheumatic Agents
p6477
(dp6478
g13
g14
sg15
V/categories/DBCAT003604
p6479
ssVPurine Antimetabolite
p6480
(dp6481
g13
g14
sg15
V/categories/DBCAT003303
p6482
ssVSequestering Agents
p6483
(dp6484
g13
g14
sg15
V/categories/DBCAT000623
p6485
ssVHepatitis C Virus NS5A Inhibitor
p6486
(dp6487
g13
g14
sg15
V/categories/DBCAT003507
p6488
ssS'Epirubicin Hydrochloride'
p6489
(dp6490
g13
g25
sg15
S'0801020N0'
p6491
ssVCapsaicin, antagonists & inhibitors
p6492
(dp6493
g13
g14
sg15
V/categories/DBCAT004829
p6494
ssVMorphinans
p6495
(dp6496
g13
g14
sg15
V/categories/DBCAT000690
p6497
ssVHeptanoic Acids
p6498
(dp6499
g13
g14
sg15
V/categories/DBCAT001257
p6500
ssVSunscreening Agents
p6501
(dp6502
g13
g14
sg15
V/categories/DBCAT001358
p6503
ssS'Fluticasone Furoate'
p6504
(dp6505
g13
g25
sg15
S'1202010W0'
p6506
ssS'Apraclonidine'
p6507
(dp6508
g13
g25
sg15
S'1108020J0'
p6509
ssVPituitary and Hypothalamic Hormones and Analogues
p6510
(dp6511
g13
g14
sg15
V/categories/DBCAT002097
p6512
ssVgamma-Aminobutyric Acid-ergic Agonist
p6513
(dp6514
g13
g14
sg15
V/categories/DBCAT003288
p6515
ssVGlinide
p6516
(dp6517
g13
g14
sg15
V/categories/DBCAT003395
p6518
ssVInosine
p6519
(dp6520
g13
g14
sg15
V/categories/DBCAT001184
p6521
ssVHCV Protease Inhibitors
p6522
(dp6523
g13
g14
sg15
V/categories/DBCAT003771
p6524
ssS'Memantine Hydrochloride'
p6525
(dp6526
g13
g25
sg15
S'0411000G0'
p6527
ssV4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor
p6528
(dp6529
g13
g14
sg15
V/categories/DBCAT003331
p6530
ssVHormones and Related Agents
p6531
(dp6532
g13
g14
sg15
V/categories/DBCAT002089
p6533
ssVOligonucleotides
p6534
(dp6535
g13
g14
sg15
V/categories/DBCAT001720
p6536
ssS'Atorvastatin'
p6537
(dp6538
g13
g25
sg15
S'0212000B0'
p6539
ssVBeta-Blockers (Beta1 Selective)
p6540
(dp6541
g13
g14
sg15
V/categories/DBCAT002681
p6542
ssVArylsulfonates
p6543
(dp6544
g13
g14
sg15
V/categories/DBCAT001614
p6545
ssVImmunoproteins
p6546
(dp6547
g13
g14
sg15
V/categories/DBCAT000023
p6548
ssS'Dalbavancin Hydrochloride'
p6549
(dp6550
g13
g25
sg15
S'0501070AF'
p6551
ssS'Sodium Perborate'
p6552
(dp6553
g13
g25
sg15
S'1203040R0'
p6554
ssVPore Forming Cytotoxic Proteins
p6555
(dp6556
g13
g14
sg15
V/categories/DBCAT000102
p6557
ssVOsmotic Laxatives
p6558
(dp6559
g13
g14
sg15
V/categories/DBCAT003379
p6560
ssVTumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors
p6561
(dp6562
g13
g14
sg15
V/categories/DBCAT002087
p6563
ssVNeuropeptides
p6564
(dp6565
g13
g14
sg15
V/categories/DBCAT000058
p6566
ssS'Macrogol'
p6567
(dp6568
g13
g25
sg15
S'1301010K0'
p6569
ssS'Glycopyrronium Bromide'
p6570
(dp6571
g13
g25
sg15
S'0301020S0'
p6572
ssVAtropine
p6573
(dp6574
g13
g14
sg15
V/categories/DBCAT000849
p6575
ssVEctoparasiticides, Incl. Scabicides
p6576
(dp6577
g13
g14
sg15
V/categories/DBCAT002370
p6578
ssS'Baclofen'
p6579
(dp6580
g13
g25
sg15
S'1002020C0'
p6581
ssVPeripheral Nervous System Agents
p6582
(dp6583
g13
g14
sg15
V/categories/DBCAT000043
p6584
ssS'Ulobetasol Propionate'
p6585
(dp6586
g13
g25
sg15
S'1304000AB'
p6587
ssVElements
p6588
(dp6589
g13
g14
sg15
V/categories/DBCAT001340
p6590
ssVAntibiotics for Topical Use
p6591
(dp6592
g13
g14
sg15
V/categories/DBCAT002363
p6593
ssS'Amylmetacresol'
p6594
(dp6595
g13
g25
sg15
S'1203030A0'
p6596
ssVAsparagine-specific Enzyme
p6597
(dp6598
g13
g14
sg15
V/categories/DBCAT003249
p6599
ssVNephrotoxic agents
p6600
(dp6601
g13
g14
sg15
V/categories/DBCAT003959
p6602
ssVDiphenhydramine
p6603
(dp6604
g13
g14
sg15
V/categories/DBCAT001217
p6605
ssVCephalexin
p6606
(dp6607
g13
g14
sg15
V/categories/DBCAT001072
p6608
ssVQuinazolines
p6609
(dp6610
g13
g14
sg15
V/categories/DBCAT000883
p6611
ssS'Rituximab'
p6612
(dp6613
g13
g25
sg15
S'0802030F0'
p6614
ssVQTc Prolonging Agents
p6615
(dp6616
g13
g14
sg15
V/categories/DBCAT003823
p6617
ssVHeparin (Low Molecular Weight)
p6618
(dp6619
g13
g14
sg15
V/categories/DBCAT002680
p6620
ssVProton Pump Inhibitors
p6621
(dp6622
g13
g14
sg15
V/categories/DBCAT000541
p6623
ssVDiuretics
p6624
(dp6625
g13
g14
sg15
V/categories/DBCAT000542
p6626
ssVCOX-2 Inhibitors
p6627
(dp6628
g13
g14
sg15
V/categories/DBCAT003908
p6629
ssS'Antithymocyte Immunoglobulin'
p6630
(dp6631
g13
g25
sg15
S'0802020X0'
p6632
ssVCholestenes
p6633
(dp6634
g13
g14
sg15
V/categories/DBCAT000307
p6635
ssVImino Acids
p6636
(dp6637
g13
g14
sg15
V/categories/DBCAT000388
p6638
ssS'Lofexidine Hydrochloride'
p6639
(dp6640
g13
g25
sg15
S'0410030D0'
p6641
ssVBiogenic Amines
p6642
(dp6643
g13
g14
sg15
V/categories/DBCAT000285
p6644
ssS'Avanafil'
p6645
(dp6646
g13
g25
sg15
S'0704050AC'
p6647
ssVStreptogramin Antibacterial
p6648
(dp6649
g13
g14
sg15
V/categories/DBCAT003441
p6650
ssVCytochrome P-450 CYP1A2 Inducers (weak)
p6651
(dp6652
g13
g14
sg15
V/categories/DBCAT003030
p6653
ssS'Zidovudine'
p6654
(dp6655
g13
g25
sg15
S'0503010Y0'
p6656
ssVHigh-risk opioids
p6657
(dp6658
g13
g14
sg15
V/categories/DBCAT004680
p6659
ssVDental Materials
p6660
(dp6661
g13
g14
sg15
V/categories/DBCAT001702
p6662
ssVAmmonium Ion Binding Activity
p6663
(dp6664
g13
g14
sg15
V/categories/DBCAT004166
p6665
ssVContraceptives, Postcoital
p6666
(dp6667
g13
g14
sg15
V/categories/DBCAT001152
p6668
ssVTrypanocidal Agents
p6669
(dp6670
g13
g14
sg15
V/categories/DBCAT001101
p6671
ssVIntravaginal Contraceptives
p6672
(dp6673
g13
g14
sg15
V/categories/DBCAT002465
p6674
ssVCystine Depleting Agents
p6675
(dp6676
g13
g14
sg15
V/categories/DBCAT001162
p6677
ssS'Tizanidine Hydrochloride'
p6678
(dp6679
g13
g25
sg15
S'1002020T0'
p6680
ssVAcetylcholine Release Inhibitors
p6681
(dp6682
g13
g14
sg15
V/categories/DBCAT000130
p6683
ssS'Phentolamine/Aviptadil'
p6684
(dp6685
g13
g25
sg15
S'0704050AD'
p6686
ssS'Oxybutynin'
p6687
(dp6688
g13
g25
sg15
S'0704020J0'
p6689
ssVPolynucleotides
p6690
(dp6691
g13
g14
sg15
V/categories/DBCAT001405
p6692
ssVMethylating Agent
p6693
(dp6694
g13
g14
sg15
V/categories/DBCAT003561
p6695
ssVHydrocarbons, Fluorinated
p6696
(dp6697
g13
g14
sg15
V/categories/DBCAT001266
p6698
ssS'Ezetimibe'
p6699
(dp6700
g13
g25
sg15
S'0212000L0'
p6701
ssVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p6702
(dp6703
g13
g14
sg15
V/categories/DBCAT004502
p6704
ssVCardiac Rhythm Alteration
p6705
(dp6706
g13
g14
sg15
V/categories/DBCAT004094
p6707
ssVP2Y12 Platelet Inhibitor
p6708
(dp6709
g13
g14
sg15
V/categories/DBCAT003400
p6710
ssVFlavones
p6711
(dp6712
g13
g14
sg15
V/categories/DBCAT001280
p6713
ssS'Aluminium Hydroxide'
p6714
(dp6715
g13
g25
sg15
S'0101010C0'
p6716
ssVCorticosteroids, Moderately Potent (Group II)
p6717
(dp6718
g13
g14
sg15
V/categories/DBCAT002248
p6719
ssVBetula
p6720
(dp6721
g13
g14
sg15
V/categories/DBCAT003228
p6722
ssVEchinocandins
p6723
(dp6724
g13
g14
sg15
V/categories/DBCAT003671
p6725
ssS'Lithium Carbonate'
p6726
(dp6727
g13
g25
sg15
S'0402030K0'
p6728
ssS'Clemastine Fumarate'
p6729
(dp6730
g13
g25
sg15
S'0304010H0'
p6731
ssVMesylates
p6732
(dp6733
g13
g14
sg15
V/categories/DBCAT001229
p6734
ssS'Diclofenamide'
p6735
(dp6736
g13
g25
sg15
S'1106000N0'
p6737
ssVCombined Inhibitors of CYP3A4 and P-glycoprotein
p6738
(dp6739
g13
g14
sg15
V/categories/DBCAT002747
p6740
ssVAnticoagulants
p6741
(dp6742
g13
g14
sg15
V/categories/DBCAT000007
p6743
ssVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p6744
(dp6745
g13
g14
sg15
V/categories/DBCAT003878
p6746
ssVAlkalies
p6747
(dp6748
g13
g14
sg15
V/categories/DBCAT001346
p6749
ssVCentral Nervous System Agents
p6750
(dp6751
g13
g14
sg15
V/categories/DBCAT000044
p6752
ssVBeta blocking agents and calcium channel blockers
p6753
(dp6754
g13
g14
sg15
V/categories/DBCAT004596
p6755
ssVMonoamine Oxidase Inhibitors, Non-Selective
p6756
(dp6757
g13
g14
sg15
V/categories/DBCAT002461
p6758
ssS'Carteolol Hydrochloride'
p6759
(dp6760
g13
g25
sg15
S'1106000K0'
p6761
ssVMelatonin, antagonists & inhibitors
p6762
(dp6763
g13
g14
sg15
V/categories/DBCAT004765
p6764
ssS'Ifosfamide'
p6765
(dp6766
g13
g25
sg15
S'0801010N0'
p6767
ssVUrea
p6768
(dp6769
g13
g14
sg15
V/categories/DBCAT000635
p6770
ssVAMPA Receptor Antagonists
p6771
(dp6772
g13
g14
sg15
V/categories/DBCAT004475
p6773
ssVSteroid Antibacterials
p6774
(dp6775
g13
g14
sg15
V/categories/DBCAT002542
p6776
ssVLipoglycopeptides
p6777
(dp6778
g13
g14
sg15
V/categories/DBCAT004291
p6779
ssVNoncompetitive AMPA Glutamate Receptor Antagonist
p6780
(dp6781
g13
g14
sg15
V/categories/DBCAT003497
p6782
ssS'Hydrocortisone Acetate'
p6783
(dp6784
g13
g25
sg15
S'1104010M0'
p6785
ssVBlood Substitutes and Plasma Protein Fractions
p6786
(dp6787
g13
g14
sg15
V/categories/DBCAT002591
p6788
ssVInterleukin 2 Receptor-directed Antibody Interactions
p6789
(dp6790
g13
g14
sg15
V/categories/DBCAT004303
p6791
ssS'Riluzole'
p6792
(dp6793
g13
g25
sg15
S'0409030R0'
p6794
ssVSulfones
p6795
(dp6796
g13
g14
sg15
V/categories/DBCAT000515
p6797
ssS'Econazole Nitrate'
p6798
(dp6799
g13
g25
sg15
S'1103020E0'
p6800
ssVEthanolamine Derivatives
p6801
(dp6802
g13
g14
sg15
V/categories/DBCAT003673
p6803
ssS'Mepolizumab'
p6804
(dp6805
g13
g25
sg15
S'0304020Y0'
p6806
ssS'Docetaxel'
p6807
(dp6808
g13
g25
sg15
S'0801050D0'
p6809
ssVEndonucleases
p6810
(dp6811
g13
g14
sg15
V/categories/DBCAT002872
p6812
ssVIndenes
p6813
(dp6814
g13
g14
sg15
V/categories/DBCAT000931
p6815
ssVUGT1A6 Inhibitors
p6816
(dp6817
g13
g14
sg15
V/categories/DBCAT002665
p6818
ssS'Nicotine Bitartrate'
p6819
(dp6820
g13
g25
sg15
S'0410020D0'
p6821
ssVPhosphate salts
p6822
(dp6823
g13
g14
sg15
V/categories/DBCAT003002
p6824
ssVUrologicals
p6825
(dp6826
g13
g14
sg15
V/categories/DBCAT002207
p6827
ssVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p6828
(dp6829
g13
g14
sg15
V/categories/DBCAT002621
p6830
ssVNicotinic Antagonists
p6831
(dp6832
g13
g14
sg15
V/categories/DBCAT000919
p6833
ssVIndicators and Reagents
p6834
(dp6835
g13
g14
sg15
V/categories/DBCAT000197
p6836
ssVAdrenergic beta-2 Receptor Agonists
p6837
(dp6838
g13
g14
sg15
V/categories/DBCAT003416
p6839
ssVMATE inhibitors
p6840
(dp6841
g13
g14
sg15
V/categories/DBCAT003957
p6842
ssS'Sodium Polystyrene Sulfonate'
p6843
(dp6844
g13
g25
sg15
S'0902011P0'
p6845
ssVCytochrome P-450 CYP2C18 Inhibitors
p6846
(dp6847
g13
g14
sg15
V/categories/DBCAT004665
p6848
ssVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p6849
(dp6850
g13
g14
sg15
V/categories/DBCAT004539
p6851
ssVOAT3/SLC22A8 Inhibitors
p6852
(dp6853
g13
g14
sg15
V/categories/DBCAT003946
p6854
ssVVenoms
p6855
(dp6856
g13
g14
sg15
V/categories/DBCAT001328
p6857
ssVThiophenes
p6858
(dp6859
g13
g14
sg15
V/categories/DBCAT000374
p6860
ssVVasopressins, antagonists & inhibitors
p6861
(dp6862
g13
g14
sg15
V/categories/DBCAT004697
p6863
ssVAdrenergics for Systemic Use
p6864
(dp6865
g13
g14
sg15
V/categories/DBCAT002232
p6866
ssS'Tolbutamide'
p6867
(dp6868
g13
g25
sg15
S'0601021X0'
p6869
ssVPsychoanaleptics
p6870
(dp6871
g13
g14
sg15
V/categories/DBCAT002156
p6872
ssVHematinics
p6873
(dp6874
g13
g14
sg15
V/categories/DBCAT000087
p6875
ssVParasympathomimetics
p6876
(dp6877
g13
g14
sg15
V/categories/DBCAT000448
p6878
ssVProstaglandin E1 Agonist
p6879
(dp6880
g13
g14
sg15
V/categories/DBCAT003402
p6881
ssS'Vinorelbine'
p6882
(dp6883
g13
g25
sg15
S'0801040R0'
p6884
ssS'Diazoxide'
p6885
(dp6886
g13
g25
sg15
S'0601040E0'
p6887
ssVMiscellaneous Local Anti-infectives
p6888
(dp6889
g13
g14
sg15
V/categories/DBCAT003645
p6890
ssVCorrinoids
p6891
(dp6892
g13
g14
sg15
V/categories/DBCAT000237
p6893
ssVAzaspirodecanedione Derivatives
p6894
(dp6895
g13
g14
sg15
V/categories/DBCAT002398
p6896
ssVMethylhydrazines
p6897
(dp6898
g13
g14
sg15
V/categories/DBCAT002513
p6899
ssVPlatelet-reducing Agents
p6900
(dp6901
g13
g14
sg15
V/categories/DBCAT003647
p6902
ssS'Alteplase'
p6903
(dp6904
g13
g25
sg15
S'0210020V0'
p6905
ssS'Isosorbide Mononitrate'
p6906
(dp6907
g13
g25
sg15
S'0206010K0'
p6908
ssVMacrolide Antimicrobial
p6909
(dp6910
g13
g14
sg15
V/categories/DBCAT003294
p6911
ssVAndrogen Receptor Inhibitor
p6912
(dp6913
g13
g14
sg15
V/categories/DBCAT003360
p6914
ssVElements, Radioactive
p6915
(dp6916
g13
g14
sg15
V/categories/DBCAT002835
p6917
ssVFatty Acids, Unsaturated
p6918
(dp6919
g13
g14
sg15
V/categories/DBCAT000300
p6920
ssS'Dexmethylphenidate Hydrochloride'
p6921
(dp6922
g13
g25
sg15
S'0404000T0'
p6923
ssVSympathomimetics Excl. Antiglaucoma Preparations
p6924
(dp6925
g13
g14
sg15
V/categories/DBCAT002349
p6926
ssVIndans
p6927
(dp6928
g13
g14
sg15
V/categories/DBCAT000930
p6929
ssVTriethylenephosphoramide
p6930
(dp6931
g13
g14
sg15
V/categories/DBCAT001594
p6932
ssS'Ertapenem Sodium'
p6933
(dp6934
g13
g25
sg15
S'0501022B0'
p6935
ssVOncogene Proteins
p6936
(dp6937
g13
g14
sg15
V/categories/DBCAT000211
p6938
ssS'Zaleplon'
p6939
(dp6940
g13
g25
sg15
S'0401010W0'
p6941
ssVPyrrolidines
p6942
(dp6943
g13
g14
sg15
V/categories/DBCAT000663
p6944
ssVPhotoenhancer
p6945
(dp6946
g13
g14
sg15
V/categories/DBCAT003355
p6947
ssVEsterases
p6948
(dp6949
g13
g14
sg15
V/categories/DBCAT000190
p6950
ssVAntiprotozoals
p6951
(dp6952
g13
g14
sg15
V/categories/DBCAT002211
p6953
ssVSphingosine 1-Phosphate Receptor Modulators
p6954
(dp6955
g13
g14
sg15
V/categories/DBCAT004396
p6956
ssVBlood
p6957
(dp6958
g13
g14
sg15
V/categories/DBCAT002883
p6959
ssVGABA Antagonists
p6960
(dp6961
g13
g14
sg15
V/categories/DBCAT000793
p6962
ssVMagnetic Resonance Contrast Activity
p6963
(dp6964
g13
g14
sg15
V/categories/DBCAT004125
p6965
ssS'Lurasidone'
p6966
(dp6967
g13
g25
sg15
S'0402010AI'
p6968
ssVDecreased Coagulation Factor Activity
p6969
(dp6970
g13
g14
sg15
V/categories/DBCAT004167
p6971
ssVBradykinin Receptor Antagonists
p6972
(dp6973
g13
g14
sg15
V/categories/DBCAT001656
p6974
ssVFirst-Generation Cephalosporins
p6975
(dp6976
g13
g14
sg15
V/categories/DBCAT002385
p6977
ssVHematologic Activity Alteration
p6978
(dp6979
g13
g14
sg15
V/categories/DBCAT004469
p6980
ssS'Metformin Hydrochloride'
p6981
(dp6982
g13
g25
sg15
S'0601022B0'
p6983
ssVCytochrome P-450 CYP2C19 Inducers (moderate)
p6984
(dp6985
g13
g14
sg15
V/categories/DBCAT003110
p6986
ssVAtropine Derivatives
p6987
(dp6988
g13
g14
sg15
V/categories/DBCAT000762
p6989
ssS'Pancreatin'
p6990
(dp6991
g13
g25
sg15
S'0109040N0'
p6992
ssVRNA Replicase Inhibitors
p6993
(dp6994
g13
g14
sg15
V/categories/DBCAT004208
p6995
ssVSemi-synthetic Opioids
p6996
(dp6997
g13
g14
sg15
V/categories/DBCAT003866
p6998
ssS'Retigabine'
p6999
(dp7000
g13
g25
sg15
S'0408010AJ'
p7001
ssVStreptomycins
p7002
(dp7003
g13
g14
sg15
V/categories/DBCAT002498
p7004
ssS'Ceftazidime Pentahydrate'
p7005
(dp7006
g13
g25
sg15
S'0501021H0'
p7007
ssVAntimetabolites
p7008
(dp7009
g13
g14
sg15
V/categories/DBCAT000276
p7010
ssVTetracycline, antagonists & inhibitors
p7011
(dp7012
g13
g14
sg15
V/categories/DBCAT004752
p7013
ssS'Pentoxifylline'
p7014
(dp7015
g13
g25
sg15
S'0206040AG'
p7016
ssVHydroxybenzoates
p7017
(dp7018
g13
g14
sg15
V/categories/DBCAT000580
p7019
ssS'Lubiprostone'
p7020
(dp7021
g13
g25
sg15
S'0106070C0'
p7022
ssVCholagogues and Choleretics
p7023
(dp7024
g13
g14
sg15
V/categories/DBCAT001385
p7025
ssVPhosphodiesterase Inhibitors
p7026
(dp7027
g13
g14
sg15
V/categories/DBCAT000509
p7028
ssS'Chlorphenamine Maleate'
p7029
(dp7030
g13
g25
sg15
S'0304010G0'
p7031
ssVIncreased Cytokine Activity
p7032
(dp7033
g13
g14
sg15
V/categories/DBCAT004408
p7034
ssVHigh-Ceiling Diuretics
p7035
(dp7036
g13
g14
sg15
V/categories/DBCAT002223
p7037
ssVReceptors, Thrombopoietin, agonists
p7038
(dp7039
g13
g14
sg15
V/categories/DBCAT001695
p7040
ssS'Orphenadrine Hydrochloride'
p7041
(dp7042
g13
g25
sg15
S'0409020N0'
p7043
ssS'Iron Carboxymaltose'
p7044
(dp7045
g13
g25
sg15
S'0901012P0'
p7046
ssVAntivirals for Systemic Use
p7047
(dp7048
g13
g14
sg15
V/categories/DBCAT002141
p7049
ssVChondroitinases and Chondroitin Lyases
p7050
(dp7051
g13
g14
sg15
V/categories/DBCAT002907
p7052
ssS'Paracetamol & Caffeine'
p7053
(dp7054
g13
g25
sg15
S'0407010U0'
p7055
ssS'Naratriptan Hydrochloride'
p7056
(dp7057
g13
g25
sg15
S'0407041M0'
p7058
ssS'Abciximab'
p7059
(dp7060
g13
g25
sg15
S'0209000W0'
p7061
ssVDecreased Immunologic Activity
p7062
(dp7063
g13
g14
sg15
V/categories/DBCAT004157
p7064
ssS'Caffeine Citrate'
p7065
(dp7066
g13
g25
sg15
S'0404000E0'
p7067
ssVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p7068
(dp7069
g13
g14
sg15
V/categories/DBCAT002252
p7070
ssVButyrates
p7071
(dp7072
g13
g14
sg15
V/categories/DBCAT000425
p7073
ssS'Cefuroxime Axetil'
p7074
(dp7075
g13
g25
sg15
S'0501021K0'
p7076
ssS'Valsartan'
p7077
(dp7078
g13
g25
sg15
S'0205052V0'
p7079
ssVDiagnostic Agents
p7080
(dp7081
g13
g14
sg15
V/categories/DBCAT002094
p7082
ssVCephamycins
p7083
(dp7084
g13
g14
sg15
V/categories/DBCAT000654
p7085
ssVIndole Derivatives
p7086
(dp7087
g13
g14
sg15
V/categories/DBCAT002255
p7088
ssVPurinergic P1 Receptor Antagonists
p7089
(dp7090
g13
g14
sg15
V/categories/DBCAT000508
p7091
ssVMonoterpenes
p7092
(dp7093
g13
g14
sg15
V/categories/DBCAT001046
p7094
ssVPotassium-removing Agents
p7095
(dp7096
g13
g14
sg15
V/categories/DBCAT003761
p7097
ssVAryloxyacetic Acid Derivatives
p7098
(dp7099
g13
g14
sg15
V/categories/DBCAT002482
p7100
ssVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p7101
(dp7102
g13
g14
sg15
V/categories/DBCAT004028
p7103
ssVHormonal Contraceptives for Systemic Use
p7104
(dp7105
g13
g14
sg15
V/categories/DBCAT002291
p7106
ssVMonoamine Oxidase A Substrates
p7107
(dp7108
g13
g14
sg15
V/categories/DBCAT004538
p7109
ssVDrugs Used in Diabetes
p7110
(dp7111
g13
g14
sg15
V/categories/DBCAT002117
p7112
ssVOxicams
p7113
(dp7114
g13
g14
sg15
V/categories/DBCAT002395
p7115
ssVNebramycin
p7116
(dp7117
g13
g14
sg15
V/categories/DBCAT001066
p7118
ssVAntimitotic Agents
p7119
(dp7120
g13
g14
sg15
V/categories/DBCAT000715
p7121
ssVAntacids and Adsorbents
p7122
(dp7123
g13
g14
sg15
V/categories/DBCAT003760
p7124
ssVAnticonvulsants
p7125
(dp7126
g13
g14
sg15
V/categories/DBCAT000455
p7127
ssVSolanaceous Alkaloids
p7128
(dp7129
g13
g14
sg15
V/categories/DBCAT000442
p7130
ssVAndrostenes
p7131
(dp7132
g13
g14
sg15
V/categories/DBCAT000980
p7133
ssVVesicular Transport Proteins
p7134
(dp7135
g13
g14
sg15
V/categories/DBCAT001682
p7136
ssVThyroxine-binding globulin substrates
p7137
(dp7138
g13
g14
sg15
V/categories/DBCAT004601
p7139
ssVPhenylbutazone
p7140
(dp7141
g13
g14
sg15
V/categories/DBCAT001278
p7142
ssVDecreased Striated Muscle Contraction
p7143
(dp7144
g13
g14
sg15
V/categories/DBCAT004296
p7145
ssV3-Oxoandrosten (4) Derivatives
p7146
(dp7147
g13
g14
sg15
V/categories/DBCAT002430
p7148
ssVMisc. Skin and Mucous Membrane Agents
p7149
(dp7150
g13
g14
sg15
V/categories/DBCAT003612
p7151
ssS'Cannabidiol'
p7152
(dp7153
g13
g25
sg15
S'0408010AM'
p7154
ssS'Methenamine Mandelate'
p7155
(dp7156
g13
g25
sg15
S'0501130K0'
p7157
ssVQuinoxalines
p7158
(dp7159
g13
g14
sg15
V/categories/DBCAT000920
p7160
ssS'Dalteparin Sodium'
p7161
(dp7162
g13
g25
sg15
S'0208010L0'
p7163
ssS'Methyldopa'
p7164
(dp7165
g13
g25
sg15
S'0205020H0'
p7166
ssVCholinergic Nicotinic Agonist
p7167
(dp7168
g13
g14
sg15
V/categories/DBCAT003289
p7169
ssS'Tadalafil'
p7170
(dp7171
g13
g25
sg15
S'0704050R0'
p7172
ssVBenzazepines
p7173
(dp7174
g13
g14
sg15
V/categories/DBCAT000451
p7175
ssS'Lisdexamfetamine Dimesylate'
p7176
(dp7177
g13
g25
sg15
S'0404000U0'
p7178
ssVCytochrome P-450 CYP2C8 Inducers
p7179
(dp7180
g13
g14
sg15
V/categories/DBCAT001247
p7181
ssVCytochrome P-450 CYP3A Inhibitors
p7182
(dp7183
g13
g14
sg15
V/categories/DBCAT000934
p7184
ssVMitomycins
p7185
(dp7186
g13
g14
sg15
V/categories/DBCAT000710
p7187
ssS'Probenecid'
p7188
(dp7189
g13
g25
sg15
S'1001040K0'
p7190
ssS'Diltiazem Hydrochloride'
p7191
(dp7192
g13
g25
sg15
S'0107010AA'
p7193
ssVBotulinum Toxins, Type A, antagonists & inhibitors
p7194
(dp7195
g13
g14
sg15
V/categories/DBCAT004698
p7196
ssS'Caffeine & Sodium Iodide'
p7197
(dp7198
g13
g25
sg15
S'0309020F0'
p7199
ssVHuman Immunodeficiency Virus Proteins
p7200
(dp7201
g13
g14
sg15
V/categories/DBCAT002896
p7202
ssVSilicic Acid
p7203
(dp7204
g13
g14
sg15
V/categories/DBCAT001374
p7205
ssVCytochrome P-450 CYP3A7 Substrates
p7206
(dp7207
g13
g14
sg15
V/categories/DBCAT003800
p7208
ssVProtein Precursors
p7209
(dp7210
g13
g14
sg15
V/categories/DBCAT000121
p7211
ssVCyclin-Dependent Kinases, antagonists & inhibitors
p7212
(dp7213
g13
g14
sg15
V/categories/DBCAT001450
p7214
ssVIron
p7215
(dp7216
g13
g14
sg15
V/categories/DBCAT004561
p7217
ssVIntegrin Receptor Antagonist
p7218
(dp7219
g13
g14
sg15
V/categories/DBCAT003280
p7220
ssS'Teriparatide'
p7221
(dp7222
g13
g14
sg15
V/categories/DBCAT004821
p7223
ssVSomatotropin Antagonists
p7224
(dp7225
g13
g14
sg15
V/categories/DBCAT003620
p7226
ssVQuinoline Derivatives
p7227
(dp7228
g13
g14
sg15
V/categories/DBCAT002551
p7229
ssVAntidepressive Agents, Tricyclic
p7230
(dp7231
g13
g14
sg15
V/categories/DBCAT000744
p7232
ssVPhenoxybenzamine
p7233
(dp7234
g13
g14
sg15
V/categories/DBCAT001810
p7235
ssVRespiratory and CNS Stimulants
p7236
(dp7237
g13
g14
sg15
V/categories/DBCAT003636
p7238
ssVOAT1/SLC22A6 Substrates
p7239
(dp7240
g13
g14
sg15
V/categories/DBCAT003904
p7241
ssVDiagnostic Uses of Chemicals
p7242
(dp7243
g13
g14
sg15
V/categories/DBCAT000559
p7244
ssVIntercalating Agents
p7245
(dp7246
g13
g14
sg15
V/categories/DBCAT000657
p7247
ssVProstatic Neoplasms, drug therapy
p7248
(dp7249
g13
g14
sg15
V/categories/DBCAT002819
p7250
ssVGonadotropin Releasing Hormone Receptor Agonists
p7251
(dp7252
g13
g14
sg15
V/categories/DBCAT004268
p7253
ssVSclerosing Solutions
p7254
(dp7255
g13
g14
sg15
V/categories/DBCAT000897
p7256
ssVSelective T Cell Costimulation Modulator
p7257
(dp7258
g13
g14
sg15
V/categories/DBCAT003439
p7259
ssVOther Macrolides
p7260
(dp7261
g13
g14
sg15
V/categories/DBCAT003637
p7262
ssVAntineoplastic Agents, Alkylating
p7263
(dp7264
g13
g14
sg15
V/categories/DBCAT000592
p7265
ssVReducing and Complexing Thiol
p7266
(dp7267
g13
g14
sg15
V/categories/DBCAT003485
p7268
ssVHousehold Products
p7269
(dp7270
g13
g14
sg15
V/categories/DBCAT001170
p7271
ssS'Primidone'
p7272
(dp7273
g13
g25
sg15
S'0408010U0'
p7274
ssS'Olopatadine'
p7275
(dp7276
g13
g25
sg15
S'1104020Z0'
p7277
ssVVasodilators Used in Cardiac Diseases
p7278
(dp7279
g13
g14
sg15
V/categories/DBCAT002457
p7280
ssVNonergot-derivative Dopamine Receptor Agonists
p7281
(dp7282
g13
g14
sg15
V/categories/DBCAT003649
p7283
ssS'Lorazepam'
p7284
(dp7285
g13
g25
sg15
S'0401020P0'
p7286
ssVDiaminopyrimidines
p7287
(dp7288
g13
g14
sg15
V/categories/DBCAT002213
p7289
ssVAdrenergic alpha-Antagonists
p7290
(dp7291
g13
g14
sg15
V/categories/DBCAT000696
p7292
ssVPyrazolones
p7293
(dp7294
g13
g14
sg15
V/categories/DBCAT001145
p7295
ssVSympathomimetic Amine Anorectic
p7296
(dp7297
g13
g14
sg15
V/categories/DBCAT003292
p7298
ssS'Ziprasidone Hydrochloride'
p7299
(dp7300
g13
g25
sg15
S'0402010AG'
p7301
ssVAnti-Estrogens
p7302
(dp7303
g13
g14
sg15
V/categories/DBCAT002405
p7304
ssS'Phenoxybenzamine Hydrochloride'
p7305
(dp7306
g13
g25
sg15
S'0205040M0'
p7307
ssVAntibodies
p7308
(dp7309
g13
g14
sg15
V/categories/DBCAT000016
p7310
ssVPlant Preparations
p7311
(dp7312
g13
g14
sg15
V/categories/DBCAT001210
p7313
ssS'Methyclothiazide'
p7314
(dp7315
g13
g25
sg15
S'0202010T0'
p7316
ssS'Lacosamide'
p7317
(dp7318
g13
g25
sg15
S'0408010AH'
p7319
ssS'Pseudoephedrine HCl/Dextrometh Hydrob'
p7320
(dp7321
g13
g25
sg15
S'0309020AF'
p7322
ssVAntiplatyhelmintic Agents
p7323
(dp7324
g13
g14
sg15
V/categories/DBCAT000943
p7325
ssVCytochrome P450 2C9 Inducers
p7326
(dp7327
g13
g14
sg15
V/categories/DBCAT004107
p7328
ssS'Felbamate'
p7329
(dp7330
g13
g25
sg15
S'0408010AA'
p7331
ssVDecreased Glycolysis
p7332
(dp7333
g13
g14
sg15
V/categories/DBCAT004428
p7334
ssS'Phenytoin Sodium'
p7335
(dp7336
g13
g25
sg15
S'0408020T0'
p7337
ssVCytochrome P-450 CYP2C19 Inhibitors
p7338
(dp7339
g13
g14
sg15
V/categories/DBCAT000403
p7340
ssVVitamins (Fat Soluble)
p7341
(dp7342
g13
g14
sg15
V/categories/DBCAT002724
p7343
ssS'Azilsartan Medoxomil'
p7344
(dp7345
g13
g25
sg15
S'0205052AD'
p7346
ssVGlucagon-like peptide-1 (GLP-1) analogues
p7347
(dp7348
g13
g14
sg15
V/categories/DBCAT004598
p7349
ssVContact Laxatives
p7350
(dp7351
g13
g14
sg15
V/categories/DBCAT002553
p7352
ssS'Nystatin'
p7353
(dp7354
g13
g25
sg15
S'0502030B0'
p7355
ssVB Lymphocyte Stimulator-directed Antibody Interactions
p7356
(dp7357
g13
g14
sg15
V/categories/DBCAT004413
p7358
ssS'Idebenone'
p7359
(dp7360
g13
g25
sg15
S'1108030AB'
p7361
ssVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p7362
(dp7363
g13
g14
sg15
V/categories/DBCAT003988
p7364
ssVPhthalic Acids
p7365
(dp7366
g13
g14
sg15
V/categories/DBCAT000723
p7367
ssVGanglionic Stimulants
p7368
(dp7369
g13
g14
sg15
V/categories/DBCAT000446
p7370
ssVBenzene Derivatives
p7371
(dp7372
g13
g14
sg15
V/categories/DBCAT000418
p7373
ssVBradycardia-Causing Agents
p7374
(dp7375
g13
g14
sg15
V/categories/DBCAT002703
p7376
ssS'Erythromycin Estolate'
p7377
(dp7378
g13
g25
sg15
S'0501050F0'
p7379
ssVPregnancy Proteins
p7380
(dp7381
g13
g14
sg15
V/categories/DBCAT001931
p7382
ssVAntianemia Drugs
p7383
(dp7384
g13
g14
sg15
V/categories/DBCAT003764
p7385
ssVSulfur Acids
p7386
(dp7387
g13
g14
sg15
V/categories/DBCAT000892
p7388
ssS'Esketamine Hydrochloride'
p7389
(dp7390
g13
g25
sg15
S'1501010R0'
p7391
ssVInterleukin-17A Antagonist
p7392
(dp7393
g13
g14
sg15
V/categories/DBCAT003508
p7394
ssS'Sucralfate'
p7395
(dp7396
g13
g25
sg15
S'0103030S0'
p7397
ssVLaxatives, magnesium containing
p7398
(dp7399
g13
g14
sg15
V/categories/DBCAT003004
p7400
ssVFish Oils
p7401
(dp7402
g13
g14
sg15
V/categories/DBCAT000298
p7403
ssVCytochrome P-450 CYP3A5 Inducers (strong)
p7404
(dp7405
g13
g14
sg15
V/categories/DBCAT004491
p7406
ssS'Albiglutide'
p7407
(dp7408
g13
g25
sg15
S'0601023AS'
p7409
ssVCytochrome P-450 CYP3A4 Inhibitors
p7410
(dp7411
g13
g14
sg15
V/categories/DBCAT003232
p7412
ssVCentral Alpha-agonists
p7413
(dp7414
g13
g14
sg15
V/categories/DBCAT003700
p7415
ssS'Panobinostat'
p7416
(dp7417
g13
g25
sg15
S'0801050BW'
p7418
ssVCarbohydrates
p7419
(dp7420
g13
g14
sg15
V/categories/DBCAT000085
p7421
ssS'Co-Dergocrine Mesilate'
p7422
(dp7423
g13
g25
sg15
S'0206040AM'
p7424
ssVProgestogens and Estrogens, Sequential Preparations
p7425
(dp7426
g13
g14
sg15
V/categories/DBCAT002296
p7427
ssS'Paracetamol & Ibuprofen'
p7428
(dp7429
g13
g25
sg15
S'0407010AD'
p7430
ssVSirolimus
p7431
(dp7432
g13
g25
sg15
S'0802020U0'
p7433
ssVDiluents
p7434
(dp7435
g13
g14
sg15
V/categories/DBCAT003618
p7436
ssVInvestigative Techniques
p7437
(dp7438
g13
g14
sg15
V/categories/DBCAT001062
p7439
ssVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p7440
(dp7441
g13
g14
sg15
V/categories/DBCAT004595
p7442
ssVOils, Volatile
p7443
(dp7444
g13
g14
sg15
V/categories/DBCAT001459
p7445
ssVCytochrome P-450 Enzyme Inhibitors
p7446
(dp7447
g13
g14
sg15
V/categories/DBCAT000394
p7448
ssVAmdinocillin
p7449
(dp7450
g13
g14
sg15
V/categories/DBCAT001398
p7451
ssVContraceptive Agents, Male
p7452
(dp7453
g13
g14
sg15
V/categories/DBCAT000994
p7454
ssVIntegrin Receptor Antagonists
p7455
(dp7456
g13
g14
sg15
V/categories/DBCAT004289
p7457
ssS'Pravastatin Sodium'
p7458
(dp7459
g13
g25
sg15
S'0212000X0'
p7460
ssVPreparations Inhibiting Uric Acid Production
p7461
(dp7462
g13
g14
sg15
V/categories/DBCAT002374
p7463
ssS'Lidocaine/Prilocaine (Prem Ejaculation)'
p7464
(dp7465
g13
g25
sg15
S'0704060B0'
p7466
ssVFood
p7467
(dp7468
g13
g14
sg15
V/categories/DBCAT000232
p7469
ssS'Vancomycin Hydrochloride'
p7470
(dp7471
g13
g25
sg15
S'0501070U0'
p7472
ssVHypercholesterolemia, drug therapy
p7473
(dp7474
g13
g14
sg15
V/categories/DBCAT001977
p7475
ssVThienopyridines
p7476
(dp7477
g13
g14
sg15
V/categories/DBCAT000530
p7478
ssVLactams, Macrocyclic
p7479
(dp7480
g13
g14
sg15
V/categories/DBCAT001006
p7481
ssVPancreatic Hormones
p7482
(dp7483
g13
g14
sg15
V/categories/DBCAT000122
p7484
ssS'Flecainide Acetate'
p7485
(dp7486
g13
g25
sg15
S'0203020I0'
p7487
ssVAcetanilides
p7488
(dp7489
g13
g14
sg15
V/categories/DBCAT000598
p7490
ssVOATP1B3 inhibitors
p7491
(dp7492
g13
g14
sg15
V/categories/DBCAT003932
p7493
ssVCorticosteroids for Local Oral Treatment
p7494
(dp7495
g13
g14
sg15
V/categories/DBCAT002425
p7496
ssS'Cariprazine'
p7497
(dp7498
g13
g25
sg15
S'0402010AJ'
p7499
ssS'Lamivudine & Zidovudine'
p7500
(dp7501
g13
g25
sg15
S'0503010A0'
p7502
ssVAntihemorrhagic Agents, Miscellaneous
p7503
(dp7504
g13
g14
sg15
V/categories/DBCAT003787
p7505
ssVCholesterol Ester Storage Disease, drug therapy
p7506
(dp7507
g13
g14
sg15
V/categories/DBCAT002075
p7508
ssVInterleukin 5 Receptor alpha-directed Antibody Interactions
p7509
(dp7510
g13
g14
sg15
V/categories/DBCAT004467
p7511
ssS'Catumaxomab'
p7512
(dp7513
g13
g25
sg15
S'0801050BF'
p7514
ssVBeta-Lactamase Sensitive Penicillins
p7515
(dp7516
g13
g14
sg15
V/categories/DBCAT002365
p7517
ssVCyclodecanes
p7518
(dp7519
g13
g14
sg15
V/categories/DBCAT001310
p7520
ssS'Enoxaparin'
p7521
(dp7522
g13
g25
sg15
S'0208010D0'
p7523
ssS'Maraviroc'
p7524
(dp7525
g13
g25
sg15
S'0503010AD'
p7526
ssS'Lindane'
p7527
(dp7528
g13
g25
sg15
S'1310040I0'
p7529
ssS'Calcium Chloride'
p7530
(dp7531
g13
g25
sg15
S'0905011B0'
p7532
ssS'Donepezil Hydrochloride'
p7533
(dp7534
g13
g25
sg15
S'0411000D0'
p7535
ssVCytochrome P-450 CYP2E1 Inhibitors (weak)
p7536
(dp7537
g13
g14
sg15
V/categories/DBCAT003036
p7538
ssVNorpregnenes
p7539
(dp7540
g13
g14
sg15
V/categories/DBCAT000704
p7541
ssVBSEP/ABCB11 Inhibitors
p7542
(dp7543
g13
g14
sg15
V/categories/DBCAT002660
p7544
ssS'Prednisolone'
p7545
(dp7546
g13
g14
sg15
V/categories/DBCAT001204
p7547
ssS'Sodium Bicarbonate'
p7548
(dp7549
g13
g25
sg15
S'0101012B0'
p7550
ssVMonosaccharides
p7551
(dp7552
g13
g14
sg15
V/categories/DBCAT001422
p7553
ssS'Selenium Sulfide'
p7554
(dp7555
g13
g25
sg15
S'0905047A0'
p7556
ssVEthylene Glycols
p7557
(dp7558
g13
g14
sg15
V/categories/DBCAT001371
p7559
ssVRecombinant Proteins
p7560
(dp7561
g13
g14
sg15
V/categories/DBCAT000097
p7562
ssS'Ticlopidine Hydrochloride'
p7563
(dp7564
g13
g25
sg15
S'0209000U0'
p7565
ssVAnti-Acne Preparations for Topical Use
p7566
(dp7567
g13
g14
sg15
V/categories/DBCAT002162
p7568
ssS'Lidocaine Hydrochloride'
p7569
(dp7570
g13
g25
sg15
S'1203030M0'
p7571
ssVPlatelet Aggregation Inhibitors Excl. Heparin
p7572
(dp7573
g13
g14
sg15
V/categories/DBCAT002125
p7574
ssVCytochrome P-450 CYP2D6 Inducers (moderate)
p7575
(dp7576
g13
g14
sg15
V/categories/DBCAT004507
p7577
ssVCarbolines
p7578
(dp7579
g13
g14
sg15
V/categories/DBCAT001148
p7580
ssVHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
p7581
(dp7582
g13
g14
sg15
V/categories/DBCAT003275
p7583
ssVGABA Uptake Inhibitors
p7584
(dp7585
g13
g14
sg15
V/categories/DBCAT004989
p7586
ssVFree Radical Scavenging Activity
p7587
(dp7588
g13
g14
sg15
V/categories/DBCAT004431
p7589
ssVGonadotropin-Releasing Hormone, antagonists & inhibitors
p7590
(dp7591
g13
g14
sg15
V/categories/DBCAT001838
p7592
ssS'Modafinil'
p7593
(dp7594
g13
g25
sg15
S'0404000R0'
p7595
ssS'Irbesartan'
p7596
(dp7597
g13
g25
sg15
S'0205052I0'
p7598
ssVChloroquinolinols
p7599
(dp7600
g13
g14
sg15
V/categories/DBCAT003171
p7601
ssVGold Compounds
p7602
(dp7603
g13
g14
sg15
V/categories/DBCAT003194
p7604
ssVStimulants
p7605
(dp7606
g13
g14
sg15
V/categories/DBCAT002730
p7607
ssS'Vismodegib'
p7608
(dp7609
g13
g25
sg15
S'0801050BM'
p7610
ssVCytokines
p7611
(dp7612
g13
g14
sg15
V/categories/DBCAT000079
p7613
ssVHydroxyquinoline Derivatives
p7614
(dp7615
g13
g14
sg15
V/categories/DBCAT002552
p7616
ssVCytochrome P-450 CYP2D6 Inhibitors
p7617
(dp7618
g13
g14
sg15
V/categories/DBCAT000911
p7619
ssVFluorouracil and prodrugs
p7620
(dp7621
g13
g14
sg15
V/categories/DBCAT001268
p7622
ssVAntineoplastic Agents, Immunological
p7623
(dp7624
g13
g14
sg15
V/categories/DBCAT004966
p7625
ssS'Metirosine'
p7626
(dp7627
g13
g25
sg15
S'0205040W0'
p7628
ssS'Zinc Paste'
p7629
(dp7630
g13
g25
sg15
S'1302020G0'
p7631
ssVSelective Serotonin Agonists
p7632
(dp7633
g13
g14
sg15
V/categories/DBCAT003639
p7634
ssVHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
p7635
(dp7636
g13
g14
sg15
V/categories/DBCAT003504
p7637
ssVAnti-Infective Agents, Local
p7638
(dp7639
g13
g14
sg15
V/categories/DBCAT000103
p7640
ssS'Chlortalidone/Potassium'
p7641
(dp7642
g13
g25
sg15
S'0202080E0'
p7643
ssVAntianemic Preparations
p7644
(dp7645
g13
g14
sg15
V/categories/DBCAT002099
p7646
ssVAminopterin
p7647
(dp7648
g13
g14
sg15
V/categories/DBCAT000974
p7649
ssS'Piroxicam'
p7650
(dp7651
g13
g25
sg15
S'1003020R0'
p7652
ssS'Benethamine Penicillin'
p7653
(dp7654
g13
g25
sg15
S'0501011C0'
p7655
ssVFatty Acids
p7656
(dp7657
g13
g14
sg15
V/categories/DBCAT000301
p7658
ssVAnthraquinones
p7659
(dp7660
g13
g14
sg15
V/categories/DBCAT001296
p7661
ssS'Streptomycin'
p7662
(dp7663
g13
g25
sg15
S'0501090U0'
p7664
ssVPyrazines
p7665
(dp7666
g13
g14
sg15
V/categories/DBCAT000459
p7667
ssS'Prednisone'
p7668
(dp7669
g13
g25
sg15
S'0603020X0'
p7670
ssS'Tenoxicam'
p7671
(dp7672
g13
g25
sg15
S'100101040'
p7673
ssVCarotenoids
p7674
(dp7675
g13
g14
sg15
V/categories/DBCAT000356
p7676
ssVPhenylcarbamates
p7677
(dp7678
g13
g14
sg15
V/categories/DBCAT000848
p7679
ssS'Cyanocobalamin'
p7680
(dp7681
g13
g25
sg15
S'0901020D0'
p7682
ssVIntegrase Inhibitors
p7683
(dp7684
g13
g14
sg15
V/categories/DBCAT001872
p7685
ssVProtectants
p7686
(dp7687
g13
g14
sg15
V/categories/DBCAT003672
p7688
ssS'Thyrotropin Alfa'
p7689
(dp7690
g13
g25
sg15
S'0602010A0'
p7691
ssS'Telotristat Ethyl'
p7692
(dp7693
g13
g25
sg15
S'0104040A0'
p7694
ssVCytochrome P450 2C9 Inhibitors
p7695
(dp7696
g13
g14
sg15
V/categories/DBCAT004132
p7697
ssS'Dapagliflozin'
p7698
(dp7699
g13
g25
sg15
S'0601023AG'
p7700
ssVSulfonamides
p7701
(dp7702
g13
g14
sg15
V/categories/DBCAT000514
p7703
ssVCalcineurin Inhibitor Immunosuppressant
p7704
(dp7705
g13
g14
sg15
V/categories/DBCAT003276
p7706
ssS'Chloroquine Phosphate'
p7707
(dp7708
g13
g25
sg15
S'0504010F0'
p7709
ssVLipid Modifying Agents, Plain
p7710
(dp7711
g13
g14
sg15
V/categories/DBCAT002167
p7712
ssS'Methylnaltrexone Bromide'
p7713
(dp7714
g13
g25
sg15
S'0106060A0'
p7715
ssS'Doxazosin Mesilate'
p7716
(dp7717
g13
g25
sg15
S'0205040D0'
p7718
ssS'Carboprost'
p7719
(dp7720
g13
g25
sg15
S'0701010D0'
p7721
ssVLipid-based Polyene Antifungal
p7722
(dp7723
g13
g14
sg15
V/categories/DBCAT003390
p7724
ssVProtein Isoforms
p7725
(dp7726
g13
g14
sg15
V/categories/DBCAT002886
p7727
ssVCariostatic Agents
p7728
(dp7729
g13
g14
sg15
V/categories/DBCAT001982
p7730
ssVMonoamine Oxidase Inhibitors
p7731
(dp7732
g13
g14
sg15
V/categories/DBCAT001004
p7733
ssS'Oxcarbazepine'
p7734
(dp7735
g13
g25
sg15
S'0408010D0'
p7736
ssVAntipsoriatics
p7737
(dp7738
g13
g14
sg15
V/categories/DBCAT002154
p7739
ssS'Olmesartan Medoxomil'
p7740
(dp7741
g13
g25
sg15
S'0205052B0'
p7742
ssVMagnesium Salts
p7743
(dp7744
g13
g14
sg15
V/categories/DBCAT002704
p7745
ssVAmino Acids and Derivatives
p7746
(dp7747
g13
g14
sg15
V/categories/DBCAT002151
p7748
ssVOxidants
p7749
(dp7750
g13
g14
sg15
V/categories/DBCAT001830
p7751
ssVGlucagon, antagonists & inhibitors
p7752
(dp7753
g13
g14
sg15
V/categories/DBCAT004688
p7754
ssVDelayed-Action Preparations
p7755
(dp7756
g13
g14
sg15
V/categories/DBCAT000158
p7757
ssVAntipsychotic Agents (First Generation [Typical])
p7758
(dp7759
g13
g14
sg15
V/categories/DBCAT002672
p7760
ssVPregnanes
p7761
(dp7762
g13
g14
sg15
V/categories/DBCAT000748
p7763
ssS'Isradipine'
p7764
(dp7765
g13
g25
sg15
S'0206020I0'
p7766
ssVCholecalciferol, antagonists & inhibitors
p7767
(dp7768
g13
g14
sg15
V/categories/DBCAT004724
p7769
ssVReceptors, Cell Surface
p7770
(dp7771
g13
g14
sg15
V/categories/DBCAT000030
p7772
ssVAllylamine
p7773
(dp7774
g13
g14
sg15
V/categories/DBCAT001194
p7775
ssVPhosphodiesterase 4 Inhibitors
p7776
(dp7777
g13
g14
sg15
V/categories/DBCAT001410
p7778
ssVIrritants
p7779
(dp7780
g13
g14
sg15
V/categories/DBCAT001178
p7781
ssVTriiodothyronine
p7782
(dp7783
g13
g14
sg15
V/categories/DBCAT004075
p7784
ssVImines
p7785
(dp7786
g13
g14
sg15
V/categories/DBCAT000389
p7787
ssVBarbiturates, Plain
p7788
(dp7789
g13
g14
sg15
V/categories/DBCAT002297
p7790
ssVCorticosteroid Hormone Receptor Agonists
p7791
(dp7792
g13
g14
sg15
V/categories/DBCAT004050
p7793
ssVMetalloproteases
p7794
(dp7795
g13
g14
sg15
V/categories/DBCAT000141
p7796
ssVCystic Fibrosis Transmembrane Conductance Regulator Potentiators
p7797
(dp7798
g13
g14
sg15
V/categories/DBCAT003776
p7799
ssS'Dipyridamole'
p7800
(dp7801
g13
g25
sg15
S'0209000L0'
p7802
ssVDinoprostone, antagonists & inhibitors
p7803
(dp7804
g13
g14
sg15
V/categories/DBCAT004759
p7805
ssVMiscellaneous Central Nervous System Agents
p7806
(dp7807
g13
g14
sg15
V/categories/DBCAT003658
p7808
ssS'Evolocumab'
p7809
(dp7810
g13
g25
sg15
S'0212000AH'
p7811
ssS'Hexachlorophene'
p7812
(dp7813
g13
g25
sg15
S'1311050K0'
p7814
ssS'Sofosbuvir/Ledipasvir'
p7815
(dp7816
g13
g25
sg15
S'0503032F0'
p7817
ssVPolyvalent cation containing laxatives, antacids, oral supplements
p7818
(dp7819
g13
g14
sg15
V/categories/DBCAT004552
p7820
ssS'Ketoconazole'
p7821
(dp7822
g13
g25
sg15
S'1309000I0'
p7823
ssS'Choline Salicylate'
p7824
(dp7825
g13
g25
sg15
S'1203010K0'
p7826
ssVRadioisotopes
p7827
(dp7828
g13
g14
sg15
V/categories/DBCAT003839
p7829
ssVAgents causing angioedema
p7830
(dp7831
g13
g14
sg15
V/categories/DBCAT004043
p7832
ssVMetals, Heavy
p7833
(dp7834
g13
g14
sg15
V/categories/DBCAT001387
p7835
ssVCYP3A Substrates (Sensitive)
p7836
(dp7837
g13
g14
sg15
V/categories/DBCAT003824
p7838
ssVAnti-Acne Preparations
p7839
(dp7840
g13
g14
sg15
V/categories/DBCAT002163
p7841
ssS'Coal Tar'
p7842
(dp7843
g13
g25
sg15
S'1309000C0'
p7844
ssS'Deferiprone'
p7845
(dp7846
g13
g25
sg15
S'0901030I0'
p7847
ssS'Melphalan'
p7848
(dp7849
g13
g25
sg15
S'0801010S0'
p7850
ssVAcromegaly
p7851
(dp7852
g13
g14
sg15
V/categories/DBCAT000182
p7853
ssS'Reteplase'
p7854
(dp7855
g13
g25
sg15
S'0210020K0'
p7856
ssVParasympathomemetic (Cholinergic) Agents
p7857
(dp7858
g13
g14
sg15
V/categories/DBCAT003681
p7859
ssVPediculicides
p7860
(dp7861
g13
g14
sg15
V/categories/DBCAT002731
p7862
ssVTyrosine
p7863
(dp7864
g13
g14
sg15
V/categories/DBCAT000465
p7865
ssVPhosphate-removing Agents
p7866
(dp7867
g13
g14
sg15
V/categories/DBCAT003646
p7868
ssVCytochrome P-450 CYP3A7 Inhibitors (strong)
p7869
(dp7870
g13
g14
sg15
V/categories/DBCAT003801
p7871
ssVCaries Prophylactic Agents
p7872
(dp7873
g13
g14
sg15
V/categories/DBCAT002594
p7874
ssVPyrimidine Derivatives
p7875
(dp7876
g13
g14
sg15
V/categories/DBCAT002332
p7877
ssS'Tigecycline'
p7878
(dp7879
g13
g25
sg15
S'0501030Y0'
p7880
ssS'Emtricitabine'
p7881
(dp7882
g13
g25
sg15
S'0503010K0'
p7883
ssS'Darunavir/Cobicistat'
p7884
(dp7885
g13
g25
sg15
S'0503010AK'
p7886
ssVAbortifacient Agents, Steroidal
p7887
(dp7888
g13
g14
sg15
V/categories/DBCAT001154
p7889
ssVAngiotensin II Type 1 Receptor Blockers
p7890
(dp7891
g13
g14
sg15
V/categories/DBCAT000409
p7892
ssVAntipsoriatics for Systemic Use
p7893
(dp7894
g13
g14
sg15
V/categories/DBCAT002388
p7895
ssS'Aclidinium Bromide'
p7896
(dp7897
g13
g25
sg15
S'0301020R0'
p7898
ssVMyeloablative Agonists
p7899
(dp7900
g13
g14
sg15
V/categories/DBCAT000956
p7901
ssVCalcimimetic Agents
p7902
(dp7903
g13
g14
sg15
V/categories/DBCAT001231
p7904
ssS'Micafungin'
p7905
(dp7906
g13
g25
sg15
S'0502040B0'
p7907
ssVSweetening Agents
p7908
(dp7909
g13
g14
sg15
V/categories/DBCAT000378
p7910
ssVCytochrome P-450 CYP3A5 Inducers (weak)
p7911
(dp7912
g13
g14
sg15
V/categories/DBCAT004492
p7913
ssVThymidine
p7914
(dp7915
g13
g14
sg15
V/categories/DBCAT000858
p7916
ssVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p7917
(dp7918
g13
g14
sg15
V/categories/DBCAT004175
p7919
ssS'Calcium Carbonate & Simeticone'
p7920
(dp7921
g13
g25
sg15
S'0101010S0'
p7922
ssVNeurokinin-1 Receptor Antagonists
p7923
(dp7924
g13
g14
sg15
V/categories/DBCAT001050
p7925
ssVAnti-Obesity Agents
p7926
(dp7927
g13
g14
sg15
V/categories/DBCAT000472
p7928
ssVDietary Fats
p7929
(dp7930
g13
g14
sg15
V/categories/DBCAT000296
p7931
ssVCinchona Alkaloids
p7932
(dp7933
g13
g14
sg15
V/categories/DBCAT000904
p7934
ssVPyridines
p7935
(dp7936
g13
g14
sg15
V/categories/DBCAT000227
p7937
ssVEstrogenic Steroids, Alkylated
p7938
(dp7939
g13
g14
sg15
V/categories/DBCAT001215
p7940
ssS'Doxepin Hydrochloride'
p7941
(dp7942
g13
g25
sg15
S'1303000F0'
p7943
ssS'Mesuximide'
p7944
(dp7945
g13
g25
sg15
S'0408010K0'
p7946
ssS'Fosamprenavir Calcium'
p7947
(dp7948
g13
g25
sg15
S'0503010M0'
p7949
ssVDecreased Mitosis
p7950
(dp7951
g13
g14
sg15
V/categories/DBCAT004357
p7952
ssVDisaccharides
p7953
(dp7954
g13
g14
sg15
V/categories/DBCAT000795
p7955
ssVVitamin K
p7956
(dp7957
g13
g14
sg15
V/categories/DBCAT000379
p7958
ssS'Trihexyphenidyl Hydrochloride'
p7959
(dp7960
g13
g25
sg15
S'0409020C0'
p7961
ssS'Sitagliptin'
p7962
(dp7963
g13
g25
sg15
S'0601023X0'
p7964
ssVWater Pollutants, Chemical
p7965
(dp7966
g13
g14
sg15
V/categories/DBCAT002011
p7967
ssVAdamantane
p7968
(dp7969
g13
g14
sg15
V/categories/DBCAT000914
p7970
ssS'Icatibant Acetate'
p7971
(dp7972
g13
g25
sg15
S'0304030H0'
p7973
ssVAntipyretics
p7974
(dp7975
g13
g14
sg15
V/categories/DBCAT000735
p7976
ssS'Methoxy Polyethylene Glycol-Epoetin Beta'
p7977
(dp7978
g13
g25
sg15
S'0901030N0'
p7979
ssS'Basiliximab'
p7980
(dp7981
g13
g25
sg15
S'0802020D0'
p7982
ssS'Rupatadine Fumarate'
p7983
(dp7984
g13
g25
sg15
S'0304010AE'
p7985
ssVImmunosuppressive Agents
p7986
(dp7987
g13
g14
sg15
V/categories/DBCAT000047
p7988
ssVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p7989
(dp7990
g13
g14
sg15
V/categories/DBCAT004039
p7991
ssVDrug Delivery Systems
p7992
(dp7993
g13
g14
sg15
V/categories/DBCAT001055
p7994
ssVBiological Products
p7995
(dp7996
g13
g14
sg15
V/categories/DBCAT000108
p7997
ssVCytochrome P-450 CYP1A2 Inhibitors (strong)
p7998
(dp7999
g13
g14
sg15
V/categories/DBCAT002610
p8000
ssVProstatic Hyperplasia
p8001
(dp8002
g13
g14
sg15
V/categories/DBCAT000776
p8003
ssVAnti-Inflammatory Agents, Non-Steroidal
p8004
(dp8005
g13
g14
sg15
V/categories/DBCAT000049
p8006
ssVMigraine Disorders
p8007
(dp8008
g13
g14
sg15
V/categories/DBCAT001190
p8009
ssS'Methylcellulose'
p8010
(dp8011
g13
g25
sg15
S'0405010M0'
p8012
ssS'Fulvestrant'
p8013
(dp8014
g13
g25
sg15
S'0803041AA'
p8015
ssVAcetates
p8016
(dp8017
g13
g14
sg15
V/categories/DBCAT000495
p8018
ssS'Ibuprofen Lysine'
p8019
(dp8020
g13
g25
sg15
S'1001010AD'
p8021
ssS'Nicotinic Acid'
p8022
(dp8023
g13
g25
sg15
S'0212000U0'
p8024
ssVCytochrome P-450 CYP2D6 Inducers (weak)
p8025
(dp8026
g13
g14
sg15
V/categories/DBCAT004508
p8027
ssS'Cyclobenzaprine Hydrochloride'
p8028
(dp8029
g13
g25
sg15
S'1002020H0'
p8030
ssS'Prucalopride'
p8031
(dp8032
g13
g25
sg15
S'0106070A0'
p8033
ssVFatty Acids, Omega-3
p8034
(dp8035
g13
g14
sg15
V/categories/DBCAT000294
p8036
ssVButanones
p8037
(dp8038
g13
g14
sg15
V/categories/DBCAT001617
p8039
ssVEstrogen Agonist/Antagonist
p8040
(dp8041
g13
g14
sg15
V/categories/DBCAT003358
p8042
ssVEpoxy Compounds
p8043
(dp8044
g13
g14
sg15
V/categories/DBCAT000834
p8045
ssVCarbonic Anhydrase Inhibitors
p8046
(dp8047
g13
g14
sg15
V/categories/DBCAT000727
p8048
ssS'Etravirine'
p8049
(dp8050
g13
g25
sg15
S'0503010AF'
p8051
ssVRadiographic Contrast Agent
p8052
(dp8053
g13
g14
sg15
V/categories/DBCAT003315
p8054
ssS'Anastrozole'
p8055
(dp8056
g13
g25
sg15
S'0803041B0'
p8057
ssVRodenticides
p8058
(dp8059
g13
g14
sg15
V/categories/DBCAT001065
p8060
ssVOtotoxic agents
p8061
(dp8062
g13
g14
sg15
V/categories/DBCAT004546
p8063
ssVProstaglandins E
p8064
(dp8065
g13
g14
sg15
V/categories/DBCAT001121
p8066
ssS'Pramipexole'
p8067
(dp8068
g13
g25
sg15
S'0409010W0'
p8069
ssVExtended-spectrum Penicillins
p8070
(dp8071
g13
g14
sg15
V/categories/DBCAT003662
p8072
ssVGonadotropins
p8073
(dp8074
g13
g14
sg15
V/categories/DBCAT000107
p8075
ssS'Adalimumab'
p8076
(dp8077
g13
g25
sg15
S'1001030S0'
p8078
ssS'Cefaclor'
p8079
(dp8080
g13
g25
sg15
S'0501021A0'
p8081
ssVRadiation-Protective Agents
p8082
(dp8083
g13
g14
sg15
V/categories/DBCAT001143
p8084
ssVSulfonylurea Compounds
p8085
(dp8086
g13
g14
sg15
V/categories/DBCAT000841
p8087
ssS'Liraglutide'
p8088
(dp8089
g13
g25
sg15
S'0601023AB'
p8090
ssVUGT1A3 substrates with narrow therapeutic index
p8091
(dp8092
g13
g14
sg15
V/categories/DBCAT004612
p8093
ssVMouthwashes and Gargles
p8094
(dp8095
g13
g14
sg15
V/categories/DBCAT003782
p8096
ssS'Amitriptyline Hydrochloride'
p8097
(dp8098
g13
g25
sg15
S'0403010B0'
p8099
ssVPhenols
p8100
(dp8101
g13
g14
sg15
V/categories/DBCAT000420
p8102
ssVHematopoietic Cell Growth Factors
p8103
(dp8104
g13
g14
sg15
V/categories/DBCAT000086
p8105
ssS'Histrelin Acetate'
p8106
(dp8107
g13
g25
sg15
S'0803042Q0'
p8108
ssVPharmaceutic Aids
p8109
(dp8110
g13
g14
sg15
V/categories/DBCAT001240
p8111
ssVDigitalis Glycosides
p8112
(dp8113
g13
g14
sg15
V/categories/DBCAT000820
p8114
ssVCytochrome P-450 CYP2A6 Inhibitors (moderate)
p8115
(dp8116
g13
g14
sg15
V/categories/DBCAT002616
p8117
ssVFurans
p8118
(dp8119
g13
g14
sg15
V/categories/DBCAT000766
p8120
ssVPyrazoles
p8121
(dp8122
g13
g14
sg15
V/categories/DBCAT000650
p8123
ssVOpioid Antagonists
p8124
(dp8125
g13
g14
sg15
V/categories/DBCAT000935
p8126
ssVFilaricides
p8127
(dp8128
g13
g14
sg15
V/categories/DBCAT000998
p8129
ssVCytochrome P-450 CYP3A4 Substrates
p8130
(dp8131
g13
g14
sg15
V/categories/DBCAT002646
p8132
ssVHydroxypyridones
p8133
(dp8134
g13
g14
sg15
V/categories/DBCAT003754
p8135
ssVSilicon Dioxide
p8136
(dp8137
g13
g14
sg15
V/categories/DBCAT001375
p8138
ssS'Acrivastine'
p8139
(dp8140
g13
g25
sg15
S'0304010A0'
p8141
ssS'Fluoxymesterone'
p8142
(dp8143
g13
g25
sg15
S'0604020E0'
p8144
ssVIncreased Acetylcholine Activity
p8145
(dp8146
g13
g14
sg15
V/categories/DBCAT004421
p8147
ssVAdrenergic alpha-Agonists
p8148
(dp8149
g13
g14
sg15
V/categories/DBCAT000536
p8150
ssVGrowth Hormone
p8151
(dp8152
g13
g14
sg15
V/categories/DBCAT000145
p8153
ssVCytochrome P-450 CYP3A5 Inhibitors (strong)
p8154
(dp8155
g13
g14
sg15
V/categories/DBCAT003808
p8156
ssVHypothalamic Hormones
p8157
(dp8158
g13
g14
sg15
V/categories/DBCAT000054
p8159
ssVNoxae
p8160
(dp8161
g13
g14
sg15
V/categories/DBCAT000150
p8162
ssS'Tramadol Hydrochloride'
p8163
(dp8164
g13
g25
sg15
S'040702040'
p8165
ssS'Candesartan Cilexetil'
p8166
(dp8167
g13
g25
sg15
S'0205052C0'
p8168
ssVNitrates and Nitrites
p8169
(dp8170
g13
g14
sg15
V/categories/DBCAT003688
p8171
ssVMineralocorticoids
p8172
(dp8173
g13
g14
sg15
V/categories/DBCAT001861
p8174
ssVAntiinfectives and Antiseptics for Local Oral Treatment
p8175
(dp8176
g13
g14
sg15
V/categories/DBCAT002259
p8177
ssVAntiallergic Agents, Excl. Corticosteroids
p8178
(dp8179
g13
g14
sg15
V/categories/DBCAT002453
p8180
ssVCough and Cold Preparations
p8181
(dp8182
g13
g14
sg15
V/categories/DBCAT002303
p8183
ssVComplex Mixtures
p8184
(dp8185
g13
g14
sg15
V/categories/DBCAT000109
p8186
ssS'Trifluoperazine'
p8187
(dp8188
g13
g25
sg15
S'0402010X0'
p8189
ssS'Lomustine'
p8190
(dp8191
g13
g25
sg15
S'0801010Q0'
p8192
ssS'Alendronic Acid & Colecalciferol'
p8193
(dp8194
g13
g25
sg15
S'0606020Y0'
p8195
ssVPhosphorus Acids
p8196
(dp8197
g13
g14
sg15
V/categories/DBCAT000925
p8198
ssVTissue-nonspecific Alkaline Phosphatase
p8199
(dp8200
g13
g14
sg15
V/categories/DBCAT003516
p8201
ssVViral Fusion Proteins
p8202
(dp8203
g13
g14
sg15
V/categories/DBCAT002897
p8204
ssS'Triazolam'
p8205
(dp8206
g13
g25
sg15
S'0401010V0'
p8207
ssVAmino Acids, Dicarboxylic
p8208
(dp8209
g13
g14
sg15
V/categories/DBCAT000288
p8210
ssS'Ciprofloxacin/Fluocinolone'
p8211
(dp8212
g13
g25
sg15
S'1201010AF'
p8213
ssVUncompetitive NMDA Receptor Antagonists
p8214
(dp8215
g13
g14
sg15
V/categories/DBCAT004206
p8216
ssS'Colestipol Hydrochloride'
p8217
(dp8218
g13
g25
sg15
S'0212000K0'
p8219
ssVIsoxazoles
p8220
(dp8221
g13
g14
sg15
V/categories/DBCAT000628
p8222
ssVNatural and Semisynthetic Estrogens, Plain
p8223
(dp8224
g13
g14
sg15
V/categories/DBCAT002269
p8225
ssS'Ramipril'
p8226
(dp8227
g13
g25
sg15
S'0205051R0'
p8228
ssVThiazepines
p8229
(dp8230
g13
g14
sg15
V/categories/DBCAT001303
p8231
ssVMorphine Derivatives
p8232
(dp8233
g13
g14
sg15
V/categories/DBCAT000689
p8234
ssVVitamin B 12, biosynthesis
p8235
(dp8236
g13
g14
sg15
V/categories/DBCAT004706
p8237
ssS'Cefotaxime Sodium'
p8238
(dp8239
g13
g25
sg15
S'0501021D0'
p8240
ssS'Rabeprazole Sodium'
p8241
(dp8242
g13
g25
sg15
S'0103050T0'
p8243
ssVTetrahydroisoquinolines
p8244
(dp8245
g13
g14
sg15
V/categories/DBCAT001295
p8246
ssVZinc Compounds
p8247
(dp8248
g13
g14
sg15
V/categories/DBCAT001980
p8249
ssVPeroxisome Proliferator-activated Receptor Activity
p8250
(dp8251
g13
g14
sg15
V/categories/DBCAT004402
p8252
ssVNeuromuscular-Blocking Agents (Nondepolarizing)
p8253
(dp8254
g13
g14
sg15
V/categories/DBCAT002684
p8255
ssVMetal divalent cations
p8256
(dp8257
g13
g14
sg15
V/categories/DBCAT004026
p8258
ssS'Zolmitriptan'
p8259
(dp8260
g13
g25
sg15
S'0407041Z0'
p8261
ssVAntimanic Agents
p8262
(dp8263
g13
g14
sg15
V/categories/DBCAT000733
p8264
ssS'Hydralazine Hydrochloride'
p8265
(dp8266
g13
g25
sg15
S'0205010J0'
p8267
ssVDietary Cholesterol Absorption Inhibitor
p8268
(dp8269
g13
g14
sg15
V/categories/DBCAT003418
p8270
ssVCholinergic Receptor Agonist
p8271
(dp8272
g13
g14
sg15
V/categories/DBCAT003290
p8273
ssS'Darbepoetin Alfa'
p8274
(dp8275
g13
g25
sg15
S'0901030J0'
p8276
ssS'Rocuronium Bromide'
p8277
(dp8278
g13
g25
sg15
S'1501050X0'
p8279
ssVReceptors, Cytokine
p8280
(dp8281
g13
g14
sg15
V/categories/DBCAT000028
p8282
ssVMood Stabilizer
p8283
(dp8284
g13
g14
sg15
V/categories/DBCAT003323
p8285
ssVGlyburide
p8286
(dp8287
g13
g14
sg15
V/categories/DBCAT004763
p8288
ssVAcetaminophen and Prodrugs
p8289
(dp8290
g13
g14
sg15
V/categories/DBCAT003969
p8291
ssVMacrolide Antibacterial
p8292
(dp8293
g13
g14
sg15
V/categories/DBCAT003494
p8294
ssS'Morphine Sulfate'
p8295
(dp8296
g13
g25
sg15
S'0407020Q0'
p8297
ssS'Efavirenz'
p8298
(dp8299
g13
g25
sg15
S'0503010D0'
p8300
ssVChloride Channel Agonists
p8301
(dp8302
g13
g14
sg15
V/categories/DBCAT001249
p8303
ssVCardiotonic Agents
p8304
(dp8305
g13
g14
sg15
V/categories/DBCAT000589
p8306
ssVMiscellaneous Calcium-channel Blocking Agents
p8307
(dp8308
g13
g14
sg15
V/categories/DBCAT003669
p8309
ssVNaphthalenes
p8310
(dp8311
g13
g14
sg15
V/categories/DBCAT000383
p8312
ssVOfloxacin
p8313
(dp8314
g13
g25
sg15
S'0501120P0'
p8315
ssVAngiotensin-Converting Enzyme Inhibitors
p8316
(dp8317
g13
g14
sg15
V/categories/DBCAT000415
p8318
ssVDecreased Blood Pressure
p8319
(dp8320
g13
g14
sg15
V/categories/DBCAT004209
p8321
ssS'Senna'
p8322
(dp8323
g13
g25
sg15
S'0106020M0'
p8324
ssS'Protamine Sulfate'
p8325
(dp8326
g13
g25
sg15
S'0208030N0'
p8327
ssVGenito Urinary System and Sex Hormones
p8328
(dp8329
g13
g14
sg15
V/categories/DBCAT002114
p8330
ssVDecreased Histamine Release
p8331
(dp8332
g13
g14
sg15
V/categories/DBCAT004192
p8333
ssS'Quinagolide Hydrochloride'
p8334
(dp8335
g13
g25
sg15
S'0607010T0'
p8336
ssVEthylenediamines
p8337
(dp8338
g13
g14
sg15
V/categories/DBCAT000760
p8339
ssS'Riboflavin'
p8340
(dp8341
g13
g25
sg15
S'0906025P0'
p8342
ssVIndolequinones
p8343
(dp8344
g13
g14
sg15
V/categories/DBCAT000712
p8345
ssVInsulin Analog
p8346
(dp8347
g13
g14
sg15
V/categories/DBCAT003257
p8348
ssVIntestinal Antiinflammatory Agents
p8349
(dp8350
g13
g14
sg15
V/categories/DBCAT002251
p8351
ssVSerotonin 1d Receptor Agonists
p8352
(dp8353
g13
g14
sg15
V/categories/DBCAT004122
p8354
ssVUGT1A9 Inhibitors
p8355
(dp8356
g13
g14
sg15
V/categories/DBCAT003965
p8357
ssVAzetines
p8358
(dp8359
g13
g14
sg15
V/categories/DBCAT001212
p8360
ssVDihydropyridines
p8361
(dp8362
g13
g14
sg15
V/categories/DBCAT000643
p8363
ssVCytochrome P-450 CYP3A Inducers
p8364
(dp8365
g13
g14
sg15
V/categories/DBCAT000492
p8366
ssVArginine Vasopressin, agonists
p8367
(dp8368
g13
g14
sg15
V/categories/DBCAT004695
p8369
ssVSerotonin-1b and Serotonin-1d Receptor Agonist
p8370
(dp8371
g13
g14
sg15
V/categories/DBCAT003299
p8372
ssS'Ciprofloxacin'
p8373
(dp8374
g13
g25
sg15
S'1201010AC'
p8375
ssVGlycogenolytic Agents
p8376
(dp8377
g13
g14
sg15
V/categories/DBCAT003609
p8378
ssVFolic Acid and Derivatives
p8379
(dp8380
g13
g14
sg15
V/categories/DBCAT001033
p8381
ssVAmaryllidaceae Alkaloids
p8382
(dp8383
g13
g14
sg15
V/categories/DBCAT001051
p8384
ssVMiscellaneous Antidepressants
p8385
(dp8386
g13
g14
sg15
V/categories/DBCAT003624
p8387
ssS'Riociguat'
p8388
(dp8389
g13
g25
sg15
S'0205010AB'
p8390
ssVPregnadienediols
p8391
(dp8392
g13
g14
sg15
V/categories/DBCAT000746
p8393
ssS'Pheniramine Maleate'
p8394
(dp8395
g13
g25
sg15
S'0304010V0'
p8396
ssVAnti-HIV Agents
p8397
(dp8398
g13
g14
sg15
V/categories/DBCAT000124
p8399
ssVAlkanes
p8400
(dp8401
g13
g14
sg15
V/categories/DBCAT000893
p8402
ssVMuscarinic Agonists
p8403
(dp8404
g13
g14
sg15
V/categories/DBCAT000447
p8405
ssS'Linaclotide'
p8406
(dp8407
g13
g25
sg15
S'0106070B0'
p8408
ssVTropanes
p8409
(dp8410
g13
g14
sg15
V/categories/DBCAT000602
p8411
ssVOvulation Stimulants, Synthetic
p8412
(dp8413
g13
g14
sg15
V/categories/DBCAT002480
p8414
ssVDecreased Fibrinolysis
p8415
(dp8416
g13
g14
sg15
V/categories/DBCAT004136
p8417
ssS'Aspirin'
p8418
(dp8419
g13
g25
sg15
S'0407010B0'
p8420
ssS'Phenytoin'
p8421
(dp8422
g13
g14
sg15
V/categories/DBCAT004731
p8423
ssVCytochrome P-450 CYP2C8 Inducers (strong)
p8424
(dp8425
g13
g14
sg15
V/categories/DBCAT002645
p8426
ssVAutonomic Agents
p8427
(dp8428
g13
g14
sg15
V/categories/DBCAT000434
p8429
ssS'Budesonide'
p8430
(dp8431
g13
g25
sg15
S'0105020A0'
p8432
ssS'Nicardipine Hydrochloride'
p8433
(dp8434
g13
g25
sg15
S'0206020Q0'
p8435
ssVBenzofurans
p8436
(dp8437
g13
g14
sg15
V/categories/DBCAT000546
p8438
ssS'Folinic Acid'
p8439
(dp8440
g13
g25
sg15
S'0901020F0'
p8441
ssVAcidifying Agents
p8442
(dp8443
g13
g14
sg15
V/categories/DBCAT003775
p8444
ssS'Danazol'
p8445
(dp8446
g13
g25
sg15
S'0607020C0'
p8447
ssS'Clarithromycin'
p8448
(dp8449
g13
g25
sg15
S'0501050B0'
p8450
ssVProtective Agents
p8451
(dp8452
g13
g14
sg15
V/categories/DBCAT000367
p8453
ssS'Boceprevir'
p8454
(dp8455
g13
g25
sg15
S'0503032A0'
p8456
ssS'Saxagliptin/Dapagliflozin'
p8457
(dp8458
g13
g25
sg15
S'0601023AV'
p8459
ssS'Trimethadione'
p8460
(dp8461
g13
g25
sg15
S'0408010V0'
p8462
ssS'Dimenhydrinate'
p8463
(dp8464
g13
g25
sg15
S'0406000H0'
p8465
ssVOCT1 inhibitors
p8466
(dp8467
g13
g14
sg15
V/categories/DBCAT004549
p8468
ssVPyridinium Compounds
p8469
(dp8470
g13
g14
sg15
V/categories/DBCAT000962
p8471
ssS'Apalutamide'
p8472
(dp8473
g13
g25
sg15
S'0803042V0'
p8474
ssVFatty Acids, Volatile
p8475
(dp8476
g13
g14
sg15
V/categories/DBCAT000426
p8477
ssVACE Inhibitors and Calcium Channel Blockers
p8478
(dp8479
g13
g14
sg15
V/categories/DBCAT002176
p8480
ssVNeurotoxins
p8481
(dp8482
g13
g14
sg15
V/categories/DBCAT000125
p8483
ssS'Levofolinic Acid'
p8484
(dp8485
g13
g25
sg15
S'0801000Z0'
p8486
ssS'Apomorphine Hydrochloride Hemihydrate'
p8487
(dp8488
g13
g25
sg15
S'0409010AC'
p8489
ssVMiscellaneous Antipsychotics
p8490
(dp8491
g13
g14
sg15
V/categories/DBCAT003680
p8492
ssS'Foscarnet Sodium'
p8493
(dp8494
g13
g25
sg15
S'0503022E0'
p8495
ssVProtein Kinase C, antagonists & inhibitors
p8496
(dp8497
g13
g14
sg15
V/categories/DBCAT001440
p8498
ssVCytochrome P-450 CYP2C19 Substrates (moderate)
p8499
(dp8500
g13
g14
sg15
V/categories/DBCAT003887
p8501
ssVHydantoins
p8502
(dp8503
g13
g14
sg15
V/categories/DBCAT000612
p8504
ssVCytochrome P450 3A Inducers
p8505
(dp8506
g13
g14
sg15
V/categories/DBCAT004106
p8507
ssVHydroxyprogesterones
p8508
(dp8509
g13
g14
sg15
V/categories/DBCAT000991
p8510
ssVPhenobarbital and similars
p8511
(dp8512
g13
g14
sg15
V/categories/DBCAT001139
p8513
ssS'Dihydroergotamine Mesilate'
p8514
(dp8515
g13
g25
sg15
S'0407041D0'
p8516
ssVCyclic Nucleotide Phosphodiesterases, Type 5
p8517
(dp8518
g13
g14
sg15
V/categories/DBCAT001777
p8519
ssVAnti-Retroviral Agents
p8520
(dp8521
g13
g14
sg15
V/categories/DBCAT000123
p8522
ssVCalcium-Regulating Hormones and Agents
p8523
(dp8524
g13
g14
sg15
V/categories/DBCAT004967
p8525
ssVModerate Risk QTc-Prolonging Agents
p8526
(dp8527
g13
g14
sg15
V/categories/DBCAT002690
p8528
ssS'Ferrous Fumarate'
p8529
(dp8530
g13
g25
sg15
S'0901011F0'
p8531
ssVAdrenergic alpha-2 Receptor Agonists
p8532
(dp8533
g13
g14
sg15
V/categories/DBCAT002651
p8534
ssVProgrammed Death Receptor-1-directed Antibody Interactions
p8535
(dp8536
g13
g14
sg15
V/categories/DBCAT004275
p8537
ssVMast-cell Stabilizers
p8538
(dp8539
g13
g14
sg15
V/categories/DBCAT003742
p8540
ssVSomatostatin and Analogues
p8541
(dp8542
g13
g14
sg15
V/categories/DBCAT002136
p8543
ssVGonadal Steroid Hormones
p8544
(dp8545
g13
g14
sg15
V/categories/DBCAT000673
p8546
ssVEndothelin A Receptor Antagonists
p8547
(dp8548
g13
g14
sg15
V/categories/DBCAT001698
p8549
ssVAntiandrogens, non-steroidal
p8550
(dp8551
g13
g14
sg15
V/categories/DBCAT002767
p8552
ssVDecreased Renal K+ Excretion
p8553
(dp8554
g13
g14
sg15
V/categories/DBCAT004229
p8555
ssVRespiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
p8556
(dp8557
g13
g14
sg15
V/categories/DBCAT003282
p8558
ssS'Tetanus Immunoglobulin'
p8559
(dp8560
g13
g25
sg15
S'1405020A0'
p8561
ssS'Nitazoxanide'
p8562
(dp8563
g13
g25
sg15
S'0501070AB'
p8564
ssVAdrenergic alpha-1 Receptor Agonists
p8565
(dp8566
g13
g14
sg15
V/categories/DBCAT000538
p8567
ssVBuffers
p8568
(dp8569
g13
g14
sg15
V/categories/DBCAT001532
p8570
ssVAcetamides
p8571
(dp8572
g13
g14
sg15
V/categories/DBCAT000493
p8573
ssVGastric Acid Lowering Agents
p8574
(dp8575
g13
g14
sg15
V/categories/DBCAT003882
p8576
ssS'Daptomycin'
p8577
(dp8578
g13
g25
sg15
S'0501070Y0'
p8579
ssS'Atropine Sulfate'
p8580
(dp8581
g13
g25
sg15
S'1105000B0'
p8582
ssS'Citric Acid Monohydrate/Ipecacuanha'
p8583
(dp8584
g13
g25
sg15
S'0309020AG'
p8585
ssVNon COX-2 selective NSAIDS
p8586
(dp8587
g13
g14
sg15
V/categories/DBCAT004608
p8588
ssVOxazolidinone Antibacterial
p8589
(dp8590
g13
g14
sg15
V/categories/DBCAT003381
p8591
ssVMiscellaneous Antiemetics
p8592
(dp8593
g13
g14
sg15
V/categories/DBCAT003691
p8594
ssS'Digoxin'
p8595
(dp8596
g13
g25
sg15
S'0201010F0'
p8597
ssS'Botulinum Toxin Type B'
p8598
(dp8599
g13
g25
sg15
S'0409030A0'
p8600
ssS'Botulinum Toxin Type A'
p8601
(dp8602
g13
g25
sg15
S'0409030B0'
p8603
ssVStomatological Preparations
p8604
(dp8605
g13
g14
sg15
V/categories/DBCAT002132
p8606
ssVMiscellaneous Vasodilatating Agents
p8607
(dp8608
g13
g14
sg15
V/categories/DBCAT003720
p8609
ssVAmphenicols
p8610
(dp8611
g13
g14
sg15
V/categories/DBCAT002381
p8612
ssVTyrosine Hydroxylase Inhibitors
p8613
(dp8614
g13
g14
sg15
V/categories/DBCAT002762
p8615
ssS'Ampicillin'
p8616
(dp8617
g13
g25
sg15
S'0501013E0'
p8618
ssVMicronutrients
p8619
(dp8620
g13
g14
sg15
V/categories/DBCAT000231
p8621
ssS'Raltegravir'
p8622
(dp8623
g13
g25
sg15
S'0503010AE'
p8624
ssS'Palbociclib'
p8625
(dp8626
g13
g25
sg15
S'0801050CB'
p8627
ssVMast Cell Stabilizers
p8628
(dp8629
g13
g14
sg15
V/categories/DBCAT002745
p8630
ssVGonadotropin Releasing Hormone Receptor Agonist
p8631
(dp8632
g13
g14
sg15
V/categories/DBCAT003246
p8633
ssVAnterior Pituitary Lobe Hormones and Analogues
p8634
(dp8635
g13
g14
sg15
V/categories/DBCAT002096
p8636
ssVPteridines
p8637
(dp8638
g13
g14
sg15
V/categories/DBCAT000333
p8639
ssVCytidine
p8640
(dp8641
g13
g14
sg15
V/categories/DBCAT001088
p8642
ssVBile Acid Sequestrants
p8643
(dp8644
g13
g14
sg15
V/categories/DBCAT002340
p8645
ssVTriazines
p8646
(dp8647
g13
g14
sg15
V/categories/DBCAT000922
p8648
ssS'Calcium Carbonate'
p8649
(dp8650
g13
g25
sg15
S'0905011D0'
p8651
ssVIsonicotinic Acids
p8652
(dp8653
g13
g14
sg15
V/categories/DBCAT001000
p8654
ssS'Venlafaxine'
p8655
(dp8656
g13
g25
sg15
S'0403040W0'
p8657
ssS'Paricalcitol'
p8658
(dp8659
g13
g25
sg15
S'0906040P0'
p8660
ssVFibroblast Growth Factors
p8661
(dp8662
g13
g14
sg15
V/categories/DBCAT000119
p8663
ssVInterleukin-6 Antagonist
p8664
(dp8665
g13
g14
sg15
V/categories/DBCAT003511
p8666
ssVAdamantane Derivatives
p8667
(dp8668
g13
g14
sg15
V/categories/DBCAT002485
p8669
ssS'Epoetin Alfa'
p8670
(dp8671
g13
g25
sg15
S'0901030D0'
p8672
ssS'Pilocarpine Nitrate'
p8673
(dp8674
g13
g25
sg15
S'1106000Y0'
p8675
ssVHCV NS3/4A Protease Inhibitors
p8676
(dp8677
g13
g14
sg15
V/categories/DBCAT004186
p8678
ssVIodides
p8679
(dp8680
g13
g14
sg15
V/categories/DBCAT001845
p8681
ssVDihydroorotate Dehydrogenase Inhibitors
p8682
(dp8683
g13
g14
sg15
V/categories/DBCAT004249
p8684
ssVAntitussive Agents
p8685
(dp8686
g13
g14
sg15
V/categories/DBCAT000738
p8687
ssVAminocaproates
p8688
(dp8689
g13
g14
sg15
V/categories/DBCAT000937
p8690
ssVCalcium Channels, N-Type
p8691
(dp8692
g13
g14
sg15
V/categories/DBCAT001786
p8693
ssS'Fludrocortisone Acetate'
p8694
(dp8695
g13
g25
sg15
S'1201010AA'
p8696
ssVInsulin
p8697
(dp8698
g13
g14
sg15
V/categories/DBCAT000170
p8699
ssVIncreased Erythroid Cell Production
p8700
(dp8701
g13
g14
sg15
V/categories/DBCAT004159
p8702
ssS'Fosaprepitant'
p8703
(dp8704
g13
g25
sg15
S'0406000AE'
p8705
ssVStilbenes
p8706
(dp8707
g13
g14
sg15
V/categories/DBCAT000618
p8708
ssVContraceptive Agents, Female
p8709
(dp8710
g13
g14
sg15
V/categories/DBCAT000688
p8711
ssVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p8712
(dp8713
g13
g14
sg15
V/categories/DBCAT002220
p8714
ssVExplosive Agents
p8715
(dp8716
g13
g14
sg15
V/categories/DBCAT001096
p8717
ssVCytochrome P-450 CYP3A5 Substrates
p8718
(dp8719
g13
g14
sg15
V/categories/DBCAT003807
p8720
ssS'Phenelzine Sulfate'
p8721
(dp8722
g13
g25
sg15
S'0403020M0'
p8723
ssS'Aprepitant'
p8724
(dp8725
g13
g25
sg15
S'0406000AD'
p8726
ssVMATE 1 Substrates with a Narrow Therapeutic Index
p8727
(dp8728
g13
g14
sg15
V/categories/DBCAT004525
p8729
ssVGallium Radioisotopes
p8730
(dp8731
g13
g14
sg15
V/categories/DBCAT003920
p8732
ssVMetabolic Alkalinizer
p8733
(dp8734
g13
g14
sg15
V/categories/DBCAT003517
p8735
ssVSulfatases
p8736
(dp8737
g13
g14
sg15
V/categories/DBCAT002901
p8738
ssVProto-Oncogene Proteins B-raf, antagonists & inhibitors
p8739
(dp8740
g13
g14
sg15
V/categories/DBCAT001918
p8741
ssS'Tolnaftate'
p8742
(dp8743
g13
g25
sg15
S'1310020Y0'
p8744
ssVCholestadienols
p8745
(dp8746
g13
g14
sg15
V/categories/DBCAT001503
p8747
ssVTricarboxylic Acids
p8748
(dp8749
g13
g14
sg15
V/categories/DBCAT001579
p8750
ssS'Pomalidomide'
p8751
(dp8752
g13
g25
sg15
S'0802040AJ'
p8753
ssVProstaglandin Receptor Agonists
p8754
(dp8755
g13
g14
sg15
V/categories/DBCAT004145
p8756
ssVHygroscopic Agents
p8757
(dp8758
g13
g14
sg15
V/categories/DBCAT003148
p8759
ssS'Cisplatin'
p8760
(dp8761
g13
g25
sg15
S'0801050I0'
p8762
ssS'Liothyronine Sodium'
p8763
(dp8764
g13
g25
sg15
S'0602010M0'
p8765
ssVNon-Standardized Chemical Allergen
p8766
(dp8767
g13
g14
sg15
V/categories/DBCAT003529
p8768
ssS'Filgrastim'
p8769
(dp8770
g13
g25
sg15
S'0901060I0'
p8771
ssS'Pembrolizumab'
p8772
(dp8773
g13
g25
sg15
S'0801050CA'
p8774
ssVCytochrome P-450 CYP2B6 Inducers (weak)
p8775
(dp8776
g13
g14
sg15
V/categories/DBCAT003034
p8777
ssS'Mepenzolate Bromide'
p8778
(dp8779
g13
g25
sg15
S'0102000R0'
p8780
ssS'Caspofungin'
p8781
(dp8782
g13
g25
sg15
S'0502040C0'
p8783
ssVMetal Chelating Activity
p8784
(dp8785
g13
g14
sg15
V/categories/DBCAT004317
p8786
ssS'Netupitant/Palonosetron Hcl'
p8787
(dp8788
g13
g25
sg15
S'0406000AG'
p8789
ssVPorphyrins
p8790
(dp8791
g13
g14
sg15
V/categories/DBCAT001084
p8792
ssVQuinolone Antimicrobial
p8793
(dp8794
g13
g14
sg15
V/categories/DBCAT003300
p8795
ssS'Isophane Insulin'
p8796
(dp8797
g13
g25
sg15
S'0601012S0'
p8798
ssVNonsteroidal Anti-inflammatory Compounds
p8799
(dp8800
g13
g14
sg15
V/categories/DBCAT004093
p8801
ssVBreast Neoplasms
p8802
(dp8803
g13
g14
sg15
V/categories/DBCAT001793
p8804
ssS'Pericyazine'
p8805
(dp8806
g13
g25
sg15
S'0402010P0'
p8807
ssS'Insulin Glargine/Lixisenatide'
p8808
(dp8809
g13
g25
sg15
S'0601012AB'
p8810
ssVBethanechol Compounds
p8811
(dp8812
g13
g14
sg15
V/categories/DBCAT001234
p8813
ssVPropylamines
p8814
(dp8815
g13
g14
sg15
V/categories/DBCAT000544
p8816
ssVEndothelin B Receptor Antagonists
p8817
(dp8818
g13
g14
sg15
V/categories/DBCAT001699
p8819
ssS'Amiodarone Hydrochloride'
p8820
(dp8821
g13
g25
sg15
S'0203020D0'
p8822
ssS'Carglumic Acid'
p8823
(dp8824
g13
g25
sg15
S'0908010AD'
p8825
ssS'Sodium Monofluorophosphate'
p8826
(dp8827
g13
g25
sg15
S'0905030N0'
p8828
ssVAziridines
p8829
(dp8830
g13
g14
sg15
V/categories/DBCAT001595
p8831
ssS'Acamprosate Calcium'
p8832
(dp8833
g13
g25
sg15
S'0410010A0'
p8834
ssVGlycosides
p8835
(dp8836
g13
g14
sg15
V/categories/DBCAT000257
p8837
ssVBeta-adrenergic Agents
p8838
(dp8839
g13
g14
sg15
V/categories/DBCAT003633
p8840
ssVCytochrome P-450 CYP1A2 Inducers
p8841
(dp8842
g13
g14
sg15
V/categories/DBCAT000614
p8843
ssVInterleukin-6 Antagonists
p8844
(dp8845
g13
g14
sg15
V/categories/DBCAT004463
p8846
ssVCarboxamide Derivatives
p8847
(dp8848
g13
g14
sg15
V/categories/DBCAT002411
p8849
ssS'Pivmecillinam Hydrochloride'
p8850
(dp8851
g13
g25
sg15
S'0501015P0'
p8852
ssVHydroxamic Acids
p8853
(dp8854
g13
g14
sg15
V/categories/DBCAT001106
p8855
ssS'Thiamazole'
p8856
(dp8857
g13
g25
sg15
S'0602020M0'
p8858
ssVDecreased Cytokine Activity
p8859
(dp8860
g13
g14
sg15
V/categories/DBCAT004354
p8861
ssS'Betaxolol'
p8862
(dp8863
g13
g25
sg15
S'1106000I0'
p8864
ssVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p8865
(dp8866
g13
g14
sg15
V/categories/DBCAT004520
p8867
ssVAntipropulsives
p8868
(dp8869
g13
g14
sg15
V/categories/DBCAT002293
p8870
ssS'Verteporfin'
p8871
(dp8872
g13
g25
sg15
S'1108020AB'
p8873
ssS'Escitalopram'
p8874
(dp8875
g13
g25
sg15
S'0403030X0'
p8876
ssVFactor Xa Inhibitors
p8877
(dp8878
g13
g14
sg15
V/categories/DBCAT001775
p8879
ssS'Niraparib'
p8880
(dp8881
g13
g25
sg15
S'0801050CJ'
p8882
ssVHeparin Reversal Agent
p8883
(dp8884
g13
g14
sg15
V/categories/DBCAT003519
p8885
ssVCalcium-sensing Receptor Agonist
p8886
(dp8887
g13
g14
sg15
V/categories/DBCAT003421
p8888
ssVIntestinal Antiinfectives
p8889
(dp8890
g13
g14
sg15
V/categories/DBCAT002401
p8891
ssVNeurotoxic agents
p8892
(dp8893
g13
g14
sg15
V/categories/DBCAT004545
p8894
ssVUridine Monophosphate
p8895
(dp8896
g13
g14
sg15
V/categories/DBCAT001919
p8897
ssVIodophors
p8898
(dp8899
g13
g14
sg15
V/categories/DBCAT001868
p8900
ssVArteriolar Smooth Muscle, Agents Acting On
p8901
(dp8902
g13
g14
sg15
V/categories/DBCAT002307
p8903
ssVAntitrichomonal Agents
p8904
(dp8905
g13
g14
sg15
V/categories/DBCAT001003
p8906
ssVHydrofluoric Acid
p8907
(dp8908
g13
g14
sg15
V/categories/DBCAT001984
p8909
ssS'Nivolumab'
p8910
(dp8911
g13
g25
sg15
S'0802040AT'
p8912
ssVPurine Nucleotides
p8913
(dp8914
g13
g14
sg15
V/categories/DBCAT000293
p8915
ssS'Esomeprazole'
p8916
(dp8917
g13
g25
sg15
S'0103050E0'
p8918
ssVMATE 1 Inhibitors
p8919
(dp8920
g13
g14
sg15
V/categories/DBCAT003950
p8921
ssS'Aciclovir Sodium'
p8922
(dp8923
g13
g25
sg15
S'0503021B0'
p8924
ssVAdrenocorticotropic Hormone
p8925
(dp8926
g13
g14
sg15
V/categories/DBCAT001331
p8927
ssS'Colesevelam Hydrochloride'
p8928
(dp8929
g13
g25
sg15
S'0212000AD'
p8930
ssVmTOR Inhibitor Immunosuppressant
p8931
(dp8932
g13
g14
sg15
V/categories/DBCAT003412
p8933
ssVProprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors
p8934
(dp8935
g13
g14
sg15
V/categories/DBCAT003788
p8936
ssVPotassium Channel Antagonists
p8937
(dp8938
g13
g14
sg15
V/categories/DBCAT004105
p8939
ssVNorsteroids
p8940
(dp8941
g13
g14
sg15
V/categories/DBCAT000706
p8942
ssVMenotropins
p8943
(dp8944
g13
g14
sg15
V/categories/DBCAT000203
p8945
ssVMiscellaneous Skeletal Muscle Relaxants
p8946
(dp8947
g13
g14
sg15
V/categories/DBCAT003751
p8948
ssS'Abiraterone'
p8949
(dp8950
g13
g25
sg15
S'0803042T0'
p8951
ssVMethyltyrosines
p8952
(dp8953
g13
g14
sg15
V/categories/DBCAT001117
p8954
ssVAntidepressive Agents, Triazolopyridine
p8955
(dp8956
g13
g14
sg15
V/categories/DBCAT003849
p8957
ssVThyroxine-binding globulin inducers
p8958
(dp8959
g13
g14
sg15
V/categories/DBCAT004602
p8960
ssVThiouracils
p8961
(dp8962
g13
g14
sg15
V/categories/DBCAT002406
p8963
ssS'Fesoterodine Fumarate'
p8964
(dp8965
g13
g25
sg15
S'0704020AD'
p8966
ssVTissue Extracts
p8967
(dp8968
g13
g14
sg15
V/categories/DBCAT000192
p8969
ssVAngiotensin II Antagonists, Plain
p8970
(dp8971
g13
g14
sg15
V/categories/DBCAT002173
p8972
ssVInterleukin-2 Receptor Blocking Antibody
p8973
(dp8974
g13
g14
sg15
V/categories/DBCAT003270
p8975
ssVHyperglycemia-Associated Agents
p8976
(dp8977
g13
g14
sg15
V/categories/DBCAT002694
p8978
ssVPhenylpropanolamine
p8979
(dp8980
g13
g14
sg15
V/categories/DBCAT001002
p8981
ssVAndrostanes
p8982
(dp8983
g13
g14
sg15
V/categories/DBCAT000981
p8984
ssS'Stavudine'
p8985
(dp8986
g13
g25
sg15
S'0503010S0'
p8987
ssVAminopyridines
p8988
(dp8989
g13
g14
sg15
V/categories/DBCAT000588
p8990
ssVNucleoside Metabolic Inhibitor
p8991
(dp8992
g13
g14
sg15
V/categories/DBCAT003348
p8993
ssVButyrophenones
p8994
(dp8995
g13
g14
sg15
V/categories/DBCAT000878
p8996
ssVScabicides and Pediculicides
p8997
(dp8998
g13
g14
sg15
V/categories/DBCAT003648
p8999
ssS'Mecobalamin'
p9000
(dp9001
g13
g25
sg15
S'0901020T0'
p9002
ssVOrganophosphonates
p9003
(dp9004
g13
g14
sg15
V/categories/DBCAT000698
p9005
ssS'Mesna'
p9006
(dp9007
g13
g14
sg15
V/categories/DBCAT004846
p9008
ssS'Losartan Potassium'
p9009
(dp9010
g13
g25
sg15
S'0205052N0'
p9011
ssS'Nadolol'
p9012
(dp9013
g13
g25
sg15
S'0204000M0'
p9014
ssVAntiarrhythmics, Class III
p9015
(dp9016
g13
g14
sg15
V/categories/DBCAT002208
p9017
ssVMiscellaneous Antifungals
p9018
(dp9019
g13
g14
sg15
V/categories/DBCAT003679
p9020
ssVOligopeptides
p9021
(dp9022
g13
g14
sg15
V/categories/DBCAT000051
p9023
ssVOther Antihistamines
p9024
(dp9025
g13
g14
sg15
V/categories/DBCAT003740
p9026
ssVCytochrome P-450 CYP3A4 Inducers (moderate)
p9027
(dp9028
g13
g14
sg15
V/categories/DBCAT002701
p9029
ssS'Flunisolide'
p9030
(dp9031
g13
g25
sg15
S'1202010L0'
p9032
ssS'Metformin Hydrochloride/Vildagliptin'
p9033
(dp9034
g13
g25
sg15
S'0601023Z0'
p9035
ssVACE Inhibitors and Diuretics
p9036
(dp9037
g13
g14
sg15
V/categories/DBCAT002175
p9038
ssVHER1 Antagonists
p9039
(dp9040
g13
g14
sg15
V/categories/DBCAT004099
p9041
ssVGalactosidases
p9042
(dp9043
g13
g14
sg15
V/categories/DBCAT000216
p9044
ssVAlpha-Adrenoreceptor Antagonists and Diuretics
p9045
(dp9046
g13
g14
sg15
V/categories/DBCAT002386
p9047
ssVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p9048
(dp9049
g13
g14
sg15
V/categories/DBCAT002648
p9050
ssVAgents that produce hypertension
p9051
(dp9052
g13
g14
sg15
V/categories/DBCAT004567
p9053
ssVTaxane Derivatives
p9054
(dp9055
g13
g14
sg15
V/categories/DBCAT002720
p9056
ssVAntidotes
p9057
(dp9058
g13
g14
sg15
V/categories/DBCAT000900
p9059
ssS'Zileuton'
p9060
(dp9061
g13
g25
sg15
S'0303020Y0'
p9062
ssVCD86-directed Antibody Interactions
p9063
(dp9064
g13
g14
sg15
V/categories/DBCAT004362
p9065
ssVPregnadien Derivatives
p9066
(dp9067
g13
g14
sg15
V/categories/DBCAT002333
p9068
ssVOxazol, Thiazine, and Triazine Derivatives
p9069
(dp9070
g13
g14
sg15
V/categories/DBCAT002334
p9071
ssVThienamycins
p9072
(dp9073
g13
g14
sg15
V/categories/DBCAT001394
p9074
ssVSerotonin Modulators
p9075
(dp9076
g13
g14
sg15
V/categories/DBCAT002706
p9077
ssVSomatostatin Agonists
p9078
(dp9079
g13
g14
sg15
V/categories/DBCAT003774
p9080
ssS'Rosuvastatin Calcium'
p9081
(dp9082
g13
g25
sg15
S'0212000AA'
p9083
ssS'Sunitinib'
p9084
(dp9085
g13
g25
sg15
S'0801050AM'
p9086
ssVGynecological Antiinfectives and Antiseptics
p9087
(dp9088
g13
g14
sg15
V/categories/DBCAT002247
p9089
ssVArginine Vasopressin
p9090
(dp9091
g13
g14
sg15
V/categories/DBCAT000110
p9092
ssS'Naphazoline Nitrate'
p9093
(dp9094
g13
g25
sg15
S'1202020H0'
p9095
ssS'Clindamycin Hydrochloride'
p9096
(dp9097
g13
g25
sg15
S'1306010D0'
p9098
ssS'Oxybutynin Hydrochloride'
p9099
(dp9100
g13
g25
sg15
S'0704040G0'
p9101
ssS'Acenocoumarol'
p9102
(dp9103
g13
g25
sg15
S'0208020H0'
p9104
ssS'Ibrutinib'
p9105
(dp9106
g13
g25
sg15
S'0801050BS'
p9107
ssS'Imiglucerase'
p9108
(dp9109
g13
g25
sg15
S'0908010I0'
p9110
ssS'Galantamine'
p9111
(dp9112
g13
g25
sg15
S'0411000F0'
p9113
ssVNorepinephrine Releasing Agent
p9114
(dp9115
g13
g14
sg15
V/categories/DBCAT003440
p9116
ssS'Dorzolamide & Timolol'
p9117
(dp9118
g13
g25
sg15
S'1106000AB'
p9119
ssVFibric Acids
p9120
(dp9121
g13
g14
sg15
V/categories/DBCAT001018
p9122
ssVHyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
p9123
(dp9124
g13
g14
sg15
V/categories/DBCAT003515
p9125
ssS'Oseltamivir Phosphate'
p9126
(dp9127
g13
g25
sg15
S'0503040B0'
p9128
ssVOtologicals
p9129
(dp9130
g13
g14
sg15
V/categories/DBCAT002282
p9131
ssS'Tocilizumab'
p9132
(dp9133
g13
g25
sg15
S'1001030W0'
p9134
ssS'Dactinomycin'
p9135
(dp9136
g13
g25
sg15
S'0801020D0'
p9137
ssVVasopressins
p9138
(dp9139
g13
g14
sg15
V/categories/DBCAT000111
p9140
ssVImipramine
p9141
(dp9142
g13
g14
sg15
V/categories/DBCAT004739
p9143
ssS'Acetazolamide'
p9144
(dp9145
g13
g25
sg15
S'1106000B0'
p9146
ssVNitrophenols
p9147
(dp9148
g13
g14
sg15
V/categories/DBCAT001591
p9149
ssVNipecotic Acids
p9150
(dp9151
g13
g14
sg15
V/categories/DBCAT004988
p9152
ssS'Miglustat'
p9153
(dp9154
g13
g25
sg15
S'0908010AC'
p9155
ssVLipoxygenase Inhibitors
p9156
(dp9157
g13
g14
sg15
V/categories/DBCAT000422
p9158
ssVFood and Beverages
p9159
(dp9160
g13
g14
sg15
V/categories/DBCAT000233
p9161
ssVPesticides
p9162
(dp9163
g13
g14
sg15
V/categories/DBCAT000639
p9164
ssS'Rotigotine'
p9165
(dp9166
g13
g25
sg15
S'0409010Z0'
p9167
ssVCardiac Therapy
p9168
(dp9169
g13
g14
sg15
V/categories/DBCAT002210
p9170
ssVAntiinfectives for Systemic Use
p9171
(dp9172
g13
g14
sg15
V/categories/DBCAT002131
p9173
ssVOpiate Antagonists
p9174
(dp9175
g13
g14
sg15
V/categories/DBCAT003713
p9176
ssVAdrenergic beta2-Antagonists
p9177
(dp9178
g13
g14
sg15
V/categories/DBCAT004124
p9179
ssS'Baricitinib'
p9180
(dp9181
g13
g25
sg15
S'1001030AC'
p9182
ssVHydroxyphenylpyruvate Dioxygenase Inhibitors
p9183
(dp9184
g13
g14
sg15
V/categories/DBCAT004325
p9185
ssVHydrolytic Lysosomal Cholesteryl Ester-specific Enzyme
p9186
(dp9187
g13
g14
sg15
V/categories/DBCAT003538
p9188
ssVBelladonna Alkaloids, Tertiary Amines
p9189
(dp9190
g13
g14
sg15
V/categories/DBCAT002367
p9191
ssS'Aciclovir'
p9192
(dp9193
g13
g25
sg15
S'0503021C0'
p9194
ssVPhosphonic Acid Derivatives
p9195
(dp9196
g13
g14
sg15
V/categories/DBCAT002404
p9197
ssS'Ritonavir'
p9198
(dp9199
g13
g25
sg15
S'0503010U0'
p9200
ssVAlpha and Beta Blocking Agents and Thiazides
p9201
(dp9202
g13
g14
sg15
V/categories/DBCAT002419
p9203
ssVAntipsychotic Agents
p9204
(dp9205
g13
g14
sg15
V/categories/DBCAT000529
p9206
ssVRifamycins
p9207
(dp9208
g13
g14
sg15
V/categories/DBCAT001005
p9209
ssVStyrene
p9210
(dp9211
g13
g14
sg15
V/categories/DBCAT001361
p9212
ssVLeukotriene Modifiers
p9213
(dp9214
g13
g14
sg15
V/categories/DBCAT003692
p9215
ssS'Empagliflozin/Metformin'
p9216
(dp9217
g13
g25
sg15
S'0601023AR'
p9218
ssVPleuromutilin Antibacterial
p9219
(dp9220
g13
g14
sg15
V/categories/DBCAT003434
p9221
ssVHypolipidemic Agents
p9222
(dp9223
g13
g14
sg15
V/categories/DBCAT000274
p9224
ssS'Medroxyprogesterone Acetate'
p9225
(dp9226
g13
g25
sg15
S'0703022M0'
p9227
ssVGlycoside Hydrolase Inhibitors
p9228
(dp9229
g13
g14
sg15
V/categories/DBCAT000670
p9230
ssS'Lenvatinib'
p9231
(dp9232
g13
g25
sg15
S'0801050BV'
p9233
ssS'Tezacaftor/Ivacaftor'
p9234
(dp9235
g13
g25
sg15
S'0307000U0'
p9236
ssVSelective Calcium Channel Blockers With Mainly Vascular Effects
p9237
(dp9238
g13
g14
sg15
V/categories/DBCAT002271
p9239
ssVLeucomycins
p9240
(dp9241
g13
g14
sg15
V/categories/DBCAT001762
p9242
ssVCyproheptadine
p9243
(dp9244
g13
g14
sg15
V/categories/DBCAT000882
p9245
ssVThalidomide Analog
p9246
(dp9247
g13
g14
sg15
V/categories/DBCAT003357
p9248
ssS'Trametinib'
p9249
(dp9250
g13
g25
sg15
S'0801050CH'
p9251
ssS'Levodopa'
p9252
(dp9253
g13
g25
sg15
S'0409010I0'
p9254
ssVAlkylating Drugs
p9255
(dp9256
g13
g14
sg15
V/categories/DBCAT003311
p9257
ssVPurine Analogues
p9258
(dp9259
g13
g14
sg15
V/categories/DBCAT002249
p9260
ssS'Paromomycin Sulfate'
p9261
(dp9262
g13
g25
sg15
S'0504050T0'
p9263
ssS'Oxymetazoline Hydrochloride'
p9264
(dp9265
g13
g25
sg15
S'1202020G0'
p9266
ssS'Aldesleukin'
p9267
(dp9268
g13
g25
sg15
S'0802040AQ'
p9269
ssVPeptides, Cyclic
p9270
(dp9271
g13
g14
sg15
V/categories/DBCAT000099
p9272
ssS'Temsirolimus'
p9273
(dp9274
g13
g25
sg15
S'0801050AU'
p9275
ssVIncreased Calcium-sensing Receptor Sensitivity
p9276
(dp9277
g13
g14
sg15
V/categories/DBCAT004280
p9278
ssVAbortifacient Agents, Nonsteroidal
p9279
(dp9280
g13
g14
sg15
V/categories/DBCAT000855
p9281
ssS'Cefprozil'
p9282
(dp9283
g13
g25
sg15
S'0501020AA'
p9284
ssVMollusk Venoms
p9285
(dp9286
g13
g14
sg15
V/categories/DBCAT002964
p9287
ssVNeuromuscular Nondepolarizing Blockade
p9288
(dp9289
g13
g14
sg15
V/categories/DBCAT004165
p9290
ssS'Belladonna & Ipecacuanha'
p9291
(dp9292
g13
g25
sg15
S'0309020C0'
p9293
ssVOAT3/SLC22A8 Inducers
p9294
(dp9295
g13
g14
sg15
V/categories/DBCAT003981
p9296
ssVThiazides
p9297
(dp9298
g13
g14
sg15
V/categories/DBCAT000576
p9299
ssS'Eculizumab'
p9300
(dp9301
g13
g25
sg15
S'0901030M0'
p9302
ssVNeprilysin, antagonists & inhibitors
p9303
(dp9304
g13
g14
sg15
V/categories/DBCAT001007
p9305
ssVCalcium Chelating Agents
p9306
(dp9307
g13
g14
sg15
V/categories/DBCAT001213
p9308
ssS'Zinc Paste & Calamine'
p9309
(dp9310
g13
g25
sg15
S'1305010AC'
p9311
ssVDecreased Leukotriene Production
p9312
(dp9313
g13
g14
sg15
V/categories/DBCAT004468
p9314
ssVNervous System
p9315
(dp9316
g13
g14
sg15
V/categories/DBCAT002148
p9317
ssVSunscreen Agents
p9318
(dp9319
g13
g14
sg15
V/categories/DBCAT003790
p9320
ssVPolyproteins
p9321
(dp9322
g13
g14
sg15
V/categories/DBCAT002895
p9323
ssS'Repaglinide'
p9324
(dp9325
g13
g25
sg15
S'0601023R0'
p9326
ssVAcetyl Aldehyde Dehydrogenase Inhibitors
p9327
(dp9328
g13
g14
sg15
V/categories/DBCAT004120
p9329
ssVActinomycines
p9330
(dp9331
g13
g14
sg15
V/categories/DBCAT002488
p9332
ssVSodium
p9333
(dp9334
g13
g14
sg15
V/categories/DBCAT002589
p9335
ssVAnti-epileptic Agent
p9336
(dp9337
g13
g14
sg15
V/categories/DBCAT003307
p9338
ssS'Adapalene & Benzoyl Peroxide'
p9339
(dp9340
g13
g25
sg15
S'1306010Z0'
p9341
ssVAntithrombins
p9342
(dp9343
g13
g14
sg15
V/categories/DBCAT000012
p9344
ssVClomiphene
p9345
(dp9346
g13
g14
sg15
V/categories/DBCAT001851
p9347
ssS'Certolizumab Pegol'
p9348
(dp9349
g13
g25
sg15
S'1001030Y0'
p9350
ssVPotential QTc-Prolonging Agents
p9351
(dp9352
g13
g14
sg15
V/categories/DBCAT002691
p9353
ssVGanciclovir and prodrug
p9354
(dp9355
g13
g14
sg15
V/categories/DBCAT002865
p9356
ssS'Estropipate'
p9357
(dp9358
g13
g25
sg15
S'0604011R0'
p9359
ssVVasopressin and Analogues
p9360
(dp9361
g13
g14
sg15
V/categories/DBCAT002108
p9362
ssVEstrogen Receptor Antagonists
p9363
(dp9364
g13
g14
sg15
V/categories/DBCAT001199
p9365
ssS'Raloxifene Hydrochloride'
p9366
(dp9367
g13
g25
sg15
S'0604011X0'
p9368
ssVDrugs for Treatment of Lepra
p9369
(dp9370
g13
g14
sg15
V/categories/DBCAT002257
p9371
ssS'Melatonin'
p9372
(dp9373
g13
g14
sg15
V/categories/DBCAT004764
p9374
ssS'Oxaliplatin'
p9375
(dp9376
g13
g25
sg15
S'0801050AL'
p9377
ssVP-glycoprotein/ABCB1 Inducers
p9378
(dp9379
g13
g14
sg15
V/categories/DBCAT002666
p9380
ssVAngiogenesis Inhibitors
p9381
(dp9382
g13
g14
sg15
V/categories/DBCAT000222
p9383
ssVPhenylpiperidine Derivatives
p9384
(dp9385
g13
g14
sg15
V/categories/DBCAT002384
p9386
ssVAlkynes
p9387
(dp9388
g13
g14
sg15
V/categories/DBCAT001692
p9389
ssVIodine Products
p9390
(dp9391
g13
g14
sg15
V/categories/DBCAT002559
p9392
ssS'Diphenhydramine Hydrochloride'
p9393
(dp9394
g13
g25
sg15
S'030902040'
p9395
ssVExcitatory Amino Acid Antagonists
p9396
(dp9397
g13
g14
sg15
V/categories/DBCAT000940
p9398
ssVAcidifying Activity
p9399
(dp9400
g13
g14
sg15
V/categories/DBCAT004091
p9401
ssS'Fenoterol Hydrobromide'
p9402
(dp9403
g13
g25
sg15
S'0301011F0'
p9404
ssVBleaching Agents
p9405
(dp9406
g13
g14
sg15
V/categories/DBCAT002035
p9407
ssVGuanylate Cyclase Stimulators
p9408
(dp9409
g13
g14
sg15
V/categories/DBCAT004472
p9410
ssS'Cladribine'
p9411
(dp9412
g13
g25
sg15
S'0801030C0'
p9413
ssS'Irinotecan Hydrochloride'
p9414
(dp9415
g13
g25
sg15
S'0801050Q0'
p9416
ssS'Imipramine Hydrochloride'
p9417
(dp9418
g13
g25
sg15
S'0403010N0'
p9419
ssS'Temazepam'
p9420
(dp9421
g13
g25
sg15
S'0401010T0'
p9422
ssVGastrointestinal Agents
p9423
(dp9424
g13
g14
sg15
V/categories/DBCAT000048
p9425
ssS'Colistin Sulfate'
p9426
(dp9427
g13
g25
sg15
S'0501070H0'
p9428
ssVSerotonin 5-HT4 Receptor Agonists
p9429
(dp9430
g13
g14
sg15
V/categories/DBCAT001723
p9431
ssS'Saquinavir Mesylate'
p9432
(dp9433
g13
g25
sg15
S'0503010R0'
p9434
ssVHuman Immunodeficiency Virus 1 Fusion Inhibitor
p9435
(dp9436
g13
g14
sg15
V/categories/DBCAT003281
p9437
ssVOpiate Alkaloids
p9438
(dp9439
g13
g14
sg15
V/categories/DBCAT000692
p9440
ssS'Antithrombin Alfa'
p9441
(dp9442
g13
g25
sg15
S'0211000AA'
p9443
ssS'Topotecan'
p9444
(dp9445
g13
g25
sg15
S'0801050AF'
p9446
ssVCytochrome P-450 CYP2E1 Inhibitors (moderate)
p9447
(dp9448
g13
g14
sg15
V/categories/DBCAT002631
p9449
ssVSalicylamides
p9450
(dp9451
g13
g14
sg15
V/categories/DBCAT000989
p9452
ssVNicotine, metabolism
p9453
(dp9454
g13
g14
sg15
V/categories/DBCAT004727
p9455
ssVNon-selective Alfa-adrenergic Blocking Agents
p9456
(dp9457
g13
g14
sg15
V/categories/DBCAT003711
p9458
ssVAutacoids
p9459
(dp9460
g13
g14
sg15
V/categories/DBCAT000351
p9461
ssS'Dextropropoxyphene'
p9462
(dp9463
g13
g25
sg15
S'0407020E0'
p9464
ssS'Cyclizine Hydrochloride'
p9465
(dp9466
g13
g25
sg15
S'0406000F0'
p9467
ssVImmunoglobulin Isotypes
p9468
(dp9469
g13
g14
sg15
V/categories/DBCAT000026
p9470
ssS'Permethrin'
p9471
(dp9472
g13
g25
sg15
S'1310040Q0'
p9473
ssVNicotine
p9474
(dp9475
g13
g14
sg15
V/categories/DBCAT001706
p9476
ssVBenzylisoquinolines
p9477
(dp9478
g13
g14
sg15
V/categories/DBCAT001091
p9479
ssVGuanidines
p9480
(dp9481
g13
g14
sg15
V/categories/DBCAT000342
p9482
ssVBody Fluids
p9483
(dp9484
g13
g14
sg15
V/categories/DBCAT002884
p9485
ssS'Bendroflumethiazide'
p9486
(dp9487
g13
g25
sg15
S'0202010B0'
p9488
ssVApnea
p9489
(dp9490
g13
g14
sg15
V/categories/DBCAT000505
p9491
ssS'Pyridostigmine Bromide'
p9492
(dp9493
g13
g25
sg15
S'1002010Q0'
p9494
ssVDigoxin, immunology
p9495
(dp9496
g13
g14
sg15
V/categories/DBCAT004734
p9497
ssVHydrocarbons, Chlorinated
p9498
(dp9499
g13
g14
sg15
V/categories/DBCAT000856
p9500
ssVGlucagon-Like Peptide-1 Receptor
p9501
(dp9502
g13
g14
sg15
V/categories/DBCAT005022
p9503
ssVNeomycin
p9504
(dp9505
g13
g14
sg15
V/categories/DBCAT000880
p9506
ssS'Gatifloxacin'
p9507
(dp9508
g13
g25
sg15
S'1103010AK'
p9509
ssVRNA, Ribosomal, 23S
p9510
(dp9511
g13
g14
sg15
V/categories/DBCAT001214
p9512
ssVAntiarrhythmic agents
p9513
(dp9514
g13
g14
sg15
V/categories/DBCAT003297
p9515
ssVIncreased Prothrombin Activity
p9516
(dp9517
g13
g14
sg15
V/categories/DBCAT004197
p9518
ssS'Tolmetin'
p9519
(dp9520
g13
g25
sg15
S'1001010V0'
p9521
ssVAmino Sugars
p9522
(dp9523
g13
g14
sg15
V/categories/DBCAT000338
p9524
ssS'Leflunomide'
p9525
(dp9526
g13
g25
sg15
S'1001030L0'
p9527
ssS'Daunorubicin/Cytarabine'
p9528
(dp9529
g13
g25
sg15
S'0801060A0'
p9530
ssVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p9531
(dp9532
g13
g14
sg15
V/categories/DBCAT004487
p9533
ssVCannabinoids and similars
p9534
(dp9535
g13
g14
sg15
V/categories/DBCAT002709
p9536
ssVGonadotropin-releasing hormone agonist
p9537
(dp9538
g13
g14
sg15
V/categories/DBCAT002742
p9539
ssS'Romiplostim'
p9540
(dp9541
g13
g25
sg15
S'0901040B0'
p9542
ssVPurinergic Agents
p9543
(dp9544
g13
g14
sg15
V/categories/DBCAT000507
p9545
ssVMonoamine Oxidase-B Inhibitors
p9546
(dp9547
g13
g14
sg15
V/categories/DBCAT004089
p9548
ssVGaultheria
p9549
(dp9550
g13
g14
sg15
V/categories/DBCAT003229
p9551
ssS'Tazarotene'
p9552
(dp9553
g13
g25
sg15
S'1305020T0'
p9554
ssVMyelosuppressive Agents
p9555
(dp9556
g13
g14
sg15
V/categories/DBCAT002716
p9557
ssVVaginal Creams, Foams, and Jellies
p9558
(dp9559
g13
g14
sg15
V/categories/DBCAT001290
p9560
ssS'Magnesium Sulfate'
p9561
(dp9562
g13
g25
sg15
S'0905013N0'
p9563
ssS'Midazolam Maleate'
p9564
(dp9565
g13
g25
sg15
S'0408020V0'
p9566
ssV17-Hydroxycorticosteroids
p9567
(dp9568
g13
g14
sg15
V/categories/DBCAT001070
p9569
ssVRespiratory System Agents
p9570
(dp9571
g13
g14
sg15
V/categories/DBCAT000132
p9572
ssVKetolides
p9573
(dp9574
g13
g14
sg15
V/categories/DBCAT002744
p9575
ssVSerine Proteinase Inhibitors
p9576
(dp9577
g13
g14
sg15
V/categories/DBCAT000001
p9578
ssS'Nizatidine'
p9579
(dp9580
g13
g25
sg15
S'0103010N0'
p9581
ssVLong-acting Insulins
p9582
(dp9583
g13
g14
sg15
V/categories/DBCAT004662
p9584
ssVIncreased Megakaryocyte Maturation
p9585
(dp9586
g13
g14
sg15
V/categories/DBCAT004193
p9587
ssS'Disulfiram'
p9588
(dp9589
g13
g25
sg15
S'0410010B0'
p9590
ssS'Regorafenib'
p9591
(dp9592
g13
g25
sg15
S'0801050BN'
p9593
ssVOrganic Anion Transporter 1 Inhibitors
p9594
(dp9595
g13
g14
sg15
V/categories/DBCAT004176
p9596
ssVAntineoplastic Agents
p9597
(dp9598
g13
g14
sg15
V/categories/DBCAT000024
p9599
ssVLipase
p9600
(dp9601
g13
g14
sg15
V/categories/DBCAT000188
p9602
ssVToluene
p9603
(dp9604
g13
g14
sg15
V/categories/DBCAT001414
p9605
ssVHydrochloric Acid
p9606
(dp9607
g13
g14
sg15
V/categories/DBCAT001115
p9608
ssS'Hydrocortisone Sodium Succinate'
p9609
(dp9610
g13
g25
sg15
S'1304000Q0'
p9611
ssS'Abatacept'
p9612
(dp9613
g13
g25
sg15
S'1001030V0'
p9614
ssVFood Preservatives
p9615
(dp9616
g13
g14
sg15
V/categories/DBCAT001548
p9617
ssS'Bexarotene'
p9618
(dp9619
g13
g25
sg15
S'0801050AB'
p9620
ssVVasopressin V2 Receptor Antagonist
p9621
(dp9622
g13
g14
sg15
V/categories/DBCAT003559
p9623
ssVUGT1A1 Inhibitors
p9624
(dp9625
g13
g14
sg15
V/categories/DBCAT002664
p9626
ssS'Palivizumab'
p9627
(dp9628
g13
g25
sg15
S'0503050A0'
p9629
ssS'Polymyxin B Sulfate'
p9630
(dp9631
g13
g25
sg15
S'0501070K0'
p9632
ssVQuinolinium Compounds
p9633
(dp9634
g13
g14
sg15
V/categories/DBCAT001571
p9635
ssVAmino Acids, Branched-Chain
p9636
(dp9637
g13
g14
sg15
V/categories/DBCAT000344
p9638
ssVCytochrome P450 2C19 Inhibitors
p9639
(dp9640
g13
g14
sg15
V/categories/DBCAT004211
p9641
ssVLow-Ceiling Diuretics, Excl. Thiazides
p9642
(dp9643
g13
g14
sg15
V/categories/DBCAT002299
p9644
ssVInterleukin 2 Receptor Antagonists
p9645
(dp9646
g13
g14
sg15
V/categories/DBCAT004302
p9647
ssVAngiogenesis Modulating Agents
p9648
(dp9649
g13
g14
sg15
V/categories/DBCAT000213
p9650
ssVStimulation Large Intestine Fluid/Electrolyte Secretion
p9651
(dp9652
g13
g14
sg15
V/categories/DBCAT004092
p9653
ssVSerotonin 5-HT2 Receptor Antagonists
p9654
(dp9655
g13
g14
sg15
V/categories/DBCAT001320
p9656
ssS'Tobramycin'
p9657
(dp9658
g13
g25
sg15
S'0501040U0'
p9659
ssS'Calcium Citrate'
p9660
(dp9661
g13
g25
sg15
S'0905011E0'
p9662
ssS'Rilpivirine'
p9663
(dp9664
g13
g25
sg15
S'0503010AG'
p9665
ssVDihydroergotoxine
p9666
(dp9667
g13
g14
sg15
V/categories/DBCAT001251
p9668
ssVAnions
p9669
(dp9670
g13
g14
sg15
V/categories/DBCAT000323
p9671
ssVBenzodiazepines and benzodiazepine derivatives
p9672
(dp9673
g13
g14
sg15
V/categories/DBCAT000450
p9674
ssVSensory System Agents
p9675
(dp9676
g13
g14
sg15
V/categories/DBCAT000042
p9677
ssVPolystyrenes
p9678
(dp9679
g13
g14
sg15
V/categories/DBCAT001359
p9680
ssVFixatives
p9681
(dp9682
g13
g14
sg15
V/categories/DBCAT001550
p9683
ssS'Triprolidine Hydrochloride'
p9684
(dp9685
g13
g25
sg15
S'0304010Z0'
p9686
ssS'Torasemide'
p9687
(dp9688
g13
g25
sg15
S'0202020U0'
p9689
ssVAngiotensin II Type 2 Receptor Blockers
p9690
(dp9691
g13
g14
sg15
V/categories/DBCAT001168
p9692
ssS'Hydrocortisone Butyrate'
p9693
(dp9694
g13
g25
sg15
S'1304000W0'
p9695
ssS'Milrinone Lactate'
p9696
(dp9697
g13
g25
sg15
S'0201020M0'
p9698
ssVAntihistamine Drugs
p9699
(dp9700
g13
g14
sg15
V/categories/DBCAT003719
p9701
ssS'Tiaprofenic Acid'
p9702
(dp9703
g13
g25
sg15
S'1001010T0'
p9704
ssS'Natalizumab'
p9705
(dp9706
g13
g25
sg15
S'0802040W0'
p9707
ssVTriazolobenzodiazepines
p9708
(dp9709
g13
g14
sg15
V/categories/DBCAT003829
p9710
ssS'Zuclopenthixol Decanoate'
p9711
(dp9712
g13
g25
sg15
S'0402020Z0'
p9713
ssVPhenylammonium Compounds
p9714
(dp9715
g13
g14
sg15
V/categories/DBCAT001230
p9716
ssVHeparin and similars
p9717
(dp9718
g13
g14
sg15
V/categories/DBCAT001307
p9719
ssVPilocarpine
p9720
(dp9721
g13
g14
sg15
V/categories/DBCAT004766
p9722
ssVAndrostanols
p9723
(dp9724
g13
g14
sg15
V/categories/DBCAT001010
p9725
ssS'Methenamine Hippurate'
p9726
(dp9727
g13
g25
sg15
S'0501130E0'
p9728
ssVAgents Against Leishmaniasis and Trypanosomiasis
p9729
(dp9730
g13
g14
sg15
V/categories/DBCAT002322
p9731
ssVNon-Selective Monoamine Reuptake Inhibitors
p9732
(dp9733
g13
g14
sg15
V/categories/DBCAT002305
p9734
ssVPentanoic Acids
p9735
(dp9736
g13
g14
sg15
V/categories/DBCAT000731
p9737
ssVStrontium
p9738
(dp9739
g13
g14
sg15
V/categories/DBCAT001969
p9740
ssS'Asfotase Alfa'
p9741
(dp9742
g13
g25
sg15
S'0908010AM'
p9743
ssVTubulin Inhibiting Agent
p9744
(dp9745
g13
g14
sg15
V/categories/DBCAT003343
p9746
ssVContraceptives, Oral
p9747
(dp9748
g13
g14
sg15
V/categories/DBCAT000707
p9749
ssS'Procaine Benzylpenicillin'
p9750
(dp9751
g13
g25
sg15
S'0501011T0'
p9752
ssVEnzymes and Coenzymes
p9753
(dp9754
g13
g14
sg15
V/categories/DBCAT000072
p9755
ssVUracil Nucleotides
p9756
(dp9757
g13
g14
sg15
V/categories/DBCAT001520
p9758
ssS'Famotidine'
p9759
(dp9760
g13
g25
sg15
S'0103010H0'
p9761
ssVSphingosine
p9762
(dp9763
g13
g14
sg15
V/categories/DBCAT001906
p9764
ssS'Nitisinone'
p9765
(dp9766
g13
g25
sg15
S'0908010AF'
p9767
ssVFerricyanides
p9768
(dp9769
g13
g14
sg15
V/categories/DBCAT000750
p9770
ssVOther Miscellaneous Antibacterial Agents
p9771
(dp9772
g13
g14
sg15
V/categories/DBCAT003765
p9773
ssS'Flumetasone Pivalate'
p9774
(dp9775
g13
g25
sg15
S'1201010F0'
p9776
ssVEnzymes
p9777
(dp9778
g13
g14
sg15
V/categories/DBCAT000071
p9779
ssS'Potassium Chloride'
p9780
(dp9781
g13
g25
sg15
S'0902011U0'
p9782
ssS'Quinapril Hydrochloride'
p9783
(dp9784
g13
g25
sg15
S'0205051Q0'
p9785
ssVPregnadienes
p9786
(dp9787
g13
g14
sg15
V/categories/DBCAT000747
p9788
ssVAntiarrhythmics, Class Ia
p9789
(dp9790
g13
g14
sg15
V/categories/DBCAT002277
p9791
ssVAntacids With Antiflatulents
p9792
(dp9793
g13
g14
sg15
V/categories/DBCAT002578
p9794
ssVSiloxanes
p9795
(dp9796
g13
g14
sg15
V/categories/DBCAT002006
p9797
ssVBacterial Toxins
p9798
(dp9799
g13
g14
sg15
V/categories/DBCAT000184
p9800
ssVEsters of Aminobenzoic Acid
p9801
(dp9802
g13
g14
sg15
V/categories/DBCAT002455
p9803
ssVContraceptives, Oral, Synthetic
p9804
(dp9805
g13
g14
sg15
V/categories/DBCAT000709
p9806
ssVAllylamines
p9807
(dp9808
g13
g14
sg15
V/categories/DBCAT003734
p9809
ssS'Calcium Acetate/Magnesium Carbonate'
p9810
(dp9811
g13
g25
sg15
S'0905022U0'
p9812
ssVCardiotoxic antineoplastic agents
p9813
(dp9814
g13
g14
sg15
V/categories/DBCAT003909
p9815
ssVBenzimidazoles
p9816
(dp9817
g13
g14
sg15
V/categories/DBCAT000770
p9818
ssS'Theophylline'
p9819
(dp9820
g13
g25
sg15
S'0301030S0'
p9821
ssS'Fosphenytoin Sodium'
p9822
(dp9823
g13
g25
sg15
S'0408020U0'
p9824
ssVFolic Acid Analogues
p9825
(dp9826
g13
g14
sg15
V/categories/DBCAT002290
p9827
ssS'Tolterodine'
p9828
(dp9829
g13
g25
sg15
S'0704020N0'
p9830
ssVMetal Chelator
p9831
(dp9832
g13
g14
sg15
V/categories/DBCAT003480
p9833
ssS'Cobimetinib'
p9834
(dp9835
g13
g25
sg15
S'0801050CI'
p9836
ssVCytochrome P-450 CYP2E1 Substrates
p9837
(dp9838
g13
g14
sg15
V/categories/DBCAT002628
p9839
ssVCholinesterase Inhibitors
p9840
(dp9841
g13
g14
sg15
V/categories/DBCAT000815
p9842
ssVHerpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
p9843
(dp9844
g13
g14
sg15
V/categories/DBCAT003553
p9845
ssS'Colistimethate Sodium'
p9846
(dp9847
g13
g25
sg15
S'0501070I0'
p9848
ssVKeratolytic Agents
p9849
(dp9850
g13
g14
sg15
V/categories/DBCAT000884
p9851
ssS'Reslizumab'
p9852
(dp9853
g13
g25
sg15
S'0304020Z0'
p9854
ssS'Fampridine'
p9855
(dp9856
g13
g25
sg15
S'1002010U0'
p9857
ssVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p9858
(dp9859
g13
g14
sg15
V/categories/DBCAT004490
p9860
ssVAntiinfectives for Treatment of Acne
p9861
(dp9862
g13
g14
sg15
V/categories/DBCAT002201
p9863
ssS'Nalbuphine Hydrochloride'
p9864
(dp9865
g13
g25
sg15
S'0407020Y0'
p9866
ssVLipid Regulating Agents
p9867
(dp9868
g13
g14
sg15
V/categories/DBCAT000275
p9869
ssS'Saline'
p9870
(dp9871
g13
g25
sg15
S'1109000S0'
p9872
ssVGene Products, env
p9873
(dp9874
g13
g14
sg15
V/categories/DBCAT002890
p9875
ssVDrugs for Functional Gastrointestinal Disorders
p9876
(dp9877
g13
g14
sg15
V/categories/DBCAT002215
p9878
ssS'Fexofenadine Hydrochloride'
p9879
(dp9880
g13
g25
sg15
S'0304010E0'
p9881
ssVHypnotics (Nonbenzodiazepine)
p9882
(dp9883
g13
g14
sg15
V/categories/DBCAT002725
p9884
ssVTryptophan Hydroxylase Inhibitor
p9885
(dp9886
g13
g14
sg15
V/categories/DBCAT003820
p9887
ssVCytochrome P-450 CYP3A4 Inhibitors (strong)
p9888
(dp9889
g13
g14
sg15
V/categories/DBCAT002647
p9890
ssVCytochrome P-450 CYP3A7 Inhibitors
p9891
(dp9892
g13
g14
sg15
V/categories/DBCAT003892
p9893
ssVInsulins and Analogues
p9894
(dp9895
g13
g14
sg15
V/categories/DBCAT002116
p9896
ssS'Ranibizumab'
p9897
(dp9898
g13
g25
sg15
S'1108020AD'
p9899
ssVPsychotropic Drugs
p9900
(dp9901
g13
g14
sg15
V/categories/DBCAT000346
p9902
ssS'Betamethasone Sodium Phosphate'
p9903
(dp9904
g13
g25
sg15
S'1201010E0'
p9905
ssS'Quinupristin/Dalfopristin'
p9906
(dp9907
g13
g25
sg15
S'0501070V0'
p9908
ssS'Carboplatin'
p9909
(dp9910
g13
g25
sg15
S'0801050F0'
p9911
ssVEnzyme Inhibitors
p9912
(dp9913
g13
g14
sg15
V/categories/DBCAT000003
p9914
ssVBiopolymers
p9915
(dp9916
g13
g14
sg15
V/categories/DBCAT001023
p9917
ssS'Quinidine Sulfate'
p9918
(dp9919
g13
g25
sg15
S'0203020U0'
p9920
ssVCalcineurin Inhibitors
p9921
(dp9922
g13
g14
sg15
V/categories/DBCAT000199
p9923
ssS'Disopyramide Phosphate'
p9924
(dp9925
g13
g25
sg15
S'0203020G0'
p9926
ssVAntiinflammatory Preparations, Non-Steroids for Topical Use
p9927
(dp9928
g13
g14
sg15
V/categories/DBCAT002313
p9929
ssVSilicon Compounds
p9930
(dp9931
g13
g14
sg15
V/categories/DBCAT001377
p9932
ssVCCR5 Receptor Antagonists
p9933
(dp9934
g13
g14
sg15
V/categories/DBCAT001623
p9935
ssVAnti-Acne Preparations for Systemic Use
p9936
(dp9937
g13
g14
sg15
V/categories/DBCAT002491
p9938
ssVPhenothiazines With Piperidine Structure
p9939
(dp9940
g13
g14
sg15
V/categories/DBCAT002446
p9941
ssVThyronines
p9942
(dp9943
g13
g14
sg15
V/categories/DBCAT000658
p9944
ssVSteroid Synthesis Inhibitors
p9945
(dp9946
g13
g14
sg15
V/categories/DBCAT000487
p9947
ssS'Isopropyl Alcohol'
p9948
(dp9949
g13
g25
sg15
S'1311010I0'
p9950
ssVAlbuterol
p9951
(dp9952
g13
g14
sg15
V/categories/DBCAT001198
p9953
ssS'Indinavir'
p9954
(dp9955
g13
g25
sg15
S'0503010T0'
p9956
ssVCytochrome P450 17A1 Inhibitors
p9957
(dp9958
g13
g14
sg15
V/categories/DBCAT003461
p9959
ssS'Buprenorphine'
p9960
(dp9961
g13
g25
sg15
S'0407020B0'
p9962
ssS'Pimecrolimus'
p9963
(dp9964
g13
g25
sg15
S'1305030B0'
p9965
ssS'Loratadine'
p9966
(dp9967
g13
g25
sg15
S'0304010D0'
p9968
ssVAnti-Ulcer Agents
p9969
(dp9970
g13
g14
sg15
V/categories/DBCAT000540
p9971
ssVIron Preparations
p9972
(dp9973
g13
g14
sg15
V/categories/DBCAT002144
p9974
ssVNitric Oxide Donors
p9975
(dp9976
g13
g14
sg15
V/categories/DBCAT000756
p9977
ssVRetinoids for Treatment of Psoriasis
p9978
(dp9979
g13
g14
sg15
V/categories/DBCAT002387
p9980
ssS'Trimipramine Maleate'
p9981
(dp9982
g13
g25
sg15
S'0403010Y0'
p9983
ssVHydrolytic Lysosomal Triacylglycerol-specific Enzyme
p9984
(dp9985
g13
g14
sg15
V/categories/DBCAT003539
p9986
ssS'Carvedilol'
p9987
(dp9988
g13
g25
sg15
S'020400080'
p9989
ssVSerotonin 1b Receptor Agonists
p9990
(dp9991
g13
g14
sg15
V/categories/DBCAT004121
p9992
ssVActinomycin
p9993
(dp9994
g13
g14
sg15
V/categories/DBCAT003417
p9995
ssS'Methocarbamol'
p9996
(dp9997
g13
g25
sg15
S'1002020S0'
p9998
ssVGuanine
p9999
(dp10000
g13
g14
sg15
V/categories/DBCAT001027
p10001
ssS'Mecasermin'
p10002
(dp10003
g13
g25
sg15
S'0607040A0'
p10004
ssS'Acebutolol Hydrochloride'
p10005
(dp10006
g13
g25
sg15
S'0204000C0'
p10007
ssVOrganometallic Compounds
p10008
(dp10009
g13
g14
sg15
V/categories/DBCAT000755
p10010
ssS'Nabumetone'
p10011
(dp10012
g13
g25
sg15
S'1001010X0'
p10013
ssVNasal Preparations
p10014
(dp10015
g13
g14
sg15
V/categories/DBCAT002159
p10016
ssS'Opicapone'
p10017
(dp10018
g13
g25
sg15
S'0409010AB'
p10019
ssVEnemas
p10020
(dp10021
g13
g14
sg15
V/categories/DBCAT002539
p10022
ssVIncreased Sympathetic Activity
p10023
(dp10024
g13
g14
sg15
V/categories/DBCAT004278
p10025
ssVAntibodies, Monoclonal
p10026
(dp10027
g13
g14
sg15
V/categories/DBCAT000015
p10028
ssVUGT1A6 inducer
p10029
(dp10030
g13
g14
sg15
V/categories/DBCAT004046
p10031
ssVIron Chelating Agents
p10032
(dp10033
g13
g14
sg15
V/categories/DBCAT001107
p10034
ssVSomatostatin Receptor Agonists
p10035
(dp10036
g13
g14
sg15
V/categories/DBCAT004140
p10037
ssVPhenylalanine
p10038
(dp10039
g13
g14
sg15
V/categories/DBCAT000466
p10040
ssS'Finasteride'
p10041
(dp10042
g13
g25
sg15
S'1309000W0'
p10043
ssVPotassium-Sparing Diuretics
p10044
(dp10045
g13
g14
sg15
V/categories/DBCAT002702
p10046
ssS'Fondaparinux Sodium'
p10047
(dp10048
g13
g25
sg15
S'0208010AB'
p10049
ssVProgrammed Death Ligand-1 Blocker
p10050
(dp10051
g13
g14
sg15
V/categories/DBCAT003819
p10052
ssVCorticosteroids
p10053
(dp10054
g13
g14
sg15
V/categories/DBCAT002235
p10055
ssS'Clomipramine Hydrochloride'
p10056
(dp10057
g13
g25
sg15
S'0403010F0'
p10058
ssVInflammation
p10059
(dp10060
g13
g14
sg15
V/categories/DBCAT003235
p10061
ssS'Zolpidem Tartrate'
p10062
(dp10063
g13
g25
sg15
S'0401010Y0'
p10064
ssVIncreased Gluconeogenesis
p10065
(dp10066
g13
g14
sg15
V/categories/DBCAT004424
p10067
ssVOpioid Agonist/Antagonist
p10068
(dp10069
g13
g14
sg15
V/categories/DBCAT003382
p10070
ssVInterleukin-5 Antagonist
p10071
(dp10072
g13
g14
sg15
V/categories/DBCAT003472
p10073
ssS'Travoprost'
p10074
(dp10075
g13
g25
sg15
S'1106000AE'
p10076
ssS'Porfimer Sodium'
p10077
(dp10078
g13
g25
sg15
S'0801050AH'
p10079
ssVBronchodilator Agents
p10080
(dp10081
g13
g14
sg15
V/categories/DBCAT000555
p10082
ssVNarcotics
p10083
(dp10084
g13
g14
sg15
V/categories/DBCAT000479
p10085
ssVAntiarrhythmics, Class I
p10086
(dp10087
g13
g14
sg15
V/categories/DBCAT003865
p10088
ssVOxyquinoline
p10089
(dp10090
g13
g14
sg15
V/categories/DBCAT001618
p10091
ssVOils
p10092
(dp10093
g13
g14
sg15
V/categories/DBCAT000299
p10094
ssVDNA-Binding Proteins
p10095
(dp10096
g13
g14
sg15
V/categories/DBCAT000208
p10097
ssS'Timolol'
p10098
(dp10099
g13
g25
sg15
S'0204000V0'
p10100
ssVFlavins
p10101
(dp10102
g13
g14
sg15
V/categories/DBCAT000330
p10103
ssS'Obinutuzumab'
p10104
(dp10105
g13
g25
sg15
S'0802030G0'
p10106
ssVIndoles
p10107
(dp10108
g13
g14
sg15
V/categories/DBCAT000528
p10109
ssVPiperidines
p10110
(dp10111
g13
g14
sg15
V/categories/DBCAT000695
p10112
ssS'Orlistat'
p10113
(dp10114
g13
g25
sg15
S'0405010P0'
p10115
ssVIncreased Large Intestinal Motility
p10116
(dp10117
g13
g14
sg15
V/categories/DBCAT004129
p10118
ssS'Chlorobutanol'
p10119
(dp10120
g13
g25
sg15
S'1202030C0'
p10121
ssS'Fidaxomicin'
p10122
(dp10123
g13
g25
sg15
S'0501070AC'
p10124
ssVMixed Agonist / Antagonist Opioids
p10125
(dp10126
g13
g14
sg15
V/categories/DBCAT002712
p10127
ssVHydrogen Cyanide
p10128
(dp10129
g13
g14
sg15
V/categories/DBCAT000752
p10130
ssVAmebicides
p10131
(dp10132
g13
g14
sg15
V/categories/DBCAT000999
p10133
ssVHydrolytic Lysosomal Glucocerebroside-specific Enzyme
p10134
(dp10135
g13
g14
sg15
V/categories/DBCAT003262
p10136
ssVGlycopeptide Antibacterials
p10137
(dp10138
g13
g14
sg15
V/categories/DBCAT002402
p10139
ssVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p10140
(dp10141
g13
g14
sg15
V/categories/DBCAT002098
p10142
ssVMiotics
p10143
(dp10144
g13
g14
sg15
V/categories/DBCAT000836
p10145
ssVCephacetrile
p10146
(dp10147
g13
g14
sg15
V/categories/DBCAT000567
p10148
ssS'Saxagliptin/Metformin'
p10149
(dp10150
g13
g25
sg15
S'0601023AH'
p10151
ssVPhosphodiesterase 5 Inhibitors
p10152
(dp10153
g13
g14
sg15
V/categories/DBCAT000518
p10154
ssVSilicones
p10155
(dp10156
g13
g14
sg15
V/categories/DBCAT002005
p10157
ssVArylsulfonic Acids
p10158
(dp10159
g13
g14
sg15
V/categories/DBCAT001615
p10160
ssVRibonucleosides
p10161
(dp10162
g13
g14
sg15
V/categories/DBCAT000258
p10163
ssS'Bendroflumethiazide/Potassium'
p10164
(dp10165
g13
g25
sg15
S'0202080B0'
p10166
ssVPreparations Containing Sulfur
p10167
(dp10168
g13
g14
sg15
V/categories/DBCAT002550
p10169
ssS'Atovaquone'
p10170
(dp10171
g13
g25
sg15
S'0504080A0'
p10172
ssVGlucaric Acid
p10173
(dp10174
g13
g14
sg15
V/categories/DBCAT005021
p10175
ssVAdministration, Topical
p10176
(dp10177
g13
g14
sg15
V/categories/DBCAT001103
p10178
ssS'Sorafenib'
p10179
(dp10180
g13
g25
sg15
S'0801050AJ'
p10181
ssVAndrogens
p10182
(dp10183
g13
g14
sg15
V/categories/DBCAT001011
p10184
ssS'Macrogol 4000'
p10185
(dp10186
g13
g25
sg15
S'0106040X0'
p10187
ssVCysteine
p10188
(dp10189
g13
g14
sg15
V/categories/DBCAT000315
p10190
ssVCyclohexenes
p10191
(dp10192
g13
g14
sg15
V/categories/DBCAT000357
p10193
ssVSodium Channel Blockers
p10194
(dp10195
g13
g14
sg15
V/categories/DBCAT000600
p10196
ssVPurines
p10197
(dp10198
g13
g14
sg15
V/categories/DBCAT000253
p10199
ssS'Mannitol'
p10200
(dp10201
g13
g25
sg15
S'0106050N0'
p10202
ssVParoxetine
p10203
(dp10204
g13
g14
sg15
V/categories/DBCAT004750
p10205
ssVHematologic Agents
p10206
(dp10207
g13
g14
sg15
V/categories/DBCAT000008
p10208
ssS'Hydroxyprogesterone Caproate'
p10209
(dp10210
g13
g25
sg15
S'0604012J0'
p10211
ssVUrate Oxidase
p10212
(dp10213
g13
g14
sg15
V/categories/DBCAT004382
p10214
ssVPotassium Ion Exchange Activity
p10215
(dp10216
g13
g14
sg15
V/categories/DBCAT004335
p10217
ssS'Mupirocin'
p10218
(dp10219
g13
g14
sg15
V/categories/DBCAT004737
p10220
ssVPeptidylprolyl Isomerase, antagonists & inhibitors
p10221
(dp10222
g13
g14
sg15
V/categories/DBCAT000767
p10223
ssVGaba-derivative Skeletal Muscle Relaxants
p10224
(dp10225
g13
g14
sg15
V/categories/DBCAT003630
p10226
ssS'Timolol & Travoprost'
p10227
(dp10228
g13
g25
sg15
S'1106000AH'
p10229
ssS'Dinoprostone'
p10230
(dp10231
g13
g25
sg15
S'0701010I0'
p10232
ssVAnti-Inflammatory Agents
p10233
(dp10234
g13
g14
sg15
V/categories/DBCAT000046
p10235
ssS'Dimercaprol'
p10236
(dp10237
g13
g25
sg15
S'1902070D0'
p10238
ssS'Adapalene'
p10239
(dp10240
g13
g25
sg15
S'1306010H0'
p10241
ssVThrombin Inhibitors
p10242
(dp10243
g13
g14
sg15
V/categories/DBCAT004228
p10244
ssS'Omega-3-Acid Ethyl Esters'
p10245
(dp10246
g13
g25
sg15
S'0212000AB'
p10247
ssVAminoketone
p10248
(dp10249
g13
g14
sg15
V/categories/DBCAT003429
p10250
ssVEstrogen Agonist-antagonists
p10251
(dp10252
g13
g14
sg15
V/categories/DBCAT003693
p10253
ssVImidazole Derivatives
p10254
(dp10255
g13
g14
sg15
V/categories/DBCAT002246
p10256
ssVMiscellaneous Therapeutic Agents
p10257
(dp10258
g13
g14
sg15
V/categories/DBCAT003605
p10259
ssVAdenosine Deaminase Inhibitors
p10260
(dp10261
g13
g14
sg15
V/categories/DBCAT000967
p10262
ssS'Nebivolol'
p10263
(dp10264
g13
g25
sg15
S'0204000AB'
p10265
ssS'Fluvoxamine Maleate'
p10266
(dp10267
g13
g25
sg15
S'0403030L0'
p10268
ssVQuinolines
p10269
(dp10270
g13
g14
sg15
V/categories/DBCAT000788
p10271
ssS'Calcitriol'
p10272
(dp10273
g13
g14
sg15
V/categories/DBCAT004713
p10274
ssS'Tinidazole'
p10275
(dp10276
g13
g25
sg15
S'0501110G0'
p10277
ssVThrombopoietin Receptor Agonists
p10278
(dp10279
g13
g14
sg15
V/categories/DBCAT004195
p10280
ssVReceptors, Opioid, mu, agonists
p10281
(dp10282
g13
g14
sg15
V/categories/DBCAT001771
p10283
ssVCarbapenems
p10284
(dp10285
g13
g14
sg15
V/categories/DBCAT001395
p10286
ssVDioxoles
p10287
(dp10288
g13
g14
sg15
V/categories/DBCAT001989
p10289
ssS'Glacial Acetic Acid'
p10290
(dp10291
g13
g25
sg15
S'1307000G0'
p10292
ssVInterleukin-1 Receptor Antagonist
p10293
(dp10294
g13
g14
sg15
V/categories/DBCAT002727
p10295
ssS'Phenol'
p10296
(dp10297
g13
g25
sg15
S'1203040K0'
p10298
ssVIron Chelating Activity
p10299
(dp10300
g13
g14
sg15
V/categories/DBCAT004279
p10301
ssVCitric Acid Derivatives
p10302
(dp10303
g13
g14
sg15
V/categories/DBCAT002728
p10304
ssS'Delamanid'
p10305
(dp10306
g13
g25
sg15
S'0501090W0'
p10307
ssS'Fluoxetine Hydrochloride'
p10308
(dp10309
g13
g25
sg15
S'0403030E0'
p10310
ssVAgrochemicals
p10311
(dp10312
g13
g14
sg15
V/categories/DBCAT000638
p10313
ssS'Povidone-Iodine'
p10314
(dp10315
g13
g25
sg15
S'1203040M0'
p10316
ssVChloroquine
p10317
(dp10318
g13
g14
sg15
V/categories/DBCAT001399
p10319
ssS'Ammonium Chloride'
p10320
(dp10321
g13
g25
sg15
S'0704030C0'
p10322
ssS'Goserelin Acetate'
p10323
(dp10324
g13
g25
sg15
S'0803042K0'
p10325
ssS'Lamivudine/Tenofovir Disop/Doravirine'
p10326
(dp10327
g13
g25
sg15
S'0503010AS'
p10328
ssVIndole Alkaloids
p10329
(dp10330
g13
g14
sg15
V/categories/DBCAT000527
p10331
ssVVasopressin V2 Receptor Antagonists
p10332
(dp10333
g13
g14
sg15
V/categories/DBCAT004476
p10334
ssS'Pilocarpine Hydrochloride'
p10335
(dp10336
g13
g25
sg15
S'1106000X0'
p10337
ssS'Insulin Aspart'
p10338
(dp10339
g13
g25
sg15
S'0601011A0'
p10340
ssVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p10341
(dp10342
g13
g14
sg15
V/categories/DBCAT003802
p10343
ssVProgestin Antagonist
p10344
(dp10345
g13
g14
sg15
V/categories/DBCAT003408
p10346
ssS'Pentamidine Isetionate'
p10347
(dp10348
g13
g25
sg15
S'0504080P0'
p10349
ssS'Lamotrigine'
p10350
(dp10351
g13
g25
sg15
S'0408010H0'
p10352
ssS'Methyl Nicotinate'
p10353
(dp10354
g13
g25
sg15
S'1314000M0'
p10355
ssS'Tranylcypromine Sulfate'
p10356
(dp10357
g13
g25
sg15
S'0403020Q0'
p10358
ssVCorticosteroids, Weak (Group I)
p10359
(dp10360
g13
g14
sg15
V/categories/DBCAT002458
p10361
ssS'Mitotane'
p10362
(dp10363
g13
g25
sg15
S'0801050R0'
p10364
ssS'Ranitidine Hydrochloride'
p10365
(dp10366
g13
g25
sg15
S'0103010T0'
p10367
ssS'Sofosbuvir'
p10368
(dp10369
g13
g25
sg15
S'0503032C0'
p10370
ssVVitamin K Inhibitors
p10371
(dp10372
g13
g14
sg15
V/categories/DBCAT004164
p10373
ssS'Carmustine'
p10374
(dp10375
g13
g25
sg15
S'0801010D0'
p10376
ssS'Dasabuvir'
p10377
(dp10378
g13
g25
sg15
S'0503032H0'
p10379
ssVSomatotropin Agonists
p10380
(dp10381
g13
g14
sg15
V/categories/DBCAT003614
p10382
ssS'Hydrochlorothiazide'
p10383
(dp10384
g13
g25
sg15
S'0202010L0'
p10385
ssVDimethylpolysiloxanes
p10386
(dp10387
g13
g14
sg15
V/categories/DBCAT002004
p10388
ssS'Nintedanib'
p10389
(dp10390
g13
g25
sg15
S'0801050BT'
p10391
ssVHydrocarbons, Brominated
p10392
(dp10393
g13
g14
sg15
V/categories/DBCAT002899
p10394
ssValpha-Glucosidases
p10395
(dp10396
g13
g14
sg15
V/categories/DBCAT004138
p10397
ssVGlycylcyclines
p10398
(dp10399
g13
g14
sg15
V/categories/DBCAT003698
p10400
ssVSoluble Guanylate Cyclase Stimulator
p10401
(dp10402
g13
g14
sg15
V/categories/DBCAT003503
p10403
ssVEthanolamines
p10404
(dp10405
g13
g14
sg15
V/categories/DBCAT000270
p10406
ssVOpioid Agonist
p10407
(dp10408
g13
g14
sg15
V/categories/DBCAT003293
p10409
ssS'Fingolimod'
p10410
(dp10411
g13
g25
sg15
S'0802040AD'
p10412
ssVUncompetitive N-methyl-D-aspartate Receptor Antagonist
p10413
(dp10414
g13
g14
sg15
V/categories/DBCAT003365
p10415
ssS'Linagliptin/Metformin'
p10416
(dp10417
g13
g25
sg15
S'0601023AF'
p10418
ssVCholic Acids
p10419
(dp10420
g13
g14
sg15
V/categories/DBCAT001382
p10421
ssVButylpyrazolidines
p10422
(dp10423
g13
g14
sg15
V/categories/DBCAT002470
p10424
ssVP-glycoprotein/ABCB1 Inhibitors
p10425
(dp10426
g13
g14
sg15
V/categories/DBCAT002667
p10427
ssS'Crisantaspase'
p10428
(dp10429
g13
g25
sg15
S'0801050J0'
p10430
ssS'Canakinumab'
p10431
(dp10432
g13
g25
sg15
S'0802040AC'
p10433
ssVAmino Acids, Sulfur
p10434
(dp10435
g13
g14
sg15
V/categories/DBCAT000247
p10436
ssVMonobactams
p10437
(dp10438
g13
g14
sg15
V/categories/DBCAT000782
p10439
ssVOrganic Nitrates
p10440
(dp10441
g13
g14
sg15
V/categories/DBCAT002456
p10442
ssVOrganophosphorus Compounds
p10443
(dp10444
g13
g14
sg15
V/categories/DBCAT000699
p10445
ssVBSEP/ABCB11 Substrates
p10446
(dp10447
g13
g14
sg15
V/categories/DBCAT003979
p10448
ssVTests for Gastric Secretion
p10449
(dp10450
g13
g14
sg15
V/categories/DBCAT002181
p10451
ssVPreparations for Treatment of Wounds and Ulcers
p10452
(dp10453
g13
g14
sg15
V/categories/DBCAT002134
p10454
ssVAngiotensin Receptor Antagonists
p10455
(dp10456
g13
g14
sg15
V/categories/DBCAT000408
p10457
ssVRifamycin Antibacterial
p10458
(dp10459
g13
g14
sg15
V/categories/DBCAT003433
p10460
ssVAcridines
p10461
(dp10462
g13
g14
sg15
V/categories/DBCAT000656
p10463
ssVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p10464
(dp10465
g13
g14
sg15
V/categories/DBCAT004036
p10466
ssVDrugs Used in Alcohol Dependence
p10467
(dp10468
g13
g14
sg15
V/categories/DBCAT002441
p10469
ssS'Ergotamine Tartrate'
p10470
(dp10471
g13
g25
sg15
S'0407041F0'
p10472
ssVPterins
p10473
(dp10474
g13
g14
sg15
V/categories/DBCAT000354
p10475
ssVDopa and Dopa Derivatives
p10476
(dp10477
g13
g14
sg15
V/categories/DBCAT002522
p10478
ssS'Cefixime'
p10479
(dp10480
g13
g25
sg15
S'0501021C0'
p10481
ssVNicotinic Agonists
p10482
(dp10483
g13
g14
sg15
V/categories/DBCAT000445
p10484
ssVUricosuric Agents
p10485
(dp10486
g13
g14
sg15
V/categories/DBCAT001241
p10487
ssVHeparinoids
p10488
(dp10489
g13
g14
sg15
V/categories/DBCAT001857
p10490
ssVPhenothiazines With Piperazine Structure
p10491
(dp10492
g13
g14
sg15
V/categories/DBCAT002373
p10493
ssS'Aspirin & Papaveretum'
p10494
(dp10495
g13
g25
sg15
S'0407010A0'
p10496
ssS'Maprotiline Hydrochloride'
p10497
(dp10498
g13
g25
sg15
S'0403010S0'
p10499
ssVSerotonin 5-HT2 Receptor Agonists
p10500
(dp10501
g13
g14
sg15
V/categories/DBCAT001689
p10502
ssVPhenothiazines With Aliphatic Side-Chain
p10503
(dp10504
g13
g14
sg15
V/categories/DBCAT002366
p10505
ssVAnti-Parathyroid Agents
p10506
(dp10507
g13
g14
sg15
V/categories/DBCAT002101
p10508
ssS'Sofosbuvir/Velpatasvir'
p10509
(dp10510
g13
g25
sg15
S'0503032J0'
p10511
ssS'Eltrombopag'
p10512
(dp10513
g13
g25
sg15
S'0901040C0'
p10514
ssS'Etafedrine Hydrochloride'
p10515
(dp10516
g13
g25
sg15
S'0301040L0'
p10517
ssS'Stiripentol'
p10518
(dp10519
g13
g25
sg15
S'0408010AG'
p10520
ssS'Darifenacin Hydrobromide'
p10521
(dp10522
g13
g25
sg15
S'0704020AC'
p10523
ssVPolyene Antimicrobial
p10524
(dp10525
g13
g14
sg15
V/categories/DBCAT003407
p10526
ssVCytochrome P-450 CYP2B6 Inducers (strong)
p10527
(dp10528
g13
g14
sg15
V/categories/DBCAT002622
p10529
ssVAnabolic Agents for Systemic Use
p10530
(dp10531
g13
g14
sg15
V/categories/DBCAT002428
p10532
ssS'Levocetirizine'
p10533
(dp10534
g13
g25
sg15
S'0304010AC'
p10535
ssVStyrenes
p10536
(dp10537
g13
g14
sg15
V/categories/DBCAT001362
p10538
ssS'Perampanel'
p10539
(dp10540
g13
g25
sg15
S'0408010AK'
p10541
ssVTeratogens
p10542
(dp10543
g13
g14
sg15
V/categories/DBCAT001141
p10544
ssVAngiotensin 2 Receptor Blocker
p10545
(dp10546
g13
g14
sg15
V/categories/DBCAT003287
p10547
ssS'Povidone Iodine'
p10548
(dp10549
g13
g25
sg15
S'0702020V0'
p10550
ssVCystic Fibrosis Transmembrane Conductance Regulator
p10551
(dp10552
g13
g14
sg15
V/categories/DBCAT001892
p10553
ssS'Pentosan Polysulfate Sodium'
p10554
(dp10555
g13
g25
sg15
S'0208010F0'
p10556
ssS'Nifedipine'
p10557
(dp10558
g13
g25
sg15
S'0206020R0'
p10559
ssVAntianginal Agents
p10560
(dp10561
g13
g14
sg15
V/categories/DBCAT002737
p10562
ssS'Letrozole'
p10563
(dp10564
g13
g25
sg15
S'0803041L0'
p10565
ssVNaloxone
p10566
(dp10567
g13
g14
sg15
V/categories/DBCAT001081
p10568
ssS'Agalsidase Alfa'
p10569
(dp10570
g13
g25
sg15
S'0908010AA'
p10571
ssVChalcogens
p10572
(dp10573
g13
g14
sg15
V/categories/DBCAT001956
p10574
ssVDoxorubicin
p10575
(dp10576
g13
g14
sg15
V/categories/DBCAT000872
p10577
ssS'Dequalinium Chloride'
p10578
(dp10579
g13
g25
sg15
S'1203030F0'
p10580
ssS'Vildagliptin'
p10581
(dp10582
g13
g25
sg15
S'0601023AA'
p10583
ssVPolystyrene Sulfonates
p10584
(dp10585
g13
g14
sg15
V/categories/DBCAT004573
p10586
ssS'Sodium Nitroprusside'
p10587
(dp10588
g13
g25
sg15
S'0205010T0'
p10589
ssVAntifungals for Systemic Use
p10590
(dp10591
g13
g14
sg15
V/categories/DBCAT002359
p10592
ssS'Trospium Chloride'
p10593
(dp10594
g13
g25
sg15
S'0704020Z0'
p10595
ssS'Pethidine Hydrochloride'
p10596
(dp10597
g13
g25
sg15
S'0407020V0'
p10598
ssVNorpregnatrienes
p10599
(dp10600
g13
g14
sg15
V/categories/DBCAT001216
p10601
ssS'Oxycodone'
p10602
(dp10603
g13
g25
sg15
S'0407020Z0'
p10604
ssVInsulin, Long-Acting
p10605
(dp10606
g13
g14
sg15
V/categories/DBCAT000138
p10607
ssVCalcitriol, antagonists & inhibitors
p10608
(dp10609
g13
g14
sg15
V/categories/DBCAT004714
p10610
ssS'Ceftriaxone Sodium'
p10611
(dp10612
g13
g25
sg15
S'0501021G0'
p10613
ssVPituitary
p10614
(dp10615
g13
g14
sg15
V/categories/DBCAT003608
p10616
ssVInsulins and Analogues for Injection, Fast-Acting
p10617
(dp10618
g13
g14
sg15
V/categories/DBCAT002120
p10619
ssVProstaglandin E1 Analog
p10620
(dp10621
g13
g14
sg15
V/categories/DBCAT003415
p10622
ssVAmino Acids, Acidic
p10623
(dp10624
g13
g14
sg15
V/categories/DBCAT000289
p10625
ssVWarfarin Reversal Agent
p10626
(dp10627
g13
g14
sg15
V/categories/DBCAT003557
p10628
ssS'Moexipril Hydrochloride'
p10629
(dp10630
g13
g25
sg15
S'0205051C0'
p10631
ssVValerates
p10632
(dp10633
g13
g14
sg15
V/categories/DBCAT000732
p10634
ssS'Butorphanol Tartrate'
p10635
(dp10636
g13
g25
sg15
S'0407020AA'
p10637
ssVChloride Channel Activation Potentiators
p10638
(dp10639
g13
g14
sg15
V/categories/DBCAT004131
p10640
ssVNeurotransmitter Agents
p10641
(dp10642
g13
g14
sg15
V/categories/DBCAT000127
p10643
ssVHistamine Agents
p10644
(dp10645
g13
g14
sg15
V/categories/DBCAT000651
p10646
ssVComplement Inactivating Agents
p10647
(dp10648
g13
g14
sg15
V/categories/DBCAT001769
p10649
ssVOATP1B1/SLCO1B1 Inhibitors
p10650
(dp10651
g13
g14
sg15
V/categories/DBCAT003931
p10652
ssS'Infliximab'
p10653
(dp10654
g13
g25
sg15
S'1001030T0'
p10655
ssVUridine
p10656
(dp10657
g13
g14
sg15
V/categories/DBCAT000609
p10658
ssVTars
p10659
(dp10660
g13
g14
sg15
V/categories/DBCAT002027
p10661
ssS'Epinastine Hydrochloride'
p10662
(dp10663
g13
g25
sg15
S'1104020AC'
p10664
ssVHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor
p10665
(dp10666
g13
g14
sg15
V/categories/DBCAT003320
p10667
ssVCytochrome P-450 CYP2C18 Inducers (strength unknown)
p10668
(dp10669
g13
g14
sg15
V/categories/DBCAT004674
p10670
ssVFood Additives
p10671
(dp10672
g13
g14
sg15
V/categories/DBCAT000377
p10673
ssS'Prochlorperazine Maleate'
p10674
(dp10675
g13
g25
sg15
S'0406000T0'
p10676
ssVTerpenes
p10677
(dp10678
g13
g14
sg15
V/categories/DBCAT000366
p10679
ssS'Penicillamine'
p10680
(dp10681
g13
g25
sg15
S'1001030F0'
p10682
ssVSpecific Immunoglobulins
p10683
(dp10684
g13
g14
sg15
V/categories/DBCAT002142
p10685
ssVUDP Glucuronosyltransferases Inducers
p10686
(dp10687
g13
g14
sg15
V/categories/DBCAT004300
p10688
ssVTriazenes
p10689
(dp10690
g13
g14
sg15
V/categories/DBCAT001163
p10691
ssS'Silver Sulfadiazine'
p10692
(dp10693
g13
g25
sg15
S'1310011Y0'
p10694
ssVBiogenic Monoamines
p10695
(dp10696
g13
g14
sg15
V/categories/DBCAT000468
p10697
ssS'Azathioprine'
p10698
(dp10699
g13
g25
sg15
S'0802010G0'
p10700
ssS'Etoposide'
p10701
(dp10702
g13
g25
sg15
S'0801040D0'
p10703
ssVPregnadienetriols
p10704
(dp10705
g13
g14
sg15
V/categories/DBCAT000826
p10706
ssVDecreased RNA Replication
p10707
(dp10708
g13
g14
sg15
V/categories/DBCAT004417
p10709
ssVCarbon-Oxygen Lyases
p10710
(dp10711
g13
g14
sg15
V/categories/DBCAT000168
p10712
ssS'Flavoxate Hydrochloride'
p10713
(dp10714
g13
g25
sg15
S'0704020G0'
p10715
ssVOxidoreductases
p10716
(dp10717
g13
g14
sg15
V/categories/DBCAT000142
p10718
ssVImmunoconjugates
p10719
(dp10720
g13
g14
sg15
V/categories/DBCAT000152
p10721
ssVAmino Acids, Aromatic
p10722
(dp10723
g13
g14
sg15
V/categories/DBCAT000262
p10724
ssS'Inosine Pranobex'
p10725
(dp10726
g13
g25
sg15
S'0503021D0'
p10727
ssS'Sodium Valproate'
p10728
(dp10729
g13
g25
sg15
S'0408010W0'
p10730
ssVSympathomimetic (Adrenergic) Agents
p10731
(dp10732
g13
g14
sg15
V/categories/DBCAT003677
p10733
ssVProlactine Inhibitors
p10734
(dp10735
g13
g14
sg15
V/categories/DBCAT002256
p10736
ssS'Clorazepate Dipotassium'
p10737
(dp10738
g13
g25
sg15
S'0401020V0'
p10739
ssS'Diclofenac Potassium'
p10740
(dp10741
g13
g25
sg15
S'1001010AG'
p10742
ssVCresols
p10743
(dp10744
g13
g14
sg15
V/categories/DBCAT001243
p10745
ssVVasodilation
p10746
(dp10747
g13
g14
sg15
V/categories/DBCAT004272
p10748
ssVTestosterone and derivatives
p10749
(dp10750
g13
g14
sg15
V/categories/DBCAT003968
p10751
ssS'Ponatinib'
p10752
(dp10753
g13
g25
sg15
S'0801050BQ'
p10754
ssVLaboratory Chemicals
p10755
(dp10756
g13
g14
sg15
V/categories/DBCAT000195
p10757
ssS'Ivacaftor'
p10758
(dp10759
g13
g25
sg15
S'0307000S0'
p10760
ssS'Metoprolol Fumarate'
p10761
(dp10762
g13
g25
sg15
S'0204000J0'
p10763
ssS'Almasilate'
p10764
(dp10765
g13
g25
sg15
S'0101010B0'
p10766
ssS'Magnesium Oxide'
p10767
(dp10768
g13
g25
sg15
S'0101010I0'
p10769
ssVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p10770
(dp10771
g13
g14
sg15
V/categories/DBCAT004037
p10772
ssVLithium Compounds
p10773
(dp10774
g13
g14
sg15
V/categories/DBCAT001348
p10775
ssVSomatropin and Somatropin Agonists
p10776
(dp10777
g13
g14
sg15
V/categories/DBCAT002095
p10778
ssS'Prasugrel'
p10779
(dp10780
g13
g25
sg15
S'0209000Y0'
p10781
ssVBlood Coagulation Factors
p10782
(dp10783
g13
g14
sg15
V/categories/DBCAT000075
p10784
ssVPlastics
p10785
(dp10786
g13
g14
sg15
V/categories/DBCAT001360
p10787
ssVAntibodies, Monoclonal, Humanized
p10788
(dp10789
g13
g14
sg15
V/categories/DBCAT000014
p10790
ssVOxazolidine Derivatives
p10791
(dp10792
g13
g14
sg15
V/categories/DBCAT002331
p10793
ssS'Teriflunomide'
p10794
(dp10795
g13
g25
sg15
S'0802040AL'
p10796
ssS'Gemfibrozil'
p10797
(dp10798
g13
g25
sg15
S'0212000Q0'
p10799
ssVRANK Ligand Inhibitor
p10800
(dp10801
g13
g14
sg15
V/categories/DBCAT003473
p10802
ssVPhosphoric Acids
p10803
(dp10804
g13
g14
sg15
V/categories/DBCAT000954
p10805
ssVTetracyclines
p10806
(dp10807
g13
g14
sg15
V/categories/DBCAT002418
p10808
ssVQTc shortening agents
p10809
(dp10810
g13
g14
sg15
V/categories/DBCAT003890
p10811
ssVTissue Plasminogen Activator, antagonists & inhibitors
p10812
(dp10813
g13
g14
sg15
V/categories/DBCAT004682
p10814
ssS'Promethazine Hydrochloride'
p10815
(dp10816
g13
g25
sg15
S'0304010W0'
p10817
ssS'Lidocaine/Cetylpyridinium'
p10818
(dp10819
g13
g25
sg15
S'1203010V0'
p10820
ssVCytochrome P-450 CYP2B6 Inhibitors (strong)
p10821
(dp10822
g13
g14
sg15
V/categories/DBCAT002620
p10823
ssVDibenzoxazepines
p10824
(dp10825
g13
g14
sg15
V/categories/DBCAT000832
p10826
ssVHydrolases
p10827
(dp10828
g13
g14
sg15
V/categories/DBCAT000070
p10829
ssVFormycins
p10830
(dp10831
g13
g14
sg15
V/categories/DBCAT000966
p10832
ssS'Emtricitabine & Tenofovir Disoproxil'
p10833
(dp10834
g13
g25
sg15
S'0503010AA'
p10835
ssVAntiandrogens
p10836
(dp10837
g13
g14
sg15
V/categories/DBCAT002554
p10838
ssS'Thiotepa'
p10839
(dp10840
g13
g25
sg15
S'1108020X0'
p10841
ssVSerotonin Agents
p10842
(dp10843
g13
g14
sg15
V/categories/DBCAT000401
p10844
ssVAntifungal Agents
p10845
(dp10846
g13
g14
sg15
V/categories/DBCAT000200
p10847
ssVDirect Vasodilators
p10848
(dp10849
g13
g14
sg15
V/categories/DBCAT003665
p10850
ssVAmprenavir and Prodrugs
p10851
(dp10852
g13
g14
sg15
V/categories/DBCAT003961
p10853
ssS'Amantadine Hydrochloride'
p10854
(dp10855
g13
g25
sg15
S'0409010B0'
p10856
ssS'Formoterol Fumarate'
p10857
(dp10858
g13
g25
sg15
S'0301011E0'
p10859
ssVRNA Synthetase Inhibitor Antibacterial
p10860
(dp10861
g13
g14
sg15
V/categories/DBCAT003344
p10862
ssVPlasma Substitutes
p10863
(dp10864
g13
g14
sg15
V/categories/DBCAT001951
p10865
ssVAntidiuretic Agents
p10866
(dp10867
g13
g14
sg15
V/categories/DBCAT000116
p10868
ssVCompounds used in a research, industrial, or household setting
p10869
(dp10870
g13
g14
sg15
V/categories/DBCAT000196
p10871
ssVPeptide Fragments
p10872
(dp10873
g13
g14
sg15
V/categories/DBCAT001722
p10874
ssVGastrointestinal Motility Inhibitor
p10875
(dp10876
g13
g14
sg15
V/categories/DBCAT003549
p10877
ssS'Amphotericin'
p10878
(dp10879
g13
g25
sg15
S'1203020C0'
p10880
ssVOintments
p10881
(dp10882
g13
g14
sg15
V/categories/DBCAT001828
p10883
ssS'Tamsulosin & Dutasteride Hydrochloride'
p10884
(dp10885
g13
g25
sg15
S'0704010V0'
p10886
ssVCytochrome P-450 CYP2C8 Substrates
p10887
(dp10888
g13
g14
sg15
V/categories/DBCAT002642
p10889
ssS'Clioquinol'
p10890
(dp10891
g13
g25
sg15
S'1310011C0'
p10892
ssVHypophosphatasia, drug therapy
p10893
(dp10894
g13
g14
sg15
V/categories/DBCAT001949
p10895
ssVPolyvinyls
p10896
(dp10897
g13
g14
sg15
V/categories/DBCAT001870
p10898
ssS'Gefitinib'
p10899
(dp10900
g13
g25
sg15
S'0801050AW'
p10901
ssVMethyl Ethers
p10902
(dp10903
g13
g14
sg15
V/categories/DBCAT000561
p10904
ssVAza Compounds
p10905
(dp10906
g13
g14
sg15
V/categories/DBCAT000572
p10907
ssVNeuromuscular Blocking Agents
p10908
(dp10909
g13
g14
sg15
V/categories/DBCAT000511
p10910
ssVAdrenergic beta-1 Receptor Agonists
p10911
(dp10912
g13
g14
sg15
V/categories/DBCAT001159
p10913
ssS'Secnidazole'
p10914
(dp10915
g13
g25
sg15
S'0702020AA'
p10916
ssVMiscellaneous Derivatives
p10917
(dp10918
g13
g14
sg15
V/categories/DBCAT003687
p10919
ssVMuscle Relaxants
p10920
(dp10921
g13
g14
sg15
V/categories/DBCAT002178
p10922
ssVPeroxisome Proliferator Receptor gamma Agonist
p10923
(dp10924
g13
g14
sg15
V/categories/DBCAT003345
p10925
ssVPeroxisome Proliferator Receptor alpha Agonist
p10926
(dp10927
g13
g14
sg15
V/categories/DBCAT003423
p10928
ssVSleep Aids, Pharmaceutical
p10929
(dp10930
g13
g14
sg15
V/categories/DBCAT001256
p10931
ssVVasoconstriction
p10932
(dp10933
g13
g14
sg15
V/categories/DBCAT004353
p10934
ssVTestosterone, antagonists & inhibitors
p10935
(dp10936
g13
g14
sg15
V/categories/DBCAT004744
p10937
ssVOther Nonsteroidal Antiimflammatory Agents
p10938
(dp10939
g13
g14
sg15
V/categories/DBCAT003666
p10940
ssVMercaptoethylamines
p10941
(dp10942
g13
g14
sg15
V/categories/DBCAT001161
p10943
ssVPhosphate Chelating Activity
p10944
(dp10945
g13
g14
sg15
V/categories/DBCAT004097
p10946
ssVPyrans
p10947
(dp10948
g13
g14
sg15
V/categories/DBCAT000371
p10949
ssS'Proguanil Hydrochloride'
p10950
(dp10951
g13
g25
sg15
S'0504010M0'
p10952
ssS'Pamidronate Disodium'
p10953
(dp10954
g13
g25
sg15
S'0606020P0'
p10955
ssVNeuraminidase Inhibitors
p10956
(dp10957
g13
g14
sg15
V/categories/DBCAT002200
p10958
ssS'Granisetron'
p10959
(dp10960
g13
g25
sg15
S'0406000AF'
p10961
ssVImmunoglobulin Fab Fragments
p10962
(dp10963
g13
g14
sg15
V/categories/DBCAT001914
p10964
ssVCatechols
p10965
(dp10966
g13
g14
sg15
V/categories/DBCAT000419
p10967
ssVGonadotropins and Antigonadotropins
p10968
(dp10969
g13
g14
sg15
V/categories/DBCAT004658
p10970
ssV14-alpha Demethylase Inhibitors
p10971
(dp10972
g13
g14
sg15
V/categories/DBCAT000488
p10973
ssS'Latanoprost'
p10974
(dp10975
g13
g25
sg15
S'1106000L0'
p10976
ssS'Flurbiprofen'
p10977
(dp10978
g13
g25
sg15
S'1001010I0'
p10979
ssVDetoxifying Agents for Antineoplastic Treatment
p10980
(dp10981
g13
g14
sg15
V/categories/DBCAT002110
p10982
ssVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p10983
(dp10984
g13
g14
sg15
V/categories/DBCAT004482
p10985
ssVMenstruation-Inducing Agents
p10986
(dp10987
g13
g14
sg15
V/categories/DBCAT001155
p10988
ssVCryoprotective Agents
p10989
(dp10990
g13
g14
sg15
V/categories/DBCAT001261
p10991
ssVNucleoproteins
p10992
(dp10993
g13
g14
sg15
V/categories/DBCAT001957
p10994
ssVDiarylquinoline Antimycobacterial
p10995
(dp10996
g13
g14
sg15
V/categories/DBCAT003502
p10997
ssVRANK Ligand Blocking Activity
p10998
(dp10999
g13
g14
sg15
V/categories/DBCAT004389
p11000
ssVDrugs Used in Benign Prostatic Hypertrophy
p11001
(dp11002
g13
g14
sg15
V/categories/DBCAT002330
p11003
ssVDecreased Respiratory Secretion Viscosity
p11004
(dp11005
g13
g14
sg15
V/categories/DBCAT004188
p11006
ssVTrisaccharides
p11007
(dp11008
g13
g14
sg15
V/categories/DBCAT000667
p11009
ssVAdrenergic Agonists
p11010
(dp11011
g13
g14
sg15
V/categories/DBCAT000537
p11012
ssVT Lymphocyte Costimulation Activity Blockade
p11013
(dp11014
g13
g14
sg15
V/categories/DBCAT004360
p11015
ssS'Risperidone'
p11016
(dp11017
g13
g25
sg15
S'040201030'
p11018
ssVAntigout Preparations
p11019
(dp11020
g13
g14
sg15
V/categories/DBCAT002123
p11021
ssS'Solifenacin/Tamsulosin'
p11022
(dp11023
g13
g25
sg15
S'0704010W0'
p11024
ssVOrganogold Compounds
p11025
(dp11026
g13
g14
sg15
V/categories/DBCAT001223
p11027
ssVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p11028
(dp11029
g13
g14
sg15
V/categories/DBCAT003877
p11030
ssVImides
p11031
(dp11032
g13
g14
sg15
V/categories/DBCAT000725
p11033
ssVHydrazines
p11034
(dp11035
g13
g14
sg15
V/categories/DBCAT000469
p11036
ssVCyclohexanecarboxylic Acids
p11037
(dp11038
g13
g14
sg15
V/categories/DBCAT000703
p11039
ssS'Etidronate Disodium'
p11040
(dp11041
g13
g25
sg15
S'0606020C0'
p11042
ssVNitroso Compounds
p11043
(dp11044
g13
g14
sg15
V/categories/DBCAT000634
p11045
ssS'Desmopressin Acetate'
p11046
(dp11047
g13
g25
sg15
S'0605020E0'
p11048
ssVProgesterone Congeners
p11049
(dp11050
g13
g14
sg15
V/categories/DBCAT000686
p11051
ssS'Atazanavir'
p11052
(dp11053
g13
g25
sg15
S'0503010L0'
p11054
ssVVenous Vasodilation
p11055
(dp11056
g13
g14
sg15
V/categories/DBCAT004183
p11057
ssVGlucagon-Like Peptide 1
p11058
(dp11059
g13
g14
sg15
V/categories/DBCAT001327
p11060
ssS'Telbivudine'
p11061
(dp11062
g13
g25
sg15
S'0503031C0'
p11063
ssVMiscellaneous Anticoagulants
p11064
(dp11065
g13
g14
sg15
V/categories/DBCAT003770
p11066
ssS'Tyrothricin'
p11067
(dp11068
g13
g25
sg15
S'1310011Z0'
p11069
ssVPurinergic Antagonists
p11070
(dp11071
g13
g14
sg15
V/categories/DBCAT000506
p11072
ssVPassively Acquired Immunity
p11073
(dp11074
g13
g14
sg15
V/categories/DBCAT004070
p11075
ssVDecreased Platelet Aggregation
p11076
(dp11077
g13
g14
sg15
V/categories/DBCAT004081
p11078
ssS'Ciclosporin'
p11079
(dp11080
g13
g25
sg15
S'0802020G0'
p11081
ssVCOMT Inhibitors
p11082
(dp11083
g13
g14
sg15
V/categories/DBCAT002655
p11084
ssS'Iron Dextran'
p11085
(dp11086
g13
g25
sg15
S'0901012K0'
p11087
ssVJanus Kinase 3, antagonists & inhibitors
p11088
(dp11089
g13
g14
sg15
V/categories/DBCAT001910
p11090
ssVAnesthetics, Intravenous
p11091
(dp11092
g13
g14
sg15
V/categories/DBCAT000683
p11093
ssVPhenol and Derivatives
p11094
(dp11095
g13
g14
sg15
V/categories/DBCAT002462
p11096
ssS'Bromocriptine'
p11097
(dp11098
g13
g25
sg15
S'0607010B0'
p11099
ssS'Strontium Ranelate'
p11100
(dp11101
g13
g25
sg15
S'0606020X0'
p11102
ssVDental Agents
p11103
(dp11104
g13
g14
sg15
V/categories/DBCAT003710
p11105
ssVPsoralens for Systemic Use
p11106
(dp11107
g13
g14
sg15
V/categories/DBCAT002408
p11108
ssVPhotoabsorption
p11109
(dp11110
g13
g14
sg15
V/categories/DBCAT004154
p11111
ssS'Vortioxetine'
p11112
(dp11113
g13
g25
sg15
S'0403040AB'
p11114
ssVDeoxyuridine
p11115
(dp11116
g13
g14
sg15
V/categories/DBCAT000608
p11117
ssVUracil
p11118
(dp11119
g13
g14
sg15
V/categories/DBCAT000961
p11120
ssVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p11121
(dp11122
g13
g14
sg15
V/categories/DBCAT003351
p11123
ssVVitamin A
p11124
(dp11125
g13
g14
sg15
V/categories/DBCAT001110
p11126
ssVDecreased Prostaglandin Production
p11127
(dp11128
g13
g14
sg15
V/categories/DBCAT004321
p11129
ssVAstringents and Deodorants
p11130
(dp11131
g13
g14
sg15
V/categories/DBCAT003794
p11132
ssS'Lenalidomide'
p11133
(dp11134
g13
g25
sg15
S'0802040Y0'
p11135
ssS'Mitoxantrone'
p11136
(dp11137
g13
g25
sg15
S'0801020R0'
p11138
ssS'Chloral Hydrate'
p11139
(dp11140
g13
g25
sg15
S'0401010B0'
p11141
ssVDecongestants and Antiallergics
p11142
(dp11143
g13
g14
sg15
V/categories/DBCAT002353
p11144
ssS'Brimonidine Tartrate'
p11145
(dp11146
g13
g25
sg15
S'1106000AA'
p11147
ssVDigestives, Incl. Enzymes
p11148
(dp11149
g13
g14
sg15
V/categories/DBCAT002547
p11150
ssS'Doxorubicin Hydrochloride'
p11151
(dp11152
g13
g25
sg15
S'0801020K0'
p11153
ssS'Methylphenidate Hydrochloride'
p11154
(dp11155
g13
g25
sg15
S'0404000M0'
p11156
ssVProgestin-containing Intrauterine Device
p11157
(dp11158
g13
g14
sg15
V/categories/DBCAT003338
p11159
ssS'Pasireotide'
p11160
(dp11161
g13
g25
sg15
S'0803043Q0'
p11162
ssS'Diphenylpyraline Hydrochloride'
p11163
(dp11164
g13
g25
sg15
S'0304010P0'
p11165
ssS'Simeprevir'
p11166
(dp11167
g13
g25
sg15
S'0503032D0'
p11168
ssVEmetics
p11169
(dp11170
g13
g14
sg15
V/categories/DBCAT001092
p11171
ssS'Diethyltoluamide'
p11172
(dp11173
g13
g25
sg15
S'1315000D0'
p11174
ssS'Sebelipase Alfa'
p11175
(dp11176
g13
g25
sg15
S'0908010AN'
p11177
ssVPyrimidinones
p11178
(dp11179
g13
g14
sg15
V/categories/DBCAT000729
p11180
ssVBeta-Lactamase Resistant Penicillins
p11181
(dp11182
g13
g14
sg15
V/categories/DBCAT002294
p11183
ssS'Amikacin'
p11184
(dp11185
g13
g25
sg15
S'0501040C0'
p11186
ssVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p11187
(dp11188
g13
g14
sg15
V/categories/DBCAT004174
p11189
ssVHeparins
p11190
(dp11191
g13
g14
sg15
V/categories/DBCAT002743
p11192
ssVProgestational Hormone Receptor Antagonists
p11193
(dp11194
g13
g14
sg15
V/categories/DBCAT004251
p11195
ssS'Lithium Citrate'
p11196
(dp11197
g13
g25
sg15
S'0402030P0'
p11198
ssVProstaglandins E, Synthetic
p11199
(dp11200
g13
g14
sg15
V/categories/DBCAT001193
p11201
ssVInsect Repellents
p11202
(dp11203
g13
g14
sg15
V/categories/DBCAT002056
p11204
ssVParamagnetic Contrast Agent
p11205
(dp11206
g13
g14
sg15
V/categories/DBCAT003301
p11207
ssS'Ribavirin'
p11208
(dp11209
g13
g25
sg15
S'0503050B0'
p11210
ssVGLP-1 Agonists
p11211
(dp11212
g13
g14
sg15
V/categories/DBCAT002693
p11213
ssVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p11214
(dp11215
g13
g14
sg15
V/categories/DBCAT003826
p11216
ssVBisphosphonates
p11217
(dp11218
g13
g14
sg15
V/categories/DBCAT001016
p11219
ssVLuminescent Agents
p11220
(dp11221
g13
g14
sg15
V/categories/DBCAT001076
p11222
ssVAntiadrenergic Agents, Centrally Acting
p11223
(dp11224
g13
g14
sg15
V/categories/DBCAT002214
p11225
ssVEmollients
p11226
(dp11227
g13
g14
sg15
V/categories/DBCAT002008
p11228
ssS'Trimethoprim'
p11229
(dp11230
g13
g25
sg15
S'0501080W0'
p11231
ssVCytochrome P-450 CYP2C9 Inducers (moderate)
p11232
(dp11233
g13
g14
sg15
V/categories/DBCAT003109
p11234
ssVAntiemetics
p11235
(dp11236
g13
g14
sg15
V/categories/DBCAT000454
p11237
ssVCross-Linking Reagents
p11238
(dp11239
g13
g14
sg15
V/categories/DBCAT000713
p11240
ssS'Cimetidine'
p11241
(dp11242
g13
g25
sg15
S'0103010D0'
p11243
ssVGlucosylceramide Synthase Inhibitors
p11244
(dp11245
g13
g14
sg15
V/categories/DBCAT004429
p11246
ssVAmphetamines
p11247
(dp11248
g13
g14
sg15
V/categories/DBCAT000431
p11249
ssVThroat Preparations
p11250
(dp11251
g13
g14
sg15
V/categories/DBCAT002106
p11252
ssVBlood Glucose Lowering Agents
p11253
(dp11254
g13
g14
sg15
V/categories/DBCAT002698
p11255
ssVAntithyroid agents
p11256
(dp11257
g13
g14
sg15
V/categories/DBCAT004964
p11258
ssS'Alogliptin'
p11259
(dp11260
g13
g25
sg15
S'0601023AK'
p11261
ssVMATE substrates
p11262
(dp11263
g13
g14
sg15
V/categories/DBCAT003956
p11264
ssS'Doxylamine Succinate/Pyridoxine HCl'
p11265
(dp11266
g13
g25
sg15
S'0406000AA'
p11267
ssS'Betaine Hydrochloride'
p11268
(dp11269
g13
g25
sg15
S'0109020B0'
p11270
ssVCentrally-mediated Muscle Relaxation
p11271
(dp11272
g13
g14
sg15
V/categories/DBCAT004231
p11273
ssS'Triptorelin Embonate'
p11274
(dp11275
g13
g25
sg15
S'0803042S0'
p11276
ssS'Procyclidine Hydrochloride'
p11277
(dp11278
g13
g25
sg15
S'0409020S0'
p11279
ssVLactones
p11280
(dp11281
g13
g14
sg15
V/categories/DBCAT000498
p11282
ssS'Duloxetine Hydrochloride'
p11283
(dp11284
g13
g25
sg15
S'0704020AA'
p11285
ssS'Belimumab'
p11286
(dp11287
g13
g25
sg15
S'1001030Z0'
p11288
ssVCytochrome P-450 CYP2E1 Inducers (moderate)
p11289
(dp11290
g13
g14
sg15
V/categories/DBCAT004495
p11291
ssS'Betahistine Hydrochloride'
p11292
(dp11293
g13
g25
sg15
S'0406000B0'
p11294
ssVNeuroprotective Agents
p11295
(dp11296
g13
g14
sg15
V/categories/DBCAT000653
p11297
ssVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p11298
(dp11299
g13
g14
sg15
V/categories/DBCAT002280
p11300
ssS'Heparin Calcium'
p11301
(dp11302
g13
g25
sg15
S'0208010N0'
p11303
ssVFolic Acid Antagonists
p11304
(dp11305
g13
g14
sg15
V/categories/DBCAT000523
p11306
ssVCarnitine Analog
p11307
(dp11308
g13
g14
sg15
V/categories/DBCAT003380
p11309
ssVCytochrome P-450 CYP3A7 Inducers (strong)
p11310
(dp11311
g13
g14
sg15
V/categories/DBCAT004500
p11312
ssS'Dacarbazine'
p11313
(dp11314
g13
g14
sg15
V/categories/DBCAT004985
p11315
ssS'Testosterone Undecanoate'
p11316
(dp11317
g13
g25
sg15
S'0604020T0'
p11318
ssS'Ephedrine HCl/Dextrometh Hydrob'
p11319
(dp11320
g13
g25
sg15
S'0309010Y0'
p11321
ssVCodeine
p11322
(dp11323
g13
g14
sg15
V/categories/DBCAT000929
p11324
ssVIsonipecotic Acids
p11325
(dp11326
g13
g14
sg15
V/categories/DBCAT000881
p11327
ssVAmidohydrolases
p11328
(dp11329
g13
g14
sg15
V/categories/DBCAT000093
p11330
ssVSympathomimetics Used as Decongestants
p11331
(dp11332
g13
g14
sg15
V/categories/DBCAT002352
p11333
ssS'Sofosbuvir/Velpatasvir/Voxilaprevir'
p11334
(dp11335
g13
g25
sg15
S'0503032L0'
p11336
ssS'Mefloquine Hydrochloride'
p11337
(dp11338
g13
g25
sg15
S'0504010L0'
p11339
ssVKidney Function
p11340
(dp11341
g13
g14
sg15
V/categories/DBCAT003715
p11342
ssVPhenothiazine Derivatives
p11343
(dp11344
g13
g14
sg15
V/categories/DBCAT002337
p11345
ssVLincomycins
p11346
(dp11347
g13
g14
sg15
V/categories/DBCAT003755
p11348
ssS'Cetuximab'
p11349
(dp11350
g13
g25
sg15
S'0801050AG'
p11351
ssS'Cyclopentolate Hydrochloride'
p11352
(dp11353
g13
g25
sg15
S'1105000E0'
p11354
ssVDrugs for Treatment of Tuberculosis
p11355
(dp11356
g13
g14
sg15
V/categories/DBCAT002243
p11357
ssS'Retapamulin'
p11358
(dp11359
g13
g25
sg15
S'1310011AA'
p11360
ssS'Levocarnitine'
p11361
(dp11362
g13
g25
sg15
S'0908010Z0'
p11363
ssVPeroxides
p11364
(dp11365
g13
g14
sg15
V/categories/DBCAT002029
p11366
ssS'Lixisenatide'
p11367
(dp11368
g13
g25
sg15
S'0601023AI'
p11369
ssS'Albendazole'
p11370
(dp11371
g13
g25
sg15
S'0505030A0'
p11372
ssVIsosorbide
p11373
(dp11374
g13
g14
sg15
V/categories/DBCAT001173
p11375
ssVIncreased Norepinephrine Activity
p11376
(dp11377
g13
g14
sg15
V/categories/DBCAT004067
p11378
ssS'Dornase Alfa'
p11379
(dp11380
g13
g25
sg15
S'0307000K0'
p11381
ssS'Magnesium Chloride'
p11382
(dp11383
g13
g25
sg15
S'0905013D0'
p11384
ssS'Letermovir'
p11385
(dp11386
g13
g25
sg15
S'0503010AR'
p11387
ssVMelanocortins
p11388
(dp11389
g13
g14
sg15
V/categories/DBCAT001332
p11390
ssS'Aloes'
p11391
(dp11392
g13
g25
sg15
S'0106020A0'
p11393
ssVAmidines
p11394
(dp11395
g13
g14
sg15
V/categories/DBCAT000343
p11396
ssVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p11397
(dp11398
g13
g14
sg15
V/categories/DBCAT002644
p11399
ssVIncreased Lymphocyte Cell Production
p11400
(dp11401
g13
g14
sg15
V/categories/DBCAT004235
p11402
ssS'Ertugliflozin'
p11403
(dp11404
g13
g25
sg15
S'0601023AX'
p11405
ssVChelating Agents
p11406
(dp11407
g13
g14
sg15
V/categories/DBCAT000624
p11408
ssVCentrally Acting Sympathomimetics
p11409
(dp11410
g13
g14
sg15
V/categories/DBCAT002179
p11411
ssVBenzodiazepinones
p11412
(dp11413
g13
g14
sg15
V/categories/DBCAT000449
p11414
ssS'Guaifenesin'
p11415
(dp11416
g13
g25
sg15
S'1203030K0'
p11417
ssVIncreased Cytokine Production
p11418
(dp11419
g13
g14
sg15
V/categories/DBCAT004409
p11420
ssVAnilides
p11421
(dp11422
g13
g14
sg15
V/categories/DBCAT000599
p11423
ssVArginine Vasopressin, antagonists & inhibitors
p11424
(dp11425
g13
g14
sg15
V/categories/DBCAT004694
p11426
ssS'Lamivudine'
p11427
(dp11428
g13
g25
sg15
S'0503010Q0'
p11429
ssVAntibody-Surface Protein Interactions
p11430
(dp11431
g13
g14
sg15
V/categories/DBCAT004395
p11432
ssVMonobactam Antibacterial
p11433
(dp11434
g13
g14
sg15
V/categories/DBCAT003333
p11435
ssV2-Pyridinylmethylsulfinylbenzimidazoles
p11436
(dp11437
g13
g14
sg15
V/categories/DBCAT000768
p11438
ssS'Salmeterol'
p11439
(dp11440
g13
g25
sg15
S'0301011U0'
p11441
ssVTrace Elements
p11442
(dp11443
g13
g14
sg15
V/categories/DBCAT001391
p11444
ssS'Ephedrine Hydrochloride'
p11445
(dp11446
g13
g25
sg15
S'0301012F0'
p11447
ssVPlatinum Compounds
p11448
(dp11449
g13
g14
sg15
V/categories/DBCAT003021
p11450
ssS'Lopinavir & Ritonavir'
p11451
(dp11452
g13
g25
sg15
S'0503010G0'
p11453
ssVOphthalmological and Otological Preparations
p11454
(dp11455
g13
g14
sg15
V/categories/DBCAT002379
p11456
ssVCD20-directed Antibody Interactions
p11457
(dp11458
g13
g14
sg15
V/categories/DBCAT004203
p11459
ssS'Levothyroxine Sodium & Potassium Iodide'
p11460
(dp11461
g13
g25
sg15
S'0602010T0'
p11462
ssVCation Exchange Resins
p11463
(dp11464
g13
g14
sg15
V/categories/DBCAT001337
p11465
ssVPovidone
p11466
(dp11467
g13
g14
sg15
V/categories/DBCAT001869
p11468
ssVChlorothiazide
p11469
(dp11470
g13
g25
sg15
S'0202010D0'
p11471
ssS'Triethanolamine'
p11472
(dp11473
g13
g25
sg15
S'1201030T0'
p11474
ssS'Macitentan'
p11475
(dp11476
g13
g25
sg15
S'0205010AA'
p11477
ssVRetinoids for Treatment of Acne
p11478
(dp11479
g13
g14
sg15
V/categories/DBCAT002490
p11480
ssVPituitary Hormones, Posterior
p11481
(dp11482
g13
g14
sg15
V/categories/DBCAT000112
p11483
ssVCentral Nervous System Depressants
p11484
(dp11485
g13
g14
sg15
V/categories/DBCAT000399
p11486
ssVAntigens, Viral
p11487
(dp11488
g13
g14
sg15
V/categories/DBCAT002888
p11489
ssVAntinematodal Agents
p11490
(dp11491
g13
g14
sg15
V/categories/DBCAT000986
p11492
ssVAgents reducing cytokine levels
p11493
(dp11494
g13
g14
sg15
V/categories/DBCAT004569
p11495
ssVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p11496
(dp11497
g13
g14
sg15
V/categories/DBCAT004509
p11498
ssVViral Envelope Proteins
p11499
(dp11500
g13
g14
sg15
V/categories/DBCAT002893
p11501
ssVOpium Alkaloids and Derivatives
p11502
(dp11503
g13
g14
sg15
V/categories/DBCAT002302
p11504
ssVAntineoplastic Agents, Hormonal
p11505
(dp11506
g13
g14
sg15
V/categories/DBCAT000063
p11507
ssS'Bictegravir/Emtricitabine/Tenofovir Alaf'
p11508
(dp11509
g13
g25
sg15
S'0503010AQ'
p11510
ssVNerve Tissue Proteins
p11511
(dp11512
g13
g14
sg15
V/categories/DBCAT000059
p11513
ssVSugar Acids
p11514
(dp11515
g13
g14
sg15
V/categories/DBCAT000971
p11516
ssVSucrose
p11517
(dp11518
g13
g14
sg15
V/categories/DBCAT000794
p11519
ssVLevodopa, antagonists & inhibitors
p11520
(dp11521
g13
g14
sg15
V/categories/DBCAT004774
p11522
ssS'Sulfinpyrazone'
p11523
(dp11524
g13
g25
sg15
S'1001040P0'
p11525
ssVBenzhydryl Compounds
p11526
(dp11527
g13
g14
sg15
V/categories/DBCAT000721
p11528
ssVGenitourinary Smooth Muscle Relaxants
p11529
(dp11530
g13
g14
sg15
V/categories/DBCAT003744
p11531
ssVImidazoline Derivatives
p11532
(dp11533
g13
g14
sg15
V/categories/DBCAT002448
p11534
ssS'Methyl Salicylate'
p11535
(dp11536
g13
g25
sg15
S'1003020N0'
p11537
ssVAntimycotics for Systemic Use
p11538
(dp11539
g13
g14
sg15
V/categories/DBCAT002194
p11540
ssS'Cycloserine'
p11541
(dp11542
g13
g25
sg15
S'0501090E0'
p11543
ssS'Ropivacaine Hydrochloride'
p11544
(dp11545
g13
g25
sg15
S'1502010R0'
p11546
ssVVancomycin
p11547
(dp11548
g13
g14
sg15
V/categories/DBCAT004741
p11549
ssS'Sarilumab'
p11550
(dp11551
g13
g25
sg15
S'1001030AD'
p11552
ssVRadiopharmaceuticals
p11553
(dp11554
g13
g14
sg15
V/categories/DBCAT001840
p11555
ssVSterols
p11556
(dp11557
g13
g14
sg15
V/categories/DBCAT000312
p11558
ssVSomatomedins
p11559
(dp11560
g13
g14
sg15
V/categories/DBCAT001330
p11561
ssS'Eribulin'
p11562
(dp11563
g13
g25
sg15
S'0801050BB'
p11564
ssVPhenylpropionates
p11565
(dp11566
g13
g14
sg15
V/categories/DBCAT000976
p11567
ssVCytochrome P-450 CYP3A5 Inducers (moderate)
p11568
(dp11569
g13
g14
sg15
V/categories/DBCAT003900
p11570
ssVMucocutaneous Epithelial Cell Growth Factor
p11571
(dp11572
g13
g14
sg15
V/categories/DBCAT003254
p11573
ssVGlycoproteins
p11574
(dp11575
g13
g14
sg15
V/categories/DBCAT000083
p11576
ssVFluorine Compounds
p11577
(dp11578
g13
g14
sg15
V/categories/DBCAT001985
p11579
ssVEstrenes
p11580
(dp11581
g13
g14
sg15
V/categories/DBCAT001042
p11582
ssVHydrazinophthalazine Derivatives
p11583
(dp11584
g13
g14
sg15
V/categories/DBCAT002524
p11585
ssVNiacin
p11586
(dp11587
g13
g14
sg15
V/categories/DBCAT004745
p11588
ssVLeucovorin
p11589
(dp11590
g13
g14
sg15
V/categories/DBCAT004543
p11591
ssS'Miconazole Nitrate'
p11592
(dp11593
g13
g25
sg15
S'0702020P0'
p11594
ssS'Fentanyl'
p11595
(dp11596
g13
g25
sg15
S'0407020A0'
p11597
ssVAntidiarrheals
p11598
(dp11599
g13
g14
sg15
V/categories/DBCAT001158
p11600
ssS'Vincristine Sulfate'
p11601
(dp11602
g13
g25
sg15
S'0801040M0'
p11603
ssS'Gentamicin Sulphate'
p11604
(dp11605
g13
g25
sg15
S'1201010R0'
p11606
ssVGABA-B Receptor Agonists
p11607
(dp11608
g13
g14
sg15
V/categories/DBCAT000430
p11609
ssVDextrans
p11610
(dp11611
g13
g14
sg15
V/categories/DBCAT001181
p11612
ssVErgotamine Derivative
p11613
(dp11614
g13
g14
sg15
V/categories/DBCAT003327
p11615
ssVAnemia, Iron-Deficiency
p11616
(dp11617
g13
g14
sg15
V/categories/DBCAT001390
p11618
ssS'Pregabalin'
p11619
(dp11620
g13
g25
sg15
S'0408010AE'
p11621
ssVPiperazines
p11622
(dp11623
g13
g14
sg15
V/categories/DBCAT000513
p11624
ssS'Lomitapide'
p11625
(dp11626
g13
g25
sg15
S'0212000AF'
p11627
ssVAntipruritics
p11628
(dp11629
g13
g14
sg15
V/categories/DBCAT000666
p11630
ssS'Pegaptanib Sodium'
p11631
(dp11632
g13
g25
sg15
S'1108020AC'
p11633
ssVProcaine
p11634
(dp11635
g13
g14
sg15
V/categories/DBCAT001979
p11636
ssVEndopeptidases
p11637
(dp11638
g13
g14
sg15
V/categories/DBCAT000068
p11639
ssVMembranes, Artificial
p11640
(dp11641
g13
g14
sg15
V/categories/DBCAT000983
p11642
ssVCitalopram
p11643
(dp11644
g13
g14
sg15
V/categories/DBCAT004729
p11645
ssS'Panitumumab'
p11646
(dp11647
g13
g25
sg15
S'0801050AR'
p11648
ssS'Dobutamine Hydrochloride'
p11649
(dp11650
g13
g25
sg15
S'0207010D0'
p11651
ssS'Xylometazoline Hydrochloride'
p11652
(dp11653
g13
g25
sg15
S'1202020P0'
p11654
ssS'Ondansetron Hydrochloride'
p11655
(dp11656
g13
g25
sg15
S'0406000S0'
p11657
ssVOATP1B3 inducers
p11658
(dp11659
g13
g14
sg15
V/categories/DBCAT003934
p11660
ssVInhibit Ovum Fertilization
p11661
(dp11662
g13
g14
sg15
V/categories/DBCAT004113
p11663
ssS'Hydroxocobalamin'
p11664
(dp11665
g13
g25
sg15
S'0901020N0'
p11666
ssS'Salbutamol'
p11667
(dp11668
g13
g25
sg15
S'0301040R0'
p11669
ssVSulfur Compounds
p11670
(dp11671
g13
g14
sg15
V/categories/DBCAT000248
p11672
ssVHIV Protease Inhibitors
p11673
(dp11674
g13
g14
sg15
V/categories/DBCAT000552
p11675
ssVOATP1B1/SLCO1B1 Substrates
p11676
(dp11677
g13
g14
sg15
V/categories/DBCAT002658
p11678
ssVAppetite Suppression
p11679
(dp11680
g13
g14
sg15
V/categories/DBCAT004277
p11681
ssVWakefulness-Promoting Agents
p11682
(dp11683
g13
g14
sg15
V/categories/DBCAT001105
p11684
ssS'Doripenem'
p11685
(dp11686
g13
g25
sg15
S'0501022C0'
p11687
ssVMiscellaneous Autonomic Drugs
p11688
(dp11689
g13
g14
sg15
V/categories/DBCAT003631
p11690
ssVBenzamidines
p11691
(dp11692
g13
g14
sg15
V/categories/DBCAT001100
p11693
ssS'Aztreonam'
p11694
(dp11695
g13
g25
sg15
S'0501023A0'
p11696
ssVThyroxine-binding globulin inhibitors
p11697
(dp11698
g13
g14
sg15
V/categories/DBCAT004603
p11699
ssVSulfonylureas
p11700
(dp11701
g13
g14
sg15
V/categories/DBCAT002233
p11702
ssVIntermediate-Acting Sulfonamides
p11703
(dp11704
g13
g14
sg15
V/categories/DBCAT002336
p11705
ssVSodium-Glucose Transport Proteins, antagonists & inhibitors
p11706
(dp11707
g13
g14
sg15
V/categories/DBCAT001788
p11708
ssVPyrimidine Synthesis Inhibitor
p11709
(dp11710
g13
g14
sg15
V/categories/DBCAT003496
p11711
ssS'Benzoyl Peroxide & Clindamycin Phosphate'
p11712
(dp11713
g13
g25
sg15
S'1306010Y0'
p11714
ssVPyrimidine Nucleosides
p11715
(dp11716
g13
g14
sg15
V/categories/DBCAT000610
p11717
ssS'Anakinra'
p11718
(dp11719
g13
g25
sg15
S'1001030R0'
p11720
ssS'Carbinoxamine Maleate'
p11721
(dp11722
g13
g25
sg15
S'030902050'
p11723
ssVCalcium Channel Blockers (Nondihydropyridine)
p11724
(dp11725
g13
g14
sg15
V/categories/DBCAT003976
p11726
ssS'Cinchocaine Hydrochloride'
p11727
(dp11728
g13
g25
sg15
S'0107010G0'
p11729
ssVArteriolar Vasodilator
p11730
(dp11731
g13
g14
sg15
V/categories/DBCAT003332
p11732
ssS'Fusidic Acid'
p11733
(dp11734
g13
g25
sg15
S'1310012F0'
p11735
ssVCoformycin
p11736
(dp11737
g13
g14
sg15
V/categories/DBCAT000965
p11738
ssVProtein Kinase Inhibitors
p11739
(dp11740
g13
g14
sg15
V/categories/DBCAT000737
p11741
ssVCyanides
p11742
(dp11743
g13
g14
sg15
V/categories/DBCAT000751
p11744
ssS'Pyrithione Zinc'
p11745
(dp11746
g13
g25
sg15
S'1309000K0'
p11747
ssVOther Diagnostics
p11748
(dp11749
g13
g14
sg15
V/categories/DBCAT003697
p11750
ssS'Iron Sucrose'
p11751
(dp11752
g13
g25
sg15
S'0901012I0'
p11753
ssVSteroids, Fluorinated
p11754
(dp11755
g13
g14
sg15
V/categories/DBCAT000749
p11756
ssVPhenothiazines
p11757
(dp11758
g13
g14
sg15
V/categories/DBCAT000801
p11759
ssS'Elosulfase Alfa'
p11760
(dp11761
g13
g25
sg15
S'0908010AP'
p11762
ssVRespiratory Agents, Miscellaneous
p11763
(dp11764
g13
g14
sg15
V/categories/DBCAT003611
p11765
ssVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p11766
(dp11767
g13
g14
sg15
V/categories/DBCAT003772
p11768
ssS'Bismuth Subgallate'
p11769
(dp11770
g13
g25
sg15
S'0107010E0'
p11771
ssVIncreased Diuresis at Loop of Henle
p11772
(dp11773
g13
g14
sg15
V/categories/DBCAT004077
p11774
ssS'Methotrexate'
p11775
(dp11776
g13
g14
sg15
V/categories/DBCAT004742
p11777
ssVInhibition Gastric Acid Secretion
p11778
(dp11779
g13
g14
sg15
V/categories/DBCAT004261
p11780
ssS'Fluorescein Sodium'
p11781
(dp11782
g13
g25
sg15
S'1108020K0'
p11783
ssVNitrogen Binding Agent
p11784
(dp11785
g13
g14
sg15
V/categories/DBCAT003445
p11786
ssVAdenosine, antagonists & inhibitors
p11787
(dp11788
g13
g14
sg15
V/categories/DBCAT004746
p11789
ssS'Aripiprazole'
p11790
(dp11791
g13
g25
sg15
S'0402010AD'
p11792
ssS'Diphenhydramine HCl/Pholcodine'
p11793
(dp11794
g13
g25
sg15
S'0309020AB'
p11795
ssVPlant Extracts
p11796
(dp11797
g13
g14
sg15
V/categories/DBCAT001604
p11798
ssS'Nelarabine'
p11799
(dp11800
g13
g25
sg15
S'0801030AB'
p11801
ssVDPP-IV Inhibitors
p11802
(dp11803
g13
g14
sg15
V/categories/DBCAT002653
p11804
ssS'Bromfenac'
p11805
(dp11806
g13
g25
sg15
S'1108020AG'
p11807
ssVOphthalmics
p11808
(dp11809
g13
g14
sg15
V/categories/DBCAT002732
p11810
ssS'Meprobamate'
p11811
(dp11812
g13
g25
sg15
S'0401020R0'
p11813
ssVMedroxyprogesterone
p11814
(dp11815
g13
g14
sg15
V/categories/DBCAT000993
p11816
ssVRadiation-Sensitizing Agents
p11817
(dp11818
g13
g14
sg15
V/categories/DBCAT000334
p11819
ssS'Fenofibrate/Simvastatin'
p11820
(dp11821
g13
g25
sg15
S'0212000AJ'
p11822
ssVAnti-IgE
p11823
(dp11824
g13
g14
sg15
V/categories/DBCAT003256
p11825
ssS'Sucroferric Oxyhydroxide'
p11826
(dp11827
g13
g25
sg15
S'0905022W0'
p11828
ssVUrease Inhibitor
p11829
(dp11830
g13
g14
sg15
V/categories/DBCAT003371
p11831
ssS'Becaplermin'
p11832
(dp11833
g13
g25
sg15
S'1311070K0'
p11834
ssVDrugs Used in Hereditary Angioedema
p11835
(dp11836
g13
g14
sg15
V/categories/DBCAT002563
p11837
ssS'Spiramycin'
p11838
(dp11839
g13
g25
sg15
S'0501050S0'
p11840
ssVCytochrome P450 1A2 Inducers
p11841
(dp11842
g13
g14
sg15
V/categories/DBCAT004281
p11843
ssVCytomegalovirus DNA Terminase Complex Inhibitor
p11844
(dp11845
g13
g14
sg15
V/categories/DBCAT003991
p11846
ssVBelladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds
p11847
(dp11848
g13
g14
sg15
V/categories/DBCAT002580
p11849
ssVB Lymphocyte Stimulator-specific Inhibitor
p11850
(dp11851
g13
g14
sg15
V/categories/DBCAT003495
p11852
ssVPurinergic P2Y Receptor Antagonists
p11853
(dp11854
g13
g14
sg15
V/categories/DBCAT000532
p11855
ssVImidazoles
p11856
(dp11857
g13
g14
sg15
V/categories/DBCAT000263
p11858
ssVUrate Oxidase, antagonists & inhibitors
p11859
(dp11860
g13
g14
sg15
V/categories/DBCAT004691
p11861
ssS'Bumetanide/Potassium'
p11862
(dp11863
g13
g25
sg15
S'0202080C0'
p11864
ssVAntidote for Acetaminophen Overdose
p11865
(dp11866
g13
g14
sg15
V/categories/DBCAT003463
p11867
ssVHormone Antagonists and Related Agents
p11868
(dp11869
g13
g14
sg15
V/categories/DBCAT002137
p11870
ssVCarbonates
p11871
(dp11872
g13
g14
sg15
V/categories/DBCAT001343
p11873
ssS'Alprostadil'
p11874
(dp11875
g13
g14
sg15
V/categories/DBCAT001248
p11876
ssVSerotonin 5-HT3 Receptor Antagonists
p11877
(dp11878
g13
g14
sg15
V/categories/DBCAT002341
p11879
ssVKeratoplastic Agents
p11880
(dp11881
g13
g14
sg15
V/categories/DBCAT003796
p11882
ssVPlatelet-Derived Growth Factor
p11883
(dp11884
g13
g14
sg15
V/categories/DBCAT000209
p11885
ssS'Cortisone Acetate'
p11886
(dp11887
g13
g25
sg15
S'0603020F0'
p11888
ssVPotassium Binder
p11889
(dp11890
g13
g14
sg15
V/categories/DBCAT003568
p11891
ssVCD22-directed Antibody Interactions
p11892
(dp11893
g13
g14
sg15
V/categories/DBCAT004406
p11894
ssVOxytocin, antagonists & inhibitors
p11895
(dp11896
g13
g14
sg15
V/categories/DBCAT004703
p11897
ssVRNA Synthetase Inhibitors
p11898
(dp11899
g13
g14
sg15
V/categories/DBCAT004255
p11900
ssVNerve Depressants
p11901
(dp11902
g13
g14
sg15
V/categories/DBCAT002481
p11903
ssVCamptothecin
p11904
(dp11905
g13
g14
sg15
V/categories/DBCAT001239
p11906
ssVExcipients
p11907
(dp11908
g13
g14
sg15
V/categories/DBCAT001545
p11909
ssS'Clonidine Hydrochloride'
p11910
(dp11911
g13
g25
sg15
S'0205020E0'
p11912
ssS'Ruxolitinib'
p11913
(dp11914
g13
g25
sg15
S'0801050BI'
p11915
ssS'Bethanechol Chloride'
p11916
(dp11917
g13
g25
sg15
S'0704010C0'
p11918
ssVMetalloendopeptidases
p11919
(dp11920
g13
g14
sg15
V/categories/DBCAT000140
p11921
ssS'Rimexolone'
p11922
(dp11923
g13
g25
sg15
S'1104010V0'
p11924
ssVPlacental Hormones
p11925
(dp11926
g13
g14
sg15
V/categories/DBCAT001932
p11927
ssVMethanolquinolines
p11928
(dp11929
g13
g14
sg15
V/categories/DBCAT002335
p11930
ssS'Cabergoline'
p11931
(dp11932
g13
g25
sg15
S'0607010C0'
p11933
ssS'Heparin Sodium'
p11934
(dp11935
g13
g25
sg15
S'0208010K0'
p11936
ssVDietary Supplements
p11937
(dp11938
g13
g14
sg15
V/categories/DBCAT002740
p11939
ssS'Mifepristone'
p11940
(dp11941
g13
g25
sg15
S'0701020K0'
p11942
ssVSerotonin Receptor Agonists
p11943
(dp11944
g13
g14
sg15
V/categories/DBCAT000547
p11945
ssV5-alpha Reductase Inhibitors
p11946
(dp11947
g13
g14
sg15
V/categories/DBCAT001276
p11948
ssVAlcohols
p11949
(dp11950
g13
g14
sg15
V/categories/DBCAT000272
p11951
ssS'Corticotropin'
p11952
(dp11953
g13
g25
sg15
S'0605010J0'
p11954
ssS'Azelastine Hydrochloride'
p11955
(dp11956
g13
g25
sg15
S'1202010A0'
p11957
ssS'Febuxostat'
p11958
(dp11959
g13
g25
sg15
S'1001040V0'
p11960
ssS'Glipizide'
p11961
(dp11962
g13
g25
sg15
S'0601021P0'
p11963
ssVOAT1/SLC22A6 inhibitors
p11964
(dp11965
g13
g14
sg15
V/categories/DBCAT004041
p11966
ssS'Anidulafungin'
p11967
(dp11968
g13
g25
sg15
S'0502040A0'
p11969
ssVAerosols
p11970
(dp11971
g13
g14
sg15
V/categories/DBCAT001102
p11972
ssVPhotoactivated Radical Generator
p11973
(dp11974
g13
g14
sg15
V/categories/DBCAT003372
p11975
ssS'Canagliflozin'
p11976
(dp11977
g13
g25
sg15
S'0601023AM'
p11978
ssS'Doxepin'
p11979
(dp11980
g13
g25
sg15
S'0403010L0'
p11981
ssVOxazines
p11982
(dp11983
g13
g14
sg15
V/categories/DBCAT000803
p11984
ssVGlycoconjugates
p11985
(dp11986
g13
g14
sg15
V/categories/DBCAT000084
p11987
ssVCytochrome P-450 CYP2D6 Inducers
p11988
(dp11989
g13
g14
sg15
V/categories/DBCAT002626
p11990
ssVCopper Absorption Inhibitor
p11991
(dp11992
g13
g14
sg15
V/categories/DBCAT003558
p11993
ssVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p11994
(dp11995
g13
g14
sg15
V/categories/DBCAT004528
p11996
ssS'Alclometasone Dipropionate'
p11997
(dp11998
g13
g25
sg15
S'1304000B0'
p11999
ssS'Capreomycin'
p12000
(dp12001
g13
g25
sg15
S'0501090C0'
p12002
ssS'Aminosalicylic Acid'
p12003
(dp12004
g13
g25
sg15
S'0501090A0'
p12005
ssVHydrocarbons, Halogenated
p12006
(dp12007
g13
g14
sg15
V/categories/DBCAT000682
p12008
ssVbeta-Lactams
p12009
(dp12010
g13
g14
sg15
V/categories/DBCAT000569
p12011
ssVOAT3/SLC22A8 Substrates with Narrow Therapeutic Index
p12012
(dp12013
g13
g14
sg15
V/categories/DBCAT003983
p12014
ssS'Vedolizumab'
p12015
(dp12016
g13
g25
sg15
S'0105030A0'
p12017
ssS'Bromazepam'
p12018
(dp12019
g13
g25
sg15
S'0401020G0'
p12020
ssVCoagulants
p12021
(dp12022
g13
g14
sg15
V/categories/DBCAT000113
p12023
ssVFats
p12024
(dp12025
g13
g14
sg15
V/categories/DBCAT000297
p12026
ssVNitroimidazole Derivatives
p12027
(dp12028
g13
g14
sg15
V/categories/DBCAT002484
p12029
ssVSynthetic Anticholinergics, Quaternary Ammonium Compounds
p12030
(dp12031
g13
g14
sg15
V/categories/DBCAT002229
p12032
ssVCentral Nervous System Depression
p12033
(dp12034
g13
g14
sg15
V/categories/DBCAT004210
p12035
ssVSulfur Containing Products
p12036
(dp12037
g13
g14
sg15
V/categories/DBCAT002472
p12038
ssVPyrophosphate Analog DNA Polymerase Inhibitor
p12039
(dp12040
g13
g14
sg15
V/categories/DBCAT003368
p12041
ssS'Oxytocin'
p12042
(dp12043
g13
g14
sg15
V/categories/DBCAT004295
p12044
ssS'Tioconazole'
p12045
(dp12046
g13
g25
sg15
S'1310020T0'
p12047
ssVUGT2B7 substrates with narrow therapeutic index
p12048
(dp12049
g13
g14
sg15
V/categories/DBCAT004613
p12050
ssS'Dolutegravir'
p12051
(dp12052
g13
g25
sg15
S'0503010AH'
p12053
ssVBulk-Forming Laxatives
p12054
(dp12055
g13
g14
sg15
V/categories/DBCAT002593
p12056
ssS'Alfacalcidol'
p12057
(dp12058
g13
g25
sg15
S'0906040B0'
p12059
ssS'Fosinopril Sodium'
p12060
(dp12061
g13
g25
sg15
S'0205051J0'
p12062
ssS'Loperamide Hydrochloride & Simeticone'
p12063
(dp12064
g13
g25
sg15
S'0104020P0'
p12065
ssS'Asenapine'
p12066
(dp12067
g13
g25
sg15
S'0402030R0'
p12068
ssVAzabicyclo Compounds
p12069
(dp12070
g13
g14
sg15
V/categories/DBCAT000571
p12071
ssS'Lactic Acid'
p12072
(dp12073
g13
g14
sg15
V/categories/DBCAT004794
p12074
ssVPreservatives, Pharmaceutical
p12075
(dp12076
g13
g14
sg15
V/categories/DBCAT002031
p12077
ssS'Ethionamide'
p12078
(dp12079
g13
g25
sg15
S'0501090I0'
p12080
ssVIodine Compounds
p12081
(dp12082
g13
g14
sg15
V/categories/DBCAT001846
p12083
ssVAzetidines
p12084
(dp12085
g13
g14
sg15
V/categories/DBCAT001211
p12086
ssVSulfur-Containing Imidazole Derivatives
p12087
(dp12088
g13
g14
sg15
V/categories/DBCAT002354
p12089
ssS'Cytarabine'
p12090
(dp12091
g13
g25
sg15
S'0801030D0'
p12092
ssVCytochrome P450 2D6 Inhibitors
p12093
(dp12094
g13
g14
sg15
V/categories/DBCAT004062
p12095
ssVUGT1A4 Inhibitors
p12096
(dp12097
g13
g14
sg15
V/categories/DBCAT004455
p12098
ssVHypnotics and Sedatives
p12099
(dp12100
g13
g14
sg15
V/categories/DBCAT000452
p12101
ssVQuinones
p12102
(dp12103
g13
g14
sg15
V/categories/DBCAT000386
p12104
ssVSympathomimetics, Labour Repressants
p12105
(dp12106
g13
g14
sg15
V/categories/DBCAT002477
p12107
ssS'Zinc Paste & Ichthammol'
p12108
(dp12109
g13
g25
sg15
S'1305010AE'
p12110
ssS'Sodium Oxybate'
p12111
(dp12112
g13
g25
sg15
S'0401010AC'
p12113
ssS'Perindopril Erbumine'
p12114
(dp12115
g13
g25
sg15
S'0205051M0'
p12116
ssVAmide Local Anesthetic
p12117
(dp12118
g13
g14
sg15
V/categories/DBCAT003317
p12119
ssVHydroxybenzoate Ethers
p12120
(dp12121
g13
g14
sg15
V/categories/DBCAT001311
p12122
ssS'Rifabutin'
p12123
(dp12124
g13
g25
sg15
S'0501090Q0'
p12125
ssS'Quinine Hydrochloride'
p12126
(dp12127
g13
g25
sg15
S'0504010X0'
p12128
ssVSelective Beta 2-adrenergic Agonists
p12129
(dp12130
g13
g14
sg15
V/categories/DBCAT003723
p12131
ssS'Clobetasol Propionate'
p12132
(dp12133
g13
g25
sg15
S'1304000G0'
p12134
ssVErgotamines
p12135
(dp12136
g13
g14
sg15
V/categories/DBCAT000741
p12137
ssVHCV Replication Complex Inhibitors
p12138
(dp12139
g13
g14
sg15
V/categories/DBCAT003783
p12140
ssVPhenethylamines
p12141
(dp12142
g13
g14
sg15
V/categories/DBCAT000432
p12143
ssVErythropoietin, genetics
p12144
(dp12145
g13
g14
sg15
V/categories/DBCAT004684
p12146
ssVCytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index
p12147
(dp12148
g13
g14
sg15
V/categories/DBCAT004035
p12149
ssVDopamine Uptake Inhibitors
p12150
(dp12151
g13
g14
sg15
V/categories/DBCAT000440
p12152
ssVAcidifiers
p12153
(dp12154
g13
g14
sg15
V/categories/DBCAT002512
p12155
sssS'node_dict_factory'
p12156
g2
(S'DictType'
p12157
tp12158
Rp12159
sS'edge_attr_dict_factory'
p12160
g12159
sS'edge'
p12161
(dp12162
g11
(dp12163
g11046
(dp12164
sg2283
(dp12165
sg12042
(dp12166
ssg17
(dp12167
g8484
(dp12168
sg1791
(dp12169
sg3105
(dp12170
sg5556
(dp12171
sg8022
(dp12172
sg8439
(dp12173
sg7680
(dp12174
sg3249
(dp12175
sg10179
(dp12176
sg8340
(dp12177
sg11664
(dp12178
sg1581
(dp12179
sg11361
(dp12180
sg2826
(dp12181
sg10272
(dp12182
sg9000
(dp12183
sg1917
(dp12184
sg8658
(dp12185
sS'Folic Acid'
p12186
(dp12187
sg12057
(dp12188
ssg20
(dp12189
g1038
(dp12190
ssg23
(dp12191
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p12192
(dp12193
sVCytochrome P-450 CYP2D6 Substrates
p12194
(dp12195
sVBronchodilator Agents
p12196
(dp12197
sVNasal Decongestants for Systemic Use
p12198
(dp12199
sVSympathomimetics
p12200
(dp12201
sVAmphetamines
p12202
(dp12203
sVAlpha-and Beta-adrenergic Agonists
p12204
(dp12205
sVHyperglycemia-Associated Agents
p12206
(dp12207
sVVasoconstrictor Agents
p12208
(dp12209
sVAmines
p12210
(dp12211
sVPeripheral Nervous System Agents
p12212
(dp12213
sVRespiratory System Agents
p12214
(dp12215
sVEthylamines
p12216
(dp12217
sVNasal Preparations
p12218
(dp12219
sVAdrenergic beta-Agonists
p12220
(dp12221
sVCardiovascular Agents
p12222
(dp12223
sVSympathomimetic (Adrenergic) Agents
p12224
(dp12225
sVNasal Decongestants
p12226
(dp12227
sVAdrenergic Agonists
p12228
(dp12229
sVAgents that produce hypertension
p12230
(dp12231
sVAnti-Asthmatic Agents
p12232
(dp12233
sVPropanolamines
p12234
(dp12235
sVAutonomic Agents
p12236
(dp12237
sVAdrenergic alpha-2 Receptor Agonists
p12238
(dp12239
sVAmino Alcohols
p12240
(dp12241
sVAdrenergic alpha-Agonists
p12242
(dp12243
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p12244
(dp12245
sVPropanols
p12246
(dp12247
sVAgents producing tachycardia
p12248
(dp12249
sVAdrenergic alpha-1 Receptor Agonists
p12250
(dp12251
sVPhenethylamines
p12252
(dp12253
sVAlcohols
p12254
(dp12255
sVNorepinephrine Releasing Agent
p12256
(dp12257
ssg27
(dp12258
g8019
(dp12259
sg11820
(dp12260
sg7053
(dp12261
sg1941
(dp12262
sg11508
(dp12263
sg4425
(dp12264
sg11961
(dp12265
sg444
(dp12266
sg8763
(dp12267
sg7428
(dp12268
sg5433
(dp12269
sg318
(dp12270
sg8163
(dp12271
sg5235
(dp12272
sg4803
(dp12273
sS'Estradiol'
p12274
(dp12275
sg9366
(dp12276
sg1239
(dp12277
sg5250
(dp12278
sg10797
(dp12279
sg8295
(dp12280
sg4596
(dp12281
sg3858
(dp12282
sg8622
(dp12283
sg3516
(dp12284
sg4077
(dp12285
sg1473
(dp12286
sg5487
(dp12287
sg6699
(dp12288
sg10977
(dp12289
sg10701
(dp12290
sg5877
(dp12291
sg702
(dp12292
sg11460
(dp12293
sg3543
(dp12294
sg10740
(dp12295
sg9009
(dp12296
sg9960
(dp12297
sg12051
(dp12298
sg2109
(dp12299
sg4299
(dp12300
sg2538
(dp12301
sg8097
(dp12302
sg11733
(dp12303
sg5520
(dp12304
sg10728
(dp12305
sg4458
(dp12306
sg10512
(dp12307
sg723
(dp12308
sg4716
(dp12309
sg9414
(dp12310
sg9987
(dp12311
sg4926
(dp12312
sg3036
(dp12313
sg7734
(dp12314
sg1527
(dp12315
sg3627
(dp12316
sg6654
(dp12317
sg6312
(dp12318
sg3651
(dp12319
sg3408
(dp12320
sg8028
(dp12321
sg537
(dp12322
sg5739
(dp12323
sg963
(dp12324
sg6999
(dp12325
sg6033
(dp12326
sg4680
(dp12327
sg6261
(dp12328
sg10350
(dp12329
sg5757
(dp12330
sg2943
(dp12331
sg5256
(dp12332
sg2715
(dp12333
sg4062
(dp12334
sg336
(dp12335
sg6537
(dp12336
sg3261
(dp12337
sg4953
(dp12338
sg4008
(dp12339
sg1008
(dp12340
sg8013
(dp12341
sg5796
(dp12342
sg11385
(dp12343
ssg30
(dp12344
VAgents that produce neuromuscular block (indirect)
p12345
(dp12346
sVCarbohydrates
p12347
(dp12348
sVCytochrome P-450 CYP3A4 Inhibitors
p12349
(dp12350
sVAnti-Acne Preparations
p12351
(dp12352
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p12353
(dp12354
sVEnzyme Inhibitors
p12355
(dp12356
sVCytochrome P-450 Enzyme Inhibitors
p12357
(dp12358
sVAnti-Infective Agents
p12359
(dp12360
sVAntiinfectives for Systemic Use
p12361
(dp12362
sVLincosamides
p12363
(dp12364
sVGynecological Antiinfectives and Antiseptics
p12365
(dp12366
sVLincomycin
p12367
(dp12368
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p12369
(dp12370
sVMacrolides, Lincosamides and Streptogramins
p12371
(dp12372
sVDecreased Sebaceous Gland Activity
p12373
(dp12374
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p12375
(dp12376
sVCytochrome P-450 CYP3A Substrates
p12377
(dp12378
sVProtein Synthesis Inhibitors
p12379
(dp12380
sVGlycosides
p12381
(dp12382
sVPyrrolidines
p12383
(dp12384
sVAnti-Bacterial Agents
p12385
(dp12386
sVDermatologicals
p12387
(dp12388
sVLincomycins
p12389
(dp12390
sVAntibacterials for Systemic Use
p12391
(dp12392
sVCytochrome P-450 CYP3A4 Substrates
p12393
(dp12394
sVNarrow Therapeutic Index Drugs
p12395
(dp12396
sVAnti-Acne Preparations for Topical Use
p12397
(dp12398
sVGenito Urinary System and Sex Hormones
p12399
(dp12400
sVCytochrome P-450 CYP3A Inhibitors
p12401
(dp12402
sVNeurotoxic agents
p12403
(dp12404
sVLincosamide Antibacterial
p12405
(dp12406
sVAntiinfectives for Treatment of Acne
p12407
(dp12408
ssg33
(dp12409
g5157
(dp12410
sg12072
(dp12411
ssg36
(dp12412
VPsychoanaleptics
p12413
(dp12414
sVCytochrome P-450 CYP2D6 Substrates
p12415
(dp12416
sVCytochrome P-450 CYP3A Substrates
p12417
(dp12418
sVNeurotransmitter Agents
p12419
(dp12420
sS'Caffeine'
p12421
(dp12422
sVCentral Nervous System Agents
p12423
(dp12424
sVPsychostimulants, Agents Used for Adhd and Nootropics
p12425
(dp12426
sVTests for Gastric Secretion
p12427
(dp12428
sVEnzyme Inhibitors
p12429
(dp12430
sVCentral Nervous System Stimulation
p12431
(dp12432
sVCytochrome P-450 Enzyme Inhibitors
p12433
(dp12434
sVDiagnostic Agents
p12435
(dp12436
sVAnorexigenic Agents & Respiratory and CNS Stimulants
p12437
(dp12438
sVPurinergic Agents
p12439
(dp12440
sVCytochrome P-450 CYP2C8 Substrates
p12441
(dp12442
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p12443
(dp12444
sVApnea
p12445
(dp12446
sVPurinergic Antagonists
p12447
(dp12448
sVPurinergic P1 Receptor Antagonists
p12449
(dp12450
sVXanthine derivatives
p12451
(dp12452
sVDrugs for Obstructive Airway Diseases
p12453
(dp12454
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p12455
(dp12456
sVCentral Nervous System Stimulants
p12457
(dp12458
sVCytochrome P-450 CYP2C9 Substrates
p12459
(dp12460
sVCaffeine and Caffeine Containing Products
p12461
(dp12462
sVCytochrome P-450 CYP1A2 Inhibitors
p12463
(dp12464
sVPhosphodiesterase Inhibitors
p12465
(dp12466
sVP-glycoprotein/ABCB1 Substrates
p12467
(dp12468
sVCytochrome P-450 CYP1A2 Substrates
p12469
(dp12470
sVTricarboxylic Acids
p12471
(dp12472
sVHeterocyclic Compounds, Fused-Ring
p12473
(dp12474
sVCytochrome P-450 CYP3A4 Substrates
p12475
(dp12476
sg7065
(dp12477
sVPurinones
p12478
(dp12479
sVPurines
p12480
(dp12481
sVRespiratory and CNS Stimulants
p12482
(dp12483
sVCytochrome P-450 CYP3A5 Substrates
p12484
(dp12485
sVAcids, Acyclic
p12486
(dp12487
sg7197
(dp12488
sVAlkaloids
p12489
(dp12490
sVP-glycoprotein/ABCB1 Inhibitors
p12491
(dp12492
sVNervous System
p12493
(dp12494
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p12495
(dp12496
sVCytochrome P-450 CYP3A7 Substrates
p12497
(dp12498
ssg39
(dp12499
g438
(dp12500
sg3633
(dp12501
sg2346
(dp12502
sg2196
(dp12503
sg10377
(dp12504
sg11079
(dp12505
sg3846
(dp12506
sg4437
(dp12507
sg1371
(dp12508
sg5817
(dp12509
sg5433
(dp12510
sg2373
(dp12511
sg2946
(dp12512
sg5832
(dp12513
sg9432
(dp12514
sg4653
(dp12515
sg6045
(dp12516
sg5766
(dp12517
sg2034
(dp12518
sg8625
(dp12519
sg8241
(dp12520
sg7458
(dp12521
sg9198
(dp12522
sg10899
(dp12523
sg11385
(dp12524
sg6699
(dp12525
sg288
(dp12526
sg5877
(dp12527
sg4680
(dp12528
sg5289
(dp12529
sg9960
(dp12530
sg9591
(dp12531
sg840
(dp12532
sg12274
(dp12533
sS'Dexamethasone'
p12534
(dp12535
sg714
(dp12536
sg2652
(dp12537
sg2460
(dp12538
sg2391
(dp12539
sg10752
(dp12540
sg2832
(dp12541
sg10179
(dp12542
sg7152
(dp12543
sg3861
(dp12544
sg9180
(dp12545
sg2493
(dp12546
sg573
(dp12547
sg11166
(dp12548
sg11733
(dp12549
sg2274
(dp12550
sg1098
(dp12551
sg3072
(dp12552
sg10794
(dp12553
sg5646
(dp12554
sg9084
(dp12555
sg9663
(dp12556
sg10512
(dp12557
sg7608
(dp12558
sg621
(dp12559
ssg42
(dp12560
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p12561
(dp12562
sVCytochrome P-450 CYP2D6 Substrates
p12563
(dp12564
sVAnalgesics
p12565
(dp12566
sVOpiate Agonists
p12567
(dp12568
sVCentral Nervous System Agents
p12569
(dp12570
sVNarcotics
p12571
(dp12572
sVPeripheral Nervous System Agents
p12573
(dp12574
sVMorphine Derivatives
p12575
(dp12576
sVCytochrome P-450 CYP3A4 Substrates
p12577
(dp12578
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p12579
(dp12580
sVCytochrome P-450 CYP3A Substrates
p12581
(dp12582
sVNatural Opium Alkaloids
p12583
(dp12584
sVCentral Nervous System Depressants
p12585
(dp12586
sVOpioids
p12587
(dp12588
sVSemi-synthetic Opioids
p12589
(dp12590
sVCodeine
p12591
(dp12592
sVOpiate Alkaloids
p12593
(dp12594
sVHeterocyclic Compounds, Fused-Ring
p12595
(dp12596
sVMorphinans
p12597
(dp12598
sVCytochrome P-450 CYP3A5 Substrates
p12599
(dp12600
sVOpioid Agonist
p12601
(dp12602
sVAlkaloids
p12603
(dp12604
sVSensory System Agents
p12605
(dp12606
sVPhenanthrenes
p12607
(dp12608
sVNervous System
p12609
(dp12610
ssg45
(dp12611
g7359
(dp12612
ssg48
(dp12613
VPyrimidines
p12614
(dp12615
sVImmunosuppressive Agents
p12616
(dp12617
sVCarbohydrates
p12618
(dp12619
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p12620
(dp12621
sVThyroxine-binding globulin inducers
p12622
(dp12623
sg10656
(dp12624
sVCytochrome P-450 CYP2C9 Inhibitors
p12625
(dp12626
sVCytochrome P-450 Enzyme Inhibitors
p12627
(dp12628
sVDeoxyribonucleosides
p12629
(dp12630
sVPyrimidine Analogues
p12631
(dp12632
sVDrugs that are Mainly Renally Excreted
p12633
(dp12634
sVMyelosuppressive Agents
p12635
(dp12636
sVAntimetabolites, Antineoplastic
p12637
(dp12638
sVAntineoplastic Agents
p12639
(dp12640
sVGlycosides
p12641
(dp12642
sg11115
(dp12643
sVRibonucleosides
p12644
(dp12645
sVNucleic Acids, Nucleotides, and Nucleosides
p12646
(dp12647
sVPyrimidine Nucleosides
p12648
(dp12649
sVToxic Actions
p12650
(dp12651
sVNucleosides
p12652
(dp12653
sVAntimetabolites
p12654
(dp12655
sVNoxae
p12656
(dp12657
sVAntineoplastic and Immunomodulating Agents
p12658
(dp12659
ssg51
(dp12660
g465
(dp12661
sg2559
(dp12662
sg11955
(dp12663
sg11592
(dp12664
sg9918
(dp12665
sg11151
(dp12666
sg3696
(dp12667
sg288
(dp12668
sg2427
(dp12669
sg8655
(dp12670
sg9591
(dp12671
sg6279
(dp12672
sg1113
(dp12673
sg9231
(dp12674
sg1899
(dp12675
sg1908
(dp12676
sg8298
(dp12677
sg573
(dp12678
sg8760
(dp12679
sg4164
(dp12680
sg4023
(dp12681
sg6333
(dp12682
ssg54
(dp12683
g2553
(dp12684
sg10767
(dp12685
sg5415
(dp12686
sg8583
(dp12687
sg9561
(dp12688
sg657
(dp12689
sg11382
(dp12690
sg3825
(dp12691
sg5457
(dp12692
sg5511
(dp12693
sg4770
(dp12694
ssg57
(dp12695
g87
(dp12696
sg10833
(dp12697
sg7881
(dp12698
sg10326
(dp12699
sg1101
(dp12700
sg11427
(dp12701
sg7500
(dp12702
ssg60
(dp12703
g2769
(dp12704
sg10365
(dp12705
sg7941
(dp12706
sg12066
(dp12707
sg11979
(dp12708
sg9579
(dp12709
sg11241
(dp12710
sg10815
(dp12711
sg9759
(dp12712
sg6303
(dp12713
sg10662
(dp12714
ssg63
(dp12715
g438
(dp12716
sg2652
(dp12717
sg10377
(dp12718
sg3912
(dp12719
sg2460
(dp12720
sg1371
(dp12721
sg9198
(dp12722
sg4437
(dp12723
sg2274
(dp12724
sg288
(dp12725
sg78
(dp12726
sg1047
(dp12727
sg8787
(dp12728
sg10512
(dp12729
ssg66
(dp12730
g2784
(dp12731
sg5739
(dp12732
sg7713
(dp12733
ssg69
(dp12734
VCytochrome P-450 CYP3A4 Substrates
p12735
(dp12736
sVDrugs that are Mainly Renally Excreted
p12737
(dp12738
sVCentral Nervous System Depressants
p12739
(dp12740
sVCytochrome P-450 CYP1A2 Substrates
p12741
(dp12742
sVHeterocyclic Compounds, Fused-Ring
p12743
(dp12744
sVCytochrome P-450 CYP2D6 Substrates
p12745
(dp12746
sVPeripheral Nervous System Agents
p12747
(dp12748
sVCentrally-mediated Muscle Relaxation
p12749
(dp12750
sVCytochrome P-450 Enzyme Inhibitors
p12751
(dp12752
sVMuscle Relaxants, Centrally Acting Agents
p12753
(dp12754
sg9069
(dp12755
sVCytochrome P-450 CYP2E1 Inhibitors
p12756
(dp12757
sVCentral Nervous System Agents
p12758
(dp12759
sVCytochrome P-450 CYP2A6 Substrates
p12760
(dp12761
sVMusculo-Skeletal System
p12762
(dp12763
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p12764
(dp12765
sVMuscle Relaxants
p12766
(dp12767
sVCytochrome P-450 CYP2E1 Substrates
p12768
(dp12769
sg3057
(dp12770
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p12771
(dp12772
sVCytochrome P-450 CYP3A Substrates
p12773
(dp12774
ssg72
(dp12775
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p12776
(dp12777
sVAnalgesics
p12778
(dp12779
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p12780
(dp12781
sVNon COX-2 selective NSAIDS
p12782
(dp12783
sVCentral Nervous System Agents
p12784
(dp12785
sVAntiinflammatory and Antirheumatic Products
p12786
(dp12787
sVEnzyme Inhibitors
p12788
(dp12789
sVPeripheral Nervous System Agents
p12790
(dp12791
sVNonsteroidal Anti-inflammatory Compounds
p12792
(dp12793
sVAnalgesics, Non-Narcotic
p12794
(dp12795
sVNephrotoxic agents
p12796
(dp12797
sVAcids, Carbocyclic
p12798
(dp12799
sVCyclooxygenase Inhibitors
p12800
(dp12801
sVMusculo-Skeletal System
p12802
(dp12803
sVAgents causing hyperkalemia
p12804
(dp12805
sVPropionates
p12806
(dp12807
sVAgents that produce hypertension
p12808
(dp12809
sVAnti-Inflammatory Agents
p12810
(dp12811
sVPhenylpropionates
p12812
(dp12813
sVAntirheumatic Agents
p12814
(dp12815
sVSensory System Agents
p12816
(dp12817
sVAnti-Inflammatory Agents, Non-Steroidal
p12818
(dp12819
ssg75
(dp12820
g3231
(dp12821
sg5934
(dp12822
sg5574
(dp12823
sg7641
(dp12824
ssg78
(dp12825
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p12826
(dp12827
sVCytochrome P-450 CYP3A4 Inhibitors
p12828
(dp12829
sVBreast Cancer Resistance Protein Inhibitors
p12830
g12726
sVCytochrome P-450 CYP3A Substrates
p12831
(dp12832
sVKinase Inhibitor
p12833
(dp12834
sVEnzyme Inhibitors
p12835
(dp12836
sVCytochrome P-450 Enzyme Inhibitors
p12837
(dp12838
sVKinase Inhibitors
p12839
(dp12840
sVAmines
p12841
(dp12842
sVCytochrome P450 1A2 Inducers
p12843
(dp12844
sVTyrosine Kinase Inhibitors
p12845
(dp12846
sVAmides
p12847
(dp12848
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p12849
(dp12850
sVCytochrome P450 3A4 Inducers
p12851
(dp12852
sVCytochrome P-450 CYP3A4 Inducers
p12853
(dp12854
sVAntineoplastic Agents
p12855
(dp12856
sg1509
(dp12857
sVCytochrome P-450 CYP1A2 Inducers
p12858
(dp12859
sVP-glycoprotein/ABCB1 Substrates
p12860
(dp12861
sVCytochrome P-450 Enzyme Inducers
p12862
(dp12863
sVCytochrome P-450 CYP3A Inducers
p12864
(dp12865
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p12866
(dp12867
sVCytochrome P-450 CYP3A4 Substrates
p12868
(dp12869
sVProtein Kinase Inhibitors
p12870
(dp12871
sVAcids, Acyclic
p12872
(dp12873
sVCytochrome P-450 CYP3A Inhibitors
p12874
(dp12875
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p12876
(dp12877
sVBCRP/ABCG2 Substrates
p12878
(dp12879
sVCytochrome P450 3A Inhibitors
p12880
(dp12881
sVAntineoplastic and Immunomodulating Agents
p12882
(dp12883
ssg81
(dp12884
g5847
(dp12885
ssg84
(dp12886
g3027
(dp12887
sg2787
(dp12888
sg6807
(dp12889
sg11562
(dp12890
ssg87
(dp12891
VPyrimidines
p12892
(dp12893
sVNucleic Acid Synthesis Inhibitors
p12894
(dp12895
sVImmunosuppressive Agents
p12896
(dp12897
sVCarbohydrates
p12898
(dp12899
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p12900
(dp12901
sVCytochrome P-450 CYP2C9 Inhibitors
p12902
(dp12903
sVCytochrome P-450 Enzyme Inhibitors
p12904
(dp12905
sVDeoxyribonucleosides
p12906
(dp12907
sVPyrimidine Analogues
p12908
(dp12909
sVDrugs that are Mainly Renally Excreted
p12910
(dp12911
sVDeoxycytidine
p12912
g12696
sVMyelosuppressive Agents
p12913
(dp12914
sVNucleoside Metabolic Inhibitor
p12915
(dp12916
sVCytidine
p12917
(dp12918
sVFluorouracil and prodrugs
p12919
(dp12920
sVAntimetabolites, Antineoplastic
p12921
(dp12922
sVAntineoplastic Agents
p12923
(dp12924
sVGlycosides
p12925
(dp12926
sVUracil
p12927
(dp12928
sVRibonucleosides
p12929
(dp12930
sVNucleic Acids, Nucleotides, and Nucleosides
p12931
(dp12932
sVFluoropyrimidines
p12933
(dp12934
sVPyrimidine Nucleosides
p12935
(dp12936
sVToxic Actions
p12937
(dp12938
sVCardiotoxic antineoplastic agents
p12939
(dp12940
sVNucleosides
p12941
(dp12942
sVAntimetabolites
p12943
(dp12944
sVPyrimidinones
p12945
(dp12946
sVNoxae
p12947
(dp12948
sVAntineoplastic and Immunomodulating Agents
p12949
(dp12950
ssg90
(dp12951
g2424
(dp12952
ssg93
(dp12953
g12060
(dp12954
ssg96
(dp12955
g11955
(dp12956
sg11793
(dp12957
sg8394
(dp12958
sg2013
(dp12959
sg10662
(dp12960
sg11265
(dp12961
sg11721
(dp12962
sg9879
(dp12963
sg7983
(dp12964
sg3975
(dp12965
sg9966
(dp12966
sg3732
(dp12967
sg405
(dp12968
sg2841
(dp12969
sg2733
(dp12970
sg10533
(dp12971
sg945
(dp12972
sg9393
(dp12973
sg11163
(dp12974
sg8139
(dp12975
sg9465
(dp12976
sg6729
(dp12977
sg1188
(dp12978
sg10815
(dp12979
sg7029
(dp12980
sg9684
(dp12981
ssg99
(dp12982
g10890
(dp12983
sg2928
(dp12984
ssg102
(dp12985
VCytochrome P-450 CYP3A4 Inhibitors
p12986
(dp12987
sVCytochrome P-450 CYP2D6 Inhibitors
p12988
(dp12989
sVHormones
p12990
(dp12991
sVCytochrome P-450 CYP3A7 Inhibitors
p12992
(dp12993
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p12994
(dp12995
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p12996
(dp12997
sVAndrostan Derivatives
p12998
(dp12999
sVCytochrome P-450 Enzyme Inhibitors
p13000
(dp13001
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p13002
(dp13003
sVAnabolic Steroids
p13004
(dp13005
sVAndrostanols
p13006
(dp13007
sVAndrostanes
p13008
(dp13009
sVFused-Ring Compounds
p13010
(dp13011
sVAnabolic Agents for Systemic Use
p13012
(dp13013
sVAndrogens
p13014
(dp13015
sVCytochrome P-450 CYP3A5 Inhibitors
p13016
(dp13017
sVAnabolic Agents
p13018
(dp13019
sVAlimentary Tract and Metabolism
p13020
(dp13021
sVSteroids
p13022
(dp13023
sVCytochrome P-450 CYP3A Inhibitors
p13024
(dp13025
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p13026
(dp13027
sVHormones, Hormone Substitutes, and Hormone Antagonists
p13028
(dp13029
ssg105
(dp13030
g8433
(dp13031
sg4023
(dp13032
sg7821
(dp13033
sg1050
(dp13034
sg1047
(dp13035
sg8787
(dp13036
sg11052
(dp13037
sg2034
(dp13038
sg9198
(dp13039
sg8448
(dp13040
sg9954
(dp13041
sg6090
(dp13042
sg2829
(dp13043
sg8820
(dp13044
sg1899
(dp13045
sg10758
(dp13046
sg5127
(dp13047
sg8298
(dp13048
sg11625
(dp13049
sg11166
(dp13050
sg4164
(dp13051
sg5289
(dp13052
sg8724
(dp13053
sg819
(dp13054
ssg108
(dp13055
g6882
(dp13056
sg5454
(dp13057
sg11601
(dp13058
ssg111
(dp13059
g219
(dp13060
sg1659
(dp13061
sg8277
(dp13062
sg11427
(dp13063
sg6408
(dp13064
sg5289
(dp13065
sg2598
(dp13066
sg8067
(dp13067
sg10326
(dp13068
sg294
(dp13069
sS'Ganciclovir'
p13070
(dp13071
sg4488
(dp13072
sg7824
(dp13073
sg7500
(dp13074
sg2769
(dp13075
sg10365
(dp13076
sg1635
(dp13077
sg6981
(dp13078
sg10854
(dp13079
sg2688
(dp13080
sg12090
(dp13081
sg9192
(dp13082
sg9033
(dp13083
sg12126
(dp13084
sg11241
(dp13085
sg8922
(dp13086
ssg114
(dp13087
g11172
(dp13088
ssg117
(dp13089
g6765
(dp13090
sS'Cyclophosphamide'
p13091
(dp13092
ssg120
(dp13093
g10062
(dp13094
sg5853
(dp13095
sg6579
(dp13096
sg6939
(dp13097
ssg123
(dp13098
g8457
(dp13099
sg1278
(dp13100
sg9126
(dp13101
sg7962
(dp13102
sg5256
(dp13103
sg5433
(dp13104
sg978
(dp13105
sg12274
(dp13106
sg5250
(dp13107
sg279
(dp13108
sg879
(dp13109
sg7653
(dp13110
sg477
(dp13111
sg10149
(dp13112
sg9879
(dp13113
sg9192
(dp13114
sg3141
(dp13115
sg7458
(dp13116
sg4710
(dp13117
sg3861
(dp13118
sg2046
(dp13119
sg9081
(dp13120
sg6432
(dp13121
sg8079
(dp13122
sg9759
(dp13123
sg2079
(dp13124
sg11685
(dp13125
sg11862
(dp13126
sg10728
(dp13127
sg11874
(dp13128
sg2769
(dp13129
sg10365
(dp13130
sg11241
(dp13131
sg9783
(dp13132
sg126
(dp13133
sg5727
(dp13134
sg6654
(dp13135
sg165
(dp13136
sg9180
(dp13137
sg1275
(dp13138
sg10230
(dp13139
sg8922
(dp13140
sg972
(dp13141
sg6231
(dp13142
sg1176
(dp13143
sg11361
(dp13144
sg5766
(dp13145
sg2316
(dp13146
sg2172
(dp13147
sg11775
(dp13148
sg4005
(dp13149
sg5595
(dp13150
sg11781
(dp13151
sg8439
(dp13152
sg2250
(dp13153
ssg126
(dp13154
VAntiinfectives for Systemic Use
p13155
(dp13156
sVDrugs that are Mainly Renally Excreted
p13157
(dp13158
sVAgents that produce neuromuscular block (indirect)
p13159
(dp13160
sVHeterocyclic Compounds, Fused-Ring
p13161
(dp13162
sVbeta-Lactams
p13163
(dp13164
sVOAT1/SLC22A6 inhibitors
p13165
(dp13166
sVOAT3/SLC22A8 Substrates
p13167
g13133
sVLactams
p13168
(dp13169
sVExtended-spectrum Penicillins
p13170
(dp13171
sVAmides
p13172
(dp13173
sVSulfur Compounds
p13174
(dp13175
sVPenicillins With Extended Spectrum
p13176
(dp13177
sVAnti-Bacterial Agents
p13178
(dp13179
sVAntibacterials for Systemic Use
p13180
(dp13181
sVPenicillin G
p13182
(dp13183
sVAnti-Infective Agents
p13184
(dp13185
sVPenicillins
p13186
(dp13187
sVBeta-Lactam Antibacterials
p13188
(dp13189
ssg129
(dp13190
VBlood Coagulation Factors
p13191
(dp13192
sVReplacement Preparations
p13193
(dp13194
sVAcids, Acyclic
p13195
(dp13196
sVCarbohydrates
p13197
(dp13198
sg3690
(dp13199
sVHydroxy Acids
p13200
(dp13201
sVDermatologicals
p13202
(dp13203
sg5697
(dp13204
sVSugar Acids
p13205
(dp13206
sVMineral Supplements
p13207
(dp13208
sVPhosphate Binder
p13209
(dp13210
sVCalcium Salts
p13211
(dp13212
sVAlimentary Tract and Metabolism
p13213
(dp13214
ssg132
(dp13215
g6768
(dp13216
sg8085
(dp13217
sg11700
(dp13218
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p13219
(dp13220
sVHypoglycemia-Associated Agents
p13221
(dp13222
sVSulfur Compounds
p13223
(dp13224
sg2997
(dp13225
sVSulfones
p13226
(dp13227
sVCytochrome P-450 CYP2C19 Inhibitors
p13228
(dp13229
sg2073
(dp13230
sVCytochrome P-450 Enzyme Inhibitors
p13231
(dp13232
sg11253
(dp13233
sVAlimentary Tract and Metabolism
p13234
(dp13235
sg7110
(dp13236
ssg135
(dp13237
VAntiinfectives for Systemic Use
p13238
(dp13239
sVHeterocyclic Compounds, Fused-Ring
p13240
(dp13241
sg7083
(dp13242
sVbeta-Lactams
p13243
(dp13244
sVNephrotoxic agents
p13245
(dp13246
sVLactams
p13247
(dp13248
sVAmides
p13249
(dp13250
sVThiazines
p13251
(dp13252
sVSulfur Compounds
p13253
(dp13254
sVAnti-Bacterial Agents
p13255
(dp13256
sVAntibacterials for Systemic Use
p13257
(dp13258
sVSecond-Generation Cephalosporins
p13259
(dp13260
sVCephalosporins
p13261
(dp13262
sVAnti-Infective Agents
p13263
(dp13264
ssg138
(dp13265
VCytochrome P-450 CYP2D6 Substrates
p13266
(dp13267
sVAntiarrhythmic agents
p13268
(dp13269
sVCytochrome P-450 CYP3A Substrates
p13270
(dp13271
sVCytochrome P-450 CYP2B6 Substrates
p13272
(dp13273
sVPhenols
p13274
(dp13275
sVCytochrome P-450 Enzyme Inhibitors
p13276
(dp13277
sVEthers
p13278
(dp13279
sVCytochrome P-450 CYP1A2 Substrates
p13280
(dp13281
sVAmines
p13282
(dp13283
sVCardiac Therapy
p13284
(dp13285
sVPropylamines
p13286
(dp13287
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p13288
(dp13289
sVCardiovascular Agents
p13290
(dp13291
sVBenzene Derivatives
p13292
(dp13293
sVCytochrome P-450 CYP1A2 Inhibitors
p13294
(dp13295
sVPhenyl Ethers
p13296
(dp13297
sVAntiarrhythmics, Class Ib
p13298
(dp13299
sVMembrane Transport Modulators
p13300
(dp13301
sVCytochrome P-450 CYP3A4 Substrates
p13302
(dp13303
sVSodium Channel Blockers
p13304
(dp13305
sVAntiarrhythmics, Class I
p13306
(dp13307
sVVoltage-Gated Sodium Channel Blockers
p13308
(dp13309
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p13310
(dp13311
ssg141
(dp13312
VHydrocarbons, Acyclic
p13313
(dp13314
sVCytochrome P-450 CYP3A4 Inhibitors
p13315
(dp13316
sVFatty Acids
p13317
(dp13318
sVMusculo-Skeletal System
p13319
(dp13320
sVAnesthetics, Local
p13321
(dp13322
sVLipids
p13323
(dp13324
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p13325
(dp13326
sVAlkenes
p13327
(dp13328
sVPhenols
p13329
(dp13330
sVCytochrome P-450 Enzyme Inhibitors
p13331
(dp13332
sVPeripheral Nervous System Agents
p13333
(dp13334
sVAntipruritics
p13335
(dp13336
sVCytochrome P-450 CYP1A2 Substrates
p13337
(dp13338
sg6492
(dp13339
sVAnesthetics
p13340
(dp13341
sVFatty Acids, Unsaturated
p13342
(dp13343
sg9387
(dp13344
sVFatty Acids, Monounsaturated
p13345
(dp13346
sVAmides
p13347
(dp13348
sVTopical Products for Joint and Muscular Pain
p13349
(dp13350
sVCytochrome P-450 CYP1A2 Inducers
p13351
(dp13352
sVBenzene Derivatives
p13353
(dp13354
sVSolanaceous Alkaloids
p13355
(dp13356
sg342
(dp13357
sVDermatologicals
p13358
(dp13359
sVCytochrome P-450 Enzyme Inducers
p13360
(dp13361
sg3054
(dp13362
sVCatechols
p13363
(dp13364
sg1740
(dp13365
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p13366
(dp13367
sVCytochrome P-450 CYP3A Inhibitors
p13368
(dp13369
sVCholinesterase Inhibitors
p13370
(dp13371
sVAlkaloids
p13372
(dp13373
sVSensory System Agents
p13374
(dp13375
sVNervous System
p13376
(dp13377
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p13378
(dp13379
ssg144
(dp13380
g2196
(dp13381
sg7884
(dp13382
sg7821
(dp13383
sg10470
(dp13384
sg1047
(dp13385
sg11052
(dp13386
sg3024
(dp13387
sg11451
(dp13388
sg6435
(dp13389
sg9198
(dp13390
sg3132
(dp13391
sg6468
(dp13392
sg8448
(dp13393
sg9954
(dp13394
sg8454
(dp13395
sg6798
(dp13396
sg4299
(dp13397
sg5739
(dp13398
sg10518
(dp13399
sg12063
(dp13400
sg4920
(dp13401
sg9432
(dp13402
sg2460
(dp13403
sg1503
(dp13404
sg1140
(dp13405
sg1899
(dp13406
sg8298
(dp13407
sg1911
(dp13408
sg573
(dp13409
sg4164
(dp13410
sg7191
(dp13411
sg819
(dp13412
ssg147
(dp13413
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p13414
(dp13415
sVCytochrome P-450 CYP2D6 Inhibitors
p13416
(dp13417
sVCytochrome P-450 CYP2D6 Substrates
p13418
(dp13419
sVCytochrome P-450 CYP3A Substrates
p13420
(dp13421
sVHormone Antagonists and Related Agents
p13422
(dp13423
sVStilbenes
p13424
(dp13425
sVCytochrome P-450 CYP3A4 Inhibitors
p13426
(dp13427
sVBenzylidene Compounds
p13428
(dp13429
sVSelective Estrogen Receptor Modulators
p13430
(dp13431
sVEstrogen Agonist/Antagonist
p13432
(dp13433
sVCytochrome P-450 CYP2B6 Substrates
p13434
(dp13435
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p13436
(dp13437
sVCytochrome P-450 CYP2C9 Inhibitors
p13438
(dp13439
sVCytochrome P-450 Enzyme Inhibitors
p13440
(dp13441
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p13442
(dp13443
sVP-glycoprotein/ABCB1 Inducers
p13444
(dp13445
sVEstrogen Antagonists
p13446
(dp13447
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p13448
(dp13449
sVCytochrome P-450 CYP2C9 Substrates
p13450
(dp13451
sVQTc Prolonging Agents
p13452
(dp13453
sVEstrogen Receptor Modulators
p13454
(dp13455
sVCytochrome P-450 CYP3A4 Inducers
p13456
(dp13457
sVAntineoplastic Agents
p13458
(dp13459
sVCytochrome P-450 CYP2C19 Substrates
p13460
(dp13461
sVBenzene Derivatives
p13462
(dp13463
sVCytochrome P-450 CYP2C8 Inhibitors
p13464
(dp13465
sVCytochrome P-450 CYP2B6 Inhibitors
p13466
(dp13467
sVP-glycoprotein/ABCB1 Substrates
p13468
(dp13469
sVAntineoplastic Agents, Hormonal
p13470
(dp13471
sVCytochrome P-450 CYP2A6 Substrates
p13472
(dp13473
sVCytochrome P-450 Enzyme Inducers
p13474
(dp13475
sVCytochrome P-450 CYP3A Inducers
p13476
(dp13477
sVBSEP/ABCB11 Inhibitors
p13478
(dp13479
sVCytochrome P-450 CYP3A4 Substrates
p13480
(dp13481
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p13482
(dp13483
sVHormone Antagonists
p13484
(dp13485
sVCardiotoxic antineoplastic agents
p13486
(dp13487
sVCytochrome P-450 CYP3A5 Substrates
p13488
(dp13489
sVPotential QTc-Prolonging Agents
p13490
(dp13491
sVCytochrome P-450 CYP3A Inhibitors
p13492
(dp13493
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p13494
(dp13495
sVBCRP/ABCG2 Substrates
p13496
(dp13497
sVAnti-Estrogens
p13498
(dp13499
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p13500
(dp13501
sVP-glycoprotein/ABCB1 Inhibitors
p13502
(dp13503
sVAntineoplastic and Immunomodulating Agents
p13504
(dp13505
sVHormones, Hormone Substitutes, and Hormone Antagonists
p13506
(dp13507
sVThyroxine-binding globulin inducers
p13508
(dp13509
sVCytochrome P-450 CYP3A7 Substrates
p13510
(dp13511
sVEndocrine Therapy
p13512
(dp13513
ssg150
(dp13514
VAcetates
p13515
(dp13516
sVIndicators and Reagents
p13517
(dp13518
sVFatty Acids, Volatile
p13519
(dp13520
sVFatty Acids
p13521
(dp13522
sVGenito Urinary System and Sex Hormones
p13523
(dp13524
sVAcids, Acyclic
p13525
(dp13526
sVSensory Organs
p13527
(dp13528
sVOtologicals
p13529
(dp13530
sVLaboratory Chemicals
p13531
(dp13532
sVGynecological Antiinfectives and Antiseptics
p13533
(dp13534
sg1812
(dp13535
sVOrganic Acids
p13536
(dp13537
sVCompounds used in a research, industrial, or household setting
p13538
(dp13539
sVAnti-Bacterial Agents
p13540
(dp13541
sVAnti-Infective Agents
p13542
(dp13543
sVLipids
p13544
(dp13545
ssg153
(dp13546
g8577
(dp13547
ssg156
(dp13548
g4737
(dp13549
ssg159
(dp13550
g8022
(dp13551
sg3105
(dp13552
ssg162
(dp13553
g5409
(dp13554
sg11631
(dp13555
sg6567
(dp13556
sg357
(dp13557
sg7977
(dp13558
sg10185
(dp13559
sg4737
(dp13560
sg5286
(dp13561
sg5073
(dp13562
sg9348
(dp13563
sg1149
(dp13564
ssg165
(dp13565
VBSEP/ABCB11 Substrates
p13566
(dp13567
sVP-glycoprotein/ABCB1 Inducers
p13568
(dp13569
sVBile and Liver Therapy
p13570
(dp13571
sVCholanes
p13572
(dp13573
sVOATP1B3 substrates
p13574
(dp13575
sVBile Acid Preparations
p13576
(dp13577
sVSteroids
p13578
(dp13579
sVOAT3/SLC22A8 Substrates
p13580
g13136
sVCholic Acids
p13581
(dp13582
sVOAT3/SLC22A8 Inhibitors
p13583
(dp13584
sVBSEP/ABCB11 Inhibitors
p13585
(dp13586
sVBSEP/ABCB11 inducers
p13587
(dp13588
sVOATP1B1/SLCO1B1 Inhibitors
p13589
(dp13590
sVBile acids and derivatives
p13591
(dp13592
sVBile Acids and Salts
p13593
(dp13594
sVBile Therapy
p13595
(dp13596
sVFused-Ring Compounds
p13597
(dp13598
sVOATP1B1/SLCO1B1 Inducers
p13599
(dp13600
sVAlimentary Tract and Metabolism
p13601
(dp13602
sVOATP1B1/SLCO1B1 Substrates
p13603
(dp13604
ssg168
(dp13605
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p13606
(dp13607
sVPsychoanaleptics
p13608
(dp13609
sVCytochrome P-450 CYP2D6 Substrates
p13610
(dp13611
sVMembrane Transport Modulators
p13612
(dp13613
sVCentral Nervous System Agents
p13614
(dp13615
sVDopamine Agents
p13616
(dp13617
sVPsychostimulants, Agents Used for Adhd and Nootropics
p13618
(dp13619
sVSympathomimetics
p13620
(dp13621
sVCentral Nervous System Stimulation
p13622
(dp13623
sVAmphetamines
p13624
(dp13625
sVCytochrome P-450 Enzyme Inhibitors
p13626
(dp13627
sVDrugs that are Mainly Renally Excreted
p13628
(dp13629
sVNeurotransmitter Uptake Inhibitors
p13630
(dp13631
sVAmines
p13632
(dp13633
sVBiogenic Monoamines
p13634
(dp13635
sVPeripheral Nervous System Agents
p13636
(dp13637
sVCentrally Acting Sympathomimetics
p13638
(dp13639
sVCentral Nervous System Stimulants
p13640
(dp13641
sVAdrenergic Agents
p13642
(dp13643
sVCentral Nervous System Depressants
p13644
(dp13645
sVNeurotransmitter Agents
p13646
(dp13647
sVPhenols
p13648
(dp13649
sVBenzene Derivatives
p13650
(dp13651
sVBiogenic Amines
p13652
(dp13653
sVAgents that reduce seizure threshold
p13654
(dp13655
sVMonoamine Oxidase Inhibitors
p13656
(dp13657
sVCatecholamines
p13658
(dp13659
sVAdrenergic Uptake Inhibitors
p13660
(dp13661
sVAgents that produce hypertension
p13662
(dp13663
sVAutonomic Agents
p13664
(dp13665
sVCatechols
p13666
(dp13667
sVDopamine Uptake Inhibitors
p13668
(dp13669
sVNervous System
p13670
(dp13671
sVCytochrome P-450 CYP2A6 Inhibitors (weak)
p13672
(dp13673
sVAntidepressive Agents
p13674
(dp13675
sVAgents producing tachycardia
p13676
(dp13677
sVPhenethylamines
p13678
(dp13679
sVCytochrome P-450 CYP2A6 Inhibitors
p13680
(dp13681
ssg171
(dp13682
VNitrogen Compounds
p13683
(dp13684
sVAnalgesics
p13685
(dp13686
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p13687
(dp13688
sVHydroxy Acids
p13689
(dp13690
sVNon COX-2 selective NSAIDS
p13691
(dp13692
sVCentral Nervous System Agents
p13693
(dp13694
sVPeripheral Nervous System Agents
p13695
(dp13696
sg7017
(dp13697
sVAnalgesics, Non-Narcotic
p13698
(dp13699
sVNephrotoxic agents
p13700
(dp13701
sVAcids, Carbocyclic
p13702
(dp13703
sVEthanolamines
p13704
(dp13705
sVAgents causing hyperkalemia
p13706
(dp13707
sVPhenols
p13708
(dp13709
sVBenzene Derivatives
p13710
(dp13711
sVOnium Compounds
p13712
(dp13713
sVAgents that produce hypertension
p13714
(dp13715
sVAmines
p13716
(dp13717
sVAmino Alcohols
p13718
(dp13719
sVBenzoates
p13720
(dp13721
sVAnti-Inflammatory Agents
p13722
(dp13723
sVAntirheumatic Agents
p13724
(dp13725
sVSensory System Agents
p13726
(dp13727
sVAnti-Inflammatory Agents, Non-Steroidal
p13728
(dp13729
sg423
(dp13730
sVQuaternary Ammonium Compounds
p13731
(dp13732
sVAlcohols
p13733
(dp13734
sVAmmonium Compounds
p13735
(dp13736
ssg174
(dp13737
g465
(dp13738
sg9918
(dp13739
sg5805
(dp13740
sg6186
(dp13741
sg1188
(dp13742
sg2703
(dp13743
sg1140
(dp13744
sg1908
(dp13745
sg414
(dp13746
sg10308
(dp13747
sg7041
(dp13748
ssg177
(dp13749
S'Triamcinolone'
p13750
(dp13751
sg1614
(dp13752
sg6345
(dp13753
ssg180
(dp13754
g9084
(dp13755
sg2754
(dp13756
sg11133
(dp13757
sg8751
(dp13758
sg9897
(dp13759
ssg183
(dp13760
VPyrimidines
p13761
(dp13762
sVAnticholinergic Agents
p13763
(dp13764
sVGABA Agents
p13765
(dp13766
sVNeurotransmitter Agents
p13767
(dp13768
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p13769
(dp13770
sVCentral Nervous System Agents
p13771
(dp13772
sVPhenobarbital and similars
p13773
(dp13774
sVBSEP/ABCB11 inducers
p13775
(dp13776
sVCytochrome P-450 CYP3A7 Inducers
p13777
(dp13778
sVGABA Modulators
p13779
(dp13780
sVCytochrome P-450 CYP2C9 Inducers
p13781
(dp13782
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p13783
(dp13784
sVCytochrome P-450 CYP2C18 Inducers (strength unknown)
p13785
(dp13786
sVCytochrome P-450 CYP2E1 Inducers
p13787
(dp13788
sVP-glycoprotein/ABCB1 Inducers
p13789
(dp13790
sVCytochrome P-450 CYP3A4 Inducers (strong)
p13791
(dp13792
sVCytochrome P-450 CYP2C8 Inducers (strong)
p13793
(dp13794
sVCytochrome P-450 CYP2B6 Inducers
p13795
(dp13796
sVExcitatory Amino Acid Antagonists
p13797
(dp13798
sVBarbiturates
p13799
(dp13800
sVCytochrome P-450 CYP1A2 Inducers (strong)
p13801
(dp13802
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p13803
(dp13804
sVEnzyme Inducing Antiepileptic Drugs
p13805
(dp13806
sVExcitatory Amino Acid Agents
p13807
(dp13808
sVCytochrome P-450 CYP2C9 Substrates
p13809
(dp13810
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p13811
(dp13812
sVCytochrome P-450 CYP3A4 Inducers
p13813
(dp13814
sVUGT2B7 inducers
p13815
(dp13816
sVCytochrome P-450 CYP2C19 Substrates
p13817
(dp13818
sVCentral Nervous System Depressants
p13819
(dp13820
sVCytochrome P-450 CYP3A5 Inducers
p13821
(dp13822
sVCytochrome P-450 CYP1A2 Inducers
p13823
(dp13824
sVP-glycoprotein/ABCB1 Substrates
p13825
(dp13826
sVAnticonvulsants
p13827
(dp13828
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p13829
(dp13830
sVCytochrome P-450 CYP2B6 Inducers (strong)
p13831
(dp13832
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p13833
(dp13834
sVCytochrome P-450 Enzyme Inducers
p13835
(dp13836
sVCytochrome P-450 CYP3A Inducers
p13837
(dp13838
sVPsycholeptics
p13839
(dp13840
sVCytochrome P-450 CYP3A Inducers (strong)
p13841
(dp13842
sVCytochrome P-450 CYP2A6 Inducers
p13843
(dp13844
sVHypnotics and Sedatives
p13845
(dp13846
sVNarrow Therapeutic Index Drugs
p13847
(dp13848
sVNicotinic Antagonists
p13849
(dp13850
sVUGT1A1 Inducers
p13851
(dp13852
sVPyrimidinones
p13853
(dp13854
sVCytochrome P-450 CYP2C8 Inducers
p13855
(dp13856
sVCytochrome P-450 2C18 Inducers
p13857
(dp13858
sVCytochrome P-450 CYP2C19 Inducers
p13859
(dp13860
sVMethemoglobinemia Associated Agents
p13861
(dp13862
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p13863
(dp13864
sVBarbiturates and Derivatives
p13865
(dp13866
sVChemically-Induced Disorders
p13867
(dp13868
sVNervous System
p13869
(dp13870
sVCytochrome P-450 CYP3A5 Inducers (strong)
p13871
(dp13872
ssg186
(dp13873
g4338
(dp13874
sg4821
(dp13875
sg2253
(dp13876
sg10338
(dp13877
sg8796
(dp13878
ssg189
(dp13879
g8472
(dp13880
sg1461
(dp13881
ssg192
(dp13882
g8670
(dp13883
sg5577
(dp13884
sg7977
(dp13885
sg8274
(dp13886
sg5382
(dp13887
sg3183
(dp13888
sg372
(dp13889
ssg195
(dp13890
VPhenols
p13891
(dp13892
sg1644
(dp13893
sVBenzene Derivatives
p13894
(dp13895
sVAcids, Acyclic
p13896
(dp13897
sVAntihypertensive Agents
p13898
(dp13899
sVCytochrome P-450 CYP3A Substrates
p13900
(dp13901
sVAgents causing hyperkalemia
p13902
(dp13903
sVHypotensive Agents
p13904
(dp13905
sVMethyl Ethers
p13906
(dp13907
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p13908
(dp13909
sVCytochrome P-450 CYP3A4 Substrates
p13910
(dp13911
sVPhenyl Ethers
p13912
(dp13913
sVEthers
p13914
(dp13915
sVAgents Acting on the Renin-Angiotensin System
p13916
(dp13917
sg4179
(dp13918
ssg198
(dp13919
g8019
(dp13920
sg6162
(dp13921
sg141
g13350
sg3408
(dp13922
sg8241
(dp13923
sg4425
(dp13924
sg4716
(dp13925
sg2109
(dp13926
sg1326
(dp13927
sg9519
(dp13928
sg10977
(dp13929
sg4803
(dp13930
sg10740
(dp13931
sg336
(dp13932
sg5250
(dp13933
sg7650
(dp13934
sg963
(dp13935
ssg201
(dp13936
g8583
(dp13937
ssg204
(dp13938
VCytochrome P-450 CYP3A4 Inhibitors
p13939
(dp13940
sVOAT1/SLC22A6 inhibitors
p13941
(dp13942
sVCentral Nervous System Agents
p13943
(dp13944
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p13945
(dp13946
sVEnzyme Inhibitors
p13947
(dp13948
sVCytochrome P-450 Enzyme Inhibitors
p13949
(dp13950
sVCarbonic Anhydrase Inhibitors
p13951
(dp13952
sVGynecological Antiinfectives and Antiseptics
p13953
(dp13954
sVThiadiazoles
p13955
(dp13956
sVSulfur Compounds
p13957
(dp13958
sVSulfonamides
p13959
(dp13960
sVDiuretics
p13961
(dp13962
sVCentral Nervous System Depressants
p13963
(dp13964
sVCardiovascular Agents
p13965
(dp13966
sVThiazoles
p13967
(dp13968
sVAnticonvulsants
p13969
(dp13970
sVSensory Organs
p13971
(dp13972
sVAntiglaucoma Preparations and Miotics
p13973
(dp13974
sVOphthalmologicals
p13975
(dp13976
sVGenito Urinary System and Sex Hormones
p13977
(dp13978
sVAntiglaucoma Agents
p13979
(dp13980
sVNatriuretic Agents
p13981
(dp13982
sVCytochrome P-450 CYP3A Inhibitors
p13983
(dp13984
ssg207
(dp13985
g10854
(dp13986
ssg210
(dp13987
VAdrenergic Agents
p13988
(dp13989
sVAdrenergic alpha-2 Receptor Agonists
p13990
(dp13991
sVCardiovascular Agents
p13992
(dp13993
sVOphthalmologicals
p13994
(dp13995
sVAdrenergic alpha-Agonists
p13996
(dp13997
sVVasoconstrictor Agents
p13998
(dp13999
sVSensory Organs
p14000
(dp14001
sVNeurotransmitter Agents
p14002
(dp14003
sVRespiratory System Agents
p14004
(dp14005
sVDecongestants and Antiallergics
p14006
(dp14007
sVNasal Decongestants
p14008
(dp14009
sVSympathomimetics Used as Decongestants
p14010
(dp14011
sVSympathomimetics, Plain
p14012
(dp14013
sVAdrenergic Agonists
p14014
(dp14015
sVAgents producing tachycardia
p14016
(dp14017
sVAgents that produce hypertension
p14018
(dp14019
sVAdrenergic alpha-1 Receptor Agonists
p14020
(dp14021
sVImidazoles
p14022
(dp14023
sVNasal Preparations
p14024
(dp14025
ssg213
(dp14026
VAmino Acids, Peptides, and Proteins
p14027
(dp14028
sVAngiotensin-Converting Enzyme Inhibitors
p14029
(dp14030
sVACE Inhibitors and Diuretics
p14031
(dp14032
sVACE Inhibitors and Calcium Channel Blockers
p14033
(dp14034
sVLipid Modifying Agents
p14035
(dp14036
sVDrugs that are Mainly Renally Excreted
p14037
(dp14038
sVAntihypertensive Agents
p14039
(dp14040
sVAgents causing hyperkalemia
p14041
(dp14042
sVHypotensive Agents
p14043
(dp14044
sVAgents causing angioedema
p14045
(dp14046
sg3300
(dp14047
sVProtease Inhibitors
p14048
(dp14049
sVPeptides
p14050
(dp14051
sVOligopeptides
p14052
(dp14053
sVCompounds used in a research, industrial, or household setting
p14054
(dp14055
sVEnzyme Inhibitors
p14056
(dp14057
sVCardiovascular Agents
p14058
(dp14059
sVCardiotonic Agents
p14060
(dp14061
sVProtective Agents
p14062
(dp14063
sVAgents Acting on the Renin-Angiotensin System
p14064
(dp14065
ssg216
(dp14066
g1719
(dp14067
ssg219
(dp14068
g11394
(dp14069
sVDrugs that are Mainly Renally Excreted
p14070
(dp14071
sg4317
(dp14072
sg1308
(dp14073
sVOCT1 substrates
p14074
g13060
sg9480
(dp14075
sg11262
(dp14076
sVOCT2 Inhibitors
p14077
(dp14078
sVOCT2 Substrates
p14079
(dp14080
sVOral Hypoglycemics
p14081
(dp14082
sVOCT2 substrates with narrow therapeutic index
p14083
(dp14084
sVBlood Glucose Lowering Agents
p14085
(dp14086
sVAlimentary Tract and Metabolism
p14087
(dp14088
sVDrugs Used in Diabetes
p14089
(dp14090
sg1506
(dp14091
ssg222
(dp14092
g2688
(dp14093
sg3222
(dp14094
sg5316
(dp14095
sg3753
(dp14096
sg7707
(dp14097
sg11337
(dp14098
sg12126
(dp14099
sg10170
(dp14100
sg10950
(dp14101
sg4542
(dp14102
sg2667
(dp14103
sg9918
(dp14104
ssg225
(dp14105
g630
(dp14106
sg8514
(dp14107
sg240
(dp14108
sg6318
(dp14109
sg11979
(dp14110
sg10470
(dp14111
sg9711
(dp14112
sg10884
(dp14113
sg6408
(dp14114
sg6051
(dp14115
sg8805
(dp14116
sg3900
(dp14117
sg8433
(dp14118
sg6069
(dp14119
sg6468
(dp14120
sg9987
(dp14121
sg11097
(dp14122
sg7299
(dp14123
sg7305
(dp14124
sg8097
(dp14125
sg9417
(dp14126
sg1707
(dp14127
sg7716
(dp14128
sg12066
(dp14129
sg3036
(dp14130
sg7941
(dp14131
sg3978
(dp14132
sg9981
(dp14133
sg11790
(dp14134
sg6303
(dp14135
sg570
(dp14136
sg696
(dp14137
sg11016
(dp14138
sg6684
(dp14139
sg6315
(dp14140
sg5169
(dp14141
sg387
(dp14142
sg5289
(dp14143
sg2664
(dp14144
sg9918
(dp14145
sg414
(dp14146
sg8187
(dp14147
sg780
(dp14148
ssg228
(dp14149
g11832
(dp14150
ssg231
(dp14151
g4155
(dp14152
sg183
g13858
ssg234
(dp14153
g10200
(dp14154
ssg237
(dp14155
g5766
(dp14156
sg9609
(dp14157
sg9693
(dp14158
sg6783
(dp14159
ssg240
(dp14160
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p14161
(dp14162
sVAdrenergic alpha-1 Receptor Antagonists
p14163
g14108
sVCytochrome P-450 CYP2D6 Substrates
p14164
(dp14165
sVSerotonin Agents
p14166
(dp14167
sVCytochrome P-450 CYP3A Substrates
p14168
(dp14169
sVNeurotransmitter Agents
p14170
(dp14171
sVSerotonin Receptor Antagonists
p14172
(dp14173
sVCentral Nervous System Agents
p14174
(dp14175
sVDopamine Agents
p14176
(dp14177
sVAdrenergic Antagonists
p14178
(dp14179
sVPsychotropic Drugs
p14180
(dp14181
sg2961
(dp14182
sg9204
(dp14183
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p14184
(dp14185
sVSulfur Compounds
p14186
(dp14187
sVAdrenergic alpha-Antagonists
p14188
(dp14189
sg5883
(dp14190
sVQTc Prolonging Agents
p14191
(dp14192
sVSerotonin 5-HT2 Receptor Antagonists
p14193
(dp14194
sVCentral Nervous System Depressants
p14195
(dp14196
sg5916
(dp14197
sVHistamine H1 Antagonists
p14198
(dp14199
sVAgents that produce hypertension
p14200
(dp14201
sg7758
(dp14202
sVCytochrome P-450 CYP3A4 Substrates
p14203
(dp14204
sg5154
(dp14205
sVHeterocyclic Compounds, Fused-Ring
p14206
(dp14207
sg6135
(dp14208
sVAntidepressive Agents
p14209
(dp14210
sVPsycholeptics
p14211
(dp14212
sg4992
(dp14213
sVNeurotoxic agents
p14214
(dp14215
sVHistamine Antagonists
p14216
(dp14217
sVNervous System
p14218
(dp14219
sVTranquilizing Agents
p14220
(dp14221
ssg243
(dp14222
g630
(dp14223
sg10854
(dp14224
sg1425
(dp14225
sg7422
(dp14226
sg1707
(dp14227
sg240
g14177
sg6318
(dp14228
sg465
(dp14229
sg9711
(dp14230
sg5247
(dp14231
sg9165
(dp14232
sg168
g13617
sg2559
(dp14233
sg10674
(dp14234
sg2658
(dp14235
sg1263
(dp14236
sg3048
(dp14237
sg8067
(dp14238
sg3111
(dp14239
sg11016
(dp14240
sg288
(dp14241
sg3156
(dp14242
sg516
(dp14243
sg11097
(dp14244
sg603
(dp14245
sg5694
(dp14246
sg1635
(dp14247
sg3018
(dp14248
sg6966
(dp14249
sg2265
(dp14250
sg8487
(dp14251
sg5535
(dp14252
sg8514
(dp14253
sg486
(dp14254
sg9252
(dp14255
sg11154
(dp14256
sg7299
(dp14257
sg10017
(dp14258
sg3570
(dp14259
sg7176
(dp14260
sg5169
(dp14261
sg8334
(dp14262
sg282
(dp14263
sg6525
(dp14264
sg11931
(dp14265
sg6921
(dp14266
sg1194
(dp14267
sg414
(dp14268
sg8187
(dp14269
sg11790
(dp14270
sg780
(dp14271
ssg246
(dp14272
g1980
(dp14273
sg8193
(dp14274
sg735
(dp14275
sg11040
(dp14276
sg2862
(dp14277
sg12057
(dp14278
sg5556
(dp14279
sg11100
(dp14280
sg10953
(dp14281
sg3216
(dp14282
sg6213
(dp14283
ssg249
(dp14284
g645
(dp14285
sg6549
(dp14286
sg1629
(dp14287
sg10272
(dp14288
sg4467
(dp14289
sg9462
(dp14290
sg5256
(dp14291
sg1038
(dp14292
sg4341
(dp14293
sg10290
(dp14294
sg2943
(dp14295
sg1812
(dp14296
sg9810
(dp14297
sg8781
(dp14298
sg4650
(dp14299
sg11619
(dp14300
sg10797
(dp14301
sg4320
(dp14302
sg1869
(dp14303
sg2256
(dp14304
sg3090
(dp14305
sg7719
(dp14306
sg8658
(dp14307
sg8241
(dp14308
sg9846
(dp14309
sg2058
(dp14310
sg891
(dp14311
sg2805
(dp14312
sg2418
(dp14313
sg6939
(dp14314
sg10977
(dp14315
sg8655
(dp14316
sg9702
(dp14317
sg4959
(dp14318
sg2505
(dp14319
sg11820
(dp14320
sg10230
(dp14321
sg10728
(dp14322
sg9426
(dp14323
sg11874
(dp14324
sg7317
(dp14325
sg4926
(dp14326
sg6471
(dp14327
sg3249
(dp14328
sg10245
(dp14329
sg6474
(dp14330
sg7905
(dp14331
sg10974
(dp14332
sg3408
(dp14333
sg5556
(dp14334
sg8493
(dp14335
sg969
(dp14336
sg5025
(dp14337
sS'Acetic Acid'
p14338
g13545
sg1356
(dp14339
sg11535
(dp14340
sg11733
(dp14341
sg12111
(dp14342
sg141
g13324
sg8577
(dp14343
sg10218
(dp14344
sg10794
(dp14345
sg10074
(dp14346
sg12186
(dp14347
sg6048
(dp14348
sg10119
(dp14349
sg7020
(dp14350
sg2715
(dp14351
sg12057
(dp14352
sg2826
(dp14353
sg6537
(dp14354
sg1401
(dp14355
sg11385
(dp14356
ssg252
(dp14357
g8088
(dp14358
sg7407
(dp14359
ssg255
(dp14360
VAdrenergic beta-Agonists
p14361
(dp14362
sVBronchodilator Agents
p14363
(dp14364
sVAdrenergic and Dopaminergic Agents
p14365
(dp14366
sVSympathomimetics
p14367
(dp14368
sVCompounds used in a research, industrial, or household setting
p14369
(dp14370
sVPhenols
p14371
(dp14372
sVDrugs for Obstructive Airway Diseases
p14373
(dp14374
sVAutonomic Agents
p14375
(dp14376
sVCardiac Stimulants Excl. Cardiac Glycosides
p14377
(dp14378
sVCardiac Therapy
p14379
(dp14380
sVRespiratory System Agents
p14381
(dp14382
sVProtective Agents
p14383
(dp14384
sVAdrenergics, Inhalants
p14385
(dp14386
sVAdrenergic Agents
p14387
(dp14388
sVNeurotransmitter Agents
p14389
(dp14390
sVCardiovascular Agents
p14391
(dp14392
sVAdrenergics for Systemic Use
p14393
(dp14394
sVBenzene Derivatives
p14395
(dp14396
sVCatecholamines
p14397
(dp14398
sVAdrenergic Agonists
p14399
(dp14400
sVAgents that produce hypertension
p14401
(dp14402
sVAnti-Asthmatic Agents
p14403
(dp14404
sVCardiotonic Agents
p14405
(dp14406
sVAmines
p14407
(dp14408
sVCatechols
p14409
(dp14410
sVAdrenergic beta-2 Receptor Agonists
p14411
(dp14412
sVEthanolamines
p14413
(dp14414
sVAmino Alcohols
p14415
(dp14416
sVPeripheral Nervous System Agents
p14417
(dp14418
sVAgents producing tachycardia
p14419
(dp14420
sVAlcohols
p14421
(dp14422
sg4800
(dp14423
ssg258
(dp14424
g6552
(dp14425
ssg261
(dp14426
g11112
(dp14427
sg6966
(dp14428
sg5169
(dp14429
sg387
(dp14430
sg11016
(dp14431
sg2664
(dp14432
sg7941
(dp14433
sg6318
(dp14434
sg1044
(dp14435
sg11979
(dp14436
sg11790
(dp14437
sg7299
(dp14438
sg9981
(dp14439
sg6468
(dp14440
ssg264
(dp14441
g11319
(dp14442
sg210
g14013
sg2067
(dp14443
sg11652
(dp14444
sg4488
(dp14445
sg9264
(dp14446
sg612
(dp14447
sg11445
(dp14448
sg5598
(dp14449
sg9093
(dp14450
ssg267
(dp14451
g6765
(dp14452
sg6009
(dp14453
sg13091
(dp14454
sg7848
(dp14455
ssg270
(dp14456
g3891
(dp14457
ssg273
(dp14458
g4974
(dp14459
ssg276
(dp14460
g10833
(dp14461
sg11061
(dp14462
sg3576
(dp14463
sg7881
(dp14464
sg8985
(dp14465
sg10326
(dp14466
sg1101
(dp14467
sg5520
(dp14468
sg1527
(dp14469
sg7500
(dp14470
sg2991
(dp14471
sg6654
(dp14472
sg11427
(dp14473
sg2250
(dp14474
sg279
(dp14475
sg4953
(dp14476
sg5871
(dp14477
ssg279
(dp14478
VAntiinfectives for Systemic Use
p14479
(dp14480
sVDrugs that are Mainly Renally Excreted
p14481
(dp14482
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p14483
g14475
sVAntivirals for Systemic Use
p14484
(dp14485
sVHeterocyclic Compounds, Fused-Ring
p14486
(dp14487
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p14488
(dp14489
sVNephrotoxic agents
p14490
(dp14491
sVAnti-Infective Agents
p14492
(dp14493
sVP-glycoprotein/ABCB1 Substrates
p14494
(dp14495
sVAntiviral Agents
p14496
(dp14497
sVDirect Acting Antivirals
p14498
(dp14499
sVOAT3/SLC22A8 Substrates
p14500
g13108
sVAnti-HIV Agents
p14501
(dp14502
sVP-glycoprotein/ABCB1 Inhibitors
p14503
(dp14504
sVPurines
p14505
(dp14506
sVTenofovir and prodrugs
p14507
(dp14508
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p14509
(dp14510
sVReverse Transcriptase Inhibitors
p14511
(dp14512
sVAnti-Retroviral Agents
p14513
(dp14514
sVOAT1/SLC22A6 Substrates
p14515
(dp14516
sVOrganophosphorus Compounds
p14517
(dp14518
ssg282
(dp14519
VCytochrome P-450 CYP3A4 Inhibitors
p14520
(dp14521
sVCytochrome P-450 CYP2D6 Substrates
p14522
(dp14523
sVCytochrome P-450 CYP3A Substrates
p14524
(dp14525
sVNeurotransmitter Agents
p14526
(dp14527
sVCentral Nervous System Agents
p14528
(dp14529
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p14530
(dp14531
sVCYP3A Substrates (Sensitive)
p14532
(dp14533
sVPsychotropic Drugs
p14534
(dp14535
sVCytochrome P-450 CYP2E1 Inhibitors
p14536
(dp14537
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p14538
(dp14539
sVCytochrome P-450 Enzyme Inhibitors
p14540
(dp14541
sg2385
(dp14542
sVCytochrome P-450 CYP1A2 Substrates
p14543
(dp14544
sVHeterocyclic Compounds, Fused-Ring
p14545
(dp14546
sVAntipsychotic Agents
p14547
(dp14548
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p14549
(dp14550
sVMiscellaneous Antipsychotics
p14551
(dp14552
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p14553
(dp14554
sVQTc Prolonging Agents
p14555
(dp14556
sVHighest Risk QTc-Prolonging Agents
p14557
(dp14558
sVCentral Nervous System Depressants
p14559
(dp14560
sVAgents that reduce seizure threshold
p14561
(dp14562
sVAnti-Dyskinesia Agents
p14563
(dp14564
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p14565
(dp14566
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p14567
(dp14568
sVPsycholeptics
p14569
(dp14570
sVAntipsychotic Agents (First Generation [Typical])
p14571
(dp14572
sVCytochrome P-450 CYP3A5 Substrates
p14573
(dp14574
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p14575
(dp14576
sVCytochrome P-450 CYP3A4 Substrates
p14577
(dp14578
sVNarrow Therapeutic Index Drugs
p14579
(dp14580
sVDopamine Agents
p14581
g14263
sVDopamine D2 Receptor Antagonists
p14582
(dp14583
sVBenzimidazoles
p14584
(dp14585
sVCytochrome P-450 CYP3A Inhibitors
p14586
(dp14587
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p14588
(dp14589
sVDopamine Antagonists
p14590
(dp14591
sVP-glycoprotein/ABCB1 Inhibitors
p14592
(dp14593
sVNeurotoxic agents
p14594
(dp14595
sVNervous System
p14596
(dp14597
sVTranquilizing Agents
p14598
(dp14599
sVCytochrome P-450 CYP3A7 Substrates
p14600
(dp14601
ssg285
(dp14602
VCytochrome P-450 CYP2C19 Substrates
p14603
(dp14604
sVCytochrome P-450 CYP2C8 Substrates
p14605
(dp14606
sVBlood and Blood Forming Organs
p14607
(dp14608
sVCytochrome P-450 CYP3A5 Substrates
p14609
(dp14610
sg9576
(dp14611
sVHematologic Agents
p14612
(dp14613
sVAnticoagulants
p14614
(dp14615
sVCytochrome P-450 CYP3A Substrates
p14616
(dp14617
sg9342
(dp14618
sVBCRP/ABCG2 Substrates
p14619
(dp14620
sVP-glycoprotein/ABCB1 Substrates
p14621
(dp14622
sVCytochrome P-450 CYP1A2 Substrates
p14623
(dp14624
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p14625
(dp14626
sVPyridines
p14627
(dp14628
sVEnzyme Inhibitors
p14629
(dp14630
sVCytochrome P-450 CYP2C9 Substrates
p14631
(dp14632
sVCytochrome P-450 CYP3A4 Substrates
p14633
(dp14634
sg8877
(dp14635
ssg288
(dp14636
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p14637
(dp14638
sVAnti-Parkinson Drugs
p14639
(dp14640
sVCytochrome P-450 CYP2D6 Inhibitors
p14641
(dp14642
sVCytochrome P-450 CYP3A Substrates
p14643
(dp14644
sVBCRP/ABCG2 Inhibitors
p14645
g12526
sVDopamine Agents
p14646
g14241
sVCytochrome P-450 CYP2E1 Inhibitors
p14647
(dp14648
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p14649
(dp14650
sVCytochrome P-450 CYP2C9 Inhibitors
p14651
(dp14652
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p14653
g12668
sVCytochrome P-450 Enzyme Inhibitors
p14654
(dp14655
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p14656
(dp14657
sVBreast Cancer Resistance Protein Inhibitors
p14658
g12725
sVAmino Acids
p14659
(dp14660
sVAmines
p14661
(dp14662
sVBenzyl Compounds
p14663
(dp14664
sVMonoamine Oxidase-B Inhibitors
p14665
(dp14666
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p14667
(dp14668
sVCentral Nervous System Depressants
p14669
(dp14670
sVMonoamine Oxidase B Inhibitors
p14671
(dp14672
sVBenzene Derivatives
p14673
(dp14674
sVAgents that reduce seizure threshold
p14675
(dp14676
sVCytochrome P-450 CYP1A2 Inhibitors
p14677
(dp14678
sVCytochrome P-450 CYP2B6 Inhibitors
p14679
(dp14680
sVMonoamine Oxidase Inhibitors
p14681
(dp14682
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p14683
(dp14684
sVCytochrome P-450 CYP3A5 Inhibitors
p14685
(dp14686
sVAgents that produce hypertension
p14687
(dp14688
sVCytochrome P-450 CYP2C19 Inhibitors
p14689
(dp14690
sVCytochrome P-450 CYP3A4 Substrates
p14691
(dp14692
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p14693
(dp14694
sVAmino Acids, Peptides, and Proteins
p14695
(dp14696
sVAntidepressive Agents
p14697
(dp14698
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p14699
(dp14700
sVCytochrome P-450 CYP3A Inhibitors
p14701
(dp14702
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p14703
(dp14704
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p14705
(dp14706
sVNervous System
p14707
(dp14708
ssg291
(dp14709
g8622
(dp14710
sg318
(dp14711
sg12051
(dp14712
sg4299
(dp14713
ssg294
(dp14714
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p14715
(dp14716
sVCytochrome P-450 CYP2D6 Substrates
p14717
(dp14718
sVOAT1/SLC22A6 inhibitors
p14719
(dp14720
sVAnalgesics
p14721
(dp14722
sVOpiate Agonists
p14723
(dp14724
sVCentral Nervous System Agents
p14725
(dp14726
sVNarcotics
p14727
(dp14728
sVDrugs that are Mainly Renally Excreted
p14729
(dp14730
sVMorphine Derivatives
p14731
(dp14732
sVCytochrome P-450 CYP3A4 Substrates
p14733
(dp14734
sVOpioids
p14735
(dp14736
sVRespiratory System Agents
p14737
(dp14738
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p14739
(dp14740
sVCytochrome P-450 CYP3A Substrates
p14741
(dp14742
sVNatural Opium Alkaloids
p14743
(dp14744
sVOCT1 inhibitors
p14745
(dp14746
sVCentral Nervous System Depressants
p14747
(dp14748
sVOCT1 substrates
p14749
g13069
sg11502
(dp14750
sVOpiate Alkaloids
p14751
(dp14752
sVAntitussive Agents
p14753
(dp14754
sVMorphinans
p14755
(dp14756
sVPhenanthrenes
p14757
(dp14758
sVHeterocyclic Compounds, Fused-Ring
p14759
(dp14760
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p14761
(dp14762
sVOpioid Agonist
p14763
(dp14764
sVUGT2B7 substrates
p14765
(dp14766
sVAlkaloids
p14767
(dp14768
sVSensory System Agents
p14769
(dp14770
sVCough and Cold Preparations
p14771
(dp14772
sVNervous System
p14773
(dp14774
ssg297
(dp14775
g6552
(dp14776
ssg300
(dp14777
g3174
(dp14778
sg30
g12368
sg9096
(dp14779
sg2739
(dp14780
sg5865
(dp14781
ssg303
(dp14782
g4911
(dp14783
sg5469
(dp14784
sg4017
(dp14785
sg4155
(dp14786
sg4023
(dp14787
sg8721
(dp14788
sg6819
(dp14789
sg183
g13804
sg4653
(dp14790
sS'Nicotine'
p14791
(dp14792
sg5085
(dp14793
sg6045
(dp14794
sg12534
(dp14795
ssg306
(dp14796
g4155
(dp14797
sg2199
(dp14798
sg183
g13808
sg6792
(dp14799
sg7329
(dp14800
sg4959
(dp14801
ssg309
(dp14802
g2850
(dp14803
ssg312
(dp14804
g4620
(dp14805
sg3117
(dp14806
sg816
(dp14807
sg831
(dp14808
sg9903
(dp14809
sg1800
(dp14810
sg2226
(dp14811
sg4653
(dp14812
sg5469
(dp14813
sg7668
(dp14814
sg8430
(dp14815
sg8445
(dp14816
sg2388
(dp14817
sg3543
(dp14818
sg10272
(dp14819
sg102
g13011
sg9225
(dp14820
sg3219
(dp14821
sS'Norgestrel'
p14822
(dp14823
sg5556
(dp14824
sg3861
(dp14825
sg5433
(dp14826
sg966
(dp14827
sg165
g13598
sg2826
(dp14828
sS'Fluocinolone Acetonide'
p14829
(dp14830
sg8595
(dp14831
sg12274
(dp14832
sg4875
(dp14833
sg1383
(dp14834
sg7545
(dp14835
sg1614
(dp14836
sg4680
(dp14837
sS'Betamethasone'
p14838
(dp14839
sg4089
(dp14840
sg8658
(dp14841
sg12534
(dp14842
sg9357
(dp14843
sg4113
(dp14844
sg6345
(dp14845
sg8694
(dp14846
sg11733
(dp14847
sg6504
(dp14848
sg10209
(dp14849
sg1245
(dp14850
sg8013
(dp14851
sg5766
(dp14852
sg2373
(dp14853
sg10041
(dp14854
sg4236
(dp14855
sg6585
(dp14856
sg4257
(dp14857
sg2043
(dp14858
sg507
(dp14859
sg11940
(dp14860
sg5895
(dp14861
sg11886
(dp14862
sg9609
(dp14863
sg543
(dp14864
sg3393
(dp14865
sg3249
(dp14866
sg2127
(dp14867
sg2133
(dp14868
sg8142
(dp14869
sg11922
(dp14870
sg13750
(dp14871
sS'Methylprednisolone'
p14872
(dp14873
sg9693
(dp14874
sg6045
(dp14875
sg4476
(dp14876
sg1470
(dp14877
sg6783
(dp14878
sg849
(dp14879
sg11997
(dp14880
sg9774
(dp14881
sg8277
(dp14882
sg9030
(dp14883
sg11316
(dp14884
sg2832
(dp14885
sg5238
(dp14886
sg6123
(dp14887
sg2286
(dp14888
sg3783
(dp14889
sg5364
(dp14890
sg8949
(dp14891
sg12132
(dp14892
sg12057
(dp14893
ssg315
(dp14894
g1188
(dp14895
ssg318
(dp14896
VAntivirals for Systemic Use
p14897
(dp14898
sVUGT1A1 Substrates
p14899
g12270
sg1557
(dp14900
sVUGT1A9 Substrates
p14901
(dp14902
sVOCT2 Inhibitors
p14903
(dp14904
sVAnti-HIV Agents
p14905
(dp14906
sVBCRP/ABCG2 Substrates
p14907
(dp14908
sVEnzyme Inhibitors
p14909
(dp14910
sVAnti-Infective Agents
p14911
(dp14912
sVAntiinfectives for Systemic Use
p14913
(dp14914
sVUGT1A3 substrates
p14915
(dp14916
sVOAT1/SLC22A6 inhibitors
p14917
(dp14918
sg2259
(dp14919
sVP-glycoprotein/ABCB1 Substrates
p14920
(dp14921
sg6369
(dp14922
sVAnti-Retroviral Agents
p14923
(dp14924
sg7683
(dp14925
sVDirect Acting Antivirals
p14926
(dp14927
sVHeterocyclic Compounds, Fused-Ring
p14928
(dp14929
sVOAT3/SLC22A8 Inhibitors
p14930
(dp14931
sVAntiviral Agents
p14932
(dp14933
sg291
g14711
ssg321
(dp14934
g219
g14080
sg1659
(dp14935
sg11427
(dp14936
sg9375
(dp14937
sg6408
(dp14938
sg2598
(dp14939
sg8067
(dp14940
sg10326
(dp14941
sg4488
(dp14942
sg7824
(dp14943
sg339
(dp14944
sg7500
(dp14945
sg2769
(dp14946
sg10365
(dp14947
sg1635
(dp14948
sg6981
(dp14949
sg10854
(dp14950
sg10416
(dp14951
sg8760
(dp14952
sg9033
(dp14953
sg11241
(dp14954
sg9855
(dp14955
sg6525
(dp14956
ssg324
(dp14957
g6411
(dp14958
sg11544
(dp14959
sg7464
(dp14960
sg10818
(dp14961
sg4635
(dp14962
sg7569
(dp14963
sg1491
(dp14964
sg3447
(dp14965
sg2433
(dp14966
ssg327
(dp14967
g11862
(dp14968
sg4062
(dp14969
sg5574
(dp14970
sg5934
(dp14971
sg3231
(dp14972
sg9687
(dp14973
sg1941
(dp14974
sg4341
(dp14975
sg978
(dp14976
sg7641
(dp14977
sg10383
(dp14978
sg879
(dp14979
sg4656
(dp14980
ssg330
(dp14981
g2805
(dp14982
ssg333
(dp14983
g8373
(dp14984
sg4017
(dp14985
sg10266
(dp14986
sg7821
(dp14987
sg5805
(dp14988
sg6186
(dp14989
sg10818
(dp14990
sg4635
(dp14991
sg12421
g12464
sg2481
(dp14992
sg5433
(dp14993
sg9507
(dp14994
sg2346
(dp14995
sg9918
(dp14996
sg834
(dp14997
sg5832
(dp14998
sg8211
(dp14999
sg2736
(dp15000
sg138
g13295
sg10797
(dp15001
sg5652
(dp15002
sg2559
(dp15003
sg8055
(dp15004
sg5256
(dp15005
sg4857
(dp15006
sg7464
(dp15007
sg288
g14678
sg9198
(dp15008
sg11655
(dp15009
sg888
(dp15010
sg2838
(dp15011
sg4680
(dp15012
sg1491
(dp15013
sg8820
(dp15014
sg5295
(dp15015
sS'Ofloxacin'
p15016
(dp15017
sg12274
(dp15018
sg2910
(dp15019
sg6447
(dp15020
sg10728
(dp15021
sg10518
(dp15022
sg2769
(dp15023
sg9231
(dp15024
sg10365
(dp15025
sg1140
(dp15026
sg696
(dp15027
sg7569
(dp15028
sg945
(dp15029
sg789
(dp15030
sg8856
(dp15031
sg9357
(dp15032
sg8298
(dp15033
sg7065
(dp15034
sg8949
(dp15035
sg11166
(dp15036
sg7698
(dp15037
sg2688
(dp15038
sg7563
(dp15039
sg3222
(dp15040
sg4164
(dp15041
sg771
(dp15042
sg9417
(dp15043
sg5757
(dp15044
sg5370
(dp15045
sg2913
(dp15046
sg12126
(dp15047
sg7197
(dp15048
sg10356
(dp15049
sg3447
(dp15050
sg11241
(dp15051
sg1185
(dp15052
sg5793
(dp15053
sg7041
(dp15054
sg1908
(dp15055
ssg336
(dp15056
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p15057
(dp15058
sVUGT1A1 Substrates
p15059
g12335
sVOAT1/SLC22A6 inhibitors
p15060
(dp15061
sVAnalgesics
p15062
(dp15063
sVAgents causing hyperkalemia
p15064
(dp15065
sVCOX-1 Inhibitors
p15066
(dp15067
sVAntiinflammatory Products for Vaginal Administration
p15068
(dp15069
sVCentral Nervous System Agents
p15070
(dp15071
sVUGT1A9 Substrates
p15072
(dp15073
sVAntiinflammatory and Antirheumatic Products
p15074
(dp15075
sVEnzyme Inhibitors
p15076
(dp15077
sVCytochrome P-450 Enzyme Inhibitors
p15078
(dp15079
sVThroat Preparations
p15080
(dp15081
sVPeripheral Nervous System Agents
p15082
(dp15083
sVDrugs that are Mainly Renally Excreted
p15084
(dp15085
sVCytochrome P-450 CYP2C8 Substrates
p15086
(dp15087
sVNonsteroidal Anti-inflammatory Compounds
p15088
(dp15089
sVAnalgesics, Non-Narcotic
p15090
(dp15091
sVUGT1A3 substrates
p15092
(dp15093
sVNephrotoxic agents
p15094
(dp15095
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p15096
(dp15097
sVAcids, Carbocyclic
p15098
(dp15099
sVPhenylpropionates
p15100
(dp15101
sVCytochrome P-450 CYP2C9 Substrates
p15102
(dp15103
sVTopical Products for Joint and Muscular Pain
p15104
g13932
sVCOX-2 Inhibitors
p15105
(dp15106
sVOpioids
p15107
(dp15108
sVP-glycoprotein/ABCB1 Substrates
p15109
(dp15110
sVAgents causing angioedema
p15111
(dp15112
sVOther Nonsteroidal Antiimflammatory Agents
p15113
(dp15114
sVPropionates
p15115
(dp15116
sVNon COX-2 selective NSAIDS
p15117
(dp15118
sVAgents that produce hypertension
p15119
(dp15120
sVUGT2B7 substrates
p15121
(dp15122
sVOAT3/SLC22A8 Inhibitors
p15123
(dp15124
sVAnti-Inflammatory Agents
p15125
(dp15126
sVCyclooxygenase Inhibitors
p15127
(dp15128
sVP-glycoprotein/ABCB1 Inhibitors
p15129
(dp15130
sVAntirheumatic Agents
p15131
(dp15132
sVSensory System Agents
p15133
(dp15134
sVAnti-Inflammatory Agents, Non-Steroidal
p15135
(dp15136
sVNervous System
p15137
(dp15138
ssg339
(dp15139
VCytochrome P-450 CYP3A4 Inhibitors
p15140
(dp15141
sVCytochrome P-450 CYP3A Substrates
p15142
(dp15143
sVDPP-IV Inhibitors
p15144
(dp15145
sVAgents causing angioedema
p15146
(dp15147
sVProtease Inhibitors
p15148
(dp15149
sVOCT2 Inhibitors
p15150
(dp15151
sVHormones
p15152
(dp15153
sVEnzyme Inhibitors
p15154
(dp15155
sVCytochrome P-450 Enzyme Inhibitors
p15156
(dp15157
sVBlood Glucose Lowering Agents
p15158
(dp15159
sVQuinazolines
p15160
(dp15161
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p15162
(dp15163
sVOral Hypoglycemics
p15164
(dp15165
sVOCT2 substrates with narrow therapeutic index
p15166
(dp15167
sVDrugs Used in Diabetes
p15168
(dp15169
sVOCT1 inhibitors
p15170
(dp15171
sVOCT2 Substrates
p15172
g14944
sVP-glycoprotein/ABCB1 Substrates
p15173
(dp15174
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p15175
(dp15176
sVIncretins
p15177
(dp15178
sVCytochrome P-450 CYP3A4 Substrates
p15179
(dp15180
sVAlimentary Tract and Metabolism
p15181
(dp15182
sVPurines
p15183
(dp15184
sVHeterocyclic Compounds, Fused-Ring
p15185
(dp15186
sVCytochrome P-450 CYP3A Inhibitors
p15187
(dp15188
sVP-glycoprotein/ABCB1 Inhibitors
p15189
(dp15190
sVHormones, Hormone Substitutes, and Hormone Antagonists
p15191
(dp15192
ssg342
(dp15193
g141
g13357
ssg345
(dp15194
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p15195
(dp15196
sg2193
(dp15197
sVCytochrome P-450 CYP2D6 Substrates
p15198
(dp15199
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p15200
(dp15201
sVSerotonin Agents
p15202
(dp15203
sVCytochrome P-450 CYP3A Substrates
p15204
(dp15205
sVNeurotransmitter Agents
p15206
(dp15207
sVCentral Nervous System Agents
p15208
(dp15209
sVCycloparaffins
p15210
(dp15211
sVPsychotropic Drugs
p15212
(dp15213
sg1443
(dp15214
sVSelective Serotonin Reuptake Inhibitors
p15215
(dp15216
sVDrugs that are Mainly Renally Excreted
p15217
(dp15218
sVCytochrome P-450 CYP2C8 Substrates
p15219
(dp15220
sVNeurotransmitter Uptake Inhibitors
p15221
(dp15222
sVSerotonin and Noradrenaline Reuptake Inhibitors
p15223
(dp15224
sVMiscellaneous Antidepressants
p15225
(dp15226
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p15227
(dp15228
sVCentral Nervous System Depressants
p15229
(dp15230
sVP-glycoprotein/ABCB1 Substrates
p15231
(dp15232
sVAdrenergic Uptake Inhibitors
p15233
(dp15234
sVMembrane Transport Modulators
p15235
(dp15236
sVCytochrome P-450 CYP3A4 Substrates
p15237
(dp15238
sVSerotonin Modulators
p15239
(dp15240
sVAntidepressive Agents
p15241
(dp15242
sVHypoglycemia-Associated Agents
p15243
(dp15244
sVNorepinephrine Uptake Inhibitors
p15245
(dp15246
sVAgents producing tachycardia
p15247
(dp15248
ssg348
(dp15249
g2736
(dp15250
ssg351
(dp15251
VDrugs that are Mainly Renally Excreted
p15252
(dp15253
sVAnti-Acne Preparations for Topical Use
p15254
(dp15255
sVAcids, Acyclic
p15256
(dp15257
sg6195
(dp15258
sVDermatologicals
p15259
(dp15260
sVAnti-Acne Preparations
p15261
(dp15262
sVMisc. Skin and Mucous Membrane Agents
p15263
(dp15264
sVDecreased Sebaceous Gland Activity
p15265
(dp15266
ssg354
(dp15267
VAgents Causing Muscle Toxicity
p15268
(dp15269
sVAntiinfectives for Systemic Use
p15270
(dp15271
sVAgents that produce neuromuscular block (indirect)
p15272
(dp15273
sVOAT1/SLC22A6 inhibitors
p15274
(dp15275
sVStomatological Preparations
p15276
(dp15277
sVOAT3/SLC22A8 Inhibitors
p15278
(dp15279
sVTetracyclines
p15280
(dp15281
sVAntiinfectives and Antiseptics for Local Oral Treatment
p15282
(dp15283
sVAnti-Bacterial Agents
p15284
(dp15285
sVAntibacterials for Systemic Use
p15286
(dp15287
sVNaphthacenes
p15288
(dp15289
sVAnti-Infective Agents
p15290
(dp15291
sVAlimentary Tract and Metabolism
p15292
(dp15293
ssg357
(dp15294
VCarbohydrates
p15295
(dp15296
sVGranulocyte Colony-Stimulating Factor
p15297
(dp15298
sVBiological Factors
p15299
(dp15300
sVGlycoconjugates
p15301
(dp15302
sVColony-Stimulating Factors
p15303
(dp15304
sVGlycols
p15305
(dp15306
sVAntineoplastic and Immunomodulating Agents
p15307
(dp15308
sVHematopoietic Cell Growth Factors
p15309
(dp15310
sVPolymers
p15311
(dp15312
sVProteins
p15313
(dp15314
sVPeptides
p15315
(dp15316
sVBiomedical and Dental Materials
p15317
(dp15318
sVAdjuvants, Immunologic
p15319
(dp15320
sVEthylene Glycols
p15321
(dp15322
sVAmino Acids, Peptides, and Proteins
p15323
(dp15324
sVIntercellular Signaling Peptides and Proteins
p15325
(dp15326
sVPegylated agents
p15327
g13557
sVMacromolecular Substances
p15328
(dp15329
sVGlycoproteins
p15330
(dp15331
sVAlcohols
p15332
(dp15333
sVCytokines
p15334
(dp15335
sVCompounds used in a research, industrial, or household setting
p15336
(dp15337
ssg360
(dp15338
g6156
(dp15339
sg1134
(dp15340
sg11655
(dp15341
sg10959
(dp15342
ssg363
(dp15343
g11079
(dp15344
ssg366
(dp15345
g10263
(dp15346
sg5805
(dp15347
sg4827
(dp15348
sg1044
(dp15349
sg5829
(dp15350
sg4452
(dp15351
sg3708
(dp15352
sg6759
(dp15353
sg9987
(dp15354
sg909
(dp15355
sg10557
(dp15356
sg9012
(dp15357
sg3036
(dp15358
sg1719
(dp15359
sg10761
(dp15360
sg3114
(dp15361
sg10005
(dp15362
sg1548
(dp15363
sg8862
(dp15364
sg10098
(dp15365
sg3531
(dp15366
sg3240
(dp15367
sg10227
(dp15368
sg4056
(dp15369
sg2304
(dp15370
sg2616
(dp15371
sg5580
(dp15372
ssg369
(dp15373
g2658
(dp15374
sg1473
(dp15375
sg3399
(dp15376
sg11172
(dp15377
sg564
(dp15378
sg4650
(dp15379
sg3930
(dp15380
ssg372
(dp15381
VAmino Acids, Peptides, and Proteins
p15382
(dp15383
sVHematologic Agents
p15384
(dp15385
sVBlood and Blood Forming Organs
p15386
(dp15387
sVPeptides
p15388
(dp15389
sVErythropoietin
p15390
(dp15391
sVColony-Stimulating Factors
p15392
(dp15393
sVHematopoietic Cell Growth Factors
p15394
(dp15395
sVHematinics
p15396
(dp15397
sVCarbohydrates
p15398
(dp15399
sVProteins
p15400
(dp15401
sVIntercellular Signaling Peptides and Proteins
p15402
(dp15403
sVIncreased Erythroid Cell Production
p15404
(dp15405
sVErythropoiesis-Stimulating Agents
p15406
g13889
sVBiological Factors
p15407
(dp15408
sVGlycoconjugates
p15409
(dp15410
sVAntianemic Preparations
p15411
(dp15412
sVGlycoproteins
p15413
(dp15414
sVCytokines
p15415
(dp15416
sVErythropoietin, genetics
p15417
(dp15418
ssg375
(dp15419
VAgents Causing Muscle Toxicity
p15420
(dp15421
sVAmino Acids, Cyclic
p15422
(dp15423
sVCOMT Substrates
p15424
(dp15425
sVNeurotransmitter Agents
p15426
(dp15427
sVHypotensive Agents
p15428
(dp15429
sVCentral Alpha-agonists
p15430
(dp15431
sVPhenols
p15432
(dp15433
sVPeripheral Nervous System Agents
p15434
(dp15435
sVSympatholytics
p15436
(dp15437
sVDrugs that are Mainly Renally Excreted
p15438
(dp15439
sVAmino Acids
p15440
(dp15441
sVAmines
p15442
(dp15443
sVAntihypertensive Agents
p15444
(dp15445
sVDihydroxyphenylalanine
p15446
(dp15447
sVTyrosine
p15448
(dp15449
sVAmino Acids, Aromatic
p15450
(dp15451
sVAdrenergic Agents
p15452
(dp15453
sVCardiovascular Agents
p15454
(dp15455
sVBenzene Derivatives
p15456
(dp15457
sVCentral alpha-2 Adrenergic Agonist
p15458
(dp15459
sVCatecholamines
p15460
(dp15461
sVAdrenergic Agonists
p15462
(dp15463
sVAutonomic Agents
p15464
(dp15465
sVAmino Acids, Peptides, and Proteins
p15466
(dp15467
sVCatechols
p15468
(dp15469
sVAdrenergic alpha-2 Receptor Agonists
p15470
(dp15471
sVAmino Acids, Essential
p15472
(dp15473
sVAdrenergic alpha-Agonists
p15474
(dp15475
sVBradycardia-Causing Agents
p15476
(dp15477
sVPhenylalanine
p15478
(dp15479
ssg378
(dp15480
g645
(dp15481
sg5532
(dp15482
sg1629
(dp15483
sg9507
(dp15484
sg4737
(dp15485
sg10296
(dp15486
ssg381
(dp15487
g4164
(dp15488
sg6075
(dp15489
sg9663
(dp15490
sg8049
(dp15491
sg8298
(dp15492
ssg384
(dp15493
g11283
(dp15494
sg6318
(dp15495
sg9165
(dp15496
sg11016
(dp15497
sg2418
(dp15498
sg3156
(dp15499
sg2427
(dp15500
sg915
(dp15501
sg3930
(dp15502
sg6726
(dp15503
sg6966
(dp15504
sg1704
(dp15505
sg8487
(dp15506
sg933
(dp15507
sg9981
(dp15508
sg450
(dp15509
sg8514
(dp15510
sg6303
(dp15511
sg3978
(dp15512
sg10497
(dp15513
sg10815
(dp15514
sg10356
(dp15515
sg7029
(dp15516
sg10056
(dp15517
sg2559
(dp15518
sg7056
(dp15519
sg11595
(dp15520
sg240
g14210
sg12066
(dp15521
sg1044
(dp15522
sg10662
(dp15523
sg6156
(dp15524
sg11655
(dp15525
sg288
g14698
sg8655
(dp15526
sg9417
(dp15527
sg3381
(dp15528
sg345
g15242
sg7941
(dp15529
sg1134
(dp15530
sg7152
(dp15531
sg8028
(dp15532
sg8721
(dp15533
sg387
(dp15534
sg1194
(dp15535
sg414
(dp15536
sg6921
(dp15537
sg1908
(dp15538
sg465
(dp15539
sg10266
(dp15540
sg8031
(dp15541
sg10308
(dp15542
sg168
g13675
sg1263
(dp15543
sg11097
(dp15544
sg7299
(dp15545
sg7389
(dp15546
sg2910
(dp15547
sg8097
(dp15548
sg6639
(dp15549
sg5919
(dp15550
sg10959
(dp15551
sg696
(dp15552
sg564
(dp15553
sg1668
(dp15554
sg4344
(dp15555
sg8874
(dp15556
sg5169
(dp15557
sg11931
(dp15558
sg11112
(dp15559
sg630
(dp15560
sg633
(dp15561
sg2199
(dp15562
sg7422
(dp15563
sg8163
(dp15564
sg11979
(dp15565
sg1434
(dp15566
sg10470
(dp15567
sg9711
(dp15568
sg5247
(dp15569
sg4266
(dp15570
sg8259
(dp15571
sg6468
(dp15572
sg2841
(dp15573
sg7497
(dp15574
sg11790
(dp15575
sg10596
(dp15576
sg2664
(dp15577
sg780
(dp15578
ssg387
(dp15579
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p15580
(dp15581
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p15582
(dp15583
sVAdrenergic alpha-1 Receptor Antagonists
p15584
g14142
sVAnticholinergic Agents
p15585
(dp15586
sVCytochrome P-450 CYP2D6 Inhibitors
p15587
(dp15588
sVCytochrome P-450 CYP2D6 Substrates
p15589
(dp15590
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p15591
(dp15592
sVSerotonin Agents
p15593
(dp15594
sVCytochrome P-450 CYP3A Substrates
p15595
(dp15596
sVMembrane Transport Modulators
p15597
(dp15598
sVAntidepressive Agents, Tricyclic
p15599
(dp15600
sVSerotonin Receptor Antagonists
p15601
(dp15602
sVCentral Nervous System Agents
p15603
(dp15604
sVPotential QTc-Prolonging Agents
p15605
(dp15606
sVAdrenergic Antagonists
p15607
(dp15608
sVPsychotropic Drugs
p15609
(dp15610
sVCytochrome P-450 CYP2B6 Substrates
p15611
(dp15612
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p15613
(dp15614
sVDopamine Antagonists
p15615
(dp15616
sVSerotonin 5-HT1 Receptor Antagonists
p15617
g14430
sVCytochrome P-450 Enzyme Inhibitors
p15618
(dp15619
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p15620
(dp15621
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p15622
(dp15623
sVCytochrome P-450 CYP1A2 Substrates
p15624
(dp15625
sVPsychoanaleptics
p15626
(dp15627
sVNon-Selective Monoamine Reuptake Inhibitors
p15628
(dp15629
sVCytochrome P-450 CYP2E1 Inhibitors
p15630
(dp15631
sVMuscarinic Antagonists
p15632
(dp15633
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p15634
(dp15635
sVAdrenergic alpha-Antagonists
p15636
(dp15637
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p15638
(dp15639
sVQTc Prolonging Agents
p15640
(dp15641
sVSerotonin 5-HT2 Receptor Antagonists
p15642
(dp15643
sVDibenzocycloheptenes
p15644
(dp15645
sVAdrenergic Agents
p15646
(dp15647
sVCentral Nervous System Depressants
p15648
(dp15649
sVNeurotransmitter Agents
p15650
(dp15651
sVHistamine Antagonists
p15652
(dp15653
sVAgents that reduce seizure threshold
p15654
(dp15655
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p15656
(dp15657
sVBenzocycloheptenes
p15658
(dp15659
sVAdrenergic Uptake Inhibitors
p15660
(dp15661
sVNeurotransmitter Uptake Inhibitors
p15662
(dp15663
sVHistamine H1 Antagonists
p15664
(dp15665
sVAgents that produce hypertension
p15666
(dp15667
sVCytochrome P-450 CYP2C19 Inhibitors
p15668
(dp15669
sVCytochrome P-450 CYP3A4 Substrates
p15670
(dp15671
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p15672
(dp15673
sVNarrow Therapeutic Index Drugs
p15674
(dp15675
sVDopamine D2 Receptor Antagonists
p15676
(dp15677
sVCytochrome P-450 CYP3A5 Substrates
p15678
(dp15679
sVSerotonin Modulators
p15680
(dp15681
sVAntidepressive Agents
p15682
g15534
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p15683
(dp15684
sVP-glycoprotein/ABCB1 Inhibitors
p15685
(dp15686
sVNeurotoxic agents
p15687
(dp15688
sVAgents producing tachycardia
p15689
(dp15690
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p15691
(dp15692
sVNervous System
p15693
(dp15694
ssg390
(dp15695
VCytochrome P-450 CYP3A Substrates
p15696
(dp15697
sVCentral Nervous System Agents
p15698
(dp15699
sVAnti-Acne Preparations
p15700
(dp15701
sVCompounds used in a research, industrial, or household setting
p15702
(dp15703
sVHormones
p15704
(dp15705
sVCorticosteroids for Systemic Use
p15706
(dp15707
sVPeripheral Nervous System Agents
p15708
(dp15709
sVHyperglycemia-Associated Agents
p15710
(dp15711
sVCorticosteroids for Systemic Use, Plain
p15712
(dp15713
sVAutonomic Agents
p15714
(dp15715
sVCorticosteroids, Dermatological Preparations
p15716
(dp15717
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p15718
(dp15719
sVPregnadienetriols
p15720
(dp15721
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p15722
(dp15723
sVProtective Agents
p15724
(dp15725
sVFused-Ring Compounds
p15726
g14873
sVCytochrome P-450 CYP3A4 Inducers
p15727
(dp15728
sVAntineoplastic Agents
p15729
(dp15730
sVAntiemetics
p15731
(dp15732
sVAdrenal Cortex Hormones
p15733
(dp15734
sVCorticosteroids, Weak (Group I)
p15735
(dp15736
sg3393
(dp15737
sVAdrenals
p15738
(dp15739
sVP-glycoprotein/ABCB1 Substrates
p15740
(dp15741
sVDermatologicals
p15742
(dp15743
sVCytochrome P-450 Enzyme Inducers
p15744
(dp15745
sVCytochrome P-450 CYP3A Inducers
p15746
(dp15747
sVPrednisolone
p15748
(dp15749
sVPregnadienes
p15750
(dp15751
sVCytochrome P-450 CYP3A4 Substrates
p15752
(dp15753
sVPregnanes
p15754
(dp15755
sVGastrointestinal Agents
p15756
(dp15757
sVAnti-Acne Preparations for Topical Use
p15758
(dp15759
sVOphthalmologicals
p15760
(dp15761
sVSteroids
p15762
(dp15763
sVNeuroprotective Agents
p15764
(dp15765
sg14872
(dp15766
sVImmunosuppressive Agents
p15767
(dp15768
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p15769
(dp15770
sVAnti-Inflammatory Agents
p15771
(dp15772
sVCorticosteroid Hormone Receptor Agonists
p15773
(dp15774
sVHormones, Hormone Substitutes, and Hormone Antagonists
p15775
(dp15776
sVCorticosteroids
p15777
(dp15778
sVSensory Organs
p15779
(dp15780
ssg393
(dp15781
g10119
(dp15782
ssg396
(dp15783
VAnions
p15784
(dp15785
sVIons
p15786
(dp15787
sg8679
(dp15788
sVAntithyroid agents
p15789
(dp15790
sVThyroid Products
p15791
(dp15792
sg2439
(dp15793
sg396
(dp15794
sVElectrolytes
p15795
(dp15796
sVLaxatives
p15797
(dp15798
sVSensory Organs
p15799
(dp15800
sVExpectorants
p15801
(dp15802
sg12081
(dp15803
sVCough and Cold Preparations
p15804
(dp15805
sg2163
(dp15806
sVAntidotes
p15807
(dp15808
sVMinerals
p15809
(dp15810
sVOphthalmologicals
p15811
(dp15812
ssg399
(dp15813
g9588
(dp15814
sg8832
(dp15815
sg5487
(dp15816
sg6261
(dp15817
ssg402
(dp15818
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p15819
(dp15820
sVCytochrome P-450 CYP3A4 Inhibitors
p15821
(dp15822
sVCytochrome P-450 CYP3A Inhibitors
p15823
(dp15824
sVNeuropeptides
p15825
(dp15826
sVNerve Tissue Proteins
p15827
(dp15828
sVSomatostatin Receptor Agonists
p15829
(dp15830
sVHormones
p15831
(dp15832
sVAcromegaly
p15833
(dp15834
sVCytochrome P-450 Enzyme Inhibitors
p15835
(dp15836
sVHyperglycemia-Associated Agents
p15837
(dp15838
sVPeptide Hormones
p15839
(dp15840
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p15841
(dp15842
sVPancreatic Hormones
p15843
(dp15844
sVAntineoplastic Agents
p15845
(dp15846
sVProteins
p15847
(dp15848
sVPeptides
p15849
(dp15850
sVAmino Acids, Peptides, and Proteins
p15851
(dp15852
sVPituitary and Hypothalamic Hormones and Analogues
p15853
(dp15854
sVSomatostatin and Analogues
p15855
(dp15856
sVHypothalamic Hormones
p15857
(dp15858
sVBradycardia-Causing Agents
p15859
(dp15860
sVHypoglycemia-Associated Agents
p15861
(dp15862
sVPituitary Hormone Release Inhibiting Hormones
p15863
(dp15864
sVHormones, Hormone Substitutes, and Hormone Antagonists
p15865
(dp15866
sVOther Miscellaneous Therapeutic Agents
p15867
(dp15868
ssg405
(dp15869
VPhenothiazine Derivatives
p15870
(dp15871
sVAntipruritics
p15872
(dp15873
sVHeterocyclic Compounds, Fused-Ring
p15874
(dp15875
sVHistamine H1 Antagonists
p15876
(dp15877
sVPhenothiazines
p15878
(dp15879
sVHistamine Agents
p15880
(dp15881
sVNeurotransmitter Agents
p15882
(dp15883
sVCentral Nervous System Depressants
p15884
(dp15885
sVAntipsychotic Agents
p15886
(dp15887
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p15888
(dp15889
sVPotential QTc-Prolonging Agents
p15890
(dp15891
sVCytochrome P-450 Enzyme Inducers
p15892
(dp15893
sVCytochrome P-450 CYP3A Inducers
p15894
(dp15895
sVHistamine Antagonists
p15896
(dp15897
sVAntihistamines for Systemic Use
p15898
g12968
sVQTc Prolonging Agents
p15899
(dp15900
sVDermatologicals
p15901
(dp15902
sVCytochrome P-450 CYP3A4 Inducers
p15903
(dp15904
sVSulfur Compounds
p15905
(dp15906
sVNeurotoxic agents
p15907
(dp15908
ssg408
(dp15909
g6630
(dp15910
ssg411
(dp15911
g11952
(dp15912
sg5409
(dp15913
sg2886
(dp15914
sg4170
(dp15915
sg6360
(dp15916
sg2283
(dp15917
sg7689
(dp15918
sg12042
(dp15919
sg11046
(dp15920
sg4143
(dp15921
ssg414
(dp15922
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p15923
(dp15924
sVAdrenergic alpha-1 Receptor Antagonists
p15925
g14146
sVCytochrome P-450 CYP2D6 Inhibitors
p15926
(dp15927
sVCytochrome P-450 CYP2D6 Substrates
p15928
(dp15929
sVSerotonin Agents
p15930
(dp15931
sVNeurotransmitter Agents
p15932
(dp15933
sVHypotensive Agents
p15934
(dp15935
sVSerotonin Receptor Antagonists
p15936
(dp15937
sVCentral Nervous System Agents
p15938
(dp15939
sVDopamine Agents
p15940
g14268
sVAdrenergic Antagonists
p15941
(dp15942
sVPsychotropic Drugs
p15943
(dp15944
sVCytochrome P-450 CYP2E1 Inhibitors
p15945
(dp15946
sVCytochrome P-450 Enzyme Inhibitors
p15947
(dp15948
sVHighest Risk QTc-Prolonging Agents
p15949
(dp15950
sg9939
(dp15951
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p15952
(dp15953
sVAntipsychotic Agents
p15954
(dp15955
sVDopamine Antagonists
p15956
(dp15957
sVSulfur Compounds
p15958
(dp15959
sVAdrenergic alpha-Antagonists
p15960
(dp15961
sVPsycholeptics
p15962
(dp15963
sVQTc Prolonging Agents
p15964
(dp15965
sVSerotonin 5-HT2 Receptor Antagonists
p15966
(dp15967
sVCytochrome P-450 CYP2C19 Substrates
p15968
(dp15969
sVCentral Nervous System Depressants
p15970
(dp15971
sVCytochrome P-450 CYP2C8 Inhibitors
p15972
(dp15973
sVAgents that produce hypertension
p15974
(dp15975
sVAntipsychotic Agents (First Generation [Typical])
p15976
(dp15977
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p15978
(dp15979
sVDopamine D2 Receptor Antagonists
p15980
(dp15981
sVHeterocyclic Compounds, Fused-Ring
p15982
(dp15983
sVAntidepressive Agents
p15984
g15536
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p15985
g13746
sVPhenothiazines
p15986
(dp15987
sVNeurotoxic agents
p15988
(dp15989
sVNervous System
p15990
(dp15991
sVTranquilizing Agents
p15992
(dp15993
ssg417
(dp15994
g1746
(dp15995
sg5193
(dp15996
ssg420
(dp15997
VHydrochloric Acid
p15998
(dp15999
sVDrugs that are Mainly Renally Excreted
p16000
(dp16001
sVNitrogen Compounds
p16002
(dp16003
sVAgents causing hyperkalemia
p16004
(dp16005
sVBlood Substitutes and Perfusion Solutions
p16006
(dp16007
sVChlorides
p16008
(dp16009
sVGenito Urinary System and Sex Hormones
p16010
(dp16011
sg8442
(dp16012
sVAcids
p16013
(dp16014
sVAcids, Noncarboxylic
p16015
(dp16016
sVElectrolytes
p16017
(dp16018
sVIons
p16019
(dp16020
sVUrinary Acidifying Agents
p16021
(dp16022
sVBlood and Blood Forming Organs
p16023
(dp16024
sVUrologicals
p16025
(dp16026
sVAnions
p16027
(dp16028
sVElectrolyte Solutions
p16029
(dp16030
sVChlorine Compounds
p16031
(dp16032
sg12153
(dp16033
sVI.V. Solution Additives
p16034
(dp16035
sVAmmonium Compounds
p16036
(dp16037
ssg423
(dp16038
g171
g13730
sg11916
(dp16039
sg11361
(dp16040
sg6381
(dp16041
sg7824
(dp16042
sg11268
(dp16043
sg4683
(dp16044
ssg426
(dp16045
VCytochrome P-450 CYP3A4 Inhibitors
p16046
(dp16047
sVAnesthetics, General
p16048
(dp16049
sVGABA Agents
p16050
(dp16051
sVCytochrome P-450 CYP3A Substrates
p16052
(dp16053
sVAnti-Anxiety Agents
p16054
(dp16055
sVCentral Nervous System Agents
p16056
(dp16057
sVBenzodiazepinones
p16058
(dp16059
sVPsychotropic Drugs
p16060
(dp16061
sVCytochrome P-450 CYP2B6 Substrates
p16062
(dp16063
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p16064
(dp16065
sVGABA Modulators
p16066
(dp16067
sVCytochrome P-450 Enzyme Inhibitors
p16068
(dp16069
sVPeripheral Nervous System Agents
p16070
(dp16071
sVDrugs that are Mainly Renally Excreted
p16072
(dp16073
sVCytochrome P-450 CYP2C8 Substrates
p16074
(dp16075
sVCytochrome P-450 CYP3A4 Substrates
p16076
(dp16077
sVAutonomic Agents
p16078
(dp16079
sVHeterocyclic Compounds, Fused-Ring
p16080
(dp16081
sVCytochrome P-450 CYP2E1 Inhibitors
p16082
(dp16083
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16084
(dp16085
sVAnesthetics, Intravenous
p16086
(dp16087
sVAdjuvants, Anesthesia
p16088
(dp16089
sVCytochrome P-450 CYP2C9 Substrates
p16090
(dp16091
sVCytochrome P-450 CYP2C19 Substrates
p16092
(dp16093
sVCentral Nervous System Depressants
p16094
(dp16095
sVAnesthetics
p16096
(dp16097
sVAnticonvulsants
p16098
(dp16099
sVP-glycoprotein/ABCB1 Substrates
p16100
(dp16101
sVMuscle Relaxants, Centrally Acting Agents
p16102
(dp16103
sVCytochrome P-450 CYP2C18 Substrates
p16104
(dp16105
sVPsycholeptics
p16106
(dp16107
sVCytochrome P-450 CYP2C19 Inhibitors
p16108
(dp16109
sVCytochrome P-450 CYP3A5 Substrates
p16110
(dp16111
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p16112
(dp16113
sVBenzazepines
p16114
(dp16115
sVHypnotics and Sedatives
p16116
(dp16117
sVBenzodiazepine hypnotics and sedatives
p16118
(dp16119
sVCytochrome P-450 CYP3A Inhibitors
p16120
(dp16121
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p16122
(dp16123
sVMuscle Relaxants
p16124
(dp16125
sVBenzodiazepines and benzodiazepine derivatives
p16126
(dp16127
sVNervous System
p16128
(dp16129
sVTranquilizing Agents
p16130
(dp16131
sVCytochrome P-450 CYP3A7 Substrates
p16132
(dp16133
ssg429
(dp16134
g6228
(dp16135
ssg432
(dp16136
g5781
(dp16137
sg2523
(dp16138
ssg435
(dp16139
g2559
(dp16140
sg6186
(dp16141
sg10017
(dp16142
sg5247
(dp16143
sg9165
(dp16144
sg11277
(dp16145
sg2583
(dp16146
sg1263
(dp16147
sg3048
(dp16148
sg8067
(dp16149
sg3111
(dp16150
sg288
g14640
sg3156
(dp16151
sg11097
(dp16152
sg11931
(dp16153
sg3018
(dp16154
sg8487
(dp16155
sg9252
(dp16156
sg10854
(dp16157
sg7959
(dp16158
sg4959
(dp16159
sg6525
(dp16160
sg603
(dp16161
sg7041
(dp16162
ssg438
(dp16163
VAntiinfectives for Systemic Use
p16164
(dp16165
sVAntivirals for Systemic Use
p16166
(dp16167
sVCytochrome P-450 CYP3A5 Substrates
p16168
(dp16169
sVBreast Cancer Resistance Protein Inhibitors
p16170
g12716
sVAntivirals for treatment of HCV infections
p16171
(dp16172
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p16173
(dp16174
sVAntiviral Agents
p16175
(dp16176
sVBCRP/ABCG2 Inhibitors
p16177
g12500
sVDirect Acting Antivirals
p16178
(dp16179
sVP-glycoprotein/ABCB1 Inhibitors
p16180
(dp16181
sVOATP1B1/SLCO1B1 Inhibitors
p16182
(dp16183
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16184
(dp16185
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p16186
(dp16187
sVOATP1B3 inhibitors
p16188
(dp16189
sg12138
(dp16190
sVHepatitis C Virus NS5A Inhibitor
p16191
(dp16192
sVCytochrome P-450 CYP3A4 Substrates
p16193
(dp16194
sVCytochrome P-450 CYP3A Substrates
p16195
(dp16196
sVCytochrome P-450 CYP3A7 Substrates
p16197
(dp16198
ssg441
(dp16199
g10062
(dp16200
sg426
g16051
sg10737
(dp16201
sg8205
(dp16202
sg2358
(dp16203
sg828
(dp16204
sg5067
(dp16205
sg6579
(dp16206
sg5853
(dp16207
sg7272
(dp16208
sg5064
(dp16209
sg7284
(dp16210
sg12018
(dp16211
sg9564
(dp16212
sg702
(dp16213
sg6939
(dp16214
sg2430
(dp16215
sg5133
(dp16216
sg5691
(dp16217
sg10728
(dp16218
sg696
(dp16219
sg9420
(dp16220
sg3204
(dp16221
sg582
(dp16222
sg4155
(dp16223
sg1938
(dp16224
sg183
g13766
sg5256
(dp16225
sg5769
(dp16226
sg1401
(dp16227
ssg444
(dp16228
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p16229
(dp16230
sg1794
(dp16231
sVUGT1A1 Substrates
p16232
g12266
sVCytochrome P-450 CYP3A Substrates
p16233
(dp16234
sVOATP1B1/SLCO1B1 Inhibitors
p16235
(dp16236
sVHormones
p16237
(dp16238
sVCytochrome P-450 Enzyme Inhibitors
p16239
(dp16240
sVThyroid Products
p16241
(dp16242
sVP-glycoprotein/ABCB1 Inducers
p16243
(dp16244
sVAmino Acids
p16245
(dp16246
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p16247
(dp16248
sVOATP1B3 inhibitors
p16249
(dp16250
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p16251
(dp16252
sg10722
(dp16253
sVUGT1A1 substrates with narrow therapeutic index
p16254
(dp16255
sVCytochrome P-450 CYP2C8 Inhibitors
p16256
(dp16257
sVThyroxine-binding globulin substrates
p16258
(dp16259
sVAgents used to treat hypothyroidism
p16260
(dp16261
sVCytochrome P-450 CYP3A4 Substrates
p16262
(dp16263
sVNarrow Therapeutic Index Drugs
p16264
(dp16265
sVAmino Acids, Peptides, and Proteins
p16266
(dp16267
sVHormones, Hormone Substitutes, and Hormone Antagonists
p16268
(dp16269
ssg447
(dp16270
VAmino Acids, Peptides, and Proteins
p16271
(dp16272
sVAntibodies
p16273
(dp16274
sVImmunomodulatory Agents
p16275
(dp16276
sVAntibodies, Monoclonal
p16277
(dp16278
sVInterleukin 2 Receptor Antagonists
p16279
(dp16280
sVAntibodies, Monoclonal, Humanized
p16281
(dp16282
sVProteins
p16283
(dp16284
sVImmunologic Factors
p16285
(dp16286
sVImmunoglobulins
p16287
(dp16288
sVImmunosuppressive Agents
p16289
(dp16290
sVInterleukin 2 Receptor-directed Antibody Interactions
p16291
(dp16292
sVSerum Globulins
p16293
(dp16294
sVInterleukin-2 Receptor Blocking Antibody
p16295
(dp16296
sVAntineoplastic and Immunomodulating Agents
p16297
(dp16298
sVBlood Proteins
p16299
(dp16300
sVGlobulins
p16301
(dp16302
sVInterleukin Inhibitors
p16303
(dp16304
sVImmunoproteins
p16305
(dp16306
ssg450
(dp16307
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p16308
(dp16309
sVCytochrome P-450 CYP2D6 Inhibitors
p16310
(dp16311
sVCytochrome P-450 CYP2D6 Substrates
p16312
(dp16313
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p16314
(dp16315
sVSerotonin Agents
p16316
(dp16317
sVAnalgesics
p16318
(dp16319
sVNeurotransmitter Agents
p16320
(dp16321
sVOpiate Agonists
p16322
(dp16323
sVCentral Nervous System Agents
p16324
(dp16325
sVUGT1A9 Substrates
p16326
(dp16327
sVCytochrome P-450 Enzyme Inhibitors
p16328
(dp16329
sVPeripheral Nervous System Agents
p16330
(dp16331
sVNeurotransmitter Uptake Inhibitors
p16332
(dp16333
sVOpioids
p16334
(dp16335
sVCytochrome P-450 CYP2C9 Substrates
p16336
(dp16337
sVAdrenergic Agents
p16338
(dp16339
sVCentral Nervous System Depressants
p16340
(dp16341
sVPhenols
p16342
(dp16343
sVBenzene Derivatives
p16344
(dp16345
sVAdrenergic Uptake Inhibitors
p16346
(dp16347
sVMembrane Transport Modulators
p16348
(dp16349
sVNarcotics
p16350
(dp16351
sVSerotonin Modulators
p16352
(dp16353
sVAntidepressive Agents
p16354
g15509
sVOpioid Agonist
p16355
(dp16356
sVUGT2B7 substrates
p16357
(dp16358
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p16359
(dp16360
sVSensory System Agents
p16361
(dp16362
sVNervous System
p16363
(dp16364
ssg453
(dp16365
g8832
(dp16366
ssg456
(dp16367
VCytochrome P-450 CYP3A4 Inhibitors
p16368
(dp16369
sVCytochrome P-450 CYP2C8 Inhibitors
p16370
(dp16371
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p16372
(dp16373
sVAmines
p16374
(dp16375
sVMyelosuppressive Agents
p16376
(dp16377
sVCytochrome P-450 CYP3A Substrates
p16378
(dp16379
sVCytochrome P-450 CYP3A Inhibitors
p16380
(dp16381
sVImmunosuppressive Agents
p16382
(dp16383
sVP-glycoprotein/ABCB1 Substrates
p16384
(dp16385
sVTyrosine Kinase Inhibitors
p16386
(dp16387
sVKinase Inhibitor
p16388
(dp16389
sVP-glycoprotein/ABCB1 Inhibitors
p16390
(dp16391
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16392
(dp16393
sVProtein Kinase Inhibitors
p16394
(dp16395
sVAntineoplastic and Immunomodulating Agents
p16396
(dp16397
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p16398
(dp16399
sVHeterocyclic Compounds, Fused-Ring
p16400
(dp16401
sVCytochrome P-450 Enzyme Inhibitors
p16402
(dp16403
sVCytochrome P-450 CYP3A4 Substrates
p16404
(dp16405
sVAntineoplastic Agents
p16406
(dp16407
ssg459
(dp16408
g10479
(dp16409
sg7650
(dp16410
sg972
(dp16411
sg8238
(dp16412
sg7671
(dp16413
sg4710
(dp16414
sg3291
(dp16415
sg135
g13252
sg6204
(dp16416
sg9282
(dp16417
sg4788
(dp16418
sg8079
(dp16419
sg6183
(dp16420
sg7074
(dp16421
sg1311
(dp16422
sg7005
(dp16423
sg4005
(dp16424
sg2436
(dp16425
sg10611
(dp16426
ssg462
(dp16427
g9852
(dp16428
ssg465
(dp16429
VAntidepressive Agents, Second-Generation
p16430
(dp16431
sVCytochrome P-450 CYP2D6 Inhibitors
p16432
(dp16433
sVCytochrome P-450 CYP2D6 Substrates
p16434
(dp16435
sVKetones
p16436
(dp16437
sVCytochrome P-450 CYP3A Substrates
p16438
(dp16439
sVNeurotransmitter Agents
p16440
(dp16441
sVCentral Nervous System Agents
p16442
(dp16443
sVDopamine Agents
p16444
g14229
sVOCT2 Inhibitors
p16445
(dp16446
sVPsychotropic Drugs
p16447
(dp16448
sVCytochrome P-450 CYP2B6 Substrates
p16449
(dp16450
sVEnzyme Inhibitors
p16451
(dp16452
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p16453
g12661
sVCytochrome P-450 Enzyme Inhibitors
p16454
(dp16455
sVSmoking Cessation Agents
p16456
(dp16457
sVDrugs that are Mainly Renally Excreted
p16458
(dp16459
sVCytochrome P-450 CYP2C8 Substrates
p16460
(dp16461
sVNeurotransmitter Uptake Inhibitors
p16462
(dp16463
sVPsychoanaleptics
p16464
(dp16465
sg8385
(dp16466
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16467
(dp16468
sVCytochrome P-450 CYP2C9 Substrates
p16469
(dp16470
sVCentrally Acting Antiobesity Products
p16471
(dp16472
sVCentral Nervous System Depressants
p16473
(dp16474
sVAgents that reduce seizure threshold
p16475
(dp16476
sVCytochrome P-450 CYP2B6 Inhibitors
p16477
(dp16478
sVCytochrome P-450 CYP2A6 Substrates
p16479
(dp16480
sVMembrane Transport Modulators
p16481
(dp16482
sg10248
(dp16483
sVCytochrome P-450 CYP3A4 Substrates
p16484
(dp16485
sVAlimentary Tract and Metabolism
p16486
(dp16487
sVDopamine Uptake Inhibitors
p16488
(dp16489
sVAntidepressive Agents
p16490
g15539
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p16491
g13738
sg3243
(dp16492
sVNorepinephrine Uptake Inhibitors
p16493
(dp16494
sg6342
(dp16495
sVIncreased Norepinephrine Activity
p16496
(dp16497
sVAntiobesity Preparations, Excl. Diet Products
p16498
(dp16499
sVChemically-Induced Disorders
p16500
(dp16501
sVNervous System
p16502
(dp16503
ssg468
(dp16504
g1980
(dp16505
sg8193
(dp16506
sg735
(dp16507
sg11040
(dp16508
sg2862
(dp16509
sg12057
(dp16510
sg5556
(dp16511
sg11100
(dp16512
sg10953
(dp16513
sg3216
(dp16514
sg6213
(dp16515
ssg471
(dp16516
g3846
(dp16517
sg2667
(dp16518
sg8049
(dp16519
sg8421
(dp16520
sg7272
(dp16521
sg11451
(dp16522
sg9198
(dp16523
sg888
(dp16524
sg5133
(dp16525
sg4911
(dp16526
sg7335
(dp16527
sg1140
(dp16528
sg8703
(dp16529
sg3432
(dp16530
sg10557
(dp16531
sg4155
(dp16532
sg9822
(dp16533
sg183
g13784
sg12123
(dp16534
sg6075
(dp16535
sg7593
(dp16536
sg8724
(dp16537
sg1401
(dp16538
sg11385
(dp16539
ssg474
(dp16540
VPyrimidines
p16541
(dp16542
sVNucleic Acid Synthesis Inhibitors
p16543
(dp16544
sVImmunosuppressive Agents
p16545
(dp16546
sVCarbohydrates
p16547
(dp16548
sVEnzyme Inhibitors
p16549
(dp16550
sVPyrimidine Analogues
p16551
(dp16552
sVAzacitidine
p16553
(dp16554
sVMyelosuppressive Agents
p16555
(dp16556
sVNucleoside Metabolic Inhibitor
p16557
(dp16558
sVCytidine
p16559
(dp16560
sVAza Compounds
p16561
(dp16562
sVAntimetabolites, Antineoplastic
p16563
(dp16564
sVAntineoplastic Agents
p16565
(dp16566
sVGlycosides
p16567
(dp16568
sVRibonucleosides
p16569
(dp16570
sVNucleic Acids, Nucleotides, and Nucleosides
p16571
(dp16572
sVPyrimidine Nucleosides
p16573
(dp16574
sVToxic Actions
p16575
(dp16576
sVNucleosides
p16577
(dp16578
sVAntimetabolites
p16579
(dp16580
sVNoxae
p16581
(dp16582
sVAntineoplastic and Immunomodulating Agents
p16583
(dp16584
ssg477
(dp16585
VNucleic Acid Synthesis Inhibitors
p16586
(dp16587
sg1989
(dp16588
sg6006
(dp16589
sVImmunosuppressive Agents
p16590
(dp16591
sg4029
(dp16592
sVEnzyme Inhibitors
p16593
(dp16594
sVDrugs for Obstructive Airway Diseases
p16595
(dp16596
sVMyelosuppressive Agents
p16597
(dp16598
sg3693
(dp16599
sg8991
(dp16600
sVSulfur Compounds
p16601
(dp16602
sVAntimetabolites, Antineoplastic
p16603
(dp16604
sVAntineoplastic Agents
p16605
(dp16606
sVOAT3/SLC22A8 Substrates
p16607
g13111
sg9258
(dp16608
sg10197
(dp16609
sVToxic Actions
p16610
(dp16611
sVHeterocyclic Compounds, Fused-Ring
p16612
(dp16613
sVAntimetabolites
p16614
(dp16615
sVNoxae
p16616
(dp16617
sVOAT3/SLC22A8 Inhibitors
p16618
(dp16619
sVAntineoplastic and Immunomodulating Agents
p16620
(dp16621
ssg480
(dp16622
g4341
(dp16623
ssg483
(dp16624
g4629
(dp16625
ssg486
(dp16626
VCytochrome P-450 CYP2D6 Inhibitors
p16627
(dp16628
sVNeurotransmitter Agents
p16629
(dp16630
sVCentral Nervous System Agents
p16631
(dp16632
sVDopamine Agents
p16633
g14254
sVPsychotropic Drugs
p16634
(dp16635
sVCytochrome P-450 CYP2E1 Inhibitors
p16636
(dp16637
sVProdrugs
p16638
(dp16639
sVCytochrome P-450 Enzyme Inhibitors
p16640
(dp16641
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p16642
(dp16643
sVPhenothiazines With Piperazine Structure
p16644
(dp16645
sVAntipsychotic Agents
p16646
(dp16647
sVDopamine Antagonists
p16648
(dp16649
sVSulfur Compounds
p16650
(dp16651
sVPsycholeptics
p16652
(dp16653
sVCentral Nervous System Depressants
p16654
(dp16655
sVAgents that reduce seizure threshold
p16656
(dp16657
sVDelayed-Action Preparations
p16658
(dp16659
sVAntipsychotic Agents (First Generation [Typical])
p16660
(dp16661
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p16662
(dp16663
sVDopamine D2 Receptor Antagonists
p16664
(dp16665
sVHeterocyclic Compounds, Fused-Ring
p16666
(dp16667
sVPhenothiazines
p16668
(dp16669
sVP-glycoprotein/ABCB1 Inhibitors
p16670
(dp16671
sVNeurotoxic agents
p16672
(dp16673
sVNervous System
p16674
(dp16675
sVTranquilizing Agents
p16676
(dp16677
ssg489
(dp16678
g8088
(dp16679
sg11367
(dp16680
sg5463
(dp16681
sg801
(dp16682
sg5514
(dp16683
ssg492
(dp16684
g11175
(dp16685
ssg495
(dp16686
VDrugs that are Mainly Renally Excreted
p16687
(dp16688
sVNitrogen Compounds
p16689
(dp16690
sVOnium Compounds
p16691
(dp16692
sVGastrointestinal Agents
p16693
(dp16694
sVAnticholinergic Agents
p16695
(dp16696
sVCholinergic Agents
p16697
(dp16698
sVQuaternary Ammonium Compounds
p16699
(dp16700
sVNeurotransmitter Agents
p16701
(dp16702
sVMuscarinic Antagonists
p16703
(dp16704
sVAmines
p16705
(dp16706
sVSynthetic Anticholinergics, Quaternary Ammonium Compounds
p16707
(dp16708
sVAgents producing tachycardia
p16709
(dp16710
sVXanthenes
p16711
(dp16712
sVHeterocyclic Compounds, Fused-Ring
p16713
(dp16714
sVAmmonium Compounds
p16715
(dp16716
sVDrugs for Functional Gastrointestinal Disorders
p16717
(dp16718
sVAlimentary Tract and Metabolism
p16719
(dp16720
sVAnti-Ulcer Agents
p16721
(dp16722
ssg498
(dp16723
g9780
(dp16724
sg5457
(dp16725
ssg501
(dp16726
VPhosphate-removing Agents
p16727
(dp16728
sVAmines
p16729
(dp16730
sVPolyamines
p16731
(dp16732
sVChelating Agents
p16733
(dp16734
sVPolystyrene Sulfonates
p16735
(dp16736
sVSequestering Agents
p16737
(dp16738
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p16739
(dp16740
sVBile Acid Sequestrants
p16741
(dp16742
sg10944
(dp16743
sVCompounds used in a research, industrial, or household setting
p16744
(dp16745
sVPhosphate Binder
p16746
(dp16747
sVLipid Regulating Agents
p16748
(dp16749
ssg504
(dp16750
g5457
(dp16751
ssg507
(dp16752
VSex Hormones and Modulators of the Genital System
p16753
(dp16754
sVCytochrome P-450 CYP3A Substrates
p16755
(dp16756
sVProgestogens and Estrogens, Sequential Preparations
p16757
(dp16758
sg2370
(dp16759
sVHormonal Contraceptives for Systemic Use
p16760
(dp16761
sVP-glycoprotein/ABCB1 Inducers
p16762
(dp16763
sVContraceptive Agents, Female
p16764
(dp16765
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16766
(dp16767
sg8940
(dp16768
sVContraceptives, Oral
p16769
(dp16770
sVFused-Ring Compounds
p16771
g14859
sVHyperglycemia-Associated Agents
p16772
(dp16773
sVAdrenal Cortex Hormones
p16774
(dp16775
sVReproductive Control Agents
p16776
(dp16777
sVProgestins
p16778
(dp16779
sVCombination Contraceptives (with Estrogen and derivatives)
p16780
(dp16781
sVCytochrome P-450 Enzyme Inducers
p16782
(dp16783
sVProgestin Contraceptives
p16784
(dp16785
sg7539
(dp16786
sg3411
(dp16787
sVContraceptives, Oral, Synthetic
p16788
(dp16789
sVCytochrome P-450 CYP3A4 Substrates
p16790
(dp16791
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p16792
(dp16793
sVCytochrome P-450 CYP3A5 Substrates
p16794
(dp16795
sVGenito Urinary System and Sex Hormones
p16796
(dp16797
sVSteroids
p16798
(dp16799
sVCytochrome P-450 CYP2C19 Inducers
p16800
(dp16801
sg3336
(dp16802
sVCytochrome P-450 CYP3A7 Substrates
p16803
(dp16804
ssg510
(dp16805
g2274
(dp16806
sg8820
(dp16807
sg2346
(dp16808
sg5757
(dp16809
ssg513
(dp16810
g4806
(dp16811
sg13750
(dp16812
sg7464
(dp16813
sg10818
(dp16814
sg9309
(dp16815
sg7629
(dp16816
sg4635
(dp16817
sg1812
(dp16818
sg9903
(dp16819
sg1800
(dp16820
sg3318
(dp16821
sg6045
(dp16822
sg5766
(dp16823
sg4653
(dp16824
sg7545
(dp16825
sg1614
(dp16826
sg14838
(dp16827
sg5895
(dp16828
sg12108
(dp16829
sg1491
(dp16830
sg4113
(dp16831
sg11727
(dp16832
sg7569
(dp16833
sg1164
(dp16834
sg7191
(dp16835
sg3447
(dp16836
sg6345
(dp16837
sg1770
(dp16838
sg12534
(dp16839
sg14829
(dp16840
ssg516
(dp16841
VProkinetic Agents
p16842
(dp16843
sVCytochrome P-450 CYP2D6 Substrates
p16844
(dp16845
sVCytochrome P-450 CYP3A Substrates
p16846
(dp16847
sVNeurotransmitter Agents
p16848
(dp16849
sVCentral Nervous System Agents
p16850
(dp16851
sVDopamine Agents
p16852
g14243
sVCytochrome P-450 CYP2B6 Substrates
p16853
(dp16854
sVPeripheral Nervous System Agents
p16855
(dp16856
sVHighest Risk QTc-Prolonging Agents
p16857
(dp16858
sVCytochrome P-450 CYP2C8 Substrates
p16859
(dp16860
sVCytochrome P-450 CYP1A2 Substrates
p16861
(dp16862
sVAutonomic Agents
p16863
(dp16864
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16865
(dp16866
sVDopamine Antagonists
p16867
(dp16868
sVQTc Prolonging Agents
p16869
(dp16870
sVAntiemetics
p16871
(dp16872
sVGastrointestinal Agents
p16873
(dp16874
sVP-glycoprotein/ABCB1 Substrates
p16875
(dp16876
sVPropulsives
p16877
(dp16878
sVPiperidines
p16879
(dp16880
sVDrugs for Functional Gastrointestinal Disorders
p16881
(dp16882
sVHeterocyclic Compounds, Fused-Ring
p16883
(dp16884
sVCytochrome P-450 CYP3A4 Substrates
p16885
(dp16886
sVAlimentary Tract and Metabolism
p16887
(dp16888
sVDopamine D2 Receptor Antagonists
p16889
(dp16890
sVBenzimidazoles
p16891
(dp16892
sVCytochrome P-450 CYP3A5 Substrates
p16893
(dp16894
sVCytochrome P-450 CYP3A7 Substrates
p16895
(dp16896
ssg519
(dp16897
g6612
(dp16898
ssg522
(dp16899
g690
(dp16900
sg11838
(dp16901
sg4920
(dp16902
sg10122
(dp16903
sg4479
(dp16904
sg7377
(dp16905
sS'Sirolimus'
p16906
(dp16907
sg4539
(dp16908
sg8448
(dp16909
sg1539
(dp16910
sg3021
(dp16911
sg9273
(dp16912
sg2829
(dp16913
ssg525
(dp16914
g2286
(dp16915
ssg528
(dp16916
VCytochrome P-450 CYP3A Substrates
p16917
(dp16918
sVHormone Antagonists and Related Agents
p16919
(dp16920
sVBenzylidene Compounds
p16921
(dp16922
sg4227
(dp16923
sg8040
(dp16924
sVHighest Risk QTc-Prolonging Agents
p16925
(dp16926
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p16927
(dp16928
sVBone Density Conservation Agents
p16929
(dp16930
sVQTc Prolonging Agents
p16931
(dp16932
sVAntineoplastic Agents
p16933
(dp16934
sVBenzene Derivatives
p16935
(dp16936
sVP-glycoprotein/ABCB1 Substrates
p16937
(dp16938
sVAntineoplastic Agents, Hormonal
p16939
(dp16940
sg8706
(dp16941
sVCytochrome P-450 CYP3A4 Substrates
p16942
(dp16943
sg576
(dp16944
sVHormone Antagonists
p16945
(dp16946
sg4980
(dp16947
sg7302
(dp16948
sVP-glycoprotein/ABCB1 Inhibitors
p16949
(dp16950
sVAntineoplastic and Immunomodulating Agents
p16951
(dp16952
sVHormones, Hormone Substitutes, and Hormone Antagonists
p16953
(dp16954
sVEndocrine Therapy
p16955
(dp16956
ssg531
(dp16957
g11316
(dp16958
sg8142
(dp16959
sg543
(dp16960
sg4236
(dp16961
ssg534
(dp16962
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p16963
(dp16964
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p16965
(dp16966
sVHypotensive Agents
p16967
(dp16968
sVCentral Nervous System Agents
p16969
(dp16970
sg8592
(dp16971
sVPsychotropic Drugs
p16972
(dp16973
sVCytochrome P-450 CYP2C9 Inhibitors
p16974
(dp16975
sVCytochrome P-450 Enzyme Inhibitors
p16976
(dp16977
sVCannabinoids and similars
p16978
(dp16979
sVPeripheral Nervous System Agents
p16980
(dp16981
sVTerpenes
p16982
(dp16983
sVAutonomic Agents
p16984
(dp16985
sVCytochrome P-450 CYP2E1 Inhibitors
p16986
(dp16987
sg3927
(dp16988
sVCentral Nervous System Depressants
p16989
(dp16990
sVAntiemetics
p16991
(dp16992
sVGastrointestinal Agents
p16993
(dp16994
sVCytochrome P-450 CYP2C8 Inhibitors
p16995
(dp16996
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p16997
(dp16998
sVAlimentary Tract and Metabolism
p16999
(dp17000
sVAgents producing tachycardia
p17001
(dp17002
sVTranquilizing Agents
p17003
(dp17004
ssg537
(dp17005
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p17006
(dp17007
sVCytochrome P-450 CYP2D6 Substrates
p17008
(dp17009
sVUGT1A1 Substrates
p17010
g12322
sVAnalgesics
p17011
(dp17012
sVHypotensive Agents
p17013
(dp17014
sVOpiate Agonists
p17015
(dp17016
sVCentral Nervous System Agents
p17017
(dp17018
sVNarcotics
p17019
(dp17020
sVPeripheral Nervous System Agents
p17021
(dp17022
sVCytochrome P-450 CYP2C8 Substrates
p17023
(dp17024
sVOpioids
p17025
(dp17026
sVUGT1A3 substrates
p17027
(dp17028
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17029
(dp17030
sVCytochrome P-450 CYP3A Substrates
p17031
(dp17032
sVNatural Opium Alkaloids
p17033
(dp17034
sVCentral Nervous System Depressants
p17035
(dp17036
sVAnesthetics
p17037
(dp17038
sVOpiate Alkaloids
p17039
(dp17040
sVP-glycoprotein/ABCB1 Substrates
p17041
(dp17042
sVHigh-risk opioids
p17043
(dp17044
sVNeuraxial Anesthetics
p17045
(dp17046
sVCytochrome P-450 CYP3A4 Substrates
p17047
(dp17048
sVHeterocyclic Compounds, Fused-Ring
p17049
(dp17050
sVOpioid Agonist
p17051
(dp17052
sVUGT2B7 substrates
p17053
(dp17054
sVAlkaloids
p17055
(dp17056
sVSensory System Agents
p17057
(dp17058
sVPhenanthrenes
p17059
(dp17060
sVNervous System
p17061
(dp17062
ssg540
(dp17063
g3588
(dp17064
ssg543
(dp17065
VSteroids
p17066
(dp17067
sVSex Hormones and Modulators of the Genital System
p17068
(dp17069
sVAndrogens and Estrogens
p17070
(dp17071
sVCytochrome P-450 CYP3A Substrates
p17072
(dp17073
sVTestosterone Congeners
p17074
(dp17075
sVCytochrome P-450 CYP2B6 Substrates
p17076
(dp17077
sVHormones
p17078
(dp17079
sVDrugs that are Mainly Renally Excreted
p17080
(dp17081
sVCytochrome P-450 CYP2C8 Substrates
p17082
(dp17083
sV3-Oxoandrosten (4) Derivatives
p17084
(dp17085
sVCytochrome P-450 CYP2B6 Inducers
p17086
(dp17087
sVAndrostanes
p17088
(dp17089
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17090
(dp17091
sVCytochrome P-450 CYP2C9 Substrates
p17092
(dp17093
sVFused-Ring Compounds
p17094
g14864
sVCytochrome P-450 CYP3A4 Inducers
p17095
(dp17096
sVAndrostenols
p17097
g16960
sVTestosterone and derivatives
p17098
(dp17099
sVAndrostenes
p17100
(dp17101
sg10935
(dp17102
sVAndrogens
p17103
(dp17104
sVCytochrome P-450 Enzyme Inducers
p17105
(dp17106
sVCytochrome P-450 CYP3A Inducers
p17107
(dp17108
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p17109
(dp17110
sVCytochrome P-450 CYP3A4 Substrates
p17111
(dp17112
sVGonadal Hormones
p17113
(dp17114
sVCytochrome P-450 CYP3A5 Substrates
p17115
(dp17116
sVGenito Urinary System and Sex Hormones
p17117
(dp17118
sVGonadal Steroid Hormones
p17119
(dp17120
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p17121
(dp17122
sVBCRP/ABCG2 Substrates
p17123
(dp17124
sVOAT3/SLC22A8 Inducers
p17125
(dp17126
sVP-glycoprotein/ABCB1 Inhibitors
p17127
(dp17128
sVHormones, Hormone Substitutes, and Hormone Antagonists
p17129
(dp17130
sVCytochrome P-450 CYP3A7 Substrates
p17131
(dp17132
ssg546
(dp17133
VDrugs that are Mainly Renally Excreted
p17134
(dp17135
sVAntipruritics
p17136
(dp17137
sVNervous System
p17138
(dp17139
sVHeterocyclic Compounds, Fused-Ring
p17140
(dp17141
sVUGT1A3 substrates
p17142
(dp17143
sVNeuroprotective Agents
p17144
(dp17145
sVOpioid Antagonists
p17146
(dp17147
sVOpiate Alkaloids
p17148
(dp17149
sVAppetite Depressants
p17150
(dp17151
sVCentral Nervous System Agents
p17152
(dp17153
sg10467
(dp17154
sVUGT2B7 substrates
p17155
(dp17156
sVAlkaloids
p17157
(dp17158
sg10566
(dp17159
sVPhenanthrenes
p17160
(dp17161
sVMorphinans
p17162
(dp17163
sVDrugs Used in Addictive Disorders
p17164
(dp17165
sVPeripheral Nervous System Agents
p17166
(dp17167
sVSensory System Agents
p17168
(dp17169
ssg549
(dp17170
g6231
(dp17171
sg13070
(dp17172
sg3795
(dp17173
ssg552
(dp17174
g2667
(dp17175
ssg555
(dp17176
g690
(dp17177
sg7464
(dp17178
sg1245
(dp17179
sg30
g12388
sg4629
(dp17180
sg129
g13203
sg4635
(dp17181
sg8394
(dp17182
sg10653
(dp17183
sg7821
(dp17184
sg1800
(dp17185
sg2226
(dp17186
sg4653
(dp17187
sg1656
(dp17188
sg1209
(dp17189
sg3447
(dp17190
sg9192
(dp17191
sg8430
(dp17192
sg3141
(dp17193
sg2046
(dp17194
sg11472
(dp17195
sg9948
(dp17196
sg2388
(dp17197
sg10818
(dp17198
sg1686
(dp17199
sg9963
(dp17200
sg9966
(dp17201
sg5283
(dp17202
sg3174
(dp17203
sg6279
(dp17204
sg3657
(dp17205
sg7377
(dp17206
sg5268
(dp17207
sg10740
(dp17208
sg4725
(dp17209
sg4875
(dp17210
sg7629
(dp17211
sg8340
(dp17212
sg6798
(dp17213
sg6312
(dp17214
sg3219
(dp17215
sg3990
(dp17216
sg1761
(dp17217
sg10815
(dp17218
sg6345
(dp17219
sg7029
(dp17220
sg1770
(dp17221
sg14829
(dp17222
sg9903
(dp17223
sg1782
(dp17224
sg1791
(dp17225
sg9309
(dp17226
sg9339
(dp17227
sg7353
(dp17228
sg11604
(dp17229
sg6393
(dp17230
sg7554
(dp17231
sg1383
(dp17232
sg7545
(dp17233
sg10890
(dp17234
sg1614
(dp17235
sg14838
(dp17236
sg5685
(dp17237
sg4902
(dp17238
sg12534
(dp17239
sg1104
(dp17240
sg4113
(dp17241
sg7941
(dp17242
sg351
g15260
sg2787
(dp17243
sg11712
(dp17244
sg2667
(dp17245
sg1917
(dp17246
sg11733
(dp17247
sg11745
(dp17248
sg1164
(dp17249
sg10218
(dp17250
sg6729
(dp17251
sg1173
(dp17252
sg2706
(dp17253
sg5766
(dp17254
sg10239
(dp17255
sg8742
(dp17256
sg11775
(dp17257
sg7812
(dp17258
sg2373
(dp17259
sg2739
(dp17260
sg10077
(dp17261
sg11793
(dp17262
sg10041
(dp17263
sg10296
(dp17264
sg5526
(dp17265
sg1239
(dp17266
sg5835
(dp17267
sg6585
(dp17268
sg1248
(dp17269
sg11832
(dp17270
sg9552
(dp17271
sg10548
(dp17272
sg5865
(dp17273
sg1266
(dp17274
sg2736
(dp17275
sg11079
(dp17276
sg9561
(dp17277
sg10314
(dp17278
sg5082
(dp17279
sg2808
(dp17280
sg5895
(dp17281
sg11592
(dp17282
sg4302
(dp17283
sg2841
(dp17284
sg2109
(dp17285
sg3021
(dp17286
sg3249
(dp17287
sg7569
(dp17288
sg1578
(dp17289
sg10578
(dp17290
sg8871
(dp17291
sg2142
(dp17292
sg2733
(dp17293
sg3573
(dp17294
sg141
g13359
sg2895
(dp17295
sg1188
(dp17296
sg4377
(dp17297
sg5973
(dp17298
sg7842
(dp17299
sg8922
(dp17300
sg2913
(dp17301
sg13750
(dp17302
sg14872
g15743
sg9693
(dp17303
sg2928
(dp17304
sg11145
(dp17305
sg11979
(dp17306
sg657
(dp17307
sg1050
(dp17308
sg1452
(dp17309
sg6045
(dp17310
sg4479
(dp17311
sg1491
(dp17312
sg1113
(dp17313
sg3711
(dp17314
sg12045
(dp17315
sg11997
(dp17316
sg3981
(dp17317
sg3393
(dp17318
sg12108
(dp17319
sg9774
(dp17320
sg3024
(dp17321
sg11727
(dp17322
sg4539
(dp17323
sg9393
(dp17324
sg11067
(dp17325
sg3963
(dp17326
sg5364
(dp17327
sg11358
(dp17328
sg405
g15902
sg9096
(dp17329
sg10692
(dp17330
sg1599
(dp17331
sg1611
(dp17332
ssg558
(dp17333
g2553
(dp17334
sg5415
(dp17335
sg8031
(dp17336
sg6567
(dp17337
sg3312
(dp17338
sg1041
(dp17339
sg3825
(dp17340
sg10185
(dp17341
sg8406
(dp17342
sg657
(dp17343
sg9561
(dp17344
sg5085
(dp17345
sg5286
(dp17346
sg5157
(dp17347
sg5511
(dp17348
sg4770
(dp17349
sg12072
(dp17350
sg789
(dp17351
sg8322
(dp17352
sg10200
(dp17353
sg8826
(dp17354
sg10767
(dp17355
sg396
g15798
sg4581
(dp17356
sg7020
(dp17357
sg8010
(dp17358
ssg561
(dp17359
VAmino Acids, Peptides, and Proteins
p17360
(dp17361
sVDrugs that are Mainly Renally Excreted
p17362
(dp17363
sVAmino Acids
p17364
(dp17365
sg3510
(dp17366
sg4569
(dp17367
sVGenito Urinary System and Sex Hormones
p17368
(dp17369
sg3237
(dp17370
sVPeptides
p17371
(dp17372
sVSulfur Compounds
p17373
(dp17374
sVAmino Acids, Sulfur
p17375
(dp17376
sg5004
(dp17377
sVUrologicals
p17378
(dp17379
sg7266
(dp17380
ssg564
(dp17381
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p17382
(dp17383
sVCytochrome P-450 CYP2D6 Inhibitors
p17384
(dp17385
sVCytochrome P-450 CYP2D6 Substrates
p17386
(dp17387
sVSerotonin Agents
p17388
(dp17389
sVAgents that produce hypertension
p17390
(dp17391
sVCentral Nervous System Agents
p17392
(dp17393
sVPsychotropic Drugs
p17394
(dp17395
sVEnzyme Inhibitors
p17396
(dp17397
sVCytochrome P-450 Enzyme Inhibitors
p17398
(dp17399
sg2580
(dp17400
sVPsychoanaleptics
p17401
(dp17402
sVAcids, Carbocyclic
p17403
(dp17404
sVAmides
p17405
(dp17406
sVCytochrome P-450 CYP2C9 Substrates
p17407
(dp17408
sVCentral Nervous System Depressants
p17409
(dp17410
sVBenzene Derivatives
p17411
(dp17412
sVAgents that reduce seizure threshold
p17413
(dp17414
sVMonoamine Oxidase Inhibitors
p17415
(dp17416
sVChlorobenzoates
p17417
(dp17418
sVCytochrome P-450 CYP2C19 Inhibitors
p17419
(dp17420
sVBenzamides and benzamide derivatives
p17421
g15378
sVSerotonin Modulators
p17422
(dp17423
sVAntidepressive Agents
p17424
g15553
sVBenzoates
p17425
(dp17426
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p17427
(dp17428
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p17429
(dp17430
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p17431
(dp17432
sVNervous System
p17433
(dp17434
ssg567
(dp17435
g8796
(dp17436
sg4821
(dp17437
sg4365
(dp17438
sg5832
(dp17439
sg2787
(dp17440
sg8241
(dp17441
sg6819
(dp17442
sg8808
(dp17443
sg9198
(dp17444
sg10338
(dp17445
sg78
g12867
sg5133
(dp17446
sg2253
(dp17447
sg4053
(dp17448
sg1140
(dp17449
sg4338
(dp17450
sg14791
(dp17451
sg141
g13379
sg3222
(dp17452
sg9822
(dp17453
sg10794
(dp17454
sg6015
(dp17455
sg10596
(dp17456
sg11370
(dp17457
sg7593
(dp17458
sg5598
(dp17459
ssg570
(dp17460
VAdrenergic alpha-1 Receptor Antagonists
p17461
g14136
sVAnticholinergic Agents
p17462
(dp17463
sVCytochrome P-450 CYP3A Substrates
p17464
(dp17465
sVNeurotransmitter Agents
p17466
(dp17467
sVHydroxy Acids
p17468
(dp17469
sVAdrenergic Antagonists
p17470
(dp17471
sVPeripheral Nervous System Agents
p17472
(dp17473
sg2028
(dp17474
sVDrugs that are Mainly Renally Excreted
p17475
(dp17476
sg6825
(dp17477
sVAutonomic Agents
p17478
(dp17479
sg3906
(dp17480
sVMuscarinic Antagonists
p17481
(dp17482
sg3348
(dp17483
sVParasympatholytics
p17484
(dp17485
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17486
(dp17487
sVAdrenergic alpha-Antagonists
p17488
(dp17489
sg5700
(dp17490
sVAgents that produce hypertension
p17491
(dp17492
sVCytochrome P-450 CYP3A4 Substrates
p17493
(dp17494
sg2790
(dp17495
sVGenito Urinary System and Sex Hormones
p17496
(dp17497
sVCholinergic Agents
p17498
(dp17499
sVAgents producing tachycardia
p17500
(dp17501
ssg573
(dp17502
VBSEP/ABCB11 Substrates
p17503
(dp17504
sVCytochrome P-450 CYP3A4 Inhibitors
p17505
(dp17506
sVAntivirals for Systemic Use
p17507
(dp17508
sVCytochrome P-450 CYP2D6 Inhibitors
p17509
(dp17510
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p17511
(dp17512
sVCytochrome P-450 CYP3A Substrates
p17513
(dp17514
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p17515
(dp17516
sVBCRP/ABCG2 Inhibitors
p17517
g12547
sVDirect Acting Antivirals
p17518
(dp17519
sVEnzyme Inhibitors
p17520
(dp17521
sVAnti-HIV Agents
p17522
(dp17523
sVCytochrome P-450 CYP2C9 Inhibitors
p17524
(dp17525
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p17526
g12678
sVCytochrome P-450 Enzyme Inhibitors
p17527
(dp17528
sVAnti-Infective Agents
p17529
(dp17530
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p17531
(dp17532
sVHyperglycemia-Associated Agents
p17533
(dp17534
sVAntiinfectives for Systemic Use
p17535
(dp17536
sVCytochrome P-450 CYP3A7 Inhibitors (strong)
p17537
(dp17538
sVAnti-Retroviral Agents
p17539
(dp17540
sVUGT1A1 Inducers
p17541
(dp17542
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17543
(dp17544
sVIsoquinolines
p17545
(dp17546
sVHIV Protease Inhibitors
p17547
(dp17548
sVP-glycoprotein/ABCB1 Inhibitors
p17549
(dp17550
sVQTc Prolonging Agents
p17551
(dp17552
sVOCT1 inhibitors
p17553
(dp17554
sVPotential QTc-Prolonging Agents
p17555
(dp17556
sVOATP1B3 inhibitors
p17557
(dp17558
sVCytochrome P-450 CYP2B6 Inhibitors
p17559
(dp17560
sVP-glycoprotein/ABCB1 Inducers
p17561
(dp17562
sVP-glycoprotein/ABCB1 Substrates
p17563
(dp17564
sVProtease Inhibitors
p17565
(dp17566
sVCytochrome P-450 CYP3A5 Inhibitors
p17567
(dp17568
sVCytochrome P-450 CYP2C19 Inhibitors
p17569
(dp17570
sVCytochrome P-450 CYP3A Inhibitors (strong)
p17571
g13409
sVCytochrome P-450 CYP3A4 Substrates
p17572
(dp17573
sVHeterocyclic Compounds, Fused-Ring
p17574
(dp17575
sVCytochrome P-450 CYP3A7 Inhibitors
p17576
(dp17577
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p17578
(dp17579
sVCytochrome P-450 CYP3A Inhibitors
p17580
(dp17581
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p17582
(dp17583
sVAntiviral Agents
p17584
(dp17585
sVOATP1B1/SLCO1B1 Inhibitors
p17586
(dp17587
sVCytochrome P450 3A Inhibitors
p17588
(dp17589
sVCytochrome P-450 CYP3A7 Substrates
p17590
(dp17591
ssg576
(dp17592
g528
g16944
sg147
g13455
sg834
(dp17593
sg9366
(dp17594
ssg579
(dp17595
g6966
(dp17596
sg8751
(dp17597
sg11133
(dp17598
sg5934
(dp17599
sg7641
(dp17600
sg3321
(dp17601
ssg582
(dp17602
VGABA Agents
p17603
g16222
sVCytochrome P-450 CYP3A Substrates
p17604
(dp17605
sVNeurotransmitter Agents
p17606
(dp17607
sVAnti-Anxiety Agents
p17608
(dp17609
sVCentral Nervous System Agents
p17610
(dp17611
sVBenzodiazepinones
p17612
(dp17613
sVPsychotropic Drugs
p17614
(dp17615
sVGABA Modulators
p17616
(dp17617
sVCytochrome P-450 Enzyme Inhibitors
p17618
(dp17619
sVHypnotics and Sedatives
p17620
(dp17621
sVCytochrome P-450 CYP2E1 Inhibitors
p17622
(dp17623
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17624
(dp17625
sVPsycholeptics
p17626
(dp17627
sVCentral Nervous System Depressants
p17628
(dp17629
sVAnticonvulsants
p17630
(dp17631
sVMuscle Relaxants, Centrally Acting Agents
p17632
(dp17633
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p17634
(dp17635
sVHeterocyclic Compounds, Fused-Ring
p17636
(dp17637
sVCytochrome P-450 CYP3A4 Substrates
p17638
(dp17639
sVBenzazepines
p17640
(dp17641
sVBenzodiazepine hypnotics and sedatives
p17642
(dp17643
sVMuscle Relaxants
p17644
(dp17645
sVBenzodiazepines and benzodiazepine derivatives
p17646
(dp17647
sVNervous System
p17648
(dp17649
sVTranquilizing Agents
p17650
(dp17651
ssg585
(dp17652
g9372
(dp17653
ssg588
(dp17654
g10062
(dp17655
sg426
g16119
sg582
g17643
sg8205
(dp17656
sg2358
(dp17657
sg7284
(dp17658
sg12018
(dp17659
sg9564
(dp17660
sg5769
(dp17661
sg9420
(dp17662
sg6939
(dp17663
sg5970
(dp17664
ssg591
(dp17665
g10410
(dp17666
ssg594
(dp17667
g2901
(dp17668
ssg597
(dp17669
g5409
(dp17670
sg11283
(dp17671
sg10266
(dp17672
sg8796
(dp17673
sg9924
(dp17674
sg11961
(dp17675
sg7962
(dp17676
sg4821
(dp17677
sg9324
(dp17678
sg4365
(dp17679
sg4830
(dp17680
sg5250
(dp17681
sg10308
(dp17682
sg9084
(dp17683
sg3885
(dp17684
sg11619
(dp17685
sg1062
(dp17686
sg8808
(dp17687
sg9507
(dp17688
sg3519
(dp17689
sg8874
(dp17690
sg2355
(dp17691
sg10338
(dp17692
sg8655
(dp17693
sg10347
(dp17694
sg8457
(dp17695
sg2253
(dp17696
sg6468
(dp17697
sg2910
(dp17698
sg5313
(dp17699
sg10149
(dp17700
sg609
(dp17701
sg6867
(dp17702
sg345
g15244
sg5889
(dp17703
sg132
g13222
sg1908
(dp17704
sg10002
(dp17705
sg4338
(dp17706
sg11160
(dp17707
sg816
(dp17708
sg2397
(dp17709
sg2688
(dp17710
sg8088
(dp17711
sg5571
(dp17712
sg6015
(dp17713
sg12126
(dp17714
sg402
g15862
sg5112
(dp17715
sg2172
(dp17716
sg11940
(dp17717
sg1185
(dp17718
sg6348
(dp17719
sg801
(dp17720
ssg600
(dp17721
VMitosis Modulators
p17722
(dp17723
sVAntimitotic Agents
p17724
(dp17725
sVCarbamates
p17726
(dp17727
sVBenzimidazoles
p17728
(dp17729
sVAntinematodal Agents
p17730
(dp17731
sVAntiparasitic Products, Insecticides and Repellents
p17732
(dp17733
sVAcids, Acyclic
p17734
(dp17735
sVTubulin Modulators
p17736
(dp17737
sVCytochrome P-450 CYP3A Substrates
p17738
(dp17739
sVAntiparasitic Agents
p17740
(dp17741
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17742
(dp17743
sg5988
(dp17744
sVHeterocyclic Compounds, Fused-Ring
p17745
(dp17746
sVCytochrome P-450 CYP3A4 Substrates
p17747
(dp17748
sVAnti-Infective Agents
p17749
(dp17750
sVAnthelmintics
p17751
(dp17752
sg2442
(dp17753
ssg603
(dp17754
VDrugs that are Mainly Renally Excreted
p17755
(dp17756
sVCentral Nervous System Depressants
p17757
(dp17758
sg9147
(dp17759
sVPhenols
p17760
(dp17761
sVAnti-Parkinson Drugs
p17762
g16161
sVBenzene Derivatives
p17763
(dp17764
sVNitro Compounds
p17765
(dp17766
sVKetones
p17767
(dp17768
sVAnti-Dyskinesia Agents
p17769
(dp17770
sVHypotensive Agents
p17771
(dp17772
sVEnzyme Inhibitors
p17773
(dp17774
sVCentral Nervous System Agents
p17775
(dp17776
sVDopamine Agents
p17777
g14245
sVCOMT Inhibitors
p17778
(dp17779
sVCytochrome P-450 CYP2C9 Inhibitors
p17780
(dp17781
sVBenzophenones
p17782
(dp17783
sVCytochrome P-450 Enzyme Inhibitors
p17784
(dp17785
sVNervous System
p17786
(dp17787
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p17788
(dp17789
ssg606
(dp17790
g5511
(dp17791
sg3825
(dp17792
sg5457
(dp17793
sg8583
(dp17794
sg9660
(dp17795
ssg609
(dp17796
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p17797
(dp17798
sVCytochrome P-450 CYP3A4 Inhibitors
p17799
(dp17800
sVCytochrome P-450 CYP3A Inhibitors
p17801
(dp17802
sVPotential QTc-Prolonging Agents
p17803
(dp17804
sVSomatostatin Receptor Agonists
p17805
(dp17806
sVCytochrome P-450 Enzyme Inhibitors
p17807
(dp17808
sVHyperglycemia-Associated Agents
p17809
(dp17810
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p17811
(dp17812
sVQTc Prolonging Agents
p17813
(dp17814
sVAntineoplastic Agents
p17815
(dp17816
sVGastrointestinal Agents
p17817
(dp17818
sVP-glycoprotein/ABCB1 Substrates
p17819
(dp17820
sVAntineoplastic Agents, Hormonal
p17821
(dp17822
sVPeptides
p17823
(dp17824
sVPeptides, Cyclic
p17825
(dp17826
sVAmino Acids, Peptides, and Proteins
p17827
(dp17828
sVPituitary and Hypothalamic Hormones and Analogues
p17829
(dp17830
sVSomatostatin and Analogues
p17831
(dp17832
sVHypothalamic Hormones
p17833
(dp17834
sVBradycardia-Causing Agents
p17835
(dp17836
sVHypoglycemia-Associated Agents
p17837
g17701
sVMiscellaneous Therapeutic Agents
p17838
(dp17839
ssg612
(dp17840
VAdrenergic beta-Agonists
p17841
(dp17842
sVOphthalmologicals
p17843
(dp17844
sVNeurotransmitter Agents
p17845
(dp17846
sVCentral Nervous System Agents
p17847
(dp17848
sVAdrenergic and Dopaminergic Agents
p17849
(dp17850
sVSympathomimetics
p17851
(dp17852
sVSympathomimetics, Plain
p17853
g14447
sVAlpha-and Beta-adrenergic Agonists
p17854
(dp17855
sVSympathomimetic (Adrenergic) Agents
p17856
(dp17857
sVNasal Preparations
p17858
(dp17859
sVAutonomic Agents
p17860
(dp17861
sVCardiac Stimulants Excl. Cardiac Glycosides
p17862
(dp17863
sVCardiac Therapy
p17864
(dp17865
sVEthylamines
p17866
(dp17867
sVCentral Nervous System Stimulants
p17868
(dp17869
sVCholinesterase substrates
p17870
(dp17871
sVDrugs for Obstructive Airway Diseases
p17872
(dp17873
sVCentrally Acting Antiobesity Products
p17874
(dp17875
sVAdrenergic Agents
p17876
(dp17877
sVCardiovascular Agents
p17878
(dp17879
sVAdrenergics for Systemic Use
p17880
(dp17881
sVVasoconstrictor Agents
p17882
(dp17883
sVIncreased Norepinephrine Activity
p17884
(dp17885
sVSensory Organs
p17886
(dp17887
sVEphedrine
p17888
(dp17889
sVAdrenergic Agonists
p17890
(dp17891
sVAgents that produce hypertension
p17892
(dp17893
sVAlimentary Tract and Metabolism
p17894
(dp17895
sVPropanolamines
p17896
(dp17897
sVAmines
p17898
(dp17899
sVMydriatics and Cycloplegics
p17900
(dp17901
sVAmino Alcohols
p17902
(dp17903
sVAdrenergic alpha-Agonists
p17904
(dp17905
sVSympathomimetics Excl. Antiglaucoma Preparations
p17906
(dp17907
sVPropanols
p17908
(dp17909
sVPeripheral Nervous System Agents
p17910
(dp17911
sVAgents producing tachycardia
p17912
(dp17913
sVAntiobesity Preparations, Excl. Diet Products
p17914
(dp17915
sVPhenethylamines
p17916
(dp17917
sVHerbs and Natural Products
p17918
(dp17919
sVAlcohols
p17920
(dp17921
sVNorepinephrine Releasing Agent
p17922
(dp17923
ssg615
(dp17924
g4683
(dp17925
sg9819
(dp17926
sg6102
(dp17927
ssg618
(dp17928
g5877
(dp17929
sg9960
(dp17930
sg6639
(dp17931
sg1434
(dp17932
ssg621
(dp17933
VCytochrome P-450 CYP3A4 Inhibitors
p17934
(dp17935
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p17936
(dp17937
sVCytochrome P-450 CYP2D6 Substrates
p17938
(dp17939
sVCytochrome P-450 CYP3A Substrates
p17940
(dp17941
sVBCRP/ABCG2 Inhibitors
p17942
g12559
sVKinase Inhibitor
p17943
(dp17944
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p17945
(dp17946
sVEnzyme Inhibitors
p17947
(dp17948
sVCytochrome P-450 Enzyme Inhibitors
p17949
(dp17950
sVHighest Risk QTc-Prolonging Agents
p17951
(dp17952
sVCytochrome P-450 CYP2C8 Substrates
p17953
(dp17954
sVCytochrome P-450 CYP1A2 Substrates
p17955
(dp17956
sVTyrosine Kinase Inhibitors
p17957
(dp17958
sVQuinazolines
p17959
(dp17960
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p17961
(dp17962
sVProtein Kinase Inhibitors
p17963
(dp17964
sVQTc Prolonging Agents
p17965
(dp17966
sVAntineoplastic Agents
p17967
(dp17968
sVCytochrome P-450 CYP2C8 Inhibitors
p17969
(dp17970
sVP-glycoprotein/ABCB1 Substrates
p17971
(dp17972
sVUGT1A1 Inhibitors
p17973
(dp17974
sVHeterocyclic Compounds, Fused-Ring
p17975
(dp17976
sVCytochrome P-450 CYP3A4 Substrates
p17977
(dp17978
sVCytochrome P-450 CYP3A5 Substrates
p17979
(dp17980
sVCytochrome P-450 CYP3A Inhibitors
p17981
(dp17982
sVP-glycoprotein/ABCB1 Inhibitors
p17983
(dp17984
sVAntineoplastic and Immunomodulating Agents
p17985
(dp17986
ssg624
(dp17987
g1599
(dp17988
ssg627
(dp17989
g5793
(dp17990
ssg630
(dp17991
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p17992
(dp17993
sVAdrenergic alpha-1 Receptor Antagonists
p17994
g14106
sVAnticholinergic Agents
p17995
(dp17996
sVSerotonin Agents
p17997
(dp17998
sVNeurotransmitter Agents
p17999
(dp18000
sVSerotonin Receptor Antagonists
p18001
(dp18002
sVCentral Nervous System Agents
p18003
(dp18004
sVDopamine Agents
p18005
g14223
sVAdrenergic Antagonists
p18006
(dp18007
sVPsychotropic Drugs
p18008
(dp18009
sVMuscarinic Antagonists
p18010
(dp18011
sVHighest Risk QTc-Prolonging Agents
p18012
(dp18013
sVAntipsychotic Agents
p18014
(dp18015
sVPiperazines
p18016
(dp18017
sVDopamine Antagonists
p18018
(dp18019
sVSulfur Compounds
p18020
(dp18021
sVAdrenergic alpha-Antagonists
p18022
(dp18023
sVPsycholeptics
p18024
(dp18025
sVQTc Prolonging Agents
p18026
(dp18027
sVSerotonin 5-HT2 Receptor Antagonists
p18028
(dp18029
sVCentral Nervous System Depressants
p18030
(dp18031
sVThioxanthene Derivatives
p18032
(dp18033
sVP-glycoprotein/ABCB1 Substrates
p18034
(dp18035
sVAgents that produce hypertension
p18036
(dp18037
sVAntipsychotic Agents (First Generation [Typical])
p18038
(dp18039
sVDopamine D2 Receptor Antagonists
p18040
(dp18041
sVHeterocyclic Compounds, Fused-Ring
p18042
(dp18043
sVThioxanthenes
p18044
(dp18045
sVAntidepressive Agents
p18046
g15560
sVXanthenes
p18047
(dp18048
sVP-glycoprotein/ABCB1 Inhibitors
p18049
(dp18050
sVNeurotoxic agents
p18051
(dp18052
sVAgents producing tachycardia
p18053
(dp18054
sVNervous System
p18055
(dp18056
sVTranquilizing Agents
p18057
(dp18058
ssg633
(dp18059
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p18060
(dp18061
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p18062
(dp18063
sVSerotonin Agents
p18064
(dp18065
sVAnalgesics
p18066
(dp18067
sVAntimigraine Preparations
p18068
(dp18069
sVSelective Serotonin Agonists
p18070
(dp18071
sVIndoles
p18072
(dp18073
sVCytochrome P-450 CYP1A2 Substrates
p18074
(dp18075
sVAmines
p18076
(dp18077
sVBiogenic Monoamines
p18078
(dp18079
sVCentral Nervous System Depressants
p18080
(dp18081
sVNeurotransmitter Agents
p18082
(dp18083
sVBiogenic Amines
p18084
(dp18085
sVSerotonin 1b Receptor Agonists
p18086
(dp18087
sVSelective Serotonin 5-HT1 Receptor Agonists
p18088
(dp18089
sVAgents that produce hypertension
p18090
(dp18091
sVSerotonin 5-HT1 Receptor Agonists
p18092
(dp18093
sVHeterocyclic Compounds, Fused-Ring
p18094
(dp18095
sVSerotonin Modulators
p18096
(dp18097
sVAntidepressive Agents
p18098
g15561
sVTriptans
p18099
(dp18100
sVSerotonin 1d Receptor Agonists
p18101
(dp18102
sVSerotonin Receptor Agonists
p18103
(dp18104
sVNervous System
p18105
(dp18106
sg8007
(dp18107
ssg636
(dp18108
g10200
(dp18109
ssg639
(dp18110
g4974
(dp18111
ssg642
(dp18112
g7740
(dp18113
sg3072
(dp18114
sg5007
(dp18115
sg5229
(dp18116
sg7077
(dp18117
sg6291
(dp18118
sg6000
(dp18119
sg7596
(dp18120
sg9009
(dp18121
sg7344
(dp18122
ssg645
(dp18123
VPharmaceutical Preparations
p18124
(dp18125
sg5466
(dp18126
sVCardiovascular Agents
p18127
(dp18128
sVFatty Acids
p18129
(dp18130
sVFatty Acids, Unsaturated
p18131
(dp18132
sVFatty Acids, Monounsaturated
p18133
(dp18134
sg5778
(dp18135
sVVasoprotectives
p18136
(dp18137
sVCompounds used in a research, industrial, or household setting
p18138
(dp18139
sg7254
(dp18140
sg2178
(dp18141
sg378
g15481
sVLipids
p18142
g14285
ssg648
(dp18143
g7416
(dp18144
sg129
g13201
sg4341
(dp18145
sg3000
(dp18146
sg3087
(dp18147
sg3504
(dp18148
sg12003
(dp18149
sg9726
(dp18150
sg8241
(dp18151
sg9099
(dp18152
sg7824
(dp18153
sg3711
(dp18154
sg5157
(dp18155
sg4707
(dp18156
sg10593
(dp18157
sg12072
(dp18158
sg11826
(dp18159
sg2658
(dp18160
sg8778
(dp18161
sg969
(dp18162
sg570
g17469
sg11535
(dp18163
sg12111
(dp18164
sg6687
(dp18165
sg171
g13690
sg10794
(dp18166
sg11751
(dp18167
sg1578
(dp18168
sg11769
(dp18169
sg7155
(dp18170
sg5394
(dp18171
ssg651
(dp18172
g2346
(dp18173
sg1674
(dp18174
sg3846
(dp18175
sg3858
(dp18176
sg816
(dp18177
sg7821
(dp18178
sg1650
(dp18179
sg10797
(dp18180
sg8421
(dp18181
sg4077
(dp18182
sg11451
(dp18183
sg8433
(dp18184
sg6279
(dp18185
sg9225
(dp18186
sg9231
(dp18187
sg4716
(dp18188
sg10170
(dp18189
sg6303
(dp18190
sg147
g13439
sg11523
(dp18191
sg7077
(dp18192
sg10815
(dp18193
sg10356
(dp18194
sg4017
(dp18195
sg48
g12626
sg11592
(dp18196
sg4830
(dp18197
sg1050
(dp18198
sg87
g12903
sg4863
(dp18199
sg10899
(dp18200
sg288
g14652
sg6348
(dp18201
sg11820
(dp18202
sg9357
(dp18203
sg4926
(dp18204
sg1899
(dp18205
sg10179
(dp18206
sg1908
(dp18207
sg8760
(dp18208
sg4164
(dp18209
sg7188
(dp18210
sg5256
(dp18211
sg6537
(dp18212
sg10266
(dp18213
sg9918
(dp18214
sg9525
(dp18215
sg2013
(dp18216
sg1239
(dp18217
sg10308
(dp18218
sg8049
(dp18219
sg8055
(dp18220
sg4263
(dp18221
sg11079
(dp18222
sg11940
(dp18223
sg8820
(dp18224
sg7329
(dp18225
sg7335
(dp18226
sg9591
(dp18227
sg534
g16975
sg8856
(dp18228
sg3432
(dp18229
sg573
g17525
sg9465
(dp18230
sg603
g17781
sg2913
(dp18231
sg2196
(dp18232
sg11955
(dp18233
sg5370
(dp18234
sg2943
(dp18235
sg10728
(dp18236
sg4452
(dp18237
sg6033
(dp18238
sg8241
(dp18239
sg9687
(dp18240
sg4488
(dp18241
sg7485
(dp18242
sg1113
(dp18243
sg6090
(dp18244
sg10518
(dp18245
sg3024
(dp18246
sg5313
(dp18247
sg1140
(dp18248
sg2832
(dp18249
sg6000
(dp18250
sg6123
(dp18251
sg8298
(dp18252
sg771
(dp18253
sg5181
(dp18254
sg8949
(dp18255
sg5289
(dp18256
sg6075
(dp18257
sg7593
(dp18258
sg11241
(dp18259
sg7563
(dp18260
sg7608
(dp18261
ssg654
(dp18262
VAmino Acids, Peptides, and Proteins
p18263
(dp18264
sVHormone Antagonists and Related Agents
p18265
(dp18266
sVPotential QTc-Prolonging Agents
p18267
(dp18268
sVPeptides
p18269
(dp18270
sg7590
(dp18271
sVAntineoplastic and Immunomodulating Agents
p18272
(dp18273
sg786
(dp18274
sVQTc Prolonging Agents
p18275
(dp18276
sVAntineoplastic Agents
p18277
(dp18278
sVEndocrine Therapy
p18279
(dp18280
ssg657
(dp18281
VAgents that produce neuromuscular block (indirect)
p18282
(dp18283
sVAntiarrhythmic agents
p18284
(dp18285
sVAnalgesics
p18286
(dp18287
sVAgents causing hyperkalemia
p18288
(dp18289
sVDrugs for Constipation
p18290
(dp18291
sVCalcium Channel Blockers
p18292
(dp18293
sVMagnesium Compounds
p18294
(dp18295
sVElectrolyte Solutions
p18296
(dp18297
sVCalculi Dissolution Agent
p18298
g12689
sVElectrolytes
p18299
(dp18300
sVDiagnostic Agents
p18301
(dp18302
sVMetal divalent cations
p18303
(dp18304
sVMiscellaneous Anticonvulsants
p18305
(dp18306
sVReplacement Preparations
p18307
(dp18308
sVTests for Bile Duct Patency
p18309
(dp18310
sVCalcium-Regulating Hormones and Agents
p18311
(dp18312
sVTocolytic Agents
p18313
(dp18314
sVMineral Supplements
p18315
(dp18316
sVReproductive Control Agents
p18317
(dp18318
sVMagnesium Salts
p18319
(dp18320
sVOsmotic Laxatives
p18321
(dp18322
sVI.V. Solution Additives
p18323
(dp18324
sVSulfur Compounds
p18325
(dp18326
sVCentral Nervous System Depressants
p18327
(dp18328
sVBlood and Blood Forming Organs
p18329
(dp18330
sVCardiovascular Agents
p18331
(dp18332
sVAnesthetics
p18333
(dp18334
sVAnticonvulsants
p18335
(dp18336
sVAcids
p18337
(dp18338
sVDermatologicals
p18339
g17307
sVVasodilating Agents
p18340
(dp18341
sVSulfuric Acids
p18342
(dp18343
sVLaxatives
p18344
g17343
sVMembrane Transport Modulators
p18345
(dp18346
sVCentral Nervous System Agents
p18347
(dp18348
sVAlimentary Tract and Metabolism
p18349
(dp18350
sVIons
p18351
(dp18352
sVBlood Substitutes and Perfusion Solutions
p18353
(dp18354
sVSulfates
p18355
(dp18356
sVBradycardia-Causing Agents
p18357
(dp18358
sVParamagnetic Contrast Agent
p18359
(dp18360
sVAcids, Noncarboxylic
p18361
(dp18362
sVSulfur Acids
p18363
(dp18364
sVPeripheral Nervous System Agents
p18365
(dp18366
sVAnions
p18367
(dp18368
sVMetal cations
p18369
(dp18370
sVLaxatives, magnesium containing
p18371
(dp18372
sVSensory System Agents
p18373
(dp18374
ssg660
(dp18375
g11940
(dp18376
sg816
(dp18377
ssg663
(dp18378
g9588
(dp18379
ssg666
(dp18380
g2346
(dp18381
sg3105
(dp18382
sg2559
(dp18383
sg11955
(dp18384
sg1326
(dp18385
sg3846
(dp18386
sg5028
(dp18387
sg6882
(dp18388
sg1044
(dp18389
sg4452
(dp18390
sg5832
(dp18391
sg10662
(dp18392
sg5454
(dp18393
sg8241
(dp18394
sg9099
(dp18395
sg3111
(dp18396
sg8022
(dp18397
sg10899
(dp18398
sg3696
(dp18399
sg4077
(dp18400
sg5877
(dp18401
sg6468
(dp18402
sg2427
(dp18403
sg8820
(dp18404
sg8655
(dp18405
sg7299
(dp18406
sg9960
(dp18407
sg9273
(dp18408
sg9432
(dp18409
sg9966
(dp18410
sg8097
(dp18411
sg9417
(dp18412
sg10593
(dp18413
sg2460
(dp18414
sg5535
(dp18415
sg486
g16643
sg8856
(dp18416
sg11337
(dp18417
sg945
(dp18418
sg5127
(dp18419
sg10950
(dp18420
sg8298
(dp18421
sg6303
(dp18422
sg6687
(dp18423
sg11016
(dp18424
sg3222
(dp18425
sg7176
(dp18426
sg4164
(dp18427
sg387
g15621
sg3240
(dp18428
sg5289
(dp18429
sg6075
(dp18430
sg11241
(dp18431
sg8190
(dp18432
ssg669
(dp18433
VAmino Acids, Peptides, and Proteins
p18434
(dp18435
sVGlobulins
p18436
(dp18437
sVAntibodies
p18438
(dp18439
sg10050
(dp18440
sVAntibodies, Monoclonal
p18441
(dp18442
sg5808
(dp18443
sg2541
(dp18444
sVImmunoglobulins
p18445
(dp18446
sVProteins
p18447
(dp18448
sVSerum Globulins
p18449
(dp18450
sVAntineoplastic and Immunomodulating Agents
p18451
(dp18452
sVBlood Proteins
p18453
(dp18454
sVAntineoplastic Agents
p18455
(dp18456
sVImmunoproteins
p18457
(dp18458
ssg672
(dp18459
g87
g12909
sg1785
(dp18460
sg4521
(dp18461
sg4863
(dp18462
sg3015
(dp18463
sg12090
(dp18464
sg1674
(dp18465
sg48
g12632
sg474
g16552
sg1275
(dp18466
sg918
(dp18467
ssg675
(dp18468
g7014
(dp18469
ssg678
(dp18470
g1266
(dp18471
sg9348
(dp18472
sg8076
(dp18473
sg10653
(dp18474
sg4905
(dp18475
ssg681
(dp18476
g12042
(dp18477
sg2283
(dp18478
ssg684
(dp18479
VDihydropyridine Derivatives
p18480
(dp18481
sVAntiarrhythmic agents
p18482
(dp18483
sVCytochrome P-450 CYP3A Substrates
p18484
(dp18485
sVAgents causing hyperkalemia
p18486
(dp18487
sVHypotensive Agents
p18488
(dp18489
sVCalcium Channel Blockers
p18490
(dp18491
sVCalcium Channel Blockers (Dihydropyridine)
p18492
(dp18493
sVAntihypertensive Agents
p18494
(dp18495
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p18496
(dp18497
sVQTc Prolonging Agents
p18498
(dp18499
sVCardiovascular Agents
p18500
(dp18501
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p18502
(dp18503
sVPyridines
p18504
(dp18505
sVVasodilating Agents
p18506
(dp18507
sVNicotinic Acids
p18508
(dp18509
sVMembrane Transport Modulators
p18510
(dp18511
sVCytochrome P-450 CYP3A4 Substrates
p18512
(dp18513
sVCalcium-Regulating Hormones and Agents
p18514
(dp18515
sVModerate Risk QTc-Prolonging Agents
p18516
(dp18517
sVCytochrome P-450 CYP3A5 Substrates
p18518
(dp18519
sVBradycardia-Causing Agents
p18520
(dp18521
sVP-glycoprotein/ABCB1 Inhibitors
p18522
(dp18523
sVDihydropyridines
p18524
(dp18525
ssg687
(dp18526
VAnticholinergic Agents
p18527
(dp18528
sVAntiarrhythmic agents
p18529
(dp18530
sVBronchodilator Agents
p18531
(dp18532
sVCentral Nervous System Agents
p18533
(dp18534
sVPotential QTc-Prolonging Agents
p18535
(dp18536
sg6573
(dp18537
sVTropanes
p18538
(dp18539
sVMuscarinic Antagonists
p18540
(dp18541
sVAutonomic Agents
p18542
(dp18543
sVBelladonna Alkaloids, Tertiary Amines
p18544
(dp18545
sVParasympatholytics
p18546
(dp18547
sVPeripheral Nervous System Agents
p18548
(dp18549
sVAza Compounds
p18550
(dp18551
sVRespiratory System Agents
p18552
(dp18553
sVAdjuvants, Anesthesia
p18554
(dp18555
sVQTc Prolonging Agents
p18556
(dp18557
sVBelladonna and Derivatives, Plain
p18558
(dp18559
sVNeurotransmitter Agents
p18560
(dp18561
sVCardiovascular Agents
p18562
(dp18563
sVAzabicyclo Compounds
p18564
(dp18565
sVSolanaceous Alkaloids
p18566
(dp18567
sVAtropine Derivatives
p18568
(dp18569
sVMydriatics
p18570
(dp18571
sVDrugs for Functional Gastrointestinal Disorders
p18572
(dp18573
sVAnti-Asthmatic Agents
p18574
(dp18575
sVAlimentary Tract and Metabolism
p18576
(dp18577
sVCholinergic Agents
p18578
(dp18579
sVBelladonna Alkaloids
p18580
(dp18581
sVAgents producing tachycardia
p18582
(dp18583
sVAlkaloids
p18584
(dp18585
ssg690
(dp18586
VBSEP/ABCB11 Substrates
p18587
(dp18588
sVCytochrome P-450 CYP3A4 Inhibitors
p18589
(dp18590
sVCytochrome P-450 CYP3A Substrates
p18591
(dp18592
sVCytochrome P-450 CYP3A7 Inhibitors
p18593
(dp18594
sVAntibacterials for Systemic Use
p18595
(dp18596
sVAnti-Acne Preparations
p18597
(dp18598
sVOATP1B1/SLCO1B1 Inhibitors
p18599
(dp18600
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p18601
(dp18602
sVEnzyme Inhibitors
p18603
(dp18604
sVCytochrome P-450 Enzyme Inhibitors
p18605
(dp18606
sVAnti-Infective Agents
p18607
(dp18608
sVAntiinfectives for Systemic Use
p18609
(dp18610
sVMacrolide Antimicrobial
p18611
(dp18612
sVLactones
p18613
(dp18614
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p18615
(dp18616
sVErythromycins
p18617
(dp18618
sVMacrolides, Lincosamides and Streptogramins
p18619
(dp18620
sVAnti-Bacterial Agents
p18621
(dp18622
sVMacrolides
p18623
g16900
sVOATP1B1/SLCO1B1 Substrates
p18624
(dp18625
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p18626
(dp18627
sVGastrointestinal Agents
p18628
(dp18629
sVOATP1B3 inhibitors
p18630
(dp18631
sVP-glycoprotein/ABCB1 Substrates
p18632
(dp18633
sVDermatologicals
p18634
g17177
sVErythromycin and similars
p18635
(dp18636
sVProtein Synthesis Inhibitors
p18637
(dp18638
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p18639
(dp18640
sVBSEP/ABCB11 Inhibitors
p18641
(dp18642
sVCytochrome P-450 CYP3A5 Substrates
p18643
(dp18644
sVCytochrome P-450 CYP3A4 Substrates
p18645
(dp18646
sVQTc Prolonging Agents
p18647
(dp18648
sVModerate Risk QTc-Prolonging Agents
p18649
(dp18650
sVAnti-Acne Preparations for Topical Use
p18651
(dp18652
sVOphthalmologicals
p18653
(dp18654
sVOATP1B3 substrates
p18655
(dp18656
sVCytochrome P-450 CYP3A Inhibitors
p18657
(dp18658
sVP-glycoprotein/ABCB1 Inhibitors
p18659
(dp18660
sVAntiinfectives for Treatment of Acne
p18661
(dp18662
sVCytochrome P-450 CYP3A7 Substrates
p18663
(dp18664
sVCytochrome P-450 CYP3A5 Inhibitors
p18665
(dp18666
ssg693
(dp18667
g9108
(dp18668
sg2343
(dp18669
sg3891
(dp18670
sg10569
(dp18671
sg2118
(dp18672
ssg696
(dp18673
VCytochrome P-450 CYP3A4 Inhibitors
p18674
(dp18675
sVDibenzazepines
p18676
(dp18677
sVAdrenergic alpha-1 Receptor Antagonists
p18678
g14137
sVAnticholinergic Agents
p18679
(dp18680
sVCytochrome P-450 CYP2D6 Inhibitors
p18681
(dp18682
sVCytochrome P-450 CYP2D6 Substrates
p18683
(dp18684
sVGABA Agents
p18685
g16219
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p18686
(dp18687
sVCytochrome P-450 CYP3A Substrates
p18688
(dp18689
sVNeurotransmitter Agents
p18690
(dp18691
sVHypotensive Agents
p18692
(dp18693
sVSerotonin Receptor Antagonists
p18694
(dp18695
sVCentral Nervous System Agents
p18696
(dp18697
sVAdrenergic Antagonists
p18698
(dp18699
sVPsychotropic Drugs
p18700
(dp18701
sVCytochrome P-450 CYP2E1 Inhibitors
p18702
(dp18703
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p18704
(dp18705
sVDopamine Antagonists
p18706
(dp18707
sVCytochrome P-450 Enzyme Inhibitors
p18708
(dp18709
sVMuscarinic Antagonists
p18710
(dp18711
sVHyperglycemia-Associated Agents
p18712
(dp18713
sVDiazepines, Oxazepines, Thiazepines and Oxepines
p18714
(dp18715
sVDrugs that are Mainly Renally Excreted
p18716
(dp18717
sVCytochrome P-450 CYP2C8 Substrates
p18718
(dp18719
sVCytochrome P-450 CYP1A2 Substrates
p18720
(dp18721
sVAntipsychotic Agents
p18722
(dp18723
sVSerotonin 5-HT2 Receptor Antagonists
p18724
(dp18725
sVUGT1A4 substrates
p18726
(dp18727
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p18728
(dp18729
sVAdrenergic alpha-Antagonists
p18730
(dp18731
sVSerotonin Agents
p18732
(dp18733
sVCytochrome P-450 CYP2C9 Substrates
p18734
(dp18735
sVQTc Prolonging Agents
p18736
(dp18737
sVCytochrome P-450 CYP3A4 Inducers
p18738
(dp18739
sVCentral Nervous System Depressants
p18740
(dp18741
sVHistamine Antagonists
p18742
(dp18743
sVAgents that reduce seizure threshold
p18744
(dp18745
sVCytochrome P-450 CYP1A2 Inhibitors
p18746
g15027
sVP-glycoprotein/ABCB1 Substrates
p18747
(dp18748
sVCytochrome P-450 CYP2A6 Substrates
p18749
(dp18750
sVCytochrome P-450 Enzyme Inducers
p18751
(dp18752
sVCytochrome P-450 CYP3A Inducers
p18753
(dp18754
sVHistamine H1 Antagonists
p18755
(dp18756
sVAgents that produce hypertension
p18757
(dp18758
sVCytochrome P-450 CYP2C19 Inhibitors
p18759
(dp18760
sVCytochrome P-450 CYP3A4 Substrates
p18761
(dp18762
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p18763
(dp18764
sVModerate Risk QTc-Prolonging Agents
p18765
(dp18766
sVDopamine D2 Receptor Antagonists
p18767
(dp18768
sVHeterocyclic Compounds, Fused-Ring
p18769
(dp18770
sVAntidepressive Agents
p18771
g15552
sVPsycholeptics
p18772
(dp18773
sVCytochrome P-450 CYP3A Inhibitors
p18774
(dp18775
sg6960
(dp18776
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p18777
(dp18778
sVTranquilizing Agents
p18779
(dp18780
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p18781
(dp18782
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p18783
(dp18784
sVNeurotoxic agents
p18785
(dp18786
sVAgents producing tachycardia
p18787
(dp18788
sVNervous System
p18789
(dp18790
sVAntipsychotic Agents (Second Generation [Atypical])
p18791
(dp18792
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p18793
(dp18794
ssg699
(dp18795
g7395
(dp18796
sg1842
(dp18797
sg6714
(dp18798
ssg702
(dp18799
VPiperidines
p18800
(dp18801
sVCentral Nervous System Depressants
p18802
(dp18803
sVFatty Acid Derivatives
p18804
(dp18805
sVGABA Agents
p18806
g16213
sVAnti-epileptic Agent
p18807
(dp18808
sVCytochrome P-450 CYP3A Substrates
p18809
(dp18810
sVMembrane Transport Modulators
p18811
(dp18812
sg7584
(dp18813
sVCentral Nervous System Agents
p18814
(dp18815
sVNeurotransmitter Agents
p18816
(dp18817
sg9150
(dp18818
sVNervous System
p18819
(dp18820
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p18821
(dp18822
sVNeurotransmitter Uptake Inhibitors
p18823
(dp18824
sVUGT1A1 Substrates
p18825
g12292
sVAnticonvulsants
p18826
(dp18827
sVCytochrome P-450 CYP3A4 Substrates
p18828
(dp18829
sVDecreased Central Nervous System Disorganized Electrical Activity
p18830
(dp18831
ssg705
(dp18832
g6180
(dp18833
sg11274
(dp18834
sg6228
(dp18835
sg816
(dp18836
sg7719
(dp18837
sg3117
(dp18838
sg2007
(dp18839
sg9225
(dp18840
sg834
(dp18841
sg657
g18318
sg10470
(dp18842
sg849
(dp18843
sg4515
(dp18844
sg1470
(dp18845
sg4623
(dp18846
sg507
g16777
sg9561
(dp18847
sg11940
(dp18848
sg2817
(dp18849
sg9402
(dp18850
sg11667
(dp18851
sg9357
(dp18852
sg2283
(dp18853
sg14822
(dp18854
sg6474
(dp18855
sg2127
(dp18856
sg12042
(dp18857
sg2133
(dp18858
sg3783
(dp18859
sg10230
(dp18860
sg10557
(dp18861
sg11775
(dp18862
ssg708
(dp18863
g6381
(dp18864
sg11916
(dp18865
ssg711
(dp18866
g4620
(dp18867
sg5409
(dp18868
sg2346
(dp18869
sg9132
(dp18870
sg3846
(dp18871
sg9249
(dp18872
sg5433
(dp18873
sg9903
(dp18874
sg6216
(dp18875
sg1800
(dp18876
sg2226
(dp18877
sg5454
(dp18878
sg4653
(dp18879
sg1656
(dp18880
sg8421
(dp18881
sg7668
(dp18882
sg8430
(dp18883
sg9198
(dp18884
sg888
(dp18885
sg10701
(dp18886
sg8448
(dp18887
sg10272
(dp18888
sg5133
(dp18889
sg9966
(dp18890
sg9225
(dp18891
sg1113
(dp18892
sg9231
(dp18893
sg7734
(dp18894
sg816
(dp18895
sg147
g13457
sg3219
(dp18896
sg11550
(dp18897
sg13091
(dp18898
sg11523
(dp18899
sg183
g13814
sg6333
(dp18900
sg6336
(dp18901
sg2538
(dp18902
sg6345
(dp18903
sg3258
(dp18904
sg14829
(dp18905
sg7053
(dp18906
sg4023
(dp18907
sg12274
(dp18908
sg7545
(dp18909
sg1062
(dp18910
sg1614
(dp18911
sg4680
(dp18912
sg14838
(dp18913
sg9030
(dp18914
sg4089
(dp18915
sg12534
(dp18916
sg4911
(dp18917
sg1104
(dp18918
sg4113
(dp18919
sg9444
(dp18920
sg8694
(dp18921
sg8703
(dp18922
sg2688
(dp18923
sg4155
(dp18924
sg4164
(dp18925
sg5757
(dp18926
sg7188
(dp18927
sg5766
(dp18928
sg9492
(dp18929
sg405
g15904
sg11775
(dp18930
sg2730
(dp18931
sg2373
(dp18932
sg9918
(dp18933
sg5832
(dp18934
sg8049
(dp18935
sg5853
(dp18936
sg2787
(dp18937
sg7272
(dp18938
sg3516
(dp18939
sg11079
(dp18940
sg11940
(dp18941
sg4287
(dp18942
sg7329
(dp18943
sg78
g12854
sg5895
(dp18944
sg7389
(dp18945
sg11952
(dp18946
sg9609
(dp18947
sg543
g17096
sg10362
(dp18948
sg3393
(dp18949
sg6504
(dp18950
sg11886
(dp18951
sg3651
(dp18952
sg7335
(dp18953
sg3432
(dp18954
sg1668
(dp18955
sg696
g18739
sg8472
(dp18956
sg1371
(dp18957
sg11922
(dp18958
sg13750
(dp18959
sg14872
g15728
sg9693
(dp18960
sg7428
(dp18961
sg2943
(dp18962
sg1434
(dp18963
sg6045
(dp18964
sg6765
(dp18965
sg1461
(dp18966
sg9618
(dp18967
sg6783
(dp18968
sg5526
(dp18969
sg3024
(dp18970
sg3027
(dp18971
sg11316
(dp18972
sg1140
(dp18973
sg2832
(dp18974
sg10539
(dp18975
sg8298
(dp18976
sg10113
(dp18977
sg10557
(dp18978
sg1098
(dp18979
sg9822
(dp18980
sg5364
(dp18981
sg5067
(dp18982
sg12126
(dp18983
sg10596
(dp18984
sg6075
(dp18985
sg12132
(dp18986
sg7593
(dp18987
sg4596
(dp18988
sg12123
(dp18989
ssg714
(dp18990
g5172
(dp18991
sVAnalgesics
p18992
(dp18993
sVNeurotransmitter Agents
p18994
(dp18995
sVBCRP/ABCG2 Inhibitors
p18996
g12536
sVMiscellaneous Antiemetics
p18997
(dp18998
sVPsychotropic Drugs
p18999
(dp19000
sVHormones
p19001
(dp19002
sVCannabinoids and similars
p19003
(dp19004
sVPeripheral Nervous System Agents
p19005
(dp19006
sVTerpenes
p19007
(dp19008
sVAnalgesics, Non-Narcotic
p19009
(dp19010
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19011
(dp19012
sVCytochrome P-450 CYP2C9 Substrates
p19013
(dp19014
sVAntiemetics and Antinauseants
p19015
(dp19016
sVCytochrome P-450 CYP3A Substrates
p19017
(dp19018
sVCentral Nervous System Depressants
p19019
(dp19020
sg3729
(dp19021
sVCytochrome P-450 CYP2A6 Substrates
p19022
(dp19023
sVCentral Nervous System Agents
p19024
(dp19025
sVCytochrome P-450 CYP3A4 Substrates
p19026
(dp19027
sVAlimentary Tract and Metabolism
p19028
(dp19029
sVP-glycoprotein/ABCB1 Inhibitors
p19030
(dp19031
sVAgents producing tachycardia
p19032
(dp19033
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19034
(dp19035
sVSensory System Agents
p19036
(dp19037
ssg717
(dp19038
VFibrin Modulating Agents
p19039
(dp19040
sVHemostatics
p19041
(dp19042
sVHematologic Agents
p19043
(dp19044
sVBlood and Blood Forming Organs
p19045
(dp19046
sVAcids, Carbocyclic
p19047
(dp19048
sg8415
(dp19049
sVCycloparaffins
p19050
(dp19051
sVAmino Acids
p19052
(dp19053
sVCyclohexanecarboxylic Acids
p19054
(dp19055
sVAntifibrinolytic Agents
p19056
(dp19057
sVCoagulants
p19058
(dp19059
sVCyclohexanes
p19060
(dp19061
ssg720
(dp19062
g1842
(dp19063
sg5415
(dp19064
sg6714
(dp19065
ssg723
(dp19066
VAdrenergic beta-Agonists
p19067
(dp19068
sVAdrenergic beta-2 Receptor Agonists
p19069
(dp19070
sVHeterocyclic Compounds, Fused-Ring
p19071
(dp19072
sVQuinolines
p19073
(dp19074
sVP-glycoprotein/ABCB1 Substrates
p19075
(dp19076
sVUGT1A1 Substrates
p19077
g12308
sVCytochrome P-450 CYP3A Substrates
p19078
(dp19079
sVAgents to Treat Airway Disease
p19080
(dp19081
sVIndenes
p19082
(dp19083
sVPotential QTc-Prolonging Agents
p19084
(dp19085
sVSelective Beta 2-adrenergic Agonists
p19086
(dp19087
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19088
(dp19089
sVAdrenergic Agonists
p19090
(dp19091
sVAgents producing tachycardia
p19092
(dp19093
sVAgents that produce hypertension
p19094
(dp19095
sVQTc Prolonging Agents
p19096
(dp19097
sVCytochrome P-450 CYP3A4 Substrates
p19098
(dp19099
sVDrugs for Obstructive Airway Diseases
p19100
(dp19101
sVAdrenergics, Inhalants
p19102
(dp19103
ssg726
(dp19104
g9153
(dp19105
sg4008
(dp19106
sg2397
(dp19107
ssg729
(dp19108
g1947
(dp19109
sg7740
(dp19110
sg5007
(dp19111
sg6291
(dp19112
sg7596
(dp19113
sg9009
(dp19114
ssg732
(dp19115
g3018
(dp19116
sg7164
(dp19117
sg375
g15461
sg11649
(dp19118
sg1635
(dp19119
sg4623
(dp19120
sg828
(dp19121
sg9252
(dp19122
sg4488
(dp19123
sg255
g14398
sg168
g13659
sg2583
(dp19124
ssg735
(dp19125
VAgents Causing Muscle Toxicity
p19126
(dp19127
sVBisphosphonates
p19128
(dp19129
sVMusculo-Skeletal System
p19130
(dp19131
sVPotential QTc-Prolonging Agents
p19132
(dp19133
sVDrugs for Treatment of Bone Diseases
p19134
g14275
sVBone Density Conservation Agents
p19135
(dp19136
sVOrganophosphonates
p19137
(dp19138
sVDrugs Affecting Bone Structure and Mineralization
p19139
g16507
sVQTc Prolonging Agents
p19140
(dp19141
sVOrganophosphorus Compounds
p19142
(dp19143
ssg738
(dp19144
g5289
(dp19145
ssg741
(dp19146
g11733
(dp19147
sg3249
(dp19148
sg12057
(dp19149
sg5556
(dp19150
sg10272
(dp19151
sg8658
(dp19152
ssg744
(dp19153
g1563
(dp19154
ssg747
(dp19155
g4017
(dp19156
sg4902
(dp19157
sg12078
(dp19158
ssg750
(dp19159
g9897
(dp19160
sg5463
(dp19161
sg9132
(dp19162
sg2754
(dp19163
sg447
g16302
sg9705
(dp19164
sg8772
(dp19165
sg9300
(dp19166
sg6213
(dp19167
sg6216
(dp19168
sg9348
(dp19169
sg11646
(dp19170
sg669
g18437
sg4200
(dp19171
sg3147
(dp19172
sg12015
(dp19173
sg11286
(dp19174
sg1482
(dp19175
sg9741
(dp19176
sg8076
(dp19177
sg6612
(dp19178
sg4977
(dp19179
sg6804
(dp19180
sg7512
(dp19181
sg6630
(dp19182
sg9612
(dp19183
sg4713
(dp19184
sg10431
(dp19185
sg1737
(dp19186
sg3801
(dp19187
sg9627
(dp19188
sg3882
(dp19189
sg4551
(dp19190
sg3573
(dp19191
sg11349
(dp19192
sg11550
(dp19193
sg3588
(dp19194
sg7980
(dp19195
sg1563
(dp19196
sg4905
(dp19197
sg8910
(dp19198
sg4185
(dp19199
sg7059
(dp19200
sg9852
(dp19201
sg7809
(dp19202
sg10104
(dp19203
sg10653
(dp19204
ssg753
(dp19205
VDrugs that are Mainly Renally Excreted
p19206
(dp19207
sVNitrogen Compounds
p19208
(dp19209
sVOnium Compounds
p19210
(dp19211
sVAmines
p19212
(dp19213
sVCholinesterase Inhibitors
p19214
(dp19215
sVQuaternary Ammonium Compounds
p19216
(dp19217
sVNeurotransmitter Agents
p19218
(dp19219
sVCholinergic Agents
p19220
(dp19221
sVCompounds used in a research, industrial, or household setting
p19222
(dp19223
sVEnzyme Inhibitors
p19224
(dp19225
sVProtective Agents
p19226
(dp19227
sg9714
(dp19228
sVAntidotes
p19229
(dp19230
sVAmmonium Compounds
p19231
(dp19232
ssg756
(dp19233
g5757
(dp19234
sg10797
(dp19235
sg10512
(dp19236
ssg759
(dp19237
g7608
(dp19238
ssg762
(dp19239
VSex Hormones and Modulators of the Genital System
p19240
(dp19241
sVGonadotropins and Antigonadotropins
p19242
(dp19243
sVGonadotropins
p19244
(dp19245
sVGenito Urinary System and Sex Hormones
p19246
(dp19247
ssg765
(dp19248
g2256
(dp19249
sg10074
(dp19250
sg6471
(dp19251
sg10974
(dp19252
sg4320
(dp19253
sg1356
(dp19254
ssg768
(dp19255
g5499
(dp19256
ssg771
(dp19257
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p19258
(dp19259
sVCytochrome P-450 CYP3A4 Inhibitors
p19260
(dp19261
sVCytochrome P-450 CYP3A Inhibitors
p19262
(dp19263
sVCytochrome P-450 CYP2D6 Substrates
p19264
(dp19265
sVCytochrome P-450 CYP3A Substrates
p19266
(dp19267
sVHypotensive Agents
p19268
(dp19269
sVPotential QTc-Prolonging Agents
p19270
(dp19271
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p19272
(dp19273
sVCytochrome P-450 CYP2C9 Inhibitors
p19274
g18253
sVCytochrome P-450 Enzyme Inhibitors
p19275
(dp19276
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p19277
(dp19278
sVCytochrome P-450 CYP1A2 Substrates
p19279
(dp19280
sg7665
(dp19281
sVMyelosuppressive Agents
p19282
(dp19283
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19284
(dp19285
sVCytochrome P-450 CYP2C9 Substrates
p19286
(dp19287
sVQTc Prolonging Agents
p19288
(dp19289
sVAntineoplastic Agents
p19290
(dp19291
sVCytochrome P-450 CYP1A2 Inhibitors
p19292
g15042
sVAcids
p19293
(dp19294
sg4941
(dp19295
sVCytochrome P-450 CYP2C19 Inhibitors
p19296
(dp19297
sg4137
(dp19298
sVCytochrome P-450 CYP3A4 Substrates
p19299
(dp19300
sVCardiotoxic antineoplastic agents
p19301
(dp19302
sg3984
(dp19303
sVImmunosuppressive Agents
p19304
(dp19305
sVAcids, Noncarboxylic
p19306
(dp19307
sVAntineoplastic and Immunomodulating Agents
p19308
(dp19309
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p19310
(dp19311
sg1860
(dp19312
ssg774
(dp19313
g8388
(dp19314
sg8406
(dp19315
ssg777
(dp19316
g11265
(dp19317
sg11721
(dp19318
sg11793
(dp19319
sg6729
(dp19320
sg9393
(dp19321
sg11163
(dp19322
ssg780
(dp19323
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p19324
(dp19325
sVPyrimidines
p19326
(dp19327
sVAdrenergic alpha-1 Receptor Antagonists
p19328
g14148
sVCytochrome P-450 CYP2D6 Substrates
p19329
(dp19330
sVSerotonin Agents
p19331
(dp19332
sVCytochrome P-450 CYP3A Substrates
p19333
(dp19334
sVNeurotransmitter Agents
p19335
(dp19336
sVSerotonin Receptor Antagonists
p19337
(dp19338
sVCentral Nervous System Agents
p19339
(dp19340
sVDopamine Agents
p19341
g14271
sVIsoxazoles
p19342
(dp19343
sVPsychotropic Drugs
p19344
(dp19345
sVHyperglycemia-Associated Agents
p19346
(dp19347
sVDrugs that are Mainly Renally Excreted
p19348
(dp19349
sVAntipsychotic Agents
p19350
(dp19351
sVDopamine Antagonists
p19352
(dp19353
sVAdrenergic alpha-Antagonists
p19354
(dp19355
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19356
(dp19357
sVQTc Prolonging Agents
p19358
(dp19359
sVHighest Risk QTc-Prolonging Agents
p19360
(dp19361
sVSerotonin 5-HT2 Receptor Antagonists
p19362
(dp19363
sVCentral Nervous System Depressants
p19364
(dp19365
sVP-glycoprotein/ABCB1 Substrates
p19366
(dp19367
sVAgents that produce hypertension
p19368
(dp19369
sVCytochrome P-450 CYP3A4 Substrates
p19370
(dp19371
sVDopamine D2 Receptor Antagonists
p19372
(dp19373
sVCytochrome P-450 CYP3A5 Substrates
p19374
(dp19375
sVAntidepressive Agents
p19376
g15578
sVPsycholeptics
p19377
(dp19378
sVTranquilizing Agents
p19379
(dp19380
sVAdrenergic Antagonists
p19381
(dp19382
sVP-glycoprotein/ABCB1 Inhibitors
p19383
(dp19384
sVNeurotoxic agents
p19385
(dp19386
sVNervous System
p19387
(dp19388
sVAntipsychotic Agents (Second Generation [Atypical])
p19389
(dp19390
ssg783
(dp19391
g9153
(dp19392
sg4023
(dp19393
sg10635
(dp19394
sg8580
(dp19395
sg7422
(dp19396
sg1803
(dp19397
sg12421
g12490
sg1809
(dp19398
sg4035
(dp19399
sg42
g12604
sg11601
(dp19400
sg10470
(dp19401
sg5454
(dp19402
sg7713
(dp19403
sg8295
(dp19404
sg9918
(dp19405
sg2784
(dp19406
sg1260
(dp19407
sg3684
(dp19408
sg6819
(dp19409
sg5781
(dp19410
sg9111
(dp19411
sg2199
(dp19412
sg294
g14768
sg5487
(dp19413
sg10335
(dp19414
sg5877
(dp19415
sg4683
(dp19416
sg3156
(dp19417
sg7896
(dp19418
sg11097
(dp19419
sg7197
(dp19420
sg9960
(dp19421
sg4101
(dp19422
sg1281
(dp19423
sg5739
(dp19424
sg8673
(dp19425
sg4458
(dp19426
sg546
g17158
sg10593
(dp19427
sg8487
(dp19428
sg9414
(dp19429
sg1140
(dp19430
sg1413
(dp19431
sg9444
(dp19432
sg6102
(dp19433
sg8514
(dp19434
sg8463
(dp19435
sg7065
(dp19436
sg2397
(dp19437
sg537
g17056
sg6882
(dp19438
sg2688
(dp19439
sg14791
(dp19440
sg141
g13373
sg9819
(dp19441
sg6261
(dp19442
sg2523
(dp19443
sg12126
(dp19444
sg687
g18585
sg11931
(dp19445
sg10602
(dp19446
sg7014
(dp19447
sg1092
(dp19448
sg4008
(dp19449
sg1008
(dp19450
sg9864
(dp19451
ssg786
(dp19452
g654
g18274
ssg789
(dp19453
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p19454
(dp19455
sVGastrointestinal Agents
p19456
(dp19457
sVCytochrome P-450 CYP2D6 Inhibitors
p19458
(dp19459
sVCytochrome P-450 CYP2D6 Substrates
p19460
(dp19461
sVLaxatives
p19462
g17351
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p19463
(dp19464
sVCytochrome P-450 CYP1A2 Inhibitors
p19465
g15030
sVCytochrome P-450 CYP2C8 Inhibitors
p19466
(dp19467
sVP-glycoprotein/ABCB1 Substrates
p19468
(dp19469
sVBCRP/ABCG2 Substrates
p19470
(dp19471
sVDrugs for Constipation
p19472
(dp19473
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p19474
(dp19475
sVCytochrome P-450 CYP2E1 Inhibitors
p19476
(dp19477
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p19478
(dp19479
sVHeterocyclic Compounds, Fused-Ring
p19480
(dp19481
sVCytochrome P-450 Enzyme Inhibitors
p19482
(dp19483
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p19484
(dp19485
sVAlimentary Tract and Metabolism
p19486
(dp19487
ssg792
(dp19488
g612
g17919
sg11445
(dp19489
sg8322
(dp19490
sg11319
(dp19491
sg2067
(dp19492
ssg795
(dp19493
g2256
(dp19494
sg10230
(dp19495
sg11874
(dp19496
sg7719
(dp19497
sg10074
(dp19498
sg6471
(dp19499
sg1038
(dp19500
sg10974
(dp19501
sg6474
(dp19502
sg1356
(dp19503
sg4320
(dp19504
ssg798
(dp19505
g5853
(dp19506
sg1461
(dp19507
sg7593
(dp19508
sg11550
(dp19509
sg9231
(dp19510
sg9132
(dp19511
sg4287
(dp19512
sg2538
(dp19513
sg6216
(dp19514
sg7329
(dp19515
sg2730
(dp19516
sg12123
(dp19517
sg7389
(dp19518
ssg801
(dp19519
VAmino Acids, Peptides, and Proteins
p19520
(dp19521
sVFluids and Secretions
p19522
(dp19523
sVGlucagon-like peptide-1 (GLP-1) analogues
p19524
(dp19525
sVIncretin Mimetics
p19526
g16682
sVGlucagon-like Peptide-1 (GLP-1) Agonists
p19527
(dp19528
sVHormones
p19529
(dp19530
sVToxins, Biological
p19531
(dp19532
sVHypoglycemia-Associated Agents
p19533
g17720
sVBodily Secretions
p19534
(dp19535
sVVenoms
p19536
(dp19537
sVPeptides
p19538
(dp19539
sVBiological Factors
p19540
(dp19541
sVAnti-Obesity Agents
p19542
(dp19543
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19544
(dp19545
sVIncretins
p19546
(dp19547
sVGlucagon-Like Peptide 1
p19548
(dp19549
sVBlood Glucose Lowering Agents
p19550
(dp19551
sVAlimentary Tract and Metabolism
p19552
(dp19553
sVDrugs Used in Diabetes
p19554
(dp19555
sVGLP-1 Agonists
p19556
(dp19557
ssg804
(dp19558
g8106
(dp19559
sg8055
(dp19560
sg10563
(dp19561
sg2043
(dp19562
sg10323
(dp19563
sg6180
(dp19564
sg8472
(dp19565
sg147
g13513
sg528
g16956
sg11274
(dp19566
sg8949
(dp19567
sg3117
(dp19568
sg2007
(dp19569
sg2763
(dp19570
sg6333
(dp19571
sg9225
(dp19572
sg654
g18280
sg3543
(dp19573
sg2817
(dp19574
sg1650
(dp19575
sg8013
(dp19576
ssg807
(dp19577
g4014
(dp19578
sg4377
(dp19579
sg1629
(dp19580
sg1791
(dp19581
sg141
g13314
sg10548
(dp19582
sg9618
(dp19583
sg7317
(dp19584
sg9006
(dp19585
sg10314
(dp19586
sg8928
(dp19587
sS'Adenosine'
p19588
(dp19589
sg1917
(dp19590
sg8832
(dp19591
sg1611
(dp19592
ssg810
(dp19593
g6228
(dp19594
sg816
(dp19595
sg5028
(dp19596
sg3117
(dp19597
sg5433
(dp19598
sg834
(dp19599
sg4236
(dp19600
sg9366
(dp19601
sg14822
(dp19602
sg1470
(dp19603
sg3861
(dp19604
sg507
g16754
sg849
(dp19605
sg8445
(dp19606
sg11940
(dp19607
sg3543
(dp19608
sg12274
(dp19609
sg9225
(dp19610
sg543
g17069
sg2832
(dp19611
sg762
g19241
sg2127
(dp19612
sg2133
(dp19613
sg3783
(dp19614
sg8142
(dp19615
sg4170
(dp19616
ssg813
(dp19617
g4725
(dp19618
ssg816
(dp19619
VBSEP/ABCB11 Substrates
p19620
(dp19621
sVCytochrome P-450 CYP3A4 Inhibitors
p19622
(dp19623
sVSteroids
p19624
(dp19625
sVSex Hormones and Modulators of the Genital System
p19626
g19595
sVCytochrome P-450 CYP2D6 Inhibitors
p19627
(dp19628
sVLuteolytic Agents
p19629
(dp19630
sVCytochrome P-450 CYP3A Substrates
p19631
(dp19632
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p19633
(dp19634
sVCytochrome P-450 CYP3A7 Inhibitors
p19635
(dp19636
sVOATP1B1/SLCO1B1 Inhibitors
p19637
(dp19638
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p19639
(dp19640
sVCytochrome P-450 CYP2C9 Inhibitors
p19641
g18177
sVProgesterone Receptor Modulators
p19642
g18377
sVCytochrome P-450 Enzyme Inhibitors
p19643
(dp19644
sVBlood Glucose Lowering Agents
p19645
(dp19646
sVHighest Risk QTc-Prolonging Agents
p19647
(dp19648
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p19649
(dp19650
sVP-glycoprotein/ABCB1 Inducers
p19651
(dp19652
sVCytochrome P-450 CYP3A4 Substrates
p19653
(dp19654
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p19655
(dp19656
sVAbortifacient Agents, Steroidal
p19657
(dp19658
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19659
(dp19660
sVContraceptives, Oral
p19661
(dp19662
sVOATP1B3 inhibitors
p19663
(dp19664
sVFused-Ring Compounds
p19665
g14807
sVHormonal Contraceptives for Systemic Use
p19666
(dp19667
sVCytochrome P-450 CYP3A4 Inducers
p19668
g18895
sVAdrenal Cortex Hormones
p19669
(dp19670
sVReproductive Control Agents
p19671
g18836
sVGenito Urinary System and Sex Hormones
p19672
(dp19673
sVCytochrome P-450 CYP2C8 Inhibitors
p19674
(dp19675
sVMenstruation-Inducing Agents
p19676
(dp19677
sVProgestin Antagonist
p19678
(dp19679
sVCytochrome P-450 Enzyme Inducers
p19680
(dp19681
sVCytochrome P-450 CYP3A Inducers
p19682
(dp19683
sVContraceptives, Oral, Synthetic
p19684
(dp19685
sVCytochrome P-450 CYP3A5 Substrates
p19686
(dp19687
sVContraceptive Agents, Female
p19688
(dp19689
sVQTc Prolonging Agents
p19690
(dp19691
sVHormone Antagonists
p19692
(dp19693
sVContraceptives, Postcoital
p19694
(dp19695
sVEstranes
p19696
(dp19697
sVCytochrome P-450 CYP3A Inhibitors
p19698
(dp19699
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p19700
(dp19701
sVHypoglycemia-Associated Agents
p19702
g17708
sVProgestational Hormone Receptor Antagonists
p19703
(dp19704
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p19705
(dp19706
sVP-glycoprotein/ABCB1 Inhibitors
p19707
(dp19708
sVAbortifacient Agents
p19709
(dp19710
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19711
(dp19712
sVEstrenes
p19713
(dp19714
ssg819
(dp19715
VBSEP/ABCB11 Substrates
p19716
(dp19717
sVCytochrome P-450 CYP3A4 Inhibitors
p19718
(dp19719
sVAntivirals for Systemic Use
p19720
(dp19721
sVCytochrome P-450 CYP3A Substrates
p19722
(dp19723
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p19724
(dp19725
sVDirect Acting Antivirals
p19726
(dp19727
sVPotential QTc-Prolonging Agents
p19728
(dp19729
sVAnti-HIV Agents
p19730
(dp19731
sVEnzyme Inhibitors
p19732
(dp19733
sVCytochrome P-450 Enzyme Inhibitors
p19734
(dp19735
sVAnti-Infective Agents
p19736
(dp19737
sVOligopeptides
p19738
(dp19739
sVHyperglycemia-Associated Agents
p19740
(dp19741
sVAntiinfectives for Systemic Use
p19742
(dp19743
sVAnti-Retroviral Agents
p19744
(dp19745
sVNephrotoxic agents
p19746
(dp19747
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19748
(dp19749
sVOATP1B3 inhibitors
p19750
(dp19751
sVHIV Protease Inhibitors
p19752
(dp19753
sVCytochrome P-450 CYP2C9 Substrates
p19754
(dp19755
sVQTc Prolonging Agents
p19756
(dp19757
sVCytochrome P450 3A4 Inhibitors
p19758
g13054
sVCytochrome P-450 CYP2C8 Inhibitors
p19759
(dp19760
sVP-glycoprotein/ABCB1 Substrates
p19761
(dp19762
sVPyridines
p19763
(dp19764
sVUGT1A1 Inhibitors
p19765
(dp19766
sVPeptides
p19767
(dp19768
sVUDP Glucuronosyltransferases Inhibitors
p19769
(dp19770
sVCytochrome P-450 CYP3A Inhibitors (strong)
p19771
g13412
sVCytochrome P-450 CYP3A4 Substrates
p19772
(dp19773
sVAmino Acids, Peptides, and Proteins
p19774
(dp19775
sVProtease Inhibitors
p19776
(dp19777
sVCytochrome P-450 CYP3A Inhibitors
p19778
(dp19779
sVAntiviral Agents
p19780
(dp19781
sVOATP1B1/SLCO1B1 Inhibitors
p19782
(dp19783
sVCytochrome P450 3A Inhibitors
p19784
(dp19785
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p19786
(dp19787
sVP-glycoprotein/ABCB1 Inhibitors
p19788
(dp19789
ssg822
(dp19790
VCentral Nervous System Depressants
p19791
(dp19792
sVNervous System
p19793
(dp19794
sVHeterocyclic Compounds, Fused-Ring
p19795
(dp19796
sVCytochrome P-450 CYP2D6 Inhibitors
p19797
(dp19798
sVCytochrome P-450 CYP2D6 Substrates
p19799
(dp19800
sVCytochrome P-450 CYP3A Substrates
p19801
(dp19802
sVDopamine D2 Receptor Antagonists
p19803
(dp19804
sVAntipsychotic Agents
p19805
(dp19806
sVPhenothiazines
p19807
(dp19808
sVPhenothiazines With Piperidine Structure
p19809
(dp19810
sVSulfur Compounds
p19811
(dp19812
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p19813
(dp19814
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19815
(dp19816
sVNeurotoxic agents
p19817
(dp19818
sVPsycholeptics
p19819
(dp19820
sVDopamine Antagonists
p19821
(dp19822
sVCytochrome P-450 Enzyme Inhibitors
p19823
(dp19824
sVCytochrome P-450 CYP3A4 Substrates
p19825
(dp19826
sVHyperglycemia-Associated Agents
p19827
(dp19828
ssg825
(dp19829
g7983
(dp19830
ssg828
(dp19831
VGABA Agents
p19832
g16204
sVCytochrome P-450 CYP3A Substrates
p19833
(dp19834
sVNeurotransmitter Agents
p19835
(dp19836
sVAnti-Anxiety Agents
p19837
(dp19838
sVCentral Nervous System Agents
p19839
(dp19840
sVCYP3A Substrates (Sensitive)
p19841
(dp19842
sVPsychotropic Drugs
p19843
(dp19844
sVTriazolobenzodiazepines
p19845
(dp19846
sVGABA Modulators
p19847
(dp19848
sVDrugs that are Mainly Renally Excreted
p19849
(dp19850
sVHypnotics and Sedatives
p19851
(dp19852
sVAmines
p19853
(dp19854
sVHeterocyclic Compounds, Fused-Ring
p19855
(dp19856
sVBiogenic Monoamines
p19857
(dp19858
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19859
(dp19860
sVEthanol
p19861
(dp19862
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p19863
(dp19864
sVEthanolamines
p19865
(dp19866
sVCentral Nervous System Depressants
p19867
(dp19868
sVPhenols
p19869
(dp19870
sVBenzene Derivatives
p19871
(dp19872
sVBiogenic Amines
p19873
(dp19874
sVCatecholamines
p19875
g19121
sVCytochrome P-450 CYP2C9 Substrates
p19876
(dp19877
sVCytochrome P-450 CYP3A5 Substrates
p19878
(dp19879
sVCytochrome P-450 CYP3A4 Substrates
p19880
(dp19881
sVCatechols
p19882
(dp19883
sVBenzazepines
p19884
(dp19885
sVAmino Alcohols
p19886
(dp19887
sVPsycholeptics
p19888
(dp19889
sVTranquilizing Agents
p19890
(dp19891
sVBenzodiazepines and benzodiazepine derivatives
p19892
(dp19893
sVNervous System
p19894
(dp19895
sVAlcohols
p19896
(dp19897
sVCytochrome P-450 CYP3A7 Substrates
p19898
(dp19899
ssg831
(dp19900
VHormone Antagonists
p19901
(dp19902
sVSteroid Synthesis Inhibitors
p19903
(dp19904
sg5100
(dp19905
sVCytochrome P-450 CYP3A4 Substrates
p19906
(dp19907
sVCytochrome P-450 CYP3A5 Substrates
p19908
(dp19909
sVGenito Urinary System and Sex Hormones
p19910
(dp19911
sVCytochrome P-450 CYP3A Substrates
p19912
(dp19913
sVSteroids
p19914
(dp19915
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19916
(dp19917
sVAdrenergic Antagonists
p19918
(dp19919
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p19920
(dp19921
sg11001
(dp19922
sVAdrenergic alpha-Antagonists
p19923
(dp19924
sVAgents that produce hypertension
p19925
(dp19926
sVEnzyme Inhibitors
p19927
(dp19928
sVFused-Ring Compounds
p19929
g14808
sg11946
(dp19930
sVUrologicals
p19931
(dp19932
ssg834
(dp19933
VEstrogen Antagonists
p19934
(dp19935
sVSex Hormones and Modulators of the Genital System
p19936
g19599
sVFertility Agents, Female
p19937
(dp19938
sg9345
(dp19939
sVStilbenes
p19940
(dp19941
sVSelective Estrogen Receptor Modulators
p19942
(dp19943
sVEstrogen Agonist/Antagonist
p19944
(dp19945
sVCytochrome P-450 Enzyme Inhibitors
p19946
(dp19947
sg8412
(dp19948
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p19949
(dp19950
sVCytochrome P-450 CYP2E1 Inhibitors
p19951
(dp19952
sVFertility Agents
p19953
(dp19954
sVReproductive Control Agents
p19955
g18841
sVBenzene Derivatives
p19956
(dp19957
sVCytochrome P-450 CYP1A2 Inhibitors
p19958
g14997
sVP-glycoprotein/ABCB1 Substrates
p19959
(dp19960
sVBenzylidene Compounds
p19961
(dp19962
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p19963
(dp19964
sVEstrogen Receptor Modulators
p19965
g17593
sVHormone Antagonists
p19966
(dp19967
sVGenito Urinary System and Sex Hormones
p19968
(dp19969
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19970
(dp19971
sg10251
(dp19972
ssg837
(dp19973
VAgents Causing Muscle Toxicity
p19974
(dp19975
sVHormone Antagonists
p19976
(dp19977
sVPyrimidines
p19978
(dp19979
sVMyelosuppressive Agents
p19980
(dp19981
sg3822
(dp19982
sg11256
(dp19983
sVAntimetabolites
p19984
(dp19985
sVPyrimidinones
p19986
(dp19987
sVNoxae
p19988
(dp19989
sg3840
(dp19990
sVImmunosuppressive Agents
p19991
(dp19992
sg8961
(dp19993
sVToxic Actions
p19994
(dp19995
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p19996
(dp19997
sg4500
(dp19998
sVHormones, Hormone Substitutes, and Hormone Antagonists
p19999
(dp20000
sVUracil
p20001
(dp20002
sVThyroid Products
p20003
(dp20004
ssg840
(dp20005
VIndoles
p20006
(dp20007
sVHeterocyclic Compounds, Fused-Ring
p20008
(dp20009
sVKinase Inhibitors
p20010
(dp20011
sVTyrosine Kinase Inhibitors
p20012
(dp20013
sVBCRP/ABCG2 Inhibitors
p20014
g12532
sVKinase Inhibitor
p20015
(dp20016
sVP-glycoprotein/ABCB1 Inhibitors
p20017
(dp20018
sVAntineoplastic and Immunomodulating Agents
p20019
(dp20020
sVProtein Kinase Inhibitors
p20021
(dp20022
sVAntineoplastic Agents
p20023
(dp20024
ssg843
(dp20025
g9870
(dp20026
sg7530
(dp20027
sg10320
(dp20028
sg9780
(dp20029
sg7548
(dp20030
sg2985
(dp20031
sg657
g18297
sg11382
(dp20032
sg9561
(dp20033
sg420
g16030
ssg846
(dp20034
g3846
(dp20035
sg2667
(dp20036
sg8049
(dp20037
sg8421
(dp20038
sg1461
(dp20039
sg7272
(dp20040
sg11451
(dp20041
sg9198
(dp20042
sg888
(dp20043
sg7335
(dp20044
sg4911
(dp20045
sg5133
(dp20046
sg1140
(dp20047
sg8703
(dp20048
sg3432
(dp20049
sg10557
(dp20050
sg4155
(dp20051
sg9822
(dp20052
sg8472
(dp20053
sg1371
(dp20054
sg183
g13782
sg1401
(dp20055
sg6333
(dp20056
sg6336
(dp20057
sg6075
(dp20058
sg7593
(dp20059
sg8724
(dp20060
sg12123
(dp20061
sg11385
(dp20062
ssg849
(dp20063
VSex Hormones and Modulators of the Genital System
p20064
g19605
sVCytochrome P-450 CYP3A Substrates
p20065
(dp20066
sVProgestogens and Estrogens, Sequential Preparations
p20067
(dp20068
sVNorpregnanes
p20069
(dp20070
sVHormonal Contraceptives for Systemic Use
p20071
(dp20072
sVP-glycoprotein/ABCB1 Inducers
p20073
(dp20074
sVContraceptive Agents, Female
p20075
(dp20076
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p20077
(dp20078
sVNorsteroids
p20079
(dp20080
sVContraceptives, Oral
p20081
(dp20082
sVFused-Ring Compounds
p20083
g14879
sVHyperglycemia-Associated Agents
p20084
(dp20085
sVAdrenal Cortex Hormones
p20086
(dp20087
sVReproductive Control Agents
p20088
g18843
sVProgestins
p20089
(dp20090
sVCombination Contraceptives (with Estrogen and derivatives)
p20091
(dp20092
sVCytochrome P-450 Enzyme Inducers
p20093
(dp20094
sVProgestin Contraceptives
p20095
(dp20096
sVNorpregnenes
p20097
(dp20098
sVEstren Derivatives
p20099
(dp20100
sVContraceptives, Oral, Synthetic
p20101
(dp20102
sVCytochrome P-450 CYP3A4 Substrates
p20103
(dp20104
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p20105
(dp20106
sVCytochrome P-450 CYP3A5 Substrates
p20107
(dp20108
sVGenito Urinary System and Sex Hormones
p20109
(dp20110
sVSteroids
p20111
(dp20112
sVCytochrome P-450 CYP2C19 Inducers
p20113
(dp20114
sVNorethindrone
p20115
(dp20116
sVCytochrome P-450 CYP3A7 Substrates
p20117
(dp20118
ssg852
(dp20119
g10557
(dp20120
sg7764
(dp20121
sg8433
(dp20122
sg3696
(dp20123
sg1857
(dp20124
sg4452
(dp20125
sg684
g18493
ssg855
(dp20126
g10149
(dp20127
sg7962
(dp20128
sg4278
(dp20129
sg7407
(dp20130
sg339
g15178
sg2172
(dp20131
sg10416
(dp20132
sg8457
(dp20133
sg8088
(dp20134
sg801
g19547
sg11259
(dp20135
ssg858
(dp20136
VCardiotoxic antineoplastic agents
p20137
(dp20138
sVDaunorubicin
p20139
(dp20140
sVAnthracyclines and Related Substances
p20141
(dp20142
sVMyelosuppressive Agents
p20143
(dp20144
sVAnthracycline Topoisomerase Inhibitor
p20145
(dp20146
sVCytochrome P-450 CYP2D6 Substrates
p20147
(dp20148
sVImmunosuppressive Agents
p20149
(dp20150
sVCarbohydrates
p20151
(dp20152
sVCytotoxic Antibiotics and Related Substances
p20153
(dp20154
sVAntibiotics, Antineoplastic
p20155
(dp20156
sVGlycosides
p20157
(dp20158
sVTopoisomerase II Inhibitors
p20159
(dp20160
sVAnthracyclines
p20161
(dp20162
sVAntineoplastic and Immunomodulating Agents
p20163
(dp20164
sVEnzyme Inhibitors
p20165
(dp20166
sVCytochrome P-450 CYP2C9 Substrates
p20167
(dp20168
sVNaphthacenes
p20169
(dp20170
sVAntineoplastic Agents
p20171
(dp20172
sVTopoisomerase Inhibitors
p20173
(dp20174
ssg861
(dp20175
g3570
(dp20176
sg5694
(dp20177
sg1707
(dp20178
ssg864
(dp20179
g5934
(dp20180
sg3321
(dp20181
sg11133
(dp20182
sg8751
(dp20183
sg7641
(dp20184
ssg867
(dp20185
g6279
(dp20186
sg3024
(dp20187
sg2913
(dp20188
sg11592
(dp20189
sg1503
(dp20190
sg1899
(dp20191
sg7821
(dp20192
sg1047
(dp20193
sg1050
(dp20194
sg6798
(dp20195
sg12045
(dp20196
ssg870
(dp20197
g6180
(dp20198
sg5409
(dp20199
sg5463
(dp20200
sg10323
(dp20201
sg7221
(dp20202
sg4821
(dp20203
sg2007
(dp20204
sg8796
(dp20205
sg4365
(dp20206
sg7407
(dp20207
sg11046
(dp20208
sg6228
(dp20209
sg4515
(dp20210
sg8808
(dp20211
sg11274
(dp20212
sg7689
(dp20213
sg10338
(dp20214
sg2817
(dp20215
sg12042
(dp20216
sg8088
(dp20217
sg5514
(dp20218
sg11952
(dp20219
sg8106
(dp20220
sg4053
(dp20221
sg2283
(dp20222
sg4935
(dp20223
sg4338
(dp20224
sg11160
(dp20225
sg4143
(dp20226
sg2253
(dp20227
sg2886
(dp20228
sg4170
(dp20229
sg6360
(dp20230
sg6015
(dp20231
sg402
g15840
sg1776
(dp20232
ssg873
(dp20233
g6678
(dp20234
sg2688
(dp20235
sg8277
(dp20236
sg12126
(dp20237
sg8601
(dp20238
sg4746
(dp20239
ssg876
(dp20240
g9117
(dp20241
sg10629
(dp20242
sg12114
(dp20243
sg7626
(dp20244
sg8388
(dp20245
sg7641
(dp20246
sg3708
(dp20247
sg3426
(dp20248
sg4656
(dp20249
sg3900
(dp20250
sg8433
(dp20251
sS'Chlorothiazide'
p20252
(dp20253
sg909
(dp20254
sg11475
(dp20255
sg7716
(dp20256
sg2835
(dp20257
sg7740
(dp20258
sg10761
(dp20259
sg10005
(dp20260
sg6312
(dp20261
sg966
(dp20262
sg7764
(dp20263
sg3231
(dp20264
sg10074
(dp20265
sg3240
(dp20266
sg7077
(dp20267
sg4056
(dp20268
sg6336
(dp20269
sg1857
(dp20270
sg7170
(dp20271
sg213
g14040
sg4806
(dp20272
sg195
g13899
sg5619
(dp20273
sg8166
(dp20274
sg1044
(dp20275
sg2262
(dp20276
sg6408
(dp20277
sg375
g15445
sg10974
(dp20278
sg2616
(dp20279
sg4320
(dp20280
sg10164
(dp20281
sg6471
(dp20282
sg9486
(dp20283
sg5595
(dp20284
sg8226
(dp20285
sg10227
(dp20286
sg3444
(dp20287
sg7191
(dp20288
sg2304
(dp20289
sg5007
(dp20290
sg10263
(dp20291
sg5829
(dp20292
sg7164
(dp20293
sg7305
(dp20294
sg5574
(dp20295
sg6639
(dp20296
sg9012
(dp20297
sg12060
(dp20298
sg3036
(dp20299
sg6885
(dp20300
sg2850
(dp20301
sg5934
(dp20302
sg10383
(dp20303
sg3114
(dp20304
sg6684
(dp20305
sg11910
(dp20306
sg4419
(dp20307
sg5199
(dp20308
sg5229
(dp20309
sg4452
(dp20310
sg6759
(dp20311
sg684
g18495
sg9687
(dp20312
sg3696
(dp20313
sg9987
(dp20314
sg9009
(dp20315
sg8265
(dp20316
sg9783
(dp20317
sg6000
(dp20318
sg1548
(dp20319
sg8862
(dp20320
sg10098
(dp20321
sg6291
(dp20322
sg3072
(dp20323
sg10587
(dp20324
sg7596
(dp20325
sg5580
(dp20326
sg3624
(dp20327
ssg879
(dp20328
VAgents Causing Muscle Toxicity
p20329
(dp20330
sVOAT1/SLC22A6 inhibitors
p20331
(dp20332
sVHypotensive Agents
p20333
(dp20334
sVHyperglycemia-Associated Agents
p20335
(dp20336
sVDrugs that are Mainly Renally Excreted
p20337
(dp20338
sVGynecological Antiinfectives and Antiseptics
p20339
(dp20340
sVNephrotoxic agents
p20341
(dp20342
sVAcids, Carbocyclic
p20343
(dp20344
sVAmides
p20345
(dp20346
sVSulfur Compounds
p20347
(dp20348
sVSulfones
p20349
(dp20350
sVNatriuretic Agents
p20351
(dp20352
sVSodium Potassium Chloride Symporter Inhibitors
p20353
(dp20354
sVDiuretics
p20355
(dp20356
sVCardiovascular Agents
p20357
(dp20358
sVBenzene Derivatives
p20359
(dp20360
sVNon Potassium Sparing Diuretics
p20361
g14979
sVOAT3/SLC22A8 Substrates
p20362
g13109
sVmeta-Aminobenzoates
p20363
(dp20364
sVHigh-Ceiling Diuretics and Potassium-Sparing Agents
p20365
(dp20366
sVMembrane Transport Modulators
p20367
(dp20368
sVAminobenzoates
p20369
(dp20370
sVGenito Urinary System and Sex Hormones
p20371
(dp20372
sVBenzoates
p20373
(dp20374
sVSulfonamides
p20375
(dp20376
sVOAT3/SLC22A8 Inhibitors
p20377
(dp20378
sVIncreased Diuresis at Loop of Henle
p20379
(dp20380
sVHigh-Ceiling Diuretics
p20381
(dp20382
ssg882
(dp20383
g8163
(dp20384
ssg885
(dp20385
g6150
(dp20386
ssg888
(dp20387
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p20388
(dp20389
sVUGT2B7 substrates
p20390
(dp20391
sVAnalgesics
p20392
(dp20393
sVMembrane Transport Modulators
p20394
(dp20395
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p20396
(dp20397
sVCentral Nervous System Agents
p20398
(dp20399
sVCytochrome P-450 CYP3A Inducers (strong)
p20400
(dp20401
sVCytochrome P-450 CYP3A5 Inducers (weak)
p20402
(dp20403
sVPsychotropic Drugs
p20404
(dp20405
sVCytochrome P-450 CYP2B6 Substrates
p20406
(dp20407
sVCytochrome P-450 CYP1A2 Inducers
p20408
(dp20409
sVCytochrome P-450 CYP2C9 Inducers
p20410
g20043
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p20411
g16524
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p20412
(dp20413
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p20414
(dp20415
sVAntimanic Agents
p20416
(dp20417
sVDrugs that are Mainly Renally Excreted
p20418
(dp20419
sVCytochrome P-450 CYP2C8 Substrates
p20420
(dp20421
sVCytochrome P-450 CYP1A2 Substrates
p20422
(dp20423
sVAnalgesics, Non-Narcotic
p20424
(dp20425
sVCytochrome P-450 CYP2B6 Inducers
p20426
(dp20427
sVMiscellaneous Anticonvulsants
p20428
(dp20429
sVCytochrome P450 1A2 Inducers
p20430
(dp20431
sVCytochrome P-450 CYP1A2 Inducers (strong)
p20432
(dp20433
sVCytochrome P-450 Enzyme Inhibitors
p20434
(dp20435
sVPeripheral Nervous System Agents
p20436
(dp20437
sVEnzyme Inducing Antiepileptic Drugs
p20438
(dp20439
sVUGT1A1 Inducers
p20440
(dp20441
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p20442
(dp20443
sVSodium Channel Blockers
p20444
(dp20445
sVThyroxine-binding globulin substrates
p20446
(dp20447
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p20448
(dp20449
sVUGT2B7 substrates with narrow therapeutic index
p20450
(dp20451
sVCytochrome P-450 CYP3A4 Inducers
p20452
g18885
sVCytochrome P-450 CYP3A Substrates
p20453
(dp20454
sVCentral Nervous System Depressants
p20455
(dp20456
sVCytochrome P-450 CYP3A5 Inducers
p20457
(dp20458
sVCardiovascular Agents
p20459
(dp20460
sVCytochrome P450 2C19 Inducers
p20461
(dp20462
sVP-glycoprotein/ABCB1 Substrates
p20463
(dp20464
sVP-glycoprotein/ABCB1 Inducers
p20465
(dp20466
sVCarboxamide Derivatives
p20467
(dp20468
sVAnticonvulsants
p20469
(dp20470
sVCytochrome P-450 CYP1A2 Inhibitors
p20471
g15010
sg6984
(dp20472
sg7734
(dp20473
sVCytochrome P-450 CYP2B6 Inducers (strong)
p20474
(dp20475
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p20476
(dp20477
sVCytochrome P-450 CYP3A4 Inducers (strong)
p20478
(dp20479
sVCytochrome P-450 Enzyme Inducers
p20480
(dp20481
sVCytochrome P-450 CYP3A Inducers
p20482
(dp20483
sVInducers of Drug Clearance
p20484
(dp20485
sVCytochrome P450 3A4 Inducers
p20486
(dp20487
sVCytochrome P-450 CYP2C19 Inhibitors
p20488
(dp20489
sVHeterocyclic Compounds, Fused-Ring
p20490
(dp20491
sVCytochrome P-450 CYP3A4 Substrates
p20492
(dp20493
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p20494
(dp20495
sVNarrow Therapeutic Index Drugs
p20496
(dp20497
sVCytochrome P450 2C9 Inducers
p20498
(dp20499
sVCytochrome P-450 CYP3A5 Substrates
p20500
(dp20501
sVMyelosuppressive Agents
p20502
(dp20503
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p20504
(dp20505
sg10029
(dp20506
sVCytochrome P-450 CYP2C8 Inducers
p20507
(dp20508
sg4983
(dp20509
sVImmunosuppressive Agents
p20510
(dp20511
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p20512
(dp20513
sVCytochrome P-450 CYP2C19 Inducers
p20514
(dp20515
sVDecreased Central Nervous System Disorganized Electrical Activity
p20516
(dp20517
sVMood Stabilizer
p20518
(dp20519
sVSensory System Agents
p20520
(dp20521
sVCytochrome P-450 CYP3A7 Substrates
p20522
(dp20523
ssg891
(dp20524
VAcetates
p20525
(dp20526
sVAcetamides
p20527
(dp20528
sVFatty Acids
p20529
(dp20530
sVAnalgesics
p20531
(dp20532
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p20533
(dp20534
sVCentral Nervous System Agents
p20535
(dp20536
sVFatty Acids, Volatile
p20537
(dp20538
sVLipids
p20539
g14311
sVPeripheral Nervous System Agents
p20540
(dp20541
sVNonsteroidal Anti-inflammatory Compounds
p20542
(dp20543
sVAnalgesics, Non-Narcotic
p20544
(dp20545
sVNephrotoxic agents
p20546
(dp20547
sVAcids, Carbocyclic
p20548
(dp20549
sVAmides
p20550
(dp20551
sVAgents causing hyperkalemia
p20552
(dp20553
sVBenzene Derivatives
p20554
(dp20555
sVSensory Organs
p20556
(dp20557
sVOphthalmologicals
p20558
(dp20559
sVAcids, Acyclic
p20560
(dp20561
sVAnti-Inflammatory Agents
p20562
(dp20563
sVCyclooxygenase Inhibitors
p20564
(dp20565
sVAntirheumatic Agents
p20566
(dp20567
sVSensory System Agents
p20568
(dp20569
sVAnti-Inflammatory Agents, Non-Steroidal
p20570
(dp20571
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p20572
(dp20573
ssg894
(dp20574
g8406
(dp20575
ssg897
(dp20576
g4488
(dp20577
ssg900
(dp20578
g11733
(dp20579
sg10548
(dp20580
sg3981
(dp20581
sg10314
(dp20582
sg4902
(dp20583
sg10890
(dp20584
ssg903
(dp20585
g2559
(dp20586
sg6186
(dp20587
sg11793
(dp20588
sg10515
(dp20589
sg4860
(dp20590
sg11649
(dp20591
sg2067
(dp20592
sg8655
(dp20593
sg7305
(dp20594
sg11319
(dp20595
sg10740
(dp20596
sg2109
(dp20597
sg7320
(dp20598
sg9393
(dp20599
sg11439
(dp20600
sg8463
(dp20601
sg11445
(dp20602
sg23
g12217
sg7176
(dp20603
sg7041
(dp20604
sg5289
(dp20605
sg612
g17867
sg1092
(dp20606
sg1605
(dp20607
ssg906
(dp20608
g8823
(dp20609
ssg909
(dp20610
VBeta Blocking Agents, Non-Selective, and Thiazides
p20611
(dp20612
sVCytochrome P-450 CYP2D6 Substrates
p20613
(dp20614
sVAntiarrhythmic agents
p20615
(dp20616
sVAgents causing hyperkalemia
p20617
(dp20618
sVHypotensive Agents
p20619
(dp20620
sVAmino Alcohols
p20621
(dp20622
sVPotential QTc-Prolonging Agents
p20623
(dp20624
sVAdrenergic Antagonists
p20625
(dp20626
sVOxazines
p20627
(dp20628
sVBeta Blocking Agents, Non-Selective
p20629
(dp20630
sVDrugs that are Mainly Renally Excreted
p20631
(dp20632
sVAmines
p20633
(dp20634
sVAntihypertensive Agents
p20635
g20254
sVThiadiazoles
p20636
(dp20637
sVSulfur Compounds
p20638
(dp20639
sVQTc Prolonging Agents
p20640
(dp20641
sVCytochrome P-450 CYP2C19 Substrates
p20642
(dp20643
sVCardiovascular Agents
p20644
(dp20645
sVThiazoles
p20646
(dp20647
sVP-glycoprotein/ABCB1 Substrates
p20648
(dp20649
sVAdrenergic beta-Antagonists
p20650
g15355
sVEENT Drugs, Miscellaneous
p20651
(dp20652
sVPropanolamines
p20653
(dp20654
sVAntiglaucoma Preparations and Miotics
p20655
(dp20656
sVBeta Blocking Agents and Thiazides
p20657
(dp20658
sVOphthalmologicals
p20659
(dp20660
sVBradycardia-Causing Agents
p20661
(dp20662
sVPropanols
p20663
(dp20664
sVMorpholines
p20665
(dp20666
sVAlcohols
p20667
(dp20668
ssg912
(dp20669
g5256
(dp20670
sg10728
(dp20671
sg702
g18805
sg1401
(dp20672
ssg915
(dp20673
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p20674
(dp20675
sVAnesthetics, General
p20676
(dp20677
sVSerotonin Agents
p20678
(dp20679
sVAnalgesics
p20680
(dp20681
sVOpiate Agonists
p20682
(dp20683
sVCentral Nervous System Agents
p20684
(dp20685
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p20686
(dp20687
sVNarcotics
p20688
(dp20689
sVPeripheral Nervous System Agents
p20690
(dp20691
sVDrugs that are Mainly Renally Excreted
p20692
(dp20693
sVPiperidines
p20694
(dp20695
sVOpioids
p20696
(dp20697
sg2976
(dp20698
sg4071
(dp20699
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p20700
(dp20701
sg11091
(dp20702
sVAdjuvants, Anesthesia
p20703
(dp20704
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p20705
(dp20706
sVCytochrome P-450 CYP3A Substrates
p20707
(dp20708
sVCentral Nervous System Depressants
p20709
(dp20710
sVAnesthetics
p20711
(dp20712
sVAgents that reduce seizure threshold
p20713
(dp20714
sVHigh-risk opioids
p20715
(dp20716
sVAgents that produce hypertension
p20717
(dp20718
sVNeuraxial Anesthetics
p20719
(dp20720
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p20721
(dp20722
sVCytochrome P-450 CYP3A4 Substrates
p20723
(dp20724
sVNarrow Therapeutic Index Drugs
p20725
(dp20726
sg9384
(dp20727
sVCytochrome P-450 CYP3A5 Substrates
p20728
(dp20729
sVSerotonin Modulators
p20730
(dp20731
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p20732
(dp20733
sVAntidepressive Agents
p20734
g15501
sVOpioid Agonist
p20735
(dp20736
sVBradycardia-Causing Agents
p20737
(dp20738
sg5373
(dp20739
sVP-glycoprotein/ABCB1 Inhibitors
p20740
(dp20741
sg6321
(dp20742
sVSensory System Agents
p20743
(dp20744
sVNervous System
p20745
(dp20746
sVCytochrome P-450 CYP3A7 Substrates
p20747
(dp20748
ssg918
(dp20749
VDrugs that are Mainly Renally Excreted
p20750
(dp20751
sVCytochrome P-450 CYP2C8 Substrates
p20752
(dp20753
sVCytochrome P-450 CYP1A2 Substrates
p20754
(dp20755
sVCytochrome P-450 CYP3A5 Substrates
p20756
(dp20757
sg7008
(dp20758
sVPyrimidinones
p20759
(dp20760
sVCytochrome P-450 CYP3A Substrates
p20761
(dp20762
sVNoxae
p20763
(dp20764
sVPyrimidines
p20765
(dp20766
sVToxic Actions
p20767
(dp20768
sg2853
(dp20769
sg8958
(dp20770
sg4329
(dp20771
sVAntineoplastic and Immunomodulating Agents
p20772
(dp20773
sg1293
(dp20774
sg11118
(dp20775
sg672
g18467
sVAntineoplastic Agents
p20776
(dp20777
sg7620
(dp20778
ssg921
(dp20779
g11379
(dp20780
ssg924
(dp20781
g6819
(dp20782
sg14791
(dp20783
ssg927
(dp20784
g11874
(dp20785
sg8487
(dp20786
sg6645
(dp20787
sg4449
(dp20788
sg3156
(dp20789
sg7170
(dp20790
ssg930
(dp20791
g10680
(dp20792
sg4272
(dp20793
sg3000
(dp20794
ssg933
(dp20795
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p20796
(dp20797
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p20798
(dp20799
sVCytochrome P-450 CYP2D6 Substrates
p20800
(dp20801
sVSerotonin Agents
p20802
(dp20803
sVAnalgesics
p20804
(dp20805
sVAntimigraine Preparations
p20806
(dp20807
sVCytochrome P-450 CYP3A Substrates
p20808
(dp20809
sVSelective Serotonin Agonists
p20810
(dp20811
sVDrugs that are Mainly Renally Excreted
p20812
(dp20813
sVCytochrome P-450 CYP2C8 Substrates
p20814
(dp20815
sVAmines
p20816
(dp20817
sVBiogenic Monoamines
p20818
(dp20819
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p20820
(dp20821
sVMonoamine Oxidase A Substrates
p20822
(dp20823
sVCentral Nervous System Depressants
p20824
(dp20825
sVNeurotransmitter Agents
p20826
(dp20827
sVIndoles
p20828
(dp20829
sVBiogenic Amines
p20830
(dp20831
sVSerotonin 1b Receptor Agonists
p20832
(dp20833
sVSelective Serotonin 5-HT1 Receptor Agonists
p20834
(dp20835
sVAgents that produce hypertension
p20836
(dp20837
sVCytochrome P-450 CYP3A4 Substrates
p20838
(dp20839
sVSerotonin 5-HT1 Receptor Agonists
p20840
(dp20841
sVHeterocyclic Compounds, Fused-Ring
p20842
(dp20843
sVSerotonin Modulators
p20844
(dp20845
sVAntidepressive Agents
p20846
g15507
sVTriptans
p20847
(dp20848
sVSerotonin 1d Receptor Agonists
p20849
(dp20850
sVSerotonin Receptor Agonists
p20851
(dp20852
sVNervous System
p20853
(dp20854
sVMigraine Disorders
p20855
(dp20856
ssg936
(dp20857
g1110
(dp20858
ssg939
(dp20859
g1719
(dp20860
sg8862
(dp20861
sg1548
(dp20862
sg9012
(dp20863
sg3240
(dp20864
sg4056
(dp20865
sg1044
(dp20866
sg5829
(dp20867
sg10005
(dp20868
sg6759
(dp20869
sg5580
(dp20870
ssg942
(dp20871
g7485
(dp20872
sg5805
(dp20873
ssg945
(dp20874
VAnticholinergic Agents
p20875
(dp20876
sVCytochrome P-450 CYP2D6 Inhibitors
p20877
(dp20878
sVNeurotransmitter Agents
p20879
(dp20880
sVHistamine Agents
p20881
(dp20882
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p20883
(dp20884
sVCytochrome P-450 Enzyme Inhibitors
p20885
(dp20886
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p20887
g18418
sVPiperidines
p20888
(dp20889
sVAntihistamines for Systemic Use
p20890
g12972
sVQTc Prolonging Agents
p20891
(dp20892
sVDibenzocycloheptenes
p20893
(dp20894
sVCentral Nervous System Depressants
p20895
(dp20896
sVCytochrome P-450 CYP1A2 Inhibitors
p20897
g15029
sVHistamine H1 Antagonists, Non-Sedating
p20898
(dp20899
sg9243
(dp20900
sVBenzocycloheptenes
p20901
(dp20902
sVHistamine H1 Antagonists
p20903
(dp20904
sVCytochrome P-450 CYP2C19 Inhibitors
p20905
(dp20906
sVModerate Risk QTc-Prolonging Agents
p20907
(dp20908
sVCholinergic Agents
p20909
(dp20910
sVP-glycoprotein/ABCB1 Inhibitors
p20911
(dp20912
sVHistamine Antagonists
p20913
(dp20914
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p20915
(dp20916
ssg948
(dp20917
g4911
(dp20918
sg12000
(dp20919
sg2715
(dp20920
sg12123
(dp20921
sg11541
(dp20922
ssg951
(dp20923
g426
g16105
sg1791
(dp20924
sg5832
(dp20925
sg7464
(dp20926
sg1425
(dp20927
sg3846
(dp20928
sg4635
(dp20929
sg1434
(dp20930
sg8421
(dp20931
sg1461
(dp20932
sg6867
(dp20933
sg5877
(dp20934
sg1491
(dp20935
sg10818
(dp20936
sg7335
(dp20937
sg9960
(dp20938
sg9417
(dp20939
sg6765
(dp20940
sg10740
(dp20941
sg2109
(dp20942
sg7569
(dp20943
sg2667
(dp20944
sg5853
(dp20945
sg13091
(dp20946
sg3447
(dp20947
ssg954
(dp20948
g1239
(dp20949
sg10275
(dp20950
sg10914
(dp20951
ssg957
(dp20952
g7812
(dp20953
ssg960
(dp20954
g10698
(dp20955
ssg963
(dp20956
VBSEP/ABCB11 Substrates
p20957
(dp20958
sVAntigout Preparations
p20959
(dp20960
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p20961
(dp20962
sVUGT1A1 Substrates
p20963
g12324
sVOAT1/SLC22A6 inhibitors
p20964
(dp20965
sVAnalgesics
p20966
(dp20967
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p20968
(dp20969
sVAntiinflammatory Products for Vaginal Administration
p20970
(dp20971
sVCentral Nervous System Agents
p20972
(dp20973
sVAntiinflammatory and Antirheumatic Products
p20974
(dp20975
sVEnzyme Inhibitors
p20976
(dp20977
sVPeripheral Nervous System Agents
p20978
(dp20979
sg6330
(dp20980
sVCytochrome P-450 CYP2C8 Substrates
p20981
(dp20982
sVCytochrome P-450 CYP1A2 Substrates
p20983
(dp20984
sVNonsteroidal Anti-inflammatory Compounds
p20985
(dp20986
sVAnalgesics, Non-Narcotic
p20987
(dp20988
sVNephrotoxic agents
p20989
(dp20990
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p20991
(dp20992
sVCytochrome P-450 CYP2C9 Substrates
p20993
(dp20994
sVMusculo-Skeletal System
p20995
(dp20996
sVTopical Products for Joint and Muscular Pain
p20997
g13935
sVAgents causing hyperkalemia
p20998
(dp20999
sVOther Nonsteroidal Antiimflammatory Agents
p21000
(dp21001
sVPropionates
p21002
(dp21003
sVNon COX-2 selective NSAIDS
p21004
(dp21005
sVAgents that produce hypertension
p21006
(dp21007
sVNaphthalenes
p21008
(dp21009
sVGenito Urinary System and Sex Hormones
p21010
(dp21011
sVUGT2B7 substrates
p21012
(dp21013
sVAnti-Inflammatory Agents
p21014
(dp21015
sVCyclooxygenase Inhibitors
p21016
(dp21017
sVP-glycoprotein/ABCB1 Inhibitors
p21018
(dp21019
sVAntirheumatic Agents
p21020
(dp21021
sVSensory System Agents
p21022
(dp21023
sVAnti-Inflammatory Agents, Non-Steroidal
p21024
(dp21025
ssg966
(dp21026
g3837
(dp21027
sVCytochrome P-450 CYP3A Substrates
p21028
(dp21029
sVAgents causing hyperkalemia
p21030
(dp21031
sVHypotensive Agents
p21032
(dp21033
sg4350
(dp21034
sVCYP3A Substrates (Sensitive)
p21035
(dp21036
sVAntihypertensive Agents
p21037
g20262
sVLactones
p21038
(dp21039
sVPotassium-Sparing Agents
p21040
(dp21041
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21042
(dp21043
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p21044
(dp21045
sVFused-Ring Compounds
p21046
g14827
sVNatriuretic Agents
p21047
(dp21048
sVDiuretics
p21049
(dp21050
sVPregnanes
p21051
(dp21052
sVCardiovascular Agents
p21053
(dp21054
sVCytochrome P-450 CYP3A4 Substrates
p21055
(dp21056
sVHormone Antagonists
p21057
(dp21058
sVCytochrome P-450 CYP3A5 Substrates
p21059
(dp21060
sVSteroids
p21061
(dp21062
sVPregnenes
p21063
(dp21064
sVPotassium-Sparing Diuretics
p21065
(dp21066
sVHormones, Hormone Substitutes, and Hormone Antagonists
p21067
(dp21068
sVCytochrome P-450 CYP3A7 Substrates
p21069
(dp21070
ssg969
(dp21071
VPharmaceutical Preparations
p21072
(dp21073
sVPlant Preparations
p21074
(dp21075
sVGaultheria
p21076
(dp21077
sVSalicylates
p21078
(dp21079
sVPhenols
p21080
(dp21081
sVBenzene Derivatives
p21082
(dp21083
sVBenzoates
p21084
(dp21085
sVHydroxy Acids
p21086
g18162
sVAcids, Carbocyclic
p21087
(dp21088
sVHydroxybenzoates
p21089
(dp21090
sVBiological Products
p21091
(dp21092
sVCompounds used in a research, industrial, or household setting
p21093
(dp21094
sVOils
p21095
(dp21096
sVAntirheumatic Agents
p21097
(dp21098
sVBetula
p21099
(dp21100
sVComplex Mixtures
p21101
(dp21102
sVFixatives
p21103
(dp21104
sVLipids
p21105
g14336
ssg972
(dp21106
VAntiinfectives for Systemic Use
p21107
(dp21108
sVOAT1/SLC22A6 Substrates
p21109
(dp21110
sVHeterocyclic Compounds, Fused-Ring
p21111
(dp21112
sVbeta-Lactams
p21113
(dp21114
sVNephrotoxic agents
p21115
(dp21116
sVOAT3/SLC22A8 Substrates
p21117
g13141
sVOAT3/SLC22A8 Inhibitors
p21118
(dp21119
sVLactams
p21120
(dp21121
sVOAT1/SLC22A6 inhibitors
p21122
(dp21123
sg6975
(dp21124
sVAmides
p21125
(dp21126
sVThiazines
p21127
g16411
sVSulfur Compounds
p21128
(dp21129
sVAnti-Bacterial Agents
p21130
(dp21131
sVAntibacterials for Systemic Use
p21132
(dp21133
sVCephalosporins
p21134
(dp21135
sVAnti-Infective Agents
p21136
(dp21137
ssg975
(dp21138
g4467
(dp21139
ssg978
(dp21140
VAgents Causing Muscle Toxicity
p21141
(dp21142
sVOAT1/SLC22A6 inhibitors
p21143
(dp21144
sVHypotensive Agents
p21145
(dp21146
sVHyperglycemia-Associated Agents
p21147
(dp21148
sVDrugs that are Mainly Renally Excreted
p21149
(dp21150
sVGynecological Antiinfectives and Antiseptics
p21151
(dp21152
sVNephrotoxic agents
p21153
(dp21154
sVAcids, Carbocyclic
p21155
(dp21156
sVAmides
p21157
(dp21158
sVSulfur Compounds
p21159
(dp21160
sVSulfones
p21161
(dp21162
sVNatriuretic Agents
p21163
(dp21164
sVSodium Potassium Chloride Symporter Inhibitors
p21165
(dp21166
sVDiuretics
p21167
(dp21168
sVCardiovascular Agents
p21169
(dp21170
sVBenzene Derivatives
p21171
(dp21172
sVNon Potassium Sparing Diuretics
p21173
g14976
sVOAT3/SLC22A8 Substrates
p21174
g13105
sVmeta-Aminobenzoates
p21175
(dp21176
sVHigh-Ceiling Diuretics and Potassium-Sparing Agents
p21177
(dp21178
sVMembrane Transport Modulators
p21179
(dp21180
sVAminobenzoates
p21181
(dp21182
sVGenito Urinary System and Sex Hormones
p21183
(dp21184
sVBenzoates
p21185
(dp21186
sVSulfonamides
p21187
(dp21188
sVOAT3/SLC22A8 Inhibitors
p21189
(dp21190
sVIncreased Diuresis at Loop of Henle
p21191
(dp21192
sVHigh-Ceiling Diuretics
p21193
(dp21194
ssg981
(dp21195
g8334
(dp21196
ssg984
(dp21197
g7221
(dp21198
ssg987
(dp21199
g3573
(dp21200
ssg990
(dp21201
g3495
(dp21202
ssg993
(dp21203
g11427
(dp21204
sg7500
(dp21205
sg10326
(dp21206
ssg996
(dp21207
g8772
(dp21208
sg8910
(dp21209
ssg999
(dp21210
g4911
(dp21211
sg2667
(dp21212
ssg1002
(dp21213
g8373
(dp21214
sg465
g16501
sg10266
(dp21215
sg9918
(dp21216
sg6186
(dp21217
sg11592
(dp21218
sg11229
(dp21219
sg2481
(dp21220
sg7821
(dp21221
sg8211
(dp21222
sg1047
(dp21223
sg10308
(dp21224
sg10797
(dp21225
sg8421
(dp21226
sg11451
(dp21227
sg9198
(dp21228
sg9432
(dp21229
sg8448
(dp21230
sg8820
(dp21231
sg7335
(dp21232
sg6798
(dp21233
sg15016
(dp21234
sg4911
(dp21235
sg6279
(dp21236
sg2838
(dp21237
sg2460
(dp21238
sg1503
(dp21239
sg7734
(dp21240
sg1899
(dp21241
sg8298
(dp21242
sg12045
(dp21243
sg4155
(dp21244
sg4164
(dp21245
sg8949
(dp21246
sg183
g13868
sg6075
(dp21247
sg7593
(dp21248
sg11241
(dp21249
sg7563
(dp21250
sg7041
(dp21251
ssg1005
(dp21252
g6999
(dp21253
ssg1008
(dp21254
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p21255
(dp21256
sVCytochrome P-450 CYP2D6 Substrates
p21257
(dp21258
sVUGT1A1 Substrates
p21259
g12340
sVAnalgesics
p21260
(dp21261
sVHypotensive Agents
p21262
(dp21263
sVOpiate Agonists
p21264
(dp21265
sVCentral Nervous System Agents
p21266
(dp21267
sVNarcotics
p21268
(dp21269
sVPeripheral Nervous System Agents
p21270
(dp21271
sVCytochrome P-450 CYP2C8 Substrates
p21272
(dp21273
sVOpioids
p21274
(dp21275
sVUGT1A3 substrates
p21276
(dp21277
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21278
(dp21279
sVCytochrome P-450 CYP3A Substrates
p21280
(dp21281
sVNatural Opium Alkaloids
p21282
(dp21283
sVCentral Nervous System Depressants
p21284
(dp21285
sVAnesthetics
p21286
(dp21287
sVOpiate Alkaloids
p21288
(dp21289
sVP-glycoprotein/ABCB1 Substrates
p21290
(dp21291
sVHigh-risk opioids
p21292
(dp21293
sVNeuraxial Anesthetics
p21294
(dp21295
sVCytochrome P-450 CYP3A4 Substrates
p21296
(dp21297
sVHeterocyclic Compounds, Fused-Ring
p21298
(dp21299
sVOpioid Agonist
p21300
(dp21301
sVUGT2B7 substrates
p21302
(dp21303
sVAlkaloids
p21304
g19450
sVSensory System Agents
p21305
(dp21306
sVPhenanthrenes
p21307
(dp21308
sVNervous System
p21309
(dp21310
ssg1011
(dp21311
g10077
(dp21312
sg2736
(dp21313
sg4725
(dp21314
sg8340
(dp21315
sg9702
(dp21316
sg1686
(dp21317
sg8871
(dp21318
ssg1014
(dp21319
VNitrogen Binding Agent
p21320
(dp21321
sVCytochrome P-450 CYP2D6 Inhibitors
p21322
(dp21323
sVVarious Alimentary Tract and Metabolism Products
p21324
(dp21325
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p21326
(dp21327
sVAcids, Carbocyclic
p21328
(dp21329
sVAntineoplastic Agents
p21330
(dp21331
sg3534
(dp21332
sg6663
(dp21333
sVCytochrome P-450 Enzyme Inhibitors
p21334
(dp21335
sVAlimentary Tract and Metabolism
p21336
(dp21337
ssg1017
(dp21338
g516
g16843
sg2658
(dp21339
ssg1020
(dp21340
g11052
(dp21341
sg819
g19770
ssg1023
(dp21342
g4419
(dp21343
ssg1026
(dp21344
g1266
(dp21345
sg9348
(dp21346
sg5463
(dp21347
sg7059
(dp21348
ssg1029
(dp21349
g10512
(dp21350
ssg1032
(dp21351
VPhosphorus Acids
p21352
(dp21353
sVImmunologic Factors
p21354
(dp21355
sVNoxae
p21356
(dp21357
sVCytochrome P-450 CYP3A Substrates
p21358
(dp21359
sVNitrogen Mustard Analogues
p21360
(dp21361
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p21362
(dp21363
sVCytochrome P-450 CYP2B6 Substrates
p21364
(dp21365
sVPhosphoric Acids
p21366
(dp21367
sVNitrogen Mustard Compounds
p21368
g14454
sVAntineoplastic Agents, Alkylating
p21369
(dp21370
sg6765
(dp21371
sVCytochrome P-450 CYP2C8 Substrates
p21372
(dp21373
sVMustard Compounds
p21374
(dp21375
sVCytochrome P-450 CYP2B6 Inducers
p21376
(dp21377
sVElectrolytes
p21378
(dp21379
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21380
(dp21381
sVMyeloablative Agonists
p21382
(dp21383
sVCytochrome P-450 CYP2C9 Substrates
p21384
(dp21385
sVCytochrome P-450 CYP3A4 Inducers
p21386
g18898
sVAntineoplastic Agents
p21387
(dp21388
sVMutagens
p21389
(dp21390
sVCytochrome P-450 CYP2C19 Substrates
p21391
(dp21392
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p21393
(dp21394
sVAnions
p21395
(dp21396
sVToxic Actions
p21397
(dp21398
sVPhosphoramide Mustards
p21399
g13092
sVAcids
p21400
(dp21401
sVCytochrome P-450 CYP2A6 Substrates
p21402
(dp21403
sVAlkylating Drugs
p21404
(dp21405
sVCytochrome P-450 Enzyme Inducers
p21406
(dp21407
sVCytochrome P-450 CYP3A Inducers
p21408
(dp21409
sVCytochrome P-450 CYP2C18 Substrates
p21410
g20946
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p21411
(dp21412
sVCytochrome P-450 CYP3A4 Substrates
p21413
(dp21414
sVIons
p21415
(dp21416
sVCardiotoxic antineoplastic agents
p21417
(dp21418
sVCytochrome P-450 CYP3A5 Substrates
p21419
(dp21420
sVMyelosuppressive Agents
p21421
(dp21422
sVCytochrome P-450 CYP2C8 Inducers
p21423
(dp21424
sVImmunosuppressive Agents
p21425
(dp21426
sVAcids, Noncarboxylic
p21427
(dp21428
sVAlkylating Activity
p21429
(dp21430
sVMethemoglobinemia Associated Agents
p21431
(dp21432
sVHydrocarbons, Halogenated
p21433
(dp21434
sVPhosphorus Compounds
p21435
(dp21436
sVNeurotoxic agents
p21437
(dp21438
sVAntineoplastic and Immunomodulating Agents
p21439
(dp21440
sVAntirheumatic Agents
p21441
(dp21442
sVPhosphoramides
p21443
(dp21444
sVOrganophosphorus Compounds
p21445
(dp21446
ssg1035
(dp21447
g9513
(dp21448
sVCytochrome P-450 CYP3A Substrates
p21449
(dp21450
sVAgents causing hyperkalemia
p21451
(dp21452
sVBradycardia-Causing Agents
p21453
(dp21454
sg3864
(dp21455
sg9351
(dp21456
sVVasodilating Agents
p21457
(dp21458
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21459
(dp21460
sg6615
(dp21461
sVCytochrome P-450 CYP3A4 Substrates
p21462
(dp21463
ssg1038
(dp21464
VAgents Causing Muscle Toxicity
p21465
(dp21466
sVAntiplatelet agents
p21467
(dp21468
sVHematologic Agents
p21469
(dp21470
sVBlood and Blood Forming Organs
p21471
(dp21472
sVAutacoids
p21473
(dp21474
sVFatty Acids
p21475
(dp21476
sg20
g12190
sVFatty Acids, Unsaturated
p21477
(dp21478
sVAnticoagulants
p21479
(dp21480
sVProstaglandins, Synthetic
p21481
(dp21482
sVHypotensive Agents
p21483
(dp21484
sVFibrinolytic Agents
p21485
(dp21486
sVInflammation Mediators
p21487
(dp21488
sVPlatelet Aggregation Inhibitors Excl. Heparin
p21489
(dp21490
sVVasodilating Agents
p21491
(dp21492
sVBiological Factors
p21493
(dp21494
sVCardiovascular Agents
p21495
(dp21496
sVProstaglandins
p21497
g19500
sVEicosanoids
p21498
(dp21499
sVLipids
p21500
g14292
ssg1041
(dp21501
g7350
(dp21502
sVEnemas
p21503
(dp21504
sVGastrointestinal Agents
p21505
(dp21506
sg10116
(dp21507
sVBenzene Derivatives
p21508
(dp21509
sVStimulation Large Intestine Fluid/Electrolyte Secretion
p21510
(dp21511
sg10743
(dp21512
sVDrugs for Constipation
p21513
(dp21514
sVLaxatives
p21515
g17339
sVPhenols
p21516
(dp21517
sVAlimentary Tract and Metabolism
p21518
(dp21519
ssg1044
(dp21520
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p21521
(dp21522
sVCytochrome P-450 CYP2D6 Inhibitors
p21523
(dp21524
sVCytochrome P-450 CYP2D6 Substrates
p21525
(dp21526
sVSerotonin Agents
p21527
(dp21528
sVNeurotransmitter Agents
p21529
(dp21530
sVHypotensive Agents
p21531
(dp21532
sVSerotonin Receptor Antagonists
p21533
(dp21534
sVAdrenergic Antagonists
p21535
(dp21536
sg261
g14435
sVCytochrome P-450 Enzyme Inhibitors
p21537
(dp21538
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p21539
g18389
sVDrugs that are Mainly Renally Excreted
p21540
(dp21541
sVAmines
p21542
(dp21543
sVAntihypertensive Agents
p21544
g20275
sVAdrenergic Agents
p21545
(dp21546
sVCentral Nervous System Depressants
p21547
(dp21548
sVAgents causing hyperkalemia
p21549
(dp21550
sVCardiovascular Agents
p21551
(dp21552
sVAdrenergic beta-Antagonists
p21553
g15349
sVPhenoxypropanolamines
p21554
g20866
sVVasodilating Agents
p21555
(dp21556
sg3417
(dp21557
sVPropanolamines
p21558
(dp21559
sVAmino Alcohols
p21560
(dp21561
sVAntidepressive Agents
p21562
g15522
sVBradycardia-Causing Agents
p21563
(dp21564
sVPropanols
p21565
(dp21566
sVAlcohols
p21567
(dp21568
ssg1047
(dp21569
VCytochrome P-450 CYP3A4 Inhibitors
p21570
(dp21571
sVBreast Cancer Resistance Protein Inhibitors
p21572
g12727
sVCytochrome P-450 CYP2D6 Inhibitors
p21573
(dp21574
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p21575
(dp21576
sVCytochrome P-450 CYP3A Substrates
p21577
(dp21578
sVAgents causing hyperkalemia
p21579
(dp21580
sVAntifungal Agents
p21581
(dp21582
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p21583
(dp21584
sVCytochrome P-450 CYP3A7 Inhibitors
p21585
(dp21586
sVPotential QTc-Prolonging Agents
p21587
(dp21588
sVEnzyme Inhibitors
p21589
(dp21590
sVCytochrome P-450 Enzyme Inhibitors
p21591
(dp21592
sVAnti-Infective Agents
p21593
(dp21594
sVPiperazines
p21595
(dp21596
sVAntiinfectives for Systemic Use
p21597
(dp21598
sVCytochrome P-450 CYP3A7 Inhibitors (strong)
p21599
(dp21600
sVAzole Antifungals
p21601
g20193
sVCytochrome P-450 CYP2E1 Inhibitors
p21602
(dp21603
sVSteroid Synthesis Inhibitors
p21604
(dp21605
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21606
(dp21607
sVQTc Prolonging Agents
p21608
(dp21609
sVCytochrome P450 3A4 Inhibitors
p21610
g13035
sVCytochrome P-450 CYP2B6 Inhibitors
p21611
(dp21612
sVP-glycoprotein/ABCB1 Substrates
p21613
(dp21614
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p21615
(dp21616
sVCytochrome P-450 CYP3A5 Inhibitors
p21617
(dp21618
sVCytochrome P-450 CYP3A Inhibitors (strong)
p21619
g13385
sVCytochrome P-450 CYP3A4 Substrates
p21620
(dp21621
sVTriazole Derivatives
p21622
(dp21623
sVHormone Antagonists
p21624
(dp21625
sVAntimycotics for Systemic Use
p21626
(dp21627
sV14-alpha Demethylase Inhibitors
p21628
(dp21629
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p21630
(dp21631
sVCytochrome P-450 CYP3A Inhibitors
p21632
(dp21633
sVP-glycoprotein/ABCB1 Inhibitors
p21634
(dp21635
sVTriazoles
p21636
(dp21637
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p21638
(dp21639
sVHormones, Hormone Substitutes, and Hormone Antagonists
p21640
(dp21641
sVChemically-Induced Disorders
p21642
g21223
ssg1050
(dp21643
VCytochrome P-450 CYP3A4 Inhibitors
p21644
(dp21645
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p21646
(dp21647
sVAntifungal Agents
p21648
(dp21649
sVEnzyme Inhibitors
p21650
(dp21651
sVCytochrome P450 3A4 Inhibitors
p21652
g13034
sVCytochrome P-450 CYP2C9 Inhibitors
p21653
g18198
sVCytochrome P-450 CYP3A5 Inhibitors (weak)
p21654
(dp21655
sVCytochrome P-450 Enzyme Inhibitors
p21656
(dp21657
sVAnti-Infective Agents
p21658
(dp21659
sVTriazoles
p21660
(dp21661
sVAntiinfectives for Systemic Use
p21662
(dp21663
sVDrugs that are Mainly Renally Excreted
p21664
(dp21665
sVImidazole and Triazole Derivatives
p21666
(dp21667
sVAzole Antifungals
p21668
g20194
sVAntifungals for Topical Use
p21669
(dp21670
sVSteroid Synthesis Inhibitors
p21671
(dp21672
sVCytochrome P450 2C9 Inhibitors
p21673
(dp21674
sVQTc Prolonging Agents
p21675
(dp21676
sVAgents causing hyperkalemia
p21677
(dp21678
sVAntifungals for Dermatological Use
p21679
(dp21680
sVDermatologicals
p21681
g17308
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p21682
(dp21683
sVCytochrome P-450 CYP2C19 Inhibitors
p21684
(dp21685
sVCytochrome P450 2C19 Inhibitors
p21686
(dp21687
sVTriazole Derivatives
p21688
(dp21689
sVHormone Antagonists
p21690
(dp21691
sVAntimycotics for Systemic Use
p21692
(dp21693
sV14-alpha Demethylase Inhibitors
p21694
(dp21695
sVPotential QTc-Prolonging Agents
p21696
(dp21697
sVCytochrome P-450 CYP3A Inhibitors
p21698
(dp21699
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p21700
(dp21701
sVP-glycoprotein/ABCB1 Inhibitors
p21702
(dp21703
sVHormones, Hormone Substitutes, and Hormone Antagonists
p21704
(dp21705
sVCytochrome P-450 CYP3A5 Inhibitors
p21706
(dp21707
ssg1053
(dp21708
g10200
(dp21709
sS'Fructose'
p21710
(dp21711
sg3699
(dp21712
sg3105
(dp21713
sg8529
(dp21714
sg5556
(dp21715
sg8022
(dp21716
sg8439
(dp21717
sg9660
(dp21718
sg10272
(dp21719
sg8340
(dp21720
sg6150
(dp21721
sg1581
(dp21722
sg11664
(dp21723
sg2826
(dp21724
sg10245
(dp21725
sg5511
(dp21726
ssg1056
(dp21727
g11781
(dp21728
ssg1059
(dp21729
VAntiarrhythmic agents
p21730
(dp21731
sVAnalgesics
p21732
(dp21733
sVAgents causing hyperkalemia
p21734
(dp21735
sVCentral Nervous System Agents
p21736
(dp21737
sVCalcium Channel Blockers
p21738
(dp21739
sVPotential QTc-Prolonging Agents
p21740
(dp21741
sVBiological Factors
p21742
(dp21743
sVPeripheral Nervous System Agents
p21744
(dp21745
sg2679
(dp21746
sg6855
(dp21747
sVAnalgesics, Non-Narcotic
p21748
(dp21749
sg2247
(dp21750
sVToxins, Biological
p21751
(dp21752
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21753
(dp21754
sVProtective Agents
p21755
(dp21756
sVQTc Prolonging Agents
p21757
(dp21758
sVNeuroprotective Agents
p21759
(dp21760
sVCytochrome P-450 CYP3A Substrates
p21761
(dp21762
sVCentral Nervous System Depressants
p21763
(dp21764
sVCardiovascular Agents
p21765
(dp21766
sg8691
(dp21767
sVVasodilating Agents
p21768
(dp21769
sVMembrane Transport Modulators
p21770
(dp21771
sVCytochrome P-450 CYP3A4 Substrates
p21772
(dp21773
sVCalcium-Regulating Hormones and Agents
p21774
(dp21775
sg3786
(dp21776
sVNervous System
p21777
(dp21778
sg9285
(dp21779
sg2700
(dp21780
sVBradycardia-Causing Agents
p21781
(dp21782
sg4176
(dp21783
sVSensory System Agents
p21784
(dp21785
sVComplex Mixtures
p21786
(dp21787
sVCompounds used in a research, industrial, or household setting
p21788
(dp21789
ssg1062
(dp21790
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p21791
(dp21792
sVCytochrome P-450 CYP3A Substrates
p21793
(dp21794
sVOATP1B1/SLCO1B1 Inhibitors
p21795
(dp21796
sVCytochrome P-450 Enzyme Inhibitors
p21797
(dp21798
sVBlood Glucose Lowering Agents
p21799
(dp21800
sVCytochrome P-450 CYP2C8 Substrates
p21801
(dp21802
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p21803
(dp21804
sVSulfur Compounds
p21805
(dp21806
sVOral Hypoglycemics
p21807
(dp21808
sVOATP1B3 inhibitors
p21809
(dp21810
sVCytochrome P-450 CYP2C9 Substrates
p21811
(dp21812
sVCytochrome P-450 CYP3A4 Inducers
p21813
g18910
sVDrugs Used in Diabetes
p21814
(dp21815
sVPeroxisome Proliferator Receptor gamma Agonist
p21816
(dp21817
sVCytochrome P-450 CYP2C8 Inhibitors
p21818
(dp21819
sVThiazoles
p21820
(dp21821
sVPeroxisome Proliferator Receptor alpha Agonist
p21822
(dp21823
sVCytochrome P-450 Enzyme Inducers
p21824
(dp21825
sVCytochrome P-450 CYP3A Inducers
p21826
(dp21827
sVCytochrome P-450 CYP3A4 Substrates
p21828
(dp21829
sVAlimentary Tract and Metabolism
p21830
(dp21831
sVPeroxisome Proliferator-activated Receptor Activity
p21832
(dp21833
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p21834
(dp21835
sVHypoglycemia-Associated Agents
p21836
g17686
sVThiazolidinediones
p21837
(dp21838
ssg1065
(dp21839
g10314
(dp21840
sg10548
(dp21841
ssg1068
(dp21842
g7395
(dp21843
ssg1071
(dp21844
g8484
(dp21845
sg1791
(dp21846
sg9618
(dp21847
sg10077
(dp21848
sg8439
(dp21849
sg4377
(dp21850
sg8340
(dp21851
sg19588
(dp21852
sg11775
(dp21853
sg1686
(dp21854
sg1917
(dp21855
sg8871
(dp21856
sg12186
(dp21857
sg1611
(dp21858
ssg1074
(dp21859
g7941
(dp21860
sg11979
(dp21861
sg7275
(dp21862
ssg1077
(dp21863
g11046
(dp21864
ssg1080
(dp21865
VAgents Causing Muscle Toxicity
p21866
(dp21867
sVAntivirals for Systemic Use
p21868
(dp21869
sVNucleic Acid Synthesis Inhibitors
p21870
(dp21871
sVOAT1/SLC22A6 inhibitors
p21872
(dp21873
sVGuanine
p21874
(dp21875
sVOAT3/SLC22A8 Inhibitors
p21876
(dp21877
sVDirect Acting Antivirals
p21878
(dp21879
sVGanciclovir and prodrug
p21880
(dp21881
sVAnti-Infective Agents
p21882
(dp21883
sVAntiinfectives for Systemic Use
p21884
(dp21885
sVDrugs that are Mainly Renally Excreted
p21886
(dp21887
sVMATE substrates
p21888
(dp21889
sVNucleosides and Nucleotides
p21890
(dp21891
sg13070
(dp21892
sVCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
p21893
(dp21894
sVAcyclovir
p21895
g17172
sVPurinones
p21896
(dp21897
sVOCT1 inhibitors
p21898
(dp21899
sVMATE 1 Substrates
p21900
(dp21901
sVOCT1 substrates
p21902
g13071
sVAgents that reduce seizure threshold
p21903
(dp21904
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p21905
(dp21906
sVSensory Organs
p21907
(dp21908
sVHeterocyclic Compounds, Fused-Ring
p21909
(dp21910
sVPurines
p21911
(dp21912
sVMATE 2 Substrates
p21913
(dp21914
sg3795
(dp21915
sVOphthalmologicals
p21916
(dp21917
sVNucleoside Analog Antiviral
p21918
(dp21919
sVAntiviral Agents
p21920
(dp21921
ssg1083
(dp21922
g11886
(dp21923
sg3219
(dp21924
sg6504
(dp21925
sg2373
(dp21926
sg7668
(dp21927
sg13750
(dp21928
sg5364
(dp21929
sg1800
(dp21930
sg4620
(dp21931
sg11922
(dp21932
sg12132
(dp21933
sg14838
(dp21934
sg6345
(dp21935
sg4089
(dp21936
sg5895
(dp21937
sg1614
(dp21938
sg9903
(dp21939
ssg1086
(dp21940
g9810
(dp21941
sg7530
(dp21942
sg7920
(dp21943
sg5226
(dp21944
sg501
g16747
sg11751
(dp21945
sg129
g13210
sg11826
(dp21946
sg4557
(dp21947
sg11085
(dp21948
sg8649
(dp21949
sg9660
(dp21950
sg5025
(dp21951
sg7044
(dp21952
ssg1089
(dp21953
g2676
(dp21954
sg9153
(dp21955
sg9108
(dp21956
ssg1092
(dp21957
VNeurotransmitter Agents
p21958
(dp21959
sVHistamine Agents
p21960
(dp21961
sVCentral Nervous System Agents
p21962
(dp21963
sVPeripheral Nervous System Agents
p21964
(dp21965
sVAutonomic Agents
p21966
(dp21967
sg6603
(dp21968
sVAmines
p21969
(dp21970
sVEthylamines
p21971
g20606
sVQTc Prolonging Agents
p21972
(dp21973
sVPurines
p21974
(dp21975
sVPharmaceutical Preparations
p21976
(dp21977
sVCentral Nervous System Depressants
p21978
(dp21979
sVAntiemetics
p21980
(dp21981
sVGastrointestinal Agents
p21982
(dp21983
sVBenzene Derivatives
p21984
(dp21985
sVHistamine H1 Antagonists
p21986
(dp21987
sVBenzhydryl Compounds
p21988
(dp21989
sVPurinones
p21990
(dp21991
sVModerate Risk QTc-Prolonging Agents
p21992
(dp21993
sVHeterocyclic Compounds, Fused-Ring
p21994
(dp21995
sVHistamine Antagonists
p21996
(dp21997
sVAlkaloids
p21998
g19448
ssg1095
(dp21999
g4551
(dp22000
ssg1098
(dp22001
VCytochrome P-450 CYP2C8 Substrates
p22002
(dp22003
sg5706
(dp22004
sVProtein Kinase Inhibitors
p22005
(dp22006
sVCytochrome P-450 CYP3A Substrates
p22007
(dp22008
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p22009
(dp22010
sVBCRP/ABCG2 Substrates
p22011
(dp22012
sVBCRP/ABCG2 Inhibitors
p22013
g12551
sVKinase Inhibitor
p22014
(dp22015
sVCytochrome P450 3A Inducers
p22016
(dp22017
sVMATE inhibitors
p22018
(dp22019
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p22020
(dp22021
sVCytochrome P-450 CYP3A Inducers
p22022
(dp22023
sVAntineoplastic and Immunomodulating Agents
p22024
(dp22025
sVTyrosine Kinase Inhibitors
p22026
(dp22027
sVMATE 1 Inhibitors
p22028
(dp22029
sVCytochrome P-450 CYP3A4 Substrates
p22030
(dp22031
sVCytochrome P-450 CYP3A4 Inducers
p22032
g18979
sVAntineoplastic Agents
p22033
(dp22034
ssg1101
(dp22035
VDideoxynucleosides
p22036
(dp22037
sVAntivirals for Systemic Use
p22038
(dp22039
sVNucleic Acid Synthesis Inhibitors
p22040
(dp22041
sVCarbohydrates
p22042
(dp22043
sVPyrimidines
p22044
(dp22045
sVDirect Acting Antivirals
p22046
(dp22047
sVAnti-HIV Agents
p22048
(dp22049
sVEnzyme Inhibitors
p22050
(dp22051
sVReverse Transcriptase Inhibitors
p22052
(dp22053
sVDeoxyribonucleosides
p22054
(dp22055
sVAntiinfectives for Systemic Use
p22056
(dp22057
sVDrugs that are Mainly Renally Excreted
p22058
(dp22059
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p22060
g14467
sVAnti-Infective Agents
p22061
(dp22062
sVCytidine
p22063
(dp22064
sVDeoxycytidine
p22065
g12700
sVGlycosides
p22066
(dp22067
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p22068
(dp22069
sVRibonucleosides
p22070
(dp22071
sVNucleic Acids, Nucleotides, and Nucleosides
p22072
(dp22073
sVPyrimidine Nucleosides
p22074
(dp22075
sVAnti-Retroviral Agents
p22076
(dp22077
sVNucleosides
p22078
(dp22079
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p22080
(dp22081
sVNucleoside Reverse Transcriptase Inhibitors
p22082
(dp22083
sVAntiviral Agents
p22084
(dp22085
ssg1104
(dp22086
VGlycols
p22087
(dp22088
sVCentral Nervous System Depressants
p22089
(dp22090
sVAntifungals for Dermatological Use
p22091
(dp22092
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p22093
(dp22094
sVMuscle Relaxants, Centrally Acting Agents
p22095
(dp22096
sVCentral Nervous System Agents
p22097
(dp22098
sVPropylene Glycols
p22099
(dp22100
sVAntifungals for Topical Use
p22101
(dp22102
sVPeripheral Nervous System Agents
p22103
(dp22104
sVCytochrome P-450 Enzyme Inducers
p22105
(dp22106
sVCytochrome P-450 CYP3A Inducers
p22107
(dp22108
sVDermatologicals
p22109
g17240
sVCytochrome P-450 CYP3A4 Inducers
p22110
g18918
sVAlcohols
p22111
(dp22112
sVMuscle Relaxants
p22113
(dp22114
ssg1107
(dp22115
g10878
(dp22116
ssg1110
(dp22117
VAntiinfectives for Systemic Use
p22118
(dp22119
sVBSEP/ABCB11 Substrates
p22120
(dp22121
sg936
g20858
sg8118
(dp22122
sg4614
(dp22123
sVAnti-Infective Agents, Urinary
p22124
(dp22125
sVDrugs that are Mainly Renally Excreted
p22126
(dp22127
sVThyroxine-binding globulin substrates
p22128
(dp22129
sVAgents causing hyperkalemia
p22130
(dp22131
sVP-glycoprotein/ABCB1 Substrates
p22132
(dp22133
sVBCRP/ABCG2 Substrates
p22134
(dp22135
sVMethemoglobinemia Associated Agents
p22136
(dp22137
sg6066
(dp22138
sVNitro Compounds
p22139
(dp22140
sVAnti-Bacterial Agents
p22141
(dp22142
sVAntibacterials for Systemic Use
p22143
(dp22144
sVAnti-Infective Agents
p22145
(dp22146
sVRenal Agents
p22147
(dp22148
ssg1113
(dp22149
VAgents Causing Muscle Toxicity
p22150
(dp22151
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p22152
(dp22153
sVCytochrome P-450 CYP3A4 Inhibitors
p22154
(dp22155
sVCytochrome P-450 CYP3A Substrates
p22156
(dp22157
sVCentral Nervous System Agents
p22158
(dp22159
sVAntiseptics and Disinfectants
p22160
(dp22161
sVAnti-Infective Agents, Local
p22162
(dp22163
sVCompounds used in a research, industrial, or household setting
p22164
(dp22165
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p22166
(dp22167
sVCytochrome P-450 CYP2C9 Inhibitors
p22168
g18243
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p22169
g12673
sVCytochrome P-450 Enzyme Inhibitors
p22170
(dp22171
sVAnti-Infective Agents
p22172
(dp22173
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p22174
(dp22175
sVCytochrome P-450 CYP2E1 Inducers
p22176
(dp22177
sVCytochrome P-450 CYP1A2 Substrates
p22178
(dp22179
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p22180
(dp22181
sg1113
(dp22182
sVCytochrome P-450 CYP3A4 Inducers
p22183
g18892
sVCentral Nervous System Depressants
p22184
(dp22185
sVCytochrome P-450 CYP2B6 Inhibitors
p22186
(dp22187
sVDermatologicals
p22188
g17313
sVSolvents
p22189
(dp22190
sVCytochrome P-450 Enzyme Inducers
p22191
(dp22192
sVCytochrome P-450 CYP3A Inducers
p22193
(dp22194
sVCytochrome P-450 CYP2C19 Inhibitors
p22195
(dp22196
sVCytochrome P-450 CYP3A4 Substrates
p22197
(dp22198
sVAntidotes
p22199
(dp22200
sg11901
(dp22201
sVNMDA Receptor Antagonists
p22202
(dp22203
sg828
g19862
sVCytochrome P-450 CYP3A Inhibitors
p22204
(dp22205
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p22206
(dp22207
sVCytochrome P-450 CYP2E1 Substrates
p22208
(dp22209
sg11289
(dp22210
sVNeurotoxic agents
p22211
(dp22212
sVAlcohols
p22213
(dp22214
sVMiscellaneous Therapeutic Agents
p22215
(dp22216
sVMiscellaneous Local Anti-infectives
p22217
(dp22218
ssg1116
(dp22219
g9918
(dp22220
sg4629
(dp22221
sg6567
(dp22222
sg9348
(dp22223
sg2784
(dp22224
sg10185
(dp22225
sg10548
(dp22226
sg6246
(dp22227
sg2805
(dp22228
sg10314
(dp22229
sg11085
(dp22230
sg4491
(dp22231
sg5286
(dp22232
sg5073
(dp22233
sg2901
(dp22234
sg8217
(dp22235
sg4737
(dp22236
sg1149
(dp22237
sg6843
(dp22238
sg357
g15312
sg7977
(dp22239
sg6150
(dp22240
sg8010
(dp22241
sg7044
(dp22242
ssg1119
(dp22243
g2985
(dp22244
sg9870
(dp22245
sg3825
(dp22246
sg5511
(dp22247
sg7548
(dp22248
ssg1122
(dp22249
g1146
(dp22250
sg171
g13713
sg495
g16692
sg11268
(dp22251
sg3684
(dp22252
sg4419
(dp22253
sg11916
(dp22254
sg11361
(dp22255
sg2277
(dp22256
sg6381
(dp22257
sg7824
(dp22258
sg6570
(dp22259
sg4683
(dp22260
sg753
g19211
sg7713
(dp22261
ssg1125
(dp22262
g10839
(dp22263
sg6765
(dp22264
sg13091
g21444
ssg1128
(dp22265
g1278
(dp22266
sg6933
(dp22267
sg135
g13248
sg6204
(dp22268
sg7074
(dp22269
sg4872
(dp22270
sg7653
(dp22271
sg1656
(dp22272
sg10479
(dp22273
sg8238
(dp22274
sg6432
(dp22275
sg8079
(dp22276
sg9750
(dp22277
sg2436
(dp22278
sg11685
(dp22279
sg4911
(dp22280
sg1311
(dp22281
sg4710
(dp22282
sg8850
(dp22283
sg1872
(dp22284
sg126
g13169
sg5736
(dp22285
sg1176
(dp22286
sg6183
(dp22287
sg7005
(dp22288
sg972
g21121
sg9282
(dp22289
sg3291
(dp22290
sg10611
(dp22291
sg11694
(dp22292
sg4005
(dp22293
sg3267
(dp22294
sg8616
(dp22295
sg12123
(dp22296
ssg1131
(dp22297
g6921
(dp22298
sg11154
(dp22299
ssg1134
(dp22300
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p22301
(dp22302
sVCytochrome P-450 CYP2D6 Substrates
p22303
(dp22304
sVIsoquinolines
p22305
(dp22306
sVCytochrome P-450 CYP3A Substrates
p22307
(dp22308
sVNeurotransmitter Agents
p22309
(dp22310
sVSerotonin Receptor Antagonists
p22311
(dp22312
sVCentral Nervous System Agents
p22313
(dp22314
sVPeripheral Nervous System Agents
p22315
(dp22316
sVQuinuclidines
p22317
(dp22318
sVDrugs that are Mainly Renally Excreted
p22319
(dp22320
sVCytochrome P-450 CYP1A2 Substrates
p22321
(dp22322
sVAutonomic Agents
p22323
(dp22324
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p22325
(dp22326
sVSerotonin Agents
p22327
(dp22328
sVAntiemetics and Antinauseants
p22329
(dp22330
sVCentral Nervous System Depressants
p22331
(dp22332
sVAntiemetics
p22333
(dp22334
sVGastrointestinal Agents
p22335
(dp22336
sVSerotonin 5-HT3 Receptor Antagonists
p22337
(dp22338
sVCytochrome P-450 CYP3A4 Substrates
p22339
(dp22340
sVAlimentary Tract and Metabolism
p22341
(dp22342
sVHeterocyclic Compounds, Fused-Ring
p22343
(dp22344
sVAntidepressive Agents
p22345
g15530
sVSerotonin 3 Receptor Antagonists
p22346
g15340
ssg1137
(dp22347
g8655
(dp22348
sg8163
(dp22349
ssg1140
(dp22350
VCytochrome P-450 CYP3A4 Inhibitors
p22351
(dp22352
sVCytochrome P-450 CYP2D6 Inhibitors
p22353
(dp22354
sVCytochrome P-450 CYP3A Substrates
p22355
(dp22356
sVCytochrome P-450 Enzyme Inhibitors
p22357
(dp22358
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p22359
(dp22360
sVCytochrome P-450 CYP3A Inducers (strong)
p22361
(dp22362
sVCytochrome P-450 CYP3A7 Inducers
p22363
(dp22364
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p22365
(dp22366
sVCytochrome P-450 CYP2C9 Inhibitors
p22367
g18248
sVCytochrome P-450 CYP2C9 Inducers
p22368
g20047
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p22369
g16528
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p22370
g13744
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p22371
(dp22372
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p22373
(dp22374
sVIndoles
p22375
(dp22376
sVCytochrome P-450 CYP3A4 Inducers (strong)
p22377
(dp22378
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p22379
(dp22380
sVCytochrome P-450 CYP2B6 Inducers
p22381
(dp22382
sVTyrosine Kinase Inhibitors
p22383
(dp22384
sVCytochrome P-450 CYP2E1 Inhibitors
p22385
(dp22386
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p22387
(dp22388
sVProtein Kinase Inhibitors
p22389
(dp22390
sg2076
(dp22391
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p22392
(dp22393
sVCytochrome P-450 CYP3A4 Inducers
p22394
g18973
sVAntineoplastic Agents
p22395
(dp22396
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p22397
(dp22398
sVCytochrome P-450 CYP3A5 Inducers
p22399
(dp22400
sVCytochrome P-450 CYP1A2 Inducers
p22401
(dp22402
sVCytochrome P-450 CYP1A2 Inhibitors
p22403
g15026
sVCytochrome P-450 CYP2C8 Inhibitors
p22404
(dp22405
sVEnzyme Inhibitors
p22406
(dp22407
sg8496
(dp22408
sVReceptor Tyrosine Kinase Inhibitors
p22409
(dp22410
sVCytochrome P-450 CYP2E1 Inhibitors (strong)
p22411
(dp22412
sVCytochrome P-450 Enzyme Inducers
p22413
(dp22414
sVCytochrome P-450 CYP3A Inducers
p22415
(dp22416
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p22417
(dp22418
sVCytochrome P-450 CYP2C19 Inhibitors
p22419
(dp22420
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p22421
g17449
sVCytochrome P-450 CYP3A Inhibitors (strong)
p22422
g13405
sVCytochrome P-450 CYP3A4 Substrates
p22423
(dp22424
sVHeterocyclic Compounds, Fused-Ring
p22425
(dp22426
sVKinase Inhibitor
p22427
(dp22428
sVCytochrome P-450 CYP2C8 Inducers
p22429
(dp22430
sVCytochrome P-450 CYP3A Inhibitors
p22431
(dp22432
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p22433
(dp22434
sVCytochrome P-450 CYP2C19 Inducers
p22435
(dp22436
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p22437
(dp22438
sVAntineoplastic and Immunomodulating Agents
p22439
(dp22440
sVAlkaloids
p22441
g19430
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p22442
(dp22443
sg10329
(dp22444
ssg1143
(dp22445
g5067
(dp22446
sg4653
(dp22447
sg1656
(dp22448
sg6045
(dp22449
sg8421
(dp22450
sg7272
(dp22451
sg888
g20401
sg4287
(dp22452
sg7335
(dp22453
sg12534
(dp22454
sg4911
(dp22455
sg3024
(dp22456
sg10362
(dp22457
sg1140
g22362
sg7734
(dp22458
sg4155
(dp22459
sg3432
(dp22460
sg9822
(dp22461
sg8472
(dp22462
sg183
g13842
sg11922
(dp22463
sg6333
(dp22464
sg6075
(dp22465
ssg1146
(dp22466
VMiscellaneous Anti-infectives
p22467
(dp22468
sVAmines
p22469
(dp22470
sVOnium Compounds
p22471
g22250
sVMiscellaneous Local Anti-infectives
p22472
(dp22473
sVNitrogen Compounds
p22474
(dp22475
sVAntiinfectives and Antiseptics for Local Oral Treatment
p22476
(dp22477
sVStomatological Preparations
p22478
(dp22479
sVAlimentary Tract and Metabolism
p22480
(dp22481
sVAmmonium Compounds
p22482
(dp22483
ssg1149
(dp22484
VGlycols
p22485
(dp22486
sVPegylated agents
p22487
g13564
sVEnzymes
p22488
(dp22489
sVDelayed-Action Preparations
p22490
(dp22491
sVThyroxine-binding globulin inhibitors
p22492
(dp22493
sVAsparagine-specific Enzyme
p22494
(dp22495
sVPolymers
p22496
g22237
sVImmunosuppressive Agents
p22497
(dp22498
sVAntineoplastic Agents
p22499
(dp22500
sg2607
(dp22501
sVAmidohydrolases
p22502
(dp22503
sVCompounds used in a research, industrial, or household setting
p22504
(dp22505
sVAntineoplastic and Immunomodulating Agents
p22506
(dp22507
sVBiomedical and Dental Materials
p22508
(dp22509
sVEnzymes and Coenzymes
p22510
(dp22511
sVAsparaginase
p22512
(dp22513
sVMacromolecular Substances
p22514
(dp22515
sVHydrolases
p22516
(dp22517
sVAlcohols
p22518
(dp22519
sVEthylene Glycols
p22520
(dp22521
ssg1152
(dp22522
VDrugs that are Mainly Renally Excreted
p22523
(dp22524
sVImidazoles
p22525
(dp22526
sVAntiparasitic Products, Insecticides and Repellents
p22527
(dp22528
sVAgents Against Leishmaniasis and Trypanosomiasis
p22529
(dp22530
sVImmunologic Factors
p22531
(dp22532
sVNoxae
p22533
(dp22534
sVToxic Actions
p22535
(dp22536
sVAntiparasitic Agents
p22537
(dp22538
sVNitroimidazole Derivatives
p22539
(dp22540
sVNitro Compounds
p22541
(dp22542
sVAntiprotozoals
p22543
(dp22544
sVTrypanocidal Agents
p22545
(dp22546
sVAnti-Infective Agents
p22547
(dp22548
sg2085
(dp22549
ssg1155
(dp22550
g9348
(dp22551
sg10185
(dp22552
sg5286
(dp22553
sg6567
(dp22554
sg4737
(dp22555
ssg1158
(dp22556
g11379
(dp22557
ssg1161
(dp22558
g4911
(dp22559
sg12000
(dp22560
sg4017
(dp22561
sg11229
(dp22562
sg4881
(dp22563
sg12078
(dp22564
sg11541
(dp22565
sg12003
(dp22566
sg3849
(dp22567
sg2667
(dp22568
sg7662
(dp22569
sg4773
(dp22570
sg12123
(dp22571
sg10305
(dp22572
ssg1164
(dp22573
VSunscreen Agents
p22574
(dp22575
sVIons
p22576
(dp22577
sVHousehold Products
p22578
(dp22579
sg3942
(dp22580
sVMetal divalent cations
p22581
(dp22582
sg8247
(dp22583
sVSunscreening Agents
p22584
(dp22585
sVDermatologicals
p22586
g17249
sg1851
(dp22587
sVRadiation-Protective Agents
p22588
(dp22589
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p22590
g16834
sVCompounds used in a research, industrial, or household setting
p22591
(dp22592
sVAnions
p22593
(dp22594
sg2379
(dp22595
sVProtective Agents
p22596
(dp22597
sVMetal cations
p22598
(dp22599
sVVasoprotectives
p22600
(dp22601
sg11991
(dp22602
sVElectrolytes
p22603
(dp22604
sg4701
(dp22605
sVCosmetics
p22606
(dp22607
ssg1167
(dp22608
g7740
(dp22609
sg3072
(dp22610
sg5007
(dp22611
sg5229
(dp22612
sg7077
(dp22613
sg6291
(dp22614
sg6000
(dp22615
sg7596
(dp22616
sg9009
(dp22617
sg7344
(dp22618
ssg1170
(dp22619
g1209
(dp22620
ssg1173
(dp22621
VAntiinfectives for Systemic Use
p22622
(dp22623
sVAntimycotics for Systemic Use
p22624
(dp22625
sVPyrimidines
p22626
(dp22627
sVMyelosuppressive Agents
p22628
(dp22629
sVAntimetabolites
p22630
(dp22631
sVDrugs that are Mainly Renally Excreted
p22632
(dp22633
sVAntifungals for Dermatological Use
p22634
(dp22635
sVPyrimidinones
p22636
(dp22637
sVAntifungal Agents
p22638
(dp22639
sg1713
(dp22640
sVDermatologicals
p22641
g17252
sVAntifungals for Topical Use
p22642
(dp22643
sVImmunosuppressive Agents
p22644
(dp22645
sVFluorouracil and prodrugs
p22646
(dp22647
sVToxic Actions
p22648
(dp22649
sVNoxae
p22650
(dp22651
sVAnti-Infective Agents
p22652
(dp22653
sVCytosine
p22654
(dp22655
ssg1176
(dp22656
VAntiinfectives for Systemic Use
p22657
(dp22658
sVBeta-Lactamase Sensitive Penicillins
p22659
(dp22660
sVHeterocyclic Compounds, Fused-Ring
p22661
(dp22662
sVOphthalmologicals
p22663
(dp22664
sVbeta-Lactams
p22665
(dp22666
sVOAT1/SLC22A6 inhibitors
p22667
(dp22668
sVNatural Penicillins
p22669
(dp22670
sVOAT3/SLC22A8 Substrates
p22671
g13143
sVOAT3/SLC22A8 Inhibitors
p22672
(dp22673
sVLactams
p22674
g22286
sVSulfur Compounds
p22675
(dp22676
sVAmides
p22677
(dp22678
sVSensory Organs
p22679
(dp22680
sVAnti-Bacterial Agents
p22681
(dp22682
sVAntibacterials for Systemic Use
p22683
(dp22684
sVPenicillin G
p22685
(dp22686
sVOATP1B1/SLCO1B1 Substrates
p22687
(dp22688
sVAnti-Infective Agents
p22689
(dp22690
sVPenicillins
p22691
(dp22692
sVBeta-Lactam Antibacterials
p22693
(dp22694
ssg1179
(dp22695
g9696
(dp22696
ssg1182
(dp22697
g11646
(dp22698
sg11349
(dp22699
ssg1185
(dp22700
VBSEP/ABCB11 Substrates
p22701
(dp22702
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p22703
(dp22704
sVCytochrome P-450 CYP2D6 Inhibitors
p22705
(dp22706
sVCytochrome P-450 CYP3A Substrates
p22707
(dp22708
sVOATP1B1/SLCO1B1 Inhibitors
p22709
(dp22710
sVCytochrome P-450 Enzyme Inhibitors
p22711
(dp22712
sVBlood Glucose Lowering Agents
p22713
(dp22714
sVDrugs that are Mainly Renally Excreted
p22715
(dp22716
sVCytochrome P-450 CYP2C8 Substrates
p22717
(dp22718
sVCytochrome P-450 CYP3A4 Substrates
p22719
(dp22720
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p22721
(dp22722
sVSulfur Compounds
p22723
(dp22724
sVOral Hypoglycemics
p22725
(dp22726
sVCytochrome P-450 CYP2C9 Substrates
p22727
(dp22728
sVDrugs Used in Diabetes
p22729
(dp22730
sg10923
(dp22731
sVThiazoles
p22732
(dp22733
sVCytochrome P-450 CYP1A2 Inhibitors
p22734
g15052
sVCytochrome P-450 CYP2C8 Inhibitors
p22735
(dp22736
sVVasodilating Agents
p22737
(dp22738
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p22739
(dp22740
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p22741
(dp22742
sVAlimentary Tract and Metabolism
p22743
(dp22744
sg8250
(dp22745
sVHypoglycemia-Associated Agents
p22746
g17718
sg2589
(dp22747
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p22748
(dp22749
sVCytochrome P-450 CYP2A6 Inhibitors
p22750
(dp22751
ssg1188
(dp22752
VAntihistamines for Topical Use
p22753
(dp22754
sVCytochrome P-450 CYP2D6 Inhibitors
p22755
(dp22756
sVNeurotransmitter Agents
p22757
(dp22758
sVHistamine Agents
p22759
(dp22760
sVCentral Nervous System Agents
p22761
(dp22762
sVPotential QTc-Prolonging Agents
p22763
(dp22764
sVCytochrome P-450 Enzyme Inhibitors
p22765
(dp22766
sg315
g14895
sVAmines
p22767
(dp22768
sVSleep Aids, Pharmaceutical
p22769
(dp22770
sVAntihistamines for Systemic Use
p22771
g12978
sVQTc Prolonging Agents
p22772
(dp22773
sVCentral Nervous System Depressants
p22774
(dp22775
sVAminopyridines
p22776
(dp22777
sVPyridines
p22778
(dp22779
sVDermatologicals
p22780
g17296
sVHistamine H1 Antagonists
p22781
(dp22782
sVHypnotics and Sedatives
p22783
(dp22784
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p22785
g13742
sVAnti-Allergic Agents
p22786
(dp22787
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p22788
(dp22789
sVHistamine Antagonists
p22790
(dp22791
ssg1191
(dp22792
g10410
(dp22793
sg4356
(dp22794
sg447
g16276
sg10794
(dp22795
sg9705
(dp22796
ssg1194
(dp22797
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p22798
(dp22799
sVSerotonin Agents
p22800
(dp22801
sVNeurotransmitter Agents
p22802
(dp22803
sVSerotonin Receptor Antagonists
p22804
(dp22805
sVCentral Nervous System Agents
p22806
(dp22807
sVDopamine Agents
p22808
g14267
sVAntipsychotic Agents (First Generation [Typical])
p22809
(dp22810
sg10824
(dp22811
sg3675
(dp22812
sVAntipsychotic Agents
p22813
(dp22814
sVDopamine Antagonists
p22815
(dp22816
sg8490
(dp22817
sVPsycholeptics
p22818
(dp22819
sVSerotonin 5-HT2 Receptor Antagonists
p22820
(dp22821
sVCentral Nervous System Depressants
p22822
(dp22823
sg1227
(dp22824
sVDopamine D2 Receptor Antagonists
p22825
(dp22826
sVHeterocyclic Compounds, Fused-Ring
p22827
(dp22828
sVAntidepressive Agents
p22829
g15535
sVP-glycoprotein/ABCB1 Inhibitors
p22830
(dp22831
sVNeurotoxic agents
p22832
(dp22833
sVPsychotropic Drugs
p22834
(dp22835
sVNervous System
p22836
(dp22837
sVTranquilizing Agents
p22838
(dp22839
ssg1197
(dp22840
g9702
(dp22841
ssg1200
(dp22842
g7221
(dp22843
sg4935
(dp22844
sg8658
(dp22845
sg2703
(dp22846
ssg1203
(dp22847
g7014
(dp22848
ssg1206
(dp22849
g1947
(dp22850
sg11301
(dp22851
sg7563
(dp22852
sg11934
(dp22853
sg5622
(dp22854
sg7854
(dp22855
sg2058
(dp22856
sg1581
(dp22857
sg717
g19040
sg10047
(dp22858
sg7161
(dp22859
sg4845
(dp22860
sg5793
(dp22861
sg3297
(dp22862
sg6903
(dp22863
sg7521
(dp22864
ssg1209
(dp22865
VIncreased Cellular Death
p22866
(dp22867
sg1170
g22620
sVMisc. Skin and Mucous Membrane Agents
p22868
(dp22869
sVTerpenes
p22870
(dp22871
sVDermatologicals
p22872
g17189
ssg1212
(dp22873
g816
g19630
sg11940
(dp22874
sg11274
(dp22875
sg6180
(dp22876
ssg1215
(dp22877
g3801
(dp22878
ssg1218
(dp22879
g4014
(dp22880
sg1629
(dp22881
sg9006
(dp22882
ssg1221
(dp22883
g6630
(dp22884
ssg1224
(dp22885
g10569
(dp22886
sg2118
(dp22887
ssg1227
(dp22888
g5169
(dp22889
sg1194
g22824
ssg1230
(dp22890
g9918
(dp22891
sg2403
(dp22892
ssg1233
(dp22893
g10200
(dp22894
sg21710
(dp22895
sg3699
(dp22896
sg3105
(dp22897
sg8529
(dp22898
sg5556
(dp22899
sg8022
(dp22900
sg8439
(dp22901
sg7680
(dp22902
sg9660
(dp22903
sg10272
(dp22904
sg8340
(dp22905
sg6150
(dp22906
sg1581
(dp22907
sg11664
(dp22908
sg2826
(dp22909
sg10245
(dp22910
sg12186
(dp22911
sg5511
(dp22912
ssg1236
(dp22913
g4683
(dp22914
sg9819
(dp22915
sg6102
(dp22916
ssg1239
(dp22917
VAntiparasitic Products, Insecticides and Repellents
p22918
(dp22919
sVCytochrome P-450 CYP3A4 Inhibitors
p22920
(dp22921
sg2517
(dp22922
sVUGT1A1 Substrates
p22923
g12277
sVCytochrome P-450 CYP3A Substrates
p22924
(dp22925
sVStomatological Preparations
p22926
(dp22927
sVPotential QTc-Prolonging Agents
p22928
(dp22929
sVMiscellaneous Local Anti-infectives
p22930
(dp22931
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p22932
(dp22933
sVCytochrome P-450 CYP2C9 Inhibitors
p22934
g18217
sVCytochrome P-450 Enzyme Inhibitors
p22935
(dp22936
sVAnti-Infective Agents
p22937
(dp22938
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p22939
(dp22940
sVAntiinfectives for Systemic Use
p22941
(dp22942
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p22943
(dp22944
sg4413
(dp22945
sVGynecological Antiinfectives and Antiseptics
p22946
(dp22947
sg12027
(dp22948
sVAnti-Bacterial Agents
p22949
(dp22950
sVAntiprotozoals
p22951
(dp22952
sVQTc Prolonging Agents
p22953
(dp22954
sVImidazoles
p22955
(dp22956
sVNitro Compounds
p22957
(dp22958
sVAgents that reduce seizure threshold
p22959
(dp22960
sVCytochrome P-450 CYP2C8 Inhibitors
p22961
(dp22962
sVDermatologicals
p22963
g17266
sVAntiparasitic Agents
p22964
(dp22965
sVCytochrome P-450 CYP2A6 Substrates
p22966
(dp22967
sVAntibacterials for Systemic Use
p22968
(dp22969
sg954
g20949
sVAlimentary Tract and Metabolism
p22970
(dp22971
sVCytochrome P-450 CYP3A5 Substrates
p22972
(dp22973
sVGenito Urinary System and Sex Hormones
p22974
(dp22975
sVCytochrome P-450 CYP3A Inhibitors
p22976
(dp22977
sVDrugs for Acid Related Disorders
p22978
(dp22979
sVP-glycoprotein/ABCB1 Inhibitors
p22980
(dp22981
sVAntiinfectives and Antiseptics for Local Oral Treatment
p22982
(dp22983
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p22984
(dp22985
sVImidazole Derivatives
p22986
(dp22987
sVCytochrome P-450 CYP3A7 Substrates
p22988
(dp22989
ssg1242
(dp22990
g10272
(dp22991
sg2736
(dp22992
sg9552
(dp22993
sg3249
(dp22994
ssg1245
(dp22995
VPregnanes
p22996
(dp22997
sVPregnenediones
p22998
(dp22999
sVCytochrome P-450 CYP3A4 Substrates
p23000
(dp23001
sVAdrenal Cortex Hormones
p23002
(dp23003
sVSteroids
p23004
(dp23005
sg2232
(dp23006
sVCorticosteroids, Dermatological Preparations
p23007
(dp23008
sVCytochrome P-450 CYP3A Substrates
p23009
(dp23010
sVImmunosuppressive Agents
p23011
(dp23012
sVDermatologicals
p23013
g17179
sVAnti-Inflammatory Agents
p23014
(dp23015
sVCorticosteroid Hormone Receptor Agonists
p23016
(dp23017
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p23018
(dp23019
sVPregnenes
p23020
(dp23021
sVFused-Ring Compounds
p23022
g14850
sVCorticosteroids
p23023
(dp23024
ssg1248
(dp23025
VQTc Prolonging Agents
p23026
(dp23027
sVAntipruritics
p23028
(dp23029
sVHistamine H1 Antagonists
p23030
(dp23031
sVCytochrome P-450 CYP2D6 Inhibitors
p23032
(dp23033
sg4485
(dp23034
sVNeurotransmitter Agents
p23035
(dp23036
sVAnti-Anxiety Agents
p23037
(dp23038
sVCentral Nervous System Depressants
p23039
(dp23040
sVHistamine Agents
p23041
(dp23042
sVDermatologicals
p23043
g17269
sVPotential QTc-Prolonging Agents
p23044
(dp23045
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p23046
(dp23047
sVHistamine Antagonists
p23048
(dp23049
sVPsycholeptics
p23050
(dp23051
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p23052
(dp23053
sVHistamine Receptor Antagonists
p23054
(dp23055
sVCytochrome P-450 Enzyme Inhibitors
p23056
(dp23057
sVNervous System
p23058
(dp23059
sVPiperazines
p23060
(dp23061
ssg1251
(dp23062
g2886
(dp23063
sg2058
(dp23064
sg9540
(dp23065
sg4488
(dp23066
sg1581
(dp23067
sg11769
(dp23068
sg717
g19042
sg11046
(dp23069
sg5400
(dp23070
sg10512
(dp23071
ssg1254
(dp23072
g4911
(dp23073
sg8421
(dp23074
sg4653
(dp23075
sg7272
(dp23076
sg9822
(dp23077
sg10362
(dp23078
sg8472
(dp23079
sg4155
(dp23080
sg183
g13792
sg5067
(dp23081
sg888
g20479
sg11922
(dp23082
sg6333
(dp23083
sg7734
(dp23084
sg6075
(dp23085
sg1140
g22378
sg7335
(dp23086
sg3432
(dp23087
sg12534
(dp23088
sg1656
(dp23089
sg6045
(dp23090
ssg1257
(dp23091
g4911
(dp23092
sg4017
(dp23093
sg4023
(dp23094
sg5805
(dp23095
sg8205
(dp23096
sg5256
(dp23097
sg3858
(dp23098
sg10017
(dp23099
sg456
g16373
sg2346
(dp23100
sg4788
(dp23101
sg7821
(dp23102
sg9366
(dp23103
sg1239
g22944
sg4650
(dp23104
sg7650
(dp23105
sg6033
(dp23106
sg5289
(dp23107
sg1461
(dp23108
sg8721
(dp23109
sg10701
(dp23110
sg11940
(dp23111
sg3543
(dp23112
sg12045
(dp23113
sg9591
(dp23114
sg10512
(dp23115
sg8097
(dp23116
sg10728
(dp23117
sg9462
(dp23118
sg3546
(dp23119
sg10752
(dp23120
sg1140
g22380
sg10179
(dp23121
sg816
g19656
sg11523
(dp23122
sg3432
(dp23123
sg5757
(dp23124
sg2895
(dp23125
sg6048
(dp23126
sg414
g15953
sg7608
(dp23127
sg11385
(dp23128
ssg1260
(dp23129
VAnticholinergic Agents
p23130
(dp23131
sVNeurotransmitter Agents
p23132
(dp23133
sVTropanes
p23134
(dp23135
sVMuscarinic Antagonists
p23136
(dp23137
sVAutonomic Agents
p23138
(dp23139
sVPeripheral Nervous System Agents
p23140
(dp23141
sVAza Compounds
p23142
(dp23143
sVRespiratory System Agents
p23144
(dp23145
sVAdrenergics, Inhalants
p23146
(dp23147
sVDrugs for Obstructive Airway Diseases
p23148
(dp23149
sVBronchodilator Agents
p23150
(dp23151
sVAzabicyclo Compounds
p23152
(dp23153
sVSolanaceous Alkaloids
p23154
(dp23155
sVAtropine Derivatives
p23156
(dp23157
sVAnti-Asthmatic Agents
p23158
(dp23159
sVNasal Preparations
p23160
(dp23161
sVAntimuscarinics Antispasmodics
p23162
(dp23163
sVAgents to Treat Airway Disease
p23164
(dp23165
sVCholinergic Agents
p23166
(dp23167
sVBelladonna Alkaloids
p23168
(dp23169
sVAgents producing tachycardia
p23170
(dp23171
sVAlkaloids
p23172
g19407
ssg1263
(dp23173
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p23174
(dp23175
sVDrugs that are Mainly Renally Excreted
p23176
(dp23177
sVCentral Nervous System Depressants
p23178
(dp23179
sVCytochrome P-450 CYP1A2 Substrates
p23180
(dp23181
sVAnti-Parkinson Drugs
p23182
g16147
sVAntidepressive Agents
p23183
g15543
sVAgents that reduce seizure threshold
p23184
(dp23185
sVSerotonin Modulators
p23186
(dp23187
sVHypotensive Agents
p23188
(dp23189
sVIndenes
p23190
(dp23191
sg7731
(dp23192
sVCentral Nervous System Agents
p23193
(dp23194
sVDopamine Agents
p23195
g14236
sVProtective Agents
p23196
(dp23197
sVSerotonin Agents
p23198
(dp23199
sVCompounds used in a research, industrial, or household setting
p23200
(dp23201
sVAgents that produce hypertension
p23202
(dp23203
sVEnzyme Inhibitors
p23204
(dp23205
sVNervous System
p23206
(dp23207
sVNeuroprotective Agents
p23208
(dp23209
sg1764
(dp23210
ssg1266
(dp23211
VImmunologic Factors
p23212
(dp23213
sg6561
(dp23214
sVSerum Globulins
p23215
(dp23216
sg1026
g21345
sVPeptide Fragments
p23217
(dp23218
sVBiologics for Rheumatoid Arthritis Treatment
p23219
(dp23220
sVMembrane Proteins
p23221
(dp23222
sg5325
(dp23223
sg5679
(dp23224
sg5682
(dp23225
sVAntibodies
p23226
(dp23227
sVAgents reducing cytokine levels
p23228
(dp23229
sg8280
(dp23230
sVProteins
p23231
(dp23232
sg678
g18471
sVDermatologicals
p23233
g17274
sVPeptides
p23234
(dp23235
sVDisease-modifying Antirheumatic Agents
p23236
(dp23237
sg5856
(dp23238
sVAmino Acids, Peptides, and Proteins
p23239
(dp23240
sg7770
(dp23241
sg3228
(dp23242
sVImmunosuppressive Agents
p23243
(dp23244
sVAnti-Inflammatory Agents
p23245
(dp23246
sVBiological Products
p23247
(dp23248
sVAntirheumatic Agents
p23249
(dp23250
sVImmunoglobulin Isotypes
p23251
(dp23252
sVComplex Mixtures
p23253
(dp23254
sVImmunoproteins
p23255
(dp23256
ssg1269
(dp23257
g5073
(dp23258
sg8769
(dp23259
ssg1272
(dp23260
g10314
(dp23261
sg10548
(dp23262
ssg1275
(dp23263
VPyrimidines
p23264
(dp23265
sVNucleic Acid Synthesis Inhibitors
p23266
(dp23267
sVImmunosuppressive Agents
p23268
(dp23269
sVCarbohydrates
p23270
(dp23271
sVOAT1/SLC22A6 Substrates
p23272
(dp23273
sVNucleoside Analog Antiviral
p23274
(dp23275
sVDeoxyribonucleosides
p23276
(dp23277
sVPyrimidine Analogues
p23278
g18466
sVDrugs that are Mainly Renally Excreted
p23279
(dp23280
sVAnti-Infective Agents
p23281
(dp23282
sVNucleoside Metabolic Inhibitor
p23283
(dp23284
sVOAT1/SLC22A6 inhibitors
p23285
(dp23286
sVAntineoplastic Agents
p23287
(dp23288
sVGlycosides
p23289
(dp23290
sVThymidine
p23291
(dp23292
sVOAT3/SLC22A8 Substrates
p23293
g13138
sVNucleic Acids, Nucleotides, and Nucleosides
p23294
(dp23295
sVSensory Organs
p23296
(dp23297
sVPyrimidine Nucleosides
p23298
(dp23299
sVOphthalmologicals
p23300
(dp23301
sVToxic Actions
p23302
(dp23303
sVNucleosides
p23304
(dp23305
sVAntimetabolites
p23306
(dp23307
sVNoxae
p23308
(dp23309
sVAntiviral Agents
p23310
(dp23311
sVAntineoplastic and Immunomodulating Agents
p23312
(dp23313
ssg1278
(dp23314
VAntiinfectives for Systemic Use
p23315
(dp23316
sVBeta-Lactamase Sensitive Penicillins
p23317
(dp23318
sVHeterocyclic Compounds, Fused-Ring
p23319
(dp23320
sVOphthalmologicals
p23321
(dp23322
sVbeta-Lactams
p23323
(dp23324
sVOAT1/SLC22A6 inhibitors
p23325
(dp23326
sVNatural Penicillins
p23327
(dp23328
sVOAT3/SLC22A8 Substrates
p23329
g13100
sVOAT3/SLC22A8 Inhibitors
p23330
(dp23331
sVLactams
p23332
g22266
sVSulfur Compounds
p23333
(dp23334
sVAmides
p23335
(dp23336
sVSensory Organs
p23337
(dp23338
sVAnti-Bacterial Agents
p23339
(dp23340
sVAntibacterials for Systemic Use
p23341
(dp23342
sVPenicillin G
p23343
(dp23344
sVOATP1B1/SLCO1B1 Substrates
p23345
(dp23346
sVAnti-Infective Agents
p23347
(dp23348
sVPenicillins
p23349
(dp23350
sVBeta-Lactam Antibacterials
p23351
(dp23352
ssg1281
(dp23353
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p23354
(dp23355
sVAnalgesics
p23356
(dp23357
sVOpiate Agonists
p23358
(dp23359
sVCentral Nervous System Agents
p23360
(dp23361
sVNarcotics
p23362
(dp23363
sVPeripheral Nervous System Agents
p23364
(dp23365
sVDrugs that are Mainly Renally Excreted
p23366
(dp23367
sVMorphine Derivatives
p23368
(dp23369
sVCytochrome P-450 CYP3A4 Substrates
p23370
(dp23371
sVUGT1A3 substrates
p23372
(dp23373
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p23374
(dp23375
sVCytochrome P-450 CYP2C9 Substrates
p23376
(dp23377
sVCytochrome P-450 CYP3A Substrates
p23378
(dp23379
sVNatural Opium Alkaloids
p23380
(dp23381
sVCentral Nervous System Depressants
p23382
(dp23383
sVOpioids
p23384
(dp23385
sVSemi-synthetic Opioids
p23386
(dp23387
sVOpiate Alkaloids
p23388
(dp23389
sVHigh-risk opioids
p23390
(dp23391
sVMorphinans
p23392
(dp23393
sVHeterocyclic Compounds, Fused-Ring
p23394
(dp23395
sVOpioid Agonist
p23396
(dp23397
sVUGT2B7 substrates
p23398
(dp23399
sVAlkaloids
p23400
g19423
sVSensory System Agents
p23401
(dp23402
sVPhenanthrenes
p23403
(dp23404
sVNervous System
p23405
(dp23406
ssg1284
(dp23407
g5922
(dp23408
ssg1287
(dp23409
g6246
(dp23410
sg4491
(dp23411
sg6843
(dp23412
ssg1290
(dp23413
g7053
(dp23414
sg3639
(dp23415
sg10818
(dp23416
sg7428
(dp23417
sg2211
(dp23418
sg4830
(dp23419
sg1650
(dp23420
sg6411
(dp23421
sg4062
(dp23422
sg7464
(dp23423
sg5283
(dp23424
sg3516
(dp23425
sg5499
(dp23426
sg1491
(dp23427
sg5685
(dp23428
sg2433
(dp23429
sg6348
(dp23430
sg10725
(dp23431
sg1881
(dp23432
sg7569
(dp23433
sg10758
(dp23434
sg4635
(dp23435
sg3651
(dp23436
sg6999
(dp23437
sg2763
(dp23438
sg11544
(dp23439
sg4974
(dp23440
sg10794
(dp23441
sg1941
(dp23442
sg10692
(dp23443
sg3447
(dp23444
sg4596
(dp23445
sg7608
(dp23446
ssg1293
(dp23447
g477
g16604
sg87
g12922
sg4521
(dp23448
sg2451
(dp23449
sg4068
(dp23450
sg12090
(dp23451
sg4863
(dp23452
sg3015
(dp23453
sg1785
(dp23454
sg1674
(dp23455
sg5880
(dp23456
sg48
g12638
sg11775
(dp23457
sg474
g16564
sg3609
(dp23458
sg918
g20774
ssg1296
(dp23459
g10701
(dp23460
sg5268
(dp23461
ssg1299
(dp23462
g8421
(dp23463
sg10728
(dp23464
sg7272
(dp23465
sg2403
(dp23466
sg9822
(dp23467
sg10350
(dp23468
sg7317
(dp23469
sg702
g18831
sg7734
(dp23470
sg888
g20517
sg5256
(dp23471
sg5235
(dp23472
sg4287
(dp23473
sg7944
(dp23474
sg7329
(dp23475
sg7335
(dp23476
sg4959
(dp23477
sg8460
(dp23478
sg1869
(dp23479
ssg1302
(dp23480
g537
g17034
sg5739
(dp23481
sg4458
(dp23482
sg6261
(dp23483
sg4101
(dp23484
sg294
g14744
sg1809
(dp23485
sg42
g12584
sg5487
(dp23486
sg10602
(dp23487
sg1008
g21283
sg8295
(dp23488
sg1281
g23381
ssg1305
(dp23489
g10365
(dp23490
sg2769
(dp23491
ssg1308
(dp23492
g219
g14073
sg8373
(dp23493
sg9357
(dp23494
sg1659
(dp23495
sg9192
(dp23496
sg11241
(dp23497
sg5646
(dp23498
sg2598
(dp23499
sg6981
(dp23500
sg13070
g21901
sg2481
(dp23501
sg9033
(dp23502
sg9444
(dp23503
sg3399
(dp23504
sg8211
(dp23505
sg5271
(dp23506
sg4005
(dp23507
sg8922
(dp23508
ssg1311
(dp23509
VAntiinfectives for Systemic Use
p23510
(dp23511
sVDrugs that are Mainly Renally Excreted
p23512
(dp23513
sVHeterocyclic Compounds, Fused-Ring
p23514
(dp23515
sVThird-Generation Cephalosporins
p23516
(dp23517
sVbeta-Lactams
p23518
(dp23519
sVNephrotoxic agents
p23520
(dp23521
sVLactams
p23522
g22281
sVOAT1/SLC22A6 inhibitors
p23523
(dp23524
sVAmides
p23525
(dp23526
sVThiazines
p23527
g16422
sVSulfur Compounds
p23528
(dp23529
sVCephaloridine
p23530
(dp23531
sVAnti-Bacterial Agents
p23532
(dp23533
sVAntibacterials for Systemic Use
p23534
(dp23535
sVCephalosporins
p23536
(dp23537
sVAnti-Infective Agents
p23538
(dp23539
ssg1314
(dp23540
g2418
(dp23541
sg11541
(dp23542
ssg1317
(dp23543
g2784
(dp23544
sg3177
(dp23545
sg10113
(dp23546
sg8031
(dp23547
sg7713
(dp23548
sg7020
(dp23549
sg2316
(dp23550
sg8406
(dp23551
sg5511
(dp23552
ssg1320
(dp23553
g1770
(dp23554
sg11727
(dp23555
sg2928
(dp23556
sg5085
(dp23557
sg10890
(dp23558
ssg1323
(dp23559
g6630
(dp23560
sg9612
(dp23561
sg1920
(dp23562
sg2829
(dp23563
sg9525
(dp23564
sg10410
(dp23565
sg12015
(dp23566
sg9705
(dp23567
sg16906
(dp23568
sg11286
(dp23569
sg3801
(dp23570
sg9300
(dp23571
sg4200
(dp23572
sg9180
(dp23573
sg3321
(dp23574
sg10794
(dp23575
sg9411
(dp23576
ssg1326
(dp23577
VCytochrome P-450 CYP3A4 Inhibitors
p23578
(dp23579
sVSulfoxides
p23580
(dp23581
sg1326
(dp23582
sVMusculo-Skeletal System
p23583
(dp23584
sVCompounds used in a research, industrial, or household setting
p23585
(dp23586
sVCytochrome P-450 Enzyme Inhibitors
p23587
(dp23588
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p23589
g18385
sVDrugs that are Mainly Renally Excreted
p23590
(dp23591
sVCytochrome P-450 CYP2D6 Inhibitors
p23592
(dp23593
sVAntioxidants
p23594
(dp23595
sVSulfur Compounds
p23596
(dp23597
sVProtective Agents
p23598
(dp23599
sVFree Radical Scavengers
p23600
(dp23601
sVTopical Products for Joint and Muscular Pain
p23602
g13927
sVSolvents
p23603
(dp23604
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p23605
(dp23606
sVCytochrome P-450 CYP2C19 Inhibitors
p23607
(dp23608
sVUrologicals
p23609
(dp23610
sVGenito Urinary System and Sex Hormones
p23611
(dp23612
sVCytochrome P-450 CYP3A Inhibitors
p23613
(dp23614
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p23615
(dp23616
sVCryoprotective Agents
p23617
(dp23618
sVMiscellaneous Therapeutic Agents
p23619
(dp23620
ssg1329
(dp23621
g2256
(dp23622
sg7971
(dp23623
sg10230
(dp23624
sg11874
(dp23625
sg6474
(dp23626
sg7719
(dp23627
sg10074
(dp23628
sg6471
(dp23629
sg1038
g21488
sg10974
(dp23630
sg7020
(dp23631
sg1356
(dp23632
sg10245
(dp23633
sg12186
(dp23634
sg4320
(dp23635
ssg1332
(dp23636
VAntiinfectives for Systemic Use
p23637
(dp23638
sVDrugs that are Mainly Renally Excreted
p23639
(dp23640
sVPyrimidines
p23641
(dp23642
sVAntivirals for Systemic Use
p23643
(dp23644
sVNucleic Acid Synthesis Inhibitors
p23645
(dp23646
sVOrganophosphonates
p23647
(dp23648
sVPyrimidinones
p23649
(dp23650
sVNephrotoxic agents
p23651
(dp23652
sVAntiviral Agents
p23653
(dp23654
sVDirect Acting Antivirals
p23655
(dp23656
sVNucleosides and Nucleotides
p23657
(dp23658
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p23659
(dp23660
sVCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor
p23661
(dp23662
sVOAT1/SLC22A6 inhibitors
p23663
(dp23664
sVEnzyme Inhibitors
p23665
(dp23666
sVAnti-Infective Agents
p23667
(dp23668
sg2868
(dp23669
sVOAT1/SLC22A6 Substrates
p23670
(dp23671
sVOrganophosphorus Compounds
p23672
(dp23673
ssg1335
(dp23674
g3627
(dp23675
sg7689
(dp23676
sg444
g16261
sg8763
(dp23677
sg11460
(dp23678
ssg1338
(dp23679
g4806
(dp23680
sg10263
(dp23681
sg3105
(dp23682
sg1947
(dp23683
sg1059
g21769
sg1035
g21458
sg19588
(dp23684
sg1038
g21492
sg8388
(dp23685
sg1044
g21556
sg4449
(dp23686
sg4452
(dp23687
sg657
g18341
sg10308
(dp23688
sg684
g18507
sg1869
(dp23689
sg6408
(dp23690
sg5289
(dp23691
sg11619
(dp23692
sg9696
(dp23693
sg8022
(dp23694
sg11652
(dp23695
sg9561
(dp23696
sg3696
(dp23697
sg8820
(dp23698
sg11475
(dp23699
sg11292
(dp23700
sg7305
(dp23701
sg2910
(dp23702
sg6906
(dp23703
sg3177
(dp23704
sg7422
(dp23705
sg1881
(dp23706
sg11874
(dp23707
sg6645
(dp23708
sg2844
(dp23709
sg9987
(dp23710
sg3036
(dp23711
sg6885
(dp23712
sg2850
(dp23713
sg8433
(dp23714
sg8265
(dp23715
sg6312
(dp23716
sg10557
(dp23717
sg7764
(dp23718
sg6684
(dp23719
sg9819
(dp23720
sg3240
(dp23721
sg10587
(dp23722
sg1185
g22738
sg7191
(dp23723
sg6336
(dp23724
sg1857
(dp23725
sg3318
(dp23726
sg7800
(dp23727
sg7014
(dp23728
sg7170
(dp23729
sg5793
(dp23730
ssg1341
(dp23731
g10878
(dp23732
ssg1344
(dp23733
g8595
(dp23734
ssg1347
(dp23735
g7812
(dp23736
sg10890
(dp23737
sg1113
g22161
sg2928
(dp23738
sg10314
(dp23739
sg10578
(dp23740
sg10296
(dp23741
sg9948
(dp23742
sg4302
(dp23743
sg4902
(dp23744
sg10548
(dp23745
ssg1350
(dp23746
g12123
(dp23747
ssg1353
(dp23748
g2343
(dp23749
sg9153
(dp23750
sg5415
(dp23751
sg11403
(dp23752
sg2355
(dp23753
sg3846
(dp23754
sg5556
(dp23755
sg129
g13214
sg3858
(dp23756
sg5457
(dp23757
sg465
g16487
sg9903
(dp23758
sg5448
(dp23759
sg8406
(dp23760
sg4653
(dp23761
sg4872
(dp23762
sg1656
(dp23763
sg8418
(dp23764
sg10149
(dp23765
sg5469
(dp23766
sg3891
(dp23767
sg2397
(dp23768
sg10113
(dp23769
sg10494
(dp23770
sg8430
(dp23771
sg3141
(dp23772
sg2046
(dp23773
sg2424
(dp23774
sg8448
(dp23775
sg11268
(dp23776
sg10272
(dp23777
sg8457
(dp23778
sg102
g13021
sg9216
(dp23779
sg6714
(dp23780
sg5514
(dp23781
sg6279
(dp23782
sg3177
(dp23783
sg3657
(dp23784
sg2391
(dp23785
sg6981
(dp23786
sg4053
(dp23787
sg6990
(dp23788
sg8340
(dp23789
sg132
g13235
sg2481
(dp23790
sg10764
(dp23791
sg3207
(dp23792
sg11445
(dp23793
sg165
g13602
sg5571
(dp23794
sg9630
(dp23795
sg10119
(dp23796
sg7020
(dp23797
sg9081
(dp23798
sg4782
(dp23799
sg5589
(dp23800
sg2826
(dp23801
sg2676
(dp23802
sg4008
(dp23803
sg8724
(dp23804
sg11259
(dp23805
sg1782
(dp23806
sg219
g14088
sg2553
(dp23807
sg6567
(dp23808
sg8580
(dp23809
sg7962
(dp23810
sg4821
(dp23811
sg8583
(dp23812
sg7353
(dp23813
sg4365
(dp23814
sg4890
(dp23815
sg1812
(dp23816
sg8916
(dp23817
sg7407
(dp23818
sg10878
(dp23819
sg7713
(dp23820
sg4113
(dp23821
sg7530
(dp23822
sg7545
(dp23823
sg1062
g21831
sg2598
(dp23824
sg10122
(dp23825
sg6156
(dp23826
sg1842
(dp23827
sg5313
(dp23828
sg3825
(dp23829
sg4884
(dp23830
sg14838
(dp23831
sg8649
(dp23832
sg5208
(dp23833
sg12534
(dp23834
sg5739
(dp23835
sg6447
(dp23836
sg11319
(dp23837
sg9426
(dp23838
sg7920
(dp23839
sg1872
(dp23840
sg6345
(dp23841
sg4398
(dp23842
sg1134
g22342
sg354
g15293
sg1911
(dp23843
sg3090
(dp23844
sg7668
(dp23845
sg10200
(dp23846
sg11175
(dp23847
sg9324
(dp23848
sg11760
(dp23849
sg3699
(dp23850
sg6093
(dp23851
sg8010
(dp23852
sg9261
(dp23853
sg9870
(dp23854
sg6552
(dp23855
sg5463
(dp23856
sg10275
(dp23857
sg8031
(dp23858
sg8778
(dp23859
sg5832
(dp23860
sg6570
(dp23861
sg1239
g22971
sg1041
g21519
sg8796
(dp23862
sg3087
(dp23863
sg11832
(dp23864
sg4257
(dp23865
sg2658
(dp23866
sg1146
g22481
sg6261
(dp23867
sg495
g16720
sg8808
(dp23868
sg3519
(dp23869
sg9561
(dp23870
sg4278
(dp23871
sg10338
(dp23872
sg5085
(dp23873
sg2067
(dp23874
sg5889
(dp23875
sg8823
(dp23876
sg8826
(dp23877
sg5094
(dp23878
sg11592
(dp23879
sg9579
(dp23880
sg534
g17000
sg339
g15182
sg10593
(dp23881
sg10959
(dp23882
sg6474
(dp23883
sg6024
(dp23884
sg2118
(dp23885
sg4557
(dp23886
sg10416
(dp23887
sg4338
(dp23888
sg7662
(dp23889
sg5025
(dp23890
sg5895
(dp23891
sg7698
(dp23892
sg4035
(dp23893
sg8088
(dp23894
sg10767
(dp23895
sg9660
(dp23896
sg3363
(dp23897
sg2172
(dp23898
sg7395
(dp23899
sg612
g17895
sg13750
(dp23900
sg11961
(dp23901
sg516
g16888
sg4437
(dp23902
sg9033
(dp23903
sg2940
(dp23904
sg11976
(dp23905
sg2946
(dp23906
sg657
g18350
sg10185
(dp23907
sg6033
(dp23908
sg1452
(dp23909
sg6045
(dp23910
sg5766
(dp23911
sg4860
(dp23912
sg8241
(dp23913
sg3684
(dp23914
sg687
g18577
sg7470
(dp23915
sg1614
(dp23916
sg6867
(dp23917
sg2985
(dp23918
sg9741
(dp23919
sg5487
(dp23920
sg11367
(dp23921
sg5286
(dp23922
sg10365
(dp23923
sg9759
(dp23924
sg2253
(dp23925
sg9765
(dp23926
sg714
g19029
sg12063
(dp23927
sg2769
(dp23928
sg9780
(dp23929
sg1659
(dp23930
sg5112
(dp23931
sg6123
(dp23932
sg3777
(dp23933
sg9810
(dp23934
sg1185
g22744
sg8322
(dp23935
sg10569
(dp23936
sg2373
(dp23937
sg10581
(dp23938
sg6015
(dp23939
sg11361
(dp23940
sg4581
(dp23941
sg1014
g21337
sg2316
(dp23942
sg12057
(dp23943
sg11241
(dp23944
sg789
g19487
sg11382
(dp23945
sg6162
(dp23946
sg9108
(dp23947
sg1605
(dp23948
sg801
g19553
sg2784
(dp23949
ssg1356
(dp23950
VLipids
p23951
g14339
sVProstaglandins
p23952
g19503
sVAutacoids
p23953
(dp23954
sVFatty Acids
p23955
(dp23956
sVProstaglandin analogs reducing intraocular pressure (IOP)
p23957
g19254
sVFatty Acids, Unsaturated
p23958
(dp23959
sVSensory Organs
p23960
(dp23961
sVProstaglandins, Synthetic
p23962
(dp23963
sVInflammation Mediators
p23964
g23632
sVOphthalmics
p23965
(dp23966
sVBiological Factors
p23967
(dp23968
sVIncreased Prostaglandin Activity
p23969
(dp23970
sVOphthalmologicals
p23971
(dp23972
sVProstaglandin Receptor Agonists
p23973
(dp23974
sVEicosanoids
p23975
(dp23976
sVAntiglaucoma Preparations and Miotics
p23977
(dp23978
ssg1359
(dp23979
g8373
(dp23980
sg4857
(dp23981
sg2838
(dp23982
sg9507
(dp23983
sg5928
(dp23984
sg2481
(dp23985
sg11790
(dp23986
sg8211
(dp23987
sg6759
(dp23988
sg5295
(dp23989
sg15016
(dp23990
ssg1362
(dp23991
g8019
(dp23992
sg7053
(dp23993
sg4425
(dp23994
sg318
g14902
sg450
g16327
sg7428
(dp23995
sg12051
(dp23996
sg11976
(dp23997
sg5250
(dp23998
sg4260
(dp23999
sg3111
(dp24000
sg11403
(dp24001
sg10977
(dp24002
sg3516
(dp24003
sg5877
(dp24004
sg1683
(dp24005
sg9960
(dp24006
sg9591
(dp24007
sg5094
(dp24008
sg2109
(dp24009
sg6447
(dp24010
sg10728
(dp24011
sg10740
(dp24012
sg9414
(dp24013
sg3036
(dp24014
sg2850
(dp24015
sg10179
(dp24016
sg3651
(dp24017
sg3408
(dp24018
sg4596
(dp24019
sg7698
(dp24020
sg6999
(dp24021
sg3570
(dp24022
sg5694
(dp24023
sg5256
(dp24024
sg5769
(dp24025
sg2715
(dp24026
sg5112
(dp24027
sg336
g15073
sg9060
(dp24028
ssg1365
(dp24029
VAgents Causing Muscle Toxicity
p24030
(dp24031
sVToxic Actions
p24032
(dp24033
sVHeterocyclic Compounds, Fused-Ring
p24034
(dp24035
sVMyelosuppressive Agents
p24036
(dp24037
sVCytochrome P-450 CYP2D6 Substrates
p24038
(dp24039
sg4428
(dp24040
sVCytochrome P-450 CYP3A Substrates
p24041
(dp24042
sVNoxae
p24043
(dp24044
sVImmunosuppressive Agents
p24045
(dp24046
sg4578
(dp24047
sVDioxoles
p24048
(dp24049
sg9255
(dp24050
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24051
(dp24052
sVAntineoplastic and Immunomodulating Agents
p24053
(dp24054
sg8244
(dp24055
sVCytochrome P-450 CYP2C9 Substrates
p24056
(dp24057
sVCytochrome P-450 CYP3A4 Substrates
p24058
(dp24059
sVAntineoplastic Agents
p24060
(dp24061
sg7263
(dp24062
ssg1368
(dp24063
g357
g15298
sg5073
(dp24064
sg8769
(dp24065
ssg1371
(dp24066
g63
g12721
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p24067
(dp24068
sg4026
(dp24069
sVCytochrome P-450 CYP3A Substrates
p24070
(dp24071
sVBCRP/ABCG2 Inhibitors
p24072
g12508
sVKinase Inhibitor
p24073
(dp24074
sVOATP1B1/SLCO1B1 Inhibitors
p24075
(dp24076
sg1638
(dp24077
sVOATP1B3 inhibitors
p24078
(dp24079
sVEnzyme Inhibitors
p24080
(dp24081
sg2949
(dp24082
sVCytochrome P-450 CYP2C9 Inducers
p24083
g20054
sVCytochrome P-450 Enzyme Inhibitors
p24084
(dp24085
sVHyperglycemia-Associated Agents
p24086
(dp24087
sVCytochrome P-450 CYP2C8 Substrates
p24088
(dp24089
sVAmines
p24090
(dp24091
sVCytochrome P-450 CYP2B6 Inducers
p24092
(dp24093
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24094
(dp24095
sVOAT1/SLC22A6 inhibitors
p24096
(dp24097
sg5892
(dp24098
sVQTc Prolonging Agents
p24099
(dp24100
sVCytochrome P-450 CYP3A4 Inducers
p24101
g18957
sVAntineoplastic Agents
p24102
(dp24103
sVCytochrome P450 2C19 Inducers
p24104
(dp24105
sg9594
(dp24106
sg9027
(dp24107
sVCytochrome P-450 CYP2C8 Inhibitors
p24108
(dp24109
sVP-glycoprotein/ABCB1 Substrates
p24110
(dp24111
sVCytochrome P450 2C9 Inducers
p24112
(dp24113
sVCytochrome P-450 Enzyme Inducers
p24114
(dp24115
sVCytochrome P-450 CYP3A Inducers
p24116
(dp24117
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p24118
(dp24119
sVCytochrome P-450 CYP3A4 Substrates
p24120
(dp24121
sVProtein Kinase Inhibitors
p24122
(dp24123
sVPotential QTc-Prolonging Agents
p24124
(dp24125
sVCytochrome P-450 CYP2C8 Inducers
p24126
(dp24127
sg11187
(dp24128
sVOAT3/SLC22A8 Inhibitors
p24129
(dp24130
sVBCRP/ABCG2 Substrates
p24131
(dp24132
sg8739
(dp24133
sg7917
(dp24134
sVAntineoplastic and Immunomodulating Agents
p24135
(dp24136
ssg1374
(dp24137
g2505
(dp24138
ssg1377
(dp24139
g6990
(dp24140
ssg1380
(dp24141
g11952
(dp24142
sg5409
(dp24143
sg4170
(dp24144
sg6360
(dp24145
sg7689
(dp24146
sg4143
(dp24147
ssg1383
(dp24148
VPregnanes
p24149
(dp24150
sVPregnenediones
p24151
(dp24152
sVCytochrome P-450 CYP3A4 Substrates
p24153
(dp24154
sVAdrenal Cortex Hormones
p24155
(dp24156
sVSteroids
p24157
(dp24158
sVCorticosteroids, Dermatological Preparations
p24159
(dp24160
sVCytochrome P-450 CYP3A Substrates
p24161
(dp24162
sVCorticosteroids, Potent (Group III)
p24163
(dp24164
sVSteroids, Fluorinated
p24165
(dp24166
sVDermatologicals
p24167
g17232
sVAnti-Inflammatory Agents
p24168
(dp24169
sVCorticosteroid Hormone Receptor Agonists
p24170
(dp24171
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24172
(dp24173
sVImmunosuppressive Agents
p24174
(dp24175
sVHormones
p24176
(dp24177
sVHormones, Hormone Substitutes, and Hormone Antagonists
p24178
(dp24179
sVPregnenes
p24180
(dp24181
sVFused-Ring Compounds
p24182
g14834
sVCorticosteroids
p24183
(dp24184
ssg1386
(dp24185
g11370
(dp24186
ssg1389
(dp24187
g11820
(dp24188
sg9918
(dp24189
sg4716
(dp24190
sg11079
(dp24191
sg3753
(dp24192
sg10017
(dp24193
sg2211
(dp24194
sg789
g19479
sg5127
(dp24195
sg5526
(dp24196
sg11241
(dp24197
sg4926
(dp24198
sg4650
(dp24199
sg7563
(dp24200
sg11052
(dp24201
sg819
g19787
ssg1392
(dp24202
g8019
(dp24203
sg4200
(dp24204
sg4425
(dp24205
sg9132
(dp24206
sg9519
(dp24207
sg11805
(dp24208
sg9525
(dp24209
sg4788
(dp24210
sg10653
(dp24211
sg5250
(dp24212
sg7650
(dp24213
sg10011
(dp24214
sg9348
(dp24215
sg5652
(dp24216
sg3000
(dp24217
sg10977
(dp24218
sg4260
(dp24219
sg1914
(dp24220
sg7671
(dp24221
sg1266
g23250
sg11958
(dp24222
sg11079
(dp24223
sg4272
(dp24224
sg891
g20567
sg8076
(dp24225
sg2088
(dp24226
sg10740
(dp24227
sg6612
(dp24228
sg9702
(dp24229
sg4356
(dp24230
sg9612
(dp24231
sg5316
(dp24232
sg4716
(dp24233
sg2109
(dp24234
sg2391
(dp24235
sg969
g21098
sg10680
(dp24236
sg7707
(dp24237
sg3408
(dp24238
sg11718
(dp24239
sg4542
(dp24240
sg72
g12815
sg1920
(dp24241
sg963
g21021
sg11535
(dp24242
sg7971
(dp24243
sg10698
(dp24244
sg3279
(dp24245
sg171
g13725
sg4974
(dp24246
sg10794
(dp24247
sg11550
(dp24248
sg13091
g21442
sg7188
(dp24249
sg4905
(dp24250
sg336
g15132
sg11775
(dp24251
sg5394
(dp24252
sg5181
(dp24253
sg4803
(dp24254
ssg1395
(dp24255
g10290
(dp24256
sg5157
(dp24257
sg12072
(dp24258
sg14338
g13537
ssg1398
(dp24259
g7821
(dp24260
sg11592
(dp24261
sg9366
(dp24262
sg2703
(dp24263
sg2763
(dp24264
sg831
g19902
sg834
g19967
sg837
g19977
sg1047
g21625
sg1050
g21691
sg1650
(dp24265
sg8055
(dp24266
sg2043
(dp24267
sg147
g13485
sg1470
(dp24268
sg8445
(dp24269
sg11940
(dp24270
sg11097
(dp24271
sg6798
(dp24272
sg528
g16946
sg6279
(dp24273
sg3024
(dp24274
sg1503
(dp24275
sg8856
(dp24276
sg1899
(dp24277
sg5238
(dp24278
sg10209
(dp24279
sg816
g19693
sg3783
(dp24280
sg12045
(dp24281
sg966
g21058
sg10563
(dp24282
sg8949
(dp24283
sg5370
(dp24284
sg6048
(dp24285
sg10041
(dp24286
sg9060
(dp24287
sg8013
(dp24288
ssg1401
(dp24289
VFatty Acids
p24290
(dp24291
sVGABA Agents
p24292
g16227
sVAnti-epileptic Agent
p24293
(dp24294
sVAminobutyrates
p24295
(dp24296
sVCentral Nervous System Agents
p24297
(dp24298
sVButyrates
p24299
(dp24300
sVFatty Acids, Volatile
p24301
(dp24302
sVLipids
p24303
g14355
sVEnzyme Inhibitors
p24304
(dp24305
sVCytochrome P-450 CYP2C9 Inducers
p24306
g20055
sVMiscellaneous Anticonvulsants
p24307
(dp24308
sVAmino Acids
p24309
(dp24310
sVgamma-Aminobutyric Acid
p24311
(dp24312
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p24313
g16538
sVFatty Acid Derivatives
p24314
g20672
sVCentral Nervous System Depressants
p24315
(dp24316
sVNeurotransmitter Agents
p24317
(dp24318
sVAnticonvulsants
p24319
(dp24320
sVCytochrome P-450 Enzyme Inducers
p24321
(dp24322
sVAmino Acids, Peptides, and Proteins
p24323
(dp24324
sVAcids, Acyclic
p24325
(dp24326
sVNervous System
p24327
(dp24328
ssg1404
(dp24329
g4260
(dp24330
sg5181
(dp24331
sg11805
(dp24332
sg891
g20573
sg4788
(dp24333
sg2088
(dp24334
sg10011
(dp24335
ssg1407
(dp24336
g9444
(dp24337
sg3399
(dp24338
sg9180
(dp24339
sg5271
(dp24340
ssg1410
(dp24341
VAgents Causing Muscle Toxicity
p24342
(dp24343
sg13750
(dp24344
sVOtologicals
p24345
(dp24346
sVCytochrome P-450 CYP3A Substrates
p24347
(dp24348
sVStomatological Preparations
p24349
(dp24350
sVSteroids, Fluorinated
p24351
(dp24352
sVVasoprotectives
p24353
(dp24354
sVHormones
p24355
(dp24356
sVEnzyme Inhibitors
p24357
(dp24358
sVCorticosteroids for Systemic Use
p24359
(dp24360
sVDrugs for Obstructive Airway Diseases
p24361
(dp24362
sVHyperglycemia-Associated Agents
p24363
(dp24364
sVCorticosteroids for Systemic Use, Plain
p24365
(dp24366
sVCorticosteroids, Dermatological Preparations
p24367
(dp24368
sg1614
(dp24369
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p24370
(dp24371
sVGlucocorticoids
p24372
g21928
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24373
(dp24374
sVCorticosteroids for Local Oral Treatment
p24375
(dp24376
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p24377
g16812
sVFused-Ring Compounds
p24378
g14871
sVCytochrome P-450 CYP3A4 Inducers
p24379
g18959
sVImmunologic Factors
p24380
(dp24381
sVCytochrome P-450 CYP3A5 Inducers
p24382
(dp24383
sVAdrenal Cortex Hormones
p24384
(dp24385
sVAdrenals
p24386
(dp24387
sVPregnadienes
p24388
(dp24389
sVDermatologicals
p24390
g17302
sVCytochrome P-450 Enzyme Inducers
p24391
(dp24392
sVCytochrome P-450 CYP3A Inducers
p24393
(dp24394
sVCytochrome P-450 CYP3A4 Substrates
p24395
(dp24396
sVAlimentary Tract and Metabolism
p24397
g23900
sVNasal Preparations
p24398
(dp24399
sVPregnanes
p24400
(dp24401
sVAgents to Treat Airway Disease
p24402
(dp24403
sVOphthalmologicals
p24404
(dp24405
sVSteroids
p24406
(dp24407
sVCorticosteroids, Moderately Potent (Group II)
p24408
(dp24409
sVProtein-Lysine 6-Oxidase, antagonists & inhibitors
p24410
g13751
sVImmunosuppressive Agents
p24411
(dp24412
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p24413
(dp24414
sVAnti-Inflammatory Agents
p24415
(dp24416
sVCorticosteroid Hormone Receptor Agonists
p24417
(dp24418
sg6345
(dp24419
sVHormones, Hormone Substitutes, and Hormone Antagonists
p24420
(dp24421
sVCorticosteroids
p24422
(dp24423
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p24424
(dp24425
sVSensory Organs
p24426
(dp24427
ssg1413
(dp24428
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p24429
(dp24430
sVCentral Nervous System Depressants
p24431
(dp24432
sVHeterocyclic Compounds, Fused-Ring
p24433
(dp24434
sVOpioids
p24435
(dp24436
sVOpioid Agonist
p24437
(dp24438
sVAnalgesics
p24439
(dp24440
sVOpiate Alkaloids
p24441
(dp24442
sVCentral Nervous System Agents
p24443
(dp24444
sVAlkaloids
p24445
g19431
sVSensory System Agents
p24446
(dp24447
sVPhenanthrenes
p24448
(dp24449
sVMorphinans
p24450
(dp24451
sVNarcotics
p24452
(dp24453
sVPeripheral Nervous System Agents
p24454
(dp24455
ssg1416
(dp24456
g630
g17996
sg2199
(dp24457
sg9393
(dp24458
sg9924
(dp24459
sg6186
(dp24460
sg11793
(dp24461
sg8580
(dp24462
sg8964
(dp24463
sg1803
(dp24464
sg4035
(dp24465
sg6318
(dp24466
sg8163
(dp24467
sg11979
(dp24468
sg183
g13764
sg1434
(dp24469
sg6570
(dp24470
sg11790
(dp24471
sg10308
(dp24472
sg11022
(dp24473
sg1626
(dp24474
sg3885
(dp24475
sg11265
(dp24476
sg7272
(dp24477
sg1260
g23131
sg3684
(dp24478
sg687
g18528
sg9099
(dp24479
sg8433
(dp24480
sg11277
(dp24481
sg9402
(dp24482
sg10713
(dp24483
sg5133
(dp24484
sg3975
(dp24485
sg10350
(dp24486
sg8097
(dp24487
sg9417
(dp24488
sg2427
(dp24489
sg10521
(dp24490
sg8277
(dp24491
sg10593
(dp24492
sg2841
(dp24493
sg7896
(dp24494
sg7941
(dp24495
sg945
g20876
sg9918
(dp24496
sg1908
(dp24497
sg10854
(dp24498
sg7299
(dp24499
sg7959
(dp24500
sg6303
(dp24501
sg570
g17463
sg8778
(dp24502
sg696
g18680
sg8874
(dp24503
sg4155
(dp24504
sg6687
(dp24505
sg5169
(dp24506
sg11352
(dp24507
sg387
g15586
sg10497
(dp24508
sg5067
(dp24509
sg495
g16696
sg2664
(dp24510
sg10815
(dp24511
sg9828
(dp24512
sg7041
(dp24513
ssg1419
(dp24514
g8265
(dp24515
ssg1422
(dp24516
g8655
(dp24517
sg8472
(dp24518
sg2832
(dp24519
sg12274
(dp24520
sg5433
(dp24521
ssg1425
(dp24522
VCytochrome P-450 CYP2D6 Inhibitors
p24523
(dp24524
sVCytochrome P-450 CYP2D6 Substrates
p24525
(dp24526
sVCytochrome P-450 CYP3A Substrates
p24527
(dp24528
sVNeurotransmitter Agents
p24529
(dp24530
sVCentral Nervous System Agents
p24531
(dp24532
sVDopamine Agents
p24533
g14225
sVPsychotropic Drugs
p24534
(dp24535
sVCytochrome P-450 CYP2B6 Substrates
p24536
(dp24537
sVCytochrome P-450 Enzyme Inhibitors
p24538
(dp24539
sVCytochrome P-450 CYP2C8 Substrates
p24540
(dp24541
sVCytochrome P-450 CYP1A2 Substrates
p24542
(dp24543
sVPhenothiazines With Piperazine Structure
p24544
(dp24545
sVAntipsychotic Agents
p24546
(dp24547
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24548
(dp24549
sVSulfur Compounds
p24550
(dp24551
sVDopamine Antagonists
p24552
(dp24553
sVCentral Nervous System Depressants
p24554
(dp24555
sVCytochrome P-450 CYP2C18 Substrates
p24556
g20927
sVCytochrome P-450 CYP2C9 Substrates
p24557
(dp24558
sVAntipsychotic Agents (First Generation [Typical])
p24559
(dp24560
sVCytochrome P-450 CYP3A4 Substrates
p24561
(dp24562
sVDopamine D2 Receptor Antagonists
p24563
(dp24564
sVHeterocyclic Compounds, Fused-Ring
p24565
(dp24566
sVPsycholeptics
p24567
(dp24568
sVPhenothiazines
p24569
(dp24570
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p24571
(dp24572
sVNeurotoxic agents
p24573
(dp24574
sVNervous System
p24575
(dp24576
sVTranquilizing Agents
p24577
(dp24578
ssg1428
(dp24579
g2346
(dp24580
sg2196
(dp24581
sg1473
(dp24582
sg9249
(dp24583
sg5817
(dp24584
sg2211
(dp24585
sg456
g16389
sg2034
(dp24586
sg8625
(dp24587
sg10389
(dp24588
sg10899
(dp24589
sg78
g12834
sg9591
(dp24590
sg840
g20016
sg2829
(dp24591
sg9231
(dp24592
sg3546
(dp24593
sg10752
(dp24594
sg1140
g22428
sg10179
(dp24595
sg9834
(dp24596
sg5127
(dp24597
sg2493
(dp24598
sg9273
(dp24599
sg16906
(dp24600
sg1098
g22015
sg1371
g24074
sg11913
(dp24601
sg5646
(dp24602
sg9084
(dp24603
sg621
g17944
sg9105
(dp24604
ssg1431
(dp24605
g11097
(dp24606
sg11931
(dp24607
ssg1434
(dp24608
g4194
(dp24609
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p24610
(dp24611
sVCytochrome P-450 CYP3A4 Inhibitors
p24612
(dp24613
sVAnticholinergic Agents
p24614
g24469
sVCytochrome P-450 CYP2D6 Inhibitors
p24615
(dp24616
sVCytochrome P-450 CYP2D6 Substrates
p24617
(dp24618
sg5424
(dp24619
sVSerotonin Agents
p24620
(dp24621
sVAnalgesics
p24622
(dp24623
sVNarcotics
p24624
(dp24625
sVOpiate Agonists
p24626
(dp24627
sVCentral Nervous System Agents
p24628
(dp24629
sVThyroxine-binding globulin inducers
p24630
(dp24631
sVCytochrome P-450 CYP2B6 Substrates
p24632
(dp24633
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p24634
(dp24635
sVCytochrome P-450 Enzyme Inhibitors
p24636
(dp24637
sVDrugs Used in Addictive Disorders
p24638
(dp24639
sVPeripheral Nervous System Agents
p24640
(dp24641
sVDrugs that are Mainly Renally Excreted
p24642
(dp24643
sVCytochrome P-450 CYP2C8 Substrates
p24644
(dp24645
sVCytochrome P-450 CYP1A2 Substrates
p24646
(dp24647
sVRespiratory System Agents
p24648
(dp24649
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24650
(dp24651
sVCytochrome P-450 CYP2C9 Substrates
p24652
(dp24653
sVQTc Prolonging Agents
p24654
(dp24655
sVCytochrome P-450 CYP3A4 Inducers
p24656
g18963
sVCytochrome P-450 CYP3A Substrates
p24657
(dp24658
sVDrugs Used in Opioid Dependence
p24659
g17932
sVCytochrome P-450 CYP2C19 Substrates
p24660
(dp24661
sVCentral Nervous System Depressants
p24662
(dp24663
sVOpioids
p24664
(dp24665
sg8685
(dp24666
sVCytochrome P-450 Enzyme Inducers
p24667
(dp24668
sVCytochrome P-450 CYP3A Inducers
p24669
(dp24670
sVCytochrome P-450 CYP2C18 Substrates
p24671
g20930
sVSensory System Agents
p24672
(dp24673
sVCytochrome P-450 CYP3A4 Substrates
p24674
(dp24675
sVModerate Risk QTc-Prolonging Agents
p24676
(dp24677
sVNicotinic Antagonists
p24678
(dp24679
sVCytochrome P-450 CYP3A5 Substrates
p24680
(dp24681
sVSerotonin Modulators
p24682
(dp24683
sVAntidepressive Agents
p24684
g15566
sg3003
(dp24685
sVCytochrome P-450 CYP3A Inhibitors
p24686
(dp24687
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p24688
(dp24689
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p24690
(dp24691
sVP-glycoprotein/ABCB1 Inhibitors
p24692
(dp24693
sg10407
(dp24694
sg6657
(dp24695
sVNervous System
p24696
(dp24697
sVCytochrome P-450 CYP3A7 Substrates
p24698
(dp24699
ssg1437
(dp24700
g8601
(dp24701
ssg1440
(dp24702
g426
g16049
sg12111
(dp24703
sg11910
(dp24704
sg11595
(dp24705
sg915
g20677
sg7389
(dp24706
ssg1443
(dp24707
g345
g15214
ssg1446
(dp24708
g4200
(dp24709
ssg1449
(dp24710
g14791
(dp24711
sg6639
(dp24712
sg546
g17165
sg6261
(dp24713
sg6819
(dp24714
sg5487
(dp24715
sg5877
(dp24716
sg1434
g24639
sg9588
(dp24717
sg9960
(dp24718
sg8832
(dp24719
ssg1452
(dp24720
g3636
(dp24721
sVDrugs for Obstructive Airway Diseases
p24722
(dp24723
sVMast Cell Stabilizers
p24724
(dp24725
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p24726
(dp24727
sVRespiratory System Agents
p24728
(dp24729
sVAdrenergics, Inhalants
p24730
(dp24731
sVDecongestants and Antiallergics
p24732
(dp24733
sVDermatologicals
p24734
g17309
sVPyrans
p24735
(dp24736
sVAnti-Asthmatic Agents
p24737
(dp24738
sVAlimentary Tract and Metabolism
p24739
g23909
sVNasal Preparations
p24740
(dp24741
sVHeterocyclic Compounds, Fused-Ring
p24742
(dp24743
sVOphthalmologicals
p24744
(dp24745
sg8538
(dp24746
sVDecreased Histamine Release
p24747
(dp24748
sVAnti-Allergic Agents
p24749
(dp24750
sg4779
(dp24751
sg3810
(dp24752
sVAntiallergic Agents, Excl. Corticosteroids
p24753
(dp24754
sVBenzopyrans
p24755
(dp24756
sVIntestinal Antiinflammatory Agents
p24757
(dp24758
sVSensory Organs
p24759
(dp24760
ssg1455
(dp24761
g11541
(dp24762
sg9726
(dp24763
sg5685
(dp24764
sg8850
(dp24765
sg11229
(dp24766
sg7188
(dp24767
sg2481
(dp24768
sg11523
(dp24769
sg1110
g22148
sg7155
(dp24770
sg15016
(dp24771
ssg1458
(dp24772
g690
g18627
sg7377
(dp24773
sg4920
(dp24774
sg2838
(dp24775
sg8721
(dp24776
sg4479
(dp24777
sg2895
(dp24778
sg1899
(dp24779
sg3912
(dp24780
sg11940
(dp24781
sg4539
(dp24782
sg8820
(dp24783
sg9432
(dp24784
sg2832
(dp24785
sg102
g13003
sg8724
(dp24786
sg3021
(dp24787
sg816
g19650
sg11385
(dp24788
ssg1461
(dp24789
VAnticoagulants
p24790
(dp24791
sVCytochrome P-450 CYP3A Substrates
p24792
(dp24793
sVCompounds used in a research, industrial, or household setting
p24794
(dp24795
sVPesticides
p24796
(dp24797
sVCytochrome P-450 CYP2C9 Inducers
p24798
g20039
sVAgrochemicals
p24799
(dp24800
sVDrugs that are Mainly Renally Excreted
p24801
(dp24802
sVCytochrome P-450 CYP2C8 Substrates
p24803
(dp24804
sVCytochrome P-450 CYP1A2 Substrates
p24805
(dp24806
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p24807
g23108
sg8058
(dp24808
sVCytochrome P-450 CYP3A4 Inducers (weak)
p24809
g19507
sVCytochrome P-450 Enzyme Inhibitors
p24810
(dp24811
sg6072
(dp24812
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24813
(dp24814
sVCytochrome P-450 CYP2C9 Substrates
p24815
(dp24816
sg5538
(dp24817
sVCytochrome P-450 CYP3A4 Inducers
p24818
g18966
sVCytochrome P-450 CYP2C19 Substrates
p24819
(dp24820
sVBlood and Blood Forming Organs
p24821
(dp24822
sVCytochrome P-450 CYP2C8 Inhibitors
p24823
(dp24824
sg10371
(dp24825
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p24826
(dp24827
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p24828
(dp24829
sVCytochrome P-450 Enzyme Inducers
p24830
(dp24831
sVCytochrome P-450 CYP3A Inducers
p24832
(dp24833
sVCytochrome P-450 CYP2C18 Substrates
p24834
g20932
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p24835
(dp24836
sVCytochrome P-450 CYP2C19 Inhibitors
p24837
(dp24838
sVCytochrome P-450 CYP3A4 Substrates
p24839
(dp24840
sVCytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index
p24841
(dp24842
sVNarrow Therapeutic Index Drugs
p24843
(dp24844
sVToxic Actions
p24845
(dp24846
sVHematologic Agents
p24847
(dp24848
sVHeterocyclic Compounds, Fused-Ring
p24849
(dp24850
sg4158
(dp24851
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p24852
(dp24853
sg189
g13881
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p24854
(dp24855
sVPyrans
p24856
(dp24857
ssg1464
(dp24858
VHeterocyclic Compounds, Fused-Ring
p24859
(dp24860
sVHistamine H1 Antagonists
p24861
(dp24862
sVSensory Organs
p24863
(dp24864
sVNeurotransmitter Agents
p24865
(dp24866
sVAnti-Allergic Agents
p24867
(dp24868
sVHistamine Agents
p24869
(dp24870
sVDecongestants and Antiallergics
p24871
(dp24872
sVHistamine Antagonists
p24873
(dp24874
sVQTc Prolonging Agents
p24875
(dp24876
sVOphthalmologicals
p24877
(dp24878
sVHistamine H1 Inhibitors
p24879
(dp24880
sVModerate Risk QTc-Prolonging Agents
p24881
(dp24882
ssg1467
(dp24883
g7191
(dp24884
sg5289
(dp24885
ssg1470
(dp24886
VSteroids
p24887
(dp24888
sVSex Hormones and Modulators of the Genital System
p24889
g19603
sVCytochrome P-450 CYP3A Substrates
p24890
(dp24891
sVProgestogens and Estrogens, Sequential Preparations
p24892
(dp24893
sVHormones
p24894
(dp24895
sVContraceptive Agents, Male
p24896
(dp24897
sVHormonal Contraceptives for Systemic Use
p24898
(dp24899
sVDrugs that are Mainly Renally Excreted
p24900
(dp24901
sVContraceptive Agents, Female
p24902
(dp24903
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24904
(dp24905
sVContraceptives, Oral
p24906
(dp24907
sVFused-Ring Compounds
p24908
g14877
sVHyperglycemia-Associated Agents
p24909
(dp24910
sVAntineoplastic Agents
p24911
(dp24912
sVAdrenal Cortex Hormones
p24913
(dp24914
sVReproductive Control Agents
p24915
g18845
sVProgestins
p24916
(dp24917
sVCombination Contraceptives (with Estrogen and derivatives)
p24918
(dp24919
sVAntineoplastic Agents, Hormonal
p24920
(dp24921
sVProgestin Contraceptives
p24922
(dp24923
sVCytochrome P-450 CYP3A4 Substrates
p24924
(dp24925
sVGonadal Hormones
p24926
(dp24927
sVHormone Antagonists
p24928
g24268
sVPregnadien Derivatives
p24929
(dp24930
sVGenito Urinary System and Sex Hormones
p24931
(dp24932
sVGonadal Steroid Hormones
p24933
(dp24934
sVTestosterone Congeners
p24935
(dp24936
sVEstranes
p24937
(dp24938
sVHormones, Hormone Substitutes, and Hormone Antagonists
p24939
(dp24940
sVEstrenes
p24941
(dp24942
ssg1473
(dp24943
VUGT1A1 Substrates
p24944
g12286
sVCytochrome P-450 CYP3A Substrates
p24945
(dp24946
sVKinase Inhibitor
p24947
g24582
sVOATP1B1/SLCO1B1 Inhibitors
p24948
(dp24949
sVEnzyme Inhibitors
p24950
(dp24951
sVCytochrome P-450 CYP1A2 Substrates
p24952
(dp24953
sVHeterocyclic Compounds, Fused-Ring
p24954
(dp24955
sVTyrosine Kinase Inhibitors
p24956
(dp24957
sVAcids, Carbocyclic
p24958
(dp24959
sVAmides
p24960
(dp24961
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p24962
(dp24963
sg11676
(dp24964
sVAntineoplastic Agents
p24965
(dp24966
sVCytochrome P-450 CYP2C19 Substrates
p24967
(dp24968
sVBenzene Derivatives
p24969
(dp24970
sVP-glycoprotein/ABCB1 Substrates
p24971
(dp24972
sVReceptor Tyrosine Kinase Inhibitors
p24973
(dp24974
sg8121
(dp24975
sVProtein Kinase Inhibitors
p24976
(dp24977
sVCytochrome P-450 CYP3A4 Substrates
p24978
(dp24979
sg369
g15375
sVCytochrome P-450 CYP3A5 Substrates
p24980
(dp24981
sg2148
(dp24982
sg2712
(dp24983
sVAntineoplastic and Immunomodulating Agents
p24984
(dp24985
ssg1476
(dp24986
g10977
(dp24987
sg9009
(dp24988
sg3072
(dp24989
sg3408
(dp24990
sg7596
(dp24991
ssg1479
(dp24992
g9588
(dp24993
sg8742
(dp24994
ssg1482
(dp24995
VAmino Acids, Peptides, and Proteins
p24996
(dp24997
sVAntiinfectives for Systemic Use
p24998
(dp24999
sVAntibodies
p25000
(dp25001
sVSpecific Immunoglobulins
p25002
(dp25003
sg11073
(dp25004
sVProteins
p25005
(dp25006
sg4797
(dp25007
sVImmunoglobulins
p25008
(dp25009
sVImmunoglobulin Isotypes
p25010
(dp25011
sVImmune Sera and Immunoglobulins
p25012
(dp25013
sVSerum
p25014
(dp25015
sVSerum Globulins
p25016
(dp25017
sVImmunoglobulin G
p25018
(dp25019
sg5775
(dp25020
sg4128
(dp25021
sg2016
(dp25022
sVBlood Proteins
p25023
(dp25024
sVGlobulins
p25025
g19175
sVImmunoproteins
p25026
(dp25027
ssg1485
(dp25028
g7221
(dp25029
sg4935
(dp25030
ssg1488
(dp25031
g8421
(dp25032
sg7272
(dp25033
sg9822
(dp25034
sg7734
(dp25035
sg183
g13806
sg888
g20439
sg4287
(dp25036
sg4155
(dp25037
sg7335
(dp25038
ssg1491
(dp25039
g5211
(dp25040
sVCytochrome P-450 CYP2D6 Inhibitors
p25041
(dp25042
sVCytochrome P-450 CYP2D6 Substrates
p25043
(dp25044
sVAntiarrhythmic agents
p25045
(dp25046
sVCytochrome P-450 CYP3A Substrates
p25047
(dp25048
sVCentral Nervous System Agents
p25049
(dp25050
sVAnesthetics, Local
p25051
(dp25052
sVAnilides
p25053
(dp25054
sVOtologicals
p25055
(dp25056
sVLocal Anesthesia
p25057
g14964
sVCytochrome P-450 Enzyme Inhibitors
p25058
(dp25059
sVThroat Preparations
p25060
(dp25061
sVPeripheral Nervous System Agents
p25062
(dp25063
sVCytochrome P-450 CYP2C8 Substrates
p25064
(dp25065
sVCytochrome P-450 CYP1A2 Substrates
p25066
(dp25067
sVAmines
p25068
(dp25069
sVAntipruritics and Local Anesthetics
p25070
(dp25071
sVCardiac Therapy
p25072
(dp25073
sVAmides
p25074
(dp25075
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p25076
g16830
sVAniline Compounds
p25077
g23427
sVVasoprotectives
p25078
(dp25079
sVCytochrome P-450 CYP2C9 Substrates
p25080
(dp25081
sVCardiovascular Agents
p25082
(dp25083
sVAnesthetics
p25084
(dp25085
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25086
(dp25087
sVAgents that reduce seizure threshold
p25088
(dp25089
sVCytochrome P-450 CYP1A2 Inhibitors
p25090
g15013
sVDermatologicals
p25091
g17312
sVAnesthetics for Topical Use
p25092
(dp25093
sVCytochrome P-450 CYP2A6 Substrates
p25094
(dp25095
sVCytochrome P-450 CYP2C18 Substrates
p25096
g20935
sVMembrane Transport Modulators
p25097
(dp25098
sVNeuraxial Anesthetics
p25099
(dp25100
sVCytochrome P-450 CYP3A4 Substrates
p25101
(dp25102
sVSodium Channel Blockers
p25103
(dp25104
sVOphthalmologicals
p25105
(dp25106
sg10086
(dp25107
sVVoltage-Gated Sodium Channel Blockers
p25108
(dp25109
sVCytochrome P-450 CYP3A5 Substrates
p25110
(dp25111
sVAmide Local Anesthetic
p25112
(dp25113
sVMethemoglobinemia Associated Agents
p25114
(dp25115
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p25116
(dp25117
sVP-glycoprotein/ABCB1 Inhibitors
p25118
(dp25119
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p25120
(dp25121
sg5355
(dp25122
sVSensory System Agents
p25123
(dp25124
sVNervous System
p25125
(dp25126
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p25127
(dp25128
sVCytochrome P-450 CYP3A7 Substrates
p25129
(dp25130
sVCytochrome P-450 CYP2B6 Substrates
p25131
(dp25132
ssg1494
(dp25133
g4017
(dp25134
ssg1497
(dp25135
g3000
(dp25136
ssg1500
(dp25137
g10017
(dp25138
sg4653
(dp25139
sg8418
(dp25140
sg7272
(dp25141
sg7668
(dp25142
sg9198
(dp25143
sg507
g16793
sg849
g20106
sg10494
(dp25144
sg5133
(dp25145
sg6045
(dp25146
sg9966
(dp25147
sg12534
(dp25148
sg6024
(dp25149
sg1140
g22393
sg8298
(dp25150
sg4155
(dp25151
sg10209
(dp25152
sg3432
(dp25153
sg4164
(dp25154
sg183
g13812
sg5589
(dp25155
ssg1503
(dp25156
VCytochrome P-450 CYP3A4 Inhibitors
p25157
(dp25158
sVCytochrome P-450 CYP3A Substrates
p25159
(dp25160
sVAntifungal Agents
p25161
(dp25162
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p25163
(dp25164
sVPotential QTc-Prolonging Agents
p25165
(dp25166
sVEnzyme Inhibitors
p25167
(dp25168
sVCytochrome P-450 Enzyme Inhibitors
p25169
(dp25170
sVAnti-Infective Agents
p25171
(dp25172
sVAntiinfectives for Systemic Use
p25173
(dp25174
sg6669
(dp25175
sVAzole Antifungals
p25176
g20190
sVSteroid Synthesis Inhibitors
p25177
(dp25178
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25179
(dp25180
sVAntiprotozoals
p25181
(dp25182
sVQTc Prolonging Agents
p25183
(dp25184
sVP-glycoprotein/ABCB1 Substrates
p25185
(dp25186
sVAntiparasitic Agents
p25187
(dp25188
sVCytochrome P-450 CYP3A Inhibitors (strong)
p25189
g13404
sVCytochrome P-450 CYP3A4 Substrates
p25190
(dp25191
sVTriazole Derivatives
p25192
(dp25193
sVHormone Antagonists
p25194
g24275
sVAntimycotics for Systemic Use
p25195
(dp25196
sV14-alpha Demethylase Inhibitors
p25197
(dp25198
sVCytochrome P-450 CYP3A Inhibitors
p25199
(dp25200
sVP-glycoprotein/ABCB1 Inhibitors
p25201
(dp25202
sVHormones, Hormone Substitutes, and Hormone Antagonists
p25203
(dp25204
sVChemically-Induced Disorders
p25205
g21239
ssg1506
(dp25206
g219
g14091
sg1659
(dp25207
sg2598
(dp25208
sg6981
(dp25209
sg9033
(dp25210
sg10950
(dp25211
ssg1509
(dp25212
g78
g12857
ssg1512
(dp25213
g4440
(dp25214
ssg1515
(dp25215
g7554
(dp25216
ssg1518
(dp25217
g11541
(dp25218
sg9726
(dp25219
sg5685
(dp25220
sg8850
(dp25221
sg11229
(dp25222
sg2481
(dp25223
sg1110
g22125
sg7155
(dp25224
sg15016
(dp25225
ssg1521
(dp25226
g7458
(dp25227
sg3858
(dp25228
sg4077
(dp25229
sg2943
(dp25230
sg9081
(dp25231
sg6537
(dp25232
sg6033
(dp25233
ssg1524
(dp25234
g11820
(dp25235
sg4650
(dp25236
sg4926
(dp25237
sg10797
(dp25238
ssg1527
(dp25239
VAntiinfectives for Systemic Use
p25240
(dp25241
sVDrugs that are Mainly Renally Excreted
p25242
(dp25243
sVGlycosides
p25244
(dp25245
sVAntivirals for Systemic Use
p25246
(dp25247
sVDeoxyribonucleosides
p25248
(dp25249
sVNucleosides
p25250
(dp25251
sVNucleic Acid Synthesis Inhibitors
p25252
(dp25253
sVNucleoside Reverse Transcriptase Inhibitors
p25254
(dp25255
sVNucleic Acids, Nucleotides, and Nucleosides
p25256
(dp25257
sVCarbohydrates
p25258
(dp25259
sVAnti-Infective Agents
p25260
(dp25261
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p25262
g14469
sVAntiviral Agents
p25263
(dp25264
sVDirect Acting Antivirals
p25265
(dp25266
sVUGT1A1 Substrates
p25267
g12315
sVAnti-HIV Agents
p25268
(dp25269
sVEnzyme Inhibitors
p25270
(dp25271
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p25272
(dp25273
sVReverse Transcriptase Inhibitors
p25274
(dp25275
sVAnti-Retroviral Agents
p25276
(dp25277
ssg1530
(dp25278
g2676
(dp25279
sg9153
(dp25280
ssg1533
(dp25281
g1875
(dp25282
sg657
g18343
sg10554
(dp25283
sg9561
(dp25284
ssg1536
(dp25285
g4173
(dp25286
ssg1539
(dp25287
VAntiinfectives for Systemic Use
p25288
(dp25289
sVQTc Prolonging Agents
p25290
(dp25291
sVAnti-Infective Agents
p25292
(dp25293
sVP-glycoprotein/ABCB1 Inhibitors
p25294
(dp25295
sVOphthalmologicals
p25296
(dp25297
sVCytochrome P-450 CYP3A Substrates
p25298
(dp25299
sVPolyketides
p25300
(dp25301
sVP-glycoprotein/ABCB1 Substrates
p25302
(dp25303
sVLactones
p25304
(dp25305
sVMacrolide Antimicrobial
p25306
(dp25307
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p25308
(dp25309
sVMacrolides, Lincosamides and Streptogramins
p25310
(dp25311
sVAnti-Bacterial Agents
p25312
(dp25313
sVAntibacterials for Systemic Use
p25314
(dp25315
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25316
(dp25317
sVCytochrome P-450 CYP3A4 Substrates
p25318
(dp25319
sVCytochrome P-450 CYP2A6 Inhibitors
p25320
(dp25321
sVMacrolides
p25322
g16910
sVModerate Risk QTc-Prolonging Agents
p25323
(dp25324
ssg1542
(dp25325
g9324
(dp25326
ssg1545
(dp25327
g10263
(dp25328
sg10629
(dp25329
sg5619
(dp25330
sg12114
(dp25331
sg5229
(dp25332
sg8166
(dp25333
sg3426
(dp25334
sg5007
(dp25335
sg9009
(dp25336
sg7344
(dp25337
sg12060
(dp25338
sg9783
(dp25339
sg7740
(dp25340
sg6000
(dp25341
sg2835
(dp25342
sg6291
(dp25343
sg3072
(dp25344
sg8226
(dp25345
sg7077
(dp25346
sg195
g13917
sg7596
(dp25347
sg5199
(dp25348
sg5595
(dp25349
sg213
g14065
ssg1548
(dp25350
VAntiarrhythmic agents
p25351
(dp25352
sVCytochrome P-450 CYP3A Substrates
p25353
(dp25354
sVAgents causing hyperkalemia
p25355
(dp25356
sVHypotensive Agents
p25357
(dp25358
sVBeta blocking agents and calcium channel blockers
p25359
(dp25360
sVAdrenergic Antagonists
p25361
(dp25362
sVPeripheral Nervous System Agents
p25363
(dp25364
sVSympatholytics
p25365
(dp25366
sVDrugs that are Mainly Renally Excreted
p25367
(dp25368
sVAmines
p25369
(dp25370
sVAdrenergic beta-1 Receptor Antagonists
p25371
(dp25372
sVAntihypertensive Agents
p25373
g20319
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25374
(dp25375
sVBeta Blocking Agents, Selective
p25376
(dp25377
sVAdrenergic Agents
p25378
(dp25379
sVNeurotransmitter Agents
p25380
(dp25381
sVCardiovascular Agents
p25382
(dp25383
sVP-glycoprotein/ABCB1 Substrates
p25384
(dp25385
sVAdrenergic beta-Antagonists
p25386
g15363
sVPhenoxypropanolamines
p25387
g20862
sVCytochrome P-450 CYP3A4 Substrates
p25388
(dp25389
sVPropanolamines
p25390
(dp25391
sVAutonomic Agents
p25392
(dp25393
sVBeta Blocking Agents and Thiazides
p25394
(dp25395
sVAmino Alcohols
p25396
(dp25397
sVBradycardia-Causing Agents
p25398
(dp25399
sVPropanols
p25400
(dp25401
sVP-glycoprotein/ABCB1 Inhibitors
p25402
(dp25403
sVBeta-Blockers (Beta1 Selective)
p25404
(dp25405
sVAlcohols
p25406
(dp25407
sVBeta Blocking Agents, Selective, and Thiazides
p25408
(dp25409
ssg1551
(dp25410
g8670
(dp25411
sg11832
(dp25412
sg3333
(dp25413
sg5577
(dp25414
sg7971
(dp25415
sg357
g15326
sg7977
(dp25416
sg3183
(dp25417
sg8274
(dp25418
sg9540
(dp25419
sg5382
(dp25420
sg10002
(dp25421
sg11718
(dp25422
sg5073
(dp25423
sg9267
(dp25424
sg3495
(dp25425
sg372
g15403
ssg1554
(dp25426
g5574
(dp25427
sg10164
(dp25428
sg5934
(dp25429
sg9486
(dp25430
sg7641
(dp25431
sg10383
(dp25432
sg4656
(dp25433
ssg1557
(dp25434
g318
g14900
sg12051
(dp25435
ssg1560
(dp25436
g11370
(dp25437
sg9324
(dp25438
sg5229
(dp25439
sg12421
g12487
sg129
g13196
sg11916
(dp25440
sg11811
(dp25441
sg600
g17735
sg1812
(dp25442
sg9996
(dp25443
sg11619
(dp25444
sg5457
(dp25445
sg4650
(dp25446
sg1869
(dp25447
sg5256
(dp25448
sg8241
(dp25449
sg5025
(dp25450
sg7884
(dp25451
sg9198
(dp25452
sg4341
(dp25453
sg10797
(dp25454
sg891
g20561
sg2058
(dp25455
sg2418
(dp25456
sg78
g12873
sg6939
(dp25457
sg6435
(dp25458
sg7329
(dp25459
sg8454
(dp25460
sg9588
(dp25461
sg3000
(dp25462
sg5511
(dp25463
sg11820
(dp25464
sg9810
(dp25465
sg10728
(dp25466
sg4707
(dp25467
sg4467
(dp25468
sg1401
g24326
sg1890
(dp25469
sg2460
(dp25470
sg7317
(dp25471
sg12060
(dp25472
sg4926
(dp25473
sg2115
(dp25474
sg8583
(dp25475
sg351
g15257
sg10977
(dp25476
sg3408
(dp25477
sg9702
(dp25478
sg8493
(dp25479
sg11826
(dp25480
sg7065
(dp25481
sg14338
g13526
sg4959
(dp25482
sg6999
(dp25483
sg10290
(dp25484
sg12111
(dp25485
sg10794
(dp25486
sg11751
(dp25487
sg7947
(dp25488
sg9660
(dp25489
sg6048
(dp25490
sg11196
(dp25491
sg9462
(dp25492
sg195
g13897
sg7197
(dp25493
sg8742
(dp25494
sg5595
(dp25495
sg3825
(dp25496
sg11385
(dp25497
ssg1563
(dp25498
VAmino Acids, Peptides, and Proteins
p25499
(dp25500
sVGlobulins
p25501
g19196
sVAntibodies
p25502
(dp25503
sVAntibodies, Monoclonal
p25504
(dp25505
sVHER2 Receptor Antagonist
p25506
(dp25507
sVAntineoplastic Agents, Immunological
p25508
(dp25509
sVImmunoglobulins
p25510
(dp25511
sVProteins
p25512
(dp25513
sg8802
(dp25514
sVSerum Globulins
p25515
(dp25516
sVAntineoplastic and Immunomodulating Agents
p25517
(dp25518
sVBlood Proteins
p25519
(dp25520
sVHER2/Neu/cerbB2 Antagonists
p25521
(dp25522
sg744
g19154
sVAntineoplastic Agents
p25523
(dp25524
sVImmunoproteins
p25525
(dp25526
ssg1566
(dp25527
g10017
(dp25528
sg849
g20114
sg1656
(dp25529
sg8418
(dp25530
sg4653
(dp25531
sg7272
(dp25532
sg7668
(dp25533
sg9198
(dp25534
sg507
g16801
sg888
g20515
sg10494
(dp25535
sg5133
(dp25536
sg6045
(dp25537
sg9966
(dp25538
sg12534
(dp25539
sg4911
(dp25540
sg8472
(dp25541
sg6024
(dp25542
sg1140
g22436
sg8298
(dp25543
sg4155
(dp25544
sg10209
(dp25545
sg3432
(dp25546
sg4164
(dp25547
sg183
g13860
sg6333
(dp25548
sg5589
(dp25549
sg12123
(dp25550
sg11385
(dp25551
ssg1569
(dp25552
g4806
(dp25553
sg7053
(dp25554
sg7464
(dp25555
sg10818
(dp25556
sg4635
(dp25557
sg5256
(dp25558
sg7428
(dp25559
sg2763
(dp25560
sg4830
(dp25561
sg4401
(dp25562
sg183
g13862
sg3318
(dp25563
sg8421
(dp25564
sg2658
(dp25565
sg3516
(dp25566
sg1491
g25115
sg5970
(dp25567
sg7335
(dp25568
sg7707
(dp25569
sg2088
(dp25570
sg6906
(dp25571
sg10728
(dp25572
sg3447
(dp25573
sg6765
(dp25574
sg5316
(dp25575
sg2391
(dp25576
sg7569
(dp25577
sg3651
(dp25578
sg2667
(dp25579
sg4596
(dp25580
sg2688
(dp25581
sg4155
(dp25582
sg3222
(dp25583
sg13091
g21432
sg10587
(dp25584
sg2706
(dp25585
sg12126
(dp25586
sg1110
g22137
sg1770
(dp25587
ssg1572
(dp25588
g3018
(dp25589
sg8487
(dp25590
sg9252
(dp25591
sg3156
(dp25592
sg8067
(dp25593
sg11097
(dp25594
sg5247
(dp25595
sg9165
(dp25596
ssg1575
(dp25597
g9897
(dp25598
sg11631
(dp25599
sg8871
(dp25600
ssg1578
(dp25601
VNitrogen Binding Agent
p25602
(dp25603
sVHydroxy Acids
p25604
g18168
sVSalicylic Acid and Derivatives
p25605
(dp25606
sVOAT1/SLC22A6 inhibitors
p25607
(dp25608
sVAnalgesics
p25609
(dp25610
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p25611
(dp25612
sVAntifungal Agents
p25613
(dp25614
sVNon COX-2 selective NSAIDS
p25615
(dp25616
sVCentral Nervous System Agents
p25617
(dp25618
sVSclerosing Solutions
p25619
(dp25620
sVEnzyme Inhibitors
p25621
(dp25622
sVAnti-Infective Agents
p25623
(dp25624
sVPeripheral Nervous System Agents
p25625
(dp25626
sVAnti-Inflammatory Agents
p25627
(dp25628
sVSalicylates
p25629
(dp25630
sVAnalgesics, Non-Narcotic
p25631
(dp25632
sVNephrotoxic agents
p25633
(dp25634
sVAcids, Carbocyclic
p25635
(dp25636
sVAntifungals for Topical Use
p25637
(dp25638
sVSalicylic Acid
p25639
(dp25640
sVCytochrome P-450 CYP2C9 Substrates
p25641
(dp25642
sVAgents causing hyperkalemia
p25643
(dp25644
sVPhenols
p25645
(dp25646
sVBenzene Derivatives
p25647
(dp25648
sVAntifungals for Dermatological Use
p25649
(dp25650
sVDermatologicals
p25651
g17289
sVSensory Organs
p25652
(dp25653
sVAgents that produce hypertension
p25654
(dp25655
sVOphthalmologicals
p25656
(dp25657
sVBenzoates
p25658
(dp25659
sVOAT3/SLC22A8 Inhibitors
p25660
(dp25661
sVHydroxybenzoates
p25662
(dp25663
sVCyclooxygenase Inhibitors
p25664
(dp25665
sVKeratolytic Agents
p25666
(dp25667
sVAnti-Inflammatory Agents, Non-Steroidal
p25668
(dp25669
sVNervous System
p25670
(dp25671
sVSensory System Agents
p25672
(dp25673
ssg1581
(dp25674
g1206
g22857
sg10626
(dp25675
sVVitamins
p25676
g12179
sg9516
(dp25677
sg5442
(dp25678
sVFood and Beverages
p25679
(dp25680
sVPhysiological Phenomena
p25681
g21722
sg12021
(dp25682
sVDrugs that are Mainly Renally Excreted
p25683
(dp25684
sVMicronutrients
p25685
(dp25686
sVFood
p25687
(dp25688
sVBlood and Blood Forming Organs
p25689
(dp25690
sVDiterpenes
p25691
(dp25692
sVTerpenes
p25693
(dp25694
sg7956
(dp25695
sg4545
(dp25696
sg4947
(dp25697
sg7341
(dp25698
sg12102
(dp25699
sVNaphthalenes
p25700
(dp25701
sVGrowth Substances
p25702
(dp25703
sVHematologic Agents
p25704
(dp25705
sg4971
(dp25706
sVDiet, Food, and Nutrition
p25707
g22907
sVHemostatics
p25708
g23067
ssg1584
(dp25709
g4911
(dp25710
sg8421
(dp25711
sg3024
(dp25712
sg7335
(dp25713
ssg1587
(dp25714
g3537
(dp25715
ssg1590
(dp25716
g6150
(dp25717
ssg1593
(dp25718
g4827
(dp25719
sg19588
(dp25720
ssg1596
(dp25721
g1737
(dp25722
ssg1599
(dp25723
g624
g17988
sVMisc. Skin and Mucous Membrane Agents
p25724
(dp25725
sVAdjuvants, Immunologic
p25726
(dp25727
sVHeterocyclic Compounds, Fused-Ring
p25728
(dp25729
sVQuinolines
p25730
(dp25731
sVImmunologic Factors
p25732
(dp25733
sg11418
(dp25734
sVCytochrome P-450 CYP3A Substrates
p25735
(dp25736
sVImmunosuppressive Agents
p25737
(dp25738
sVAminoquinolines
p25739
(dp25740
sVDermatologicals
p25741
g17331
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25742
(dp25743
sg7032
(dp25744
sVCytochrome P-450 CYP3A4 Substrates
p25745
(dp25746
sVAntineoplastic Agents
p25747
(dp25748
ssg1602
(dp25749
g8388
(dp25750
sg6336
(dp25751
sg7170
(dp25752
sg11475
(dp25753
sg2850
(dp25754
ssg1605
(dp25755
VCentrally Acting Antiobesity Products
p25756
(dp25757
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p25758
(dp25759
sVAppetite Depressants
p25760
(dp25761
sVIncreased Sympathetic Activity
p25762
(dp25763
sVAmines
p25764
(dp25765
sVAgents that produce hypertension
p25766
(dp25767
sVCentral Nervous System Depressants
p25768
(dp25769
sVEthylamines
p25770
g20607
sVSympathomimetic Amine Anorectic
p25771
(dp25772
sVSympathomimetics
p25773
(dp25774
sVAgents producing tachycardia
p25775
(dp25776
sVAnti-Obesity Agents
p25777
(dp25778
sVAntiobesity Preparations, Excl. Diet Products
p25779
(dp25780
sVAmphetamines
p25781
(dp25782
sVAppetite Suppression
p25783
(dp25784
sVStimulants
p25785
(dp25786
sVAlimentary Tract and Metabolism
p25787
g23948
ssg1608
(dp25788
g8484
(dp25789
sg8439
(dp25790
ssg1611
(dp25791
VAgents Causing Muscle Toxicity
p25792
(dp25793
sg807
g19592
sg5070
(dp25794
sVCytochrome P-450 CYP3A Substrates
p25795
(dp25796
sVCycloparaffins
p25797
(dp25798
sVAnti-Acne Preparations
p25799
(dp25800
sg3306
(dp25801
sVRetinoids
p25802
(dp25803
sg2214
(dp25804
sVDrugs that are Mainly Renally Excreted
p25805
(dp25806
sVTerpenes
p25807
(dp25808
sg7674
(dp25809
sg1071
g21858
sg9936
(dp25810
sg5496
(dp25811
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25812
(dp25813
sVCyclohexanes
p25814
(dp25815
sg11478
(dp25816
sVDermatologicals
p25817
g17332
sVMisc. Skin and Mucous Membrane Agents
p25818
(dp25819
sVTeratogens
p25820
(dp25821
sg10191
(dp25822
sVCytochrome P-450 CYP3A4 Substrates
p25823
(dp25824
sVNarrow Therapeutic Index Drugs
p25825
(dp25826
sVToxic Actions
p25827
(dp25828
sVAnti-Acne Preparations for Topical Use
p25829
(dp25830
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p25831
(dp25832
sVNoxae
p25833
(dp25834
ssg1614
(dp25835
VAgents Causing Muscle Toxicity
p25836
(dp25837
sVTriamcinolone
p25838
g24369
sVOtologicals
p25839
(dp25840
sVCytochrome P-450 CYP3A Substrates
p25841
(dp25842
sVStomatological Preparations
p25843
(dp25844
sVSteroids, Fluorinated
p25845
(dp25846
sVVasoprotectives
p25847
(dp25848
sVHormones
p25849
(dp25850
sVEnzyme Inhibitors
p25851
(dp25852
sVCorticosteroids for Systemic Use
p25853
(dp25854
sVDrugs for Obstructive Airway Diseases
p25855
(dp25856
sVHyperglycemia-Associated Agents
p25857
(dp25858
sVCorticosteroids for Systemic Use, Plain
p25859
(dp25860
sVCorticosteroids, Dermatological Preparations
p25861
(dp25862
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p25863
(dp25864
sVGlucocorticoids
p25865
g21938
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25866
(dp25867
sVCorticosteroids for Local Oral Treatment
p25868
(dp25869
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p25870
g16826
sVFused-Ring Compounds
p25871
g14836
sVCytochrome P-450 CYP3A4 Inducers
p25872
g18911
sVImmunologic Factors
p25873
(dp25874
sVCytochrome P-450 CYP3A5 Inducers
p25875
(dp25876
sVAdrenal Cortex Hormones
p25877
(dp25878
sVAdrenals
p25879
(dp25880
sVPregnadienes
p25881
(dp25882
sVDermatologicals
p25883
g17235
sVCytochrome P-450 Enzyme Inducers
p25884
(dp25885
sVCytochrome P-450 CYP3A Inducers
p25886
(dp25887
sVCytochrome P-450 CYP3A4 Substrates
p25888
(dp25889
sVAlimentary Tract and Metabolism
p25890
g23916
sVNasal Preparations
p25891
(dp25892
sVPregnanes
p25893
(dp25894
sVAgents to Treat Airway Disease
p25895
(dp25896
sVOphthalmologicals
p25897
(dp25898
sVSteroids
p25899
(dp25900
sVCorticosteroids, Moderately Potent (Group II)
p25901
(dp25902
sVProtein-Lysine 6-Oxidase, antagonists & inhibitors
p25903
g13752
sVImmunosuppressive Agents
p25904
(dp25905
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p25906
(dp25907
sVAnti-Inflammatory Agents
p25908
(dp25909
sVCorticosteroid Hormone Receptor Agonists
p25910
(dp25911
sVTriamcinolone Acetonide
p25912
(dp25913
sVHormones, Hormone Substitutes, and Hormone Antagonists
p25914
(dp25915
sVCorticosteroids
p25916
(dp25917
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p25918
(dp25919
sVSensory Organs
p25920
(dp25921
ssg1617
(dp25922
g19588
(dp25923
ssg1620
(dp25924
g4398
(dp25925
sg8826
(dp25926
ssg1623
(dp25927
g5532
(dp25928
ssg1626
(dp25929
VDrugs for Urinary Frequency and Incontinence
p25930
(dp25931
sVTetrahydroisoquinolines
p25932
(dp25933
sVNeurotransmitter Agents
p25934
(dp25935
sVHeterocyclic Compounds, Fused-Ring
p25936
(dp25937
sVAnticholinergic Agents
p25938
g24474
sVUrologicals
p25939
(dp25940
sVCytochrome P-450 CYP2D6 Substrates
p25941
(dp25942
sVPotential QTc-Prolonging Agents
p25943
(dp25944
sVIsoquinolines
p25945
(dp25946
sVCytochrome P-450 CYP3A Substrates
p25947
(dp25948
sVGenito Urinary System and Sex Hormones
p25949
(dp25950
sVUrological Agents
p25951
(dp25952
sVCholinergic Agents
p25953
(dp25954
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p25955
(dp25956
sVDrugs Used in Benign Prostatic Hypertrophy
p25957
(dp25958
sVAgents producing tachycardia
p25959
(dp25960
sVAgents that produce hypertension
p25961
(dp25962
sVQTc Prolonging Agents
p25963
(dp25964
sVCytochrome P-450 CYP3A4 Substrates
p25965
(dp25966
sVMuscarinic Antagonists
p25967
(dp25968
sVQuinuclidines
p25969
(dp25970
ssg1629
(dp25971
VHydrocarbons, Acyclic
p25972
g19580
sVAlkanesulfonates
p25973
g22881
sVAlkanes
p25974
(dp25975
sVCompounds used in a research, industrial, or household setting
p25976
(dp25977
sVSclerosing Solutions
p25978
(dp25979
sVVasoprotectives
p25980
(dp25981
sVSclerosing Agents for Local Injection
p25982
(dp25983
sVSulfonic Acids
p25984
(dp25985
sVFatty Alcohols
p25986
(dp25987
sVSulfur Compounds
p25988
(dp25989
sVPharmaceutical Preparations
p25990
(dp25991
sVCardiovascular Agents
p25992
(dp25993
sVAcids
p25994
(dp25995
sVSurface-Active Agents
p25996
(dp25997
sVAcids, Noncarboxylic
p25998
(dp25999
sVAlkanesulfonic Acids
p26000
(dp26001
sVSulfur Acids
p26002
(dp26003
sVSolutions
p26004
(dp26005
sVAntivaricose Therapy
p26006
(dp26007
sVPharmaceutical Solutions
p26008
g15483
sVAlcohols
p26009
(dp26010
sVLipids
p26011
g14287
ssg1632
(dp26012
g8598
(dp26013
sg8601
(dp26014
ssg1635
(dp26015
VCardiac Stimulants Excl. Cardiac Glycosides
p26016
(dp26017
sVCOMT Substrates
p26018
(dp26019
sVNeurotransmitter Agents
p26020
(dp26021
sVDopamine Agents
p26022
g14247
sVOCT2 Inhibitors
p26023
(dp26024
sVAdrenergic and Dopaminergic Agents
p26025
(dp26026
sVSympathomimetics
p26027
(dp26028
sVCompounds used in a research, industrial, or household setting
p26029
(dp26030
sVPhenols
p26031
(dp26032
sVPeripheral Nervous System Agents
p26033
(dp26034
sVDrugs that are Mainly Renally Excreted
p26035
(dp26036
sVAutonomic Agents
p26037
(dp26038
sVSelective Beta 1-adrenergic Agonists
p26039
(dp26040
sVBiogenic Monoamines
p26041
(dp26042
sVCardiac Therapy
p26043
(dp26044
sVOCT2 substrates with narrow therapeutic index
p26045
(dp26046
sVOCT1 substrates
p26047
g13077
sVMonoamine Oxidase A Substrates
p26048
(dp26049
sVOCT2 Substrates
p26050
g14948
sVCardiovascular Agents
p26051
(dp26052
sVBenzene Derivatives
p26053
(dp26054
sVBiogenic Amines
p26055
(dp26056
sVCatecholamines
p26057
g19119
sVProtective Agents
p26058
(dp26059
sVAgents that produce hypertension
p26060
(dp26061
sVCardiotonic Agents
p26062
(dp26063
sVAmines
p26064
(dp26065
sVCatechols
p26066
(dp26067
sVAgents producing tachycardia
p26068
(dp26069
sg6234
(dp26070
ssg1638
(dp26071
g10266
(dp26072
sg1371
g24077
sg7416
(dp26073
sg3504
(dp26074
ssg1641
(dp26075
g1866
(dp26076
ssg1644
(dp26077
g195
g13893
ssg1647
(dp26078
g11301
(dp26079
sg7521
(dp26080
sg11934
(dp26081
sg3297
(dp26082
sg4845
(dp26083
sg7161
(dp26084
sg10554
(dp26085
ssg1650
(dp26086
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p26087
(dp26088
sVCytochrome P-450 CYP3A4 Inhibitors
p26089
(dp26090
sg10836
(dp26091
sg9537
(dp26092
sVCytochrome P-450 CYP3A Substrates
p26093
(dp26094
sg11868
(dp26095
sVCytochrome P-450 CYP2C9 Inhibitors
p26096
g18179
sVCytochrome P-450 Enzyme Inhibitors
p26097
(dp26098
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p26099
(dp26100
sVAmines
p26101
(dp26102
sVAmides
p26103
(dp26104
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p26105
(dp26106
sVSulfur Compounds
p26107
(dp26108
sg1290
g23420
sVSulfones
p26109
(dp26110
sVAntineoplastic Agents
p26111
(dp26112
sg9603
(dp26113
sVAdrenal Cortex Hormones
p26114
(dp26115
sVBenzene Derivatives
p26116
(dp26117
sVCytochrome P-450 CYP2C19 Inhibitors
p26118
(dp26119
sVCytochrome P-450 CYP2D6 Inhibitors
p26120
(dp26121
sVCytochrome P-450 CYP3A4 Substrates
p26122
(dp26123
sg6912
(dp26124
sg1398
g24265
sVCytochrome P-450 CYP3A Inhibitors
p26125
(dp26126
sg10983
(dp26127
sg8550
(dp26128
sg6531
(dp26129
sg5772
(dp26130
sVP-glycoprotein/ABCB1 Inhibitors
p26131
(dp26132
sg3612
(dp26133
sVHormones, Hormone Substitutes, and Hormone Antagonists
p26134
(dp26135
sg1779
(dp26136
sg804
g19575
ssg1653
(dp26137
g23
g12205
sg7320
(dp26138
sg4488
(dp26139
sg2067
(dp26140
sg612
g17855
sg11445
(dp26141
sg11319
(dp26142
ssg1656
(dp26143
VCytochrome P-450 CYP2C19 Inducers (strong)
p26144
(dp26145
sVCytochrome P-450 CYP3A Substrates
p26146
(dp26147
sg10458
(dp26148
sVCytochrome P-450 CYP2D6 Inducers
p26149
(dp26150
sVAnti-Infective Agents
p26151
(dp26152
sVCytochrome P-450 CYP3A4 Inducers (strong)
p26153
g23089
sVAntibiotics for Topical Use
p26154
(dp26155
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p26156
(dp26157
sVRifamycins
p26158
(dp26159
sVAmides
p26160
(dp26161
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p26162
(dp26163
sVAnti-Bacterial Agents
p26164
(dp26165
sVCytochrome P-450 CYP3A4 Inducers
p26166
g18880
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p26167
(dp26168
sVGastrointestinal Agents
p26169
(dp26170
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p26171
(dp26172
sVLactams, Macrocyclic
p26173
(dp26174
sVLactams
p26175
g22272
sVDermatologicals
p26176
g17188
sVCytochrome P-450 Enzyme Inducers
p26177
(dp26178
sVCytochrome P-450 CYP3A Inducers
p26179
(dp26180
sVCytochrome P-450 CYP3A Inducers (strong)
p26181
g22448
sVCytochrome P-450 CYP3A4 Substrates
p26182
(dp26183
sVAlimentary Tract and Metabolism
p26184
g23763
sVHeterocyclic Compounds, Fused-Ring
p26185
(dp26186
sVCytochrome P-450 CYP2C8 Inducers
p26187
(dp26188
sVIntestinal Antiinfectives
p26189
(dp26190
sVCytochrome P-450 CYP2C19 Inducers
p26191
g25529
ssg1659
(dp26192
VAmidines
p26193
(dp26194
sVDrugs that are Mainly Renally Excreted
p26195
(dp26196
sVMATE 2 Substrates
p26197
(dp26198
sVMATE 1 Substrates
p26199
g23495
sVOCT1 substrates
p26200
g13061
sVGuanidines
p26201
(dp26202
sVMATE substrates
p26203
(dp26204
sVOCT2 Inhibitors
p26205
(dp26206
sVOCT2 Substrates
p26207
g14935
sVOral Hypoglycemics
p26208
(dp26209
sVOCT2 substrates with narrow therapeutic index
p26210
(dp26211
sVBlood Glucose Lowering Agents
p26212
(dp26213
sVAlimentary Tract and Metabolism
p26214
g23930
sVDrugs Used in Diabetes
p26215
(dp26216
sVBiguanides
p26217
g25207
ssg1662
(dp26218
g3174
(dp26219
sg5865
(dp26220
sg30
g12364
sg6240
(dp26221
sg9096
(dp26222
sg2739
(dp26223
ssg1665
(dp26224
g9540
(dp26225
sg10512
(dp26226
ssg1668
(dp26227
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p26228
(dp26229
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p26230
(dp26231
sVCytochrome P-450 CYP2D6 Substrates
p26232
(dp26233
sVSerotonin Agents
p26234
(dp26235
sVAnalgesics
p26236
(dp26237
sVAntimigraine Preparations
p26238
(dp26239
sVSelective Serotonin Agonists
p26240
(dp26241
sVCYP3A Substrates (Sensitive)
p26242
(dp26243
sVIndoles
p26244
(dp26245
sVAmines
p26246
(dp26247
sVBiogenic Monoamines
p26248
(dp26249
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p26250
(dp26251
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p26252
(dp26253
sVCytochrome P-450 CYP3A4 Inducers
p26254
g18955
sVCytochrome P-450 CYP3A Substrates
p26255
(dp26256
sVCentral Nervous System Depressants
p26257
(dp26258
sVNeurotransmitter Agents
p26259
(dp26260
sVBiogenic Amines
p26261
(dp26262
sVSerotonin 1b Receptor Agonists
p26263
(dp26264
sVP-glycoprotein/ABCB1 Substrates
p26265
(dp26266
sVSelective Serotonin 5-HT1 Receptor Agonists
p26267
(dp26268
sVCytochrome P-450 Enzyme Inducers
p26269
(dp26270
sVCytochrome P-450 CYP3A Inducers
p26271
(dp26272
sVAgents that produce hypertension
p26273
(dp26274
sVCytochrome P-450 CYP2A6 Inducers
p26275
(dp26276
sVCytochrome P-450 CYP3A4 Substrates
p26277
(dp26278
sVCytochrome P-450 CYP2C9 Substrates
p26279
(dp26280
sVSerotonin 5-HT1 Receptor Agonists
p26281
(dp26282
sVHeterocyclic Compounds, Fused-Ring
p26283
(dp26284
sVSerotonin Modulators
p26285
(dp26286
sVAntidepressive Agents
p26287
g15554
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p26288
(dp26289
sVTriptans
p26290
(dp26291
sVSerotonin 1d Receptor Agonists
p26292
(dp26293
sVSerotonin Receptor Agonists
p26294
(dp26295
sVNervous System
p26296
(dp26297
ssg1671
(dp26298
g5622
(dp26299
sg1038
g21486
sg3297
(dp26300
sg7854
(dp26301
sg10047
(dp26302
sg7059
(dp26303
sg4752
(dp26304
sg4845
(dp26305
sg5793
(dp26306
sg7161
(dp26307
sg6903
(dp26308
ssg1674
(dp26309
VPyrimidines
p26310
(dp26311
sVNucleic Acid Synthesis Inhibitors
p26312
(dp26313
sVImmunosuppressive Agents
p26314
(dp26315
sVImmunologic Factors
p26316
(dp26317
sVThyroxine-binding globulin inducers
p26318
(dp26319
sVCytochrome P-450 CYP2C9 Inhibitors
p26320
g18174
sVCytochrome P-450 Enzyme Inhibitors
p26321
(dp26322
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p26323
(dp26324
sVPyrimidine Analogues
p26325
g18465
sVCytochrome P-450 CYP2C8 Substrates
p26326
(dp26327
sVCytochrome P-450 CYP1A2 Substrates
p26328
(dp26329
sVMyelosuppressive Agents
p26330
(dp26331
sVNucleoside Metabolic Inhibitor
p26332
(dp26333
sVFluorouracil and prodrugs
p26334
(dp26335
sVAntimetabolites, Antineoplastic
p26336
g23455
sVQTc Prolonging Agents
p26337
(dp26338
sVAntineoplastic Agents
p26339
(dp26340
sVUracil
p26341
(dp26342
sVCytochrome P-450 CYP2A6 Substrates
p26343
(dp26344
sVMisc. Skin and Mucous Membrane Agents
p26345
(dp26346
sVFluoropyrimidines
p26347
(dp26348
sVModerate Risk QTc-Prolonging Agents
p26349
(dp26350
sVToxic Actions
p26351
(dp26352
sVCardiotoxic antineoplastic agents
p26353
(dp26354
sVAntimetabolites
p26355
(dp26356
sVPyrimidinones
p26357
(dp26358
sVNoxae
p26359
(dp26360
sVBCRP/ABCG2 Substrates
p26361
(dp26362
sVAntineoplastic and Immunomodulating Agents
p26363
(dp26364
ssg1677
(dp26365
g6315
(dp26366
ssg1680
(dp26367
g11760
(dp26368
sg3777
(dp26369
ssg1683
(dp26370
VDrugs that are Mainly Renally Excreted
p26371
(dp26372
sVHematologic Agents
p26373
(dp26374
sVBlood and Blood Forming Organs
p26375
(dp26376
sVBenzimidazoles
p26377
(dp26378
sVSerine Proteinase Inhibitors
p26379
(dp26380
sVAnticoagulants
p26381
(dp26382
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p26383
(dp26384
sVAntithrombins
p26385
(dp26386
sVPyridines
p26387
(dp26388
sVP-glycoprotein/ABCB1 Substrates
p26389
(dp26390
sVUGT1A9 Substrates
p26391
g24005
sVProtease Inhibitors
p26392
(dp26393
sVEnzyme Inhibitors
p26394
(dp26395
sVHeterocyclic Compounds, Fused-Ring
p26396
(dp26397
sVUGT1A9 substrates with narrow therapeutic index
p26398
(dp26399
sVNarrow Therapeutic Index Drugs
p26400
(dp26401
ssg1686
(dp26402
VHeterocyclic Compounds, Fused-Ring
p26403
(dp26404
sVPigments, Biological
p26405
g21854
sVDermatologicals
p26406
g17199
sVBiological Factors
p26407
(dp26408
sVAntineoplastic and Immunomodulating Agents
p26409
(dp26410
sVRadiation-Sensitizing Agents
p26411
(dp26412
sg8790
(dp26413
sVAntineoplastic Agents
p26414
(dp26415
sVPhotosensitizing Agents
p26416
g21317
sg2622
(dp26417
ssg1689
(dp26418
g7197
(dp26419
sg12421
g12462
sg7065
(dp26420
ssg1692
(dp26421
g11283
(dp26422
sg10635
(dp26423
sg42
g12566
sg4788
(dp26424
sg4803
(dp26425
sg7650
(dp26426
sg10011
(dp26427
sg8418
(dp26428
sg1914
(dp26429
sg10494
(dp26430
sg888
g20393
sg891
g20532
sg3516
(dp26431
sg7824
(dp26432
sg9960
(dp26433
sg9963
(dp26434
sg915
g20681
sg1704
(dp26435
sg10740
(dp26436
sg2391
(dp26437
sg933
g20805
sg450
g16319
sg8514
(dp26438
sg19588
(dp26439
sg963
g20967
sg3279
(dp26440
sg171
g13686
sg10794
(dp26441
sg2523
(dp26442
sg5589
(dp26443
sg1008
g21261
sg7053
(dp26444
sg7056
(dp26445
sg11595
(dp26446
sg9339
(dp26447
sg7707
(dp26448
sg1809
(dp26449
sg11619
(dp26450
sg5652
(dp26451
sg294
g14722
sg4101
(dp26452
sg5739
(dp26453
sg9462
(dp26454
sg3408
(dp26455
sg72
g12779
sg4959
(dp26456
sg537
g17012
sg7971
(dp26457
sg2688
(dp26458
sg4974
(dp26459
sg7671
(dp26460
sg10239
(dp26461
sg1281
g23357
sg9519
(dp26462
sg11805
(dp26463
sg1059
g21733
sg3087
(dp26464
sg4260
(dp26465
sg6261
(dp26466
sg5781
(dp26467
sg9561
(dp26468
sg10977
(dp26469
sg5877
(dp26470
sg9702
(dp26471
sg2088
(dp26472
sg8097
(dp26473
sg4458
(dp26474
sg5919
(dp26475
sg2109
(dp26476
sg11136
(dp26477
sg6024
(dp26478
sg1413
g24440
sg1578
g25610
sg3651
(dp26479
sg1668
g26237
sg6678
(dp26480
sg11910
(dp26481
sg336
g15063
sg8019
(dp26482
sg657
g18287
sg633
g18067
sg4425
(dp26483
sg7428
(dp26484
sg8163
(dp26485
sg1434
g24623
sg10470
(dp26486
sg5250
(dp26487
sg8295
(dp26488
sg8259
(dp26489
sg5487
(dp26490
sg6468
(dp26491
sg4716
(dp26492
sg3711
(dp26493
sg714
g18993
sg5316
(dp26494
sg10854
(dp26495
sg9060
(dp26496
sg5181
(dp26497
sg12126
(dp26498
sg10596
(dp26499
sg6381
(dp26500
sg10602
(dp26501
sg4596
(dp26502
sg5394
(dp26503
sg9864
(dp26504
ssg1695
(dp26505
g11862
(dp26506
sg4062
(dp26507
sg9687
(dp26508
sg1941
(dp26509
sg4341
(dp26510
sg978
g21166
sg879
g20354
ssg1698
(dp26511
g8406
(dp26512
ssg1701
(dp26513
g9117
(dp26514
sg1629
g25993
sg2844
(dp26515
sg10629
(dp26516
sg138
g13291
sg7464
(dp26517
sg1980
(dp26518
sg7740
(dp26519
sg12114
(dp26520
sg19588
(dp26521
sg4635
(dp26522
sg3531
(dp26523
sg7641
(dp26524
sg4647
(dp26525
sg3105
(dp26526
sg3426
(dp26527
sg5457
(dp26528
sg6903
(dp26529
sg8418
(dp26530
sg8421
(dp26531
sg3885
(dp26532
sg9924
(dp26533
sg5472
(dp26534
sg3114
(dp26535
sg5007
(dp26536
sg8022
(dp26537
sg888
g20460
sg8820
(dp26538
sg6267
(dp26539
sg4887
(dp26540
sg7485
(dp26541
sg3177
(dp26542
sg7716
(dp26543
sg966
g21054
sg7734
(dp26544
sg6291
(dp26545
sg10761
(dp26546
sg8514
(dp26547
sg9264
(dp26548
sg10005
(dp26549
sg11445
(dp26550
sg6312
(dp26551
sg2835
(dp26552
sg7764
(dp26553
sg6315
(dp26554
sg5580
(dp26555
sg3231
(dp26556
sg1767
(dp26557
sg3240
(dp26558
sg7077
(dp26559
sg4056
(dp26560
sg2886
(dp26561
sg6336
(dp26562
sg2616
(dp26563
sg5589
(dp26564
sg7800
(dp26565
sg204
g13966
sg5595
(dp26566
sg5598
(dp26567
sg213
g14059
sg4806
(dp26568
sg3708
(dp26569
sg5619
(dp26570
sg5622
(dp26571
sg8580
(dp26572
sg1038
g21496
sg4341
(dp26573
sg1044
g21552
sg255
g14392
sg7854
(dp26574
sg11619
(dp26575
sg6408
(dp26576
sg4062
(dp26577
sg375
g15455
sg7056
(dp26578
sg11649
(dp26579
sg8433
(dp26580
sg11652
(dp26581
sg10974
(dp26582
sg1857
(dp26583
sg4656
(dp26584
sg2538
(dp26585
sg1881
(dp26586
sg10164
(dp26587
sg10047
(dp26588
sg6471
(dp26589
sg3399
(dp26590
sg7161
(dp26591
sg7563
(dp26592
sg10200
(dp26593
sg23
g12223
sg210
g13993
sg4320
(dp26594
sg1941
(dp26595
sg8226
(dp26596
sg9486
(dp26597
sg10227
(dp26598
sg3444
(dp26599
sg7191
(dp26600
sg3447
(dp26601
sg2730
(dp26602
sg5793
(dp26603
sg645
g18128
sg10263
(dp26604
sg4197
(dp26605
sg9918
(dp26606
sg5805
(dp26607
sg978
g21170
sg5829
(dp26608
sg10296
(dp26609
sg11046
(dp26610
sg1059
g21766
sg879
g20358
sg6585
(dp26611
sg1947
(dp26612
sg7164
(dp26613
sg20252
(dp26614
sg3519
(dp26615
sg9561
(dp26616
sg7170
(dp26617
sg2067
(dp26618
sg7335
(dp26619
sg10350
(dp26620
sg7305
(dp26621
sg11862
(dp26622
sg7422
(dp26623
sg5574
(dp26624
sg6639
(dp26625
sg11874
(dp26626
sg10557
(dp26627
sg5919
(dp26628
sg7314
(dp26629
sg9012
(dp26630
sg7320
(dp26631
sg3036
(dp26632
sg6885
(dp26633
sg2850
(dp26634
sg7569
(dp26635
sg8166
(dp26636
sg10383
(dp26637
sg909
g20645
sg4827
(dp26638
sg9819
(dp26639
sg6684
(dp26640
sg3624
(dp26641
sg11910
(dp26642
sg9144
(dp26643
sg4419
(dp26644
sg8595
(dp26645
sg3318
(dp26646
sg11934
(dp26647
sg1635
g26052
sg7014
(dp26648
sg612
g17879
sg5199
(dp26649
sg5229
(dp26650
sg11145
(dp26651
sg5235
(dp26652
sg4449
(dp26653
sg4452
(dp26654
sg657
g18332
sg10470
(dp26655
sg5250
(dp26656
sg6759
(dp26657
sg684
g18501
sg4845
(dp26658
sg687
g18563
sg9687
(dp26659
sg3696
(dp26660
sg10494
(dp26661
sg10818
(dp26662
sg4488
(dp26663
sg1491
g25083
sg9987
(dp26664
sg9009
(dp26665
sg8265
(dp26666
sg11292
(dp26667
sg7317
(dp26668
sg6906
(dp26669
sg11301
(dp26670
sg12060
(dp26671
sg2262
(dp26672
sg7521
(dp26673
sg9696
(dp26674
sg11319
(dp26675
sg9783
(dp26676
sg6102
(dp26677
sg5238
(dp26678
sg6000
(dp26679
sg6024
(dp26680
sg3297
(dp26681
sg1548
g25383
sg8862
(dp26682
sg10098
(dp26683
sg9822
(dp26684
sg5934
(dp26685
sg3072
(dp26686
sg10587
(dp26687
sg5289
(dp26688
sg9093
(dp26689
sg6381
(dp26690
sg7596
(dp26691
sg9855
(dp26692
sg4737
(dp26693
ssg1704
(dp26694
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p26695
(dp26696
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p26697
(dp26698
sVSerotonin Agents
p26699
(dp26700
sVAnalgesics
p26701
g26435
sVNeurotransmitter Agents
p26702
(dp26703
sVSelective Serotonin Agonists
p26704
(dp26705
sVDrugs that are Mainly Renally Excreted
p26706
(dp26707
sVAmines
p26708
(dp26709
sVBiogenic Monoamines
p26710
(dp26711
sVMonoamine Oxidase A Substrates
p26712
(dp26713
sVCentral Nervous System Depressants
p26714
(dp26715
sVAntimigraine Preparations
p26716
(dp26717
sVIndoles
p26718
(dp26719
sVBiogenic Amines
p26720
(dp26721
sVSerotonin 1b Receptor Agonists
p26722
(dp26723
sVSelective Serotonin 5-HT1 Receptor Agonists
p26724
(dp26725
sVAgents that produce hypertension
p26726
(dp26727
sVSerotonin 5-HT1 Receptor Agonists
p26728
(dp26729
sVHeterocyclic Compounds, Fused-Ring
p26730
(dp26731
sVSerotonin Modulators
p26732
(dp26733
sVAntidepressive Agents
p26734
g15505
sVTriptans
p26735
(dp26736
sVSerotonin 1d Receptor Agonists
p26737
(dp26738
sVSerotonin Receptor Agonists
p26739
(dp26740
sVNervous System
p26741
(dp26742
sVMigraine Disorders
p26743
(dp26744
ssg1707
(dp26745
VAdrenergic alpha-1 Receptor Antagonists
p26746
g14127
sVKetones
p26747
(dp26748
sVNeurotransmitter Agents
p26749
(dp26750
sVCentral Nervous System Agents
p26751
(dp26752
sVDopamine Agents
p26753
g14227
sVAntipsychotic Agents (First Generation [Typical])
p26754
(dp26755
sVAdrenergic Antagonists
p26756
(dp26757
sVPsychotropic Drugs
p26758
(dp26759
sVPeripheral Nervous System Agents
p26760
(dp26761
sVButyrophenone Derivatives
p26762
g20178
sVAutonomic Agents
p26763
(dp26764
sVAntipsychotic Agents
p26765
(dp26766
sVButyrophenones
p26767
(dp26768
sVDopamine Antagonists
p26769
(dp26770
sVAdjuvants, Anesthesia
p26771
(dp26772
sVPsycholeptics
p26773
(dp26774
sVQTc Prolonging Agents
p26775
(dp26776
sVCentral Nervous System Depressants
p26777
(dp26778
sVAntiemetics
p26779
(dp26780
sVGastrointestinal Agents
p26781
(dp26782
sVAdrenergic alpha-Antagonists
p26783
(dp26784
sVAgents that produce hypertension
p26785
(dp26786
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p26787
(dp26788
sVBenzimidazoles
p26789
(dp26790
sVModerate Risk QTc-Prolonging Agents
p26791
(dp26792
sVDopamine D2 Receptor Antagonists
p26793
(dp26794
sVHeterocyclic Compounds, Fused-Ring
p26795
(dp26796
sVNeurotoxic agents
p26797
(dp26798
sVNervous System
p26799
(dp26800
sVTranquilizing Agents
p26801
(dp26802
ssg1710
(dp26803
g11046
(dp26804
ssg1713
(dp26805
g1173
g22640
ssg1716
(dp26806
g8097
(dp26807
sg9417
(dp26808
sg387
g15657
sg10596
(dp26809
sg9981
(dp26810
sg2427
(dp26811
sg10056
(dp26812
sg7389
(dp26813
ssg1719
(dp26814
g216
g14067
sVCytochrome P-450 CYP2D6 Substrates
p26815
(dp26816
sVAgents causing hyperkalemia
p26817
(dp26818
sVHypotensive Agents
p26819
(dp26820
sVAmino Alcohols
p26821
(dp26822
sVAdrenergic Antagonists
p26823
(dp26824
sVPeripheral Nervous System Agents
p26825
(dp26826
sVSympatholytics
p26827
(dp26828
sVAmines
p26829
(dp26830
sVNeurotransmitter Agents
p26831
(dp26832
sVAntiglaucoma Preparations and Miotics
p26833
(dp26834
sVAdrenergic Agents
p26835
(dp26836
sVBeta-adrenergic Agents
p26837
(dp26838
sVAdrenergic beta-Antagonists
p26839
g15359
sVPhenoxypropanolamines
p26840
g20860
sVSensory Organs
p26841
(dp26842
sVNaphthalenes
p26843
(dp26844
sVPropanolamines
p26845
(dp26846
sVAutonomic Agents
p26847
(dp26848
sVOphthalmologicals
p26849
(dp26850
sVBradycardia-Causing Agents
p26851
(dp26852
sVTetrahydronaphthalenes
p26853
(dp26854
sVPropanols
p26855
(dp26856
sVAlcohols
p26857
(dp26858
ssg1722
(dp26859
g5877
(dp26860
sg9960
(dp26861
ssg1725
(dp26862
g426
g16113
sg9198
(dp26863
sg3105
(dp26864
sg2559
(dp26865
sg11955
(dp26866
sg2430
(dp26867
sg6318
(dp26868
sg834
g19964
sg3318
(dp26869
sg5469
(dp26870
sg282
g14568
sg5064
(dp26871
sg8022
(dp26872
sg12018
(dp26873
sg288
g14684
sg2427
(dp26874
sg4887
(dp26875
sg6798
(dp26876
sg9417
(dp26877
sg10740
(dp26878
sg2109
(dp26879
sg5535
(dp26880
sg486
g16663
sg696
g18784
sg14791
(dp26881
sg9267
(dp26882
sg69
g12772
sg9588
(dp26883
sg10557
(dp26884
sg582
g17635
sg387
g15673
sg6819
(dp26885
sg10356
(dp26886
sg11241
(dp26887
sg414
g15979
ssg1728
(dp26888
g5928
(dp26889
ssg1731
(dp26890
g6933
(dp26891
sg11685
(dp26892
sg5736
(dp26893
ssg1734
(dp26894
g10200
(dp26895
sg21710
(dp26896
sg5511
(dp26897
sg9660
(dp26898
ssg1737
(dp26899
VAmino Acids, Peptides, and Proteins
p26900
(dp26901
sVDrugs that are Mainly Renally Excreted
p26902
(dp26903
sVAntibodies
p26904
(dp26905
sVAntibodies, Monoclonal
p26906
(dp26907
sVAntibodies, Monoclonal, Humanized
p26908
(dp26909
sVAntineoplastic Agents, Immunological
p26910
(dp26911
sVImmunoglobulins
p26912
(dp26913
sVProteins
p26914
(dp26915
sVImmunoglobulin G
p26916
(dp26917
sg1596
g25722
sVGlobulins
p26918
g19186
sVSerum Globulins
p26919
(dp26920
sVAntineoplastic and Immunomodulating Agents
p26921
(dp26922
sg3876
(dp26923
sVBlood Proteins
p26924
(dp26925
sVAdjuvants, Immunologic
p26926
(dp26927
sVAntineoplastic Agents
p26928
(dp26929
sg3276
(dp26930
sVImmunoproteins
p26931
(dp26932
ssg1740
(dp26933
g141
g13365
sg5334
(dp26934
ssg1743
(dp26935
g4707
(dp26936
ssg1746
(dp26937
VCytoprotective Agent
p26938
(dp26939
sg6063
(dp26940
sVHypotensive Agents
p26941
(dp26942
sVDetoxifying Agents for Antineoplastic Treatment
p26943
(dp26944
sVRadiation-Protective Agents
p26945
(dp26946
sg7587
(dp26947
sVCompounds used in a research, industrial, or household setting
p26948
(dp26949
sg6030
(dp26950
sVProtective Agents
p26951
(dp26952
sg417
g15995
sVSulfur Compounds
p26953
(dp26954
sVOrganophosphorus Compounds
p26955
(dp26956
ssg1749
(dp26957
g6867
(dp26958
ssg1752
(dp26959
g2553
(dp26960
sg10767
(dp26961
sg5415
(dp26962
sg1842
(dp26963
sg6714
(dp26964
sg10764
(dp26965
sg4770
(dp26966
ssg1755
(dp26967
g1938
(dp26968
ssg1758
(dp26969
g11913
(dp26970
ssg1761
(dp26971
VAntiinfectives for Systemic Use
p26972
(dp26973
sVProtein Synthesis Inhibitors
p26974
(dp26975
sVAgents that produce neuromuscular block (indirect)
p26976
(dp26977
sg4188
(dp26978
sg6591
(dp26979
sVOphthalmologicals
p26980
(dp26981
sg3225
(dp26982
sVOphthalmological and Otological Preparations
p26983
(dp26984
sVNephrotoxic agents
p26985
(dp26986
sVAminoglycoside Antibacterials
p26987
(dp26988
sVOtologicals
p26989
(dp26990
sVGlycosides
p26991
(dp26992
sVDermatologicals
p26993
g17217
sg11964
(dp26994
sVEnzyme Inhibitors
p26995
(dp26996
sVSensory Organs
p26997
(dp26998
sVAnti-Bacterial Agents
p26999
(dp27000
sVAntibacterials for Systemic Use
p27001
(dp27002
sVAnti-Infective Agents
p27003
(dp27004
sVCarbohydrates
p27005
(dp27006
sVNarrow Therapeutic Index Drugs
p27007
(dp27008
ssg1764
(dp27009
g288
g14672
sg2559
(dp27010
sg1263
g23210
ssg1767
(dp27011
VCardiovascular Agents
p27012
g26557
sVDecreased Renal K+ Excretion
p27013
(dp27014
sVAgents causing hyperkalemia
p27015
(dp27016
sVHypotensive Agents
p27017
(dp27018
sVPotassium-Sparing Agents
p27019
(dp27020
sVEpithelial Sodium Channel Blockers
p27021
(dp27022
sg4641
(dp27023
sVOCT2 Inhibitors
p27024
(dp27025
sVPotassium-Sparing Diuretics
p27026
(dp27027
sVIncreased Diuresis
p27028
(dp27029
sVMembrane Transport Modulators
p27030
(dp27031
sVPyrazines
p27032
(dp27033
sVNatriuretic Agents
p27034
(dp27035
sVSodium Channel Blockers
p27036
(dp27037
sVDiuretics
p27038
(dp27039
ssg1770
(dp27040
VCentral Nervous System Agents
p27041
(dp27042
sVAnesthetics, Local
p27043
(dp27044
sVVasoprotectives
p27045
(dp27046
sVThroat Preparations
p27047
(dp27048
sVPeripheral Nervous System Agents
p27049
(dp27050
sVBenzene Derivatives
p27051
(dp27052
sg2406
(dp27053
sVAcids, Carbocyclic
p27054
(dp27055
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p27056
g16838
sVAnesthetics
p27057
(dp27058
sg1320
g23554
sVDermatologicals
p27059
g17221
sg4152
(dp27060
sg6117
(dp27061
sg9801
(dp27062
sg2184
(dp27063
sg4566
(dp27064
sVBenzoates
p27065
(dp27066
sVMethemoglobinemia Associated Agents
p27067
g25587
sg4380
(dp27068
sVP-glycoprotein/ABCB1 Inhibitors
p27069
(dp27070
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p27071
(dp27072
sVSensory System Agents
p27073
(dp27074
sg1770
(dp27075
sVNervous System
p27076
(dp27077
ssg1773
(dp27078
g4680
(dp27079
sg12274
(dp27080
sg5433
(dp27081
ssg1776
(dp27082
g10065
(dp27083
sg8376
(dp27084
sVGastrointestinal Hormones
p27085
(dp27086
sg3852
(dp27087
sg7752
(dp27088
sVHormones
p27089
(dp27090
sg10875
(dp27091
sVPeptide Hormones
p27092
g20232
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p27093
(dp27094
sVPancreatic Hormones
p27095
(dp27096
sg4908
(dp27097
sVGastrointestinal Agents
p27098
(dp27099
sg3648
(dp27100
sVProteins
p27101
(dp27102
sVHormones, Hormone Substitutes, and Hormone Antagonists
p27103
(dp27104
sVPeptides
p27105
(dp27106
sVAmino Acids, Peptides, and Proteins
p27107
(dp27108
sg7332
(dp27109
sg1776
(dp27110
sg2205
(dp27111
sg4833
(dp27112
sVProtein Precursors
p27113
(dp27114
sVProglucagon
p27115
(dp27116
ssg1779
(dp27117
g2763
(dp27118
sg6333
(dp27119
sg1650
g26136
ssg1782
(dp27120
VAgents that produce neuromuscular block (indirect)
p27121
(dp27122
sVOphthalmological and Otological Preparations
p27123
(dp27124
sVCarbohydrates
p27125
(dp27126
sVIrrigating Solutions
p27127
(dp27128
sVStomatological Preparations
p27129
(dp27130
sVEnzyme Inhibitors
p27131
(dp27132
sVAnti-Infective Agents
p27133
(dp27134
sVAntiinfectives for Systemic Use
p27135
(dp27136
sVThroat Preparations
p27137
(dp27138
sVAntibiotics for Topical Use
p27139
(dp27140
sVNephrotoxic agents
p27141
(dp27142
sVOtologicals
p27143
(dp27144
sVAnti-Bacterial Agents
p27145
(dp27146
sVProtein Synthesis Inhibitors
p27147
(dp27148
sVGlycosides
p27149
(dp27150
sVBlood and Blood Forming Organs
p27151
(dp27152
sVAminoglycoside Antibacterials
p27153
(dp27154
sVDermatologicals
p27155
g17224
sVSensory Organs
p27156
(dp27157
sVAntibacterials for Systemic Use
p27158
(dp27159
sVAlimentary Tract and Metabolism
p27160
g23806
sVNarrow Therapeutic Index Drugs
p27161
(dp27162
sVBlood Substitutes and Perfusion Solutions
p27163
(dp27164
sVOphthalmologicals
p27165
(dp27166
sVIntestinal Antiinfectives
p27167
(dp27168
sVAntiinfectives and Antiseptics for Local Oral Treatment
p27169
(dp27170
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p27171
(dp27172
ssg1785
(dp27173
VDrugs that are Mainly Renally Excreted
p27174
(dp27175
sVCytochrome P-450 CYP2C8 Substrates
p27176
(dp27177
sVCytochrome P-450 CYP1A2 Substrates
p27178
(dp27179
sVCytochrome P-450 CYP3A5 Substrates
p27180
(dp27181
sVAntimetabolites
p27182
(dp27183
sVPyrimidinones
p27184
(dp27185
sVCytochrome P-450 CYP3A Substrates
p27186
(dp27187
sVNoxae
p27188
(dp27189
sVPyrimidines
p27190
(dp27191
sVToxic Actions
p27192
(dp27193
sVCytochrome P-450 CYP2A6 Substrates
p27194
(dp27195
sVThyroxine-binding globulin inducers
p27196
(dp27197
sVFluoropyrimidines
p27198
(dp27199
sVAntineoplastic and Immunomodulating Agents
p27200
(dp27201
sVAntimetabolites, Antineoplastic
p27202
g23454
sVUracil
p27203
(dp27204
sVPyrimidine Analogues
p27205
g18460
sVAntineoplastic Agents
p27206
(dp27207
sVFluorouracil and prodrugs
p27208
(dp27209
ssg1788
(dp27210
g7041
(dp27211
sg6186
(dp27212
ssg1791
(dp27213
VHydrocarbons, Acyclic
p27214
g19581
sg1791
(dp27215
sVVitamins
p27216
g12169
sVRetinoids for Topical Use in Acne
p27217
(dp27218
sVCytochrome P-450 CYP3A Substrates
p27219
(dp27220
sVHypotensive Agents
p27221
(dp27222
sVCycloparaffins
p27223
(dp27224
sVAnti-Acne Preparations
p27225
(dp27226
sVCytochrome P-450 CYP2B6 Substrates
p27227
(dp27228
sVRetinoids
p27229
(dp27230
sVAlkenes
p27231
(dp27232
sg1917
(dp27233
sVCytochrome P-450 CYP2C8 Substrates
p27234
(dp27235
sVVitamins (Fat Soluble)
p27236
(dp27237
sVCarotenoids
p27238
(dp27239
sVPigments, Biological
p27240
g21846
sVPolyenes
p27241
(dp27242
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27243
(dp27244
sVCytochrome P-450 CYP2C9 Substrates
p27245
(dp27246
sVAntineoplastic Agents
p27247
(dp27248
sVCyclohexanes
p27249
(dp27250
sVTerpenes
p27251
(dp27252
sVDermatologicals
p27253
g17225
sVCytochrome P-450 CYP2A6 Substrates
p27254
(dp27255
sVCytochrome P-450 CYP2C18 Substrates
p27256
g20924
sVCytochrome P-450 CYP3A5 Substrates
p27257
(dp27258
sVCyclohexenes
p27259
(dp27260
sVCytochrome P-450 CYP3A4 Substrates
p27261
(dp27262
sg6129
(dp27263
sVCardiotoxic antineoplastic agents
p27264
(dp27265
sVAnti-Acne Preparations for Topical Use
p27266
(dp27267
sVImmunosuppressive Agents
p27268
(dp27269
sg11124
(dp27270
sVAntineoplastic and Immunomodulating Agents
p27271
(dp27272
sVKeratolytic Agents
p27273
(dp27274
sVCytochrome P-450 CYP3A7 Substrates
p27275
(dp27276
sVBiological Factors
p27277
(dp27278
ssg1794
(dp27279
g3627
(dp27280
sg3018
(dp27281
sg7626
(dp27282
sg7164
(dp27283
sg375
g15423
sg444
g16231
sg5112
(dp27284
sg11460
(dp27285
sg9252
(dp27286
sg2316
(dp27287
sg7692
(dp27288
sg7848
(dp27289
sg8454
(dp27290
sg12060
(dp27291
sg5595
(dp27292
ssg1797
(dp27293
g6348
(dp27294
ssg1800
(dp27295
VImmunosuppressive Agents
p27296
(dp27297
sVCytochrome P-450 CYP3A Substrates
p27298
(dp27299
sVSteroids, Fluorinated
p27300
(dp27301
sg8391
(dp27302
sVAnti-Acne Preparations
p27303
(dp27304
sVVasoprotectives
p27305
(dp27306
sVHormones
p27307
(dp27308
sVHyperglycemia-Associated Agents
p27309
(dp27310
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p27311
g16820
sVCorticosteroids, Dermatological Preparations
p27312
(dp27313
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27314
(dp27315
sVGlucocorticoids
p27316
g21930
sVFused-Ring Compounds
p27317
g14810
sVCytochrome P-450 CYP3A4 Inducers
p27318
g18876
sVCytochrome P-450 CYP3A5 Inducers
p27319
(dp27320
sVAdrenal Cortex Hormones
p27321
(dp27322
sVPregnadienes
p27323
(dp27324
sVDermatologicals
p27325
g17185
sVCytochrome P-450 Enzyme Inducers
p27326
(dp27327
sVCytochrome P-450 CYP3A Inducers
p27328
(dp27329
sVCytochrome P-450 CYP3A4 Substrates
p27330
(dp27331
sVPregnanes
p27332
(dp27333
sVAnti-Acne Preparations for Topical Use
p27334
(dp27335
sVOphthalmologicals
p27336
(dp27337
sVSteroids
p27338
(dp27339
sVCorticosteroids, Moderately Potent (Group II)
p27340
(dp27341
sVAnti-Allergic Agents
p27342
(dp27343
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p27344
(dp27345
sVAnti-Inflammatory Agents
p27346
(dp27347
sVCorticosteroid Hormone Receptor Agonists
p27348
(dp27349
sVHormones, Hormone Substitutes, and Hormone Antagonists
p27350
(dp27351
sVCorticosteroids
p27352
(dp27353
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p27354
(dp27355
sVSensory Organs
p27356
(dp27357
ssg1803
(dp27358
VAnticholinergic Agents
p27359
g24464
sVCytochrome P-450 CYP2D6 Substrates
p27360
(dp27361
sVCytochrome P-450 CYP3A Substrates
p27362
(dp27363
sVNeurotransmitter Agents
p27364
(dp27365
sVTropanes
p27366
(dp27367
sVMuscarinic Antagonists
p27368
(dp27369
sVDrugs that are Mainly Renally Excreted
p27370
(dp27371
sVAutonomic Agents
p27372
(dp27373
sVParasympatholytics
p27374
(dp27375
sVPeripheral Nervous System Agents
p27376
(dp27377
sVAza Compounds
p27378
(dp27379
sVRespiratory System Agents
p27380
(dp27381
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27382
(dp27383
sVDrugs for Obstructive Airway Diseases
p27384
(dp27385
sVBronchodilator Agents
p27386
(dp27387
sVScopolamine Derivatives
p27388
(dp27389
sVAzabicyclo Compounds
p27390
(dp27391
sVAnti-Asthmatic Agents
p27392
(dp27393
sVCytochrome P-450 CYP3A4 Substrates
p27394
(dp27395
sVAdrenergics, Inhalants
p27396
(dp27397
sVAntimuscarinics Antispasmodics
p27398
(dp27399
sVAgents to Treat Airway Disease
p27400
(dp27401
sVCholinergic Agents
p27402
(dp27403
sVAgents producing tachycardia
p27404
(dp27405
sVAlkaloids
p27406
g19397
ssg1806
(dp27407
g8019
(dp27408
sg4425
(dp27409
sg4803
(dp27410
sg336
g15069
sg6162
(dp27411
sg963
g20971
ssg1809
(dp27412
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p27413
(dp27414
sVCytochrome P-450 CYP2D6 Substrates
p27415
(dp27416
sVAnalgesics
p27417
g26449
sVOpiate Agonists
p27418
(dp27419
sVCentral Nervous System Agents
p27420
(dp27421
sVNarcotics
p27422
(dp27423
sVPeripheral Nervous System Agents
p27424
(dp27425
sVMorphine Derivatives
p27426
(dp27427
sVCytochrome P-450 CYP3A4 Substrates
p27428
(dp27429
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27430
(dp27431
sVCytochrome P-450 CYP3A Substrates
p27432
(dp27433
sVNatural Opium Alkaloids
p27434
g23485
sVCentral Nervous System Depressants
p27435
(dp27436
sVOpioids
p27437
(dp27438
sVSemi-synthetic Opioids
p27439
(dp27440
sVCodeine
p27441
(dp27442
sVOpiate Alkaloids
p27443
(dp27444
sVHeterocyclic Compounds, Fused-Ring
p27445
(dp27446
sVMorphinans
p27447
(dp27448
sVCytochrome P-450 CYP3A5 Substrates
p27449
(dp27450
sVOpioid Agonist
p27451
(dp27452
sVAlkaloids
p27453
g19398
sVSensory System Agents
p27454
(dp27455
sVPhenanthrenes
p27456
(dp27457
sVNervous System
p27458
(dp27459
ssg1812
(dp27460
VAcetates
p27461
(dp27462
sVMetal divalent cations
p27463
(dp27464
sVFatty Acids, Volatile
p27465
(dp27466
sVFatty Acids
p27467
(dp27468
sVVarious Alimentary Tract and Metabolism Products
p27469
(dp27470
sVAcids, Acyclic
p27471
g25442
sVZinc Compounds
p27472
(dp27473
sVAlimentary Tract and Metabolism
p27474
g23816
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p27475
g16818
sVLipids
p27476
g14296
sVMetal cations
p27477
(dp27478
sVVasoprotectives
p27479
(dp27480
sVCopper Absorption Inhibitor
p27481
(dp27482
sg150
g13535
ssg1815
(dp27483
g4437
(dp27484
sg8787
(dp27485
sg8724
(dp27486
sg8703
(dp27487
ssg1818
(dp27488
VSteroids
p27489
(dp27490
sVSex Hormones and Modulators of the Genital System
p27491
g19609
sVEstradiol Congeners
p27492
(dp27493
sVAndrogens and Estrogens
p27494
(dp27495
sVUGT1A1 Substrates
p27496
g12275
sVBCRP/ABCG2 Inducers
p27497
g24520
sVCytochrome P-450 CYP3A Substrates
p27498
(dp27499
sVNatural and Semisynthetic Estrogens, Plain
p27500
(dp27501
sVProgestogens and Estrogens, Sequential Preparations
p27502
(dp27503
sVBCRP/ABCG2 Inhibitors
p27504
g12533
sVOCT2 Inhibitors
p27505
(dp27506
sVOATP1B1/SLCO1B1 Inhibitors
p27507
(dp27508
sg12274
(dp27509
sVHormones
p27510
(dp27511
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p27512
(dp27513
sVAntiandrogens and Estrogens
p27514
(dp27515
sVCytochrome P-450 Enzyme Inhibitors
p27516
(dp27517
sVHormonal Contraceptives for Systemic Use
p27518
(dp27519
sVDrugs that are Mainly Renally Excreted
p27520
(dp27521
sVCytochrome P-450 CYP2C8 Substrates
p27522
(dp27523
sVContraceptive Agents, Female
p27524
(dp27525
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p27526
(dp27527
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27528
(dp27529
sVContraceptives, Oral
p27530
(dp27531
sg5433
(dp27532
sVCytochrome P-450 CYP2C9 Substrates
p27533
(dp27534
sVFused-Ring Compounds
p27535
g14832
sVHyperglycemia-Associated Agents
p27536
(dp27537
sVCytochrome P-450 CYP3A4 Inducers
p27538
g18908
sVOCT1 inhibitors
p27539
(dp27540
sVAdrenal Cortex Hormones
p27541
(dp27542
sVCytochrome P-450 CYP1A2 Inhibitors
p27543
g15018
sVOAT3/SLC22A8 Substrates
p27544
g13106
sVP-glycoprotein/ABCB1 Substrates
p27545
(dp27546
sVEstrogen Contraceptives
p27547
(dp27548
sVCytochrome P-450 CYP1A2 Substrates
p27549
(dp27550
sVCytochrome P-450 Enzyme Inducers
p27551
(dp27552
sVCytochrome P-450 CYP3A Inducers
p27553
(dp27554
sVCytochrome P-450 CYP2C19 Inhibitors
p27555
(dp27556
sVCytochrome P-450 CYP3A4 Substrates
p27557
(dp27558
sVIntravaginal Contraceptives
p27559
(dp27560
sVGonadal Hormones
p27561
(dp27562
sVCytochrome P-450 CYP3A5 Substrates
p27563
(dp27564
sg4680
(dp27565
sVGenito Urinary System and Sex Hormones
p27566
(dp27567
sVGonadal Steroid Hormones
p27568
(dp27569
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p27570
(dp27571
sVEstrogens
p27572
(dp27573
sVEstrogens, agonists
p27574
(dp27575
sVEstranes
p27576
(dp27577
sVHormones, Hormone Substitutes, and Hormone Antagonists
p27578
(dp27579
sVEstrenes
p27580
(dp27581
sVEstradiol, agonists
p27582
g27080
sg8013
(dp27583
sVCytochrome P-450 CYP3A7 Substrates
p27584
(dp27585
ssg1821
(dp27586
g4257
(dp27587
sg5469
(dp27588
sg165
g13596
ssg1824
(dp27589
g1050
g21655
sg8433
(dp27590
sg7593
(dp27591
sg9954
(dp27592
ssg1827
(dp27593
g11820
(dp27594
sg2658
(dp27595
sg195
g13915
sg10218
(dp27596
sg4926
(dp27597
sg9996
(dp27598
sg11415
(dp27599
sg138
g13279
sg4650
(dp27600
sg4902
(dp27601
sg10797
(dp27602
ssg1830
(dp27603
g4911
(dp27604
sg5469
(dp27605
sg4017
(dp27606
sg4155
(dp27607
sg4023
(dp27608
sg8721
(dp27609
sg6819
(dp27610
sg183
g13788
sg4653
(dp27611
sg14791
(dp27612
sg5085
(dp27613
sg1113
g22177
sg12534
(dp27614
sg6045
(dp27615
ssg1833
(dp27616
g1605
g25761
sg3363
(dp27617
sg546
g17151
ssg1836
(dp27618
g3087
(dp27619
sg12003
(dp27620
sg5394
(dp27621
sg2391
(dp27622
sg6024
(dp27623
sg969
g21079
sg10494
(dp27624
sg1578
g25630
sg5589
(dp27625
sg3711
(dp27626
sg8418
(dp27627
sg7824
(dp27628
sg11535
(dp27629
ssg1839
(dp27630
g9870
(dp27631
sg4557
(dp27632
sg7530
(dp27633
sg657
g18308
sg7920
(dp27634
sg9780
(dp27635
sg129
g13194
sg9561
(dp27636
sg2985
(dp27637
sg6150
(dp27638
sg8649
(dp27639
sg5457
(dp27640
ssg1842
(dp27641
VIons
p27642
(dp27643
sVGastrointestinal Agents
p27644
(dp27645
sVGastric Acid Lowering Agents
p27646
(dp27647
sVHydroxides
p27648
g19063
sVMetal divalent cations
p27649
(dp27650
sVMetal cations
p27651
(dp27652
sVAluminum and magnesium containing antacids
p27653
g26963
sVAlkalies
p27654
(dp27655
sVAntacids
p27656
(dp27657
sVDrugs for Acid Related Disorders
p27658
(dp27659
sVAluminium Compounds
p27660
g18797
sVAnions
p27661
(dp27662
sg9792
(dp27663
sVMagnesium Compounds
p27664
(dp27665
sVElectrolytes
p27666
(dp27667
sVAlimentary Tract and Metabolism
p27668
g23827
ssg1845
(dp27669
g11781
(dp27670
ssg1848
(dp27671
g645
g18134
sg7020
(dp27672
sg141
g13346
sg11874
(dp27673
ssg1851
(dp27674
g10767
(dp27675
sg1164
g22587
sg9309
(dp27676
sg7629
(dp27677
sg4770
(dp27678
sg10764
(dp27679
sg12108
(dp27680
ssg1854
(dp27681
g2505
(dp27682
sg4737
(dp27683
ssg1857
(dp27684
VDihydropyridine Derivatives
p27685
(dp27686
sVAntiarrhythmic agents
p27687
(dp27688
sVCytochrome P-450 CYP3A Substrates
p27689
(dp27690
sVAgents causing hyperkalemia
p27691
(dp27692
sVHypotensive Agents
p27693
(dp27694
sVCalcium Channel Blockers
p27695
(dp27696
sVCYP3A Substrates (Sensitive)
p27697
(dp27698
sVCalcium Channel Blockers (Dihydropyridine)
p27699
g20124
sVDrugs that are Mainly Renally Excreted
p27700
(dp27701
sVAntihypertensive Agents
p27702
g20270
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27703
(dp27704
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p27705
(dp27706
sVCardiovascular Agents
p27707
g26583
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p27708
(dp27709
sVPyridines
p27710
(dp27711
sVVasodilating Agents
p27712
g23725
sVMembrane Transport Modulators
p27713
(dp27714
sVCytochrome P-450 CYP3A4 Substrates
p27715
(dp27716
sVCalcium-Regulating Hormones and Agents
p27717
(dp27718
sg8319
(dp27719
sVCytochrome P-450 CYP3A5 Substrates
p27720
(dp27721
sVBradycardia-Causing Agents
p27722
(dp27723
sVP-glycoprotein/ABCB1 Inhibitors
p27724
(dp27725
sVDihydropyridines
p27726
(dp27727
sVCytochrome P-450 CYP3A7 Substrates
p27728
(dp27729
ssg1860
(dp27730
g9417
(dp27731
sg2346
(dp27732
sg3447
(dp27733
sg7464
(dp27734
sg771
g19312
sg9507
(dp27735
sg12421
g12496
sg4635
(dp27736
sg7065
(dp27737
sg7569
(dp27738
sg4857
(dp27739
sg7197
(dp27740
sg1491
g25128
sg7821
(dp27741
sg10818
(dp27742
sg5295
(dp27743
sg138
g13311
sg11166
(dp27744
ssg1863
(dp27745
VAntiinfectives for Systemic Use
p27746
(dp27747
sVHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
p27748
(dp27749
sVAntivirals for Systemic Use
p27750
(dp27751
sVHeterocyclic Compounds, Fused-Ring
p27752
(dp27753
sVOphthalmologicals
p27754
(dp27755
sVCytochrome P-450 CYP3A Substrates
p27756
(dp27757
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p27758
(dp27759
sVSensory Organs
p27760
(dp27761
sVAntiviral Agents
p27762
(dp27763
sVDirect Acting Antivirals
p27764
(dp27765
sVNucleosides and Nucleotides
p27766
(dp27767
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27768
(dp27769
sVHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor
p27770
(dp27771
sVEnzyme Inhibitors
p27772
(dp27773
sVNucleic Acid Synthesis Inhibitors
p27774
(dp27775
sVCytochrome P-450 CYP3A4 Substrates
p27776
(dp27777
sVAnti-Infective Agents
p27778
(dp27779
sVPurines
p27780
(dp27781
ssg1866
(dp27782
VRecombinant Proteins
p27783
(dp27784
sVAntigout Preparations
p27785
(dp27786
sg10212
(dp27787
sVEnzymes
p27788
(dp27789
sVMusculo-Skeletal System
p27790
(dp27791
sVDetoxifying Agents for Antineoplastic Treatment
p27792
(dp27793
sg1641
g26076
sg11859
(dp27794
sVEnzymes and Coenzymes
p27795
(dp27796
sVOxidoreductases
p27797
(dp27798
ssg1869
(dp27799
VAcetates
p27800
(dp27801
sg8571
(dp27802
sVFatty Acids
p27803
(dp27804
sVAntiarrhythmic agents
p27805
(dp27806
sVCytochrome P-450 CYP3A Substrates
p27807
(dp27808
sVAgents causing hyperkalemia
p27809
(dp27810
sVCentral Nervous System Agents
p27811
(dp27812
sVCalcium Channel Blockers
p27813
(dp27814
sVPotential QTc-Prolonging Agents
p27815
(dp27816
sVLipids
p27817
g14303
sVMiscellaneous Anticonvulsants
p27818
(dp27819
sg4074
(dp27820
sVAmides
p27821
(dp27822
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27823
(dp27824
sVPyrrolidines
p27825
(dp27826
sVQTc Prolonging Agents
p27827
(dp27828
sVDecreased Central Nervous System Disorganized Electrical Activity
p27829
g23479
sVCentral Nervous System Depressants
p27830
(dp27831
sVFatty Acids, Volatile
p27832
(dp27833
sVAnticonvulsants
p27834
(dp27835
sVP-glycoprotein/ABCB1 Substrates
p27836
(dp27837
sVVasodilating Agents
p27838
g23689
sg2124
(dp27839
sVCytochrome P-450 CYP3A4 Substrates
p27840
(dp27841
sVAcids, Acyclic
p27842
g25447
sVBradycardia-Causing Agents
p27843
(dp27844
sVNervous System
p27845
(dp27846
ssg1872
(dp27847
VAntiinfectives for Systemic Use
p27848
(dp27849
sVDrugs that are Mainly Renally Excreted
p27850
(dp27851
sg2877
(dp27852
sVbeta-Lactams
p27853
(dp27854
sVOAT1/SLC22A6 inhibitors
p27855
(dp27856
sVPenicillins With Extended Spectrum
p27857
(dp27858
sVLactams
p27859
g22284
sVPenicillins
p27860
(dp27861
sVDrugs for Acid Related Disorders
p27862
(dp27863
sVPenicillin G
p27864
(dp27865
sVAmides
p27866
(dp27867
sVSulfur Compounds
p27868
(dp27869
sVAnti-Bacterial Agents
p27870
(dp27871
sVAntibacterials for Systemic Use
p27872
(dp27873
sVHeterocyclic Compounds, Fused-Ring
p27874
(dp27875
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p27876
(dp27877
sVAnti-Infective Agents
p27878
(dp27879
sVAlimentary Tract and Metabolism
p27880
g23840
sVBeta-Lactam Antibacterials
p27881
(dp27882
ssg1875
(dp27883
VChelating Agents
p27884
(dp27885
sVIons
p27886
(dp27887
sVAntituberculosis Agents
p27888
(dp27889
sVSulfates
p27890
(dp27891
sVAntioxidants
p27892
(dp27893
sVAcids
p27894
(dp27895
sVAcids, Noncarboxylic
p27896
(dp27897
sVSequestering Agents
p27898
(dp27899
sVElectrolytes
p27900
(dp27901
sVSulfur Acids
p27902
(dp27903
sVSulfuric Acids
p27904
g25282
sVCompounds used in a research, industrial, or household setting
p27905
(dp27906
sVAnions
p27907
(dp27908
sVProtective Agents
p27909
(dp27910
sVAnti-Infective Agents
p27911
(dp27912
sVAntidotes
p27913
(dp27914
sVMinerals
p27915
(dp27916
sVSulfur Compounds
p27917
(dp27918
ssg1878
(dp27919
g10680
(dp27920
ssg1881
(dp27921
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p27922
(dp27923
sVBSEP/ABCB11 Substrates
p27924
(dp27925
sVCytochrome P-450 CYP3A4 Inhibitors
p27926
(dp27927
sVCytochrome P-450 CYP2D6 Inhibitors
p27928
(dp27929
sVCytochrome P-450 CYP2D6 Substrates
p27930
(dp27931
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p27932
(dp27933
sVCytochrome P-450 CYP3A Substrates
p27934
(dp27935
sVOCT2 Inhibitors
p27936
(dp27937
sVAnilides
p27938
(dp27939
sVAcetanilides
p27940
(dp27941
sVCytochrome P-450 Enzyme Inhibitors
p27942
(dp27943
sVDrugs that are Mainly Renally Excreted
p27944
(dp27945
sVAmines
p27946
(dp27947
sVCardiac Therapy
p27948
(dp27949
sVAmides
p27950
(dp27951
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p27952
(dp27953
sVAniline Compounds
p27954
g23432
sVQTc Prolonging Agents
p27955
(dp27956
sVCardiovascular Agents
p27957
g26586
sVP-glycoprotein/ABCB1 Substrates
p27958
(dp27959
sVVasodilating Agents
p27960
g23706
sVMembrane Transport Modulators
p27961
(dp27962
sVCytochrome P-450 CYP3A4 Substrates
p27963
(dp27964
sVSodium Channel Blockers
p27965
(dp27966
sVModerate Risk QTc-Prolonging Agents
p27967
(dp27968
sVPiperazines
p27969
(dp27970
sVAntianginal Agents
p27971
(dp27972
sVCytochrome P-450 CYP3A Inhibitors
p27973
(dp27974
sVP-glycoprotein/ABCB1 Inhibitors
p27975
(dp27976
ssg1884
(dp27977
g9870
(dp27978
sg7530
(dp27979
sg10320
(dp27980
sg9780
(dp27981
sg2985
(dp27982
sg11382
(dp27983
sg420
g16009
ssg1887
(dp27984
g102
g13005
sg6123
(dp27985
ssg1890
(dp27986
VCytochrome P-450 CYP3A4 Substrates
p27987
(dp27988
sg6870
(dp27989
sVEnzyme Inhibitors
p27990
(dp27991
sVCholinesterase Inhibitors
p27992
(dp27993
sg1560
g25469
sVCytochrome P-450 CYP3A Substrates
p27994
(dp27995
sVNeurotransmitter Agents
p27996
(dp27997
sVBradycardia-Causing Agents
p27998
(dp27999
sVCentral Nervous System Agents
p28000
(dp28001
sVCholinergic Agents
p28002
(dp28003
sVNervous System
p28004
(dp28005
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28006
(dp28007
sg10869
(dp28008
sg5136
(dp28009
sg8451
(dp28010
sVParasympathomemetic (Cholinergic) Agents
p28011
(dp28012
sg4461
(dp28013
sg11295
(dp28014
sg7677
(dp28015
ssg1893
(dp28016
g9471
(dp28017
ssg1896
(dp28018
g2256
(dp28019
sg10230
(dp28020
sg11874
(dp28021
sg7719
(dp28022
sg10074
(dp28023
sg6471
(dp28024
sg1038
g21482
sg10974
(dp28025
sg6474
(dp28026
sg1356
g23963
sg4320
(dp28027
ssg1899
(dp28028
VCytochrome P-450 CYP3A4 Inhibitors
p28029
(dp28030
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p28031
(dp28032
sVCytochrome P-450 CYP3A Substrates
p28033
(dp28034
sVAntifungal Agents
p28035
(dp28036
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p28037
(dp28038
sVCytochrome P-450 CYP3A7 Inhibitors
p28039
(dp28040
sVEnzyme Inhibitors
p28041
(dp28042
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p28043
(dp28044
sVCytochrome P-450 CYP2C9 Inhibitors
p28045
g18205
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p28046
g12675
sVCytochrome P-450 Enzyme Inhibitors
p28047
(dp28048
sVAnti-Infective Agents
p28049
(dp28050
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p28051
(dp28052
sVAntiinfectives for Systemic Use
p28053
(dp28054
sVCytochrome P450 2C19 Inhibitors
p28055
(dp28056
sVAzole Antifungals
p28057
g20191
sVSteroid Synthesis Inhibitors
p28058
(dp28059
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28060
(dp28061
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p28062
(dp28063
sVCytochrome P-450 CYP2C9 Substrates
p28064
(dp28065
sVQTc Prolonging Agents
p28066
(dp28067
sVCytochrome P-450 CYP2C19 Substrates
p28068
(dp28069
sVCytochrome P450 3A4 Inhibitors
p28070
g13045
sVCytochrome P-450 CYP2B6 Inhibitors
p28071
(dp28072
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p28073
(dp28074
sVCytochrome P-450 CYP2C19 Inhibitors
p28075
(dp28076
sVCytochrome P-450 CYP3A Inhibitors (strong)
p28077
g13406
sVCytochrome P-450 CYP3A4 Substrates
p28078
(dp28079
sg4956
(dp28080
sVHormone Antagonists
p28081
g24277
sVAntimycotics for Systemic Use
p28082
(dp28083
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p28084
g24779
sV14-alpha Demethylase Inhibitors
p28085
(dp28086
sVPotential QTc-Prolonging Agents
p28087
(dp28088
sVCytochrome P-450 CYP3A Inhibitors
p28089
(dp28090
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p28091
(dp28092
sg4842
(dp28093
sVHormones, Hormone Substitutes, and Hormone Antagonists
p28094
(dp28095
sVChemically-Induced Disorders
p28096
g21241
sVCytochrome P-450 CYP3A5 Inhibitors
p28097
(dp28098
ssg1902
(dp28099
g4164
(dp28100
sg11079
(dp28101
sg8298
(dp28102
ssg1905
(dp28103
g4620
(dp28104
sg5409
(dp28105
sg2346
(dp28106
sg9132
(dp28107
sg3846
(dp28108
sg9249
(dp28109
sg3858
(dp28110
sg5433
(dp28111
sg8796
(dp28112
sg9903
(dp28113
sg6216
(dp28114
sg1800
g27327
sg2226
(dp28115
sg5454
(dp28116
sg4653
(dp28117
sg10797
(dp28118
sg1656
g26178
sg8418
(dp28119
sg8421
(dp28120
sg7668
(dp28121
sg8430
(dp28122
sg11451
(dp28123
sg8433
(dp28124
sg888
g20481
sg11952
(dp28125
sg10701
(dp28126
sg8448
(dp28127
sg10272
(dp28128
sg5133
(dp28129
sg9966
(dp28130
sg10728
(dp28131
sg5526
(dp28132
sg9231
(dp28133
sg4053
(dp28134
sg7734
(dp28135
sg5469
(dp28136
sg147
g13475
sg3219
(dp28137
sg3222
(dp28138
sg11550
(dp28139
sg10794
(dp28140
sg13091
g21407
sg11523
(dp28141
sg183
g13836
sg6333
(dp28142
sg6336
(dp28143
sg5589
(dp28144
sg6345
(dp28145
sg3258
(dp28146
sg5598
(dp28147
sg14829
(dp28148
sg7053
(dp28149
sg4017
(dp28150
sg4023
(dp28151
sg4821
(dp28152
sg4365
(dp28153
sg12274
g27552
sg7545
(dp28154
sg1062
g21825
sg1614
g25885
sg4680
(dp28155
sg14838
(dp28156
sg9030
(dp28157
sg4089
(dp28158
sg12534
(dp28159
sg4911
(dp28160
sg1104
g22106
sg4113
(dp28161
sg9444
(dp28162
sg9198
(dp28163
sg8694
(dp28164
sg8703
(dp28165
sg2667
(dp28166
sg9471
(dp28167
sg2688
(dp28168
sg14791
(dp28169
sg3432
(dp28170
sg4164
(dp28171
sg8724
(dp28172
sg5757
(dp28173
sg7188
(dp28174
sg2538
(dp28175
sg5766
(dp28176
sg6819
(dp28177
sg9492
(dp28178
sg405
g15893
sg6537
(dp28179
sg2730
(dp28180
sg11385
(dp28181
sg2373
(dp28182
sg9918
(dp28183
sg816
g19681
sg10017
(dp28184
sg9528
(dp28185
sg4155
(dp28186
sg5832
(dp28187
sg8049
(dp28188
sg2196
(dp28189
sg5853
(dp28190
sg2787
(dp28191
sg7272
(dp28192
sg5256
(dp28193
sg8721
(dp28194
sg3516
(dp28195
sg8808
(dp28196
sg11079
(dp28197
sg507
g16783
sg10338
(dp28198
sg4287
(dp28199
sg5085
(dp28200
sg7329
(dp28201
sg78
g12863
sg5895
(dp28202
sg7389
(dp28203
sg11886
(dp28204
sg9609
(dp28205
sg543
g17106
sg9618
(dp28206
sg3393
(dp28207
sg6504
(dp28208
sg6024
(dp28209
sg696
g18752
sg10209
(dp28210
sg3651
(dp28211
sg7335
(dp28212
sg4338
(dp28213
sg1668
g26270
sg141
g13361
sg8472
(dp28214
sg1371
g24115
sS'Daunorubicin'
p28215
(dp28216
sg11922
(dp28217
sg11940
(dp28218
sg1401
g24322
sg13750
g24392
sg3633
(dp28219
sg14872
g15745
sg9693
(dp28220
sg7428
(dp28221
sg2943
(dp28222
sg9225
(dp28223
sg1434
g24668
sg6033
(dp28224
sg6045
(dp28225
sg6048
(dp28226
sg1461
g24831
sg8241
(dp28227
sg10362
(dp28228
sg6783
(dp28229
sg849
g20094
sg10494
(dp28230
sg1113
g22192
sg11370
(dp28231
sg2253
(dp28232
sg3024
(dp28233
sg6765
(dp28234
sg3027
(dp28235
sg11316
(dp28236
sg1140
g22414
sg2832
(dp28237
sg10539
(dp28238
sg8298
(dp28239
sg10113
(dp28240
sg10557
(dp28241
sg5289
(dp28242
sg9822
(dp28243
sg5364
(dp28244
sg6015
(dp28245
sg5067
(dp28246
sg12126
(dp28247
sg10596
(dp28248
sg6075
(dp28249
sg12132
(dp28250
sg7593
(dp28251
sg4596
(dp28252
sg12123
(dp28253
ssg1908
(dp28254
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p28255
(dp28256
sVAntidepressive Agents, Second-Generation
p28257
(dp28258
sVCytochrome P-450 CYP3A4 Inhibitors
p28259
(dp28260
sVAnticholinergic Agents
p28261
g24497
sVCytochrome P-450 CYP2D6 Inhibitors
p28262
(dp28263
sVCytochrome P-450 CYP2D6 Substrates
p28264
(dp28265
sVSerotonin Agents
p28266
(dp28267
sVCytochrome P-450 CYP3A Substrates
p28268
(dp28269
sVNeurotransmitter Agents
p28270
(dp28271
sVCentral Nervous System Agents
p28272
(dp28273
sVEnzyme Inhibitors
p28274
(dp28275
sVPsychotropic Drugs
p28276
(dp28277
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p28278
(dp28279
sVCytochrome P-450 CYP2C9 Inhibitors
p28280
g18207
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p28281
g12676
sVCytochrome P-450 Enzyme Inhibitors
p28282
(dp28283
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p28284
(dp28285
sVSelective Serotonin Reuptake Inhibitors
p28286
(dp28287
sVCytochrome P-450 CYP1A2 Substrates
p28288
(dp28289
sVPsychoanaleptics
p28290
(dp28291
sVMuscarinic Antagonists
p28292
(dp28293
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28294
(dp28295
sVCytochrome P-450 CYP2C9 Substrates
p28296
(dp28297
sVCytochrome P-450 CYP2C19 Substrates
p28298
(dp28299
sVCentral Nervous System Depressants
p28300
(dp28301
sVCytochrome P-450 CYP1A2 Inhibitors
p28302
g15055
sVCytochrome P-450 CYP2B6 Inhibitors
p28303
(dp28304
sVNeurotransmitter Uptake Inhibitors
p28305
(dp28306
sVMembrane Transport Modulators
p28307
(dp28308
sVCytochrome P-450 CYP2C19 Inhibitors
p28309
(dp28310
sVCytochrome P-450 CYP3A4 Substrates
p28311
(dp28312
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p28313
(dp28314
sg10203
(dp28315
sVSerotonin Modulators
p28316
(dp28317
sVAntidepressive Agents
p28318
g15538
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p28319
g13745
sVCytochrome P-450 CYP3A Inhibitors
p28320
(dp28321
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p28322
(dp28323
sVHypoglycemia-Associated Agents
p28324
g17704
sVP-glycoprotein/ABCB1 Inhibitors
p28325
(dp28326
sVPiperidines
p28327
(dp28328
sVAgents producing tachycardia
p28329
(dp28330
sVNervous System
p28331
(dp28332
ssg1911
(dp28333
VCytochrome P-450 CYP3A4 Inhibitors
p28334
(dp28335
sVCytochrome P-450 CYP2D6 Substrates
p28336
(dp28337
sVAntiarrhythmic agents
p28338
(dp28339
sVCytochrome P-450 CYP3A Substrates
p28340
(dp28341
sVAgents causing hyperkalemia
p28342
(dp28343
sVAntidiarrheals
p28344
(dp28345
sVCalcium Channel Blockers
p28346
(dp28347
sVCytochrome P-450 CYP2B6 Substrates
p28348
(dp28349
sVCytochrome P-450 Enzyme Inhibitors
p28350
(dp28351
sVCytochrome P-450 CYP2C8 Substrates
p28352
(dp28353
sVPiperidines
p28354
(dp28355
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p28356
(dp28357
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28358
(dp28359
sVQTc Prolonging Agents
p28360
(dp28361
sVGastrointestinal Agents
p28362
(dp28363
sVP-glycoprotein/ABCB1 Substrates
p28364
(dp28365
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p28366
(dp28367
sVAntipropulsives
p28368
(dp28369
sVCytochrome P-450 CYP3A Inhibitors (strong)
p28370
g13408
sVCytochrome P-450 CYP3A4 Substrates
p28371
(dp28372
sVAlimentary Tract and Metabolism
p28373
g23843
sVModerate Risk QTc-Prolonging Agents
p28374
(dp28375
sVOpioid Agonist
p28376
(dp28377
sVCytochrome P-450 CYP3A Inhibitors
p28378
(dp28379
sVBradycardia-Causing Agents
p28380
(dp28381
sVP-glycoprotein/ABCB1 Inhibitors
p28382
(dp28383
ssg1914
(dp28384
VAcetic Acid Derivatives and Related Substances
p28385
(dp28386
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p28387
(dp28388
sVSympathomimetics Excl. Antiglaucoma Preparations
p28389
(dp28390
sVAnalgesics
p28391
g26429
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p28392
(dp28393
sVNon COX-2 selective NSAIDS
p28394
(dp28395
sVAntiinflammatory and Antirheumatic Products
p28396
(dp28397
sVEnzyme Inhibitors
p28398
(dp28399
sVNonsteroidal Anti-inflammatory Compounds
p28400
(dp28401
sVAnalgesics, Non-Narcotic
p28402
(dp28403
sVNephrotoxic agents
p28404
(dp28405
sVMusculo-Skeletal System
p28406
(dp28407
sVAgents causing hyperkalemia
p28408
(dp28409
sVOther Nonsteroidal Antiimflammatory Agents
p28410
(dp28411
sVMydriatics
p28412
(dp28413
sVSensory Organs
p28414
(dp28415
sVAgents that produce hypertension
p28416
(dp28417
sVMydriatics and Cycloplegics
p28418
(dp28419
sVHeterocyclic Compounds, Fused-Ring
p28420
(dp28421
sVOphthalmologicals
p28422
(dp28423
sVAnti-Inflammatory Agents
p28424
(dp28425
sg4869
(dp28426
sVCyclooxygenase Inhibitors
p28427
(dp28428
sVAntirheumatic Agents
p28429
g24220
sVAnti-Inflammatory Agents, Non-Steroidal
p28430
(dp28431
ssg1917
(dp28432
VHydrocarbons, Acyclic
p28433
g19590
sVTerpenes
p28434
(dp28435
sVTretinoin
p28436
g27233
sVRetinoids
p28437
(dp28438
sVCarotenoids
p28439
(dp28440
sVPigments, Biological
p28441
g21855
sVP-glycoprotein/ABCB1 Substrates
p28442
(dp28443
sVAgents for Dermatitis, Excluding Corticosteroids
p28444
(dp28445
sVDermatologicals
p28446
g17246
sVCycloparaffins
p28447
(dp28448
sVVitamin A
p28449
(dp28450
sVPolyenes
p28451
(dp28452
sVMisc. Skin and Mucous Membrane Agents
p28453
(dp28454
sVBiological Factors
p28455
(dp28456
sVAntineoplastic and Immunomodulating Agents
p28457
(dp28458
sVAlkenes
p28459
(dp28460
sVCyclohexenes
p28461
(dp28462
sVVitamins (Fat Soluble)
p28463
(dp28464
sVAntineoplastic Agents
p28465
(dp28466
sVCyclohexanes
p28467
(dp28468
sVVitamins
p28469
g12184
ssg1920
(dp28470
VJanus Kinase Inhibitors
p28471
(dp28472
sg11088
(dp28473
sVMyelosuppressive Agents
p28474
(dp28475
sVSelective Immunosuppressants
p28476
g23562
sVCytochrome P-450 CYP3A Substrates
p28477
(dp28478
sVImmunosuppressive Agents
p28479
(dp28480
sVBradycardia-Causing Agents
p28481
(dp28482
sVEnzyme Inhibitors
p28483
(dp28484
sVDisease-modifying Antirheumatic Agents
p28485
(dp28486
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28487
(dp28488
sVAntineoplastic and Immunomodulating Agents
p28489
(dp28490
sVAntirheumatic Agents
p28491
g24241
sVProtein Kinase Inhibitors
p28492
(dp28493
sVBiologics for Rheumatoid Arthritis Treatment
p28494
(dp28495
sVCytochrome P-450 CYP3A4 Substrates
p28496
(dp28497
sVJanus Kinase Inhibitor
p28498
(dp28499
ssg1923
(dp28500
g11952
(dp28501
sg6360
(dp28502
ssg1926
(dp28503
g2403
(dp28504
ssg1929
(dp28505
g3801
(dp28506
ssg1932
(dp28507
g7353
(dp28508
ssg1935
(dp28509
g8763
(dp28510
sg4479
(dp28511
sg7740
(dp28512
sg2943
(dp28513
sg9366
(dp28514
sg8781
(dp28515
sg5007
(dp28516
sg690
g18656
sg2250
(dp28517
sg6807
(dp28518
sg4911
(dp28519
sg7377
(dp28520
sg2652
(dp28521
sg3027
(dp28522
sg3021
(dp28523
sg2850
(dp28524
sg2274
(dp28525
sg11775
(dp28526
sg9834
(dp28527
sg6000
(dp28528
sg4539
(dp28529
sg11166
(dp28530
sg6291
(dp28531
sg165
g13575
sg7077
(dp28532
sg2715
(dp28533
sg6537
(dp28534
sg7458
(dp28535
sg11385
(dp28536
ssg1938
(dp28537
VDrugs that are Mainly Renally Excreted
p28538
(dp28539
sVBenzazepines
p28540
(dp28541
sVGABA Agents
p28542
g16224
sVNeurotransmitter Agents
p28543
(dp28544
sVBenzodiazepinones
p28545
(dp28546
sVProtective Agents
p28547
(dp28548
sg1755
g26968
sVCompounds used in a research, industrial, or household setting
p28549
(dp28550
sVMiscellaneous Central Nervous System Agents
p28551
(dp28552
sVGABA Modulators
p28553
(dp28554
sVHeterocyclic Compounds, Fused-Ring
p28555
(dp28556
sVAntidotes
p28557
(dp28558
ssg1941
(dp28559
VUGT1A1 Substrates
p28560
g12262
sVOAT1/SLC22A6 inhibitors
p28561
(dp28562
sVSulfanilamides
p28563
(dp28564
sVHypotensive Agents
p28565
(dp28566
sVHyperglycemia-Associated Agents
p28567
(dp28568
sVDrugs that are Mainly Renally Excreted
p28569
(dp28570
sVAmines
p28571
(dp28572
sVOtotoxic agents
p28573
(dp28574
sVGynecological Antiinfectives and Antiseptics
p28575
(dp28576
sVNephrotoxic agents
p28577
(dp28578
sVAcids, Carbocyclic
p28579
(dp28580
sVAmides
p28581
(dp28582
sVSulfur Compounds
p28583
(dp28584
sVAniline Compounds
p28585
g23442
sVSulfones
p28586
(dp28587
sVNatriuretic Agents
p28588
(dp28589
sVSodium Potassium Chloride Symporter Inhibitors
p28590
g26509
sVDiuretics
p28591
(dp28592
sVCardiovascular Agents
p28593
g26595
sVBenzene Derivatives
p28594
(dp28595
sVNon Potassium Sparing Diuretics
p28596
g14974
sVThyroxine-binding globulin substrates
p28597
(dp28598
sVHigh-Ceiling Diuretics and Potassium-Sparing Agents
p28599
(dp28600
sVMembrane Transport Modulators
p28601
(dp28602
sVAminobenzoates
p28603
(dp28604
sVGenito Urinary System and Sex Hormones
p28605
(dp28606
sVBenzoates
p28607
(dp28608
sVSulfonamides
p28609
(dp28610
sVOAT3/SLC22A8 Inhibitors
p28611
(dp28612
sVIncreased Diuresis at Loop of Henle
p28613
(dp28614
sVHigh-Ceiling Diuretics
p28615
(dp28616
ssg1944
(dp28617
g8019
(dp28618
sg4425
(dp28619
sg3858
(dp28620
sg2943
(dp28621
sg4803
(dp28622
sg5250
(dp28623
sg6699
(dp28624
sg6033
(dp28625
sg8295
(dp28626
sg4260
(dp28627
sg11403
(dp28628
sg294
g14766
sg888
g20391
sg10977
(dp28629
sg4077
(dp28630
sg9009
(dp28631
sg6447
(dp28632
sg10728
(dp28633
sg4458
(dp28634
sg546
g17156
sg10740
(dp28635
sg2109
(dp28636
sg3036
(dp28637
sg2850
(dp28638
sg6654
(dp28639
sg450
g16358
sg3408
(dp28640
sg6489
(dp28641
sg963
g21013
sg7698
(dp28642
sg537
g17054
sg5256
(dp28643
sg5769
(dp28644
sg2715
(dp28645
sg1281
g23399
sg336
g15122
sg1008
g21303
ssg1947
(dp28646
VAntiplatelet agents
p28647
(dp28648
sVFibrin Modulating Agents
p28649
g22850
sVQuinolines
p28650
(dp28651
sVCytochrome P-450 CYP2D6 Substrates
p28652
(dp28653
sVCytochrome P-450 CYP3A Substrates
p28654
(dp28655
sVBronchodilator Agents
p28656
(dp28657
sVPhosphodiesterase 3 Inhibitors
p28658
(dp28659
sVCentral Nervous System Agents
p28660
(dp28661
sVPotential QTc-Prolonging Agents
p28662
(dp28663
sVCompounds used in a research, industrial, or household setting
p28664
(dp28665
sVEnzyme Inhibitors
p28666
(dp28667
sVPeripheral Nervous System Agents
p28668
(dp28669
sVDrugs that are Mainly Renally Excreted
p28670
(dp28671
sVCytochrome P-450 CYP1A2 Substrates
p28672
(dp28673
sVAutonomic Agents
p28674
(dp28675
sVRespiratory System Agents
p28676
(dp28677
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28678
(dp28679
sVProtective Agents
p28680
(dp28681
sVQTc Prolonging Agents
p28682
(dp28683
sVNeuroprotective Agents
p28684
(dp28685
sVBlood and Blood Forming Organs
p28686
(dp28687
sVCardiovascular Agents
p28688
g26612
sVTetrazoles
p28689
g19109
sVVasodilating Agents
p28690
g23683
sVAnti-Asthmatic Agents
p28691
(dp28692
sVCytochrome P-450 CYP3A5 Substrates
p28693
(dp28694
sVCytochrome P-450 CYP3A4 Substrates
p28695
(dp28696
sVHematologic Agents
p28697
(dp28698
sVHeterocyclic Compounds, Fused-Ring
p28699
(dp28700
sVPlatelet Aggregation Inhibitors Excl. Heparin
p28701
(dp28702
sVAgents producing tachycardia
p28703
(dp28704
sVPhosphodiesterase Inhibitors
p28705
(dp28706
sVCytochrome P-450 CYP3A7 Substrates
p28707
(dp28708
ssg1950
(dp28709
g11022
(dp28710
sg6186
(dp28711
sg8580
(dp28712
sg8964
(dp28713
sg1803
g27403
sg4035
(dp28714
sg8598
(dp28715
sg8601
(dp28716
sg6570
(dp28717
sg11277
(dp28718
sg9918
(dp28719
sg1626
g25954
sg1260
g23167
sg3684
(dp28720
sg687
g18579
sg9099
(dp28721
sg9111
(dp28722
sg10335
(dp28723
sg495
g16698
sg8673
(dp28724
sg10521
(dp28725
sg1890
g28003
sg2277
(dp28726
sg945
g20910
sg753
g19221
sg7959
(dp28727
sg570
g17499
sg14791
(dp28728
sg6687
(dp28729
sg11352
(dp28730
sg7533
(dp28731
sg11916
(dp28732
sg10593
(dp28733
sg6819
(dp28734
sg9492
(dp28735
sg6381
(dp28736
sg5193
(dp28737
sg9828
(dp28738
sg7041
(dp28739
ssg1953
(dp28740
g9324
(dp28741
ssg1956
(dp28742
g10179
(dp28743
ssg1959
(dp28744
g11886
(dp28745
sg9609
(dp28746
sg10209
(dp28747
sg9693
(dp28748
sg966
g21064
sg8430
(dp28749
sg1245
g23021
sg6783
(dp28750
sg1383
g24181
sg2832
(dp28751
sg5766
(dp28752
sg8694
(dp28753
sg9225
(dp28754
sg4620
(dp28755
sg5238
(dp28756
ssg1962
(dp28757
g3777
(dp28758
ssg1965
(dp28759
g3174
(dp28760
sg30
g12406
sg9096
(dp28761
sg2739
(dp28762
sg5865
(dp28763
ssg1968
(dp28764
g5334
(dp28765
ssg1971
(dp28766
g9870
(dp28767
sg9855
(dp28768
sg4860
(dp28769
sg2460
(dp28770
sg2703
(dp28771
sg2985
(dp28772
sg402
g15868
sg8598
(dp28773
sg8601
(dp28774
sg11268
(dp28775
sg2676
(dp28776
sg4008
(dp28777
sg3783
(dp28778
sg9765
(dp28779
ssg1974
(dp28780
g4272
(dp28781
sg3000
(dp28782
ssg1977
(dp28783
g10635
(dp28784
sg5781
(dp28785
sg2523
(dp28786
sg5877
(dp28787
sg9960
(dp28788
sg9864
(dp28789
ssg1980
(dp28790
VAgents Causing Muscle Toxicity
p28791
(dp28792
sVBisphosphonates
p28793
(dp28794
sVCardiovascular Agents
p28795
g26518
sVMusculo-Skeletal System
p28796
(dp28797
sVPyridines
p28798
(dp28799
sVDrugs for Treatment of Bone Diseases
p28800
g14273
sVBone Density Conservation Agents
p28801
(dp28802
sVOrganophosphonates
p28803
(dp28804
sVMembrane Transport Modulators
p28805
(dp28806
sVDrugs Affecting Bone Structure and Mineralization
p28807
g16505
sVCalcium-Regulating Hormones and Agents
p28808
(dp28809
sVOrganophosphorus Compounds
p28810
(dp28811
ssg1983
(dp28812
g4773
(dp28813
ssg1986
(dp28814
g4260
(dp28815
sg1914
g28386
sg10740
(dp28816
sg2109
(dp28817
sg9519
(dp28818
sg3279
(dp28819
sg5250
(dp28820
ssg1989
(dp28821
g477
g16588
sg9819
(dp28822
sg12421
g12452
sg6102
(dp28823
sg7065
(dp28824
sg7197
(dp28825
sg7014
(dp28826
sg4683
(dp28827
ssg1992
(dp28828
g10200
(dp28829
sg10185
(dp28830
sg6567
(dp28831
sg4581
(dp28832
sg6150
(dp28833
sg5286
(dp28834
ssg1995
(dp28835
g87
g12901
sg6279
(dp28836
sg3024
(dp28837
sg11592
(dp28838
sg8433
(dp28839
sg10179
(dp28840
sg48
g12621
sg1050
g21647
sg10797
(dp28841
ssg1998
(dp28842
g543
g17071
sg12274
g27495
sg4236
(dp28843
sg5433
(dp28844
ssg2001
(dp28845
g11361
(dp28846
ssg2004
(dp28847
g7944
(dp28848
sg2403
(dp28849
ssg2007
(dp28850
VAgents Causing Muscle Toxicity
p28851
(dp28852
sVFertility Agents, Female
p28853
(dp28854
sVCytochrome P-450 CYP3A Substrates
p28855
(dp28856
sVNeuropeptides
p28857
(dp28858
sVPituitary Hormone-Releasing Hormones
p28859
(dp28860
sVGonadotropin Releasing Hormone Receptor Agonists
p28861
(dp28862
sVHormones
p28863
(dp28864
sVHyperglycemia-Associated Agents
p28865
(dp28866
sVDrugs that are Mainly Renally Excreted
p28867
(dp28868
sVPeptide Hormones
p28869
g20204
sVGonadotropin Releasing Hormone Receptor Agonist
p28870
(dp28871
sVGonadotropins
p28872
(dp28873
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p28874
(dp28875
sVReproductive Control Agents
p28876
g18839
sVFertility Agents
p28877
(dp28878
sVQTc Prolonging Agents
p28879
(dp28880
sVAntineoplastic Agents
p28881
(dp28882
sVOligopeptides
p28883
(dp28884
sVAdrenal Cortex Hormones
p28885
(dp28886
sVProteins
p28887
(dp28888
sVAntineoplastic Agents, Hormonal
p28889
(dp28890
sVNerve Tissue Proteins
p28891
(dp28892
sVGonadotropin-releasing hormone agonist
p28893
(dp28894
sVCytochrome P-450 CYP3A4 Substrates
p28895
(dp28896
sVModerate Risk QTc-Prolonging Agents
p28897
(dp28898
sVAmino Acids, Peptides, and Proteins
p28899
(dp28900
sVHypothalamic Hormones
p28901
(dp28902
sVPeptides
p28903
(dp28904
sVHormones and Related Agents
p28905
(dp28906
sVAntineoplastic and Immunomodulating Agents
p28907
(dp28908
sVHormones, Hormone Substitutes, and Hormone Antagonists
p28909
(dp28910
sVEndocrine Therapy
p28911
g19569
ssg2010
(dp28912
g6819
(dp28913
sg14791
(dp28914
ssg2013
(dp28915
VPiperazines
p28916
(dp28917
sVCentral Nervous System Depressants
p28918
(dp28919
sVAntiemetics
p28920
(dp28921
sVGastrointestinal Agents
p28922
(dp28923
sVAutonomic Agents
p28924
(dp28925
sVHistamine H1 Antagonists
p28926
(dp28927
sVNeurotransmitter Agents
p28928
(dp28929
sVHistamine Agents
p28930
(dp28931
sVCentral Nervous System Agents
p28932
(dp28933
sVPotential QTc-Prolonging Agents
p28934
(dp28935
sVPiperazine Derivatives
p28936
(dp28937
sVPeripheral Nervous System Agents
p28938
(dp28939
sVHistamine Antagonists
p28940
(dp28941
sVAntihistamines for Systemic Use
p28942
g12959
sVCytochrome P-450 CYP2C9 Inhibitors
p28943
g18216
sVCytochrome P-450 Enzyme Inhibitors
p28944
(dp28945
sVQTc Prolonging Agents
p28946
(dp28947
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p28948
(dp28949
ssg2016
(dp28950
g1482
g25022
ssg2019
(dp28951
g10833
(dp28952
sg5520
(dp28953
sg3576
(dp28954
sg4164
(dp28955
sg7881
(dp28956
sg8985
(dp28957
sg10326
(dp28958
sg1101
g22053
sg1527
g25275
sg7500
(dp28959
sg11427
(dp28960
sg2991
(dp28961
sg6654
(dp28962
sg9663
(dp28963
sg2808
(dp28964
sg8298
(dp28965
sg8493
(dp28966
sg4953
(dp28967
sg279
g14512
sg8049
(dp28968
sg6075
(dp28969
ssg2022
(dp28970
g5415
(dp28971
ssg2025
(dp28972
g3627
(dp28973
sg8763
(dp28974
sg4935
(dp28975
sg7221
(dp28976
sg444
g16242
sg396
g15792
sg8856
(dp28977
sg11460
(dp28978
sg7689
(dp28979
sg837
g20004
ssg2028
(dp28980
g1626
g25931
sg11022
(dp28981
sg10521
(dp28982
sg10593
(dp28983
sg9099
(dp28984
sg8964
(dp28985
sg5499
(dp28986
sg10713
(dp28987
sg9828
(dp28988
sg570
g17474
sg6687
(dp28989
ssg2031
(dp28990
g6765
(dp28991
sg6009
(dp28992
sg13091
g21375
sg7848
(dp28993
ssg2034
(dp28994
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p28995
(dp28996
sVCytochrome P-450 CYP3A4 Inhibitors
p28997
(dp28998
sVCytochrome P-450 CYP3A Substrates
p28999
(dp29000
sVPyrimidines
p29001
(dp29002
sVBCRP/ABCG2 Inhibitors
p29003
g12518
sVKinase Inhibitor
p29004
g24586
sVEnzyme Inhibitors
p29005
(dp29006
sVCytochrome P-450 Enzyme Inhibitors
p29007
(dp29008
sVCytochrome P-450 CYP1A2 Substrates
p29009
(dp29010
sVMyelosuppressive Agents
p29011
(dp29012
sVTyrosine Kinase Inhibitors
p29013
(dp29014
sVThiazoles
p29015
(dp29016
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p29017
(dp29018
sVSulfur Compounds
p29019
(dp29020
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p29021
(dp29022
sVQTc Prolonging Agents
p29023
(dp29024
sVAntineoplastic Agents
p29025
(dp29026
sVCytochrome P450 3A4 Inhibitors
p29027
g13038
sVPotential QTc-Prolonging Agents
p29028
(dp29029
sVP-glycoprotein/ABCB1 Substrates
p29030
(dp29031
sVProtein Kinase Inhibitors
p29032
(dp29033
sVCytochrome P-450 CYP3A4 Substrates
p29034
(dp29035
sVCytochrome P-450 CYP3A5 Substrates
p29036
(dp29037
sVCYP3A Substrates (Sensitive)
p29038
(dp29039
sVCytochrome P-450 CYP3A Inhibitors
p29040
(dp29041
sVImmunosuppressive Agents
p29042
(dp29043
sVBCRP/ABCG2 Substrates
p29044
(dp29045
sVP-glycoprotein/ABCB1 Inhibitors
p29046
(dp29047
sVAntineoplastic and Immunomodulating Agents
p29048
(dp29049
ssg2037
(dp29050
g8217
(dp29051
sg4491
(dp29052
ssg2040
(dp29053
g11832
(dp29054
ssg2043
(dp29055
VAromatase Inhibitors
p29056
(dp29057
sVHormone Antagonists
p29058
g24267
sVEstrogen Antagonists
p29059
(dp29060
sVSteroids
p29061
(dp29062
sVAndrostanes
p29063
(dp29064
sVCytochrome P-450 CYP3A Substrates
p29065
(dp29066
sVHormone Antagonists and Related Agents
p29067
(dp29068
sVAndrostenes
p29069
(dp29070
sVHormones, Hormone Substitutes, and Hormone Antagonists
p29071
(dp29072
sVSteroid Synthesis Inhibitors
p29073
(dp29074
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p29075
(dp29076
sVAntineoplastic and Immunomodulating Agents
p29077
(dp29078
sVEnzyme Inhibitors
p29079
(dp29080
sVFused-Ring Compounds
p29081
g14858
sVCytochrome P-450 CYP3A4 Substrates
p29082
(dp29083
sVAntineoplastic Agents
p29084
(dp29085
sVEndocrine Therapy
p29086
g19562
ssg2046
(dp29087
VAgents that produce neuromuscular block (indirect)
p29088
(dp29089
sVOphthalmological and Otological Preparations
p29090
(dp29091
sVOAT1/SLC22A6 inhibitors
p29092
(dp29093
sVCytochrome P-450 CYP3A Substrates
p29094
(dp29095
sVStomatological Preparations
p29096
(dp29097
sVCytochrome P-450 CYP3A4 Inhibitors
p29098
(dp29099
sVTetracycline, antagonists & inhibitors
p29100
(dp29101
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p29102
(dp29103
sVEnzyme Inhibitors
p29104
(dp29105
sVCytochrome P-450 Enzyme Inhibitors
p29106
(dp29107
sVAnti-Infective Agents
p29108
(dp29109
sVAntiinfectives for Systemic Use
p29110
(dp29111
sVDrugs that are Mainly Renally Excreted
p29112
(dp29113
sVAntibiotics for Topical Use
p29114
(dp29115
sVOtologicals
p29116
(dp29117
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p29118
(dp29119
sVAnti-Bacterial Agents
p29120
(dp29121
sVNaphthacenes
p29122
(dp29123
sVProtein Synthesis Inhibitors
p29124
(dp29125
sVOAT3/SLC22A8 Substrates
p29126
g13119
sVP-glycoprotein/ABCB1 Substrates
p29127
(dp29128
sVDermatologicals
p29129
g17194
sVSensory Organs
p29130
(dp29131
sVAntibacterials for Systemic Use
p29132
(dp29133
sVCytochrome P-450 CYP3A4 Substrates
p29134
(dp29135
sVAlimentary Tract and Metabolism
p29136
g23773
sVOphthalmologicals
p29137
(dp29138
sVCytochrome P-450 CYP3A Inhibitors
p29139
(dp29140
sVOAT3/SLC22A8 Inhibitors
p29141
(dp29142
sVTetracyclines
p29143
(dp29144
sVDrugs for Acid Related Disorders
p29145
(dp29146
sVAntiinfectives and Antiseptics for Local Oral Treatment
p29147
(dp29148
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p29149
(dp29150
ssg2049
(dp29151
g10209
(dp29152
ssg2052
(dp29153
g657
g18310
sg9561
(dp29154
ssg2055
(dp29155
g1635
g26017
sg11319
(dp29156
sg9696
(dp29157
sg11649
(dp29158
sg2067
(dp29159
sg4488
(dp29160
sg4647
(dp29161
sg255
g14378
sg612
g17863
sg11445
(dp29162
sg5598
(dp29163
ssg2058
(dp29164
VAmino Acids, Peptides, and Proteins
p29165
(dp29166
sVFibrin Modulating Agents
p29167
g22856
sVHematologic Agents
p29168
(dp29169
sVBlood and Blood Forming Organs
p29170
(dp29171
sVFatty Acids
p29172
(dp29173
sg4995
(dp29174
sVHemostatics
p29175
g23064
sVAcids, Acyclic
p29176
g25455
sg8688
(dp29177
sVDecreased Fibrinolysis
p29178
(dp29179
sVFatty Acids, Volatile
p29180
(dp29181
sVAmino Acids
p29182
(dp29183
sVLipids
p29184
g14310
sVAntifibrinolytic Agents
p29185
(dp29186
sVCoagulants
p29187
(dp29188
ssg2061
(dp29189
g9117
(dp29190
sg6186
(dp29191
sg30
g12370
sg12421
g12456
sg3117
(dp29192
sg816
g19660
sg42
g12580
sg9165
(dp29193
sg10797
(dp29194
sg2133
(dp29195
sg3141
(dp29196
sg9198
(dp29197
sg10818
(dp29198
sg6807
(dp29199
sg3174
(dp29200
sg6279
(dp29201
sg3177
(dp29202
sg9225
(dp29203
sg9231
(dp29204
sg9234
(dp29205
sg9981
(dp29206
sg3204
(dp29207
sg147
g13449
sg9273
(dp29208
sg3219
(dp29209
sg3222
(dp29210
sg6315
(dp29211
sg6318
(dp29212
sg3231
(dp29213
sg7533
(dp29214
sg13091
g21381
sg3240
(dp29215
sg6333
(dp29216
sg6336
(dp29217
sg195
g13909
sg6345
(dp29218
sg7170
(dp29219
sg14829
(dp29220
sg7053
(dp29221
sg7962
(dp29222
sg240
g14185
sg7884
(dp29223
sg12066
(dp29224
sg3318
(dp29225
sg3321
(dp29226
sg10662
(dp29227
sg9462
(dp29228
sg1626
g25956
sg6411
(dp29229
sg7545
(dp29230
sg282
g14550
sg285
g14626
sg1614
g25867
sg294
g14740
sg14838
(dp29231
sg9663
(dp29232
sg6447
(dp29233
sg9432
(dp29234
sg3393
(dp29235
sg8028
(dp29236
sg6504
(dp29237
sg14791
(dp29238
sg387
g15639
sg14872
g15723
sg3444
(dp29239
sg3447
(dp29240
sg6537
(dp29241
sg426
g16085
sg2373
(dp29242
sg2430
(dp29243
sg456
g16393
sg9528
(dp29244
sg3867
(dp29245
sg3516
(dp29246
sg507
g16767
sg9564
(dp29247
sg78
g12850
sg9588
(dp29248
sg9591
(dp29249
sg2910
(dp29250
sg11886
(dp29251
sg9609
(dp29252
sg543
g17091
sg9618
(dp29253
sg10959
(dp29254
sg6645
(dp29255
sg3021
(dp29256
sg3963
(dp29257
sg6654
(dp29258
sg11439
(dp29259
sg9180
(dp29260
sg570
g17487
sg573
g17544
sg3570
(dp29261
sg582
g17625
sg6687
(dp29262
sg8472
(dp29263
sg3597
(dp29264
sg600
g17743
sg3363
(dp29265
sg621
g17962
sg3633
(dp29266
sg9693
(dp29267
sg3651
(dp29268
sg9324
(dp29269
sg9711
(dp29270
sg9828
(dp29271
sg8295
(dp29272
sg6765
(dp29273
sg690
g18616
sg6783
(dp29274
sg3696
(dp29275
sg702
g18822
sg9987
(dp29276
sg3975
(dp29277
sg9774
(dp29278
sg723
g19089
sg11625
(dp29279
sg3783
(dp29280
sg9819
(dp29281
sg9822
(dp29282
sg771
g19285
sg10758
(dp29283
sg2664
(dp29284
sg10305
(dp29285
sg4620
(dp29286
sg11283
(dp29287
sg138
g13289
sg7464
(dp29288
sg819
g19749
sg3846
(dp29289
sg3858
(dp29290
sg3861
(dp29291
sg6882
(dp29292
sg828
g19860
sg831
g19921
sg4788
(dp29293
sg9903
(dp29294
sg3885
(dp29295
sg5805
(dp29296
sg6819
(dp29297
sg11016
(dp29298
sg888
g20443
sg6939
(dp29299
sg9954
(dp29300
sg9960
(dp29301
sg9963
(dp29302
sg915
g20701
sg6966
(dp29303
sg7377
(dp29304
sg933
g20821
sg11337
(dp29305
sg10170
(dp29306
sg966
g21043
sg3978
(dp29307
sg11523
(dp29308
sg5646
(dp29309
sg9081
(dp29310
sg7029
(dp29311
sg4005
(dp29312
sg1008
g21279
sg7041
(dp29313
sg4014
(dp29314
sg4023
(dp29315
sg714
g19012
sg1035
g21460
sg7707
(dp29316
sg7065
(dp29317
sg2262
(dp29318
sg10308
(dp29319
sg1062
g21804
sg6156
(dp29320
sg4077
(dp29321
sg4089
(dp29322
sg4101
(dp29323
sg11820
(dp29324
sg4113
(dp29325
sg6435
(dp29326
sg345
g15228
sg10179
(dp29327
sg1134
g22326
sg7152
(dp29328
sg7275
(dp29329
sg537
g17030
sg10209
(dp29330
sg4164
(dp29331
sg7191
(dp29332
sg7197
(dp29333
sg780
g19357
sg465
g16468
sg10266
(dp29334
sg9084
(dp29335
sg10275
(dp29336
sg4236
(dp29337
sg1047
g21607
sg1059
g21754
sg4257
(dp29338
sg4263
(dp29339
sg7284
(dp29340
sg4278
(dp29341
sg4287
(dp29342
sg7329
(dp29343
sg7335
(dp29344
sg7389
(dp29345
sg1503
g25180
sg7569
(dp29346
sg11151
(dp29347
sg7299
(dp29348
sg10416
(dp29349
sg4827
(dp29350
sg10389
(dp29351
sg9096
(dp29352
sg7698
(dp29353
sg1365
g24052
sg1371
g24095
sg1383
g24173
sg1863
g27769
sg4299
(dp29354
sg13750
g24374
sg7422
(dp29355
sg4437
(dp29356
sg7428
(dp29357
sg16906
(dp29358
sg8163
(dp29359
sg4449
(dp29360
sg4452
(dp29361
sg1434
g24651
sg10470
(dp29362
sg684
g18497
sg1461
g24814
sg4476
(dp29363
sg4479
(dp29364
sg1473
g24963
sg1491
g25087
sg5970
(dp29365
sg7497
(dp29366
sg7317
(dp29367
sg10521
(dp29368
sg10539
(dp29369
sg2739
(dp29370
sg1539
g25317
sg10557
(dp29371
sg10563
(dp29372
sg12090
(dp29373
sg8949
(dp29374
sg10596
(dp29375
sg10602
(dp29376
sg7593
(dp29377
sg4596
(dp29378
sg1599
g25743
sg7608
(dp29379
sg9105
(dp29380
sg1611
g25813
sg4635
(dp29381
sg4638
(dp29382
sg4650
(dp29383
sg4653
(dp29384
sg1650
g26106
sg1656
g26163
sg10674
(dp29385
sg7668
(dp29386
sg1668
g26251
sg1470
g24905
sg10701
(dp29387
sg2388
(dp29388
sg3543
(dp29389
sg4344
(dp29390
sg7716
(dp29391
sg10740
(dp29392
sg10752
(dp29393
sg9834
(dp29394
sg10761
(dp29395
sg4746
(dp29396
sg10779
(dp29397
sg7764
(dp29398
sg10737
(dp29399
sg4782
(dp29400
sg5112
(dp29401
sg11259
(dp29402
sg1791
g27244
sg9417
(dp29403
sg10839
(dp29404
sg1803
g27383
sg1809
g27431
sg4830
(dp29405
sg12274
g27529
sg10884
(dp29406
sg10899
(dp29407
sg4881
(dp29408
sg288
g14668
sg4680
(dp29409
sg4773
(dp29410
sg4911
(dp29411
sg1881
g27953
sg4920
(dp29412
sg10149
(dp29413
sg1890
g28007
sg4926
(dp29414
sg1899
g28061
sg7941
(dp29415
sg7947
(dp29416
sg1908
g28295
sg10950
(dp29417
sg1911
g28359
sg1920
g28488
sg4959
(dp29418
sg11022
(dp29419
sg339
g15163
sg8031
(dp29420
sg2007
g28875
sg8049
(dp29421
sg1947
g28679
sg2034
g29018
sg11721
(dp29422
sg2043
g29076
sg5064
(dp29423
sg11079
(dp29424
sg10263
(dp29425
sg5094
(dp29426
sg11952
(dp29427
sg2094
(dp29428
sg8448
(dp29429
sg2109
(dp29430
sg2115
(dp29431
sg10272
(dp29432
sg2127
(dp29433
sg5127
(dp29434
sg69
g12765
sg5145
(dp29435
sg11166
(dp29436
sg2142
(dp29437
sg2943
(dp29438
sg9966
(dp29439
sg2172
(dp29440
sg5199
(dp29441
sg438
g16185
sg2196
(dp29442
sg2199
(dp29443
sg8205
(dp29444
sg516
g16866
sg528
g16928
sg11229
(dp29445
sg2211
(dp29446
sg5235
(dp29447
sg8241
(dp29448
sg822
g19816
sg849
g20078
sg1113
g22181
sg2250
(dp29449
sg11997
(dp29450
sg5313
(dp29451
sg5316
(dp29452
sg11316
(dp29453
sg1140
g22388
sg8298
(dp29454
sg14822
(dp29455
sg5289
(dp29456
sg5364
(dp29457
sg7416
(dp29458
sg11358
(dp29459
sg11370
(dp29460
sg7524
(dp29461
sg7563
(dp29462
sg2346
(dp29463
sg2403
(dp29464
sg10377
(dp29465
sg2358
(dp29466
sg5433
(dp29467
sg8388
(dp29468
sg7821
(dp29469
sg1800
g27315
sg2226
(dp29470
sg5454
(dp29471
sg5460
(dp29472
sg1869
g27824
sg8421
(dp29473
sg5472
(dp29474
sg7983
(dp29475
sg8430
(dp29476
sg11451
(dp29477
sg8433
(dp29478
sg4446
(dp29479
sg2046
g29119
sg5499
(dp29480
sg2088
(dp29481
sg2427
(dp29482
sg2433
(dp29483
sg8454
(dp29484
sg8457
(dp29485
sg8460
(dp29486
sg5028
(dp29487
sg2460
(dp29488
sg8514
(dp29489
sg5556
(dp29490
sg2493
(dp29491
sg11544
(dp29492
sg11112
(dp29493
sg2616
(dp29494
sg2676
(dp29495
sg8724
(dp29496
sg2559
(dp29497
sg11592
(dp29498
sg11595
(dp29499
sg11601
(dp29500
sg8916
(dp29501
sg11619
(dp29502
sg3024
(dp29503
sg8625
(dp29504
sg9099
(dp29505
sg9111
(dp29506
sg11655
(dp29507
sg11052
(dp29508
sg3132
(dp29509
sg1857
g27704
sg9030
(dp29510
sg8655
(dp29511
sg5691
(dp29512
sg8658
(dp29513
sg5694
(dp29514
sg5208
(dp29515
sg12534
(dp29516
sg9357
(dp29517
sg2652
(dp29518
sg9414
(dp29519
sg9471
(dp29520
sg8694
(dp29521
sg11508
(dp29522
sg8703
(dp29523
sg2667
(dp29524
sg11733
(dp29525
sg2688
(dp29526
sg10056
(dp29527
sg1245
g23019
sg2703
(dp29528
sg8013
(dp29529
sg5766
(dp29530
sg5769
(dp29531
sg2715
(dp29532
sg1281
g23375
sg11775
(dp29533
sg2730
(dp29534
sg8751
(dp29535
sg5796
(dp29536
sg4539
(dp29537
sg10062
(dp29538
sg9918
(dp29539
sg9924
(dp29540
sg3912
(dp29541
sg1425
g24549
sg2763
(dp29542
sg10041
(dp29543
sg5829
(dp29544
sg5832
(dp29545
sg8781
(dp29546
sg8787
(dp29547
sg2784
(dp29548
sg5853
(dp29549
sg11838
(dp29550
sg5865
(dp29551
sg5877
(dp29552
sg11940
(dp29553
sg8820
(dp29554
sg2814
(dp29555
sg5895
(dp29556
sg4458
(dp29557
sg2829
(dp29558
sg1548
g25375
sg2850
(dp29559
sg696
g18729
sg11097
(dp29560
sg8874
(dp29561
sg11910
(dp29562
sg28215
(dp29563
sg11913
(dp29564
sg11922
(dp29565
sg11931
(dp29566
sg8097
(dp29567
sg11955
(dp29568
sg11961
(dp29569
sg11976
(dp29570
sg11979
(dp29571
sg2946
(dp29572
sg8964
(dp29573
sg6033
(dp29574
sg6045
(dp29575
sg6048
(dp29576
sg6051
(dp29577
sg12018
(dp29578
sg6069
(dp29579
sg6468
(dp29580
sg5526
(dp29581
sg3546
(dp29582
sg9009
(dp29583
sg3009
(dp29584
sg6090
(dp29585
sg6906
(dp29586
sg11475
(dp29587
sg12063
(dp29588
sg3027
(dp29589
sg6102
(dp29590
sg2832
(dp29591
sg9420
(dp29592
sg11790
(dp29593
sg9060
(dp29594
sg1098
g22021
sg5181
(dp29595
sg12126
(dp29596
sg6075
(dp29597
sg12132
(dp29598
sg9102
(dp29599
sg1185
g22722
sg12123
(dp29600
sg3624
(dp29601
ssg2064
(dp29602
g8097
(dp29603
sg9417
(dp29604
sg387
g15583
sg10497
(dp29605
sg7941
(dp29606
sg11979
(dp29607
sg2427
(dp29608
sg9981
(dp29609
sg10056
(dp29610
ssg2067
(dp29611
VAdrenergic beta-Agonists
p29612
(dp29613
sVOphthalmologicals
p29614
(dp29615
sVNeurotransmitter Agents
p29616
(dp29617
sVCentral Nervous System Agents
p29618
(dp29619
sVAdrenergic and Dopaminergic Agents
p29620
(dp29621
sVSympathomimetics
p29622
(dp29623
sVSympathomimetics, Plain
p29624
g14443
sVAlpha-and Beta-adrenergic Agonists
p29625
g26140
sVSympathomimetic (Adrenergic) Agents
p29626
(dp29627
sVNasal Preparations
p29628
(dp29629
sVAutonomic Agents
p29630
(dp29631
sVCardiac Stimulants Excl. Cardiac Glycosides
p29632
g29159
sVCardiac Therapy
p29633
(dp29634
sVEthylamines
p29635
g20592
sg5502
(dp29636
sg3921
(dp29637
sVDrugs for Obstructive Airway Diseases
p29638
(dp29639
sg5301
(dp29640
sVAdrenergic Agents
p29641
(dp29642
sVCardiovascular Agents
p29643
g26618
sg6864
(dp29644
sVVasoconstrictor Agents
p29645
(dp29646
sg11376
(dp29647
sVSensory Organs
p29648
(dp29649
sg4290
(dp29650
sVAdrenergic Agonists
p29651
(dp29652
sVAgents that produce hypertension
p29653
(dp29654
sVAlimentary Tract and Metabolism
p29655
g23874
sVPropanolamines
p29656
(dp29657
sVAmines
p29658
(dp29659
sVMydriatics and Cycloplegics
p29660
(dp29661
sVAmino Alcohols
p29662
(dp29663
sVAdrenergic alpha-Agonists
p29664
(dp29665
sg6924
(dp29666
sVPropanols
p29667
(dp29668
sVPeripheral Nervous System Agents
p29669
(dp29670
sVAgents producing tachycardia
p29671
(dp29672
sg3615
(dp29673
sVPhenethylamines
p29674
(dp29675
sg792
g19492
sVAlcohols
p29676
(dp29677
sVNorepinephrine Releasing Agent
p29678
(dp29679
ssg2070
(dp29680
g219
g14084
sg1659
g26211
sg11427
(dp29681
sg9375
(dp29682
sg2598
(dp29683
sg8067
(dp29684
sg10326
(dp29685
sg4488
(dp29686
sg7824
(dp29687
sg339
g15167
sg7500
(dp29688
sg2769
(dp29689
sg10365
(dp29690
sg1635
g26046
sg6981
(dp29691
sg3399
(dp29692
sg10854
(dp29693
sg10416
(dp29694
sg8760
(dp29695
sg9033
(dp29696
sg11241
(dp29697
sg9855
(dp29698
sg6525
(dp29699
ssg2073
(dp29700
g9117
(dp29701
sg11283
(dp29702
sg7464
(dp29703
sg819
g19755
sg2355
(dp29704
sg10818
(dp29705
sg3846
(dp29706
sg5427
(dp29707
sg4635
(dp29708
sg5433
(dp29709
sg828
g19877
sg4788
(dp29710
sg4803
(dp29711
sg7650
(dp29712
sg10011
(dp29713
sg8418
(dp29714
sg858
g20168
sg8421
(dp29715
sg7983
(dp29716
sg6819
(dp29717
sg5256
(dp29718
sg2088
(dp29719
sg9960
(dp29720
sg8460
(dp29721
sg10728
(dp29722
sg7716
(dp29723
sg4716
(dp29724
sg9987
(dp29725
sg12421
g12460
sg132
g13230
sg147
g13451
sg963
g20994
sg10779
(dp29726
sg5571
(dp29727
sg7533
(dp29728
sg13091
g21385
sg11523
(dp29729
sg183
g13810
sg7077
(dp29730
sg6333
(dp29731
sg6336
(dp29732
sg9081
(dp29733
sg5589
(dp29734
sg10062
(dp29735
sg1791
g27246
sg2559
(dp29736
sg8166
(dp29737
sg7065
(dp29738
sg10857
(dp29739
sg9918
(dp29740
sg12274
g27534
sg8787
(dp29741
sg1062
g21812
sg285
g14632
sg11655
(dp29742
sg8049
(dp29743
sg4680
(dp29744
sg5970
(dp29745
sg8655
(dp29746
sg5694
(dp29747
sg6447
(dp29748
sg9357
(dp29749
sg1899
g28065
sg7941
(dp29750
sg7152
(dp29751
sg10950
(dp29752
sg2667
(dp29753
sg9981
(dp29754
sg2688
(dp29755
sg14791
(dp29756
sg4155
(dp29757
sg6048
(dp29758
sg4974
(dp29759
sg7671
(dp29760
sg7191
(dp29761
sg9420
(dp29762
sg7197
(dp29763
sg1281
g23377
sg3447
(dp29764
sg9828
(dp29765
sg1908
g28297
sg426
g16091
sg465
g16470
sg3408
(dp29766
sg11793
(dp29767
sg1425
g24558
sg5028
(dp29768
sg450
g16337
sg9525
(dp29769
sg5832
(dp29770
sg10308
(dp29771
sg11052
(dp29772
sg4260
(dp29773
sg7272
(dp29774
sg4263
(dp29775
sg2199
(dp29776
sg3519
(dp29777
sg10977
(dp29778
sg5877
(dp29779
sg7335
(dp29780
sg7389
(dp29781
sg8097
(dp29782
sg543
g17093
sg9618
(dp29783
sg7317
(dp29784
sg5112
(dp29785
sg6024
(dp29786
sg696
g18735
sg7569
(dp29787
sg1578
g25642
sg564
g17408
sg1668
g26280
sg5145
(dp29788
sg7698
(dp29789
sg3570
(dp29790
sg1365
g24057
sg336
g15103
sg9372
(dp29791
sg8019
(dp29792
sg11112
(dp29793
sg11955
(dp29794
sg4425
(dp29795
sg11961
(dp29796
sg2094
(dp29797
sg11229
(dp29798
sg2211
(dp29799
sg2943
(dp29800
sg11979
(dp29801
sg1434
g24653
sg5250
(dp29802
sg6765
(dp29803
sg1461
g24816
sg9687
(dp29804
sg6867
(dp29805
sg3861
(dp29806
sg10494
(dp29807
sg6075
(dp29808
sg1491
g25081
sg5526
(dp29809
sg10740
(dp29810
sg3711
(dp29811
sg9009
(dp29812
sg2109
(dp29813
sg714
g19014
sg5313
(dp29814
sg11316
(dp29815
sg2832
(dp29816
sg6000
(dp29817
sg9393
(dp29818
sg5289
(dp29819
sg9822
(dp29820
sg771
g19287
sg5181
(dp29821
sg5370
(dp29822
sg12126
(dp29823
sg6654
(dp29824
sg7596
(dp29825
sg9102
(dp29826
sg9060
(dp29827
sg1185
g22728
sg7608
(dp29828
sg3624
(dp29829
ssg2076
(dp29830
g11655
(dp29831
sg1140
g22391
sg9987
(dp29832
ssg2079
(dp29833
VAmino Acids, Acidic
p29834
(dp29835
sVNucleic Acid Synthesis Inhibitors
p29836
(dp29837
sVAmino Acids, Dicarboxylic
p29838
(dp29839
sVGuanine
p29840
(dp29841
sVEnzyme Inhibitors
p29842
(dp29843
sVDrugs that are Mainly Renally Excreted
p29844
(dp29845
sVAmino Acids
p29846
(dp29847
sg4590
(dp29848
sVMyelosuppressive Agents
p29849
(dp29850
sVPurinones
p29851
(dp29852
sVAntineoplastic Agents
p29853
(dp29854
sVFolic Acid Antagonists
p29855
(dp29856
sVOAT3/SLC22A8 Substrates
p29857
g13124
sVCytochrome P-450 CYP1A2 Substrates
p29858
(dp29859
sVPurines
p29860
(dp29861
sVAmino Acids, Peptides, and Proteins
p29862
(dp29863
sVHeterocyclic Compounds, Fused-Ring
p29864
(dp29865
sVAntimetabolites
p29866
(dp29867
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p29868
(dp29869
sVFolic Acid Analogues
p29870
(dp29871
sVImmunosuppressive Agents
p29872
(dp29873
sVAntineoplastic and Immunomodulating Agents
p29874
(dp29875
ssg2082
(dp29876
g11793
(dp29877
sg9393
(dp29878
ssg2085
(dp29879
g13091
g21390
sg1152
g22549
ssg2088
(dp29880
VCytochrome P-450 CYP2D6 Inhibitors
p29881
(dp29882
sVCytochrome P-450 CYP2D6 Substrates
p29883
(dp29884
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p29885
(dp29886
sVAnalgesics
p29887
g26472
sVAgents causing hyperkalemia
p29888
(dp29889
sVCentral Nervous System Agents
p29890
(dp29891
sVAntiinflammatory and Antirheumatic Products
p29892
(dp29893
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p29894
g24334
sVEnzyme Inhibitors
p29895
(dp29896
sVCyclooxygenase Inhibitors
p29897
(dp29898
sVCytochrome P-450 Enzyme Inhibitors
p29899
(dp29900
sVPeripheral Nervous System Agents
p29901
(dp29902
sVCytochrome P-450 CYP2C8 Substrates
p29903
(dp29904
sVNonsteroidal Anti-inflammatory Compounds
p29905
(dp29906
sVAnalgesics, Non-Narcotic
p29907
(dp29908
sVGynecological Antiinfectives and Antiseptics
p29909
(dp29910
sVNephrotoxic agents
p29911
(dp29912
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p29913
(dp29914
sVAmides
p29915
(dp29916
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p29917
g29481
sVSulfur Compounds
p29918
(dp29919
sVCytochrome P-450 CYP2C9 Substrates
p29920
g29719
sVSulfonamides
p29921
(dp29922
sVCytochrome P-450 CYP3A Substrates
p29923
(dp29924
sVCOX-2 Inhibitors
p29925
(dp29926
sVSulfones
p29927
(dp29928
sVP-glycoprotein/ABCB1 Substrates
p29929
(dp29930
sVPyrazoles
p29931
(dp29932
sVAgents that produce hypertension
p29933
(dp29934
sVBSEP/ABCB11 Inhibitors
p29935
(dp29936
sVCyclooxygenase-2 (COX-2) Inhibitors
p29937
(dp29938
sVCytochrome P-450 CYP3A4 Substrates
p29939
(dp29940
sVMusculo-Skeletal System
p29941
(dp29942
sVGenito Urinary System and Sex Hormones
p29943
(dp29944
sVBCRP/ABCG2 Substrates
p29945
(dp29946
sVMethemoglobinemia Associated Agents
p29947
g25570
sVAnti-Inflammatory Agents
p29948
(dp29949
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p29950
(dp29951
sVAntineoplastic and Immunomodulating Agents
p29952
(dp29953
sVAntirheumatic Agents
p29954
g24226
sVSensory System Agents
p29955
(dp29956
sVAnti-Inflammatory Agents, Non-Steroidal
p29957
(dp29958
ssg2091
(dp29959
g9609
(dp29960
sg10209
(dp29961
sg9693
(dp29962
sg8430
(dp29963
sg1245
g22999
sg6783
(dp29964
sg1383
g24152
sg2832
(dp29965
sg5766
(dp29966
sg8694
(dp29967
sg9225
(dp29968
ssg2094
(dp29969
VAmino Acids, Peptides, and Proteins
p29970
(dp29971
sVDrugs that are Mainly Renally Excreted
p29972
(dp29973
sVCytochrome P-450 CYP2C8 Substrates
p29974
(dp29975
sVAmino Acids
p29976
(dp29977
sVCytochrome P-450 CYP2D6 Substrates
p29978
(dp29979
sVCytochrome P-450 CYP3A Substrates
p29980
(dp29981
sVProtease Inhibitors
p29982
(dp29983
sVCytochrome P-450 CYP1A2 Substrates
p29984
(dp29985
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p29986
g29428
sVCytochrome P-450 CYP2B6 Substrates
p29987
(dp29988
sVAntineoplastic and Immunomodulating Agents
p29989
(dp29990
sVProteasome Inhibitors
p29991
(dp29992
sVEnzyme Inhibitors
p29993
(dp29994
sVCytochrome P-450 CYP2C9 Substrates
p29995
g29797
sVCytochrome P-450 CYP3A4 Substrates
p29996
(dp29997
sVAntineoplastic Agents
p29998
(dp29999
ssg2097
(dp30000
g13750
g24385
sg4476
(dp30001
sg11274
(dp30002
sg9693
(dp30003
sg10323
(dp30004
sg9774
(dp30005
sg816
g19670
sg11922
(dp30006
sg3117
(dp30007
sg5433
(dp30008
sg2373
(dp30009
sg9903
(dp30010
sg12274
g27542
sg1800
g27322
sg2226
(dp30011
sg14822
(dp30012
sg4653
(dp30013
sg1650
g26115
sg2388
(dp30014
sg6585
(dp30015
sg6045
(dp30016
sg1383
g24156
sg9225
(dp30017
sg7545
(dp30018
sg7668
(dp30019
sg8430
(dp30020
sg6180
(dp30021
sg1614
g25878
sg1470
g24914
sg6783
(dp30022
sg507
g16775
sg849
g20087
sg11952
(dp30023
sg11940
(dp30024
sg2817
(dp30025
sg14838
(dp30026
sg3543
(dp30027
sg4089
(dp30028
sg5895
(dp30029
sg11997
(dp30030
sg3393
(dp30031
sg2901
(dp30032
sg12534
(dp30033
sg11886
(dp30034
sg9609
(dp30035
sg9357
(dp30036
sg4113
(dp30037
sg10557
(dp30038
sg8106
(dp30039
sg9030
(dp30040
sg2007
g28886
sg1245
g23003
sg4620
(dp30041
sg4875
(dp30042
sg2832
(dp30043
sg8694
(dp30044
sg2127
(dp30045
sg3861
(dp30046
sg2133
(dp30047
sg3783
(dp30048
sg3219
(dp30049
sg6504
(dp30050
sg10209
(dp30051
sg4680
(dp30052
sg5364
(dp30053
sg14872
g15734
sg5766
(dp30054
sg4515
(dp30055
sg12132
(dp30056
sg6345
(dp30057
sg14829
(dp30058
ssg2100
(dp30059
g2814
(dp30060
sg11781
(dp30061
sg7596
(dp30062
ssg2103
(dp30063
g5226
(dp30064
ssg2106
(dp30065
g6279
(dp30066
sg2787
(dp30067
sg3024
(dp30068
sg1104
g22092
sg1050
g21680
sg11592
(dp30069
sg1173
g22635
sg2913
(dp30070
sg7353
(dp30071
sg8742
(dp30072
sg3657
(dp30073
sg5283
(dp30074
sg7821
(dp30075
sg5526
(dp30076
sg3711
(dp30077
sg1578
g25650
sg6798
(dp30078
sg12045
(dp30079
sg7554
(dp30080
sg5973
(dp30081
ssg2109
(dp30082
VBSEP/ABCB11 Substrates
p30083
(dp30084
sVAcetic Acid Derivatives and Related Substances
p30085
g28817
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p30086
(dp30087
sVUGT1A1 Substrates
p30088
g12299
sVOAT1/SLC22A6 inhibitors
p30089
(dp30090
sVAnalgesics
p30091
g26476
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p30092
(dp30093
sVAgents causing angioedema
p30094
(dp30095
sVNon COX-2 selective NSAIDS
p30096
(dp30097
sVCentral Nervous System Agents
p30098
(dp30099
sVUGT1A9 Substrates
p30100
g24009
sVAntiinflammatory and Antirheumatic Products
p30101
(dp30102
sVOATP1B1/SLCO1B1 Inhibitors
p30103
(dp30104
sVCytochrome P-450 CYP2B6 Substrates
p30105
(dp30106
sVEnzyme Inhibitors
p30107
(dp30108
sVCytochrome P-450 Enzyme Inhibitors
p30109
(dp30110
sVPeripheral Nervous System Agents
p30111
(dp30112
sVCytochrome P-450 CYP2C8 Substrates
p30113
(dp30114
sVCytochrome P-450 CYP1A2 Substrates
p30115
(dp30116
sVAnalgesics, Non-Narcotic
p30117
(dp30118
sVUGT1A3 substrates
p30119
(dp30120
sVNephrotoxic agents
p30121
(dp30122
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p30123
(dp30124
sVAcids, Carbocyclic
p30125
(dp30126
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30127
g29430
sVEthylamines
p30128
g20597
sVCytochrome P-450 CYP2C9 Substrates
p30129
g29813
sVCytochrome P-450 CYP3A Substrates
p30130
(dp30131
sVTopical Products for Joint and Muscular Pain
p30132
g13926
sVAgents causing hyperkalemia
p30133
(dp30134
sVDecreased Prostaglandin Production
p30135
(dp30136
sVCytochrome P-450 CYP2E1 Inhibitors
p30137
(dp30138
sVDermatologicals
p30139
g17285
sVOther Nonsteroidal Antiimflammatory Agents
p30140
(dp30141
sVSensory Organs
p30142
(dp30143
sVCytochrome P-450 CYP2C18 Substrates
p30144
g20942
sVAgents that produce hypertension
p30145
(dp30146
sg6225
(dp30147
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p30148
g26879
sVPhenylacetates
p30149
(dp30150
sVAmines
p30151
(dp30152
sVCytochrome P-450 CYP3A4 Substrates
p30153
(dp30154
sVMusculo-Skeletal System
p30155
(dp30156
sVOphthalmologicals
p30157
(dp30158
sVUGT2B7 substrates
p30159
g28636
sVOAT3/SLC22A8 Inhibitors
p30160
(dp30161
sVAnti-Inflammatory Agents
p30162
(dp30163
sVCyclooxygenase Inhibitors
p30164
(dp30165
sVP-glycoprotein/ABCB1 Inhibitors
p30166
(dp30167
sVAntirheumatic Agents
p30168
g24234
sVSensory System Agents
p30169
(dp30170
sVAnti-Inflammatory Agents, Non-Steroidal
p30171
(dp30172
ssg2112
(dp30173
VToxic Actions
p30174
(dp30175
sVHeterocyclic Compounds, Fused-Ring
p30176
(dp30177
sVBenzofurans
p30178
(dp30179
sVNoxae
p30180
(dp30181
sVCompounds used in a research, industrial, or household setting
p30182
(dp30183
sVEnzyme Inhibitors
p30184
(dp30185
sg7779
(dp30186
ssg2115
(dp30187
VProtein Kinase Inhibitors
p30188
(dp30189
sVCytochrome P-450 CYP2D6 Substrates
p30190
(dp30191
sVAcids, Acyclic
p30192
g25474
sVCytochrome P-450 CYP3A Substrates
p30193
(dp30194
sVAmides
p30195
(dp30196
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30197
g29431
sVSulfur Compounds
p30198
(dp30199
sVAntineoplastic and Immunomodulating Agents
p30200
(dp30201
sVSulfones
p30202
(dp30203
sVCytochrome P-450 CYP3A4 Substrates
p30204
(dp30205
sVAntineoplastic Agents
p30206
(dp30207
ssg2118
(dp30208
VAmino Acids, Peptides, and Proteins
p30209
(dp30210
sVGalactosidases
p30211
(dp30212
sVEnzymes
p30213
(dp30214
sVProtein Isoforms
p30215
(dp30216
sVProteins
p30217
(dp30218
sVGlycoside Hydrolases
p30219
g18672
sVHydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
p30220
g22887
sVEnzymes and Coenzymes
p30221
(dp30222
sVHydrolases
p30223
(dp30224
sVAlimentary Tract and Metabolism
p30225
g23885
ssg2121
(dp30226
g9906
(dp30227
ssg2124
(dp30228
g8622
(dp30229
sg10548
(dp30230
sg2403
(dp30231
sg5922
(dp30232
sg10314
(dp30233
sg7944
(dp30234
sg1869
g27839
ssg2127
(dp30235
VHyperglycemia-Associated Agents
p30236
(dp30237
sVCytochrome P-450 CYP3A4 Substrates
p30238
(dp30239
sVAdrenal Cortex Hormones
p30240
g30045
sVNorpregnenes
p30241
(dp30242
sVGenito Urinary System and Sex Hormones
p30243
(dp30244
sVProgestins
p30245
(dp30246
sVCytochrome P-450 CYP3A Substrates
p30247
(dp30248
sVSteroids
p30249
(dp30250
sVCombination Contraceptives (with Estrogen and derivatives)
p30251
(dp30252
sVReproductive Control Agents
p30253
g18856
sVNorpregnanes
p30254
(dp30255
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30256
g29433
sVNorsteroids
p30257
(dp30258
sVContraceptives, Oral
p30259
(dp30260
sVContraceptives, Oral, Synthetic
p30261
(dp30262
sVSex Hormones and Modulators of the Genital System
p30263
g19612
sVFused-Ring Compounds
p30264
g14867
sVContraceptive Agents, Female
p30265
(dp30266
sVProgestin Contraceptives
p30267
(dp30268
sVHormonal Contraceptives for Systemic Use
p30269
(dp30270
ssg2130
(dp30271
g10200
(dp30272
ssg2133
(dp30273
VSex Hormones and Modulators of the Genital System
p30274
g19613
sVCytochrome P-450 CYP3A Substrates
p30275
(dp30276
sVProgestogens and Estrogens, Sequential Preparations
p30277
(dp30278
sVNorpregnanes
p30279
(dp30280
sVHyperglycemia-Associated Agents
p30281
(dp30282
sVContraceptive Agents, Female
p30283
(dp30284
sg11661
(dp30285
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30286
g29195
sVNorsteroids
p30287
(dp30288
sVContraceptives, Oral
p30289
(dp30290
sVFused-Ring Compounds
p30291
g14868
sVHormonal Contraceptives for Systemic Use
p30292
(dp30293
sVAdrenal Cortex Hormones
p30294
g30047
sVReproductive Control Agents
p30295
g18858
sVProgestins
p30296
(dp30297
sVCombination Contraceptives (with Estrogen and derivatives)
p30298
(dp30299
sg3960
(dp30300
sVProgestin Contraceptives
p30301
(dp30302
sVNorpregnenes
p30303
(dp30304
sVContraceptives, Oral, Synthetic
p30305
(dp30306
sg11157
(dp30307
sVCytochrome P-450 CYP3A4 Substrates
p30308
(dp30309
sg6666
(dp30310
sVGenito Urinary System and Sex Hormones
p30311
(dp30312
sVSteroids
p30313
(dp30314
ssg2136
(dp30315
g10680
(dp30316
sg5757
(dp30317
sg7845
(dp30318
sg10236
(dp30319
ssg2139
(dp30320
g7155
(dp30321
sg9726
(dp30322
ssg2142
(dp30323
VAgents Causing Muscle Toxicity
p30324
(dp30325
sVAntiparasitic Products, Insecticides and Repellents
p30326
(dp30327
sVCytochrome P-450 CYP3A4 Inhibitors
p30328
(dp30329
sVCytochrome P-450 CYP3A Substrates
p30330
(dp30331
sVInsecticides
p30332
(dp30333
sVOATP1B1/SLCO1B1 Inhibitors
p30334
(dp30335
sVCompounds used in a research, industrial, or household setting
p30336
(dp30337
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p30338
(dp30339
sVPesticides
p30340
(dp30341
sVCytochrome P-450 Enzyme Inhibitors
p30342
(dp30343
sVAnti-Infective Agents
p30344
(dp30345
sg4464
(dp30346
sVAgrochemicals
p30347
(dp30348
sg7860
(dp30349
sVLactones
p30350
(dp30351
sVScabicides and Pediculicides
p30352
(dp30353
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30354
g29437
sVAnti-Bacterial Agents
p30355
(dp30356
sg11490
(dp30357
sVOATP1B3 inhibitors
p30358
(dp30359
sVP-glycoprotein/ABCB1 Substrates
p30360
(dp30361
sVDermatologicals
p30362
g17292
sVAntiparasitic Agents
p30363
(dp30364
sg3474
(dp30365
sVPolyketides
p30366
(dp30367
sVCytochrome P-450 CYP3A4 Substrates
p30368
(dp30369
sVToxic Actions
p30370
(dp30371
sVCytochrome P-450 CYP3A Inhibitors
p30372
(dp30373
sVBCRP/ABCG2 Substrates
p30374
(dp30375
sVP-glycoprotein/ABCB1 Inhibitors
p30376
(dp30377
ssg2145
(dp30378
g10587
(dp30379
ssg2148
(dp30380
g1941
g28608
sg978
g21186
sg4650
(dp30381
sg3930
(dp30382
sg879
g20374
sg12003
(dp30383
sg3087
(dp30384
sg2658
(dp30385
sg9726
(dp30386
sg1473
g24982
sg4638
(dp30387
sg7824
(dp30388
sg3711
(dp30389
sg9765
(dp30390
sg11862
(dp30391
sg9750
(dp30392
sg969
g21085
sg3399
(dp30393
sg1578
g25659
sg11712
(dp30394
sg564
g17426
sg11535
(dp30395
sg11172
(dp30396
sg171
g13721
sg4974
(dp30397
sg5757
(dp30398
sg3990
(dp30399
sg11769
(dp30400
sg4062
(dp30401
sg7155
(dp30402
sg1770
g27066
sg5394
(dp30403
ssg2151
(dp30404
g6000
(dp30405
sg8166
(dp30406
sg7077
(dp30407
ssg2154
(dp30408
g858
g20156
sg11151
(dp30409
sg6171
(dp30410
sg9528
(dp30411
sg28215
(dp30412
sg9135
(dp30413
sg2466
(dp30414
sg16906
(dp30415
sg2715
(dp30416
sg6489
(dp30417
ssg2157
(dp30418
g3009
(dp30419
ssg2160
(dp30420
g10833
(dp30421
sg10326
(dp30422
sg11508
(dp30423
sg9126
(dp30424
sg7815
(dp30425
sg3912
(dp30426
sg3576
(dp30427
sg10725
(dp30428
sg438
g16176
sg7884
(dp30429
sg8622
(dp30430
sg11427
(dp30431
sg279
g14497
sg819
g19781
sg11052
(dp30432
sg5847
(dp30433
sg5871
(dp30434
sg6231
(dp30435
sg11061
(dp30436
sg9663
(dp30437
sg9192
(dp30438
sg11451
(dp30439
sg8985
(dp30440
sg9198
(dp30441
sg13070
g21921
sg8049
(dp30442
sg3132
(dp30443
sg10377
(dp30444
sg2991
(dp30445
sg6075
(dp30446
sg2808
(dp30447
sg9954
(dp30448
sg8454
(dp30449
sg2250
(dp30450
sg9432
(dp30451
sg10509
(dp30452
sg318
g14933
sg4299
(dp30453
sg5520
(dp30454
sg4707
(dp30455
sg5268
(dp30456
sg2652
(dp30457
sg6435
(dp30458
sg10368
(dp30459
sg7524
(dp30460
sg1527
g25264
sg2274
(dp30461
sg7947
(dp30462
sg9627
(dp30463
sg10854
(dp30464
sg8298
(dp30465
sg8493
(dp30466
sg11334
(dp30467
sg1275
g23311
sg11166
(dp30468
sg1332
g23654
sg8922
(dp30469
sg3795
(dp30470
sg4164
(dp30471
sg12051
(dp30472
sg1101
g22085
sg7500
(dp30473
sg6654
(dp30474
sg1863
g27763
sg573
g17585
sg7881
(dp30475
sg4953
(dp30476
sg11208
(dp30477
sg11385
(dp30478
ssg2163
(dp30479
g9780
(dp30480
sg5457
(dp30481
sg396
g15806
sg3312
(dp30482
ssg2166
(dp30483
g10674
(dp30484
ssg2169
(dp30485
g5289
(dp30486
sg8373
(dp30487
sg10266
(dp30488
sg11241
(dp30489
sg1899
g28092
sg7191
(dp30490
sg8211
(dp30491
ssg2172
(dp30492
VCytochrome P-450 CYP3A Substrates
p30493
(dp30494
sVDPP-IV Inhibitors
p30495
(dp30496
sVAgents causing angioedema
p30497
(dp30498
sVCycloparaffins
p30499
(dp30500
sVProtease Inhibitors
p30501
(dp30502
sVHormones
p30503
(dp30504
sVEnzyme Inhibitors
p30505
(dp30506
sVBlood Glucose Lowering Agents
p30507
(dp30508
sVDrugs that are Mainly Renally Excreted
p30509
(dp30510
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30511
g29440
sVOral Hypoglycemics
p30512
(dp30513
sVDrugs Used in Diabetes
p30514
(dp30515
sVOligopeptides
p30516
(dp30517
sVOAT3/SLC22A8 Substrates
p30518
g13147
sVPeptides
p30519
(dp30520
sVIncretins
p30521
g20131
sVCytochrome P-450 CYP3A4 Substrates
p30522
(dp30523
sVAlimentary Tract and Metabolism
p30524
g23898
sVAmino Acids, Peptides, and Proteins
p30525
(dp30526
sVCytochrome P-450 CYP3A5 Substrates
p30527
(dp30528
sVHypoglycemia-Associated Agents
p30529
g17716
sVHormones, Hormone Substitutes, and Hormone Antagonists
p30530
(dp30531
ssg2175
(dp30532
g2769
(dp30533
sg771
g19311
sg10365
(dp30534
sg945
g20916
sg11241
(dp30535
sg5793
(dp30536
sg2910
(dp30537
ssg2178
(dp30538
g645
g18141
sg11301
(dp30539
sg11934
(dp30540
sg1629
g26007
sg4737
(dp30541
sg10296
(dp30542
sg10554
(dp30543
ssg2181
(dp30544
g5469
(dp30545
ssg2184
(dp30546
g2658
(dp30547
sg1770
g27063
sg12003
(dp30548
sg3399
(dp30549
sg9750
(dp30550
ssg2187
(dp30551
g10320
(dp30552
sg171
g13736
sg495
g16716
sg11268
(dp30553
sg3684
(dp30554
sg4419
(dp30555
sg11916
(dp30556
sg11361
(dp30557
sg7713
(dp30558
sg2277
(dp30559
sg6381
(dp30560
sg7824
(dp30561
sg6570
(dp30562
sg1146
g22483
sg753
g19232
sg420
g16037
sg4683
(dp30563
ssg2190
(dp30564
g2928
(dp30565
sg10275
(dp30566
sg10914
(dp30567
sg7707
(dp30568
sg600
g17733
sg1239
g22919
sg10890
(dp30569
sg2424
(dp30570
sg9588
(dp30571
sg10347
(dp30572
sg3009
(dp30573
sg5316
(dp30574
sg7527
(dp30575
sg3753
(dp30576
sg11337
(dp30577
sg9471
(dp30578
sg10170
(dp30579
sg10950
(dp30580
sg4542
(dp30581
sg1152
g22528
sg2142
g30327
sg8562
(dp30582
sg2688
(dp30583
sg11172
(dp30584
sg3222
(dp30585
sg12126
(dp30586
sg11370
(dp30587
sg5193
(dp30588
ssg2193
(dp30589
g345
g15197
ssg2196
(dp30590
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p30591
(dp30592
sVCytochrome P-450 CYP2D6 Inhibitors
p30593
(dp30594
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p30595
(dp30596
sVCytochrome P-450 CYP3A Substrates
p30597
(dp30598
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p30599
(dp30600
sVBCRP/ABCG2 Inhibitors
p30601
g12503
sVKinase Inhibitor
p30602
g24581
sVOATP1B1/SLCO1B1 Inhibitors
p30603
(dp30604
sVCytochrome P-450 CYP2C9 Inhibitors
p30605
g18232
sVCytochrome P-450 Enzyme Inhibitors
p30606
(dp30607
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p30608
(dp30609
sVHighest Risk QTc-Prolonging Agents
p30610
(dp30611
sVCytochrome P-450 CYP2B6 Inducers
p30612
(dp30613
sVTyrosine Kinase Inhibitors
p30614
(dp30615
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30616
g29442
sVQTc Prolonging Agents
p30617
(dp30618
sVHyperglycemia-Associated Agents
p30619
(dp30620
sVAntineoplastic Agents
p30621
(dp30622
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p30623
(dp30624
sVCytochrome P-450 CYP2C8 Inhibitors
p30625
(dp30626
sVP-glycoprotein/ABCB1 Substrates
p30627
(dp30628
sVUGT1A1 Inhibitors
p30629
(dp30630
sVCytochrome P-450 Enzyme Inducers
p30631
g28189
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p30632
(dp30633
sVCytochrome P-450 CYP3A Inhibitors (strong)
p30634
g13381
sVCytochrome P-450 CYP3A4 Substrates
p30635
(dp30636
sVCytochrome P-450 CYP3A4 Inhibitors
p30637
(dp30638
sVProtein Kinase Inhibitors
p30639
(dp30640
sVMyelosuppressive Agents
p30641
(dp30642
sVCytochrome P-450 CYP2C8 Inducers
p30643
(dp30644
sVCytochrome P-450 CYP3A Inhibitors
p30645
(dp30646
sVImmunosuppressive Agents
p30647
(dp30648
sVBCRP/ABCG2 Substrates
p30649
(dp30650
sVP-glycoprotein/ABCB1 Inhibitors
p30651
(dp30652
sVAntineoplastic and Immunomodulating Agents
p30653
(dp30654
ssg2199
(dp30655
VNMDA Receptor Antagonists
p30656
(dp30657
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p30658
(dp30659
sVAnticholinergic Agents
p30660
g24457
sVCytochrome P-450 CYP2D6 Substrates
p30661
(dp30662
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p30663
(dp30664
sVSerotonin Agents
p30665
(dp30666
sVCytochrome P-450 CYP3A Substrates
p30667
(dp30668
sVNeurotransmitter Agents
p30669
(dp30670
sg8214
(dp30671
sVCentral Nervous System Agents
p30672
(dp30673
sg5964
(dp30674
sVCytochrome P-450 CYP2B6 Substrates
p30675
(dp30676
sg3663
(dp30677
sVNarcotics
p30678
(dp30679
sVCytochrome P-450 CYP2C8 Substrates
p30680
(dp30681
sVCytochrome P-450 CYP3A4 Substrates
p30682
(dp30683
sVExcitatory Amino Acid Antagonists
p30684
(dp30685
sVRespiratory System Agents
p30686
(dp30687
sVExcitatory Amino Acid Agents
p30688
g14798
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30689
g29443
sVCytochrome P-450 CYP2C9 Substrates
p30690
g29776
sVCentral Nervous System Depressants
p30691
(dp30692
sVOpium Alkaloids and Derivatives
p30693
(dp30694
sVOpiate Alkaloids
p30695
(dp30696
sVAntitussive Agents
p30697
(dp30698
sVExpectorants
p30699
(dp30700
sVHeterocyclic Compounds, Fused-Ring
p30701
(dp30702
sVMorphinans
p30703
(dp30704
sVPhenanthrenes
p30705
(dp30706
sVNicotinic Antagonists
p30707
(dp30708
sVCytochrome P-450 CYP3A5 Substrates
p30709
(dp30710
sVSerotonin Modulators
p30711
(dp30712
sVAntidepressive Agents
p30713
g15562
sg10413
(dp30714
sVAlkaloids
p30715
g19412
sVCough and Cold Preparations
p30716
(dp30717
sVNervous System
p30718
(dp30719
sVCytochrome P-450 CYP3A7 Substrates
p30720
(dp30721
ssg2202
(dp30722
g11379
(dp30723
ssg2205
(dp30724
g1776
g27111
ssg2208
(dp30725
g6207
(dp30726
sg9996
(dp30727
ssg2211
(dp30728
VProtein Kinase Inhibitors
p30729
(dp30730
sVAmines
p30731
(dp30732
sg4584
(dp30733
sVCytochrome P-450 CYP3A Substrates
p30734
(dp30735
sVCytochrome P-450 CYP2C8 Inhibitors
p30736
(dp30737
sVTyrosine Kinase Inhibitors
p30738
(dp30739
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p30740
g24194
sVKinase Inhibitor
p30741
g24585
sVAmides
p30742
(dp30743
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30744
g29446
sVAntineoplastic and Immunomodulating Agents
p30745
(dp30746
sVAniline Compounds
p30747
g23418
sVCytochrome P-450 CYP2C9 Substrates
p30748
g29799
sVCytochrome P-450 Enzyme Inhibitors
p30749
(dp30750
sVCytochrome P-450 CYP3A4 Substrates
p30751
(dp30752
sVAntineoplastic Agents
p30753
(dp30754
ssg2214
(dp30755
g4377
(dp30756
sg1791
g27232
sg141
g13328
sg10548
(dp30757
sg9618
(dp30758
sg10314
(dp30759
sg8928
(dp30760
sg19588
(dp30761
sg1917
g28460
sg1611
g25804
ssg2217
(dp30762
g11154
(dp30763
sg7176
(dp30764
sg12421
g12432
sg7065
(dp30765
sg7197
(dp30766
sg7593
(dp30767
sg168
g13623
sg6921
(dp30768
ssg2220
(dp30769
g8772
(dp30770
ssg2223
(dp30771
g8055
(dp30772
sg10563
(dp30773
sg2043
g29057
ssg2226
(dp30774
VPregnanes
p30775
(dp30776
sVPregnadienes
p30777
(dp30778
sVCytochrome P-450 CYP3A4 Substrates
p30779
(dp30780
sVAdrenal Cortex Hormones
p30781
g30011
sVOphthalmologicals
p30782
(dp30783
sVSteroids
p30784
(dp30785
sVCorticosteroids, Moderately Potent (Group II)
p30786
(dp30787
sVCytochrome P-450 CYP3A Substrates
p30788
(dp30789
sVImmunosuppressive Agents
p30790
(dp30791
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p30792
(dp30793
sVDermatologicals
p30794
g17186
sVAnti-Inflammatory Agents
p30795
(dp30796
sVCorticosteroid Hormone Receptor Agonists
p30797
(dp30798
sVPregnadienetriols
p30799
(dp30800
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30801
g29470
sVCytochrome P-450 CYP3A Inducers
p30802
(dp30803
sVCytochrome P-450 Enzyme Inducers
p30804
g28115
sVFused-Ring Compounds
p30805
g14811
sVCorticosteroids
p30806
(dp30807
sVCytochrome P-450 CYP3A4 Inducers
p30808
g18877
sVSensory Organs
p30809
(dp30810
ssg2229
(dp30811
g3633
(dp30812
sg8880
(dp30813
ssg2232
(dp30814
g1245
g23006
ssg2235
(dp30815
g2343
(dp30816
ssg2238
(dp30817
g9357
(dp30818
sg3861
(dp30819
ssg2241
(dp30820
g2346
(dp30821
sg2196
g30615
sg1473
g24957
sg5817
(dp30822
sg2211
g30739
sg456
g16387
sg2034
g29014
sg10389
(dp30823
sg10899
(dp30824
sg78
g12846
sg9591
(dp30825
sg840
g20013
sg9231
(dp30826
sg3546
(dp30827
sg10752
(dp30828
sg1140
g22384
sg10179
(dp30829
sg5127
(dp30830
sg2493
(dp30831
sg1098
g22027
sg11913
(dp30832
sg9084
(dp30833
sg621
g17958
sg9105
(dp30834
ssg2244
(dp30835
g10701
(dp30836
sg4929
(dp30837
sg288
g14664
sg6273
(dp30838
sg5268
(dp30839
ssg2247
(dp30840
g1059
g21750
sg8598
(dp30841
sg801
g19535
ssg2250
(dp30842
VAntiinfectives for Systemic Use
p30843
(dp30844
sVOAT1/SLC22A6 Substrates
p30845
(dp30846
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p30847
g14474
sVAntivirals for Systemic Use
p30848
(dp30849
sVHeterocyclic Compounds, Fused-Ring
p30850
(dp30851
sVOATP1B3 substrates
p30852
g28517
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p30853
(dp30854
sVNephrotoxic agents
p30855
(dp30856
sVCytochrome P-450 CYP3A Substrates
p30857
(dp30858
sVOAT3/SLC22A8 Substrates
p30859
g13153
sVP-glycoprotein/ABCB1 Substrates
p30860
(dp30861
sVBCRP/ABCG2 Substrates
p30862
(dp30863
sVDirect Acting Antivirals
p30864
(dp30865
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30866
g29449
sVAntiviral Agents
p30867
g30450
sg5592
(dp30868
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p30869
(dp30870
sVOATP1B1/SLCO1B1 Substrates
p30871
(dp30872
sVCytochrome P-450 CYP3A4 Substrates
p30873
(dp30874
sVPurines
p30875
(dp30876
ssg2253
(dp30877
VAmino Acids, Peptides, and Proteins
p30878
(dp30879
sVCytochrome P-450 CYP1A2 Inducers
p30880
(dp30881
sVPeptide Hormones
p30882
g20227
sVProteins
p30883
(dp30884
sVInsulin Analog
p30885
(dp30886
sVHypoglycemia-Associated Agents
p30887
g17696
sVInsulins and Analogues for Injection, Fast-Acting
p30888
(dp30889
sVInsulin, Short-Acting
p30890
g13876
sVInsulins and Analogues
p30891
(dp30892
sVPeptides
p30893
(dp30894
sVCytochrome P-450 Enzyme Inducers
p30895
g28232
sVInsulin
p30896
(dp30897
sVHormones
p30898
(dp30899
sVHormones, Hormone Substitutes, and Hormone Antagonists
p30900
(dp30901
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p30902
g17447
sVPancreatic Hormones
p30903
(dp30904
sVBlood Glucose Lowering Agents
p30905
(dp30906
sVAlimentary Tract and Metabolism
p30907
g23925
sVDrugs Used in Diabetes
p30908
(dp30909
ssg2256
(dp30910
VLipids
p30911
g14304
sVProstaglandins
p30912
g19494
sVAutacoids
p30913
(dp30914
sVFatty Acids
p30915
(dp30916
sVProstaglandin analogs reducing intraocular pressure (IOP)
p30917
g19249
sVFatty Acids, Unsaturated
p30918
(dp30919
sVSensory Organs
p30920
(dp30921
sVProstaglandins, Synthetic
p30922
g28019
sVInflammation Mediators
p30923
g23622
sVOphthalmics
p30924
(dp30925
sVBiological Factors
p30926
(dp30927
sg6189
(dp30928
sVOphthalmologicals
p30929
(dp30930
sVProstaglandin Receptor Agonists
p30931
(dp30932
sVEicosanoids
p30933
(dp30934
sVAntiglaucoma Preparations and Miotics
p30935
(dp30936
ssg2259
(dp30937
g318
g14919
sg12051
(dp30938
ssg2262
(dp30939
VAmidines
p30940
(dp30941
sVAntiadrenergic Agents, Centrally Acting
p30942
(dp30943
sVCytochrome P-450 CYP3A Substrates
p30944
(dp30945
sVNeurotransmitter Agents
p30946
(dp30947
sVHypotensive Agents
p30948
(dp30949
sVCentral Alpha-agonists
p30950
(dp30951
sVDrugs that are Mainly Renally Excreted
p30952
(dp30953
sVAntihypertensive Agents
p30954
g20276
sVAcids, Carbocyclic
p30955
(dp30956
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p30957
g29318
sVImidazoline Receptor Agonists
p30958
(dp30959
sVAdrenergic Agents
p30960
(dp30961
sVCentral Nervous System Depressants
p30962
(dp30963
sVCardiovascular Agents
p30964
g26672
sVCentral alpha-2 Adrenergic Agonist
p30965
(dp30966
sVAdrenergic Agonists
p30967
(dp30968
sVAgents that produce hypertension
p30969
(dp30970
sVCytochrome P-450 CYP3A4 Substrates
p30971
(dp30972
sVPhenylacetates
p30973
(dp30974
sVAdrenergic alpha-2 Receptor Agonists
p30975
(dp30976
sVAdrenergic alpha-Agonists
p30977
(dp30978
sVGuanidines
p30979
(dp30980
sVBradycardia-Causing Agents
p30981
(dp30982
sVAgents producing tachycardia
p30983
(dp30984
ssg2265
(dp30985
VCytochrome P-450 CYP2D6 Inhibitors
p30986
(dp30987
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p30988
(dp30989
sVNeurotransmitter Agents
p30990
(dp30991
sVCentral Nervous System Agents
p30992
(dp30993
sVDopamine Agents
p30994
g14250
sVPotential QTc-Prolonging Agents
p30995
(dp30996
sVPsychotropic Drugs
p30997
(dp30998
sVCytochrome P-450 Enzyme Inhibitors
p30999
(dp31000
sVCytochrome P-450 CYP1A2 Substrates
p31001
(dp31002
sVAntipsychotic Agents
p31003
(dp31004
sVDopamine Antagonists
p31005
(dp31006
sVSulfur Compounds
p31007
(dp31008
sVPsycholeptics
p31009
(dp31010
sVQTc Prolonging Agents
p31011
(dp31012
sVCentral Nervous System Depressants
p31013
(dp31014
sVThioxanthene Derivatives
p31015
(dp31016
sVAntipsychotic Agents (First Generation [Typical])
p31017
(dp31018
sVDopamine D2 Receptor Antagonists
p31019
(dp31020
sVHeterocyclic Compounds, Fused-Ring
p31021
(dp31022
sVThioxanthenes
p31023
(dp31024
sVXanthenes
p31025
(dp31026
sVNeurotoxic agents
p31027
(dp31028
sVNervous System
p31029
(dp31030
sVTranquilizing Agents
p31031
(dp31032
ssg2268
(dp31033
g7815
(dp31034
sg438
g16172
sg3912
(dp31035
sg10368
(dp31036
sg9198
(dp31037
sg2652
(dp31038
sg2274
(dp31039
sg10377
(dp31040
sg11334
(dp31041
sg8454
(dp31042
sg11208
(dp31043
sg10509
(dp31044
sg11166
(dp31045
ssg2271
(dp31046
g10209
(dp31047
sg1470
g24919
sg507
g16781
sg849
g20092
sg9225
(dp31048
sg2127
g30252
sg3117
(dp31049
sg14822
(dp31050
sg2133
g30299
sg3783
(dp31051
ssg2274
(dp31052
VAntivirals for Systemic Use
p31053
(dp31054
sVBreast Cancer Resistance Protein Inhibitors
p31055
g12724
sVBCRP/ABCG2 Inhibitors
p31056
g12550
sVDirect Acting Antivirals
p31057
(dp31058
sVOATP1B1/SLCO1B1 Inhibitors
p31059
(dp31060
sVBCRP/ABCG2 Substrates
p31061
(dp31062
sVNS3/4A Protease Inhibitors
p31063
(dp31064
sVAntiinfectives for Systemic Use
p31065
(dp31066
sVCytochrome P450 1A2 Inhibitors
p31067
g16806
sVSulfur Compounds
p31068
(dp31069
sVOATP1B3 inhibitors
p31070
(dp31071
sVP-glycoprotein/ABCB1 Inhibitors
p31072
(dp31073
sVOATP1B1/SLCO1B1 Substrates
p31074
(dp31075
sVHCV NS3/4A Protease Inhibitors
p31076
(dp31077
sVAntivirals for treatment of HCV infections
p31078
g31039
sVP-glycoprotein/ABCB1 Substrates
p31079
(dp31080
sVUGT1A1 Inhibitors
p31081
(dp31082
sVSulfones
p31083
(dp31084
sVAmides
p31085
(dp31086
sVHeterocyclic Compounds, Fused-Ring
p31087
(dp31088
sVOATP1B3 substrates
p31089
g28525
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p31090
(dp31091
sVAntiviral Agents
p31092
g30461
sVCytochrome P450 3A Inhibitors
p31093
(dp31094
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p31095
(dp31096
ssg2277
(dp31097
VNitrogen Compounds
p31098
(dp31099
sVNervous System
p31100
(dp31101
sVAutonomic Agents
p31102
(dp31103
sVOnium Compounds
p31104
g22256
sVCholinesterase Inhibitors
p31105
(dp31106
sVQuaternary Ammonium Compounds
p31107
(dp31108
sVOphthalmologicals
p31109
(dp31110
sVNeurotransmitter Agents
p31111
(dp31112
sVP-glycoprotein/ABCB1 Substrates
p31113
(dp31114
sVPeripheral Nervous System Agents
p31115
(dp31116
sVAmines
p31117
(dp31118
sVCholinergic Agents
p31119
g28726
sVParasympathomemetic (Cholinergic) Agents
p31120
(dp31121
sVSensory Organs
p31122
(dp31123
sVEnzyme Inhibitors
p31124
(dp31125
sVAmmonium Compounds
p31126
g30559
sVPhenylammonium Compounds
p31127
(dp31128
sVParasympathomimetics
p31129
(dp31130
sVAntiglaucoma Preparations and Miotics
p31131
(dp31132
ssg2280
(dp31133
g8598
(dp31134
ssg2283
(dp31135
VAmino Acids, Peptides, and Proteins
p31136
(dp31137
sVPharmaceutical Preparations
p31138
(dp31139
sg681
g18478
sVPeptide Hormones
p31140
g20222
sg11
g12165
sVReproductive Control Agents
p31141
g18853
sVUterotonic agents
p31142
(dp31143
sVHypotensive Agents
p31144
(dp31145
sVDrug Delivery Systems
p31146
(dp31147
sVPeptides
p31148
(dp31149
sVInvestigative Techniques
p31150
(dp31151
sVPituitary Hormones
p31152
g15917
sVDelayed-Action Preparations
p31153
(dp31154
sVHormones
p31155
(dp31156
sVHormones, Hormone Substitutes, and Hormone Antagonists
p31157
(dp31158
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p31159
(dp31160
sVPituitary Hormones, Posterior
p31161
(dp31162
sVPituitary and Hypothalamic Hormones and Analogues
p31163
(dp31164
ssg2286
(dp31165
VSteroids
p31166
(dp31167
sg6849
(dp31168
sg8544
(dp31169
sg4986
(dp31170
sVHormones, Hormone Substitutes, and Hormone Antagonists
p31171
(dp31172
sg10182
(dp31173
sg3705
(dp31174
sg5388
(dp31175
sVHormones
p31176
(dp31177
sg2670
(dp31178
sg11580
(dp31179
sg525
g16915
sVFused-Ring Compounds
p31180
g14888
sg2682
(dp31181
ssg2289
(dp31182
VPsychostimulants, Agents Used for Adhd and Nootropics
p31183
(dp31184
sVAdrenergic Agents
p31185
(dp31186
sVCentral Nervous System Depressants
p31187
(dp31188
sVNeurotransmitter Agents
p31189
(dp31190
sVAmines
p31191
(dp31192
sVCytochrome P-450 CYP2D6 Substrates
p31193
(dp31194
sVPropylamines
p31195
(dp31196
sVMembrane Transport Modulators
p31197
(dp31198
sVQTc Prolonging Agents
p31199
(dp31200
sVPotential QTc-Prolonging Agents
p31201
(dp31202
sVNeurotransmitter Uptake Inhibitors
p31203
(dp31204
sVAgents producing tachycardia
p31205
(dp31206
sVAgents that produce hypertension
p31207
(dp31208
sVMiscellaneous Central Nervous System Agents
p31209
(dp31210
sVCytochrome P-450 Enzyme Inhibitors
p31211
(dp31212
sVNervous System
p31213
(dp31214
sVDrugs that are Mainly Renally Excreted
p31215
(dp31216
sg2958
(dp31217
sVNorepinephrine Uptake Inhibitors
p31218
(dp31219
ssg2292
(dp31220
g1260
g23163
sg3684
(dp31221
sg8580
(dp31222
sg7896
(dp31223
sg1803
g27399
sg9291
(dp31224
sg4035
(dp31225
sg6570
(dp31226
ssg2295
(dp31227
g9357
(dp31228
ssg2298
(dp31229
g5334
(dp31230
ssg2301
(dp31231
g2664
(dp31232
ssg2304
(dp31233
VAdrenergic Agents
p31234
(dp31235
sVNeurotransmitter Agents
p31236
(dp31237
sVPropanols
p31238
(dp31239
sVAmines
p31240
(dp31241
sVHypotensive Agents
p31242
(dp31243
sVAdrenergic beta-1 Receptor Antagonists
p31244
(dp31245
sVAntiarrhythmic agents
p31246
(dp31247
sVAntihypertensive Agents
p31248
g20289
sVAgents causing hyperkalemia
p31249
(dp31250
sVCytochrome P-450 CYP2D6 Substrates
p31251
(dp31252
sVBradycardia-Causing Agents
p31253
(dp31254
sVAdrenergic beta-Antagonists
p31255
g15370
sVPotential QTc-Prolonging Agents
p31256
(dp31257
sVAdrenergic Antagonists
p31258
(dp31259
sVBeta Blocking Agents, Selective
p31260
(dp31261
sVQTc Prolonging Agents
p31262
(dp31263
sVBeta-Blockers (Beta1 Selective)
p31264
(dp31265
sVAlcohols
p31266
(dp31267
sVAmino Alcohols
p31268
(dp31269
ssg2307
(dp31270
g3846
(dp31271
sg8916
(dp31272
sg2946
(dp31273
sg5832
(dp31274
sg8241
(dp31275
ssg2310
(dp31276
g9432
(dp31277
sg9954
(dp31278
ssg2313
(dp31279
g4845
(dp31280
ssg2316
(dp31281
VAmino Acids, Peptides, and Proteins
p31282
(dp31283
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p31284
(dp31285
sVAmino Acids
p31286
(dp31287
sVGastrointestinal Agents
p31288
(dp31289
sVAmino Acids, Cyclic
p31290
g27287
sVAmino Acids, Essential
p31291
(dp31292
sVMiscellaneous GI Drugs
p31293
g23550
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p31294
(dp31295
sVMixed Agonist / Antagonist Opioids
p31296
(dp31297
sVOAT3/SLC22A8 Substrates
p31298
g13146
sg5931
(dp31299
sg10281
(dp31300
sVOATP1B1/SLCO1B1 Inhibitors
p31301
(dp31302
sVOpioids
p31303
(dp31304
sVOpioid Antagonists
p31305
(dp31306
sg8868
(dp31307
sVOATP1B1/SLCO1B1 Substrates
p31308
(dp31309
sVAlimentary Tract and Metabolism
p31310
g23942
sVAmino Acids, Aromatic
p31311
(dp31312
ssg2319
(dp31313
g8097
(dp31314
sg9417
(dp31315
sg7941
(dp31316
sg11979
(dp31317
sg9981
(dp31318
sg10056
(dp31319
ssg2322
(dp31320
g3609
(dp31321
ssg2325
(dp31322
g3144
(dp31323
ssg2328
(dp31324
g6990
(dp31325
ssg2331
(dp31326
g9102
(dp31327
sg2736
(dp31328
sg10263
(dp31329
sg1452
g24756
sg10713
(dp31330
ssg2334
(dp31331
g9411
(dp31332
ssg2337
(dp31333
g19588
(dp31334
ssg2340
(dp31335
g4143
(dp31336
ssg2343
(dp31337
g3198
(dp31338
sVEnzymes
p31339
(dp31340
sg2235
g30816
sg693
g18669
sg6459
(dp31341
sVEnzymes and Coenzymes
p31342
(dp31343
sVHydrolases
p31344
(dp31345
sVAlimentary Tract and Metabolism
p31346
g23749
sg10395
(dp31347
ssg2346
(dp31348
g510
g16808
sVCytochrome P-450 CYP2D6 Inhibitors
p31349
(dp31350
sVCytochrome P-450 CYP3A Substrates
p31351
(dp31352
sVBCRP/ABCG2 Inhibitors
p31353
g12502
sVEnzyme Inhibitors
p31354
(dp31355
sVCytochrome P-450 CYP2C9 Inhibitors
p31356
g18173
sVCytochrome P-450 Enzyme Inhibitors
p31357
(dp31358
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p31359
g18381
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p31360
(dp31361
sVHighest Risk QTc-Prolonging Agents
p31362
(dp31363
sVKinase Inhibitor
p31364
g24580
sVIndoles
p31365
(dp31366
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p31367
g23100
sVCytochrome P-450 CYP2B6 Inducers
p31368
(dp31369
sVGynecological Antiinfectives and Antiseptics
p31370
(dp31371
sVTyrosine Kinase Inhibitors
p31372
g30821
sVAmides
p31373
(dp31374
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p31375
g29463
sVSulfur Compounds
p31376
(dp31377
sVSulfones
p31378
(dp31379
sVQTc Prolonging Agents
p31380
(dp31381
sVCytochrome P-450 CYP3A4 Inducers
p31382
g18869
sVAntineoplastic Agents
p31383
(dp31384
sVCytochrome P-450 CYP1A2 Inhibitors
p31385
g14995
sVCytochrome P-450 CYP2C8 Inhibitors
p31386
(dp31387
sVP-glycoprotein/ABCB1 Substrates
p31388
(dp31389
sVCytochrome P-450 Enzyme Inducers
p31390
g28106
sVCytochrome P-450 CYP3A Inducers
p31391
(dp31392
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p31393
(dp31394
sVProtein Kinase Inhibitors
p31395
(dp31396
sVCytochrome P-450 CYP3A4 Substrates
p31397
(dp31398
sVHeterocyclic Compounds, Fused-Ring
p31399
(dp31400
sVGenito Urinary System and Sex Hormones
p31401
(dp31402
sVSulfonamides
p31403
(dp31404
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p31405
(dp31406
sVBCRP/ABCG2 Substrates
p31407
(dp31408
sVP-glycoprotein/ABCB1 Inhibitors
p31409
(dp31410
sVAntineoplastic and Immunomodulating Agents
p31411
(dp31412
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p31413
g27732
ssg2349
(dp31414
g6819
(dp31415
sg14791
(dp31416
sg8598
(dp31417
sg8601
(dp31418
ssg2352
(dp31419
g8472
(dp31420
sg4911
(dp31421
sg1656
g26145
ssg2355
(dp31422
VDrugs that are Mainly Renally Excreted
p31423
(dp31424
sVUrea
p31425
(dp31426
sVSulfonylurea Compounds
p31427
(dp31428
sVSulfonylureas
p31429
(dp31430
sVHypoglycemia-Associated Agents
p31431
g17691
sVSulfur Compounds
p31432
(dp31433
sVOral Hypoglycemics
p31434
(dp31435
sVSulfones
p31436
(dp31437
sVCytochrome P-450 CYP2C9 Substrates
p31438
g29704
sVBlood Glucose Lowering Agents
p31439
(dp31440
sVAlimentary Tract and Metabolism
p31441
g23753
sVDrugs Used in Diabetes
p31442
(dp31443
ssg2358
(dp31444
VCytochrome P-450 CYP3A4 Inhibitors
p31445
(dp31446
sVUGT1A4 substrates
p31447
(dp31448
sVGABA Agents
p31449
g16203
sVCytochrome P-450 CYP3A Substrates
p31450
(dp31451
sVNeurotransmitter Agents
p31452
(dp31453
sVAnti-Anxiety Agents
p31454
(dp31455
sVCentral Nervous System Agents
p31456
(dp31457
sVCYP3A Substrates (Sensitive)
p31458
(dp31459
sVPsychotropic Drugs
p31460
(dp31461
sg9708
(dp31462
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p31463
(dp31464
sVGABA Modulators
p31465
(dp31466
sVCytochrome P-450 Enzyme Inhibitors
p31467
(dp31468
sVDrugs that are Mainly Renally Excreted
p31469
(dp31470
sVHypnotics and Sedatives
p31471
(dp31472
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p31473
g29466
sVAdjuvants, Anesthesia
p31474
(dp31475
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p31476
(dp31477
sVCentral Nervous System Depressants
p31478
(dp31479
sVAnesthetics
p31480
(dp31481
sVPsycholeptics
p31482
(dp31483
sVHeterocyclic Compounds, Fused-Ring
p31484
(dp31485
sVCytochrome P-450 CYP3A4 Substrates
p31486
(dp31487
sVCytochrome P-450 CYP3A5 Substrates
p31488
(dp31489
sVBenzodiazepine hypnotics and sedatives
p31490
g17657
sVCytochrome P-450 CYP3A Inhibitors
p31491
(dp31492
sVBenzodiazepines and benzodiazepine derivatives
p31493
(dp31494
sVNervous System
p31495
(dp31496
sVTranquilizing Agents
p31497
(dp31498
sVCytochrome P-450 CYP3A7 Substrates
p31499
(dp31500
ssg2361
(dp31501
g8193
(dp31502
sg6207
(dp31503
sg4023
(dp31504
sg1326
g23584
sg8028
(dp31505
sg9519
(dp31506
sg9702
(dp31507
sg11523
(dp31508
sg4746
(dp31509
sg4788
(dp31510
sg6213
(dp31511
sg8601
(dp31512
sg1866
g27791
sg5250
(dp31513
sg7650
(dp31514
sg6579
(dp31515
sg8418
(dp31516
sg10977
(dp31517
sg4260
(dp31518
sg1914
g28407
sg8241
(dp31519
sg7671
(dp31520
sg6474
(dp31521
sg10011
(dp31522
sg11958
(dp31523
sg11040
(dp31524
sg8598
(dp31525
sg10494
(dp31526
sg2862
(dp31527
sg2088
g29942
sg10740
(dp31528
sg11100
(dp31529
sg3000
(dp31530
sg12057
(dp31531
sg4272
(dp31532
sg8277
(dp31533
sg4716
(dp31534
sg2109
g30156
sg1980
g28797
sg6024
(dp31535
sg9996
(dp31536
sg5727
(dp31537
sg10680
(dp31538
sg3408
(dp31539
sg5556
(dp31540
sg6186
(dp31541
sg72
g12803
sg10953
(dp31542
sg69
g12763
sg963
g20996
sg3216
(dp31543
sg6678
(dp31544
sg2688
(dp31545
sg3279
(dp31546
sg141
g13320
sg735
g19131
sg4974
(dp31547
sg5181
(dp31548
sg7188
(dp31549
sg12126
(dp31550
sg5589
(dp31551
sg8916
(dp31552
sg6162
(dp31553
sg7041
(dp31554
sg4803
(dp31555
ssg2364
(dp31556
g5622
(dp31557
sg7854
(dp31558
sg6903
(dp31559
ssg2367
(dp31560
g9852
(dp31561
ssg2370
(dp31562
g507
g16759
sg14822
(dp31563
sg2127
g30255
sg849
g20070
sg3543
(dp31564
sg2133
g30280
ssg2373
(dp31565
VImmunosuppressive Agents
p31566
(dp31567
sVCytochrome P-450 CYP3A Substrates
p31568
(dp31569
sVBCRP/ABCG2 Inhibitors
p31570
g12511
sVOATP1B1/SLCO1B1 Inhibitors
p31571
(dp31572
sVHormones
p31573
(dp31574
sVDrugs for Obstructive Airway Diseases
p31575
(dp31576
sVHyperglycemia-Associated Agents
p31577
(dp31578
sVP-glycoprotein/ABCB1 Inducers
p31579
(dp31580
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p31581
(dp31582
sVCorticosteroids Acting Locally
p31583
(dp31584
sVRespiratory System Agents
p31585
(dp31586
sVPregnadienetriols
p31587
(dp31588
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p31589
g29242
sVOATP1B3 inhibitors
p31590
(dp31591
sVGlucocorticoids
p31592
g21926
sVFused-Ring Compounds
p31593
g14853
sVCytochrome P-450 CYP3A4 Inducers
p31594
g18932
sVCytochrome P-450 CYP3A5 Inducers
p31595
(dp31596
sVAdrenal Cortex Hormones
p31597
g30009
sVAdrenals
p31598
(dp31599
sVP-glycoprotein/ABCB1 Substrates
p31600
(dp31601
sVDermatologicals
p31602
g17259
sVCytochrome P-450 Enzyme Inducers
p31603
g28182
sVCytochrome P-450 CYP3A Inducers
p31604
(dp31605
sVAnti-Asthmatic Agents
p31606
(dp31607
sVPregnadienes
p31608
(dp31609
sVCytochrome P-450 CYP3A4 Substrates
p31610
(dp31611
sVAlimentary Tract and Metabolism
p31612
g23937
sVNasal Preparations
p31613
(dp31614
sVPregnanes
p31615
(dp31616
sVAgents to Treat Airway Disease
p31617
(dp31618
sVSteroids
p31619
(dp31620
sVCorticosteroids, Potent (Group III)
p31621
(dp31622
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p31623
(dp31624
sVAnti-Inflammatory Agents
p31625
(dp31626
sVCorticosteroid Hormone Receptor Agonists
p31627
(dp31628
sVSteroids, Chlorinated
p31629
(dp31630
sVCorticosteroids, Dermatological Preparations
p31631
(dp31632
sVHormones, Hormone Substitutes, and Hormone Antagonists
p31633
(dp31634
sVCorticosteroids
p31635
(dp31636
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p31637
(dp31638
sVIntestinal Antiinflammatory Agents
p31639
(dp31640
ssg2376
(dp31641
g8484
(dp31642
sg8340
(dp31643
sg7359
(dp31644
sg8439
(dp31645
ssg2379
(dp31646
g9309
(dp31647
sg7629
(dp31648
sg12108
(dp31649
sg1164
g22595
ssg2382
(dp31650
g9897
(dp31651
sg11631
(dp31652
sg8871
(dp31653
ssg2385
(dp31654
g282
g14542
ssg2388
(dp31655
VCytochrome P-450 CYP3A Substrates
p31656
(dp31657
sVHormones
p31658
(dp31659
sg10881
(dp31660
sVDrugs that are Mainly Renally Excreted
p31661
(dp31662
sVCorticosteroids, Dermatological Preparations
p31663
(dp31664
sVPregnadienetriols
p31665
(dp31666
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p31667
g29388
sVBetamethasone
p31668
(dp31669
sVFused-Ring Compounds
p31670
g14817
sVAdrenal Cortex Hormones
p31671
g30014
sVPregnadienes
p31672
(dp31673
sVDermatologicals
p31674
g17197
sVSensory Organs
p31675
(dp31676
sVCytochrome P-450 CYP3A4 Substrates
p31677
(dp31678
sVPregnanes
p31679
(dp31680
sVOphthalmologicals
p31681
(dp31682
sVSteroids
p31683
(dp31684
sVCorticosteroids, Moderately Potent (Group II)
p31685
(dp31686
sVImmunosuppressive Agents
p31687
(dp31688
sVSteroids, Fluorinated
p31689
(dp31690
sVAnti-Inflammatory Agents
p31691
(dp31692
sVHormones, Hormone Substitutes, and Hormone Antagonists
p31693
(dp31694
sVCorticosteroids
p31695
(dp31696
ssg2391
(dp31697
VAnalgesics
p31698
g26437
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p31699
(dp31700
sVNon COX-2 selective NSAIDS
p31701
(dp31702
sVBCRP/ABCG2 Inhibitors
p31703
g12539
sVOATP1B1/SLCO1B1 Inhibitors
p31704
(dp31705
sVAminosalicylate
p31706
(dp31707
sVAnti-Infective Agents
p31708
(dp31709
sVPeripheral Nervous System Agents
p31710
(dp31711
sVSalicylates
p31712
g27622
sVAnalgesics, Non-Narcotic
p31713
(dp31714
sVGynecological Antiinfectives and Antiseptics
p31715
(dp31716
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p31717
(dp31718
sVAmides
p31719
(dp31720
sVSulfur Compounds
p31721
(dp31722
sVOATP1B3 inhibitors
p31723
(dp31724
sVSulfones
p31725
(dp31726
sVSulfonamides
p31727
(dp31728
sVAgents causing hyperkalemia
p31729
(dp31730
sVGastrointestinal Agents
p31731
(dp31732
sVAgents that produce hypertension
p31733
(dp31734
sVCentral Nervous System Agents
p31735
(dp31736
sVAlimentary Tract and Metabolism
p31737
g23785
sVGenito Urinary System and Sex Hormones
p31738
(dp31739
sVImmunosuppressive Agents
p31740
(dp31741
sVBCRP/ABCG2 Substrates
p31742
(dp31743
sVMethemoglobinemia Associated Agents
p31744
g25576
sVAnti-Inflammatory Agents
p31745
(dp31746
sVNephrotoxic agents
p31747
(dp31748
sVAntirheumatic Agents
p31749
g24235
sVSensory System Agents
p31750
(dp31751
sVAnti-Inflammatory Agents, Non-Steroidal
p31752
(dp31753
sVIntestinal Antiinflammatory Agents
p31754
(dp31755
ssg2394
(dp31756
g13750
g24366
sg14872
g15713
sg7545
(dp31757
sg4113
(dp31758
sg3393
(dp31759
sg1614
g25860
sg9903
(dp31760
sg11922
(dp31761
sg5766
(dp31762
sg8694
(dp31763
sg14838
(dp31764
sg6345
(dp31765
sg4089
(dp31766
sg5895
(dp31767
sg12534
(dp31768
sg4653
(dp31769
sg7668
(dp31770
sg6045
(dp31771
ssg2397
(dp31772
VPiperidines
p31773
(dp31774
sVGlycoside Hydrolase Inhibitors
p31775
(dp31776
sVCarbohydrates
p31777
(dp31778
sVImino Sugars
p31779
g19107
sVImines
p31780
(dp31781
sVHypoglycemia-Associated Agents
p31782
g17709
sVImino Pyranoses
p31783
(dp31784
sVOral Hypoglycemics
p31785
(dp31786
sVAlkaloids
p31787
g19437
sVEnzyme Inhibitors
p31788
(dp31789
sVBlood Glucose Lowering Agents
p31790
(dp31791
sVAlimentary Tract and Metabolism
p31792
g23768
sVDrugs Used in Diabetes
p31793
(dp31794
ssg2400
(dp31795
g8019
(dp31796
sg4425
(dp31797
sg3858
(dp31798
sg2943
(dp31799
sg3072
(dp31800
sg6033
(dp31801
sg8295
(dp31802
sg4260
(dp31803
sg6699
(dp31804
sg10977
(dp31805
sg4077
(dp31806
sg2841
(dp31807
sg9009
(dp31808
sg12051
(dp31809
sg318
g14916
sg10512
(dp31810
sg537
g17028
sg10728
(dp31811
sg4458
(dp31812
sg546
g17143
sg10740
(dp31813
sg2109
g30120
sg336
g15093
sg2850
(dp31814
sg8166
(dp31815
sg3408
(dp31816
sg6999
(dp31817
sg10350
(dp31818
sg5256
(dp31819
sg1281
g23373
sg7596
(dp31820
sg6537
(dp31821
sg1008
g21277
sg11385
(dp31822
ssg2403
(dp31823
VAntiarrhythmic agents
p31824
(dp31825
sVAnti-epileptic Agent
p31826
(dp31827
sVCytochrome P-450 CYP3A Substrates
p31828
(dp31829
sVAgents causing hyperkalemia
p31830
(dp31831
sg2004
g28849
sVCentral Nervous System Agents
p31832
(dp31833
sVCalcium Channel Blockers
p31834
(dp31835
sVPotential QTc-Prolonging Agents
p31836
(dp31837
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p31838
g29464
sg1926
g28504
sVPyrrolidines
p31839
(dp31840
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p31841
(dp31842
sVQTc Prolonging Agents
p31843
(dp31844
sVDecreased Central Nervous System Disorganized Electrical Activity
p31845
g23466
sVCentral Nervous System Depressants
p31846
(dp31847
sVImides
p31848
(dp31849
sVAnticonvulsants
p31850
(dp31851
sVPyrrolidinones
p31852
g30231
sVCytochrome P-450 CYP3A4 Substrates
p31853
(dp31854
sVNarrow Therapeutic Index Drugs
p31855
(dp31856
sVCytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index
p31857
g22892
sVBradycardia-Causing Agents
p31858
(dp31859
sVCytochrome P-450 CYP2E1 Substrates
p31860
(dp31861
sVNervous System
p31862
(dp31863
ssg2406
(dp31864
g7464
(dp31865
sg10818
(dp31866
sg4635
(dp31867
sg11727
(dp31868
sg7941
(dp31869
sg7569
(dp31870
sg11979
(dp31871
sg1491
g25071
sg3447
(dp31872
sg4401
(dp31873
sg1770
g27053
sg5334
(dp31874
ssg2409
(dp31875
g3432
(dp31876
sg12123
(dp31877
ssg2412
(dp31878
g6069
(dp31879
sg6051
(dp31880
sg10884
(dp31881
ssg2415
(dp31882
g11619
(dp31883
sg6579
(dp31884
sg1401
g24312
sg4959
(dp31885
ssg2418
(dp31886
VAcetates
p31887
(dp31888
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p31889
(dp31890
sVAcetamides
p31891
(dp31892
sVFatty Acids
p31893
(dp31894
sVSerotonin Agents
p31895
(dp31896
sVLipids
p31897
g14313
sVEnzyme Inhibitors
p31898
(dp31899
sVAnti-Infective Agents
p31900
(dp31901
sVAntiinfectives for Systemic Use
p31902
(dp31903
sVMyelosuppressive Agents
p31904
(dp31905
sVAmides
p31906
(dp31907
sg1314
g23541
sVAnti-Bacterial Agents
p31908
(dp31909
sVProtein Synthesis Inhibitors
p31910
(dp31911
sVCentral Nervous System Depressants
p31912
(dp31913
sVFatty Acids, Volatile
p31914
(dp31915
sVAgents that reduce seizure threshold
p31916
(dp31917
sVMonoamine Oxidase Inhibitors
p31918
(dp31919
sVAgents that produce hypertension
p31920
(dp31921
sVAntibacterials for Systemic Use
p31922
(dp31923
sVSerotonin Modulators
p31924
(dp31925
sVAntidepressive Agents
p31926
g15498
sVAcids, Acyclic
p31927
g25456
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p31928
(dp31929
sVImmunosuppressive Agents
p31930
(dp31931
sg8589
(dp31932
sVOxazoles
p31933
(dp31934
ssg2421
(dp31935
g6489
(dp31936
sg858
g20162
sg28215
(dp31937
sg9528
(dp31938
sg11151
(dp31939
ssg2424
(dp31940
VAntiparasitic Products, Insecticides and Repellents
p31941
g30570
sVOrganometallic Compounds
p31942
(dp31943
sVDrugs that are Mainly Renally Excreted
p31944
(dp31945
sVGynecological Antiinfectives and Antiseptics
p31946
(dp31947
sg9729
(dp31948
sVIntestinal Antiinfectives
p31949
(dp31950
sVGenito Urinary System and Sex Hormones
p31951
(dp31952
sg90
g12952
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p31953
(dp31954
sg6951
(dp31955
sVAnti-Infective Agents
p31956
(dp31957
sVAlimentary Tract and Metabolism
p31958
g23774
ssg2427
(dp31959
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p31960
(dp31961
sVCytochrome P-450 CYP3A4 Inhibitors
p31962
(dp31963
sVDibenzazepines
p31964
(dp31965
sVAnticholinergic Agents
p31966
g24489
sVCytochrome P-450 CYP2D6 Inhibitors
p31967
(dp31968
sVCytochrome P-450 CYP2D6 Substrates
p31969
(dp31970
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p31971
(dp31972
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p31973
(dp31974
sVCytochrome P-450 CYP3A Substrates
p31975
(dp31976
sVMembrane Transport Modulators
p31977
(dp31978
sVAntidepressive Agents, Tricyclic
p31979
(dp31980
sVSerotonin Receptor Antagonists
p31981
(dp31982
sVCentral Nervous System Agents
p31983
(dp31984
sVPotential QTc-Prolonging Agents
p31985
(dp31986
sVOCT2 Inhibitors
p31987
(dp31988
sVPsychotropic Drugs
p31989
(dp31990
sVCytochrome P-450 CYP2B6 Substrates
p31991
(dp31992
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p31993
(dp31994
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p31995
(dp31996
sVEnzyme Inhibitors
p31997
(dp31998
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p31999
g12669
sVCytochrome P-450 Enzyme Inhibitors
p32000
(dp32001
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p32002
g18403
sVMuscarinic Antagonists
p32003
(dp32004
sVDrugs that are Mainly Renally Excreted
p32005
(dp32006
sVCytochrome P-450 CYP1A2 Substrates
p32007
(dp32008
sVPsychoanaleptics
p32009
(dp32010
sVNon-Selective Monoamine Reuptake Inhibitors
p32011
(dp32012
sVCytochrome P-450 CYP2E1 Inhibitors
p32013
(dp32014
sg4281
(dp32015
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p32016
(dp32017
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p32018
g29608
sVSerotonin Agents
p32019
(dp32020
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32021
g29482
sVQTc Prolonging Agents
p32022
(dp32023
sVSerotonin 5-HT2 Receptor Antagonists
p32024
(dp32025
sVOCT1 inhibitors
p32026
(dp32027
sVAdrenergic Agents
p32028
(dp32029
sVCentral Nervous System Depressants
p32030
(dp32031
sVNeurotransmitter Agents
p32032
(dp32033
sVHistamine Antagonists
p32034
(dp32035
sVAgents that reduce seizure threshold
p32036
(dp32037
sVCytochrome P-450 CYP2B6 Inhibitors
p32038
(dp32039
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p32040
g26811
sVAdrenergic Uptake Inhibitors
p32041
(dp32042
sVNeurotransmitter Uptake Inhibitors
p32043
(dp32044
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p32045
(dp32046
sVHistamine H1 Antagonists
p32047
(dp32048
sVAgents that produce hypertension
p32049
(dp32050
sVCytochrome P-450 CYP2C19 Inhibitors
p32051
(dp32052
sVCytochrome P-450 CYP3A4 Substrates
p32053
(dp32054
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p32055
g26874
sVNarrow Therapeutic Index Drugs
p32056
(dp32057
sVNervous System
p32058
(dp32059
sVHeterocyclic Compounds, Fused-Ring
p32060
(dp32061
sVSerotonin Modulators
p32062
(dp32063
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p32064
(dp32065
sVAntidepressive Agents
p32066
g15500
sVCytochrome P-450 CYP3A Inhibitors
p32067
(dp32068
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p32069
(dp32070
sVP-glycoprotein/ABCB1 Inhibitors
p32071
(dp32072
sVNeurotoxic agents
p32073
(dp32074
sVAgents producing tachycardia
p32075
(dp32076
sVCytochrome P-450 CYP2A6 Inhibitors
p32077
(dp32078
ssg2430
(dp32079
VGABA Agents
p32080
g16215
sVCytochrome P-450 CYP3A Substrates
p32081
(dp32082
sVNeurotransmitter Agents
p32083
(dp32084
sVAnti-Anxiety Agents
p32085
(dp32086
sVCentral Nervous System Agents
p32087
(dp32088
sVBenzodiazepinones
p32089
(dp32090
sVPsychotropic Drugs
p32091
(dp32092
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p32093
g26867
sVGABA Modulators
p32094
(dp32095
sVCytochrome P-450 Enzyme Inhibitors
p32096
(dp32097
sVDrugs that are Mainly Renally Excreted
p32098
(dp32099
sVHypnotics and Sedatives
p32100
(dp32101
sVCytochrome P-450 CYP2E1 Inhibitors
p32102
(dp32103
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32104
g29243
sVPsycholeptics
p32105
(dp32106
sVCentral Nervous System Depressants
p32107
(dp32108
sVCytochrome P-450 CYP2A6 Substrates
p32109
(dp32110
sVHeterocyclic Compounds, Fused-Ring
p32111
(dp32112
sVCytochrome P-450 CYP3A4 Substrates
p32113
(dp32114
sVBenzazepines
p32115
(dp32116
sVOCT2 Inhibitors
p32117
(dp32118
sVP-glycoprotein/ABCB1 Inhibitors
p32119
(dp32120
sVBenzodiazepines and benzodiazepine derivatives
p32121
(dp32122
sVNervous System
p32123
(dp32124
sVTranquilizing Agents
p32125
(dp32126
ssg2433
(dp32127
VNeuraxial Anesthetics
p32128
(dp32129
sVNervous System
p32130
(dp32131
sVLocal Anesthesia
p32132
g14966
sVAmide Local Anesthetic
p32133
(dp32134
sVAnesthetics
p32135
(dp32136
sVCytochrome P-450 CYP2D6 Substrates
p32137
(dp32138
sVAgents that reduce seizure threshold
p32139
(dp32140
sVCytochrome P-450 CYP3A Substrates
p32141
(dp32142
sVHypotensive Agents
p32143
(dp32144
sVCentral Nervous System Agents
p32145
(dp32146
sVAmides
p32147
(dp32148
sVAnesthetics, Local
p32149
(dp32150
sVAnilides
p32151
(dp32152
sVAniline Compounds
p32153
g23429
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32154
g29483
sVSensory System Agents
p32155
(dp32156
sVCytochrome P-450 CYP3A4 Substrates
p32157
(dp32158
sVPeripheral Nervous System Agents
p32159
(dp32160
sVAmines
p32161
(dp32162
ssg2436
(dp32163
VAntiinfectives for Systemic Use
p32164
(dp32165
sVHeterocyclic Compounds, Fused-Ring
p32166
(dp32167
sVOphthalmologicals
p32168
(dp32169
sVbeta-Lactams
p32170
(dp32171
sVNephrotoxic agents
p32172
(dp32173
sVLactams
p32174
g22278
sVAmides
p32175
(dp32176
sVThiazines
p32177
g16425
sVSensory Organs
p32178
(dp32179
sVAnti-Bacterial Agents
p32180
(dp32181
sVAntibacterials for Systemic Use
p32182
(dp32183
sVSecond-Generation Cephalosporins
p32184
(dp32185
sVCephalosporins
p32186
(dp32187
sVAnti-Infective Agents
p32188
(dp32189
sVSulfur Compounds
p32190
(dp32191
ssg2439
(dp32192
g9780
(dp32193
sg396
g15793
ssg2442
(dp32194
g600
g17753
sg11370
(dp32195
sg3009
(dp32196
ssg2445
(dp32197
g6090
(dp32198
ssg2448
(dp32199
g1563
g25507
sg4185
(dp32200
ssg2451
(dp32201
VToxic Actions
p32202
(dp32203
sVFolic Acid Antagonists
p32204
(dp32205
sVHeterocyclic Compounds, Fused-Ring
p32206
(dp32207
sVMyelosuppressive Agents
p32208
(dp32209
sVAntimetabolites
p32210
(dp32211
sVFolic Acid Analogues
p32212
(dp32213
sVNoxae
p32214
(dp32215
sVImmunosuppressive Agents
p32216
(dp32217
sVEnzyme Inhibitors
p32218
(dp32219
sVSulfur Compounds
p32220
(dp32221
sVAntineoplastic and Immunomodulating Agents
p32222
(dp32223
sVAntimetabolites, Antineoplastic
p32224
g23449
sVAntineoplastic Agents
p32225
(dp32226
sg5799
(dp32227
ssg2454
(dp32228
g8019
(dp32229
sg4425
(dp32230
sg11595
(dp32231
sg450
g16335
sg1809
g27438
sg42
g12588
sg8163
(dp32232
sg1434
g24665
sg8295
(dp32233
sg6261
(dp32234
sg5781
(dp32235
sg10635
(dp32236
sg294
g14736
sg5487
(dp32237
sg5877
(dp32238
sg9960
(dp32239
sg915
g20697
sg4101
(dp32240
sg1281
g23385
sg5739
(dp32241
sg4458
(dp32242
sg9462
(dp32243
sg1413
g24436
sg537
g17026
sg2523
(dp32244
sg10596
(dp32245
sg2316
g31304
sg10602
(dp32246
sg336
g15108
sg1008
g21275
sg9864
(dp32247
ssg2457
(dp32248
g4770
(dp32249
ssg2460
(dp32250
VCytochrome P-450 CYP3A4 Inhibitors
p32251
(dp32252
sVBreast Cancer Resistance Protein Inhibitors
p32253
g12720
sVCytochrome P-450 CYP2D6 Inhibitors
p32254
(dp32255
sVCytochrome P-450 CYP3A Substrates
p32256
(dp32257
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p32258
(dp32259
sVBCRP/ABCG2 Inhibitors
p32260
g12538
sVAnti-HIV Agents
p32261
(dp32262
sVEnzyme Inhibitors
p32263
(dp32264
sVCytochrome P-450 Enzyme Inhibitors
p32265
(dp32266
sVCarbamates
p32267
(dp32268
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p32269
g18414
sVAntiinfectives for Systemic Use
p32270
(dp32271
sVCytochrome P-450 CYP3A7 Inhibitors (strong)
p32272
(dp32273
sVAnti-Infective Agents
p32274
(dp32275
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32276
g29488
sVSulfur Compounds
p32277
(dp32278
sVOATP1B3 inhibitors
p32279
(dp32280
sVP-glycoprotein/ABCB1 Inhibitors
p32281
(dp32282
sVThiazoles
p32283
(dp32284
sVCytochrome P-450 CYP3A5 Inhibitors
p32285
(dp32286
sVCytochrome P450 2D6 Inhibitors
p32287
(dp32288
sVCytochrome P-450 CYP3A Inhibitors (strong)
p32289
g13403
sVCytochrome P-450 CYP3A7 Inhibitors
p32290
(dp32291
sVCytochrome P-450 CYP3A4 Substrates
p32292
(dp32293
sVCytochrome P-450 CYP3A5 Substrates
p32294
(dp32295
sVAcids, Acyclic
p32296
g25470
sVCytochrome P-450 CYP3A Inhibitors
p32297
(dp32298
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p32299
(dp32300
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p32301
(dp32302
sVOATP1B1/SLCO1B1 Inhibitors
p32303
(dp32304
sVCytochrome P450 3A Inhibitors
p32305
(dp32306
sVOther Miscellaneous Therapeutic Agents
p32307
g28770
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p32308
(dp32309
sVChemically-Induced Disorders
p32310
g21238
sVCytochrome P-450 CYP3A7 Substrates
p32311
(dp32312
ssg2463
(dp32313
g8097
(dp32314
sg9417
(dp32315
sg3381
(dp32316
sg5169
(dp32317
sg387
g15661
sg10497
(dp32318
sg345
g15234
sg450
g16347
sg9981
(dp32319
sg2427
g32042
sg168
g13661
ssg2466
(dp32320
VNucleic Acid Synthesis Inhibitors
p32321
(dp32322
sVNoxae
p32323
(dp32324
sVCompounds used in a research, industrial, or household setting
p32325
(dp32326
sg11238
(dp32327
sVEnzyme Inhibitors
p32328
(dp32329
sVAzirines
p32330
(dp32331
sVIndoles
p32332
(dp32333
sVMyelosuppressive Agents
p32334
(dp32335
sVCytotoxic Antibiotics and Related Substances
p32336
(dp32337
sVAntineoplastic Agents
p32338
(dp32339
sg7185
(dp32340
sVToxic Actions
p32341
(dp32342
sVP-glycoprotein/ABCB1 Substrates
p32343
(dp32344
sVLaboratory Chemicals
p32345
(dp32346
sVAlkylating Drugs
p32347
(dp32348
sVAntibiotics, Antineoplastic
p32349
g30414
sVQuinones
p32350
(dp32351
sVIndicators and Reagents
p32352
(dp32353
sVCardiotoxic antineoplastic agents
p32354
(dp32355
sVHeterocyclic Compounds, Fused-Ring
p32356
(dp32357
sVImmunosuppressive Agents
p32358
(dp32359
sVAlkylating Activity
p32360
(dp32361
sg8343
(dp32362
sVAntineoplastic and Immunomodulating Agents
p32363
(dp32364
ssg2469
(dp32365
g4551
(dp32366
sg1209
g22867
ssg2472
(dp32367
g11268
(dp32368
ssg2475
(dp32369
g3696
(dp32370
sg10557
(dp32371
ssg2478
(dp32372
g1704
g26717
sg633
g18069
sg11910
(dp32373
sg7056
(dp32374
sg933
g20807
sg5919
(dp32375
sg8259
(dp32376
sg8514
(dp32377
sg10470
(dp32378
sg1668
g26239
ssg2481
(dp32379
VCytochrome P-450 CYP3A4 Inhibitors
p32380
(dp32381
sVQuinolines
p32382
(dp32383
sVOAT1/SLC22A6 Substrates
p32384
(dp32385
sVOCT2 Inhibitors
p32386
(dp32387
sVMATE 2 Inhibitors
p32388
(dp32389
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p32390
(dp32391
sVEnzyme Inhibitors
p32392
(dp32393
sVCytochrome P-450 Enzyme Inhibitors
p32394
(dp32395
sVAnti-Infective Agents
p32396
(dp32397
sVQuinolone Antimicrobial
p32398
(dp32399
sVRenal Agents
p32400
g24768
sVAntiinfectives for Systemic Use
p32401
(dp32402
sVDrugs that are Mainly Renally Excreted
p32403
(dp32404
sVMATE substrates
p32405
(dp32406
sVAlimentary Tract and Metabolism
p32407
g23790
sVAnti-Bacterial Agents
p32408
(dp32409
sVQTc Prolonging Agents
p32410
(dp32411
sVQuinolones
p32412
g23985
sg8313
(dp32413
sVMATE 1 Substrates
p32414
g23501
sVAnti-Infective Agents, Urinary
p32415
g25223
sVCytochrome P-450 CYP1A2 Inhibitors
p32416
g14992
sVP-glycoprotein/ABCB1 Substrates
p32417
(dp32418
sVFluoroquinolones
p32419
(dp32420
sVSensory Organs
p32421
(dp32422
sVAntibacterials for Systemic Use
p32423
(dp32424
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p32425
(dp32426
sVMATE 1 Inhibitors
p32427
(dp32428
sVModerate Risk QTc-Prolonging Agents
p32429
(dp32430
sVMATE inhibitors
p32431
(dp32432
sVHeterocyclic Compounds, Fused-Ring
p32433
(dp32434
sVOphthalmologicals
p32435
(dp32436
sVCytochrome P-450 CYP3A Inhibitors
p32437
(dp32438
sVDrugs for Acid Related Disorders
p32439
(dp32440
sVP-glycoprotein/ABCB1 Inhibitors
p32441
(dp32442
sVTopoisomerase II Inhibitors
p32443
(dp32444
sVChemically-Induced Disorders
p32445
g21220
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p32446
(dp32447
sVTopoisomerase Inhibitors
p32448
(dp32449
ssg2484
(dp32450
VHydrocarbons, Acyclic
p32451
g19589
sg11787
(dp32452
sVAntiarrhythmic agents
p32453
(dp32454
sVAnalgesics
p32455
g26439
sVNeurotransmitter Agents
p32456
(dp32457
sVCentral Nervous System Agents
p32458
(dp32459
sVCycloparaffins
p32460
(dp32461
sVBiological Factors
p32462
(dp32463
sVAlkenes
p32464
g30761
sVPeripheral Nervous System Agents
p32465
(dp32466
sg9411
(dp32467
sVTerpenes
p32468
(dp32469
sg3609
(dp32470
sVPigments, Biological
p32471
g21852
sVCardiac Therapy
p32472
(dp32473
sVPolyenes
p32474
(dp32475
sVPurines
p32476
(dp32477
sVEnzymes and Coenzymes
p32478
(dp32479
sg10716
(dp32480
sVQTc Prolonging Agents
p32481
(dp32482
sg9543
(dp32483
sVCarbohydrates
p32484
(dp32485
sVCyclohexanes
p32486
(dp32487
sg3621
(dp32488
sg6090
(dp32489
sVGlycosides
p32490
(dp32491
sVCardiovascular Agents
p32492
g26521
sVRibonucleosides
p32493
(dp32494
sVEnzymes
p32495
(dp32496
sVNucleic Acids, Nucleotides, and Nucleosides
p32497
(dp32498
sVVasodilating Agents
p32499
g23684
sg1617
g25923
sg19588
(dp32500
sVCyclohexenes
p32501
(dp32502
sVModerate Risk QTc-Prolonging Agents
p32503
(dp32504
sVPurine Nucleosides
p32505
(dp32506
sVHeterocyclic Compounds, Fused-Ring
p32507
(dp32508
sVNucleosides
p32509
(dp32510
sg4140
(dp32511
sVMiscellaneous Therapeutic Agents
p32512
(dp32513
sVAgents producing tachycardia
p32514
(dp32515
sg1593
g25720
sg2337
g31334
sVSensory System Agents
p32516
(dp32517
ssg2487
(dp32518
g8373
(dp32519
sg4479
(dp32520
sg30
g12392
sg135
g13258
sg9282
(dp32521
sg4872
(dp32522
sg7653
(dp32523
sg354
g15287
sg3141
(dp32524
sg9507
(dp32525
sg2046
g29133
sg8448
(dp32526
sg2436
g32183
sg15016
(dp32527
sg3174
(dp32528
sg7377
(dp32529
sg4710
(dp32530
sg9750
(dp32531
sg126
g13181
sg3207
(dp32532
sg972
g21133
sg7005
(dp32533
sg6204
(dp32534
sg7878
(dp32535
sg9630
(dp32536
sg1761
g27002
sg4782
(dp32537
sg5208
(dp32538
sg1110
g22144
sg7155
(dp32539
sg4005
(dp32540
sg3267
(dp32541
sg8616
(dp32542
sg1782
g27159
sg1278
g23342
sg4830
(dp32543
sg11604
(dp32544
sg4857
(dp32545
sg6432
(dp32546
sg11685
(dp32547
sg6348
(dp32548
sg11694
(dp32549
sg9426
(dp32550
sg4920
(dp32551
sg1872
g27873
sg11733
(dp32552
sg11184
(dp32553
sg6933
(dp32554
sg10275
(dp32555
sg10914
(dp32556
sg2481
g32424
sg1239
g22969
sg7074
(dp32557
sg11838
(dp32558
sg5865
(dp32559
sg5082
(dp32560
sg8079
(dp32561
sg1311
g23535
sg2838
(dp32562
sg8850
(dp32563
sg3021
(dp32564
sg6240
(dp32565
sg6183
(dp32566
sg7662
(dp32567
sg9657
(dp32568
sg5295
(dp32569
sg3291
(dp32570
sg2895
(dp32571
sg6549
(dp32572
sg11229
(dp32573
sg2940
(dp32574
sg8211
(dp32575
sg10479
(dp32576
sg9726
(dp32577
sg8238
(dp32578
sg7470
(dp32579
sg690
g18596
sg2418
g31923
sg5736
(dp32580
sg1176
g22684
sg4539
(dp32581
sg2739
(dp32582
sg1539
g25315
sg8577
(dp32583
sg3090
(dp32584
sg9096
(dp32585
sg10611
(dp32586
ssg2490
(dp32587
g537
g17046
sg6411
(dp32588
sg11544
(dp32589
sg7464
(dp32590
sg10818
(dp32591
sg11595
(dp32592
sg4635
(dp32593
sg7569
(dp32594
sg1491
g25100
sg3447
(dp32595
sg2433
g32129
sg4458
(dp32596
sg1008
g21295
sg915
g20720
sg8295
(dp32597
ssg2493
(dp32598
VHeterocyclic Compounds, Fused-Ring
p32599
(dp32600
sVCytochrome P-450 CYP3A Substrates
p32601
(dp32602
sVTyrosine Kinase Inhibitors
p32603
g30831
sVBCRP/ABCG2 Inhibitors
p32604
g12546
sVKinase Inhibitor
p32605
g24598
sVOCT2 Inhibitors
p32606
(dp32607
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32608
g29491
sVProtein Kinase Inhibitors
p32609
(dp32610
sVAntineoplastic and Immunomodulating Agents
p32611
(dp32612
sVP-glycoprotein/ABCB1 Inhibitors
p32613
(dp32614
sVQTc Prolonging Agents
p32615
(dp32616
sVCytochrome P-450 CYP3A4 Substrates
p32617
(dp32618
sVAntineoplastic Agents
p32619
(dp32620
sVHighest Risk QTc-Prolonging Agents
p32621
(dp32622
ssg2496
(dp32623
g9864
(dp32624
sg10635
(dp32625
ssg2499
(dp32626
g4338
(dp32627
sg10338
(dp32628
sg4821
(dp32629
sg4053
(dp32630
sg8796
(dp32631
ssg2502
(dp32632
g13750
g24403
sg2373
g31618
sg4620
(dp32633
sg1803
g27401
sg5427
(dp32634
sg10857
(dp32635
sg1260
g23165
sg8430
(dp32636
sg1614
g25896
sg4623
(dp32637
sg4638
(dp32638
sg11667
(dp32639
sg9402
(dp32640
sg7896
(dp32641
sg723
g19081
sg9030
(dp32642
sg11439
(dp32643
sg6504
(dp32644
sg3147
(dp32645
sg5370
(dp32646
sg6048
(dp32647
sg6345
(dp32648
sg9060
(dp32649
sg5796
(dp32650
ssg2505
(dp32651
VPlant Preparations
p32652
(dp32653
sVBasic Ointments and Protectants
p32654
(dp32655
sg1374
g24138
sVDetergents
p32656
g27682
sVBiological Products
p32657
(dp32658
sVLipids
p32659
g14319
sVOils
p32660
(dp32661
sVComplex Mixtures
p32662
(dp32663
ssg2508
(dp32664
g10263
(dp32665
sg3708
(dp32666
sg10857
(dp32667
sg1044
g21561
sg5829
(dp32668
sg4647
(dp32669
sg255
g14416
sg6759
(dp32670
sg11439
(dp32671
sg4623
(dp32672
sg828
g19887
sg11472
(dp32673
sg11667
(dp32674
sg7824
(dp32675
sg9402
(dp32676
sg2067
g29663
sg909
g20622
sg10515
(dp32677
sg11319
(dp32678
sg9987
(dp32679
sg9012
(dp32680
sg7320
(dp32681
sg3036
(dp32682
sg1719
g26822
sg8862
(dp32683
sg10761
(dp32684
sg3114
(dp32685
sg10005
(dp32686
sg11445
(dp32687
sg1548
g25397
sg23
g12241
sg10098
(dp32688
sg171
g13719
sg3531
(dp32689
sg9828
(dp32690
sg10410
(dp32691
sg3240
(dp32692
sg10227
(dp32693
sg4056
(dp32694
sg2304
g31269
sg2616
(dp32695
sg6381
(dp32696
sg4683
(dp32697
sg612
g17903
sg5598
(dp32698
sg5580
(dp32699
ssg2511
(dp32700
g3261
(dp32701
sg9834
(dp32702
sg9249
(dp32703
ssg2514
(dp32704
g204
g13980
sg9144
(dp32705
ssg2517
(dp32706
g1239
g22922
sg10170
(dp32707
sg10347
(dp32708
ssg2520
(dp32709
g6408
(dp32710
sg6684
(dp32711
sg7716
(dp32712
sg3900
(dp32713
sg3036
(dp32714
sg6069
(dp32715
sg3978
(dp32716
sg6051
(dp32717
sg7305
(dp32718
sg10884
(dp32719
ssg2523
(dp32720
VOpiate Partial Agonists
p32721
g28786
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p32722
(dp32723
sVAnalgesics
p32724
g26442
sVCentral Nervous System Agents
p32725
(dp32726
sVNarcotics
p32727
(dp32728
sVPeripheral Nervous System Agents
p32729
(dp32730
sVMixed Agonist / Antagonist Opioids
p32731
(dp32732
sVBenzomorphan Derivatives
p32733
g16138
sVAdjuvants, Anesthesia
p32734
(dp32735
sVCentral Nervous System Depressants
p32736
(dp32737
sVOpioids
p32738
g32244
sVAgents that reduce seizure threshold
p32739
(dp32740
sVOpiate Alkaloids
p32741
(dp32742
sVP-glycoprotein/ABCB1 Substrates
p32743
(dp32744
sVOpioid Antagonists
p32745
(dp32746
sVBenzomorphans
p32747
(dp32748
sVMorphinans
p32749
(dp32750
sVHeterocyclic Compounds, Fused-Ring
p32751
(dp32752
sVP-glycoprotein/ABCB1 Inhibitors
p32753
(dp32754
sVAlkaloids
p32755
g19443
sVSensory System Agents
p32756
(dp32757
sVPhenanthrenes
p32758
(dp32759
sVNervous System
p32760
(dp32761
sVPartial Opioid Agonist/Antagonist
p32762
(dp32763
ssg2526
(dp32764
g4014
(dp32765
sg1629
g26001
sg8832
(dp32766
sg9006
(dp32767
ssg2529
(dp32768
g1767
g27022
sg6267
(dp32769
ssg2532
(dp32770
g9444
(dp32771
sg9414
(dp32772
ssg2535
(dp32773
g8019
(dp32774
sg4425
(dp32775
sg9519
(dp32776
sg11805
(dp32777
sg4788
(dp32778
sg4803
(dp32779
sg5250
(dp32780
sg7650
(dp32781
sg10011
(dp32782
sg8418
(dp32783
sg10977
(dp32784
sg4260
(dp32785
sg1914
g28428
sg7671
(dp32786
sg891
g20565
sg10494
(dp32787
sg2088
g29898
sg10740
(dp32788
sg3711
(dp32789
sg4716
(dp32790
sg2109
g30165
sg6024
(dp32791
sg1578
g25665
sg3408
(dp32792
sg72
g12801
sg963
g21017
sg3279
(dp32793
sg4974
(dp32794
sg5181
(dp32795
sg5589
(dp32796
sg336
g15128
sg5394
(dp32797
ssg2538
(dp32798
VCentral Nervous System Depressants
p32799
(dp32800
sVCardiovascular Agents
p32801
g26585
sVCarboxamide Derivatives
p32802
(dp32803
sVAnticonvulsants
p32804
(dp32805
sVCytochrome P-450 CYP3A4 Inducers (weak)
p32806
g19513
sg6423
(dp32807
sVVoltage-Gated Sodium Channel Blockers
p32808
(dp32809
sVCentral Nervous System Agents
p32810
(dp32811
sVUGT1A1 Substrates
p32812
g12301
sVCytochrome P-450 Enzyme Inducers
p32813
g28175
sVCytochrome P-450 CYP3A Inducers
p32814
(dp32815
sVMembrane Transport Modulators
p32816
(dp32817
sVCytochrome P-450 CYP2C19 Inhibitors
p32818
(dp32819
sVHeterocyclic Compounds, Fused-Ring
p32820
(dp32821
sVCytochrome P-450 Enzyme Inhibitors
p32822
(dp32823
sVNervous System
p32824
(dp32825
sVCytochrome P-450 CYP3A4 Inducers
p32826
g18902
sVSodium Channel Blockers
p32827
(dp32828
ssg2541
(dp32829
g669
g18444
ssg2544
(dp32830
g10635
(dp32831
sg1809
g27457
sg42
g12608
sg7713
(dp32832
sg8295
(dp32833
sg2784
(dp32834
sg6261
(dp32835
sg5781
(dp32836
sg2199
g30706
sg294
g14758
sg5487
(dp32837
sg5877
(dp32838
sg9960
(dp32839
sg4101
(dp32840
sg10602
(dp32841
sg5739
(dp32842
sg4458
(dp32843
sg546
g17161
sg1413
g24449
sg537
g17060
sg2523
g32759
sg1281
g23404
sg1008
g21308
sg9864
(dp32844
ssg2547
(dp32845
g858
g20174
sg11151
(dp32846
sg8373
(dp32847
sg4857
(dp32848
sg4197
(dp32849
sg2838
(dp32850
sg9414
(dp32851
sg9507
(dp32852
sg11136
(dp32853
sg2481
g32449
sg9444
(dp32854
sg10701
(dp32855
sg9528
(dp32856
sg8211
(dp32857
sg6489
(dp32858
sg28215
(dp32859
sg5295
(dp32860
sg15016
(dp32861
ssg2550
(dp32862
g2835
(dp32863
sg3633
(dp32864
sg8265
(dp32865
sg11955
(dp32866
ssg2553
(dp32867
VAgents that produce neuromuscular block (indirect)
p32868
(dp32869
sVGastric Acid Lowering Agents
p32870
(dp32871
sVNoxae
p32872
(dp32873
sVOsmotic Laxatives
p32874
(dp32875
sVAntacids
p32876
(dp32877
sVCompounds used in a research, industrial, or household setting
p32878
(dp32879
sVMagnesium Compounds
p32880
(dp32881
sVCalculi Dissolution Agent
p32882
g12684
sVMetal divalent cations
p32883
(dp32884
sVDrugs that are Mainly Renally Excreted
p32885
(dp32886
sVElements
p32887
(dp32888
sg7749
(dp32889
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p32890
(dp32891
sg9405
(dp32892
sVLaxatives
p32893
g17334
sVDrugs for Constipation
p32894
(dp32895
sVAlimentary Tract and Metabolism
p32896
g23807
sVToxic Actions
p32897
(dp32898
sVAluminum and magnesium containing antacids
p32899
g26960
sVMetals
p32900
(dp32901
sVDrugs for Acid Related Disorders
p32902
(dp32903
sVMetal cations
p32904
(dp32905
sVLaxatives, magnesium containing
p32906
(dp32907
sg5508
(dp32908
sg8757
(dp32909
sVMetals, Light
p32910
(dp32911
ssg2556
(dp32912
g6192
(dp32913
ssg2559
(dp32914
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p32915
(dp32916
sVAnti-Parkinson Drugs
p32917
g16140
sVCytochrome P-450 CYP2D6 Inhibitors
p32918
(dp32919
sVSerotonin Agents
p32920
(dp32921
sVCytochrome P-450 CYP3A Substrates
p32922
(dp32923
sVHypotensive Agents
p32924
(dp32925
sVCentral Nervous System Agents
p32926
(dp32927
sVDopamine Agents
p32928
g14233
sVPsychotropic Drugs
p32929
(dp32930
sVCytochrome P-450 CYP2B6 Substrates
p32931
(dp32932
sVEnzyme Inhibitors
p32933
(dp32934
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p32935
g12662
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p32936
(dp32937
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p32938
g18383
sVCytochrome P-450 Enzyme Inhibitors
p32939
(dp32940
sVCytochrome P-450 CYP2C8 Substrates
p32941
(dp32942
sVCytochrome P-450 CYP1A2 Substrates
p32943
(dp32944
sVAmines
p32945
(dp32946
sVCytochrome P-450 CYP2E1 Inhibitors
p32947
(dp32948
sg9546
(dp32949
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p32950
g29497
sVEthylamines
p32951
g20586
sVProtective Agents
p32952
(dp32953
sVCytochrome P-450 CYP2C9 Substrates
p32954
g29736
sVNeuroprotective Agents
p32955
(dp32956
sVCentral Nervous System Depressants
p32957
(dp32958
sVMonoamine Oxidase B Inhibitors
p32959
g27010
sVAgents that reduce seizure threshold
p32960
(dp32961
sVCytochrome P-450 CYP1A2 Inhibitors
p32962
g15003
sVAnti-Dyskinesia Agents
p32963
(dp32964
sVCytochrome P-450 CYP2B6 Inhibitors
p32965
(dp32966
sVMonoamine Oxidase Inhibitors
p32967
(dp32968
sVCytochrome P-450 CYP2A6 Substrates
p32969
(dp32970
sVAgents that produce hypertension
p32971
(dp32972
sVCytochrome P-450 CYP3A4 Substrates
p32973
(dp32974
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p32975
g26865
sVSerotonin Modulators
p32976
(dp32977
sVAntidepressive Agents
p32978
g15518
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p32979
(dp32980
sVP-glycoprotein/ABCB1 Inhibitors
p32981
(dp32982
sVPhenethylamines
p32983
(dp32984
sVNervous System
p32985
(dp32986
sVCompounds used in a research, industrial, or household setting
p32987
(dp32988
ssg2562
(dp32989
g6048
(dp32990
sg9060
(dp32991
sg5370
(dp32992
ssg2565
(dp32993
g6231
(dp32994
sg8922
(dp32995
sg9192
(dp32996
ssg2568
(dp32997
g5847
(dp32998
ssg2571
(dp32999
g426
g16063
sg1791
g27228
sg2559
g32932
sg7464
(dp33000
sg2199
g30676
sg10818
(dp33001
sg2094
g29988
sg5256
(dp33002
sg4635
(dp33003
sg8163
(dp33004
sg465
g16450
sg1434
g24633
sg10662
(dp33005
sg10308
(dp33006
sg12063
(dp33007
sg6765
(dp33008
sg4263
(dp33009
sg543
g17077
sg6819
(dp33010
sg147
g13435
sg9198
(dp33011
sg3861
(dp33012
sg888
g20407
sg3696
(dp33013
sg1491
g25132
sg2427
g31992
sg1425
g24537
sg5028
(dp33014
sg3975
(dp33015
sg9414
(dp33016
sg7389
(dp33017
sg8097
(dp33018
sg9417
(dp33019
sg516
g16854
sg10728
(dp33020
sg5193
(dp33021
sg5853
(dp33022
sg10740
(dp33023
sg11316
(dp33024
sg9471
(dp33025
sg7569
(dp33026
sg9420
(dp33027
sg9981
(dp33028
sg10539
(dp33029
sg138
g13273
sg8298
(dp33030
sg1911
g28349
sg2109
g30106
sg5145
(dp33031
sg10779
(dp33032
sg14791
(dp33033
sg11544
(dp33034
sg4164
(dp33035
sg387
g15612
sg13091
g21365
sg5289
(dp33036
sg10596
(dp33037
sg4236
(dp33038
sg6075
(dp33039
sg10815
(dp33040
sg3447
(dp33041
sg11112
(dp33042
sg10056
(dp33043
ssg2574
(dp33044
g2553
g32881
sg10767
(dp33045
sg5415
(dp33046
sg1842
g27665
sg9561
(dp33047
sg657
g18295
sg11382
(dp33048
sg3825
(dp33049
sg4770
(dp33050
ssg2577
(dp33051
g87
g12907
sg10833
(dp33052
sg11061
(dp33053
sg3576
(dp33054
sg3015
(dp33055
sg7881
(dp33056
sg8985
(dp33057
sg10326
(dp33058
sg1101
g22055
sg3264
(dp33059
sg1527
g25249
sg7500
(dp33060
sg6654
(dp33061
sg5520
(dp33062
sg48
g12630
sg11427
(dp33063
sg4953
(dp33064
sg1275
g23277
sg9411
(dp33065
ssg2580
(dp33066
g564
g17400
ssg2583
(dp33067
VCatechols
p33068
(dp33069
sVPhenols
p33070
(dp33071
sVAmines
p33072
(dp33073
sVBenzene Derivatives
p33074
(dp33075
sVDrugs that are Mainly Renally Excreted
p33076
(dp33077
sVBiogenic Amines
p33078
(dp33079
sVAnti-Dyskinesia Agents
p33080
(dp33081
sVBiogenic Monoamines
p33082
(dp33083
sVCentral Nervous System Agents
p33084
(dp33085
sVCatecholamines
p33086
g19124
sVHydrazines
p33087
(dp33088
sg3606
(dp33089
sVEnzyme Inhibitors
p33090
(dp33091
sVAnti-Parkinson Drugs
p33092
g16146
ssg2586
(dp33093
g3090
(dp33094
sg9846
(dp33095
sg9630
(dp33096
sg9426
(dp33097
sg2940
(dp33098
ssg2589
(dp33099
g1185
g22747
sg1062
g21838
ssg2592
(dp33100
g11781
(dp33101
ssg2595
(dp33102
g9414
(dp33103
sg11751
(dp33104
sg11826
(dp33105
sg10047
(dp33106
sg5889
(dp33107
sg7044
(dp33108
ssg2598
(dp33109
VAmidines
p33110
(dp33111
sVDrugs that are Mainly Renally Excreted
p33112
(dp33113
sVMATE 2 Substrates
p33114
(dp33115
sVMATE 1 Substrates
p33116
g23499
sVOCT1 substrates
p33117
g13066
sVGuanidines
p33118
(dp33119
sVMATE substrates
p33120
(dp33121
sVOCT2 Inhibitors
p33122
(dp33123
sVOCT2 Substrates
p33124
g14939
sVOral Hypoglycemics
p33125
(dp33126
sVOCT2 substrates with narrow therapeutic index
p33127
g29683
sVBlood Glucose Lowering Agents
p33128
(dp33129
sVAlimentary Tract and Metabolism
p33130
g23824
sVDrugs Used in Diabetes
p33131
(dp33132
sVBiguanides
p33133
g25208
ssg2601
(dp33134
g9267
(dp33135
ssg2604
(dp33136
g2715
(dp33137
ssg2607
(dp33138
g1149
g22501
ssg2610
(dp33139
g5691
(dp33140
sg3204
(dp33141
ssg2613
(dp33142
g10557
(dp33143
sg9402
(dp33144
sg4623
(dp33145
sg9561
(dp33146
sg11667
(dp33147
sg657
g18314
sg5250
(dp33148
ssg2616
(dp33149
VCytochrome P-450 CYP2D6 Inhibitors
p33150
(dp33151
sVCytochrome P-450 CYP2D6 Substrates
p33152
(dp33153
sVAntiarrhythmic agents
p33154
(dp33155
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p33156
(dp33157
sVCytochrome P-450 CYP3A Substrates
p33158
(dp33159
sVAgents causing hyperkalemia
p33160
(dp33161
sVHypotensive Agents
p33162
(dp33163
sVBeta blocking agents and calcium channel blockers
p33164
(dp33165
sVOCT2 Inhibitors
p33166
(dp33167
sVAdrenergic Antagonists
p33168
(dp33169
sVCytochrome P-450 Enzyme Inhibitors
p33170
(dp33171
sVDrugs that are Mainly Renally Excreted
p33172
(dp33173
sVAmines
p33174
(dp33175
sVAdrenergic beta-1 Receptor Antagonists
p33176
(dp33177
sVAntihypertensive Agents
p33178
g20279
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33179
g29494
sVBeta Blocking Agents, Selective
p33180
(dp33181
sVAdrenergic Agents
p33182
(dp33183
sVCardiovascular Agents
p33184
g26563
sVP-glycoprotein/ABCB1 Substrates
p33185
(dp33186
sVAdrenergic beta-Antagonists
p33187
g15371
sVCytochrome P-450 CYP3A4 Substrates
p33188
(dp33189
sVPropanolamines
p33190
(dp33191
sVBeta Blocking Agents and Thiazides
p33192
(dp33193
sVAmino Alcohols
p33194
g32695
sVBradycardia-Causing Agents
p33195
(dp33196
sVBeta-Blockers (Beta1 Selective)
p33197
(dp33198
sVAlcohols
p33199
(dp33200
sVBeta Blocking Agents, Selective, and Thiazides
p33201
(dp33202
ssg2619
(dp33203
g10296
(dp33204
ssg2622
(dp33205
g1686
g26417
sg10077
(dp33206
ssg2625
(dp33207
g3174
(dp33208
sg690
g18620
sg2739
(dp33209
sg4920
(dp33210
sg5865
(dp33211
sg30
g12372
sg4479
(dp33212
sg7377
(dp33213
sg6240
(dp33214
sg9096
(dp33215
sg4539
(dp33216
sg8448
(dp33217
sg1539
g25311
sg3021
(dp33218
sg11838
(dp33219
ssg2628
(dp33220
g11541
(dp33221
sg10017
(dp33222
sg8259
(dp33223
sg2418
g31934
sg8460
(dp33224
sg7344
(dp33225
ssg2631
(dp33226
g10062
(dp33227
sg426
g16107
sg630
g18025
sg11790
(dp33228
sg8205
(dp33229
sg2358
g31483
sg1425
g24568
sg240
g14212
sg11811
(dp33230
sg828
g19889
sg183
g13840
sg9711
(dp33231
sg10674
(dp33232
sg5853
(dp33233
sg7272
(dp33234
sg282
g14570
sg8805
(dp33235
sg7284
(dp33236
sg11016
(dp33237
sg822
g19820
sg12018
(dp33238
sg9564
(dp33239
sg6939
(dp33240
sg5970
(dp33241
sg2430
g32106
sg2814
(dp33242
sg5133
(dp33243
sg5691
(dp33244
sg5694
(dp33245
sg1248
g23051
sg1707
g26774
sg6966
(dp33246
sg2265
g31010
sg12066
(dp33247
sg5535
(dp33248
sg11139
(dp33249
sg486
g16653
sg696
g18773
sg7497
(dp33250
sg3204
(dp33251
sg7299
(dp33252
sg6303
(dp33253
sg9372
(dp33254
sg4035
(dp33255
sg3570
(dp33256
sg582
g17627
sg4155
(dp33257
sg6318
(dp33258
sg5067
(dp33259
sg5769
(dp33260
sg2664
(dp33261
sg1194
g22819
sg414
g15963
sg8187
(dp33262
sg780
g19378
ssg2634
(dp33263
g9870
(dp33264
sg7530
(dp33265
sg10320
(dp33266
sg9780
(dp33267
sg2985
(dp33268
sg8760
(dp33269
sg11382
(dp33270
sg420
g16032
ssg2637
(dp33271
g8655
(dp33272
sg465
g16494
sg11283
(dp33273
sg345
g15246
sg2289
g31219
ssg2640
(dp33274
g3036
(dp33275
sg9987
(dp33276
ssg2643
(dp33277
g2736
(dp33278
ssg2646
(dp33279
g1791
g27250
sg9618
(dp33280
sg7524
(dp33281
sg5112
(dp33282
sg4377
(dp33283
sg5973
(dp33284
sg8163
(dp33285
sg7389
(dp33286
sg717
g19061
sg19588
g32487
sg8655
(dp33287
sg1917
g28468
sg4959
(dp33288
sg9765
(dp33289
sg1611
g25815
ssg2649
(dp33290
g9225
(dp33291
sg10209
(dp33292
sg2832
(dp33293
ssg2652
(dp33294
VAntivirals for Systemic Use
p33295
(dp33296
sVBreast Cancer Resistance Protein Inhibitors
p33297
g12717
sVCytochrome P-450 CYP3A Substrates
p33298
(dp33299
sVBCRP/ABCG2 Inhibitors
p33300
g12537
sVDirect Acting Antivirals
p33301
(dp33302
sVOATP1B1/SLCO1B1 Inhibitors
p33303
(dp33304
sVNS3/4A Protease Inhibitors
p33305
(dp33306
sVAntiinfectives for Systemic Use
p33307
(dp33308
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33309
g29518
sVOATP1B3 inhibitors
p33310
(dp33311
sVOATP1B1/SLCO1B1 Substrates
p33312
(dp33313
sVHCV NS3/4A Protease Inhibitors
p33314
(dp33315
sVAntivirals for treatment of HCV infections
p33316
g31038
sVP-glycoprotein/ABCB1 Substrates
p33317
(dp33318
sVUGT1A1 Inhibitors
p33319
(dp33320
sVCytochrome P-450 CYP3A4 Substrates
p33321
(dp33322
sVCytochrome P-450 CYP3A5 Substrates
p33323
(dp33324
sVOATP1B3 substrates
p33325
g28521
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p33326
(dp33327
sVAntiviral Agents
p33328
g30457
sVP-glycoprotein/ABCB1 Inhibitors
p33329
(dp33330
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p33331
(dp33332
ssg2655
(dp33333
g5793
(dp33334
ssg2658
(dp33335
VAgents Causing Muscle Toxicity
p33336
(dp33337
sg1017
g21339
sVCytochrome P-450 CYP2D6 Inhibitors
p33338
(dp33339
sVCytochrome P-450 CYP2D6 Substrates
p33340
(dp33341
sVNeurotransmitter Agents
p33342
(dp33343
sVHydroxy Acids
p33344
g18160
sVCentral Nervous System Agents
p33345
(dp33346
sVDopamine Agents
p33347
g14235
sVPotential QTc-Prolonging Agents
p33348
(dp33349
sVPhenols
p33350
(dp33351
sVCytochrome P-450 Enzyme Inhibitors
p33352
(dp33353
sVEthers
p33354
g27595
sVDrugs that are Mainly Renally Excreted
p33355
(dp33356
sVAutonomic Agents
p33357
(dp33358
sVAcids, Carbocyclic
p33359
(dp33360
sVPeripheral Nervous System Agents
p33361
(dp33362
sVAmides
p33363
(dp33364
sVDopamine Antagonists
p33365
(dp33366
sVQTc Prolonging Agents
p33367
(dp33368
sVAntiemetics
p33369
(dp33370
sVGastrointestinal Agents
p33371
(dp33372
sVBenzene Derivatives
p33373
(dp33374
sVPhenyl Ethers
p33375
(dp33376
sg4689
(dp33377
sVDrugs for Functional Gastrointestinal Disorders
p33378
(dp33379
sVChlorobenzoates
p33380
(dp33381
sVBenzamides and benzamide derivatives
p33382
g15374
sVAlimentary Tract and Metabolism
p33383
g23866
sVDopamine D2 Receptor Antagonists
p33384
(dp33385
sVAminobenzoates
p33386
(dp33387
sVBenzoates
p33388
g30385
sg12120
(dp33389
sVMethemoglobinemia Associated Agents
p33390
g25565
sVHydroxybenzoates
p33391
(dp33392
sVCholinesterase Inhibitors
p33393
(dp33394
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p33395
(dp33396
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p33397
(dp33398
sVpara-Aminobenzoates
p33399
g30547
ssg2661
(dp33400
g3015
(dp33401
ssg2664
(dp33402
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p33403
(dp33404
sVAdrenergic alpha-1 Receptor Antagonists
p33405
g14144
sVAnticholinergic Agents
p33406
g24510
sVCytochrome P-450 CYP2D6 Substrates
p33407
(dp33408
sVSerotonin Agents
p33409
(dp33410
sVCytochrome P-450 CYP3A Substrates
p33411
(dp33412
sVHypotensive Agents
p33413
(dp33414
sVSerotonin Receptor Antagonists
p33415
(dp33416
sVCentral Nervous System Agents
p33417
(dp33418
sVCYP3A Substrates (Sensitive)
p33419
(dp33420
sVAdrenergic Antagonists
p33421
(dp33422
sVPsychotropic Drugs
p33423
(dp33424
sVDopamine Antagonists
p33425
(dp33426
sVSerotonin 5-HT1 Receptor Antagonists
p33427
g14432
sVMuscarinic Antagonists
p33428
(dp33429
sVHighest Risk QTc-Prolonging Agents
p33430
(dp33431
sVDiazepines, Oxazepines, Thiazepines and Oxepines
p33432
(dp33433
sVDrugs that are Mainly Renally Excreted
p33434
(dp33435
sVAntipsychotic Agents
p33436
(dp33437
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33438
g29284
sVSulfur Compounds
p33439
(dp33440
sVAdrenergic alpha-Antagonists
p33441
(dp33442
sg5205
(dp33443
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p33444
(dp33445
sVQTc Prolonging Agents
p33446
(dp33447
sVHyperglycemia-Associated Agents
p33448
(dp33449
sVSerotonin 5-HT2 Receptor Antagonists
p33450
(dp33451
sg8229
(dp33452
sVCentral Nervous System Depressants
p33453
(dp33454
sg4704
(dp33455
sVHistamine Antagonists
p33456
(dp33457
sVP-glycoprotein/ABCB1 Substrates
p33458
(dp33459
sVHistamine H1 Antagonists
p33460
(dp33461
sVAgents that produce hypertension
p33462
(dp33463
sVHeterocyclic Compounds, Fused-Ring
p33464
(dp33465
sVCytochrome P-450 CYP3A4 Substrates
p33466
(dp33467
sVDopamine D2 Receptor Antagonists
p33468
(dp33469
sVCytochrome P-450 CYP3A5 Substrates
p33470
(dp33471
sVAntidepressive Agents
p33472
g15577
sVPsycholeptics
p33473
g33261
sg2301
g31232
sVTranquilizing Agents
p33474
(dp33475
sVNeurotoxic agents
p33476
(dp33477
sVAgents producing tachycardia
p33478
(dp33479
sVNervous System
p33480
(dp33481
sVAntipsychotic Agents (Second Generation [Atypical])
p33482
(dp33483
sVCytochrome P-450 CYP3A7 Substrates
p33484
(dp33485
ssg2667
(dp33486
VAntimalarials
p33487
g14103
sVCytochrome P-450 CYP3A Substrates
p33488
(dp33489
sVAnti-Acne Preparations
p33490
(dp33491
sVMiscellaneous Local Anti-infectives
p33492
(dp33493
sg552
g17175
sVEnzyme Inhibitors
p33494
(dp33495
sVCytochrome P-450 CYP2C9 Inducers
p33496
g20036
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p33497
g16518
sVAntiinfectives for Systemic Use
p33498
(dp33499
sVCytochrome P-450 CYP2C8 Substrates
p33500
(dp33501
sVAnti-Infective Agents
p33502
(dp33503
sVMethemoglobinemia Associated Agents
p33504
g25579
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33505
g29524
sVSulfur Compounds
p33506
(dp33507
sVAnti-Bacterial Agents
p33508
(dp33509
sVAntiprotozoals
p33510
(dp33511
sVCytochrome P-450 CYP2C19 Substrates
p33512
(dp33513
sVFolic Acid Antagonists
p33514
(dp33515
sVDermatologicals
p33516
g17245
sVAntiparasitic Agents
p33517
(dp33518
sVCytochrome P-450 Enzyme Inducers
p33519
g28166
sVAntimycobacterials
p33520
g22568
sVCytochrome P-450 CYP2C18 Substrates
p33521
g20944
sVCytochrome P-450 CYP2C9 Substrates
p33522
g29753
sVCytochrome P-450 CYP3A5 Substrates
p33523
(dp33524
sVCytochrome P-450 CYP3A4 Substrates
p33525
(dp33526
sVAnti-Acne Preparations for Topical Use
p33527
(dp33528
sVSulfones
p33529
(dp33530
sg9369
(dp33531
sg999
g21212
sVCytochrome P-450 CYP3A7 Substrates
p33532
(dp33533
ssg2670
(dp33534
g2286
g31178
sg102
g13019
sg8142
(dp33535
sg4236
(dp33536
sg6123
(dp33537
ssg2673
(dp33538
g6939
(dp33539
ssg2676
(dp33540
g11244
(dp33541
sVCytochrome P-450 CYP2D6 Inhibitors
p33542
(dp33543
sVCytochrome P-450 CYP2D6 Substrates
p33544
(dp33545
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p33546
(dp33547
sVCytochrome P-450 CYP3A Substrates
p33548
(dp33549
sg1089
g21954
sVQTc Prolonging Agents
p33550
(dp33551
sg4206
(dp33552
sVCYP3A Substrates (Sensitive)
p33553
(dp33554
sg1530
g25279
sVP-glycoprotein/ABCB1 Inhibitors
p33555
(dp33556
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33557
g29495
sVEnzyme Inhibitors
p33558
(dp33559
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p33560
(dp33561
sVCytochrome P-450 Enzyme Inhibitors
p33562
(dp33563
sVCytochrome P-450 CYP3A4 Substrates
p33564
(dp33565
sVAlimentary Tract and Metabolism
p33566
g23802
sVOther Miscellaneous Therapeutic Agents
p33567
g28776
sVHighest Risk QTc-Prolonging Agents
p33568
(dp33569
ssg2679
(dp33570
g1059
g21746
ssg2682
(dp33571
g9225
(dp33572
sg9357
(dp33573
sg4236
(dp33574
sg11316
(dp33575
sg1470
g24927
sg3861
(dp33576
sg5433
(dp33577
sg4680
(dp33578
sg10209
(dp33579
sg3543
(dp33580
sg2286
g31181
sg2832
(dp33581
sg8013
(dp33582
sg12274
g27562
sg543
g17114
ssg2685
(dp33583
g4023
(dp33584
sg5268
(dp33585
sg3027
(dp33586
sg600
g17723
sg6882
(dp33587
sg11601
(dp33588
sg11370
(dp33589
sg5454
(dp33590
sg6807
(dp33591
ssg2688
(dp33592
VAntiparasitic Products, Insecticides and Repellents
p33593
g30583
sVAgents that produce neuromuscular block (indirect)
p33594
(dp33595
sVAntimalarials
p33596
g14093
sVQuinolines
p33597
(dp33598
sVCytochrome P-450 CYP2D6 Inhibitors
p33599
(dp33600
sVCytochrome P-450 CYP2D6 Substrates
p33601
(dp33602
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p33603
(dp33604
sVAnalgesics
p33605
g26458
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p33606
(dp33607
sVCentral Nervous System Agents
p33608
(dp33609
sVOCT2 Inhibitors
p33610
(dp33611
sVOATP1B1/SLCO1B1 Inhibitors
p33612
(dp33613
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p33614
(dp33615
sVCytochrome P-450 Enzyme Inhibitors
p33616
(dp33617
sVAnti-Infective Agents
p33618
(dp33619
sVBlood Glucose Lowering Agents
p33620
(dp33621
sVPeripheral Nervous System Agents
p33622
(dp33623
sVQuinuclidines
p33624
(dp33625
sVHighest Risk QTc-Prolonging Agents
p33626
(dp33627
sVCytochrome P-450 CYP2C8 Substrates
p33628
(dp33629
sVCytochrome P-450 CYP1A2 Substrates
p33630
(dp33631
sVAnalgesics, Non-Narcotic
p33632
(dp33633
sVNeuromuscular Agents
p33634
g20235
sVQuinine and Derivatives
p33635
(dp33636
sVMethanolquinolines
p33637
(dp33638
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33639
g29526
sVAntiprotozoals
p33640
(dp33641
sVQTc Prolonging Agents
p33642
(dp33643
sVCytochrome P-450 CYP3A4 Inducers
p33644
g18923
sVCytochrome P-450 CYP3A Substrates
p33645
(dp33646
sVOCT1 inhibitors
p33647
(dp33648
sVCytochrome P-450 CYP2C19 Substrates
p33649
(dp33650
sVCentral Nervous System Depressants
p33651
(dp33652
sVOCT1 substrates
p33653
g13080
sVAgents that reduce seizure threshold
p33654
(dp33655
sVCytochrome P-450 CYP1A2 Inhibitors
p33656
g15038
sVCytochrome P-450 CYP2C8 Inhibitors
p33657
(dp33658
sVCinchona Alkaloids
p33659
(dp33660
sVMuscle Relaxants, Centrally Acting Agents
p33661
(dp33662
sVP-glycoprotein/ABCB1 Substrates
p33663
(dp33664
sVAntiparasitic Agents
p33665
(dp33666
sVCytochrome P-450 Enzyme Inducers
p33667
g28168
sVCytochrome P-450 CYP3A Inducers
p33668
(dp33669
sVCytochrome P-450 CYP2C9 Substrates
p33670
g29755
sVCytochrome P-450 CYP2C19 Inhibitors
p33671
(dp33672
sVHeterocyclic Compounds, Fused-Ring
p33673
(dp33674
sVCytochrome P-450 CYP3A4 Substrates
p33675
(dp33676
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p33677
(dp33678
sVCytochrome P-450 CYP3A4 Inhibitors
p33679
(dp33680
sVMusculo-Skeletal System
p33681
g31545
sVCytochrome P-450 CYP3A5 Substrates
p33682
(dp33683
sVCytochrome P-450 CYP3A Inhibitors
p33684
(dp33685
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p33686
(dp33687
sVHypoglycemia-Associated Agents
p33688
g17710
sVMethemoglobinemia Associated Agents
p33689
g25581
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p33690
(dp33691
sVP-glycoprotein/ABCB1 Inhibitors
p33692
(dp33693
sVMuscle Relaxants
p33694
(dp33695
sVHerbs (Hypotensive Properties)
p33696
(dp33697
sVAlkaloids
p33698
g19439
sVSensory System Agents
p33699
(dp33700
sVCytochrome P-450 CYP3A7 Substrates
p33701
(dp33702
ssg2691
(dp33703
g3117
(dp33704
ssg2694
(dp33705
g6549
(dp33706
sg9426
(dp33707
sg8577
(dp33708
sg9846
(dp33709
sg9630
(dp33710
sg3090
(dp33711
sg2940
(dp33712
sg7905
(dp33713
sg8781
(dp33714
ssg2697
(dp33715
g11292
(dp33716
ssg2700
(dp33717
g1059
g21780
ssg2703
(dp33718
VHormone Antagonists
p33719
g24263
sVCytochrome P-450 CYP1A2 Substrates
p33720
(dp33721
sVCytochrome P-450 CYP2D6 Inhibitors
p33722
(dp33723
sg8886
(dp33724
sg7902
(dp33725
sVCytochrome P-450 CYP3A Substrates
p33726
(dp33727
sVNaphthalenes
p33728
(dp33729
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p33730
(dp33731
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33732
g29528
sg9276
(dp33733
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p33734
g13743
sVHormones, Hormone Substitutes, and Hormone Antagonists
p33735
(dp33736
sVCytochrome P-450 Enzyme Inhibitors
p33737
(dp33738
sVCytochrome P-450 CYP3A4 Substrates
p33739
(dp33740
sg1200
g22846
sVCalcium-Regulating Hormones and Agents
p33741
(dp33742
sVOther Miscellaneous Therapeutic Agents
p33743
g28771
sg10506
(dp33744
ssg2706
(dp33745
VDrugs that are Mainly Renally Excreted
p33746
(dp33747
sVGenito Urinary System and Sex Hormones
p33748
(dp33749
sVGynecological Antiinfectives and Antiseptics
p33750
(dp33751
sVSulfonamides
p33752
(dp33753
sVSulfones
p33754
(dp33755
sVSulfonamide Antibacterial
p33756
(dp33757
sVMethemoglobinemia Associated Agents
p33758
g25585
sVDermatologicals
p33759
g17253
sVAnti-Infective Agents, Local
p33760
(dp33761
sVSulfur Compounds
p33762
(dp33763
sVAnti-Bacterial Agents
p33764
(dp33765
sVEnzyme Inhibitors
p33766
(dp33767
sVAmides
p33768
(dp33769
sVAnti-Infective Agents
p33770
(dp33771
sVCarbonic Anhydrase Inhibitors
p33772
(dp33773
sVDiuretics
p33774
(dp33775
ssg2709
(dp33776
g8472
(dp33777
sg165
g13600
ssg2712
(dp33778
g6156
(dp33779
sg6162
(dp33780
sg1473
g24983
sg10959
(dp33781
ssg2715
(dp33782
VAgents Causing Muscle Toxicity
p33783
(dp33784
sVFatty Acids
p33785
(dp33786
sVUGT1A1 Substrates
p33787
g12333
sVAntibiotics, Antineoplastic
p33788
g30416
sVImmunologic Factors
p33789
(dp33790
sVUGT1A9 Substrates
p33791
g24026
sVLipids
p33792
g14351
sVAnti-Infective Agents
p33793
(dp33794
sg2604
g33137
sVDrugs that are Mainly Renally Excreted
p33795
(dp33796
sVCytochrome P-450 CYP2C8 Substrates
p33797
(dp33798
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33799
g29532
sVAnti-Bacterial Agents
p33800
(dp33801
sg3162
(dp33802
sVOATP1B1/SLCO1B1 Substrates
p33803
(dp33804
sVCytochrome P-450 CYP3A Substrates
p33805
(dp33806
sVUGT1A6 substrate
p33807
(dp33808
sVAntituberculosis Agents
p33809
(dp33810
sVP-glycoprotein/ABCB1 Substrates
p33811
(dp33812
sVUGT2B7 substrates
p33813
g28645
sVCytochrome P-450 CYP3A4 Substrates
p33814
(dp33815
sVAntibiotics, Antitubercular
p33816
g20920
sVCytochrome P-450 CYP3A5 Substrates
p33817
(dp33818
sVOATP1B3 substrates
p33819
g28533
sVImmunosuppressive Agents
p33820
(dp33821
sVBCRP/ABCG2 Substrates
p33822
(dp33823
ssg2718
(dp33824
g1704
g26736
sg633
g18100
sg5919
(dp33825
sg7056
(dp33826
sg933
g20848
sg8259
(dp33827
sg1668
g26291
ssg2721
(dp33828
g9918
(dp33829
sg4629
(dp33830
sg6567
(dp33831
sg9348
(dp33832
sg2784
(dp33833
sg10185
(dp33834
sg10548
(dp33835
sg6246
(dp33836
sg2805
(dp33837
sg10314
(dp33838
sg11085
(dp33839
sg4491
(dp33840
sg5286
(dp33841
sg5073
(dp33842
sg2901
(dp33843
sg8217
(dp33844
sg4737
(dp33845
sg1149
g22515
sg6843
(dp33846
sg357
g15329
sg7977
(dp33847
sg6150
(dp33848
sg8010
(dp33849
sg7044
(dp33850
ssg2724
(dp33851
g4023
(dp33852
sg5268
(dp33853
sg3027
(dp33854
sg600
g17737
sg6882
(dp33855
sg11601
(dp33856
sg11370
(dp33857
sg5454
(dp33858
sg6807
(dp33859
ssg2727
(dp33860
g4737
(dp33861
ssg2730
(dp33862
VSodium Channel Blockers
p33863
(dp33864
sVCentral Nervous System Depressants
p33865
(dp33866
sVMiscellaneous Anticonvulsants
p33867
(dp33868
sVCardiovascular Agents
p33869
g26602
sg8847
(dp33870
sVAnticonvulsants
p33871
(dp33872
sVCytochrome P-450 CYP3A Substrates
p33873
(dp33874
sVVoltage-Gated Sodium Channel Blockers
p33875
(dp33876
sVCytochrome P-450 CYP2E1 Inhibitors
p33877
(dp33878
sVCentral Nervous System Agents
p33879
(dp33880
sVNervous System
p33881
(dp33882
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p33883
(dp33884
sVCytochrome P-450 CYP3A Inducers
p33885
(dp33886
sVMembrane Transport Modulators
p33887
(dp33888
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p33889
g29534
sVCytochrome P-450 Enzyme Inhibitors
p33890
(dp33891
sVCytochrome P-450 CYP3A4 Substrates
p33892
(dp33893
sVCytochrome P-450 CYP3A4 Inducers
p33894
g18931
sVCytochrome P-450 CYP3A4 Inducers (weak)
p33895
g19516
sVCytochrome P-450 Enzyme Inducers
p33896
g28180
ssg2733
(dp33897
VAntipruritics
p33898
(dp33899
sVPiperidines
p33900
(dp33901
sVHistamine H1 Antagonists
p33902
(dp33903
sVAntihistamine Drugs
p33904
(dp33905
sVNeurotransmitter Agents
p33906
(dp33907
sVAnti-Allergic Agents
p33908
(dp33909
sVSensory Organs
p33910
(dp33911
sVDecongestants and Antiallergics
p33912
(dp33913
sVDermatologicals
p33914
g17293
sVPotential QTc-Prolonging Agents
p33915
(dp33916
sg6858
(dp33917
sVHistamine Agents
p33918
(dp33919
sVHistamine Antagonists
p33920
(dp33921
sVAntihistamines for Systemic Use
p33922
g12970
sg9024
(dp33923
sVQTc Prolonging Agents
p33924
(dp33925
sVSulfur Compounds
p33926
(dp33927
sVHistamine H1 Inhibitors
p33928
(dp33929
sVOphthalmologicals
p33930
(dp33931
ssg2736
(dp33932
VPhotoactivated Radical Generator
p33933
(dp33934
sVCompounds used in a research, industrial, or household setting
p33935
(dp33936
sVCross-Linking Reagents
p33937
(dp33938
sVAntipsoriatics for Topical Use
p33939
g22992
sVCytochrome P-450 Enzyme Inhibitors
p33940
(dp33941
sVDrugs that are Mainly Renally Excreted
p33942
(dp33943
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p33944
(dp33945
sVPhotosensitizing Activity
p33946
(dp33947
sg2643
g33278
sVPhotoabsorption
p33948
(dp33949
sVAntipsoriatics for Systemic Use
p33950
(dp33951
sVRadiation-Sensitizing Agents
p33952
(dp33953
sVColoring Agents
p33954
(dp33955
sVCytochrome P-450 CYP1A2 Inhibitors
p33956
g15000
sVDermatologicals
p33957
g17275
sVLaboratory Chemicals
p33958
(dp33959
sVCytochrome P-450 CYP2A6 Substrates
p33960
(dp33961
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p33962
(dp33963
sVPyrans
p33964
(dp33965
sVAntipsoriatics
p33966
(dp33967
sg11106
(dp33968
sVIndicators and Reagents
p33969
(dp33970
sVHeterocyclic Compounds, Fused-Ring
p33971
(dp33972
sg348
g15250
sVBenzopyrans
p33973
g31328
sVCytochrome P-450 CYP2A6 Inhibitors
p33974
(dp33975
sVPhotosensitizing Agents
p33976
g21313
ssg2739
(dp33977
VAgents that produce neuromuscular block (indirect)
p33978
(dp33979
sVCarbohydrates
p33980
(dp33981
sVCytochrome P-450 CYP3A4 Inhibitors
p33982
(dp33983
sVAnti-Acne Preparations
p33984
(dp33985
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p33986
(dp33987
sVEnzyme Inhibitors
p33988
(dp33989
sVCytochrome P-450 Enzyme Inhibitors
p33990
(dp33991
sVAnti-Infective Agents
p33992
(dp33993
sVAntiinfectives for Systemic Use
p33994
(dp33995
sVLincosamides
p33996
g26223
sVGynecological Antiinfectives and Antiseptics
p33997
(dp33998
sVLincomycin
p33999
g14780
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34000
g29370
sVMacrolides, Lincosamides and Streptogramins
p34001
g33209
sVDecreased Sebaceous Gland Activity
p34002
(dp34003
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p34004
(dp34005
sVCytochrome P-450 CYP3A Substrates
p34006
(dp34007
sVProtein Synthesis Inhibitors
p34008
(dp34009
sVGlycosides
p34010
(dp34011
sVPyrrolidines
p34012
(dp34013
sVAnti-Bacterial Agents
p34014
(dp34015
sVDermatologicals
p34016
g17260
sVLincomycins
p34017
(dp34018
sVAntibacterials for Systemic Use
p34019
g32582
sVCytochrome P-450 CYP3A4 Substrates
p34020
(dp34021
sVNarrow Therapeutic Index Drugs
p34022
(dp34023
sVAnti-Acne Preparations for Topical Use
p34024
(dp34025
sVGenito Urinary System and Sex Hormones
p34026
(dp34027
sVCytochrome P-450 CYP3A Inhibitors
p34028
(dp34029
sVNeurotoxic agents
p34030
(dp34031
sVLincosamide Antibacterial
p34032
g28762
sVAntiinfectives for Treatment of Acne
p34033
(dp34034
ssg2742
(dp34035
g8055
(dp34036
sg8874
(dp34037
sg10563
(dp34038
sg10581
(dp34039
sg9663
(dp34040
sg2910
(dp34041
ssg2745
(dp34042
g6312
(dp34043
sg8265
(dp34044
ssg2748
(dp34045
g4821
(dp34046
sg8796
(dp34047
ssg2751
(dp34048
g10200
(dp34049
sg6906
(dp34050
sg3318
(dp34051
sg5085
(dp34052
ssg2754
(dp34053
VAntineoplastic Agents, Immunological
p34054
(dp34055
sVSerum Globulins
p34056
(dp34057
sg4455
(dp34058
sg3720
(dp34059
sVAngiogenesis Inhibitors
p34060
(dp34061
sVMyelosuppressive Agents
p34062
(dp34063
sVImmunoglobulins
p34064
(dp34065
sVAntineoplastic Agents
p34066
(dp34067
sVAntibodies
p34068
(dp34069
sVProteins
p34070
(dp34071
sVGlobulins
p34072
g19163
sVGrowth Substances
p34073
(dp34074
sVAmino Acids, Peptides, and Proteins
p34075
(dp34076
sVCardiotoxic antineoplastic agents
p34077
(dp34078
sVAntibodies, Monoclonal
p34079
(dp34080
sVAngiogenesis Modulating Agents
p34081
(dp34082
sVAntibodies, Monoclonal, Humanized
p34083
(dp34084
sVGrowth Inhibitors
p34085
g13756
sVImmunosuppressive Agents
p34086
(dp34087
sg3084
(dp34088
sVAntineoplastic and Immunomodulating Agents
p34089
(dp34090
sVBlood Proteins
p34091
(dp34092
sVImmunoproteins
p34093
(dp34094
ssg2757
(dp34095
g2844
(dp34096
sg10629
(dp34097
sg7740
(dp34098
sg12114
(dp34099
sg3114
(dp34100
sg8388
(dp34101
sg6318
(dp34102
sg3531
(dp34103
sg7641
(dp34104
sg3708
(dp34105
sg9165
(dp34106
sg3426
(dp34107
sg4656
(dp34108
sg3900
(dp34109
sg8433
(dp34110
sg20252
(dp34111
sg3156
(dp34112
sg6267
(dp34113
sg2433
g32144
sg4887
(dp34114
sg9216
(dp34115
sg7344
(dp34116
sg7716
(dp34117
sg2835
(dp34118
sg8487
(dp34119
sg2283
g31145
sg1719
g26820
sg9252
(dp34120
sg10761
(dp34121
sg10005
(dp34122
sg9267
(dp34123
sg6303
(dp34124
sg6312
(dp34125
sg966
g21033
sg7764
(dp34126
sg11544
(dp34127
sg3231
(dp34128
sg1767
g27018
sg3240
(dp34129
sg7077
(dp34130
sg4056
(dp34131
sg2616
g33163
sg10356
(dp34132
sg7800
(dp34133
sg5595
(dp34134
sg1008
g21263
sg213
g14044
sg4806
(dp34135
sg1791
g27222
sg2559
g32925
sg9417
(dp34136
sg5619
(dp34137
sg1038
g21484
sg4341
(dp34138
sg4890
(dp34139
sg1044
g21532
sg3318
(dp34140
sg10884
(dp34141
sg6408
(dp34142
sg6411
(dp34143
sg4062
(dp34144
sg375
g15429
sg4068
(dp34145
sg195
g13905
sg6447
(dp34146
sg10164
(dp34147
sg9486
(dp34148
sg5574
(dp34149
sg537
g17014
sg6507
(dp34150
sg8721
(dp34151
sg10056
(dp34152
sg1941
g28566
sg8226
(dp34153
sg10227
(dp34154
sg3444
(dp34155
sg7191
(dp34156
sg2304
g31243
sg414
g15935
sg5007
(dp34157
sg10263
(dp34158
sg978
g21146
sg5829
(dp34159
sg879
g20334
sg7164
(dp34160
sg1263
g23189
sg8067
(dp34161
sg8820
(dp34162
sg11097
(dp34163
sg5094
(dp34164
sg7305
(dp34165
sg534
g16968
sg10200
(dp34166
sg4458
(dp34167
sg6639
(dp34168
sg10557
(dp34169
sg7314
(dp34170
sg9012
(dp34171
sg12060
(dp34172
sg3036
(dp34173
sg6885
(dp34174
sg696
g18693
sg5934
(dp34175
sg8166
(dp34176
sg10383
(dp34177
sg909
g20620
sg7698
(dp34178
sg6678
(dp34179
sg6684
(dp34180
sg11910
(dp34181
sg4419
(dp34182
sg10878
(dp34183
sg603
g17772
sg3072
(dp34184
sg5199
(dp34185
sg11862
(dp34186
sg6735
(dp34187
sg1857
g27694
sg5229
(dp34188
sg11145
(dp34189
sg11976
(dp34190
sg4452
(dp34191
sg5247
(dp34192
sg6759
(dp34193
sg4266
(dp34194
sg8295
(dp34195
sg4467
(dp34196
sg6051
(dp34197
sg9687
(dp34198
sg1746
g26942
sg3696
(dp34199
sg684
g18489
sg9987
(dp34200
sg9009
(dp34201
sg8265
(dp34202
sg10104
(dp34203
sg6906
(dp34204
sg3018
(dp34205
sg2262
g30949
sg3027
(dp34206
sg9783
(dp34207
sg5238
(dp34208
sg6000
(dp34209
sg1548
g25358
sg8862
(dp34210
sg10098
(dp34211
sg6291
(dp34212
sg771
g19269
sg10587
(dp34213
sg5289
(dp34214
sg2664
g33414
sg7596
(dp34215
sg5580
(dp34216
ssg2760
(dp34217
g7320
(dp34218
sg5598
(dp34219
sg23
g12199
ssg2763
(dp34220
VAntiandrogens
p34221
(dp34222
sVCytochrome P-450 CYP3A Substrates
p34223
(dp34224
sVHormone Antagonists and Related Agents
p34225
(dp34226
sVAnilides
p34227
(dp34228
sVDrugs that are Mainly Renally Excreted
p34229
(dp34230
sVCytochrome P-450 CYP1A2 Substrates
p34231
(dp34232
sVAmines
p34233
(dp34234
sVAmides
p34235
(dp34236
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34237
g29542
sVAniline Compounds
p34238
g23438
sVAntineoplastic Agents
p34239
(dp34240
sVAntineoplastic Agents, Hormonal
p34241
(dp34242
sVCytochrome P-450 CYP3A4 Substrates
p34243
(dp34244
sVAndrogen Receptor Inhibitor
p34245
(dp34246
sVHormone Antagonists
p34247
g24264
sVCytochrome P-450 CYP3A5 Substrates
p34248
(dp34249
sVMethemoglobinemia Associated Agents
p34250
g25560
sVAntiandrogens, non-steroidal
p34251
(dp34252
sVAntineoplastic and Immunomodulating Agents
p34253
(dp34254
sVHormones, Hormone Substitutes, and Hormone Antagonists
p34255
(dp34256
sVAndrogen Receptor Antagonists
p34257
g27118
sVEndocrine Therapy
p34258
g19570
ssg2766
(dp34259
g9309
(dp34260
sg7629
(dp34261
sg4725
(dp34262
sg12108
(dp34263
sg1164
g22607
ssg2769
(dp34264
VAgents Causing Muscle Toxicity
p34265
(dp34266
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p34267
(dp34268
sVCytochrome P-450 CYP3A4 Inhibitors
p34269
(dp34270
sVGastric Acid Lowering Agents
p34271
(dp34272
sVCytochrome P-450 CYP2D6 Inhibitors
p34273
(dp34274
sVOAT1/SLC22A6 inhibitors
p34275
(dp34276
sg7827
(dp34277
sVOAT1/SLC22A6 Substrates
p34278
(dp34279
sVOCT2 Inhibitors
p34280
(dp34281
sVCholinesterase Inhibitors
p34282
(dp34283
sVCytochrome P-450 Enzyme Inhibitors
p34284
(dp34285
sVHistamine H2 Antagonists
p34286
g12704
sVAcid Reducers
p34287
(dp34288
sVDrugs that are Mainly Renally Excreted
p34289
(dp34290
sVCytochrome P-450 CYP1A2 Substrates
p34291
(dp34292
sg6915
(dp34293
sVOCT2 substrates with narrow therapeutic index
p34294
g29689
sVAnti-Ulcer Agents
p34295
(dp34296
sg1305
g23491
sVOCT2 Substrates
p34297
g14946
sVGastrointestinal Agents
p34298
(dp34299
sVOCT1 substrates
p34300
g13075
sVCytochrome P-450 CYP1A2 Inhibitors
p34301
g15023
sVOAT3/SLC22A8 Substrates
p34302
g13129
sVP-glycoprotein/ABCB1 Substrates
p34303
(dp34304
sVAlimentary Tract and Metabolism
p34305
g23928
sVFurans
p34306
(dp34307
sVCytochrome P-450 CYP3A Inhibitors
p34308
(dp34309
sVDrugs for Acid Related Disorders
p34310
(dp34311
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p34312
(dp34313
sVP-glycoprotein/ABCB1 Inhibitors
p34314
(dp34315
sVHistamine Antagonists
p34316
(dp34317
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p34318
g30533
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p34319
(dp34320
ssg2772
(dp34321
g1278
g23344
sg8616
(dp34322
sg1872
g27865
sg126
g13183
sg1176
g22686
sg6432
(dp34323
sg9750
(dp34324
sg4872
(dp34325
sg7653
(dp34326
ssg2775
(dp34327
g6819
(dp34328
sg465
g16457
sg14791
(dp34329
ssg2778
(dp34330
g4164
(dp34331
sg6075
(dp34332
sg9663
(dp34333
sg8049
(dp34334
sg8298
(dp34335
ssg2781
(dp34336
g11301
(dp34337
sg7521
(dp34338
sg11934
(dp34339
ssg2784
(dp34340
g66
g12731
sVCytochrome P-450 CYP2D6 Inhibitors
p34341
(dp34342
sVCytochrome P-450 CYP3A Substrates
p34343
(dp34344
sVDrugs for Constipation
p34345
(dp34346
sVCYP3A Substrates (Sensitive)
p34347
(dp34348
sVCompounds used in a research, industrial, or household setting
p34349
(dp34350
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p34351
(dp34352
sVCytochrome P-450 Enzyme Inhibitors
p34353
(dp34354
sVPeripheral Nervous System Agents
p34355
(dp34356
sVCytochrome P-450 CYP3A4 Substrates
p34357
(dp34358
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34359
g29548
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p34360
(dp34361
sVMiscellaneous GI Drugs
p34362
g23544
sVPolymers
p34363
g22224
sVOpiate Alkaloids
p34364
(dp34365
sVOpioid Antagonists
p34366
(dp34367
sVCytochrome P-450 CYP2C19 Inhibitors
p34368
(dp34369
sVBiomedical and Dental Materials
p34370
(dp34371
sVCentral Nervous System Agents
p34372
(dp34373
sVAlimentary Tract and Metabolism
p34374
g23949
sVEthylene Glycols
p34375
(dp34376
sVGlycols
p34377
(dp34378
sVHeterocyclic Compounds, Fused-Ring
p34379
(dp34380
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p34381
(dp34382
sVMacromolecular Substances
p34383
g33833
sVAlkaloids
p34384
g19406
sVSensory System Agents
p34385
(dp34386
sVPhenanthrenes
p34387
g32834
sVAlcohols
p34388
(dp34389
ssg2787
(dp34390
VHeterocyclic Compounds, Fused-Ring
p34391
(dp34392
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p34393
(dp34394
sVCytochrome P-450 CYP1A2 Inducers
p34395
(dp34396
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p34397
(dp34398
sg2106
g30067
sg8436
(dp34399
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p34400
(dp34401
sVMicrotubule Inhibition
p34402
g12888
sVDermatologicals
p34403
g17243
sg3525
(dp34404
sg10845
(dp34405
sVCytochrome P-450 Enzyme Inducers
p34406
g28191
sVCytochrome P-450 CYP3A Inducers
p34407
(dp34408
sg9744
(dp34409
sVCytochrome P-450 CYP2C8 Inducers
p34410
(dp34411
sVCytochrome P-450 CYP2D6 Inducers
p34412
(dp34413
sg567
g17440
sVAnti-Infective Agents
p34414
(dp34415
sVCytochrome P-450 CYP3A4 Inducers
p34416
g18937
sg10590
(dp34417
sg7950
(dp34418
ssg2790
(dp34419
g11352
(dp34420
sg10740
(dp34421
sg2109
g30150
sg3444
(dp34422
sg10593
(dp34423
sg11154
(dp34424
sg8778
(dp34425
sg2262
g30974
sg570
g17495
sg6921
(dp34426
ssg2793
(dp34427
g8724
(dp34428
sg8703
(dp34429
ssg2796
(dp34430
g4911
(dp34431
sg4155
(dp34432
sg7272
(dp34433
sg183
g13802
sg888
g20433
ssg2799
(dp34434
g11229
(dp34435
ssg2802
(dp34436
g4200
(dp34437
ssg2805
(dp34438
VLipids
p34439
g14312
sVToxic Actions
p34440
(dp34441
sg4587
(dp34442
sg330
g14982
sVPolymers
p34443
g22228
sVNoxae
p34444
(dp34445
sVSolvents
p34446
(dp34447
sVBiological Products
p34448
(dp34449
sVCompounds used in a research, industrial, or household setting
p34450
(dp34451
sVMacromolecular Substances
p34452
g33837
sVOils
p34453
(dp34454
sg7443
(dp34455
sVBiomedical and Dental Materials
p34456
(dp34457
sVComplex Mixtures
p34458
(dp34459
sVBiopolymers
p34460
(dp34461
sVIrritants
p34462
(dp34463
ssg2808
(dp34464
VAntiinfectives for Systemic Use
p34465
(dp34466
sVAntivirals for Systemic Use
p34467
(dp34468
sVHeterocyclic Compounds, Fused-Ring
p34469
(dp34470
sVHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor
p34471
(dp34472
sVAntiviral Agents
p34473
g30447
sVDermatologicals
p34474
g17280
sVDirect Acting Antivirals
p34475
(dp34476
sVCytochrome P-450 CYP1A2 Substrates
p34477
(dp34478
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p34479
(dp34480
sVGuanine
p34481
(dp34482
sVNucleic Acid Synthesis Inhibitors
p34483
(dp34484
sVPurinones
p34485
(dp34486
sVAnti-Infective Agents
p34487
(dp34488
sVReverse Transcriptase Inhibitors
p34489
g28964
sVPurines
p34490
(dp34491
ssg2811
(dp34492
g4476
(dp34493
ssg2814
(dp34494
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p34495
(dp34496
sVPyrimidines
p34497
(dp34498
sVCytochrome P-450 CYP2D6 Substrates
p34499
(dp34500
sVCytochrome P-450 CYP3A Substrates
p34501
(dp34502
sVNeurotransmitter Agents
p34503
(dp34504
sVCentral Nervous System Agents
p34505
(dp34506
sVCYP3A Substrates (Sensitive)
p34507
(dp34508
sg6894
(dp34509
sVPiperazines
p34510
(dp34511
sVDrugs that are Mainly Renally Excreted
p34512
(dp34513
sVDopamine Antagonists
p34514
(dp34515
sVSpiro Compounds
p34516
g30060
sVPsycholeptics
p34517
g33242
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34518
g29555
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p34519
(dp34520
sVAgents that produce hypertension
p34521
(dp34522
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p34523
(dp34524
sVCytochrome P-450 CYP3A4 Substrates
p34525
(dp34526
sVDopamine D2 Receptor Antagonists
p34527
(dp34528
sVCytochrome P-450 CYP3A5 Substrates
p34529
(dp34530
sVP-glycoprotein/ABCB1 Inhibitors
p34531
(dp34532
sVNervous System
p34533
(dp34534
sVTranquilizing Agents
p34535
(dp34536
sVCytochrome P-450 CYP3A7 Substrates
p34537
(dp34538
ssg2817
(dp34539
g3477
(dp34540
sVNeuropeptides
p34541
(dp34542
sVPituitary Hormone-Releasing Hormones
p34543
(dp34544
sVPotential QTc-Prolonging Agents
p34545
(dp34546
sVHormones
p34547
(dp34548
sVHyperglycemia-Associated Agents
p34549
(dp34550
sVPeptide Hormones
p34551
g20215
sg3915
(dp34552
sVReproductive Control Agents
p34553
g18849
sVQTc Prolonging Agents
p34554
(dp34555
sVAntineoplastic Agents
p34556
(dp34557
sVOligopeptides
p34558
(dp34559
sVAdrenal Cortex Hormones
p34560
g30025
sVProteins
p34561
(dp34562
sVPeptides
p34563
(dp34564
sVGonadotropin-releasing hormone agonist
p34565
(dp34566
sVAmino Acids, Peptides, and Proteins
p34567
(dp34568
sVHypothalamic Hormones
p34569
(dp34570
sVNerve Tissue Proteins
p34571
(dp34572
sVHormones and Related Agents
p34573
(dp34574
sVAntineoplastic and Immunomodulating Agents
p34575
(dp34576
sVHormones, Hormone Substitutes, and Hormone Antagonists
p34577
(dp34578
sVMiscellaneous Therapeutic Agents
p34579
(dp34580
sVEndocrine Therapy
p34581
g19574
ssg2820
(dp34582
g11112
(dp34583
sg8514
(dp34584
sg633
g18093
sg5919
(dp34585
sg7056
(dp34586
sg933
g20841
sg7497
(dp34587
sg8259
(dp34588
sg11931
(dp34589
sg7152
(dp34590
sg11790
(dp34591
sg10470
(dp34592
sg7299
(dp34593
sg9165
(dp34594
sg1668
g26282
sg1704
g26729
ssg2823
(dp34595
g5847
(dp34596
ssg2826
(dp34597
VLipids
p34598
g14353
sVMicronutrients
p34599
(dp34600
sVVitamins (Fat Soluble)
p34601
(dp34602
sVSecosteroids
p34603
(dp34604
sVFood
p34605
(dp34606
sVCalcium-Regulating Hormones and Agents
p34607
(dp34608
sVDiet, Food, and Nutrition
p34609
g22909
sVBone Density Conservation Agents
p34610
(dp34611
sVFood and Beverages
p34612
(dp34613
sVVitamin D and Analogues
p34614
(dp34615
sVFused-Ring Compounds
p34616
g14828
sVPhysiological Phenomena
p34617
g21724
sVVitamins
p34618
g12181
sVAlimentary Tract and Metabolism
p34619
g23801
sVGrowth Substances
p34620
(dp34621
ssg2829
(dp34622
VImmunologic Factors
p34623
(dp34624
sg7062
(dp34625
sg7431
(dp34626
sVKinase Inhibitor
p34627
g24591
sVOATP1B1/SLCO1B1 Inhibitors
p34628
(dp34629
sVPolyketides
p34630
(dp34631
sVHyperglycemia-Associated Agents
p34632
(dp34633
sVMyelosuppressive Agents
p34634
(dp34635
sg8931
(dp34636
sVLactones
p34637
(dp34638
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34639
g29558
sVAnti-Bacterial Agents
p34640
(dp34641
sVMacrolides
p34642
g16913
sVCytochrome P-450 CYP3A Substrates
p34643
(dp34644
sVCytochrome P450 3A4 Inhibitors
p34645
g13043
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p34646
(dp34647
sVOATP1B3 inhibitors
p34648
(dp34649
sVSelective Immunosuppressants
p34650
g23563
sg12093
(dp34651
sg2865
(dp34652
sVCytochrome P-450 CYP3A4 Substrates
p34653
(dp34654
sVNarrow Therapeutic Index Drugs
p34655
(dp34656
sVProtein Kinase Inhibitors
p34657
(dp34658
sVCYP3A Substrates (Sensitive)
p34659
(dp34660
sVImmunosuppressive Agents
p34661
(dp34662
sVAntineoplastic Agents
p34663
(dp34664
sVP-glycoprotein/ABCB1 Inhibitors
p34665
(dp34666
sVAntineoplastic and Immunomodulating Agents
p34667
(dp34668
ssg2832
(dp34669
VGonadal Steroid Hormones
p34670
(dp34671
sVSex Hormones and Modulators of the Genital System
p34672
g19611
sVCytochrome P-450 CYP2D6 Substrates
p34673
(dp34674
sVBCRP/ABCG2 Inducers
p34675
g24519
sVCytochrome P-450 CYP3A Substrates
p34676
(dp34677
sVBCRP/ABCG2 Inhibitors
p34678
g12541
sVBSEP/ABCB11 Inhibitors
p34679
(dp34680
sVOCT2 Inhibitors
p34681
(dp34682
sVOATP1B1/SLCO1B1 Inhibitors
p34683
(dp34684
sVHormones
p34685
(dp34686
sVCytochrome P-450 CYP2C9 Inhibitors
p34687
g18249
sVCytochrome P-450 Enzyme Inhibitors
p34688
(dp34689
sVSteroids
p34690
(dp34691
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p34692
(dp34693
sVHormonal Contraceptives for Systemic Use
p34694
(dp34695
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p34696
g24785
sVP-glycoprotein/ABCB1 Inducers
p34697
(dp34698
sVCorpus Luteum Hormones
p34699
g33293
sVOATP1B3 inducers
p34700
(dp34701
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p34702
g29591
sVCytochrome P-450 CYP2C9 Substrates
p34703
g29816
sVFused-Ring Compounds
p34704
g14885
sVHyperglycemia-Associated Agents
p34705
(dp34706
sVCytochrome P-450 CYP3A4 Inducers
p34707
g18974
sVOCT1 inhibitors
p34708
(dp34709
sVCytochrome P-450 CYP2C19 Substrates
p34710
(dp34711
sVPregnenediones
p34712
g29965
sVAdrenal Cortex Hormones
p34713
g30043
sVPregnenes
p34714
g28751
sVProgestins
p34715
(dp34716
sg3456
(dp34717
sVP-glycoprotein/ABCB1 Substrates
p34718
(dp34719
sVCytochrome P-450 CYP2A6 Substrates
p34720
(dp34721
sVCytochrome P-450 Enzyme Inducers
p34722
g28237
sVCytochrome P-450 CYP3A Inducers
p34723
(dp34724
sVCytochrome P-450 CYP2C19 Inhibitors
p34725
(dp34726
sVProgestin-containing Intrauterine Device
p34727
(dp34728
sVCytochrome P-450 CYP3A4 Substrates
p34729
(dp34730
sVCytochrome P-450 CYP3A7 Inhibitors
p34731
(dp34732
sVGonadal Hormones
p34733
g33581
sVPregnanes
p34734
(dp34735
sVCytochrome P-450 CYP3A5 Substrates
p34736
(dp34737
sVGenito Urinary System and Sex Hormones
p34738
(dp34739
sVCytochrome P-450 CYP3A Inhibitors
p34740
(dp34741
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p34742
(dp34743
sVProgesterone and Derivatives
p34744
(dp34745
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p34746
(dp34747
sVP-glycoprotein/ABCB1 Inhibitors
p34748
(dp34749
sVHormones, Hormone Substitutes, and Hormone Antagonists
p34750
(dp34751
sVCytochrome P-450 CYP3A7 Substrates
p34752
(dp34753
ssg2835
(dp34754
g8316
(dp34755
sg2550
g32863
sg9036
(dp34756
sVCardiovascular Agents
p34757
g26552
sVAntihypertensive Agents
p34758
g20257
sg4212
(dp34759
sVHypotensive Agents
p34760
g34118
sg7830
(dp34761
sVP-glycoprotein/ABCB1 Inhibitors
p34762
(dp34763
sVEnzyme Inhibitors
p34764
(dp34765
sg1545
g25342
ssg2838
(dp34766
VAgents Causing Muscle Toxicity
p34767
(dp34768
sVCytochrome P-450 CYP3A4 Inhibitors
p34769
(dp34770
sVQuinolines
p34771
(dp34772
sVOAT1/SLC22A6 inhibitors
p34773
(dp34774
sVCytochrome P-450 CYP3A7 Inhibitors
p34775
(dp34776
sVPotential QTc-Prolonging Agents
p34777
(dp34778
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p34779
(dp34780
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p34781
(dp34782
sVEnzyme Inhibitors
p34783
(dp34784
sVCytochrome P-450 Enzyme Inhibitors
p34785
(dp34786
sVAnti-Infective Agents
p34787
(dp34788
sVQuinolone Antimicrobial
p34789
(dp34790
sVAntiinfectives for Systemic Use
p34791
(dp34792
sVAnti-Bacterial Agents
p34793
(dp34794
sVQTc Prolonging Agents
p34795
(dp34796
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p34797
g24775
sVCytochrome P-450 CYP1A2 Inhibitors
p34798
g15011
sVFluoroquinolones
p34799
(dp34800
sVCytochrome P-450 CYP3A5 Inhibitors
p34801
(dp34802
sVAntibacterials for Systemic Use
p34803
g32562
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p34804
(dp34805
sVQuinolones
p34806
g23982
sVHeterocyclic Compounds, Fused-Ring
p34807
(dp34808
sVOphthalmologicals
p34809
(dp34810
sVCytochrome P-450 CYP3A Inhibitors
p34811
(dp34812
sVTopoisomerase II Inhibitors
p34813
(dp34814
sVChemically-Induced Disorders
p34815
g21237
sVTopoisomerase Inhibitors
p34816
g32850
sVSensory Organs
p34817
(dp34818
ssg2841
(dp34819
VAnticholinergic Agents
p34820
g24493
sVSerotonin Agents
p34821
(dp34822
sVNeurotransmitter Agents
p34823
(dp34824
sVSerotonin Receptor Antagonists
p34825
(dp34826
sVHistamine Agents
p34827
(dp34828
sVPotential QTc-Prolonging Agents
p34829
(dp34830
sVMuscarinic Antagonists
p34831
(dp34832
sVAntipruritics
p34833
(dp34834
sVPiperidines
p34835
(dp34836
sVUGT1A3 substrates
p34837
g31807
sVAntihistamines for Systemic Use
p34838
g12969
sVQTc Prolonging Agents
p34839
(dp34840
sVSerotonin 5-HT2 Receptor Antagonists
p34841
(dp34842
sVDibenzocycloheptenes
p34843
(dp34844
sVCentral Nervous System Depressants
p34845
(dp34846
sVGastrointestinal Agents
p34847
(dp34848
sVAgents producing tachycardia
p34849
(dp34850
sVAgents that reduce seizure threshold
p34851
(dp34852
sVDermatologicals
p34853
g17284
sVBenzocycloheptenes
p34854
(dp34855
sg10917
(dp34856
sVHistamine H1 Antagonists
p34857
(dp34858
sVAntidepressive Agents
p34859
g15573
sVAnti-Allergic Agents
p34860
(dp34861
sVHistamine Antagonists
p34862
(dp34863
ssg2844
(dp34864
VAntiplatelet agents
p34865
(dp34866
sVBSEP/ABCB11 Substrates
p34867
(dp34868
sVHematologic Agents
p34869
(dp34870
sVBlood and Blood Forming Organs
p34871
(dp34872
sVCardiovascular Agents
p34873
g26515
sVPyrimidines
p34874
(dp34875
sVPhosphodiesterase Inhibitors
p34876
(dp34877
sVPlatelet Aggregation Inhibitors Excl. Heparin
p34878
(dp34879
sVAnticoagulants
p34880
(dp34881
sVDecreased Platelet Aggregation
p34882
(dp34883
sVHypotensive Agents
p34884
g34096
sVP-glycoprotein/ABCB1 Substrates
p34885
(dp34886
sVVasodilating Agents
p34887
g23709
sVOATP1B1/SLCO1B1 Inhibitors
p34888
(dp34889
sVP-glycoprotein/ABCB1 Inhibitors
p34890
(dp34891
sVOATP1B3 inhibitors
p34892
(dp34893
sVEnzyme Inhibitors
p34894
(dp34895
sVMiscellaneous Vasodilatating Agents
p34896
(dp34897
sVPhosphodiesterase 5 Inhibitors
p34898
(dp34899
ssg2847
(dp34900
g8373
(dp34901
sg2346
g31389
sg9879
(dp34902
sg11403
(dp34903
sg10377
(dp34904
sg9135
(dp34905
sg3846
(dp34906
sg6192
(dp34907
sg12421
g12468
sg3858
(dp34908
sg5433
(dp34909
sg6882
(dp34910
sg6318
(dp34911
sg2373
g31601
sg834
g19960
sg7821
(dp34912
sg11427
(dp34913
sg7848
(dp34914
sg10662
(dp34915
sg279
g14495
sg8418
(dp34916
sg8421
(dp34917
sg7668
(dp34918
sg5472
(dp34919
sg3141
(dp34920
sg8433
(dp34921
sg888
g20464
sg10701
(dp34922
sg2481
g32418
sg5499
(dp34923
sg2088
g29930
sg8448
(dp34924
sg9954
(dp34925
sg1683
g26390
sg909
g20649
sg6807
(dp34926
sg1881
g27959
sg7377
(dp34927
sg9231
(dp34928
sg9234
(dp34929
sg10752
(dp34930
sg2466
g32344
sg11337
(dp34931
sg8031
(dp34932
sg789
g19469
sg10761
(dp34933
sg690
g18633
sg5454
(dp34934
sg10005
(dp34935
sg6303
(dp34936
sg147
g13469
sg7500
(dp34937
sg9273
(dp34938
sg12051
(dp34939
sg2523
g32744
sg183
g13826
sg5646
(dp34940
sg2616
g33186
sg5589
(dp34941
sg1110
g22133
sg7800
(dp34942
sg1008
g21291
sg2844
g34886
sg9903
(dp34943
sg7815
(dp34944
sg7053
(dp34945
sg4023
(dp34946
sg9417
(dp34947
sg7962
(dp34948
sg7707
(dp34949
sg7065
(dp34950
sg8595
(dp34951
sg8916
(dp34952
sg12274
g27546
sg9366
(dp34953
sg5766
(dp34954
sg12063
(dp34955
sg6408
(dp34956
sg4653
(dp34957
sg7545
(dp34958
sg8625
(dp34959
sg10122
(dp34960
sg7458
(dp34961
sg10899
(dp34962
sg11655
(dp34963
sg9432
(dp34964
sg4680
(dp34965
sg14838
(dp34966
sg8655
(dp34967
sg4752
(dp34968
sg1869
g27837
sg5694
(dp34969
sg318
g14921
sg12534
(dp34970
sg5739
(dp34971
sg6447
(dp34972
sg4113
(dp34973
sg11151
(dp34974
sg2652
g33318
sg9414
(dp34975
sg609
g17820
sg3393
(dp34976
sg345
g15232
sg7941
(dp34977
sg9198
(dp34978
sg1911
g28365
sg1917
g28443
sg4263
(dp34979
sg10200
(dp34980
sg9444
(dp34981
sg6504
(dp34982
sg4155
(dp34983
sg10350
(dp34984
sg10326
(dp34985
sg3015
(dp34986
sg3114
(dp34987
sg10227
(dp34988
sg7191
(dp34989
sg2715
g33812
sg7197
(dp34990
sg11775
(dp34991
sg8751
(dp34992
sg5796
(dp34993
sg11385
(dp34994
sg426
g16101
sg11016
(dp34995
sg9918
(dp34996
sg3912
(dp34997
sg5817
(dp34998
sg456
g16385
sg9528
(dp34999
sg5829
(dp35000
sg5832
(dp35001
sg1539
g25303
sg1047
g21614
sg3867
(dp35002
sg11052
(dp35003
sg5853
(dp35004
sg2034
g29031
sg7275
(dp35005
sg2046
g29128
sg5781
(dp35006
sg3543
(dp35007
sg11079
(dp35008
sg6699
(dp35009
sg4287
(dp35010
sg9579
(dp35011
sg11097
(dp35012
sg78
g12861
sg5895
(dp35013
sg9591
(dp35014
sg10179
(dp35015
sg2910
(dp35016
sg8097
(dp35017
sg537
g17042
sg6009
(dp35018
sg4458
(dp35019
sg339
g15174
sg10557
(dp35020
sg5919
(dp35021
sg10365
(dp35022
sg10368
(dp35023
sg11133
(dp35024
sg11136
(dp35025
sg2688
g33664
sg6024
(dp35026
sg2850
(dp35027
sg696
g18748
sg6654
(dp35028
sg3651
(dp35029
sg7335
(dp35030
sg10416
(dp35031
sg8760
(dp35032
sg9180
(dp35033
sg10389
(dp35034
sg573
g17564
sg11166
(dp35035
sg7698
(dp35036
sg2142
g30361
sg3570
(dp35037
sg11910
(dp35038
sg5094
(dp35039
sg1371
g24111
sg28215
(dp35040
sg8163
(dp35041
sg11601
(dp35042
sg11931
(dp35043
sg336
g15110
sg4449
(dp35044
sg8187
(dp35045
sg621
g17972
sg8019
(dp35046
sg3633
(dp35047
sg630
g18035
sg2196
g30628
sg4425
(dp35048
sg516
g16876
sg528
g16938
sg8964
(dp35049
sg1503
g25186
sg14872
g15741
sg7428
(dp35050
sg16906
(dp35051
sg11976
(dp35052
sg11979
(dp35053
sg2946
(dp35054
sg8211
(dp35055
sg5250
(dp35056
sg6033
(dp35057
sg8295
(dp35058
sg6045
(dp35059
sg9084
(dp35060
sg3516
(dp35061
sg1668
g26266
sg4479
(dp35062
sg1473
g24972
sg3861
(dp35063
sg3696
(dp35064
sg10494
(dp35065
sg2277
g31114
sg4911
(dp35066
sg5289
(dp35067
sg9009
(dp35068
sg2250
g30861
sg10509
(dp35069
sg9012
(dp35070
sg6090
(dp35071
sg3021
(dp35072
sg3732
(dp35073
sg3024
(dp35074
sg3240
(dp35075
sg2769
g34304
sg723
g19076
sg3027
(dp35076
sg2832
g34719
sg2274
g31080
sg6537
(dp35077
sg4539
(dp35078
sg11334
(dp35079
sg3963
(dp35080
sg4551
(dp35081
sg1548
g25385
sg5316
(dp35082
sg10098
(dp35083
sg12090
(dp35084
sg7416
(dp35085
sg9834
(dp35086
sg12126
(dp35087
sg285
g14622
sg2664
g33459
sg780
g19367
sg11241
(dp35088
sg9981
(dp35089
sg4596
(dp35090
sg819
g19762
sg7608
(dp35091
sg5127
(dp35092
ssg2850
(dp35093
g5346
(dp35094
sVCardiovascular Agents
p35095
g26634
sVUGT1A3 substrates
p35096
g31814
sVOATP1B3 substrates
p35097
g28524
sVAntihypertensive Agents
p35098
g20301
sVCytochrome P-450 CYP3A Substrates
p35099
(dp35100
sVUGT2B7 substrates
p35101
g28638
sVP-glycoprotein/ABCB1 Substrates
p35102
g35027
sVAcids, Carbocyclic
p35103
(dp35104
sVUGT1A9 Substrates
p35105
g24015
sVVasodilating Agents
p35106
g23713
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p35107
g29559
sg309
g14803
sVCytochrome P-450 CYP3A5 Substrates
p35108
(dp35109
sVOATP1B1/SLCO1B1 Substrates
p35110
(dp35111
sVCytochrome P-450 CYP3A4 Substrates
p35112
(dp35113
sVAntihypertensives for Pulmonary Arterial Hypertension
p35114
g25754
ssg2853
(dp35115
g11112
(dp35116
sg7053
(dp35117
sg1791
g27255
sg2559
g32970
sg7464
(dp35118
sg714
g19023
sg1674
g26344
sg2430
g32110
sg4635
(dp35119
sg5256
(dp35120
sg7428
(dp35121
sg10857
(dp35122
sg465
g16480
sg1239
g22967
sg3321
(dp35123
sg6765
(dp35124
sg4863
(dp35125
sg6819
(dp35126
sg2736
g33961
sg3516
(dp35127
sg1491
g25095
sg10818
(dp35128
sg918
g20769
sg1785
g27195
sg6447
(dp35129
sg10728
(dp35130
sg2832
g34721
sg696
g18750
sg7569
(dp35131
sg6654
(dp35132
sg3651
(dp35133
sg69
g12761
sg147
g13473
sg7698
(dp35134
sg10557
(dp35135
sg10563
(dp35136
sg14791
(dp35137
sg13091
g21403
sg6048
(dp35138
sg6075
(dp35139
sg3447
(dp35140
sg4596
(dp35141
ssg2856
(dp35142
g4341
(dp35143
ssg2859
(dp35144
g6699
(dp35145
ssg2862
(dp35146
VAgents Causing Muscle Toxicity
p35147
(dp35148
sVBisphosphonates
p35149
(dp35150
sVMusculo-Skeletal System
p35151
g31527
sVDrugs for Treatment of Bone Diseases
p35152
g14277
sVBone Density Conservation Agents
p35153
(dp35154
sVOrganophosphonates
p35155
(dp35156
sVDrugs Affecting Bone Structure and Mineralization
p35157
g16509
sVOrganophosphorus Compounds
p35158
(dp35159
ssg2865
(dp35160
g16906
(dp35161
sg2829
g34652
ssg2868
(dp35162
g1332
g23669
sg1173
g22655
ssg2871
(dp35163
g9117
(dp35164
sg8373
(dp35165
sg690
g18654
sg7464
(dp35166
sg10818
(dp35167
sg3114
(dp35168
sg4635
(dp35169
sg9903
(dp35170
sg1800
g27337
sg2226
g30783
sg10662
(dp35171
sg7650
(dp35172
sg7653
(dp35173
sg6903
(dp35174
sg1914
g28423
sg9192
(dp35175
sg3141
(dp35176
sg9507
(dp35177
sg3144
(dp35178
sg891
g20559
sg2046
g29138
sg2388
g31682
sg4887
(dp35179
sg2436
g32169
sg15016
(dp35180
sg3657
(dp35181
sg7377
(dp35182
sg10740
(dp35183
sg1719
g26850
sg8340
(dp35184
sg11805
(dp35185
sg9264
(dp35186
sg3207
(dp35187
sg11445
(dp35188
sg9630
(dp35189
sg10074
(dp35190
sg4056
(dp35191
sg1761
g26981
sg6345
(dp35192
sg204
g13976
sg6348
(dp35193
sg5598
(dp35194
sg14829
(dp35195
sg1782
g27166
sg1278
g23322
sg8580
(dp35196
sg4035
(dp35197
sg11604
(dp35198
sg8616
(dp35199
sg4857
(dp35200
sg7545
(dp35201
sg1614
g25898
sg11652
(dp35202
sg10974
(dp35203
sg13070
g21917
sg14838
(dp35204
sg5685
(dp35205
sg12534
(dp35206
sg8673
(dp35207
sg4113
(dp35208
sg6471
(dp35209
sg8694
(dp35210
sg3408
(dp35211
sg10548
(dp35212
sg11733
(dp35213
sg6507
(dp35214
sg210
g13995
sg4320
(dp35215
sg14872
g15761
sg396
g15812
sg10227
(dp35216
sg5766
(dp35217
sg3447
(dp35218
sg5460
(dp35219
sg11781
(dp35220
sg6759
(dp35221
sg9144
(dp35222
sg9897
(dp35223
sg2481
g32436
sg1539
g25297
sg7074
(dp35224
sg10977
(dp35225
sg7275
(dp35226
sg11079
(dp35227
sg10314
(dp35228
sg10335
(dp35229
sg2067
g29615
sg5895
(dp35230
sg4446
(dp35231
sg2838
g34810
sg2109
g30158
sg3021
(dp35232
sg5928
(dp35233
sg11145
(dp35234
sg7569
(dp35235
sg1578
g25657
sg909
g20660
sg4653
(dp35236
sg1356
g23972
sg8871
(dp35237
sg2733
g33931
sg11910
(dp35238
sg9657
(dp35239
sg5295
(dp35240
sg2895
(dp35241
sg3597
(dp35242
sg11922
(dp35243
sg1863
g27755
sg11934
(dp35244
sg612
g17844
sg8922
(dp35245
sg13750
g24405
sg6735
(dp35246
sg11955
(dp35247
sg6012
(dp35248
sg16906
(dp35249
sg2940
(dp35250
sg8211
(dp35251
sg5250
(dp35252
sg1452
g24745
sg6045
(dp35253
sg2256
g30930
sg4479
(dp35254
sg4488
(dp35255
sg1491
g25106
sg3711
(dp35256
sg4440
(dp35257
sg11997
(dp35258
sg3981
(dp35259
sg3393
(dp35260
sg11301
(dp35261
sg11319
(dp35262
sg11727
(dp35263
sg2277
g31110
sg1176
g22664
sg11631
(dp35264
sg4539
(dp35265
sg11067
(dp35266
sg4860
(dp35267
sg1275
g23301
sg8862
(dp35268
sg10098
(dp35269
sg11352
(dp35270
sg1464
g24878
sg9093
(dp35271
sg6381
(dp35272
sg3624
(dp35273
sg5580
(dp35274
ssg2874
(dp35275
g6150
(dp35276
ssg2877
(dp35277
g8616
(dp35278
sg1872
g27852
sg4872
(dp35279
ssg2880
(dp35280
g6231
(dp35281
sg3018
(dp35282
sg7164
(dp35283
sg375
g15473
sg5112
(dp35284
sg9252
(dp35285
sg2316
g31292
sg7692
(dp35286
sg7848
(dp35287
ssg2883
(dp35288
g10431
(dp35289
ssg2886
(dp35290
g8367
(dp35291
sg9138
(dp35292
sg3969
(dp35293
sg10866
(dp35294
sg11424
(dp35295
sVHormones
p35296
(dp35297
sVCoagulants
p35298
(dp35299
sVHemostatics
p35300
g23063
sVPeptide Hormones
p35301
g20228
sVNatriuretic Agents
p35302
(dp35303
sg11481
(dp35304
sVOligopeptides
p35305
(dp35306
sVCardiovascular Agents
p35307
g26561
sVVasoconstrictor Agents
p35308
(dp35309
sVProteins
p35310
(dp35311
sVNerve Tissue Proteins
p35312
(dp35313
sVPituitary Hormones
p35314
g15914
sVNeuropeptides
p35315
(dp35316
sVPituitary
p35317
(dp35318
sVAmino Acids, Peptides, and Proteins
p35319
(dp35320
sVHematologic Agents
p35321
(dp35322
sVPeptides
p35323
(dp35324
sg9090
(dp35325
sVHormones, Hormone Substitutes, and Hormone Antagonists
p35326
(dp35327
sg9360
(dp35328
sg6861
(dp35329
ssg2889
(dp35330
g5085
(dp35331
ssg2892
(dp35332
VBSEP/ABCB11 Substrates
p35333
(dp35334
sVCytochrome P-450 CYP3A4 Inhibitors
p35335
(dp35336
sg28215
(dp35337
sVImmunosuppressive Agents
p35338
(dp35339
sVCarbohydrates
p35340
(dp35341
sVCytotoxic Antibiotics and Related Substances
p35342
(dp35343
sg9528
(dp35344
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p35345
(dp35346
sVEnzyme Inhibitors
p35347
(dp35348
sVCytochrome P-450 Enzyme Inhibitors
p35349
(dp35350
sg858
g20140
sg11151
(dp35351
sVP-glycoprotein/ABCB1 Inducers
p35352
(dp35353
sVMyelosuppressive Agents
p35354
(dp35355
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p35356
g29563
sVAnthracyclines
p35357
g31937
sVNaphthacenes
p35358
(dp35359
sVCytochrome P-450 CYP3A Substrates
p35360
(dp35361
sVGlycosides
p35362
(dp35363
sVCytochrome P-450 CYP3A5 Inducers
p35364
(dp35365
sVAnthracyclines and Related Substances
p35366
(dp35367
sVP-glycoprotein/ABCB1 Substrates
p35368
g35040
sVTopoisomerase II Inhibitors
p35369
(dp35370
sVCytochrome P-450 Enzyme Inducers
p35371
g28216
sVCytochrome P-450 CYP3A Inducers
p35372
(dp35373
sg6489
(dp35374
sVCytochrome P-450 CYP3A4 Substrates
p35375
(dp35376
sVCardiotoxic antineoplastic agents
p35377
(dp35378
sVAnthracycline Topoisomerase Inhibitor
p35379
(dp35380
sVCytochrome P-450 CYP3A Inhibitors
p35381
(dp35382
sVAntibiotics, Antineoplastic
p35383
g30412
sVBCRP/ABCG2 Substrates
p35384
(dp35385
sVAntineoplastic Agents
p35386
(dp35387
sVP-glycoprotein/ABCB1 Inhibitors
p35388
(dp35389
sVAntineoplastic and Immunomodulating Agents
p35390
(dp35391
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p35392
(dp35393
sVTopoisomerase Inhibitors
p35394
g32859
ssg2895
(dp35395
VCytochrome P-450 CYP3A4 Inhibitors
p35396
(dp35397
sVNitro Compounds
p35398
(dp35399
sVOAT1/SLC22A6 inhibitors
p35400
(dp35401
sVCytochrome P-450 CYP3A7 Inhibitors
p35402
(dp35403
sVAntibacterials for Systemic Use
p35404
g32571
sVAnti-Acne Preparations
p35405
(dp35406
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p35407
(dp35408
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p35409
(dp35410
sVEnzyme Inhibitors
p35411
(dp35412
sg8610
(dp35413
sVAnti-Infective Agents
p35414
(dp35415
sVCytochrome P-450 Enzyme Inhibitors
p35416
(dp35417
sVAntiinfectives for Systemic Use
p35418
(dp35419
sVProtein Synthesis Inhibitors
p35420
(dp35421
sVAntibiotics for Topical Use
p35422
(dp35423
sVMyelosuppressive Agents
p35424
(dp35425
sVGynecological Antiinfectives and Antiseptics
p35426
(dp35427
sVOphthalmological and Otological Preparations
p35428
(dp35429
sVPropylene Glycols
p35430
(dp35431
sVAnti-Bacterial Agents
p35432
(dp35433
sVOtologicals
p35434
(dp35435
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p35436
g24778
sg5304
(dp35437
sVBenzene Derivatives
p35438
(dp35439
sVCytochrome P-450 CYP2C8 Inhibitors
p35440
(dp35441
sVDermatologicals
p35442
g17295
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p35443
(dp35444
sVCytochrome P-450 CYP3A5 Inhibitors
p35445
(dp35446
sVCytochrome P-450 CYP2C19 Inhibitors
p35447
(dp35448
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p35449
g23125
sVGlycols
p35450
(dp35451
sVAnti-Acne Preparations for Topical Use
p35452
(dp35453
sVOphthalmologicals
p35454
g35241
sVGenito Urinary System and Sex Hormones
p35455
(dp35456
sVCytochrome P-450 CYP3A Inhibitors
p35457
(dp35458
sVImmunosuppressive Agents
p35459
(dp35460
sg2895
(dp35461
sVAlcohols
p35462
(dp35463
sVAntiinfectives for Treatment of Acne
p35464
(dp35465
sVSensory Organs
p35466
(dp35467
ssg2898
(dp35468
g3027
(dp35469
sg6807
(dp35470
ssg2901
(dp35471
VPlastics
p35472
(dp35473
sVAdrenal Cortex Hormones
p35474
g30032
sVMacromolecular Substances
p35475
g33843
sg5307
(dp35476
sVPolymers
p35477
g22234
sg594
g17668
sVCompounds used in a research, industrial, or household setting
p35478
(dp35479
sg6660
(dp35480
sVBiomedical and Dental Materials
p35481
(dp35482
sVContraceptive Agents, Female
p35483
(dp35484
sVHormonal Contraceptives for Systemic Use
p35485
(dp35486
ssg2904
(dp35487
g5622
(dp35488
sg7854
(dp35489
sg6903
(dp35490
ssg2907
(dp35491
g4257
(dp35492
sg5469
(dp35493
sg165
g13594
ssg2910
(dp35494
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p35495
(dp35496
sg5214
(dp35497
sVCytochrome P-450 CYP3A4 Inhibitors
p35498
(dp35499
sVCytochrome P-450 CYP2D6 Inhibitors
p35500
(dp35501
sVCytochrome P-450 CYP2D6 Substrates
p35502
(dp35503
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p35504
(dp35505
sVSerotonin Agents
p35506
(dp35507
sVCytochrome P-450 CYP3A Substrates
p35508
(dp35509
sVNeurotransmitter Agents
p35510
(dp35511
sVSerotonin Receptor Antagonists
p35512
(dp35513
sVCentral Nervous System Agents
p35514
(dp35515
sVPsychotropic Drugs
p35516
(dp35517
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p35518
(dp35519
sVCytochrome P-450 Enzyme Inhibitors
p35520
(dp35521
sg3498
(dp35522
sVHighest Risk QTc-Prolonging Agents
p35523
(dp35524
sVNeurotransmitter Uptake Inhibitors
p35525
(dp35526
sVAmines
p35527
(dp35528
sg11643
(dp35529
sVBenzofurans
p35530
(dp35531
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p35532
(dp35533
sVPropylamines
p35534
(dp35535
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p35536
g29250
sVPsychoanaleptics
p35537
(dp35538
sVQTc Prolonging Agents
p35539
(dp35540
sVSerotonin 5-HT2 Receptor Antagonists
p35541
(dp35542
sVCytochrome P-450 CYP2C19 Substrates
p35543
(dp35544
sVCentral Nervous System Depressants
p35545
(dp35546
sVCytochrome P-450 CYP1A2 Inhibitors
p35547
g15019
sVCytochrome P-450 CYP2B6 Inhibitors
p35548
(dp35549
sVP-glycoprotein/ABCB1 Substrates
p35550
g35016
sVVasodilating Agents
p35551
g23702
sVCytochrome P-450 CYP2C19 Inhibitors
p35552
(dp35553
sVCytochrome P-450 CYP3A4 Substrates
p35554
(dp35555
sVHeterocyclic Compounds, Fused-Ring
p35556
(dp35557
sVSerotonin Modulators
p35558
(dp35559
sVAntidepressive Agents
p35560
g15547
sVCytochrome P-450 CYP3A Inhibitors
p35561
(dp35562
sVHypoglycemia-Associated Agents
p35563
g17698
sg2742
g34041
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p35564
(dp35565
sVP-glycoprotein/ABCB1 Inhibitors
p35566
(dp35567
sg2175
g30537
sVNervous System
p35568
(dp35569
ssg2913
(dp35570
VImidazole and Triazole Derivatives
p35571
(dp35572
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p35573
(dp35574
sVAzole Antifungals
p35575
g20188
sVCytochrome P-450 CYP2D6 Inhibitors
p35576
(dp35577
sVAntifungals for Dermatological Use
p35578
g30070
sVCytochrome P-450 CYP1A2 Inhibitors
p35579
g15046
sVAntifungal Agents
p35580
(dp35581
sVDermatologicals
p35582
g17301
sVAntifungals for Topical Use
p35583
(dp35584
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p35585
(dp35586
sVCytochrome P-450 CYP2C9 Inhibitors
p35587
g18231
sVCytochrome P-450 Enzyme Inhibitors
p35588
(dp35589
sVAnti-Infective Agents
p35590
(dp35591
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p35592
(dp35593
ssg2916
(dp35594
g5409
(dp35595
ssg2919
(dp35596
g8373
(dp35597
sg8211
(dp35598
ssg2922
(dp35599
g8421
(dp35600
sg9822
(dp35601
sg7335
(dp35602
ssg2925
(dp35603
g5973
(dp35604
ssg2928
(dp35605
VAntiparasitic Products, Insecticides and Repellents
p35606
g30565
sVHydroxyquinoline Derivatives
p35607
(dp35608
sVHeterocyclic Compounds, Fused-Ring
p35609
(dp35610
sVQuinolines
p35611
(dp35612
sVGenito Urinary System and Sex Hormones
p35613
(dp35614
sVGynecological Antiinfectives and Antiseptics
p35615
(dp35616
sVCell-mediated Immunity
p35617
g23556
sVQuinoline Derivatives
p35618
(dp35619
sVDermatologicals
p35620
g17304
sVStandardized Chemical Allergen
p35621
(dp35622
sVAnti-Infective Agents, Local
p35623
(dp35624
sVIncreased Histamine Release
p35625
(dp35626
sg7599
(dp35627
sVOxyquinoline
p35628
(dp35629
sVHydroxyquinolines
p35630
g12984
sVAntiseptics and Disinfectants
p35631
g23738
sVAntiprotozoals
p35632
(dp35633
sVAnti-Infective Agents
p35634
(dp35635
sVThroat Preparations
p35636
(dp35637
ssg2931
(dp35638
g8406
(dp35639
ssg2934
(dp35640
g426
g16055
sg10737
(dp35641
sg10266
(dp35642
sg8205
(dp35643
sg2358
g31455
sg11811
(dp35644
sg828
g19838
sg12018
(dp35645
sg11619
(dp35646
sg1248
g23038
sg5853
(dp35647
sg7284
(dp35648
sg11655
(dp35649
sg9564
(dp35650
sg2430
g32086
sg5691
(dp35651
sg4959
(dp35652
sg11112
(dp35653
sg3978
(dp35654
sg3204
(dp35655
sg4344
(dp35656
sg582
g17609
sg5769
(dp35657
sg9420
(dp35658
sg10356
(dp35659
ssg2937
(dp35660
g11112
(dp35661
sg630
g18002
sg240
g14173
sg6318
(dp35662
sg8163
(dp35663
sg1044
g21534
sg11979
(dp35664
sg9711
(dp35665
sg10662
(dp35666
sg10308
(dp35667
sg6156
(dp35668
sg11016
(dp35669
sg11655
(dp35670
sg6468
(dp35671
sg3156
(dp35672
sg2427
g31982
sg8487
(dp35673
sg7299
(dp35674
sg2910
g35513
sg8097
(dp35675
sg9417
(dp35676
sg6966
(dp35677
sg10959
(dp35678
sg2841
g34826
sg7941
(dp35679
sg7497
(dp35680
sg1134
g22312
sg9981
(dp35681
sg11790
(dp35682
sg8028
(dp35683
sg6303
(dp35684
sg4344
(dp35685
sg696
g18695
sg3978
(dp35686
sg5169
(dp35687
sg387
g15602
sg2664
g33416
sg1194
g22805
sg414
g15937
sg10056
(dp35688
sg780
g19338
ssg2940
(dp35689
VAmino Acids, Peptides, and Proteins
p35690
(dp35691
sVAntiinfectives for Systemic Use
p35692
(dp35693
sVPeptides, Cyclic
p35694
(dp35695
sVLipopeptides
p35696
g33712
sVOphthalmologicals
p35697
g35250
sVOphthalmological and Otological Preparations
p35698
(dp35699
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p35700
(dp35701
sVIntestinal Antiinfectives
p35702
(dp35703
sVOtologicals
p35704
(dp35705
sVProteins
p35706
(dp35707
sVSensory Organs
p35708
(dp35709
sVPolymyxin-class Antibacterial
p35710
(dp35711
sVPeptides
p35712
(dp35713
sVNeurotoxic agents
p35714
(dp35715
sVAnti-Bacterial Agents
p35716
(dp35717
sVAntibacterials for Systemic Use
p35718
g32574
sVAnti-Infective Agents
p35719
(dp35720
sVPore Forming Cytotoxic Proteins
p35721
(dp35722
sVAlimentary Tract and Metabolism
p35723
g23904
sVPolymyxins
p35724
(dp35725
sVAntimicrobial Cationic Peptides
p35726
g33098
ssg2943
(dp35727
VAgents Causing Muscle Toxicity
p35728
(dp35729
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p35730
(dp35731
sVFatty Acids
p35732
(dp35733
sVCytochrome P-450 CYP2D6 Substrates
p35734
(dp35735
sVUGT1A1 Substrates
p35736
g12331
sVCytochrome P-450 CYP3A Substrates
p35737
(dp35738
sVCytochrome P-450 CYP3A4 Inhibitors
p35739
(dp35740
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p35741
(dp35742
sVOATP1B1/SLCO1B1 Inhibitors
p35743
(dp35744
sVLipids
p35745
g14295
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p35746
(dp35747
sVCytochrome P-450 CYP2C9 Inhibitors
p35748
g18235
sVCytochrome P-450 Enzyme Inhibitors
p35749
(dp35750
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p35751
(dp35752
sVIndoles
p35753
(dp35754
sVCytochrome P-450 CYP2C8 Substrates
p35755
(dp35756
sVCytochrome P-450 CYP2B6 Inducers
p35757
(dp35758
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p35759
g29438
sVLipid Modifying Agents, Plain
p35760
(dp35761
sVCytochrome P-450 CYP2C9 Substrates
p35762
g29800
sVOATP1B1/SLCO1B1 Substrates
p35763
(dp35764
sVCytochrome P-450 CYP3A4 Inducers
p35765
g18962
sVLipid Modifying Agents
p35766
(dp35767
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p35768
g25230
sVCytochrome P-450 CYP2C8 Inhibitors
p35769
(dp35770
sVCytochrome P-450 Enzyme Inducers
p35771
g28222
sVCytochrome P-450 CYP3A Inducers
p35772
(dp35773
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p35774
(dp35775
sVCytochrome P-450 CYP2C19 Inhibitors
p35776
(dp35777
sVHeterocyclic Compounds, Fused-Ring
p35778
(dp35779
sVCytochrome P-450 CYP3A4 Substrates
p35780
(dp35781
sVCytochrome P-450 CYP3A5 Substrates
p35782
(dp35783
sVUGT1A3 substrates
p35784
g31799
sVOATP1B3 substrates
p35785
g28513
sVCytochrome P-450 CYP3A Inhibitors
p35786
(dp35787
sVUGT2B7 substrates
p35788
g28621
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p35789
(dp35790
sVHeptanoic Acids
p35791
(dp35792
sVLipid Regulating Agents
p35793
(dp35794
ssg2946
(dp35795
g11436
(dp35796
sg6366
(dp35797
sVCytochrome P-450 CYP3A Substrates
p35798
(dp35799
sVBCRP/ABCG2 Inhibitors
p35800
g12512
sVOATP1B1/SLCO1B1 Inhibitors
p35801
(dp35802
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p35803
(dp35804
sVEnzyme Inhibitors
p35805
(dp35806
sVCytochrome P-450 Enzyme Inhibitors
p35807
(dp35808
sVGastric Acid Lowering Agents
p35809
(dp35810
sVDrugs that are Mainly Renally Excreted
p35811
(dp35812
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p35813
g29572
sVSulfur Compounds
p35814
(dp35815
sVAcid Reducers
p35816
(dp35817
sg6621
(dp35818
sVAnti-Ulcer Agents
p35819
(dp35820
sVCytochrome P-450 CYP2C19 Substrates
p35821
(dp35822
sVGastrointestinal Agents
p35823
(dp35824
sVP-glycoprotein/ABCB1 Substrates
p35825
g35054
sVPyridines
p35826
(dp35827
sg2307
g31273
sVCytochrome P-450 CYP2C19 Inhibitors
p35828
(dp35829
sVHeterocyclic Compounds, Fused-Ring
p35830
(dp35831
sVCytochrome P-450 CYP3A4 Substrates
p35832
(dp35833
sVAlimentary Tract and Metabolism
p35834
g23906
sg9816
(dp35835
sVOAT3/SLC22A8 Inhibitors
p35836
(dp35837
sVBCRP/ABCG2 Substrates
p35838
(dp35839
sVDrugs for Acid Related Disorders
p35840
(dp35841
sVP-glycoprotein/ABCB1 Inhibitors
p35842
(dp35843
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p35844
(dp35845
ssg2949
(dp35846
g1371
g24082
sg9918
(dp35847
sg12123
(dp35848
ssg2952
(dp35849
g3783
(dp35850
sg12274
g27515
sg5433
(dp35851
ssg2955
(dp35852
g12060
(dp35853
sg5595
(dp35854
ssg2958
(dp35855
g2289
g31217
ssg2961
(dp35856
g630
g18013
sg2196
g30611
sg9924
(dp35857
sg816
g19648
sg516
g16858
sg528
g16926
sg240
g14182
sg12066
(dp35858
sg2346
g31363
sg9711
(dp35859
sg10308
(dp35860
sg9918
(dp35861
sg5256
(dp35862
sg3885
(dp35863
sg282
g14558
sg11451
(dp35864
sg11940
(dp35865
sg8820
(dp35866
sg7299
(dp35867
sg2910
g35524
sg10728
(dp35868
sg8874
(dp35869
sg3399
(dp35870
sg4173
(dp35871
sg4827
(dp35872
sg2493
g32622
sg414
g15950
sg2688
g33627
sg6315
(dp35873
sg3531
(dp35874
sg6729
(dp35875
sg12126
(dp35876
sg2664
g33431
sg2676
g33569
sg5793
(dp35877
sg780
g19361
sg621
g17952
ssg2964
(dp35878
g23
g12209
sg4647
(dp35879
sg5919
(dp35880
sg210
g13999
sg7320
(dp35881
sg11652
(dp35882
sg11319
(dp35883
sg2886
g35309
sg4488
(dp35884
sg10470
(dp35885
sg8514
(dp35886
sg2067
g29646
sg612
g17883
sg9264
(dp35887
sg11445
(dp35888
sg5598
(dp35889
sg7056
(dp35890
sg6585
(dp35891
sg9093
(dp35892
ssg2967
(dp35893
g11733
(dp35894
ssg2970
(dp35895
g11718
(dp35896
ssg2973
(dp35897
g6150
(dp35898
ssg2976
(dp35899
g11595
(dp35900
sg915
g20698
ssg2979
(dp35901
g10098
(dp35902
sg8703
(dp35903
sg10227
(dp35904
sg3114
(dp35905
sg3867
(dp35906
sg909
g20666
sg8724
(dp35907
ssg2982
(dp35908
g8493
(dp35909
ssg2985
(dp35910
g9333
(dp35911
sg7434
(dp35912
sVElectrolyte Solutions
p35913
g20031
sVReplacement Preparations
p35914
g27637
sVElectrolytes
p35915
(dp35916
sVMineral Supplements
p35917
(dp35918
sg2634
g33268
sVI.V. Solution Additives
p35919
(dp35920
sg11763
(dp35921
sg9606
(dp35922
sVBlood and Blood Forming Organs
p35923
(dp35924
sg1884
g27982
sg1119
g22244
sVAcids
p35925
(dp35926
sg3201
(dp35927
sg3780
(dp35928
sVAlimentary Tract and Metabolism
p35929
g23918
sVIons
p35930
(dp35931
sVBlood Substitutes and Perfusion Solutions
p35932
(dp35933
sVAcids, Noncarboxylic
p35934
(dp35935
sg3870
(dp35936
sg1971
g28772
sVAnions
p35937
(dp35938
sg10257
(dp35939
ssg2988
(dp35940
g3177
(dp35941
sg6687
(dp35942
sg3684
(dp35943
sg687
g18547
sg9099
(dp35944
sg8580
(dp35945
sg6186
(dp35946
sg1803
g27375
sg10593
(dp35947
sg11352
(dp35948
sg10713
(dp35949
sg570
g17485
sg7041
(dp35950
ssg2991
(dp35951
VAntiinfectives for Systemic Use
p35952
(dp35953
sVOAT1/SLC22A6 Substrates
p35954
(dp35955
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p35956
g14471
sVAntivirals for Systemic Use
p35957
(dp35958
sVHeterocyclic Compounds, Fused-Ring
p35959
(dp35960
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p35961
(dp35962
sVNephrotoxic agents
p35963
(dp35964
sVAntiviral Agents
p35965
g30445
sVDirect Acting Antivirals
p35966
(dp35967
sVNucleosides and Nucleotides
p35968
(dp35969
sVOAT1/SLC22A6 inhibitors
p35970
(dp35971
sVEnzyme Inhibitors
p35972
(dp35973
sVNucleic Acid Synthesis Inhibitors
p35974
(dp35975
sg2019
g28961
sVAnti-Infective Agents
p35976
(dp35977
sVPurines
p35978
(dp35979
sVOrganophosphorus Compounds
p35980
(dp35981
ssg2994
(dp35982
g11097
(dp35983
sg7422
(dp35984
sg11931
(dp35985
sg8514
(dp35986
ssg2997
(dp35987
g219
g14082
sg1659
g26209
sg11961
(dp35988
sg7962
(dp35989
sg2397
g31786
sg9033
(dp35990
sg4890
(dp35991
sg4278
(dp35992
sg11976
(dp35993
sg10149
(dp35994
sg1062
g21808
sg2598
g33126
sg6867
(dp35995
sg3519
(dp35996
sg2355
g31435
sg339
g15165
sg5889
(dp35997
sg8457
(dp35998
sg5094
(dp35999
sg6447
(dp36000
sg5313
(dp36001
sg6981
(dp36002
sg5112
(dp36003
sg132
g13225
sg10416
(dp36004
sg7698
(dp36005
sg5571
(dp36006
sg9216
(dp36007
sg10581
(dp36008
sg9324
(dp36009
sg2172
g30513
sg1185
g22726
sg11259
(dp36010
ssg3000
(dp36011
VDrugs that are Mainly Renally Excreted
p36012
(dp36013
sg11025
(dp36014
sVAcids, Acyclic
p36015
g25462
sVSpecific Antirheumatic Agents
p36016
g20794
sg5664
(dp36017
sVHydroxy Acids
p36018
g18146
sVUGT1A1 Inhibitors
p36019
(dp36020
sVAntiinflammatory and Antirheumatic Products
p36021
(dp36022
sVSulfhydryl Compounds
p36023
(dp36024
sg1974
g28782
sg1497
g25136
sVAntirheumatic Agents
p36025
g24217
sg7602
(dp36026
sVOrganometallic Compounds
p36027
(dp36028
sVSulfur Compounds
p36029
(dp36030
sVMusculo-Skeletal System
p36031
g31530
sVDicarboxylic Acids
p36032
(dp36033
ssg3003
(dp36034
g9462
(dp36035
sg1434
g24685
ssg3006
(dp36036
g4551
(dp36037
ssg3009
(dp36038
VAntiparasitic Products, Insecticides and Repellents
p36039
g30573
sVCytochrome P-450 CYP1A2 Substrates
p36040
(dp36041
sVCytochrome P-450 CYP3A5 Substrates
p36042
(dp36043
sVCytochrome P-450 CYP2C19 Substrates
p36044
(dp36045
sVIsoquinolines
p36046
(dp36047
sVCytochrome P-450 CYP3A Substrates
p36048
(dp36049
sg5115
(dp36050
sVAntiparasitic Agents
p36051
(dp36052
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p36053
g29584
sg2157
g30419
sVHeterocyclic Compounds, Fused-Ring
p36054
(dp36055
sVCytochrome P-450 CYP3A4 Substrates
p36056
(dp36057
sVAnti-Infective Agents
p36058
(dp36059
sVAnthelmintics
p36060
(dp36061
sVCytochrome P-450 CYP3A7 Substrates
p36062
(dp36063
sVAntihelminthic
p36064
g32196
ssg3012
(dp36065
g9765
(dp36066
ssg3015
(dp36067
VPyrimidines
p36068
(dp36069
sVNucleic Acid Synthesis Inhibitors
p36070
(dp36071
sg2661
g33401
sVImmunosuppressive Agents
p36072
(dp36073
sVCarbohydrates
p36074
(dp36075
sVEnzyme Inhibitors
p36076
(dp36077
sVDeoxyribonucleosides
p36078
g33055
sVPyrimidine Analogues
p36079
g18463
sVDrugs that are Mainly Renally Excreted
p36080
(dp36081
sVAnti-Infective Agents
p36082
(dp36083
sVMyelosuppressive Agents
p36084
(dp36085
sVNucleoside Metabolic Inhibitor
p36086
(dp36087
sVCytidine
p36088
(dp36089
sVRadiation-Sensitizing Agents
p36090
(dp36091
sVAntimetabolites, Antineoplastic
p36092
g23453
sVImmunologic Factors
p36093
(dp36094
sVGlycosides
p36095
(dp36096
sVRibonucleosides
p36097
(dp36098
sVNucleic Acids, Nucleotides, and Nucleosides
p36099
(dp36100
sVP-glycoprotein/ABCB1 Substrates
p36101
g34986
sVPyrimidine Nucleosides
p36102
(dp36103
sVToxic Actions
p36104
(dp36105
sVNucleosides
p36106
(dp36107
sVAntimetabolites
p36108
(dp36109
sVNoxae
p36110
(dp36111
sVAntineoplastic Agents
p36112
(dp36113
sVAntineoplastic and Immunomodulating Agents
p36114
(dp36115
ssg3018
(dp36116
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p36117
(dp36118
sVAnti-Parkinson Drugs
p36119
g16154
sVAmino Acids, Cyclic
p36120
g27281
sVNeurotransmitter Agents
p36121
(dp36122
sVHypotensive Agents
p36123
g34205
sVCentral Nervous System Agents
p36124
(dp36125
sVDopamine Agents
p36126
g14248
sVDopa and Dopa Derivatives
p36127
(dp36128
sVTyrosine
p36129
(dp36130
sVAmino Acids
p36131
(dp36132
sVAmines
p36133
(dp36134
sVBiogenic Monoamines
p36135
(dp36136
sVDihydroxyphenylalanine
p36137
(dp36138
sVAmino Acids, Aromatic
p36139
(dp36140
sVCentral Nervous System Depressants
p36141
(dp36142
sVPhenols
p36143
(dp36144
sVBenzene Derivatives
p36145
(dp36146
sVBiogenic Amines
p36147
(dp36148
sVAnti-Dyskinesia Agents
p36149
(dp36150
sVCatecholamines
p36151
g19116
sVLevodopa, antagonists & inhibitors
p36152
(dp36153
sVAmino Acids, Peptides, and Proteins
p36154
(dp36155
sVCatechols
p36156
(dp36157
sVAmino Acids, Essential
p36158
g35282
sVPhenylalanine
p36159
(dp36160
sVAnti-Parkinson Agents (Dopamine Agonist)
p36161
g25589
sVNervous System
p36162
(dp36163
ssg3021
(dp36164
VBSEP/ABCB11 Substrates
p36165
(dp36166
sVCytochrome P-450 CYP3A4 Inhibitors
p36167
(dp36168
sVCytochrome P-450 CYP3A Substrates
p36169
(dp36170
sVCytochrome P-450 CYP3A7 Inhibitors
p36171
(dp36172
sVAntibacterials for Systemic Use
p36173
g32564
sVAnti-Acne Preparations
p36174
(dp36175
sVOATP1B1/SLCO1B1 Inhibitors
p36176
(dp36177
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p36178
(dp36179
sVEnzyme Inhibitors
p36180
(dp36181
sVCytochrome P-450 Enzyme Inhibitors
p36182
(dp36183
sVAnti-Infective Agents
p36184
(dp36185
sVAntiinfectives for Systemic Use
p36186
(dp36187
sVMacrolide Antimicrobial
p36188
(dp36189
sVLactones
p36190
(dp36191
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p36192
g29256
sVErythromycins
p36193
(dp36194
sVMacrolides, Lincosamides and Streptogramins
p36195
g33218
sVAnti-Bacterial Agents
p36196
(dp36197
sVMacrolides
p36198
g16911
sVOATP1B1/SLCO1B1 Substrates
p36199
(dp36200
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p36201
g24787
sVGastrointestinal Agents
p36202
(dp36203
sVOATP1B3 inhibitors
p36204
(dp36205
sVP-glycoprotein/ABCB1 Substrates
p36206
g35072
sVDermatologicals
p36207
g17286
sVErythromycin and similars
p36208
(dp36209
sVProtein Synthesis Inhibitors
p36210
(dp36211
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p36212
(dp36213
sVBSEP/ABCB11 Inhibitors
p36214
(dp36215
sVCytochrome P-450 CYP3A5 Substrates
p36216
(dp36217
sVCytochrome P-450 CYP3A4 Substrates
p36218
(dp36219
sVQTc Prolonging Agents
p36220
(dp36221
sVModerate Risk QTc-Prolonging Agents
p36222
(dp36223
sVAnti-Acne Preparations for Topical Use
p36224
(dp36225
sVOphthalmologicals
p36226
g35232
sVOATP1B3 substrates
p36227
g28523
sVCytochrome P-450 CYP3A Inhibitors
p36228
(dp36229
sVP-glycoprotein/ABCB1 Inhibitors
p36230
(dp36231
sVAntiinfectives for Treatment of Acne
p36232
(dp36233
sVCytochrome P-450 CYP3A7 Substrates
p36234
(dp36235
sVCytochrome P-450 CYP3A5 Inhibitors
p36236
(dp36237
ssg3024
(dp36238
VBSEP/ABCB11 Substrates
p36239
(dp36240
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p36241
(dp36242
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p36243
(dp36244
sVCytochrome P-450 CYP2D6 Substrates
p36245
(dp36246
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p36247
(dp36248
sVCytochrome P-450 CYP3A Substrates
p36249
(dp36250
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p36251
(dp36252
sVAntifungal Agents
p36253
(dp36254
sVCytochrome P-450 CYP3A4 Inhibitors
p36255
(dp36256
sVCytochrome P-450 CYP3A Inducers (strong)
p36257
g22456
sVAnti-Infective Agents, Local
p36258
(dp36259
sVCytochrome P-450 CYP3A7 Inducers
p36260
(dp36261
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p36262
(dp36263
sVCytochrome P-450 CYP2C9 Inhibitors
p36264
g18246
sVCytochrome P-450 Enzyme Inhibitors
p36265
(dp36266
sVAnti-Infective Agents
p36267
(dp36268
sg11658
(dp36269
sVAntifungal Agents (Vaginal)
p36270
(dp36271
sVP-glycoprotein/ABCB1 Inducers
p36272
(dp36273
sVImidazole and Triazole Derivatives
p36274
(dp36275
sVAzole Antifungals
p36276
g20187
sVCytochrome P-450 CYP2D6 Inhibitors
p36277
(dp36278
sVCytochrome P-450 CYP2B6 Inducers
p36279
(dp36280
sVGynecological Antiinfectives and Antiseptics
p36281
(dp36282
sVCytochrome P-450 CYP2E1 Inhibitors
p36283
(dp36284
sVAntifungals for Topical Use
p36285
(dp36286
sVSteroid Synthesis Inhibitors
p36287
(dp36288
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p36289
g29503
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p36290
(dp36291
sVOATP1B1/SLCO1B1 Substrates
p36292
(dp36293
sVImidazoles
p36294
(dp36295
sVCytochrome P-450 CYP3A4 Inducers
p36296
g18970
sg1584
g25712
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p36297
g28837
sVP-glycoprotein/ABCB1 Substrates
p36298
g35074
sg11310
(dp36299
sVAntifungals for Dermatological Use
p36300
g30068
sVCytochrome P-450 CYP2C8 Inhibitors
p36301
(dp36302
sVCytochrome P-450 CYP2B6 Inhibitors
p36303
(dp36304
sVEnzyme Inhibitors
p36305
(dp36306
sVDermatologicals
p36307
g17321
sVCytochrome P-450 CYP2E1 Inhibitors (moderate)
p36308
(dp36309
sVCytochrome P-450 Enzyme Inducers
p36310
g28233
sVCytochrome P-450 CYP3A Inducers
p36311
(dp36312
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p36313
(dp36314
sVBSEP/ABCB11 Inhibitors
p36315
(dp36316
sVCytochrome P-450 CYP3A Inhibitors (strong)
p36317
g13387
sVCytochrome P-450 CYP3A4 Substrates
p36318
(dp36319
sVHormone Antagonists
p36320
g24274
sVCytochrome P-450 CYP3A Inhibitors
p36321
(dp36322
sVStomatological Preparations
p36323
(dp36324
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p36325
(dp36326
sVOATP1B1/SLCO1B1 Inhibitors
p36327
(dp36328
sVP-glycoprotein/ABCB1 Inhibitors
p36329
(dp36330
sVAntiinfectives and Antiseptics for Local Oral Treatment
p36331
(dp36332
sg10821
(dp36333
sVHormones, Hormone Substitutes, and Hormone Antagonists
p36334
(dp36335
sVCytochrome P-450 CYP2A6 Inhibitors
p36336
(dp36337
sVImidazole Derivatives
p36338
(dp36339
ssg3027
(dp36340
VAgents Causing Muscle Toxicity
p36341
(dp36342
sVBSEP/ABCB11 Substrates
p36343
(dp36344
sVCytochrome P-450 CYP3A Substrates
p36345
(dp36346
sVHypotensive Agents
p36347
g34206
sg4221
(dp36348
sg7119
(dp36349
sVCytochrome P-450 CYP2C8 Substrates
p36350
(dp36351
sg9054
(dp36352
sVMyelosuppressive Agents
p36353
(dp36354
sg2724
g33854
sg84
g12887
sg6255
(dp36355
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p36356
g29589
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p36357
(dp36358
sVCytochrome P-450 CYP3A4 Inducers
p36359
g18971
sVAntineoplastic Agents
p36360
(dp36361
sg7518
(dp36362
sg5055
(dp36363
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p36364
(dp36365
sVP-glycoprotein/ABCB1 Substrates
p36366
g35076
sg3033
(dp36367
sVCytochrome P-450 Enzyme Inducers
p36368
g28235
sVCytochrome P-450 CYP3A Inducers
p36369
(dp36370
sg7542
(dp36371
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p36372
(dp36373
sVCytochrome P-450 CYP3A4 Substrates
p36374
(dp36375
sVNarrow Therapeutic Index Drugs
p36376
(dp36377
sg2685
g33586
sg10464
(dp36378
sg9813
(dp36379
sg10677
(dp36380
sVCytochrome P-450 CYP3A5 Substrates
p36381
(dp36382
sg1935
g28522
sg5166
(dp36383
sVImmunosuppressive Agents
p36384
(dp36385
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p36386
(dp36387
sVBCRP/ABCG2 Substrates
p36388
(dp36389
sg2898
g35469
sVP-glycoprotein/ABCB1 Inhibitors
p36390
(dp36391
sVNeurotoxic agents
p36392
(dp36393
sVAntineoplastic and Immunomodulating Agents
p36394
(dp36395
sg12147
(dp36396
sVCytochrome P-450 CYP3A7 Substrates
p36397
(dp36398
ssg3030
(dp36399
g5532
(dp36400
sg3099
(dp36401
sg8529
(dp36402
sg11751
(dp36403
sg10587
(dp36404
sg11826
(dp36405
sg11085
(dp36406
sg3699
(dp36407
sg7044
(dp36408
ssg3033
(dp36409
g3027
g36367
sg6807
(dp36410
sg11562
(dp36411
ssg3036
(dp36412
VAdrenergic alpha-1 Receptor Antagonists
p36413
g14130
sVCytochrome P-450 CYP2D6 Inhibitors
p36414
(dp36415
sVUGT1A1 Substrates
p36416
g12313
sVUGT2B7 substrates
p36417
g28637
sVAgents causing hyperkalemia
p36418
(dp36419
sVHypotensive Agents
p36420
g34173
sVUGT1A9 Substrates
p36421
g24014
sVAdrenergic Antagonists
p36422
(dp36423
sVSympathomimetics
p36424
(dp36425
sVCytochrome P-450 Enzyme Inhibitors
p36426
(dp36427
sVPeripheral Nervous System Agents
p36428
(dp36429
sVDrugs that are Mainly Renally Excreted
p36430
(dp36431
sg9450
(dp36432
sVAutonomic Agents
p36433
(dp36434
sVAntihypertensive Agents
p36435
g20299
sg9201
(dp36436
sVAmides
p36437
(dp36438
sVAdrenergic alpha-Antagonists
p36439
(dp36440
sVEthanolamines
p36441
(dp36442
sg2640
g33275
sVAdrenergic Agents
p36443
(dp36444
sVNeurotransmitter Agents
p36445
(dp36446
sVCardiovascular Agents
p36447
g26632
sVAdrenergic beta-Antagonists
p36448
g15358
sVVasodilating Agents
p36449
g23711
sVAmines
p36450
(dp36451
sVBeta Blocking Agents and Thiazides
p36452
(dp36453
sVAmino Alcohols
p36454
g32682
sVPeripheral alpha-1 blockers
p36455
g32714
sVBradycardia-Causing Agents
p36456
(dp36457
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p36458
(dp36459
sVAgents producing tachycardia
p36460
(dp36461
sVAlcohols
p36462
(dp36463
ssg3039
(dp36464
g8097
(dp36465
sg6678
(dp36466
sg1461
g24829
sg9819
(dp36467
sg282
g14566
sg11910
(dp36468
sg387
g15635
sg8028
(dp36469
sg6102
(dp36470
sg888
g20477
sg7941
(dp36471
sg9417
(dp36472
sg11979
(dp36473
sg2427
g32017
sg8820
(dp36474
sg9102
(dp36475
sg10056
(dp36476
ssg3042
(dp36477
g6567
(dp36478
sg10185
(dp36479
sg5286
(dp36480
sg1326
g23604
sg2805
g34447
sg9948
(dp36481
sg5085
(dp36482
sg1113
g22190
sg4302
(dp36483
ssg3045
(dp36484
g8019
(dp36485
sg72
g12807
sg9462
(dp36486
sg4425
(dp36487
sg4716
(dp36488
sg10977
(dp36489
sg6474
(dp36490
sg8916
(dp36491
sg4803
(dp36492
sg3408
(dp36493
sg336
g15116
sg9702
(dp36494
sg963
g21003
ssg3048
(dp36495
VDrugs that are Mainly Renally Excreted
p36496
(dp36497
sVNeurotransmitter Agents
p36498
(dp36499
sVAnti-Parkinson Drugs
p36500
g16148
sVAnti-Dyskinesia Agents
p36501
(dp36502
sVCentral Nervous System Agents
p36503
(dp36504
sVDopamine Agents
p36505
g14237
sVHydrazines
p36506
(dp36507
sVEnzyme Inhibitors
p36508
(dp36509
ssg3051
(dp36510
g2373
g31607
sg11955
(dp36511
sg8580
(dp36512
sg1803
g27393
sg5427
(dp36513
sg10857
(dp36514
sg9903
(dp36515
sg255
g14404
sg1452
g24738
sg1947
g28692
sg1260
g23159
sg687
g18575
sg4623
(dp36516
sg4488
(dp36517
sg11667
(dp36518
sg14838
(dp36519
sg9402
(dp36520
sg4683
(dp36521
sg5895
(dp36522
sg9030
(dp36523
sg7320
(dp36524
sg5928
(dp36525
sg6102
(dp36526
sg3147
(dp36527
sg11439
(dp36528
sg3882
(dp36529
sg23
g12233
sg9819
(dp36530
sg5370
(dp36531
sg6048
(dp36532
sg8430
(dp36533
sg9852
(dp36534
ssg3054
(dp36535
g141
g13362
ssg3057
(dp36536
g69
g12770
ssg3060
(dp36537
g5256
(dp36538
sg1683
g26399
sg10728
(dp36539
ssg3063
(dp36540
g8421
(dp36541
sg1461
g24842
sg7335
(dp36542
ssg3066
(dp36543
g9117
(dp36544
sg6735
(dp36545
sg3114
(dp36546
sg11145
(dp36547
sg9144
(dp36548
sg6759
(dp36549
sg5460
(dp36550
sg2256
g30936
sg10974
(dp36551
sg10335
(dp36552
sg4488
(dp36553
sg4320
(dp36554
sg909
g20656
sg4446
(dp36555
sg8673
(dp36556
sg6471
(dp36557
sg1719
g26834
sg2277
g31132
sg4887
(dp36558
sg1356
g23978
sg8862
(dp36559
sg6507
(dp36560
sg10098
(dp36561
sg11910
(dp36562
sg10074
(dp36563
sg10227
(dp36564
sg3597
(dp36565
sg4056
(dp36566
sg6381
(dp36567
sg204
g13974
sg3624
(dp36568
sg5580
(dp36569
ssg3069
(dp36570
g9180
(dp36571
sg1920
g28472
ssg3072
(dp36572
VBSEP/ABCB11 Substrates
p36573
(dp36574
sVAngiotensin Receptor Antagonists
p36575
(dp36576
sVAngiotensin II receptor blockers (ARBs) and diuretics
p36577
g18114
sVAgents causing hyperkalemia
p36578
(dp36579
sVHypotensive Agents
p36580
g34184
sVAgents causing angioedema
p36581
(dp36582
sVBCRP/ABCG2 Inhibitors
p36583
g12552
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p36584
(dp36585
sVAngiotensin 2 Receptor Blocker
p36586
(dp36587
sVCytochrome P-450 Enzyme Inhibitors
p36588
(dp36589
sVUGT1A3 substrates
p36590
g31800
sVAntihypertensive Agents
p36591
g20323
sVBiphenyl Compounds
p36592
g24989
sVAngiotensin II Type 1 Receptor Blockers
p36593
(dp36594
sVCardiovascular Agents
p36595
g26686
sVBenzene Derivatives
p36596
(dp36597
sVCytochrome P-450 CYP2C19 Inhibitors
p36598
(dp36599
sVHeterocyclic Compounds, Fused-Ring
p36600
(dp36601
sVAgents Acting on the Renin-Angiotensin System
p36602
g25344
sVBenzimidazoles
p36603
(dp36604
sVAngiotensin II receptor blockers (ARBs), plain
p36605
g22610
sVAngiotensin II Type 2 Receptor Blockers
p36606
(dp36607
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p36608
(dp36609
sVP-glycoprotein/ABCB1 Inhibitors
p36610
(dp36611
ssg3075
(dp36612
g7530
(dp36613
sg9780
(dp36614
sg11382
(dp36615
sg7548
(dp36616
ssg3078
(dp36617
g6150
(dp36618
sg10878
(dp36619
ssg3081
(dp36620
g8097
(dp36621
sg9417
(dp36622
sg3531
(dp36623
sg6507
(dp36624
sg9819
(dp36625
sg3381
(dp36626
sg5169
(dp36627
sg11910
(dp36628
sg387
g15684
sg282
g14589
sg7941
(dp36629
sg10596
(dp36630
sg3399
(dp36631
sg11979
(dp36632
sg7485
(dp36633
sg2427
g32070
sg8820
(dp36634
sg9981
(dp36635
sg10056
(dp36636
sg8028
(dp36637
ssg3084
(dp36638
g2754
g34088
sg9897
(dp36639
ssg3087
(dp36640
VAnalgesics
p36641
g26464
sVAgents causing hyperkalemia
p36642
(dp36643
sVHydroxy Acids
p36644
g18147
sVNon COX-2 selective NSAIDS
p36645
(dp36646
sVCentral Nervous System Agents
p36647
(dp36648
sg6210
(dp36649
sVPhenols
p36650
(dp36651
sVPeripheral Nervous System Agents
p36652
(dp36653
sVAnti-Inflammatory Agents
p36654
(dp36655
sVSalicylates
p36656
g27619
sVAnalgesics, Non-Narcotic
p36657
(dp36658
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p36659
(dp36660
sVAcids, Carbocyclic
p36661
(dp36662
sVGastrointestinal Agents
p36663
(dp36664
sVBenzene Derivatives
p36665
(dp36666
sVAgents that produce hypertension
p36667
(dp36668
sVAlimentary Tract and Metabolism
p36669
g23863
sVBenzoates
p36670
g30384
sVHydroxybenzoates
p36671
(dp36672
sVNephrotoxic agents
p36673
(dp36674
sVSensory System Agents
p36675
(dp36676
sVAnti-Inflammatory Agents, Non-Steroidal
p36677
(dp36678
sVIntestinal Antiinflammatory Agents
p36679
(dp36680
ssg3090
(dp36681
VAmino Acids, Peptides, and Proteins
p36682
(dp36683
sVAntiinfectives for Systemic Use
p36684
(dp36685
sVAgents that produce neuromuscular block (indirect)
p36686
(dp36687
sVPeptides, Cyclic
p36688
(dp36689
sVLipopeptides
p36690
g33711
sVNephrotoxic agents
p36691
(dp36692
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p36693
(dp36694
sVAminoglycoside Antibacterials
p36695
(dp36696
sVMembrane Proteins
p36697
(dp36698
sVProteins
p36699
(dp36700
sVIntestinal Antiinfectives
p36701
(dp36702
sVPeptides
p36703
(dp36704
sVLipids
p36705
g14305
sVAnti-Bacterial Agents
p36706
(dp36707
sVAntibacterials for Systemic Use
p36708
g32584
sVAnti-Infective Agents
p36709
(dp36710
sVPore Forming Cytotoxic Proteins
p36711
(dp36712
sVAlimentary Tract and Metabolism
p36713
g23844
sVPolymyxins
p36714
(dp36715
sVAntimicrobial Cationic Peptides
p36716
g33094
ssg3093
(dp36717
g3777
(dp36718
ssg3096
(dp36719
g11832
(dp36720
sg6765
(dp36721
sg10839
(dp36722
sg12060
(dp36723
sg13091
g21436
sg3312
(dp36724
sg8826
(dp36725
ssg3099
(dp36726
g11616
(dp36727
sg6357
(dp36728
sVHematologic Agents
p36729
(dp36730
sVBlood and Blood Forming Organs
p36731
(dp36732
sVPolyvalent cation containing laxatives, antacids, oral supplements
p36733
(dp36734
sVIron Preparations
p36735
(dp36736
sVHematinics
p36737
(dp36738
sVIron Compounds
p36739
g36401
sg7383
(dp36740
sVAntianemic Preparations
p36741
(dp36742
sVOrganometallic Compounds
p36743
(dp36744
sVMinerals
p36745
(dp36746
ssg3102
(dp36747
g11175
(dp36748
sg6990
(dp36749
ssg3105
(dp36750
VAgents Causing Muscle Toxicity
p36751
(dp36752
sVNiacin
p36753
(dp36754
sVCytochrome P-450 CYP3A4 Inhibitors
p36755
(dp36756
sVVitamins
p36757
g12170
sVCytochrome P-450 CYP2D6 Inhibitors
p36758
(dp36759
sVFood and Beverages
p36760
(dp36761
sVDiet, Food, and Nutrition
p36762
g22897
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p36763
(dp36764
sVCytochrome P-450 Enzyme Inhibitors
p36765
(dp36766
sVPhysiological Phenomena
p36767
g21713
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p36768
g18382
sVHyperglycemia-Associated Agents
p36769
(dp36770
sVMicronutrients
p36771
(dp36772
sVThyroxine-binding globulin inhibitors
p36773
(dp36774
sVFood
p36775
(dp36776
sVCytochrome P-450 CYP2E1 Inhibitors
p36777
(dp36778
sVLipid Modifying Agents, Plain
p36779
(dp36780
sVVitamin B Complex
p36781
(dp36782
sVHypolipidemic Agents
p36783
(dp36784
sVCardiovascular Agents
p36785
g26526
sVLipid Modifying Agents
p36786
(dp36787
sVPyridines
p36788
(dp36789
sVVasodilating Agents
p36790
g23682
sVNicotinic Acids
p36791
(dp36792
sVMiscellaneous Antilipemic Agents
p36793
(dp36794
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p36795
g26864
sVGrowth Substances
p36796
(dp36797
sVToxic Actions
p36798
(dp36799
sVNicotinic Acid and Derivatives
p36800
g13552
sVCytochrome P-450 CYP3A Inhibitors
p36801
(dp36802
sVNoxae
p36803
(dp36804
sVPeripheral Vasodilators
p36805
(dp36806
sVLipid Regulating Agents
p36807
(dp36808
ssg3108
(dp36809
g5394
(dp36810
sg6024
(dp36811
sg10494
(dp36812
sg1578
g25606
sg5589
(dp36813
sg3711
(dp36814
sg8418
(dp36815
sg7824
(dp36816
ssg3111
(dp36817
VUGT1A9 Substrates
p36818
g24000
sVCentral Nervous System Depressants
p36819
(dp36820
sVPhenols
p36821
(dp36822
sVAnti-Parkinson Drugs
p36823
g16150
sVBenzene Derivatives
p36824
(dp36825
sVAnti-Dyskinesia Agents
p36826
(dp36827
sVCentral Nervous System Agents
p36828
(dp36829
sVDopamine Agents
p36830
g14239
sg11082
(dp36831
sVEnzyme Inhibitors
p36832
(dp36833
sVCytochrome P-450 CYP2D6 Inhibitors
p36834
(dp36835
sVNervous System
p36836
(dp36837
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p36838
g18396
sVCytochrome P-450 Enzyme Inhibitors
p36839
(dp36840
ssg3114
(dp36841
VBeta Blocking Agents, Non-Selective, and Thiazides
p36842
(dp36843
sVCytochrome P-450 CYP2D6 Substrates
p36844
(dp36845
sVAntiarrhythmic agents
p36846
(dp36847
sVAgents causing hyperkalemia
p36848
(dp36849
sVHypotensive Agents
p36850
g34100
sVAmino Alcohols
p36851
g32685
sVPotential QTc-Prolonging Agents
p36852
(dp36853
sVAdrenergic Antagonists
p36854
(dp36855
sVOxazines
p36856
(dp36857
sVBeta Blocking Agents, Non-Selective
p36858
(dp36859
sVDrugs that are Mainly Renally Excreted
p36860
(dp36861
sVAmines
p36862
(dp36863
sVAntihypertensive Agents
p36864
g20304
sVThiadiazoles
p36865
(dp36866
sVSulfur Compounds
p36867
(dp36868
sVQTc Prolonging Agents
p36869
(dp36870
sVCytochrome P-450 CYP2C19 Substrates
p36871
(dp36872
sVCardiovascular Agents
p36873
g26535
sVThiazoles
p36874
(dp36875
sVP-glycoprotein/ABCB1 Substrates
p36876
g34987
sVAdrenergic beta-Antagonists
p36877
g15361
sVEENT Drugs, Miscellaneous
p36878
(dp36879
sVPropanolamines
p36880
(dp36881
sVAntiglaucoma Preparations and Miotics
p36882
g36546
sVBeta Blocking Agents and Thiazides
p36883
(dp36884
sVOphthalmologicals
p36885
g35168
sVBradycardia-Causing Agents
p36886
(dp36887
sVPropanols
p36888
(dp36889
sVMorpholines
p36890
g35905
sVAlcohols
p36891
(dp36892
ssg3117
(dp36893
VSex Hormones and Modulators of the Genital System
p36894
g19597
sVCytochrome P-450 CYP3A Substrates
p36895
(dp36896
sg7425
(dp36897
sVCentral Nervous System Agents
p36898
(dp36899
sVHormonal Contraceptives for Systemic Use
p36900
(dp36901
sVDrugs that are Mainly Renally Excreted
p36902
(dp36903
sVCytochrome P-450 CYP3A4 Substrates
p36904
(dp36905
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p36906
g29192
sVContraceptives, Oral
p36907
(dp36908
sVCentral Nervous System Stimulants
p36909
(dp36910
sVFused-Ring Compounds
p36911
g14806
sVHyperglycemia-Associated Agents
p36912
(dp36913
sVAntineoplastic Agents
p36914
(dp36915
sVAdrenal Cortex Hormones
p36916
g30007
sVReproductive Control Agents
p36917
g18838
sVProgestins
p36918
(dp36919
sVPregnadienes
p36920
(dp36921
sVCombination Contraceptives (with Estrogen and derivatives)
p36922
g31049
sVAntineoplastic Agents, Hormonal
p36923
(dp36924
sVProgestin Contraceptives
p36925
(dp36926
sg9804
(dp36927
sVContraceptive Agents, Female
p36928
(dp36929
sVPregnanes
p36930
(dp36931
sg9066
(dp36932
sg2691
g33704
sVGenito Urinary System and Sex Hormones
p36933
(dp36934
sVSteroids
p36935
(dp36936
sVHormones and Related Agents
p36937
(dp36938
sVP-glycoprotein/ABCB1 Inhibitors
p36939
(dp36940
sVAntineoplastic and Immunomodulating Agents
p36941
(dp36942
sg5790
(dp36943
sVEndocrine Therapy
p36944
g19568
ssg3120
(dp36945
g7353
(dp36946
sg3657
(dp36947
sg10878
(dp36948
ssg3123
(dp36949
g9267
(dp36950
ssg3126
(dp36951
VEnzymes
p36952
(dp36953
sg10428
(dp36954
sVThyroxine-binding globulin inhibitors
p36955
(dp36956
sg6597
(dp36957
sg1149
g22513
sg11328
(dp36958
sVAntineoplastic and Immunomodulating Agents
p36959
(dp36960
sVEnzymes and Coenzymes
p36961
(dp36962
sg3126
(dp36963
sVHydrolases
p36964
(dp36965
sVAntineoplastic Agents
p36966
(dp36967
ssg3129
(dp36968
g7524
(dp36969
ssg3132
(dp36970
VBSEP/ABCB11 Substrates
p36971
(dp36972
sVCytochrome P-450 CYP3A4 Inhibitors
p36973
(dp36974
sVAntivirals for Systemic Use
p36975
(dp36976
sVCytochrome P-450 CYP2D6 Inhibitors
p36977
(dp36978
sVCytochrome P-450 CYP2D6 Substrates
p36979
(dp36980
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p36981
(dp36982
sVCytochrome P-450 CYP3A Substrates
p36983
(dp36984
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p36985
(dp36986
sVDirect Acting Antivirals
p36987
(dp36988
sVCYP3A Substrates (Sensitive)
p36989
(dp36990
sVAnti-HIV Agents
p36991
(dp36992
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p36993
(dp36994
sVCytochrome P-450 Enzyme Inhibitors
p36995
(dp36996
sVAnti-Infective Agents
p36997
(dp36998
sVHyperglycemia-Associated Agents
p36999
(dp37000
sVAntiinfectives for Systemic Use
p37001
(dp37002
sVAnti-Retroviral Agents
p37003
(dp37004
sVUGT1A1 Inducers
p37005
(dp37006
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37007
g29509
sVOATP1B3 inhibitors
p37008
(dp37009
sVHIV Protease Inhibitors
p37010
(dp37011
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p37012
(dp37013
sVPyrans
p37014
(dp37015
sVCytochrome P-450 CYP2C19 Inhibitors
p37016
(dp37017
sVCytochrome P-450 CYP3A Inhibitors (strong)
p37018
g13391
sVCytochrome P-450 CYP3A4 Substrates
p37019
(dp37020
sVProtease Inhibitors
p37021
(dp37022
sVCytochrome P-450 CYP3A Inhibitors
p37023
(dp37024
sVAntiviral Agents
p37025
g30443
sVOATP1B1/SLCO1B1 Inhibitors
p37026
(dp37027
sVBSEP/ABCB11 Inhibitors
p37028
(dp37029
sVP-glycoprotein/ABCB1 Inhibitors
p37030
(dp37031
ssg3135
(dp37032
g4257
(dp37033
sg5469
(dp37034
sg165
g13571
ssg3138
(dp37035
g4287
(dp37036
sg21710
(dp37037
ssg3141
(dp37038
VAgents that produce neuromuscular block (indirect)
p37039
(dp37040
sVOphthalmological and Otological Preparations
p37041
(dp37042
sVOAT1/SLC22A6 inhibitors
p37043
(dp37044
sVCytochrome P-450 CYP3A Substrates
p37045
(dp37046
sVStomatological Preparations
p37047
(dp37048
sVCytochrome P-450 CYP3A4 Inhibitors
p37049
(dp37050
sg7011
(dp37051
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p37052
(dp37053
sVEnzyme Inhibitors
p37054
(dp37055
sVCytochrome P-450 Enzyme Inhibitors
p37056
(dp37057
sVAnti-Infective Agents
p37058
(dp37059
sVAntiinfectives for Systemic Use
p37060
(dp37061
sVDrugs that are Mainly Renally Excreted
p37062
(dp37063
sVAntibiotics for Topical Use
p37064
(dp37065
sVOtologicals
p37066
(dp37067
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37068
g29196
sVAnti-Bacterial Agents
p37069
(dp37070
sg3717
(dp37071
sVProtein Synthesis Inhibitors
p37072
(dp37073
sVOAT3/SLC22A8 Substrates
p37074
g13115
sVP-glycoprotein/ABCB1 Substrates
p37075
g34920
sVDermatologicals
p37076
g17193
sVSensory Organs
p37077
(dp37078
sVAntibacterials for Systemic Use
p37079
g32524
sVCytochrome P-450 CYP3A4 Substrates
p37080
(dp37081
sVAlimentary Tract and Metabolism
p37082
g23772
sVOphthalmologicals
p37083
g35176
sVCytochrome P-450 CYP3A Inhibitors
p37084
(dp37085
sVOAT3/SLC22A8 Inhibitors
p37086
(dp37087
sg10806
(dp37088
sVDrugs for Acid Related Disorders
p37089
(dp37090
sVAntiinfectives and Antiseptics for Local Oral Treatment
p37091
(dp37092
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p37093
(dp37094
ssg3144
(dp37095
VSulfhydryl Compounds
p37096
(dp37097
sVOATP1B1/SLCO1B1 Inhibitors
p37098
(dp37099
sVCompounds used in a research, industrial, or household setting
p37100
(dp37101
sVAnti-Infective Agents
p37102
(dp37103
sg6057
(dp37104
sVAmino Acids
p37105
(dp37106
sVRespiratory System Agents
p37107
(dp37108
sVSulfur Compounds
p37109
(dp37110
sVProtective Agents
p37111
(dp37112
sg4503
(dp37113
sg11865
(dp37114
sg5709
(dp37115
sg10434
(dp37116
sg10188
(dp37117
sVSensory Organs
p37118
(dp37119
sVExpectorants
p37120
(dp37121
sVAntidotes
p37122
(dp37123
sVAmino Acids, Peptides, and Proteins
p37124
(dp37125
sVOphthalmologicals
p37126
g35178
sg11004
(dp37127
sg2325
g31323
sVCough and Cold Preparations
p37128
(dp37129
sg3270
(dp37130
ssg3147
(dp37131
VAmino Acids, Peptides, and Proteins
p37132
(dp37133
sVGlobulins
p37134
g19172
sVAgents to Treat Airway Disease
p37135
g32645
sVImmunoglobulins
p37136
(dp37137
sVAntibodies, Monoclonal
p37138
(dp37139
sVAntibodies, Monoclonal, Humanized
p37140
(dp37141
sVProteins
p37142
(dp37143
sg3378
(dp37144
sVAnti-Allergic Agents
p37145
(dp37146
sVAntibodies
p37147
(dp37148
sVRespiratory System Agents
p37149
(dp37150
sVSerum Globulins
p37151
(dp37152
sVAnti-Asthmatic Agents
p37153
g36527
sg11823
(dp37154
sVRespiratory Agents, Miscellaneous
p37155
(dp37156
sVBlood Proteins
p37157
(dp37158
sg5190
(dp37159
sVImmunoproteins
p37160
(dp37161
ssg3150
(dp37162
g8826
(dp37163
ssg3153
(dp37164
g9810
(dp37165
sg2553
g32891
sg6843
(dp37166
sg11751
(dp37167
sg501
g16740
sg6246
(dp37168
sg11826
(dp37169
sg5226
(dp37170
sg5025
(dp37171
ssg3156
(dp37172
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p37173
(dp37174
sVAnti-Parkinson Drugs
p37175
g16151
sVIsoquinolines
p37176
(dp37177
sVNeurotransmitter Agents
p37178
(dp37179
sVHypotensive Agents
p37180
g34112
sVOpiate Agonists
p37181
(dp37182
sVCentral Nervous System Agents
p37183
(dp37184
sVDopamine Agents
p37185
g14242
sVPotential QTc-Prolonging Agents
p37186
(dp37187
sVPeripheral Nervous System Agents
p37188
(dp37189
sVAutonomic Agents
p37190
(dp37191
sVNonergot-derivative Dopamine Receptor Agonists
p37192
(dp37193
sVAporphines
p37194
(dp37195
sVSerotonin Agents
p37196
(dp37197
sVQTc Prolonging Agents
p37198
(dp37199
sVCentral Nervous System Depressants
p37200
(dp37201
sVGastrointestinal Agents
p37202
(dp37203
sVGenito Urinary System and Sex Hormones
p37204
(dp37205
sVDrugs Used in Erectile Dysfunction
p37206
g20789
sVDopamine Agonists
p37207
(dp37208
sVSerotonin Receptor Antagonists
p37209
g35672
sVUrologicals
p37210
(dp37211
sVEmetics
p37212
(dp37213
sVHeterocyclic Compounds, Fused-Ring
p37214
(dp37215
sVAntidepressive Agents
p37216
g15499
sVBenzylisoquinolines
p37217
(dp37218
sVAnti-Parkinson Agents (Dopamine Agonist)
p37219
g25592
sVAlkaloids
p37220
g19417
sVNervous System
p37221
(dp37222
ssg3159
(dp37223
g5622
(dp37224
sg6903
(dp37225
ssg3162
(dp37226
g2715
g33802
ssg3165
(dp37227
g5847
(dp37228
sg7524
(dp37229
ssg3168
(dp37230
g9870
(dp37231
sg7530
(dp37232
sg10320
(dp37233
sg9780
(dp37234
sg7548
(dp37235
sg2985
g35920
sg657
g18324
sg11382
(dp37236
sg9561
(dp37237
sg420
g16035
ssg3171
(dp37238
g11832
(dp37239
sg11472
(dp37240
ssg3174
(dp37241
g3282
(dp37242
sVCarbohydrates
p37243
(dp37244
sVCytochrome P-450 CYP3A4 Inhibitors
p37245
(dp37246
sVAnti-Acne Preparations
p37247
(dp37248
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p37249
(dp37250
sVEnzyme Inhibitors
p37251
(dp37252
sVCytochrome P-450 Enzyme Inhibitors
p37253
(dp37254
sVAnti-Infective Agents
p37255
(dp37256
sVAntiinfectives for Systemic Use
p37257
(dp37258
sg1662
g26219
sVGynecological Antiinfectives and Antiseptics
p37259
(dp37260
sg300
g14778
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37261
g29200
sg2625
g33208
sg4086
(dp37262
sg7101
(dp37263
sVCytochrome P-450 CYP3A Substrates
p37264
(dp37265
sg4470
(dp37266
sg8835
(dp37267
sVPyrrolidines
p37268
(dp37269
sVAnti-Bacterial Agents
p37270
(dp37271
sVDermatologicals
p37272
g17203
sg11346
(dp37273
sg2487
g32528
sVCytochrome P-450 CYP3A4 Substrates
p37274
(dp37275
sg5352
(dp37276
sVAnti-Acne Preparations for Topical Use
p37277
(dp37278
sVGenito Urinary System and Sex Hormones
p37279
(dp37280
sVCytochrome P-450 CYP3A Inhibitors
p37281
(dp37282
sg8892
(dp37283
sg1965
g28760
sg9861
(dp37284
ssg3177
(dp37285
VPotential QTc-Prolonging Agents
p37286
(dp37287
sVCardiovascular Agents
p37288
g26542
sVAutonomic Agents
p37289
(dp37290
sVMiscellaneous GI Drugs
p37291
g23545
sVAntiarrhythmic agents
p37292
(dp37293
sVPeripheral Nervous System Agents
p37294
(dp37295
sVCytochrome P-450 CYP3A Substrates
p37296
(dp37297
sVAgents causing hyperkalemia
p37298
(dp37299
sVBradycardia-Causing Agents
p37300
(dp37301
sVCalcium-Regulating Hormones and Agents
p37302
(dp37303
sVCalcium Channel Blockers
p37304
(dp37305
sVParasympatholytics
p37306
g35941
sVVasodilating Agents
p37307
g23704
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37308
g29202
sg11982
(dp37309
sVDrugs for Functional Gastrointestinal Disorders
p37310
(dp37311
sVMembrane Transport Modulators
p37312
(dp37313
sVQTc Prolonging Agents
p37314
(dp37315
sVCytochrome P-450 CYP3A4 Substrates
p37316
(dp37317
sVAlimentary Tract and Metabolism
p37318
g23783
ssg3180
(dp37319
g10854
(dp37320
ssg3183
(dp37321
VAmino Acids, Peptides, and Proteins
p37322
(dp37323
sVHematologic Agents
p37324
(dp37325
sVBlood and Blood Forming Organs
p37326
(dp37327
sVPeptides
p37328
(dp37329
sVErythropoietin
p37330
(dp37331
sVColony-Stimulating Factors
p37332
(dp37333
sVHematopoietic Cell Growth Factors
p37334
(dp37335
sVHematinics
p37336
(dp37337
sVCarbohydrates
p37338
(dp37339
sVProteins
p37340
(dp37341
sVIntercellular Signaling Peptides and Proteins
p37342
g25417
sVIncreased Erythroid Cell Production
p37343
(dp37344
sVErythropoiesis-Stimulating Agents
p37345
g13888
sVBiological Factors
p37346
(dp37347
sVGlycoconjugates
p37348
(dp37349
sVAntianemic Preparations
p37350
(dp37351
sVGlycoproteins
p37352
(dp37353
sVCytokines
p37354
(dp37355
sVErythropoietin, genetics
p37356
(dp37357
ssg3186
(dp37358
g11874
(dp37359
ssg3189
(dp37360
g13750
g24387
sg2373
g31599
sg4620
(dp37361
sg9903
(dp37362
sg14872
g15739
sg4653
(dp37363
sg6045
(dp37364
sg7545
(dp37365
sg7668
(dp37366
sg8430
(dp37367
sg1614
g25880
sg14838
(dp37368
sg5895
(dp37369
sg12534
(dp37370
sg11886
(dp37371
sg4113
(dp37372
sg9030
(dp37373
sg3393
(dp37374
sg8694
(dp37375
sg5364
(dp37376
sg6360
(dp37377
sg5766
(dp37378
sg6345
(dp37379
ssg3192
(dp37380
g426
g16103
sg6207
(dp37381
sg6186
(dp37382
sg11811
(dp37383
sg11619
(dp37384
sg6579
(dp37385
sg5064
(dp37386
sg7284
(dp37387
sg12018
(dp37388
sg1104
g22096
sg9996
(dp37389
sg9420
(dp37390
sg8028
(dp37391
sg4746
(dp37392
sg69
g12754
sg4959
(dp37393
sg6678
(dp37394
sg2688
g33662
sg582
g17633
sg7533
(dp37395
sg12126
(dp37396
sg7041
(dp37397
ssg3195
(dp37398
g8097
(dp37399
sg8421
(dp37400
sg1461
g24827
sg4155
(dp37401
sg9822
(dp37402
sg9417
(dp37403
sg8820
(dp37404
sg183
g13834
sg7941
(dp37405
sg11979
(dp37406
sg9102
(dp37407
sg7335
(dp37408
sg10056
(dp37409
ssg3198
(dp37410
g2343
g31338
ssg3201
(dp37411
g2985
g35927
sg4398
(dp37412
sg9870
(dp37413
sg7548
(dp37414
ssg3204
(dp37415
VPyrimidines
p37416
(dp37417
sVGABA Agents
p37418
g16221
sVCarbohydrates
p37419
(dp37420
sVNeurotransmitter Agents
p37421
(dp37422
sVAnti-Anxiety Agents
p37423
g35655
sVGlycosides
p37424
(dp37425
sVCentral Nervous System Agents
p37426
(dp37427
sVPsychotropic Drugs
p37428
(dp37429
sVGABA Modulators
p37430
(dp37431
sVCytochrome P-450 CYP3A4 Substrates
p37432
(dp37433
sVRibonucleotides
p37434
(dp37435
sVCytosine Nucleotides
p37436
g33141
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37437
g29207
sVAdjuvants, Anesthesia
p37438
(dp37439
sVPsycholeptics
p37440
g33251
sVCytochrome P-450 CYP3A Substrates
p37441
(dp37442
sVCentral Nervous System Depressants
p37443
(dp37444
sVNucleic Acids, Nucleotides, and Nucleosides
p37445
(dp37446
sVHeterocyclic Compounds, Fused-Ring
p37447
(dp37448
sVNucleotides
p37449
(dp37450
sVHypnotics and Sedatives
p37451
(dp37452
sVPyrimidine Nucleotides
p37453
(dp37454
sVBenzazepines
p37455
(dp37456
sVBenzodiazepines and benzodiazepine derivatives
p37457
(dp37458
sVNervous System
p37459
(dp37460
sVTranquilizing Agents
p37461
(dp37462
ssg3207
(dp37463
VAntiinfectives for Systemic Use
p37464
(dp37465
sVProtein Synthesis Inhibitors
p37466
(dp37467
sVAgents that produce neuromuscular block (indirect)
p37468
(dp37469
sVOphthalmologicals
p37470
g35187
sVNephrotoxic agents
p37471
(dp37472
sg11184
(dp37473
sg9657
(dp37474
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p37475
(dp37476
sVAminoglycoside Antibacterials
p37477
(dp37478
sVGlycosides
p37479
(dp37480
sVCarbohydrates
p37481
(dp37482
sVIntestinal Antiinfectives
p37483
(dp37484
sVEnzyme Inhibitors
p37485
(dp37486
sVSensory Organs
p37487
(dp37488
sVAnti-Bacterial Agents
p37489
(dp37490
sVAntibacterials for Systemic Use
p37491
g32532
sVAnti-Infective Agents
p37492
(dp37493
sVAlimentary Tract and Metabolism
p37494
g23792
sVNarrow Therapeutic Index Drugs
p37495
(dp37496
ssg3210
(dp37497
g5847
(dp37498
ssg3213
(dp37499
g1044
g21559
sg5829
(dp37500
sg6759
(dp37501
sg2067
g29657
sg909
g20654
sg10515
(dp37502
sg11319
(dp37503
sg9987
(dp37504
sg9012
(dp37505
sg7320
(dp37506
sg1719
g26846
sg23
g12235
sg10761
(dp37507
sg3114
g36881
sg10005
(dp37508
sg11445
(dp37509
sg1548
g25391
sg8862
(dp37510
sg10098
(dp37511
sg3240
(dp37512
sg10227
(dp37513
sg4056
(dp37514
sg2616
g33191
sg612
g17897
sg9828
(dp37515
sg5580
(dp37516
ssg3216
(dp37517
VBisphosphonates
p37518
(dp37519
sVMusculo-Skeletal System
p37520
g31543
sVDrugs for Treatment of Bone Diseases
p37521
g14282
sVBone Density Conservation Agents
p37522
(dp37523
sVOrganophosphonates
p37524
(dp37525
sVDrugs Affecting Bone Structure and Mineralization
p37526
g16514
sVImidazoles
p37527
(dp37528
sVOrganophosphorus Compounds
p37529
(dp37530
ssg3219
(dp37531
VAnti-Allergic Agents
p37532
(dp37533
sVCytochrome P-450 CYP3A Substrates
p37534
(dp37535
sVSteroids, Fluorinated
p37536
(dp37537
sVHormones
p37538
(dp37539
sVCorticosteroids, Dermatological Preparations
p37540
(dp37541
sVImmunosuppressive Agents
p37542
(dp37543
sVGlucocorticoids
p37544
g21924
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37545
g29209
sVFused-Ring Compounds
p37546
g14821
sVCytochrome P-450 CYP3A4 Inducers
p37547
g18896
sVCytochrome P-450 CYP3A5 Inducers
p37548
(dp37549
sVAdrenal Cortex Hormones
p37550
g30049
sVPregnadienes
p37551
(dp37552
sVDermatologicals
p37553
g17215
sVCytochrome P-450 Enzyme Inducers
p37554
g28137
sVCytochrome P-450 CYP3A Inducers
p37555
(dp37556
sVCytochrome P-450 CYP3A4 Substrates
p37557
(dp37558
sVPregnanes
p37559
(dp37560
sVSteroids
p37561
(dp37562
sVCorticosteroids, Potent (Group III)
p37563
(dp37564
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p37565
(dp37566
sVAnti-Inflammatory Agents
p37567
(dp37568
sVCorticosteroid Hormone Receptor Agonists
p37569
(dp37570
sVHormones, Hormone Substitutes, and Hormone Antagonists
p37571
(dp37572
sVCorticosteroids
p37573
(dp37574
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p37575
(dp37576
sg6351
(dp37577
ssg3222
(dp37578
VAntiparasitic Products, Insecticides and Repellents
p37579
g30585
sVCytochrome P-450 CYP3A4 Inhibitors
p37580
(dp37581
sVAntimalarials
p37582
g14094
sVQuinolines
p37583
(dp37584
sVCytochrome P-450 CYP2D6 Inhibitors
p37585
(dp37586
sVCytochrome P-450 CYP3A Substrates
p37587
(dp37588
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p37589
(dp37590
sVCytochrome P-450 Enzyme Inhibitors
p37591
(dp37592
sVAnti-Infective Agents
p37593
(dp37594
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p37595
g18425
sVCytochrome P-450 CYP1A2 Substrates
p37596
(dp37597
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37598
g29210
sVAntiprotozoals
p37599
(dp37600
sVQTc Prolonging Agents
p37601
(dp37602
sVCytochrome P-450 CYP1A2 Inducers
p37603
(dp37604
sVCytochrome P-450 CYP1A2 Inhibitors
p37605
g15040
sVAminoquinolines
p37606
(dp37607
sVAntiparasitic Agents
p37608
(dp37609
sVCytochrome P-450 Enzyme Inducers
p37610
g28138
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p37611
(dp37612
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p37613
g17452
sVCytochrome P-450 CYP3A4 Substrates
p37614
(dp37615
sVModerate Risk QTc-Prolonging Agents
p37616
(dp37617
sVHeterocyclic Compounds, Fused-Ring
p37618
(dp37619
sVCytochrome P-450 CYP3A Inhibitors
p37620
(dp37621
sVMethemoglobinemia Associated Agents
p37622
g25583
sVP-glycoprotein/ABCB1 Inhibitors
p37623
(dp37624
ssg3225
(dp37625
g5316
(dp37626
sg1761
g26982
sg11604
(dp37627
sg7707
(dp37628
sg8820
(dp37629
ssg3228
(dp37630
g1266
g23242
ssg3231
(dp37631
VCytochrome P-450 CYP3A Substrates
p37632
(dp37633
sVHypotensive Agents
p37634
g34128
sVPotential QTc-Prolonging Agents
p37635
(dp37636
sVHyperglycemia-Associated Agents
p37637
(dp37638
sVDrugs that are Mainly Renally Excreted
p37639
(dp37640
sVThiazide-like Diuretic
p37641
g12821
sVGynecological Antiinfectives and Antiseptics
p37642
(dp37643
sVAntihypertensive Agents
p37644
g20264
sVNon Potassium Sparing Diuretics
p37645
g14972
sVAmides
p37646
(dp37647
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37648
g29213
sVSulfur Compounds
p37649
(dp37650
sVSulfones
p37651
(dp37652
sVQTc Prolonging Agents
p37653
(dp37654
sVNatriuretic Agents
p37655
(dp37656
sVDiuretics
p37657
(dp37658
sVCardiovascular Agents
p37659
g26556
sVLipid Modifying Agents
p37660
(dp37661
sVIndoles
p37662
(dp37663
sVMembrane Transport Modulators
p37664
(dp37665
sVCytochrome P-450 CYP3A4 Substrates
p37666
(dp37667
sVLow-Ceiling Diuretics, Excl. Thiazides
p37668
(dp37669
sVHeterocyclic Compounds, Fused-Ring
p37670
(dp37671
sVGenito Urinary System and Sex Hormones
p37672
(dp37673
sVSulfonamides
p37674
(dp37675
sVIncreased Diuresis
p37676
(dp37677
sVSodium Chloride Symporter Inhibitors
p37678
(dp37679
ssg3234
(dp37680
g7188
(dp37681
ssg3237
(dp37682
g4860
(dp37683
sg561
g17370
ssg3240
(dp37684
VBeta Blocking Agents, Non-Selective, and Thiazides
p37685
(dp37686
sVCytochrome P-450 CYP2D6 Inhibitors
p37687
(dp37688
sVCytochrome P-450 CYP2D6 Substrates
p37689
(dp37690
sVAntiarrhythmic agents
p37691
(dp37692
sVCytochrome P-450 CYP3A Substrates
p37693
(dp37694
sVAgents causing hyperkalemia
p37695
(dp37696
sVHypotensive Agents
p37697
g34129
sVOCT2 Inhibitors
p37698
(dp37699
sVAdrenergic Antagonists
p37700
(dp37701
sVCytochrome P-450 Enzyme Inhibitors
p37702
(dp37703
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p37704
g18428
sVDrugs that are Mainly Renally Excreted
p37705
(dp37706
sVCytochrome P-450 CYP1A2 Substrates
p37707
(dp37708
sVAmines
p37709
(dp37710
sVAntihypertensive Agents
p37711
g20266
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p37712
g29215
sVQTc Prolonging Agents
p37713
(dp37714
sVAdrenergic Agents
p37715
(dp37716
sVNeurotransmitter Agents
p37717
(dp37718
sVCardiovascular Agents
p37719
g26558
sVP-glycoprotein/ABCB1 Substrates
p37720
g35075
sVAdrenergic beta-Antagonists
p37721
g15367
sVPhenoxypropanolamines
p37722
g20864
sVVasodilating Agents
p37723
g23721
sVBeta Blocking Agents, Non-Selective
p37724
(dp37725
sVCytochrome P-450 CYP3A4 Substrates
p37726
(dp37727
sVNaphthalenes
p37728
(dp37729
sVPropanolamines
p37730
g37512
sVModerate Risk QTc-Prolonging Agents
p37731
(dp37732
sVBeta Blocking Agents and Thiazides
p37733
(dp37734
sVCytochrome P-450 CYP3A5 Substrates
p37735
(dp37736
sVAmino Alcohols
p37737
g32692
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p37738
(dp37739
sVBradycardia-Causing Agents
p37740
(dp37741
sVPropanols
p37742
(dp37743
sVP-glycoprotein/ABCB1 Inhibitors
p37744
(dp37745
sVAlcohols
p37746
(dp37747
sVCytochrome P-450 CYP3A7 Substrates
p37748
(dp37749
ssg3243
(dp37750
g465
g16492
sg5805
(dp37751
ssg3246
(dp37752
VTerpenes
p37753
(dp37754
sVBenzene Derivatives
p37755
(dp37756
sVAntifungal Agents
p37757
(dp37758
sg7092
(dp37759
sVAnti-Infective Agents, Local
p37760
(dp37761
sVAnti-Infective Agents
p37762
(dp37763
ssg3249
(dp37764
g6633
(dp37765
sVVitamins (Fat Soluble)
p37766
(dp37767
sg4311
(dp37768
sVSteroids
p37769
(dp37770
sg4818
(dp37771
sg11556
(dp37772
sVDermatologicals
p37773
g17287
sVMisc. Skin and Mucous Membrane Agents
p37774
(dp37775
sVLipids
p37776
g14328
sg741
g19148
sVAntipsoriatics for Topical Use
p37777
g22994
sVFused-Ring Compounds
p37778
g14866
sVAntipsoriatics
p37779
(dp37780
sVVitamins
p37781
g12175
sg3672
(dp37782
ssg3252
(dp37783
g2256
g30934
sg10230
(dp37784
sg11874
(dp37785
sg6474
(dp37786
sg7719
(dp37787
sg10074
(dp37788
sg6471
(dp37789
sg1038
g21499
sg10974
(dp37790
sg7020
(dp37791
sg1356
g23976
sg10245
(dp37792
sg4320
(dp37793
ssg3255
(dp37794
g11775
(dp37795
sg6474
(dp37796
sg11940
(dp37797
sg7719
(dp37798
sg816
g19710
ssg3258
(dp37799
VDrugs that are Mainly Renally Excreted
p37800
(dp37801
sVMyelosuppressive Agents
p37802
(dp37803
sVToxic Actions
p37804
(dp37805
sVDacarbazine
p37806
(dp37807
sVTriazenes
p37808
(dp37809
sVImmunosuppressive Agents
p37810
(dp37811
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p37812
(dp37813
sVAlkylating Activity
p37814
(dp37815
sVAlkylating Drugs
p37816
(dp37817
sVCytochrome P-450 Enzyme Inducers
p37818
g28146
sVCytochrome P-450 CYP3A Inducers
p37819
(dp37820
sVAntineoplastic and Immunomodulating Agents
p37821
(dp37822
sVNoxae
p37823
(dp37824
sVImidazoles
p37825
(dp37826
sVCytochrome P-450 CYP3A4 Inducers
p37827
g18904
sVAntineoplastic Agents
p37828
(dp37829
sVAntineoplastic Agents, Alkylating
p37830
(dp37831
ssg3261
(dp37832
VCytochrome P-450 CYP1A2 Substrates
p37833
(dp37834
sVHeterocyclic Compounds, Fused-Ring
p37835
(dp37836
sg2511
g32701
sVUGT1A1 Substrates
p37837
g12337
sg5376
(dp37838
sVAntineoplastic and Immunomodulating Agents
p37839
(dp37840
sVProtein Kinase Inhibitors
p37841
(dp37842
sVAntineoplastic Agents
p37843
(dp37844
ssg3264
(dp37845
g10260
(dp37846
sVDrugs that are Mainly Renally Excreted
p37847
(dp37848
sVCardiotoxic antineoplastic agents
p37849
(dp37850
sVDeoxyribonucleosides
p37851
g33059
sVNucleic Acid Synthesis Inhibitors
p37852
(dp37853
sVNucleosides
p37854
(dp37855
sVMyelosuppressive Agents
p37856
(dp37857
sVRibonucleosides
p37858
(dp37859
sVNucleic Acids, Nucleotides, and Nucleosides
p37860
(dp37861
sVCarbohydrates
p37862
(dp37863
sVImmunosuppressive Agents
p37864
(dp37865
sVGlycosides
p37866
(dp37867
sVNucleoside Metabolic Inhibitor
p37868
(dp37869
sVPyrimidine Nucleosides
p37870
(dp37871
sVPyrimidines
p37872
(dp37873
sVAntineoplastic and Immunomodulating Agents
p37874
(dp37875
sVEnzyme Inhibitors
p37876
(dp37877
sg11736
(dp37878
sVAntineoplastic Agents
p37879
(dp37880
sg10830
(dp37881
ssg3267
(dp37882
VAntiinfectives for Systemic Use
p37883
(dp37884
sVHeterocyclic Compounds, Fused-Ring
p37885
(dp37886
sVbeta-Lactams
p37887
(dp37888
sg11181
(dp37889
sg5277
(dp37890
sVLactams
p37891
g22294
sVOAT1/SLC22A6 inhibitors
p37892
(dp37893
sVAmides
p37894
(dp37895
sVSulfur Compounds
p37896
(dp37897
sVAnti-Bacterial Agents
p37898
(dp37899
sVAntibacterials for Systemic Use
p37900
g32541
sg4092
(dp37901
sVAnti-Infective Agents
p37902
(dp37903
sg5742
(dp37904
sg4605
(dp37905
ssg3270
(dp37906
g3144
g37130
ssg3273
(dp37907
g4488
(dp37908
ssg3276
(dp37909
g1737
g26930
ssg3279
(dp37910
VAcetic Acid Derivatives and Related Substances
p37911
g28819
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p37912
(dp37913
sVOAT1/SLC22A6 inhibitors
p37914
(dp37915
sVAnalgesics
p37916
g26440
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p37917
(dp37918
sVNon COX-2 selective NSAIDS
p37919
(dp37920
sVCentral Nervous System Agents
p37921
(dp37922
sVAntiinflammatory and Antirheumatic Products
p37923
(dp37924
sVEnzyme Inhibitors
p37925
(dp37926
sVPeripheral Nervous System Agents
p37927
(dp37928
sVNonsteroidal Anti-inflammatory Compounds
p37929
(dp37930
sVAnalgesics, Non-Narcotic
p37931
(dp37932
sVNephrotoxic agents
p37933
(dp37934
sVMusculo-Skeletal System
p37935
g31546
sVAgents causing hyperkalemia
p37936
(dp37937
sVIndenes
p37938
(dp37939
sVOther Nonsteroidal Antiimflammatory Agents
p37940
(dp37941
sVAgents that produce hypertension
p37942
(dp37943
sVAnti-Inflammatory Agents
p37944
(dp37945
sVCyclooxygenase Inhibitors
p37946
g32793
sVAntirheumatic Agents
p37947
g24245
sVSensory System Agents
p37948
(dp37949
sVAnti-Inflammatory Agents, Non-Steroidal
p37950
(dp37951
ssg3282
(dp37952
g1782
g27122
sg2553
g32869
sg5415
(dp37953
sg30
g12346
sg7707
(dp37954
sg4341
(dp37955
sg4746
(dp37956
sg11604
(dp37957
sg8598
(dp37958
sg8601
(dp37959
sg3825
(dp37960
sg9918
(dp37961
sg12000
(dp37962
sg354
g15273
sg657
g18283
sg5865
(dp37963
sg3141
g37040
sg11079
(dp37964
sg9561
(dp37965
sg2046
g29089
sg6432
(dp37966
sg5082
(dp37967
sg3981
(dp37968
sg5208
(dp37969
sg3174
g37242
sg9426
(dp37970
sg5316
(dp37971
sg9846
(dp37972
sg126
g13160
sg3399
(dp37973
sg6240
(dp37974
sg9261
(dp37975
sg2739
g33979
sg3207
g37469
sg7662
(dp37976
sg9096
(dp37977
sg2688
g33595
sg10767
(dp37978
sg3090
g36687
sg7878
(dp37979
sg9657
(dp37980
sg12126
(dp37981
sg1761
g26977
sg4782
(dp37982
sg4770
(dp37983
sg7470
(dp37984
sg11382
(dp37985
ssg3285
(dp37986
g4263
(dp37987
ssg3288
(dp37988
g11832
(dp37989
ssg3291
(dp37990
VAntiinfectives for Systemic Use
p37991
(dp37992
sVHeterocyclic Compounds, Fused-Ring
p37993
(dp37994
sVbeta-Lactams
p37995
(dp37996
sVNephrotoxic agents
p37997
(dp37998
sVLactams
p37999
g22290
sVAmides
p38000
(dp38001
sVThiazines
p38002
g16415
sVSulfur Compounds
p38003
(dp38004
sVAnti-Bacterial Agents
p38005
(dp38006
sVAntibacterials for Systemic Use
p38007
g32570
sVCephalosporins
p38008
(dp38009
sVAnti-Infective Agents
p38010
(dp38011
sg5397
(dp38012
ssg3294
(dp38013
g12126
(dp38014
sg2688
g33697
ssg3297
(dp38015
VFibrin Modulating Agents
p38016
g22862
sVHematologic Agents
p38017
(dp38018
sVBlood and Blood Forming Organs
p38019
(dp38020
sVCardiovascular Agents
p38021
g26681
sVPolysaccharides
p38022
(dp38023
sVAnticoagulants
p38024
(dp38025
sVCarbohydrates
p38026
(dp38027
sVAgents causing hyperkalemia
p38028
(dp38029
sVFibrinolytic Agents
p38030
g26300
sVHeparin (Low Molecular Weight)
p38031
(dp38032
sVGlycosaminoglycans
p38033
g26082
sVHeparin and similars
p38034
(dp38035
ssg3300
(dp38036
g5199
(dp38037
sg213
g14047
ssg3303
(dp38038
g10833
(dp38039
sg10326
(dp38040
sg9126
(dp38041
sg7815
(dp38042
sg3912
(dp38043
sg3576
(dp38044
sg7884
(dp38045
sg8622
(dp38046
sg11427
(dp38047
sg279
g14499
sg11052
(dp38048
sg5847
(dp38049
sg5871
(dp38050
sg6231
(dp38051
sg11061
(dp38052
sg9663
(dp38053
sg9192
(dp38054
sg11451
(dp38055
sg8985
(dp38056
sg9198
(dp38057
sg13070
g21879
sg8049
(dp38058
sg3132
g36988
sg10377
(dp38059
sg2991
g35967
sg2808
g34476
sg9954
(dp38060
sg8454
(dp38061
sg2250
g30865
sg9432
(dp38062
sg10509
(dp38063
sg318
g14927
sg4299
(dp38064
sg5520
(dp38065
sg4707
(dp38066
sg819
g19727
sg2652
g33302
sg6435
(dp38067
sg10368
(dp38068
sg7524
(dp38069
sg1527
g25266
sg2274
g31058
sg7947
(dp38070
sg6654
(dp38071
sg11508
(dp38072
sg8298
(dp38073
sg8493
(dp38074
sg11334
(dp38075
sg573
g17519
sg11166
(dp38076
sg1332
g23656
sg11208
(dp38077
sg3795
(dp38078
sg4164
(dp38079
sg12051
(dp38080
sg1101
g22047
sg7500
(dp38081
sg6075
(dp38082
sg1863
g27765
sg438
g16179
sg7881
(dp38083
sg4953
(dp38084
sg8922
(dp38085
sg11385
(dp38086
ssg3306
(dp38087
g1791
g27278
sg8769
(dp38088
sg5622
(dp38089
sg10077
(dp38090
sg19588
g32463
sg1038
g21494
sg8439
(dp38091
sg3333
(dp38092
sg8598
(dp38093
sg8601
(dp38094
sg7854
(dp38095
sg3495
(dp38096
sg9267
(dp38097
sg5847
(dp38098
sg2256
g30927
sg11832
(dp38099
sg1059
g21743
sg1356
g23968
sg5073
(dp38100
sg10974
(dp38101
sg6903
(dp38102
sg3183
g37347
sg1686
g26408
sg12186
(dp38103
sg5382
(dp38104
sg8670
(dp38105
sg7719
(dp38106
sg11874
(dp38107
sg9618
(dp38108
sg6471
(dp38109
sg10245
(dp38110
sg8340
(dp38111
sg9540
(dp38112
sg10002
(dp38113
sg11718
(dp38114
sg1917
g28456
sg372
g15408
sg8871
(dp38115
sg10230
(dp38116
sg7971
(dp38117
sg5577
(dp38118
sg357
g15300
sg7977
(dp38119
sg4320
(dp38120
sg6474
(dp38121
sg4377
(dp38122
sg8274
(dp38123
sg7020
(dp38124
sg8484
(dp38125
sg801
g19541
sg11775
(dp38126
sg5400
(dp38127
sg1611
g25801
ssg3309
(dp38128
g2274
g31064
sg8454
(dp38129
sg2652
g33306
sg11166
(dp38130
ssg3312
(dp38131
VIons
p38132
(dp38133
sVPhosphorus Acids
p38134
(dp38135
sVAgents that reduce seizure threshold
p38136
(dp38137
sVOsmotic Laxatives
p38138
(dp38139
sVAcids
p38140
(dp38141
sVAcids, Noncarboxylic
p38142
(dp38143
sVElectrolytes
p38144
(dp38145
sVUrinary Acidifying Agents
p38146
(dp38147
sVPhosphorus Compounds
p38148
g36724
sVLaxatives
p38149
g17338
sVAnions
p38150
(dp38151
sVPotassium Salt
p38152
g30482
sg6822
(dp38153
sVPhosphoric Acids
p38154
(dp38155
ssg3315
(dp38156
g10833
(dp38157
sg5520
(dp38158
sg3576
(dp38159
sg7881
(dp38160
sg8985
(dp38161
sg10326
(dp38162
sg1101
g22069
sg1527
g25273
sg7500
(dp38163
sg6654
(dp38164
sg11427
(dp38165
sg2250
g30870
sg279
g14510
sg4953
(dp38166
ssg3318
(dp38167
VCarbohydrates
p38168
(dp38169
sVHypotensive Agents
p38170
g34140
sVVasoprotectives
p38171
(dp38172
sVCytochrome P-450 Enzyme Inhibitors
p38173
(dp38174
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p38175
g26869
sVVasodilators Used in Cardiac Diseases
p38176
(dp38177
sVCytochrome P-450 CYP2E1 Inhibitors
p38178
(dp38179
sVCardiac Therapy
p38180
(dp38181
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38182
g29225
sVSugar Alcohols
p38183
g34051
sVSorbitol
p38184
(dp38185
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p38186
g16821
sVCytochrome P-450 CYP3A Substrates
p38187
(dp38188
sVCardiovascular Agents
p38189
g26646
sVNitric Oxide Donors
p38190
(dp38191
sVVasodilation
p38192
(dp38193
sVNitrate Vasodilator
p38194
(dp38195
sVVasodilating Agents
p38196
g23726
sVOrganic Nitrates
p38197
(dp38198
sVCytochrome P-450 CYP3A4 Substrates
p38199
(dp38200
sVAntianginal Agents
p38201
(dp38202
sVNitrates and Nitrites
p38203
(dp38204
sVMethemoglobinemia Associated Agents
p38205
g25563
sVIsosorbide
p38206
(dp38207
sVAlcohols
p38208
(dp38209
ssg3321
(dp38210
VDrugs that are Mainly Renally Excreted
p38211
(dp38212
sVPhthalimides
p38213
g20181
sVCytochrome P-450 CYP1A2 Substrates
p38214
(dp38215
sVHeterocyclic Compounds, Fused-Ring
p38216
(dp38217
sVAgents reducing cytokine levels
p38218
(dp38219
sVSelective Immunosuppressants
p38220
g23574
sVPhosphodiesterase 4 Inhibitors
p38221
(dp38222
sVCytochrome P-450 CYP3A Substrates
p38223
(dp38224
sVImmunosuppressive Agents
p38225
(dp38226
sVIsoindoles
p38227
g17601
sVAnti-Inflammatory Agents
p38228
(dp38229
sVCytochrome P-450 CYP2A6 Substrates
p38230
g35123
sVDisease-modifying Antirheumatic Agents
p38231
(dp38232
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38233
g29226
sVAntineoplastic and Immunomodulating Agents
p38234
(dp38235
sVPhosphodiesterase Inhibitors
p38236
(dp38237
sVCytochrome P-450 CYP3A4 Substrates
p38238
(dp38239
ssg3324
(dp38240
g7197
(dp38241
sg12421
g12438
sg7065
(dp38242
ssg3327
(dp38243
g5085
(dp38244
ssg3330
(dp38245
g5781
(dp38246
sg2523
g32763
ssg3333
(dp38247
VAmino Acids, Peptides, and Proteins
p38248
(dp38249
sVIntercellular Signaling Peptides and Proteins
p38250
g25413
sVColony-Stimulating Factors
p38251
(dp38252
sVHematopoietic Cell Growth Factors
p38253
(dp38254
sVCarbohydrates
p38255
(dp38256
sVProteins
p38257
(dp38258
sVPeptides
p38259
(dp38260
sVBiological Factors
p38261
g38092
sVGlycoconjugates
p38262
(dp38263
sVGlycoproteins
p38264
(dp38265
sVCytokines
p38266
(dp38267
ssg3336
(dp38268
g507
g16802
sg849
g20116
ssg3339
(dp38269
g21710
(dp38270
ssg3342
(dp38271
g9375
(dp38272
ssg3345
(dp38273
g11649
(dp38274
sg1635
g26040
ssg3348
(dp38275
g1626
g25952
sg6051
(dp38276
sg11022
(dp38277
sg6687
(dp38278
sg11874
(dp38279
sg10593
(dp38280
sg9099
(dp38281
sg3900
(dp38282
sg8964
(dp38283
sg5499
(dp38284
sg6069
(dp38285
sg10041
(dp38286
sg4449
(dp38287
sg10713
(dp38288
sg10521
(dp38289
sg9828
(dp38290
sg7170
(dp38291
sg570
g17483
sg10884
(dp38292
ssg3351
(dp38293
g9870
(dp38294
sg4557
(dp38295
sg7530
(dp38296
sg10767
(dp38297
sg657
g18316
sg7920
(dp38298
sg9780
(dp38299
sg129
g13208
sg9660
(dp38300
sg2985
g35918
sg9561
(dp38301
sg8649
(dp38302
sg4398
(dp38303
sg11382
(dp38304
sg8826
(dp38305
sg5457
(dp38306
sg3825
(dp38307
ssg3354
(dp38308
g11781
(dp38309
ssg3357
(dp38310
g8373
(dp38311
sg4479
(dp38312
sg30
g12386
sg135
g13256
sg6204
(dp38313
sg9906
(dp38314
sg4872
(dp38315
sg7653
(dp38316
sg1656
g26165
sg354
g15285
sg3141
g37070
sg9507
(dp38317
sg2046
g29121
sg8448
(dp38318
sg2436
g32181
sg15016
(dp38319
sg3174
g37271
sg3657
(dp38320
sg7377
(dp38321
sg4710
(dp38322
sg9750
(dp38323
sg126
g13179
sg9261
(dp38324
sg3849
(dp38325
sg3207
g37490
sg7005
(dp38326
sg14338
g13541
sg9273
(dp38327
sg11541
(dp38328
sg972
g21131
sg9282
(dp38329
sg7878
(dp38330
sg9630
(dp38331
sg1761
g27000
sg4782
(dp38332
sg5208
(dp38333
sg1110
g22142
sg7155
(dp38334
sg4005
(dp38335
sg3267
g37899
sg8616
(dp38336
sg1782
g27146
sg4017
(dp38337
sg1278
g23340
sg7353
(dp38338
sg4830
(dp38339
sg11604
(dp38340
sg4857
(dp38341
sg10122
(dp38342
sg4881
(dp38343
sg6432
(dp38344
sg5685
(dp38345
sg4773
(dp38346
sg11685
(dp38347
sg6348
(dp38348
sg4911
(dp38349
sg11694
(dp38350
sg9426
(dp38351
sg4920
(dp38352
sg1872
g27871
sg12078
(dp38353
sg2667
g33509
sg11733
(dp38354
sg11184
(dp38355
sg10218
(dp38356
sg2706
g33765
sg2715
g33801
sg6933
(dp38357
sg10275
(dp38358
sg2481
g32409
sg1239
g22950
sg7074
(dp38359
sg11838
(dp38360
sg5865
(dp38361
sg5082
(dp38362
sg8079
(dp38363
sg1311
g23533
sg2829
g34641
sg2838
g34794
sg8850
(dp38364
sg3021
g36197
sg3963
(dp38365
sg6240
(dp38366
sg6183
(dp38367
sg7662
(dp38368
sg2142
g30356
sg10290
(dp38369
sg9963
(dp38370
sg9657
(dp38371
sg5295
(dp38372
sg3291
g38006
sg2895
g35433
sg10878
(dp38373
sg6549
(dp38374
sg16906
(dp38375
sg2940
g35717
sg8211
(dp38376
sg10479
(dp38377
sg12000
(dp38378
sg12003
(dp38379
sg9726
(dp38380
sg8238
(dp38381
sg7470
(dp38382
sg690
g18622
sg2418
g31909
sg3981
(dp38383
sg5736
(dp38384
sg1176
g22682
sg4539
(dp38385
sg2739
g34015
sg11067
(dp38386
sg1539
g25313
sg8577
(dp38387
sg11358
(dp38388
sg10611
(dp38389
sg3090
g36707
sg9096
(dp38390
sg10692
(dp38391
sg12123
(dp38392
ssg3360
(dp38393
g3588
(dp38394
ssg3363
(dp38395
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p38396
(dp38397
sVCytochrome P-450 CYP3A Substrates
p38398
(dp38399
sVNeurotransmitter Agents
p38400
(dp38401
sVCentral Nervous System Agents
p38402
(dp38403
sVSympathomimetics
p38404
(dp38405
sVAmphetamines
p38406
(dp38407
sVPeripheral Nervous System Agents
p38408
(dp38409
sg1833
g27617
sVAmines
p38410
(dp38411
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38412
g29265
sg7296
(dp38413
sg11679
(dp38414
sVCentrally Acting Antiobesity Products
p38415
(dp38416
sVAdrenergic Agents
p38417
(dp38418
sVAgents that produce hypertension
p38419
(dp38420
sVCytochrome P-450 CYP3A4 Substrates
p38421
(dp38422
sVAlimentary Tract and Metabolism
p38423
g23897
sVAutonomic Agents
p38424
(dp38425
sVIncreased Sympathetic Activity
p38426
(dp38427
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p38428
(dp38429
sVAgents producing tachycardia
p38430
(dp38431
sVAnti-Obesity Agents
p38432
(dp38433
sVAntiobesity Preparations, Excl. Diet Products
p38434
(dp38435
sVPhenethylamines
p38436
(dp38437
ssg3366
(dp38438
g4299
(dp38439
ssg3369
(dp38440
g10113
(dp38441
ssg3372
(dp38442
g5409
(dp38443
ssg3375
(dp38444
g6171
(dp38445
sg4197
(dp38446
sg1746
g26939
sg9006
(dp38447
ssg3378
(dp38448
g3147
g37144
ssg3381
(dp38449
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p38450
(dp38451
sVPsychoanaleptics
p38452
(dp38453
sVCytochrome P-450 CYP2D6 Substrates
p38454
(dp38455
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p38456
(dp38457
sVSerotonin Agents
p38458
(dp38459
sVNeurotransmitter Agents
p38460
(dp38461
sVAntidepressive Agents, Tricyclic
p38462
(dp38463
sVCentral Nervous System Agents
p38464
(dp38465
sVPotential QTc-Prolonging Agents
p38466
(dp38467
sVPsychotropic Drugs
p38468
(dp38469
sVNeurotransmitter Uptake Inhibitors
p38470
(dp38471
sVNon-Selective Monoamine Reuptake Inhibitors
p38472
(dp38473
sVQTc Prolonging Agents
p38474
(dp38475
sVDibenzocycloheptenes
p38476
(dp38477
sVAdrenergic Agents
p38478
(dp38479
sVCentral Nervous System Depressants
p38480
(dp38481
sVAgents that reduce seizure threshold
p38482
(dp38483
sVBenzocycloheptenes
p38484
(dp38485
sVAdrenergic Uptake Inhibitors
p38486
g32316
sVMembrane Transport Modulators
p38487
(dp38488
sVNarrow Therapeutic Index Drugs
p38489
(dp38490
sVSerotonin Modulators
p38491
(dp38492
sVAntidepressive Agents
p38493
g15528
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p38494
g36626
sVP-glycoprotein/ABCB1 Inhibitors
p38495
(dp38496
sVNeurotoxic agents
p38497
(dp38498
sVAgents that produce hypertension
p38499
(dp38500
sVNervous System
p38501
(dp38502
ssg3384
(dp38503
g6549
(dp38504
sg7470
(dp38505
sg6171
(dp38506
ssg3387
(dp38507
g7053
(dp38508
sg10728
(dp38509
sg7845
(dp38510
sg3516
(dp38511
sg7428
(dp38512
sg5256
(dp38513
sg10494
(dp38514
sg2715
g33808
sg6024
(dp38515
sg5589
(dp38516
sg3651
(dp38517
sg4596
(dp38518
sg8418
(dp38519
ssg3390
(dp38520
g8139
(dp38521
sg3732
(dp38522
sg7275
(dp38523
sg11955
(dp38524
sg7983
(dp38525
sg9879
(dp38526
sg6012
(dp38527
sg10533
(dp38528
sg945
g20899
sg9966
(dp38529
ssg3393
(dp38530
VCytochrome P-450 CYP3A Substrates
p38531
(dp38532
sVCentral Nervous System Agents
p38533
(dp38534
sVAnti-Acne Preparations
p38535
(dp38536
sVCompounds used in a research, industrial, or household setting
p38537
(dp38538
sVHormones
p38539
(dp38540
sVCorticosteroids for Systemic Use
p38541
(dp38542
sVPeripheral Nervous System Agents
p38543
(dp38544
sVHyperglycemia-Associated Agents
p38545
(dp38546
sVCorticosteroids for Systemic Use, Plain
p38547
g31759
sVAutonomic Agents
p38548
(dp38549
sVCorticosteroids, Dermatological Preparations
p38550
(dp38551
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p38552
(dp38553
sVPregnadienetriols
p38554
(dp38555
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38556
g29235
sVProtective Agents
p38557
(dp38558
sVFused-Ring Compounds
p38559
g14865
sVCytochrome P-450 CYP3A4 Inducers
p38560
g18949
sVAntineoplastic Agents
p38561
(dp38562
sVAntiemetics
p38563
(dp38564
sVAdrenal Cortex Hormones
p38565
g30031
sVCorticosteroids, Weak (Group I)
p38566
(dp38567
sVAdrenals
p38568
g37374
sVP-glycoprotein/ABCB1 Substrates
p38569
g34976
sVDermatologicals
p38570
g17318
sVCytochrome P-450 Enzyme Inducers
p38571
g28207
sVCytochrome P-450 CYP3A Inducers
p38572
(dp38573
sVPrednisolone
p38574
(dp38575
sVPregnadienes
p38576
(dp38577
sVCytochrome P-450 CYP3A4 Substrates
p38578
(dp38579
sVPregnanes
p38580
(dp38581
sVGastrointestinal Agents
p38582
(dp38583
sVAnti-Acne Preparations for Topical Use
p38584
(dp38585
sVOphthalmologicals
p38586
g35260
sVSteroids
p38587
(dp38588
sVNeuroprotective Agents
p38589
(dp38590
sg390
g15737
sVImmunosuppressive Agents
p38591
(dp38592
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p38593
(dp38594
sVAnti-Inflammatory Agents
p38595
(dp38596
sVCorticosteroid Hormone Receptor Agonists
p38597
(dp38598
sVHormones, Hormone Substitutes, and Hormone Antagonists
p38599
(dp38600
sVCorticosteroids
p38601
(dp38602
sVSensory Organs
p38603
(dp38604
ssg3396
(dp38605
g10266
(dp38606
ssg3399
(dp38607
VAgents Causing Muscle Toxicity
p38608
(dp38609
sVMATE 2 Substrates with a Narrow Therapeutic Index
p38610
g24338
sVAgents that produce neuromuscular block (indirect)
p38611
g37973
sVCytochrome P-450 CYP2D6 Substrates
p38612
(dp38613
sVAntiarrhythmic agents
p38614
(dp38615
sVMATE 1 Substrates with a Narrow Therapeutic Index
p38616
(dp38617
sVOCT2 Inhibitors
p38618
(dp38619
sVHighest Risk QTc-Prolonging Agents
p38620
g35870
sVDrugs that are Mainly Renally Excreted
p38621
(dp38622
sVMATE substrates
p38623
(dp38624
sVAcids, Carbocyclic
p38625
(dp38626
sVCardiac Therapy
p38627
(dp38628
sVAmides
p38629
(dp38630
sVSodium Channel Blockers
p38631
(dp38632
sVOCT2 substrates with narrow therapeutic index
p38633
g29692
sVQTc Prolonging Agents
p38634
(dp38635
sVOCT1 inhibitors
p38636
(dp38637
sVMATE 1 Substrates
p38638
g23504
sVCardiovascular Agents
p38639
g26590
sVBenzene Derivatives
p38640
(dp38641
sVVoltage-Gated Sodium Channel Blockers
p38642
(dp38643
sg9789
(dp38644
sVMembrane Transport Modulators
p38645
(dp38646
sVBenzamides and benzamide derivatives
p38647
g15376
sVNarrow Therapeutic Index Drugs
p38648
(dp38649
sVAntiarrhythmics, Class I
p38650
(dp38651
sVMATE 2 Substrates
p38652
(dp38653
sVAminobenzoates
p38654
(dp38655
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p38656
(dp38657
sVBenzoates
p38658
g30393
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p38659
g36631
sVCholinesterase Inhibitors
p38660
(dp38661
sVpara-Aminobenzoates
p38662
g30549
ssg3402
(dp38663
g12042
(dp38664
ssg3405
(dp38665
g4272
(dp38666
ssg3408
(dp38667
VFatty Acids
p38668
(dp38669
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p38670
(dp38671
sVUGT1A1 Substrates
p38672
g12320
sVOAT1/SLC22A6 inhibitors
p38673
(dp38674
sVAnalgesics
p38675
g26455
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p38676
(dp38677
sVNon COX-2 selective NSAIDS
p38678
(dp38679
sVCentral Nervous System Agents
p38680
(dp38681
sVUGT1A9 Substrates
p38682
g24018
sVAntiinflammatory and Antirheumatic Products
p38683
(dp38684
sVFatty Acids, Volatile
p38685
(dp38686
sVLipids
p38687
g14333
sVEnzyme Inhibitors
p38688
(dp38689
sVThroat Preparations
p38690
(dp38691
sVPeripheral Nervous System Agents
p38692
(dp38693
sVDrugs that are Mainly Renally Excreted
p38694
(dp38695
sVNonsteroidal Anti-inflammatory Compounds
p38696
(dp38697
sVAnalgesics, Non-Narcotic
p38698
(dp38699
sVUGT1A3 substrates
p38700
g31816
sVNephrotoxic agents
p38701
(dp38702
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p38703
(dp38704
sVBiphenyl Compounds
p38705
g24990
sVCytochrome P-450 CYP2C9 Substrates
p38706
g29766
sVMusculo-Skeletal System
p38707
g31539
sVTopical Products for Joint and Muscular Pain
p38708
g13922
sVAgents causing hyperkalemia
p38709
(dp38710
sVBenzene Derivatives
p38711
(dp38712
sVUGT1A1 Inhibitors
p38713
(dp38714
sVOther Nonsteroidal Antiimflammatory Agents
p38715
(dp38716
sVPropionates
p38717
g36493
sVSensory Organs
p38718
(dp38719
sVAgents that produce hypertension
p38720
(dp38721
sVOphthalmologicals
p38722
g35211
sVAcids, Acyclic
p38723
g25477
sVUGT2B7 substrates
p38724
g28640
sVAnti-Inflammatory Agents
p38725
(dp38726
sVCyclooxygenase Inhibitors
p38727
g32792
sVAntirheumatic Agents
p38728
g24238
sVSensory System Agents
p38729
(dp38730
sVAnti-Inflammatory Agents, Non-Steroidal
p38731
(dp38732
ssg3411
(dp38733
g507
g16787
sg849
g20100
ssg3414
(dp38734
g5973
(dp38735
sg3978
(dp38736
sg5652
(dp38737
sg7845
(dp38738
ssg3417
(dp38739
g3531
(dp38740
sg10098
(dp38741
sg9012
(dp38742
sg3240
g37725
sg10227
(dp38743
sg1044
g21557
sg3114
g36859
sg909
g20630
sg6759
(dp38744
ssg3420
(dp38745
g11046
(dp38746
ssg3423
(dp38747
g10113
(dp38748
ssg3426
(dp38749
VAngiotensin-Converting Enzyme Inhibitors
p38750
(dp38751
sVDrugs that are Mainly Renally Excreted
p38752
(dp38753
sVACE Inhibitors and Diuretics
p38754
(dp38755
sVACE Inhibitors and Calcium Channel Blockers
p38756
(dp38757
sVLipid Modifying Agents
p38758
(dp38759
sVIndoles
p38760
(dp38761
sVAntihypertensive Agents
p38762
g20248
sVAgents causing hyperkalemia
p38763
(dp38764
sVHypotensive Agents
p38765
g34107
sVAgents causing angioedema
p38766
(dp38767
sVHeterocyclic Compounds, Fused-Ring
p38768
(dp38769
sVCholinesterase Inhibitors
p38770
(dp38771
sVProtease Inhibitors
p38772
(dp38773
sVEnzyme Inhibitors
p38774
(dp38775
sVCardiovascular Agents
p38776
g26527
sVAgents Acting on the Renin-Angiotensin System
p38777
g25334
ssg3429
(dp38778
g6090
(dp38779
sg10725
(dp38780
sg3576
(dp38781
sg19588
g32506
sg3609
(dp38782
sg9411
(dp38783
ssg3432
(dp38784
g10287
(dp38785
sVCytochrome P-450 CYP2C9 Inhibitors
p38786
g18229
sVCytochrome P-450 Enzyme Inhibitors
p38787
(dp38788
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p38789
g16530
sVCytochrome P-450 CYP2C9 Inducers
p38790
g20049
sVP-glycoprotein/ABCB1 Inducers
p38791
(dp38792
sVCytochrome P-450 CYP3A4 Inducers (strong)
p38793
g23087
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p38794
g23123
sVAmines
p38795
(dp38796
sVCytochrome P-450 CYP2B6 Inducers
p38797
(dp38798
sg2409
g31876
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p38799
(dp38800
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p38801
g25153
sVCytochrome P-450 CYP3A4 Inducers
p38802
g18954
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p38803
(dp38804
sVCytochrome P450 2C19 Inducers
p38805
(dp38806
sVCytochrome P-450 CYP2C8 Inhibitors
p38807
(dp38808
sVPyridines
p38809
(dp38810
sVCytochrome P450 3A Inducers
p38811
(dp38812
sVCytochrome P-450 Enzyme Inducers
p38813
g28170
sVCytochrome P-450 CYP3A Inducers
p38814
(dp38815
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p38816
(dp38817
sVCytochrome P-450 CYP3A Inducers (strong)
p38818
g22460
sg10551
(dp38819
sVHeterocyclic Compounds, Fused-Ring
p38820
(dp38821
sVCytochrome P-450 CYP2C8 Inducers
p38822
(dp38823
sVCytochrome P-450 CYP2C19 Inducers
p38824
g25546
sVP-glycoprotein/ABCB1 Inhibitors
p38825
(dp38826
ssg3435
(dp38827
g10230
(dp38828
sg7719
(dp38829
sg2283
g31143
sg6474
(dp38830
sg10470
(dp38831
sg12042
(dp38832
ssg3438
(dp38833
g10833
(dp38834
sg11061
(dp38835
sg3576
(dp38836
sg7881
(dp38837
sg8985
(dp38838
sg10326
(dp38839
sg1101
g22083
sg5520
(dp38840
sg1527
g25255
sg5871
(dp38841
sg6654
(dp38842
sg11427
(dp38843
sg4953
(dp38844
sg7500
(dp38845
ssg3441
(dp38846
g3699
(dp38847
sg4725
(dp38848
ssg3444
(dp38849
VAmidines
p38850
(dp38851
sVAntiadrenergic Agents, Centrally Acting
p38852
(dp38853
sVCytochrome P-450 CYP3A Substrates
p38854
(dp38855
sVNeurotransmitter Agents
p38856
(dp38857
sVHypotensive Agents
p38858
g34155
sVCentral Alpha-agonists
p38859
(dp38860
sVDrugs that are Mainly Renally Excreted
p38861
(dp38862
sVAntihypertensive Agents
p38863
g20287
sVAcids, Carbocyclic
p38864
(dp38865
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38866
g29239
sVImidazoline Receptor Agonists
p38867
(dp38868
sVAdrenergic Agents
p38869
(dp38870
sVCentral Nervous System Depressants
p38871
(dp38872
sVCardiovascular Agents
p38873
g26599
sVCentral alpha-2 Adrenergic Agonist
p38874
(dp38875
sVAdrenergic Agonists
p38876
(dp38877
sVAgents that produce hypertension
p38878
(dp38879
sVCytochrome P-450 CYP3A4 Substrates
p38880
(dp38881
sVPhenylacetates
p38882
g34422
sVAdrenergic alpha-2 Receptor Agonists
p38883
(dp38884
sVAdrenergic alpha-Agonists
p38885
(dp38886
sVGuanidines
p38887
(dp38888
sVBradycardia-Causing Agents
p38889
(dp38890
sVAgents producing tachycardia
p38891
(dp38892
ssg3447
(dp38893
VAnalgesics and Anesthetics
p38894
(dp38895
sVCytochrome P-450 CYP2D6 Inhibitors
p38896
(dp38897
sVCytochrome P-450 CYP2D6 Substrates
p38898
(dp38899
sVAntiarrhythmic agents
p38900
(dp38901
sVCytochrome P-450 CYP3A Substrates
p38902
(dp38903
sVCentral Nervous System Agents
p38904
(dp38905
sVAnesthetics, Local
p38906
(dp38907
sVAnilides
p38908
(dp38909
sVOtologicals
p38910
(dp38911
sVLocal Anesthesia
p38912
g14965
sVCytochrome P-450 Enzyme Inhibitors
p38913
(dp38914
sVThroat Preparations
p38915
(dp38916
sVPeripheral Nervous System Agents
p38917
(dp38918
sVCytochrome P-450 CYP2C8 Substrates
p38919
(dp38920
sVCytochrome P-450 CYP1A2 Substrates
p38921
(dp38922
sVAmines
p38923
(dp38924
sVAntipruritics and Local Anesthetics
p38925
g31872
sVCardiac Therapy
p38926
(dp38927
sVAmides
p38928
(dp38929
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p38930
g16836
sVAniline Compounds
p38931
g23444
sVVasoprotectives
p38932
(dp38933
sVCytochrome P-450 CYP2C9 Substrates
p38934
g29764
sVCardiovascular Agents
p38935
g26601
sVAnesthetics
p38936
(dp38937
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p38938
g29240
sVAgents that reduce seizure threshold
p38939
(dp38940
sVCytochrome P-450 CYP1A2 Inhibitors
p38941
g15050
sVDermatologicals
p38942
g17190
sVAnesthetics for Topical Use
p38943
(dp38944
sVCytochrome P-450 CYP2A6 Substrates
p38945
g35140
sVCytochrome P-450 CYP2C18 Substrates
p38946
g20947
sVMembrane Transport Modulators
p38947
(dp38948
sVNeuraxial Anesthetics
p38949
g32595
sVCytochrome P-450 CYP3A4 Substrates
p38950
(dp38951
sVSodium Channel Blockers
p38952
(dp38953
sVOphthalmologicals
p38954
g35218
sVAntiarrhythmics, Class I
p38955
(dp38956
sVVoltage-Gated Sodium Channel Blockers
p38957
(dp38958
sVCytochrome P-450 CYP3A5 Substrates
p38959
(dp38960
sVAmide Local Anesthetic
p38961
(dp38962
sVMethemoglobinemia Associated Agents
p38963
g25573
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p38964
(dp38965
sVP-glycoprotein/ABCB1 Inhibitors
p38966
(dp38967
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p38968
(dp38969
sVAntiarrhythmics, Class Ib
p38970
(dp38971
sVSensory System Agents
p38972
(dp38973
sVNervous System
p38974
(dp38975
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p38976
g27733
sVCytochrome P-450 CYP3A7 Substrates
p38977
(dp38978
sVCytochrome P-450 CYP2B6 Substrates
p38979
g33041
ssg3450
(dp38980
g10077
(dp38981
sg2736
g33947
sg8871
(dp38982
ssg3453
(dp38983
g11832
(dp38984
ssg3456
(dp38985
g2832
g34717
ssg3459
(dp38986
g4143
(dp38987
ssg3462
(dp38988
g9471
(dp38989
ssg3465
(dp38990
g3531
(dp38991
sg10098
(dp38992
sg9012
(dp38993
sg3240
g37686
sg10227
(dp38994
sg4056
(dp38995
sg3114
g36843
sg909
g20612
ssg3468
(dp38996
g7713
(dp38997
sg10320
(dp38998
sg171
g13684
sg495
g16690
sg11268
(dp38999
sg3684
(dp39000
sg4419
(dp39001
sg11916
(dp39002
sg11361
(dp39003
sg8760
(dp39004
sg2277
g31099
sg6381
(dp39005
sg10587
(dp39006
sg6570
(dp39007
sg1146
g22475
sg4683
(dp39008
sg753
g19209
sg420
g16003
sg7824
(dp39009
ssg3471
(dp39010
g11793
(dp39011
sg6729
(dp39012
sg1188
g22754
sg8394
(dp39013
sg10815
(dp39014
sg9393
(dp39015
ssg3474
(dp39016
g2142
g30365
ssg3477
(dp39017
g4515
(dp39018
sg2817
g34540
sg834
g19938
sg2007
g28854
ssg3480
(dp39019
g6447
(dp39020
sg11403
(dp39021
sg9216
(dp39022
sg11976
(dp39023
sg4890
(dp39024
sg5094
(dp39025
sg7698
(dp39026
ssg3483
(dp39027
g1947
g28659
sg5793
(dp39028
sg9696
(dp39029
ssg3486
(dp39030
g6090
(dp39031
sg7563
(dp39032
sg4263
(dp39033
ssg3489
(dp39034
g4911
(dp39035
sg8421
(dp39036
sg4653
(dp39037
sg4155
(dp39038
sg3024
g36261
sg4164
(dp39039
sg9198
(dp39040
sg11079
(dp39041
sg1140
g22364
sg183
g13778
sg8298
(dp39042
sg7335
(dp39043
sg12534
(dp39044
sg6045
(dp39045
ssg3492
(dp39046
g426
g16067
sg10737
(dp39047
sg8205
(dp39048
sg2358
g31466
sg828
g19848
sg5067
(dp39049
sg7272
(dp39050
sg5064
(dp39051
sg7284
(dp39052
sg12018
(dp39053
sg9564
(dp39054
sg6939
(dp39055
sg2430
g32095
sg5133
(dp39056
sg5691
(dp39057
sg9420
(dp39058
sg3204
g37431
sg582
g17617
sg4155
(dp39059
sg1938
g28554
sg183
g13780
sg5769
(dp39060
ssg3495
(dp39061
VAmino Acids, Peptides, and Proteins
p39062
(dp39063
sVIntercellular Signaling Peptides and Proteins
p39064
g25425
sVProteins
p39065
(dp39066
sg11571
(dp39067
sg10980
(dp39068
sg990
g21202
sVPeptides
p39069
(dp39070
sVBiological Factors
p39071
g38096
sg8661
(dp39072
ssg3498
(dp39073
g8874
(dp39074
sg11283
(dp39075
sg10266
(dp39076
sg345
g15216
sg3978
(dp39077
sg6468
(dp39078
sg1908
g28287
sg10308
(dp39079
sg2910
g35522
ssg3501
(dp39080
g6279
(dp39081
sg3024
g36271
sg11592
(dp39082
sg7353
(dp39083
sg10548
(dp39084
sg6798
(dp39085
sg12045
(dp39086
sg10314
(dp39087
ssg3504
(dp39088
g11829
(dp39089
sVGenito Urinary System and Sex Hormones
p39090
(dp39091
sVHydroxy Acids
p39092
g18148
sVHydroxylamines
p39093
g26074
sVEnzyme Inhibitors
p39094
(dp39095
sVUrologicals
p39096
(dp39097
sg5649
(dp39098
sVAmines
p39099
(dp39100
ssg3507
(dp39101
g6231
(dp39102
sg11061
(dp39103
sg8922
(dp39104
sg3795
(dp39105
sg9192
(dp39106
sg13070
g21891
sg1332
g23658
sg2991
g35969
sg1863
g27767
sg11208
(dp39107
sg5871
(dp39108
ssg3510
(dp39109
g561
g17366
ssg3513
(dp39110
g3633
(dp39111
sg2346
g31369
sg2196
g30613
sg3858
(dp39112
sg2943
g35758
sg6033
(dp39113
sg4653
(dp39114
sg6045
(dp39115
sg8421
(dp39116
sg7272
(dp39117
sg543
g17087
sg8433
(dp39118
sg888
g20427
sg7335
(dp39119
sg7389
(dp39120
sg12534
(dp39121
sg4911
(dp39122
sg3024
g36280
sg11316
(dp39123
sg1140
g22382
sg9471
(dp39124
sg9198
(dp39125
sg8298
(dp39126
sg3432
g38798
sg10557
(dp39127
sg4155
(dp39128
sg9822
(dp39129
sg4164
(dp39130
sg1371
g24093
sg13091
g21377
sg11523
(dp39131
sg183
g13796
sg5289
(dp39132
sg6075
(dp39133
sg7593
(dp39134
sg6537
(dp39135
sg12123
(dp39136
sg11385
(dp39137
ssg3516
(dp39138
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p39139
(dp39140
sVCytochrome P-450 CYP3A4 Inhibitors
p39141
(dp39142
sVCytochrome P-450 CYP2D6 Substrates
p39143
(dp39144
sVUGT1A1 Substrates
p39145
g12284
sVAnalgesics
p39146
g26431
sVCentral Nervous System Agents
p39147
(dp39148
sVUGT1A9 Substrates
p39149
g24003
sVAnilides
p39150
(dp39151
sVCytochrome P-450 Enzyme Inhibitors
p39152
(dp39153
sVMethemoglobinemia Associated Agents
p39154
g25566
sVDrugs that are Mainly Renally Excreted
p39155
(dp39156
sVCytochrome P-450 CYP1A2 Substrates
p39157
(dp39158
sVAmines
p39159
(dp39160
sVAmides
p39161
(dp39162
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39163
g29246
sVAniline Compounds
p39164
g23425
sVCytochrome P-450 CYP3A4 Inducers
p39165
g18939
sVCytochrome P-450 CYP3A Substrates
p39166
(dp39167
sVUGT1A6 substrate
p39168
g38511
sVP-glycoprotein/ABCB1 Substrates
p39169
g35061
sVAntipyretics
p39170
(dp39171
sVCytochrome P-450 CYP2A6 Substrates
p39172
g35127
sVAcetaminophen and Prodrugs
p39173
(dp39174
sVCytochrome P-450 Enzyme Inducers
p39175
g28195
sVCytochrome P-450 CYP3A Inducers
p39176
(dp39177
sVCytochrome P-450 CYP3A4 Substrates
p39178
(dp39179
sVAnalgesics, Non-Narcotic
p39180
(dp39181
sVCytochrome P-450 CYP3A Inhibitors
p39182
(dp39183
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p39184
(dp39185
sVCytochrome P-450 CYP2E1 Substrates
p39186
(dp39187
sVP-glycoprotein/ABCB1 Inhibitors
p39188
(dp39189
sVSensory System Agents
p39190
(dp39191
sVNervous System
p39192
(dp39193
sVMiscellaneous Analgesics and Antipyretics
p39194
(dp39195
ssg3519
(dp39196
VBSEP/ABCB11 Substrates
p39197
(dp39198
sVCardiovascular Agents
p39199
g26615
sVAntiarrhythmic agents
p39200
(dp39201
sVSulfonylureas
p39202
(dp39203
sVImmunosuppressive Agents
p39204
(dp39205
sVHypoglycemia-Associated Agents
p39206
g17689
sVSulfur Compounds
p39207
(dp39208
sVOral Hypoglycemics
p39209
g35996
sVSulfones
p39210
(dp39211
sVCytochrome P-450 CYP2C9 Substrates
p39212
g29777
sVBlood Glucose Lowering Agents
p39213
(dp39214
sVAlimentary Tract and Metabolism
p39215
g23869
sVDrugs Used in Diabetes
p39216
(dp39217
ssg3522
(dp39218
g10098
(dp39219
sg9144
(dp39220
sg909
g20637
sg10227
(dp39221
sg3114
g36866
sg204
g13956
sg4887
(dp39222
ssg3525
(dp39223
g6279
(dp39224
sg2787
g34404
sg3024
g36286
sg1104
g22102
sg1050
g21670
sg11592
(dp39225
sg1173
g22643
sg2913
g35584
sg7353
(dp39226
sg8742
(dp39227
sg3657
(dp39228
sg5283
(dp39229
sg7821
(dp39230
sg5526
(dp39231
sg3711
(dp39232
sg1578
g25638
sg6798
(dp39233
sg12045
(dp39234
sg7554
(dp39235
sg5973
(dp39236
ssg3528
(dp39237
g4911
(dp39238
sg8421
(dp39239
sg9198
(dp39240
sg7272
(dp39241
sg4164
(dp39242
sg8298
(dp39243
sg183
g13852
sg888
g20441
sg3132
g37006
sg6654
(dp39244
sg7734
(dp39245
sg3543
(dp39246
sg7335
(dp39247
sg4155
(dp39248
sg10350
(dp39249
sg573
g17542
ssg3531
(dp39250
VBeta Blocking Agents, Non-Selective, and Thiazides
p39251
g38991
sVCytochrome P-450 CYP2D6 Substrates
p39252
(dp39253
sVAntiarrhythmic agents
p39254
(dp39255
sVNeurotransmitter Agents
p39256
(dp39257
sVHypotensive Agents
p39258
g34103
sVBradycardia-Causing Agents
p39259
(dp39260
sVAdrenergic Antagonists
p39261
(dp39262
sVPeripheral Nervous System Agents
p39263
(dp39264
sVHighest Risk QTc-Prolonging Agents
p39265
g35874
sVAmines
p39266
(dp39267
sVSympatholytics
p39268
(dp39269
sVQTc Prolonging Agents
p39270
(dp39271
sVEthanolamines
p39272
(dp39273
sVAdrenergic Agents
p39274
(dp39275
sVAgents causing hyperkalemia
p39276
(dp39277
sVCardiovascular Agents
p39278
g26523
sVAdrenergic beta-Antagonists
p39279
g15366
sVBeta Blocking Agents, Non-Selective
p39280
g38740
sVNarrow Therapeutic Index Drugs
p39281
(dp39282
sVAutonomic Agents
p39283
(dp39284
sVBeta Blocking Agents and Thiazides
p39285
(dp39286
sVAmino Alcohols
p39287
g32689
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p39288
g36623
sg6705
(dp39289
sVAlcohols
p39290
(dp39291
ssg3534
(dp39292
g1014
g21332
sg6093
(dp39293
ssg3537
(dp39294
g1587
g25715
ssg3540
(dp39295
g6726
(dp39296
sg7920
(dp39297
sg7548
(dp39298
sg4557
(dp39299
sg8649
(dp39300
sg6714
(dp39301
ssg3543
(dp39302
VSteroids
p39303
(dp39304
sVSex Hormones and Modulators of the Genital System
p39305
g19608
sVEstradiol Congeners
p39306
(dp39307
sVUGT1A1 Substrates
p39308
g12294
sVCytochrome P-450 CYP3A Substrates
p39309
(dp39310
sVNatural and Semisynthetic Estrogens, Plain
p39311
(dp39312
sVProgestogens and Estrogens, Sequential Preparations
p39313
(dp39314
sVBSEP/ABCB11 Inhibitors
p39315
(dp39316
sVBSEP/ABCB11 inducers
p39317
(dp39318
sVHormones
p39319
(dp39320
sVCytochrome P-450 Enzyme Inhibitors
p39321
(dp39322
sVHormonal Contraceptives for Systemic Use
p39323
(dp39324
sVCytochrome P-450 CYP2C8 Substrates
p39325
(dp39326
sVContraceptive Agents, Female
p39327
(dp39328
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p39329
g23112
sg10599
(dp39330
sVUGT1A1 Inducers
p39331
g39246
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39332
g29389
sVNorsteroids
p39333
(dp39334
sVContraceptives, Oral
p39335
(dp39336
sVFused-Ring Compounds
p39337
g14818
sVHyperglycemia-Associated Agents
p39338
(dp39339
sVAdrenal Cortex Hormones
p39340
g30027
sVCytochrome P-450 CYP2C8 Inhibitors
p39341
(dp39342
sVP-glycoprotein/ABCB1 Substrates
p39343
g35007
sVEstrogen Contraceptives
p39344
(dp39345
sg7938
(dp39346
sVNorpregnanes
p39347
g31564
sVCytochrome P-450 CYP2C19 Inhibitors
p39348
(dp39349
sVCytochrome P-450 CYP3A4 Substrates
p39350
(dp39351
sVGonadal Hormones
p39352
g33580
sVContraceptives, Postcoital
p39353
(dp39354
sVGenito Urinary System and Sex Hormones
p39355
(dp39356
sVGonadal Steroid Hormones
p39357
(dp39358
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p39359
(dp39360
sVHormones and Related Agents
p39361
(dp39362
sVAntineoplastic and Immunomodulating Agents
p39363
(dp39364
sVHormones, Hormone Substitutes, and Hormone Antagonists
p39365
(dp39366
sVEstrogens
p39367
(dp39368
sVEndocrine Therapy
p39369
g19573
ssg3546
(dp39370
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p39371
(dp39372
sVCytochrome P-450 CYP3A4 Inhibitors
p39373
(dp39374
sVCytochrome P-450 CYP3A Substrates
p39375
(dp39376
sVPotential QTc-Prolonging Agents
p39377
(dp39378
sVEnzyme Inhibitors
p39379
(dp39380
sVCytochrome P-450 Enzyme Inhibitors
p39381
(dp39382
sVCytochrome P-450 CYP2C8 Substrates
p39383
(dp39384
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p39385
g23119
sVTyrosine Kinase Inhibitors
p39386
g30827
sVQuinazolines
p39387
(dp39388
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39389
g29582
sVQTc Prolonging Agents
p39390
(dp39391
sVAntineoplastic Agents
p39392
(dp39393
sVCytochrome P-450 CYP2C19 Substrates
p39394
(dp39395
sVCytochrome P-450 CYP2C8 Inhibitors
p39396
(dp39397
sVProtein Kinase Inhibitors
p39398
(dp39399
sVCytochrome P-450 CYP3A4 Substrates
p39400
(dp39401
sVHeterocyclic Compounds, Fused-Ring
p39402
(dp39403
sVKinase Inhibitor
p39404
g24593
sVCytochrome P-450 CYP3A Inhibitors
p39405
(dp39406
sVP-glycoprotein/ABCB1 Inhibitors
p39407
(dp39408
sVCytochrome P-450 CYP3A5 Substrates
p39409
(dp39410
sVAntineoplastic and Immunomodulating Agents
p39411
(dp39412
ssg3549
(dp39413
g4170
(dp39414
ssg3552
(dp39415
g10839
(dp39416
ssg3555
(dp39417
g12042
(dp39418
ssg3558
(dp39419
g4650
(dp39420
sg2658
g33381
sg564
g17418
ssg3561
(dp39421
g4911
(dp39422
sg4653
(dp39423
sg10728
(dp39424
sg4155
(dp39425
sg5067
(dp39426
sg5256
(dp39427
sg183
g13844
sg6045
(dp39428
sg1668
g26276
sg12534
(dp39429
ssg3564
(dp39430
g10725
(dp39431
sg4356
(dp39432
sg357
g15320
sg1737
g26927
sg8910
(dp39433
sg5073
(dp39434
sg9267
(dp39435
sg1599
g25727
sg6714
(dp39436
ssg3567
(dp39437
g5073
(dp39438
sg8769
(dp39439
ssg3570
(dp39440
VNMDA Receptor Antagonists
p39441
(dp39442
sVCytochrome P-450 CYP3A4 Inhibitors
p39443
(dp39444
sVCytochrome P-450 CYP2D6 Inhibitors
p39445
(dp39446
sVCytochrome P-450 CYP2D6 Substrates
p39447
(dp39448
sVKetones
p39449
(dp39450
sVCytochrome P-450 CYP3A Substrates
p39451
(dp39452
sVNeurotransmitter Agents
p39453
(dp39454
sVCentral Nervous System Agents
p39455
(dp39456
sVDopamine Agents
p39457
g14259
sVPsychotropic Drugs
p39458
(dp39459
sVDopamine Antagonists
p39460
(dp39461
sVCytochrome P-450 Enzyme Inhibitors
p39462
(dp39463
sVPeripheral Nervous System Agents
p39464
(dp39465
sVHyperglycemia-Associated Agents
p39466
(dp39467
sVButyrophenone Derivatives
p39468
g20176
sVCytochrome P-450 CYP1A2 Substrates
p39469
(dp39470
sVAutonomic Agents
p39471
(dp39472
sVAntipsychotic Agents
p39473
(dp39474
sVButyrophenones
p39475
(dp39476
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39477
g29261
sVCytochrome P-450 CYP2C9 Substrates
p39478
g29790
sVQTc Prolonging Agents
p39479
(dp39480
sVCentral Nervous System Depressants
p39481
(dp39482
sVAntiemetics
p39483
(dp39484
sVGastrointestinal Agents
p39485
(dp39486
sVDrugs that are Mainly Renally Excreted
p39487
(dp39488
sVAgents that reduce seizure threshold
p39489
(dp39490
sVAnti-Dyskinesia Agents
p39491
(dp39492
sVP-glycoprotein/ABCB1 Substrates
p39493
g35037
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p39494
(dp39495
sVPsycholeptics
p39496
g33256
sVAntipsychotic Agents (First Generation [Typical])
p39497
(dp39498
sVCytochrome P-450 CYP3A4 Substrates
p39499
(dp39500
sVModerate Risk QTc-Prolonging Agents
p39501
(dp39502
sVUGT1A9 Substrates
p39503
g24022
sVDopamine D2 Receptor Antagonists
p39504
(dp39505
sVCytochrome P-450 CYP3A5 Substrates
p39506
(dp39507
sVCytochrome P-450 CYP3A Inhibitors
p39508
(dp39509
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p39510
(dp39511
sVP-glycoprotein/ABCB1 Inhibitors
p39512
(dp39513
sVNeurotoxic agents
p39514
(dp39515
sVNervous System
p39516
(dp39517
sVTranquilizing Agents
p39518
(dp39519
sVCytochrome P-450 CYP3A7 Substrates
p39520
(dp39521
ssg3573
(dp39522
VAmino Acids, Peptides, and Proteins
p39523
(dp39524
sVAntibodies
p39525
(dp39526
sVProteins
p39527
(dp39528
sg5217
(dp39529
sVAntibodies, Monoclonal
p39530
(dp39531
sg5811
(dp39532
sVImmunoglobulins
p39533
(dp39534
sVImmunosuppressive Agents
p39535
(dp39536
sg987
g21200
sVDermatologicals
p39537
g17294
sVMisc. Skin and Mucous Membrane Agents
p39538
(dp39539
sg7392
(dp39540
sVAntineoplastic and Immunomodulating Agents
p39541
(dp39542
sVSerum Globulins
p39543
(dp39544
sVBlood Proteins
p39545
(dp39546
sVGlobulins
p39547
g19191
sVImmunoproteins
p39548
(dp39549
ssg3576
(dp39550
VDideoxynucleosides
p39551
(dp39552
sVAntivirals for Systemic Use
p39553
(dp39554
sVNucleic Acid Synthesis Inhibitors
p39555
(dp39556
sVCarbohydrates
p39557
(dp39558
sVDirect Acting Antivirals
p39559
g38044
sVAnti-HIV Agents
p39560
(dp39561
sVEnzyme Inhibitors
p39562
(dp39563
sVReverse Transcriptase Inhibitors
p39564
g28954
sVAnti-Infective Agents
p39565
(dp39566
sVAntiinfectives for Systemic Use
p39567
(dp39568
sVDrugs that are Mainly Renally Excreted
p39569
(dp39570
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p39571
g14463
sVDeoxyribonucleosides
p39572
g33054
sVRibonucleosides
p39573
(dp39574
sVGlycosides
p39575
(dp39576
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p39577
g38159
sVPurine Nucleosides
p39578
g38781
sVNucleic Acids, Nucleotides, and Nucleosides
p39579
(dp39580
sVToxic Actions
p39581
(dp39582
sVAnti-Retroviral Agents
p39583
(dp39584
sVPurines
p39585
(dp39586
sVOAT1/SLC22A6 Substrates
p39587
(dp39588
sVHeterocyclic Compounds, Fused-Ring
p39589
(dp39590
sVNucleosides
p39591
(dp39592
sVAntimetabolites
p39593
(dp39594
sVInosine
p39595
(dp39596
sVNoxae
p39597
(dp39598
sVAntiviral Agents
p39599
g30427
sVNucleoside Reverse Transcriptase Inhibitors
p39600
g38836
sVNeurotoxic agents
p39601
(dp39602
ssg3579
(dp39603
g5526
(dp39604
ssg3582
(dp39605
g8142
(dp39606
ssg3585
(dp39607
g12090
(dp39608
sg3609
(dp39609
sg4068
(dp39610
ssg3588
(dp39611
VAmino Acids, Peptides, and Proteins
p39612
(dp39613
sg750
g19194
sg7308
(dp39614
sg10026
(dp39615
sg3903
(dp39616
sg5718
(dp39617
sg540
g17064
sg5196
(dp39618
sVAntineoplastic and Immunomodulating Agents
p39619
(dp39620
sg3360
g38394
sg3618
(dp39621
sVAntineoplastic Agents
p39622
(dp39623
sg6546
(dp39624
ssg3591
(dp39625
g4746
(dp39626
ssg3594
(dp39627
g4365
(dp39628
sg8808
(dp39629
sg6015
(dp39630
sg4053
(dp39631
ssg3597
(dp39632
VOphthalmologicals
p39633
g35242
sVCytochrome P-450 CYP3A Substrates
p39634
(dp39635
sVOphthalmics
p39636
(dp39637
sVDiuretics
p39638
(dp39639
sVAmides
p39640
(dp39641
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39642
g29264
sVSensory Organs
p39643
(dp39644
sVEnzyme Inhibitors
p39645
(dp39646
sVSulfones
p39647
(dp39648
sVCytochrome P-450 CYP3A4 Substrates
p39649
(dp39650
sVCarbonic Anhydrase Inhibitors
p39651
(dp39652
sVSulfur Compounds
p39653
(dp39654
sVAntiglaucoma Preparations and Miotics
p39655
g36565
ssg3600
(dp39656
g5226
(dp39657
ssg3603
(dp39658
g9225
(dp39659
sg10209
(dp39660
sg2832
g34745
ssg3606
(dp39661
g2583
g33089
ssg3609
(dp39662
VNucleic Acid Synthesis Inhibitors
p39663
(dp39664
sVImmunosuppressive Agents
p39665
(dp39666
sVImmunologic Factors
p39667
(dp39668
sVEnzyme Inhibitors
p39669
(dp39670
sVMyelosuppressive Agents
p39671
(dp39672
sVNucleoside Metabolic Inhibitor
p39673
(dp39674
sVRibonucleotides
p39675
(dp39676
sVAntimetabolites, Antineoplastic
p39677
g23458
sVCarbohydrates
p39678
(dp39679
sVGlycosides
p39680
(dp39681
sg5910
(dp39682
sVPurine Nucleotides
p39683
(dp39684
sVRibonucleosides
p39685
(dp39686
sVNucleic Acids, Nucleotides, and Nucleosides
p39687
(dp39688
sVCardiotoxic antineoplastic agents
p39689
(dp39690
sVToxic Actions
p39691
(dp39692
sVMyeloablative Agonists
p39693
(dp39694
sVPurine Analogues
p39695
(dp39696
sVAdenosine
p39697
g32470
sVNucleotides
p39698
(dp39699
sVPurines
p39700
(dp39701
sVPurine Nucleosides
p39702
g38782
sVAdenine Nucleotides
p39703
(dp39704
sVHeterocyclic Compounds, Fused-Ring
p39705
(dp39706
sVNucleosides
p39707
(dp39708
sVAntimetabolites
p39709
(dp39710
sVArabinonucleosides
p39711
g39609
sVNoxae
p39712
(dp39713
sVAntineoplastic Agents
p39714
(dp39715
sVAntineoplastic and Immunomodulating Agents
p39716
(dp39717
sg2322
g31321
ssg3612
(dp39718
g6180
(dp39719
sg2346
g31412
sg9132
(dp39720
sg9135
(dp39721
sg6192
(dp39722
sg9249
(dp39723
sg3117
g36942
sg6882
(dp39724
sg9300
(dp39725
sg10653
(dp39726
sg6216
(dp39727
sg2079
g29875
sg5454
(dp39728
sg1650
g26133
sg9411
(dp39729
sg858
g20164
sg11151
(dp39730
sg10374
(dp39731
sg6171
(dp39732
sg12015
(dp39733
sg147
g13505
sg10698
(dp39734
sg10701
(dp39735
sg2088
g29953
sg3543
g39364
sg1686
g26410
sg6807
(dp39736
sg3609
g39717
sg918
g20773
sg9225
(dp39737
sg8751
(dp39738
sg9231
(dp39739
sg10752
(dp39740
sg2466
g32364
sg9834
(dp39741
sg9267
(dp39742
sg2493
g32612
sg9273
(dp39743
sg2763
g34254
sg11550
(dp39744
sg10794
(dp39745
sg13091
g21440
sg11562
(dp39746
sg5646
(dp39747
sg6333
(dp39748
sg4002
(dp39749
sg3261
g37840
sg1371
g24136
sg4014
(dp39750
sg1791
g27272
sg48
g12659
sg10323
(dp39751
sg10839
(dp39752
sg10077
(dp39753
sg9618
(dp39754
sg11601
(dp39755
sg4905
(dp39756
sg7848
(dp39757
sg3321
g38235
sg9375
(dp39758
sg10104
(dp39759
sg87
g12950
sg4521
(dp39760
sg8625
(dp39761
sg4068
(dp39762
sg8076
(dp39763
sg10899
(dp39764
sg11313
(dp39765
sg1785
g27201
sg4917
(dp39766
sg9414
(dp39767
sg9444
(dp39768
sg3258
g37822
sg11718
(dp39769
sg6489
(dp39770
sg474
g16584
sg1920
g28490
sg1149
g22507
sg10179
(dp39771
sg8760
(dp39772
sg7980
(dp39773
sg8013
(dp39774
sg4185
(dp39775
sg11775
(dp39776
sg8190
(dp39777
sg5793
(dp39778
sg4200
(dp39779
sg2754
g34090
sg11799
(dp39780
sg447
g16298
sg5817
(dp39781
sg2007
g28908
sg8772
(dp39782
sg456
g16397
sg9528
(dp39783
sg9348
(dp39784
sg11646
(dp39785
sg1917
g28458
sg477
g16621
sg8055
(dp39786
sg2034
g29049
sg2043
g29078
sg1674
g26364
sg3015
g36115
sg5880
(dp39787
sg78
g12883
sg2817
g34576
sg9591
(dp39788
sg840
g20020
sg6630
(dp39789
sg9612
(dp39790
sg6009
(dp39791
sg2829
g34668
sg10362
(dp39792
sg8106
(dp39793
sg3546
g39412
sg11133
(dp39794
sg11136
(dp39795
sg2115
g30201
sg1737
g26922
sg5127
(dp39796
sg5073
(dp39797
sg3126
g36960
sg9180
(dp39798
sg10389
(dp39799
sg11349
(dp39800
sg16906
(dp39801
sg3573
g39542
sg1365
g24054
sg8880
(dp39802
sg8472
(dp39803
sg3588
g39620
sg10410
(dp39804
sg28215
g35391
sg11913
(dp39805
sg357
g15308
sg8910
(dp39806
sg3930
(dp39807
sg10431
(dp39808
sg621
g17986
sg3633
(dp39809
sg3801
(dp39810
sg2196
g30654
sg528
g16952
sg2094
g29990
sg9705
(dp39811
sg2211
g30746
sg654
g18273
sg669
g18452
sg2451
g32223
sg6765
(dp39812
sg9525
(dp39813
sg11274
(dp39814
sg1473
g24985
sg9909
(dp39815
sg11286
(dp39816
sg5652
(dp39817
sg7512
(dp39818
sg3027
g36395
sg1140
g22440
sg8769
(dp39819
sg3963
(dp39820
sg4551
(dp39821
sg1275
g23313
sg4863
(dp39822
sg3264
g37875
sg10563
(dp39823
sg1098
g22025
sg12090
(dp39824
sg771
g19309
sg1563
g25518
sg7416
(dp39825
sg8949
(dp39826
sg9084
(dp39827
sg4356
(dp39828
sg7608
(dp39829
sg9105
(dp39830
ssg3615
(dp39831
g465
g16499
sg10113
(dp39832
sg6261
(dp39833
sg1605
g25780
sg11319
(dp39834
sg5487
(dp39835
sg3363
g38435
sg2067
g29673
sg612
g17915
sg11445
(dp39836
ssg3618
(dp39837
g9897
(dp39838
sg5463
(dp39839
sg9132
(dp39840
sg5622
(dp39841
sg2754
g34092
sg447
g16300
sg9705
(dp39842
sg8772
(dp39843
sg9300
(dp39844
sg6213
(dp39845
sg6216
(dp39846
sg7854
(dp39847
sg11646
(dp39848
sg669
g18454
sg6903
(dp39849
sg4200
(dp39850
sg11832
(dp39851
sg3147
g37158
sg12015
(dp39852
sg11286
(dp39853
sg1482
g25024
sg9741
(dp39854
sg8076
(dp39855
sg6612
(dp39856
sg4977
(dp39857
sg6804
(dp39858
sg7512
(dp39859
sg6630
(dp39860
sg9612
(dp39861
sg4713
(dp39862
sg10431
(dp39863
sg1737
g26925
sg3801
(dp39864
sg9627
(dp39865
sg10002
(dp39866
sg3882
(dp39867
sg4551
(dp39868
sg3573
g39546
sg11349
(dp39869
sg11550
(dp39870
sg3588
g39621
sg7980
(dp39871
sg1563
g25520
sg4905
(dp39872
sg8910
(dp39873
sg4185
(dp39874
sg7059
(dp39875
sg9852
(dp39876
sg7809
(dp39877
sg10104
(dp39878
sg5400
(dp39879
sg10653
(dp39880
ssg3621
(dp39881
g19588
g32488
ssg3624
(dp39882
VDrugs that are Mainly Renally Excreted
p39883
(dp39884
sVCardiovascular Agents
p39885
g26641
sVOphthalmologicals
p39886
g35273
sVAntihypertensive Agents
p39887
g20327
sVCytochrome P-450 CYP3A Substrates
p39888
(dp39889
sVDiuretics
p39890
(dp39891
sVAmides
p39892
(dp39893
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39894
g29601
sVSensory Organs
p39895
(dp39896
sVSulfones
p39897
(dp39898
sVEnzyme Inhibitors
p39899
(dp39900
sVCytochrome P-450 CYP2C9 Substrates
p39901
g29829
sVCytochrome P-450 CYP3A4 Substrates
p39902
(dp39903
sVCarbonic Anhydrase Inhibitors
p39904
(dp39905
sVSulfur Compounds
p39906
(dp39907
sVAntiglaucoma Preparations and Miotics
p39908
g36568
ssg3627
(dp39909
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p39910
(dp39911
sVAmino Acids, Cyclic
p39912
g27280
sVUGT1A1 Substrates
p39913
g12316
sVCytochrome P-450 CYP3A Substrates
p39914
(dp39915
sVOATP1B1/SLCO1B1 Inhibitors
p39916
(dp39917
sVHormones
p39918
(dp39919
sVCytochrome P-450 Enzyme Inhibitors
p39920
(dp39921
sVThyroid Products
p39922
g28973
sVP-glycoprotein/ABCB1 Inducers
p39923
(dp39924
sVAmino Acids
p39925
(dp39926
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p39927
(dp39928
sVOATP1B3 inhibitors
p39929
(dp39930
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p39931
(dp39932
sVAmino Acids, Aromatic
p39933
(dp39934
sVUGT1A1 substrates with narrow therapeutic index
p39935
(dp39936
sVCytochrome P-450 CYP2C8 Inhibitors
p39937
(dp39938
sVThyroxine-binding globulin substrates
p39939
(dp39940
sVAgents used to treat hypothyroidism
p39941
g23675
sVCytochrome P-450 CYP3A4 Substrates
p39942
(dp39943
sVNarrow Therapeutic Index Drugs
p39944
(dp39945
sVAmino Acids, Peptides, and Proteins
p39946
(dp39947
sVHormones, Hormone Substitutes, and Hormone Antagonists
p39948
(dp39949
ssg3630
(dp39950
VAgents Causing Muscle Toxicity
p39951
(dp39952
sVOphthalmological and Otological Preparations
p39953
(dp39954
sVImmunosuppressive Agents
p39955
(dp39956
sVCytochrome P-450 CYP3A Substrates
p39957
(dp39958
sVSteroids, Fluorinated
p39959
(dp39960
sVVasoprotectives
p39961
(dp39962
sg9903
(dp39963
sVHormones
p39964
(dp39965
sVCorticosteroids for Systemic Use
p39966
(dp39967
sVDrugs for Obstructive Airway Diseases
p39968
(dp39969
sg6585
(dp39970
sVHyperglycemia-Associated Agents
p39971
(dp39972
sVCorticosteroids for Systemic Use, Plain
p39973
g31764
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p39974
(dp39975
sVCorticosteroids Acting Locally
p39976
(dp39977
sVOtologicals
p39978
(dp39979
sVRespiratory System Agents
p39980
(dp39981
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p39982
(dp39983
sVPregnadienetriols
p39984
(dp39985
sVGlucocorticoids
p39986
g21934
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p39987
g16827
sg14838
(dp39988
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p39989
g29231
sg5895
(dp39990
sVCytochrome P-450 CYP3A4 Inducers
p39991
g18913
sg2388
g31669
sVCytochrome P-450 CYP3A5 Inducers
p39992
(dp39993
sVAdrenal Cortex Hormones
p39994
g30026
sVAdrenals
p39995
g37368
sVP-glycoprotein/ABCB1 Substrates
p39996
g34966
sVDermatologicals
p39997
g17236
sVCytochrome P-450 Enzyme Inducers
p39998
g28156
sVCytochrome P-450 CYP3A Inducers
p39999
(dp40000
sVFused-Ring Compounds
p40001
g14839
sVAnti-Asthmatic Agents
p40002
g36519
sVPregnadienes
p40003
(dp40004
sVCytochrome P-450 CYP3A4 Substrates
p40005
(dp40006
sVAlimentary Tract and Metabolism
p40007
g23831
sVNasal Preparations
p40008
(dp40009
sVPregnanes
p40010
(dp40011
sVOphthalmologicals
p40012
g35204
sVSteroids
p40013
(dp40014
sVCorticosteroids, Potent (Group III)
p40015
(dp40016
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p40017
(dp40018
sVAnti-Inflammatory Agents
p40019
(dp40020
sVCorticosteroid Hormone Receptor Agonists
p40021
(dp40022
sg12132
(dp40023
sVCorticosteroids, Dermatological Preparations
p40024
(dp40025
sVHormones, Hormone Substitutes, and Hormone Antagonists
p40026
(dp40027
sVCorticosteroids
p40028
(dp40029
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p40030
(dp40031
sVIntestinal Antiinflammatory Agents
p40032
(dp40033
sVSensory Organs
p40034
(dp40035
ssg3633
(dp40036
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p40037
(dp40038
sVPyridazines
p40039
g32864
sVCytochrome P-450 CYP3A4 Inhibitors
p40040
(dp40041
sg8718
(dp40042
sg9555
(dp40043
sVCytochrome P-450 CYP2B6 Inducers
p40044
g39111
sVCytochrome P-450 CYP3A Substrates
p40045
(dp40046
sVCytochrome P-450 CYP3A Inhibitors
p40047
(dp40048
sVImmunosuppressive Agents
p40049
(dp40050
sVP-glycoprotein/ABCB1 Substrates
p40051
g35047
sVBCRP/ABCG2 Inhibitors
p40052
g12501
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p40053
g29266
sVAntineoplastic and Immunomodulating Agents
p40054
g39809
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p40055
(dp40056
sVEnzyme Inhibitors
p40057
(dp40058
sVCytochrome P-450 Enzyme Inducers
p40059
g28219
sVCytochrome P-450 Enzyme Inhibitors
p40060
(dp40061
sVCytochrome P-450 CYP3A4 Substrates
p40062
(dp40063
sVAntineoplastic Agents
p40064
(dp40065
sg2229
g30812
ssg3636
(dp40066
g1452
g24721
ssg3639
(dp40067
VToxic Actions
p40068
(dp40069
sVAmines
p40070
(dp40071
sVBenzene Derivatives
p40072
(dp40073
sVScabicides and Pediculicides
p40074
(dp40075
sVCompounds used in a research, industrial, or household setting
p40076
(dp40077
sVAniline Compounds
p40078
g23415
sVPesticides
p40079
(dp40080
sVAgrochemicals
p40081
(dp40082
sVToluene
p40083
(dp40084
ssg3642
(dp40085
g9132
(dp40086
sg11550
(dp40087
ssg3645
(dp40088
g9471
(dp40089
sg2142
g30333
sg7527
(dp40090
sg5193
(dp40091
ssg3648
(dp40092
g1776
g27100
ssg3651
(dp40093
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p40094
(dp40095
sVCytochrome P-450 CYP3A4 Inhibitors
p40096
(dp40097
sVCytochrome P-450 CYP2D6 Substrates
p40098
(dp40099
sVUGT1A1 Substrates
p40100
g12319
sVAnalgesics
p40101
g26479
sVCentral Nervous System Agents
p40102
(dp40103
sVUGT1A9 Substrates
p40104
g24017
sVAnilides
p40105
(dp40106
sVCytochrome P-450 Enzyme Inhibitors
p40107
(dp40108
sg1569
g25578
sVDrugs that are Mainly Renally Excreted
p40109
(dp40110
sVCytochrome P-450 CYP1A2 Substrates
p40111
(dp40112
sVAmines
p40113
(dp40114
sVAmides
p40115
(dp40116
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p40117
g29268
sVAniline Compounds
p40118
g23436
sVCytochrome P-450 CYP3A4 Inducers
p40119
g18952
sVCytochrome P-450 CYP3A Substrates
p40120
(dp40121
sVUGT1A6 substrate
p40122
g38517
sVP-glycoprotein/ABCB1 Substrates
p40123
g35029
sVAntipyretics
p40124
(dp40125
sVCytochrome P-450 CYP2A6 Substrates
p40126
g35133
sg8289
(dp40127
sVCytochrome P-450 Enzyme Inducers
p40128
g28211
sVCytochrome P-450 CYP3A Inducers
p40129
(dp40130
sVCytochrome P-450 CYP3A4 Substrates
p40131
(dp40132
sVAnalgesics, Non-Narcotic
p40133
(dp40134
sVCytochrome P-450 CYP3A Inhibitors
p40135
(dp40136
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p40137
(dp40138
sg9837
(dp40139
sVP-glycoprotein/ABCB1 Inhibitors
p40140
(dp40141
sVSensory System Agents
p40142
(dp40143
sVNervous System
p40144
(dp40145
sg4125
(dp40146
ssg3654
(dp40147
g6180
(dp40148
sg10323
(dp40149
sg4515
(dp40150
sg11274
(dp40151
sg2007
g28860
sg8106
(dp40152
sg2817
g34544
ssg3657
(dp40153
VCytochrome P-450 CYP3A4 Inhibitors
p40154
(dp40155
sVStomatological Preparations
p40156
(dp40157
sVAntifungal Agents
p40158
(dp40159
sg3120
g36947
sVAnti-Infective Agents, Local
p40160
(dp40161
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p40162
(dp40163
sVCytochrome P-450 Enzyme Inhibitors
p40164
(dp40165
sVAnti-Infective Agents
p40166
(dp40167
sVGynecological Antiinfectives and Antiseptics
p40168
(dp40169
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p40170
(dp40171
sVLactones
p40172
(dp40173
sVAntifungals for Topical Use
p40174
g39228
sVAnti-Bacterial Agents
p40175
g38320
sVAntifungals for Dermatological Use
p40176
g30073
sg10524
(dp40177
sVDermatologicals
p40178
g17205
sVSensory Organs
p40179
(dp40180
sVPolyketides
p40181
(dp40182
sVAlimentary Tract and Metabolism
p40183
g23784
sVOphthalmologicals
p40184
g35181
sVGenito Urinary System and Sex Hormones
p40185
(dp40186
sVIntestinal Antiinfectives
p40187
(dp40188
sVCytochrome P-450 CYP3A Inhibitors
p40189
(dp40190
sVAntiinfectives and Antiseptics for Local Oral Treatment
p40191
(dp40192
ssg3660
(dp40193
g4143
(dp40194
ssg3663
(dp40195
g2199
g30677
ssg3666
(dp40196
g1563
g25522
sg4185
(dp40197
ssg3669
(dp40198
g8325
(dp40199
ssg3672
(dp40200
g2826
g34615
sg3249
g37782
sg12057
(dp40201
sg5556
(dp40202
sg10272
(dp40203
sg8658
(dp40204
ssg3675
(dp40205
g696
g18715
sg12066
(dp40206
sg6303
(dp40207
sg2664
g33433
sg1194
g22812
ssg3678
(dp40208
g8487
(dp40209
sg3156
g37195
ssg3681
(dp40210
g5226
(dp40211
ssg3684
(dp40212
VNitrogen Compounds
p40213
g39000
sVAnticholinergic Agents
p40214
g24478
sVNeurotransmitter Agents
p40215
(dp40216
sVTropanes
p40217
(dp40218
sVMuscarinic Antagonists
p40219
(dp40220
sVAutonomic Agents
p40221
(dp40222
sVParasympatholytics
p40223
g35943
sVPeripheral Nervous System Agents
p40224
(dp40225
sg11847
(dp40226
sVAza Compounds
p40227
(dp40228
sVBelladonna and Derivatives, Plain
p40229
(dp40230
sg4509
(dp40231
sVAzabicyclo Compounds
p40232
(dp40233
sVOnium Compounds
p40234
g22252
sVDrugs for Functional Gastrointestinal Disorders
p40235
(dp40236
sVAlimentary Tract and Metabolism
p40237
g23914
sVAmines
p40238
(dp40239
sVAntimuscarinics Antispasmodics
p40240
g31221
sVCholinergic Agents
p40241
g28720
sVAgents producing tachycardia
p40242
(dp40243
sVAlkaloids
p40244
g19408
sVQuaternary Ammonium Compounds
p40245
(dp40246
sVAmmonium Compounds
p40247
g30554
ssg3687
(dp40248
g5289
(dp40249
ssg3690
(dp40250
g129
g13199
ssg3693
(dp40251
g477
g16599
sg10698
(dp40252
sg5880
(dp40253
ssg3696
(dp40254
VDihydropyridine Derivatives
p40255
(dp40256
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p40257
(dp40258
sg4020
(dp40259
sVCytochrome P-450 CYP2D6 Inhibitors
p40260
(dp40261
sVAntiarrhythmic agents
p40262
(dp40263
sVCytochrome P-450 CYP3A Substrates
p40264
(dp40265
sVAgents causing hyperkalemia
p40266
(dp40267
sVHypotensive Agents
p40268
g34199
sVCalcium Channel Blockers
p40269
(dp40270
sVPotential QTc-Prolonging Agents
p40271
(dp40272
sVCytochrome P-450 CYP2B6 Substrates
p40273
g33013
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p40274
(dp40275
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p40276
g12667
sVCytochrome P-450 Enzyme Inhibitors
p40277
(dp40278
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p40279
g18399
sVAntihypertensive Agents
p40280
g20313
sVACE Inhibitors and Calcium Channel Blockers
p40281
(dp40282
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p40283
g29275
sVQTc Prolonging Agents
p40284
(dp40285
sVCardiovascular Agents
p40286
g26660
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p40287
(dp40288
sVCytochrome P-450 CYP2C8 Inhibitors
p40289
(dp40290
sVCytochrome P-450 CYP2B6 Inhibitors
p40291
(dp40292
sVP-glycoprotein/ABCB1 Substrates
p40293
g35064
sVPyridines
p40294
(dp40295
sVVasodilating Agents
p40296
g23697
sVMembrane Transport Modulators
p40297
(dp40298
sVCytochrome P-450 CYP3A4 Substrates
p40299
(dp40300
sVCalcium-Regulating Hormones and Agents
p40301
(dp40302
sVCalcium Channel Blockers (Dihydropyridine)
p40303
g20123
sVAntianginal Agents
p40304
(dp40305
sg2475
g32370
sVCytochrome P-450 CYP3A5 Substrates
p40306
(dp40307
sVBradycardia-Causing Agents
p40308
(dp40309
sVP-glycoprotein/ABCB1 Inhibitors
p40310
(dp40311
sVDihydropyridines
p40312
(dp40313
ssg3699
(dp40314
VMicronutrients
p40315
(dp40316
sVElements
p40317
(dp40318
sVPhysiological Phenomena
p40319
g21712
sVIron Preparations
p40320
(dp40321
sVSupplements
p40322
(dp40323
sVFood
p40324
(dp40325
sVIron Compounds
p40326
g36407
sVTransition Elements
p40327
g38847
sVMetals
p40328
(dp40329
sVMinerals
p40330
(dp40331
sg11442
(dp40332
sVBlood and Blood Forming Organs
p40333
(dp40334
sVDiet, Food, and Nutrition
p40335
g22896
sg7215
(dp40336
sVFood and Beverages
p40337
(dp40338
sVAntianemic Preparations
p40339
(dp40340
sg7833
(dp40341
sVOrganometallic Compounds
p40342
(dp40343
sVAlimentary Tract and Metabolism
p40344
g23850
sVGrowth Substances
p40345
(dp40346
ssg3702
(dp40347
g4911
(dp40348
ssg3705
(dp40349
g8193
(dp40350
sg1980
g28802
sg7221
(dp40351
sg528
g16930
sg5556
(dp40352
sg11040
(dp40353
sg10272
(dp40354
sg735
g19136
sg2862
g35154
sg6213
(dp40355
sg2826
g34611
sg2286
g31174
sg11100
(dp40356
sg10953
(dp40357
sg8658
(dp40358
sg9366
(dp40359
sg3216
g37523
sg12057
(dp40360
ssg3708
(dp40361
VBSEP/ABCB11 Substrates
p40362
(dp40363
sVCytochrome P-450 CYP2D6 Substrates
p40364
(dp40365
sVAntiarrhythmic agents
p40366
(dp40367
sVAgents causing hyperkalemia
p40368
(dp40369
sVHypotensive Agents
p40370
g34105
sVBeta blocking agents and calcium channel blockers
p40371
(dp40372
sVAdrenergic Antagonists
p40373
(dp40374
sVPeripheral Nervous System Agents
p40375
(dp40376
sVSympatholytics
p40377
(dp40378
sVAmines
p40379
(dp40380
sVAdrenergic beta-1 Receptor Antagonists
p40381
(dp40382
sVAntihypertensive Agents
p40383
g20247
sVBeta Blocking Agents, Selective
p40384
(dp40385
sVAdrenergic Agents
p40386
(dp40387
sVCardiovascular Agents
p40388
g26569
sVAdrenergic beta-Antagonists
p40389
g15352
sVAutonomic Agents
p40390
(dp40391
sVBeta Blocking Agents and Thiazides
p40392
(dp40393
sVAmino Alcohols
p40394
g32666
sVBradycardia-Causing Agents
p40395
(dp40396
sVQTc shortening agents
p40397
(dp40398
sVBeta-Blockers (Beta1 Selective)
p40399
(dp40400
sVAlcohols
p40401
(dp40402
sVBeta Blocking Agents, Selective, and Thiazides
p40403
(dp40404
ssg3711
(dp40405
g11784
(dp40406
sVHydroxy Acids
p40407
g18154
sVSalicylic Acid and Derivatives
p40408
g36814
sVOAT1/SLC22A6 inhibitors
p40409
(dp40410
sVAnalgesics
p40411
g26493
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p40412
(dp40413
sVAntifungal Agents
p40414
(dp40415
sVNon COX-2 selective NSAIDS
p40416
(dp40417
sVCentral Nervous System Agents
p40418
(dp40419
sVSclerosing Solutions
p40420
(dp40421
sVEnzyme Inhibitors
p40422
(dp40423
sVAnti-Infective Agents
p40424
(dp40425
sVPeripheral Nervous System Agents
p40426
(dp40427
sVAnti-Inflammatory Agents
p40428
(dp40429
sVSalicylates
p40430
g27626
sVAnalgesics, Non-Narcotic
p40431
(dp40432
sVNephrotoxic agents
p40433
(dp40434
sVAcids, Carbocyclic
p40435
(dp40436
sVAntifungals for Topical Use
p40437
g39232
sg3711
(dp40438
sVCytochrome P-450 CYP2C9 Substrates
p40439
g29811
sVAgents causing hyperkalemia
p40440
(dp40441
sVPhenols
p40442
(dp40443
sVBenzene Derivatives
p40444
(dp40445
sVAntifungals for Dermatological Use
p40446
g30077
sVDermatologicals
p40447
g17314
sg1578
g25640
sVSensory Organs
p40448
(dp40449
sVAgents that produce hypertension
p40450
(dp40451
sVOphthalmologicals
p40452
g35256
sVBenzoates
p40453
g30389
sVOAT3/SLC22A8 Inhibitors
p40454
(dp40455
sVHydroxybenzoates
p40456
(dp40457
sVCyclooxygenase Inhibitors
p40458
g32789
sVKeratolytic Agents
p40459
(dp40460
sVAnti-Inflammatory Agents, Non-Steroidal
p40461
(dp40462
sVNervous System
p40463
(dp40464
sVSensory System Agents
p40465
(dp40466
ssg3714
(dp40467
g8493
(dp40468
ssg3717
(dp40469
g858
g20170
sg11151
(dp40470
sg354
g15289
sg3141
g37071
sg28215
g35359
sg2046
g29123
sg9528
(dp40471
sg4782
(dp40472
sg7878
(dp40473
sg6489
(dp40474
sg5082
(dp40475
sg5208
(dp40476
ssg3720
(dp40477
g2754
g34059
ssg3723
(dp40478
g1767
g27035
sg9144
(dp40479
sg4341
(dp40480
sg978
g21164
sg7641
(dp40481
sg11046
(dp40482
sg879
g20352
sg4656
(dp40483
sg4062
(dp40484
sg5472
(dp40485
sg9687
(dp40486
sg20252
(dp40487
sg6267
(dp40488
sg4887
(dp40489
sg5457
(dp40490
sg11862
(dp40491
sg5574
(dp40492
sg7314
(dp40493
sg10164
(dp40494
sg5238
(dp40495
sg5934
(dp40496
sg9486
(dp40497
sg10383
(dp40498
sg10200
(dp40499
sg966
g21048
sg2886
g35303
sg1941
g28589
sg3231
g37656
sg204
g13982
ssg3726
(dp40500
g9741
(dp40501
ssg3729
(dp40502
g714
g19021
ssg3732
(dp40503
VDrugs that are Mainly Renally Excreted
p40504
(dp40505
sVCentral Nervous System Depressants
p40506
(dp40507
sVHistamine H1 Antagonists
p40508
(dp40509
sVHistamine H1 Antagonists, Non-Sedating
p40510
g38522
sVAnti-Allergic Agents
p40511
(dp40512
sVP-glycoprotein/ABCB1 Substrates
p40513
g35073
sVHistamine Agents
p40514
(dp40515
sVPotential QTc-Prolonging Agents
p40516
(dp40517
sVPiperazine Derivatives
p40518
(dp40519
sVP-glycoprotein/ABCB1 Inhibitors
p40520
(dp40521
sVHistamine Antagonists
p40522
(dp40523
sVAntihistamines for Systemic Use
p40524
g12967
sVQTc Prolonging Agents
p40525
(dp40526
sVPiperazines
p40527
(dp40528
ssg3735
(dp40529
g7626
(dp40530
ssg3738
(dp40531
g3105
g36787
sg12114
(dp40532
sg3858
(dp40533
sg2943
g35767
sg8928
(dp40534
sg4650
(dp40535
sg3426
g38759
sg10797
(dp40536
sg7458
(dp40537
sg8022
(dp40538
sg6033
(dp40539
sg6699
(dp40540
sg4077
(dp40541
sg4491
(dp40542
sg11820
(dp40543
sg8217
(dp40544
sg4926
(dp40545
sg11625
(dp40546
sg3231
g37661
sg4977
(dp40547
sg8226
(dp40548
sg9081
(dp40549
sg6537
(dp40550
sg7809
(dp40551
sg213
g14036
ssg3741
(dp40552
g6999
(dp40553
sg8217
(dp40554
sg9726
(dp40555
sg501
g16732
sg6102
(dp40556
sg3849
(dp40557
sg7155
(dp40558
ssg3744
(dp40559
g5256
(dp40560
sg10728
(dp40561
sg7416
(dp40562
ssg3747
(dp40563
g9870
(dp40564
sg4014
(dp40565
sg1629
g25995
sg6552
(dp40566
sg10839
(dp40567
sg657
g18338
sg3312
g38141
sg11832
(dp40568
sg7530
(dp40569
sg10320
(dp40570
sg6246
(dp40571
sg9561
(dp40572
sg2985
g35926
sg8649
(dp40573
sg9006
(dp40574
sg9588
(dp40575
sg8826
(dp40576
sg6714
(dp40577
sg8832
(dp40578
sg6726
(dp40579
sg1875
g27895
sg12060
(dp40580
sg7920
(dp40581
sg9780
(dp40582
sg7548
(dp40583
sg4557
(dp40584
sg10764
(dp40585
sg5025
(dp40586
sg10554
(dp40587
sg9810
(dp40588
sg6843
(dp40589
sg771
g19294
sg13091
g21401
sg10587
(dp40590
sg6765
(dp40591
sg4770
(dp40592
sg11382
(dp40593
sg420
g16014
ssg3750
(dp40594
g11820
(dp40595
sg2658
g33376
sg195
g13913
sg4926
(dp40596
sg9996
(dp40597
sg11415
(dp40598
sg138
g13297
sg4650
(dp40599
sg4902
(dp40600
sg10797
(dp40601
ssg3753
(dp40602
VAntiparasitic Products, Insecticides and Repellents
p40603
g30576
sVPyrimidines
p40604
(dp40605
sVAntimalarials
p40606
g14096
sg7287
(dp40607
sVCytochrome P-450 CYP2C8 Inhibitors
p40608
(dp40609
sVMATE inhibitors
p40610
(dp40611
sVAntiparasitic Agents
p40612
(dp40613
sVFolic Acid Antagonists
p40614
(dp40615
sVMATE 2 Inhibitors
p40616
(dp40617
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p40618
g24192
sVEnzyme Inhibitors
p40619
(dp40620
sVAntiprotozoals
p40621
(dp40622
sVCytochrome P-450 Enzyme Inhibitors
p40623
(dp40624
sVAnti-Infective Agents
p40625
(dp40626
sVMATE 1 Inhibitors
p40627
(dp40628
ssg3756
(dp40629
g858
g20160
sg11151
(dp40630
sg8373
(dp40631
sg4857
(dp40632
sg4197
(dp40633
sg2838
g34814
sg9507
(dp40634
sg11136
(dp40635
sg2481
g32444
sg10701
(dp40636
sg9528
(dp40637
sg8211
(dp40638
sg6489
(dp40639
sg28215
g35370
sg5295
(dp40640
sg15016
(dp40641
ssg3759
(dp40642
g9918
(dp40643
sg10275
(dp40644
sg10914
(dp40645
sg11229
(dp40646
sg7707
(dp40647
sg4830
(dp40648
sg1239
g22965
sg11838
(dp40649
sg11370
(dp40650
sg10347
(dp40651
sg5208
(dp40652
sg5316
(dp40653
sg1503
g25188
sg3753
g40613
sg11337
(dp40654
sg8562
(dp40655
sg10170
(dp40656
sg9261
(dp40657
sg10950
(dp40658
sg4542
(dp40659
sg2667
g33518
sg1152
g22538
sg2142
g30364
sg2688
g33666
sg3222
g37609
sg10878
(dp40660
sg12126
(dp40661
sg600
g17741
sg4782
(dp40662
sg3009
g36052
ssg3762
(dp40663
g8781
(dp40664
sg7905
(dp40665
sg11967
(dp40666
ssg3765
(dp40667
g9117
(dp40668
sg8373
(dp40669
sg9144
(dp40670
sg9903
(dp40671
sg1800
g27357
sg2226
g30810
sg10662
(dp40672
sg7650
(dp40673
sg7653
(dp40674
sg6903
(dp40675
sg1914
g28415
sg9192
(dp40676
sg3141
g37078
sg9507
(dp40677
sg3144
g37119
sg891
g20557
sg2046
g29131
sg2388
g31676
sg4887
(dp40678
sg2436
g32179
sg15016
(dp40679
sg6279
(dp40680
sg3657
g40180
sg10740
(dp40681
sg1719
g26842
sg8340
(dp40682
sg11805
(dp40683
sg9264
(dp40684
sg3207
g37488
sg11445
(dp40685
sg14338
g13528
sg9630
(dp40686
sg4056
(dp40687
sg1761
g26998
sg6345
(dp40688
sg204
g13972
sg6348
(dp40689
sg210
g14001
sg1782
g27157
sg1278
g23338
sg8580
(dp40690
sg4035
(dp40691
sg11604
(dp40692
sg8616
(dp40693
sg4857
(dp40694
sg7545
(dp40695
sg10890
(dp40696
sg1614
g25921
sg11652
(dp40697
sg10974
(dp40698
sg13070
g21908
sg14838
g40035
sg5685
(dp40699
sg12534
(dp40700
sg8673
(dp40701
sg4113
(dp40702
sg6471
(dp40703
sg8694
(dp40704
sg3408
g38719
sg10548
(dp40705
sg11733
(dp40706
sg6507
(dp40707
sg5598
(dp40708
sg4320
(dp40709
sg14872
g15780
sg396
g15800
sg5766
(dp40710
sg5460
(dp40711
sg11781
(dp40712
sg6759
(dp40713
sg9897
(dp40714
sg2481
g32422
sg7074
(dp40715
sg10977
(dp40716
sg7275
(dp40717
sg10314
(dp40718
sg10335
(dp40719
sg2067
g29649
sg5895
(dp40720
sg11592
(dp40721
sg4446
(dp40722
sg2838
g34818
sg2109
g30143
sg5928
(dp40723
sg11145
(dp40724
sg1578
g25653
sg4653
(dp40725
sg1356
g23961
sg8871
(dp40726
sg16906
(dp40727
sg2733
g33911
sg11910
(dp40728
sg9657
(dp40729
sg5295
(dp40730
sg2895
g35467
sg3597
g39644
sg11922
(dp40731
sg1863
g27761
sg11934
(dp40732
sg612
g17887
sg8922
(dp40733
sg13750
g24427
sg6735
(dp40734
sg11955
(dp40735
sg6012
(dp40736
sg10290
(dp40737
sg2940
g35709
sg8211
(dp40738
sg5250
(dp40739
sg1452
g24760
sg6045
(dp40740
sg2256
g30921
sg3711
g40449
sg4440
(dp40741
sg11997
(dp40742
sg3981
(dp40743
sg3393
g38604
sg9774
(dp40744
sg11301
(dp40745
sg11319
(dp40746
sg11727
(dp40747
sg2277
g31123
sg1176
g22680
sg11631
(dp40748
sg11067
(dp40749
sg4860
(dp40750
sg1275
g23297
sg8862
(dp40751
sg11352
(dp40752
sg1464
g24864
sg9093
(dp40753
sg6381
(dp40754
sg3624
g39896
sg5580
(dp40755
ssg3768
(dp40756
g6729
(dp40757
sg11790
(dp40758
sg11955
(dp40759
sg6186
(dp40760
sg11793
(dp40761
sg9879
(dp40762
sg6012
(dp40763
sg240
g14199
sg6318
(dp40764
sg8394
(dp40765
sg11979
(dp40766
sg2013
g28927
sg9711
(dp40767
sg10662
(dp40768
sg11265
(dp40769
sg1248
g23031
sg6303
(dp40770
sg11721
(dp40771
sg7275
(dp40772
sg7983
(dp40773
sg11016
(dp40774
sg10497
(dp40775
sg2427
g32048
sg7299
(dp40776
sg3975
(dp40777
sg9966
(dp40778
sg8097
(dp40779
sg9417
(dp40780
sg3732
g40509
sg405
g15877
sg12066
(dp40781
sg2841
g34858
sg2733
g33903
sg10533
(dp40782
sg945
g20904
sg9981
(dp40783
sg9393
(dp40784
sg7497
(dp40785
sg8463
(dp40786
sg11163
(dp40787
sg4344
(dp40788
sg696
g18756
sg7941
(dp40789
sg8139
(dp40790
sg3978
(dp40791
sg5169
(dp40792
sg387
g15665
sg9465
(dp40793
sg1188
g22782
sg1464
g24862
sg2664
g33461
sg10815
(dp40794
sg7029
(dp40795
sg1092
g21987
sg7041
(dp40796
sg9684
(dp40797
ssg3771
(dp40798
g2553
g32905
sg4770
(dp40799
sg10767
(dp40800
sg5415
(dp40801
sg1164
g22599
sg9309
(dp40802
sg5226
(dp40803
sg7629
(dp40804
sg9561
(dp40805
sg1812
g27478
sg12108
(dp40806
sg657
g18370
sg7395
(dp40807
sg11382
(dp40808
sg3825
(dp40809
sg1842
g27652
sg6714
(dp40810
ssg3774
(dp40811
g1248
g23053
sg10062
(dp40812
sg1707
g26788
sg11139
(dp40813
sg10815
(dp40814
sg6939
(dp40815
sg5970
(dp40816
sg2814
g34524
ssg3777
(dp40817
VAmino Acids, Peptides, and Proteins
p40818
(dp40819
sVEsterases
p40820
(dp40821
sVEnzymes
p40822
(dp40823
sVProteins
p40824
(dp40825
sVHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
p40826
(dp40827
sVPolysaccharide-Lyases
p40828
(dp40829
sg3093
g36718
sVSulfatases
p40830
(dp40831
sVCarbon-Oxygen Lyases
p40832
(dp40833
sVChondroitinases and Chondroitin Lyases
p40834
(dp40835
sVLyases
p40836
g26369
sVEnzymes and Coenzymes
p40837
(dp40838
sVHydrolases
p40839
(dp40840
sVAlimentary Tract and Metabolism
p40841
g23933
sg1962
g28758
ssg3780
(dp40842
g9870
(dp40843
sg9897
(dp40844
sg4860
(dp40845
sg10098
(dp40846
sg3114
g36879
sg10227
(dp40847
sg2985
g35928
sg909
g20652
sg6507
(dp40848
sg8010
(dp40849
sg8871
(dp40850
ssg3783
(dp40851
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p40852
(dp40853
sVCytochrome P-450 CYP3A4 Inhibitors
p40854
(dp40855
sVSteroids
p40856
(dp40857
sVSex Hormones and Modulators of the Genital System
p40858
g19614
sVAntiandrogens
p40859
(dp40860
sVCytochrome P-450 CYP3A Substrates
p40861
(dp40862
sVCytochrome P-450 Enzyme Inhibitors
p40863
(dp40864
sg2952
g35850
sg7452
(dp40865
sVHyperglycemia-Associated Agents
p40866
(dp40867
sg8709
(dp40868
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p40869
g29280
sg9747
(dp40870
sVFused-Ring Compounds
p40871
g14889
sg7104
(dp40872
sVAntineoplastic Agents
p40873
(dp40874
sVPregnanes
p40875
(dp40876
sVAdrenal Cortex Hormones
p40877
g30048
sVReproductive Control Agents
p40878
g18859
sg4116
(dp40879
sVPregnadienes
p40880
(dp40881
sg2271
g31051
sg5553
(dp40882
sVCytochrome P-450 CYP3A4 Substrates
p40883
(dp40884
sVHormone Antagonists
p40885
g24280
sVGenito Urinary System and Sex Hormones
p40886
(dp40887
sg5583
(dp40888
sVCytochrome P-450 CYP3A Inhibitors
p40889
(dp40890
sg5979
(dp40891
sVHormones, Hormone Substitutes, and Hormone Antagonists
p40892
(dp40893
sVOther Miscellaneous Therapeutic Agents
p40894
g28778
ssg3786
(dp40895
g6630
(dp40896
sg1059
g21776
sg8598
(dp40897
sg801
g19523
ssg3789
(dp40898
g8421
(dp40899
sg3885
(dp40900
sg9924
(dp40901
sg5805
(dp40902
sg7464
(dp40903
sg10818
(dp40904
sg7317
(dp40905
sg7734
(dp40906
sg4635
(dp40907
sg7485
(dp40908
sg7569
(dp40909
sg3399
g38643
sg9918
(dp40910
sg1491
g25109
sg3447
g38958
sg7335
(dp40911
sg2730
g33876
sg138
g13309
sg2538
g32809
ssg3792
(dp40912
g9402
(dp40913
ssg3795
(dp40914
VAntiinfectives for Systemic Use
p40915
(dp40916
sVDrugs that are Mainly Renally Excreted
p40917
(dp40918
sVAntivirals for Systemic Use
p40919
(dp40920
sVHeterocyclic Compounds, Fused-Ring
p40921
(dp40922
sVNucleoside Analog Antiviral
p40923
(dp40924
sVAgents that reduce seizure threshold
p40925
(dp40926
sg9354
(dp40927
sVAntiviral Agents
p40928
g30470
sVDirect Acting Antivirals
p40929
g38078
sg1080
g21915
sVNucleosides and Nucleotides
p40930
g39105
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p40931
(dp40932
sVGuanine
p40933
(dp40934
sg4083
(dp40935
sg549
g17173
sVNucleic Acid Synthesis Inhibitors
p40936
(dp40937
sVPurinones
p40938
(dp40939
sVAnti-Infective Agents
p40940
(dp40941
sVPurines
p40942
(dp40943
ssg3798
(dp40944
g6549
(dp40945
ssg3801
(dp40946
VAmino Acids, Peptides, and Proteins
p40947
(dp40948
sVGlobulins
p40949
g19187
sVAntibodies
p40950
(dp40951
sVProteins
p40952
(dp40953
sVMyelosuppressive Agents
p40954
(dp40955
sVAntibodies, Monoclonal
p40956
(dp40957
sVAntibodies, Monoclonal, Humanized
p40958
(dp40959
sg1215
g22878
sVAntineoplastic Agents, Immunological
p40960
(dp40961
sVImmunoglobulins
p40962
(dp40963
sVImmunosuppressive Agents
p40964
(dp40965
sVSelective Immunosuppressants
p40966
g23570
sVSerum Globulins
p40967
(dp40968
sVAntineoplastic and Immunomodulating Agents
p40969
g39810
sg1929
g28506
sVBlood Proteins
p40970
g39864
sVAntineoplastic Agents
p40971
(dp40972
sVImmunoproteins
p40973
(dp40974
ssg3804
(dp40975
g7029
(dp40976
sg3975
(dp40977
ssg3807
(dp40978
g1776
g27086
sg8088
(dp40979
sg5463
(dp40980
sg7407
(dp40981
sg5514
(dp40982
ssg3810
(dp40983
g1452
g24752
sg10713
(dp40984
ssg3813
(dp40985
g8673
(dp40986
sg14791
(dp40987
sg6819
(dp40988
sg11916
(dp40989
sg10335
(dp40990
sg6381
(dp40991
ssg3816
(dp40992
g10200
(dp40993
sg5574
(dp40994
sg5934
(dp40995
sg3231
g37677
sg7314
(dp40996
sg10164
(dp40997
sg1767
g27029
sg20252
(dp40998
sg9486
(dp40999
sg7641
(dp41000
sg10383
(dp41001
sg6267
(dp41002
sg4656
(dp41003
ssg3819
(dp41004
g4257
(dp41005
sg5469
(dp41006
sg165
g13592
ssg3822
(dp41007
g8856
(dp41008
sg837
g19982
ssg3825
(dp41009
VSalt Solutions
p41010
g22246
sVMetal divalent cations
p41011
(dp41012
sVAgents that produce neuromuscular block (indirect)
p41013
g37960
sVBlood and Blood Forming Organs
p41014
(dp41015
sVBlood Substitutes and Perfusion Solutions
p41016
(dp41017
sVAcids, Acyclic
p41018
g25496
sVOsmotic Laxatives
p41019
(dp41020
sVMetal cations
p41021
g40809
sVLaxatives, magnesium containing
p41022
(dp41023
sVDrugs for Constipation
p41024
(dp41025
sVIrrigating Solutions
p41026
(dp41027
sVLaxatives
p41028
g17340
sVCitrates
p41029
g17792
sVMagnesium Compounds
p41030
g33049
sVGastrointestinal Agents
p41031
(dp41032
sVCalculi Dissolution Agent
p41033
g12691
sVTricarboxylic Acids
p41034
(dp41035
sVAlimentary Tract and Metabolism
p41036
g23829
sVMineral Supplements
p41037
g38307
ssg3828
(dp41038
g10701
(dp41039
sg11976
(dp41040
sg5094
(dp41041
ssg3831
(dp41042
g10713
(dp41043
ssg3834
(dp41044
g6999
(dp41045
sg5256
(dp41046
sg10350
(dp41047
sg10728
(dp41048
sg696
g18727
sg2358
g31448
sg9564
(dp41049
sg12066
(dp41050
sg6303
(dp41051
sg8658
(dp41052
sg8187
(dp41053
ssg3837
(dp41054
g5238
(dp41055
sg966
g21027
ssg3840
(dp41056
g8856
(dp41057
sg837
g19990
ssg3843
(dp41058
g4017
(dp41059
sg10266
(dp41060
sg2196
g30596
sg2427
g31974
sg4437
(dp41061
sg7707
(dp41062
sg6318
(dp41063
sg11283
(dp41064
sg7821
(dp41065
sg1047
g21576
sg1881
g27933
sg5853
(dp41066
sg2265
g30989
sg11451
(dp41067
sg8433
(dp41068
sg11079
(dp41069
sg3132
g36982
sg1014
g21327
sg5499
(dp41070
sg2088
g29886
sg5526
(dp41071
sg9954
(dp41072
sg8655
(dp41073
sg6090
(dp41074
sg9417
(dp41075
sg3024
g36248
sg10521
(dp41076
sg5316
(dp41077
sg696
g18687
sg9198
(dp41078
sg789
g19464
sg10761
(dp41079
sg5556
(dp41080
sg573
g17512
sg11733
(dp41081
sg2688
g33604
sg6315
(dp41082
sg7416
(dp41083
sg8949
(dp41084
sg12126
(dp41085
sg2616
g33157
sg10356
(dp41086
sg11241
(dp41087
sg2676
g33547
sg6093
(dp41088
sg2913
g35586
ssg3846
(dp41089
VCytochrome P-450 CYP3A4 Inhibitors
p41090
(dp41091
sVGastric Acid Lowering Agents
p41092
(dp41093
sVCytochrome P-450 CYP2D6 Inhibitors
p41094
(dp41095
sVCytochrome P-450 CYP3A Substrates
p41096
(dp41097
sVBCRP/ABCG2 Inhibitors
p41098
g12506
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p41099
(dp41100
sVCytochrome P-450 CYP2C9 Inhibitors
p41101
g18175
sVCytochrome P-450 CYP2C9 Inducers
p41102
g20035
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p41103
g16517
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p41104
g18386
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p41105
(dp41106
sVAcid Reducers
p41107
(dp41108
sVCytochrome P-450 CYP2C8 Substrates
p41109
(dp41110
sVSulfoxides
p41111
(dp41112
sVOAT3/SLC22A8 Inhibitors
p41113
(dp41114
sVCytochrome P-450 Enzyme Inhibitors
p41115
(dp41116
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41117
g29289
sVSulfur Compounds
p41118
(dp41119
sVCytochrome P-450 CYP2C9 Substrates
p41120
g29706
sVCytochrome P-450 CYP3A4 Inducers
p41121
g18871
sVProton Pump Inhibitors
p41122
(dp41123
sVAnti-Ulcer Agents
p41124
(dp41125
sVCytochrome P-450 CYP2C19 Substrates
p41126
(dp41127
sVGastrointestinal Agents
p41128
(dp41129
sVP-glycoprotein/ABCB1 Substrates
p41130
g34906
sVPyridines
p41131
(dp41132
sVProton-pump Inhibitors
p41133
g31271
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p41134
(dp41135
sVCytochrome P-450 Enzyme Inducers
p41136
g28108
sVCytochrome P-450 CYP3A Inducers
p41137
(dp41138
sVCytochrome P-450 CYP2C18 Substrates
p41139
g20928
sVCytochrome P-450 CYP2C19 Inhibitors
p41140
(dp41141
sVHeterocyclic Compounds, Fused-Ring
p41142
(dp41143
sVCytochrome P-450 CYP3A4 Substrates
p41144
(dp41145
sVAlimentary Tract and Metabolism
p41146
g23754
sVBenzimidazoles
p41147
(dp41148
sVCytochrome P-450 CYP3A Inhibitors
p41149
(dp41150
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p41151
(dp41152
sVDrugs for Acid Related Disorders
p41153
(dp41154
sVP-glycoprotein/ABCB1 Inhibitors
p41155
(dp41156
sg11778
(dp41157
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p41158
(dp41159
ssg3849
(dp41160
VAntiinfectives for Systemic Use
p41161
(dp41162
sVDrugs that are Mainly Renally Excreted
p41163
(dp41164
sVAntimycobacterials
p41165
g22567
sVAmines
p41166
(dp41167
sVPolyamines
p41168
g40557
sg8337
(dp41169
sVAntituberculosis Agents
p41170
(dp41171
sVDrugs for Treatment of Tuberculosis
p41172
(dp41173
sVAnti-Bacterial Agents
p41174
g38325
sVDiamines
p41175
(dp41176
sVAnti-Infective Agents
p41177
(dp41178
ssg3852
(dp41179
g1776
g27087
ssg3855
(dp41180
g11133
(dp41181
sg8751
(dp41182
ssg3858
(dp41183
VAgents Causing Muscle Toxicity
p41184
(dp41185
sVBSEP/ABCB11 Substrates
p41186
(dp41187
sVCytochrome P-450 CYP3A4 Inhibitors
p41188
(dp41189
sVCytochrome P-450 CYP2D6 Substrates
p41190
(dp41191
sVUGT1A1 Substrates
p41192
g12282
sVUGT2B7 substrates
p41193
g28620
sVCytochrome P-450 CYP3A Substrates
p41194
(dp41195
sVCYP3A Substrates (Sensitive)
p41196
(dp41197
sVOATP1B1/SLCO1B1 Inhibitors
p41198
(dp41199
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p41200
(dp41201
sVCytochrome P-450 CYP2C9 Inhibitors
p41202
g18176
sVCytochrome P-450 Enzyme Inhibitors
p41203
(dp41204
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p41205
(dp41206
sVCytochrome P-450 CYP2C8 Substrates
p41207
(dp41208
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p41209
g23098
sVCytochrome P-450 CYP2B6 Inducers
p41210
g39112
sVNaphthalenes
p41211
(dp41212
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41213
g29290
sVLipid Modifying Agents, Plain
p41214
(dp41215
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p41216
(dp41217
sVOATP1B1/SLCO1B1 Substrates
p41218
(dp41219
sVDrugs Used in Diabetes
p41220
(dp41221
sVHypolipidemic Agents
p41222
(dp41223
sVLipid Modifying Agents
p41224
g40533
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p41225
g25228
sVCytochrome P-450 CYP2C8 Inhibitors
p41226
(dp41227
sVCytochrome P-450 CYP2B6 Inhibitors
p41228
(dp41229
sVEnzyme Inhibitors
p41230
(dp41231
sVP-glycoprotein/ABCB1 Substrates
p41232
g34908
sVCytochrome P-450 CYP2B6 Inhibitors (weak)
p41233
(dp41234
sVCytochrome P-450 Enzyme Inducers
p41235
g28110
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p41236
(dp41237
sVCytochrome P-450 CYP3A4 Substrates
p41238
(dp41239
sVAlimentary Tract and Metabolism
p41240
g23756
sVToxic Actions
p41241
(dp41242
sVAnticholesteremic Agents
p41243
(dp41244
sVCytochrome P-450 CYP3A5 Substrates
p41245
(dp41246
sVUGT1A3 substrates
p41247
g31798
sVCytochrome P-450 CYP3A Inhibitors
p41248
(dp41249
sVNoxae
p41250
(dp41251
sVP-glycoprotein/ABCB1 Inhibitors
p41252
(dp41253
sVCytochrome P-450 CYP3A7 Substrates
p41254
(dp41255
sVLipid Regulating Agents
p41256
(dp41257
ssg3861
(dp41258
VSteroids
p41259
(dp41260
sVSex Hormones and Modulators of the Genital System
p41261
g19604
sVEstradiol Congeners
p41262
(dp41263
sVCytochrome P-450 CYP3A Substrates
p41264
(dp41265
sVNatural and Semisynthetic Estrogens, Plain
p41266
(dp41267
sVBCRP/ABCG2 Inhibitors
p41268
g12544
sVOATP1B1/SLCO1B1 Inhibitors
p41269
(dp41270
sVCytochrome P-450 CYP2B6 Substrates
p41271
g33012
sVHormones
p41272
(dp41273
sV17-Ketosteroids
p41274
(dp41275
sVP-glycoprotein/ABCB1 Inducers
p41276
(dp41277
sVCytochrome P-450 CYP1A2 Substrates
p41278
(dp41279
sg3861
(dp41280
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41281
g29291
sVCytochrome P-450 CYP2C9 Substrates
p41282
g29806
sVFused-Ring Compounds
p41283
g14825
sVAdrenal Cortex Hormones
p41284
g30046
sVOAT3/SLC22A8 Substrates
p41285
g13118
sVP-glycoprotein/ABCB1 Substrates
p41286
g35063
sVCytochrome P-450 CYP3A4 Substrates
p41287
(dp41288
sVKetosteroids
p41289
g30819
sVGonadal Hormones
p41290
g33576
sVCytochrome P-450 CYP3A5 Substrates
p41291
(dp41292
sVGenito Urinary System and Sex Hormones
p41293
(dp41294
sVGonadal Steroid Hormones
p41295
(dp41296
sVEstranes
p41297
(dp41298
sVHormones, Hormone Substitutes, and Hormone Antagonists
p41299
(dp41300
sVEstrenes
p41301
(dp41302
sVEstrogens
p41303
(dp41304
ssg3864
(dp41305
g2403
g31835
sg1035
g21455
sg5235
(dp41306
sg4452
(dp41307
sg657
g18293
sg1059
g21739
sg684
g18491
sg1869
g27814
sg5289
(dp41308
sg11619
(dp41309
sg8433
(dp41310
sg11652
(dp41311
sg9561
(dp41312
sg3696
g40270
sg8820
(dp41313
sg8460
(dp41314
sg3177
g37305
sg12063
(dp41315
sg9987
(dp41316
sg7944
(dp41317
sg1911
g28347
sg4959
(dp41318
sg10557
(dp41319
sg7764
(dp41320
sg10350
(dp41321
sg7191
(dp41322
sg1857
g27696
ssg3867
(dp41323
VDrugs that are Mainly Renally Excreted
p41324
(dp41325
sVHematologic Agents
p41326
(dp41327
sVBlood and Blood Forming Organs
p41328
(dp41329
sVCytochrome P-450 CYP3A5 Substrates
p41330
(dp41331
sVProtease Inhibitors
p41332
(dp41333
sVAnticoagulants
p41334
(dp41335
sVCytochrome P-450 CYP3A Substrates
p41336
(dp41337
sVSerine Proteinase Inhibitors
p41338
(dp41339
sVAntithrombins
p41340
(dp41341
sVBCRP/ABCG2 Substrates
p41342
(dp41343
sVP-glycoprotein/ABCB1 Substrates
p41344
g35002
sVCYP3A Substrates (Sensitive)
p41345
(dp41346
sVThiophenes
p41347
(dp41348
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41349
g29245
sVOxazines
p41350
(dp41351
sVMorpholines
p41352
g35906
sVEnzyme Inhibitors
p41353
(dp41354
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p41355
(dp41356
sVCytochrome P-450 CYP3A4 Substrates
p41357
(dp41358
sVFactor Xa Inhibitors
p41359
(dp41360
sVSulfur Compounds
p41361
(dp41362
ssg3870
(dp41363
g1782
g27128
sg10200
(dp41364
sg10548
(dp41365
sg7548
(dp41366
sg2985
g35936
sg5085
(dp41367
sg3825
g41027
sg5511
(dp41368
sg9870
(dp41369
sg10314
(dp41370
ssg3873
(dp41371
g6999
(dp41372
ssg3876
(dp41373
g1737
g26923
ssg3879
(dp41374
g4806
(dp41375
sg645
g18137
sg1629
g25981
sg7464
(dp41376
sg13750
g24354
sg10818
(dp41377
sg9309
(dp41378
sg7629
(dp41379
sg4635
(dp41380
sg1812
g27480
sg9903
(dp41381
sg10296
(dp41382
sg1800
g27306
sg3318
g38172
sg6045
(dp41383
sg5766
(dp41384
sg4653
(dp41385
sg7545
(dp41386
sg1614
g25848
sg14838
g39962
sg5895
(dp41387
sg12108
(dp41388
sg1491
g25079
sg11301
(dp41389
sg4113
(dp41390
sg11727
(dp41391
sg7569
(dp41392
sg4737
(dp41393
sg10554
(dp41394
sg1164
g22601
sg11934
(dp41395
sg7191
(dp41396
sg3447
g38933
sg6345
(dp41397
sg1770
g27046
sg12534
(dp41398
sg14829
(dp41399
ssg3882
(dp41400
VAmino Acids, Peptides, and Proteins
p41401
(dp41402
sVGlobulins
p41403
g19189
sVAntibodies
p41404
(dp41405
sg4758
(dp41406
sVAntibodies, Monoclonal
p41407
(dp41408
sVImmunoglobulins
p41409
(dp41410
sVProteins
p41411
(dp41412
sVRespiratory System Agents
p41413
(dp41414
sVSerum Globulins
p41415
(dp41416
sVAnti-Asthmatic Agents
p41417
g36529
sVBlood Proteins
p41418
g39867
sVRespiratory Agents, Miscellaneous
p41419
(dp41420
sVDrugs for Obstructive Airway Diseases
p41421
(dp41422
sg7509
(dp41423
sVImmunoproteins
p41424
(dp41425
ssg3885
(dp41426
VAnticholinergic Agents
p41427
g24475
sVAntiarrhythmic agents
p41428
(dp41429
sVCytochrome P-450 CYP3A Substrates
p41430
(dp41431
sVOCT2 Inhibitors
p41432
(dp41433
sVBlood Glucose Lowering Agents
p41434
(dp41435
sVMuscarinic Antagonists
p41436
(dp41437
sVHighest Risk QTc-Prolonging Agents
p41438
g35863
sVDrugs that are Mainly Renally Excreted
p41439
(dp41440
sVCytochrome P-450 CYP1A2 Substrates
p41441
(dp41442
sVCardiac Therapy
p41443
(dp41444
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41445
g29295
sVQTc Prolonging Agents
p41446
(dp41447
sVOCT1 inhibitors
p41448
(dp41449
sVCardiovascular Agents
p41450
g26532
sVPyridines
p41451
(dp41452
sVAntiarrhythmics, Class Ia
p41453
(dp41454
sVMembrane Transport Modulators
p41455
(dp41456
sVCytochrome P-450 CYP3A4 Substrates
p41457
(dp41458
sVSodium Channel Blockers
p41459
(dp41460
sVAntiarrhythmics, Class I
p41461
(dp41462
sVVoltage-Gated Sodium Channel Blockers
p41463
g40900
sVHypoglycemia-Associated Agents
p41464
g17684
sVAgents producing tachycardia
p41465
(dp41466
ssg3888
(dp41467
g8325
(dp41468
ssg3891
(dp41469
VEnzymes
p41470
(dp41471
sVGlycoside Hydrolases
p41472
g18670
sVEnzymes and Coenzymes
p41473
(dp41474
sg270
g14457
sVHydrolases
p41475
(dp41476
sVAlimentary Tract and Metabolism
p41477
g23767
ssg3894
(dp41478
g4197
(dp41479
ssg3897
(dp41480
g9588
(dp41481
ssg3900
(dp41482
VAdrenergic Agents
p41483
(dp41484
sVAdrenergic alpha-1 Receptor Antagonists
p41485
g14117
sVGenito Urinary System and Sex Hormones
p41486
(dp41487
sVAntihypertensive Agents
p41488
g20250
sVNeurotransmitter Agents
p41489
(dp41490
sVHypotensive Agents
p41491
g34109
sVUrological Agents
p41492
g38282
sVQuinazolines
p41493
(dp41494
sVAdrenergic Antagonists
p41495
(dp41496
sVP-glycoprotein/ABCB1 Inhibitors
p41497
(dp41498
sVDrugs Used in Benign Prostatic Hypertrophy
p41499
(dp41500
sVAdrenergic alpha-Antagonists
p41501
(dp41502
sVPeripheral alpha-1 blockers
p41503
g32713
sVHeterocyclic Compounds, Fused-Ring
p41504
(dp41505
sVUrologicals
p41506
(dp41507
ssg3903
(dp41508
g9897
(dp41509
sg5463
(dp41510
sg9132
(dp41511
sg2754
g34065
sg447
g16288
sg9705
(dp41512
sg8772
(dp41513
sg9300
(dp41514
sg6213
(dp41515
sg6216
(dp41516
sg9348
(dp41517
sg11646
(dp41518
sg669
g18446
sg10104
(dp41519
sg3147
g37137
sg12015
(dp41520
sg11286
(dp41521
sg1482
g25009
sg9741
(dp41522
sg8076
(dp41523
sg6612
(dp41524
sg4977
(dp41525
sg6804
(dp41526
sg7512
(dp41527
sg6630
(dp41528
sg4713
(dp41529
sg10431
(dp41530
sg1737
g26913
sg3801
g40963
sg9627
(dp41531
sg3882
g41410
sg4551
(dp41532
sg3573
g39534
sg11349
(dp41533
sg11550
(dp41534
sg3588
g39616
sg7980
(dp41535
sg1563
g25511
sg4905
(dp41536
sg8910
(dp41537
sg8559
(dp41538
sg4185
(dp41539
sg7059
(dp41540
sg9852
(dp41541
sg7809
(dp41542
sg10653
(dp41543
ssg3906
(dp41544
g8019
(dp41545
sg3930
(dp41546
sg1941
g28580
sg4425
(dp41547
sg978
g21156
sg7641
(dp41548
sg8778
(dp41549
sg4650
(dp41550
sg2262
g30956
sg879
g20344
sg8418
(dp41551
sg3087
g36662
sg12003
(dp41552
sg9726
(dp41553
sg9099
(dp41554
sg1473
g24959
sg4638
(dp41555
sg891
g20549
sg10494
(dp41556
sg3444
g38865
sg1014
g21329
sg7824
(dp41557
sg9750
(dp41558
sg10740
(dp41559
sg3711
g40436
sg4959
(dp41560
sg9765
(dp41561
sg10512
(dp41562
sg11862
(dp41563
sg10593
(dp41564
sg4716
(dp41565
sg2109
g30126
sg11133
(dp41566
sg6024
(dp41567
sg2850
g35104
sg5934
(dp41568
sg3399
g38626
sg2658
g33360
sg11712
(dp41569
sg11154
(dp41570
sg564
g17404
sg72
g12799
sg969
g21088
sg570
g17480
sg11535
(dp41571
sg4062
(dp41572
sg11172
(dp41573
sg6687
(dp41574
sg171
g13703
sg4974
(dp41575
sg6093
(dp41576
sg5757
(dp41577
sg3990
(dp41578
sg11352
(dp41579
sg1578
g25636
sg11769
(dp41580
sg5589
(dp41581
sg717
g19048
sg336
g15099
sg7155
(dp41582
sg1770
g27055
sg5394
(dp41583
sg8751
(dp41584
ssg3909
(dp41585
g11781
(dp41586
ssg3912
(dp41587
VCytochrome P-450 CYP3A4 Inhibitors
p41588
(dp41589
sVAntivirals for Systemic Use
p41590
(dp41591
sVBreast Cancer Resistance Protein Inhibitors
p41592
g12719
sVCytochrome P-450 CYP3A Substrates
p41593
(dp41594
sVCytochrome P-450 CYP3A7 Inhibitors
p41595
(dp41596
sVDirect Acting Antivirals
p41597
g38043
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p41598
(dp41599
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p41600
(dp41601
sVCytochrome P-450 Enzyme Inhibitors
p41602
(dp41603
sVAntiinfectives for Systemic Use
p41604
(dp41605
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41606
g29541
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p41607
g24780
sVAntivirals for treatment of HCV infections
p41608
g31035
sVP-glycoprotein/ABCB1 Substrates
p41609
g34997
sg6486
(dp41610
sVCytochrome P-450 CYP3A5 Inhibitors
p41611
(dp41612
sVHeterocyclic Compounds, Fused-Ring
p41613
(dp41614
sVCytochrome P-450 CYP3A4 Substrates
p41615
(dp41616
sVCytochrome P-450 CYP3A5 Substrates
p41617
(dp41618
sVCytochrome P-450 CYP3A Inhibitors
p41619
(dp41620
sVAntiviral Agents
p41621
g30426
sVCytochrome P-450 CYP3A7 Substrates
p41622
(dp41623
ssg3915
(dp41624
g4515
(dp41625
sg2817
g34552
sg834
g19954
sg2007
g28878
ssg3918
(dp41626
g9252
(dp41627
sg3018
g36138
sg375
g15447
sg7164
(dp41628
ssg3921
(dp41629
g11352
(dp41630
sg9414
(dp41631
sg11319
(dp41632
sg5499
(dp41633
sg2067
g29637
sg612
g17871
sg11445
(dp41634
sg7896
(dp41635
ssg3924
(dp41636
g5226
(dp41637
ssg3927
(dp41638
g534
g16988
sg714
g19016
sg6156
(dp41639
sg4437
(dp41640
sg11655
(dp41641
sg4035
(dp41642
sg10119
(dp41643
sg1134
g22330
sg10959
(dp41644
sg8724
(dp41645
ssg3930
(dp41646
VAgents Causing Muscle Toxicity
p41647
(dp41648
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p41649
(dp41650
sVAlkylating Drugs
p41651
(dp41652
sVMyelosuppressive Agents
p41653
(dp41654
sVBenzene Derivatives
p41655
(dp41656
sVAntidepressive Agents
p41657
g15502
sVBenzoates
p41658
g30382
sVSerotonin Agents
p41659
(dp41660
sVImmunosuppressive Agents
p41661
(dp41662
sVCentral Nervous System Depressants
p41663
(dp41664
sVAlkylating Activity
p41665
(dp41666
sVMonoamine Oxidase Inhibitors
p41667
(dp41668
sVAmides
p41669
(dp41670
sVAcids, Carbocyclic
p41671
g41546
sVAntineoplastic and Immunomodulating Agents
p41672
g39807
sg6897
(dp41673
sVBenzamides and benzamide derivatives
p41674
g15380
sVAntineoplastic Agents
p41675
(dp41676
sVSerotonin Modulators
p41677
(dp41678
ssg3933
(dp41679
g5532
(dp41680
sg11085
(dp41681
sg11751
(dp41682
sg7044
(dp41683
sg11826
(dp41684
ssg3936
(dp41685
g10263
(dp41686
sg3708
g40387
sg7422
(dp41687
sg9987
(dp41688
sg11145
(dp41689
sg450
g16339
sg10857
(dp41690
sg1044
g21546
sg5829
(dp41691
sg4647
(dp41692
sg10470
(dp41693
sg6759
(dp41694
sg2262
g30961
sg168
g13643
sg10884
(dp41695
sg11439
(dp41696
sg6051
(dp41697
sg7164
(dp41698
sg6639
(dp41699
sg3900
g41484
sg4623
(dp41700
sg6069
(dp41701
sg4488
(dp41702
sg11667
(dp41703
sg3531
g39275
sg9402
(dp41704
sg2067
g29642
sg5499
(dp41705
sg255
g14388
sg7305
(dp41706
sg9093
(dp41707
sg9417
(dp41708
sg6966
(dp41709
sg2427
g32029
sg3381
g38479
sg6678
(dp41710
sg9012
(dp41711
sg11319
(dp41712
sg7716
(dp41713
sg3036
g36444
sg1719
g26836
sg6684
(dp41714
sg9981
(dp41715
sg10761
(dp41716
sg9264
(dp41717
sg10005
(dp41718
sg9918
(dp41719
sg11445
(dp41720
sg2289
g31186
sg4344
(dp41721
sg1548
g25379
sg8862
(dp41722
sg6507
(dp41723
sg375
g15453
sg5169
(dp41724
sg11910
(dp41725
sg210
g13989
sg387
g15647
sg10497
(dp41726
sg4419
(dp41727
sg3240
g37716
sg4173
(dp41728
sg3444
g38870
sg4056
(dp41729
sg2304
g31235
sg2616
g33183
sg3363
g38418
sg612
g17877
sg5598
(dp41730
sg11649
(dp41731
sg5580
(dp41732
ssg3939
(dp41733
g13750
g24383
sg2373
g31596
sg4620
(dp41734
sg9528
(dp41735
sg9903
(dp41736
sg1800
g27320
sg4653
(dp41737
sg6045
(dp41738
sg8421
(dp41739
sg7668
(dp41740
sg8430
(dp41741
sg1614
g25876
sg9198
(dp41742
sg11079
(dp41743
sg888
g20458
sg10701
(dp41744
sg14838
g39993
sg4089
(dp41745
sg7335
(dp41746
sg5895
(dp41747
sg12534
(dp41748
sg11886
(dp41749
sg1140
g22400
sg7734
(dp41750
sg8298
(dp41751
sg3219
g37549
sg6504
(dp41752
sg4155
(dp41753
sg4164
(dp41754
sg5364
(dp41755
sg28215
g35365
sg4911
(dp41756
sg183
g13822
sg11922
(dp41757
sg12132
(dp41758
sg7593
(dp41759
sg6345
(dp41760
ssg3942
(dp41761
g5415
(dp41762
sg1164
g22580
sg9309
(dp41763
sg12072
(dp41764
sg7629
(dp41765
sg5085
(dp41766
sg5157
(dp41767
sg2505
g32655
sg12108
(dp41768
ssg3945
(dp41769
g11301
(dp41770
sg9918
(dp41771
sg9414
(dp41772
sg11751
(dp41773
sg7044
(dp41774
sg11826
(dp41775
sg11085
(dp41776
sg6150
(dp41777
sg8010
(dp41778
sg11934
(dp41779
sg10047
(dp41780
sg5889
(dp41781
sg7161
(dp41782
sg4845
(dp41783
sg3297
g38023
sg10554
(dp41784
sg7521
(dp41785
ssg3948
(dp41786
g7530
(dp41787
sg3699
g40323
sg12186
(dp41788
sg11085
(dp41789
ssg3951
(dp41790
g8097
(dp41791
sg3627
g39936
sg10728
(dp41792
sg444
g16255
sg11460
(dp41793
sg5256
(dp41794
sg8028
(dp41795
ssg3954
(dp41796
g10077
(dp41797
ssg3957
(dp41798
g8265
(dp41799
ssg3960
(dp41800
VSex Hormones and Modulators of the Genital System
p41801
g19602
sVCytochrome P-450 CYP3A Substrates
p41802
(dp41803
sVProgestogens and Estrogens, Sequential Preparations
p41804
(dp41805
sVNorpregnanes
p41806
g31563
sVHormonal Contraceptives for Systemic Use
p41807
(dp41808
sVCytochrome P-450 CYP3A4 Substrates
p41809
(dp41810
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41811
g29455
sVNorsteroids
p41812
(dp41813
sVReproductive Control Agents
p41814
g18854
sVFused-Ring Compounds
p41815
g14823
sVAdrenal Cortex Hormones
p41816
g30012
sVContraceptives, Oral
p41817
(dp41818
sVProgestins
p41819
(dp41820
sVCombination Contraceptives (with Estrogen and derivatives)
p41821
g31050
sVProgestin Contraceptives
p41822
(dp41823
sVNorpregnenes
p41824
(dp41825
sVContraceptives, Oral, Synthetic
p41826
(dp41827
sg2133
g30300
sVContraceptives, Postcoital
p41828
(dp41829
sVContraceptive Agents, Female
p41830
(dp41831
sVGenito Urinary System and Sex Hormones
p41832
(dp41833
sVSteroids
p41834
(dp41835
ssg3963
(dp41836
VAgents Causing Muscle Toxicity
p41837
(dp41838
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p41839
(dp41840
sVCytochrome P-450 CYP3A4 Inhibitors
p41841
(dp41842
sVImmunologic Factors
p41843
(dp41844
sVCytochrome P-450 CYP3A Substrates
p41845
(dp41846
sVAgents causing hyperkalemia
p41847
(dp41848
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p41849
(dp41850
sVCYP3A Substrates (Sensitive)
p41851
(dp41852
sVOATP1B1/SLCO1B1 Inhibitors
p41853
(dp41854
sVEnzyme Inhibitors
p41855
(dp41856
sVPolyketides
p41857
(dp41858
sVHyperglycemia-Associated Agents
p41859
(dp41860
sVCalcineurin Inhibitors
p41861
(dp41862
sVMyelosuppressive Agents
p41863
(dp41864
sVNephrotoxic agents
p41865
(dp41866
sVLactones
p41867
(dp41868
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41869
g29257
sVAnti-Bacterial Agents
p41870
g38365
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p41871
(dp41872
sVQTc Prolonging Agents
p41873
(dp41874
sVCalcineurin Inhibitor Immunosuppressant
p41875
(dp41876
sVP-glycoprotein/ABCB1 Substrates
p41877
g35080
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p41878
(dp41879
sVP-glycoprotein/ABCB1 Inducers
p41880
(dp41881
sVDermatologicals
p41882
g17326
sg3963
(dp41883
sVMisc. Skin and Mucous Membrane Agents
p41884
(dp41885
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p41886
(dp41887
sVCytochrome P-450 CYP3A4 Substrates
p41888
(dp41889
sVNarrow Therapeutic Index Drugs
p41890
(dp41891
sVCytochrome P-450 CYP3A5 Substrates
p41892
(dp41893
sVPotential QTc-Prolonging Agents
p41894
(dp41895
sVCytochrome P-450 CYP3A Inhibitors
p41896
(dp41897
sVImmunosuppressive Agents
p41898
(dp41899
sVAgents for Dermatitis, Excluding Corticosteroids
p41900
(dp41901
sVP-glycoprotein/ABCB1 Inhibitors
p41902
(dp41903
sVAntineoplastic and Immunomodulating Agents
p41904
g39820
sVCytochrome P-450 CYP3A7 Substrates
p41905
(dp41906
ssg3966
(dp41907
g11625
(dp41908
ssg3969
(dp41909
g2886
g35293
ssg3972
(dp41910
g6090
(dp41911
sg11451
(dp41912
sg6303
(dp41913
sg7563
(dp41914
ssg3975
(dp41915
VCentral Nervous System Depressants
p41916
(dp41917
sVAnticholinergic Agents
p41918
g24485
sVPotential QTc-Prolonging Agents
p41919
(dp41920
sVHistamine H1 Antagonists
p41921
g40777
sVCytochrome P-450 CYP3A Substrates
p41922
(dp41923
sVNeurotransmitter Agents
p41924
(dp41925
sVAnti-Allergic Agents
p41926
(dp41927
sVCytochrome P-450 CYP2C8 Substrates
p41928
(dp41929
sVHistamine Agents
p41930
(dp41931
sg5490
(dp41932
sVPyridines
p41933
(dp41934
sVHistamine Antagonists
p41935
(dp41936
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41937
g29277
sVCytochrome P-450 CYP2B6 Substrates
p41938
g33015
sVAgents producing tachycardia
p41939
(dp41940
sVAntihistamines for Systemic Use
p41941
g12965
sg5391
(dp41942
sVQTc Prolonging Agents
p41943
(dp41944
sVCytochrome P-450 CYP3A4 Substrates
p41945
(dp41946
sVMuscarinic Antagonists
p41947
(dp41948
sg3804
g40977
ssg3978
(dp41949
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p41950
(dp41951
sVAntidepressive Agents, Second-Generation
p41952
(dp41953
sVAdrenergic alpha-1 Receptor Antagonists
p41954
g14132
sVCytochrome P-450 CYP2D6 Inhibitors
p41955
(dp41956
sVCytochrome P-450 CYP2D6 Substrates
p41957
(dp41958
sVSerotonin Agents
p41959
(dp41960
sVCytochrome P-450 CYP3A Substrates
p41961
(dp41962
sVMembrane Transport Modulators
p41963
(dp41964
sVAnti-Anxiety Agents
p41965
g35654
sVSerotonin Receptor Antagonists
p41966
g35686
sVCentral Nervous System Agents
p41967
(dp41968
sVPotential QTc-Prolonging Agents
p41969
(dp41970
sVAdrenergic Antagonists
p41971
(dp41972
sVPsychotropic Drugs
p41973
(dp41974
sVCytochrome P-450 Enzyme Inhibitors
p41975
(dp41976
sVPiperazines
p41977
(dp41978
sVSelective Serotonin Reuptake Inhibitors
p41979
g39077
sVP-glycoprotein/ABCB1 Inducers
p41980
(dp41981
sVNeurotransmitter Uptake Inhibitors
p41982
(dp41983
sVPyridones
p41984
g38736
sVPsychoanaleptics
p41985
(dp41986
sVNeurotransmitter Agents
p41987
(dp41988
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p41989
g29307
sVAdrenergic alpha-Antagonists
p41990
(dp41991
sVQTc Prolonging Agents
p41992
(dp41993
sVSerotonin 5-HT2 Receptor Antagonists
p41994
(dp41995
sVCentral Nervous System Depressants
p41996
(dp41997
sVAntidepressive Agents, Triazolopyridine
p41998
(dp41999
sVAgents that reduce seizure threshold
p42000
(dp42001
sVPyridines
p42002
(dp42003
sVHistamine H1 Antagonists
p42004
g40791
sVAgents that produce hypertension
p42005
(dp42006
sVCytochrome P-450 CYP3A4 Substrates
p42007
(dp42008
sVCytochrome P-450 CYP3A5 Substrates
p42009
(dp42010
sVSerotonin Modulators
p42011
(dp42012
sVAntidepressive Agents
p42013
g15512
sVPeripheral alpha-1 blockers
p42014
g32716
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p42015
(dp42016
sVHistamine Antagonists
p42017
(dp42018
sVNervous System
p42019
(dp42020
sVTranquilizing Agents
p42021
(dp42022
sVCytochrome P-450 CYP3A7 Substrates
p42023
(dp42024
ssg3981
(dp42025
VSensory Organs
p42026
g40743
sVAgents that produce neuromuscular block (indirect)
p42027
g37968
sg4146
(dp42028
sg6600
(dp42029
sg5715
(dp42030
sVGlycosides
p42031
(dp42032
sVDermatologicals
p42033
g17317
sVOphthalmologicals
p42034
g35259
sg900
g20581
sg9504
(dp42035
sVAnti-Bacterial Agents
p42036
g38383
sVAnti-Infective Agents
p42037
(dp42038
sVCarbohydrates
p42039
(dp42040
sVNarrow Therapeutic Index Drugs
p42041
(dp42042
sVNasal Preparations
p42043
(dp42044
ssg3984
(dp42045
g771
g19303
sg6552
(dp42046
ssg3987
(dp42047
g7815
(dp42048
sg2346
g31408
sg2196
g30650
sg11403
(dp42049
sg1674
g26362
sg9135
(dp42050
sg12051
(dp42051
sg10326
(dp42052
sg5817
(dp42053
sg9528
(dp42054
sg8388
(dp42055
sg11601
(dp42056
sg2274
g31062
sg2946
g35839
sg9366
(dp42057
sg11427
(dp42058
sg9375
(dp42059
sg9411
(dp42060
sg6408
(dp42061
sg11151
(dp42062
sg2034
g29045
sg8625
(dp42063
sg4068
(dp42064
sg9414
(dp42065
sg9525
(dp42066
sg7458
(dp42067
sg9198
(dp42068
sg10899
(dp42069
sg9909
(dp42070
sg6699
(dp42071
sg10701
(dp42072
sg9081
(dp42073
sg78
g12879
sg2088
g29946
sg6792
(dp42074
sg2250
g30863
sg10509
(dp42075
sg11316
(dp42076
sg543
g17124
sg5313
(dp42077
sg9231
(dp42078
sg3027
g36389
sg10368
(dp42079
sg2391
g31743
sg11136
(dp42080
sg10752
(dp42081
sg318
g14908
sg10179
(dp42082
sg5727
(dp42083
sg6654
(dp42084
sg789
g19471
sg5127
(dp42085
sg3867
g41343
sg11334
(dp42086
sg9180
(dp42087
sg147
g13497
sg7500
(dp42088
sg11166
(dp42089
sg4863
(dp42090
sg2142
g30375
sg9444
(dp42091
sg12186
(dp42092
sg8760
(dp42093
sg1098
g22012
sg6807
(dp42094
sg1371
g24132
sg28215
g35385
sg5646
(dp42095
sg5919
(dp42096
sg285
g14620
sg2715
g33823
sg1110
g22135
sg11775
(dp42097
sg10794
(dp42098
ssg3990
(dp42099
VNitrogen Binding Agent
p42100
(dp42101
sVAnti-Acne Preparations for Topical Use
p42102
(dp42103
sVBenzene Derivatives
p42104
(dp42105
sVBenzoates
p42106
g30399
sVPeroxides
p42107
(dp42108
sVAcids, Carbocyclic
p42109
g41578
sVDermatologicals
p42110
g17216
sVAnti-Acne Preparations
p42111
(dp42112
sVKeratolytic Agents
p42113
(dp42114
ssg3993
(dp42115
g8595
(dp42116
ssg3996
(dp42117
g9267
(dp42118
ssg3999
(dp42119
g4155
(dp42120
sg7272
(dp42121
sg183
g13866
ssg4002
(dp42122
g6834
(dp42123
sVCardiotoxic antineoplastic agents
p42124
(dp42125
sVHeterocyclic Compounds, Fused-Ring
p42126
(dp42127
sVMyelosuppressive Agents
p42128
(dp42129
sVImmunosuppressive Agents
p42130
(dp42131
sg10461
(dp42132
sVLaboratory Chemicals
p42133
(dp42134
sg7245
(dp42135
sVP-glycoprotein/ABCB1 Inhibitors
p42136
(dp42137
sVCompounds used in a research, industrial, or household setting
p42138
(dp42139
sVAntineoplastic and Immunomodulating Agents
p42140
g39749
sg6165
(dp42141
sVAntineoplastic Agents
p42142
(dp42143
ssg4005
(dp42144
VOAT1/SLC22A6 inhibitors
p42145
(dp42146
sVCytochrome P-450 CYP3A Substrates
p42147
(dp42148
sVOAT1/SLC22A6 Substrates
p42149
(dp42150
sVThiazines
p42151
g16424
sVAnti-Infective Agents
p42152
(dp42153
sVAntiinfectives for Systemic Use
p42154
(dp42155
sVDrugs that are Mainly Renally Excreted
p42156
(dp42157
sVMATE substrates
p42158
(dp42159
sVbeta-Lactams
p42160
(dp42161
sVNephrotoxic agents
p42162
(dp42163
sVAza Compounds
p42164
(dp42165
sVAmides
p42166
(dp42167
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42168
g29312
sVSulfur Compounds
p42169
(dp42170
sVAnti-Bacterial Agents
p42171
g38335
sVCephalosporins
p42172
(dp42173
sVMATE 1 Substrates
p42174
g23507
sVFirst-Generation Cephalosporins
p42175
(dp42176
sVAzabicyclo Compounds
p42177
(dp42178
sVOAT3/SLC22A8 Substrates
p42179
g13149
sVLactams
p42180
g22293
sVAntibacterials for Systemic Use
p42181
g32540
sVCytochrome P-450 CYP3A4 Substrates
p42182
(dp42183
sVHeterocyclic Compounds, Fused-Ring
p42184
(dp42185
sVOAT3/SLC22A8 Inhibitors
p42186
(dp42187
ssg4008
(dp42188
VDrugs that are Mainly Renally Excreted
p42189
(dp42190
sVPiperidines
p42191
(dp42192
sVVarious Alimentary Tract and Metabolism Products
p42193
(dp42194
sVUGT1A1 Substrates
p42195
g12339
sVCarbohydrates
p42196
(dp42197
sg726
g19106
sg7785
(dp42198
sg5826
(dp42199
sVAlkaloids
p42200
g19449
sVAlimentary Tract and Metabolism
p42201
g23803
sVOther Miscellaneous Therapeutic Agents
p42202
g28777
ssg4011
(dp42203
g1719
g26854
sg10701
(dp42204
sg5268
(dp42205
sg9618
(dp42206
ssg4014
(dp42207
VHydrocarbons, Acyclic
p42208
g19578
sg6732
(dp42209
sVNoxae
p42210
(dp42211
sVImmunologic Factors
p42212
(dp42213
sVCytochrome P-450 CYP3A Substrates
p42214
(dp42215
sVAlkanes
p42216
(dp42217
sVAntineoplastic Agents, Alkylating
p42218
(dp42219
sVMyelosuppressive Agents
p42220
(dp42221
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42222
g29314
sVSulfonic Acids
p42223
(dp42224
sVMyeloablative Agonists
p42225
(dp42226
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p42227
(dp42228
sVAlkanesulfonates
p42229
g22880
sVSulfur Compounds
p42230
(dp42231
sVAcids
p42232
g40565
sg6450
(dp42233
sVAlkylating Drugs
p42234
(dp42235
sVCytochrome P-450 CYP3A4 Substrates
p42236
(dp42237
sVNarrow Therapeutic Index Drugs
p42238
(dp42239
sVGlycols
p42240
(dp42241
sVToxic Actions
p42242
(dp42243
sVCardiotoxic antineoplastic agents
p42244
(dp42245
sVImmunosuppressive Agents
p42246
(dp42247
sVAcids, Noncarboxylic
p42248
(dp42249
sVAlkylating Activity
p42250
(dp42251
sVAlkanesulfonic Acids
p42252
g32765
sVSulfur Acids
p42253
(dp42254
sVAntineoplastic Agents
p42255
(dp42256
sVAntineoplastic and Immunomodulating Agents
p42257
g39750
sVAlcohols
p42258
(dp42259
ssg4017
(dp42260
VAgents Causing Muscle Toxicity
p42261
(dp42262
sg11214
(dp42263
sVCytochrome P-450 CYP3A4 Inhibitors
p42264
(dp42265
sg7617
(dp42266
sg3843
g41059
sg11034
(dp42267
sg1494
g25134
sg5244
(dp42268
sVCytochrome P-450 CYP2C9 Inhibitors
p42269
g18195
sVCytochrome P-450 Enzyme Inhibitors
p42270
(dp42271
sVAnti-Infective Agents
p42272
(dp42273
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p42274
(dp42275
sg9171
(dp42276
sg4254
(dp42277
sg1257
g23093
sg8160
(dp42278
sg8652
(dp42279
sg4674
(dp42280
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p42281
g14785
sg3357
g38337
sVCytochrome P-450 CYP2E1 Inducers
p42282
g27606
sg9222
(dp42283
sg6099
(dp42284
sg4512
(dp42285
sg333
g14985
sg4719
(dp42286
sVPyridines
p42287
(dp42288
sg9447
(dp42289
sg4323
(dp42290
sg8865
(dp42291
sg9048
(dp42292
sg7338
(dp42293
sg747
g19156
sg5142
(dp42294
sg5151
(dp42295
sg1161
g22561
sVCytochrome P-450 CYP3A Inhibitors
p42296
(dp42297
sg11355
(dp42298
sVCytochrome P-450 Enzyme Inducers
p42299
g28150
sg4968
(dp42300
sg9867
(dp42301
ssg4020
(dp42302
g6291
(dp42303
sg7740
(dp42304
sg5007
(dp42305
sg7077
(dp42306
sg3696
g40259
sg6000
(dp42307
ssg4023
(dp42308
VAgents Causing Muscle Toxicity
p42309
(dp42310
sVCytochrome P-450 CYP3A4 Inhibitors
p42311
(dp42312
sVAntigout Preparations
p42313
(dp42314
sVCytochrome P-450 CYP3A Substrates
p42315
(dp42316
sg4218
(dp42317
sVCYP3A Substrates (Sensitive)
p42318
(dp42319
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p42320
(dp42321
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p42322
g12681
sVCytochrome P-450 Enzyme Inhibitors
p42323
(dp42324
sg6222
(dp42325
sVCytochrome P-450 CYP2E1 Inducers
p42326
g27608
sVAntimitotic Agents
p42327
(dp42328
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p42329
g23094
sVMyelosuppressive Agents
p42330
(dp42331
sVTubulin Modulators
p42332
g33852
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p42333
g14787
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42334
g29315
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p42335
(dp42336
sVCytochrome P-450 CYP3A4 Inducers
p42337
g18907
sVMusculo-Skeletal System
p42338
g31504
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p42339
(dp42340
sVCytochrome P450 3A4 Inhibitors
p42341
g13032
sVDrugs that are Mainly Renally Excreted
p42342
(dp42343
sVCytochrome P-450 CYP2C8 Inhibitors
p42344
(dp42345
sVCytochrome P-450 CYP2B6 Inhibitors
p42346
(dp42347
sVP-glycoprotein/ABCB1 Substrates
p42348
g34946
sVCytochrome P-450 Enzyme Inducers
p42349
g28151
sVCytochrome P-450 CYP3A Inducers
p42350
(dp42351
sVCytochrome P-450 CYP3A4 Substrates
p42352
(dp42353
sVMitosis Modulators
p42354
g33584
sVCytochrome P-450 CYP2C8 Inducers
p42355
(dp42356
sVCytochrome P-450 CYP3A Inhibitors
p42357
(dp42358
sVImmunosuppressive Agents
p42359
(dp42360
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p42361
(dp42362
sVP-glycoprotein/ABCB1 Inhibitors
p42363
(dp42364
sVAlkaloids
p42365
g19393
ssg4026
(dp42366
g1371
g24069
ssg4029
(dp42367
g4014
g42213
sg13750
g24381
sg4200
(dp42368
sg10839
(dp42369
sg447
g16286
sg10725
(dp42370
sg9705
(dp42371
sg16906
(dp42372
sg9525
(dp42373
sg7848
(dp42374
sg9348
(dp42375
sg9411
(dp42376
sg477
g16592
sg4863
(dp42377
sg3015
g36094
sg1266
g23213
sg1614
g25874
sg11079
(dp42378
sg1674
g26317
sg6612
(dp42379
sg9963
(dp42380
sg3609
g39668
sg6630
(dp42381
sg9612
(dp42382
sg2829
g34624
sg11133
(dp42383
sg11286
(dp42384
sg3963
g41844
sg10794
(dp42385
sg1152
g22532
sg7971
(dp42386
sg10698
(dp42387
sg4356
(dp42388
sg12090
(dp42389
sg10410
(dp42390
sg13091
g21355
sg2715
g33790
sg6714
(dp42391
sg6345
(dp42392
sg11775
(dp42393
sg1599
g25733
sg8751
(dp42394
sg7980
(dp42395
ssg4032
(dp42396
g2553
g32877
sg10767
(dp42397
sg5415
(dp42398
sg7920
(dp42399
sg1842
g27657
sg7548
(dp42400
sg4557
(dp42401
sg4770
(dp42402
sg8649
(dp42403
sg10764
(dp42404
sg6714
(dp42405
ssg4035
(dp42406
VAnticholinergic Agents
p42407
g24465
sVNeurotransmitter Agents
p42408
(dp42409
sVCentral Nervous System Agents
p42410
(dp42411
sVTropanes
p42412
(dp42413
sVMuscarinic Antagonists
p42414
(dp42415
sVAutonomic Agents
p42416
(dp42417
sVAdjuvants
p42418
(dp42419
sVPeripheral Nervous System Agents
p42420
(dp42421
sVAza Compounds
p42422
(dp42423
sVAdjuvants, Anesthesia
p42424
(dp42425
sVPsycholeptics
p42426
g33255
sVAntiemetics and Antinauseants
p42427
g41642
sVCentral Nervous System Depressants
p42428
(dp42429
sVAntiemetics
p42430
(dp42431
sVGastrointestinal Agents
p42432
(dp42433
sVScopolamine Derivatives
p42434
(dp42435
sVAzabicyclo Compounds
p42436
(dp42437
sVSolanaceous Alkaloids
p42438
(dp42439
sVMydriatics
p42440
(dp42441
sVSensory Organs
p42442
g40691
sVHypnotics and Sedatives
p42443
(dp42444
sVAlimentary Tract and Metabolism
p42445
g23893
sVAntimuscarinics Antispasmodics
p42446
g31225
sVMydriatics and Cycloplegics
p42447
(dp42448
sVOphthalmologicals
p42449
g35197
sVCholinergic Agents
p42450
g28714
sVBelladonna Alkaloids
p42451
(dp42452
sVP-glycoprotein/ABCB1 Inhibitors
p42453
(dp42454
sVAgents producing tachycardia
p42455
(dp42456
sVAlkaloids
p42457
g19399
sVNervous System
p42458
(dp42459
ssg4038
(dp42460
g219
g14078
sg465
g16446
sg10854
(dp42461
sg9924
(dp42462
sg11793
(dp42463
sg2430
g32118
sg11229
(dp42464
sg2481
g32387
sg5433
(dp42465
sg9918
(dp42466
sg12274
g27506
sg9033
(dp42467
sg1659
g26206
sg3885
g41433
sg4263
(dp42468
sg2598
g33123
sg6819
(dp42469
sg5271
(dp42470
sg4488
(dp42471
sg7824
(dp42472
sg339
g15151
sg8820
(dp42473
sg9759
(dp42474
sg12051
(dp42475
sg7305
(dp42476
sg9417
(dp42477
sg1881
g27937
sg2427
g31988
sg3240
g37699
sg2769
g34281
sg9231
(dp42478
sg10365
(dp42479
sg318
g14904
sg11241
(dp42480
sg6981
(dp42481
sg2832
g34682
sg3399
g38619
sg10761
(dp42482
sg9393
(dp42483
sg10416
(dp42484
sg9180
(dp42485
sg2493
g32607
sg10230
(dp42486
sg2688
g33611
sg14791
(dp42487
sg8760
(dp42488
sg4680
(dp42489
sg8472
(dp42490
sg10350
(dp42491
sg1767
g27025
sg7188
(dp42492
sg12126
(dp42493
sg2616
g33167
sg1635
g26024
sg7029
(dp42494
ssg4041
(dp42495
g5409
(dp42496
ssg4044
(dp42497
g10839
(dp42498
sg2466
g32331
ssg4047
(dp42499
g5847
(dp42500
ssg4050
(dp42501
g13750
g24362
sg2373
g31576
sg4620
(dp42502
sg255
g14374
sg1803
g27385
sg5427
(dp42503
sg7065
(dp42504
sg10857
(dp42505
sg9903
(dp42506
sg6570
(dp42507
sg1452
g24723
sg477
g16596
sg1260
g23149
sg8430
(dp42508
sg1614
g25856
sg4623
(dp42509
sg4638
(dp42510
sg4488
(dp42511
sg11667
(dp42512
sg14838
g39969
sg9402
(dp42513
sg2067
g29639
sg4683
(dp42514
sg5895
(dp42515
sg6804
(dp42516
sg723
g19101
sg9030
(dp42517
sg11319
(dp42518
sg5928
(dp42519
sg6102
(dp42520
sg12421
g12454
sg11439
(dp42521
sg3882
g41422
sg11445
(dp42522
sg6504
(dp42523
sg9819
(dp42524
sg5370
(dp42525
sg7896
(dp42526
sg6048
(dp42527
sg7197
(dp42528
sg6345
(dp42529
sg7014
(dp42530
sg612
g17873
sg9852
(dp42531
sg5796
(dp42532
ssg4053
(dp42533
VAmino Acids, Peptides, and Proteins
p42534
(dp42535
sVInsulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting
p42536
g32630
sVCytochrome P-450 CYP1A2 Inducers
p42537
(dp42538
sVPeptide Hormones
p42539
g20221
sVInsulin, Long-Acting
p42540
(dp42541
sVInsulin Analog
p42542
(dp42543
sVInsulins and Analogues for Injection, Long-Acting
p42544
g39631
sVInsulins and Analogues
p42545
(dp42546
sVPeptides
p42547
(dp42548
sVCytochrome P-450 Enzyme Inducers
p42549
g28134
sVInsulin
p42550
(dp42551
sVHormones
p42552
(dp42553
sVHormones, Hormone Substitutes, and Hormone Antagonists
p42554
(dp42555
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p42556
g17448
sVPancreatic Hormones
p42557
(dp42558
sVBlood Glucose Lowering Agents
p42559
(dp42560
sVAlimentary Tract and Metabolism
p42561
g23787
sVDrugs Used in Diabetes
p42562
(dp42563
sg9582
(dp42564
ssg4056
(dp42565
g3465
g38995
sVCytochrome P-450 CYP2D6 Substrates
p42566
(dp42567
sVAntiarrhythmic agents
p42568
(dp42569
sVNeurotransmitter Agents
p42570
(dp42571
sVHypotensive Agents
p42572
g34131
sVAmino Alcohols
p42573
g32694
sVAdrenergic Antagonists
p42574
(dp42575
sVPeripheral Nervous System Agents
p42576
(dp42577
sVSympatholytics
p42578
(dp42579
sVAmines
p42580
(dp42581
sVAntihypertensive Agents
p42582
g20268
sVAntiglaucoma Preparations and Miotics
p42583
g36566
sVAdrenergic Agents
p42584
g41729
sVAgents causing hyperkalemia
p42585
(dp42586
sVCardiovascular Agents
p42587
g26560
sVAdrenergic beta-Antagonists
p42588
g15369
sVPhenoxypropanolamines
p42589
g20865
sVSensory Organs
p42590
g40687
sVPropanolamines
p42591
g37514
sVAutonomic Agents
p42592
(dp42593
sVBeta Blocking Agents and Thiazides
p42594
(dp42595
sVOphthalmologicals
p42596
g35191
sVBradycardia-Causing Agents
p42597
(dp42598
sVPropanols
p42599
(dp42600
sVAlcohols
p42601
(dp42602
ssg4059
(dp42603
g8484
(dp42604
sg8439
(dp42605
ssg4062
(dp42606
VUGT1A1 Substrates
p42607
g12334
sVOAT1/SLC22A6 inhibitors
p42608
(dp42609
sVSulfanilamides
p42610
(dp42611
sVHypotensive Agents
p42612
g34144
sVHyperglycemia-Associated Agents
p42613
(dp42614
sVDrugs that are Mainly Renally Excreted
p42615
(dp42616
sVAmines
p42617
(dp42618
sVOtotoxic agents
p42619
(dp42620
sVGynecological Antiinfectives and Antiseptics
p42621
(dp42622
sVNephrotoxic agents
p42623
(dp42624
sVAcids, Carbocyclic
p42625
g41572
sVAmides
p42626
(dp42627
sVSulfur Compounds
p42628
(dp42629
sVAniline Compounds
p42630
g23422
sVSulfones
p42631
(dp42632
sVNatriuretic Agents
p42633
g40484
sVSodium Potassium Chloride Symporter Inhibitors
p42634
g26507
sVDiuretics
p42635
(dp42636
sVCardiovascular Agents
p42637
g26577
sVBenzene Derivatives
p42638
(dp42639
sVNon Potassium Sparing Diuretics
p42640
g14969
sVThyroxine-binding globulin substrates
p42641
(dp42642
sVHigh-Ceiling Diuretics and Potassium-Sparing Agents
p42643
(dp42644
sVMembrane Transport Modulators
p42645
(dp42646
sVAminobenzoates
p42647
(dp42648
sVGenito Urinary System and Sex Hormones
p42649
(dp42650
sVBenzoates
p42651
g30401
sVSulfonamides
p42652
(dp42653
sVOAT3/SLC22A8 Inhibitors
p42654
(dp42655
sVIncreased Diuresis at Loop of Henle
p42656
(dp42657
sVHigh-Ceiling Diuretics
p42658
(dp42659
ssg4065
(dp42660
g7464
(dp42661
sg6186
(dp42662
sg10818
(dp42663
sg4635
(dp42664
sg828
g19854
sg3531
g39267
sg4647
(dp42665
sg1650
g26102
sg3516
g39160
sg11472
(dp42666
sg4683
(dp42667
sg7824
(dp42668
sg11268
(dp42669
sg2433
g32162
sg909
g20634
sg5283
(dp42670
sg10725
(dp42671
sg5685
(dp42672
sg10740
(dp42673
sg9987
(dp42674
sg933
g20817
sg10410
(dp42675
sg1719
g26830
sg9252
(dp42676
sg10761
(dp42677
sg138
g13283
sg3849
g41167
sg10005
(dp42678
sg11445
(dp42679
sg6999
(dp42680
sg11544
(dp42681
sg171
g13717
sg10794
(dp42682
sg3240
g37710
sg5646
(dp42683
sg4056
g42581
sg2616
g33175
sg10815
(dp42684
sg10356
(dp42685
sg1605
g25765
sg7155
(dp42686
sg5598
(dp42687
sg7041
(dp42688
sg7053
(dp42689
sg2559
g32946
sg7056
(dp42690
sg10857
(dp42691
sg1044
g21543
sg4401
(dp42692
sg8928
(dp42693
sg255
g14408
sg7713
(dp42694
sg2583
g33073
sg6411
(dp42695
sg4062
g42618
sg4860
(dp42696
sg375
g15443
sg11649
(dp42697
sg4623
(dp42698
sg4638
(dp42699
sg288
g14662
sg11667
(dp42700
sg9402
(dp42701
sg8655
(dp42702
sg6348
(dp42703
sg1881
g27947
sg8463
(dp42704
sg4959
(dp42705
sg23
g12211
sg3432
g38796
sg7176
(dp42706
sg4974
(dp42707
sg1941
g28572
sg10227
(dp42708
sg2304
g31241
sg3447
g38924
sg1092
g21970
sg9828
(dp42709
sg10263
(dp42710
sg10266
(dp42711
sg11793
(dp42712
sg2763
g34234
sg456
g16375
sg5829
(dp42713
sg6570
(dp42714
sg10308
(dp42715
sg168
g13633
sg3504
g39100
sg1146
g22470
sg633
g18077
sg495
g16706
sg501
g16730
sg78
g12842
sg2067
g29659
sg5499
(dp42716
sg7305
(dp42717
sg2910
g35528
sg5919
(dp42718
sg9012
(dp42719
sg7320
(dp42720
sg3036
g36451
sg7569
(dp42721
sg7428
(dp42722
sg3114
g36863
sg11439
(dp42723
sg1668
g26247
sg8874
(dp42724
sg1371
g24091
sg4419
(dp42725
sg11916
(dp42726
sg1188
g22768
sg4830
(dp42727
sg3363
g38411
sg1635
g26065
sg612
g17899
sg9372
(dp42728
sg3639
g40071
sg8217
(dp42729
sg3651
g40114
sg2211
g30732
sg8163
(dp42730
sg6759
(dp42731
sg1704
g26709
sg9726
(dp42732
sg3684
g40239
sg8259
(dp42733
sg4488
(dp42734
sg1491
g25069
sg3708
g40380
sg2109
g30152
sg10692
(dp42735
sg3018
g36134
sg10515
(dp42736
sg9696
(dp42737
sg11319
(dp42738
sg6102
(dp42739
sg2277
g31118
sg9393
(dp42740
sg753
g19213
sg2289
g31192
sg1548
g25370
sg8862
(dp42741
sg10098
(dp42742
sg7416
(dp42743
sg10758
(dp42744
sg11361
(dp42745
sg5289
(dp42746
sg6381
(dp42747
sg7164
(dp42748
sg4596
(dp42749
sg9855
(dp42750
sg7608
(dp42751
sg5580
(dp42752
ssg4068
(dp42753
VNucleic Acid Synthesis Inhibitors
p42754
(dp42755
sVNoxae
p42756
(dp42757
sVCarbohydrates
p42758
(dp42759
sVHypotensive Agents
p42760
g34145
sVDrugs that are Mainly Renally Excreted
p42761
(dp42762
sVMyelosuppressive Agents
p42763
(dp42764
sVNucleoside Metabolic Inhibitor
p42765
(dp42766
sVRibonucleotides
p42767
(dp42768
sVAntimetabolites, Antineoplastic
p42769
g23450
sVAntineoplastic Agents
p42770
(dp42771
sVGlycosides
p42772
(dp42773
sVAntineoplastic and Immunomodulating Agents
p42774
g39762
sVNucleic Acids, Nucleotides, and Nucleosides
p42775
(dp42776
sVPurine Analogues
p42777
(dp42778
sVNucleotides
p42779
(dp42780
sVPurines
p42781
(dp42782
sVToxic Actions
p42783
(dp42784
sg4353
(dp42785
sVHeterocyclic Compounds, Fused-Ring
p42786
(dp42787
sVNucleosides
p42788
(dp42789
sVAntimetabolites
p42790
(dp42791
sg3585
g39610
sVImmunosuppressive Agents
p42792
(dp42793
sVBCRP/ABCG2 Substrates
p42794
g42064
sg8913
(dp42795
ssg4071
(dp42796
g11595
(dp42797
sg915
g20699
ssg4074
(dp42798
g10245
(dp42799
sg9111
(dp42800
sg7422
(dp42801
sg7533
(dp42802
sg1869
g27820
ssg4077
(dp42803
VAgents Causing Muscle Toxicity
p42804
(dp42805
sVBSEP/ABCB11 Substrates
p42806
(dp42807
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p42808
(dp42809
sVCytochrome P-450 CYP2D6 Inhibitors
p42810
(dp42811
sVUGT1A1 Substrates
p42812
g12285
sVCytochrome P-450 CYP3A Substrates
p42813
(dp42814
sVCytochrome P-450 CYP3A4 Inhibitors
p42815
(dp42816
sVCytochrome P-450 CYP2C9 Inhibitors
p42817
g18182
sVOATP1B1/SLCO1B1 Inhibitors
p42818
(dp42819
sVEnzyme Inhibitors
p42820
(dp42821
sVCytochrome P-450 Enzyme Inhibitors
p42822
(dp42823
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p42824
g18400
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p42825
(dp42826
sVCytochrome P-450 CYP2C8 Substrates
p42827
(dp42828
sVUGT1A3 substrates
p42829
g31806
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42830
g29321
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p42831
(dp42832
sVOATP1B1/SLCO1B1 Substrates
p42833
(dp42834
sVHypolipidemic Agents
p42835
(dp42836
sVLipid Modifying Agents
p42837
g40541
sg1521
g25229
sVCytochrome P-450 CYP2C8 Inhibitors
p42838
(dp42839
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p42840
(dp42841
sVCytochrome P-450 CYP3A4 Substrates
p42842
(dp42843
sVAnticholesteremic Agents
p42844
(dp42845
sVCytochrome P-450 CYP3A5 Substrates
p42846
(dp42847
sVCytochrome P-450 CYP3A Inhibitors
p42848
(dp42849
sVUGT2B7 substrates
p42850
g28630
sVP-glycoprotein/ABCB1 Inhibitors
p42851
(dp42852
sVCytochrome P-450 CYP3A7 Substrates
p42853
(dp42854
sVLipid Regulating Agents
p42855
(dp42856
ssg4080
(dp42857
g12274
g27575
sg5433
(dp42858
ssg4083
(dp42859
g1332
g23662
sg13070
g21894
sg3795
g40935
ssg4086
(dp42860
g3174
g37262
sg5865
(dp42861
sg30
g12374
sg351
g15266
sg9096
(dp42862
sg2739
g34003
ssg4089
(dp42863
VCytochrome P-450 CYP3A4 Substrates
p42864
(dp42865
sVAdrenal Cortex Hormones
p42866
g30028
sVSteroids
p42867
(dp42868
sVGlucocorticoids
p42869
g21936
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p42870
(dp42871
sVCytochrome P-450 CYP3A Substrates
p42872
(dp42873
sVImmunosuppressive Agents
p42874
(dp42875
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p42876
(dp42877
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p42878
(dp42879
sVAnti-Inflammatory Agents
p42880
(dp42881
sVCorticosteroid Hormone Receptor Agonists
p42882
(dp42883
sVCytochrome P-450 CYP3A5 Inducers
p42884
g41745
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42885
g29322
sVCytochrome P-450 CYP3A Inducers
p42886
(dp42887
sVCorticosteroids for Systemic Use
p42888
(dp42889
sVCorticosteroids for Systemic Use, Plain
p42890
g31766
sVFused-Ring Compounds
p42891
g14840
sVCorticosteroids
p42892
(dp42893
sVCytochrome P-450 CYP3A4 Inducers
p42894
g18915
sVCytochrome P-450 Enzyme Inducers
p42895
g28158
sVHyperglycemia-Associated Agents
p42896
(dp42897
ssg4092
(dp42898
g3267
g37901
ssg4095
(dp42899
VFolic Acid and Derivatives
p42900
(dp42901
sVVitamins
p42902
g12187
sVHematinics
p42903
(dp42904
sVInflammation Mediators
p42905
g23634
sVPteridines
p42906
(dp42907
sVDiet, Food, and Nutrition
p42908
g22911
sVLipids
p42909
g14347
sVFood and Beverages
p42910
(dp42911
sVAntianemic Preparations
p42912
(dp42913
sVPterins
p42914
(dp42915
sVDrugs that are Mainly Renally Excreted
p42916
(dp42917
sVMicronutrients
p42918
(dp42919
sVAutacoids
p42920
(dp42921
sVFood
p42922
(dp42923
sVPigments, Biological
p42924
g21857
sg8439
(dp42925
sVOAT1/SLC22A6 inhibitors
p42926
(dp42927
sg12186
(dp42928
sVVitamin B Complex
p42929
(dp42930
sVVITAMIN B12 AND FOLIC ACID
p42931
(dp42932
sVSupplements
p42933
g41788
sVGrowth Substances
p42934
(dp42935
sg8484
(dp42936
sVHematologic Agents
p42937
(dp42938
sVHeterocyclic Compounds, Fused-Ring
p42939
(dp42940
sVBCRP/ABCG2 Substrates
p42941
g42092
sVDietary Supplements
p42942
(dp42943
sVBiological Factors
p42944
g38103
ssg4098
(dp42945
g5622
(dp42946
sg7854
(dp42947
sg6903
(dp42948
sg8601
(dp42949
sg8598
(dp42950
ssg4101
(dp42951
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p42952
(dp42953
sVCytochrome P-450 CYP2D6 Substrates
p42954
(dp42955
sVAnalgesics
p42956
g26452
sVCentral Nervous System Agents
p42957
(dp42958
sVNarcotics
p42959
(dp42960
sVPeripheral Nervous System Agents
p42961
(dp42962
sVMorphine Derivatives
p42963
(dp42964
sVMorphinans
p42965
(dp42966
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p42967
g29323
sVCytochrome P-450 CYP3A Substrates
p42968
(dp42969
sVNatural Opium Alkaloids
p42970
g23484
sVCentral Nervous System Depressants
p42971
(dp42972
sVOpioids
p42973
g32240
sVOpiate Alkaloids
p42974
(dp42975
sVCytochrome P-450 CYP3A4 Substrates
p42976
(dp42977
sVSemi-synthetic Opioids
p42978
(dp42979
sVHeterocyclic Compounds, Fused-Ring
p42980
(dp42981
sVOpioid Agonist
p42982
(dp42983
sVAlkaloids
p42984
g19422
sVSensory System Agents
p42985
(dp42986
sVPhenanthrenes
p42987
g32840
sVNervous System
p42988
(dp42989
ssg4104
(dp42990
g6090
(dp42991
sg8454
(dp42992
sg7821
(dp42993
ssg4107
(dp42994
g10263
(dp42995
sg23
g12221
sg723
g19068
sg11649
(dp42996
sg7320
(dp42997
sg4623
(dp42998
sg5427
(dp42999
sg11319
(dp43000
sg5499
(dp43001
sg10857
(dp43002
sg4488
(dp43003
sg11667
(dp43004
sg10515
(dp43005
sg9402
(dp43006
sg2067
g29613
sg11439
(dp43007
sg612
g17842
sg11445
(dp43008
sg255
g14362
sg5796
(dp43009
ssg4110
(dp43010
g687
g18559
sg8580
(dp43011
sg3684
g40230
ssg4113
(dp43012
VOphthalmological and Otological Preparations
p43013
(dp43014
sVCytochrome P-450 CYP3A Substrates
p43015
(dp43016
sVStomatological Preparations
p43017
(dp43018
sVVasoprotectives
p43019
g41390
sVProdrugs
p43020
(dp43021
sVHormones
p43022
(dp43023
sVCorticosteroids for Systemic Use
p43024
(dp43025
sVHyperglycemia-Associated Agents
p43026
(dp43027
sVCorticosteroids for Systemic Use, Plain
p43028
g31758
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p43029
(dp43030
sVCorticosteroids Acting Locally
p43031
(dp43032
sVOtologicals
p43033
(dp43034
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p43035
(dp43036
sVPregnadienetriols
p43037
(dp43038
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p43039
g16831
sVCorticosteroids for Local Oral Treatment
p43040
(dp43041
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p43042
g29325
sVFused-Ring Compounds
p43043
g14844
sVCytochrome P-450 CYP3A4 Inducers
p43044
g18919
sVAntineoplastic Agents
p43045
(dp43046
sVAdrenal Cortex Hormones
p43047
g30037
sVCorticosteroids, Weak (Group I)
p43048
(dp43049
sVAdrenals
p43050
g37372
sVP-glycoprotein/ABCB1 Substrates
p43051
g34973
sVAntineoplastic Agents, Hormonal
p43052
(dp43053
sVDermatologicals
p43054
g17241
sVCytochrome P-450 Enzyme Inducers
p43055
g28161
sVCytochrome P-450 CYP3A Inducers
p43056
(dp43057
sVPrednisolone
p43058
(dp43059
sVPregnadienes
p43060
(dp43061
sVCytochrome P-450 CYP3A4 Substrates
p43062
(dp43063
sVAntidotes
p43064
(dp43065
sVAlimentary Tract and Metabolism
p43066
g23821
sVNasal Preparations
p43067
(dp43068
sVPregnanes
p43069
(dp43070
sVOphthalmologicals
p43071
g35208
sVSteroids
p43072
(dp43073
sVImmunosuppressive Agents
p43074
(dp43075
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p43076
(dp43077
sVAnti-Inflammatory Agents
p43078
(dp43079
sVCorticosteroid Hormone Receptor Agonists
p43080
(dp43081
sVCorticosteroids, Dermatological Preparations
p43082
(dp43083
sVHormones, Hormone Substitutes, and Hormone Antagonists
p43084
(dp43085
sVCorticosteroids
p43086
(dp43087
sVIntestinal Antiinflammatory Agents
p43088
(dp43089
sVSensory Organs
p43090
g40702
ssg4116
(dp43091
g10209
(dp43092
sg2832
g34716
sg1470
g24917
sg507
g16779
sg849
g20090
sg9225
(dp43093
sg2127
g30246
sg3117
g36919
sg14822
g41820
sg2133
g30297
sg3783
g40879
ssg4119
(dp43094
g6279
(dp43095
sg12045
(dp43096
sg11592
(dp43097
sg1140
g22412
ssg4122
(dp43098
g3627
g39926
sg444
g16246
sg7848
(dp43099
sg11619
(dp43100
sg6579
(dp43101
sg6231
(dp43102
sg10680
(dp43103
sg7164
(dp43104
sg375
g15441
sg11460
(dp43105
sg3144
g37106
sg2058
g29183
sg288
g14660
sg8454
(dp43106
sg8823
(dp43107
sg2079
g29847
sg3018
g36132
sg2094
g29977
sg4467
(dp43108
sg12060
(dp43109
sg5112
(dp43110
sg9252
(dp43111
sg561
g17365
sg4440
(dp43112
sg4959
(dp43113
sg11541
(dp43114
sg7626
(dp43115
sg2316
g31287
sg7692
(dp43116
sg717
g19053
sg5595
(dp43117
sg1401
g24310
ssg4125
(dp43118
g4596
(dp43119
sg7053
(dp43120
sg7428
(dp43121
sg3651
g40146
sg3516
g39195
ssg4128
(dp43122
g1482
g25021
ssg4131
(dp43123
g6765
(dp43124
sg6009
(dp43125
sg13091
g21361
sg7848
(dp43126
ssg4134
(dp43127
g6843
(dp43128
sg528
g16922
sg5028
(dp43129
sg6246
(dp43130
sg4491
(dp43131
sg834
g19962
sg9366
(dp43132
sg147
g13429
ssg4137
(dp43133
g771
g19298
ssg4140
(dp43134
g19588
g32511
ssg4143
(dp43135
VAgents Causing Muscle Toxicity
p43136
(dp43137
sVAmino Acids, Peptides, and Proteins
p43138
(dp43139
sg6414
(dp43140
sVPituitary and Hypothalamic Hormones and Analogues
p43141
(dp43142
sVPeptide Hormones
p43143
g20226
sg8151
(dp43144
sVAnterior Pituitary Lobe Hormones and Analogues
p43145
(dp43146
sg10380
(dp43147
sVPituitary Hormones, Anterior
p43148
g24147
sg3459
g38987
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p43149
(dp43150
sVPeptides
p43151
(dp43152
sg3660
g40194
sVHormones
p43153
(dp43154
sVHormones, Hormone Substitutes, and Hormone Antagonists
p43155
(dp43156
sVPituitary Hormones
p43157
g15921
sg10614
(dp43158
sVSomatropin and Somatropin Agonists
p43159
(dp43160
sg2340
g31336
ssg4146
(dp43161
g11733
(dp43162
sg10548
(dp43163
sg3981
g42028
sg10314
(dp43164
sg4902
(dp43165
sg10890
(dp43166
ssg4149
(dp43167
g1260
g23147
sg723
g19103
sg1803
g27397
sg255
g14386
sg4623
(dp43168
sg5427
(dp43169
sg7896
(dp43170
sg10857
(dp43171
sg4488
(dp43172
sg11667
(dp43173
sg9402
(dp43174
sg6570
(dp43175
sg11439
(dp43176
sg1452
g24731
sg5796
(dp43177
ssg4152
(dp43178
g7464
(dp43179
sg10818
(dp43180
sg4635
(dp43181
sg11727
(dp43182
sg7569
(dp43183
sg1491
g25093
sg3447
g38944
sg1770
g27060
ssg4155
(dp43184
VPyrimidines
p43185
(dp43186
sVAnticholinergic Agents
p43187
g24504
sVGABA Agents
p43188
g16223
sVNeurotransmitter Agents
p43189
(dp43190
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p43191
(dp43192
sVCentral Nervous System Agents
p43193
(dp43194
sVPhenobarbital and similars
p43195
(dp43196
sVBSEP/ABCB11 inducers
p43197
(dp43198
sVCytochrome P-450 CYP3A7 Inducers
p43199
g39038
sVGABA Modulators
p43200
g39059
sVCytochrome P-450 CYP2C9 Inducers
p43201
g20051
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p43202
g16532
sg10668
(dp43203
sVCytochrome P-450 CYP2E1 Inducers
p43204
g27607
sVP-glycoprotein/ABCB1 Inducers
p43205
(dp43206
sVCytochrome P-450 CYP3A4 Inducers (strong)
p43207
g23080
sVCytochrome P-450 CYP2C8 Inducers (strong)
p43208
(dp43209
sVCytochrome P-450 CYP2B6 Inducers
p43210
g39128
sVExcitatory Amino Acid Antagonists
p43211
(dp43212
sVBarbiturates
p43213
(dp43214
sVCytochrome P-450 CYP1A2 Inducers (strong)
p43215
g34432
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p43216
g14786
sVEnzyme Inducing Antiepileptic Drugs
p43217
g25037
sVExcitatory Amino Acid Agents
p43218
g14797
sVCytochrome P-450 CYP2C9 Substrates
p43219
g29757
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p43220
g25151
sVCytochrome P-450 CYP3A4 Inducers
p43221
g18924
sg5994
(dp43222
sVCytochrome P-450 CYP2C19 Substrates
p43223
(dp43224
sVCentral Nervous System Depressants
p43225
(dp43226
sVCytochrome P-450 CYP3A5 Inducers
p43227
g41753
sVCytochrome P-450 CYP1A2 Inducers
p43228
(dp43229
sVP-glycoprotein/ABCB1 Substrates
p43230
g34983
sVAnticonvulsants
p43231
(dp43232
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p43233
(dp43234
sVCytochrome P-450 CYP2B6 Inducers (strong)
p43235
(dp43236
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p43237
g37401
sVCytochrome P-450 Enzyme Inducers
p43238
g28186
sVCytochrome P-450 CYP3A Inducers
p43239
(dp43240
sVPsycholeptics
p43241
g33257
sVCytochrome P-450 CYP3A Inducers (strong)
p43242
g22459
sVCytochrome P-450 CYP2A6 Inducers
p43243
g39425
sVHypnotics and Sedatives
p43244
(dp43245
sVNarrow Therapeutic Index Drugs
p43246
(dp43247
sVNicotinic Antagonists
p43248
(dp43249
sVUGT1A1 Inducers
p43250
g39248
sVPyrimidinones
p43251
(dp43252
sVCytochrome P-450 CYP2C8 Inducers
p43253
(dp43254
sg231
g14152
sVCytochrome P-450 CYP2C19 Inducers
p43255
g25544
sVMethemoglobinemia Associated Agents
p43256
g25582
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p43257
(dp43258
sVBarbiturates and Derivatives
p43259
g42120
sVChemically-Induced Disorders
p43260
g21244
sVNervous System
p43261
(dp43262
sg7404
(dp43263
ssg4158
(dp43264
g9102
(dp43265
sg1461
g24851
ssg4161
(dp43266
g6489
(dp43267
sg858
g20146
sg28215
g35380
sg9528
(dp43268
sg11151
(dp43269
ssg4164
(dp43270
VBSEP/ABCB11 Substrates
p43271
(dp43272
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p43273
(dp43274
sVAntivirals for Systemic Use
p43275
(dp43276
sVNucleic Acid Synthesis Inhibitors
p43277
(dp43278
sVCytochrome P-450 CYP2D6 Inhibitors
p43279
(dp43280
sVCytochrome P-450 CYP3A Substrates
p43281
(dp43282
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p43283
(dp43284
sVCytochrome P-450 CYP3A4 Inhibitors
p43285
(dp43286
sVDirect Acting Antivirals
p43287
g38079
sVEnzyme Inhibitors
p43288
(dp43289
sVCytochrome P450 3A4 Inhibitors
p43290
g13051
sVAntiviral Agents
p43291
g30471
sVCytochrome P-450 CYP2C9 Inhibitors
p43292
g18209
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p43293
g12680
sVCytochrome P-450 Enzyme Inhibitors
p43294
(dp43295
sVAnti-Infective Agents
p43296
(dp43297
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p43298
g18427
sVReverse Transcriptase Inhibitors
p43299
g28955
sVNonnucleoside Reverse Transcriptase Inhibitors
p43300
g34331
sVAntiinfectives for Systemic Use
p43301
(dp43302
sVAnti-Retroviral Agents
p43303
(dp43304
sVCytochrome P-450 CYP2B6 Inducers
p43305
g39130
sVCytochrome P-450 CYP2C19 Inhibitors (moderate)
p43306
(dp43307
sVUGT1A1 Inducers
p43308
g39242
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p43309
g29331
sVCytochrome P450 2C9 Inhibitors
p43310
(dp43311
sVQTc Prolonging Agents
p43312
(dp43313
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p43314
g25154
sVCytochrome P-450 CYP3A4 Inducers
p43315
g18925
sVOCT1 inhibitors
p43316
(dp43317
sVOxazines
p43318
(dp43319
sVCentral Nervous System Depressants
p43320
(dp43321
sVCytochrome P-450 CYP3A5 Inducers
p43322
g41754
sVCytochrome P-450 CYP3A7 Inducers
p43323
g39039
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p43324
(dp43325
sVCytochrome P-450 CYP1A2 Inhibitors
p43326
g15041
sVCytochrome P-450 CYP2C8 Inhibitors
p43327
(dp43328
sVCytochrome P-450 CYP2B6 Inhibitors
p43329
(dp43330
sVHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
p43331
(dp43332
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p43333
(dp43334
sVCytochrome P450 3A Inducers
p43335
(dp43336
sVCytochrome P-450 Enzyme Inducers
p43337
g28171
sVCytochrome P-450 CYP3A Inducers
p43338
(dp43339
sVInducers of Drug Clearance
p43340
(dp43341
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p43342
(dp43343
sVCytochrome P-450 CYP2C19 Inhibitors
p43344
(dp43345
sVCytochrome P-450 CYP3A Inhibitors (strong)
p43346
g13410
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p43347
(dp43348
sVModerate Risk QTc-Prolonging Agents
p43349
(dp43350
sVCytochrome P-450 CYP3A4 Substrates
p43351
(dp43352
sVHeterocyclic Compounds, Fused-Ring
p43353
(dp43354
sVNon-Nucleoside Reverse Transcriptase Inhibitors
p43355
g15488
sVCytochrome P-450 CYP3A Inhibitors
p43356
(dp43357
sVCytochrome P-450 CYP2C19 Inducers
p43358
g25547
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p43359
(dp43360
sVCytochrome P-450 CYP3A7 Inducers (moderate)
p43361
g28100
sVChemically-Induced Disorders
p43362
g21245
sVCytochrome P450 2C19 Inhibitors
p43363
(dp43364
sVCytochrome P-450 CYP2B6 Substrates
p43365
g33035
ssg4167
(dp43366
g171
g13732
sg495
g16700
sg11268
(dp43367
sg3684
g40246
sg4419
(dp43368
sg11916
(dp43369
sg11361
(dp43370
sg2277
g31108
sg6381
(dp43371
sg7824
(dp43372
sg6570
(dp43373
sg4683
(dp43374
sg753
g19217
ssg4170
(dp43375
VAmino Acids, Peptides, and Proteins
p43376
(dp43377
sg10968
(dp43378
sg870
g20229
sVGenito Urinary System and Sex Hormones
p43379
(dp43380
sg3549
g39414
sg8943
(dp43381
sg4734
(dp43382
sg8073
(dp43383
sg7995
(dp43384
sg411
g15915
sg1380
g24144
sVHormones
p43385
(dp43386
sVHormones, Hormone Substitutes, and Hormone Antagonists
p43387
(dp43388
sg810
g19616
sg8184
(dp43389
ssg4173
(dp43390
VAdrenergic Agents
p43391
g41728
sVNeurotransmitter Uptake Inhibitors
p43392
(dp43393
sVHeterocyclic Compounds, Fused-Ring
p43394
(dp43395
sg5913
(dp43396
sVCytochrome P-450 CYP2D6 Substrates
p43397
(dp43398
sVNeurotransmitter Agents
p43399
(dp43400
sg5253
(dp43401
sVMembrane Transport Modulators
p43402
(dp43403
sg1536
g25286
sVMiscellaneous Central Nervous System Agents
p43404
(dp43405
sVQTc Prolonging Agents
p43406
(dp43407
sVNervous System
p43408
(dp43409
sVHighest Risk QTc-Prolonging Agents
p43410
g35871
ssg4176
(dp43411
g1059
g21783
ssg4179
(dp43412
g195
g13918
sg3000
g36033
ssg4182
(dp43413
g6729
(dp43414
sg11790
(dp43415
sg11955
(dp43416
sg6186
(dp43417
sg11793
(dp43418
sg9879
(dp43419
sg6012
(dp43420
sg240
g14217
sg6318
(dp43421
sg8394
(dp43422
sg11979
(dp43423
sg10296
(dp43424
sg2013
g28941
sg9711
(dp43425
sg10662
(dp43426
sg11265
(dp43427
sg1248
g23049
sg6303
(dp43428
sg11721
(dp43429
sg7275
(dp43430
sg7983
(dp43431
sg11016
(dp43432
sg10497
(dp43433
sg9579
(dp43434
sg2427
g32035
sg10365
(dp43435
sg7299
(dp43436
sg9759
(dp43437
sg11292
(dp43438
sg9966
(dp43439
sg8097
(dp43440
sg9417
(dp43441
sg3732
g40523
sg405
g15897
sg2769
g34317
sg12066
(dp43442
sg2841
g34863
sg2733
g33921
sg10533
(dp43443
sg945
g20914
sg9981
(dp43444
sg9393
(dp43445
sg7497
(dp43446
sg8463
(dp43447
sg11163
(dp43448
sg3975
g41936
sg4344
(dp43449
sg696
g18743
sg7941
(dp43450
sg8139
(dp43451
sg3978
g42018
sg5169
(dp43452
sg387
g15653
sg9465
(dp43453
sg1188
g22791
sg1464
g24874
sg2664
g33457
sg10815
(dp43454
sg11241
(dp43455
sg7029
(dp43456
sg1092
g21997
sg7041
(dp43457
sg9684
(dp43458
ssg4185
(dp43459
VAmino Acids, Peptides, and Proteins
p43460
(dp43461
sVGlobulins
p43462
g19199
sVAntibodies
p43463
(dp43464
sVAntibodies, Monoclonal
p43465
(dp43466
sg2448
g32200
sVAntibodies, Monoclonal, Humanized
p43467
(dp43468
sVProteins
p43469
(dp43470
sVAntineoplastic Agents, Immunological
p43471
(dp43472
sVImmunoglobulins
p43473
g41539
sVImmunosuppressive Agents
p43474
(dp43475
sVCardiotoxic antineoplastic agents
p43476
(dp43477
sVSerum Globulins
p43478
(dp43479
sVAntineoplastic and Immunomodulating Agents
p43480
g39775
sVBlood Proteins
p43481
g39874
sg3666
g40197
sVAntineoplastic Agents
p43482
(dp43483
sVImmunoproteins
p43484
(dp43485
ssg4188
(dp43486
g1761
g26978
sg11604
(dp43487
ssg4191
(dp43488
g1464
g24880
sg2733
g33929
sg7275
(dp43489
sg10662
(dp43490
ssg4194
(dp43491
g3570
g39442
sg1113
g22203
sg6186
(dp43492
sg2199
g30657
sg6525
(dp43493
sg10596
(dp43494
sg8163
(dp43495
sg10854
(dp43496
sg7329
(dp43497
sg5694
(dp43498
sg7041
(dp43499
sg1434
g24609
ssg4197
(dp43500
g3375
g38446
sVCardiovascular Agents
p43501
g26605
sg3894
g41479
sVMyelosuppressive Agents
p43502
(dp43503
sVDrugs that are Mainly Renally Excreted
p43504
(dp43505
sVImmunosuppressive Agents
p43506
(dp43507
sVDetoxifying Agents for Antineoplastic Treatment
p43508
(dp43509
sVTopoisomerase II Inhibitors
p43510
g40633
sVProtective Agents
p43511
(dp43512
sVCompounds used in a research, industrial, or household setting
p43513
(dp43514
sVEnzyme Inhibitors
p43515
(dp43516
sg8304
(dp43517
sVPiperazines
p43518
(dp43519
sVMiscellaneous Therapeutic Agents
p43520
(dp43521
sVTopoisomerase Inhibitors
p43522
g32849
ssg4200
(dp43523
VAmino Acids, Peptides, and Proteins
p43524
(dp43525
sg9063
(dp43526
sVAntibodies
p43527
(dp43528
sVProteins
p43529
(dp43530
sg11013
(dp43531
sVSelective Immunosuppressants
p43532
g23572
sVNoxae
p43533
(dp43534
sVImmunologic Factors
p43535
g42368
sVImmunosuppressive Agents
p43536
(dp43537
sg2802
g34437
sVToxic Actions
p43538
(dp43539
sVSerum Globulins
p43540
(dp43541
sVAntineoplastic and Immunomodulating Agents
p43542
g39779
sVAntirheumatic Agents
p43543
g24204
sVBlood Proteins
p43544
g39850
sg1446
g24709
sVImmunoconjugates
p43545
(dp43546
sVGlobulins
p43547
g19171
sVImmunoproteins
p43548
(dp43549
ssg4203
(dp43550
g10200
(dp43551
sg21710
(dp43552
ssg4206
(dp43553
g9153
(dp43554
sg1812
g27470
sg2676
g33552
sg4008
g42194
sg6093
(dp43555
sg9765
(dp43556
sg1014
g21325
ssg4209
(dp43557
g7164
(dp43558
sg375
g15425
sg11649
(dp43559
sg7905
(dp43560
sg1635
g26019
sg4488
(dp43561
ssg4212
(dp43562
g10629
(dp43563
sg2403
g31831
sg7740
(dp43564
sg12114
(dp43565
sg10005
(dp43566
sg3531
g39277
sg4788
(dp43567
sg4803
(dp43568
sg7821
(dp43569
sg7650
(dp43570
sg10011
(dp43571
sg8418
(dp43572
sg1914
g28409
sg5472
(dp43573
sg7671
(dp43574
sg5007
(dp43575
sg8433
(dp43576
sg891
g20553
sg2088
g29889
sg6267
(dp43577
sg909
g20618
sg10347
(dp43578
sg8460
(dp43579
sg7344
(dp43580
sg3177
g37299
sg2835
g34759
sg10740
(dp43581
sg2391
g31730
sg1719
g26818
sg10761
(dp43582
sg4746
(dp43583
sg963
g20999
sg966
g21031
sg7764
(dp43584
sg3279
g37937
sg171
g13707
sg1767
g27016
sg3240
g37696
sg7077
(dp43585
sg4056
g42586
sg2616
g33161
sg5589
(dp43586
sg1110
g22131
sg5595
(dp43587
sg213
g14042
sg3708
g40369
sg5619
(dp43588
sg1035
g21452
sg8166
(dp43589
sg1044
g21550
sg1050
g21678
sg11619
(dp43590
sg7521
(dp43591
sg3426
g38764
sg5457
(dp43592
sg195
g13903
sg1869
g27810
sg9987
(dp43593
sg3408
g38710
sg1911
g28343
sg72
g12805
sg7161
(dp43594
sg4959
(dp43595
sg10200
(dp43596
sg4974
(dp43597
sg8226
(dp43598
sg10227
(dp43599
sg7191
(dp43600
sg2304
g31250
sg420
g16005
sg10263
(dp43601
sg5805
(dp43602
sg9519
(dp43603
sg11805
(dp43604
sg5829
(dp43605
sg1047
g21580
sg1059
g21735
sg3087
g36643
sg4260
(dp43606
sg10320
(dp43607
sg11079
(dp43608
sg9561
(dp43609
sg10977
(dp43610
sg8820
(dp43611
sg9702
(dp43612
sg5094
(dp43613
sg10557
(dp43614
sg9012
(dp43615
sg12060
(dp43616
sg3036
g36419
sg6024
(dp43617
sg3963
g41848
sg1578
g25644
sg7944
(dp43618
sg3114
g36849
sg10350
(dp43619
sg8595
(dp43620
sg11934
(dp43621
sg336
g15065
sg5199
(dp43622
sg8019
(dp43623
sg4425
(dp43624
sg5229
(dp43625
sg11229
(dp43626
sg11976
(dp43627
sg5235
(dp43628
sg4452
(dp43629
sg657
g18289
sg1857
g27692
sg5250
(dp43630
sg6759
(dp43631
sg684
g18487
sg4845
(dp43632
sg3696
g40267
sg10494
(dp43633
sg4716
(dp43634
sg3711
g40441
sg9009
(dp43635
sg2109
g30134
sg11301
(dp43636
sg12063
(dp43637
sg9780
(dp43638
sg9783
(dp43639
sg5238
(dp43640
sg6000
(dp43641
sg3297
g38029
sg5394
(dp43642
sg1548
g25356
sg8862
(dp43643
sg10098
(dp43644
sg6291
(dp43645
sg3072
g36579
sg5181
(dp43646
sg5289
(dp43647
sg7596
(dp43648
sg6162
(dp43649
sg5580
(dp43650
ssg4215
(dp43651
g8055
(dp43652
sg10563
(dp43653
sg2043
g29060
sg8445
(dp43654
sg10209
(dp43655
sg834
g19935
sg9366
(dp43656
sg147
g13447
sg8013
(dp43657
ssg4218
(dp43658
g4023
g42317
ssg4221
(dp43659
g1791
g27224
sg8163
(dp43660
sg10149
(dp43661
sg9726
(dp43662
sg4638
(dp43663
sg8655
(dp43664
sg8457
(dp43665
sg6807
(dp43666
sg7389
(dp43667
sg9618
(dp43668
sg3027
g36348
sg7524
(dp43669
sg345
g15211
sg5112
(dp43670
sg10854
(dp43671
sg19588
g32461
sg1917
g28448
sg4959
(dp43672
sg10581
(dp43673
sg4377
(dp43674
sg5973
(dp43675
sg9765
(dp43676
sg717
g19051
sg2172
g30500
sg7155
(dp43677
sg1611
g25798
ssg4224
(dp43678
g10854
(dp43679
ssg4227
(dp43680
g528
g16923
sg5028
(dp43681
sg834
g19943
sg9366
(dp43682
sg147
g13431
sg8013
(dp43683
ssg4230
(dp43684
g5067
(dp43685
ssg4233
(dp43686
g4713
(dp43687
ssg4236
(dp43688
VSteroids
p43689
(dp43690
sVSex Hormones and Modulators of the Genital System
p43691
g19600
sVAndrogens and Estrogens
p43692
g28843
sVCytochrome P-450 CYP3A Substrates
p43693
(dp43694
sVCytochrome P-450 CYP2B6 Substrates
p43695
g33038
sVHormones
p43696
(dp43697
sVDrugs that are Mainly Renally Excreted
p43698
(dp43699
sV3-Oxoandrosten (4) Derivatives
p43700
(dp43701
sVAndrostanes
p43702
(dp43703
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p43704
g29337
sVFused-Ring Compounds
p43705
g14855
sVAntineoplastic Agents
p43706
(dp43707
sVAndrostenols
p43708
g16961
sVAndrostenes
p43709
(dp43710
sVAntineoplastic Agents, Hormonal
p43711
(dp43712
sVAndrogens
p43713
(dp43714
sVAnabolic Agents
p43715
g33536
sVCytochrome P-450 CYP3A4 Substrates
p43716
(dp43717
sVGonadal Hormones
p43718
g33574
sVGenito Urinary System and Sex Hormones
p43719
(dp43720
sVGonadal Steroid Hormones
p43721
(dp43722
sVTestosterone Congeners
p43723
(dp43724
sVOAT3/SLC22A8 Inducers
p43725
(dp43726
sVHormones, Hormone Substitutes, and Hormone Antagonists
p43727
(dp43728
ssg4239
(dp43729
g8373
(dp43730
sg3105
g36764
sg30
g12354
sg3846
g41100
sg3858
g41201
sg816
g19640
sg5454
(dp43731
sg11151
(dp43732
sg3141
g37053
sg8022
(dp43733
sg2046
g29103
sg2427
g31996
sg2358
g31464
sg4887
(dp43734
sg102
g12997
sg6807
(dp43735
sg3174
g37250
sg3657
g40163
sg11337
(dp43736
sg9144
(dp43737
sg8514
(dp43738
sg9267
(dp43739
sg147
g13437
sg4782
(dp43740
sg10356
(dp43741
sg204
g13946
sg4023
g42321
sg7353
(dp43742
sg11601
(dp43743
sg9366
(dp43744
sg282
g14539
sg10122
(dp43745
sg9099
(dp43746
sg10899
(dp43747
sg11667
(dp43748
sg5208
(dp43749
sg8673
(dp43750
sg9462
(dp43751
sg9444
(dp43752
sg1908
g28279
sg10179
(dp43753
sg2688
g33615
sg5256
(dp43754
sg621
g17946
sg11385
(dp43755
sg426
g16065
sg10266
(dp43756
sg3912
g41601
sg2481
g32391
sg456
g16399
sg9528
(dp43757
sg5832
(dp43758
sg1239
g22933
sg10308
(dp43759
sg11838
(dp43760
sg8721
(dp43761
sg5865
(dp43762
sg6699
(dp43763
sg9564
(dp43764
sg10335
(dp43765
sg11940
(dp43766
sg8820
(dp43767
sg11097
(dp43768
sg9591
(dp43769
sg2838
g34782
sg11136
(dp43770
sg6504
(dp43771
sg8454
(dp43772
sg2142
g30339
sg9963
(dp43773
sg141
g13326
sg6687
(dp43774
sg28215
g35346
sg2895
g35410
sg10878
(dp43775
sg11931
(dp43776
sg8190
(dp43777
sg10470
(dp43778
sg2943
g35747
sg10728
(dp43779
sg4452
(dp43780
sg1434
g24635
sg8211
(dp43781
sg6033
(dp43782
sg6765
(dp43783
sg8241
(dp43784
sg4488
(dp43785
sg9009
(dp43786
sg8265
(dp43787
sg6090
(dp43788
sg3024
g36263
sg11316
(dp43789
sg2739
g33987
sg10557
(dp43790
sg9084
(dp43791
sg5370
(dp43792
sg12126
(dp43793
sg9096
(dp43794
sg7596
(dp43795
ssg4242
(dp43796
g102
g12999
sg6123
(dp43797
ssg4245
(dp43798
g4287
(dp43799
sg21710
(dp43800
ssg4248
(dp43801
g7959
(dp43802
sg11277
(dp43803
ssg4251
(dp43804
g8241
(dp43805
sg2769
g34288
sg10365
(dp43806
sg3846
g41108
sg7941
(dp43807
sg12066
(dp43808
sg8916
(dp43809
sg10815
(dp43810
sg2946
g35817
sg5832
(dp43811
sg11241
(dp43812
sg11979
(dp43813
sg9759
(dp43814
sg10662
(dp43815
sg9579
(dp43816
ssg4254
(dp43817
g9117
(dp43818
sg9126
(dp43819
sg1326
g23591
sg3117
g36903
sg6204
(dp43820
sg48
g12634
sg279
g14482
sg10797
(dp43821
sg6231
(dp43822
sg9192
(dp43823
sg3141
g37063
sg9216
(dp43824
sg6726
(dp43825
sg9225
(dp43826
sg126
g13158
sg9267
(dp43827
sg6318
(dp43828
sg3231
g37640
sg3240
g37706
sg6333
(dp43829
sg5208
(dp43830
sg1110
g22127
sg3258
g37801
sg7170
(dp43831
sg14829
(dp43832
sg213
g14038
sg219
g14071
sg7053
(dp43833
sg6273
(dp43834
sg7962
(dp43835
sg3321
g38212
sg2388
g31662
sg87
g12911
sg294
g14730
sg6432
(dp43836
sg1785
g27175
sg9417
(dp43837
sg12060
(dp43838
sg1872
g27851
sg336
g15085
sg6471
(dp43839
sg9444
(dp43840
sg351
g15253
sg3408
g38695
sg3444
g38862
sg420
g16001
sg426
g16073
sg2430
g32099
sg2481
g32404
sg6579
(dp43841
sg168
g13629
sg2658
g33356
sg8721
(dp43842
sg495
g16688
sg2736
g33943
sg9564
(dp43843
sg10236
(dp43844
sg6639
(dp43845
sg546
g17135
sg9012
(dp43846
sg3036
g36431
sg561
g17363
sg3114
g36861
sg9180
(dp43847
sg570
g17476
sg3570
g39488
sg6684
(dp43848
sg3576
g39570
sg8472
(dp43849
sg603
g17756
sg7014
(dp43850
sg3651
g40110
sg6765
(dp43851
sg9750
(dp43852
sg3732
g40505
sg9696
(dp43853
sg9780
(dp43854
sg753
g19207
sg10698
(dp43855
sg3795
g40918
sg8577
(dp43856
sg9828
(dp43857
sg9033
(dp43858
sg2664
g33435
sg9855
(dp43859
sg10611
(dp43860
sg11283
(dp43861
sg12114
(dp43862
sg10764
(dp43863
sg828
g19850
sg4197
g43505
sg4872
(dp43864
sg3885
g41440
sg888
g20419
sg3048
g36497
sg6939
(dp43865
sg909
g20632
sg915
g20693
sg918
g20751
sg4713
(dp43866
sg6981
(dp43867
sg6999
(dp43868
sg7005
(dp43869
sg5571
(dp43870
sg7020
(dp43871
sg11664
(dp43872
sg10047
(dp43873
sg4005
g42157
sg4008
g42190
sg10056
(dp43874
sg4017
g42277
sg4023
g42343
sg7707
(dp43875
sg4890
(dp43876
sg1044
g21541
sg1050
g21665
sg2262
g30953
sg7713
(dp43877
sg4062
g42616
sg4068
g42762
sg13070
g21887
sg11313
(dp43878
sg4782
(dp43879
sg12186
g42917
sg5739
(dp43880
sg345
g15218
sg10179
(dp43881
sg1134
g22320
sg7164
(dp43882
sg10200
(dp43883
sg8760
(dp43884
sg1173
g22633
sg7188
(dp43885
sg10227
(dp43886
sg780
g19349
sg465
g16459
sg10266
(dp43887
sg7815
(dp43888
sg6933
(dp43889
sg10275
(dp43890
sg978
g21150
sg4236
g43699
sg4260
(dp43891
sg10320
(dp43892
sg1152
g22524
sg1263
g23177
sg7284
(dp43893
sg10326
(dp43894
sg4272
(dp43895
sg4278
(dp43896
sg4287
(dp43897
sg10350
(dp43898
sg4770
(dp43899
sg1311
g23513
sg10365
(dp43900
sg10368
(dp43901
sg1527
g25243
sg1737
g26903
sg1332
g23640
sg5889
(dp43902
sg7359
(dp43903
sg1635
g26036
sg7395
(dp43904
sg8019
(dp43905
sg12274
g27521
sg4425
(dp43906
sg2094
g29973
sg7428
(dp43907
sg8163
(dp43908
sg1434
g24643
sg8211
(dp43909
sg1461
g24802
sg7470
(dp43910
sg1470
g24901
sg10494
(dp43911
sg7500
(dp43912
sg10509
(dp43913
sg10515
(dp43914
sg10518
(dp43915
sg10533
(dp43916
sg10854
(dp43917
sg10374
(dp43918
sg11820
(dp43919
sg10557
(dp43920
sg5394
(dp43921
sg10587
(dp43922
sg10596
(dp43923
sg1581
g25684
sg11241
(dp43924
sg4596
(dp43925
sg1611
g25806
sg9249
(dp43926
sg4638
(dp43927
sg7650
(dp43928
sg1659
g26196
sg6171
(dp43929
sg7668
(dp43930
sg7680
(dp43931
sg3516
g39156
sg7824
(dp43932
sg10713
(dp43933
sg1683
g26372
sg10725
(dp43934
sg4707
(dp43935
sg1704
g26707
sg4710
(dp43936
sg4716
(dp43937
sg10761
(dp43938
sg3849
g41164
sg3867
g41325
sg10779
(dp43939
sg7764
(dp43940
sg10737
(dp43941
sg10497
(dp43942
sg10815
(dp43943
sg5112
(dp43944
sg11259
(dp43945
sg10833
(dp43946
sg10323
(dp43947
sg11913
(dp43948
sg1803
g27371
sg4830
(dp43949
sg7845
(dp43950
sg10884
(dp43951
sg4521
(dp43952
sg375
g15439
sg7881
(dp43953
sg4881
(dp43954
sg4680
(dp43955
sg7896
(dp43956
sg4752
(dp43957
sg1881
g27945
sg4926
(dp43958
sg4929
(dp43959
sg7941
(dp43960
sg4398
(dp43961
sg7971
(dp43962
sg1938
g28539
sg1941
g28570
sg3399
g38622
sg8031
(dp43963
sg2007
g28868
sg3264
g37848
sg11046
(dp43964
sg879
g20338
sg1947
g28671
sg3015
g36081
sg5064
(dp43965
sg8067
(dp43966
sg8079
(dp43967
sg2079
g29845
sg5094
(dp43968
sg11112
(dp43969
sg11133
(dp43970
sg11139
(dp43971
sg6024
(dp43972
sg11154
(dp43973
sg5133
(dp43974
sg69
g12738
sg5145
(dp43975
sg8139
(dp43976
sg11196
(dp43977
sg2172
g30510
sg11208
(dp43978
sg6525
(dp43979
sg8205
(dp43980
sg11229
(dp43981
sg5235
(dp43982
sg8241
(dp43983
sg6867
(dp43984
sg9909
(dp43985
sg8265
(dp43986
sg5316
(dp43987
sg933
g20813
sg11316
(dp43988
sg11334
(dp43989
sg1275
g23280
sg2289
g31216
sg11361
(dp43990
sg11367
(dp43991
sg11382
(dp43992
sg7563
(dp43993
sg8373
(dp43994
sg5415
(dp43995
sg2355
g31424
sg2358
g31470
sg5433
(dp43996
sg11427
(dp43997
sg3426
g38753
sg8418
(dp43998
sg10149
(dp43999
sg8430
(dp44000
sg2046
g29113
sg11472
(dp44001
sg5499
(dp44002
sg2424
g31945
sg2427
g32006
sg8457
(dp44003
sg5520
(dp44004
sg11544
(dp44005
sg2616
g33173
sg5589
(dp44006
sg2553
g32886
sg11595
(dp44007
sg8595
(dp44008
sg11619
(dp44009
sg2583
g33077
sg3000
g36013
sg11631
(dp44010
sg2598
g33113
sg11649
(dp44011
sg1857
g27701
sg11667
(dp44012
sg8655
(dp44013
sg5694
(dp44014
sg11685
(dp44015
sg9357
(dp44016
sg11694
(dp44017
sg9471
(dp44018
sg5727
(dp44019
sg11745
(dp44020
sg8616
(dp44021
sg2706
g33747
sg5769
(dp44022
sg2715
g33796
sg11769
(dp44023
sg1281
g23367
sg11775
(dp44024
sg8751
(dp44025
sg8763
(dp44026
sg9918
(dp44027
sg9924
(dp44028
sg2763
g34230
sg5829
(dp44029
sg9348
(dp44030
sg5853
(dp44031
sg10977
(dp44032
sg2814
g34513
sg11862
(dp44033
sg5574
(dp44034
sg4467
(dp44035
sg1548
g25368
sg5919
(dp44036
sg5928
(dp44037
sg8856
(dp44038
sg696
g18717
sg1101
g22059
sg4953
(dp44039
sg8922
(dp44040
sg8097
(dp44041
sg11961
(dp44042
sg11976
(dp44043
sg11979
(dp44044
sg2946
g35812
sg8964
(dp44045
sg543
g17081
sg12000
(dp44046
sg6051
(dp44047
sg12018
(dp44048
sg6468
(dp44049
sg6906
(dp44050
sg11475
(dp44051
sg2769
g34290
sg5736
(dp44052
sg9420
(dp44053
sg6162
(dp44054
sg10098
(dp44055
sg5067
(dp44056
sg5289
(dp44057
sg6150
(dp44058
sg1185
g22716
sg9111
(dp44059
sg3624
g39884
ssg4257
(dp44060
VGastrointestinal Agents
p44061
(dp44062
sVBile and Liver Therapy
p44063
g37033
sVCholanes
p44064
(dp44065
sVBile Acid Preparations
p44066
(dp44067
sVDeoxycholic Acid
p44068
(dp44069
sVCytochrome P-450 CYP3A Substrates
p44070
(dp44071
sVSteroids
p44072
(dp44073
sVUGT2B7 Inhibitors
p44074
(dp44075
sVCholic Acids
p44076
(dp44077
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44078
g29338
sVBile acids and derivatives
p44079
g41005
sVBile Acids and Salts
p44080
g35492
sVBile Therapy
p44081
g27587
sVFused-Ring Compounds
p44082
g14857
sVCytochrome P-450 CYP3A4 Substrates
p44083
(dp44084
sVAlimentary Tract and Metabolism
p44085
g23865
ssg4260
(dp44086
VAcetic Acid Derivatives and Related Substances
p44087
g28815
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p44088
(dp44089
sVOAT1/SLC22A6 inhibitors
p44090
(dp44091
sVAnalgesics
p44092
g26465
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p44093
(dp44094
sVCentral Nervous System Agents
p44095
(dp44096
sVUGT1A9 Substrates
p44097
g23999
sVAntiinflammatory and Antirheumatic Products
p44098
(dp44099
sg1404
g24330
sVEnzyme Inhibitors
p44100
(dp44101
sVPeripheral Nervous System Agents
p44102
(dp44103
sVDrugs that are Mainly Renally Excreted
p44104
g43891
sVNonsteroidal Anti-inflammatory Compounds
p44105
(dp44106
sVAnalgesics, Non-Narcotic
p44107
(dp44108
sVUGT1A3 substrates
p44109
g31803
sVNephrotoxic agents
p44110
(dp44111
sg6081
(dp44112
sVCytochrome P-450 CYP2C9 Substrates
p44113
g29773
sVMusculo-Skeletal System
p44114
g31518
sVCOX-2 Inhibitors
p44115
(dp44116
sVAgents causing hyperkalemia
p44117
g43606
sVIndoles
p44118
(dp44119
sVOther Nonsteroidal Antiimflammatory Agents
p44120
(dp44121
sVAgents that produce hypertension
p44122
(dp44123
sVHeterocyclic Compounds, Fused-Ring
p44124
(dp44125
sVUGT2B7 substrates
p44126
g28627
sVAnti-Inflammatory Agents
p44127
(dp44128
sVCyclooxygenase Inhibitors
p44129
g32785
sVAntirheumatic Agents
p44130
g24219
sVSensory System Agents
p44131
(dp44132
sVAnti-Inflammatory Agents, Non-Steroidal
p44133
(dp44134
ssg4263
(dp44135
VAntiplatelet agents
p44136
(dp44137
sg3285
g37987
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p44138
(dp44139
sg11853
(dp44140
sVCytochrome P-450 CYP3A Substrates
p44141
(dp44142
sVNeurotransmitter Agents
p44143
(dp44144
sg3486
g39033
sVOCT2 Inhibitors
p44145
g42468
sVCytochrome P-450 CYP2B6 Substrates
p44146
g33009
sVCytochrome P-450 CYP2C9 Inhibitors
p44147
g18221
sVCytochrome P-450 Enzyme Inhibitors
p44148
(dp44149
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p44150
(dp44151
sVPurinergic Agents
p44152
(dp44153
sVCytochrome P-450 CYP1A2 Substrates
p44154
(dp44155
sVPurinergic Antagonists
p44156
(dp44157
sVDecreased Platelet Aggregation
p44158
(dp44159
sg7476
(dp44160
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44161
g29339
sVSulfur Compounds
p44162
(dp44163
sVCytochrome P-450 CYP2C9 Substrates
p44164
g29775
sVOCT1 inhibitors
p44165
(dp44166
sVCytochrome P-450 CYP2C19 Substrates
p44167
(dp44168
sVBlood and Blood Forming Organs
p44169
(dp44170
sVCytochrome P-450 CYP2C8 Inhibitors
p44171
(dp44172
sVCytochrome P-450 CYP2B6 Inhibitors
p44173
(dp44174
sVP-glycoprotein/ABCB1 Substrates
p44175
g34979
sVPyridines
p44176
(dp44177
sVThiophenes
p44178
(dp44179
sVHeterocyclic Compounds, Fused-Ring
p44180
(dp44181
sVCytochrome P-450 CYP3A4 Substrates
p44182
(dp44183
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p44184
(dp44185
sVHematologic Agents
p44186
(dp44187
sVCytochrome P-450 CYP3A5 Substrates
p44188
(dp44189
sVPlatelet Aggregation Inhibitors Excl. Heparin
p44190
(dp44191
sg6708
(dp44192
ssg4266
(dp44193
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p44194
(dp44195
sVCentral Nervous System Depressants
p44196
(dp44197
sVSerotonin Modulators
p44198
(dp44199
sVPsychoanaleptics
p44200
(dp44201
sVAntidepressive Agents
p44202
g15570
sVAgents that reduce seizure threshold
p44203
(dp44204
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p44205
(dp44206
sVHypotensive Agents
p44207
g34194
sVMonoamine Oxidase Inhibitors
p44208
(dp44209
sVCentral Nervous System Agents
p44210
(dp44211
sVSerotonin Agents
p44212
(dp44213
sVIsoxazoles
p44214
(dp44215
sVPsychotropic Drugs
p44216
(dp44217
sVAgents that produce hypertension
p44218
(dp44219
sVEnzyme Inhibitors
p44220
(dp44221
sVNervous System
p44222
(dp44223
sg6756
(dp44224
ssg4269
(dp44225
g7422
(dp44226
sg6684
(dp44227
sg8514
(dp44228
sg10470
(dp44229
ssg4272
(dp44230
VDrugs that are Mainly Renally Excreted
p44231
g43895
sVOrganogold Compounds
p44232
(dp44233
sVSpecific Antirheumatic Agents
p44234
g20793
sVMusculo-Skeletal System
p44235
g31532
sVAntiinflammatory and Antirheumatic Products
p44236
(dp44237
sVGold Preparations
p44238
g28781
sVAntirheumatic Agents
p44239
g24224
sg3405
g38666
sVOrganometallic Compounds
p44240
(dp44241
sVGold Compounds
p44242
(dp44243
ssg4275
(dp44244
g11910
(dp44245
sg6678
(dp44246
sg6507
(dp44247
sg6639
(dp44248
ssg4278
(dp44249
VDrugs that are Mainly Renally Excreted
p44250
g43896
sVPyrimidines
p44251
(dp44252
sVCytochrome P-450 CYP2D6 Substrates
p44253
(dp44254
sVCytochrome P-450 CYP3A Substrates
p44255
(dp44256
sVPyrimidinones
p44257
(dp44258
sVDPP-IV Inhibitors
p44259
(dp44260
sVAgents causing angioedema
p44261
(dp44262
sVHormones, Hormone Substitutes, and Hormone Antagonists
p44263
(dp44264
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44265
g29341
sVOral Hypoglycemics
p44266
g35992
sVHormones
p44267
(dp44268
sVEnzyme Inhibitors
p44269
(dp44270
sVIncretins
p44271
g20129
sVCytochrome P-450 CYP3A4 Substrates
p44272
(dp44273
sVBlood Glucose Lowering Agents
p44274
(dp44275
sVAlimentary Tract and Metabolism
p44276
g23871
sVDrugs Used in Diabetes
p44277
(dp44278
ssg4281
(dp44279
g2427
g32015
ssg4284
(dp44280
g9117
(dp44281
sg2346
g31374
sg6183
(dp44282
sg9126
(dp44283
sg10377
(dp44284
sg10818
(dp44285
sg4635
(dp44286
sg6204
(dp44287
sg7641
(dp44288
sg4650
(dp44289
sg1650
g26104
sg7653
(dp44290
sg4656
(dp44291
sg1869
g27822
sg7464
(dp44292
sg891
g20551
sg20252
(dp44293
sg5499
(dp44294
sg6939
(dp44295
sg2433
g32148
sg11475
(dp44296
sg2436
g32176
sg3930
g41670
sg10725
(dp44297
sg4710
(dp44298
sg9750
(dp44299
sg2391
g31720
sg126
g13173
sg135
g13250
sg7005
(dp44300
sg11544
(dp44301
sg9282
(dp44302
sg3231
g37647
sg10611
(dp44303
sg6336
(dp44304
sg9081
(dp44305
sg7155
(dp44306
sg4005
g42167
sg3267
g37895
sg8616
(dp44307
sg7053
(dp44308
sg1278
g23336
sg7884
(dp44309
sg4830
(dp44310
sg10884
(dp44311
sg6411
(dp44312
sg4062
g42627
sg4872
(dp44313
sg1656
g26161
sg4638
(dp44314
sg6432
(dp44315
sg5460
(dp44316
sg5685
(dp44317
sg10164
(dp44318
sg11685
(dp44319
sg6348
(dp44320
sg4911
(dp44321
sg11694
(dp44322
sg1881
g27951
sg6435
(dp44323
sg1872
g27867
sg6471
(dp44324
sg972
g21126
sg9486
(dp44325
sg11727
(dp44326
sg1941
g28582
sg7947
(dp44327
sg2706
g33769
sg3447
g38929
sg6933
(dp44328
sg5817
(dp44329
sg2763
g34236
sg978
g21158
sg7074
(dp44330
sg879
g20346
sg2658
g33364
sg3516
g39162
sg78
g12848
sg8079
(dp44331
sg2088
g29916
sg11862
(dp44332
sg1311
g23526
sg5919
(dp44333
sg8850
(dp44334
sg7317
(dp44335
sg2115
g30196
sg6885
(dp44336
sg7569
(dp44337
sg3651
g40116
sg10383
(dp44338
sg564
g17406
sg9180
(dp44339
sg11166
(dp44340
sg11172
(dp44341
sg141
g13348
sg3291
g38001
sg3597
g39641
sg4446
(dp44342
sg6735
(dp44343
sg5736
(dp44344
sg7428
(dp44345
sg7188
(dp44346
sg2211
g30743
sg5235
(dp44347
sg5574
(dp44348
sg10479
(dp44349
sg6051
(dp44350
sg9726
(dp44351
sg8238
(dp44352
sg1473
g24961
sg2418
g31907
sg1491
g25075
sg7314
(dp44353
sg3036
g36438
sg2274
g31086
sg1176
g22678
sg5934
(dp44354
sg3399
g38630
sg12123
(dp44355
sg10692
(dp44356
sg4596
(dp44357
sg3624
g39893
sg7608
(dp44358
sg5127
(dp44359
ssg4287
(dp44360
VCarbohydrates
p44361
(dp44362
sVCytochrome P-450 CYP3A Substrates
p44363
(dp44364
sVCentral Nervous System Agents
p44365
(dp44366
sVCytochrome P-450 CYP2C19 Inhibitors
p44367
(dp44368
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p44369
(dp44370
sVCytochrome P-450 Enzyme Inhibitors
p44371
(dp44372
sVMiscellaneous Anticonvulsants
p44373
(dp44374
sVCarbonic Anhydrase Inhibitors
p44375
(dp44376
sg4245
g43799
sVDrugs that are Mainly Renally Excreted
p44377
g43897
sVBlood Glucose Lowering Agents
p44378
(dp44379
sVCytochrome P-450 CYP3A4 Inducers (weak)
p44380
g19512
sg3138
g37036
sVEnzyme Inducing Antiepileptic Drugs
p44381
g25036
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44382
g29342
sg5925
(dp44383
sVCytochrome P-450 CYP3A4 Inducers
p44384
g18942
sVDecreased Central Nervous System Disorganized Electrical Activity
p44385
g23473
sVDiuretics
p44386
(dp44387
sVCentral Nervous System Depressants
p44388
(dp44389
sVAnticonvulsants
p44390
(dp44391
sVP-glycoprotein/ABCB1 Substrates
p44392
g35010
sVCytochrome P-450 Enzyme Inducers
p44393
g28199
sVCytochrome P-450 CYP3A Inducers
p44394
(dp44395
sVCytochrome P-450 CYP3A Inducers (strong)
p44396
g22452
sVCytochrome P-450 CYP3A4 Substrates
p44397
(dp44398
sg7551
(dp44399
sVNeuroprotective Agents
p44400
(dp44401
sg7926
(dp44402
sVNervous System
p44403
(dp44404
ssg4290
(dp44405
g612
g17889
sg11445
(dp44406
sg11319
(dp44407
sg2067
g29650
ssg4293
(dp44408
g9471
(dp44409
sg9588
(dp44410
sg11172
(dp44411
sg7527
(dp44412
sg5193
(dp44413
ssg4296
(dp44414
g11781
(dp44415
ssg4299
(dp44416
VAntiinfectives for Systemic Use
p44417
(dp44418
sg3366
g38439
sVCytochrome P-450 CYP3A4 Inhibitors
p44419
(dp44420
sVAntivirals for Systemic Use
p44421
(dp44422
sVHeterocyclic Compounds, Fused-Ring
p44423
(dp44424
sVQuinolines
p44425
(dp44426
sVHIV Integrase Inhibitors
p44427
(dp44428
sVCytochrome P-450 CYP3A Substrates
p44429
(dp44430
sVCytochrome P-450 CYP3A Inhibitors
p44431
(dp44432
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p44433
(dp44434
sVAntiviral Agents
p44435
g30453
sVCytochrome P450 2C9 Inducers
p44436
(dp44437
sVDirect Acting Antivirals
p44438
g38064
sVUGT1A1 Substrates
p44439
g12300
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44440
g29354
sVHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor
p44441
g14713
sVCytochrome P-450 CYP3A Inhibitors (strong)
p44442
g13397
sVCytochrome P-450 CYP3A4 Substrates
p44443
(dp44444
sVCytochrome P-450 Enzyme Inhibitors
p44445
(dp44446
ssg4302
(dp44447
VDermatologicals
p44448
g17283
sVSolvents
p44449
g36483
sVPropanols
p44450
(dp44451
sVMiscellaneous Local Anti-infectives
p44452
(dp44453
sVAntiseptics and Disinfectants
p44454
g23743
sVAlcohols
p44455
(dp44456
sVCompounds used in a research, industrial, or household setting
p44457
(dp44458
ssg4305
(dp44459
g9609
(dp44460
sg2787
g34394
sg3432
g38804
sg9693
(dp44461
sg6765
(dp44462
sg2196
g30624
sg12534
(dp44463
sg13091
g21394
sg7188
(dp44464
sg1140
g22398
sg6783
(dp44465
sg5766
(dp44466
sg9198
(dp44467
sg4023
g42340
sg183
g13770
sg4155
g43192
sg888
g20397
sg4653
(dp44468
sg10797
(dp44469
sg1656
g26168
sg6045
(dp44470
ssg4308
(dp44471
g11268
(dp44472
ssg4311
(dp44473
g2826
g34604
sg3249
g37768
sg12057
(dp44474
sg5556
(dp44475
sg10272
(dp44476
sg8658
(dp44477
ssg4314
(dp44478
g5463
(dp44479
sg11367
(dp44480
sg7407
(dp44481
sg8088
(dp44482
sg801
g19528
sg5514
(dp44483
ssg4317
(dp44484
g219
g14072
sg9357
(dp44485
sg1659
g26198
sg9192
(dp44486
sg2598
g33115
sg6981
(dp44487
sg13070
g21914
sg9033
(dp44488
sg9444
(dp44489
sg3399
g38653
sg11241
(dp44490
sg5271
(dp44491
sg9180
(dp44492
sg8922
(dp44493
ssg4320
(dp44494
VLipids
p44495
g14302
sVProstaglandins
p44496
g19504
sVCardiovascular Agents
p44497
g26594
sVFatty Acids
p44498
(dp44499
sVProstaglandin analogs reducing intraocular pressure (IOP)
p44500
g19253
sVFatty Acids, Unsaturated
p44501
(dp44502
sVAntihypertensive Agents
p44503
g20280
sVSensory Organs
p44504
g40709
sVProstaglandins, Synthetic
p44505
g28027
sVInflammation Mediators
p44506
g23635
sVProstaglandins F, Synthetic
p44507
(dp44508
sVBiological Factors
p44509
g38120
sVAutacoids
p44510
(dp44511
sVOphthalmologicals
p44512
g35215
sVEicosanoids
p44513
g37793
sVAntiglaucoma Preparations and Miotics
p44514
g36554
ssg4323
(dp44515
g6279
(dp44516
sg3846
g41135
sg4017
g42290
sg10518
(dp44517
sg9417
(dp44518
sg11592
(dp44519
sg5370
(dp44520
sg2895
g35444
sg6537
(dp44521
sg10266
(dp44522
sg12045
(dp44523
sg10308
(dp44524
sg10056
(dp44525
sg10797
(dp44526
sg7563
(dp44527
ssg4326
(dp44528
g11862
(dp44529
sg978
g21178
sg4062
g42644
sg879
g20366
sg1941
g28600
ssg4329
(dp44530
g87
g12934
sg1785
g27199
sg4863
(dp44531
sg1674
g26348
sg918
g20771
ssg4332
(dp44532
g8421
(dp44533
sg4653
(dp44534
sg4164
g43341
sg888
g20485
sg6075
(dp44535
sg8298
(dp44536
sg7335
(dp44537
sg6045
(dp44538
sg12534
(dp44539
ssg4335
(dp44540
g3633
g40056
sg2346
g31394
sg2196
g30633
sg3858
g41237
sg2943
g35775
sg6033
(dp44541
sg4653
(dp44542
sg543
g17110
sg8433
(dp44543
sg6045
(dp44544
sg12534
(dp44545
sg3024
g36314
sg11316
(dp44546
sg1140
g22418
sg9471
(dp44547
sg9198
(dp44548
sg8298
(dp44549
sg10557
(dp44550
sg3432
g38817
sg4164
g43343
sg1371
g24119
sg13091
g21412
sg11523
(dp44551
sg5289
(dp44552
sg6537
(dp44553
sg11385
(dp44554
ssg4338
(dp44555
VAmino Acids, Peptides, and Proteins
p44556
(dp44557
sg2499
g32627
sVCytochrome P-450 CYP1A2 Inducers
p44558
(dp44559
sVPeptide Hormones
p44560
g20224
sVInsulin Analog
p44561
(dp44562
sVHypoglycemia-Associated Agents
p44563
g17706
sg10617
(dp44564
sg186
g13874
sVInsulins and Analogues
p44565
(dp44566
sVPeptides
p44567
(dp44568
sVCytochrome P-450 Enzyme Inducers
p44569
g28213
sVInsulin
p44570
(dp44571
sVHormones
p44572
(dp44573
sVHormones, Hormone Substitutes, and Hormone Antagonists
p44574
(dp44575
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p44576
g17450
sVPancreatic Hormones
p44577
(dp44578
sVBlood Glucose Lowering Agents
p44579
(dp44580
sVAlimentary Tract and Metabolism
p44581
g23888
sVDrugs Used in Diabetes
p44582
(dp44583
ssg4341
(dp44584
VAcetates
p44585
(dp44586
sVAgents that produce neuromuscular block (indirect)
p44587
g37955
sVFatty Acids
p44588
(dp44589
sVOAT1/SLC22A6 inhibitors
p44590
(dp44591
sVHypotensive Agents
p44592
g34138
sVLipids
p44593
g14293
sVEnzyme Inhibitors
p44594
(dp44595
sVHyperglycemia-Associated Agents
p44596
(dp44597
sg480
g16623
sVOtotoxic agents
p44598
(dp44599
sVNephrotoxic agents
p44600
(dp44601
sg7098
(dp44602
sVNatriuretic Agents
p44603
g40480
sVSodium Potassium Chloride Symporter Inhibitors
p44604
g26510
sVDiuretics
p44605
(dp44606
sVFatty Acids, Volatile
p44607
(dp44608
sVCardiovascular Agents
p44609
g26573
sVNon Potassium Sparing Diuretics
p44610
g14975
sVHydroxy Acids
p44611
g18145
sg2856
g35143
sVAcids, Acyclic
p44612
g25453
sVIncreased Diuresis at Loop of Henle
p44613
(dp44614
sVHigh-Ceiling Diuretics
p44615
(dp44616
ssg4344
(dp44617
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p44618
(dp44619
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p44620
(dp44621
sVCytochrome P-450 CYP3A4 Inhibitors
p44622
(dp44623
sVPsychoanaleptics
p44624
(dp44625
sVCytochrome P-450 CYP2D6 Substrates
p44626
(dp44627
sVSerotonin Agents
p44628
(dp44629
sVCytochrome P-450 CYP3A Substrates
p44630
(dp44631
sVNeurotransmitter Agents
p44632
(dp44633
sVAnti-Anxiety Agents
p44634
g35656
sVSerotonin Receptor Antagonists
p44635
g35685
sVHistamine Agents
p44636
(dp44637
sVCentral Nervous System Agents
p44638
(dp44639
sVPotential QTc-Prolonging Agents
p44640
(dp44641
sVAdrenergic Antagonists
p44642
(dp44643
sVPsychotropic Drugs
p44644
(dp44645
sVCytochrome P-450 Enzyme Inhibitors
p44646
(dp44647
sVCytochrome P-450 CYP1A2 Substrates
p44648
(dp44649
sVMiscellaneous Antidepressants
p44650
(dp44651
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p44652
g29390
sg4686
(dp44653
sVAdrenergic alpha-Antagonists
p44654
(dp44655
sVQTc Prolonging Agents
p44656
(dp44657
sVSerotonin 5-HT2 Receptor Antagonists
p44658
(dp44659
sVAdrenergic Agents
p44660
g41721
sVCentral Nervous System Depressants
p44661
(dp44662
sVSerotonin 5-HT3 Receptor Antagonists
p44663
(dp44664
sVHistamine H1 Antagonists
p44665
g40788
sVAgents that produce hypertension
p44666
(dp44667
sVCytochrome P-450 CYP3A4 Substrates
p44668
(dp44669
sVHeterocyclic Compounds, Fused-Ring
p44670
(dp44671
sVSerotonin Modulators
p44672
(dp44673
sVAntidepressive Agents
p44674
g15555
sVCytochrome P-450 CYP3A Inhibitors
p44675
(dp44676
sVAntidepressive Agents, Tetracyclic
p44677
(dp44678
sVHistamine Antagonists
p44679
g43449
sVNervous System
p44680
(dp44681
sVTranquilizing Agents
p44682
(dp44683
ssg4347
(dp44684
g8421
(dp44685
sg7335
(dp44686
ssg4350
(dp44687
g5238
(dp44688
sg966
g21034
ssg4353
(dp44689
g3609
g39704
sg4068
g42785
ssg4356
(dp44690
VAmino Acids, Peptides, and Proteins
p44691
(dp44692
sVMembrane Proteins
p44693
(dp44694
sVAntineoplastic and Immunomodulating Agents
p44695
g39828
sVProteins
p44696
(dp44697
sVImmunologic Factors
p44698
g42388
sVImmunosuppressive Agents
p44699
(dp44700
sg5241
(dp44701
sVPeptides
p44702
(dp44703
sVImmunomodulatory Agents
p44704
g22794
sVAntirheumatic Agents
p44705
g24230
sVAdjuvants, Immunologic
p44706
g39432
sg7134
(dp44707
ssg4359
(dp44708
g10479
(dp44709
sg1311
g23517
sg8238
(dp44710
sg4710
(dp44711
sg6183
(dp44712
sg7005
(dp44713
sg10611
(dp44714
ssg4362
(dp44715
g9918
(dp44716
sg4629
(dp44717
sg6567
(dp44718
sg2784
g34371
sg10185
(dp44719
sg10548
(dp44720
sg6246
(dp44721
sg11085
(dp44722
sg10314
(dp44723
sg2805
g34457
sg4491
(dp44724
sg5286
(dp44725
sg5073
(dp44726
sg8826
(dp44727
sg2901
g35482
sg4725
(dp44728
sg4737
(dp44729
sg1149
g22509
sg6843
(dp44730
sg357
g15318
sg7977
(dp44731
sg10878
(dp44732
sg6150
(dp44733
sg8010
(dp44734
sg4398
(dp44735
sg7044
(dp44736
ssg4365
(dp44737
VAmino Acids, Peptides, and Proteins
p44738
(dp44739
sVCytochrome P-450 CYP1A2 Inducers
p44740
(dp44741
sVPeptide Hormones
p44742
g20206
sVInsulin, Long-Acting
p44743
(dp44744
sVInsulin Analog
p44745
(dp44746
sVHypoglycemia-Associated Agents
p44747
g17679
sVInsulins and Analogues for Injection, Long-Acting
p44748
g39628
sVInsulins and Analogues
p44749
(dp44750
sVPeptides
p44751
(dp44752
sVCytochrome P-450 Enzyme Inducers
p44753
g28153
sVInsulin
p44754
(dp44755
sVHormones
p44756
(dp44757
sVHormones, Hormone Substitutes, and Hormone Antagonists
p44758
(dp44759
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p44760
g17438
sVPancreatic Hormones
p44761
(dp44762
sVBlood Glucose Lowering Agents
p44763
(dp44764
sVAlimentary Tract and Metabolism
p44765
g23814
sVDrugs Used in Diabetes
p44766
(dp44767
ssg4368
(dp44768
g9855
(dp44769
sg8820
(dp44770
ssg4371
(dp44771
g4257
g44067
sg5469
(dp44772
sg165
g13577
ssg4374
(dp44773
g10539
(dp44774
ssg4377
(dp44775
VCycloparaffins
p44776
g43674
sVTerpenes
p44777
(dp44778
sVHydrocarbons, Acyclic
p44779
g19579
sg9978
(dp44780
sVCarotenoids
p44781
(dp44782
sVPigments, Biological
p44783
g21850
sVAntipsoriatics
p44784
(dp44785
sg4377
(dp44786
sVPolyenes
p44787
(dp44788
sVMisc. Skin and Mucous Membrane Agents
p44789
(dp44790
sVBiological Factors
p44791
g38122
sVRetinoids
p44792
(dp44793
sVAlkenes
p44794
g30756
sVKeratolytic Agents
p44795
(dp44796
sVCyclohexenes
p44797
(dp44798
sVDermatologicals
p44799
g17297
sVCyclohexanes
p44800
g33283
sg7893
(dp44801
ssg4380
(dp44802
g1770
g27068
sg2928
g35622
sg10890
(dp44803
sg11727
(dp44804
ssg4383
(dp44805
g1482
g25019
sg6630
(dp44806
sg8910
(dp44807
sg1737
g26917
ssg4386
(dp44808
g11625
(dp44809
ssg4389
(dp44810
g7314
(dp44811
sg10164
(dp44812
sg6885
(dp44813
sg20252
(dp44814
sg9486
(dp44815
sg10383
(dp44816
sg4656
(dp44817
ssg4392
(dp44818
g10497
(dp44819
sg4344
g44678
sg5169
(dp44820
ssg4395
(dp44821
g12003
(dp44822
ssg4398
(dp44823
VDrugs that are Mainly Renally Excreted
p44824
g43961
sVCaries Prophylactic Agents
p44825
(dp44826
sVFluorides
p44827
g25925
sVIons
p44828
(dp44829
sVCariostatic Agents
p44830
(dp44831
sg8094
(dp44832
sVSodium Compounds
p44833
g37412
sVCompounds used in a research, industrial, or household setting
p44834
(dp44835
sVAnions
p44836
(dp44837
sVStomatological Preparations
p44838
(dp44839
sVProtective Agents
p44840
(dp44841
sVBiomedical and Dental Materials
p44842
g44735
sVFluorine Compounds
p44843
(dp44844
sVDental Agents
p44845
(dp44846
sVAlimentary Tract and Metabolism
p44847
g23842
sVMiscellaneous Therapeutic Agents
p44848
(dp44849
sVMineral Supplements
p44850
g38303
ssg4401
(dp44851
VAminopyridines
p44852
(dp44853
sVAmines
p44854
g42692
sVGenito Urinary System and Sex Hormones
p44855
(dp44856
sVAntipruritics and Local Anesthetics
p44857
g31873
sVPyridines
p44858
(dp44859
sVMethemoglobinemia Associated Agents
p44860
g25562
sVUrologicals
p44861
(dp44862
ssg4404
(dp44863
g7548
(dp44864
ssg4407
(dp44865
g10701
(dp44866
ssg4410
(dp44867
g1176
g22670
sg1278
g23328
sg7653
(dp44868
ssg4413
(dp44869
g1239
g22945
sg10275
(dp44870
sg10914
(dp44871
ssg4416
(dp44872
g4830
(dp44873
sg11838
(dp44874
ssg4419
(dp44875
VAdrenergic Agents
p44876
g41727
sVNitrogen Compounds
p44877
g39001
sVNeurotransmitter Agents
p44878
(dp44879
sVCardiovascular Agents
p44880
g26644
sVAmines
p44881
g42725
sVOnium Compounds
p44882
g22253
sVAntiarrhythmic agents
p44883
(dp44884
sVAntihypertensive Agents
p44885
g20307
sg1023
g21343
sVHypotensive Agents
p44886
g34182
sVBradycardia-Causing Agents
p44887
(dp44888
sVCardiac Therapy
p44889
(dp44890
sVPotential QTc-Prolonging Agents
p44891
(dp44892
sVAdrenergic Antagonists
p44893
(dp44894
sVAntiarrhythmics, Class III
p44895
(dp44896
sVQTc Prolonging Agents
p44897
(dp44898
sVQuaternary Ammonium Compounds
p44899
g43368
sg5568
(dp44900
sVAmmonium Compounds
p44901
g30555
ssg4422
(dp44902
g11385
(dp44903
ssg4425
(dp44904
g5418
(dp44905
sVUGT1A1 Substrates
p44906
g12264
sVOAT1/SLC22A6 inhibitors
p44907
(dp44908
sVAnalgesics
p44909
g26483
sVAgents causing hyperkalemia
p44910
g43624
sg6198
(dp44911
sg1806
g27409
sVCentral Nervous System Agents
p44912
(dp44913
sg1362
g23994
sg6384
(dp44914
sVEnzyme Inhibitors
p44915
(dp44916
sVCytochrome P-450 Enzyme Inhibitors
p44917
(dp44918
sVThroat Preparations
p44919
(dp44920
sVPeripheral Nervous System Agents
p44921
(dp44922
sVDrugs that are Mainly Renally Excreted
p44923
g43906
sVCytochrome P-450 CYP2C8 Substrates
p44924
(dp44925
sg8799
(dp44926
sVAnalgesics, Non-Narcotic
p44927
(dp44928
sg2400
g31797
sVNephrotoxic agents
p44929
(dp44930
sg9927
(dp44931
sVAcids, Carbocyclic
p44932
g41547
sg11565
(dp44933
sVCytochrome P-450 CYP2C9 Substrates
p44934
g29795
sg198
g13924
sg6627
(dp44935
sg2454
g32230
sVP-glycoprotein/ABCB1 Substrates
p44936
g35048
sVAgents causing angioedema
p44937
(dp44938
sg10938
(dp44939
sg3045
g36487
sg8586
(dp44940
sVAgents that produce hypertension
p44941
(dp44942
sg1944
g28619
sVOAT3/SLC22A8 Inhibitors
p44943
(dp44944
sVAnti-Inflammatory Agents
p44945
(dp44946
sg2535
g32775
sVP-glycoprotein/ABCB1 Inhibitors
p44947
(dp44948
sg1392
g24205
sVSensory System Agents
p44949
(dp44950
sg8004
(dp44951
sVNervous System
p44952
(dp44953
ssg4428
(dp44954
g1626
g25946
sg1365
g24040
sg11022
(dp44955
sg9432
(dp44956
sg8487
(dp44957
sg9783
(dp44958
sg1134
g22306
sg3156
g37177
sg10629
(dp44959
sg573
g17546
sg3009
g36047
ssg4431
(dp44960
g9117
(dp44961
sg6186
(dp44962
sg30
g12378
sg12421
g12418
sg3117
g36896
sg816
g19632
sg42
g12582
sg9165
(dp44963
sg10797
(dp44964
sg2133
g30276
sg3141
g37046
sg9198
(dp44965
sg10818
(dp44966
sg6807
(dp44967
sg3174
g37265
sg6279
(dp44968
sg3177
g37297
sg9225
(dp44969
sg9231
(dp44970
sg9234
(dp44971
sg9981
(dp44972
sg3204
g37442
sg147
g13421
sg9273
(dp44973
sg3219
g37535
sg3222
g37588
sg6315
(dp44974
sg6318
(dp44975
sg3231
g37633
sg7533
(dp44976
sg13091
g21359
sg3240
g37694
sg6333
(dp44977
sg6336
(dp44978
sg195
g13901
sg6345
(dp44979
sg7170
(dp44980
sg14829
(dp44981
sg7053
(dp44982
sg7962
(dp44983
sg240
g14169
sg7884
(dp44984
sg12066
(dp44985
sg3318
g38188
sg3321
g38224
sg10662
(dp44986
sg9462
(dp44987
sg1626
g25948
sg6411
(dp44988
sg7545
(dp44989
sg282
g14525
sg285
g14617
sg1614
g25842
sg294
g14742
sg14838
g39958
sg9663
(dp44990
sg1785
g27187
sg6447
(dp44991
sg9432
(dp44992
sg3393
g38532
sg6471
(dp44993
sg8028
(dp44994
sg6504
(dp44995
sg14791
(dp44996
sg387
g15596
sg14872
g15697
sg3444
g38855
sg3447
g38903
sg6537
(dp44997
sg426
g16053
sg2373
g31569
sg2430
g32082
sg444
g16234
sg456
g16379
sg9528
(dp44998
sg3867
g41337
sg3516
g39167
sg507
g16756
sg9564
(dp44999
sg78
g12832
sg9588
(dp45000
sg9591
(dp45001
sg2910
g35509
sg11886
(dp45002
sg9609
(dp45003
sg543
g17073
sg9618
(dp45004
sg10959
(dp45005
sg6645
(dp45006
sg3021
g36170
sg3963
g41846
sg6654
(dp45007
sg11439
(dp45008
sg9180
(dp45009
sg570
g17465
sg573
g17514
sg3570
g39452
sg582
g17605
sg6687
(dp45010
sg8472
(dp45011
sg3597
g39635
sg600
g17739
sg3363
g38399
sg621
g17941
sg3627
g39915
sg3633
g40046
sg9693
(dp45012
sg3651
g40121
sg9324
(dp45013
sg9711
(dp45014
sg9828
(dp45015
sg8295
(dp45016
sg6765
(dp45017
sg690
g18592
sg6783
(dp45018
sg3696
g40265
sg702
g18810
sg9987
(dp45019
sg3975
g41923
sg9774
(dp45020
sg723
g19079
sg11625
(dp45021
sg3783
g40862
sg9819
(dp45022
sg9822
(dp45023
sg771
g19267
sg10758
(dp45024
sg2664
g33412
sg10305
(dp45025
sg4620
(dp45026
sg11283
(dp45027
sg138
g13271
sg7464
(dp45028
sg819
g19723
sg3846
g41097
sg3858
g41195
sg3861
g41265
sg6882
(dp45029
sg828
g19834
sg831
g19913
sg4788
(dp45030
sg9903
(dp45031
sg3885
g41431
sg5805
(dp45032
sg6819
(dp45033
sg11016
(dp45034
sg888
g20454
sg6939
(dp45035
sg9954
(dp45036
sg9960
(dp45037
sg9963
(dp45038
sg915
g20708
sg918
g20762
sg6966
(dp45039
sg7377
(dp45040
sg933
g20809
sg11337
(dp45041
sg10170
(dp45042
sg966
g21029
sg3978
g41962
sg11523
(dp45043
sg5646
(dp45044
sg9081
(dp45045
sg7029
(dp45046
sg4005
g42148
sg1008
g21281
sg7041
(dp45047
sg4014
g42215
sg4344
g44631
sg4023
g42316
sg714
g19018
sg1035
g21450
sg7707
(dp45048
sg7065
(dp45049
sg2262
g30945
sg10308
(dp45050
sg1062
g21794
sg6156
(dp45051
sg4077
g42814
sg4089
g42873
sg4101
g42969
sg11820
(dp45052
sg4113
g43016
sg6435
(dp45053
sg345
g15205
sg10179
(dp45054
sg1134
g22308
sg7152
(dp45055
sg7275
(dp45056
sg537
g17032
sg10209
(dp45057
sg4164
g43282
sg7191
(dp45058
sg7197
(dp45059
sg780
g19334
sg465
g16439
sg10266
(dp45060
sg9084
(dp45061
sg10275
(dp45062
sg4236
g43694
sg1239
g22925
sg1047
g21578
sg1059
g21762
sg4257
g44071
sg4263
g44142
sg7284
(dp45063
sg4278
g44256
sg4287
g44364
sg7329
(dp45064
sg7335
(dp45065
sg10350
(dp45066
sg7389
(dp45067
sg1503
g25160
sg7569
(dp45068
sg11151
(dp45069
sg7299
(dp45070
sg10416
(dp45071
sg4827
(dp45072
sg10389
(dp45073
sg9096
(dp45074
sg7698
(dp45075
sg1365
g24042
sg1371
g24071
sg1383
g24162
sg1863
g27757
sg4299
g44430
sg13750
g24348
sg7422
(dp45076
sg4437
(dp45077
sg7428
(dp45078
sg16906
(dp45079
sg8163
(dp45080
sg4449
(dp45081
sg4452
(dp45082
sg1434
g24658
sg10470
(dp45083
sg684
g18485
sg1461
g24793
sg4476
(dp45084
sg4479
(dp45085
sg1473
g24946
sg1491
g25048
sg5970
(dp45086
sg7497
(dp45087
sg7317
(dp45088
sg10521
(dp45089
sg10539
(dp45090
sg2739
g34007
sg1539
g25299
sg10557
(dp45091
sg10563
(dp45092
sg12090
(dp45093
sg8949
(dp45094
sg10596
(dp45095
sg10602
(dp45096
sg7593
(dp45097
sg4596
(dp45098
sg1599
g25736
sg7608
(dp45099
sg9105
(dp45100
sg1611
g25796
sg4635
(dp45101
sg4638
(dp45102
sg4650
(dp45103
sg4653
(dp45104
sg1650
g26094
sg1656
g26147
sg10674
(dp45105
sg7668
(dp45106
sg1668
g26256
sg1470
g24891
sg10701
(dp45107
sg2388
g31657
sg3543
g39310
sg10347
(dp45108
sg10728
(dp45109
sg7716
(dp45110
sg10740
(dp45111
sg10752
(dp45112
sg9834
(dp45113
sg10761
(dp45114
sg4746
(dp45115
sg10779
(dp45116
sg7764
(dp45117
sg10737
(dp45118
sg4782
(dp45119
sg5112
(dp45120
sg11259
(dp45121
sg1791
g27220
sg9417
(dp45122
sg10839
(dp45123
sg1803
g27363
sg1809
g27433
sg4830
(dp45124
sg12274
g27499
sg10884
(dp45125
sg10899
(dp45126
sg4881
(dp45127
sg288
g14644
sg4680
(dp45128
sg4773
(dp45129
sg4911
(dp45130
sg1881
g27935
sg4920
(dp45131
sg10149
(dp45132
sg1890
g27995
sg4926
(dp45133
sg1899
g28034
sg7941
(dp45134
sg7947
(dp45135
sg1908
g28269
sg10950
(dp45136
sg1911
g28341
sg1920
g28478
sg4959
(dp45137
sg5256
(dp45138
sg11022
(dp45139
sg339
g15143
sg8031
(dp45140
sg2007
g28856
sg8049
(dp45141
sg1947
g28655
sg2034
g29000
sg11721
(dp45142
sg2043
g29066
sg5064
(dp45143
sg11079
(dp45144
sg10263
(dp45145
sg5094
(dp45146
sg11952
(dp45147
sg2094
g29981
sg8448
(dp45148
sg2109
g30131
sg2115
g30194
sg10272
(dp45149
sg2127
g30248
sg5127
(dp45150
sg69
g12774
sg5145
(dp45151
sg11166
(dp45152
sg2142
g30331
sg2943
g35738
sg9966
(dp45153
sg2172
g30494
sg5199
(dp45154
sg438
g16196
sg2196
g30598
sg2199
g30668
sg8205
(dp45155
sg516
g16847
sg528
g16918
sg11229
(dp45156
sg2211
g30735
sg5235
(dp45157
sg8241
(dp45158
sg822
g19802
sg849
g20066
sg1113
g22157
sg2250
g30858
sg11997
(dp45159
sg5313
(dp45160
sg5316
(dp45161
sg11316
(dp45162
sg1140
g22356
sg8298
(dp45163
sg14822
g41803
sg5289
(dp45164
sg5364
(dp45165
sg7416
(dp45166
sg11358
(dp45167
sg11370
(dp45168
sg7524
(dp45169
sg7563
(dp45170
sg2346
g31352
sg2403
g31829
sg10377
(dp45171
sg2358
g31451
sg5433
(dp45172
sg8388
(dp45173
sg7821
(dp45174
sg1800
g27299
sg2226
g30789
sg5454
(dp45175
sg5460
(dp45176
sg1869
g27808
sg8421
(dp45177
sg5472
(dp45178
sg7983
(dp45179
sg8430
(dp45180
sg11451
(dp45181
sg8433
(dp45182
sg11460
(dp45183
sg4446
(dp45184
sg2046
g29095
sg5499
(dp45185
sg2088
g29924
sg2427
g31976
sg2433
g32142
sg8454
(dp45186
sg8457
(dp45187
sg8460
(dp45188
sg5028
(dp45189
sg2460
g32257
sg8514
(dp45190
sg5556
(dp45191
sg2493
g32602
sg11544
(dp45192
sg11112
(dp45193
sg2616
g33159
sg2676
g33549
sg8724
(dp45194
sg2559
g32923
sg11592
(dp45195
sg11595
(dp45196
sg11601
(dp45197
sg8916
(dp45198
sg11619
(dp45199
sg3024
g36250
sg8625
(dp45200
sg9099
(dp45201
sg9111
(dp45202
sg11655
(dp45203
sg11052
(dp45204
sg3132
g36984
sg1857
g27690
sg9030
(dp45205
sg8655
(dp45206
sg5691
(dp45207
sg8658
(dp45208
sg5694
(dp45209
sg5208
(dp45210
sg12534
(dp45211
sg9357
(dp45212
sg2652
g33299
sg9414
(dp45213
sg9471
(dp45214
sg8694
(dp45215
sg11508
(dp45216
sg8703
(dp45217
sg2667
g33489
sg11733
(dp45218
sg2688
g33646
sg10056
(dp45219
sg1245
g23010
sg2703
g33727
sg8013
(dp45220
sg5766
(dp45221
sg5769
(dp45222
sg2715
g33806
sg1281
g23379
sg11775
(dp45223
sg2730
g33874
sg8751
(dp45224
sg5796
(dp45225
sg4539
(dp45226
sg10062
(dp45227
sg9918
(dp45228
sg9924
(dp45229
sg3912
g41594
sg1425
g24528
sg2763
g34224
sg10041
(dp45230
sg5829
(dp45231
sg5832
(dp45232
sg8781
(dp45233
sg8787
(dp45234
sg2784
g34344
sg5853
(dp45235
sg11838
(dp45236
sg5865
(dp45237
sg5877
(dp45238
sg11940
(dp45239
sg8820
(dp45240
sg2814
g34502
sg5895
(dp45241
sg4458
(dp45242
sg2829
g34644
sg1548
g25354
sg2850
g35100
sg696
g18689
sg11097
(dp45243
sg8874
(dp45244
sg11910
(dp45245
sg28215
g35361
sg11913
(dp45246
sg11922
(dp45247
sg11931
(dp45248
sg8097
(dp45249
sg11955
(dp45250
sg11961
(dp45251
sg11976
(dp45252
sg11979
(dp45253
sg2946
g35799
sg8964
(dp45254
sg6033
(dp45255
sg6045
(dp45256
sg6048
(dp45257
sg6051
(dp45258
sg12018
(dp45259
sg6069
(dp45260
sg6468
(dp45261
sg5526
(dp45262
sg3546
g39376
sg9009
(dp45263
sg3009
g36049
sg6090
(dp45264
sg6906
(dp45265
sg11475
(dp45266
sg12063
(dp45267
sg3027
g36346
sg6102
(dp45268
sg2832
g34677
sg9420
(dp45269
sg11790
(dp45270
sg9060
(dp45271
sg1098
g22008
sg5181
(dp45272
sg12126
(dp45273
sg6075
(dp45274
sg12132
(dp45275
sg9102
(dp45276
sg1185
g22708
sg12123
(dp45277
sg3624
g39889
ssg4434
(dp45278
g4062
g42611
sg1941
g28564
sg4830
(dp45279
sg10692
(dp45280
sg5685
(dp45281
sg6348
(dp45282
ssg4437
(dp45283
VSubstance P/Neurokinin-1 Receptor Antagonist
p45284
g27484
sVBreast Cancer Resistance Protein Inhibitors
p45285
g12723
sVCytochrome P-450 CYP2D6 Inhibitors
p45286
(dp45287
sVNeurokinin-1 Receptor Antagonists
p45288
(dp45289
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p45290
g41061
sVCytochrome P-450 CYP3A Substrates
p45291
g45077
sVNeurotransmitter Agents
p45292
(dp45293
sVBCRP/ABCG2 Inhibitors
p45294
g12507
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45295
g29356
sVNeurokinin 1 Antagonists
p45296
(dp45297
sVCytochrome P450 2D6 Inhibitors
p45298
(dp45299
sVP-glycoprotein/ABCB1 Inhibitors
p45300
(dp45301
sVCytochrome P-450 Enzyme Inhibitors
p45302
(dp45303
sVCytochrome P-450 CYP3A4 Substrates
p45304
(dp45305
sVAntiemetics and Antinauseants
p45306
g41640
sVAlimentary Tract and Metabolism
p45307
g23902
ssg4440
(dp45308
VAmino Acids, Peptides, and Proteins
p45309
(dp45310
sVGlycols
p45311
(dp45312
sVAmino Acids
p45313
g43112
sg1512
g25214
sVOphthalmologicals
p45314
g35257
sVMast Cell Stabilizers
p45315
(dp45316
sVDecreased Histamine Release
p45317
(dp45318
sVSensory Organs
p45319
g40741
sVNeurotransmitter Agents
p45320
(dp45321
sVAnti-Allergic Agents
p45322
(dp45323
sVDecongestants and Antiallergics
p45324
(dp45325
sVPropylene Glycols
p45326
(dp45327
sVHistamine Agents
p45328
(dp45329
sVAntioxidants
p45330
(dp45331
sVAlcohols
p45332
(dp45333
sg4791
(dp45334
ssg4443
(dp45335
g5145
(dp45336
ssg4446
(dp45337
VOphthalmologicals
p45338
g35231
sVCytochrome P-450 CYP3A Substrates
p45339
g45184
sVOphthalmics
p45340
(dp45341
sVDiuretics
p45342
(dp45343
sVAmides
p45344
g44342
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45345
g29479
sVSensory Organs
p45346
g40722
sVEnzyme Inhibitors
p45347
(dp45348
sVSulfones
p45349
(dp45350
sVCytochrome P-450 CYP3A4 Substrates
p45351
(dp45352
sVCarbonic Anhydrase Inhibitors
p45353
(dp45354
sVSulfur Compounds
p45355
(dp45356
sVAntiglaucoma Preparations and Miotics
p45357
g36555
ssg4449
(dp45358
VImidazoles
p45359
(dp45360
sVCardiovascular Agents
p45361
g26653
sVUrologicals
p45362
(dp45363
sVGenito Urinary System and Sex Hormones
p45364
(dp45365
sVDrugs Used in Erectile Dysfunction
p45366
g20788
sVCytochrome P-450 CYP3A Substrates
p45367
g45081
sVP-glycoprotein/ABCB1 Substrates
p45368
g35044
sVPotential QTc-Prolonging Agents
p45369
(dp45370
sVUrological Agents
p45371
g38287
sVCYP3A Substrates (Sensitive)
p45372
(dp45373
sVVasodilating Agents
p45374
g23686
sVP-glycoprotein/ABCB1 Inhibitors
p45375
(dp45376
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45377
g29360
sVCytochrome P-450 CYP3A5 Substrates
p45378
(dp45379
sVPhosphodiesterase Inhibitors
p45380
(dp45381
sVEnzyme Inhibitors
p45382
(dp45383
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p45384
(dp45385
sVQTc Prolonging Agents
p45386
(dp45387
sVCytochrome P-450 CYP3A4 Substrates
p45388
(dp45389
sVPiperazines
p45390
(dp45391
sVPhosphodiesterase 5 Inhibitors
p45392
(dp45393
ssg4452
(dp45394
VDihydropyridine Derivatives
p45395
(dp45396
sVBSEP/ABCB11 Substrates
p45397
(dp45398
sVCytochrome P-450 CYP3A4 Inhibitors
p45399
(dp45400
sVCytochrome P-450 CYP2D6 Inhibitors
p45401
(dp45402
sVAntiarrhythmic agents
p45403
(dp45404
sVCytochrome P-450 CYP3A Substrates
p45405
g45082
sVAgents causing hyperkalemia
p45406
g43629
sVHypotensive Agents
p45407
g34191
sVCalcium Channel Blockers
p45408
g41307
sVCYP3A Substrates (Sensitive)
p45409
(dp45410
sVAdrenergic Antagonists
p45411
(dp45412
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p45413
g43780
sVCytochrome P-450 CYP2C9 Inhibitors
p45414
g18237
sVCardiovascular Agents
p45415
g26654
sVCytochrome P-450 Enzyme Inhibitors
p45416
(dp45417
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p45418
g18390
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p45419
(dp45420
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p45421
(dp45422
sVAntihypertensive Agents
p45423
g20310
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45424
g29361
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p45425
(dp45426
sVQTc Prolonging Agents
p45427
(dp45428
sVACE Inhibitors and Calcium Channel Blockers
p45429
(dp45430
sVPotential QTc-Prolonging Agents
p45431
(dp45432
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p45433
(dp45434
sVCytochrome P-450 CYP2C8 Inhibitors
p45435
(dp45436
sVPyridines
p45437
(dp45438
sVAdrenergic beta-Antagonists
p45439
g15351
sVVasodilating Agents
p45440
g23687
sVMembrane Transport Modulators
p45441
(dp45442
sVCytochrome P-450 CYP3A4 Substrates
p45443
(dp45444
sVCalcium-Regulating Hormones and Agents
p45445
(dp45446
sVCalcium Channel Blockers (Dihydropyridine)
p45447
g20125
sVCytochrome P-450 CYP3A5 Substrates
p45448
(dp45449
sVBeta blocking agents and calcium channel blockers
p45450
(dp45451
sVCytochrome P-450 CYP3A Inhibitors
p45452
(dp45453
sVBradycardia-Causing Agents
p45454
(dp45455
sVP-glycoprotein/ABCB1 Inhibitors
p45456
(dp45457
sVDihydropyridines
p45458
(dp45459
sVCytochrome P-450 CYP3A7 Substrates
p45460
(dp45461
ssg4455
(dp45462
g2754
g34058
sg9897
(dp45463
ssg4458
(dp45464
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p45465
(dp45466
sVCytochrome P-450 CYP2D6 Substrates
p45467
(dp45468
sVUGT1A1 Substrates
p45469
g12306
sVAnalgesics
p45470
g26474
sVHypotensive Agents
p45471
g34167
sVOpiate Agonists
p45472
(dp45473
sVCentral Nervous System Agents
p45474
(dp45475
sVNarcotics
p45476
(dp45477
sVPeripheral Nervous System Agents
p45478
(dp45479
sVCytochrome P-450 CYP2C8 Substrates
p45480
(dp45481
sVOpioids
p45482
g32242
sVUGT1A3 substrates
p45483
g31812
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45484
g29557
sVCytochrome P-450 CYP3A Substrates
p45485
g45242
sVNatural Opium Alkaloids
p45486
g23482
sVCentral Nervous System Depressants
p45487
(dp45488
sVAnesthetics
p45489
(dp45490
sVOpiate Alkaloids
p45491
(dp45492
sVP-glycoprotein/ABCB1 Substrates
p45493
g35019
sVHigh-risk opioids
p45494
(dp45495
sVNeuraxial Anesthetics
p45496
g32596
sVCytochrome P-450 CYP3A4 Substrates
p45497
(dp45498
sVHeterocyclic Compounds, Fused-Ring
p45499
(dp45500
sVOpioid Agonist
p45501
(dp45502
sVUGT2B7 substrates
p45503
g28634
sVAlkaloids
p45504
g19426
sVSensory System Agents
p45505
(dp45506
sVPhenanthrenes
p45507
g32843
sVNervous System
p45508
(dp45509
ssg4461
(dp45510
g7884
(dp45511
sg6207
(dp45512
sg1890
g28013
sg2460
g32268
sg11916
(dp45513
sg9996
(dp45514
sg11811
(dp45515
sg600
g17727
sg11370
(dp45516
sg8742
(dp45517
sg6435
(dp45518
sg7329
(dp45519
sg9588
(dp45520
ssg4464
(dp45521
g2142
g30346
sg600
g17752
sg11370
(dp45522
sg3009
g36061
ssg4467
(dp45523
VAmino Acids, Peptides, and Proteins
p45524
(dp45525
sVDrugs that are Mainly Renally Excreted
p45526
g44035
sVAmino Acids
p45527
g43108
sVFatty Acids
p45528
(dp45529
sVAcids, Acyclic
p45530
g25468
sVHypotensive Agents
p45531
g34196
sVAgents causing angioedema
p45532
(dp45533
sVOATP1B1/SLCO1B1 Inhibitors
p45534
(dp45535
sg9303
(dp45536
sVButyrates
p45537
(dp45538
sVFatty Acids, Volatile
p45539
(dp45540
sVLipids
p45541
g14289
sVOATP1B3 inhibitors
p45542
(dp45543
sg975
g21139
ssg4470
(dp45544
g1782
g27148
sg690
g18638
sg30
g12380
sg11604
(dp45545
sg12000
(dp45546
sg5973
(dp45547
sg5865
(dp45548
sg3141
g37073
sg4479
(dp45549
sg9135
(dp45550
sg2046
g29125
sg2418
g31911
sg8448
(dp45551
sg3174
g37266
sg7377
(dp45552
sg4920
(dp45553
sg3021
g36211
sg6240
(dp45554
sg4539
(dp45555
sg2739
g34009
sg3207
g37467
sg7662
(dp45556
sg11733
(dp45557
sg10218
(dp45558
sg2895
g35421
sg1761
g26975
sg9096
(dp45559
sg7878
(dp45560
ssg4473
(dp45561
g11283
(dp45562
sg7464
(dp45563
sg1674
g26329
sg10818
(dp45564
sg12421
g12470
sg4635
(dp45565
sg5433
(dp45566
sg6318
(dp45567
sg4803
(dp45568
sg10011
(dp45569
sg3885
g41442
sg9924
(dp45570
sg9192
(dp45571
sg6819
(dp45572
sg888
g20423
sg10701
(dp45573
sg4683
(dp45574
sg2427
g32008
sg6267
(dp45575
sg4344
g44649
sg918
g20755
sg1113
g22179
sg10740
(dp45576
sg138
g13281
sg6303
(dp45577
sg963
g20984
sg11544
(dp45578
sg3222
g37597
sg2265
g31002
sg10497
(dp45579
sg3240
g37708
sg3261
g37834
sg10056
(dp45580
sg10062
(dp45581
sg7053
(dp45582
sg2559
g32944
sg9417
(dp45583
sg7065
(dp45584
sg12066
(dp45585
sg12274
g27550
sg3321
g38215
sg5652
(dp45586
sg4863
(dp45587
sg282
g14544
sg285
g14624
sg11655
(dp45588
sg4680
(dp45589
sg5694
(dp45590
sg1785
g27179
sg6447
(dp45591
sg9357
(dp45592
sg7941
(dp45593
sg1134
g22322
sg1908
g28289
sg8028
(dp45594
sg10179
(dp45595
sg2688
g33631
sg14791
(dp45596
sg387
g15625
sg2703
g33721
sg7197
(dp45597
sg3447
g38922
sg5793
(dp45598
sg10266
(dp45599
sg5805
(dp45600
sg1425
g24543
sg2763
g34232
sg10308
(dp45601
sg1947
g28673
sg2034
g29010
sg4263
g44155
sg1263
g23181
sg3516
g39158
sg2808
g34478
sg8820
(dp45602
sg7299
(dp45603
sg2079
g29859
sg8097
(dp45604
sg6639
(dp45605
sg10365
(dp45606
sg2109
g30116
sg10374
(dp45607
sg696
g18721
sg7569
(dp45608
sg5127
(dp45609
sg69
g12742
sg7698
(dp45610
sg6678
(dp45611
sg3570
g39470
sg141
g13338
sg11910
(dp45612
sg5193
(dp45613
sg7014
(dp45614
sg9372
(dp45615
sg8922
(dp45616
sg8187
(dp45617
sg621
g17956
sg11955
(dp45618
sg516
g16862
sg2094
g29985
sg7428
(dp45619
sg11979
(dp45620
sg1434
g24647
sg5247
(dp45621
sg5289
(dp45622
sg1461
g24806
sg9525
(dp45623
sg1473
g24953
sg3861
g41279
sg12018
(dp45624
sg8259
(dp45625
sg5871
(dp45626
sg1491
g25067
sg5526
(dp45627
sg9987
(dp45628
sg3009
g36041
sg10512
(dp45629
sg10518
(dp45630
sg633
g18075
sg2769
g34292
sg11313
(dp45631
sg6102
(dp45632
sg10539
(dp45633
sg9060
(dp45634
sg10557
(dp45635
sg10698
(dp45636
sg8862
(dp45637
sg9819
(dp45638
sg6792
(dp45639
sg771
g19280
sg8751
(dp45640
sg12126
(dp45641
sg11370
(dp45642
sg3651
g40112
sg9102
(dp45643
sg4596
(dp45644
sg5580
(dp45645
ssg4476
(dp45646
VCytochrome P-450 CYP3A4 Substrates
p45647
(dp45648
sVAdrenal Cortex Hormones
p45649
g30001
sVSteroids
p45650
(dp45651
sVAndrostanes
p45652
(dp45653
sVCytochrome P-450 CYP3A Substrates
p45654
g45084
sVAnti-Allergic Agents
p45655
(dp45656
sVAndrostenes
p45657
(dp45658
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45659
g29363
sVImmunosuppressive Agents
p45660
(dp45661
sg2811
g34493
sVFused-Ring Compounds
p45662
g14876
sVCorticosteroids
p45663
(dp45664
ssg4479
(dp45665
VBSEP/ABCB11 Substrates
p45666
(dp45667
sVCytochrome P-450 CYP3A4 Inhibitors
p45668
(dp45669
sVCytochrome P-450 CYP3A Substrates
p45670
g45085
sVCytochrome P-450 CYP3A7 Inhibitors
p45671
(dp45672
sVAntibacterials for Systemic Use
p45673
g32520
sVAnti-Acne Preparations
p45674
(dp45675
sVOATP1B1/SLCO1B1 Inhibitors
p45676
(dp45677
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p45678
(dp45679
sVEnzyme Inhibitors
p45680
(dp45681
sVCytochrome P-450 Enzyme Inhibitors
p45682
(dp45683
sVAnti-Infective Agents
p45684
(dp45685
sVAntiinfectives for Systemic Use
p45686
(dp45687
sVMacrolide Antimicrobial
p45688
(dp45689
sVLactones
p45690
(dp45691
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p45692
g29364
sVErythromycins
p45693
(dp45694
sVMacrolides, Lincosamides and Streptogramins
p45695
g33212
sVAnti-Bacterial Agents
p45696
g38312
sVMacrolides
p45697
g16904
sVOATP1B1/SLCO1B1 Substrates
p45698
(dp45699
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p45700
g24777
sVGastrointestinal Agents
p45701
(dp45702
sVOATP1B3 inhibitors
p45703
(dp45704
sVP-glycoprotein/ABCB1 Substrates
p45705
g35062
sVDermatologicals
p45706
g17311
sVErythromycin and similars
p45707
(dp45708
sVProtein Synthesis Inhibitors
p45709
g45549
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p45710
(dp45711
sVBSEP/ABCB11 Inhibitors
p45712
(dp45713
sVCytochrome P-450 CYP3A5 Substrates
p45714
(dp45715
sVCytochrome P-450 CYP3A4 Substrates
p45716
(dp45717
sVQTc Prolonging Agents
p45718
(dp45719
sVModerate Risk QTc-Prolonging Agents
p45720
(dp45721
sVAnti-Acne Preparations for Topical Use
p45722
(dp45723
sVOphthalmologicals
p45724
g35254
sVOATP1B3 substrates
p45725
g28511
sVCytochrome P-450 CYP3A Inhibitors
p45726
(dp45727
sVP-glycoprotein/ABCB1 Inhibitors
p45728
(dp45729
sVAntiinfectives for Treatment of Acne
p45730
(dp45731
sVCytochrome P-450 CYP3A7 Substrates
p45732
(dp45733
sVCytochrome P-450 CYP3A5 Inhibitors
p45734
(dp45735
ssg4482
(dp45736
g9588
(dp45737
ssg4485
(dp45738
g1248
g23034
ssg4488
(dp45739
VCytochrome P-450 CYP3A4 Inhibitors
p45740
(dp45741
sg4107
g43003
sg4209
g43561
sg10080
(dp45742
sg9570
(dp45743
sg4038
g42471
sg5439
(dp45744
sg5031
(dp45745
sg4239
g43785
sg651
g18241
sg8100
(dp45746
sVCytochrome P-450 Enzyme Inhibitors
p45747
(dp45748
sg264
g14445
sg1653
g26139
sVHyperglycemia-Associated Agents
p45749
(dp45750
sg1251
g23066
sg5952
(dp45751
sVAmines
p45752
g42734
sg5475
(dp45753
sg2055
g29160
sg10695
(dp45754
sg9168
(dp45755
sg897
g20577
sg2964
g35884
sg2070
g29686
sg10911
(dp45756
sg3066
g36553
sg111
g13072
sVDrugs for Obstructive Airway Diseases
p45757
g42511
sg3936
g41702
sVNeurotransmitter Agents
p45758
(dp45759
sVCardiovascular Agents
p45760
g26663
sg10731
(dp45761
sg7371
(dp45762
sg321
g14942
sg6642
(dp45763
sg732
g19123
sg5124
(dp45764
sg11010
(dp45765
sg9051
(dp45766
sg3051
g36517
sg11103
(dp45767
sVAutonomic Agents
p45768
(dp45769
sg10965
(dp45770
sg6837
(dp45771
sg8532
(dp45772
sVOphthalmologicals
p45773
g35255
sg8148
(dp45774
sg11994
(dp45775
sVCytochrome P-450 CYP3A Inhibitors
p45776
(dp45777
sVStomatological Preparations
p45778
(dp45779
sVPeripheral Nervous System Agents
p45780
(dp45781
sg3273
g37908
sVAgents producing tachycardia
p45782
(dp45783
sg8565
(dp45784
sVNasal Preparations
p45785
(dp45786
sVAdrenergics, Inhalants
p45787
g43172
ssg4491
(dp45788
g9210
(dp45789
sVCompounds used in a research, industrial, or household setting
p45790
(dp45791
sg2037
g29052
sg5733
(dp45792
sVBenzene Derivatives
p45793
(dp45794
sg8643
(dp45795
sVLipid Modifying Agents, Plain
p45796
(dp45797
sg1287
g23411
sg9678
(dp45798
sVHypolipidemic Agents
p45799
(dp45800
sVLipid Modifying Agents
p45801
g40542
sVPolymers
p45802
g22231
sVLaboratory Chemicals
p45803
(dp45804
sg10536
(dp45805
sg5358
(dp45806
sg4134
g43131
sVBiomedical and Dental Materials
p45807
g44724
sVToxic Actions
p45808
(dp45809
sg10785
(dp45810
sVNoxae
p45811
(dp45812
sVMacromolecular Substances
p45813
g33840
sVLipid Regulating Agents
p45814
(dp45815
ssg4494
(dp45816
g3021
g36194
sg690
g18618
sg4479
g45694
sg4539
(dp45817
sg7377
(dp45818
ssg4497
(dp45819
g6279
(dp45820
sg8673
(dp45821
sg10563
(dp45822
sg3024
g36291
sg11592
(dp45823
sg10335
(dp45824
sg10356
(dp45825
ssg4500
(dp45826
g837
g19998
ssg4503
(dp45827
g7014
(dp45828
sg5727
(dp45829
sg3144
g37113
sg1326
g23601
ssg4506
(dp45830
g11910
(dp45831
sg2262
g30959
sg3444
g38868
ssg4509
(dp45832
g4035
g42435
sg1803
g27389
sg3684
g40231
ssg4512
(dp45833
g4017
g42285
sg2559
g32961
sg7464
(dp45834
sg10818
(dp45835
sg11595
(dp45836
sg4635
(dp45837
sg6318
(dp45838
sg8163
(dp45839
sg465
g16476
sg11979
(dp45840
sg3312
g38137
sg1239
g22960
sg10308
(dp45841
sg4266
g44204
sg9918
(dp45842
sg6411
(dp45843
sg8238
(dp45844
sg1263
g23185
sg282
g14562
sg5781
(dp45845
sg11016
(dp45846
sg11079
(dp45847
sg168
g13655
sg288
g14676
sg13070
g21904
sg2418
g31917
sg1491
g25089
sg2427
g32037
sg8820
(dp45848
sg8655
(dp45849
sg9588
(dp45850
sg5694
(dp45851
sg915
g20714
sg8097
(dp45852
sg9417
(dp45853
sg6009
(dp45854
sg9462
(dp45855
sg3381
g38483
sg2433
g32140
sg5316
(dp45856
sg2841
g34852
sg5535
(dp45857
sg7527
(dp45858
sg3570
g39490
sg6102
(dp45859
sg486
g16657
sg7941
(dp45860
sg7569
(dp45861
sg9981
(dp45862
sg7707
(dp45863
sg11154
(dp45864
sg564
g17414
sg11337
(dp45865
sg9819
(dp45866
sg696
g18745
sg2688
g33655
sg3978
g42001
sg3795
g40926
sg8721
(dp45867
sg5169
(dp45868
sg387
g15655
sg10497
(dp45869
sg2523
g32740
sg10878
(dp45870
sg12126
(dp45871
sg10596
(dp45872
sg10815
(dp45873
sg10356
(dp45874
sg3447
g38940
sg10056
(dp45875
sg8028
(dp45876
ssg4515
(dp45877
VAgents Causing Muscle Toxicity
p45878
(dp45879
sVFertility Agents, Female
p45880
g39018
sVNeuropeptides
p45881
(dp45882
sVNerve Tissue Proteins
p45883
(dp45884
sVGonadotropin Releasing Hormone Receptor Agonists
p45885
(dp45886
sVHormones
p45887
(dp45888
sVPeptide Hormones
p45889
g20210
sVGonadotropin Releasing Hormone Receptor Agonist
p45890
(dp45891
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p45892
(dp45893
sVFertility Agents
p45894
g41625
sVReproductive Control Agents
p45895
g18844
sVOligopeptides
p45896
(dp45897
sVAdrenal Cortex Hormones
p45898
g30055
sVProteins
p45899
(dp45900
sVPeptides
p45901
(dp45902
sVGonadotropin-releasing hormone agonist
p45903
(dp45904
sVAmino Acids, Peptides, and Proteins
p45905
(dp45906
sVGonadotropins and Antigonadotropins
p45907
(dp45908
sVPituitary and Hypothalamic Hormones and Analogues
p45909
(dp45910
sVHypothalamic Hormones
p45911
(dp45912
sVPituitary Hormone-Releasing Hormones
p45913
g40150
sVHormones, Hormone Substitutes, and Hormone Antagonists
p45914
(dp45915
ssg4518
(dp45916
g2427
g32039
sg465
g16478
sg10266
(dp45917
sg4023
g42347
sg11955
(dp45918
sg6186
(dp45919
sg10839
(dp45920
sg11592
(dp45921
sg5556
(dp45922
sg3858
g41229
sg9918
(dp45923
sg7821
(dp45924
sg9366
(dp45925
sg1047
g21612
sg6033
(dp45926
sg2559
g32966
sg11151
(dp45927
sg4263
g44174
sg11451
(dp45928
sg9198
(dp45929
sg3696
g40292
sg288
g14680
sg1113
g22187
sg8655
(dp45930
sg9591
(dp45931
sg2910
g35549
sg6279
(dp45932
sg3024
g36304
sg9231
(dp45933
sg8856
(dp45934
sg1899
g28072
sg10179
(dp45935
sg1908
g28304
sg8298
(dp45936
sg147
g13467
sg573
g17560
sg8760
(dp45937
sg4164
g43330
sg6525
(dp45938
sg6333
(dp45939
sg9663
(dp45940
sg7593
(dp45941
sg7563
(dp45942
sg7041
(dp45943
ssg4521
(dp45944
VPyrimidines
p45945
(dp45946
sVNucleic Acid Synthesis Inhibitors
p45947
(dp45948
sVImmunosuppressive Agents
p45949
(dp45950
sVCarbohydrates
p45951
(dp45952
sVEnzyme Inhibitors
p45953
(dp45954
sVPyrimidine Analogues
p45955
g18461
sVDrugs that are Mainly Renally Excreted
p45956
g43952
sVMyelosuppressive Agents
p45957
(dp45958
sVNucleoside Metabolic Inhibitor
p45959
(dp45960
sVCytidine
p45961
(dp45962
sVAza Compounds
p45963
(dp45964
sVAntimetabolites, Antineoplastic
p45965
g23448
sVAntineoplastic Agents
p45966
(dp45967
sVGlycosides
p45968
(dp45969
sVRibonucleosides
p45970
(dp45971
sVNucleic Acids, Nucleotides, and Nucleosides
p45972
(dp45973
sVPyrimidine Nucleosides
p45974
(dp45975
sg474
g16554
sVToxic Actions
p45976
(dp45977
sVNucleosides
p45978
(dp45979
sVAntimetabolites
p45980
(dp45981
sVNoxae
p45982
(dp45983
sVAntineoplastic and Immunomodulating Agents
p45984
g39760
ssg4524
(dp45985
g4680
(dp45986
sg12274
g27548
sg3543
g39345
sg5433
(dp45987
ssg4527
(dp45988
g4164
g43332
sg6075
(dp45989
sg9663
(dp45990
sg8049
(dp45991
sg8298
(dp45992
ssg4530
(dp45993
g9507
(dp45994
ssg4533
(dp45995
g8421
(dp45996
sg9822
(dp45997
sg8472
(dp45998
sg6333
(dp45999
sg4746
(dp46000
sg7335
(dp46001
ssg4536
(dp46002
g7596
(dp46003
ssg4539
(dp46004
VBSEP/ABCB11 Substrates
p46005
(dp46006
sVCytochrome P-450 CYP3A4 Inhibitors
p46007
(dp46008
sVCytochrome P-450 CYP3A Substrates
p46009
g45226
sg9891
(dp46010
sVAntibacterials for Systemic Use
p46011
g32581
sVAnti-Acne Preparations
p46012
(dp46013
sVOATP1B1/SLCO1B1 Inhibitors
p46014
(dp46015
sg9531
(dp46016
sVEnzyme Inhibitors
p46017
(dp46018
sVCytochrome P-450 Enzyme Inhibitors
p46019
(dp46020
sVAnti-Infective Agents
p46021
(dp46022
sVAntiinfectives for Systemic Use
p46023
(dp46024
sg6909
(dp46025
sg11280
(dp46026
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46027
g29537
sg4494
g45817
sVMacrolides, Lincosamides and Streptogramins
p46028
g33216
sVAnti-Bacterial Agents
p46029
g38385
sg522
g16908
sVOATP1B1/SLCO1B1 Substrates
p46030
(dp46031
sg1458
g24782
sVGastrointestinal Agents
p46032
(dp46033
sg7491
(dp46034
sVP-glycoprotein/ABCB1 Substrates
p46035
g35078
sVDermatologicals
p46036
g17323
sg5121
(dp46037
sVProtein Synthesis Inhibitors
p46038
g45555
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p46039
(dp46040
sVBSEP/ABCB11 Inhibitors
p46041
(dp46042
sVCytochrome P-450 CYP3A5 Substrates
p46043
(dp46044
sVCytochrome P-450 CYP3A4 Substrates
p46045
(dp46046
sVQTc Prolonging Agents
p46047
(dp46048
sVModerate Risk QTc-Prolonging Agents
p46049
(dp46050
sVAnti-Acne Preparations for Topical Use
p46051
(dp46052
sVOphthalmologicals
p46053
g35265
sVOATP1B3 substrates
p46054
g28529
sVCytochrome P-450 CYP3A Inhibitors
p46055
(dp46056
sVP-glycoprotein/ABCB1 Inhibitors
p46057
(dp46058
sVAntiinfectives for Treatment of Acne
p46059
(dp46060
sVCytochrome P-450 CYP3A7 Substrates
p46061
(dp46062
sg6174
(dp46063
ssg4542
(dp46064
VAntiparasitic Products, Insecticides and Repellents
p46065
g30581
sg10317
(dp46066
sg222
g14102
sVHeterocyclic Compounds, Fused-Ring
p46067
(dp46068
sVQuinolines
p46069
(dp46070
sVCytochrome P-450 CYP2D6 Inhibitors
p46071
(dp46072
sVPotential QTc-Prolonging Agents
p46073
(dp46074
sVImmunosuppressive Agents
p46075
(dp46076
sg6120
(dp46077
sg3759
g40659
sVEnzyme Inhibitors
p46078
(dp46079
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p46080
(dp46081
sVP-glycoprotein/ABCB1 Inhibitors
p46082
(dp46083
sVAntirheumatic Agents
p46084
g24240
sVAntiprotozoals
p46085
(dp46086
sVCytochrome P-450 Enzyme Inhibitors
p46087
(dp46088
sVAnti-Infective Agents
p46089
(dp46090
sVQTc Prolonging Agents
p46091
(dp46092
ssg4545
(dp46093
g1581
g25696
sg717
g19057
sg2058
g29186
ssg4548
(dp46094
g10389
(dp46095
sg5652
(dp46096
ssg4551
(dp46097
VAmino Acids, Peptides, and Proteins
p46098
(dp46099
sVGlobulins
p46100
g19190
sVAntibodies
p46101
(dp46102
sVAntibodies, Monoclonal
p46103
(dp46104
sVImmunoglobulins
p46105
g41532
sVProteins
p46106
(dp46107
sVP-glycoprotein/ABCB1 Substrates
p46108
g35081
sg11892
(dp46109
sg3006
g36037
sg2469
g32366
sVSerum Globulins
p46110
(dp46111
sVAntineoplastic and Immunomodulating Agents
p46112
g39821
sVBlood Proteins
p46113
g39868
sVAntineoplastic Agents
p46114
(dp46115
sg1095
g22000
sVImmunoproteins
p46116
(dp46117
ssg4554
(dp46118
g11832
(dp46119
sg11133
(dp46120
sg3105
g36797
sg12186
g42935
sg10272
(dp46121
sg8529
(dp46122
sg2754
g34074
sg8022
(dp46123
sg8439
(dp46124
sg7680
(dp46125
sg9084
(dp46126
sg5556
(dp46127
sg8340
(dp46128
sg11664
(dp46129
sg1581
g25703
sg10002
(dp46130
sg2826
g34621
sg9897
(dp46131
sg8751
(dp46132
sg3699
g40346
ssg4557
(dp46133
VPolyvalent cation containing laxatives, antacids, oral supplements
p46134
(dp46135
sVGastric Acid Lowering Agents
p46136
(dp46137
sVAlkalies
p46138
(dp46139
sVAntacids
p46140
g42401
sVCarbonic Acid
p46141
(dp46142
sVCalcium Compounds
p46143
(dp46144
sVCalcium Salts
p46145
(dp46146
sVReplacement Preparations
p46147
g27632
sVElectrolytes
p46148
(dp46149
sVMineral Supplements
p46150
g38295
sVPhosphate Binder
p46151
g21947
sVMinerals
p46152
(dp46153
sVGastrointestinal Agents
p46154
(dp46155
sVCarbonates
p46156
(dp46157
sVIons
p46158
(dp46159
sVAntacids and Adsorbents
p46160
(dp46161
sVAcids
p46162
g40584
sVAlimentary Tract and Metabolism
p46163
g23886
sVCarbon Compounds, Inorganic
p46164
g39299
sVBlood Coagulation Factors
p46165
(dp46166
sVAcids, Noncarboxylic
p46167
(dp46168
sVDrugs for Acid Related Disorders
p46169
(dp46170
sVAnions
p46171
(dp46172
ssg4560
(dp46173
g11286
(dp46174
ssg4563
(dp46175
g10113
(dp46176
ssg4566
(dp46177
g11862
(dp46178
sg12003
(dp46179
sg4974
(dp46180
sg9750
(dp46181
sg1941
g28604
sg978
g21182
sg3399
g38655
sg2658
g33387
sg4062
g42648
sg1770
g27064
sg879
g20370
ssg4569
(dp46182
g561
g17367
ssg4572
(dp46183
g8577
(dp46184
ssg4575
(dp46185
g6579
(dp46186
sg8598
(dp46187
sg8601
(dp46188
sg8277
(dp46189
ssg4578
(dp46190
g4014
g42251
sg6765
(dp46191
sg1365
g24047
sg4917
(dp46192
sg10839
(dp46193
sg11313
(dp46194
sg6009
(dp46195
sg13091
g21430
sg2466
g32361
sg10374
(dp46196
sg3258
g37815
sg7848
(dp46197
sg3930
g41666
sg8190
(dp46198
ssg4581
(dp46199
VGastrointestinal Agents
p46200
(dp46201
sVStimulation Large Intestine Fluid/Electrolyte Secretion
p46202
(dp46203
sVOsmotic Activity
p46204
g28832
sVCarbohydrates
p46205
(dp46206
sVDrugs for Constipation
p46207
(dp46208
sVAcidifying Activity
p46209
(dp46210
sVLaxatives
p46211
g17356
sVAmmonia Detoxicants
p46212
(dp46213
sVDisaccharides
p46214
(dp46215
sVOsmotic Laxatives
p46216
(dp46217
sVAlimentary Tract and Metabolism
p46218
g23941
ssg4584
(dp46219
g2211
g30733
ssg4587
(dp46220
g2805
g34442
ssg4590
(dp46221
g2079
g29848
ssg4593
(dp46222
g7422
(dp46223
sg3105
g36806
sg8022
(dp46224
sg6684
(dp46225
sg7014
(dp46226
sg7305
(dp46227
ssg4596
(dp46228
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p46229
(dp46230
sVCytochrome P-450 CYP3A4 Inhibitors
p46231
(dp46232
sVCytochrome P-450 CYP2D6 Substrates
p46233
(dp46234
sVUGT1A1 Substrates
p46235
g12281
sVAnalgesics
p46236
g26502
sVCentral Nervous System Agents
p46237
(dp46238
sVUGT1A9 Substrates
p46239
g24019
sVAnilides
p46240
(dp46241
sVCytochrome P-450 Enzyme Inhibitors
p46242
(dp46243
sVMethemoglobinemia Associated Agents
p46244
g25580
sVDrugs that are Mainly Renally Excreted
p46245
g43925
sVCytochrome P-450 CYP1A2 Substrates
p46246
g45644
sVAmines
p46247
g42749
sVAmides
p46248
g44357
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46249
g29378
sVAniline Compounds
p46250
g23445
sVCytochrome P-450 CYP3A4 Inducers
p46251
g18988
sVCytochrome P-450 CYP3A Substrates
p46252
g45098
sVUGT1A6 substrate
p46253
g38518
sVP-glycoprotein/ABCB1 Substrates
p46254
g35090
sVAntipyretics
p46255
(dp46256
sVCytochrome P-450 CYP2A6 Substrates
p46257
g35141
sVAcetaminophen and Prodrugs
p46258
(dp46259
sVCytochrome P-450 Enzyme Inducers
p46260
g28252
sVCytochrome P-450 CYP3A Inducers
p46261
(dp46262
sVCytochrome P-450 CYP3A4 Substrates
p46263
(dp46264
sVAnalgesics, Non-Narcotic
p46265
(dp46266
sVCytochrome P-450 CYP3A Inhibitors
p46267
(dp46268
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p46269
(dp46270
sVCytochrome P-450 CYP2E1 Substrates
p46271
(dp46272
sVP-glycoprotein/ABCB1 Inhibitors
p46273
(dp46274
sVSensory System Agents
p46275
(dp46276
sVNervous System
p46277
(dp46278
sVMiscellaneous Analgesics and Antipyretics
p46279
g43119
ssg4599
(dp46280
g6447
(dp46281
sg4890
(dp46282
sg7698
(dp46283
sg9216
(dp46284
sg11403
(dp46285
ssg4602
(dp46286
g3090
g36715
sg9846
(dp46287
sg9630
(dp46288
sg9426
(dp46289
sg2940
g35725
ssg4605
(dp46290
g8616
(dp46291
sg1278
g23352
sg8850
(dp46292
sg1872
g27882
sg126
g13189
sg1176
g22694
sg6432
(dp46293
sg9750
(dp46294
sg3267
g37905
sg4872
(dp46295
sg7653
(dp46296
ssg4608
(dp46297
g6090
(dp46298
sg1947
g28648
sg2844
g34866
sg4263
g44137
sg11523
(dp46299
sg1038
g21468
sg10494
(dp46300
sg6024
(dp46301
sg5589
(dp46302
sg7800
(dp46303
sg7014
(dp46304
sg7059
(dp46305
sg5946
(dp46306
sg7563
(dp46307
sg5793
(dp46308
sg10779
(dp46309
sg8418
(dp46310
ssg4611
(dp46311
g6525
(dp46312
ssg4614
(dp46313
g1110
g22123
ssg4617
(dp46314
g6504
(dp46315
sg3024
g36244
sg11451
(dp46316
sg1371
g24068
sg9198
(dp46317
sg10797
(dp46318
sg5370
(dp46319
sg8166
(dp46320
sg9249
(dp46321
sg10179
(dp46322
sg11439
(dp46323
sg4263
g44139
sg5556
(dp46324
sg4452
g45422
sg5364
(dp46325
sg621
g17937
ssg4620
(dp46326
VImmunosuppressive Agents
p46327
(dp46328
sVCytochrome P-450 CYP3A Substrates
p46329
g45026
sVHormones
p46330
(dp46331
sVDrugs for Obstructive Airway Diseases
p46332
g42502
sVHyperglycemia-Associated Agents
p46333
(dp46334
sVGlucocorticoids
p46335
g21931
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46336
g29286
sVFused-Ring Compounds
p46337
g14805
sVCytochrome P-450 CYP3A4 Inducers
p46338
g18867
sVCytochrome P-450 CYP3A5 Inducers
p46339
g41734
sVAdrenal Cortex Hormones
p46340
g30041
sVAdrenals
p46341
g37361
sVCytochrome P-450 Enzyme Inducers
p46342
g28104
sVCytochrome P-450 CYP3A Inducers
p46343
(dp46344
sVCytochrome P-450 CYP3A4 Substrates
p46345
(dp46346
sVNasal Preparations
p46347
(dp46348
sVPregnanes
p46349
(dp46350
sVAgents to Treat Airway Disease
p46351
g32633
sVSteroids
p46352
(dp46353
sVAnti-Allergic Agents
p46354
(dp46355
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p46356
(dp46357
sVPregnenes
p46358
g28755
sVHormones, Hormone Substitutes, and Hormone Antagonists
p46359
(dp46360
sVCorticosteroids
p46361
(dp46362
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p46363
(dp46364
ssg4623
(dp46365
VAdrenergic beta-Agonists
p46366
g42998
sVNeurotransmitter Agents
p46367
(dp46368
sVSympathomimetics
p46369
(dp46370
sVDrugs for Obstructive Airway Diseases
p46371
g42509
sVAutonomic Agents
p46372
(dp46373
sVTocolytic Agents
p46374
g33145
sVPeripheral Nervous System Agents
p46375
(dp46376
sVRespiratory System Agents
p46377
(dp46378
sVReproductive Control Agents
p46379
g18846
sVEthanolamines
p46380
(dp46381
sVAdrenergic Agents
p46382
g41700
sVBronchodilator Agents
p46383
(dp46384
sVPhenols
p46385
(dp46386
sVAdrenergics for Systemic Use
p46387
(dp46388
sVBenzene Derivatives
p46389
(dp46390
sVAgents to Treat Airway Disease
p46391
g32637
sVCatecholamines
p46392
g19120
sVAdrenergic Agonists
p46393
(dp46394
sVAgents that produce hypertension
p46395
(dp46396
sVAnti-Asthmatic Agents
p46397
g36516
sVAmines
p46398
g42698
sVCatechols
p46399
(dp46400
sVAdrenergic beta-2 Receptor Agonists
p46401
(dp46402
sVAmino Alcohols
p46403
g32672
sVSelective Beta 2-adrenergic Agonists
p46404
(dp46405
sVAgents producing tachycardia
p46406
(dp46407
sVAlcohols
p46408
(dp46409
sVAdrenergics, Inhalants
p46410
g43168
sVNon-selective Beta-adrenergic Agonists
p46411
(dp46412
ssg4626
(dp46413
g534
g16966
sg6279
(dp46414
sg10728
(dp46415
sg10266
(dp46416
sg3024
g36252
sg816
g19634
sg4164
g43284
sg11592
(dp46417
sg8820
(dp46418
sg8949
(dp46419
sg11523
(dp46420
sg5256
(dp46421
sg11940
(dp46422
sg8298
(dp46423
sg7329
(dp46424
sg10308
(dp46425
sg9918
(dp46426
ssg4629
(dp46427
g483
g16625
sg5961
(dp46428
sVPolymers
p46429
g22221
sg11226
(dp46430
sVSilicon Compounds
p46431
(dp46432
sVDermatologicals
p46433
g17180
sVSurface-Active Agents
p46434
(dp46435
sVCompounds used in a research, industrial, or household setting
p46436
(dp46437
sVMacromolecular Substances
p46438
g33830
sg10386
(dp46439
sVBiomedical and Dental Materials
p46440
g44717
sg10155
(dp46441
sg9795
(dp46442
ssg4632
(dp46443
g537
g17016
sg4458
g45473
sg10596
(dp46444
sg8487
(dp46445
sg11595
(dp46446
sg294
g14724
sg8163
(dp46447
sg450
g16323
sg1809
g27419
sg42
g12568
sg5877
(dp46448
sg1281
g23359
sg10602
(dp46449
sg1434
g24627
sg9960
(dp46450
sg1008
g21265
sg915
g20683
sg8295
(dp46451
sg3156
g37182
ssg4635
(dp46452
VAnalgesics and Anesthetics
p46453
(dp46454
sVCytochrome P-450 CYP2D6 Inhibitors
p46455
(dp46456
sVCytochrome P-450 CYP2D6 Substrates
p46457
(dp46458
sVAntiarrhythmic agents
p46459
(dp46460
sVCytochrome P-450 CYP3A Substrates
p46461
g45101
sVCentral Nervous System Agents
p46462
(dp46463
sVAnesthetics, Local
p46464
(dp46465
sVAnilides
p46466
(dp46467
sVOtologicals
p46468
(dp46469
sVLocal Anesthesia
p46470
g14962
sVCytochrome P-450 Enzyme Inhibitors
p46471
(dp46472
sVThroat Preparations
p46473
(dp46474
sVPeripheral Nervous System Agents
p46475
(dp46476
sVCytochrome P-450 CYP2C8 Substrates
p46477
(dp46478
sVCytochrome P-450 CYP1A2 Substrates
p46479
g45565
sVAmines
p46480
g42664
sVAntipruritics and Local Anesthetics
p46481
g31867
sVCardiac Therapy
p46482
(dp46483
sVAmides
p46484
g44286
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p46485
g16817
sVAniline Compounds
p46486
g23435
sVVasoprotectives
p46487
g41380
sVCytochrome P-450 CYP2C9 Substrates
p46488
g29708
sVCardiovascular Agents
p46489
g26522
sVAnesthetics
p46490
(dp46491
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46492
g29381
sVAgents that reduce seizure threshold
p46493
g45837
sVCytochrome P-450 CYP1A2 Inhibitors
p46494
g14991
sVDermatologicals
p46495
g17181
sVAnesthetics for Topical Use
p46496
g43181
sVCytochrome P-450 CYP2A6 Substrates
p46497
g35119
sVCytochrome P-450 CYP2C18 Substrates
p46498
g20929
sVMembrane Transport Modulators
p46499
(dp46500
sVNeuraxial Anesthetics
p46501
g32593
sVCytochrome P-450 CYP3A4 Substrates
p46502
(dp46503
sVSodium Channel Blockers
p46504
(dp46505
sVOphthalmologicals
p46506
g35169
sVAntiarrhythmics, Class I
p46507
(dp46508
sVVoltage-Gated Sodium Channel Blockers
p46509
g40907
sVCytochrome P-450 CYP3A5 Substrates
p46510
(dp46511
sVAmide Local Anesthetic
p46512
(dp46513
sVMethemoglobinemia Associated Agents
p46514
g25557
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p46515
(dp46516
sVP-glycoprotein/ABCB1 Inhibitors
p46517
(dp46518
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p46519
(dp46520
sVAntiarrhythmics, Class Ib
p46521
(dp46522
sVSensory System Agents
p46523
(dp46524
sVNervous System
p46525
(dp46526
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p46527
g27736
sVCytochrome P-450 CYP3A7 Substrates
p46528
(dp46529
sVCytochrome P-450 CYP2B6 Substrates
p46530
g33003
ssg4638
(dp46531
VDrugs that are Mainly Renally Excreted
p46532
g43927
sVAgents to Treat Airway Disease
p46533
g32638
sVAmines
p46534
g42699
sVBenzene Derivatives
p46535
(dp46536
sVBenzoates
p46537
g30387
sg7776
(dp46538
sVCytochrome P-450 CYP3A Substrates
p46539
g45102
sVAcids, Carbocyclic
p46540
g41555
sVCycloparaffins
p46541
g43663
sVAmides
p46542
g44314
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46543
g29382
sVPyridines
p46544
(dp46545
sVPhosphodiesterase Inhibitors
p46546
(dp46547
sVCytochrome P-450 CYP3A4 Substrates
p46548
(dp46549
sVDrugs for Obstructive Airway Diseases
p46550
g42510
ssg4641
(dp46551
g1767
g27023
ssg4644
(dp46552
g5457
(dp46553
sg5511
(dp46554
sg9660
(dp46555
ssg4647
(dp46556
VCytochrome P-450 CYP2D6 Inhibitors
p46557
(dp46558
sVCardiac Stimulants Excl. Cardiac Glycosides
p46559
g29161
sVNeurotransmitter Agents
p46560
(dp46561
sVAdrenergic and Dopaminergic Agents
p46562
(dp46563
sVSympathomimetics
p46564
(dp46565
sVCytochrome P-450 Enzyme Inhibitors
p46566
(dp46567
sVPeripheral Nervous System Agents
p46568
(dp46569
sVVasoconstrictor Agents
p46570
g35879
sVAmines
p46571
g42665
sVCardiac Therapy
p46572
(dp46573
sVEthanolamines
p46574
(dp46575
sVAdrenergic Agents
p46576
g41692
sVCardiovascular Agents
p46577
g26525
sVAdrenergic Agonists
p46578
(dp46579
sVAgents that produce hypertension
p46580
(dp46581
sVAutonomic Agents
p46582
(dp46583
sVAmino Alcohols
p46584
g32669
sVAdrenergic alpha-Agonists
p46585
(dp46586
sVBradycardia-Causing Agents
p46587
(dp46588
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p46589
(dp46590
sVAgents producing tachycardia
p46591
(dp46592
sVAdrenergic alpha-1 Receptor Agonists
p46593
(dp46594
sVAlcohols
p46595
(dp46596
ssg4650
(dp46597
VAgents Causing Muscle Toxicity
p46598
(dp46599
sVFatty Acids
p46600
(dp46601
sVCytochrome P-450 CYP3A Substrates
p46602
g45103
sg6426
(dp46603
sVButyrates
p46604
(dp46605
sVOATP1B1/SLCO1B1 Inhibitors
p46606
(dp46607
sVLipids
p46608
g14299
sVCytochrome P-450 Enzyme Inhibitors
p46609
(dp46610
sVEthers
p46611
g27600
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p46612
g23104
sVLipid Modifying Agents
p46613
g40535
sVAcids, Carbocyclic
p46614
g41550
sVAmides
p46615
g44289
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46616
g29383
sVLipid Modifying Agents, Plain
p46617
(dp46618
sVHypolipidemic Agents
p46619
(dp46620
sVFatty Acids, Volatile
p46621
(dp46622
sVPhenols
p46623
(dp46624
sVBenzene Derivatives
p46625
(dp46626
sg1524
g25236
sVCytochrome P-450 CYP2C8 Inhibitors
p46627
(dp46628
sVPhenyl Ethers
p46629
g40599
sg3558
g39420
sVCytochrome P-450 CYP3A4 Substrates
p46630
(dp46631
sVBenzamides and benzamide derivatives
p46632
g15379
sVToxic Actions
p46633
(dp46634
sVAcids, Acyclic
p46635
g25446
sVNoxae
p46636
(dp46637
sg9120
(dp46638
sVBenzoates
p46639
g30381
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p46640
g24199
sVLipid Regulating Agents
p46641
(dp46642
ssg4653
(dp46643
VAgents Causing Muscle Toxicity
p46644
(dp46645
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p46646
(dp46647
sVCytochrome P-450 CYP3A4 Inhibitors
p46648
(dp46649
sVOphthalmological and Otological Preparations
p46650
(dp46651
sVCytochrome P-450 CYP3A Substrates
p46652
g45104
sVStomatological Preparations
p46653
(dp46654
sVBCRP/ABCG2 Inhibitors
p46655
g12515
sVBSEP/ABCB11 inducers
p46656
(dp46657
sVCytochrome P-450 CYP3A5 Inducers
p46658
g41737
sVVasoprotectives
p46659
g41385
sVCytochrome P-450 CYP3A7 Inducers
p46660
g39037
sVHormones
p46661
(dp46662
sVCytochrome P-450 CYP2D6 Inducers
p46663
(dp46664
sVCorticosteroids for Systemic Use
p46665
(dp46666
sVCytochrome P-450 Enzyme Inhibitors
p46667
(dp46668
sVPeripheral Nervous System Agents
p46669
(dp46670
sVHyperglycemia-Associated Agents
p46671
(dp46672
sVCytochrome P-450 CYP2E1 Inducers
p46673
g27611
sVP-glycoprotein/ABCB1 Inducers
p46674
(dp46675
sVCytochrome P-450 CYP3A4 Inducers (strong)
p46676
g23075
sVCorticosteroids for Systemic Use, Plain
p46677
g31769
sVAutonomic Agents
p46678
(dp46679
sVCytochrome P-450 CYP2B6 Inducers
p46680
g39114
sVSteroids, Fluorinated
p46681
(dp46682
sVCorticosteroids, Dermatological Preparations
p46683
(dp46684
sVOtologicals
p46685
(dp46686
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p46687
g14790
sVPregnadienetriols
p46688
(dp46689
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p46690
g16824
sVCorticosteroids for Local Oral Treatment
p46691
(dp46692
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46693
g29384
sVFused-Ring Compounds
p46694
g14812
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p46695
g25139
sVCytochrome P-450 CYP3A4 Inducers
p46696
g18879
sVAntineoplastic Agents
p46697
(dp46698
sVDexamethasone
p46699
(dp46700
sVPregnadienes
p46701
(dp46702
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p46703
g44468
sVAntiemetics
p46704
(dp46705
sVAdrenal Cortex Hormones
p46706
g30013
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p46707
(dp46708
sVAdrenals
p46709
g37363
sVP-glycoprotein/ABCB1 Substrates
p46710
g34957
sVAntineoplastic Agents, Hormonal
p46711
(dp46712
sVDermatologicals
p46713
g17187
sVCytochrome P-450 Enzyme Inducers
p46714
g28117
sVCytochrome P-450 CYP3A Inducers
p46715
(dp46716
sVInducers of Drug Clearance
p46717
g44534
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p46718
g44542
sVCytochrome P-450 CYP3A Inducers (strong)
p46719
g22447
sVCytochrome P-450 CYP2A6 Inducers
p46720
g39423
sVCytochrome P-450 CYP3A4 Substrates
p46721
(dp46722
sVCentral Nervous System Agents
p46723
(dp46724
sVAlimentary Tract and Metabolism
p46725
g23761
sVNasal Preparations
p46726
(dp46727
sVPregnanes
p46728
(dp46729
sVGastrointestinal Agents
p46730
(dp46731
sVAnti-Acne Preparations for Topical Use
p46732
(dp46733
sVOphthalmologicals
p46734
g35236
sVSteroids
p46735
(dp46736
sVCorticosteroids, Moderately Potent (Group II)
p46737
(dp46738
sVCytochrome P-450 CYP3A Inhibitors
p46739
(dp46740
sVImmunosuppressive Agents
p46741
(dp46742
sVAnti-Acne Preparations
p46743
(dp46744
sVCytochrome P-450 CYP2C19 Inducers
p46745
g25531
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p46746
(dp46747
sVAnti-Inflammatory Agents
p46748
(dp46749
sVCorticosteroid Hormone Receptor Agonists
p46750
(dp46751
sVP-glycoprotein/ABCB1 Inhibitors
p46752
(dp46753
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p46754
(dp46755
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p46756
(dp46757
sVCytochrome P-450 CYP2C8 Inducers
p46758
(dp46759
sVHormones, Hormone Substitutes, and Hormone Antagonists
p46760
(dp46761
sVCorticosteroids
p46762
(dp46763
sVCytochrome P-450 CYP3A7 Substrates
p46764
(dp46765
sVSensory Organs
p46766
g40725
ssg4656
(dp46767
VOAT1/SLC22A6 inhibitors
p46768
(dp46769
sVHypotensive Agents
p46770
g34108
sVPotential QTc-Prolonging Agents
p46771
(dp46772
sVHyperglycemia-Associated Agents
p46773
(dp46774
sVGynecological Antiinfectives and Antiseptics
p46775
(dp46776
sVAntihypertensive Agents
p46777
g20249
sVChlorothiazide
p46778
(dp46779
sVAmides
p46780
g44291
sVSulfur Compounds
p46781
(dp46782
sVSulfones
p46783
(dp46784
sVQTc Prolonging Agents
p46785
(dp46786
sVSulfonamides
p46787
(dp46788
sVSodium Chloride Symporter Inhibitors
p46789
(dp46790
sVCardiovascular Agents
p46791
g26584
sVNon Potassium Sparing Diuretics
p46792
g14980
sVMembrane Transport Modulators
p46793
(dp46794
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p46795
g25433
sVHeterocyclic Compounds, Fused-Ring
p46796
(dp46797
sVGenito Urinary System and Sex Hormones
p46798
(dp46799
sVNatriuretic Agents
p46800
g40483
sVThiazides
p46801
(dp46802
sVBenzothiadiazines
p46803
g44817
sVIncreased Diuresis
p46804
g41003
sVNephrotoxic agents
p46805
(dp46806
sVDiuretics
p46807
(dp46808
ssg4659
(dp46809
g9225
(dp46810
ssg4662
(dp46811
g12003
(dp46812
ssg4665
(dp46813
g8655
(dp46814
ssg4668
(dp46815
g1548
g25372
sg8862
(dp46816
sg2304
g31245
sg2616
g33177
sg5829
(dp46817
sg10761
(dp46818
sg3708
g40382
sg9987
(dp46819
sg10005
(dp46820
sg5580
(dp46821
ssg4671
(dp46822
g9741
(dp46823
sg9108
(dp46824
ssg4674
(dp46825
g426
g16083
sg4017
g42280
sg3105
g36778
sg2559
g32948
sg11955
(dp46826
sg9417
(dp46827
sg2730
g33878
sg11592
(dp46828
sg6318
(dp46829
sg834
g19952
sg1047
g21603
sg3318
g38179
sg5469
(dp46830
sg282
g14537
sg5064
(dp46831
sg8022
(dp46832
sg12018
(dp46833
sg288
g14648
sg2427
g32014
sg2430
g32103
sg4887
(dp46834
sg12045
(dp46835
sg9588
(dp46836
sg534
g16987
sg6279
(dp46837
sg3024
g36284
sg10740
(dp46838
sg2109
g30138
sg5535
(dp46839
sg486
g16637
sg8856
(dp46840
sg696
g18703
sg9198
(dp46841
sg14791
(dp46842
sg789
g19477
sg1140
g22386
sg9267
(dp46843
sg69
g12757
sg6798
(dp46844
sg10557
(dp46845
sg582
g17623
sg387
g15631
sg5370
(dp46846
sg6819
(dp46847
sg10356
(dp46848
sg11241
(dp46849
sg414
g15946
sg7563
(dp46850
ssg4677
(dp46851
g7815
(dp46852
sg4068
g42768
sg10368
(dp46853
sg3204
g37435
sg11334
(dp46854
sg5691
(dp46855
sg10509
(dp46856
sg3609
g39676
ssg4680
(dp46857
VEstradiol Congeners
p46858
(dp46859
sVUGT1A1 Substrates
p46860
g12327
sVCytochrome P-450 CYP3A Substrates
p46861
g45128
sVBCRP/ABCG2 Inhibitors
p46862
g12528
sVOCT2 Inhibitors
p46863
g42489
sVOATP1B1/SLCO1B1 Inhibitors
p46864
(dp46865
sVEstradiol
p46866
g27565
sVHormones
p46867
(dp46868
sVCytochrome P-450 Enzyme Inhibitors
p46869
(dp46870
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p46871
(dp46872
sVHormonal Contraceptives for Systemic Use
p46873
(dp46874
sVDrugs that are Mainly Renally Excreted
p46875
g43955
sVCytochrome P-450 CYP2C8 Substrates
p46876
(dp46877
sVCytochrome P-450 CYP1A2 Substrates
p46878
g45589
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p46879
g29409
sVCytochrome P-450 CYP2C9 Substrates
p46880
g29744
sVFused-Ring Compounds
p46881
g14837
sVCytochrome P-450 CYP3A4 Inducers
p46882
g18912
sVOCT1 inhibitors
p46883
(dp46884
sVAdrenal Cortex Hormones
p46885
g30052
sVCytochrome P-450 CYP1A2 Inhibitors
p46886
g15012
sVP-glycoprotein/ABCB1 Substrates
p46887
g34965
sVEstrogen Contraceptives
p46888
g45986
sVCytochrome P-450 Enzyme Inducers
p46889
g28155
sVCytochrome P-450 CYP3A Inducers
p46890
(dp46891
sVCytochrome P-450 CYP3A4 Substrates
p46892
(dp46893
sVGonadal Hormones
p46894
g33578
sVCytochrome P-450 CYP3A5 Substrates
p46895
(dp46896
sVContraceptive Agents, Female
p46897
(dp46898
sVSteroids
p46899
(dp46900
sVGonadal Steroid Hormones
p46901
(dp46902
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p46903
(dp46904
sVEstranes
p46905
(dp46906
sVHormones, Hormone Substitutes, and Hormone Antagonists
p46907
(dp46908
sVEstrenes
p46909
(dp46910
sVEstradiol, agonists
p46911
g27079
sVEstrogens
p46912
(dp46913
sVCytochrome P-450 CYP3A7 Substrates
p46914
(dp46915
ssg4683
(dp46916
VNitrogen Compounds
p46917
g39008
sVXanthine derivatives
p46918
g28827
sVBronchodilator Agents
p46919
(dp46920
sVRespiratory Smooth Muscle Relaxants
p46921
g17925
sVXanthines and Adrenergics
p46922
g22914
sVDrugs for Obstructive Airway Diseases
p46923
g42514
sVCytochrome P-450 CYP1A2 Substrates
p46924
g45574
sVAmines
p46925
g42667
sVPeripheral Nervous System Agents
p46926
(dp46927
sVRespiratory System Agents
p46928
(dp46929
sVPurinones
p46930
(dp46931
sVEthanolamines
p46932
(dp46933
sVOnium Compounds
p46934
g22260
sVAnti-Asthmatic Agents
p46935
g36521
sVAutonomic Agents
p46936
(dp46937
sVHeterocyclic Compounds, Fused-Ring
p46938
(dp46939
sVAmino Alcohols
p46940
g32697
sVAlkaloids
p46941
g19416
sVAmmonium Compounds
p46942
g30563
sVQuaternary Ammonium Compounds
p46943
g43374
sVAlcohols
p46944
(dp46945
sVPurines
p46946
(dp46947
sVTrimethyl Ammonium Compounds
p46948
g16044
ssg4686
(dp46949
g6966
(dp46950
sg4344
g44653
ssg4689
(dp46951
g516
g16878
sg2658
g33377
ssg4692
(dp46952
g9180
(dp46953
sg1920
g28499
ssg4695
(dp46954
g8928
(dp46955
ssg4698
(dp46956
g9588
(dp46957
ssg4701
(dp46958
g10767
(dp46959
sg1164
g22605
sg9309
(dp46960
sg7629
(dp46961
sg4770
(dp46962
sg10764
(dp46963
sg12108
(dp46964
ssg4704
(dp46965
g2664
g33455
ssg4707
(dp46966
VAmidines
p46967
(dp46968
sVAntiinfectives for Systemic Use
p46969
(dp46970
sg6108
(dp46971
sVAntivirals for Systemic Use
p46972
(dp46973
sVDrugs that are Mainly Renally Excreted
p46974
g43935
sVAcids, Acyclic
p46975
g25467
sVGuanidines
p46976
(dp46977
sVCarbohydrates
p46978
(dp46979
sg1743
g26936
sVHydroxy Acids
p46980
g18156
sVAntiviral Agents
p46981
g30455
sg9522
(dp46982
sVDirect Acting Antivirals
p46983
g38066
sVNeuraminidase Inhibitors
p46984
(dp46985
sVSugar Acids
p46986
(dp46987
sVPyrans
p46988
(dp46989
sVEnzyme Inhibitors
p46990
(dp46991
sVAnti-Infective Agents
p46992
(dp46993
ssg4710
(dp46994
VAntiinfectives for Systemic Use
p46995
(dp46996
sVDrugs that are Mainly Renally Excreted
p46997
g43936
sVHeterocyclic Compounds, Fused-Ring
p46998
(dp46999
sVThird-Generation Cephalosporins
p47000
g44711
sVbeta-Lactams
p47001
(dp47002
sVNephrotoxic agents
p47003
(dp47004
sVOAT3/SLC22A8 Substrates
p47005
g13117
sVOAT3/SLC22A8 Inhibitors
p47006
(dp47007
sVLactams
p47008
g22282
sVOAT1/SLC22A6 Substrates
p47009
(dp47010
sVAmides
p47011
g44298
sVThiazines
p47012
g16414
sVSulfur Compounds
p47013
(dp47014
sVAnti-Bacterial Agents
p47015
g38322
sVAntibacterials for Systemic Use
p47016
g32530
sVCephalosporins
p47017
(dp47018
sVAnti-Infective Agents
p47019
(dp47020
ssg4713
(dp47021
VAmino Acids, Peptides, and Proteins
p47022
(dp47023
sVDrugs that are Mainly Renally Excreted
p47024
g43866
sVAntibodies
p47025
(dp47026
sVAntibodies, Monoclonal
p47027
(dp47028
sVAntibodies, Monoclonal, Humanized
p47029
(dp47030
sVAntidotes
p47031
(dp47032
sVImmunoglobulins
p47033
g41529
sVProteins
p47034
(dp47035
sVSerum Globulins
p47036
(dp47037
sg4233
g43687
sVBlood Proteins
p47038
g39862
sg7503
(dp47039
sVGlobulins
p47040
g19184
sVImmunoproteins
p47041
(dp47042
ssg4716
(dp47043
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p47044
(dp47045
sVUGT1A1 Substrates
p47046
g12309
sVOAT1/SLC22A6 inhibitors
p47047
(dp47048
sVAnalgesics
p47049
g26492
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p47050
(dp47051
sVNon COX-2 selective NSAIDS
p47052
(dp47053
sVCentral Nervous System Agents
p47054
(dp47055
sVEnzyme Inhibitors
p47056
(dp47057
sVCytochrome P-450 CYP2C9 Inhibitors
p47058
g18188
sVCytochrome P-450 Enzyme Inhibitors
p47059
(dp47060
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p47061
(dp47062
sVDrugs that are Mainly Renally Excreted
p47063
g43937
sVNonsteroidal Anti-inflammatory Compounds
p47064
(dp47065
sVAnalgesics, Non-Narcotic
p47066
(dp47067
sVNephrotoxic agents
p47068
(dp47069
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p47070
(dp47071
sVAcids, Carbocyclic
p47072
g41565
sVPeripheral Nervous System Agents
p47073
(dp47074
sVPhenylpropionates
p47075
(dp47076
sVCytochrome P-450 CYP2C9 Substrates
p47077
g29724
sVMusculo-Skeletal System
p47078
g31534
sVTopical Products for Joint and Muscular Pain
p47079
g13925
sVAgents causing hyperkalemia
p47080
g43634
sVCytochrome P-450 CYP2C8 Inhibitors
p47081
(dp47082
sVOther Nonsteroidal Antiimflammatory Agents
p47083
(dp47084
sVPropionates
p47085
g36488
sVAgents that produce hypertension
p47086
(dp47087
sVAntiinflammatory and Antirheumatic Products
p47088
(dp47089
sVOAT3/SLC22A8 Inhibitors
p47090
(dp47091
sVAnti-Inflammatory Agents
p47092
(dp47093
sVCyclooxygenase Inhibitors
p47094
g32790
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p47095
g24190
sVAntirheumatic Agents
p47096
g24233
sVSensory System Agents
p47097
(dp47098
sVAnti-Inflammatory Agents, Non-Steroidal
p47099
(dp47100
ssg4719
(dp47101
g4911
(dp47102
sg12000
(dp47103
sg4017
g42286
sg1875
g27889
sg4881
(dp47104
sg12078
(dp47105
sg12123
(dp47106
sg11541
(dp47107
sg2715
g33810
sg3849
g41171
sg4773
(dp47108
sg12003
(dp47109
ssg4722
(dp47110
g10833
(dp47111
sg7815
(dp47112
sg11799
(dp47113
sg10725
(dp47114
sg48
g12647
sg11427
(dp47115
sg9411
(dp47116
sg87
g12932
sg11061
(dp47117
sg11631
(dp47118
sg4068
g42776
sg7881
(dp47119
sg8985
(dp47120
sg10326
(dp47121
sg5691
(dp47122
sg10509
(dp47123
sg3609
g39688
sg6090
(dp47124
sg5520
(dp47125
sg10368
(dp47126
sg4521
g45973
sg1527
g25257
sg10698
(dp47127
sg6654
(dp47128
sg3204
g37446
sg19588
g32498
sg11334
(dp47129
sg474
g16572
sg1275
g23295
sg3264
g37861
sg3576
g39580
sg12090
(dp47130
sg3015
g36100
sg1101
g22073
sg7500
(dp47131
sg4953
(dp47132
sg11208
(dp47133
ssg4725
(dp47134
g6390
(dp47135
sg9318
(dp47136
sg6588
(dp47137
sg813
g19618
sg11130
(dp47138
sg3441
g38848
sg4989
(dp47139
sVDermatologicals
p47140
g17209
sg8082
(dp47141
sg7269
(dp47142
sg2766
g34262
sg7965
(dp47143
sg11817
(dp47144
sVProtective Agents
p47145
(dp47146
sVBiomedical and Dental Materials
p47147
g44728
sg6501
(dp47148
sg5298
(dp47149
sg1011
g21314
sVCompounds used in a research, industrial, or household setting
p47150
(dp47151
ssg4728
(dp47152
g11751
(dp47153
sg11826
(dp47154
ssg4731
(dp47155
g10245
(dp47156
ssg4734
(dp47157
g6180
(dp47158
sg5409
(dp47159
sg6228
(dp47160
sg9906
(dp47161
sg3333
g38260
sg11160
(dp47162
sg10149
(dp47163
sg6171
(dp47164
sg7689
(dp47165
sg8457
(dp47166
sg5514
(dp47167
sg4053
g42548
sg2283
g31149
sg10002
(dp47168
sg9267
(dp47169
sg5577
(dp47170
sg9630
(dp47171
sg213
g14051
sg8796
(dp47172
sg10323
(dp47173
sg4821
(dp47174
sg4365
g44752
sg7407
(dp47175
sg4515
g45902
sg9135
(dp47176
sg9540
(dp47177
sg3183
g37329
sg9426
(dp47178
sg2172
g30520
sg4935
(dp47179
sg11718
(dp47180
sg4143
g43152
sg372
g15389
sg7971
(dp47181
sg7977
(dp47182
sg4170
g43382
sg402
g15850
sg7059
(dp47183
sg5463
(dp47184
sg7221
(dp47185
sg2007
g28904
sg8781
(dp47186
sg11046
(dp47187
sg9348
(dp47188
sg3495
g39070
sg11052
(dp47189
sg5847
(dp47190
sg11832
(dp47191
sg1266
g23235
sg8808
(dp47192
sg11079
(dp47193
sg10338
(dp47194
sg2817
g34564
sg5073
(dp47195
sg8088
(dp47196
sg11952
(dp47197
sg8106
(dp47198
sg561
g17372
sg4338
g44568
sg5946
(dp47199
sg4356
g44703
sg2886
g35324
sg1776
g27106
sg6360
(dp47200
sg609
g17824
sg5199
(dp47201
sg6549
(dp47202
sg11967
(dp47203
sg2940
g35713
sg654
g18270
sg12000
(dp47204
sg7470
(dp47205
sg11274
(dp47206
sg12042
(dp47207
sg2253
g30894
sg8670
(dp47208
sg7905
(dp47209
sg8769
(dp47210
sg11067
(dp47211
sg8577
(dp47212
sg357
g15316
sg6015
(dp47213
sg3090
g36704
sg8274
(dp47214
sg5382
(dp47215
sg9846
(dp47216
sg801
g19539
sg819
g19768
ssg4737
(dp47217
VVasoprotectives
p47218
g41393
sVCompounds used in a research, industrial, or household setting
p47219
(dp47220
sVSclerosing Solutions
p47221
(dp47222
sVSclerosing Agents for Local Injection
p47223
(dp47224
sVHousehold Products
p47225
(dp47226
sg1854
g27683
sVPharmaceutical Preparations
p47227
(dp47228
sVCardiovascular Agents
p47229
g26693
sg156
g13549
sVPolymers
p47230
g22236
sVSurface-Active Agents
p47231
(dp47232
sVAntivaricose Therapy
p47233
g30541
sVBiomedical and Dental Materials
p47234
g44729
sVEthylene Glycols
p47235
(dp47236
sVGlycols
p47237
(dp47238
sVPolyethylene Glycols
p47239
g22555
sVPegylated agents
p47240
g13560
sVSolutions
p47241
(dp47242
sVMacromolecular Substances
p47243
g33845
sg2727
g33861
sVPharmaceutical Solutions
p47244
g15485
sVAlcohols
p47245
(dp47246
ssg4740
(dp47247
g7593
(dp47248
ssg4743
(dp47249
g11832
(dp47250
ssg4746
(dp47251
VAgents that produce neuromuscular block (indirect)
p47252
g37956
sg4749
(dp47253
sVNeuromuscular Agents
p47254
g20239
sVImidazolidines
p47255
g46000
sVImidazoles
p47256
(dp47257
sVCytochrome P-450 CYP3A Substrates
p47258
g45115
sVAgents causing hyperkalemia
p47259
g43583
sVCentral Nervous System Depressants
p47260
(dp47261
sVMuscle Relaxants, Centrally Acting Agents
p47262
g37392
sVCentral Nervous System Agents
p47263
(dp47264
sVHydantoins
p47265
(dp47266
sg7143
(dp47267
sg3591
g39626
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47268
g29396
sg6153
(dp47269
sVPeripheral Nervous System Agents
p47270
(dp47271
sVCytochrome P-450 CYP3A4 Substrates
p47272
(dp47273
sVMusculo-Skeletal System
p47274
g31509
sVThyroxine-binding globulin substrates
p47275
(dp47276
sVMuscle Relaxants
p47277
(dp47278
ssg4749
(dp47279
g4746
g47253
ssg4752
(dp47280
VDrugs that are Mainly Renally Excreted
p47281
g43957
sVHematologic Agents
p47282
(dp47283
sVBlood and Blood Forming Organs
p47284
(dp47285
sVP-glycoprotein/ABCB1 Substrates
p47286
g34968
sVSerine Proteinase Inhibitors
p47287
(dp47288
sVAnticoagulants
p47289
(dp47290
sVAntithrombins
p47291
(dp47292
sVFibrinolytic Agents
p47293
g26304
sVProtease Inhibitors
p47294
(dp47295
sVSulfur Compounds
p47296
(dp47297
sVEnzyme Inhibitors
p47298
(dp47299
sVFactor Xa Inhibitors
p47300
(dp47301
ssg4755
(dp47302
g6150
(dp47303
ssg4758
(dp47304
g3882
g41406
ssg4761
(dp47305
g6180
(dp47306
sg5409
(dp47307
sg6228
(dp47308
sg9132
(dp47309
sg7626
(dp47310
sg9300
(dp47311
sg6213
(dp47312
sg6216
(dp47313
sg8406
(dp47314
sg3333
g38249
sg5946
(dp47315
sg6903
(dp47316
sg4200
g43525
sg10149
(dp47317
sg10680
(dp47318
sg12015
(dp47319
sg11286
(dp47320
sg11460
(dp47321
sg3144
g37125
sg7689
(dp47322
sg8454
(dp47323
sg8457
(dp47324
sg5514
(dp47325
sg4713
g47023
sg4053
g42535
sg2283
g31137
sg9252
(dp47326
sg3147
g37133
sg9267
(dp47327
sg10002
(dp47328
sg4440
g45310
sg3882
g41402
sg11541
(dp47329
sg5577
(dp47330
sg11550
(dp47331
sg9630
(dp47332
sg4905
(dp47333
sg2079
g29863
sg5595
(dp47334
sg10653
(dp47335
sg9906
(dp47336
sg10323
(dp47337
sg402
g15852
sg5622
(dp47338
sg4821
(dp47339
sg4365
g44739
sg7407
(dp47340
sg8601
(dp47341
sg7848
(dp47342
sg7854
(dp47343
sg11619
(dp47344
sg10104
(dp47345
sg375
g15467
sg4515
g45906
sg6579
(dp47346
sg9135
(dp47347
sg288
g14696
sg9540
(dp47348
sg3183
g37323
sg6804
(dp47349
sg9426
(dp47350
sg6231
(dp47351
sg2172
g30526
sg4935
(dp47352
sg6171
(dp47353
sg11718
(dp47354
sg4143
g43139
sg372
g15383
sg4959
(dp47355
sg7971
(dp47356
sg7809
(dp47357
sg4977
(dp47358
sg4170
g43377
sg1401
g24324
sg8076
(dp47359
sg7692
(dp47360
sg7977
(dp47361
sg4185
g43461
sg7059
(dp47362
sg213
g14028
sg11379
(dp47363
sg3627
g39947
sg9897
(dp47364
sg5463
(dp47365
sg7221
(dp47366
sg2754
g34076
sg444
g16267
sg447
g16272
sg2007
g28900
sg8772
(dp47367
sg609
g17828
sg8781
(dp47368
sg11046
(dp47369
sg9348
(dp47370
sg3495
g39063
sg11646
(dp47371
sg11052
(dp47372
sg5847
(dp47373
sg8796
(dp47374
sg11832
(dp47375
sg7164
(dp47376
sg1266
g23240
sg8808
(dp47377
sg5382
(dp47378
sg11079
(dp47379
sg2058
g29166
sg10338
(dp47380
sg2817
g34568
sg6612
(dp47381
sg5073
(dp47382
sg8823
(dp47383
sg8088
(dp47384
sg11952
(dp47385
sg6630
(dp47386
sg9612
(dp47387
sg4467
g45525
sg8106
(dp47388
sg12060
(dp47389
sg5112
(dp47390
sg2118
g30210
sg9627
(dp47391
sg561
g17361
sg4338
g44557
sg11160
(dp47392
sg11349
(dp47393
sg3573
g39524
sg2886
g35320
sg3588
g39613
sg1776
g27108
sg6360
(dp47394
sg8910
(dp47395
sg10431
(dp47396
sg5199
(dp47397
sg7980
(dp47398
sg8598
(dp47399
sg6549
(dp47400
sg3801
g40948
sg2094
g29971
sg11967
(dp47401
sg9705
(dp47402
sg2940
g35691
sg654
g18264
sg669
g18435
sg12000
(dp47403
sg8325
(dp47404
sg7470
(dp47405
sg11274
(dp47406
sg1482
g24997
sg9741
(dp47407
sg2316
g31283
sg12042
(dp47408
sg2253
g30879
sg7512
(dp47409
sg8670
(dp47410
sg3018
g36155
sg7905
(dp47411
sg8769
(dp47412
sg11067
(dp47413
sg3777
g40819
sg1737
g26901
sg4551
g46099
sg10569
(dp47414
sg8577
(dp47415
sg357
g15324
sg1563
g25500
sg6015
(dp47416
sg3090
g36683
sg8274
(dp47417
sg11367
(dp47418
sg801
g19521
sg9846
(dp47419
sg9852
(dp47420
sg4356
g44692
sg5400
(dp47421
sg819
g19775
ssg4764
(dp47422
g1548
g25395
sg10263
(dp47423
sg10098
(dp47424
sg3531
g39286
sg9012
(dp47425
sg3036
g36453
sg10227
(dp47426
sg3240
g37734
sg4056
g42595
sg2616
g33193
sg5829
(dp47427
sg10761
(dp47428
sg3708
g40393
sg3114
g36884
sg10005
(dp47429
sg909
g20658
ssg4767
(dp47430
g1914
g28419
sg11352
(dp47431
sg8580
(dp47432
sg11319
(dp47433
sg4035
g42448
sg2067
g29661
sg612
g17901
sg11445
(dp47434
sg5598
(dp47435
ssg4770
(dp47436
VAgents that produce neuromuscular block (indirect)
p47437
g37983
sVGastric Acid Lowering Agents
p47438
(dp47439
sVOsmotic Laxatives
p47440
(dp47441
sVAntacids
p47442
g42402
sVSilicon Dioxide
p47443
(dp47444
sVMagnesium Compounds
p47445
g33050
sVCalculi Dissolution Agent
p47446
g12694
sVMetal divalent cations
p47447
(dp47448
sg2457
g32249
sVDrugs that are Mainly Renally Excreted
p47449
g43899
sVSilicon Compounds
p47450
(dp47451
sVElectrolytes
p47452
(dp47453
sVOxides
p47454
g27678
sVMinerals
p47455
(dp47456
sVOxygen Compounds
p47457
g46962
sVGastrointestinal Agents
p47458
(dp47459
sVAcids
p47460
g40592
sVLaxatives
p47461
g17349
sVIons
p47462
(dp47463
sVAluminum and magnesium containing antacids
p47464
g26966
sVAcids, Noncarboxylic
p47465
(dp47466
sVAnions
p47467
(dp47468
sVSilicic Acid
p47469
(dp47470
sVMetal cations
p47471
g40799
ssg4773
(dp47472
VAntiinfectives for Systemic Use
p47473
(dp47474
sg1983
g28813
sVCytochrome P-450 CYP3A4 Substrates
p47475
(dp47476
sVAntimycobacterials
p47477
g22570
sVQuinolines
p47478
(dp47479
sVCytochrome P-450 CYP3A Substrates
p47480
g45129
sVAntituberculosis Agents
p47481
g47108
sVDrugs for Treatment of Tuberculosis
p47482
(dp47483
sg10995
(dp47484
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47485
g29410
sVAnti-Bacterial Agents
p47486
g38346
sVHeterocyclic Compounds, Fused-Ring
p47487
(dp47488
sVQTc Prolonging Agents
p47489
(dp47490
sVAnti-Infective Agents
p47491
(dp47492
sVModerate Risk QTc-Prolonging Agents
p47493
(dp47494
ssg4776
(dp47495
g8421
(dp47496
sg10728
(dp47497
sg9918
(dp47498
sg9822
(dp47499
sg5256
(dp47500
sg7941
(dp47501
sg11979
(dp47502
sg9102
(dp47503
sg7335
(dp47504
ssg4779
(dp47505
g1917
g28445
sg9963
(dp47506
sg1452
g24751
sg3963
g41901
ssg4782
(dp47507
VAntiinfectives for Systemic Use
p47508
(dp47509
sVDrugs that are Mainly Renally Excreted
p47510
g43879
sVAgents that produce neuromuscular block (indirect)
p47511
g37982
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p47512
g43740
sVTetracyclines
p47513
(dp47514
sVOAT1/SLC22A6 inhibitors
p47515
(dp47516
sVCytochrome P-450 CYP3A Substrates
p47517
g45119
sVCytochrome P-450 CYP3A Inhibitors
p47518
(dp47519
sVStomatological Preparations
p47520
(dp47521
sVCytochrome P-450 CYP3A4 Inhibitors
p47522
(dp47523
sVCytochrome P-450 Enzyme Inhibitors
p47524
(dp47525
sVAntiparasitic Agents
p47526
g40662
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47527
g29400
sVAntiinfectives and Antiseptics for Local Oral Treatment
p47528
(dp47529
sVAnti-Bacterial Agents
p47530
g38332
sVAntibacterials for Systemic Use
p47531
g32537
sVAntiprotozoals
p47532
(dp47533
sVCytochrome P-450 CYP3A4 Substrates
p47534
(dp47535
sVAnti-Infective Agents
p47536
(dp47537
sVAlimentary Tract and Metabolism
p47538
g23799
sVNaphthacenes
p47539
g40472
ssg4785
(dp47540
g1776
g27116
sg8088
(dp47541
sg5463
(dp47542
sg7407
(dp47543
sg5514
(dp47544
ssg4788
(dp47545
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p47546
(dp47547
sVAnalgesics
p47548
g26424
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p47549
(dp47550
sVCentral Nervous System Agents
p47551
(dp47552
sVAntiinflammatory and Antirheumatic Products
p47553
(dp47554
sVThiazines
p47555
g16418
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p47556
g24333
sVEnzyme Inhibitors
p47557
(dp47558
sVCytochrome P-450 Enzyme Inhibitors
p47559
(dp47560
sVPeripheral Nervous System Agents
p47561
(dp47562
sVCytochrome P-450 CYP2C8 Substrates
p47563
(dp47564
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p47565
g23101
sVAnalgesics, Non-Narcotic
p47566
(dp47567
sVNephrotoxic agents
p47568
(dp47569
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47570
g29293
sVSulfur Compounds
p47571
(dp47572
sVCytochrome P-450 CYP2C9 Substrates
p47573
g29710
sVCytochrome P-450 CYP3A Substrates
p47574
g45030
sVCOX-2 Inhibitors
p47575
(dp47576
sVAgents causing hyperkalemia
p47577
g43567
sVThiazoles
p47578
(dp47579
sVCytochrome P-450 CYP2C8 Inhibitors
p47580
(dp47581
sVOther Nonsteroidal Antiimflammatory Agents
p47582
(dp47583
sVAgents that produce hypertension
p47584
(dp47585
sVNonsteroidal Anti-inflammatory Compounds
p47586
(dp47587
sVCytochrome P-450 CYP3A4 Substrates
p47588
(dp47589
sVMusculo-Skeletal System
p47590
g31510
sVAnti-Inflammatory Agents
p47591
(dp47592
sVCyclooxygenase Inhibitors
p47593
g32778
sVOxicams
p47594
(dp47595
sVAntirheumatic Agents
p47596
g24210
sVSensory System Agents
p47597
(dp47598
sVAnti-Inflammatory Agents, Non-Steroidal
p47599
(dp47600
ssg4791
(dp47601
g4440
g45334
ssg4794
(dp47602
g10374
(dp47603
sg8190
(dp47604
ssg4797
(dp47605
g1482
g25007
ssg4800
(dp47606
g4623
g46412
sg255
g14423
ssg4803
(dp47607
VBSEP/ABCB11 Substrates
p47608
(dp47609
sVAntigout Preparations
p47610
(dp47611
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p47612
(dp47613
sVUGT1A1 Substrates
p47614
g12273
sVOAT1/SLC22A6 inhibitors
p47615
(dp47616
sVAnalgesics
p47617
g26425
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p47618
(dp47619
sVAntiinflammatory Products for Vaginal Administration
p47620
g27410
sVCentral Nervous System Agents
p47621
(dp47622
sVAntiinflammatory and Antirheumatic Products
p47623
(dp47624
sVEnzyme Inhibitors
p47625
(dp47626
sVPeripheral Nervous System Agents
p47627
(dp47628
sVNaphthaleneacetic Acids
p47629
(dp47630
sVCytochrome P-450 CYP2C8 Substrates
p47631
(dp47632
sVCytochrome P-450 CYP1A2 Substrates
p47633
g45568
sVNonsteroidal Anti-inflammatory Compounds
p47634
(dp47635
sVAnalgesics, Non-Narcotic
p47636
(dp47637
sVNephrotoxic agents
p47638
(dp47639
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p47640
(dp47641
sVCytochrome P-450 CYP2C9 Substrates
p47642
g29711
sVMusculo-Skeletal System
p47643
g31555
sVTopical Products for Joint and Muscular Pain
p47644
g13930
sVAgents causing hyperkalemia
p47645
g43568
sVOther Nonsteroidal Antiimflammatory Agents
p47646
(dp47647
sVPropionates
p47648
g36492
sVNon COX-2 selective NSAIDS
p47649
(dp47650
sVAgents that produce hypertension
p47651
(dp47652
sVNaphthalenes
p47653
(dp47654
sVGenito Urinary System and Sex Hormones
p47655
(dp47656
sVUGT2B7 substrates
p47657
g28622
sVAnti-Inflammatory Agents
p47658
(dp47659
sVCyclooxygenase Inhibitors
p47660
g32779
sVP-glycoprotein/ABCB1 Inhibitors
p47661
(dp47662
sVAntirheumatic Agents
p47663
g24254
sVSensory System Agents
p47664
(dp47665
sVAnti-Inflammatory Agents, Non-Steroidal
p47666
(dp47667
ssg4806
(dp47668
g5517
(dp47669
sg10560
(dp47670
sVCardiovascular Agents
p47671
g26568
sg8715
(dp47672
sg8169
(dp47673
sVAntihypertensive Agents
p47674
g20272
sg10746
(dp47675
sVHypotensive Agents
p47676
g34135
sVCardiac Therapy
p47677
(dp47678
sg5328
(dp47679
sg7278
(dp47680
sVVasodilating Agents
p47681
g23680
sg10440
(dp47682
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p47683
g16811
sVCompounds used in a research, industrial, or household setting
p47684
(dp47685
sVVasoprotectives
p47686
g41375
sVMethemoglobinemia Associated Agents
p47687
g25553
ssg4809
(dp47688
g10833
(dp47689
sg2844
g34875
sg48
g12615
sg7815
(dp47690
sg1674
g26311
sg1101
g22045
sg11229
(dp47691
sg9249
(dp47692
sg183
g13762
sg837
g19979
sg11427
(dp47693
sg87
g12893
sg2034
g29002
sg7272
(dp47694
sg4863
(dp47695
sg10377
(dp47696
sg3015
g36069
sg7881
(dp47697
sg8985
(dp47698
sg11016
(dp47699
sg4278
g44252
sg2814
g34498
sg5133
(dp47700
sg5691
(dp47701
sg10509
(dp47702
sg918
g20766
sg1785
g27191
sg10368
(dp47703
sg7800
(dp47704
sg4521
g45946
sg3753
g40605
sg1332
g23642
sg6654
(dp47705
sg3204
g37417
sg11334
(dp47706
sg474
g16542
sg1275
g23265
sg6312
(dp47707
sg3264
g37873
sg4155
g43186
sg12090
(dp47708
sg10326
(dp47709
sg11061
(dp47710
sg1173
g22627
sg5067
(dp47711
sg7500
(dp47712
sg6336
(dp47713
sg9081
(dp47714
sg9663
(dp47715
sg11451
(dp47716
sg780
g19327
sg11259
(dp47717
ssg4812
(dp47718
g5271
(dp47719
ssg4815
(dp47720
g7941
(dp47721
sg10218
(dp47722
sg11979
(dp47723
ssg4818
(dp47724
g11733
(dp47725
sg3249
g37771
sg12057
(dp47726
sg5556
(dp47727
sg10272
(dp47728
sg8658
(dp47729
ssg4821
(dp47730
VAmino Acids, Peptides, and Proteins
p47731
g47339
sVInsulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting
p47732
g32629
sVCytochrome P-450 CYP1A2 Inducers
p47733
(dp47734
sVPeptide Hormones
p47735
g20203
sg2748
g34046
sVHypoglycemia-Associated Agents
p47736
g17677
sVInsulins and Analogues for Injection, Fast-Acting
p47737
(dp47738
sVInsulin, Short-Acting
p47739
g13875
sVInsulins and Analogues
p47740
(dp47741
sVPeptides
p47742
g47174
sVCytochrome P-450 Enzyme Inducers
p47743
g28152
sVInsulin
p47744
(dp47745
sVHormones
p47746
(dp47747
sVHormones, Hormone Substitutes, and Hormone Antagonists
p47748
(dp47749
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p47750
g17437
sVPancreatic Hormones
p47751
(dp47752
sVBlood Glucose Lowering Agents
p47753
(dp47754
sVAlimentary Tract and Metabolism
p47755
g23811
sVDrugs Used in Diabetes
p47756
(dp47757
ssg4824
(dp47758
g4920
(dp47759
ssg4827
(dp47760
VCytochrome P-450 CYP3A4 Substrates
p47761
(dp47762
sVCardiovascular Agents
p47763
g26638
sg9123
(dp47764
sVHeterocyclic Compounds, Fused-Ring
p47765
(dp47766
sVCytochrome P-450 CYP3A Substrates
p47767
g45072
sVBradycardia-Causing Agents
p47768
(dp47769
sVCardiac Therapy
p47770
(dp47771
sg5178
(dp47772
sVAdrenergic Antagonists
p47773
(dp47774
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47775
g29350
sVMiscellaneous Cardiac Drugs
p47776
g25719
sVBenzazepines
p47777
(dp47778
sVQTc Prolonging Agents
p47779
(dp47780
sVAdrenergic beta-Antagonists
p47781
g15348
sVHighest Risk QTc-Prolonging Agents
p47782
g35872
ssg4830
(dp47783
VCytochrome P-450 CYP3A Substrates
p47784
g45124
sVSulfanilamides
p47785
g45279
sVCoccidiostats
p47786
g44873
sVCytochrome P-450 CYP2C9 Inhibitors
p47787
g18197
sVCytochrome P-450 Enzyme Inhibitors
p47788
(dp47789
sVAnti-Infective Agents
p47790
(dp47791
sVBlood Glucose Lowering Agents
p47792
(dp47793
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p47794
(dp47795
sVAntiinfectives for Systemic Use
p47796
(dp47797
sVDrugs that are Mainly Renally Excreted
p47798
g43949
sVCytochrome P-450 CYP2C8 Substrates
p47799
(dp47800
sVAmines
p47801
g42727
sVGynecological Antiinfectives and Antiseptics
p47802
(dp47803
sVAmides
p47804
g44310
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p47805
g29405
sVSulfur Compounds
p47806
(dp47807
sVAniline Compounds
p47808
g23419
sVAntiprotozoals
p47809
(dp47810
sVSulfonamides
p47811
(dp47812
sVSulfonamide Antibacterial
p47813
(dp47814
sVAnti-Bacterial Agents
p47815
g38339
sg11703
(dp47816
sVAntiparasitic Agents
p47817
g40648
sVSulfones
p47818
(dp47819
sVAntibacterials for Systemic Use
p47820
g32543
sVCytochrome P-450 CYP3A4 Substrates
p47821
(dp47822
sVGenito Urinary System and Sex Hormones
p47823
(dp47824
sVHypoglycemia-Associated Agents
p47825
g17680
sVMethemoglobinemia Associated Agents
p47826
g25561
sg10692
(dp47827
ssg4833
(dp47828
g1776
g27112
ssg4836
(dp47829
g10374
(dp47830
sg8190
(dp47831
ssg4839
(dp47832
g11745
(dp47833
ssg4842
(dp47834
g8055
(dp47835
sg10563
(dp47836
sg7524
(dp47837
sg5757
(dp47838
sg1899
g28093
sg7962
(dp47839
sg1047
g21637
sg1050
g21661
ssg4845
(dp47840
VFibrin Modulating Agents
p47841
g22860
sVHematologic Agents
p47842
(dp47843
sVBlood and Blood Forming Organs
p47844
(dp47845
sVCardiovascular Agents
p47846
g26658
sVPolysaccharides
p47847
g41783
sg10488
(dp47848
sVAnticoagulants
p47849
(dp47850
sVCarbohydrates
p47851
(dp47852
sVAgents causing hyperkalemia
p47853
g43632
sVFibrinolytic Agents
p47854
g26305
sg2313
g31280
sVGlycosaminoglycans
p47855
g26083
sVHeparin and similars
p47856
(dp47857
ssg4848
(dp47858
g9612
(dp47859
sg11550
(dp47860
sg9132
(dp47861
sg1266
g23220
sg4905
(dp47862
sg8076
(dp47863
sg10653
(dp47864
sg11718
(dp47865
sg6612
(dp47866
sg9348
(dp47867
sg1920
g28495
ssg4851
(dp47868
g5289
(dp47869
ssg4854
(dp47870
g78
g12840
sg9834
(dp47871
sg840
g20011
sg8625
(dp47872
sg5646
(dp47873
ssg4857
(dp47874
VAntiinfectives for Systemic Use
p47875
(dp47876
sVTopoisomerase Inhibitors
p47877
g32848
sVQuinolones
p47878
g23981
sVTopoisomerase II Inhibitors
p47879
g40632
sVHeterocyclic Compounds, Fused-Ring
p47880
(dp47881
sVOphthalmologicals
p47882
g35200
sVCytochrome P-450 CYP1A2 Inhibitors
p47883
g15006
sVQTc Prolonging Agents
p47884
(dp47885
sg5322
(dp47886
sg8793
(dp47887
sVEnzyme Inhibitors
p47888
(dp47889
sVQuinolines
p47890
(dp47891
sVSensory Organs
p47892
g40694
sVAnti-Bacterial Agents
p47893
g38341
sVAntibacterials for Systemic Use
p47894
g32545
sVCytochrome P-450 Enzyme Inhibitors
p47895
(dp47896
sVAnti-Infective Agents
p47897
(dp47898
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p47899
g27739
sVModerate Risk QTc-Prolonging Agents
p47900
(dp47901
ssg4860
(dp47902
VAmines
p47903
g42696
sVSulfhydryl Compounds
p47904
(dp47905
sVCystine Disulfide Reduction
p47906
g37683
sVOphthalmics
p47907
(dp47908
sVSulfur Compounds
p47909
(dp47910
sVAmino Acids and Derivatives
p47911
(dp47912
sg10941
(dp47913
sVSensory Organs
p47914
g40750
sVEthylamines
p47915
g20590
sVEENT Drugs, Miscellaneous
p47916
g40845
sVOphthalmologicals
p47917
g35267
sVAlimentary Tract and Metabolism
p47918
g23912
sVOther Miscellaneous Therapeutic Agents
p47919
g28769
sg6675
(dp47920
ssg4863
(dp47921
VPyrimidines
p47922
g47695
sVNucleic Acid Synthesis Inhibitors
p47923
(dp47924
sVImmunosuppressive Agents
p47925
(dp47926
sVImmunologic Factors
p47927
g42377
sVThyroxine-binding globulin inducers
p47928
(dp47929
sVCytochrome P-450 CYP2C9 Inhibitors
p47930
g18199
sVCytochrome P-450 Enzyme Inhibitors
p47931
(dp47932
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p47933
(dp47934
sVPyrimidine Analogues
p47935
g18462
sVCytochrome P-450 CYP2C8 Substrates
p47936
(dp47937
sVCytochrome P-450 CYP1A2 Substrates
p47938
g45587
sVMyelosuppressive Agents
p47939
(dp47940
sVNucleoside Metabolic Inhibitor
p47941
(dp47942
sVFluorouracil and prodrugs
p47943
(dp47944
sVAntimetabolites, Antineoplastic
p47945
g23452
sVQTc Prolonging Agents
p47946
(dp47947
sVAntineoplastic Agents
p47948
(dp47949
sVUracil
p47950
(dp47951
sVCytochrome P-450 CYP2A6 Substrates
p47952
g35125
sVMisc. Skin and Mucous Membrane Agents
p47953
(dp47954
sVFluoropyrimidines
p47955
g44531
sVModerate Risk QTc-Prolonging Agents
p47956
(dp47957
sVToxic Actions
p47958
(dp47959
sVCardiotoxic antineoplastic agents
p47960
(dp47961
sVAntimetabolites
p47962
(dp47963
sVPyrimidinones
p47964
(dp47965
sVNoxae
p47966
(dp47967
sVBCRP/ABCG2 Substrates
p47968
g42090
sVAntineoplastic and Immunomodulating Agents
p47969
g39822
ssg4866
(dp47970
g8670
(dp47971
sg5577
(dp47972
sg357
g15304
sg7977
(dp47973
sg3183
g37333
sg8274
(dp47974
sg9540
(dp47975
sg5382
(dp47976
sg8769
(dp47977
sg5073
(dp47978
sg3333
g38252
sg372
g15393
ssg4869
(dp47979
g7719
(dp47980
sg1914
g28426
ssg4872
(dp47981
VAntiinfectives for Systemic Use
p47982
(dp47983
sVDrugs that are Mainly Renally Excreted
p47984
g43864
sVAminopenicillins
p47985
g35279
sVbeta-Lactams
p47986
(dp47987
sVOAT1/SLC22A6 inhibitors
p47988
(dp47989
sVPenicillins With Extended Spectrum
p47990
(dp47991
sVLactams
p47992
g22270
sVPenicillins
p47993
(dp47994
sVDrugs for Acid Related Disorders
p47995
(dp47996
sVPenicillin G
p47997
g34325
sVAmides
p47998
g44313
sVSulfur Compounds
p47999
(dp48000
sVAnti-Bacterial Agents
p48001
g38315
sVAntibacterials for Systemic Use
p48002
g32522
sVHeterocyclic Compounds, Fused-Ring
p48003
(dp48004
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p48005
(dp48006
sVAnti-Infective Agents
p48007
(dp48008
sVAlimentary Tract and Metabolism
p48009
g23762
sVBeta-Lactam Antibacterials
p48010
g46295
ssg4875
(dp48011
VPregnanes
p48012
(dp48013
sVSteroids, Fluorinated
p48014
(dp48015
sVAdrenal Cortex Hormones
p48016
g30042
sVPregnadienediols
p48017
(dp48018
sVCorticosteroids, Dermatological Preparations
p48019
(dp48020
sVSteroids
p48021
(dp48022
sVCorticosteroids, Potent (Group III)
p48023
(dp48024
sVPregnadienes
p48025
(dp48026
sVDermatologicals
p48027
g17210
sVAnti-Inflammatory Agents
p48028
(dp48029
sVCorticosteroid Hormone Receptor Agonists
p48030
(dp48031
sVPregnadienetriols
p48032
(dp48033
sVImmunosuppressive Agents
p48034
(dp48035
sVHormones
p48036
(dp48037
sVHormones, Hormone Substitutes, and Hormone Antagonists
p48038
(dp48039
sVFused-Ring Compounds
p48040
g14833
sVCorticosteroids
p48041
(dp48042
sVDexamethasone
p48043
(dp48044
ssg4878
(dp48045
g8010
(dp48046
ssg4881
(dp48047
VAntiinfectives for Systemic Use
p48048
(dp48049
sVDrugs that are Mainly Renally Excreted
p48050
g43954
sVCytochrome P-450 CYP3A4 Substrates
p48051
(dp48052
sVAntimycobacterials
p48053
g22563
sVCytochrome P-450 CYP3A Substrates
p48054
g45127
sVAntituberculosis Agents
p48055
g47104
sVDrugs for Treatment of Tuberculosis
p48056
(dp48057
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48058
g29408
sVAnti-Bacterial Agents
p48059
g38343
sVPyrazines
p48060
(dp48061
sVAnti-Infective Agents
p48062
(dp48063
ssg4884
(dp48064
VEnzymes
p48065
(dp48066
sVAlimentary Tract and Metabolism
p48067
g23830
sVHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
p48068
(dp48069
ssg4887
(dp48070
VCytochrome P-450 CYP3A4 Inhibitors
p48071
(dp48072
sVCytochrome P-450 CYP2D6 Inhibitors
p48073
(dp48074
sVOAT1/SLC22A6 inhibitors
p48075
(dp48076
sVHypotensive Agents
p48077
g34114
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p48078
g43734
sVEnzyme Inhibitors
p48079
(dp48080
sVCytochrome P-450 Enzyme Inhibitors
p48081
(dp48082
sVCarbonic Anhydrase Inhibitors
p48083
(dp48084
sVCytochrome P-450 CYP2E1 Inhibitors
p48085
g46834
sVThiadiazoles
p48086
g39222
sVSulfur Compounds
p48087
(dp48088
sVNatriuretic Agents
p48089
g40489
sVDiuretics
p48090
(dp48091
sVCardiovascular Agents
p48092
g26540
sVThiazoles
p48093
(dp48094
sVSensory Organs
p48095
g40678
sVCytochrome P-450 CYP2C19 Inhibitors
p48096
(dp48097
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p48098
g26875
sVAntiglaucoma Preparations and Miotics
p48099
g36558
sVOphthalmologicals
p48100
g35179
sVCytochrome P-450 CYP3A Inhibitors
p48101
(dp48102
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p48103
(dp48104
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p48105
(dp48106
ssg4890
(dp48107
VDrugs that are Mainly Renally Excreted
p48108
g43876
sVGlycosides
p48109
(dp48110
sVBenzene Derivatives
p48111
(dp48112
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p48113
g39024
sVCarbohydrates
p48114
(dp48115
sVHypotensive Agents
p48116
g34139
sVSodium-Glucose Transporter 2 Inhibitors
p48117
g46282
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p48118
(dp48119
sVOral Hypoglycemics
p48120
g35991
sVBlood Glucose Lowering Agents
p48121
(dp48122
sVAlimentary Tract and Metabolism
p48123
g23815
sVDrugs Used in Diabetes
p48124
(dp48125
sVDiuretics
p48126
(dp48127
ssg4893
(dp48128
g6906
(dp48129
sg3318
g38185
ssg4896
(dp48130
g1248
g23055
sg11265
(dp48131
ssg4899
(dp48132
g6231
(dp48133
sg2079
g29852
sg3795
g40939
sg9819
(dp48134
sg9192
(dp48135
sg12421
g12479
sg6102
(dp48136
sg7065
(dp48137
sg13070
g21897
sg7197
(dp48138
sg2808
g34486
sg8463
(dp48139
sg7014
(dp48140
sg4683
g46931
sg1092
g21991
sg8922
(dp48141
sg5871
(dp48142
ssg4902
(dp48143
VToxic Actions
p48144
(dp48145
sVHypolipidemic Agents
p48146
(dp48147
sVPhenols
p48148
(dp48149
sVMedicated Dressings With Antiinfectives
p48150
g43165
sVBenzene Derivatives
p48151
(dp48152
sVPhenyl Ethers
p48153
g40600
sVNoxae
p48154
(dp48155
sVDermatologicals
p48156
g17238
sVMedicated Dressings
p48157
g20583
sVAnti-Infective Agents, Local
p48158
(dp48159
sVMiscellaneous Local Anti-infectives
p48160
(dp48161
sg11094
(dp48162
sVAntiseptics and Disinfectants
p48163
g23744
sVFatty Acid Synthesis Inhibitors
p48164
g19157
sVAnti-Infective Agents
p48165
(dp48166
sg4902
(dp48167
sVEthers
p48168
g27601
sVLipid Regulating Agents
p48169
(dp48170
ssg4905
(dp48171
VAmino Acids, Peptides, and Proteins
p48172
g47333
sVGlobulins
p48173
g19197
sVAntibodies
p48174
(dp48175
sVAntibodies, Monoclonal
p48176
(dp48177
sVAgents reducing cytokine levels
p48178
(dp48179
sVProteins
p48180
(dp48181
sVImmunoglobulins
p48182
g41536
sVImmunosuppressive Agents
p48183
(dp48184
sVTumor Necrosis Factor Receptor Blocking Activity
p48185
g18475
sVDisease-modifying Antirheumatic Agents
p48186
(dp48187
sVSerum Globulins
p48188
(dp48189
sVTumor Necrosis Factor Blocker
p48190
(dp48191
sVAntineoplastic and Immunomodulating Agents
p48192
g39756
sVAntirheumatic Agents
p48193
g24250
sVBiologics for Rheumatoid Arthritis Treatment
p48194
g47862
sVTumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors
p48195
(dp48196
sVBlood Proteins
p48197
g39872
sVImmunoproteins
p48198
(dp48199
ssg4908
(dp48200
g1776
g27097
ssg4911
(dp48201
VCytochrome P-450 CYP2C19 Inducers (strong)
p48202
g31421
sVNucleic Acid Synthesis Inhibitors
p48203
(dp48204
sVOAT1/SLC22A6 inhibitors
p48205
(dp48206
sVCytochrome P-450 CYP3A Substrates
p48207
g45130
sVRifamycin Antibacterial
p48208
(dp48209
sVUGT1A1 Inducers
p48210
g39238
sVCytochrome P-450 CYP3A Inducers (strong)
p48211
g22455
sVCytochrome P-450 CYP3A5 Inducers
p48212
g41756
sVCytochrome P-450 CYP3A7 Inducers
p48213
g39035
sVCytochrome P-450 CYP2A6 Inducers
p48214
g39422
sVCytochrome P-450 CYP2D6 Inducers
p48215
(dp48216
sVCytochrome P-450 CYP2C9 Inducers
p48217
g20045
sVAnti-Infective Agents
p48218
(dp48219
sVAntiinfectives for Systemic Use
p48220
(dp48221
sVCytochrome P-450 CYP2C8 Substrates
p48222
(dp48223
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p48224
g16526
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p48225
g23092
sVCytochrome P-450 CYP2B6 Inducers
p48226
g39122
sVRifamycins
p48227
(dp48228
sVHeterocyclic Compounds, Fused-Ring
p48229
(dp48230
sVCytochrome P-450 CYP1A2 Inducers (strong)
p48231
g34431
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p48232
g14783
sVAmides
p48233
g44321
sg3702
g40348
sVAnti-Bacterial Agents
p48234
g38349
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48235
g29411
sVCytochrome P-450 CYP3A4 Inducers
p48236
g18917
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p48237
(dp48238
sVCytochrome P-450 CYP2E1 Inducers
p48239
g27604
sVAntituberculosis Agents
p48240
g47102
sVCytochrome P-450 CYP1A2 Inducers
p48241
(dp48242
sVOATP1B3 inhibitors
p48243
(dp48244
sVP-glycoprotein/ABCB1 Inducers
p48245
(dp48246
sVCytochrome P-450 CYP3A7 Inducers (strong)
p48247
(dp48248
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p48249
(dp48250
sVLactams, Macrocyclic
p48251
(dp48252
sVCytochrome P-450 CYP2C8 Inhibitors
p48253
(dp48254
sVCytochrome P-450 CYP2B6 Inducers (strong)
p48255
(dp48256
sVLactams
p48257
g22280
sVP-glycoprotein/ABCB1 Substrates
p48258
g35066
sVCytochrome P-450 CYP3A4 Inducers (strong)
p48259
g23073
sVCytochrome P-450 Enzyme Inducers
p48260
g28160
sVCytochrome P-450 CYP3A Inducers
p48261
(dp48262
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p48263
(dp48264
sVBSEP/ABCB11 Inhibitors
p48265
(dp48266
sVCytochrome P-450 CYP2C8 Inducers (strong)
p48267
(dp48268
sVCytochrome P-450 CYP3A4 Substrates
p48269
(dp48270
sVNarrow Therapeutic Index Drugs
p48271
(dp48272
sVAntibiotics, Antitubercular
p48273
g20918
sVAntimycobacterials
p48274
g22559
sVOATP1B3 substrates
p48275
g28519
sVCytochrome P-450 CYP2C8 Inducers
p48276
(dp48277
sg5403
(dp48278
sVDrugs for Treatment of Tuberculosis
p48279
(dp48280
sVOAT3/SLC22A8 Inhibitors
p48281
(dp48282
sVCytochrome P-450 CYP2C19 Inducers
p48283
g25540
sVOATP1B1/SLCO1B1 Inhibitors
p48284
(dp48285
sVP-glycoprotein/ABCB1 Inhibitors
p48286
(dp48287
sVCytochrome P-450 CYP3A7 Inducers (weak)
p48288
g25710
sVEnzyme Inhibitors
p48289
(dp48290
sVLeprostatic Agents
p48291
g21211
sVChemically-Induced Disorders
p48292
g21235
sVCytochrome P-450 CYP3A5 Inducers (strong)
p48293
(dp48294
ssg4914
(dp48295
g6585
(dp48296
ssg4917
(dp48297
VToxic Actions
p48298
(dp48299
sVMyelosuppressive Agents
p48300
(dp48301
sVNoxae
p48302
(dp48303
sVImmunosuppressive Agents
p48304
(dp48305
sVAlkylating Activity
p48306
g46192
sVAlkylating Drugs
p48307
(dp48308
sVAntineoplastic and Immunomodulating Agents
p48309
g39766
sVAntineoplastic Agents
p48310
(dp48311
sg8646
(dp48312
sVAntineoplastic Agents, Alkylating
p48313
(dp48314
ssg4920
(dp48315
VCytochrome P-450 CYP3A4 Inhibitors
p48316
(dp48317
sg9510
(dp48318
sVCytochrome P-450 CYP3A Substrates
p48319
g45131
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p48320
(dp48321
sg4824
g47759
sVCytochrome P-450 CYP3A7 Inhibitors
p48322
(dp48323
sVOATP1B1/SLCO1B1 Inhibitors
p48324
(dp48325
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p48326
(dp48327
sVCytochrome P-450 Enzyme Inhibitors
p48328
(dp48329
sVAnti-Infective Agents
p48330
(dp48331
sVPolyketides
p48332
(dp48333
sVAntiinfectives for Systemic Use
p48334
(dp48335
sVProtein Synthesis Inhibitors
p48336
g45553
sVLactones
p48337
(dp48338
sg9573
(dp48339
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48340
g29412
sVMacrolides, Lincosamides and Streptogramins
p48341
g33210
sVAnti-Bacterial Agents
p48342
g38352
sVMacrolides
p48343
g16902
sVQTc Prolonging Agents
p48344
(dp48345
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p48346
g24774
sVOATP1B3 inhibitors
p48347
(dp48348
sVErythromycin and similars
p48349
(dp48350
sVCytochrome P-450 CYP3A5 Inhibitors
p48351
(dp48352
sVAntibacterials for Systemic Use
p48353
g32551
sVCytochrome P-450 CYP3A Inhibitors (strong)
p48354
g13401
sVCytochrome P-450 CYP3A4 Substrates
p48355
(dp48356
sVModerate Risk QTc-Prolonging Agents
p48357
(dp48358
sVCytochrome P-450 CYP3A5 Substrates
p48359
(dp48360
sVCytochrome P-450 CYP3A Inhibitors
p48361
(dp48362
sVCytochrome P-450 CYP3A7 Substrates
p48363
(dp48364
ssg4923
(dp48365
g8484
(dp48366
sg8439
(dp48367
ssg4926
(dp48368
VAgents Causing Muscle Toxicity
p48369
(dp48370
sVBSEP/ABCB11 Substrates
p48371
(dp48372
sVFatty Acids
p48373
(dp48374
sVKetones
p48375
(dp48376
sVCytochrome P-450 CYP3A Substrates
p48377
g45133
sVFribic Acid Derivatives
p48378
(dp48379
sVButyrates
p48380
(dp48381
sVLipids
p48382
g14326
sVCytochrome P-450 CYP2C9 Inhibitors
p48383
g18204
sVCytochrome P-450 Enzyme Inhibitors
p48384
(dp48385
sVEthers
p48386
g27597
sVDrugs that are Mainly Renally Excreted
p48387
g43958
sVLipid Modifying Agents
p48388
g40545
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p48389
(dp48390
sVUGT1A1 Substrates
p48391
g12312
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48392
g29414
sVLipid Modifying Agents, Plain
p48393
(dp48394
sVHypolipidemic Agents
p48395
(dp48396
sVFatty Acids, Volatile
p48397
(dp48398
sVPhenols
p48399
(dp48400
sVBenzene Derivatives
p48401
(dp48402
sVIsobutyrates
p48403
g25237
sVCytochrome P-450 CYP2C8 Inhibitors
p48404
(dp48405
sVPhenyl Ethers
p48406
g40596
sVCytochrome P-450 CYP3A4 Substrates
p48407
(dp48408
sVToxic Actions
p48409
(dp48410
sVPeroxisome Proliferator-activated Receptor alpha Agonists
p48411
(dp48412
sVAcids, Acyclic
p48413
g25473
sVNoxae
p48414
(dp48415
sVFibric Acids
p48416
(dp48417
sVP-glycoprotein/ABCB1 Inhibitors
p48418
(dp48419
sVPeroxisome Proliferator Receptor alpha Agonist
p48420
(dp48421
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p48422
g24198
sVBenzophenones
p48423
(dp48424
sVLipid Regulating Agents
p48425
(dp48426
ssg4929
(dp48427
VDrugs that are Mainly Renally Excreted
p48428
g43959
sVBenzene Derivatives
p48429
(dp48430
sVBenzyl Compounds
p48431
g30837
sVAnti-Infective Agents, Local
p48432
(dp48433
sVThroat Preparations
p48434
(dp48435
sVAlcohols
p48436
(dp48437
ssg4932
(dp48438
g5409
(dp48439
ssg4935
(dp48440
VAmino Acids, Peptides, and Proteins
p48441
g47352
sVPeptide Hormones
p48442
g20223
sVThyroid Products
p48443
g28975
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p48444
(dp48445
sVPeptides
p48446
g47179
sVParathyroid Hormones and Analogues
p48447
g25030
sVHormones
p48448
(dp48449
sVHormones, Hormone Substitutes, and Hormone Antagonists
p48450
(dp48451
sVCalcium Homeostasis
p48452
g22844
sVCalcium-Regulating Hormones and Agents
p48453
(dp48454
ssg4938
(dp48455
g1629
g25997
sg10185
(dp48456
sg6567
(dp48457
sg4629
g46435
sg4737
g47232
sg5286
(dp48458
ssg4941
(dp48459
g771
g19295
sg2094
g29992
ssg4944
(dp48460
g5085
(dp48461
ssg4947
(dp48462
g10170
(dp48463
sg1581
g25697
ssg4950
(dp48464
g2142
g30367
sg16906
(dp48465
sg3657
g40182
sg11838
(dp48466
sg4920
g48333
sg10122
(dp48467
sg9963
(dp48468
sg10878
(dp48469
sg7353
(dp48470
sg3963
g41858
sg8448
(dp48471
sg1539
g25301
sg9273
(dp48472
sg2829
g34631
ssg4953
(dp48473
VAntiinfectives for Systemic Use
p48474
(dp48475
sVDrugs that are Mainly Renally Excreted
p48476
g44039
sVGlycosides
p48477
(dp48478
sVAntivirals for Systemic Use
p48479
(dp48480
sVDeoxyribonucleosides
p48481
g33064
sVNucleosides
p48482
(dp48483
sVNucleic Acid Synthesis Inhibitors
p48484
(dp48485
sVNucleoside Reverse Transcriptase Inhibitors
p48486
g38844
sVNucleic Acids, Nucleotides, and Nucleosides
p48487
g47132
sVCarbohydrates
p48488
(dp48489
sVAnti-Infective Agents
p48490
(dp48491
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p48492
g14476
sVAntiviral Agents
p48493
g30476
sVDirect Acting Antivirals
p48494
g38084
sVUGT1A1 Substrates
p48495
g12338
sVAnti-HIV Agents
p48496
(dp48497
sVEnzyme Inhibitors
p48498
(dp48499
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p48500
g38166
sVReverse Transcriptase Inhibitors
p48501
g28967
sVAnti-Retroviral Agents
p48502
(dp48503
ssg4956
(dp48504
g1050
g21689
sg1503
g25193
sg1047
g21623
sg1899
g28080
ssg4959
(dp48505
g435
g16159
sVAntiarrhythmic agents
p48506
(dp48507
sVAnti-epileptic Agent
p48508
(dp48509
sVAnalgesics
p48510
g26456
sVAgents causing hyperkalemia
p48511
g43595
sVAnti-Anxiety Agents
p48512
g35652
sVCentral Nervous System Agents
p48513
(dp48514
sVCycloparaffins
p48515
g43672
sVPotential QTc-Prolonging Agents
p48516
(dp48517
sVButyrates
p48518
(dp48519
sVFatty Acids, Volatile
p48520
(dp48521
sg11037
(dp48522
sVLipids
p48523
g14318
sVMiscellaneous Anticonvulsants
p48524
(dp48525
sVPeripheral Nervous System Agents
p48526
(dp48527
sg8262
(dp48528
sVFatty Acids
p48529
(dp48530
sVAmino Acids
p48531
g43113
sVAmines
p48532
g42705
sVAcids, Carbocyclic
p48533
g41560
sVNeurotransmitter Agents
p48534
(dp48535
sg9396
(dp48536
sVgamma-Aminobutyric Acid
p48537
g31885
sg306
g14801
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48538
g29418
sVQTc Prolonging Agents
p48539
(dp48540
sVCytochrome P-450 CYP3A Substrates
p48541
g45137
sg2646
g33288
sVCentral Nervous System Depressants
p48542
(dp48543
sVAminobutyrates
p48544
(dp48545
sVAnticonvulsants
p48546
(dp48547
sVMuscle Relaxants, Centrally Acting Agents
p48548
g37393
sVSensory System Agents
p48549
(dp48550
sVCytochrome P-450 CYP3A4 Substrates
p48551
(dp48552
sVAmino Acids, Peptides, and Proteins
p48553
g47355
sVCalcium Channel Blockers
p48554
g41318
sVAcids, Acyclic
p48555
g25482
sVBradycardia-Causing Agents
p48556
(dp48557
sVDecreased Central Nervous System Disorganized Electrical Activity
p48558
g23477
sVMuscle Relaxants
p48559
(dp48560
sVPsychotropic Drugs
p48561
(dp48562
sVNervous System
p48563
(dp48564
sVTranquilizing Agents
p48565
(dp48566
ssg4962
(dp48567
g7815
(dp48568
sg10368
(dp48569
sg3204
g37454
sg11334
(dp48570
sg5691
(dp48571
sg10509
(dp48572
ssg4965
(dp48573
g1482
g25013
sg9627
(dp48574
sg8559
(dp48575
ssg4968
(dp48576
g4017
g42300
sg11955
(dp48577
sg11592
(dp48578
sg7821
(dp48579
sg168
g13681
sg6819
(dp48580
sg2736
g33975
sg10335
(dp48581
sg5877
(dp48582
sg2427
g32078
sg8820
(dp48583
sg9960
(dp48584
sg6279
(dp48585
sg8673
(dp48586
sg3024
g36337
sg8856
(dp48587
sg10563
(dp48588
sg1539
g25321
sg14791
(dp48589
sg10356
(dp48590
sg1185
g22751
sg6525
(dp48591
ssg4971
(dp48592
g1581
g25706
ssg4974
(dp48593
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p48594
(dp48595
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p48596
(dp48597
sg639
g18111
sVAnalgesics
p48598
g26459
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p48599
(dp48600
sVCentral Nervous System Agents
p48601
(dp48602
sVAntiinflammatory and Antirheumatic Products
p48603
(dp48604
sVEnzyme Inhibitors
p48605
(dp48606
sVCytochrome P-450 Enzyme Inhibitors
p48607
(dp48608
sVPeripheral Nervous System Agents
p48609
(dp48610
sg273
g14459
sVCytochrome P-450 CYP2C8 Substrates
p48611
(dp48612
sVNonsteroidal Anti-inflammatory Compounds
p48613
(dp48614
sVAnalgesics, Non-Narcotic
p48615
(dp48616
sVNephrotoxic agents
p48617
(dp48618
sVAcids, Carbocyclic
p48619
g41575
sVAniline Compounds
p48620
g23440
sVCytochrome P-450 CYP2C9 Substrates
p48621
g29759
sVMusculo-Skeletal System
p48622
g31547
sVAgents causing hyperkalemia
p48623
g43597
sVBenzene Derivatives
p48624
(dp48625
sVCytochrome P-450 CYP2C8 Inhibitors
p48626
(dp48627
sVOther Nonsteroidal Antiimflammatory Agents
p48628
(dp48629
sVAgents that produce hypertension
p48630
(dp48631
sVAmines
p48632
g42707
sVUGT1A9 Inhibitors
p48633
(dp48634
sVAminobenzoates
p48635
g46180
sVBenzoates
p48636
g30397
sVAnti-Inflammatory Agents
p48637
(dp48638
sVCyclooxygenase Inhibitors
p48639
g32794
sVAntirheumatic Agents
p48640
g24246
sVSensory System Agents
p48641
(dp48642
sVAnti-Inflammatory Agents, Non-Steroidal
p48643
(dp48644
ssg4977
(dp48645
VAmino Acids, Peptides, and Proteins
p48646
g47358
sVAntibodies
p48647
(dp48648
sVLipid Modifying Agents
p48649
g40547
sVAntibodies, Monoclonal
p48650
(dp48651
sVImmunoglobulins
p48652
g41525
sVProteins
p48653
(dp48654
sg8934
(dp48655
sg7473
(dp48656
sVSerum Globulins
p48657
(dp48658
sVLipid Modifying Agents, Plain
p48659
(dp48660
sVGlobulins
p48661
g19179
sg5898
(dp48662
sVBlood Proteins
p48663
g39857
sVImmunoproteins
p48664
(dp48665
ssg4980
(dp48666
g528
g16947
sg9366
(dp48667
ssg4983
(dp48668
g9417
(dp48669
sg7734
(dp48670
sg888
g20509
sg696
g18677
sg9981
(dp48671
sg2427
g31965
sg10056
(dp48672
ssg4986
(dp48673
g2286
g31170
sg11316
(dp48674
sg1470
g24936
sg543
g17075
sg4236
g43724
ssg4989
(dp48675
g2553
g32901
sg3699
g40329
sg5226
(dp48676
sg4725
g47139
ssg4992
(dp48677
g630
g18048
sg2265
g31026
sg495
g16712
sg240
g14213
sg9711
(dp48678
sg11781
(dp48679
ssg4995
(dp48680
g2058
g29174
ssg4998
(dp48681
g5532
(dp48682
ssg5001
(dp48683
g9441
(dp48684
ssg5004
(dp48685
g561
g17377
ssg5007
(dp48686
VCardiovascular Agents
p48687
g26536
sVBSEP/ABCB11 Substrates
p48688
(dp48689
sVAngiotensin II Antagonists and Calcium Channel Blockers
p48690
g42305
sVAntihypertensive Agents
p48691
g20290
sVOATP1B3 substrates
p48692
g28516
sVAngiotensin Receptor Antagonists
p48693
(dp48694
sVAngiotensin II receptor blockers (ARBs) and diuretics
p48695
g18115
sVAgents causing hyperkalemia
p48696
g43575
sVHypotensive Agents
p48697
g34157
sVTetrazoles
p48698
g19111
sVAngiotensin II Antagonists, Plain
p48699
(dp48700
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p48701
(dp48702
sVAngiotensin II receptor blockers (ARBs), plain
p48703
g22611
sVAngiotensin 2 Receptor Blocker
p48704
(dp48705
sVOATP1B1/SLCO1B1 Substrates
p48706
(dp48707
sVImidazoles
p48708
(dp48709
sVAgents Acting on the Renin-Angiotensin System
p48710
g25335
ssg5010
(dp48711
g5970
(dp48712
ssg5013
(dp48713
g11769
(dp48714
ssg5016
(dp48715
g10833
(dp48716
sg3576
g39552
sg7881
(dp48717
sg8985
(dp48718
sg10326
(dp48719
sg1101
g22037
sg6654
(dp48720
sg11427
(dp48721
sg7500
(dp48722
ssg5019
(dp48723
g10833
(dp48724
sg1674
g26313
sg11799
(dp48725
sg11427
(dp48726
sg8049
(dp48727
sg477
g16587
sg6231
(dp48728
sg11061
(dp48729
sg4863
g47924
sg9192
(dp48730
sg7881
(dp48731
sg8985
(dp48732
sg10326
(dp48733
sg9135
(dp48734
sg2991
g35975
sg3015
g36071
sg13070
g21871
sg2808
g34484
sg9663
(dp48735
sg7500
(dp48736
sg2079
g29837
sg3609
g39664
sg4911
g48204
sg87
g12895
sg5520
(dp48737
sg6192
(dp48738
sg4521
g45948
sg2466
g32322
sg1527
g25253
sg1332
g23646
sg10698
(dp48739
sg6654
(dp48740
sg8298
(dp48741
sg8493
(dp48742
sg3576
g39556
sg474
g16544
sg1275
g23267
sg3264
g37853
sg3795
g40937
sg12090
(dp48743
sg4068
g42755
sg1101
g22041
sg4164
g43278
sg6075
(dp48744
sg1863
g27775
sg11775
(dp48745
sg4953
g48485
sg8922
(dp48746
ssg5022
(dp48747
g6630
(dp48748
ssg5025
(dp48749
VFatty Acids
p48750
(dp48751
sVChelating Agents
p48752
(dp48753
sVFatty Acids, Volatile
p48754
(dp48755
sVCompounds used in a research, industrial, or household setting
p48756
(dp48757
sVCalcium Salts
p48758
(dp48759
sVPhosphate-removing Agents
p48760
(dp48761
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p48762
g37171
sVSulfonic Acids
p48763
(dp48764
sVPhosphate Binder
p48765
g21951
sVMinerals
p48766
(dp48767
sVSulfur Compounds
p48768
(dp48769
sVAcids
p48770
g40586
sVBenzene Derivatives
p48771
(dp48772
sg10158
(dp48773
sVSequestering Agents
p48774
(dp48775
sVAlimentary Tract and Metabolism
p48776
g23890
sVBlood Coagulation Factors
p48777
(dp48778
sVAcids, Acyclic
p48779
g25450
sVAcids, Noncarboxylic
p48780
(dp48781
sVSulfur Acids
p48782
(dp48783
sg6543
(dp48784
sVLipids
p48785
g14337
ssg5028
(dp48786
VSex Hormones and Modulators of the Genital System
p48787
g19596
sVBenzene Derivatives
p48788
(dp48789
sVCytochrome P-450 CYP2D6 Inhibitors
p48790
(dp48791
sVGenito Urinary System and Sex Hormones
p48792
(dp48793
sVCytochrome P-450 CYP3A Substrates
p48794
g45189
sVEstrogen Agonist/Antagonist
p48795
(dp48796
sVStilbenes
p48797
(dp48798
sVSelective Estrogen Receptor Modulators
p48799
g43681
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48800
g29487
sVCytochrome P-450 CYP2B6 Substrates
p48801
g33014
sVBenzylidene Compounds
p48802
g43129
sVCytochrome P-450 CYP2C9 Substrates
p48803
g29768
sVCytochrome P-450 Enzyme Inhibitors
p48804
(dp48805
sVCytochrome P-450 CYP3A4 Substrates
p48806
(dp48807
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p48808
g18387
ssg5031
(dp48809
g1635
g26028
sg23
g12201
sg4647
g46565
sg7176
(dp48810
sg5598
(dp48811
sg11649
(dp48812
sg7320
(dp48813
sg4623
g46370
sg3036
g36425
sg10005
(dp48814
sg4488
g45745
sg3363
g38405
sg9402
(dp48815
sg2067
g29623
sg1605
g25774
sg612
g17852
sg9264
(dp48816
sg11445
(dp48817
sg255
g14368
sg168
g13621
sg11319
(dp48818
ssg5034
(dp48819
g10062
(dp48820
sg5853
(dp48821
sg6939
(dp48822
ssg5037
(dp48823
g9552
(dp48824
sg9618
(dp48825
sg9339
(dp48826
sg4377
g44793
sg10239
(dp48827
sg1791
g27230
sg1917
g28438
sg1611
g25803
ssg5040
(dp48828
g6726
(dp48829
sg7920
(dp48830
sg7548
(dp48831
sg4557
g46142
sg8649
(dp48832
sg6714
(dp48833
ssg5043
(dp48834
g11886
(dp48835
sg13750
g24360
sg14872
g15707
sg7545
(dp48836
sg4113
g43025
sg11952
(dp48837
sg8430
(dp48838
sg9030
(dp48839
sg3393
g38542
sg1614
g25854
sg9903
(dp48840
sg5766
(dp48841
sg8694
(dp48842
sg14838
g39967
sg6345
(dp48843
sg4089
g42889
sg5895
(dp48844
sg12534
(dp48845
sg4653
g46666
sg7668
(dp48846
sg6045
(dp48847
ssg5046
(dp48848
g7971
(dp48849
ssg5049
(dp48850
g630
g18011
sg11022
(dp48851
sg9924
(dp48852
sg6186
(dp48853
sg11793
(dp48854
sg8580
(dp48855
sg8964
(dp48856
sg1803
g27369
sg4035
g42415
sg6318
(dp48857
sg8163
(dp48858
sg11979
(dp48859
sg6570
(dp48860
sg11790
(dp48861
sg11265
(dp48862
sg9918
(dp48863
sg1626
g25968
sg3885
g41437
sg11277
(dp48864
sg1260
g23137
sg3684
g40220
sg687
g18541
sg9099
(dp48865
sg8433
(dp48866
sg2427
g32004
sg10713
(dp48867
sg7299
(dp48868
sg3975
g41948
sg10350
(dp48869
sg8097
(dp48870
sg9417
(dp48871
sg10521
(dp48872
sg8277
(dp48873
sg10593
(dp48874
sg2841
g34832
sg7896
(dp48875
sg7941
(dp48876
sg1908
g28293
sg9393
(dp48877
sg7959
(dp48878
sg6303
(dp48879
sg570
g17482
sg8778
(dp48880
sg696
g18711
sg8874
(dp48881
sg6687
(dp48882
sg5169
(dp48883
sg11352
(dp48884
sg387
g15633
sg10497
(dp48885
sg495
g16704
sg2664
g33429
sg10815
(dp48886
sg9828
(dp48887
sg7041
(dp48888
ssg5052
(dp48889
g1626
g25970
sg2688
g33625
sg11022
(dp48890
sg12126
(dp48891
sg1134
g22318
sg9918
(dp48892
ssg5055
(dp48893
g3027
g36363
sg1581
g25692
sg6807
(dp48894
ssg5058
(dp48895
g12111
(dp48896
ssg5061
(dp48897
g8763
(dp48898
ssg5064
(dp48899
VDrugs that are Mainly Renally Excreted
p48900
g43965
sVCentral Nervous System Depressants
p48901
(dp48902
sVCytochrome P-450 CYP3A4 Substrates
p48903
(dp48904
sVBenzazepines
p48905
(dp48906
sVGABA Agents
p48907
g16209
sVAnticonvulsants
p48908
(dp48909
sVCytochrome P-450 CYP3A Substrates
p48910
g45143
sVMuscle Relaxants, Centrally Acting Agents
p48911
g37386
sVCytochrome P-450 CYP2E1 Inhibitors
p48912
g46831
sVCentral Nervous System Agents
p48913
(dp48914
sVGABA Modulators
p48915
g39051
sVBenzodiazepinones
p48916
(dp48917
sVNervous System
p48918
(dp48919
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p48920
g29423
sVMuscle Relaxants
p48921
(dp48922
sVBenzodiazepines and benzodiazepine derivatives
p48923
(dp48924
sVHeterocyclic Compounds, Fused-Ring
p48925
(dp48926
sVCytochrome P-450 Enzyme Inhibitors
p48927
(dp48928
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p48929
g26871
ssg5067
(dp48930
VPyrimidines
p48931
g47711
sVAnticholinergic Agents
p48932
g24509
sVGABA Agents
p48933
g16205
sVNeurotransmitter Agents
p48934
(dp48935
sVCentral Nervous System Agents
p48936
(dp48937
sg4230
g43685
sVGABA Modulators
p48938
g39049
sVDrugs that are Mainly Renally Excreted
p48939
g44056
sVCytochrome P-450 CYP3A4 Inducers (strong)
p48940
g23081
sVBarbiturates
p48941
(dp48942
sVAdjuvants, Anesthesia
p48943
(dp48944
sVPsycholeptics
p48945
g33259
sVCytochrome P-450 CYP3A4 Inducers
p48946
g18982
sg7788
(dp48947
sVCytochrome P-450 CYP2C19 Substrates
p48948
(dp48949
sVCentral Nervous System Depressants
p48950
(dp48951
sVAnticonvulsants
p48952
(dp48953
sVCytochrome P-450 Enzyme Inducers
p48954
g28246
sVCytochrome P-450 CYP3A Inducers
p48955
(dp48956
sVCytochrome P-450 CYP3A Inducers (strong)
p48957
g22446
sVCytochrome P-450 CYP2A6 Inducers
p48958
g39426
sVHypnotics and Sedatives
p48959
(dp48960
sVNicotinic Antagonists
p48961
(dp48962
sVPyrimidinones
p48963
(dp48964
sVNervous System
p48965
(dp48966
ssg5070
(dp48967
g10239
(dp48968
sg1791
g27218
sg9339
(dp48969
sg1611
g25794
ssg5073
(dp48970
VHematinics
p48971
(dp48972
sVCarbohydrates
p48973
(dp48974
sVGranulocyte Colony-Stimulating Factor
p48975
g24064
sVBiological Factors
p48976
g38100
sVGlycoconjugates
p48977
(dp48978
sVLeukocyte Growth Factor
p48979
g39438
sVColony-Stimulating Factors
p48980
g47978
sVIncreased Myeloid Cell Production
p48981
g23258
sVGlycols
p48982
(dp48983
sVAntineoplastic and Immunomodulating Agents
p48984
g39797
sVHematopoietic Cell Growth Factors
p48985
(dp48986
sVPolymers
p48987
g22233
sVProteins
p48988
(dp48989
sVPeptides
p48990
g47195
sVBiomedical and Dental Materials
p48991
g44726
sVAdjuvants, Immunologic
p48992
g39434
sVEthylene Glycols
p48993
(dp48994
sVAmino Acids, Peptides, and Proteins
p48995
g47382
sVIntercellular Signaling Peptides and Proteins
p48996
g25423
sVPegylated agents
p48997
g13562
sVMacromolecular Substances
p48998
g33842
sVGlycoproteins
p48999
(dp49000
sVAlcohols
p49001
(dp49002
sVCytokines
p49003
(dp49004
sVCompounds used in a research, industrial, or household setting
p49005
(dp49006
ssg5076
(dp49007
g11097
(dp49008
sg7422
(dp49009
sg11931
(dp49010
sg8514
(dp49011
sg10470
(dp49012
ssg5079
(dp49013
g9540
(dp49014
sg10512
(dp49015
ssg5082
(dp49016
VAntiinfectives for Systemic Use
p49017
(dp49018
sVAgents that produce neuromuscular block (indirect)
p49019
g37967
sVAntibiotics for Topical Use
p49020
(dp49021
sVTetracyclines
p49022
(dp49023
sVDermatologicals
p49024
g17279
sVAnti-Bacterial Agents
p49025
g38362
sVAntibacterials for Systemic Use
p49026
g32560
sVNaphthacenes
p49027
g40475
sVAnti-Infective Agents
p49028
(dp49029
ssg5085
(dp49030
g8766
(dp49031
sVCarbohydrates
p49032
(dp49033
sVDrugs for Constipation
p49034
(dp49035
sVIrrigating Solutions
p49036
g41367
sVCompounds used in a research, industrial, or household setting
p49037
(dp49038
sVCytochrome P-450 CYP2E1 Inducers
p49039
g27613
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p49040
g14793
sg2751
g34052
sVProtective Agents
p49041
(dp49042
sg2889
g35331
sVOsmotic Laxatives
p49043
(dp49044
sg3327
g38244
sVBasic Ointments and Protectants
p49045
g41766
sVCell-mediated Immunity
p49046
g23557
sVSolvents
p49047
g36482
sVLaxatives
p49048
g17345
sg4944
g48461
sVIncreased Histamine Release
p49049
(dp49050
sVAlimentary Tract and Metabolism
p49051
g23873
sg10020
(dp49052
sg11748
(dp49053
sVAlcohols
p49054
(dp49055
sVP-glycoprotein/ABCB1 Inhibitors
p49056
(dp49057
sVCytochrome P-450 Enzyme Inducers
p49058
g28200
sg10989
(dp49059
ssg5088
(dp49060
g8595
(dp49061
ssg5091
(dp49062
g10479
(dp49063
sg972
g21135
sg8238
(dp49064
sg4710
g47018
sg3291
g38009
sg135
g13262
sg6204
(dp49065
sg9282
(dp49066
sg8079
(dp49067
sg6183
(dp49068
sg7074
(dp49069
sg1311
g23537
sg7005
(dp49070
sg4005
g42173
sg2436
g32187
sg10611
(dp49071
ssg5094
(dp49072
VDrugs that are Mainly Renally Excreted
p49073
g43968
sVThiophenes
p49074
(dp49075
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p49076
g39025
sVCytochrome P-450 CYP3A Substrates
p49077
g45146
sVAgents causing hyperkalemia
p49078
g43613
sVHypotensive Agents
p49079
g34164
sVP-glycoprotein/ABCB1 Substrates
p49080
g35039
sVUGT1A9 Substrates
p49081
g24008
sVSulfur Compounds
p49082
(dp49083
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p49084
(dp49085
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49086
g29426
sVGlucosides
p49087
g41041
sVOral Hypoglycemics
p49088
g35999
sVP-glycoprotein/ABCB1 Inhibitors
p49089
(dp49090
sVCytochrome P-450 CYP3A4 Substrates
p49091
(dp49092
sVBlood Glucose Lowering Agents
p49093
(dp49094
sVAlimentary Tract and Metabolism
p49095
g23878
sVDrugs Used in Diabetes
p49096
(dp49097
sVDiuretics
p49098
(dp49099
ssg5097
(dp49100
g3381
g38477
sg7983
(dp49101
sg2841
g34844
sg387
g15645
sg945
g20894
sg8028
(dp49102
sg9966
(dp49103
ssg5100
(dp49104
g10041
(dp49105
sg831
g19905
ssg5103
(dp49106
g9870
(dp49107
sg6552
(dp49108
sg5415
(dp49109
sg10839
(dp49110
sg9309
(dp49111
sg7629
(dp49112
sg657
g18352
sg3312
g38133
sg11832
(dp49113
sg7530
(dp49114
sg10320
(dp49115
sg1842
g27643
sg9561
(dp49116
sg2985
g35931
sg8649
(dp49117
sg9588
(dp49118
sg8826
(dp49119
sg6714
(dp49120
sg6726
(dp49121
sg1875
g27887
sg7920
(dp49122
sg9780
(dp49123
sg7548
(dp49124
sg4557
g46159
sg10764
(dp49125
sg4770
g47463
sg10767
(dp49126
sg1164
g22577
sg13091
g21416
sg396
g15787
sg10587
(dp49127
sg6765
(dp49128
sg12108
(dp49129
sg4398
g44829
sg11382
(dp49130
sg420
g16020
ssg5106
(dp49131
g9144
(dp49132
sg2034
g29016
sg6966
(dp49133
sg1062
g21821
sg2460
g32284
sg11958
(dp49134
sg8067
(dp49135
sg3114
g36875
sg9198
(dp49136
sg10227
(dp49137
sg4788
g47579
sg9579
(dp49138
sg6792
(dp49139
sg909
g20647
sg204
g13968
sg4887
g48094
sg9759
(dp49140
sg1185
g22733
sg10098
(dp49141
ssg5109
(dp49142
g8097
(dp49143
sg8421
(dp49144
sg4155
g43234
sg9918
(dp49145
sg9417
(dp49146
sg11910
(dp49147
sg3027
g36365
sg11079
(dp49148
sg9981
(dp49149
sg183
g13830
sg888
g20413
sg16906
(dp49150
sg8595
(dp49151
sg11601
(dp49152
sg1683
g26384
sg7335
(dp49153
sg3963
g41879
sg4911
g48238
sg9273
(dp49154
ssg5112
(dp49155
VAmino Acids, Cyclic
p49156
g27284
sVCytochrome P-450 CYP2D6 Substrates
p49157
(dp49158
sVPotassium Channel Antagonists
p49159
(dp49160
sVOAT1/SLC22A6 inhibitors
p49161
(dp49162
sVCytochrome P-450 CYP3A Substrates
p49163
g45120
sVCycloparaffins
p49164
g43670
sVBlood Glucose Lowering Agents
p49165
(dp49166
sVDrugs that are Mainly Renally Excreted
p49167
g43944
sVAmino Acids
p49168
g43110
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49169
g29401
sVOral Hypoglycemics
p49170
g36003
sVCytochrome P-450 CYP2C9 Substrates
p49171
g29785
sVDrugs Used in Diabetes
p49172
(dp49173
sVAmino Acids, Aromatic
p49174
(dp49175
sVCytochrome P-450 CYP3A4 Substrates
p49176
(dp49177
sVAlimentary Tract and Metabolism
p49178
g23931
sVAmino Acids, Peptides, and Proteins
p49179
g47390
sVUGT1A9 Substrates
p49180
g24027
sVCytochrome P-450 CYP3A5 Substrates
p49181
(dp49182
sVAmino Acids, Essential
p49183
g35284
sVGlinide
p49184
(dp49185
sVHypoglycemia-Associated Agents
p49186
g17715
sVPhenylalanine
p49187
(dp49188
sVCyclohexanes
p49189
g33282
sVCytochrome P-450 CYP3A7 Substrates
p49190
(dp49191
ssg5115
(dp49192
g3009
g36050
ssg5118
(dp49193
g3381
g38485
sg7983
(dp49194
sg2841
g34855
sg387
g15659
sg945
g20902
sg8028
(dp49195
sg9966
(dp49196
ssg5121
(dp49197
g4479
g45708
sg7377
(dp49198
sg4920
g48350
sg690
g18636
sg4539
g46037
sg8448
(dp49199
sg3021
g36209
ssg5124
(dp49200
g1914
g28413
sg687
g18571
sg8580
(dp49201
sg4035
g42441
sg11352
(dp49202
sg4488
g45764
sg5598
(dp49203
ssg5127
(dp49204
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p49205
(dp49206
sVCytochrome P-450 CYP3A4 Inhibitors
p49207
(dp49208
sVCytochrome P-450 CYP2D6 Inhibitors
p49209
(dp49210
sVCytochrome P-450 CYP2D6 Substrates
p49211
(dp49212
sVCytochrome P-450 CYP3A Substrates
p49213
g45150
sg6201
(dp49214
sVKinase Inhibitor
p49215
g24597
sVOATP1B1/SLCO1B1 Inhibitors
p49216
(dp49217
sVCytochrome P-450 Enzyme Inhibitors
p49218
(dp49219
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p49220
g18419
sVCytochrome P-450 CYP2C8 Substrates
p49221
(dp49222
sVCytochrome P-450 CYP1A2 Substrates
p49223
g45609
sVAngiogenesis Inhibitors
p49224
(dp49225
sVTyrosine Kinase Inhibitors
p49226
g30830
sVAmides
p49227
g44359
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49228
g29434
sVSulfur Compounds
p49229
(dp49230
sVSulfones
p49231
(dp49232
sVQTc Prolonging Agents
p49233
(dp49234
sVAntineoplastic Agents
p49235
(dp49236
sVCytochrome P450 3A4 Inhibitors
p49237
g13047
sVCytochrome P-450 CYP2C8 Inhibitors
p49238
(dp49239
sVP-glycoprotein/ABCB1 Substrates
p49240
g35092
sVUGT1A1 Inhibitors
p49241
(dp49242
sVCytochrome P-450 CYP3A4 Substrates
p49243
(dp49244
sVModerate Risk QTc-Prolonging Agents
p49245
(dp49246
sVProtein Kinase Inhibitors
p49247
(dp49248
sVCytochrome P-450 CYP3A Inhibitors
p49249
(dp49250
sVImmunosuppressive Agents
p49251
(dp49252
sVBCRP/ABCG2 Substrates
p49253
g42085
sVAntineoplastic and Immunomodulating Agents
p49254
g39796
sg1389
g24195
ssg5130
(dp49255
g10200
(dp49256
sg2199
g30700
sg5457
(dp49257
sg396
g15802
sg3144
g37121
sg11415
(dp49258
sg9006
(dp49259
sg11379
(dp49260
ssg5133
(dp49261
VPyrimidines
p49262
g47700
sVAnticholinergic Agents
p49263
g24484
sVGABA Agents
p49264
g16216
sVNeurotransmitter Agents
p49265
(dp49266
sVCentral Nervous System Agents
p49267
(dp49268
sVGABA Modulators
p49269
g39056
sVCytochrome P-450 CYP2C9 Inducers
p49270
g20046
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p49271
g16525
sVDrugs that are Mainly Renally Excreted
p49272
g43974
sVCytochrome P-450 CYP2C8 Inducers (strong)
p49273
(dp49274
sVBarbiturates
p49275
(dp49276
sVAdjuvants, Anesthesia
p49277
(dp49278
sVPsycholeptics
p49279
g33243
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p49280
g25145
sVCytochrome P-450 CYP3A4 Inducers
p49281
g18889
sVBarbiturates, Plain
p49282
(dp49283
sVCentral Nervous System Depressants
p49284
(dp49285
sVCytochrome P-450 CYP1A2 Inducers
p49286
(dp49287
sVAnticonvulsants
p49288
(dp49289
sVCytochrome P-450 Enzyme Inducers
p49290
g28129
sVCytochrome P-450 CYP3A Inducers
p49291
(dp49292
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p49293
g17446
sVHypnotics and Sedatives
p49294
(dp49295
sVNicotinic Antagonists
p49296
(dp49297
sVPyrimidinones
p49298
(dp49299
sVCytochrome P-450 CYP2C8 Inducers
p49300
(dp49301
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p49302
(dp49303
sVCytochrome P-450 CYP2C19 Inducers
p49304
g25536
sVAdjuvants
p49305
(dp49306
sVNervous System
p49307
(dp49308
ssg5136
(dp49309
g1890
g28009
sg9111
(dp49310
sg7533
(dp49311
sg6525
(dp49312
ssg5139
(dp49313
g7815
(dp49314
sg11631
(dp49315
sg4068
g42780
sg10368
(dp49316
sg3204
g37450
sg11334
(dp49317
sg5691
(dp49318
sg10509
(dp49319
sg3609
g39699
ssg5142
(dp49320
g4017
g42294
sg2559
g32937
sg5805
(dp49321
sg6186
(dp49322
sg12421
g12444
sg2481
g32426
sg5433
(dp49323
sg9357
(dp49324
sg834
g19950
sg5832
(dp49325
sg2736
g33945
sg10797
(dp49326
sg5652
(dp49327
sg8055
(dp49328
sg5256
(dp49329
sg288
g14694
sg9198
(dp49330
sg11655
(dp49331
sg888
g20495
sg2838
g34805
sg4680
g46872
sg8820
(dp49332
sg15016
(dp49333
sg12274
g27513
sg6447
(dp49334
sg10728
(dp49335
sg10518
(dp49336
sg9231
(dp49337
sg8856
(dp49338
sg696
g18764
sg789
g19485
sg1908
g28314
sg8298
(dp49339
sg7065
(dp49340
sg7698
(dp49341
sg2688
g33678
sg7563
(dp49342
sg3222
g37590
sg4164
g43348
sg9417
(dp49343
sg5757
(dp49344
sg5370
(dp49345
sg2913
g35574
sg12126
(dp49346
sg7197
(dp49347
sg10356
(dp49348
sg1185
g22742
sg7041
(dp49349
ssg5145
(dp49350
VDrugs that are Mainly Renally Excreted
p49351
g43975
sVCentral Nervous System Depressants
p49352
(dp49353
sVMiscellaneous Anticonvulsants
p49354
(dp49355
sVAnticonvulsants
p49356
(dp49357
sVCytochrome P-450 CYP3A Substrates
p49358
g45151
sg4443
g45336
sVCentral Nervous System Agents
p49359
(dp49360
sVNervous System
p49361
(dp49362
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49363
g29435
sVCytochrome P-450 CYP2B6 Substrates
p49364
g33031
sVPyrrolidines
p49365
(dp49366
sVCytochrome P-450 CYP2C9 Substrates
p49367
g29788
sVCytochrome P-450 CYP3A4 Substrates
p49368
(dp49369
ssg5148
(dp49370
g9852
(dp49371
sg6804
(dp49372
ssg5151
(dp49373
g4014
g42243
sg11820
(dp49374
sg2553
g32898
sg4017
g42295
sg3105
g36799
sg837
g19995
sg3639
g40069
sg7458
(dp49375
sg10839
(dp49376
sg10275
(dp49377
sg6009
(dp49378
sg7527
(dp49379
sg3858
g41242
sg3576
g39582
sg7809
(dp49380
sg8928
(dp49381
sg8601
(dp49382
sg7848
(dp49383
sg4650
g46634
sg6699
(dp49384
sg10797
(dp49385
sg2451
g32203
sg477
g16611
sg6765
(dp49386
sg1461
g24846
sg9552
(dp49387
sg4863
g47959
sg4068
g42784
sg8808
(dp49388
sg8022
(dp49389
sg6033
(dp49390
sg3015
g36105
sg1674
g26352
sg2805
g34441
sg5880
(dp49391
sg4491
g45809
sg2112
g30175
sg11541
(dp49392
sg4902
g48145
sg3609
g39692
sg918
g20768
sg1785
g27193
sg87
g12938
sg9612
(dp49393
sg4917
g48299
sg8190
(dp49394
sg11313
(dp49395
sg11268
(dp49396
sg4926
g48410
sg4521
g45977
sg12078
(dp49397
sg10374
(dp49398
sg9471
(dp49399
sg6537
(dp49400
sg6654
(dp49401
sg2466
g32342
sg10950
(dp49402
sg3258
g37805
sg474
g16576
sg1275
g23303
sg1152
g22536
sg2142
g30371
sg10698
(dp49403
sg11172
(dp49404
sg1365
g24033
sg12090
(dp49405
sg48
g12651
sg1173
g22649
sg6015
(dp49406
sg13091
g21398
sg9081
(dp49407
sg4200
g43539
sg5193
(dp49408
sg11775
(dp49409
sg11208
(dp49410
sg8985
(dp49411
sg1611
g25828
ssg5154
(dp49412
g630
g18041
sg1425
g24564
sg240
g14205
sg6318
(dp49413
sg9711
(dp49414
sg10674
(dp49415
sg2658
g33385
sg282
g14583
sg11016
(dp49416
sg822
g19804
sg516
g16890
sg2814
g34528
sg7299
(dp49417
sg5694
(dp49418
sg1707
g26794
sg6966
(dp49419
sg2265
g31020
sg12066
(dp49420
sg5535
(dp49421
sg486
g16665
sg696
g18768
sg11790
(dp49422
sg6303
(dp49423
sg3570
g39505
sg5169
(dp49424
sg387
g15677
sg2664
g33469
sg10815
(dp49425
sg1194
g22826
sg414
g15981
sg8187
(dp49426
sg780
g19373
ssg5157
(dp49427
VBasic Ointments and Protectants
p49428
g41767
sVGenito Urinary System and Sex Hormones
p49429
(dp49430
sVGynecological Antiinfectives and Antiseptics
p49431
(dp49432
sVLactic Acid
p49433
(dp49434
sVLactates
p49435
g12410
sVHydroxy Acids
p49436
g18155
sVLaxatives
p49437
g17347
sVMiscellaneous Local Anti-infectives
p49438
(dp49439
sVOrganic Acids
p49440
g24257
ssg5160
(dp49441
g1782
g27164
sg10200
(dp49442
sg7548
(dp49443
sg10320
(dp49444
sg9780
(dp49445
sg7530
(dp49446
sg420
g16007
sg2985
g35933
sg6150
(dp49447
sg657
g18354
sg11382
(dp49448
sg9561
(dp49449
sg5511
(dp49450
sg9870
(dp49451
sg3825
g41017
ssg5163
(dp49452
g10833
(dp49453
sg7815
(dp49454
sg11799
(dp49455
sg10725
(dp49456
sg48
g12653
sg11427
(dp49457
sg9411
(dp49458
sg87
g12942
sg11061
(dp49459
sg4068
g42789
sg7881
(dp49460
sg8985
(dp49461
sg10326
(dp49462
sg7500
(dp49463
sg10509
(dp49464
sg3609
g39708
sg6090
(dp49465
sg5520
(dp49466
sg10368
(dp49467
sg4521
g45979
sg1527
g25251
sg10698
(dp49468
sg6654
(dp49469
sg19588
g32510
sg11334
(dp49470
sg474
g16578
sg1275
g23305
sg3264
g37855
sg3576
g39592
sg12090
(dp49471
sg3015
g36107
sg1101
g22079
sg4953
g48483
sg11208
(dp49472
ssg5166
(dp49473
g3027
g36383
sg8595
(dp49474
sg8820
(dp49475
ssg5169
(dp49476
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p49477
(dp49478
sVAdrenergic alpha-1 Receptor Antagonists
p49479
g14141
sVAnticholinergic Agents
p49480
g24506
sVCytochrome P-450 CYP2D6 Inhibitors
p49481
(dp49482
sVCytochrome P-450 CYP2D6 Substrates
p49483
(dp49484
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p49485
(dp49486
sVSerotonin Agents
p49487
(dp49488
sVMembrane Transport Modulators
p49489
(dp49490
sVAntidepressive Agents, Tricyclic
p49491
(dp49492
sVSerotonin Receptor Antagonists
p49493
g35687
sVCentral Nervous System Agents
p49494
(dp49495
sVDopamine Agents
p49496
g14261
sVPotential QTc-Prolonging Agents
p49497
(dp49498
sVAdrenergic Antagonists
p49499
(dp49500
sVDibenzoxazepines
p49501
(dp49502
sVSerotonin 5-HT1 Receptor Antagonists
p49503
g14429
sVCytochrome P-450 Enzyme Inhibitors
p49504
(dp49505
sVMuscarinic Antagonists
p49506
g48883
sVNeurotransmitter Uptake Inhibitors
p49507
(dp49508
sVPsychoanaleptics
p49509
(dp49510
sVNon-Selective Monoamine Reuptake Inhibitors
p49511
(dp49512
sVAntipsychotic Agents
p49513
(dp49514
sVDopamine Antagonists
p49515
(dp49516
sVAdrenergic alpha-Antagonists
p49517
(dp49518
sVQTc Prolonging Agents
p49519
(dp49520
sVSerotonin 5-HT2 Receptor Antagonists
p49521
(dp49522
sVNeurotoxic agents
p49523
(dp49524
sVAdrenergic Agents
p49525
g41724
sVCentral Nervous System Depressants
p49526
(dp49527
sVNeurotransmitter Agents
p49528
(dp49529
sVHistamine Antagonists
p49530
g43452
sVAgents that reduce seizure threshold
p49531
g45868
sVAdrenergic Uptake Inhibitors
p49532
g32317
sVHistamine H1 Antagonists
p49533
g40792
sVAgents that produce hypertension
p49534
(dp49535
sVLoxapine
p49536
g22889
sVNarrow Therapeutic Index Drugs
p49537
(dp49538
sVDopamine D2 Receptor Antagonists
p49539
g49424
sVHeterocyclic Compounds, Fused-Ring
p49540
(dp49541
sVSerotonin Modulators
p49542
(dp49543
sVAntidepressive Agents
p49544
g15557
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p49545
g36627
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p49546
(dp49547
sVP-glycoprotein/ABCB1 Inhibitors
p49548
(dp49549
sg4392
g44820
sVAgents producing tachycardia
p49550
(dp49551
sVPsychotropic Drugs
p49552
(dp49553
sVNervous System
p49554
(dp49555
ssg5172
(dp49556
g714
g18991
ssg5175
(dp49557
g11664
(dp49558
ssg5178
(dp49559
g4827
g47772
ssg5181
(dp49560
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p49561
(dp49562
sVAnalgesics
p49563
g26497
sVAgents causing hyperkalemia
p49564
g43646
sVCytochrome P-450 CYP3A Substrates
p49565
g45272
sVCentral Nervous System Agents
p49566
(dp49567
sVEnzyme Inhibitors
p49568
(dp49569
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p49570
g24331
sVCytochrome P-450 CYP2C9 Inhibitors
p49571
g18254
sVCytochrome P-450 Enzyme Inhibitors
p49572
(dp49573
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p49574
(dp49575
sVAnalgesics, Non-Narcotic
p49576
(dp49577
sVNephrotoxic agents
p49578
(dp49579
sVPeripheral Nervous System Agents
p49580
(dp49581
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49582
g29595
sVCytochrome P-450 CYP2C9 Substrates
p49583
g29821
sVMusculo-Skeletal System
p49584
g31548
sVCOX-2 Inhibitors
p49585
(dp49586
sVAgents that produce hypertension
p49587
(dp49588
sVCytochrome P-450 CYP3A4 Substrates
p49589
(dp49590
sVAntiinflammatory and Antirheumatic Products
p49591
(dp49592
sVAnti-Inflammatory Agents
p49593
(dp49594
sVCyclooxygenase Inhibitors
p49595
g32795
sVAntirheumatic Agents
p49596
g24253
sVSensory System Agents
p49597
(dp49598
sVAnti-Inflammatory Agents, Non-Steroidal
p49599
(dp49600
ssg5184
(dp49601
g687
g18581
sg4035
g42452
sg8580
(dp49602
sg1260
g23169
ssg5187
(dp49603
g4257
g44069
sg5469
(dp49604
ssg5190
(dp49605
g3147
g37159
ssg5193
(dp49606
VAntiparasitic Products, Insecticides and Repellents
p49607
g30588
sVOrganothiophosphates
p49608
(dp49609
sVCytochrome P-450 CYP1A2 Substrates
p49610
g45613
sVCholinergic Agents
p49611
g28737
sVPotential QTc-Prolonging Agents
p49612
(dp49613
sVInsecticides
p49614
g40091
sVQTc Prolonging Agents
p49615
(dp49616
sVToxic Actions
p49617
g49408
sVNeurotransmitter Agents
p49618
(dp49619
sVCholinesterase Inhibitors
p49620
(dp49621
sVOrganothiophosphorus Compounds
p49622
g15996
sVPesticides
p49623
(dp49624
sVCompounds used in a research, industrial, or household setting
p49625
(dp49626
sVOrganophosphates
p49627
(dp49628
sVEnzyme Inhibitors
p49629
(dp49630
sVEctoparasiticides, Incl. Scabicides
p49631
(dp49632
sVEctoparasiticides, Incl. Scabicides, Insecticides and Repellents
p49633
g44413
sVOrganophosphorus Compounds
p49634
(dp49635
sVSulfur Compounds
p49636
(dp49637
sVAgrochemicals
p49638
(dp49639
sVCytochrome P-450 CYP2B6 Substrates
p49640
g33021
ssg5196
(dp49641
g9897
(dp49642
sg5463
(dp49643
sg9132
(dp49644
sg2754
g34057
sg447
g16294
sg9705
(dp49645
sg8772
(dp49646
sg9300
(dp49647
sg6213
(dp49648
sg6216
(dp49649
sg9348
(dp49650
sg11646
(dp49651
sg669
g18450
sg4200
g43541
sg3147
g37152
sg12015
(dp49652
sg11286
(dp49653
sg1266
g23216
sg1482
g25017
sg9741
(dp49654
sg8076
(dp49655
sg6612
(dp49656
sg4977
g48658
sg6804
(dp49657
sg7512
(dp49658
sg6630
(dp49659
sg9612
(dp49660
sg4713
g47037
sg10431
(dp49661
sg1737
g26920
sg3801
g40968
sg9627
(dp49662
sg3882
g41416
sg4551
g46111
sg3573
g39544
sg11349
(dp49663
sg11550
(dp49664
sg3588
g39618
sg7980
(dp49665
sg1563
g25516
sg4905
g48189
sg8910
(dp49666
sg8559
(dp49667
sg4185
g43479
sg7059
(dp49668
sg9852
(dp49669
sg7809
(dp49670
sg10104
(dp49671
sg10653
(dp49672
ssg5199
(dp49673
VAgents Causing Muscle Toxicity
p49674
(dp49675
sVOAT1/SLC22A6 inhibitors
p49676
(dp49677
sVCytochrome P-450 CYP3A Substrates
p49678
g45154
sVAgents causing hyperkalemia
p49679
g43622
sVHypotensive Agents
p49680
g34185
sVAgents causing angioedema
p49681
(dp49682
sVProtease Inhibitors
p49683
(dp49684
sVEnzyme Inhibitors
p49685
(dp49686
sVCardiovascular Agents
p49687
g26649
sVAntihypertensive Agents
p49688
g20308
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49689
g29441
sVOATP1B1/SLCO1B1 Substrates
p49690
(dp49691
sVAngiotensin-Converting Enzyme Inhibitors
p49692
(dp49693
sVOligopeptides
p49694
(dp49695
sVACE Inhibitors and Calcium Channel Blockers
p49696
(dp49697
sVACE Inhibitors and Diuretics
p49698
(dp49699
sVDipeptides
p49700
g38037
sVPeptides
p49701
g47201
sVCytochrome P-450 CYP3A4 Substrates
p49702
(dp49703
sVAgents Acting on the Renin-Angiotensin System
p49704
g25348
sVAmino Acids, Peptides, and Proteins
p49705
g47397
sVDecreased Blood Pressure
p49706
(dp49707
sVOAT3/SLC22A8 Inhibitors
p49708
(dp49709
sVP-glycoprotein/ABCB1 Inhibitors
p49710
(dp49711
ssg5202
(dp49712
g9357
(dp49713
sg3543
g39368
sg3861
g41304
sg5433
(dp49714
sg4680
g46913
sg12274
g27573
ssg5205
(dp49715
g2664
g33443
ssg5208
(dp49716
VAntiinfectives for Systemic Use
p49717
(dp49718
sVDrugs that are Mainly Renally Excreted
p49719
g43830
sVAgents that produce neuromuscular block (indirect)
p49720
g37969
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p49721
g43749
sVTetracyclines
p49722
(dp49723
sVOAT1/SLC22A6 inhibitors
p49724
(dp49725
sVCytochrome P-450 CYP3A Substrates
p49726
g45210
sVCytochrome P-450 CYP3A Inhibitors
p49727
(dp49728
sVStomatological Preparations
p49729
(dp49730
sVCytochrome P-450 CYP3A4 Inhibitors
p49731
(dp49732
sVCytochrome P-450 Enzyme Inhibitors
p49733
(dp49734
sVAntiparasitic Agents
p49735
g40652
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49736
g29515
sVAntiinfectives and Antiseptics for Local Oral Treatment
p49737
(dp49738
sVAnti-Bacterial Agents
p49739
g38333
sVAntibacterials for Systemic Use
p49740
g32538
sVAntiprotozoals
p49741
(dp49742
sVCytochrome P-450 CYP3A4 Substrates
p49743
(dp49744
sVAnti-Infective Agents
p49745
(dp49746
sVAlimentary Tract and Metabolism
p49747
g23833
sVNaphthacenes
p49748
g40476
ssg5211
(dp49749
g7464
(dp49750
sg10818
(dp49751
sg4635
g46454
sg11727
(dp49752
sg7569
(dp49753
sg1491
g25040
sg3447
g38895
ssg5214
(dp49754
g8874
(dp49755
sg465
g16431
sg10266
(dp49756
sg10497
(dp49757
sg3978
g41953
sg6468
(dp49758
sg1908
g28258
sg8655
(dp49759
sg10308
(dp49760
sg2910
g35497
ssg5217
(dp49761
g3573
g39529
sg11550
(dp49762
sg9132
(dp49763
sg7980
(dp49764
sg10431
(dp49765
sg447
g16304
sg6216
(dp49766
sg11718
(dp49767
ssg5220
(dp49768
g9357
(dp49769
sg3543
g39307
sg3861
g41263
sg5433
(dp49770
sg4680
g46859
sg12274
g27493
sg8013
(dp49771
ssg5223
(dp49772
g8067
(dp49773
ssg5226
(dp49774
VPhosphate-removing Agents
p49775
(dp49776
sg3600
g39657
sVElements
p49777
(dp49778
sg3681
g40211
sg2103
g30064
sVMetals
p49779
g48676
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p49780
g37170
sVPhosphate Binder
p49781
g21944
sVMetal cations
p49782
g40803
sg3924
g41637
ssg5229
(dp49783
VAgents Causing Muscle Toxicity
p49784
(dp49785
sVCardiovascular Agents
p49786
g26650
sVAntihypertensive Agents
p49787
g20309
sVAcids, Acyclic
p49788
g25439
sVAngiotensin II receptor blockers (ARBs) and diuretics
p49789
g18116
sVAgents causing hyperkalemia
p49790
g43625
sVHypotensive Agents
p49791
g34188
sVAgents causing angioedema
p49792
(dp49793
sVAngiotensin Receptor Antagonists
p49794
(dp49795
sVAngiotensin II Type 1 Receptor Blockers
p49796
(dp49797
sVSulfur Compounds
p49798
(dp49799
sVAngiotensin II receptor blockers (ARBs), plain
p49800
g22612
sVAngiotensin 2 Receptor Blocker
p49801
(dp49802
sVAgents Acting on the Renin-Angiotensin System
p49803
g25332
ssg5232
(dp49804
g6630
(dp49805
ssg5235
(dp49806
VAntiarrhythmic agents
p49807
(dp49808
sVAnti-epileptic Agent
p49809
(dp49810
sVCytochrome P-450 CYP3A Substrates
p49811
g45157
sVAgents causing hyperkalemia
p49812
g43628
sVCentral Nervous System Agents
p49813
(dp49814
sVCalcium Channel Blockers
p49815
g41306
sVPotential QTc-Prolonging Agents
p49816
(dp49817
sg8220
(dp49818
sVCompounds used in a research, industrial, or household setting
p49819
(dp49820
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p49821
(dp49822
sVCytochrome P-450 Enzyme Inhibitors
p49823
(dp49824
sVCarbonic Anhydrase Inhibitors
p49825
(dp49826
sVDrugs that are Mainly Renally Excreted
p49827
g43982
sVGynecological Antiinfectives and Antiseptics
p49828
(dp49829
sVUGT1A1 Substrates
p49830
g12272
sVAmides
p49831
g44347
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p49832
g29447
sVSulfur Compounds
p49833
(dp49834
sVSulfones
p49835
(dp49836
sVQTc Prolonging Agents
p49837
(dp49838
sVSulfonamides
p49839
(dp49840
sVDecreased Central Nervous System Disorganized Electrical Activity
p49841
g23472
sVDiuretics
p49842
(dp49843
sVCytochrome P-450 CYP2C19 Substrates
p49844
(dp49845
sVCentral Nervous System Depressants
p49846
(dp49847
sVCardiovascular Agents
p49848
g26652
sVAnticonvulsants
p49849
(dp49850
sVMembrane Transport Modulators
p49851
(dp49852
sVCytochrome P-450 CYP2C19 Inhibitors
p49853
(dp49854
sVCytochrome P-450 CYP3A4 Substrates
p49855
(dp49856
sVCalcium-Regulating Hormones and Agents
p49857
(dp49858
sVCytochrome P-450 CYP3A5 Substrates
p49859
(dp49860
sVGenito Urinary System and Sex Hormones
p49861
(dp49862
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p49863
(dp49864
sVBradycardia-Causing Agents
p49865
(dp49866
sVP-glycoprotein/ABCB1 Inhibitors
p49867
(dp49868
sVNervous System
p49869
(dp49870
ssg5238
(dp49871
VHormone Antagonists
p49872
g24278
sVBSEP/ABCB11 Substrates
p49873
(dp49874
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p49875
(dp49876
sVCytochrome P-450 CYP2C8 Inhibitors
p49877
(dp49878
sVCardiovascular Agents
p49879
g26678
sVMineralocorticoid (Aldosterone) Receptor Antagonists
p49880
g41055
sVSteroids
p49881
(dp49882
sVPregnanes
p49883
(dp49884
sVAgents causing hyperkalemia
p49885
g43640
sVHypotensive Agents
p49886
g34208
sVP-glycoprotein/ABCB1 Inducers
p49887
(dp49888
sVLactones
p49889
(dp49890
sVMineralocorticoid Receptor Antagonists
p49891
g44688
sVPotassium-Sparing Agents
p49892
(dp49893
sVPregnenes
p49894
g28756
sVPotassium-Sparing Diuretics
p49895
(dp49896
sVHormones, Hormone Substitutes, and Hormone Antagonists
p49897
(dp49898
sVCytochrome P-450 Enzyme Inhibitors
p49899
(dp49900
sVNatriuretic Agents
p49901
g40495
sVFused-Ring Compounds
p49902
g14886
sVDiuretics
p49903
(dp49904
ssg5241
(dp49905
g4356
g44701
ssg5244
(dp49906
g2784
g34352
sg696
g18705
sg4017
g42268
sg5832
(dp49907
sg771
g19273
sg387
g15614
sg2427
g31994
sg1140
g22366
sg1899
g28044
sg3132
g36994
sg945
g20884
sg5235
g49822
sg4287
g44370
sg2946
g35804
sg1113
g22167
sg11451
(dp49908
sg8916
(dp49909
sg6303
(dp49910
sg8724
(dp49911
sg6525
(dp49912
sg2910
g35519
ssg5247
(dp49913
VCentral Nervous System Depressants
p49914
(dp49915
sVCytochrome P-450 CYP1A2 Substrates
p49916
g45621
sVHeterocyclic Compounds, Fused-Ring
p49917
(dp49918
sVAnti-Parkinson Drugs
p49919
g16143
sVAntidepressive Agents
p49920
g15569
sVNeurotransmitter Agents
p49921
(dp49922
sVHypotensive Agents
p49923
g34192
sVAnti-Dyskinesia Agents
p49924
(dp49925
sVDopamine Agonists
p49926
(dp49927
sVCentral Nervous System Agents
p49928
(dp49929
sVDopamine Agents
p49930
g14231
sg1572
g25595
sg7281
(dp49931
sVNervous System
p49932
(dp49933
ssg5250
(dp49934
VBSEP/ABCB11 Substrates
p49935
(dp49936
sVAntigout Preparations
p49937
(dp49938
sVAcetic Acid Derivatives and Related Substances
p49939
g28820
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p49940
(dp49941
sVUGT1A1 Substrates
p49942
g12278
sVOAT1/SLC22A6 inhibitors
p49943
(dp49944
sVAnalgesics
p49945
g26487
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p49946
(dp49947
sg5859
(dp49948
sVNon COX-2 selective NSAIDS
p49949
(dp49950
sVCentral Nervous System Agents
p49951
(dp49952
sVOAT1/SLC22A6 Substrates
p49953
(dp49954
sVAntiinflammatory and Antirheumatic Products
p49955
(dp49956
sVOATP1B1/SLCO1B1 Inhibitors
p49957
(dp49958
sVEnzyme Inhibitors
p49959
(dp49960
sVCytochrome P-450 Enzyme Inhibitors
p49961
(dp49962
sVPeripheral Nervous System Agents
p49963
(dp49964
sVIndoles
p49965
(dp49966
sVNonsteroidal Anti-inflammatory Compounds
p49967
(dp49968
sVAnalgesics, Non-Narcotic
p49969
(dp49970
sVMyelosuppressive Agents
p49971
(dp49972
sVNephrotoxic agents
p49973
(dp49974
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p49975
(dp49976
sVCardiac Therapy
p49977
(dp49978
sVUGT2B7 substrates
p49979
g28623
sVTocolytic Agents
p49980
g33148
sVCytochrome P-450 CYP2C9 Substrates
p49981
g29802
sVMusculo-Skeletal System
p49982
g31513
sVTopical Products for Joint and Muscular Pain
p49983
g13933
sVAgents causing hyperkalemia
p49984
g43630
sVCardiovascular Agents
p49985
g26656
sVOAT3/SLC22A8 Substrates
p49986
g13107
sVP-glycoprotein/ABCB1 Substrates
p49987
g35056
sVUGT1A1 Inhibitors
p49988
(dp49989
sVOther Nonsteroidal Antiimflammatory Agents
p49990
(dp49991
sVSensory Organs
p49992
g40739
sVAgents that produce hypertension
p49993
(dp49994
sVCytochrome P-450 CYP2C19 Inhibitors
p49995
(dp49996
sVOAT3/SLC22A8 Inhibitors
p49997
(dp49998
sVUGT1A9 Substrates
p49999
g23998
sVHeterocyclic Compounds, Fused-Ring
p50000
(dp50001
sVOphthalmologicals
p50002
g35252
sVImmunosuppressive Agents
p50003
(dp50004
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p50005
(dp50006
sVHypoglycemia-Associated Agents
p50007
g17681
sVAnti-Inflammatory Agents
p50008
(dp50009
sVCyclooxygenase Inhibitors
p50010
g32780
sVP-glycoprotein/ABCB1 Inhibitors
p50011
(dp50012
sVAntirheumatic Agents
p50013
g24212
sVSensory System Agents
p50014
(dp50015
sVAnti-Inflammatory Agents, Non-Steroidal
p50016
(dp50017
ssg5253
(dp50018
g4173
g43401
ssg5256
(dp50019
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p50020
(dp50021
sVCytochrome P-450 CYP3A4 Inhibitors
p50022
(dp50023
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p50024
g47500
sVFatty Acids
p50025
(dp50026
sVValerates
p50027
(dp50028
sVGABA Agents
p50029
g16225
sVAnti-epileptic Agent
p50030
(dp50031
sVCytochrome P-450 CYP3A Substrates
p50032
g45138
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p50033
g46421
sVCentral Nervous System Agents
p50034
(dp50035
sVOAT1/SLC22A6 inhibitors
p50036
(dp50037
sVEnzyme Inhibitors
p50038
(dp50039
sVUGT1A4 substrates
p50040
g41046
sVPsychotropic Drugs
p50041
(dp50042
sVCytochrome P-450 CYP2B6 Substrates
p50043
g33002
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p50044
g43754
sVCytochrome P-450 CYP2C9 Inhibitors
p50045
g18211
sVCytochrome P-450 Enzyme Inhibitors
p50046
(dp50047
sVMethemoglobinemia Associated Agents
p50048
g25558
sVAntimanic Agents
p50049
(dp50050
sVHighest Risk QTc-Prolonging Agents
p50051
g35862
sVMiscellaneous Anticonvulsants
p50052
(dp50053
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p50054
g23097
sVUGT1A3 substrates
p50055
g31819
sVOAT3/SLC22A8 Substrates with Narrow Therapeutic Index
p50056
(dp50057
sVOAT3/SLC22A8 Inhibitors
p50058
(dp50059
sVNeurotransmitter Agents
p50060
(dp50061
sVUGT1A1 Substrates
p50062
g12332
sVPentanoic Acids
p50063
(dp50064
sVHistone Deacetylase Inhibitors
p50065
g40560
sVCytochrome P-450 CYP2C9 Substrates
p50066
g29718
sVQTc Prolonging Agents
p50067
(dp50068
sVFatty Acid Derivatives
p50069
g20670
sVAntineoplastic Agents
p50070
(dp50071
sVUGT1A9 substrates with narrow therapeutic index
p50072
g36538
sVCentral Nervous System Depressants
p50073
(dp50074
sVFatty Acids, Volatile
p50075
(dp50076
sVUGT1A1 substrates with narrow therapeutic index
p50077
g41794
sVAnticonvulsants
p50078
(dp50079
sVCytochrome P-450 CYP1A2 Inhibitors
p50080
g15005
sVCytochrome P-450 CYP2C8 Inhibitors
p50081
(dp50082
sVOAT3/SLC22A8 Substrates
p50083
g13103
sVMood Stabilizer
p50084
(dp50085
sVUGT1A1 Inhibitors
p50086
(dp50087
sVCytochrome P-450 CYP2A6 Substrates
p50088
g35120
sVCytochrome P-450 Enzyme Inducers
p50089
g28193
sVUGT1A3 substrates with narrow therapeutic index
p50090
(dp50091
sVCytochrome P-450 CYP2C19 Inhibitors
p50092
(dp50093
sVCytochrome P-450 CYP2A6 Inducers
p50094
g39427
sVUGT1A6 substrate
p50095
g38513
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p50096
g49329
sVNarrow Therapeutic Index Drugs
p50097
(dp50098
sVUGT1A9 Substrates
p50099
g24024
sVUGT2B7 substrates with narrow therapeutic index
p50100
(dp50101
sVCytochrome P-450 CYP3A5 Substrates
p50102
(dp50103
sVUGT1A6 substrate with narrow therapeutic index
p50104
(dp50105
sVAcids, Acyclic
p50106
g25448
sVCytochrome P-450 CYP3A Inhibitors
p50107
(dp50108
sVUGT2B7 substrates
p50109
g28643
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p50110
(dp50111
sVDecreased Central Nervous System Disorganized Electrical Activity
p50112
g23471
sVNervous System
p50113
(dp50114
sVTranquilizing Agents
p50115
(dp50116
sVLipids
p50117
g14291
ssg5259
(dp50118
g6231
(dp50119
sg8922
(dp50120
sg1863
g27749
sg9192
(dp50121
ssg5262
(dp50122
g9132
(dp50123
sg11550
(dp50124
ssg5265
(dp50125
g6360
(dp50126
ssg5268
(dp50127
VMitosis Modulators
p50128
g33585
sVAntimitotic Agents
p50129
(dp50130
sVAntiviral Agents
p50131
g30456
sVBenzene Derivatives
p50132
(dp50133
sg10701
(dp50134
sVTubulin Modulators
p50135
g33853
sg2244
g30839
sVDermatologicals
p50136
g17207
sVAntineoplastic Agents, Phytogenic
p50137
(dp50138
sVMisc. Skin and Mucous Membrane Agents
p50139
(dp50140
sVDecreased Mitosis
p50141
(dp50142
sg1296
g23461
sVKeratolytic Agents
p50143
(dp50144
sVNaphthalenes
p50145
(dp50146
sVTetrahydronaphthalenes
p50147
g42205
ssg5271
(dp50148
VAmidines
p50149
(dp50150
sVMATE 2 Substrates with a Narrow Therapeutic Index
p50151
g24340
sVMATE 2 Substrates
p50152
g44491
sVMATE 1 Substrates
p50153
g23506
sg8145
(dp50154
sVGuanidines
p50155
(dp50156
sVMATE 1 Substrates with a Narrow Therapeutic Index
p50157
(dp50158
sVMATE substrates
p50159
(dp50160
sVOCT2 Inhibitors
p50161
g42470
sg4812
g47719
sVOAT3/SLC22A8 Inhibitors
p50162
(dp50163
sVOCT1 inhibitors
p50164
(dp50165
ssg5274
(dp50166
g7299
(dp50167
ssg5277
(dp50168
g3267
g37890
ssg5280
(dp50169
g858
g20154
sg11151
(dp50170
sg6171
(dp50171
sg9135
(dp50172
sg28215
g35343
sg11136
(dp50173
sg2466
g32337
sg9528
(dp50174
sg6489
(dp50175
ssg5283
(dp50176
VAmines
p50177
g42670
sVGenito Urinary System and Sex Hormones
p50178
(dp50179
sVGynecological Antiinfectives and Antiseptics
p50180
(dp50181
sVAntifungals for Dermatological Use
p50182
g30074
sVDermatologicals
p50183
g17202
sVAntifungals for Topical Use
p50184
g39229
sVAnti-Infective Agents, Local
p50185
(dp50186
sVMiscellaneous Antifungals
p50187
(dp50188
sVAniline Compounds
p50189
g23424
sVAnti-Infective Agents
p50190
(dp50191
ssg5286
(dp50192
VOsmotic Activity
p50193
g28834
sVOsmotic Laxatives
p50194
(dp50195
sVDrugs for Constipation
p50196
(dp50197
sVCompounds used in a research, industrial, or household setting
p50198
(dp50199
sVElectrolytes
p50200
(dp50201
sVPharmaceutical Vehicles
p50202
(dp50203
sVPharmaceutical Preparations
p50204
(dp50205
sVGastrointestinal Agents
p50206
(dp50207
sVPolymers
p50208
g22232
sVPharmaceutic Aids
p50209
(dp50210
sVSolvents
p50211
g36480
sVSurface-Active Agents
p50212
g48458
sVLaxatives
p50213
g17346
sVBiomedical and Dental Materials
p50214
g44725
sVAlimentary Tract and Metabolism
p50215
g23922
sVEthylene Glycols
p50216
(dp50217
sVGlycols
p50218
(dp50219
sVPolyethylene Glycols
p50220
g22553
sVExcipients
p50221
(dp50222
sVPegylated agents
p50223
g13561
sVStimulation Large Intestine Fluid/Electrolyte Secretion
p50224
(dp50225
sVDrug Delivery Systems
p50226
(dp50227
sVP-glycoprotein/ABCB1 Inhibitors
p50228
(dp50229
sVMacromolecular Substances
p50230
g33841
sVAlcohols
p50231
(dp50232
ssg5289
(dp50233
VBSEP/ABCB11 Substrates
p50234
(dp50235
sVCytochrome P-450 CYP3A4 Inhibitors
p50236
(dp50237
sVAdrenergic alpha-1 Receptor Antagonists
p50238
g14143
sVCytochrome P-450 CYP2D6 Inhibitors
p50239
(dp50240
sVAntiarrhythmic agents
p50241
(dp50242
sVCytochrome P-450 CYP3A Substrates
p50243
g45164
sVAgents causing hyperkalemia
p50244
g43647
sVHypotensive Agents
p50245
g34214
sVBCRP/ABCG2 Inhibitors
p50246
g12529
sVCalcium Channel Blockers
p50247
g41308
sVPotential QTc-Prolonging Agents
p50248
(dp50249
sVAdrenergic Antagonists
p50250
(dp50251
sVCytochrome P-450 CYP2B6 Substrates
p50252
g33036
sVCytochrome P-450 CYP2C9 Inhibitors
p50253
g18256
sVACE Inhibitors and Calcium Channel Blockers
p50254
(dp50255
sVCytochrome P-450 Enzyme Inhibitors
p50256
(dp50257
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p50258
g18429
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p50259
(dp50260
sg4851
g47869
sVDrugs that are Mainly Renally Excreted
p50261
g44057
sVCytochrome P-450 CYP2C8 Substrates
p50262
(dp50263
sVCytochrome P-450 CYP1A2 Substrates
p50264
g45622
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p50265
g23107
sVAmines
p50266
g42746
sVCytochrome P-450 CYP2B6 Inducers
p50267
g39132
sg3687
g40249
sVMembrane Transport Modulators
p50268
(dp50269
sVPhenethylamines
p50270
(dp50271
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p50272
g29456
sVAdrenergic alpha-Antagonists
p50273
(dp50274
sVCytochrome P-450 CYP2C9 Substrates
p50275
g29819
sVQTc Prolonging Agents
p50276
(dp50277
sVOCT1 inhibitors
p50278
(dp50279
sVCytochrome P450 3A4 Inhibitors
p50280
g13052
sVCardiovascular Agents
p50281
g26688
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p50282
(dp50283
sVOCT1 substrates
p50284
g13065
sVCytochrome P450 3A Inhibitors
p50285
(dp50286
sVCytochrome P-450 CYP2C8 Inhibitors
p50287
(dp50288
sVP-glycoprotein/ABCB1 Inducers
p50289
(dp50290
sVP-glycoprotein/ABCB1 Substrates
p50291
g35067
sVVasodilating Agents
p50292
g23691
sVCytochrome P-450 Enzyme Inducers
p50293
g28242
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p50294
(dp50295
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p50296
g44552
sVBSEP/ABCB11 Inhibitors
p50297
(dp50298
sVCalcium Channel Blockers (Nondihydropyridine)
p50299
(dp50300
sVCytochrome P-450 CYP3A4 Substrates
p50301
(dp50302
sVMiscellaneous Calcium-channel Blocking Agents
p50303
(dp50304
sVCalcium-Regulating Hormones and Agents
p50305
(dp50306
sVCytochrome P-450 CYP3A5 Substrates
p50307
(dp50308
sVSelective Calcium Channel Blockers With Direct Cardiac Effects
p50309
g24885
sVCytochrome P-450 CYP3A7 Inhibitors
p50310
(dp50311
sVCytochrome P-450 CYP3A Inhibitors
p50312
(dp50313
sg738
g19145
sVBradycardia-Causing Agents
p50314
(dp50315
sVEthylamines
p50316
g20605
sVOATP1B1/SLCO1B1 Inhibitors
p50317
(dp50318
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p50319
g30486
sVP-glycoprotein/ABCB1 Inhibitors
p50320
(dp50321
sVCytochrome P-450 CYP3A7 Substrates
p50322
(dp50323
sVCytochrome P-450 CYP3A5 Inhibitors
p50324
(dp50325
ssg5292
(dp50326
g8583
(dp50327
sg11268
(dp50328
ssg5295
(dp50329
VAntiinfectives for Systemic Use
p50330
(dp50331
sVTopoisomerase Inhibitors
p50332
g32860
sVQuinolones
p50333
g23989
sVTopoisomerase II Inhibitors
p50334
g40640
sVHeterocyclic Compounds, Fused-Ring
p50335
(dp50336
sVOphthalmologicals
p50337
g35240
sVCytochrome P-450 CYP1A2 Inhibitors
p50338
g15015
sVQTc Prolonging Agents
p50339
(dp50340
sVFluoroquinolones
p50341
(dp50342
sVQuinolone Antimicrobial
p50343
(dp50344
sVEnzyme Inhibitors
p50345
(dp50346
sVQuinolines
p50347
(dp50348
sVSensory Organs
p50349
g40730
sVAnti-Bacterial Agents
p50350
g38372
sVAntibacterials for Systemic Use
p50351
g32569
sVCytochrome P-450 Enzyme Inhibitors
p50352
(dp50353
sVAnti-Infective Agents
p50354
(dp50355
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p50356
g27743
sVModerate Risk QTc-Prolonging Agents
p50357
(dp50358
ssg5298
(dp50359
g2736
g33955
sg11781
(dp50360
sg4725
g47149
ssg5301
(dp50361
g465
g16472
sg6261
(dp50362
sg1605
g25757
sg11319
(dp50363
sg5487
(dp50364
sg3363
g38416
sg2067
g29640
sg612
g17875
sg11445
(dp50365
ssg5304
(dp50366
g2895
g35437
ssg5307
(dp50367
g2901
g35476
ssg5310
(dp50368
g6885
(dp50369
ssg5313
(dp50370
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p50371
(dp50372
sVBSEP/ABCB11 Substrates
p50373
(dp50374
sVCytochrome P-450 CYP3A4 Inhibitors
p50375
(dp50376
sVOAT1/SLC22A6 inhibitors
p50377
(dp50378
sVCytochrome P-450 CYP3A Substrates
p50379
g45160
sVHypoglycemia-Associated Agents
p50380
g17699
sVSulfonylurea Compounds
p50381
(dp50382
sVCytochrome P-450 CYP2C9 Inhibitors
p50383
g18247
sg8286
(dp50384
sVBlood Glucose Lowering Agents
p50385
(dp50386
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p50387
(dp50388
sVUrea
p50389
(dp50390
sVCytochrome P-450 Enzyme Inhibitors
p50391
(dp50392
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p50393
g29451
sVSulfur Compounds
p50394
(dp50395
sVOral Hypoglycemics
p50396
g36001
sVSulfones
p50397
(dp50398
sVDrugs Used in Diabetes
p50399
(dp50400
sVSulfonylureas
p50401
(dp50402
sVCytochrome P-450 CYP2C9 Substrates
p50403
g29814
sVBSEP/ABCB11 Inhibitors
p50404
(dp50405
sVCytochrome P-450 CYP3A4 Substrates
p50406
(dp50407
sVAlimentary Tract and Metabolism
p50408
g23828
sVCytochrome P-450 CYP3A Inhibitors
p50409
(dp50410
sVBCRP/ABCG2 Substrates
p50411
g42077
sVP-glycoprotein/ABCB1 Inhibitors
p50412
(dp50413
ssg5316
(dp50414
VAgents Causing Muscle Toxicity
p50415
(dp50416
sVAntiparasitic Products, Insecticides and Repellents
p50417
g30574
sVAgents that produce neuromuscular block (indirect)
p50418
g37971
sVAntimalarials
p50419
g14095
sVQuinolines
p50420
(dp50421
sVCytochrome P-450 CYP2D6 Inhibitors
p50422
(dp50423
sVCytochrome P-450 CYP2D6 Substrates
p50424
(dp50425
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p50426
g41077
sVAnalgesics
p50427
g26494
sVCentral Nervous System Agents
p50428
(dp50429
sVCytochrome P-450 Enzyme Inhibitors
p50430
(dp50431
sVAnti-Infective Agents
p50432
(dp50433
sVPeripheral Nervous System Agents
p50434
(dp50435
sVDrugs that are Mainly Renally Excreted
p50436
g43987
sVCytochrome P-450 CYP2C8 Substrates
p50437
(dp50438
sVAnalgesics, Non-Narcotic
p50439
(dp50440
sVAmebicides
p50441
(dp50442
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p50443
g29452
sVAntiprotozoals
p50444
(dp50445
sVQTc Prolonging Agents
p50446
(dp50447
sVCytochrome P-450 CYP3A Substrates
p50448
g45161
sVAntinematodal Agents
p50449
(dp50450
sVAgents that reduce seizure threshold
p50451
g45856
sVChloroquine
p50452
(dp50453
sVAminoquinolines
p50454
(dp50455
sVP-glycoprotein/ABCB1 Substrates
p50456
g35082
sVAntiparasitic Agents
p50457
g40653
sVFilaricides
p50458
(dp50459
sVHeterocyclic Compounds, Fused-Ring
p50460
(dp50461
sVCytochrome P-450 CYP3A4 Substrates
p50462
(dp50463
sVModerate Risk QTc-Prolonging Agents
p50464
(dp50465
sVCytochrome P-450 CYP3A5 Substrates
p50466
(dp50467
sValpha-Galactosidase, antagonists & inhibitors
p50468
g37626
sVMethemoglobinemia Associated Agents
p50469
g25575
sVAnti-Inflammatory Agents
p50470
(dp50471
sVP-glycoprotein/ABCB1 Inhibitors
p50472
(dp50473
sVAntirheumatic Agents
p50474
g24232
sVSensory System Agents
p50475
(dp50476
ssg5319
(dp50477
g2559
g32964
sg6186
(dp50478
sg11229
(dp50479
sg10017
(dp50480
sg8598
(dp50481
sg5247
g49925
sg11277
(dp50482
sg2583
g33081
sg282
g14564
sg8067
(dp50483
sg3111
g36827
sg3048
g36502
sg11097
(dp50484
sg11931
(dp50485
sg5694
(dp50486
sg3018
g36150
sg9252
(dp50487
sg10854
(dp50488
sg7959
(dp50489
sg3570
g39492
sg6525
(dp50490
sg603
g17770
sg7041
(dp50491
ssg5322
(dp50492
g8373
(dp50493
sg4857
g47886
sg2838
g34800
sg9507
(dp50494
sg2481
g32420
sg8211
(dp50495
sg5295
g50342
sg15016
(dp50496
ssg5325
(dp50497
g1266
g23223
sg9540
(dp50498
ssg5328
(dp50499
g4806
g47679
sg6906
(dp50500
sg3318
g38195
ssg5331
(dp50501
g10179
(dp50502
sg10353
(dp50503
sg8022
(dp50504
sg3105
g36792
sg684
g18509
ssg5334
(dp50505
VPharmaceutical Preparations
p50506
(dp50507
sVPlant Preparations
p50508
(dp50509
sVTerpenes
p50510
(dp50511
sVBasic Lotions and Liniments
p50512
g26934
sg2298
g31230
sVKetones
p50513
(dp50514
sVAntipruritics and Local Anesthetics
p50515
g31874
sVComplex Mixtures
p50516
(dp50517
sVCardiac Therapy
p50518
(dp50519
sg1968
g28765
sVPlant Extracts
p50520
(dp50521
sVBiological Products
p50522
(dp50523
sVAnti-Infective Agents, Local
p50524
(dp50525
sVAnti-Infective Agents
p50526
(dp50527
sVMonoterpenes
p50528
(dp50529
ssg5337
(dp50530
g4437
g45297
sg8787
(dp50531
sg8724
(dp50532
sg8703
(dp50533
ssg5340
(dp50534
g11625
(dp50535
sg8022
(dp50536
sg3105
g36794
ssg5343
(dp50537
g5847
(dp50538
ssg5346
(dp50539
g6336
(dp50540
sg11475
(dp50541
sg2850
g35094
ssg5349
(dp50542
g6999
(dp50543
sg6102
(dp50544
sg3849
g41176
ssg5352
(dp50545
g1782
g27162
sg8097
(dp50546
sg3531
g39282
sg8514
(dp50547
sg2403
g31856
sg30
g12396
sg444
g16265
sg4014
g42239
sg16906
(dp50548
sg8595
(dp50549
sg11604
(dp50550
sg10470
(dp50551
sg9918
(dp50552
sg12000
(dp50553
sg1461
g24844
sg10596
(dp50554
sg282
g14580
sg5865
(dp50555
sg7470
(dp50556
sg11079
(dp50557
sg11460
(dp50558
sg888
g20497
sg11196
(dp50559
sg7485
(dp50560
sg2427
g32057
sg8820
(dp50561
sg1683
g26401
sg7335
(dp50562
sg3981
g42042
sg915
g20726
sg3174
g37276
sg9417
(dp50563
sg11301
(dp50564
sg10728
(dp50565
sg11595
(dp50566
sg2829
g34656
sg3381
g38490
sg8421
(dp50567
sg6726
(dp50568
sg3027
g36377
sg6102
(dp50569
sg3963
g41891
sg7941
(dp50570
sg3399
g38649
sg9981
(dp50571
sg9261
(dp50572
sg2739
g34023
sg8028
(dp50573
sg3207
g37496
sg11979
(dp50574
sg7662
(dp50575
sg9273
(dp50576
sg4155
g43247
sg9819
(dp50577
sg9822
(dp50578
sg5169
g49538
sg11910
(dp50579
sg9657
(dp50580
sg11184
(dp50581
sg4911
g48272
sg3627
g39945
sg183
g13848
sg10878
(dp50582
sg5256
g50098
sg1761
g27008
sg9096
(dp50583
sg11934
(dp50584
sg9102
(dp50585
sg10056
(dp50586
sg387
g15675
sg1611
g25826
ssg5355
(dp50587
g3447
g38971
sg7464
(dp50588
sg10818
(dp50589
sg4635
g46522
sg7569
(dp50590
sg1491
g25122
sg138
g13299
ssg5358
(dp50591
g7458
(dp50592
sg3858
g41244
sg6699
(dp50593
sg4077
g42845
sg9081
(dp50594
sg4491
g45806
sg8928
(dp50595
sg6537
(dp50596
sg6033
(dp50597
sg7809
(dp50598
ssg5361
(dp50599
g7191
(dp50600
ssg5364
(dp50601
VCytochrome P-450 CYP2C8 Inhibitors (strong)
p50602
g46325
sVImmunosuppressive Agents
p50603
(dp50604
sVCytochrome P-450 CYP3A Substrates
p50605
g45165
sVHyperglycemia-Associated Agents
p50606
(dp50607
sVCytochrome P-450 CYP2C8 Substrates
p50608
(dp50609
sVCorticosteroids, Dermatological Preparations
p50610
(dp50611
sVGlucocorticoids
p50612
g21929
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p50613
g29457
sVFused-Ring Compounds
p50614
g14890
sVCytochrome P-450 CYP3A4 Inducers
p50615
g18981
sVCytochrome P-450 CYP3A5 Inducers
p50616
g41755
sVAdrenal Cortex Hormones
p50617
g30053
sVCytochrome P-450 CYP2C8 Inhibitors
p50618
(dp50619
sVAdrenals
p50620
g37376
sVPregnadienes
p50621
(dp50622
sVDermatologicals
p50623
g17327
sVCytochrome P-450 Enzyme Inducers
p50624
g28244
sVCytochrome P-450 CYP3A Inducers
p50625
(dp50626
sVCytochrome P-450 CYP3A4 Substrates
p50627
(dp50628
sVSteroids
p50629
(dp50630
sVAnti-Allergic Agents
p50631
(dp50632
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p50633
(dp50634
sVAnti-Inflammatory Agents
p50635
(dp50636
sVCorticosteroids
p50637
(dp50638
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p50639
(dp50640
ssg5367
(dp50641
g4620
g46355
sg11955
(dp50642
sg11793
(dp50643
sg9879
(dp50644
sg6012
(dp50645
sg8394
(dp50646
sg1800
g27343
sg1452
g24750
sg7275
(dp50647
sg4476
g45656
sg4440
g45323
sg3975
g41927
sg9966
(dp50648
sg3732
g40512
sg2841
g34861
sg5928
(dp50649
sg9393
(dp50650
sg3219
g37533
sg2733
g33909
sg3147
g37146
sg5364
g50632
sg6729
(dp50651
sg1188
g22787
sg1464
g24868
sg10815
(dp50652
sg7029
(dp50653
sg9684
(dp50654
ssg5370
(dp50655
VCytochrome P-450 CYP3A4 Inhibitors
p50656
(dp50657
sg4617
g46319
sg2562
g32992
sVAnti-Asthmatic Agents
p50658
g36531
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p50659
g43792
sVCytochrome P-450 CYP2C9 Inhibitors
p50660
g18234
sVCytochrome P-450 Enzyme Inhibitors
p50661
(dp50662
sVDrugs for Obstructive Airway Diseases
p50663
g42525
sVCytochrome P-450 CYP2C8 Substrates
p50664
(dp50665
sVCytochrome P-450 CYP2E1 Inhibitors
p50666
g46846
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p50667
(dp50668
sVRespiratory System Agents
p50669
(dp50670
sVSulfur Compounds
p50671
(dp50672
sg9213
(dp50673
sg7695
(dp50674
sVToluene
p50675
(dp50676
sVSulfones
p50677
(dp50678
sVBenzene Derivatives
p50679
(dp50680
sVCytochrome P-450 CYP1A2 Inhibitors
p50681
g15045
sVCytochrome P-450 CYP2C8 Inhibitors
p50682
(dp50683
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p50684
g44520
sg7536
(dp50685
sVCytochrome P-450 CYP2C9 Substrates
p50686
g29822
sVCytochrome P-450 CYP2C19 Inhibitors
p50687
(dp50688
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p50689
g49345
sVHormone Antagonists
p50690
g24284
sg2502
g32646
sVCytochrome P-450 CYP3A Inhibitors
p50691
(dp50692
sg7998
(dp50693
sVHormones, Hormone Substitutes, and Hormone Antagonists
p50694
(dp50695
ssg5373
(dp50696
g9525
(dp50697
sg11595
(dp50698
sg4035
g42419
sg10596
(dp50699
sg11241
(dp50700
sg5133
g49306
sg915
g20739
ssg5376
(dp50701
g3261
g37838
sg9249
(dp50702
ssg5379
(dp50703
g10533
(dp50704
sg2013
g28937
sg3732
g40519
sg9465
(dp50705
ssg5382
(dp50706
VAmino Acids, Peptides, and Proteins
p50707
g47378
sVHematologic Agents
p50708
(dp50709
sVBlood and Blood Forming Organs
p50710
(dp50711
sVPeptides
p50712
g47215
sVErythropoietin
p50713
(dp50714
sVColony-Stimulating Factors
p50715
g47976
sVHematopoietic Cell Growth Factors
p50716
(dp50717
sVHematinics
p50718
(dp50719
sVCarbohydrates
p50720
(dp50721
sVProteins
p50722
(dp50723
sVIntercellular Signaling Peptides and Proteins
p50724
g25420
sVIncreased Erythroid Cell Production
p50725
(dp50726
sVErythropoiesis-Stimulating Agents
p50727
g13887
sVBiological Factors
p50728
g38104
sVGlycoconjugates
p50729
(dp50730
sVAntianemic Preparations
p50731
(dp50732
sVGlycoproteins
p50733
(dp50734
sVCytokines
p50735
(dp50736
sVErythropoietin, genetics
p50737
(dp50738
ssg5385
(dp50739
g11283
(dp50740
sg6186
(dp50741
sg11652
(dp50742
sg19588
g32515
sg5427
(dp50743
sg2664
g33479
sg6318
(dp50744
sg4647
g46592
sg9918
(dp50745
sg3885
g41466
sg11445
(dp50746
sg6819
(dp50747
sg8433
(dp50748
sg5499
(dp50749
sg2427
g32076
sg10713
(dp50750
sg9264
(dp50751
sg6303
(dp50752
sg10497
(dp50753
sg10815
(dp50754
sg210
g14017
sg7041
(dp50755
sg8580
(dp50756
sg1803
g27405
sg4035
g42456
sg10857
(dp50757
sg255
g14420
sg2262
g30984
sg1626
g25960
sg9099
(dp50758
sg11649
(dp50759
sg4623
g46407
sg11667
(dp50760
sg9402
(dp50761
sg7896
(dp50762
sg8655
(dp50763
sg9417
(dp50764
sg345
g15248
sg7941
(dp50765
sg7152
(dp50766
sg7959
(dp50767
sg14791
(dp50768
sg7176
(dp50769
sg5598
(dp50770
sg387
g15690
sg3444
g38892
sg9828
(dp50771
sg5796
(dp50772
sg1908
g28330
sg11022
(dp50773
sg9924
(dp50774
sg11793
(dp50775
sg6570
(dp50776
sg168
g13677
sg1947
g28704
sg1260
g23171
sg495
g16710
sg2067
g29672
sg11097
(dp50777
sg10350
(dp50778
sg7389
(dp50779
sg534
g17002
sg6639
(dp50780
sg10593
(dp50781
sg2841
g34850
sg7320
(dp50782
sg3036
g36461
sg696
g18788
sg23
g12249
sg11439
(dp50783
sg570
g17501
sg6678
(dp50784
sg6687
(dp50785
sg5169
g49551
sg11910
(dp50786
sg3363
g38431
sg1635
g26069
sg612
g17913
sg8097
(dp50787
sg630
g18054
sg8163
(dp50788
sg11979
(dp50789
sg8964
(dp50790
sg11265
(dp50791
sg11277
(dp50792
sg3684
g40243
sg687
g18583
sg4488
g45783
sg3975
g41940
sg714
g19033
sg10515
(dp50793
sg10521
(dp50794
sg8277
(dp50795
sg723
g19093
sg11319
(dp50796
sg11790
(dp50797
sg8778
(dp50798
sg2289
g31206
sg9393
(dp50799
sg5793
(dp50800
sg9093
(dp50801
sg1605
g25776
ssg5388
(dp50802
g9357
(dp50803
sg4680
g46906
sg1470
g24938
sg3861
g41298
sg5433
(dp50804
sg11940
(dp50805
sg12274
g27577
sg2286
g31175
sg816
g19697
sg8013
(dp50806
ssg5391
(dp50807
g7029
(dp50808
sg3975
g41942
ssg5394
(dp50809
VSalicylic Acid and Derivatives
p50810
g36810
sVOAT1/SLC22A6 inhibitors
p50811
(dp50812
sVAnalgesics
p50813
g26503
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p50814
(dp50815
sVHydroxy Acids
p50816
g18171
sVNon COX-2 selective NSAIDS
p50817
(dp50818
sVCentral Nervous System Agents
p50819
(dp50820
sVEnzyme Inhibitors
p50821
(dp50822
sVPeripheral Nervous System Agents
p50823
(dp50824
sVDrugs that are Mainly Renally Excreted
p50825
g43921
sVSalicylates
p50826
g27621
sVNonsteroidal Anti-inflammatory Compounds
p50827
(dp50828
sVAnalgesics, Non-Narcotic
p50829
(dp50830
sVNephrotoxic agents
p50831
(dp50832
sVAcids, Carbocyclic
p50833
g41583
sVHydroxybenzoates
p50834
(dp50835
sVAgents causing hyperkalemia
p50836
g43642
sVPhenols
p50837
(dp50838
sVBenzene Derivatives
p50839
(dp50840
sVOther Nonsteroidal Antiimflammatory Agents
p50841
(dp50842
sVAgents that produce hypertension
p50843
(dp50844
sVUGT1A9 Inhibitors
p50845
(dp50846
sVBenzoates
p50847
g30403
sVAnti-Inflammatory Agents
p50848
(dp50849
sVCyclooxygenase Inhibitors
p50850
g32797
sVAntirheumatic Agents
p50851
g24252
sVSensory System Agents
p50852
(dp50853
sVAnti-Inflammatory Agents, Non-Steroidal
p50854
(dp50855
sVNervous System
p50856
(dp50857
ssg5397
(dp50858
g3291
g38012
ssg5400
(dp50859
VAmino Acids, Peptides, and Proteins
p50860
g47421
sVBlood Coagulation Factors
p50861
(dp50862
sVHematologic Agents
p50863
(dp50864
sVBlood and Blood Forming Organs
p50865
(dp50866
sVHemostatics
p50867
g23070
sVProteins
p50868
(dp50869
sVReversed Anticoagulation Activity
p50870
(dp50871
sVBiological Factors
p50872
g38127
sVBlood Proteins
p50873
g39879
sVCoagulants
p50874
(dp50875
ssg5403
(dp50876
g4911
g48278
ssg5406
(dp50877
g10479
(dp50878
sg10611
(dp50879
sg6183
(dp50880
ssg5409
(dp50881
g2916
g35595
sg7224
(dp50882
sg4932
g48439
sg4041
g42496
sVPituitary Hormones, Anterior
p50883
g24143
sVHormones
p50884
(dp50885
sg7851
(dp50886
sVPeptide Hormones
p50887
g20199
sVAnterior Pituitary Lobe Hormones and Analogues
p50888
(dp50889
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p50890
(dp50891
sVCytochrome P-450 CYP3A4 Inducers
p50892
g18868
sVPeptides
p50893
g47159
sVCytochrome P-450 Enzyme Inducers
p50894
g28105
sVCytochrome P-450 CYP3A Inducers
p50895
(dp50896
sVAmino Acids, Peptides, and Proteins
p50897
g47307
sVPegylated agents
p50898
g13554
sVPituitary and Hypothalamic Hormones and Analogues
p50899
(dp50900
sg6846
(dp50901
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p50902
(dp50903
sVHypoglycemia-Associated Agents
p50904
g17670
sVCholinesterase Inhibitors
p50905
(dp50906
sg3372
g38443
sVHormones, Hormone Substitutes, and Hormone Antagonists
p50907
(dp50908
sVPituitary Hormones
p50909
g15913
ssg5412
(dp50910
g11301
(dp50911
sg11934
(dp50912
ssg5415
(dp50913
VAgents that produce neuromuscular block (indirect)
p50914
g37953
sVGastric Acid Lowering Agents
p50915
(dp50916
sVOsmotic Laxatives
p50917
(dp50918
sg6747
(dp50919
sg4032
g42398
sVMagnesium Compounds
p50920
g33046
sVCalculi Dissolution Agent
p50921
g12686
sg2022
g28971
sVMetal divalent cations
p50922
(dp50923
sg5415
(dp50924
sVDrugs that are Mainly Renally Excreted
p50925
g43995
sVElectrolytes
p50926
(dp50927
sVMagnesium Salts
p50928
(dp50929
sVBasic Ointments and Protectants
p50930
g41762
sg720
g19064
sg7122
(dp50931
sVLaxatives
p50932
g17335
sVUrologicals
p50933
(dp50934
sVAlimentary Tract and Metabolism
p50935
g23751
sVIons
p50936
g49109
sVGastrointestinal Agents
p50937
(dp50938
sVGenito Urinary System and Sex Hormones
p50939
(dp50940
sg1752
g26962
sVDrugs for Acid Related Disorders
p50941
(dp50942
sVAnions
p50943
(dp50944
sVMetal cations
p50945
g40801
sVLaxatives, magnesium containing
p50946
(dp50947
ssg5418
(dp50948
g8019
(dp50949
sg4425
g44905
sg9519
(dp50950
sg8916
(dp50951
sg4803
g47613
sg5250
g49941
sg7650
(dp50952
sg10011
(dp50953
sg4260
g44089
sg1914
g28388
sg8241
(dp50954
sg7671
(dp50955
sg10977
(dp50956
sg2088
g29914
sg10740
(dp50957
sg9702
(dp50958
sg4716
g47045
sg2109
g30087
sg6474
(dp50959
sg3408
g38671
sg72
g12777
sg963
g20962
sg3279
g37913
sg4974
g48597
sg5181
g49562
sg336
g15058
sg4788
g47547
sg6162
(dp50960
ssg5421
(dp50961
g8655
(dp50962
sg6468
(dp50963
sg11283
(dp50964
sg345
g15224
ssg5424
(dp50965
g11820
(dp50966
sg3570
g39450
sg465
g16437
sg5805
(dp50967
sg10011
(dp50968
sg4926
g48376
sg1707
g26748
sg11805
(dp50969
sg5934
(dp50970
sg603
g17768
sg7641
(dp50971
sg1434
g24619
sg5694
(dp50972
sg9765
(dp50973
sg5334
g50514
ssg5427
(dp50974
VOxazines
p50975
(dp50976
sVAdrenergic beta-Agonists
p50977
g42999
sVAdrenergic beta-2 Receptor Agonists
p50978
(dp50979
sVHeterocyclic Compounds, Fused-Ring
p50980
(dp50981
sVAutonomic Agents
p50982
(dp50983
sVCytochrome P-450 CYP2C8 Substrates
p50984
(dp50985
sVBronchodilator Agents
p50986
(dp50987
sVAgents to Treat Airway Disease
p50988
g32634
sVDrugs for Obstructive Airway Diseases
p50989
g42503
sVPotential QTc-Prolonging Agents
p50990
(dp50991
sVRespiratory System Agents
p50992
(dp50993
sVSelective Beta 2-adrenergic Agonists
p50994
(dp50995
sVPeripheral Nervous System Agents
p50996
(dp50997
sVAdrenergic Agonists
p50998
(dp50999
sVAgents producing tachycardia
p51000
g50743
sVAgents that produce hypertension
p51001
(dp51002
sVAnti-Asthmatic Agents
p51003
g36513
sVAdrenergic beta-1 Receptor Agonists
p51004
(dp51005
sVQTc Prolonging Agents
p51006
(dp51007
sVCytochrome P-450 CYP2C9 Substrates
p51008
g29707
sVAdrenergics, Inhalants
p51009
g43169
ssg5430
(dp51010
g9588
(dp51011
ssg5433
(dp51012
VSteroids
p51013
(dp51014
sVSex Hormones and Modulators of the Genital System
p51015
g19598
sVEstradiol Congeners
p51016
g49770
sg1998
g28844
sVUGT1A1 Substrates
p51017
g12269
sVBCRP/ABCG2 Inducers
p51018
g24521
sVCytochrome P-450 CYP3A Substrates
p51019
g45172
sg8223
(dp51020
sVProgestogens and Estrogens, Sequential Preparations
p51021
(dp51022
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p51023
(dp51024
sVOCT2 Inhibitors
p51025
g42465
sVOATP1B1/SLCO1B1 Inhibitors
p51026
(dp51027
sVEstradiol
p51028
g27532
sVHormones
p51029
(dp51030
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p51031
g49323
sVAntiandrogens and Estrogens
p51032
g35851
sVCytochrome P-450 Enzyme Inhibitors
p51033
(dp51034
sVHormonal Contraceptives for Systemic Use
p51035
(dp51036
sVDrugs that are Mainly Renally Excreted
p51037
g43996
sVCytochrome P-450 CYP2C8 Substrates
p51038
(dp51039
sVContraceptive Agents, Female
p51040
(dp51041
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51042
g29467
sVContraceptives, Oral
p51043
(dp51044
sVCytochrome P-450 CYP2C9 Substrates
p51045
g29709
sVFused-Ring Compounds
p51046
g14826
sVHyperglycemia-Associated Agents
p51047
(dp51048
sVCytochrome P-450 CYP3A4 Inducers
p51049
g18873
sVOCT1 inhibitors
p51050
(dp51051
sVAdrenal Cortex Hormones
p51052
g30008
sVBCRP/ABCG2 Inhibitors
p51053
g12510
sVCytochrome P-450 CYP1A2 Inhibitors
p51054
g14993
sVOAT3/SLC22A8 Substrates
p51055
g13104
sVP-glycoprotein/ABCB1 Substrates
p51056
g34909
sg4524
g45987
sVCytochrome P-450 CYP1A2 Substrates
p51057
g45566
sVCytochrome P-450 Enzyme Inducers
p51058
g28111
sVCytochrome P-450 CYP3A Inducers
p51059
(dp51060
sVCytochrome P-450 CYP2C19 Inhibitors
p51061
(dp51062
sVCytochrome P-450 CYP3A4 Substrates
p51063
(dp51064
sg6672
(dp51065
sVGonadal Hormones
p51066
g33577
sVCytochrome P-450 CYP3A5 Substrates
p51067
(dp51068
sVGenito Urinary System and Sex Hormones
p51069
(dp51070
sVGonadal Steroid Hormones
p51071
(dp51072
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p51073
(dp51074
sg4080
g42858
sVEstranes
p51075
g50804
sVHormones, Hormone Substitutes, and Hormone Antagonists
p51076
(dp51077
sVEstrenes
p51078
(dp51079
sg1773
g27081
sVEstrogens
p51080
g49714
sVCytochrome P-450 CYP3A7 Substrates
p51081
(dp51082
ssg5436
(dp51083
g8457
(dp51084
sg10629
(dp51085
sg5619
(dp51086
sg12114
(dp51087
sg2094
g29983
sg7884
(dp51088
sg3867
g41333
sg3426
g38773
sg11052
(dp51089
sg10149
(dp51090
sg11451
(dp51091
sg9198
(dp51092
sg3132
g37022
sg339
g15149
sg9954
(dp51093
sg1683
g26393
sg8454
(dp51094
sg4752
g47295
sg7962
(dp51095
sg12060
(dp51096
sg9432
(dp51097
sg6435
(dp51098
sg2172
g30502
sg9783
(dp51099
sg7947
(dp51100
sg10416
(dp51101
sg573
g17566
sg11166
(dp51102
sg10581
(dp51103
sg8226
(dp51104
sg10047
(dp51105
sg5199
g49684
sg819
g19777
sg213
g14049
ssg5439
(dp51106
g1635
g26026
sg11319
(dp51107
sg11649
(dp51108
sg2067
g29621
sg4488
g45744
sg4647
g46563
sg255
g14366
sg612
g17850
sg11445
(dp51109
sg5598
(dp51110
ssg5442
(dp51111
g1581
g25678
sg5400
g50871
ssg5445
(dp51112
g11631
(dp51113
ssg5448
(dp51114
VCompounds used in a research, industrial, or household setting
p51115
(dp51116
sVStomatological Preparations
p51117
(dp51118
sVAlimentary Tract and Metabolism
p51119
g23759
sVCaries Prophylactic Agents
p51120
(dp51121
ssg5451
(dp51122
g11832
(dp51123
sg7530
(dp51124
sg7920
(dp51125
sg9660
(dp51126
sg4557
g46144
sg8649
(dp51127
ssg5454
(dp51128
VBSEP/ABCB11 Substrates
p51129
(dp51130
sVCytochrome P-450 CYP3A4 Inhibitors
p51131
(dp51132
sVCytochrome P-450 CYP2D6 Inhibitors
p51133
(dp51134
sVSecologanin Tryptamine Alkaloids
p51135
(dp51136
sVCytochrome P-450 CYP3A Substrates
p51137
g45175
sVOATP1B1/SLCO1B1 Inhibitors
p51138
(dp51139
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p51140
g43731
sVCytochrome P-450 Enzyme Inhibitors
p51141
(dp51142
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p51143
g18393
sVAntimitotic Agents
p51144
(dp51145
sVP-glycoprotein/ABCB1 Inducers
p51146
(dp51147
sVMyelosuppressive Agents
p51148
(dp51149
sVTubulin Modulators
p51150
g33858
sVAntineoplastic Agents, Phytogenic
p51151
(dp51152
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51153
g29471
sVVinca Alkaloids
p51154
g13057
sVCytochrome P-450 CYP3A4 Inducers
p51155
g18878
sVAntineoplastic Agents
p51156
(dp51157
sVIndoles
p51158
(dp51159
sVP-glycoprotein/ABCB1 Substrates
p51160
g34934
sVCytochrome P-450 Enzyme Inducers
p51161
g28116
sVCytochrome P-450 CYP3A Inducers
p51162
(dp51163
sVBSEP/ABCB11 Inhibitors
p51164
(dp51165
sVCytochrome P-450 CYP3A4 Substrates
p51166
(dp51167
sVMitosis Modulators
p51168
g33590
sVCardiotoxic antineoplastic agents
p51169
(dp51170
sVHeterocyclic Compounds, Fused-Ring
p51171
(dp51172
sVCytochrome P-450 CYP3A Inhibitors
p51173
(dp51174
sVImmunosuppressive Agents
p51175
(dp51176
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p51177
(dp51178
sVP-glycoprotein/ABCB1 Inhibitors
p51179
(dp51180
sVAntineoplastic and Immunomodulating Agents
p51181
g39728
sVAlkaloids
p51182
g19402
sVIndole Alkaloids
p51183
(dp51184
ssg5457
(dp51185
VUrinary Alkalinisers
p51186
(dp51187
sVMineral Supplements
p51188
g38306
sVCardiovascular Agents
p51189
g26528
sVReplacement Preparations
p51190
g27640
sVAcids, Acyclic
p51191
g25445
sVAnticoagulants
p51192
(dp51193
sVPotassium
p51194
g16725
sVAgents causing hyperkalemia
p51195
g43592
sVRespiratory System Agents
p51196
(dp51197
sg8733
(dp51198
sVCitric Acid
p51199
g46553
sVPotassium Salt
p51200
g30481
sVTricarboxylic Acids
p51201
(dp51202
sVCitrates
p51203
g17793
sVExpectorants
p51204
g49257
sVCitric Acid Derivatives
p51205
(dp51206
sVCalculi Dissolution Agent
p51207
g12692
sg504
g16751
sVNatriuretic Agents
p51208
g40490
sVAlimentary Tract and Metabolism
p51209
g23757
sVDiuretics
p51210
(dp51211
ssg5460
(dp51212
VOphthalmologicals
p51213
g35219
sVCytochrome P-450 CYP3A Substrates
p51214
g45176
sVOphthalmics
p51215
(dp51216
sVDiuretics
p51217
(dp51218
sVAmides
p51219
g44316
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51220
g29472
sVSensory Organs
p51221
g40711
sVEnzyme Inhibitors
p51222
(dp51223
sVSulfones
p51224
(dp51225
sVCytochrome P-450 CYP3A4 Substrates
p51226
(dp51227
sVCarbonic Anhydrase Inhibitors
p51228
(dp51229
sVSulfur Compounds
p51230
(dp51231
sVAntiglaucoma Preparations and Miotics
p51232
g36550
ssg5463
(dp51233
VGastrointestinal Hormones
p51234
g40980
sVPeptide Hormones
p51235
g20200
sVSerum Globulins
p51236
g49643
sVGLP-1 Agonists
p51237
(dp51238
sVImmunoglobulin Fragments
p51239
g21347
sVHormones
p51240
(dp51241
sVPeptide Fragments
p51242
(dp51243
sVBlood Glucose Lowering Agents
p51244
(dp51245
sVIncretin Mimetics
p51246
g16681
sVImmunoglobulins
p51247
g41510
sVPancreatic Hormones
p51248
(dp51249
sVDrugs Used in Diabetes
p51250
(dp51251
sVRecombinant Proteins
p51252
(dp51253
sVGlucagon-like Peptide-1 (GLP-1) Agonists
p51254
g44479
sVProteins
p51255
(dp51256
sVHormones, Hormone Substitutes, and Hormone Antagonists
p51257
(dp51258
sVPeptides
p51259
g47184
sVGlobulins
p51260
g19161
sVImmunoglobulin Constant Regions
p51261
(dp51262
sVAlimentary Tract and Metabolism
p51263
g23856
sVAmino Acids, Peptides, and Proteins
p51264
g47365
sVGlucagon-like peptide-1 (GLP-1) analogues
p51265
(dp51266
sVProtein Precursors
p51267
(dp51268
sVProglucagon
p51269
g47542
sVBlood Proteins
p51270
g39839
sVImmunoproteins
p51271
(dp51272
ssg5466
(dp51273
g645
g18126
sg1629
g25983
sg4737
g47224
sg10296
(dp51274
ssg5469
(dp51275
VBSEP/ABCB11 Substrates
p51276
(dp51277
sg6363
(dp51278
sVBSEP/ABCB11 inducers
p51279
(dp51280
sg1821
g27588
sVCytochrome P-450 Enzyme Inhibitors
p51281
(dp51282
sVCytochrome P-450 CYP2E1 Inducers
p51283
g27605
sg3135
g37034
sVCytochrome P-450 CYP2E1 Inhibitors
p51284
g46830
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p51285
g14784
sVFused-Ring Compounds
p51286
g14813
sVGastrointestinal Agents
p51287
(dp51288
sg4371
g44772
sVCytochrome P-450 Enzyme Inducers
p51289
g28136
sVBSEP/ABCB11 Inhibitors
p51290
(dp51291
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p51292
g26870
sVAlimentary Tract and Metabolism
p51293
g23766
sVSteroids
p51294
(dp51295
sg10419
(dp51296
sg5187
g49604
sg7023
(dp51297
sg3819
g41006
sg2907
g35493
sg2181
g30545
ssg5472
(dp51298
g5547
(dp51299
sVCardiovascular Agents
p51300
g26534
sVHeterocyclic Compounds, Fused-Ring
p51301
(dp51302
sVCytochrome P-450 CYP3A Substrates
p51303
g45178
sVAgents causing hyperkalemia
p51304
g43573
sVP-glycoprotein/ABCB1 Substrates
p51305
g34919
sg9621
(dp51306
sg10332
(dp51307
sVCYP3A Substrates (Sensitive)
p51308
(dp51309
sVP-glycoprotein/ABCB1 Inhibitors
p51310
(dp51311
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51312
g29474
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p51313
(dp51314
sVBenzazepines
p51315
(dp51316
sVCytochrome P-450 CYP3A4 Substrates
p51317
(dp51318
sVNatriuretic Agents
p51319
g40485
sVDiuretics
p51320
(dp51321
ssg5475
(dp51322
g11910
(dp51323
sg4488
g45753
sg6507
(dp51324
sg11145
(dp51325
ssg5478
(dp51326
g13750
g24368
sg2373
g31632
sg9693
(dp51327
sg1245
g23008
sg9903
(dp51328
sg1800
g27313
sg4653
g46684
sg6585
(dp51329
sg11997
(dp51330
sg5766
(dp51331
sg7545
(dp51332
sg8430
(dp51333
sg1614
g25862
sg14838
g40025
sg5895
(dp51334
sg6045
(dp51335
sg2388
g31664
sg9774
(dp51336
sg4113
g43083
sg3393
g38551
sg4875
g48020
sg3219
g37541
sg5364
g50611
sg14872
g15717
sg1383
g24160
sg6345
(dp51337
sg12534
(dp51338
sg14829
(dp51339
ssg5481
(dp51340
g4155
g43214
sg7272
(dp51341
sg183
g13800
sg5067
g48942
sg5133
g49276
ssg5484
(dp51342
g6882
(dp51343
sg5454
g51136
sg11601
(dp51344
ssg5487
(dp51345
VAgents Causing Muscle Toxicity
p51346
(dp51347
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p51348
(dp51349
sVUGT1A1 Substrates
p51350
g12287
sVAnalgesics
p51351
g26490
sVCentral Nervous System Agents
p51352
(dp51353
sVDrugs Used in Alcohol Dependence
p51354
(dp51355
sVOpiate Antagonists
p51356
(dp51357
sVDrugs Used in Addictive Disorders
p51358
g24715
sVPeripheral Nervous System Agents
p51359
(dp51360
sVNatural Opium Alkaloids
p51361
g23486
sVCentrally Acting Antiobesity Products
p51362
g50364
sVOpioids
p51363
g32237
sVOpiate Alkaloids
p51364
(dp51365
sVOpioid Antagonists
p51366
(dp51367
sVNaloxone
p51368
(dp51369
sVMorphinans
p51370
(dp51371
sVAlimentary Tract and Metabolism
p51372
g23920
sVHeterocyclic Compounds, Fused-Ring
p51373
(dp51374
sVAlcohol Deterrents
p51375
g15816
sVAlkaloids
p51376
g19413
sVAntiobesity Preparations, Excl. Diet Products
p51377
g39835
sVSensory System Agents
p51378
(dp51379
sVPhenanthrenes
p51380
g32837
sVNervous System
p51381
(dp51382
ssg5490
(dp51383
g7029
(dp51384
sg3975
g41932
ssg5493
(dp51385
g1059
g21752
sg801
g19532
sg8601
(dp51386
sg8598
(dp51387
ssg5496
(dp51388
g10314
(dp51389
sg1791
g27242
sg10548
(dp51390
sg9618
(dp51391
sg4377
g44788
sg10878
(dp51392
sg7353
(dp51393
sg19588
g32475
sg1917
g28452
sg1611
g25811
ssg5499
(dp51394
VCytochrome P-450 CYP2D6 Inhibitors
p51395
(dp51396
sVAdrenergic beta-Agonists
p51397
g43001
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p51398
g41070
sVCytochrome P-450 CYP3A Substrates
p51399
g45185
sVNeurotransmitter Agents
p51400
(dp51401
sVPotential QTc-Prolonging Agents
p51402
(dp51403
sVAnilides
p51404
(dp51405
sVCytochrome P-450 Enzyme Inhibitors
p51406
(dp51407
sVDrugs for Urinary Frequency and Incontinence
p51408
g28986
sVDrugs that are Mainly Renally Excreted
p51409
g44002
sVUrologicals
p51410
(dp51411
sVAmines
p51412
g42716
sVCytochrome P-450 CYP2D6 Substrates
p51413
(dp51414
sVUrological Agents
p51415
g38284
sVAmides
p51416
g44294
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51417
g29480
sVSulfur Compounds
p51418
(dp51419
sVAniline Compounds
p51420
g23426
sVCholinesterase substrates
p51421
g41633
sVQTc Prolonging Agents
p51422
(dp51423
sVAdrenergic Agents
p51424
g41705
sVP-glycoprotein/ABCB1 Substrates
p51425
g34923
sVAdrenergic Agonists
p51426
(dp51427
sVAgents that produce hypertension
p51428
(dp51429
sVCytochrome P-450 CYP3A4 Substrates
p51430
(dp51431
sVAdrenergic beta-3 Receptor Agonists
p51432
(dp51433
sg768
g19256
sVGenito Urinary System and Sex Hormones
p51434
(dp51435
sVP-glycoprotein/ABCB1 Inhibitors
p51436
(dp51437
sVAgents producing tachycardia
p51438
g50749
ssg5502
(dp51439
g11154
(dp51440
sg7176
(dp51441
sg5922
(dp51442
sg11319
(dp51443
sg12421
g12458
sg3117
g36910
sg7065
(dp51444
sg7197
(dp51445
sg7593
(dp51446
sg2067
g29636
sg612
g17869
sg11445
(dp51447
sg168
g13641
sg6921
(dp51448
ssg5505
(dp51449
g1548
g25377
sg10263
(dp51450
sg2304
g31261
sg2616
g33181
sg5829
(dp51451
sg10761
(dp51452
sg3708
g40385
sg10005
(dp51453
sg5580
(dp51454
sg8862
(dp51455
ssg5508
(dp51456
g2553
g32908
ssg5511
(dp51457
VFood Additives
p51458
(dp51459
sVAnticoagulants
p51460
(dp51461
sVIrrigating Solutions
p51462
g41368
sg9615
(dp51463
sVDiet, Food, and Nutrition
p51464
g22912
sVCompounds used in a research, industrial, or household setting
p51465
(dp51466
sVFood and Beverages
p51467
(dp51468
sg10302
(dp51469
sVCalculi Dissolution Agent
p51470
g12693
sVPhysiological Phenomena
p51471
g21726
sVUrinary Alkalinisers
p51472
(dp51473
sVFood
p51474
(dp51475
sVNeurotoxic agents
p51476
(dp51477
sVBlood and Blood Forming Organs
p51478
(dp51479
sg1317
g23552
sVAntacids and Adsorbents
p51480
(dp51481
sVSalt Solutions
p51482
g22247
sg10755
(dp51483
sVLaxatives
p51484
g17348
sg11064
(dp51485
sVFood Ingredients
p51486
g26897
sVHematologic Agents
p51487
(dp51488
sVBlood Substitutes and Perfusion Solutions
p51489
g49450
sVAcids, Acyclic
p51490
g25463
sVCitric Acid
p51491
g46554
sVCitrates
p51492
g17791
sVTricarboxylic Acids
p51493
(dp51494
sg8568
(dp51495
ssg5514
(dp51496
VAmino Acids, Peptides, and Proteins
p51497
g47325
sVOATP1B3 inhibitors
p51498
(dp51499
sg7347
(dp51500
sg489
g16683
sg3807
g40982
sg4314
g44483
sVProteins
p51501
(dp51502
sVPeptide Hormones
p51503
g20218
sg4785
g47544
sVPeptides
p51504
g47167
sVOATP1B1/SLCO1B1 Inhibitors
p51505
(dp51506
sVPancreatic Hormones
p51507
(dp51508
sg11211
(dp51509
sVHormones
p51510
(dp51511
sVHormones, Hormone Substitutes, and Hormone Antagonists
p51512
(dp51513
sVBlood Glucose Lowering Agents
p51514
(dp51515
sVAlimentary Tract and Metabolism
p51516
g23781
sVDrugs Used in Diabetes
p51517
(dp51518
sg7209
(dp51519
ssg5517
(dp51520
g4806
g47669
sg1152
g22542
sg10275
(dp51521
sg10914
(dp51522
sg2895
g35399
sg603
g17766
sg1110
g22140
sg1239
g22958
sg10305
(dp51523
ssg5520
(dp51524
VAntiinfectives for Systemic Use
p51525
(dp51526
sVDrugs that are Mainly Renally Excreted
p51527
g44004
sVGlycosides
p51528
(dp51529
sVAntivirals for Systemic Use
p51530
(dp51531
sVDeoxyribonucleosides
p51532
g33062
sVNucleosides
p51533
g49466
sVNucleic Acid Synthesis Inhibitors
p51534
g48737
sVNucleoside Reverse Transcriptase Inhibitors
p51535
g38840
sVNucleic Acids, Nucleotides, and Nucleosides
p51536
g47125
sVCarbohydrates
p51537
(dp51538
sVAnti-Infective Agents
p51539
(dp51540
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p51541
g14468
sVAntiviral Agents
p51542
g30454
sVDirect Acting Antivirals
p51543
g38065
sVUGT1A1 Substrates
p51544
g12304
sVAnti-HIV Agents
p51545
(dp51546
sVEnzyme Inhibitors
p51547
(dp51548
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p51549
g38158
sVReverse Transcriptase Inhibitors
p51550
g28953
sVAnti-Retroviral Agents
p51551
(dp51552
ssg5523
(dp51553
g858
g20142
sg11151
(dp51554
sg28215
g35367
sg11136
(dp51555
sg9528
(dp51556
sg6489
(dp51557
ssg5526
(dp51558
VAgents Causing Muscle Toxicity
p51559
(dp51560
sVCytochrome P-450 CYP2D6 Inhibitors
p51561
(dp51562
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p51563
g41071
sVCytochrome P-450 CYP3A Substrates
p51564
g45262
sVAntifungal Agents
p51565
(dp51566
sVEnzyme Inhibitors
p51567
(dp51568
sVCytochrome P-450 Enzyme Inhibitors
p51569
(dp51570
sVAnti-Infective Agents
p51571
(dp51572
sVCytochrome P-450 CYP2C8 Substrates
p51573
(dp51574
sVCytochrome P-450 CYP1A2 Substrates
p51575
g45627
sVAntifungals for Topical Use
p51576
g39231
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51577
g29581
sVCytochrome P-450 CYP2C9 Substrates
p51578
g29809
sVCytochrome P-450 CYP3A4 Inducers
p51579
g18969
sVAntifungals for Dermatological Use
p51580
g30076
sVCytochrome P-450 CYP2C8 Inhibitors
p51581
(dp51582
sVDermatologicals
p51583
g17265
sVCytochrome P-450 Enzyme Inducers
p51584
g28132
sVCytochrome P-450 CYP3A Inducers
p51585
(dp51586
sVCytochrome P-450 CYP3A4 Substrates
p51587
(dp51588
sVNaphthalenes
p51589
(dp51590
sg9807
(dp51591
sg3579
g39604
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p51592
(dp51593
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p51594
g24196
sVAntifungals for Systemic Use
p51595
(dp51596
ssg5529
(dp51597
g426
g16097
sg657
g18334
sg7464
(dp51598
sg11793
(dp51599
sg2358
g31481
sg11595
(dp51600
sg4635
g46491
sg10296
(dp51601
sg8295
(dp51602
sg6411
(dp51603
sg9561
(dp51604
sg9564
(dp51605
sg1491
g25085
sg10818
(dp51606
sg2433
g32136
sg915
g20712
sg7389
(dp51607
sg4458
g45490
sg11727
(dp51608
sg7569
(dp51609
sg9393
(dp51610
sg141
g13341
sg537
g17038
sg12111
(dp51611
sg11544
(dp51612
sg11910
(dp51613
sg3447
g38937
sg1770
g27058
sg1008
g21287
ssg5532
(dp51614
VPharmaceutical Preparations
p51615
(dp51616
sVHematologic Agents
p51617
(dp51618
sVPharmaceutical Solutions
p51619
g15482
sg1623
g25928
sVHematinics
p51620
(dp51621
sVIron Compounds
p51622
g36400
sg6963
(dp51623
sVMinerals
p51624
(dp51625
sVSolutions
p51626
(dp51627
sg4998
g48682
sVParenteral Iron Replacement
p51628
g41680
sVParamagnetic Contrast Agent
p51629
(dp51630
sVOrganometallic Compounds
p51631
(dp51632
sVFerric Compounds
p51633
(dp51634
sVCompounds used in a research, industrial, or household setting
p51635
(dp51636
ssg5535
(dp51637
VCytochrome P-450 CYP2D6 Inhibitors
p51638
(dp51639
sVNeurotransmitter Agents
p51640
(dp51641
sVCentral Nervous System Agents
p51642
(dp51643
sVDopamine Agents
p51644
g14252
sVPsychotropic Drugs
p51645
(dp51646
sVCytochrome P-450 CYP2E1 Inhibitors
p51647
g46839
sVProdrugs
p51648
(dp51649
sVCytochrome P-450 Enzyme Inhibitors
p51650
(dp51651
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p51652
g18415
sVPhenothiazines With Piperazine Structure
p51653
(dp51654
sVAntipsychotic Agents
p51655
(dp51656
sVDopamine Antagonists
p51657
(dp51658
sVSulfur Compounds
p51659
(dp51660
sVPsycholeptics
p51661
g33248
sVCentral Nervous System Depressants
p51662
(dp51663
sVAgents that reduce seizure threshold
p51664
g45857
sVDelayed-Action Preparations
p51665
(dp51666
sVAntipsychotic Agents (First Generation [Typical])
p51667
(dp51668
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p51669
g26880
sVDopamine D2 Receptor Antagonists
p51670
g49421
sVHeterocyclic Compounds, Fused-Ring
p51671
(dp51672
sVPhenothiazines
p51673
(dp51674
sVP-glycoprotein/ABCB1 Inhibitors
p51675
(dp51676
sVNeurotoxic agents
p51677
(dp51678
sVNervous System
p51679
(dp51680
sVTranquilizing Agents
p51681
(dp51682
ssg5538
(dp51683
g9102
(dp51684
sg1461
g24817
ssg5541
(dp51685
g9231
(dp51686
sg1473
g24974
sg1140
g22410
ssg5544
(dp51687
g10266
(dp51688
sg11451
(dp51689
sg3858
g41234
sg7593
(dp51690
sg5556
(dp51691
sg6033
(dp51692
ssg5547
(dp51693
g5472
g51299
ssg5550
(dp51694
g6231
(dp51695
sg3795
g40932
sg9192
(dp51696
sg1332
g23660
sg13070
g21906
sg1863
g27759
sg2808
g34480
sg8922
(dp51697
ssg5553
(dp51698
g10209
(dp51699
sg1470
g24923
sg507
g16785
sg849
g20096
sg9225
(dp51700
sg2127
g30268
sg3117
g36926
sg14822
g41823
sg2133
g30302
sg3783
g40882
ssg5556
(dp51701
VVitamins
p51702
g12171
sVCytochrome P-450 CYP2D6 Inhibitors
p51703
(dp51704
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p51705
g41080
sVCytochrome P-450 CYP3A Substrates
p51706
g45191
sVDrugs for Treatment of Bone Diseases
p51707
g14279
sVLipids
p51708
g14334
sVFood and Beverages
p51709
(dp51710
sVDrugs Affecting Bone Structure and Mineralization
p51711
g16511
sVCytochrome P-450 Enzyme Inhibitors
p51712
(dp51713
sVPhysiological Phenomena
p51714
g21715
sVVitamin D and Analogues
p51715
g40202
sVMicronutrients
p51716
(dp51717
sVVitamins (Fat Soluble)
p51718
(dp51719
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p51720
g46324
sVFood
p51721
(dp51722
sVAlimentary Tract and Metabolism
p51723
g23755
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p51724
g29490
sVBone Density Conservation Agents
p51725
g40352
sVMembrane Lipids
p51726
g47727
sVFused-Ring Compounds
p51727
g14824
sVMusculo-Skeletal System
p51728
g31540
sVCholestenes
p51729
(dp51730
sVSecosteroids
p51731
g44475
sVCytochrome P-450 CYP2C8 Inhibitors
p51732
(dp51733
sVCytochrome P-450 CYP2B6 Inhibitors
p51734
g45922
sVCytochrome P-450 CYP2B6 Inhibitors (weak)
p51735
g51691
sVCholestanes
p51736
g19150
sVCytochrome P-450 CYP3A4 Substrates
p51737
(dp51738
sVCalcium-Regulating Hormones and Agents
p51739
(dp51740
sVGrowth Substances
p51741
g46127
sg7767
(dp51742
sVSteroids
p51743
(dp51744
sVSterols
p51745
(dp51746
sVDiet, Food, and Nutrition
p51747
g22899
ssg5559
(dp51748
g9846
(dp51749
sg9630
(dp51750
sg2940
g35711
ssg5562
(dp51751
g11085
(dp51752
sg6150
(dp51753
sg7044
(dp51754
sg8010
(dp51755
ssg5565
(dp51756
g6279
(dp51757
sg3024
g36275
sg11592
(dp51758
sg2913
g35572
sg7821
(dp51759
sg1050
g21667
sg6798
(dp51760
sg12045
(dp51761
ssg5568
(dp51762
g4419
g44900
ssg5571
(dp51763
VDrugs that are Mainly Renally Excreted
p51764
g43870
sVUrea
p51765
(dp51766
sVSulfonylurea Compounds
p51767
(dp51768
sVOAT1/SLC22A6 inhibitors
p51769
(dp51770
sVSulfonylureas
p51771
(dp51772
sVHypoglycemia-Associated Agents
p51773
g17712
sVSulfur Compounds
p51774
(dp51775
sVOral Hypoglycemics
p51776
g36006
sVSulfones
p51777
(dp51778
sVCytochrome P-450 CYP2C9 Substrates
p51779
g29727
sVBlood Glucose Lowering Agents
p51780
(dp51781
sVAlimentary Tract and Metabolism
p51782
g23794
sVDrugs Used in Diabetes
p51783
(dp51784
ssg5574
(dp51785
VHypotensive Agents
p51786
g34149
sVHyperglycemia-Associated Agents
p51787
(dp51788
sVDrugs that are Mainly Renally Excreted
p51789
g44034
sVThiazide-like Diuretic
p51790
g12823
sVGynecological Antiinfectives and Antiseptics
p51791
(dp51792
sVAntihypertensive Agents
p51793
g20295
sVQuinazolines
p51794
(dp51795
sVAmides
p51796
g44348
sVSulfur Compounds
p51797
(dp51798
sVSulfones
p51799
(dp51800
sVSulfonamides
p51801
(dp51802
sVSodium Chloride Symporter Inhibitors
p51803
(dp51804
sVCardiovascular Agents
p51805
g26624
sVNon Potassium Sparing Diuretics
p51806
g14970
sg6438
(dp51807
sVLow-Ceiling Diuretics, Excl. Thiazides
p51808
(dp51809
sVMembrane Transport Modulators
p51810
(dp51811
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p51812
g25427
sVHeterocyclic Compounds, Fused-Ring
p51813
(dp51814
sVGenito Urinary System and Sex Hormones
p51815
(dp51816
sVNatriuretic Agents
p51817
g40492
sVIncreased Diuresis
p51818
g40994
sVDiuretics
p51819
(dp51820
ssg5577
(dp51821
VHematinics
p51822
(dp51823
sVCarbohydrates
p51824
(dp51825
sVBiological Factors
p51826
g38118
sg11985
(dp51827
sVAntianemic Preparations
p51828
(dp51829
sg4866
g47972
sg3183
g37331
sg8670
(dp51830
sVBlood and Blood Forming Organs
p51831
(dp51832
sg8103
(dp51833
sVProteins
p51834
(dp51835
sVIntercellular Signaling Peptides and Proteins
p51836
g25414
sVPeptides
p51837
g47170
sg8700
(dp51838
sg372
g15391
sVAmino Acids, Peptides, and Proteins
p51839
g47330
sVHematologic Agents
p51840
(dp51841
sg5577
(dp51842
sg8274
(dp51843
sg192
g13884
sg5382
g50714
sg11574
(dp51844
sg7611
(dp51845
sg12144
(dp51846
ssg5580
(dp51847
VCytochrome P-450 CYP2D6 Substrates
p51848
(dp51849
sVAntiarrhythmic agents
p51850
(dp51851
sVOphthalmologicals
p51852
g35274
sVAgents causing hyperkalemia
p51853
g43650
sVHypotensive Agents
p51854
g34216
sVAdrenergic Antagonists
p51855
(dp51856
sVPeripheral Nervous System Agents
p51857
(dp51858
sVSympatholytics
p51859
(dp51860
sVCytochrome P-450 CYP1A2 Substrates
p51861
g45645
sVAmines
p51862
g42752
sVAdrenergic beta-1 Receptor Antagonists
p51863
g46821
sVAntihypertensive Agents
p51864
g20326
sVNeurotransmitter Agents
p51865
(dp51866
sVBeta Blocking Agents, Selective
p51867
g51454
sVQTc Prolonging Agents
p51868
(dp51869
sVModerate Risk QTc-Prolonging Agents
p51870
(dp51871
sVAdrenergic Agents
p51872
g41732
sVBeta-adrenergic Agents
p51873
(dp51874
sVCardiovascular Agents
p51875
g26555
sVAdrenergic beta-Antagonists
p51876
g15372
sVPhenoxypropanolamines
p51877
g20870
sVSensory Organs
p51878
g40755
sVPropanolamines
p51879
g37516
sVAutonomic Agents
p51880
(dp51881
sVAmino Alcohols
p51882
g32699
sVAntiglaucoma Preparations and Miotics
p51883
g36569
sVBradycardia-Causing Agents
p51884
(dp51885
sVPropanols
p51886
(dp51887
sVBeta-Blockers (Beta1 Selective)
p51888
(dp51889
sVAlcohols
p51890
(dp51891
ssg5583
(dp51892
g3783
g40888
ssg5586
(dp51893
g5847
(dp51894
ssg5589
(dp51895
VAntiplatelet agents
p51896
g46302
sVSalicylic Acid and Derivatives
p51897
g36813
sVUGT1A6 substrate
p51898
g38516
sVAnticoagulants
p51899
(dp51900
sVAnalgesics
p51901
g26443
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p51902
(dp51903
sVAgents causing angioedema
p51904
(dp51905
sVNon COX-2 selective NSAIDS
p51906
(dp51907
sVAntiinflammatory and Antirheumatic Products
p51908
(dp51909
sVBlood and Blood Forming Organs
p51910
(dp51911
sVStomatological Preparations
p51912
(dp51913
sVPeripheral Nervous System Agents
p51914
(dp51915
sVDrugs that are Mainly Renally Excreted
p51916
g44006
sVP-glycoprotein/ABCB1 Inducers
p51917
(dp51918
sVSalicylates
p51919
g27625
sVNonsteroidal Anti-inflammatory Compounds
p51920
(dp51921
sVAnalgesics, Non-Narcotic
p51922
(dp51923
sVNephrotoxic agents
p51924
(dp51925
sVDecreased Platelet Aggregation
p51926
(dp51927
sVAcids, Carbocyclic
p51928
g41581
sVOAT1/SLC22A6 inhibitors
p51929
(dp51930
sVCytochrome P-450 CYP2C9 Substrates
p51931
g29734
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p51932
g25155
sVMusculo-Skeletal System
p51933
g31551
sVAgents causing hyperkalemia
p51934
g43586
sVCardiovascular Agents
p51935
g26564
sVBenzene Derivatives
p51936
(dp51937
sVDecreased Prostaglandin Production
p51938
(dp51939
sVP-glycoprotein/ABCB1 Substrates
p51940
g34941
sVAntipyretics
p51941
(dp51942
sVCytochrome P-450 Enzyme Inducers
p51943
g28144
sVAgents that produce hypertension
p51944
(dp51945
sVHydroxybenzoates
p51946
(dp51947
sVAlimentary Tract and Metabolism
p51948
g23800
sVHematologic Agents
p51949
(dp51950
sVPlatelet Aggregation Inhibitors Excl. Heparin
p51951
(dp51952
sVOAT3/SLC22A8 Inhibitors
p51953
(dp51954
sVCytochrome P-450 CYP2C19 Inducers
p51955
g25549
sVAnti-Inflammatory Agents
p51956
(dp51957
sVCyclooxygenase Inhibitors
p51958
g32796
sVSensory System Agents
p51959
(dp51960
sVAnti-Inflammatory Agents, Non-Steroidal
p51961
(dp51962
ssg5592
(dp51963
g2250
g30868
sg279
g14508
ssg5595
(dp51964
VAgents Causing Muscle Toxicity
p51965
(dp51966
sVAmino Acids, Cyclic
p51967
g27292
sVCytochrome P-450 CYP2D6 Substrates
p51968
(dp51969
sVOAT1/SLC22A6 inhibitors
p51970
(dp51971
sVAgents causing hyperkalemia
p51972
g43587
sVHypotensive Agents
p51973
g34134
sVAgents causing angioedema
p51974
(dp51975
sVOAT1/SLC22A6 Substrates
p51976
(dp51977
sVEnzyme Inhibitors
p51978
(dp51979
sg2955
g35854
sVAmino Acids
p51980
g43117
sVAntihypertensive Agents
p51981
g20284
sVAngiotensin-Converting Enzyme Inhibitors
p51982
(dp51983
sVCardiovascular Agents
p51984
g26566
sVACE Inhibitors and Diuretics
p51985
(dp51986
sVOAT3/SLC22A8 Substrates
p51987
g13150
sVAgents Acting on the Renin-Angiotensin System
p51988
g25349
sVAmino Acids, Peptides, and Proteins
p51989
g47334
sVAcids, Acyclic
p51990
g25495
sVImino Acids
p51991
(dp51992
sVImines
p51993
(dp51994
sVP-glycoprotein/ABCB1 Inhibitors
p51995
(dp51996
ssg5598
(dp51997
VCardiac Stimulants Excl. Cardiac Glycosides
p51998
g29163
sVOphthalmologicals
p51999
g35194
sVNeurotransmitter Agents
p52000
(dp52001
sVNasal Decongestants for Systemic Use
p52002
g34219
sVAdrenergic and Dopaminergic Agents
p52003
g51110
sVSympathomimetics
p52004
g48811
sVCompounds used in a research, industrial, or household setting
p52005
(dp52006
sVCytochrome P-450 CYP1A2 Inducers
p52007
(dp52008
sVSympathomimetics, Plain
p52009
g14449
sVPeripheral Nervous System Agents
p52010
(dp52011
sVVasoconstrictor Agents
p52012
g35889
sVAmines
p52013
g42687
sVSympathomimetics Excl. Antiglaucoma Preparations
p52014
(dp52015
sVCardiac Therapy
p52016
(dp52017
sVRespiratory System Agents
p52018
(dp52019
sVProtective Agents
p52020
(dp52021
sVEthanolamines
p52022
(dp52023
sVMonoamine Oxidase A Substrates
p52024
(dp52025
sVAdrenergic Agents
p52026
g41730
sVCardiovascular Agents
p52027
g26567
sVSympathomimetic (Adrenergic) Agents
p52028
(dp52029
sVDecongestants and Antiallergics
p52030
(dp52031
sVNasal Decongestants
p52032
(dp52033
sVMydriatics
p52034
g49203
sVCytochrome P-450 Enzyme Inducers
p52035
g28147
sVAdrenergic Agonists
p52036
(dp52037
sVAgents that produce hypertension
p52038
(dp52039
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p52040
g17459
sVCardiotonic Agents
p52041
(dp52042
sVAutonomic Agents
p52043
(dp52044
sVMydriatics and Cycloplegics
p52045
g47435
sVAmino Alcohols
p52046
g32698
sVAdrenergic alpha-Agonists
p52047
(dp52048
sVSympathomimetics Used as Decongestants
p52049
(dp52050
sVAgents producing tachycardia
p52051
g50770
sVAdrenergic alpha-1 Receptor Agonists
p52052
(dp52053
sVNasal Preparations
p52054
(dp52055
sVAlcohols
p52056
(dp52057
sVSensory Organs
p52058
g40708
ssg5601
(dp52059
g6966
(dp52060
sg11016
(dp52061
sg696
g18792
sg12066
(dp52062
sg2664
g33483
sg11790
(dp52063
sg7497
(dp52064
sg7299
(dp52065
sg6303
(dp52066
sg780
g19390
ssg5604
(dp52067
g1548
g25409
sg10263
(dp52068
sg2616
g33202
sg5829
(dp52069
sg10761
(dp52070
sg3708
g40404
sg10005
(dp52071
ssg5607
(dp52072
g3633
g40038
sg11283
(dp52073
sg9906
(dp52074
sg6186
(dp52075
sg7053
(dp52076
sg3651
g40095
sg9918
(dp52077
sg6216
(dp52078
sg4653
g46647
sg1650
g26088
sg11625
(dp52079
sg6045
(dp52080
sg2034
g28996
sg8625
(dp52081
sg5313
g50372
sg11079
(dp52082
sg3516
g39140
sg5877
(dp52083
sg78
g12827
sg1113
g22153
sg10365
(dp52084
sg9960
(dp52085
sg9966
(dp52086
sg2910
g35496
sg1881
g27923
sg7428
(dp52087
sg2769
g34268
sg9231
(dp52088
sg3546
g39372
sg609
g17798
sg8856
(dp52089
sg3963
g41840
sg10758
(dp52090
sg5127
g49206
sg8703
(dp52091
sg11160
(dp52092
sg6303
(dp52093
sg3783
g40853
sg4344
g44619
sg8874
(dp52094
sg11550
(dp52095
sg771
g19259
sg402
g15820
sg9663
(dp52096
sg11241
(dp52097
sg4596
g46230
sg12534
(dp52098
sg7041
(dp52099
ssg5610
(dp52100
g7188
(dp52101
sg11523
(dp52102
ssg5613
(dp52103
g8325
(dp52104
ssg5616
(dp52105
g11283
(dp52106
sg7464
(dp52107
sg10377
(dp52108
sg10818
(dp52109
sg3114
g36845
sg12421
g12416
sg4635
g46458
sg42
g12564
sg465
g16435
sg3708
g40365
sg9165
(dp52110
sg9918
(dp52111
sg858
g20148
sg11151
(dp52112
sg69
g12746
sg7983
(dp52113
sg6819
(dp52114
sg11016
(dp52115
sg3516
g39144
sg5499
g51414
sg2088
g29884
sg2427
g31970
sg2433
g32138
sg909
g20614
sg9960
(dp52116
sg10347
(dp52117
sg9966
(dp52118
sg7485
(dp52119
sg7716
(dp52120
sg933
g20801
sg10752
(dp52121
sg1719
g26816
sg789
g19461
sg10761
(dp52122
sg138
g13267
sg10005
(dp52123
sg6303
(dp52124
sg147
g13419
sg3978
g41958
sg6315
(dp52125
sg5580
g51849
sg7533
(dp52126
sg3240
g37690
sg4056
g42567
sg9462
(dp52127
sg2616
g33153
sg10815
(dp52128
sg5112
g49158
sg7029
(dp52129
sg2676
g33545
sg5595
g51969
sg1008
g21258
sg11259
(dp52130
sg10062
(dp52131
sg7053
(dp52132
sg10497
(dp52133
sg9417
(dp52134
sg1803
g27361
sg7707
(dp52135
sg240
g14165
sg10857
(dp52136
sg1044
g21526
sg10662
(dp52137
sg10884
(dp52138
sg1626
g25942
sg6411
(dp52139
sg8787
(dp52140
sg4344
g44627
sg10674
(dp52141
sg9111
(dp52142
sg10899
(dp52143
sg11655
(dp52144
sg3132
g36980
sg8655
(dp52145
sg5694
(dp52146
sg4101
g42955
sg6447
(dp52147
sg6318
(dp52148
sg1881
g27931
sg3381
g38455
sg345
g15199
sg7941
(dp52149
sg9198
(dp52150
sg3399
g38613
sg1908
g28265
sg8028
(dp52151
sg1911
g28337
sg7563
(dp52152
sg537
g17009
sg2688
g33602
sg23
g12195
sg6507
(dp52153
sg7176
(dp52154
sg10056
(dp52155
sg387
g15590
sg1134
g22304
sg10227
(dp52156
sg7191
(dp52157
sg2304
g31252
sg7197
(dp52158
sg3447
g38899
sg414
g15929
sg9828
(dp52159
sg780
g19330
sg11385
(dp52160
sg10263
(dp52161
sg10266
(dp52162
sg11022
(dp52163
sg5805
(dp52164
sg11793
(dp52165
sg1425
g24526
sg3858
g41191
sg450
g16313
sg12063
(dp52166
sg10308
(dp52167
sg168
g13611
sg1947
g28653
sg2658
g33341
sg4278
g44254
sg5877
(dp52168
sg294
g14718
sg8820
(dp52169
sg2814
g34500
sg8874
(dp52170
sg2910
g35503
sg8097
(dp52171
sg11733
(dp52172
sg4458
g45468
sg6639
(dp52173
sg9012
(dp52174
sg7320
(dp52175
sg2115
g30191
sg696
g18684
sg7569
(dp52176
sg14791
(dp52177
sg7428
(dp52178
sg564
g17387
sg4173
g43398
sg1809
g27416
sg1668
g26233
sg7698
(dp52179
sg3570
g39448
sg1365
g24039
sg5169
g49484
sg11910
(dp52180
sg2943
g35735
sg621
g17939
sg11112
(dp52181
sg11955
(dp52182
sg2199
g30662
sg516
g16845
sg2094
g29979
sg3651
g40099
sg8163
(dp52183
sg11979
(dp52184
sg1434
g24618
sg8964
(dp52185
sg9711
(dp52186
sg6759
(dp52187
sg6033
(dp52188
sg8295
(dp52189
sg6051
(dp52190
sg7065
(dp52191
sg9819
(dp52192
sg822
g19800
sg6468
(dp52193
sg1491
g25044
sg9987
(dp52194
sg7497
(dp52195
sg3024
g36246
sg10521
(dp52196
sg5316
g50425
sg2832
g34674
sg9393
(dp52197
sg2289
g31194
sg10557
(dp52198
sg8862
(dp52199
sg10098
(dp52200
sg3531
g39253
sg771
g19265
sg282
g14523
sg12126
(dp52201
sg10596
(dp52202
sg2664
g33408
sg10602
(dp52203
sg9981
(dp52204
sg4596
g46234
sg9105
(dp52205
sg11790
(dp52206
sg5127
g49212
ssg5619
(dp52207
VAngiotensin-Converting Enzyme Inhibitors
p52208
(dp52209
sg8478
(dp52210
sVProtease Inhibitors
p52211
g51086
sVAntihypertensive Agents
p52212
g20273
sVAgents causing hyperkalemia
p52213
g43588
sVHypotensive Agents
p52214
g34137
sVAgents causing angioedema
p52215
(dp52216
sVHeterocyclic Compounds, Fused-Ring
p52217
(dp52218
sVEnzyme Inhibitors
p52219
(dp52220
sVCardiovascular Agents
p52221
g26570
sVAgents Acting on the Renin-Angiotensin System
p52222
g25330
ssg5622
(dp52223
VAmino Acids, Peptides, and Proteins
p52224
g47338
sVFibrin Modulating Agents
p52225
g22854
sVHematologic Agents
p52226
(dp52227
sVBlood and Blood Forming Organs
p52228
(dp52229
sVCardiovascular Agents
p52230
g26571
sVEndopeptidases
p52231
(dp52232
sVEnzymes
p52233
(dp52234
sVAnticoagulants
p52235
(dp52236
sVProteins
p52237
(dp52238
sVAgents causing angioedema
p52239
(dp52240
sVFibrinolytic Agents
p52241
g26299
sVBiological Factors
p52242
g38089
sVTissue Plasminogen Activator
p52243
g37224
sVEnzymes and Coenzymes
p52244
(dp52245
sVBlood Proteins
p52246
g39841
sVSerine Endopeptidases
p52247
g35488
sVHydrolases
p52248
(dp52249
sVPeptide Hydrolases
p52250
g42946
sVSerine Proteases
p52251
g31557
sVPlasminogen Activators
p52252
(dp52253
ssg5625
(dp52254
g7221
(dp52255
ssg5628
(dp52256
g8595
(dp52257
ssg5631
(dp52258
g6045
(dp52259
sg4653
g46657
sg4155
g43198
sg183
g13776
sg3543
g39318
sg165
g13588
sg5469
g51280
sg12534
(dp52260
ssg5634
(dp52261
g10263
(dp52262
sg11790
(dp52263
sg5805
(dp52264
sg1719
g26824
sg4419
g44894
sg7422
(dp52265
sg2664
g33422
sg240
g14179
sg6318
(dp52266
sg1044
g21536
sg5829
(dp52267
sg4452
g45412
sg3708
g40374
sg10470
(dp52268
sg9711
(dp52269
sg6759
(dp52270
sg10884
(dp52271
sg6408
(dp52272
sg5289
g50251
sg6051
(dp52273
sg8805
(dp52274
sg3900
g41496
sg8433
(dp52275
sg4827
g47774
sg6069
(dp52276
sg6468
(dp52277
sg9987
(dp52278
sg10041
(dp52279
sg909
g20626
sg7305
(dp52280
sg8097
(dp52281
sg9417
(dp52282
sg1707
g26757
sg10557
(dp52283
sg6966
(dp52284
sg2616
g33169
sg1548
g25362
sg12066
(dp52285
sg9012
(dp52286
sg7716
(dp52287
sg3036
g36423
sg7941
(dp52288
sg11097
(dp52289
sg3978
g41972
sg6684
(dp52290
sg9981
(dp52291
sg10761
(dp52292
sg8514
(dp52293
sg3114
g36855
sg10005
(dp52294
sg6303
(dp52295
sg570
g17471
sg4344
g44643
sg696
g18699
sg11016
(dp52296
sg8862
(dp52297
sg10098
(dp52298
sg6315
(dp52299
sg5169
g49500
sg3531
g39262
sg387
g15608
sg630
g18007
sg3240
g37701
sg10227
(dp52300
sg4056
g42575
sg2304
g31259
sg831
g19919
sg9918
(dp52301
sg7299
(dp52302
sg11979
(dp52303
sg414
g15942
sg8187
(dp52304
sg780
g19382
sg5580
g51856
ssg5637
(dp52305
g6381
(dp52306
ssg5640
(dp52307
g6231
(dp52308
sg9552
(dp52309
sg7545
(dp52310
sg4113
g43021
sg9822
(dp52311
sg5535
g51649
sg486
g16639
sg6183
(dp52312
ssg5643
(dp52313
g7074
(dp52314
sg2436
g32185
sg8079
(dp52315
sg135
g13260
sg9282
(dp52316
ssg5646
(dp52317
VPyridines
p52318
(dp52319
sVKinase Inhibitors
p52320
g47873
sVMATE substrates
p52321
(dp52322
sVMATE 1 Substrates
p52323
g23498
sVHeterocyclic Compounds, Fused-Ring
p52324
(dp52325
sVAmines
p52326
g42683
sVP-glycoprotein/ABCB1 Substrates
p52327
g34940
sVCytochrome P-450 CYP3A Substrates
p52328
g45044
sVMATE 1 Substrates with a Narrow Therapeutic Index
p52329
(dp52330
sVBCRP/ABCG2 Substrates
p52331
g42095
sVBCRP/ABCG2 Inhibitors
p52332
g12554
sVMATE inhibitors
p52333
(dp52334
sVKinase Inhibitor
p52335
g24602
sVMATE 2 Inhibitors
p52336
(dp52337
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p52338
g29309
sVProtein Kinase Inhibitors
p52339
(dp52340
sVAntineoplastic and Immunomodulating Agents
p52341
g39747
sVP-glycoprotein/ABCB1 Inhibitors
p52342
(dp52343
sVMATE 1 Inhibitors
p52344
(dp52345
sVCytochrome P-450 CYP3A4 Substrates
p52346
(dp52347
sVAntineoplastic Agents
p52348
(dp52349
ssg5649
(dp52350
g3504
g39098
ssg5652
(dp52351
VCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p52352
g49327
sVPyridones
p52353
g38737
sVAnalgesics, Non-Narcotic
p52354
(dp52355
sVAnalgesics
p52356
g26451
sVImmunosuppressive Agents
p52357
(dp52358
sVPyridines
p52359
(dp52360
sVAntifibrotic Agents
p52361
g46096
sVAnti-Inflammatory Agents
p52362
(dp52363
sVCytochrome P-450 CYP1A2 Inhibitors
p52364
g15002
sVCytochrome P-450 CYP1A2 Substrates
p52365
g45586
sVPeripheral Nervous System Agents
p52366
(dp52367
sVAntineoplastic and Immunomodulating Agents
p52368
g39817
sVAntirheumatic Agents
p52369
g24216
sVSensory System Agents
p52370
(dp52371
sVCytochrome P-450 Enzyme Inhibitors
p52372
(dp52373
sVCentral Nervous System Agents
p52374
(dp52375
sVAntineoplastic Agents
p52376
(dp52377
ssg5655
(dp52378
g9426
(dp52379
sg1266
g23222
sg3090
g36698
sg5847
(dp52380
sg9846
(dp52381
sg4356
g44694
sg9540
(dp52382
ssg5658
(dp52383
g11112
(dp52384
sg465
g16463
sg10266
(dp52385
sg450
g16333
sg11283
(dp52386
sg10308
(dp52387
sg168
g13631
sg702
g18824
sg2427
g32044
sg8655
(dp52388
sg6468
(dp52389
sg2910
g35526
sg8097
(dp52390
sg9417
(dp52391
sg3381
g38471
sg345
g15222
sg9981
(dp52392
sg1908
g28306
sg11154
(dp52393
sg4173
g43393
sg2289
g31204
sg8874
(dp52394
sg3978
g41983
sg7176
(dp52395
sg5169
g49508
sg387
g15663
sg10497
(dp52396
sg10056
(dp52397
sg6921
(dp52398
ssg5661
(dp52399
g12126
(dp52400
sg2688
g33636
ssg5664
(dp52401
g3000
g36017
ssg5667
(dp52402
g8445
(dp52403
ssg5670
(dp52404
g10533
(dp52405
ssg5673
(dp52406
g9870
(dp52407
sg6552
(dp52408
sg5415
g50927
sg10839
(dp52409
sg9309
(dp52410
sg7629
(dp52411
sg6567
(dp52412
sg3312
g38145
sg11832
(dp52413
sg7530
(dp52414
sg10185
(dp52415
sg10320
(dp52416
sg657
g18300
sg1842
g27667
sg9561
(dp52417
sg2985
g35916
sg5286
g50201
sg9588
(dp52418
sg8826
(dp52419
sg6714
(dp52420
sg6726
(dp52421
sg1875
g27901
sg8649
(dp52422
sg7920
(dp52423
sg9780
(dp52424
sg7548
(dp52425
sg4557
g46149
sg10764
(dp52426
sg4770
g47453
sg10767
(dp52427
sg1164
g22604
sg13091
g21379
sg396
g15796
sg10587
(dp52428
sg6765
(dp52429
sg12108
(dp52430
sg11382
(dp52431
sg420
g16018
ssg5676
(dp52432
g5847
(dp52433
ssg5679
(dp52434
g1266
g23224
ssg5682
(dp52435
g1266
g23225
sg9348
(dp52436
sg8076
(dp52437
sg10653
(dp52438
sg4905
g48191
ssg5685
(dp52439
VAnti-Infective Agents, Local
p52440
(dp52441
sg4434
g45281
sVAnti-Acne Preparations for Topical Use
p52442
(dp52443
sVAmines
p52444
g42672
sg1518
g25220
sVGenito Urinary System and Sex Hormones
p52445
(dp52446
sVGynecological Antiinfectives and Antiseptics
p52447
(dp52448
sVAniline Compounds
p52449
g23428
sg5712
(dp52450
sVDermatologicals
p52451
g17237
sVSulfur Compounds
p52452
(dp52453
sVAnti-Acne Preparations
p52454
(dp52455
sVAmides
p52456
g44317
sVSensory Organs
p52457
g40699
sVAnti-Bacterial Agents
p52458
g38345
sVSulfones
p52459
(dp52460
sVAnti-Infective Agents
p52461
(dp52462
sVSulfonamides
p52463
(dp52464
sVAntiinfectives for Treatment of Acne
p52465
(dp52466
sg1455
g24764
sVOphthalmologicals
p52467
g35205
ssg5688
(dp52468
g10104
(dp52469
ssg5691
(dp52470
VPyrimidines
p52471
g47701
sVGABA Agents
p52472
g16217
sVCarbohydrates
p52473
(dp52474
sVNeurotransmitter Agents
p52475
(dp52476
sVAnti-Anxiety Agents
p52477
g35651
sVGlycosides
p52478
(dp52479
sVCentral Nervous System Agents
p52480
(dp52481
sVPsychotropic Drugs
p52482
(dp52483
sVGABA Modulators
p52484
g39057
sVCytochrome P-450 CYP3A4 Substrates
p52485
(dp52486
sVRibonucleotides
p52487
g46855
sg2610
g33140
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p52488
g29512
sVAdjuvants, Anesthesia
p52489
(dp52490
sVPsycholeptics
p52491
g33244
sVCytochrome P-450 CYP3A Substrates
p52492
g45207
sVCentral Nervous System Depressants
p52493
(dp52494
sVNucleic Acids, Nucleotides, and Nucleosides
p52495
g47122
sVHeterocyclic Compounds, Fused-Ring
p52496
(dp52497
sVNucleotides
p52498
g49318
sVHypnotics and Sedatives
p52499
(dp52500
sVPyrimidine Nucleotides
p52501
g48571
sVBenzazepines
p52502
(dp52503
sVBenzodiazepines and benzodiazepine derivatives
p52504
(dp52505
sVNervous System
p52506
(dp52507
sVTranquilizing Agents
p52508
(dp52509
ssg5694
(dp52510
VNMDA Receptor Antagonists
p52511
g43498
sVCytochrome P-450 CYP3A4 Inhibitors
p52512
(dp52513
sVCytochrome P-450 CYP2D6 Inhibitors
p52514
(dp52515
sVCytochrome P-450 CYP2D6 Substrates
p52516
g52146
sVKetones
p52517
g50972
sVCytochrome P-450 CYP3A Substrates
p52518
g45209
sVNeurotransmitter Agents
p52519
(dp52520
sVCentral Nervous System Agents
p52521
(dp52522
sVDopamine Agents
p52523
g14246
sVPsychotropic Drugs
p52524
(dp52525
sVDopamine Antagonists
p52526
(dp52527
sVCytochrome P-450 Enzyme Inhibitors
p52528
(dp52529
sVPeripheral Nervous System Agents
p52530
(dp52531
sVHyperglycemia-Associated Agents
p52532
(dp52533
sg861
g20177
sVCytochrome P-450 CYP1A2 Substrates
p52534
g45590
sVAutonomic Agents
p52535
(dp52536
sVAntipsychotic Agents
p52537
(dp52538
sg8994
(dp52539
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p52540
g29514
sVCytochrome P-450 CYP2C9 Substrates
p52541
g29747
sVQTc Prolonging Agents
p52542
(dp52543
sVCentral Nervous System Depressants
p52544
(dp52545
sVAntiemetics
p52546
(dp52547
sVGastrointestinal Agents
p52548
(dp52549
sVDrugs that are Mainly Renally Excreted
p52550
g44014
sVAgents that reduce seizure threshold
p52551
g45851
sVAnti-Dyskinesia Agents
p52552
g50486
sVP-glycoprotein/ABCB1 Substrates
p52553
g34969
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p52554
(dp52555
sVPsycholeptics
p52556
g33245
sVAntipsychotic Agents (First Generation [Typical])
p52557
(dp52558
sVCytochrome P-450 CYP3A4 Substrates
p52559
(dp52560
sVModerate Risk QTc-Prolonging Agents
p52561
(dp52562
sVUGT1A9 Substrates
p52563
g24023
sVDopamine D2 Receptor Antagonists
p52564
g49418
sVCytochrome P-450 CYP3A5 Substrates
p52565
(dp52566
sVCytochrome P-450 CYP3A Inhibitors
p52567
(dp52568
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p52569
(dp52570
sVP-glycoprotein/ABCB1 Inhibitors
p52571
(dp52572
sVNeurotoxic agents
p52573
(dp52574
sVNervous System
p52575
(dp52576
sVTranquilizing Agents
p52577
(dp52578
sVCytochrome P-450 CYP3A7 Substrates
p52579
(dp52580
ssg5697
(dp52581
g9810
(dp52582
sg1875
g27916
sg10767
(dp52583
sg7920
(dp52584
sg8529
(dp52585
sg9780
(dp52586
sg396
g15810
sg129
g13204
sg4557
g46153
sg3699
g40331
sg5532
g51625
sg8649
(dp52587
sg10764
(dp52588
sg11382
(dp52589
sg5025
g48767
sg3099
g36746
sg4770
g47456
ssg5700
(dp52590
g10593
(dp52591
sg8778
(dp52592
sg570
g17490
ssg5703
(dp52593
VAgents Causing Muscle Toxicity
p52594
(dp52595
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p52596
g52098
sVCytochrome P-450 CYP3A4 Inhibitors
p52597
(dp52598
sVOphthalmological and Otological Preparations
p52599
(dp52600
sVCytochrome P-450 CYP3A Substrates
p52601
g45211
sVStomatological Preparations
p52602
(dp52603
sVBCRP/ABCG2 Inhibitors
p52604
g12535
sVBSEP/ABCB11 inducers
p52605
g52260
sVCytochrome P-450 CYP3A5 Inducers
p52606
g41748
sVVasoprotectives
p52607
g41398
sVCytochrome P-450 CYP3A7 Inducers
p52608
g39044
sVHyperglycemia-Associated Agents
p52609
(dp52610
sVHormones
p52611
(dp52612
sVCytochrome P-450 CYP2D6 Inducers
p52613
(dp52614
sVCorticosteroids for Systemic Use
p52615
g48845
sVCytochrome P-450 Enzyme Inhibitors
p52616
(dp52617
sg4653
g46700
sVPeripheral Nervous System Agents
p52618
(dp52619
sg4875
g48044
sg6045
(dp52620
sVCytochrome P-450 CYP2E1 Inducers
p52621
g27614
sVP-glycoprotein/ABCB1 Inducers
p52622
(dp52623
sVCytochrome P-450 CYP3A4 Inducers (strong)
p52624
g23088
sVCorticosteroids for Systemic Use, Plain
p52625
g31768
sVAutonomic Agents
p52626
(dp52627
sVCytochrome P-450 CYP2B6 Inducers
p52628
g39121
sVSteroids, Fluorinated
p52629
(dp52630
sVCorticosteroids, Dermatological Preparations
p52631
g51338
sVOtologicals
p52632
(dp52633
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p52634
g14795
sVPregnadienetriols
p52635
(dp52636
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p52637
g16839
sVCorticosteroids for Local Oral Treatment
p52638
(dp52639
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p52640
g29516
sVFused-Ring Compounds
p52641
g14842
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p52642
g25148
sVCytochrome P-450 CYP3A4 Inducers
p52643
g18916
sVAntineoplastic Agents
p52644
(dp52645
sg12534
(dp52646
sVPregnadienes
p52647
(dp52648
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p52649
g44463
sVAntiemetics
p52650
(dp52651
sVAdrenal Cortex Hormones
p52652
g30033
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p52653
(dp52654
sVAdrenals
p52655
g37370
sVP-glycoprotein/ABCB1 Substrates
p52656
g34970
sVAntineoplastic Agents, Hormonal
p52657
(dp52658
sVDermatologicals
p52659
g17239
sVCytochrome P-450 Enzyme Inducers
p52660
g28159
sVCytochrome P-450 CYP3A Inducers
p52661
(dp52662
sVInducers of Drug Clearance
p52663
g44539
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p52664
g44545
sVCytochrome P-450 CYP3A Inducers (strong)
p52665
g22454
sVCytochrome P-450 CYP2A6 Inducers
p52666
g39429
sVCytochrome P-450 CYP3A4 Substrates
p52667
(dp52668
sVCentral Nervous System Agents
p52669
(dp52670
sVAlimentary Tract and Metabolism
p52671
g23834
sVNasal Preparations
p52672
(dp52673
sVPregnanes
p52674
(dp52675
sVGastrointestinal Agents
p52676
(dp52677
sVAnti-Acne Preparations for Topical Use
p52678
(dp52679
sVOphthalmologicals
p52680
g35206
sVSteroids
p52681
(dp52682
sVCorticosteroids, Moderately Potent (Group II)
p52683
(dp52684
sVCytochrome P-450 CYP3A Inhibitors
p52685
(dp52686
sVImmunosuppressive Agents
p52687
(dp52688
sVAnti-Acne Preparations
p52689
(dp52690
sVCytochrome P-450 CYP2C19 Inducers
p52691
g25539
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p52692
(dp52693
sVAnti-Inflammatory Agents
p52694
(dp52695
sVCorticosteroid Hormone Receptor Agonists
p52696
(dp52697
sVP-glycoprotein/ABCB1 Inhibitors
p52698
(dp52699
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p52700
(dp52701
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p52702
(dp52703
sVCytochrome P-450 CYP2C8 Inducers
p52704
(dp52705
sVHormones, Hormone Substitutes, and Hormone Antagonists
p52706
(dp52707
sVCorticosteroids
p52708
(dp52709
sVCytochrome P-450 CYP3A7 Substrates
p52710
(dp52711
sVSensory Organs
p52712
g40700
ssg5706
(dp52713
g8373
(dp52714
sg1098
g22004
sg8472
(dp52715
sg8211
(dp52716
sg3753
g40617
sg2481
g32389
sg5646
g52337
sg11241
(dp52717
sg9180
(dp52718
ssg5709
(dp52719
g11541
(dp52720
sg3144
g37115
ssg5712
(dp52721
g10692
(dp52722
sg4830
g47814
sg6348
(dp52723
sg5685
g52450
sg2706
g33757
ssg5715
(dp52724
g1782
g27154
sg12000
(dp52725
sg9426
(dp52726
sg11184
(dp52727
sg9657
(dp52728
sg3090
g36696
sg1761
g26988
sg11604
(dp52729
sg9261
(dp52730
sg3207
g37478
sg7662
(dp52731
sg3981
g42030
ssg5718
(dp52732
g6180
(dp52733
sg6228
(dp52734
sg9132
(dp52735
sg9300
(dp52736
sg6213
(dp52737
sg6216
(dp52738
sg3333
g38258
sg9267
(dp52739
sg6903
(dp52740
sg5463
g51256
sg12015
(dp52741
sg11286
(dp52742
sg5514
g51502
sg4713
g47035
sg3801
g40953
sg10002
(dp52743
sg3882
g41412
sg3147
g37143
sg5577
g51835
sg11550
(dp52744
sg9630
(dp52745
sg4905
g48181
sg7809
(dp52746
sg10653
(dp52747
sg10323
(dp52748
sg5622
g52238
sg7407
(dp52749
sg8601
(dp52750
sg7854
(dp52751
sg10104
(dp52752
sg4515
g45900
sg4356
g44697
sg9540
(dp52753
sg3183
g37341
sg6804
(dp52754
sg9426
(dp52755
sg10431
(dp52756
sg11718
(dp52757
sg372
g15401
sg7971
(dp52758
sg4977
g48654
sg7980
(dp52759
sg402
g15848
sg4185
g43470
sg7059
(dp52760
sg11379
(dp52761
sg9897
(dp52762
sg4200
g43530
sg2754
g34071
sg447
g16284
sg2007
g28888
sg8772
(dp52763
sg11046
(dp52764
sg9348
(dp52765
sg3495
g39066
sg11646
(dp52766
sg5847
(dp52767
sg11832
(dp52768
sg1266
g23232
sg8076
(dp52769
sg2817
g34562
sg6612
(dp52770
sg5073
g48989
sg8088
(dp52771
sg11952
(dp52772
sg6630
(dp52773
sg9612
(dp52774
sg8106
(dp52775
sg2118
g30218
sg9627
(dp52776
sg11160
(dp52777
sg10569
(dp52778
sg3573
g39528
sg2886
g35311
sg3588
g39617
sg1776
g27102
sg6360
(dp52779
sg8910
(dp52780
sg7977
(dp52781
sg8598
(dp52782
sg9705
(dp52783
sg2940
g35707
sg669
g18448
sg8325
(dp52784
sg9846
(dp52785
sg11274
(dp52786
sg1482
g25006
sg9741
(dp52787
sg2253
g30884
sg7512
(dp52788
sg8670
(dp52789
sg8769
(dp52790
sg3777
g40825
sg1737
g26915
sg4551
g46107
sg11349
(dp52791
sg357
g15314
sg1563
g25513
sg3090
g36700
sg8274
(dp52792
sg5382
g50723
sg9852
(dp52793
sg5400
g50869
ssg5721
(dp52794
g1704
g26725
sg633
g18089
sg5919
(dp52795
sg7056
(dp52796
sg933
g20835
sg8259
(dp52797
sg1668
g26268
ssg5724
(dp52798
g11862
(dp52799
sg978
g21176
sg879
g20364
ssg5727
(dp52800
g5955
(dp52801
sVDrugs that are Mainly Renally Excreted
p52802
g44019
sVAntigout Preparations
p52803
(dp52804
sg7461
(dp52805
sVAntimetabolites
p52806
(dp52807
sVUricosuric Agents
p52808
(dp52809
sVFree Radical Scavengers
p52810
g45829
sVMusculo-Skeletal System
p52811
g31537
sVOAT3/SLC22A8 Substrates
p52812
g13134
sVBCRP/ABCG2 Substrates
p52813
g42083
sVProtective Agents
p52814
(dp52815
sVEnzyme Inhibitors
p52816
(dp52817
sVHeterocyclic Compounds, Fused-Ring
p52818
(dp52819
sVAntioxidants
p52820
(dp52821
sVPurines
p52822
(dp52823
ssg5730
(dp52824
g7395
(dp52825
ssg5733
(dp52826
g8217
(dp52827
sg4491
g45792
sg8928
(dp52828
ssg5736
(dp52829
VAntiinfectives for Systemic Use
p52830
(dp52831
sVDrugs that are Mainly Renally Excreted
p52832
g44052
sVHeterocyclic Compounds, Fused-Ring
p52833
(dp52834
sVbeta-Lactams
p52835
(dp52836
sVLactams
p52837
g22285
sVCarbapenems
p52838
(dp52839
sVAmides
p52840
g44344
sVSulfur Compounds
p52841
(dp52842
sVAnti-Bacterial Agents
p52843
g38384
sVAntibacterials for Systemic Use
p52844
g32580
sg9072
(dp52845
sVAnti-Infective Agents
p52846
(dp52847
sVPenem Antibacterial
p52848
g26893
ssg5739
(dp52849
VCytochrome P-450 CYP3A4 Inhibitors
p52850
(dp52851
sVPeripheral Opioid Receptor Antagonists
p52852
g12732
sVUGT1A1 Substrates
p52853
g12323
sVAnalgesics
p52854
g26453
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p52855
(dp52856
sVDrugs for Constipation
p52857
(dp52858
sVCytochrome P-450 Enzyme Inhibitors
p52859
(dp52860
sVOpiate Antagonists
p52861
(dp52862
sVPeripheral Nervous System Agents
p52863
(dp52864
sVDrugs that are Mainly Renally Excreted
p52865
g43880
sVCytochrome P-450 CYP2C8 Substrates
p52866
(dp52867
sVNatural Opium Alkaloids
p52868
g23481
sVOpioids
p52869
g32241
sVOpiate Alkaloids
p52870
(dp52871
sVP-glycoprotein/ABCB1 Substrates
p52872
g34971
sVCentral Nervous System Agents
p52873
(dp52874
sVOpioid Antagonists
p52875
(dp52876
sVCytochrome P-450 CYP3A Inhibitors (strong)
p52877
g13398
sVMorphinans
p52878
(dp52879
sVAntidotes
p52880
(dp52881
sVAlimentary Tract and Metabolism
p52882
g23835
sVHeterocyclic Compounds, Fused-Ring
p52883
(dp52884
sVCytochrome P-450 CYP3A Inhibitors
p52885
(dp52886
sVAlkaloids
p52887
g19424
sVSensory System Agents
p52888
(dp52889
sVPhenanthrenes
p52890
g32842
sVNervous System
p52891
(dp52892
ssg5742
(dp52893
g8616
(dp52894
sg1278
g23350
sg8850
(dp52895
sg1872
g27861
sg126
g13187
sg1176
g22692
sg6432
(dp52896
sg9750
(dp52897
sg3267
g37904
sg4872
g47994
sg7653
(dp52898
ssg5745
(dp52899
g5256
g50105
sg10728
(dp52900
ssg5748
(dp52901
g1875
g27891
sg657
g18356
sg9561
(dp52902
ssg5751
(dp52903
g5766
(dp52904
sg9609
(dp52905
sg8694
(dp52906
sg9693
(dp52907
sg6783
(dp52908
ssg5754
(dp52909
g5847
(dp52910
sg7524
(dp52911
ssg5757
(dp52912
VUGT1A1 Substrates
p52913
g12330
sVChelating Agents
p52914
(dp52915
sVCompounds used in a research, industrial, or household setting
p52916
(dp52917
sg10299
(dp52918
sVCytochrome P-450 Enzyme Inhibitors
p52919
(dp52920
sVTriazoles
p52921
g47838
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p52922
g23124
sVAcids, Carbocyclic
p52923
g41577
sVCytochrome P450 1A2 Inhibitors
p52924
g16809
sVCytochrome P450 3A4 Inducers
p52925
(dp52926
sVCytochrome P-450 CYP3A4 Inducers
p52927
g18926
sVBenzene Derivatives
p52928
(dp52929
sVCytochrome P-450 CYP1A2 Inhibitors
p52930
g15044
sVCytochrome P-450 CYP2C8 Inhibitors
p52931
(dp52932
sVSequestering Agents
p52933
(dp52934
sVUGT1A1 Inhibitors
p52935
(dp52936
sVCytochrome P-450 Enzyme Inducers
p52937
g28173
sVCytochrome P-450 CYP3A Inducers
p52938
(dp52939
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p52940
g49344
sg2136
g30317
sVUGT1A3 Inhibitors
p52941
g19234
sVBenzoates
p52942
g30398
sg10032
(dp52943
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p52944
(dp52945
sVUGT1A9 Inhibitors
p52946
(dp52947
ssg5760
(dp52948
g8823
(dp52949
ssg5763
(dp52950
g5622
g52253
sg7854
(dp52951
sg6903
(dp52952
ssg5766
(dp52953
g6243
(dp52954
sVCytochrome P-450 CYP3A Substrates
p52955
g45221
sVStomatological Preparations
p52956
(dp52957
sg237
g14156
sVBCRP/ABCG2 Inhibitors
p52958
g12517
sVVasoprotectives
p52959
g41384
sVHormones
p52960
(dp52961
sVOtologicals
p52962
(dp52963
sVCorticosteroids for Systemic Use
p52964
g48841
sVHyperglycemia-Associated Agents
p52965
(dp52966
sVCorticosteroids for Systemic Use, Plain
p52967
g31762
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p52968
(dp52969
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p52970
(dp52971
sVCorticosteroids Acting Locally
p52972
(dp52973
sVOphthalmological and Otological Preparations
p52974
(dp52975
sg9567
(dp52976
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p52977
g16823
sVCorticosteroids for Local Oral Treatment
p52978
(dp52979
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p52980
g29530
sVFused-Ring Compounds
p52981
g14852
sVCytochrome P-450 CYP3A4 Inducers
p52982
g18928
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p52983
g44466
sVAdrenal Cortex Hormones
p52984
g30054
sg10359
(dp52985
sg123
g13145
sVAdrenals
p52986
g37378
sVP-glycoprotein/ABCB1 Substrates
p52987
g34954
sVDermatologicals
p52988
g17254
sVCytochrome P-450 Enzyme Inducers
p52989
g28176
sVCytochrome P-450 CYP3A Inducers
p52990
(dp52991
sVCytochrome P-450 CYP3A4 Substrates
p52992
(dp52993
sVAlimentary Tract and Metabolism
p52994
g23911
sVNasal Preparations
p52995
(dp52996
sVPregnanes
p52997
(dp52998
sVCytochrome P-450 CYP3A5 Substrates
p52999
(dp53000
sVOphthalmologicals
p53001
g35217
sVPregnenediones
p53002
g29966
sg5751
g52904
sVCytochrome P-450 CYP2C8 Inducers
p53003
(dp53004
sVSteroids
p53005
(dp53006
sVImmunosuppressive Agents
p53007
(dp53008
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p53009
(dp53010
sVAnti-Inflammatory Agents
p53011
(dp53012
sVCorticosteroid Hormone Receptor Agonists
p53013
(dp53014
sVPregnenes
p53015
g28752
sVIntestinal Antiinflammatory Agents
p53016
(dp53017
sVCorticosteroids, Dermatological Preparations
p53018
g51331
sVHormones, Hormone Substitutes, and Hormone Antagonists
p53019
(dp53020
sVCorticosteroids
p53021
(dp53022
sVCytochrome P-450 CYP3A7 Substrates
p53023
(dp53024
sVSensory Organs
p53025
g40710
ssg5769
(dp53026
VGABA Agents
p53027
g16226
sVCytochrome P-450 CYP3A Substrates
p53028
g45222
sVNeurotransmitter Agents
p53029
(dp53030
sVAnti-Anxiety Agents
p53031
g35657
sVCentral Nervous System Agents
p53032
(dp53033
sVUGT1A9 Substrates
p53034
g24025
sg11412
(dp53035
sVPsychotropic Drugs
p53036
(dp53037
sVGABA Modulators
p53038
g39060
sVDrugs that are Mainly Renally Excreted
p53039
g44022
sVCytochrome P-450 CYP3A4 Substrates
p53040
(dp53041
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53042
g29531
sVPsycholeptics
p53043
g33260
sVCentral Nervous System Depressants
p53044
(dp53045
sVHeterocyclic Compounds, Fused-Ring
p53046
(dp53047
sVHypnotics and Sedatives
p53048
(dp53049
sg7173
(dp53050
sg588
g17661
sVUGT2B7 substrates
p53051
g28644
sg9672
(dp53052
sVNervous System
p53053
(dp53054
sVTranquilizing Agents
p53055
(dp53056
ssg5772
(dp53057
g4647
g46590
sg7464
(dp53058
sg11793
(dp53059
sg10818
(dp53060
sg11592
(dp53061
sg6192
(dp53062
sg4635
g46516
sg816
g19706
sg6318
(dp53063
sg12066
(dp53064
sg11979
(dp53065
sg1434
g24691
sg9165
(dp53066
sg1650
g26130
sg1248
g23047
sg11151
(dp53067
sg2658
g33398
sg8721
(dp53068
sg10005
(dp53069
sg7029
(dp53070
sg822
g19814
sg288
g14706
sg11940
(dp53071
sg1491
g25117
sg1425
g24572
sg4887
g48106
sg102
g13027
sg5694
g52570
sg8874
(dp53072
sg2910
g35565
sg6279
(dp53073
sg10518
(dp53074
sg9462
(dp53075
sg2769
g34313
sg9231
(dp53076
sg10365
(dp53077
sg3036
g36459
sg7941
(dp53078
sg7569
(dp53079
sg450
g16360
sg9393
(dp53080
sg564
g17432
sg4542
g46081
sg147
g13501
sg7563
(dp53081
sg10179
(dp53082
sg3570
g39511
sg3978
g42016
sg5169
g49547
sg9663
(dp53083
sg6729
(dp53084
sg2088
g29951
sg10815
(dp53085
sg3447
g38965
sg6537
(dp53086
sg1185
g22749
sg10056
(dp53087
sg2784
g34382
ssg5775
(dp53088
g1482
g25020
ssg5778
(dp53089
g645
g18135
sg5532
g51627
sg1629
g26005
sg9507
(dp53090
sg4737
g47242
sg10296
(dp53091
ssg5781
(dp53092
VOpiate Partial Agonists
p53093
g28785
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p53094
(dp53095
sVAnalgesics
p53096
g26467
sVCentral Nervous System Agents
p53097
(dp53098
sVNarcotics
p53099
(dp53100
sVPeripheral Nervous System Agents
p53101
(dp53102
sVMixed Agonist / Antagonist Opioids
p53103
(dp53104
sg432
g16137
sVAdjuvants, Anesthesia
p53105
(dp53106
sVCentral Nervous System Depressants
p53107
(dp53108
sVOpioids
p53109
g32235
sVAgents that reduce seizure threshold
p53110
g45845
sVOpiate Alkaloids
p53111
(dp53112
sVP-glycoprotein/ABCB1 Substrates
p53113
g35006
sVOpioid Antagonists
p53114
(dp53115
sg5943
(dp53116
sVMorphinans
p53117
(dp53118
sVHeterocyclic Compounds, Fused-Ring
p53119
(dp53120
sVP-glycoprotein/ABCB1 Inhibitors
p53121
(dp53122
sVAlkaloids
p53123
g19410
sVSensory System Agents
p53124
(dp53125
sVPhenanthrenes
p53126
g32836
sVNervous System
p53127
(dp53128
sg3330
g38246
ssg5784
(dp53129
g6180
(dp53130
sg5409
g50908
sg11274
(dp53131
sg6228
(dp53132
sg4620
g46360
sg4935
g48451
sg5433
g51077
sg831
g19917
sg834
g19971
sg837
g20000
sg1800
g27351
sg4653
g46761
sg1650
g26135
sg10149
(dp53133
sg7668
(dp53134
sg543
g17130
sg8430
(dp53135
sg11460
(dp53136
sg11952
(dp53137
sg8445
(dp53138
sg2388
g31694
sg339
g15192
sg8457
(dp53139
sg102
g13029
sg5514
g51513
sg6279
(dp53140
sg9225
(dp53141
sg3219
g37572
sg9903
(dp53142
sg4053
g42555
sg2283
g31158
sg3861
g41300
sg816
g19712
sg147
g13507
sg12045
(dp53143
sg966
g21068
sg8949
(dp53144
sg6345
(dp53145
sg8013
(dp53146
sg11259
(dp53147
sg7821
(dp53148
sg10323
(dp53149
sg714
g19035
sg11592
(dp53150
sg7962
(dp53151
sg4821
g47749
sg4365
g44759
sg7407
(dp53152
sg12274
g27579
sg11046
(dp53153
sg1050
g21705
sg4875
g48039
sg11922
(dp53154
sg7545
(dp53155
sg4515
g45915
sg1614
g25915
sg4680
g46908
sg14838
g40027
sg12534
g52707
sg9357
(dp53156
sg4113
g43085
sg1899
g28095
sg8694
(dp53157
sg4143
g43156
sg10209
(dp53158
sg4170
g43388
sg14872
g15776
sg2703
g33736
sg14829
(dp53159
sg5766
g53020
sg402
g15866
sg8763
(dp53160
sg2373
g31634
sg5463
g51258
sg7221
(dp53161
sg444
g16269
sg2007
g28910
sg2763
g34256
sg10041
(dp53162
sg4236
g43728
sg1047
g21641
sg8796
(dp53163
sg8055
(dp53164
sg2043
g29072
sg8808
(dp53165
sg7689
(dp53166
sg4278
g44264
sg10338
(dp53167
sg2817
g34578
sg11097
(dp53168
sg5895
(dp53169
sg8088
(dp53170
sg11886
(dp53171
sg9609
(dp53172
sg3543
g39366
sg8106
(dp53173
sg1503
g25204
sg8856
(dp53174
sg10416
(dp53175
sg4338
g44575
sg11160
(dp53176
sg8142
(dp53177
sg2886
g35327
sg1776
g27104
sg6360
(dp53178
sg1383
g24179
sg2172
g30531
sg11940
(dp53179
sg9372
(dp53180
sg3627
g39949
sg13750
g24421
sg9693
(dp53181
sg528
g16954
sg9366
(dp53182
sg5370
g50695
sg6045
(dp53183
sg11997
(dp53184
sg1470
g24940
sg6783
(dp53185
sg12042
(dp53186
sg6798
(dp53187
sg2253
g30901
sg3393
g38600
sg9774
(dp53188
sg3024
g36335
sg11316
(dp53189
sg2832
g34751
sg5238
g49898
sg6123
(dp53190
sg2286
g31172
sg3783
g40893
sg10563
(dp53191
sg6015
(dp53192
sg6048
(dp53193
sg12132
(dp53194
sg9060
(dp53195
sg801
g19545
ssg5787
(dp53196
g11820
(dp53197
sg603
g17783
sg4926
g48424
sg7641
(dp53198
sg5934
(dp53199
ssg5790
(dp53200
g3117
g36943
ssg5793
(dp53201
VAntiplatelet agents
p53202
g46308
sg627
g17990
sVAnticoagulants
p53203
(dp53204
sVFibrin Modulating Agents
p53205
g22861
sg3483
g39028
sg2655
g33334
sVCytochrome P-450 Enzyme Inhibitors
p53206
(dp53207
sVHighest Risk QTc-Prolonging Agents
p53208
g35877
sVCytochrome P-450 CYP1A2 Substrates
p53209
g45598
sg1671
g26306
sg6900
(dp53210
sVQTc Prolonging Agents
p53211
(dp53212
sVAntineoplastic Agents
p53213
(dp53214
sVPhosphodiesterase 5 Inhibitors
p53215
(dp53216
sVCardiovascular Agents
p53217
g26603
sVAntineoplastic and Immunomodulating Agents
p53218
g39778
sVCytochrome P-450 CYP1A2 Inhibitors
p53219
g15053
sVVasodilating Agents
p53220
g23730
sVHematologic Agents
p53221
(dp53222
sVHeterocyclic Compounds, Fused-Ring
p53223
(dp53224
sVAgents producing tachycardia
p53225
g50800
sVPhosphodiesterase Inhibitors
p53226
(dp53227
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p53228
g30536
ssg5796
(dp53229
VAdrenergic beta-Agonists
p53230
g43009
sVAdrenergic beta-2 Receptor Agonists
p53231
(dp53232
sVHeterocyclic Compounds, Fused-Ring
p53233
(dp53234
sVQuinolines
p53235
(dp53236
sVP-glycoprotein/ABCB1 Substrates
p53237
g34993
sVUGT1A1 Substrates
p53238
g12342
sVCytochrome P-450 CYP3A Substrates
p53239
g45225
sVAgents to Treat Airway Disease
p53240
g32650
sg6813
(dp53241
sVPotential QTc-Prolonging Agents
p53242
(dp53243
sVSelective Beta 2-adrenergic Agonists
p53244
(dp53245
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53246
g29536
sVAdrenergic Agonists
p53247
(dp53248
sVAgents producing tachycardia
p53249
g50772
sVAgents that produce hypertension
p53250
(dp53251
sVQTc Prolonging Agents
p53252
(dp53253
sVCytochrome P-450 CYP3A4 Substrates
p53254
(dp53255
sVDrugs for Obstructive Airway Diseases
p53256
g42532
sVAdrenergics, Inhalants
p53257
g43177
ssg5799
(dp53258
g2451
g32227
ssg5802
(dp53259
g7014
(dp53260
ssg5805
(dp53261
VCytochrome P-450 CYP2D6 Inhibitors
p53262
(dp53263
sVCytochrome P-450 CYP2D6 Substrates
p53264
g52164
sVAntiarrhythmic agents
p53265
(dp53266
sVCytochrome P-450 CYP3A Substrates
p53267
g45032
sVAgents causing hyperkalemia
p53268
g43602
sVAdrenergic Antagonists
p53269
g52264
sVCytochrome P-450 Enzyme Inhibitors
p53270
(dp53271
sVCytochrome P-450 CYP3A4 Substrates
p53272
(dp53273
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p53274
g23095
sVCardiac Therapy
p53275
(dp53276
sVKetones
p53277
g50967
sVMembrane Transport Modulators
p53278
(dp53279
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53280
g29296
sVQTc Prolonging Agents
p53281
(dp53282
sVCardiovascular Agents
p53283
g26607
sVCytochrome P-450 CYP1A2 Inhibitors
p53284
g14988
sVCytochrome P-450 CYP2C8 Inhibitors
p53285
(dp53286
sVAdrenergic beta-Antagonists
p53287
g15347
sg942
g20873
sVCytochrome P-450 CYP1A2 Substrates
p53288
g45600
sVAgents that produce hypertension
p53289
(dp53290
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p53291
g49321
sVSodium Channel Blockers
p53292
(dp53293
sVModerate Risk QTc-Prolonging Agents
p53294
(dp53295
sVAntiarrhythmics, Class I
p53296
(dp53297
sVVoltage-Gated Sodium Channel Blockers
p53298
g40902
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p53299
g13740
sVBradycardia-Causing Agents
p53300
(dp53301
sVPropiophenones
p53302
g37751
sVP-glycoprotein/ABCB1 Inhibitors
p53303
(dp53304
ssg5808
(dp53305
g669
g18443
ssg5811
(dp53306
g3573
g39532
ssg5814
(dp53307
g8388
(dp53308
ssg5817
(dp53309
VHeterocyclic Compounds, Fused-Ring
p53310
(dp53311
sVP-glycoprotein/ABCB1 Substrates
p53312
g34998
sVBCRP/ABCG2 Substrates
p53313
g42053
sVBCRP/ABCG2 Inhibitors
p53314
g12509
sVKinase Inhibitor
p53315
g24584
sVQuinazolines
p53316
(dp53317
sVAmides
p53318
g44329
sVP-glycoprotein/ABCB1 Inhibitors
p53319
(dp53320
sVAntineoplastic and Immunomodulating Agents
p53321
g39781
sVTyrosine Kinase Inhibitors
p53322
g30822
sVEnzyme Inhibitors
p53323
(dp53324
sVProtein Kinase Inhibitors
p53325
(dp53326
sVAntineoplastic Agents
p53327
(dp53328
ssg5820
(dp53329
g10200
(dp53330
sg2784
g34346
sg2553
g32895
sg10185
(dp53331
sg10767
(dp53332
sg6567
(dp53333
sg657
g18291
sg7713
(dp53334
sg8322
(dp53335
sg8031
(dp53336
sg9561
(dp53337
sg7020
(dp53338
sg789
g19473
sg5085
g49035
sg5286
g50197
sg1041
g21514
sg8406
(dp53339
sg4581
g46208
sg5739
g52858
sg3825
g41025
sg8010
(dp53340
ssg5823
(dp53341
g7971
(dp53342
ssg5826
(dp53343
g9153
(dp53344
sg4008
g42199
sg2397
g31784
ssg5829
(dp53345
VAntiarrhythmic agents
p53346
(dp53347
sVCytochrome P-450 CYP3A Substrates
p53348
g45231
sVAgents causing hyperkalemia
p53349
g43605
sVHypotensive Agents
p53350
g34159
sVBeta blocking agents and calcium channel blockers
p53351
(dp53352
sVAdrenergic Antagonists
p53353
g52267
sVPeripheral Nervous System Agents
p53354
(dp53355
sg6405
(dp53356
sVDrugs that are Mainly Renally Excreted
p53357
g44029
sVAmines
p53358
g42713
sg4668
g46817
sVAntihypertensive Agents
p53359
g20292
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53360
g29544
sVBeta Blocking Agents, Selective
p53361
g51451
sVAdrenergic Agents
p53362
g41691
sVNeurotransmitter Agents
p53363
(dp53364
sVCardiovascular Agents
p53365
g26608
sVP-glycoprotein/ABCB1 Substrates
p53366
g35000
sVAdrenergic beta-Antagonists
p53367
g15350
sg939
g20867
sVCytochrome P-450 CYP3A4 Substrates
p53368
(dp53369
sg3213
g37500
sVAutonomic Agents
p53370
(dp53371
sVBeta Blocking Agents and Thiazides
p53372
g47427
sVAmino Alcohols
p53373
g32668
sVBradycardia-Causing Agents
p53374
(dp53375
sg6339
(dp53376
sVP-glycoprotein/ABCB1 Inhibitors
p53377
(dp53378
sVBeta-Blockers (Beta1 Selective)
p53379
(dp53380
sVAlcohols
p53381
(dp53382
sVBeta Blocking Agents, Selective, and Thiazides
p53383
g52069
ssg5832
(dp53384
VCytochrome P-450 CYP3A4 Inhibitors
p53385
(dp53386
sV2-Pyridinylmethylsulfinylbenzimidazoles
p53387
(dp53388
sVCytochrome P-450 CYP2D6 Inhibitors
p53389
(dp53390
sVCytochrome P-450 CYP3A Substrates
p53391
g45232
sVBCRP/ABCG2 Inhibitors
p53392
g12513
sg8916
(dp53393
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p53394
g49907
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p53395
g43758
sVEnzyme Inhibitors
p53396
(dp53397
sVGastrointestinal Agents
p53398
(dp53399
sVCytochrome P-450 Enzyme Inhibitors
p53400
(dp53401
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p53402
g18391
sVAcid Reducers
p53403
g43811
sVCytochrome P-450 CYP2C8 Substrates
p53404
(dp53405
sVCytochrome P-450 CYP3A4 Substrates
p53406
(dp53407
sVSulfoxides
p53408
(dp53409
sVHeterocyclic Compounds, Fused-Ring
p53410
(dp53411
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53412
g29545
sVSulfur Compounds
p53413
(dp53414
sVCytochrome P-450 CYP2C9 Substrates
p53415
g29770
sVCytochrome P-450 CYP3A4 Inducers
p53416
g18934
sVProton Pump Inhibitors
p53417
(dp53418
sVAnti-Ulcer Agents
p53419
(dp53420
sVCytochrome P-450 CYP2C19 Substrates
p53421
(dp53422
sVCytochrome P-450 CYP1A2 Inducers
p53423
(dp53424
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p53425
(dp53426
sVCytochrome P-450 CYP1A2 Inhibitors
p53427
g14998
sVP-glycoprotein/ABCB1 Substrates
p53428
g35001
sVPyridines
p53429
(dp53430
sVGastric Acid Lowering Agents
p53431
(dp53432
sVProton-pump Inhibitors
p53433
g31274
sVCytochrome P-450 Enzyme Inducers
p53434
g28187
sVCytochrome P-450 CYP3A Inducers
p53435
(dp53436
sVCytochrome P-450 CYP2C18 Substrates
p53437
g20925
sVCytochrome P-450 CYP2C19 Inhibitors
p53438
(dp53439
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p53440
g17439
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p53441
g49325
sVAlimentary Tract and Metabolism
p53442
g23860
sVBenzimidazoles
p53443
(dp53444
sVCytochrome P-450 CYP3A Inhibitors
p53445
(dp53446
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p53447
(dp53448
sVDrugs for Acid Related Disorders
p53449
(dp53450
sVP-glycoprotein/ABCB1 Inhibitors
p53451
(dp53452
sVCytochrome P450 2C19 Inhibitors
p53453
(dp53454
ssg5835
(dp53455
VTars
p53456
(dp53457
sVKeratolytic Agents
p53458
(dp53459
sVComplex Mixtures
p53460
(dp53461
sVKeratoplastic Agents
p53462
(dp53463
sVDermatologicals
p53464
g17267
ssg5838
(dp53465
g6411
(dp53466
sg11544
(dp53467
sg10296
(dp53468
sg7464
(dp53469
sg11793
(dp53470
sg10818
(dp53471
sg4635
g46465
sg9393
(dp53472
sg7569
(dp53473
sg1491
g25052
sg3447
g38907
sg2433
g32150
sg141
g13322
sg1770
g27044
sg11727
(dp53474
ssg5841
(dp53475
g10728
(dp53476
sg10518
(dp53477
sg1401
g24308
sg7317
(dp53478
sg7734
(dp53479
sg9561
(dp53480
sg5256
g50053
sg4287
g44374
sg10539
(dp53481
sg657
g18306
sg1869
g27819
sg888
g20429
sg2730
g33868
sg11619
(dp53482
sg10350
(dp53483
sg5145
g49355
sg4959
g48525
ssg5844
(dp53484
g5532
g51634
sg11085
(dp53485
sg11751
(dp53486
sg10587
(dp53487
sg11826
(dp53488
ssg5847
(dp53489
g9321
(dp53490
sVAntivirals for Systemic Use
p53491
(dp53492
sg8202
(dp53493
sg2568
g32998
sVDirect Acting Antivirals
p53494
g38049
sVAnti-HIV Agents
p53495
(dp53496
sVBiological Factors
p53497
g38098
sg9873
(dp53498
sg10872
(dp53499
sVAnti-Infective Agents
p53500
(dp53501
sVFusion Protein Inhibitors
p53502
(dp53503
sVAntiinfectives for Systemic Use
p53504
(dp53505
sg4047
g42500
sg81
g12885
sg5676
g52433
sg3165
g37228
sVMembrane Proteins
p53506
g52380
sg11487
(dp53507
sg9435
(dp53508
sg11499
(dp53509
sVProteins
p53510
g52767
sg5343
g50538
sVPeptides
p53511
g47190
sg3210
g37498
sg5586
g51894
sVAmino Acids, Peptides, and Proteins
p53512
g47373
sVAnti-Retroviral Agents
p53513
(dp53514
sg5754
g52910
sVAntiviral Agents
p53515
g30433
sg2823
g34596
sg7200
(dp53516
ssg5850
(dp53517
g9627
(dp53518
sg5847
g53503
ssg5853
(dp53519
VCytochrome P-450 CYP3A4 Inhibitors
p53520
(dp53521
sVCytochrome P-450 CYP2D6 Inhibitors
p53522
(dp53523
sVGABA Agents
p53524
g16207
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p53525
g41066
sVCytochrome P-450 CYP3A Substrates
p53526
g45235
sVNeurotransmitter Agents
p53527
(dp53528
sVAnti-Anxiety Agents
p53529
g35647
sVCentral Nervous System Agents
p53530
(dp53531
sVGABA-A Receptor Agonists
p53532
g48821
sVPsychotropic Drugs
p53533
(dp53534
sVCytochrome P-450 CYP2B6 Substrates
p53535
g33022
sVCytochrome P-450 Enzyme Inhibitors
p53536
(dp53537
sVDrugs that are Mainly Renally Excreted
p53538
g44031
sVCytochrome P-450 CYP3A4 Inducers (weak)
p53539
g19506
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53540
g29549
sVCytochrome P450 3A4 Inducers
p53541
(dp53542
sVCytochrome P-450 CYP3A4 Inducers
p53543
g18936
sVCytochrome P-450 CYP2C19 Substrates
p53544
(dp53545
sVCentral Nervous System Depressants
p53546
(dp53547
sVAnticonvulsants
p53548
(dp53549
sVP-glycoprotein/ABCB1 Substrates
p53550
g35004
sVCytochrome P-450 Enzyme Inducers
p53551
g28190
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p53552
(dp53553
sVCytochrome P-450 CYP2C18 Substrates
p53554
g20945
sVCytochrome P450 2D6 Inhibitors
p53555
(dp53556
sVHeterocyclic Compounds, Fused-Ring
p53557
(dp53558
sVCytochrome P-450 CYP3A4 Substrates
p53559
(dp53560
sVBenzazepines
p53561
(dp53562
sVPsycholeptics
p53563
g33233
sVCytochrome P-450 CYP3A Inhibitors
p53564
(dp53565
sVGABA Agonists
p53566
g13095
sVBenzodiazepines and benzodiazepine derivatives
p53567
(dp53568
sVNervous System
p53569
(dp53570
sVTranquilizing Agents
p53571
(dp53572
sVCytochrome P-450 CYP3A Inducers
p53573
(dp53574
ssg5856
(dp53575
g1266
g23238
sg5463
g51262
ssg5859
(dp53576
g5250
g49948
sg4257
g44075
sg7821
(dp53577
sg10512
(dp53578
ssg5862
(dp53579
g8322
(dp53580
sg10497
(dp53581
sg11136
(dp53582
ssg5865
(dp53583
VAgents that produce neuromuscular block (indirect)
p53584
g37963
sVCarbohydrates
p53585
(dp53586
sVCytochrome P-450 CYP3A4 Inhibitors
p53587
(dp53588
sVAnti-Acne Preparations
p53589
(dp53590
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p53591
g43762
sVEnzyme Inhibitors
p53592
(dp53593
sVCytochrome P-450 Enzyme Inhibitors
p53594
(dp53595
sVAnti-Infective Agents
p53596
(dp53597
sVAntiinfectives for Systemic Use
p53598
(dp53599
sVLincosamides
p53600
g26220
sVGynecological Antiinfectives and Antiseptics
p53601
(dp53602
sVLincomycin
p53603
g14781
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53604
g29551
sVMacrolides, Lincosamides and Streptogramins
p53605
g33211
sVDecreased Sebaceous Gland Activity
p53606
g42861
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p53607
(dp53608
sVCytochrome P-450 CYP3A Substrates
p53609
g45237
sVProtein Synthesis Inhibitors
p53610
g45548
sVGlycosides
p53611
(dp53612
sVPyrrolidines
p53613
(dp53614
sVAnti-Bacterial Agents
p53615
g38361
sVDermatologicals
p53616
g17273
sVLincomycins
p53617
(dp53618
sVAntibacterials for Systemic Use
p53619
g32559
sVCytochrome P-450 CYP3A4 Substrates
p53620
(dp53621
sVNarrow Therapeutic Index Drugs
p53622
g50555
sVAnti-Acne Preparations for Topical Use
p53623
(dp53624
sVGenito Urinary System and Sex Hormones
p53625
(dp53626
sVCytochrome P-450 CYP3A Inhibitors
p53627
(dp53628
sVNeurotoxic agents
p53629
(dp53630
sVLincosamide Antibacterial
p53631
g28763
sVAntiinfectives for Treatment of Acne
p53632
(dp53633
ssg5868
(dp53634
g11370
(dp53635
ssg5871
(dp53636
VAntiinfectives for Systemic Use
p53637
(dp53638
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p53639
g14477
sVAntivirals for Systemic Use
p53640
(dp53641
sVHeterocyclic Compounds, Fused-Ring
p53642
(dp53643
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p53644
(dp53645
sVNucleoside Reverse Transcriptase Inhibitors
p53646
g38841
sVNucleosides and Nucleotides
p53647
g39108
sVAntiviral Agents
p53648
g30434
sVDirect Acting Antivirals
p53649
g38050
sVCytochrome P-450 CYP1A2 Substrates
p53650
g45626
sVPurinones
p53651
g48142
sVAnti-Infective Agents
p53652
(dp53653
sVPurines
p53654
(dp53655
ssg5874
(dp53656
g168
g13673
sg8856
(dp53657
sg6525
(dp53658
ssg5877
(dp53659
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p53660
g52083
sg1977
g28787
sVCytochrome P-450 CYP3A4 Inhibitors
p53661
(dp53662
sg1722
g26860
sVCytochrome P-450 CYP2D6 Inhibitors
p53663
(dp53664
sVCytochrome P-450 CYP2D6 Substrates
p53665
g52168
sVUGT1A1 Substrates
p53666
g12291
sVAnalgesics
p53667
g26470
sg10083
(dp53668
sg4632
g46448
sVBCRP/ABCG2 Inhibitors
p53669
g12527
sVUGT1A9 Substrates
p53670
g24004
sVCytochrome P-450 Enzyme Inhibitors
p53671
(dp53672
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p53673
g18401
sVPeripheral Nervous System Agents
p53674
(dp53675
sVCytochrome P-450 CYP2C8 Substrates
p53676
(dp53677
sVCytochrome P-450 CYP3A4 Substrates
p53678
(dp53679
sg1449
g24716
sg10125
(dp53680
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53681
g29552
sg6495
(dp53682
sVCytochrome P-450 CYP2C9 Substrates
p53683
g29779
sVCytochrome P-450 CYP3A Substrates
p53684
g45238
sg618
g17929
sVCentral Nervous System Depressants
p53685
(dp53686
sVOpioids
p53687
g32238
sg9438
(dp53688
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p53689
(dp53690
sg951
g20934
sg8124
(dp53691
sVCytochrome P-450 CYP2C19 Inhibitors
p53692
(dp53693
sVHeterocyclic Compounds, Fused-Ring
p53694
(dp53695
sVCentral Nervous System Agents
p53696
(dp53697
sVNervous System
p53698
(dp53699
sVCytochrome P-450 CYP3A5 Substrates
p53700
(dp53701
sVCytochrome P-450 CYP3A Inhibitors
p53702
(dp53703
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p53704
(dp53705
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p53706
(dp53707
sVP-glycoprotein/ABCB1 Inhibitors
p53708
(dp53709
sVAlkaloids
p53710
g19415
sVSensory System Agents
p53711
(dp53712
sg2544
g32838
sVCytochrome P-450 CYP2A6 Inhibitors
p53713
g48582
sVCytochrome P-450 CYP3A7 Substrates
p53714
(dp53715
ssg5880
(dp53716
VToxic Actions
p53717
g49391
sVHeterocyclic Compounds, Fused-Ring
p53718
(dp53719
sVMyelosuppressive Agents
p53720
(dp53721
sVAntimetabolites
p53722
(dp53723
sVNoxae
p53724
(dp53725
sVImmunosuppressive Agents
p53726
(dp53727
sVPurine Analogues
p53728
(dp53729
sVAntineoplastic and Immunomodulating Agents
p53730
g39787
sVAntimetabolites, Antineoplastic
p53731
g23456
sVThiopurine Analogs
p53732
g40253
sVAntineoplastic Agents
p53733
(dp53734
sVPurines
p53735
(dp53736
ssg5883
(dp53737
g630
g18019
sg1425
g24553
sg240
g14190
sg6318
(dp53738
sg11979
(dp53739
sg9711
(dp53740
sg10674
(dp53741
sg2658
g33366
sg282
g14591
sg8805
(dp53742
sg11016
(dp53743
sg822
g19822
sg516
g16868
sg2814
g34515
sg7299
(dp53744
sg5694
g52527
sg1707
g26770
sg6966
(dp53745
sg2265
g31006
sg12066
(dp53746
sg5535
g51658
sg486
g16649
sg7941
(dp53747
sg11790
(dp53748
sg6303
(dp53749
sg696
g18707
sg3570
g39461
sg5169
g49516
sg387
g15616
sg2664
g33426
sg10815
(dp53750
sg1194
g22816
sg414
g15957
sg8187
(dp53751
sg780
g19353
ssg5886
(dp53752
g7359
(dp53753
sg11154
(dp53754
sg7176
(dp53755
sg12421
g12426
sg7065
(dp53756
sg7197
(dp53757
sg6921
(dp53758
sg7593
(dp53759
sg168
g13619
sg2289
g31184
ssg5889
(dp53760
VDrugs that are Mainly Renally Excreted
p53761
g43902
sVOligosaccharides
p53762
g33107
sVGlycoside Hydrolase Inhibitors
p53763
(dp53764
sVCarbohydrates
p53765
(dp53766
sVHypoglycemia-Associated Agents
p53767
g17703
sVOral Hypoglycemics
p53768
g35997
sVEnzyme Inhibitors
p53769
(dp53770
sg11007
(dp53771
sVBlood Glucose Lowering Agents
p53772
(dp53773
sVAlimentary Tract and Metabolism
p53774
g23875
sVDrugs Used in Diabetes
p53775
(dp53776
sVPolysaccharides
p53777
g41781
ssg5892
(dp53778
g5853
g53542
sg10362
(dp53779
sg1371
g24098
sg5757
g52926
sg888
g20487
sg6333
(dp53780
sg78
g12852
sg8724
(dp53781
ssg5895
(dp53782
VAgents Causing Muscle Toxicity
p53783
(dp53784
sVOphthalmological and Otological Preparations
p53785
(dp53786
sVImmunosuppressive Agents
p53787
(dp53788
sVCytochrome P-450 CYP3A Substrates
p53789
g45241
sVSteroids, Fluorinated
p53790
(dp53791
sVVasoprotectives
p53792
g41387
sVHormones
p53793
(dp53794
sVCorticosteroids for Systemic Use
p53795
g48844
sVDrugs for Obstructive Airway Diseases
p53796
g42515
sVHyperglycemia-Associated Agents
p53797
(dp53798
sVCorticosteroids for Systemic Use, Plain
p53799
g31767
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p53800
(dp53801
sVCorticosteroids Acting Locally
p53802
(dp53803
sVOtologicals
p53804
(dp53805
sVRespiratory System Agents
p53806
(dp53807
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p53808
(dp53809
sVPregnadienetriols
p53810
(dp53811
sg1083
g21937
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p53812
g29556
sg3630
g39990
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p53813
g16828
sVFused-Ring Compounds
p53814
g14861
sVCytochrome P-450 CYP3A4 Inducers
p53815
g18944
sVCytochrome P-450 CYP3A5 Inducers
p53816
g41747
sVAdrenal Cortex Hormones
p53817
g30029
sVAdrenals
p53818
g37369
sVP-glycoprotein/ABCB1 Substrates
p53819
g35013
sVDermatologicals
p53820
g17281
sVCytochrome P-450 Enzyme Inducers
p53821
g28202
sVCytochrome P-450 CYP3A Inducers
p53822
(dp53823
sVAnti-Asthmatic Agents
p53824
g36522
sVPregnadienes
p53825
(dp53826
sVCytochrome P-450 CYP3A4 Substrates
p53827
(dp53828
sVAlimentary Tract and Metabolism
p53829
g23891
sVNasal Preparations
p53830
(dp53831
sVPregnanes
p53832
(dp53833
sVOphthalmologicals
p53834
g35230
sVSteroids
p53835
(dp53836
sVCorticosteroids, Potent (Group III)
p53837
(dp53838
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p53839
(dp53840
sVAnti-Inflammatory Agents
p53841
(dp53842
sVCorticosteroid Hormone Receptor Agonists
p53843
(dp53844
sVCorticosteroids, Dermatological Preparations
p53845
g51334
sVHormones, Hormone Substitutes, and Hormone Antagonists
p53846
g53169
sVCorticosteroids
p53847
(dp53848
sg9858
(dp53849
sVIntestinal Antiinflammatory Agents
p53850
(dp53851
sVSensory Organs
p53852
g40720
ssg5898
(dp53853
g4977
g48662
sg7809
(dp53854
ssg5901
(dp53855
g645
g18125
sg1629
g25991
sg10296
(dp53856
sg7719
(dp53857
sg6567
(dp53858
sg9918
(dp53859
sg10185
(dp53860
sg9507
(dp53861
sg7824
(dp53862
sg5286
g50205
sg21710
(dp53863
sg9414
(dp53864
sg6102
(dp53865
sg11826
(dp53866
sg4737
g47228
sg8463
(dp53867
sg969
g21073
sg2283
g31139
sg11535
(dp53868
sg10200
(dp53869
sg5532
g51616
sg8322
(dp53870
sg11751
(dp53871
sg7188
(dp53872
sg10878
(dp53873
sg10119
(dp53874
sg10245
(dp53875
sg1092
g21977
sg5334
g50507
ssg5904
(dp53876
g10062
(dp53877
sg426
g16093
sg6207
(dp53878
sg1434
g24661
sg9417
(dp53879
sg3846
g41127
sg3114
g36872
sg5235
g49845
sg11979
(dp53880
sg2946
g35822
sg5832
g53422
sg10308
(dp53881
sg8049
(dp53882
sg8421
(dp53883
sg1461
g24820
sg7272
(dp53884
sg4263
g44168
sg8241
(dp53885
sg285
g14604
sg1473
g24968
sg8820
(dp53886
sg7335
(dp53887
sg8460
(dp53888
sg7389
(dp53889
sg2910
g35544
sg8097
(dp53890
sg10227
(dp53891
sg7716
(dp53892
sg5853
g53545
sg3546
g39395
sg7317
(dp53893
sg8874
(dp53894
sg1899
g28069
sg7941
(dp53895
sg7944
(dp53896
sg8916
(dp53897
sg1908
g28299
sg10950
(dp53898
sg909
g20643
sg2667
g33513
sg2832
g34711
sg147
g13461
sg2688
g33650
sg4155
g43224
sg10098
(dp53899
sg9822
(dp53900
sg13091
g21392
sg183
g13818
sg5067
g48949
sg12126
(dp53901
sg11370
(dp53902
sg3009
g36045
sg11112
(dp53903
sg9102
(dp53904
sg414
g15969
sg10056
(dp53905
ssg5907
(dp53906
g1782
g27152
sg9870
(dp53907
sg2844
g34872
sg6090
(dp53908
sg10779
(dp53909
sg3825
g41015
sg5622
g52229
sg1038
g21472
sg657
g18330
sg7854
(dp53910
sg4845
g47845
sg7161
(dp53911
sg6903
(dp53912
sg8418
(dp53913
sg1947
g28687
sg1461
g24822
sg10320
(dp53914
sg4263
g44170
sg285
g14608
sg8529
(dp53915
sg7521
(dp53916
sg5382
g50711
sg7680
(dp53917
sg9561
(dp53918
sg2985
g35924
sg10494
(dp53919
sg11664
(dp53920
sg9000
(dp53921
sg3183
g37327
sg3699
g40334
sg1683
g26376
sg4752
g47285
sg5511
g51479
sg10512
(dp53922
sg8670
(dp53923
sg11301
(dp53924
sg11934
(dp53925
sg3099
g36732
sg9780
(dp53926
sg7530
(dp53927
sg6024
(dp53928
sg7548
(dp53929
sg3297
g38020
sg9540
(dp53930
sg7059
(dp53931
sg3867
g41329
sg5946
(dp53932
sg11826
(dp53933
sg372
g15387
sg10200
(dp53934
sg7971
(dp53935
sg7563
(dp53936
sg5577
g51832
sg2058
g29171
sg11751
(dp53937
sg8274
(dp53938
sg6150
(dp53939
sg1581
g25690
sg5589
g51911
sg717
g19046
sg7800
(dp53940
sg9102
(dp53941
sg11382
(dp53942
sg7977
(dp53943
sg420
g16024
sg5400
g50866
sg10047
(dp53944
ssg5910
(dp53945
g3609
g39682
ssg5913
(dp53946
g4173
g43396
ssg5916
(dp53947
g9711
(dp53948
sg630
g18033
sg2265
g31016
sg240
g14197
ssg5919
(dp53949
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p53950
(dp53951
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p53952
(dp53953
sVVasoconstrictor Agents
p53954
g35880
sVSerotonin Agents
p53955
(dp53956
sVAnalgesics
p53957
g26475
sVNeurotransmitter Agents
p53958
(dp53959
sVSelective Serotonin Agonists
p53960
(dp53961
sVDrugs that are Mainly Renally Excreted
p53962
g44036
sVAmines
p53963
g42718
sVBiogenic Monoamines
p53964
(dp53965
sVAmides
p53966
g44333
sVSulfur Compounds
p53967
(dp53968
sVSulfones
p53969
(dp53970
sVOATP1B1/SLCO1B1 Substrates
p53971
(dp53972
sVSulfonamides
p53973
(dp53974
sVMonoamine Oxidase A Substrates
p53975
(dp53976
sVTryptamines
p53977
(dp53978
sVCentral Nervous System Depressants
p53979
(dp53980
sVAntimigraine Preparations
p53981
g32375
sVCardiovascular Agents
p53982
g26628
sVIndoles
p53983
(dp53984
sVBiogenic Amines
p53985
(dp53986
sVSerotonin 1b Receptor Agonists
p53987
(dp53988
sVP-glycoprotein/ABCB1 Substrates
p53989
g35021
sVSelective Serotonin 5-HT1 Receptor Agonists
p53990
g52795
sVAgents that produce hypertension
p53991
(dp53992
sVSerotonin 5-HT1 Receptor Agonists
p53993
g34585
sVHeterocyclic Compounds, Fused-Ring
p53994
(dp53995
sVSerotonin Modulators
p53996
(dp53997
sVAntidepressive Agents
p53998
g15550
sVGenito Urinary System and Sex Hormones
p53999
(dp54000
sVBCRP/ABCG2 Substrates
p54001
g42096
sVTriptans
p54002
g33825
sVSerotonin 1d Receptor Agonists
p54003
(dp54004
sVSerotonin Receptor Agonists
p54005
(dp54006
sVNervous System
p54007
(dp54008
ssg5922
(dp54009
VAgents that produce hypertension
p54010
(dp54011
sVCentral Nervous System Agents
p54012
(dp54013
sVRespiratory System Agents
p54014
(dp54015
sVPyrrolidinones
p54016
g30232
sVPyrrolidines
p54017
(dp54018
sVCentral Nervous System Stimulants
p54019
g51442
sg1284
g23408
ssg5925
(dp54020
VFood Ingredients
p54021
g26896
sVPharmaceutical Preparations
p54022
g53863
sVSweetening Agents
p54023
(dp54024
sVFood Additives
p54025
(dp54026
sVFlavoring Agents
p54027
g43552
sVFood
p54028
(dp54029
sg3339
g38270
sVCarbohydrates
p54030
(dp54031
sg21710
(dp54032
sVPharmaceutic Aids
p54033
(dp54034
sVKetoses
p54035
g37037
sVDiet, Food, and Nutrition
p54036
g22895
sVCompounds used in a research, industrial, or household setting
p54037
(dp54038
sVFood and Beverages
p54039
(dp54040
sg4287
g44383
sVHexoses
p54041
g43800
sVPhysiological Phenomena
p54042
g21711
sVMonosaccharides
p54043
(dp54044
ssg5928
(dp54045
VDrugs that are Mainly Renally Excreted
p54046
g44037
sVHeterocyclic Compounds, Fused-Ring
p54047
(dp54048
sVOphthalmologicals
p54049
g35233
sVMast Cell Stabilizers
p54050
(dp54051
sVDecreased Histamine Release
p54052
(dp54053
sVAnti-Allergic Agents
p54054
g50649
sVDecongestants and Antiallergics
p54055
(dp54056
sVAnti-Inflammatory Agents
p54057
(dp54058
sVRespiratory Agents, Miscellaneous
p54059
(dp54060
sVRespiratory System Agents
p54061
(dp54062
sVQuinolines
p54063
(dp54064
sVSensory Organs
p54065
g40723
sVAntiallergic Agents, Excl. Corticosteroids
p54066
(dp54067
sVAnti-Asthmatic Agents
p54068
g36525
sg1359
g23984
sg1728
g26889
sVDrugs for Obstructive Airway Diseases
p54069
g42519
sVNasal Preparations
p54070
(dp54071
ssg5931
(dp54072
g2316
g31299
ssg5934
(dp54073
VKetones
p54074
g50970
sVImides
p54075
(dp54076
sVHypotensive Agents
p54077
g34175
sVHyperglycemia-Associated Agents
p54078
(dp54079
sVPhthalimides
p54080
g20180
sVThiazide-like Diuretic
p54081
g12822
sVAntihypertensive Agents
p54082
g20302
sVAcids, Carbocyclic
p54083
g41568
sVAmides
p54084
g44354
sVSulfur Compounds
p54085
(dp54086
sVSulfones
p54087
(dp54088
sVNatriuretic Agents
p54089
g40496
sVSodium Chloride Symporter Inhibitors
p54090
(dp54091
sVCardiovascular Agents
p54092
g26685
sVBenzene Derivatives
p54093
(dp54094
sVNon Potassium Sparing Diuretics
p54095
g14971
sVLow-Ceiling Diuretics, Excl. Thiazides
p54096
(dp54097
sVMembrane Transport Modulators
p54098
(dp54099
sVIsoindoles
p54100
g17599
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p54101
g25429
sVHeterocyclic Compounds, Fused-Ring
p54102
(dp54103
sVPhthalic Acids
p54104
(dp54105
sVSulfonamides
p54106
(dp54107
sVIncreased Diuresis
p54108
g40995
sVBenzophenones
p54109
g53199
sVDiuretics
p54110
(dp54111
ssg5937
(dp54112
g11292
(dp54113
ssg5940
(dp54114
g11283
(dp54115
sg10383
(dp54116
sg7464
(dp54117
sg10818
(dp54118
sg4635
g46500
sg7641
(dp54119
sg4656
g46794
sg8421
(dp54120
sg3885
g41456
sg9924
(dp54121
sg8433
(dp54122
sg888
g20395
sg20252
(dp54123
sg6468
(dp54124
sg2427
g31978
sg6267
(dp54125
sg10272
(dp54126
sg7485
(dp54127
sg3177
g37313
sg7734
(dp54128
sg10758
(dp54129
sg9981
(dp54130
sg138
g13301
sg6999
(dp54131
sg7764
(dp54132
sg3978
g41964
sg3231
g37665
sg10497
(dp54133
sg11112
(dp54134
sg7020
(dp54135
sg1857
g27714
sg2538
g32817
sg10056
(dp54136
sg1767
g27031
sg7353
(dp54137
sg8598
(dp54138
sg8601
(dp54139
sg11619
(dp54140
sg10308
(dp54141
sg8655
(dp54142
sg9417
(dp54143
sg1881
g27962
sg3381
g38488
sg10164
(dp54144
sg345
g15236
sg3399
g38646
sg1908
g28308
sg7176
(dp54145
sg387
g15598
sg1941
g28602
sg9486
(dp54146
sg7191
(dp54147
sg3447
g38948
sg2730
g33888
sg6921
(dp54148
sg1980
g28806
sg465
g16482
sg10266
(dp54149
sg9918
(dp54150
sg5805
g53279
sg450
g16349
sg978
g21180
sg1059
g21771
sg879
g20368
sg168
g13613
sg9561
(dp54151
sg8820
(dp54152
sg7335
(dp54153
sg10350
(dp54154
sg11862
(dp54155
sg5574
g51811
sg7314
(dp54156
sg7317
(dp54157
sg7569
(dp54158
sg11154
(dp54159
sg4173
g43403
sg8874
(dp54160
sg5169
g49490
sg8097
(dp54161
sg5235
g49852
sg4452
g45442
sg657
g18346
sg684
g18511
sg9687
(dp54162
sg3696
g40298
sg702
g18812
sg1491
g25098
sg9987
(dp54163
sg4062
g42646
sg2289
g31198
sg10557
(dp54164
sg9822
(dp54165
sg5934
g54099
sg5289
g50269
sg9855
(dp54166
ssg5943
(dp54167
g5781
g53116
sg2523
g32748
ssg5946
(dp54168
VAmino Acids, Peptides, and Proteins
p54169
g47315
sg4608
g46306
sVHematologic Agents
p54170
(dp54171
sVBlood and Blood Forming Organs
p54172
g53932
sg7572
(dp54173
sg11076
(dp54174
sVPeptides
p54175
g47199
sVPeptides, Cyclic
p54176
(dp54177
ssg5949
(dp54178
g11415
(dp54179
sg9996
(dp54180
ssg5952
(dp54181
g4488
g45751
sg5499
g51433
ssg5955
(dp54182
g5727
g52801
sg11958
(dp54183
ssg5958
(dp54184
g1146
g22468
sg10578
(dp54185
sg6594
(dp54186
ssg5961
(dp54187
g4629
g46428
ssg5964
(dp54188
g2199
g30674
ssg5967
(dp54189
g9870
(dp54190
sg4014
g42249
sg1629
g25999
sg6552
(dp54191
sg10839
(dp54192
sg657
g18362
sg3312
g38143
sg11832
(dp54193
sg7530
(dp54194
sg10320
(dp54195
sg6246
(dp54196
sg9561
(dp54197
sg2985
g35935
sg8649
(dp54198
sg9006
(dp54199
sg9588
(dp54200
sg8826
(dp54201
sg6714
(dp54202
sg8832
(dp54203
sg6726
(dp54204
sg1875
g27897
sg12060
(dp54205
sg7920
(dp54206
sg9780
(dp54207
sg7548
(dp54208
sg4557
g46168
sg10764
(dp54209
sg5025
g48781
sg10554
(dp54210
sg9810
(dp54211
sg6843
(dp54212
sg771
g19307
sg13091
g21428
sg10587
(dp54213
sg6765
(dp54214
sg4770
g47466
sg11382
(dp54215
sg420
g16016
ssg5970
(dp54216
VCentral Nervous System Depressants
p54217
(dp54218
sVHypnotics and Sedatives
p54219
(dp54220
sVBenzodiazepine hypnotics and sedatives
p54221
g17664
sVHypnotics (Nonbenzodiazepine)
p54222
(dp54223
sVCytochrome P-450 CYP3A Substrates
p54224
g45086
sVMethemoglobinemia Associated Agents
p54225
g25567
sVCytochrome P-450 CYP2C8 Substrates
p54226
(dp54227
sVCentral Nervous System Agents
p54228
(dp54229
sVAza Compounds
p54230
(dp54231
sVNervous System
p54232
(dp54233
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54234
g29365
sVPsycholeptics
p54235
g33241
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p54236
g40816
sVCytochrome P-450 CYP2C9 Substrates
p54237
g29745
sVCytochrome P-450 CYP3A4 Substrates
p54238
(dp54239
sg5010
g48712
ssg5973
(dp54240
g8133
(dp54241
sVProtein Synthesis Inhibitors
p54242
g45547
sVPyridines
p54243
(dp54244
sg2925
g35604
sVGenito Urinary System and Sex Hormones
p54245
(dp54246
sVGynecological Antiinfectives and Antiseptics
p54247
(dp54248
sVAntifungals for Dermatological Use
p54249
g30081
sVAntifungal Agents
p54250
(dp54251
sVDecreased Protein Synthesis
p54252
(dp54253
sVDermatologicals
p54254
g17298
sVCycloparaffins
p54255
g43675
sVAntifungals for Topical Use
p54256
g39236
sVVaginal Creams, Foams, and Jellies
p54257
(dp54258
sg10707
(dp54259
sVPyridones
p54260
g38735
sVAnti-Infective Agents
p54261
(dp54262
sVCyclohexanes
p54263
g33284
ssg5976
(dp54264
g5289
g50286
sg8625
(dp54265
sg9432
(dp54266
sg11451
(dp54267
sg7884
(dp54268
sg9198
(dp54269
sg573
g17589
sg2274
g31094
sg10758
(dp54270
sg78
g12881
sg8448
(dp54271
sg2460
g32306
sg6435
(dp54272
sg819
g19785
sg11052
(dp54273
sg11385
(dp54274
ssg5979
(dp54275
g2373
g31630
sg3783
g40891
ssg5982
(dp54276
g1311
g23531
sg7005
(dp54277
ssg5985
(dp54278
g11160
(dp54279
sg402
g15864
ssg5988
(dp54280
g600
g17744
sg11370
(dp54281
ssg5991
(dp54282
g10353
(dp54283
ssg5994
(dp54284
g4155
g43222
sg183
g13816
ssg5997
(dp54285
g1482
g25015
sg6630
(dp54286
sg8559
(dp54287
ssg6000
(dp54288
g2151
g30405
sVAngiotensin II Antagonists and Calcium Channel Blockers
p54289
g42307
sVAngiotensin Receptor Antagonists
p54290
(dp54291
sVAngiotensin II receptor blockers (ARBs) and diuretics
p54292
g18119
sVAgents causing hyperkalemia
p54293
g43641
sVHypotensive Agents
p54294
g34209
sVAgents causing angioedema
p54295
(dp54296
sVOATP1B1/SLCO1B1 Inhibitors
p54297
(dp54298
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p54299
(dp54300
sVCytochrome P-450 CYP2C9 Inhibitors
p54301
g18250
sVCytochrome P-450 Enzyme Inhibitors
p54302
(dp54303
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p54304
(dp54305
sVAntihypertensive Agents
p54306
g20318
sVAngiotensin II Type 1 Receptor Blockers
p54307
(dp54308
sVCytochrome P-450 CYP2C9 Substrates
p54309
g29817
sVOATP1B1/SLCO1B1 Substrates
p54310
(dp54311
sVCardiovascular Agents
p54312
g26679
sVAngiotensin 2 Receptor Blocker
p54313
(dp54314
sVAgents Acting on the Renin-Angiotensin System
p54315
g25341
sVOATP1B3 substrates
p54316
g28528
sVAngiotensin II receptor blockers (ARBs), plain
p54317
g22615
sVAngiotensin II Type 2 Receptor Blockers
p54318
(dp54319
sVAngiotensin II Antagonists, Plain
p54320
(dp54321
ssg6003
(dp54322
g8598
(dp54323
sg8601
(dp54324
ssg6006
(dp54325
g477
g16589
sg10698
(dp54326
sg4860
g47905
sg8856
(dp54327
sg3144
g37097
sg9006
(dp54328
sg10236
(dp54329
sg3000
g36024
ssg6009
(dp54330
VToxic Actions
p54331
g49378
sVMustard Compounds
p54332
g28992
sVMyelosuppressive Agents
p54333
(dp54334
sVAgents that reduce seizure threshold
p54335
g45854
sVImmunosuppressive Agents
p54336
(dp54337
sVP-glycoprotein/ABCB1 Substrates
p54338
g35018
sVAlkylating Activity
p54339
g46195
sVHydrocarbons, Halogenated
p54340
(dp54341
sVAlkylating Drugs
p54342
(dp54343
sVAntineoplastic and Immunomodulating Agents
p54344
g39791
sVNitrogen Mustard Analogues
p54345
g43125
sVNoxae
p54346
(dp54347
sVNitrogen Mustard Compounds
p54348
g14453
sVAntineoplastic Agents
p54349
(dp54350
sVAntineoplastic Agents, Alkylating
p54351
(dp54352
ssg6012
(dp54353
VCentral Nervous System Depressants
p54354
(dp54355
sVNeurotransmitter Agents
p54356
(dp54357
sVHistamine H1 Antagonists
p54358
g40763
sVSensory Organs
p54359
g40736
sVHistamine H1 Antagonists, Non-Sedating
p54360
g38527
sVAnti-Allergic Agents
p54361
g50645
sVHistamine Agents
p54362
(dp54363
sVPotential QTc-Prolonging Agents
p54364
(dp54365
sVDecongestants and Antiallergics
p54366
(dp54367
sVHistamine Antagonists
p54368
g43420
sVAntiallergic Agents, Excl. Corticosteroids
p54369
(dp54370
sVQTc Prolonging Agents
p54371
(dp54372
sVOphthalmologicals
p54373
g35248
sVNasal Preparations
p54374
(dp54375
ssg6015
(dp54376
g9894
(dp54377
sVHormones
p54378
(dp54379
sVBlood Glucose Lowering Agents
p54380
(dp54381
sVPeptide Hormones
p54382
g20231
sg10605
(dp54383
sVPancreatic Hormones
p54384
(dp54385
sVDrugs Used in Diabetes
p54386
(dp54387
sVHypolipidemic Agents
p54388
(dp54389
sVCytochrome P-450 CYP1A2 Inducers
p54390
(dp54391
sVPeptides
p54392
g47213
sVCytochrome P-450 Enzyme Inducers
p54393
g28245
sg8697
(dp54394
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p54395
g17455
sVAlimentary Tract and Metabolism
p54396
g23939
sVAmino Acids, Peptides, and Proteins
p54397
g47416
sVToxic Actions
p54398
g49406
sVAntimetabolites
p54399
(dp54400
sVNoxae
p54401
(dp54402
sg3594
g39630
sVHypoglycemia-Associated Agents
p54403
g17713
sVBiological Products
p54404
(dp54405
sg8346
(dp54406
sVHormones, Hormone Substitutes, and Hormone Antagonists
p54407
g53192
sVComplex Mixtures
p54408
(dp54409
sVLipid Regulating Agents
p54410
(dp54411
ssg6018
(dp54412
g11760
(dp54413
sg3777
g40829
ssg6021
(dp54414
g7608
(dp54415
ssg6024
(dp54416
VAntiplatelet agents
p54417
g46301
sVSalicylic Acid and Derivatives
p54418
g36811
sVUGT1A6 substrate
p54419
g38515
sVAnticoagulants
p54420
(dp54421
sVAnalgesics
p54422
g26478
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p54423
(dp54424
sVAgents causing angioedema
p54425
(dp54426
sVNon COX-2 selective NSAIDS
p54427
(dp54428
sVAntiinflammatory and Antirheumatic Products
p54429
(dp54430
sVBlood and Blood Forming Organs
p54431
g53928
sVStomatological Preparations
p54432
(dp54433
sVPeripheral Nervous System Agents
p54434
(dp54435
sVDrugs that are Mainly Renally Excreted
p54436
g43972
sVP-glycoprotein/ABCB1 Inducers
p54437
(dp54438
sVSalicylates
p54439
g27623
sVNonsteroidal Anti-inflammatory Compounds
p54440
(dp54441
sVAnalgesics, Non-Narcotic
p54442
(dp54443
sVNephrotoxic agents
p54444
(dp54445
sVDecreased Platelet Aggregation
p54446
(dp54447
sVAcids, Carbocyclic
p54448
g41567
sVOAT1/SLC22A6 inhibitors
p54449
(dp54450
sVCytochrome P-450 CYP2C9 Substrates
p54451
g29786
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p54452
g25149
sVMusculo-Skeletal System
p54453
g31535
sVAgents causing hyperkalemia
p54454
g43617
sVCardiovascular Agents
p54455
g26680
sVBenzene Derivatives
p54456
(dp54457
sVDecreased Prostaglandin Production
p54458
(dp54459
sVP-glycoprotein/ABCB1 Substrates
p54460
g35026
sVAntipyretics
p54461
(dp54462
sVCytochrome P-450 Enzyme Inducers
p54463
g28209
sVAgents that produce hypertension
p54464
(dp54465
sVHydroxybenzoates
p54466
(dp54467
sVAlimentary Tract and Metabolism
p54468
g23884
sVHematologic Agents
p54469
(dp54470
sVPlatelet Aggregation Inhibitors Excl. Heparin
p54471
(dp54472
sVOAT3/SLC22A8 Inhibitors
p54473
(dp54474
sVCytochrome P-450 CYP2C19 Inducers
p54475
g25542
sVAnti-Inflammatory Agents
p54476
(dp54477
sVCyclooxygenase Inhibitors
p54478
g32791
sVSensory System Agents
p54479
(dp54480
sVAnti-Inflammatory Agents, Non-Steroidal
p54481
(dp54482
ssg6027
(dp54483
g10119
(dp54484
ssg6030
(dp54485
g1746
g26950
sg5193
g49628
ssg6033
(dp54486
VAgents Causing Muscle Toxicity
p54487
(dp54488
sVBSEP/ABCB11 Substrates
p54489
(dp54490
sVCytochrome P-450 CYP3A4 Inhibitors
p54491
(dp54492
sVCytochrome P-450 CYP2D6 Substrates
p54493
g52188
sVUGT1A1 Substrates
p54494
g12326
sVUGT2B7 substrates
p54495
g28625
sVCytochrome P-450 CYP3A Substrates
p54496
g45255
sVCYP3A Substrates (Sensitive)
p54497
(dp54498
sVOATP1B1/SLCO1B1 Inhibitors
p54499
(dp54500
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p54501
g43782
sVCytochrome P-450 CYP2C9 Inhibitors
p54502
g18238
sVCytochrome P-450 Enzyme Inhibitors
p54503
(dp54504
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p54505
(dp54506
sVCytochrome P-450 CYP2C8 Substrates
p54507
(dp54508
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p54509
g23106
sVCytochrome P-450 CYP2B6 Inducers
p54510
g39113
sVNaphthalenes
p54511
(dp54512
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54513
g29574
sVLipid Modifying Agents, Plain
p54514
(dp54515
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p54516
(dp54517
sVOATP1B1/SLCO1B1 Substrates
p54518
(dp54519
sVDrugs Used in Diabetes
p54520
(dp54521
sVHypolipidemic Agents
p54522
(dp54523
sVLipid Modifying Agents
p54524
g40539
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p54525
g25233
sVCytochrome P-450 CYP2C8 Inhibitors
p54526
(dp54527
sVCytochrome P-450 CYP2B6 Inhibitors
p54528
g45926
sVEnzyme Inhibitors
p54529
(dp54530
sVP-glycoprotein/ABCB1 Substrates
p54531
g35057
sVCytochrome P-450 CYP2B6 Inhibitors (weak)
p54532
g51692
sVCytochrome P-450 Enzyme Inducers
p54533
g28224
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p54534
g44541
sVCytochrome P-450 CYP3A4 Substrates
p54535
(dp54536
sVAlimentary Tract and Metabolism
p54537
g23908
sVToxic Actions
p54538
g49390
sVAnticholesteremic Agents
p54539
g50597
sVCytochrome P-450 CYP3A5 Substrates
p54540
(dp54541
sVUGT1A3 substrates
p54542
g31801
sVCytochrome P-450 CYP3A Inhibitors
p54543
(dp54544
sVNoxae
p54545
(dp54546
sVP-glycoprotein/ABCB1 Inhibitors
p54547
(dp54548
sVCytochrome P-450 CYP3A7 Substrates
p54549
(dp54550
sVLipid Regulating Agents
p54551
(dp54552
ssg6036
(dp54553
g8373
(dp54554
sg9153
(dp54555
sg9126
(dp54556
sg30
g12360
sg690
g18608
sg135
g13264
sg6204
(dp54557
sg7821
(dp54558
sg11427
(dp54559
sg279
g14493
sg4872
g48008
sg7653
(dp54560
sg1656
g26152
sg9918
(dp54561
sg6231
(dp54562
sg354
g15291
sg9192
(dp54563
sg3141
g37059
sg6240
(dp54564
sg9198
(dp54565
sg5871
g53653
sg3144
g37103
sg14338
g13543
sg2046
g29109
sg2424
g31957
sg8448
(dp54566
sg9954
(dp54567
sg2436
g32189
sg15016
(dp54568
sg3174
g37256
sg6279
(dp54569
sg5520
g51540
sg3657
g40167
sg4707
g46993
sg7377
(dp54570
sg4710
g47020
sg9750
(dp54571
sg6654
(dp54572
sg2391
g31709
sg126
g13185
sg11337
(dp54573
sg10170
(dp54574
sg9261
(dp54575
sg3849
g41178
sg3207
g37493
sg7005
(dp54576
sg9267
(dp54577
sg12045
(dp54578
sg11541
(dp54579
sg972
g21137
sg3222
g37594
sg9282
(dp54580
sg3981
g42038
sg9630
(dp54581
sg7500
(dp54582
sg3246
g37763
sg8493
(dp54583
sg4782
g47537
sg5208
g49746
sg1110
g22146
sg7878
(dp54584
sg7155
(dp54585
sg4005
g42153
sg3267
g37903
sg8616
(dp54586
sg1782
g27134
sg10833
(dp54587
sg4017
g42273
sg1278
g23348
sg9906
(dp54588
sg1101
g22062
sg11592
(dp54589
sg1152
g22548
sg7707
(dp54590
sg7353
(dp54591
sg8781
(dp54592
sg4830
g47791
sg11604
(dp54593
sg1047
g21594
sg1050
g21659
sg4857
g47898
sg8622
(dp54594
sg10890
(dp54595
sg1761
g27004
sg10122
(dp54596
sg7881
(dp54597
sg7884
(dp54598
sg9135
(dp54599
sg4881
g48063
sg8049
(dp54600
sg3132
g36998
sg13070
g21883
sg6432
(dp54601
sg5685
g52462
sg9663
(dp54602
sg4902
g48166
sg318
g14912
sg11685
(dp54603
sg6348
(dp54604
sg4911
g48219
sg1875
g27912
sg11967
(dp54605
sg11694
(dp54606
sg9426
(dp54607
sg4920
g48331
sg9432
(dp54608
sg6435
(dp54609
sg1872
g27879
sg12078
(dp54610
sg1899
g28050
sg7947
(dp54611
sg10950
(dp54612
sg2667
g33503
sg3090
g36710
sg10548
(dp54613
sg11733
(dp54614
sg2688
g33619
sg8922
(dp54615
sg11745
(dp54616
sg11184
(dp54617
sg4164
g43297
sg10218
(dp54618
sg1173
g22653
sg2706
g33771
sg2715
g33794
sg11769
(dp54619
sg8742
(dp54620
sg11451
(dp54621
sg5334
g50527
sg7812
(dp54622
sg9507
(dp54623
sg10854
(dp54624
sg7815
(dp54625
sg6933
(dp54626
sg10275
(dp54627
sg10914
(dp54628
sg12051
(dp54629
sg2481
g32397
sg4773
g47492
sg11067
(dp54630
sg10296
(dp54631
sg5526
g51572
sg1239
g22938
sg7074
(dp54632
sg11052
(dp54633
sg5847
g53501
sg11061
(dp54634
sg2787
g34415
sg11838
(dp54635
sg3015
g36083
sg5865
g53597
sg10326
(dp54636
sg11079
(dp54637
sg10314
(dp54638
sg5082
g49029
sg8079
(dp54639
sg2808
g34488
sg1311
g23539
sg2838
g34788
sg8850
(dp54640
sg10368
(dp54641
sg3021
g36185
sg1527
g25261
sg1332
g23668
sg9627
(dp54642
sg10578
(dp54643
sg6183
(dp54644
sg7662
(dp54645
sg573
g17530
sg11166
(dp54646
sg2142
g30345
sg16906
(dp54647
sg10347
(dp54648
sg3576
g39566
sg9657
(dp54649
sg5295
g50355
sg3291
g38011
sg2895
g35415
sg10878
(dp54650
sg6075
(dp54651
sg1863
g27779
sg4953
g48491
sg11208
(dp54652
sg2913
g35591
sg6549
(dp54653
sg2928
g35635
sg11229
(dp54654
sg10725
(dp54655
sg10290
(dp54656
sg2940
g35720
sg1539
g25293
sg600
g17750
sg8211
(dp54657
sg10479
(dp54658
sg12000
(dp54659
sg12003
(dp54660
sg9726
(dp54661
sg8238
(dp54662
sg7470
(dp54663
sg8985
(dp54664
sg4479
g45685
sg2991
g35977
sg2418
g31901
sg5283
g50191
sg1113
g22173
sg2460
g32275
sg3711
g40425
sg11370
(dp54665
sg6798
(dp54666
sg10509
(dp54667
sg1503
g25172
sg3009
g36059
sg5973
g54262
sg3024
g36268
sg5316
g50433
sg3753
g40626
sg5736
g52847
sg8562
(dp54668
sg1176
g22690
sg7905
(dp54669
sg4539
g46022
sg2739
g33993
sg8298
(dp54670
sg4542
g46090
sg11334
(dp54671
sg1275
g23282
sg3795
g40941
sg8577
(dp54672
sg12090
(dp54673
sg11358
(dp54674
sg10611
(dp54675
sg12126
(dp54676
sg1578
g25624
sg9096
(dp54677
sg10692
(dp54678
sg7524
(dp54679
sg12123
(dp54680
sg819
g19737
ssg6039
(dp54681
g9810
(dp54682
sg7530
(dp54683
sg7920
(dp54684
sg129
g13212
sg9660
(dp54685
sg4557
g46146
sg8649
(dp54686
sg5025
g48759
ssg6042
(dp54687
g9267
(dp54688
ssg6045
(dp54689
g6177
(dp54690
sg5607
g52080
sg7410
(dp54691
sg11454
(dp54692
sg4431
g45256
sg8604
(dp54693
sg39
g12516
sg5631
g52259
sg3939
g41738
sg3879
g41383
sg3489
g39045
sg6219
(dp54694
sg11988
(dp54695
sg5043
g48847
sg7446
(dp54696
sg6582
(dp54697
sg8976
(dp54698
sg1830
g27615
sg9378
(dp54699
sg1254
g23090
sg2394
g31771
sg8427
(dp54700
sg3513
g39115
sg11754
(dp54701
sg5478
g51335
sg9129
(dp54702
sg303
g14794
sg10704
(dp54703
sg513
g16822
sg7494
(dp54704
sg2061
g29575
sg312
g14875
sg1500
g25146
sg711
g18964
sg9597
(dp54705
sg5703
g52620
sg9786
(dp54706
sg4305
g44470
sg11235
(dp54707
sg2097
g30016
sg11496
(dp54708
sg3189
g37364
sg2847
g35059
sg11505
(dp54709
sg555
g17310
sg1905
g28225
sg8364
(dp54710
sg4332
g44538
sg4335
g44544
sg1143
g22449
sg3561
g39428
sg8130
(dp54711
sg6750
(dp54712
sg1353
g23910
sg10014
(dp54713
sg7761
(dp54714
sg9423
(dp54715
sg7566
(dp54716
sg2871
g35253
sg6324
(dp54717
sg6717
(dp54718
sg7182
(dp54719
sg7986
(dp54720
sg7839
(dp54721
sg1566
g25537
sg10140
(dp54722
sg10233
(dp54723
sg7791
(dp54724
sg10425
(dp54725
sg6702
(dp54726
sg11568
(dp54727
sg7179
(dp54728
sg5784
g53183
sg10053
(dp54729
sg7206
(dp54730
sg3765
g40740
ssg6048
(dp54731
VAgents Causing Muscle Toxicity
p54732
(dp54733
sVFatty Acids
p54734
(dp54735
sVLeukotriene Antagonists
p54736
g32990
sVCytochrome P-450 CYP3A Substrates
p54737
g45257
sVLipids
p54738
g14348
sVCytochrome P-450 Enzyme Inhibitors
p54739
(dp54740
sVDrugs for Obstructive Airway Diseases
p54741
g42527
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p54742
g23126
sVRespiratory System Agents
p54743
(dp54744
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54745
g29576
sVLeukotriene Modifiers
p54746
(dp54747
sVCytochrome P-450 CYP2C9 Substrates
p54748
g29758
sVFatty Acids, Volatile
p54749
(dp54750
sVCytochrome P-450 CYP1A2 Inducers
p54751
(dp54752
sVCytochrome P-450 CYP2C8 Inhibitors
p54753
(dp54754
sVCytochrome P-450 CYP2A6 Substrates
p54755
g35138
sVCytochrome P-450 Enzyme Inducers
p54756
g28226
sVAnti-Asthmatic Agents
p54757
g36532
sVCytochrome P-450 CYP3A4 Substrates
p54758
(dp54759
sVHormone Antagonists
p54760
g24285
sVAgents to Treat Airway Disease
p54761
g32647
sVHeterocyclic Compounds, Fused-Ring
p54762
(dp54763
sVAcids, Acyclic
p54764
g25490
sVHormones, Hormone Substitutes, and Hormone Antagonists
p54765
g53193
ssg6051
(dp54766
VAdrenergic alpha-1 Receptor Antagonists
p54767
g14115
sVCytochrome P-450 CYP2D6 Substrates
p54768
g52190
sVCytochrome P-450 CYP3A Substrates
p54769
g45258
sVNeurotransmitter Agents
p54770
(dp54771
sVHypotensive Agents
p54772
g34197
sVAdrenergic Antagonists
p54773
g52273
sVDrugs that are Mainly Renally Excreted
p54774
g44047
sVUrologicals
p54775
(dp54776
sVGynecological Antiinfectives and Antiseptics
p54777
(dp54778
sVUrological Agents
p54779
g38276
sVSelective Alfa-1-adrenergic Blocking Agents
p54780
g31880
sVAmides
p54781
g44350
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54782
g29577
sVSulfur Compounds
p54783
(dp54784
sVAdrenergic alpha-Antagonists
p54785
(dp54786
sVSulfones
p54787
(dp54788
sVSulfonamides
p54789
(dp54790
sVAdrenergic Agents
p54791
g41697
sVCytochrome P-450 CYP3A4 Substrates
p54792
(dp54793
sVGenito Urinary System and Sex Hormones
p54794
(dp54795
sVPeripheral alpha-1 blockers
p54796
g32717
sVDrugs Used in Benign Prostatic Hypertrophy
p54797
(dp54798
ssg6054
(dp54799
g10974
(dp54800
sg7719
(dp54801
sg10074
(dp54802
sg6471
(dp54803
sg4320
g44508
ssg6057
(dp54804
g1875
g27893
sg7359
(dp54805
sg1326
g23595
sg8067
(dp54806
sg3144
g37104
sg5727
g52821
sg9987
(dp54807
sg7014
(dp54808
sg4440
g45331
sg9372
(dp54809
ssg6060
(dp54810
g2373
g31584
sg7545
(dp54811
sg4113
g43032
sg8430
(dp54812
sg5766
g52973
sg14838
g39977
sg5895
g53803
sg7668
(dp54813
sg9903
(dp54814
ssg6063
(dp54815
g1746
g26940
sg5193
g49609
ssg6066
(dp54816
g1110
g22138
ssg6069
(dp54817
VAdrenergic Agents
p54818
g41701
sVUrologicals
p54819
(dp54820
sVAdrenergic alpha-1 Receptor Antagonists
p54821
g14119
sg8001
(dp54822
sVGenito Urinary System and Sex Hormones
p54823
(dp54824
sVCytochrome P-450 CYP3A Substrates
p54825
g45260
sVNeurotransmitter Agents
p54826
(dp54827
sVPeripheral alpha-1 blockers
p54828
g32715
sVUrological Agents
p54829
g38285
sVPotential QTc-Prolonging Agents
p54830
(dp54831
sVAdrenergic Antagonists
p54832
g52276
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54833
g29579
sVDrugs Used in Benign Prostatic Hypertrophy
p54834
(dp54835
sVAdrenergic alpha-Antagonists
p54836
(dp54837
sVSelective Alfa-1-adrenergic Blocking Agents
p54838
g31879
sVHeterocyclic Compounds, Fused-Ring
p54839
(dp54840
sVQTc Prolonging Agents
p54841
(dp54842
sVCytochrome P-450 CYP3A4 Substrates
p54843
(dp54844
ssg6072
(dp54845
g9102
(dp54846
sg1461
g24812
ssg6075
(dp54847
VAntivirals for Systemic Use
p54848
(dp54849
sVNucleic Acid Synthesis Inhibitors
p54850
g48744
sVCytochrome P-450 CYP2D6 Inhibitors
p54851
(dp54852
sVCytochrome P-450 CYP3A Substrates
p54853
g45274
sVDirect Acting Antivirals
p54854
g38082
sVEnzyme Inhibitors
p54855
(dp54856
sVAnti-HIV Agents
p54857
(dp54858
sVCytochrome P-450 CYP2B6 Substrates
p54859
g33039
sVCytochrome P-450 CYP2C9 Inhibitors
p54860
g18257
sVCytochrome P-450 CYP2C9 Inducers
p54861
g20058
sVAnti-Infective Agents
p54862
g54651
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p54863
g18430
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p54864
(dp54865
sVNonnucleoside Reverse Transcriptase Inhibitors
p54866
g34332
sVAntiinfectives for Systemic Use
p54867
(dp54868
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p54869
g16535
sVCytochrome P-450 CYP2B6 Inducers
p54870
g39133
sVCytochrome P-450 Enzyme Inhibitors
p54871
(dp54872
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54873
g29597
sVCytochrome P-450 CYP2C9 Substrates
p54874
g29808
sVReverse Transcriptase Inhibitors
p54875
g28969
sVCytochrome P-450 CYP3A4 Inducers
p54876
g18985
sVOCT1 inhibitors
p54877
(dp54878
sVCytochrome P-450 CYP2B6 Inducers (strong)
p54879
(dp54880
sVPyridines
p54881
(dp54882
sVHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
p54883
g45989
sVCytochrome P-450 CYP2A6 Substrates
p54884
g35139
sVCytochrome P-450 CYP3A4 Inducers (strong)
p54885
g23085
sVCytochrome P-450 Enzyme Inducers
p54886
g28249
sVCytochrome P-450 CYP3A Inducers
p54887
(dp54888
sVInducers of Drug Clearance
p54889
g44535
sVCytochrome P-450 CYP3A Inducers (strong)
p54890
g22465
sVCytochrome P-450 CYP3A4 Substrates
p54891
(dp54892
sVAnti-Retroviral Agents
p54893
(dp54894
sVCytochrome P-450 CYP3A5 Substrates
p54895
(dp54896
sVNon-Nucleoside Reverse Transcriptase Inhibitors
p54897
g15489
sVAntiviral Agents
p54898
g30446
sVChemically-Induced Disorders
p54899
g21247
sVCytochrome P-450 CYP3A7 Substrates
p54900
(dp54901
ssg6078
(dp54902
g8823
(dp54903
sg4581
g46213
ssg6081
(dp54904
g4260
g44112
ssg6084
(dp54905
g8655
(dp54906
sg10119
(dp54907
sg1629
g25987
ssg6087
(dp54908
g8484
(dp54909
sg3105
g36782
sg8022
(dp54910
sg8439
(dp54911
sg11361
(dp54912
sg10179
(dp54913
sg8340
(dp54914
sg11664
(dp54915
sg7680
(dp54916
sg12186
g42930
sg9000
(dp54917
ssg6090
(dp54918
VAntiplatelet agents
p54919
g46298
sg2445
g32198
sVCytochrome P-450 CYP3A4 Inhibitors
p54920
(dp54921
sVCytochrome P-450 CYP2D6 Inhibitors
p54922
(dp54923
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p54924
g41074
sVCarbohydrates
p54925
(dp54926
sVNeurotransmitter Agents
p54927
(dp54928
sVPurinergic P2 Receptor Antagonists
p54929
g39031
sVCYP3A Substrates (Sensitive)
p54930
(dp54931
sVCytochrome P450 3A4 Inhibitors
p54932
g13042
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p54933
g43788
sVCytochrome P-450 CYP2C9 Inhibitors
p54934
g18244
sVCytochrome P-450 Enzyme Inhibitors
p54935
(dp54936
sVPurinergic Agents
p54937
(dp54938
sVPurinergic Antagonists
p54939
(dp54940
sVDecreased Platelet Aggregation
p54941
(dp54942
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p54943
g29585
sVAnticoagulants
p54944
(dp54945
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p54946
(dp54947
sVCytochrome P-450 CYP3A Substrates
p54948
g45264
sVCytochrome P450 3A5 Inhibitors
p54949
g42991
sVGlycosides
p54950
(dp54951
sVBlood and Blood Forming Organs
p54952
g53908
sVRibonucleosides
p54953
(dp54954
sVNucleic Acids, Nucleotides, and Nucleosides
p54955
g47124
sVP-glycoprotein/ABCB1 Substrates
p54956
g35071
sVAdenosine
p54957
g32489
sVCytochrome P-450 CYP3A4 Substrates
p54958
(dp54959
sVPurines
p54960
(dp54961
sVPurine Nucleosides
p54962
g38779
sVHematologic Agents
p54963
(dp54964
sVPurinergic P2Y Receptor Antagonists
p54965
(dp54966
sVHeterocyclic Compounds, Fused-Ring
p54967
(dp54968
sVNucleosides
p54969
g49465
sVCytochrome P-450 CYP2C9 Inhibitors (weak)
p54970
g41911
sVPlatelet Aggregation Inhibitors Excl. Heparin
p54971
(dp54972
sVCytochrome P-450 CYP3A Inhibitors
p54973
(dp54974
sVP2Y12 Platelet Inhibitor
p54975
(dp54976
sVP-glycoprotein/ABCB1 Inhibitors
p54977
(dp54978
ssg6093
(dp54979
VNitrogen Binding Agent
p54980
(dp54981
sVCytochrome P-450 CYP2D6 Inhibitors
p54982
(dp54983
sVVarious Alimentary Tract and Metabolism Products
p54984
g43555
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p54985
g41088
sVAcids, Carbocyclic
p54986
g41576
sVAntineoplastic Agents
p54987
(dp54988
sVUrea Cycle Disorder Agents
p54989
g39293
sVAmmonium Ion Binding Activity
p54990
(dp54991
sVCytochrome P-450 Enzyme Inhibitors
p54992
(dp54993
sVAlimentary Tract and Metabolism
p54994
g23851
ssg6096
(dp54995
g8265
(dp54996
ssg6099
(dp54997
g2346
g31387
sg9249
(dp54998
sg3858
g41227
sg816
g19675
sg4788
g47581
sg7821
(dp54999
sg4650
g46628
sg7650
(dp55000
sg10797
(dp55001
sg11451
(dp55002
sg9198
(dp55003
sg11460
(dp55004
sg10701
(dp55005
sg3543
g39342
sg9966
(dp55006
sg9225
(dp55007
sg9231
(dp55008
sg4716
g47082
sg10752
(dp55009
sg789
g19467
sg5556
g51733
sg147
g13465
sg10794
(dp55010
sg11523
(dp55011
sg6333
(dp55012
sg4911
g48254
sg4017
g42284
sg4023
g42345
sg8166
(dp55013
sg9366
(dp55014
sg1062
g21819
sg9099
(dp55015
sg4077
g42839
sg11820
(dp55016
sg9462
(dp55017
sg9432
(dp55018
sg4926
g48405
sg10179
(dp55019
sg6504
(dp55020
sg3432
g38808
sg6048
g54754
sg4974
g48627
sg5757
g52932
sg7191
(dp55021
sg414
g15973
sg11385
(dp55022
sg8433
(dp55023
sg10266
(dp55024
sg9918
(dp55025
sg5805
g53286
sg444
g16257
sg10017
(dp55026
sg456
g16371
sg1239
g22962
sg11052
(dp55027
sg4263
g44172
sg8721
(dp55028
sg11079
(dp55029
sg11940
(dp55030
sg9591
(dp55031
sg534
g16996
sg9618
(dp55032
sg3546
g39397
sg2688
g33658
sg5127
g49239
sg11439
(dp55033
sg6687
(dp55034
sg1371
g24109
sg2895
g35441
sg4164
g43328
sg621
g17970
sg3627
g39938
sg8097
(dp55035
sg2196
g30626
sg8205
(dp55036
sg11229
(dp55037
sg5370
g50683
sg2211
g30737
sg2943
g35770
sg10728
(dp55038
sg4452
g45436
sg6033
g54527
sg12126
(dp55039
sg1461
g24824
sg8241
(dp55040
sg5256
g50082
sg3696
g40290
sg5526
g51582
sg9009
(dp55041
sg12045
(dp55042
sg10512
(dp55043
sg3024
g36302
sg7596
(dp55044
sg3753
g40609
sg1140
g22405
sg5238
g49878
sg8298
(dp55045
sg10557
(dp55046
sg7563
(dp55047
sg5364
g50619
sg8949
(dp55048
sg5289
g50288
sg11241
(dp55049
sg1185
g22736
sg7608
(dp55050
sg819
g19760
ssg6102
(dp55051
VXanthine derivatives
p55052
g28823
sVCytochrome P-450 CYP3A Substrates
p55053
g45268
sVBronchodilator Agents
p55054
(dp55055
sg615
g17927
sVCompounds used in a research, industrial, or household setting
p55056
(dp55057
sg1236
g22916
sVEnzyme Inhibitors
p55058
(dp55059
sVDrugs for Obstructive Airway Diseases
p55060
g42520
sVPurinergic Agents
p55061
(dp55062
sVCytochrome P-450 CYP1A2 Substrates
p55063
g45632
sVAutonomic Agents
p55064
(dp55065
sg7089
(dp55066
sVPeripheral Nervous System Agents
p55067
(dp55068
sVRespiratory System Agents
p55069
(dp55070
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p55071
g29590
sVNarrow Therapeutic Index Drugs
p55072
g50569
sVProtective Agents
p55073
(dp55074
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p55075
(dp55076
sVPurinones
p55077
g48136
sVPurines
p55078
(dp55079
sVPharmaceutical Preparations
p55080
g53865
sVNeurotransmitter Agents
p55081
(dp55082
sVCardiovascular Agents
p55083
g26677
sg11070
(dp55084
sVPolyamines
p55085
g40556
sVAgents that reduce seizure threshold
p55086
g45859
sVPhosphodiesterase Inhibitors
p55087
(dp55088
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p55089
g36470
sVAnti-Asthmatic Agents
p55090
g36526
sVCytochrome P-450 CYP3A4 Substrates
p55091
(dp55092
sVCardiotonic Agents
p55093
(dp55094
sVAmines
p55095
g42739
sVHeterocyclic Compounds, Fused-Ring
p55096
(dp55097
sVEthylenediamines
p55098
(dp55099
sVAlkaloids
p55100
g19433
sVDiamines
p55101
g50544
ssg6105
(dp55102
g8067
(dp55103
sg6792
(dp55104
ssg6108
(dp55105
g4707
g46971
ssg6111
(dp55106
g23
g12227
sg210
g14009
sg7320
(dp55107
sg11652
(dp55108
sg9093
(dp55109
sg9264
(dp55110
sg5598
g52033
ssg6114
(dp55111
g9411
(dp55112
ssg6117
(dp55113
g1770
g27061
sg11727
(dp55114
sg2928
g35626
sg5085
g49050
sg10890
(dp55115
ssg6120
(dp55116
g3222
g37607
sg5316
g50455
sg7707
(dp55117
sg11337
(dp55118
sg4542
g46077
sg1599
g25740
ssg6123
(dp55119
g1887
g27985
sg9723
(dp55120
sVHormones
p55121
(dp55122
sVSteroids
p55123
(dp55124
sVAndrostanes
p55125
(dp55126
sVCytochrome P-450 Enzyme Inhibitors
p55127
(dp55128
sg10530
(dp55129
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p55130
(dp55131
sVHormones, Hormone Substitutes, and Hormone Antagonists
p55132
g53190
sVAndrogens
p55133
(dp55134
sVFused-Ring Compounds
p55135
g14887
sVCytochrome P-450 CYP2C9 Inhibitors
p55136
g18251
sg4242
g43797
sVAnabolic Agents
p55137
g33537
sVAlimentary Tract and Metabolism
p55138
g23932
ssg6126
(dp55139
g10377
(dp55140
ssg6129
(dp55141
g1791
g27263
ssg6132
(dp55142
g4014
g42241
sg2784
g34378
sg10185
(dp55143
sg6567
(dp55144
sg1104
g22088
sg357
g15306
sg7977
(dp55145
sg10410
(dp55146
sg7719
(dp55147
sg2895
g35451
sg11139
(dp55148
sg4737
g47238
sg5286
g50219
sg4440
g45312
sg7329
(dp55149
sg5073
g48983
sg9348
(dp55150
sg1149
g22486
ssg6135
(dp55151
g9711
(dp55152
sg630
g18045
sg2265
g31024
sg240
g14208
ssg6138
(dp55153
g11820
(dp55154
sg4926
g48412
sg10797
(dp55155
ssg6141
(dp55156
g12078
(dp55157
ssg6144
(dp55158
g9588
(dp55159
ssg6147
(dp55160
g2553
g32903
sg5415
g50942
sg10275
(dp55161
sg3846
g41154
sg2481
g32440
sg8916
(dp55162
sg2946
g35841
sg5832
g53450
sg1239
g22979
sg4872
g47996
sg8241
(dp55163
sg3141
g37090
sg1842
g27659
sg2769
g34311
sg2046
g29146
sg9579
(dp55164
sg8649
(dp55165
sg9759
(dp55166
sg6714
(dp55167
sg8448
(dp55168
sg7920
(dp55169
sg10365
(dp55170
sg1872
g27863
sg4557
g46170
sg6474
(dp55171
sg10764
(dp55172
sg10767
(dp55173
sg11241
(dp55174
sg7395
(dp55175
ssg6150
(dp55176
VOsmotic Activity
p55177
g28833
sVCarbohydrates
p55178
(dp55179
sg10863
(dp55180
sVDiet, Food, and Nutrition
p55181
g22906
sVCompounds used in a research, industrial, or household setting
p55182
(dp55183
sVFood and Beverages
p55184
(dp55185
sVPhysiological Phenomena
p55186
g21721
sg9915
(dp55187
sVDrugs that are Mainly Renally Excreted
p55188
g44058
sVReplacement Preparations
p55189
g27638
sg2973
g35898
sVFood
p55190
(dp55191
sg885
g20386
sg6786
(dp55192
sVBlood and Blood Forming Organs
p55193
g53939
sVPolysaccharides
p55194
g41777
sVPolymers
p55195
g22240
sg5562
g51753
sg4755
g47303
sg2874
g35276
sVHematologic Agents
p55196
(dp55197
sVBlood Substitutes and Perfusion Solutions
p55198
g49447
sVBiomedical and Dental Materials
p55199
g44733
sg3078
g36618
sVMacromolecular Substances
p55200
g33848
sg1590
g25717
ssg6153
(dp55201
g4746
g47269
ssg6156
(dp55202
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p55203
(dp55204
sVSerotonin Agents
p55205
(dp55206
sVCytochrome P-450 CYP3A Substrates
p55207
g45051
sVNeurotransmitter Agents
p55208
(dp55209
sVSerotonin Receptor Antagonists
p55210
g35668
sVCentral Nervous System Agents
p55211
(dp55212
sVPeripheral Nervous System Agents
p55213
(dp55214
sVAutonomic Agents
p55215
(dp55216
sVAza Compounds
p55217
(dp55218
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p55219
g29320
sVQTc Prolonging Agents
p55220
(dp55221
sVAntiemetics and Antinauseants
p55222
g41639
sVCentral Nervous System Depressants
p55223
(dp55224
sVAntiemetics
p55225
(dp55226
sVGastrointestinal Agents
p55227
(dp55228
sVAzabicyclo Compounds
p55229
(dp55230
sVSerotonin 5-HT3 Receptor Antagonists
p55231
(dp55232
sVPyrazoles
p55233
(dp55234
sVCytochrome P-450 CYP3A4 Substrates
p55235
(dp55236
sVAlimentary Tract and Metabolism
p55237
g23826
sVModerate Risk QTc-Prolonging Agents
p55238
(dp55239
sVHeterocyclic Compounds, Fused-Ring
p55240
(dp55241
sVAntidepressive Agents
p55242
g15524
sVIndazoles
p55243
g33779
sVSerotonin 3 Receptor Antagonists
p55244
g15339
ssg6159
(dp55245
g9588
(dp55246
ssg6162
(dp55247
VDrugs that are Mainly Renally Excreted
p55248
g44054
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p55249
(dp55250
sVHeterocyclic Compounds, Fused-Ring
p55251
(dp55252
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p55253
g50960
sVGenito Urinary System and Sex Hormones
p55254
(dp55255
sVNephrotoxic agents
p55256
(dp55257
sVMusculo-Skeletal System
p55258
g31553
sVAgents causing hyperkalemia
p55259
g43649
sVStomatological Preparations
p55260
(dp55261
sVAntiinflammatory Products for Vaginal Administration
p55262
g27411
sVAnti-Inflammatory Agents
p55263
(dp55264
sVAntiinflammatory and Antirheumatic Products
p55265
(dp55266
sVIndazoles
p55267
g33780
sVPyrazoles
p55268
(dp55269
sVNon COX-2 selective NSAIDS
p55270
(dp55271
sVAgents that produce hypertension
p55272
(dp55273
sVAnti-Inflammatory Agents, Non-Steroidal
p55274
(dp55275
sVThroat Preparations
p55276
(dp55277
sVAlimentary Tract and Metabolism
p55278
g23946
sVTopical Products for Joint and Muscular Pain
p55279
g13921
sVMouthwashes and Gargles
p55280
(dp55281
ssg6165
(dp55282
g4002
g42141
ssg6168
(dp55283
g6726
(dp55284
sg630
g18058
sg10266
(dp55285
sg11790
(dp55286
sg426
g16131
sg8205
(dp55287
sg2358
g31498
sg1425
g24578
sg240
g14221
sg11811
(dp55288
sg828
g19891
sg10737
(dp55289
sg9711
(dp55290
sg11619
(dp55291
sg10674
(dp55292
sg5853
g53572
sg282
g14599
sg7284
(dp55293
sg11016
(dp55294
sg12018
(dp55295
sg9564
(dp55296
sg2664
g33475
sg2430
g32126
sg2814
g34536
sg7299
(dp55297
sg5691
g52509
sg4344
g44683
sg5694
g52578
sg534
g17004
sg1707
g26802
sg10728
(dp55298
sg6966
(dp55299
sg2265
g31032
sg12066
(dp55300
sg5535
g51682
sg486
g16677
sg696
g18780
sg7497
(dp55301
sg3978
g42022
sg3204
g37462
sg8028
(dp55302
sg6303
(dp55303
sg4959
g48566
sg3570
g39519
sg582
g17651
sg6318
(dp55304
sg10350
(dp55305
sg5256
g50116
sg5769
g53056
sg9420
(dp55306
sg10356
(dp55307
sg1194
g22839
sg11112
(dp55308
sg414
g15993
sg8187
(dp55309
sg780
g19380
ssg6171
(dp55310
VAmino Acids, Peptides, and Proteins
p55311
g47353
sVCytoprotective Agent
p55312
g38445
sVCardiotoxic antineoplastic agents
p55313
(dp55314
sg6171
(dp55315
sVGlycoconjugates
p55316
(dp55317
sVDrugs that are Mainly Renally Excreted
p55318
g43929
sVImmunosuppressive Agents
p55319
(dp55320
sVCarbohydrates
p55321
(dp55322
sVGlycopeptides
p55323
g38506
sVAntibiotics, Antineoplastic
p55324
g30410
sVPeptides
p55325
g47164
sVCytotoxic Antibiotics and Related Substances
p55326
g50171
sVAntineoplastic and Immunomodulating Agents
p55327
g39732
sVAntineoplastic Agents
p55328
(dp55329
ssg6174
(dp55330
g8373
(dp55331
sg8433
(dp55332
sg10266
(dp55333
sg3912
g41612
sg8211
(dp55334
sg7821
(dp55335
sg1047
g21618
sg1050
g21707
sg690
g18666
sg5289
g50325
sg8721
(dp55336
sg4479
g45735
sg11079
(dp55337
sg288
g14686
sg6468
(dp55338
sg8448
(dp55339
sg8820
(dp55340
sg8454
(dp55341
sg102
g13017
sg9432
(dp55342
sg3021
g36237
sg7377
(dp55343
sg4920
g48352
sg2838
g34802
sg2460
g32286
sg9954
(dp55344
sg1899
g28098
sg9198
(dp55345
sg4539
g46063
sg573
g17568
sg9273
(dp55346
sg6504
(dp55347
sg2895
g35446
sg7191
(dp55348
sg9081
(dp55349
sg7593
(dp55350
sg11241
(dp55351
sg8724
(dp55352
sg11385
(dp55353
ssg6177
(dp55354
g8373
(dp55355
sg3105
g36752
sg3858
g41185
sg10653
(dp55356
sg837
g19975
sg11427
(dp55357
sg4650
g46599
sg4653
g46645
sg10797
(dp55358
sg9411
(dp55359
sg8421
(dp55360
sg354
g15269
sg9198
(dp55361
sg9954
(dp55362
sg15016
(dp55363
sg3930
g41648
sg5526
g51560
sg11337
(dp55364
sg9081
(dp55365
sg6345
(dp55366
sg5595
g51966
sg9903
(dp55367
sg4017
g42262
sg4023
g42310
sg1038
g21466
sg11601
(dp55368
sg8622
(dp55369
sg375
g15421
sg4515
g45879
sg879
g20330
sg7458
(dp55370
sg1614
g25837
sg4077
g42805
sg13070
g21867
sg14838
g39952
sg12534
g52595
sg11820
(dp55371
sg9432
(dp55372
sg4926
g48370
sg3399
g38609
sg10680
(dp55373
sg10953
(dp55374
sg4143
g43137
sg11733
(dp55375
sg2715
g33784
sg6537
(dp55376
sg1980
g28792
sg8022
(dp55377
sg13750
g24343
sg2007
g28852
sg978
g21142
sg6579
(dp55378
sg2658
g33337
sg7164
(dp55379
sg6261
(dp55380
sg10326
(dp55381
sg11079
(dp55382
sg9579
(dp55383
sg8820
(dp55384
sg7335
(dp55385
sg5895
g53784
sg11862
(dp55386
sg2838
g34768
sg10365
(dp55387
sg3963
g41838
sg6654
(dp55388
sg7707
(dp55389
sg11439
(dp55390
sg2142
g30325
sg1365
g24031
sg735
g19127
sg6807
(dp55391
sg10878
(dp55392
sg5199
g49675
sg8193
(dp55393
sg8205
(dp55394
sg5229
g49785
sg11229
(dp55395
sg2943
g35729
sg8211
(dp55396
sg6033
g54488
sg6045
g54690
sg9525
(dp55397
sg8985
(dp55398
sg5487
g51347
sg1113
g22151
sg7500
(dp55399
sg2769
g34266
sg5316
g50416
sg3027
g36342
sg11775
(dp55400
sg2862
g35148
sg10563
(dp55401
sg8577
(dp55402
sg12090
(dp55403
sg6048
g54733
sg11241
(dp55404
sg1611
g25793
ssg6180
(dp55405
VLuteolytic Agents
p55406
g22876
sVNeuropeptides
p55407
(dp55408
sVPituitary Hormone-Releasing Hormones
p55409
g40148
sVPotential QTc-Prolonging Agents
p55410
(dp55411
sVGonadotropin Releasing Hormone Receptor Agonists
p55412
(dp55413
sVHormones
p55414
(dp55415
sVHyperglycemia-Associated Agents
p55416
(dp55417
sVPeptide Hormones
p55418
g20198
sVGonadotropin Releasing Hormone Receptor Agonist
p55419
(dp55420
sVReproductive Control Agents
p55421
g18833
sVQTc Prolonging Agents
p55422
(dp55423
sVAntineoplastic Agents
p55424
(dp55425
sVOligopeptides
p55426
(dp55427
sVAdrenal Cortex Hormones
p55428
g30021
sVProteins
p55429
g52733
sVAntineoplastic Agents, Hormonal
p55430
(dp55431
sVNerve Tissue Proteins
p55432
(dp55433
sVGonadotropin-releasing hormone agonist
p55434
(dp55435
sVAmino Acids, Peptides, and Proteins
p55436
g47306
sVHypothalamic Hormones
p55437
(dp55438
sVPeptides
p55439
g47158
sVHormones and Related Agents
p55440
(dp55441
sVAntineoplastic and Immunomodulating Agents
p55442
g39719
sVHormones, Hormone Substitutes, and Hormone Antagonists
p55443
g53130
sVEndocrine Therapy
p55444
g19564
ssg6183
(dp55445
VAntiinfectives for Systemic Use
p55446
(dp55447
sVCefotaxime
p55448
g50880
sVHeterocyclic Compounds, Fused-Ring
p55449
(dp55450
sVThird-Generation Cephalosporins
p55451
g44712
sVbeta-Lactams
p55452
(dp55453
sVCephacetrile
p55454
(dp55455
sVLactams
p55456
g22287
sVAmides
p55457
g44282
sVThiazines
p55458
g16420
sVSulfur Compounds
p55459
(dp55460
sVProdrugs
p55461
g52312
sVAnti-Bacterial Agents
p55462
g38367
sVAntibacterials for Systemic Use
p55463
g32566
sVCephalosporins
p55464
g49068
sVAnti-Infective Agents
p55465
g54644
sVNephrotoxic agents
p55466
(dp55467
ssg6186
(dp55468
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p55469
g52075
sVNMDA Receptor Antagonists
p55470
g43492
sVCytochrome P-450 CYP3A4 Inhibitors
p55471
(dp55472
sVAnti-Parkinson Drugs
p55473
g16141
sVCytochrome P-450 CYP2D6 Inhibitors
p55474
(dp55475
sVCytochrome P-450 CYP3A Substrates
p55476
g44962
sVNeurotransmitter Agents
p55477
(dp55478
sVEthers, Chemically Close to Antihistamines
p55479
g27212
sVCentral Nervous System Agents
p55480
(dp55481
sVPotential QTc-Prolonging Agents
p55482
(dp55483
sVEnzyme Inhibitors
p55484
(dp55485
sVCytochrome P-450 Enzyme Inhibitors
p55486
(dp55487
sVMuscarinic Antagonists
p55488
g48853
sVAnticholinergic Agents
p55489
g24460
sVCytochrome P-450 CYP3A4 Substrates
p55490
(dp55491
sVAmines
p55492
g42662
sVCentrally-mediated Muscle Relaxation
p55493
(dp55494
sVPeripheral Nervous System Agents
p55495
(dp55496
sVParasympatholytics
p55497
g35946
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p55498
g29191
sVEthylamines
p55499
g20587
sVQTc Prolonging Agents
p55500
(dp55501
sVMusculo-Skeletal System
p55502
g31541
sVCentral Nervous System Depressants
p55503
(dp55504
sVHistamine Antagonists
p55505
g43417
sVBenzene Derivatives
p55506
(dp55507
sVCytochrome P-450 CYP1A2 Inhibitors
p55508
g14989
sVAnti-Dyskinesia Agents
p55509
g50478
sVCytochrome P-450 CYP2B6 Inhibitors
p55510
g45919
sVMuscle Relaxants, Centrally Acting Agents
p55511
g37382
sVMiscellaneous Skeletal Muscle Relaxants
p55512
(dp55513
sVHistamine H1 Antagonists
p55514
g40760
sVBenzhydryl Compounds
p55515
(dp55516
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p55517
g49322
sVAutonomic Agents
p55518
(dp55519
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p55520
g13741
sVCytochrome P-450 CYP3A Inhibitors
p55521
(dp55522
sVCholinergic Agents
p55523
g28711
sVMuscle Relaxants
p55524
(dp55525
sVAgents producing tachycardia
p55526
g50741
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p55527
(dp55528
sVChemically-Induced Disorders
p55529
g21217
sVNervous System
p55530
(dp55531
ssg6189
(dp55532
g2256
g30928
sg1356
g23970
ssg6192
(dp55533
VUrea
p55534
(dp55535
sVHematologic Agents
p55536
(dp55537
sg2556
g32913
sVNucleic Acid Synthesis Inhibitors
p55538
g48738
sVMyelosuppressive Agents
p55539
(dp55540
sVCytochrome P-450 CYP2D6 Inhibitors
p55541
(dp55542
sVImmunosuppressive Agents
p55543
(dp55544
sVP-glycoprotein/ABCB1 Substrates
p55545
g34907
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p55546
g53062
sVAntineoplastic and Immunomodulating Agents
p55547
g39722
sVEnzyme Inhibitors
p55548
(dp55549
sVCytochrome P-450 Enzyme Inhibitors
p55550
(dp55551
sVAntineoplastic Agents
p55552
(dp55553
ssg6195
(dp55554
g5973
g54253
sg351
g15258
ssg6198
(dp55555
g8019
(dp55556
sg336
g15067
sg4425
g44911
ssg6201
(dp55557
g5127
g49214
ssg6204
(dp55558
VAntiinfectives for Systemic Use
p55559
(dp55560
sVDrugs that are Mainly Renally Excreted
p55561
g43820
sVHeterocyclic Compounds, Fused-Ring
p55562
(dp55563
sVbeta-Lactams
p55564
(dp55565
sVNephrotoxic agents
p55566
(dp55567
sVCephalexin
p55568
(dp55569
sVOAT3/SLC22A8 Inhibitors
p55570
(dp55571
sVLactams
p55572
g22268
sVOAT1/SLC22A6 inhibitors
p55573
(dp55574
sVFirst-Generation Cephalosporins
p55575
(dp55576
sVAmides
p55577
g44287
sVThiazines
p55578
g16416
sVSulfur Compounds
p55579
(dp55580
sVAnti-Bacterial Agents
p55581
g38313
sVAntibacterials for Systemic Use
p55582
g32534
sVCephalosporins
p55583
g49065
sVAnti-Infective Agents
p55584
g54557
ssg6207
(dp55585
VCytochrome P-450 CYP2C19 Substrates
p55586
g53878
sVCentral Nervous System Depressants
p55587
(dp55588
sVCentrally-mediated Muscle Relaxation
p55589
(dp55590
sVCarbamic Acid Esters
p55591
g30726
sVMuscle Relaxants, Centrally Acting Agents
p55592
g37381
sVCentral Nervous System Agents
p55593
(dp55594
sVMuscle Relaxants
p55595
(dp55596
sVCarbamates
p55597
g45512
sVMusculo-Skeletal System
p55598
g31503
ssg6210
(dp55599
g3087
g36649
sg2391
g31707
ssg6213
(dp55600
VAmino Acids, Peptides, and Proteins
p55601
g47312
sVAntibodies
p55602
(dp55603
sg10998
(dp55604
sVAntibodies, Monoclonal
p55605
(dp55606
sg10788
(dp55607
sVProteins
p55608
g52737
sVMusculo-Skeletal System
p55609
g31511
sVImmunoglobulins
p55610
g41515
sVImmunosuppressive Agents
p55611
(dp55612
sVSerum Globulins
p55613
g49648
sg10800
(dp55614
sg246
g14283
sVBone Density Conservation Agents
p55615
g40355
sg468
g16515
sVBlood Proteins
p55616
g39845
sVGlobulins
p55617
g19167
sVImmunoproteins
p55618
(dp55619
ssg6216
(dp55620
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p55621
g52078
sVCytochrome P-450 CYP3A4 Inhibitors
p55622
(dp55623
sVInterleukin Inhibitors
p55624
g49766
sVSerum Globulins
p55625
g49649
sVCytochrome P-450 CYP3A4 Inducers (weak)
p55626
g19514
sVImmunoglobulins
p55627
g41516
sVCytochrome P-450 CYP3A4 Inducers
p55628
g18875
sg8664
(dp55629
sVAntibodies
p55630
(dp55631
sg8844
(dp55632
sVAgents reducing cytokine levels
p55633
(dp55634
sVProteins
p55635
g52738
sVCytochrome P-450 Enzyme Inducers
p55636
g28114
sVCytochrome P-450 CYP3A Inducers
p55637
(dp55638
sVGlobulins
p55639
g19168
sVAmino Acids, Peptides, and Proteins
p55640
g47313
sVCytochrome P-450 CYP3A Inhibitors
p55641
(dp55642
sVImmunosuppressive Agents
p55643
(dp55644
sVAntineoplastic Agents
p55645
(dp55646
sVAntineoplastic and Immunomodulating Agents
p55647
g39727
sVBlood Proteins
p55648
g39846
sVImmunoproteins
p55649
(dp55650
ssg6219
(dp55651
g6180
g55415
sg5409
g50885
sg11274
(dp55652
sg6228
(dp55653
sg4620
g46331
sg5433
g51030
sg9903
(dp55654
sg1800
g27308
sg4653
g46662
sg10149
(dp55655
sg7668
(dp55656
sg8430
(dp55657
sg11460
(dp55658
sg7689
(dp55659
sg2388
g31659
sg339
g15153
sg8457
(dp55660
sg102
g12991
sg5514
g51511
sg9225
(dp55661
sg4053
g42553
sg2283
g31156
sg3861
g41273
sg3219
g37539
sg6345
(dp55662
sg14829
(dp55663
sg11259
(dp55664
sg8796
(dp55665
sg10323
(dp55666
sg714
g19002
sg7962
(dp55667
sg4821
g47747
sg4365
g44757
sg7407
(dp55668
sg12274
g27511
sg4875
g48037
sg11922
(dp55669
sg7545
(dp55670
sg4515
g45888
sg1614
g25850
sg4680
g46868
sg14838
g39965
sg3543
g39320
sg12534
g52612
sg9357
(dp55671
sg4113
g43023
sg8694
(dp55672
sg4143
g43154
sg10209
(dp55673
sg4170
g43386
sg14872
g15705
sg4935
g48449
sg8013
(dp55674
sg5766
g52961
sg402
g15832
sg8763
(dp55675
sg2373
g31574
sg5463
g51241
sg7221
(dp55676
sg444
g16238
sg2007
g28864
sg4236
g43697
sg11046
(dp55677
sg8808
(dp55678
sg4278
g44268
sg10338
(dp55679
sg2817
g34548
sg5895
g53794
sg8088
(dp55680
sg11952
(dp55681
sg9609
(dp55682
sg543
g17079
sg8106
(dp55683
sg3393
g38540
sg11886
(dp55684
sg10416
(dp55685
sg4338
g44573
sg11160
(dp55686
sg8142
(dp55687
sg2886
g35297
sg1776
g27090
sg6360
(dp55688
sg1383
g24177
sg2172
g30504
sg9372
(dp55689
sg3627
g39919
sg13750
g24356
sg9693
(dp55690
sg6045
g54694
sg11997
(dp55691
sg1470
g24895
sg6783
(dp55692
sg12042
(dp55693
sg2253
g30899
sg9774
(dp55694
sg11316
(dp55695
sg2832
g34686
sg6123
g55122
sg2286
g31177
sg6015
g54379
sg12132
(dp55696
sg801
g19530
ssg6222
(dp55697
g4023
g42325
ssg6225
(dp55698
g10740
(dp55699
sg2109
g30147
sg2088
g29938
ssg6228
(dp55700
VAmino Acids, Peptides, and Proteins
p55701
g47308
sg429
g16135
sVGonadotropins and Antigonadotropins
p55702
(dp55703
sVPeptide Hormones
p55704
g20209
sVGenito Urinary System and Sex Hormones
p55705
(dp55706
sVProteins
p55707
g52734
sVGonadotropins
p55708
(dp55709
sg11925
(dp55710
sVPeptides
p55711
g47160
sVReproductive Control Agents
p55712
g18835
sVHormones
p55713
g55653
sVHormones, Hormone Substitutes, and Hormone Antagonists
p55714
g53132
sVSex Hormones and Modulators of the Genital System
p55715
g19594
sg7380
(dp55716
ssg6231
(dp55717
VAntivirals for Systemic Use
p55718
(dp55719
sVNucleic Acid Synthesis Inhibitors
p55720
g48728
sVGuanine
p55721
(dp55722
sVDirect Acting Antivirals
p55723
g38051
sVProdrugs
p55724
g52308
sVAcyclovir and prodrug
p55725
g32994
sVHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor
p55726
(dp55727
sVAntiinfectives for Systemic Use
p55728
(dp55729
sVDrugs that are Mainly Renally Excreted
p55730
g43822
sVHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
p55731
g50119
sVAmino Acids
p55732
g43102
sVNephrotoxic agents
p55733
(dp55734
sVAnti-Infective Agents
p55735
g54562
sVAcyclovir
p55736
g17171
sVPurinones
p55737
g48133
sVOAT3/SLC22A8 Substrates
p55738
g13142
sVHerpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
p55739
(dp55740
sVNucleosides and Nucleotides
p55741
g39102
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p55742
g51695
sg9636
(dp55743
sVPurines
p55744
(dp55745
sVAmino Acids, Peptides, and Proteins
p55746
g47351
sVHeterocyclic Compounds, Fused-Ring
p55747
(dp55748
sVAmino Acids, Essential
p55749
g35281
sVAntiviral Agents
p55750
g30435
ssg6234
(dp55751
g1635
g26070
ssg6237
(dp55752
g6408
(dp55753
sg7716
(dp55754
ssg6240
(dp55755
VAntiinfectives for Systemic Use
p55756
(dp55757
sVProtein Synthesis Inhibitors
p55758
g45554
sVAgents that produce neuromuscular block (indirect)
p55759
g37974
sVLincosamides
p55760
g26221
sVPyrrolidines
p55761
(dp55762
sVCarbohydrates
p55763
(dp55764
sVGlycosides
p55765
(dp55766
sVEnzyme Inhibitors
p55767
(dp55768
sVNeurotoxic agents
p55769
(dp55770
sVMacrolides, Lincosamides and Streptogramins
p55771
g33214
sVAnti-Bacterial Agents
p55772
g38366
sVAntibacterials for Systemic Use
p55773
g32565
sVAnti-Infective Agents
p55774
g54564
ssg6243
(dp55775
g11886
(dp55776
sg9609
(dp55777
sg9693
(dp55778
sg6783
(dp55779
sg5766
g52954
sg8694
(dp55780
ssg6246
(dp55781
VStyrene
p55782
(dp55783
sVChelating Agents
p55784
(dp55785
sVCompounds used in a research, industrial, or household setting
p55786
(dp55787
sVCation Exchange Resins
p55788
(dp55789
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p55790
g37168
sVPotassium-removing Agents
p55791
(dp55792
sVSulfur Compounds
p55793
(dp55794
sVIon Exchange Resins
p55795
g23410
sVBenzene Derivatives
p55796
(dp55797
sVPolymers
p55798
g22227
sVAcids
p55799
g40571
sVSequestering Agents
p55800
(dp55801
sVLaboratory Chemicals
p55802
(dp55803
sVStyrenes
p55804
(dp55805
sVBenzylidene Compounds
p55806
g43130
sVBiomedical and Dental Materials
p55807
g44721
sVPlastics
p55808
(dp55809
sVPotassium Binder
p55810
(dp55811
sVPotassium Ion Exchange Activity
p55812
(dp55813
sVPolystyrene Sulfonates
p55814
(dp55815
sVAcids, Noncarboxylic
p55816
g54196
sVSulfur Acids
p55817
(dp55818
sVMacromolecular Substances
p55819
g33836
ssg6249
(dp55820
g11046
(dp55821
ssg6252
(dp55822
g1104
g22100
sg10410
(dp55823
sg7719
(dp55824
sg2895
g35431
sg7329
(dp55825
sg4440
g45327
ssg6255
(dp55826
g5268
g50138
sg3027
g36355
sg6882
(dp55827
sg10701
(dp55828
sg11601
(dp55829
sg5454
g51152
ssg6258
(dp55830
g5238
g49893
sg966
g21041
sg1767
g27020
sg6267
(dp55831
ssg6261
(dp55832
VAgents Causing Muscle Toxicity
p55833
g55380
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p55834
(dp55835
sVUGT1A1 Substrates
p55836
g12328
sVAnalgesics
p55837
g26466
sVCentral Nervous System Agents
p55838
(dp55839
sVDrugs Used in Alcohol Dependence
p55840
(dp55841
sg9174
(dp55842
sVDrugs Used in Addictive Disorders
p55843
g24713
sVPeripheral Nervous System Agents
p55844
(dp55845
sVNatural Opium Alkaloids
p55846
g23483
sVCentrally Acting Antiobesity Products
p55847
g50362
sVOpioids
p55848
g32234
sVOpiate Alkaloids
p55849
(dp55850
sVOpioid Antagonists
p55851
(dp55852
sVNaloxone
p55853
(dp55854
sVMorphinans
p55855
(dp55856
sVAlimentary Tract and Metabolism
p55857
g23867
sVHeterocyclic Compounds, Fused-Ring
p55858
(dp55859
sVAlcohol Deterrents
p55860
g15817
sVAlkaloids
p55861
g19442
sVAntiobesity Preparations, Excl. Diet Products
p55862
g39833
sVSensory System Agents
p55863
(dp55864
sVPhenanthrenes
p55865
g32835
sVNervous System
p55866
(dp55867
ssg6264
(dp55868
g4035
g42425
sg1707
g26772
sg12111
(dp55869
sg426
g16089
sg687
g18555
sg2358
g31475
sg8580
(dp55870
sg11595
(dp55871
sg2523
g32735
sg5067
g48944
sg9564
(dp55872
sg10596
(dp55873
sg5781
g53106
sg3204
g37439
sg6570
(dp55874
sg8205
(dp55875
sg5133
g49278
sg5691
g52490
sg915
g20704
ssg6267
(dp55876
VCytochrome P-450 CYP1A2 Substrates
p55877
g45575
sVCardiovascular Agents
p55878
g26539
sVNephrotoxic agents
p55879
(dp55880
sVAgents causing hyperkalemia
p55881
g43577
sVHypotensive Agents
p55882
g34113
sVPteridines
p55883
(dp55884
sg2529
g32769
sg8553
(dp55885
sg6258
g55831
sg10044
(dp55886
sVIncreased Diuresis
p55887
g41002
sVMembrane Transport Modulators
p55888
g54125
sVHeterocyclic Compounds, Fused-Ring
p55889
(dp55890
sVNatriuretic Agents
p55891
g40488
sVSodium Channel Blockers
p55892
(dp55893
sVDiuretics
p55894
(dp55895
ssg6270
(dp55896
g10185
(dp55897
sg5286
g50203
sg6567
(dp55898
ssg6273
(dp55899
VDrugs that are Mainly Renally Excreted
p55900
g43834
sVBenzene Derivatives
p55901
(dp55902
sVBenzyl Compounds
p55903
g30838
sVAnti-Infective Agents, Local
p55904
(dp55905
sVThroat Preparations
p55906
(dp55907
sVAlcohols
p55908
(dp55909
ssg6276
(dp55910
g5574
g51804
sg5934
g54091
sg3231
g37679
sg7314
(dp55911
sg10164
(dp55912
sg20252
(dp55913
sg9486
(dp55914
sg7641
(dp55915
sg10383
(dp55916
sg4656
g46790
ssg6279
(dp55917
VCytochrome P-450 CYP3A4 Inhibitors
p55918
(dp55919
sVCytochrome P-450 CYP2D6 Inhibitors
p55920
(dp55921
sVOtologicals
p55922
(dp55923
sVCytochrome P-450 CYP3A Substrates
p55924
g44968
sg4626
g46414
sVAntifungal Agents
p55925
(dp55926
sVEnzyme Inhibitors
p55927
(dp55928
sg9558
(dp55929
sVStomatological Preparations
p55930
(dp55931
sVCytochrome P-450 CYP2C9 Inhibitors
p55932
g18185
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p55933
g12672
sVCytochrome P-450 Enzyme Inhibitors
p55934
(dp55935
sVAnti-Infective Agents
p55936
g54569
sVAntifungal Agents (Vaginal)
p55937
g39081
sVAntiinfectives for Systemic Use
p55938
(dp55939
sVImidazole and Triazole Derivatives
p55940
g51757
sVAzole Antifungals
p55941
g20186
sVGynecological Antiinfectives and Antiseptics
p55942
(dp55943
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p55944
(dp55945
sVCytochrome P-450 CYP2E1 Inhibitors
p55946
g46837
sVAntifungals for Topical Use
p55947
g39224
sVSteroid Synthesis Inhibitors
p55948
(dp55949
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p55950
g29201
sg4497
g45820
sVImidazoles
p55951
(dp55952
sg1995
g28836
sVAntifungals for Dermatological Use
p55953
g30066
sVCytochrome P-450 CYP2B6 Inhibitors
p55954
g45932
sVDermatologicals
p55955
g17204
sg4119
g43095
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p55956
g44516
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p55957
(dp55958
sVCytochrome P-450 CYP2C19 Inhibitors
p55959
(dp55960
sVCytochrome P-450 CYP3A4 Substrates
p55961
(dp55962
sVAlimentary Tract and Metabolism
p55963
g23782
sVHormone Antagonists
p55964
g24273
sg11538
(dp55965
sV14-alpha Demethylase Inhibitors
p55966
(dp55967
sVGenito Urinary System and Sex Hormones
p55968
(dp55969
sVIntestinal Antiinfectives
p55970
(dp55971
sVCytochrome P-450 CYP3A Inhibitors
p55972
(dp55973
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p55974
(dp55975
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p55976
g53073
sVP-glycoprotein/ABCB1 Inhibitors
p55977
(dp55978
sg8175
(dp55979
sVHormones, Hormone Substitutes, and Hormone Antagonists
p55980
g53140
sVChemically-Induced Disorders
p55981
g21236
sVCytochrome P-450 CYP2A6 Inhibitors
p55982
g48585
sVImidazole Derivatives
p55983
(dp55984
sVSensory Organs
p55985
g40680
ssg6282
(dp55986
g8595
(dp55987
ssg6285
(dp55988
g9372
(dp55989
ssg6288
(dp55990
g11664
(dp55991
sg12186
g42932
sg9000
(dp55992
sg7680
(dp55993
ssg6291
(dp55994
VCardiovascular Agents
p55995
g26545
sVBSEP/ABCB11 Substrates
p55996
(dp55997
sVAngiotensin II Antagonists and Calcium Channel Blockers
p55998
g42303
sVAntihypertensive Agents
p55999
g20322
sVOATP1B3 substrates
p56000
g28531
sVAngiotensin Receptor Antagonists
p56001
(dp56002
sVAngiotensin II receptor blockers (ARBs) and diuretics
p56003
g18118
sVAgents causing hyperkalemia
p56004
g43645
sVHypotensive Agents
p56005
g34212
sVTetrazoles
p56006
g19112
sg8970
(dp56007
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p56008
(dp56009
sVAngiotensin II receptor blockers (ARBs), plain
p56010
g22614
sVAngiotensin 2 Receptor Blocker
p56011
(dp56012
sVOATP1B1/SLCO1B1 Substrates
p56013
(dp56014
sVImidazoles
p56015
(dp56016
sVAgents Acting on the Renin-Angiotensin System
p56017
g25343
ssg6294
(dp56018
g10320
(dp56019
sg8583
(dp56020
sg3312
g38147
sg9726
(dp56021
sg420
g16022
sg7155
(dp56022
ssg6297
(dp56023
g6885
(dp56024
ssg6300
(dp56025
g8373
(dp56026
sg2346
g31400
sg10629
(dp56027
sg8514
(dp56028
sg11337
(dp56029
sg10635
(dp56030
sg4911
g48230
sg2358
g31485
sg3846
g41143
sg12114
(dp56031
sg5427
g50981
sg135
g13241
sg6882
(dp56032
sg828
g19856
sg7641
(dp56033
sg9135
(dp56034
sg10662
(dp56035
sg279
g14487
sg4872
g48004
sg7653
(dp56036
sg4656
g46797
sg9411
(dp56037
sg10674
(dp56038
sg6231
g55748
sg69
g12744
sg1914
g28421
sg5472
g51302
sg9192
(dp56039
sg1668
g26284
sg3900
g41505
sg9507
(dp56040
sg4827
g47766
sg9981
(dp56041
sg7680
(dp56042
sg888
g20491
sg20252
(dp56043
sg2481
g32434
sg4683
g46939
sg3156
g37215
sg339
g15186
sg6267
g55890
sg1683
g26397
sg1686
g26404
sg9960
(dp56044
sg2436
g32167
sg15016
(dp56045
sg7344
(dp56046
sg3609
g39706
sg6318
(dp56047
sg10725
(dp56048
sg6966
(dp56049
sg8751
(dp56050
sg4710
g46999
sg9231
(dp56051
sg9234
(dp56052
sg5535
g51672
sg7716
(dp56053
sg2466
g32357
sg12421
g12474
sg8340
(dp56054
sg789
g19481
sg8031
(dp56055
sg3204
g37448
sg19588
g32508
sg7005
(dp56056
sg6303
(dp56057
sg2493
g32600
sg2928
g35610
sg3576
g39590
sg8484
(dp56058
sg5574
g51814
sg10737
(dp56059
sg972
g21112
sg3222
g37619
sg6315
(dp56060
sg42
g12596
sg3231
g37671
sg12186
g42940
sg2523
g32752
sg8805
(dp56061
sg11664
(dp56062
sg10815
(dp56063
sg2538
g32821
sg4002
g42127
sg3261
g37836
sg4005
g42185
sg3267
g37886
sg1008
g21299
sg822
g19796
sg1278
g23320
sg11781
(dp56064
sg9417
(dp56065
sg5619
g52218
sg7056
(dp56066
sg10077
(dp56067
sg8166
(dp56068
sg240
g14207
sg12066
(dp56069
sg11601
(dp56070
sg8916
(dp56071
sg5646
g52325
sg3321
g38217
sg7713
(dp56072
sg2265
g31022
sg4101
g42981
sg6408
(dp56073
sg7734
(dp56074
sg4857
g47881
sg10890
(dp56075
sg4068
g42787
sg6156
g55241
sg9111
(dp56076
sg10899
(dp56077
sg11655
(dp56078
sg5316
g50461
sg13070
g21910
sg6432
(dp56079
sg1656
g26186
sg11931
(dp56080
sg5691
g52497
sg4773
g47488
sg1872
g27875
sg11685
(dp56081
sg2808
g34470
sg5739
g52884
sg2784
g34380
sg11694
(dp56082
sg9432
(dp56083
sg10164
(dp56084
sg7941
(dp56085
sg5727
g52819
sg4260
g44125
sg8487
(dp56086
sg6102
g55097
sg11508
(dp56087
sg9918
(dp56088
sg5736
g52834
sg10959
(dp56089
sg4263
g44181
sg537
g17050
sg2688
g33674
sg7170
(dp56090
sg3432
g38821
sg6048
g54763
sg4164
g43354
sg8616
(dp56091
sg8226
(dp56092
sg1134
g22344
sg1947
g28700
sg7191
(dp56093
sg5064
g48926
sg3426
g38769
sg7197
(dp56094
sg1281
g23395
sg1194
g22828
sg11775
(dp56095
sg414
g15983
sg5793
g53224
sg6759
(dp56096
sg11385
(dp56097
sg426
g16081
sg10263
(dp56098
sg11154
(dp56099
sg11022
(dp56100
sg3912
g41614
sg2430
g32112
sg5817
g53311
sg8439
(dp56101
sg456
g16401
sg1626
g25937
sg10056
(dp56102
sg5832
g53411
sg8463
(dp56103
sg9486
(dp56104
sg7074
(dp56105
sg5487
g51374
sg477
g16613
sg5853
g53558
sg2787
g34392
sg7275
(dp56106
sg6261
g55859
sg495
g16714
sg8067
(dp56107
sg7284
(dp56108
sg2736
g33972
sg5871
g53643
sg7314
(dp56109
sg9564
(dp56110
sg5877
g53695
sg5880
g53719
sg8211
(dp56111
sg8079
(dp56112
sg9750
(dp56113
sg8820
(dp56114
sg11097
(dp56115
sg2079
g29865
sg840
g20009
sg5781
g53120
sg4299
g44424
sg2910
g35557
sg5796
g53234
sg1707
g26796
sg4458
g45500
sg2427
g32061
sg546
g17141
sg2838
g34808
sg3546
g39403
sg10713
(dp56116
sg5928
g54048
sg6885
(dp56117
sg1413
g24434
sg696
g18770
sg5934
g54103
sg10578
(dp56118
sg7707
(dp56119
sg10383
(dp56120
sg10416
(dp56121
sg4173
g43395
sg1809
g27446
sg10389
(dp56122
sg573
g17575
sg11166
(dp56123
sg4344
g44671
sg8874
(dp56124
sg582
g17637
sg1365
g24035
sg8880
(dp56125
sg5169
g49541
sg5295
g50336
sg3291
g37994
sg600
g17746
sg1863
g27753
sg1938
g28556
sg7014
(dp56126
sg9372
(dp56127
sg8922
(dp56128
sg8187
(dp56129
sg7563
(dp56130
sg621
g17976
sg6183
g55450
sg5454
g51172
sg630
g18043
sg633
g18095
sg2199
g30702
sg8205
(dp56131
sg516
g16884
sg7422
(dp56132
sg1425
g24566
sg11145
(dp56133
sg6933
(dp56134
sg318
g14929
sg2943
g35779
sg3072
g36601
sg11979
(dp56135
sg2946
g35831
sg2112
g30177
sg10470
(dp56136
sg9711
(dp56137
sg5247
g49918
sg5250
g50001
sg1452
g24743
sg8295
(dp56138
sg2451
g32207
sg10479
(dp56139
sg9084
(dp56140
sg1461
g24850
sg9282
(dp56141
sg8238
(dp56142
sg8241
(dp56143
sg5769
g53047
sg7065
(dp56144
sg1473
g24955
sg12018
(dp56145
sg6069
g54840
sg8259
(dp56146
sg2991
g35960
sg9000
(dp56147
sg6792
(dp56148
sg8850
(dp56149
sg294
g14760
sg2250
g30851
sg12051
(dp56150
sg3009
g36055
sg6090
g54968
sg1311
g23515
sg11133
(dp56151
sg5919
g53995
sg9987
(dp56152
sg10521
(dp56153
sg723
g19072
sg933
g20843
sg9783
(dp56154
sg486
g16667
sg1140
g22426
sg11727
(dp56155
sg2274
g31088
sg1176
g22662
sg9420
(dp56156
sg126
g13162
sg11790
(dp56157
sg8298
(dp56158
sg4542
g46068
sg11625
(dp56159
sg1704
g26731
sg1092
g21995
sg10698
(dp56160
sg1599
g25729
sg3795
g40922
sg9819
(dp56161
sg8871
(dp56162
sg8334
(dp56163
sg282
g14546
sg7416
(dp56164
sg10758
(dp56165
sg405
g15875
sg10611
(dp56166
sg12126
(dp56167
sg1464
g24860
sg6204
g55563
sg2664
g33465
sg11370
(dp56168
sg10602
(dp56169
sg9102
(dp56170
sg6162
g55252
sg12123
(dp56171
sg9864
(dp56172
ssg6303
(dp56173
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p56174
g52093
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p56175
(dp56176
sVCytochrome P-450 CYP3A4 Inhibitors
p56177
(dp56178
sVUGT1A4 substrates
p56179
g41051
sVAdrenergic alpha-1 Receptor Antagonists
p56180
g14135
sVAnticholinergic Agents
p56181
g24501
sVCytochrome P-450 CYP2D6 Inhibitors
p56182
(dp56183
sVCytochrome P-450 CYP2D6 Substrates
p56184
g52124
sVSerotonin Agents
p56185
(dp56186
sVNeurotransmitter Agents
p56187
(dp56188
sVHypotensive Agents
p56189
g34124
sVSerotonin Receptor Antagonists
p56190
g35684
sVCentral Nervous System Agents
p56191
(dp56192
sVPotential QTc-Prolonging Agents
p56193
(dp56194
sVAdrenergic Antagonists
p56195
g52295
sVPsychotropic Drugs
p56196
(dp56197
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p56198
g49910
sVCytochrome P-450 CYP2C9 Inhibitors
p56199
g18190
sVCytochrome P-450 Enzyme Inhibitors
p56200
(dp56201
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p56202
g18422
sVHistamine H2 Antagonists
p56203
g12713
sVHyperglycemia-Associated Agents
p56204
(dp56205
sVDiazepines, Oxazepines, Thiazepines and Oxepines
p56206
g40207
sVCytochrome P-450 CYP1A2 Substrates
p56207
g45577
sVAutonomic Agents
p56208
(dp56209
sVAntipsychotic Agents
p56210
(dp56211
sVMuscarinic Antagonists
p56212
g48879
sVDopamine Antagonists
p56213
g53749
sVAdrenergic alpha-Antagonists
p56214
(dp56215
sVPsycholeptics
p56216
g33253
sVQTc Prolonging Agents
p56217
(dp56218
sVSerotonin 5-HT2 Receptor Antagonists
p56219
(dp56220
sVCentral Nervous System Depressants
p56221
(dp56222
sVAntiemetics
p56223
(dp56224
sVGastrointestinal Agents
p56225
(dp56226
sVHistamine Antagonists
p56227
g43428
sVP-glycoprotein/ABCB1 Substrates
p56228
g34936
sVHistamine H1 Antagonists
p56229
g40770
sVCytochrome P-450 CYP2C19 Inhibitors
p56230
(dp56231
sVHeterocyclic Compounds, Fused-Ring
p56232
g56057
sVDopamine D2 Receptor Antagonists
p56233
g49423
sVBenzazepines
p56234
(dp56235
sVCytochrome P-450 CYP2C9 Inhibitors (weak)
p56236
g41913
sVAntidepressive Agents
p56237
g15511
sVCytochrome P-450 CYP3A Inhibitors
p56238
(dp56239
sVTranquilizing Agents
p56240
g55303
sVPeripheral Nervous System Agents
p56241
(dp56242
sVAgents producing tachycardia
p56243
g50752
sVBenzodiazepines and benzodiazepine derivatives
p56244
(dp56245
sVNervous System
p56246
(dp56247
sVAntipsychotic Agents (Second Generation [Atypical])
p56248
g52066
ssg6306
(dp56249
g11268
(dp56250
ssg6309
(dp56251
g6612
(dp56252
sg10104
(dp56253
ssg6312
(dp56254
g2745
g34043
sVPyrimidines
p56255
g47707
sVPiperidines
p56256
(dp56257
sVCardiovascular Agents
p56258
g26551
sg11730
(dp56259
sg7875
(dp56260
sVUGT1A1 Substrates
p56261
g12318
sVAntihypertensive Agents
p56262
g20261
sVHypotensive Agents
p56263
g34125
sVDirect Vasodilators
p56264
(dp56265
sVDermatologicals
p56266
g17214
sVVasodilating Agents
p56267
g23716
sVMisc. Skin and Mucous Membrane Agents
p56268
(dp56269
sVArteriolar Smooth Muscle, Agents Acting On
p56270
(dp56271
ssg6315
(dp56272
VCytochrome P-450 CYP3A4 Inhibitors
p56273
(dp56274
sVAdrenergic alpha-1 Receptor Antagonists
p56275
g14140
sVCytochrome P-450 CYP2D6 Inhibitors
p56276
(dp56277
sVCytochrome P-450 CYP2D6 Substrates
p56278
g52125
sVAntiarrhythmic agents
p56279
(dp56280
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p56281
g41082
sVCytochrome P-450 CYP3A Substrates
p56282
g44974
sVCYP3A Substrates (Sensitive)
p56283
(dp56284
sVAdrenergic Antagonists
p56285
g52299
sVCytochrome P-450 Enzyme Inhibitors
p56286
(dp56287
sVHighest Risk QTc-Prolonging Agents
p56288
g35873
sVBenzofurans
p56289
(dp56290
sVCardiac Therapy
p56291
(dp56292
sg6738
(dp56293
sg1677
g26366
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56294
g29211
sVAdrenergic alpha-Antagonists
p56295
(dp56296
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p56297
(dp56298
sVQTc Prolonging Agents
p56299
(dp56300
sVCardiovascular Agents
p56301
g26554
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p56302
(dp56303
sVAgents that produce hypertension
p56304
(dp56305
sVCytochrome P-450 CYP3A4 Substrates
p56306
(dp56307
sVHeterocyclic Compounds, Fused-Ring
p56308
g56060
sVCytochrome P-450 CYP3A Inhibitors
p56309
(dp56310
sVBradycardia-Causing Agents
p56311
(dp56312
sVP-glycoprotein/ABCB1 Inhibitors
p56313
(dp56314
sg9015
(dp56315
ssg6318
(dp56316
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p56317
(dp56318
sVAdrenergic alpha-1 Receptor Antagonists
p56319
g14109
sVAnticholinergic Agents
p56320
g24466
sVCytochrome P-450 CYP2D6 Inhibitors
p56321
(dp56322
sVCytochrome P-450 CYP2D6 Substrates
p56323
g52148
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p56324
g41063
sVCytochrome P-450 CYP3A Substrates
p56325
g44975
sVNeurotransmitter Agents
p56326
(dp56327
sVHypotensive Agents
p56328
g34102
sVSerotonin Receptor Antagonists
p56329
g35662
sVCentral Nervous System Agents
p56330
(dp56331
sVDopamine Agents
p56332
g14228
sVAntipsychotic Agents (First Generation [Typical])
p56333
(dp56334
sVAdrenergic Antagonists
p56335
g52266
sVPsychotropic Drugs
p56336
(dp56337
sVCytochrome P-450 CYP2E1 Inhibitors
p56338
g46829
sVPsycholeptics
p56339
g33258
sVSerotonin 5-HT1 Receptor Antagonists
p56340
g14434
sVCytochrome P-450 Enzyme Inhibitors
p56341
(dp56342
sVMuscarinic Antagonists
p56343
g48857
sVHyperglycemia-Associated Agents
p56344
(dp56345
sVDrugs that are Mainly Renally Excreted
p56346
g43828
sVCytochrome P-450 CYP1A2 Substrates
p56347
g45567
sVAutonomic Agents
p56348
(dp56349
sVAntipsychotic Agents
p56350
(dp56351
sVPeripheral Nervous System Agents
p56352
(dp56353
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56354
g29212
sVSulfur Compounds
p56355
(dp56356
sVAdrenergic alpha-Antagonists
p56357
(dp56358
sVSerotonin Agents
p56359
(dp56360
sVDopamine Antagonists
p56361
g53738
sVQTc Prolonging Agents
p56362
(dp56363
sVSerotonin 5-HT2 Receptor Antagonists
p56364
(dp56365
sVCentral Nervous System Depressants
p56366
(dp56367
sVAntiemetics
p56368
(dp56369
sVGastrointestinal Agents
p56370
(dp56371
sVHistamine Antagonists
p56372
g43421
sVAgents that reduce seizure threshold
p56373
g45838
sVP-glycoprotein/ABCB1 Substrates
p56374
g34911
sVHistamine H1 Antagonists
p56375
g40764
sVAgents that produce hypertension
p56376
(dp56377
sVBSEP/ABCB11 Inhibitors
p56378
(dp56379
sVCytochrome P-450 CYP3A4 Substrates
p56380
(dp56381
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p56382
g26868
sVModerate Risk QTc-Prolonging Agents
p56383
(dp56384
sVDopamine D2 Receptor Antagonists
p56385
g49413
sVHeterocyclic Compounds, Fused-Ring
p56386
g56047
sVAntidepressive Agents
p56387
g15495
sg10503
(dp56388
sVPhenothiazines
p56389
(dp56390
sVCholinesterase Inhibitors
p56391
(dp56392
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p56393
g53063
sVP-glycoprotein/ABCB1 Inhibitors
p56394
(dp56395
sVNeurotoxic agents
p56396
(dp56397
sVAgents producing tachycardia
p56398
g50744
sVNervous System
p56399
(dp56400
sVTranquilizing Agents
p56401
g55304
ssg6321
(dp56402
g11595
(dp56403
sg915
g20742
ssg6324
(dp56404
g13750
g24407
sg4476
g45651
sg2373
g31620
sg9693
(dp56405
sg8277
(dp56406
sg9774
(dp56407
sg816
g19625
sg11922
(dp56408
sg3117
g36936
sg5433
g51014
sg10041
(dp56409
sg9903
(dp56410
sg4236
g43690
sg1800
g27339
sg2226
g30785
sg14822
g41835
sg4653
g46736
sg2388
g31684
sg6585
(dp56411
sg6045
g54717
sg1383
g24158
sg9225
(dp56412
sg5469
g51295
sg7545
(dp56413
sg2043
g29062
sg543
g17067
sg8430
(dp56414
sg1614
g25900
sg1470
g24888
sg6783
(dp56415
sg507
g16799
sg849
g20112
sg8445
(dp56416
sg11940
(dp56417
sg4620
g46353
sg14838
g40014
sg3543
g39304
sg4089
g42868
sg5895
g53836
sg11997
(dp56418
sg3393
g38588
sg12274
g27490
sg12534
g52682
sg11886
(dp56419
sg9609
(dp56420
sg9357
(dp56421
sg4113
g43073
sg2832
g34691
sg966
g21062
sg9030
(dp56422
sg11316
(dp56423
sg1245
g23005
sg4257
g44073
sg165
g13579
sg3249
g37770
sg5238
g49882
sg10272
(dp56424
sg8694
(dp56425
sg10209
(dp56426
sg2127
g30250
sg6123
g55124
sg5556
g51744
sg2286
g31167
sg3861
g41260
sg2133
g30314
sg3783
g40857
sg7668
(dp56427
sg11733
(dp56428
sg3219
g37562
sg6504
(dp56429
sg8658
(dp56430
sg8142
(dp56431
sg4680
g46900
sg4875
g48022
sg5364
g50630
sg14872
g15763
sg8949
(dp56432
sg14829
(dp56433
sg5766
g53006
sg102
g13023
sg831
g19915
sg12132
(dp56434
sg12057
(dp56435
sg6345
(dp56436
sg8013
(dp56437
ssg6327
(dp56438
g3219
g37564
sg2373
g31622
sg8430
(dp56439
sg4875
g48024
sg1383
g24164
sg14838
g40016
sg5895
g53838
sg6585
(dp56440
sg9903
(dp56441
ssg6330
(dp56442
g963
g20980
sg4803
g47630
ssg6333
(dp56443
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p56444
(dp56445
sg8025
(dp56446
sVCytochrome P-450 CYP3A Substrates
p56447
g44977
sVHormone Antagonists and Related Agents
p56448
(dp56449
sVCytochrome P-450 CYP2C9 Inducers (moderate)
p56450
(dp56451
sVCytochrome P-450 CYP2D6 Inducers
p56452
(dp56453
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p56454
g12682
sVCytochrome P-450 CYP2C9 Inducers
p56455
g20056
sVCytochrome P-450 Enzyme Inhibitors
p56456
(dp56457
sVAntiandrogens
p56458
(dp56459
sVDrugs that are Mainly Renally Excreted
p56460
g43829
sVCytochrome P-450 CYP2C8 Substrates
p56461
(dp56462
sVCytochrome P-450 CYP3A4 Inducers (strong)
p56463
g23083
sVAndrogen Receptor Inhibitor
p56464
(dp56465
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56466
g29216
sVCytochrome P-450 CYP2C9 Substrates
p56467
g29731
sVImidazoles
p56468
(dp56469
sVCytochrome P-450 CYP3A4 Inducers
p56470
g18900
sVAntineoplastic Agents
p56471
(dp56472
sVCytochrome P450 2C19 Inducers
p56473
(dp56474
sVCytochrome P-450 CYP2C8 Inhibitors
p56475
g55012
sVCytochrome P-450 CYP2B6 Inhibitors
p56476
g45939
sVCytochrome P-450 CYP2C19 Inducers (moderate)
p56477
(dp56478
sVCytochrome P450 2C9 Inducers
p56479
(dp56480
sVHydantoins
p56481
(dp56482
sVCytochrome P-450 Enzyme Inducers
p56483
g28142
sVCytochrome P-450 CYP3A Inducers
p56484
(dp56485
sVCytochrome P450 3A4 Inducers
p56486
g53780
sVCytochrome P-450 CYP3A Inducers (strong)
p56487
g22464
sVCytochrome P-450 CYP3A4 Substrates
p56488
(dp56489
sVThyroxine-binding globulin substrates
p56490
(dp56491
sVCytochrome P-450 CYP3A5 Substrates
p56492
(dp56493
sVImidazolidines
p56494
g45999
sVCytochrome P-450 CYP2D6 Inducers (moderate)
p56495
(dp56496
sVCytochrome P-450 CYP2C19 Inducers
p56497
g25548
sVAntiandrogens, non-steroidal
p56498
(dp56499
sVP-glycoprotein/ABCB1 Inhibitors
p56500
(dp56501
sVAntineoplastic and Immunomodulating Agents
p56502
g39748
sVAndrogen Receptor Antagonists
p56503
g27119
sVEndocrine Therapy
p56504
g19571
ssg6336
(dp56505
VPyrimidines
p56506
g47713
sVCytochrome P-450 CYP3A Substrates
p56507
g44978
sg11232
(dp56508
sVCytochrome P-450 CYP2C9 Inducers
p56509
g20057
sVGynecological Antiinfectives and Antiseptics
p56510
(dp56511
sVAntihypertensive Agents
p56512
g20269
sVAmides
p56513
g44304
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56514
g29217
sVSulfur Compounds
p56515
(dp56516
sVCytochrome P-450 CYP2C9 Substrates
p56517
g29732
sVOATP1B1/SLCO1B1 Substrates
p56518
(dp56519
sVCytochrome P-450 CYP3A4 Inducers
p56520
g18901
sVCardiovascular Agents
p56521
g26562
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p56522
(dp56523
sVCytochrome P450 2C9 Inducers
p56524
(dp56525
sVCytochrome P450 3A Inducers
p56526
(dp56527
sVCytochrome P-450 Enzyme Inducers
p56528
g28143
sVCytochrome P-450 CYP3A Inducers
p56529
(dp56530
sVSulfones
p56531
(dp56532
sVBSEP/ABCB11 Inhibitors
p56533
(dp56534
sVCytochrome P-450 CYP3A4 Substrates
p56535
(dp56536
sVEndothelin Receptor Antagonists
p56537
g50540
sVGenito Urinary System and Sex Hormones
p56538
(dp56539
sVSulfonamides
p56540
(dp56541
sVVasodilating Agents
p56542
g23724
sVAntihypertensives for Pulmonary Arterial Hypertension
p56543
g25751
ssg6339
(dp56544
g1044
g21566
sg5829
g53376
sg6759
(dp56545
sg9948
(dp56546
sg2067
g29668
sg909
g20664
sg10515
(dp56547
sg4302
g44451
sg11319
(dp56548
sg9987
(dp56549
sg9012
(dp56550
sg7320
(dp56551
sg1719
g26856
sg23
g12247
sg3114
g36889
sg10005
(dp56552
sg11445
(dp56553
sg1548
g25401
sg8862
(dp56554
sg10098
(dp56555
sg3240
g37743
sg10227
(dp56556
sg4056
g42600
sg2304
g31239
sg612
g17909
sg9828
(dp56557
sg5580
g51887
ssg6342
(dp56558
g465
g16495
ssg6345
(dp56559
VAgents Causing Muscle Toxicity
p56560
g55366
sg1410
g24419
sVOtologicals
p56561
(dp56562
sVCytochrome P-450 CYP3A Substrates
p56563
g44979
sVStomatological Preparations
p56564
(dp56565
sVSteroids, Fluorinated
p56566
(dp56567
sVVasoprotectives
p56568
g41397
sVHormones
p56569
g55662
sVEnzyme Inhibitors
p56570
(dp56571
sVCorticosteroids for Systemic Use
p56572
g48843
sVDrugs for Obstructive Airway Diseases
p56573
g42529
sVHyperglycemia-Associated Agents
p56574
(dp56575
sVCorticosteroids for Systemic Use, Plain
p56576
g31765
sVCorticosteroids, Dermatological Preparations
p56577
g51337
sg1614
g25913
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p56578
(dp56579
sVGlucocorticoids
p56580
g21935
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56581
g29218
sVCorticosteroids for Local Oral Treatment
p56582
(dp56583
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p56584
g16837
sVFused-Ring Compounds
p56585
g14845
sVCytochrome P-450 CYP3A4 Inducers
p56586
g18903
sVImmunologic Factors
p56587
g42392
sVCytochrome P-450 CYP3A5 Inducers
p56588
g41760
sVAdrenal Cortex Hormones
p56589
g30057
sVAdrenals
p56590
g37379
sVPregnadienes
p56591
(dp56592
sVDermatologicals
p56593
g17219
sVCytochrome P-450 Enzyme Inducers
p56594
g28145
sVCytochrome P-450 CYP3A Inducers
p56595
(dp56596
sVCytochrome P-450 CYP3A4 Substrates
p56597
(dp56598
sVAlimentary Tract and Metabolism
p56599
g23841
sVNasal Preparations
p56600
(dp56601
sVPregnanes
p56602
(dp56603
sVAgents to Treat Airway Disease
p56604
g32648
sVOphthalmologicals
p56605
g35192
sVSteroids
p56606
g56436
sVCorticosteroids, Moderately Potent (Group II)
p56607
(dp56608
sg177
g13753
sVImmunosuppressive Agents
p56609
(dp56610
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p56611
(dp56612
sVAnti-Inflammatory Agents
p56613
(dp56614
sVCorticosteroid Hormone Receptor Agonists
p56615
(dp56616
sg6345
(dp56617
sVHormones, Hormone Substitutes, and Hormone Antagonists
p56618
g53145
sVCorticosteroids
p56619
(dp56620
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p56621
(dp56622
sVSensory Organs
p56623
g40688
ssg6348
(dp56624
g1797
g27294
sVSulfanilamides
p56625
g45282
sVCytochrome P-450 CYP2C9 Inhibitors
p56626
g18201
sVCytochrome P-450 Enzyme Inhibitors
p56627
(dp56628
sVAnti-Infective Agents
p56629
g54604
sVBlood Glucose Lowering Agents
p56630
(dp56631
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p56632
(dp56633
sVAntiinfectives for Systemic Use
p56634
(dp56635
sVAmines
p56636
g42703
sVGynecological Antiinfectives and Antiseptics
p56637
(dp56638
sVAmides
p56639
g44320
sVSulfur Compounds
p56640
(dp56641
sVAniline Compounds
p56642
g23430
sVSulfones
p56643
(dp56644
sVQTc Prolonging Agents
p56645
(dp56646
sVSulfonamides
p56647
(dp56648
sVSulfonamide Antibacterial
p56649
g52723
sVAnti-Bacterial Agents
p56650
g38348
sVSensory Organs
p56651
g40689
sVAntibacterials for Systemic Use
p56652
g32548
sVModerate Risk QTc-Prolonging Agents
p56653
(dp56654
sVOphthalmologicals
p56655
g35193
sVGenito Urinary System and Sex Hormones
p56656
(dp56657
sVHypoglycemia-Associated Agents
p56658
g17719
ssg6351
(dp56659
VOtologicals
p56660
(dp56661
sVCytochrome P-450 CYP3A Substrates
p56662
g44981
sVSteroids, Fluorinated
p56663
(dp56664
sVVasoprotectives
p56665
g41399
sVHormones
p56666
g55663
sVDrugs that are Mainly Renally Excreted
p56667
g43832
sVCorticosteroids, Dermatological Preparations
p56668
g51339
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p56669
g16840
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56670
g29220
sVFused-Ring Compounds
p56671
g14830
sVCytochrome P-450 CYP3A4 Inducers
p56672
g18905
sVAdrenal Cortex Hormones
p56673
g30058
sVPregnadienes
p56674
(dp56675
sVDermatologicals
p56676
g17222
sVCytochrome P-450 Enzyme Inducers
p56677
g28148
sVCytochrome P-450 CYP3A Inducers
p56678
(dp56679
sVCytochrome P-450 CYP3A4 Substrates
p56680
(dp56681
sVPregnanes
p56682
(dp56683
sg3219
g37577
sVOphthalmologicals
p56684
g35195
sVSteroids
p56685
g56433
sVImmunosuppressive Agents
p56686
(dp56687
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p56688
(dp56689
sVAnti-Inflammatory Agents
p56690
(dp56691
sVCorticosteroid Hormone Receptor Agonists
p56692
(dp56693
sVHormones, Hormone Substitutes, and Hormone Antagonists
p56694
g53159
sVCorticosteroids
p56695
(dp56696
ssg6354
(dp56697
g10557
(dp56698
sg7764
(dp56699
sg8433
(dp56700
sg3696
g40256
sg1857
g27686
sg4452
g45396
sg684
g18481
ssg6357
(dp56701
g3099
g36728
sg8529
(dp56702
ssg6360
(dp56703
VAmino Acids, Peptides, and Proteins
p56704
g47394
sVAnterior Pituitary Lobe Hormones and Analogues
p56705
(dp56706
sVProteins
p56707
g52779
sVPituitary and Hypothalamic Hormones and Analogues
p56708
(dp56709
sVPeptide Hormones
p56710
g20230
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p56711
(dp56712
sg5265
g50126
sVAdrenals
p56713
g37377
sVPeptides
p56714
g47200
sVNeuropeptides
p56715
(dp56716
sVPro-Opiomelanocortin
p56717
g28502
sVNerve Tissue Proteins
p56718
(dp56719
sVMelanocortins
p56720
(dp56721
sVPituitary Hormones
p56722
g15916
sVPituitary Hormones, Anterior
p56723
g24145
sVHormones
p56724
g55688
sVHormones, Hormone Substitutes, and Hormone Antagonists
p56725
g53178
sVPituitary
p56726
(dp56727
sVAdrenocorticotropic Hormone
p56728
(dp56729
sVProtein Precursors
p56730
(dp56731
ssg6363
(dp56732
g4257
g44065
sg5469
g51278
sg165
g13573
ssg6366
(dp56733
g8241
(dp56734
sg1326
g23581
sg3846
g41112
sg8916
(dp56735
sg2946
g35797
sg5832
g53409
ssg6369
(dp56736
g8622
(dp56737
sg318
g14922
sg12051
(dp56738
sg4299
g44428
ssg6372
(dp56739
g4014
g42224
sg9810
(dp56740
sg1629
g25985
sg9006
(dp56741
sg5025
g48764
sg8832
(dp56742
ssg6375
(dp56743
g11619
(dp56744
sg6579
(dp56745
sg1401
g24296
sg4959
g48545
ssg6378
(dp56746
g8514
(dp56747
sg8487
(dp56748
sg8334
(dp56749
sg7422
(dp56750
sg11931
(dp56751
sg3156
g37208
sg11790
(dp56752
sg8067
(dp56753
sg11097
(dp56754
sg5247
g49927
sg9165
(dp56755
ssg6381
(dp56756
VNitrogen Compounds
p56757
g39005
sVAnalgesics
p56758
g26500
sVNeurotransmitter Agents
p56759
(dp56760
sVCentral Nervous System Agents
p56761
(dp56762
sVOphthalmologicals
p56763
g35272
sVAmmonium Compounds
p56764
g30560
sg5637
g52306
sVParasympathomemetic (Cholinergic) Agents
p56765
(dp56766
sVPeripheral Nervous System Agents
p56767
(dp56768
sVAnalgesics, Non-Narcotic
p56769
(dp56770
sVAmines
p56771
g42747
sVMiotics
p56772
(dp56773
sVCholine Esters
p56774
g18864
sVEthanolamines
p56775
(dp56776
sVParasympathomimetics
p56777
(dp56778
sVCholinergic Receptor Agonist
p56779
(dp56780
sVCardiovascular Agents
p56781
g26690
sVOnium Compounds
p56782
g22257
sVProtective Agents
p56783
(dp56784
sVSensory Organs
p56785
g40754
sVCardiotonic Agents
p56786
(dp56787
sVAutonomic Agents
p56788
(dp56789
sVAmino Alcohols
p56790
g32696
sVAntiglaucoma Preparations and Miotics
p56791
g36567
sVTrimethyl Ammonium Compounds
p56792
g16041
sVCholinergic Agents
p56793
g28736
sVCholinergic Agonists
p56794
g40991
sVSensory System Agents
p56795
(dp56796
sVNervous System
p56797
(dp56798
sVQuaternary Ammonium Compounds
p56799
g43371
sVAlcohols
p56800
(dp56801
sVCompounds used in a research, industrial, or household setting
p56802
(dp56803
ssg6384
(dp56804
g8019
(dp56805
sg4425
g44914
sg9519
(dp56806
sg4788
g47554
sg4803
g47624
sg5250
g49956
sg7650
(dp56807
sg10011
(dp56808
sg8418
(dp56809
sg4260
g44099
sg1914
g28397
sg8241
(dp56810
sg7671
(dp56811
sg4272
g44237
sg10977
(dp56812
sg10494
(dp56813
sg2088
g29893
sg10740
(dp56814
sg9702
(dp56815
sg3000
g36022
sg4716
g47089
sg2109
g30102
sg6024
g54430
sg6474
(dp56816
sg10680
(dp56817
sg3408
g38684
sg72
g12787
sg963
g20975
sg3279
g37924
sg4974
g48604
sg5181
g49592
sg5589
g51909
sg336
g15075
sg8916
(dp56818
sg6162
g55266
ssg6387
(dp56819
g13070
g21919
sg11208
(dp56820
sg3795
g40924
sg1275
g23275
ssg6390
(dp56821
g2553
g32911
sg4725
g47135
ssg6393
(dp56822
VElements
p56823
(dp56824
sVAnti-Acne Preparations for Topical Use
p56825
(dp56826
sg10167
(dp56827
sVDermatologicals
p56828
g17230
sVAnti-Acne Preparations
p56829
(dp56830
sg6393
(dp56831
sVKeratolytic Agents
p56832
(dp56833
sg10572
(dp56834
ssg6396
(dp56835
g7548
(dp56836
sg5457
g51187
sg8583
(dp56837
sg5511
g51473
ssg6399
(dp56838
g9081
(dp56839
ssg6402
(dp56840
g9357
(dp56841
sg3861
g41275
ssg6405
(dp56842
g1719
g26828
sg8862
(dp56843
sg7164
(dp56844
sg375
g15437
sg1548
g25366
sg11910
(dp56845
sg9012
(dp56846
sg4056
g42579
sg3531
g39269
sg5829
g53356
sg3708
g40378
sg6759
(dp56847
sg5580
g51860
ssg6408
(dp56848
g2520
g32710
sVOCT2 Substrates
p56849
g14938
sg225
g14114
sVOCT1 substrates
p56850
g13064
sVAntihypertensive Agents
p56851
g20277
sVHypotensive Agents
p56852
g34142
sVP-glycoprotein/ABCB1 Substrates
p56853
g34956
sg3987
g42061
sVHeterocyclic Compounds, Fused-Ring
p56854
g56073
sg6609
(dp56855
sg5634
g52272
sg9045
(dp56856
sg7290
(dp56857
sg6237
g55753
sVCardiovascular Agents
p56858
g26576
sVP-glycoprotein/ABCB1 Inhibitors
p56859
(dp56860
sg1338
g23690
sg8466
(dp56861
ssg6411
(dp56862
g2490
g32588
sVNervous System
p56863
(dp56864
sg324
g14958
sg12117
(dp56865
sVAnesthetics
p56866
g51603
sVCytochrome P-450 CYP2D6 Substrates
p56867
g52139
sVAgents that reduce seizure threshold
p56868
g45843
sVCytochrome P-450 CYP3A Substrates
p56869
g44988
sVHypotensive Agents
p56870
g34143
sVCentral Nervous System Agents
p56871
(dp56872
sVAmides
p56873
g44312
sVAnesthetics, Local
p56874
g53466
sg11421
(dp56875
sVAniline Compounds
p56876
g23421
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56877
g29229
sVSensory System Agents
p56878
(dp56879
sVCytochrome P-450 CYP3A4 Substrates
p56880
(dp56881
sVPeripheral Nervous System Agents
p56882
(dp56883
sVAmines
p56884
g42695
ssg6414
(dp56885
g4143
g43140
ssg6417
(dp56886
g8019
(dp56887
sg7053
(dp56888
sg10854
(dp56889
sg4425
g44928
sg1059
g21749
sg9519
(dp56890
sg7428
(dp56891
sg4788
g47567
sg4803
g47637
sg4596
g46266
sg10470
(dp56892
sg5250
g49970
sg7650
(dp56893
sg10011
(dp56894
sg5652
g52355
sg8418
(dp56895
sg3087
g36658
sg10977
(dp56896
sg11805
(dp56897
sg4260
g44108
sg1914
g28403
sg3516
g39181
sg7671
(dp56898
sg888
g20425
sg891
g20545
sg10494
(dp56899
sg9339
(dp56900
sg2088
g29908
sg10740
(dp56901
sg3711
g40432
sg9702
(dp56902
sg9963
(dp56903
sg7707
(dp56904
sg8097
(dp56905
sg714
g19010
sg5316
g50440
sg4716
g47067
sg2109
g30118
sg2391
g31714
sg6024
g54443
sg1578
g25632
sg3651
g40134
sg8514
(dp56906
sg72
g12795
sg963
g20988
sg3408
g38699
sg7971
(dp56907
sg2688
g33633
sg3279
g37932
sg171
g13699
sg4974
g48616
sg10794
(dp56908
sg12126
(dp56909
sg10239
(dp56910
sg6381
g56770
sg5589
g51923
sg336
g15091
sg9060
(dp56911
sg5394
g50830
sg5181
g49577
ssg6420
(dp56912
g6921
(dp56913
ssg6423
(dp56914
g4164
g43307
sg8949
(dp56915
sg2538
g32807
sg7563
(dp56916
sg8298
(dp56917
ssg6426
(dp56918
g11820
(dp56919
sg4650
g46603
sg4926
g48379
sg10797
(dp56920
ssg6429
(dp56921
g7812
(dp56922
ssg6432
(dp56923
VAntiinfectives for Systemic Use
p56924
(dp56925
sVDrugs that are Mainly Renally Excreted
p56926
g43836
sVAgents that produce neuromuscular block (indirect)
p56927
g37966
sVHeterocyclic Compounds, Fused-Ring
p56928
g56079
sVbeta-Lactams
p56929
(dp56930
sVOAT1/SLC22A6 inhibitors
p56931
(dp56932
sVOAT3/SLC22A8 Substrates
p56933
g13121
sVLactams
p56934
g22275
sg8070
(dp56935
sVAmides
p56936
g44315
sVSulfur Compounds
p56937
(dp56938
sg6444
(dp56939
sVAnti-Bacterial Agents
p56940
g38344
sVAntibacterials for Systemic Use
p56941
g32546
sg2772
g34323
sVAnti-Infective Agents
p56942
g54601
sVPenicillins
p56943
g52896
sVBeta-Lactam Antibacterials
p56944
g46293
ssg6435
(dp56945
VCytochrome P-450 CYP3A4 Inhibitors
p56946
(dp56947
sVAntivirals for Systemic Use
p56948
(dp56949
sVCytochrome P-450 CYP3A Substrates
p56950
g45053
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p56951
(dp56952
sVDirect Acting Antivirals
p56953
g38067
sVCYP3A Substrates (Sensitive)
p56954
(dp56955
sVAnti-HIV Agents
p56956
(dp56957
sVEnzyme Inhibitors
p56958
(dp56959
sVCytochrome P-450 Enzyme Inhibitors
p56960
(dp56961
sVAnti-Infective Agents
p56962
g54609
sVHyperglycemia-Associated Agents
p56963
(dp56964
sVAntiinfectives for Systemic Use
p56965
(dp56966
sVCarbamates
p56967
g45518
sVGynecological Antiinfectives and Antiseptics
p56968
(dp56969
sVAmides
p56970
g44323
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p56971
g29326
sVSulfur Compounds
p56972
(dp56973
sVHIV Protease Inhibitors
p56974
(dp56975
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p56976
(dp56977
sVSulfonamides
p56978
(dp56979
sVSulfones
p56980
(dp56981
sVProtease Inhibitors
p56982
g51098
sVCytochrome P450 2D6 Inhibitors
p56983
(dp56984
sVCytochrome P-450 CYP3A Inhibitors (strong)
p56985
g13389
sVCytochrome P-450 CYP3A4 Substrates
p56986
(dp56987
sVAnti-Retroviral Agents
p56988
(dp56989
sVFurans
p56990
(dp56991
sVGenito Urinary System and Sex Hormones
p56992
(dp56993
sVAcids, Acyclic
p56994
g25458
sVCytochrome P-450 CYP3A Inhibitors
p56995
(dp56996
sVAntiviral Agents
p56997
g30458
sVOATP1B1/SLCO1B1 Inhibitors
p56998
(dp56999
sVCytochrome P450 3A Inhibitors
p57000
g54272
sVP-glycoprotein/ABCB1 Inhibitors
p57001
(dp57002
ssg6438
(dp57003
g5574
g51807
ssg6441
(dp57004
g5919
g53978
sg9372
(dp57005
ssg6444
(dp57006
g8850
(dp57007
sg1872
g27858
sg126
g13177
sg6432
g56939
sg8616
(dp57008
sg4872
g47991
ssg6447
(dp57009
VCytochrome P-450 CYP2D6 Substrates
p57010
g52147
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p57011
g39020
sVCytochrome P-450 CYP3A Substrates
p57012
g44991
sVHypotensive Agents
p57013
g34146
sVUGT1A9 Substrates
p57014
g24010
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p57015
g49334
sVBlood Glucose Lowering Agents
p57016
(dp57017
sVCytochrome P-450 CYP1A2 Substrates
p57018
g45591
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p57019
g29233
sVOral Hypoglycemics
p57020
g36000
sVCytochrome P-450 CYP2C9 Substrates
p57021
g29748
sVCarbohydrates
p57022
(dp57023
sVDrugs Used in Diabetes
p57024
(dp57025
sVDiuretics
p57026
(dp57027
sVGlycosides
p57028
(dp57029
sVBenzene Derivatives
p57030
(dp57031
sVCytochrome P-450 CYP1A2 Inhibitors
p57032
g15020
sVP-glycoprotein/ABCB1 Substrates
p57033
g34972
sg11706
(dp57034
sVCytochrome P-450 CYP2A6 Substrates
p57035
g35129
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p57036
(dp57037
sVCytochrome P-450 CYP3A4 Substrates
p57038
(dp57039
sVAlimentary Tract and Metabolism
p57040
g23836
sVUGT2B7 substrates
p57041
g28632
sVSodium-Glucose Transporter 2 Inhibitors
p57042
g46281
ssg6450
(dp57043
g4014
g42233
ssg6453
(dp57044
g8421
(dp57045
sg3432
g38806
sg1371
g24105
sg9198
(dp57046
sg888
g20462
sg6333
g56474
sg7335
(dp57047
sg11385
(dp57048
ssg6456
(dp57049
g7527
(dp57050
ssg6459
(dp57051
g2343
g31341
sg9108
(dp57052
ssg6462
(dp57053
g10077
(dp57054
ssg6465
(dp57055
g6678
(dp57056
sg7164
(dp57057
sg375
g15459
sg11910
(dp57058
sg3444
g38875
sg2262
g30966
ssg6468
(dp57059
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p57060
(dp57061
sVBSEP/ABCB11 Substrates
p57062
(dp57063
sVCytochrome P-450 CYP3A4 Inhibitors
p57064
(dp57065
sVAdrenergic alpha-1 Receptor Antagonists
p57066
g14120
sVCytochrome P-450 CYP2D6 Inhibitors
p57067
(dp57068
sVAntidepressive Agents, Second-Generation
p57069
g49758
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p57070
(dp57071
sVSerotonin Agents
p57072
(dp57073
sVAnalgesics
p57074
g26491
sVMembrane Transport Modulators
p57075
g54124
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p57076
(dp57077
sVCentral Nervous System Agents
p57078
(dp57079
sVAdrenergic Antagonists
p57080
g52277
sVPsychotropic Drugs
p57081
(dp57082
sVSerotonin 5-HT1 Receptor Antagonists
p57083
g14440
sVCytochrome P-450 Enzyme Inhibitors
p57084
(dp57085
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p57086
g18402
sVSelective Serotonin Reuptake Inhibitors
p57087
g39078
sVDrugs that are Mainly Renally Excreted
p57088
g44049
sVP-glycoprotein/ABCB1 Inducers
p57089
(dp57090
sVNeurotransmitter Uptake Inhibitors
p57091
g52389
sVPsychoanaleptics
p57092
(dp57093
sVCytochrome P-450 CYP2D6 Substrates
p57094
g52193
sVNeurotransmitter Agents
p57095
(dp57096
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p57097
g29580
sVAdrenergic alpha-Antagonists
p57098
(dp57099
sVOATP1B3 inhibitors
p57100
(dp57101
sVSerotonin 5-HT2 Receptor Antagonists
p57102
(dp57103
sVCytochrome P-450 CYP3A Substrates
p57104
g45261
sVCentral Nervous System Depressants
p57105
(dp57106
sg8955
(dp57107
sVSerotonin and Noradrenaline Reuptake Inhibitors
p57108
g50963
sVSerotonin Receptor Antagonists
p57109
g35671
sVCytochrome P-450 CYP3A5 Inhibitors
p57110
g55338
sVAgents that produce hypertension
p57111
(dp57112
sVCytochrome P-450 CYP3A Inhibitors (strong)
p57113
g13392
sVCytochrome P-450 CYP3A4 Substrates
p57114
(dp57115
sVSerotonin Modulators
p57116
(dp57117
sVAntidepressive Agents
p57118
g15572
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p57119
(dp57120
sVCytochrome P-450 CYP3A Inhibitors
p57121
(dp57122
sVHypoglycemia-Associated Agents
p57123
g17697
sVP-glycoprotein/ABCB1 Inhibitors
p57124
(dp57125
sVNervous System
p57126
(dp57127
ssg6471
(dp57128
VLipids
p57129
g14327
sVDrugs that are Mainly Renally Excreted
p57130
g43839
sVProstaglandins
p57131
g19499
sVCardiovascular Agents
p57132
g26589
sVFatty Acids
p57133
(dp57134
sg765
g19251
sVFatty Acids, Unsaturated
p57135
(dp57136
sVAntihypertensive Agents
p57137
g20282
sVCytochrome P-450 CYP3A Substrates
p57138
g44993
sVProstaglandins, Synthetic
p57139
g28024
sVCytochrome P-450 CYP3A5 Substrates
p57140
(dp57141
sVInflammation Mediators
p57142
g23629
sVSensory Organs
p57143
g40703
sVAmides
p57144
g44324
sg6054
g54803
sVBiological Factors
p57145
g38109
sVAutacoids
p57146
(dp57147
sVOphthalmologicals
p57148
g35209
sVEicosanoids
p57149
g37789
sVAntiglaucoma Preparations and Miotics
p57150
g36557
ssg6474
(dp57151
VFatty Acids
p57152
(dp57153
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p57154
g50959
sVMusculo-Skeletal System
p57155
g31521
sVInflammation Mediators
p57156
g23626
sVAntiinflammatory and Antirheumatic Products
p57157
g56816
sVLipids
p57158
g14330
sVAutacoids
p57159
(dp57160
sVFatty Acids, Unsaturated
p57161
(dp57162
sVReproductive Control Agents
p57163
g18855
sVEicosanoids
p57164
g37786
sVAnti-Ulcer Agents
p57165
(dp57166
sVGastrointestinal Agents
p57167
(dp57168
sVProstaglandins, Synthetic
p57169
g28026
sVPropionates
p57170
g36490
sVAlimentary Tract and Metabolism
p57171
g23883
sVAbortifacient Agents, Nonsteroidal
p57172
(dp57173
sVGenito Urinary System and Sex Hormones
p57174
(dp57175
sVUterotonic agents
p57176
g38830
sVDrugs for Acid Related Disorders
p57177
g55171
sg10620
(dp57178
sg11199
(dp57179
sVAbortifacient Agents
p57180
g37796
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p57181
(dp57182
sVProstaglandins
p57183
g19502
sVBiological Factors
p57184
g38121
ssg6477
(dp57185
g9612
(dp57186
sg11550
(dp57187
sg9132
(dp57188
sg1266
g23237
sg4905
g48187
sg9525
(dp57189
sg8076
(dp57190
sg10653
(dp57191
sg11718
(dp57192
sg9348
(dp57193
sg1920
g28486
sg3321
g38232
ssg6480
(dp57194
g10698
(dp57195
sg9411
(dp57196
ssg6483
(dp57197
g9810
(dp57198
sg1875
g27899
sg8217
(dp57199
sg10680
(dp57200
sg6843
(dp57201
sg5757
g52934
sg6246
g55801
sg8583
(dp57202
sg7845
(dp57203
sg501
g16738
sg5025
g48775
sg10236
(dp57204
ssg6486
(dp57205
g3912
g41610
sg438
g16192
ssg6489
(dp57206
VCardiotoxic antineoplastic agents
p57207
(dp57208
sg5523
g51557
sVMyelosuppressive Agents
p57209
(dp57210
sg4161
g43267
sVImmunosuppressive Agents
p57211
(dp57212
sVCarbohydrates
p57213
(dp57214
sg2892
g35374
sg2154
g30417
sVGlycosides
p57215
(dp57216
sVTopoisomerase II Inhibitors
p57217
g40639
sg10575
(dp57218
sg2421
g31936
sVUGT2B7 substrates
p57219
g28641
sVAntineoplastic and Immunomodulating Agents
p57220
g39770
sVEnzyme Inhibitors
p57221
(dp57222
sg5280
g50175
sVNaphthacenes
p57223
g40474
sVAntineoplastic Agents
p57224
(dp57225
sVTopoisomerase Inhibitors
p57226
g32858
ssg6492
(dp57227
g141
g13339
ssg6495
(dp57228
g5739
g52879
sg2199
g30704
sg546
g17163
sg10635
(dp57229
sg5781
g53118
sg6261
g55856
sg294
g14756
sg2523
g32750
sg1413
g24451
sg42
g12598
sg5877
g53682
sg1281
g23393
sg10602
(dp57230
sg9864
(dp57231
sg9960
(dp57232
sg1809
g27448
sg7713
(dp57233
sg4101
g42966
sg5487
g51371
ssg6498
(dp57234
g6537
(dp57235
sg2943
g35792
ssg6501
(dp57236
g9309
(dp57237
sg7629
(dp57238
sg4725
g47148
sg12108
(dp57239
sg1164
g22585
ssg6504
(dp57240
VCytochrome P-450 CYP3A4 Inhibitors
p57241
(dp57242
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p57243
g46315
sVCytochrome P-450 CYP3A Substrates
p57244
g44995
sVOATP1B1/SLCO1B1 Inhibitors
p57245
(dp57246
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p57247
(dp57248
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p57249
g43771
sVCytochrome P-450 Enzyme Inhibitors
p57250
(dp57251
sVDrugs for Obstructive Airway Diseases
p57252
g42523
sVHyperglycemia-Associated Agents
p57253
(dp57254
sVAndrostanes
p57255
(dp57256
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p57257
g29237
sVGlucocorticoids
p57258
g21925
sVFused-Ring Compounds
p57259
g14848
sVCytochrome P-450 CYP3A4 Inducers
p57260
g18950
sVCytochrome P-450 CYP3A5 Inducers
p57261
g41752
sVAdrenal Cortex Hormones
p57262
g30050
sVCytochrome P-450 CYP2C8 Inhibitors
p57263
g55020
sVAndrostenes
p57264
(dp57265
sVP-glycoprotein/ABCB1 Substrates
p57266
g34982
sVCytochrome P-450 Enzyme Inducers
p57267
g28208
sVCytochrome P-450 CYP3A Inducers
p57268
(dp57269
sVCytochrome P-450 CYP3A4 Substrates
p57270
(dp57271
sVNasal Preparations
p57272
(dp57273
sVAgents to Treat Airway Disease
p57274
g32644
sVCytochrome P-450 CYP3A5 Substrates
p57275
(dp57276
sVSteroids
p57277
g56429
sVCytochrome P-450 CYP3A Inhibitors
p57278
(dp57279
sVImmunosuppressive Agents
p57280
(dp57281
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p57282
(dp57283
sVCorticosteroids
p57284
(dp57285
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p57286
(dp57287
sVCytochrome P-450 CYP3A7 Substrates
p57288
(dp57289
sVCytochrome P-450 CYP3A5 Inhibitors
p57290
g55347
ssg6507
(dp57291
VAdrenergic Agents
p57292
g41723
sVAdrenergic alpha-2 Receptor Agonists
p57293
(dp57294
sVOphthalmologicals
p57295
g35214
sVAdrenergic alpha-Agonists
p57296
(dp57297
sVCytochrome P-450 CYP2D6 Substrates
p57298
g52153
sVSympathomimetics in Glaucoma Therapy
p57299
g51324
sVSensory Organs
p57300
g40707
sVNeurotransmitter Agents
p57301
(dp57302
sVHypotensive Agents
p57303
g34150
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p57304
g36624
sVOphthalmics
p57305
(dp57306
sg4275
g44247
sVAdrenergic Agonists
p57307
(dp57308
sVAdrenergic alpha-1 Receptor Agonists
p57309
(dp57310
sVEENT Drugs, Miscellaneous
p57311
g40848
sVImidazoles
p57312
(dp57313
sVAntiglaucoma Preparations and Miotics
p57314
g36560
ssg6510
(dp57315
g11952
(dp57316
sg5409
g50900
sg4515
g45910
sg6360
g56709
sg2283
g31164
sg12042
(dp57317
sg7689
(dp57318
sg402
g15854
sg10002
(dp57319
sg609
g17830
sg11046
(dp57320
sg11160
(dp57321
sg4143
g43142
ssg6513
(dp57322
g10062
(dp57323
sg6579
(dp57324
ssg6516
(dp57325
g9324
(dp57326
sg5112
g49185
ssg6519
(dp57327
g10725
(dp57328
sg3576
g39596
ssg6522
(dp57329
g11166
(dp57330
ssg6525
(dp57331
VNMDA Receptor Antagonists
p57332
g43493
sVAnti-Parkinson Drugs
p57333
g16160
sVPsychoanaleptics
p57334
(dp57335
sVNeurotransmitter Agents
p57336
(dp57337
sVCentral Nervous System Agents
p57338
(dp57339
sVDopamine Agents
p57340
g14264
sVAnti-Dementia Drugs
p57341
g49312
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p57342
g49912
sVCytochrome P-450 Enzyme Inhibitors
p57343
(dp57344
sVDrugs that are Mainly Renally Excreted
p57345
g43979
sg4611
g46312
sVExcitatory Amino Acid Antagonists
p57346
(dp57347
sVOCT2 substrates with narrow therapeutic index
p57348
g29699
sVOCT2 Substrates
p57349
g14956
sVAnti-Dyskinesia Agents
p57350
g50490
sVCytochrome P-450 CYP2B6 Inhibitors
p57351
g45938
sVCytochrome P-450 CYP2C19 Inhibitors
p57352
(dp57353
sVAdamantane
p57354
(dp57355
sVCytochrome P-450 CYP2A6 Inhibitors
p57356
g48591
sVCytochrome P-450 CYP2A6 Inhibitors (weak)
p57357
g53658
sVCholinesterase Inhibitors
p57358
(dp57359
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p57360
(dp57361
sVMiscellaneous Central Nervous System Agents
p57362
(dp57363
sVNervous System
p57364
(dp57365
ssg6528
(dp57366
g9765
(dp57367
ssg6531
(dp57368
g6180
g55441
sg9225
(dp57369
sg10323
(dp57370
sg8106
(dp57371
sg11274
(dp57372
sg3117
g36938
sg2007
g28906
sg2817
g34574
sg3543
g39362
sg1650
g26129
ssg6534
(dp57373
g11631
(dp57374
ssg6537
(dp57375
VAgents Causing Muscle Toxicity
p57376
g55376
sVBSEP/ABCB11 Substrates
p57377
(dp57378
sVFatty Acids
p57379
(dp57380
sVCytochrome P-450 CYP2D6 Inhibitors
p57381
(dp57382
sVUGT1A1 Substrates
p57383
g12336
sVCytochrome P-450 CYP3A Substrates
p57384
g44997
sVCytochrome P-450 CYP2C9 Inhibitors
p57385
g18212
sVOATP1B1/SLCO1B1 Inhibitors
p57386
(dp57387
sVLipids
p57388
g14354
sVEnzyme Inhibitors
p57389
(dp57390
sVCytochrome P-450 Enzyme Inhibitors
p57391
(dp57392
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p57393
(dp57394
sVCytochrome P-450 CYP2C8 Substrates
p57395
(dp57396
sVCytochrome P-450 CYP2B6 Inducers
p57397
g39135
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p57398
g29241
sVLipid Modifying Agents, Plain
p57399
(dp57400
sVOATP1B1/SLCO1B1 Substrates
p57401
(dp57402
sVHypolipidemic Agents
p57403
(dp57404
sVLipid Modifying Agents
p57405
g40550
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p57406
g25232
sVP-glycoprotein/ABCB1 Substrates
p57407
g35077
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p57408
g44521
sVCytochrome P-450 Enzyme Inducers
p57409
g28179
sVCytochrome P-450 CYP3A Inducers
p57410
(dp57411
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p57412
g44553
sVCytochrome P-450 CYP2C19 Inhibitors
p57413
(dp57414
sVCytochrome P-450 CYP3A4 Substrates
p57415
(dp57416
sVToxic Actions
p57417
g49400
sVAnticholesteremic Agents
p57418
g50596
sVCytochrome P-450 CYP3A5 Substrates
p57419
(dp57420
sVUGT1A3 substrates
p57421
g31821
sVOATP1B3 substrates
p57422
g28534
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p57423
g53086
sVP-glycoprotein/ABCB1 Inhibitors
p57424
(dp57425
sg6498
g57235
sVCytochrome P-450 CYP3A7 Substrates
p57426
(dp57427
sVLipid Regulating Agents
p57428
(dp57429
ssg6540
(dp57430
g1548
g25405
sg10263
(dp57431
sg2304
g31265
sg2616
g33198
sg5829
g53380
sg10761
(dp57432
sg3708
g40400
sg10005
(dp57433
sg5580
g51889
sg8862
(dp57434
ssg6543
(dp57435
g9810
(dp57436
sg5025
g48784
ssg6546
(dp57437
g9897
(dp57438
sg5463
g51272
sg9132
(dp57439
sg2754
g34094
sg447
g16306
sg9705
(dp57440
sg8772
(dp57441
sg9300
(dp57442
sg6213
g55619
sg6216
g55650
sg9348
(dp57443
sg11646
(dp57444
sg669
g18458
sg4200
g43549
sg3147
g37161
sg12015
(dp57445
sg11286
(dp57446
sg1266
g23256
sg1482
g25027
sg9741
(dp57447
sg8076
(dp57448
sg6612
(dp57449
sg4977
g48665
sg6804
(dp57450
sg7512
(dp57451
sg6630
(dp57452
sg9612
(dp57453
sg4713
g47042
sg10431
(dp57454
sg1737
g26932
sg3801
g40974
sg9627
(dp57455
sg3882
g41425
sg4551
g46117
sg3573
g39549
sg11349
(dp57456
sg11550
(dp57457
sg3588
g39624
sg7980
(dp57458
sg1563
g25526
sg4905
g48199
sg8910
(dp57459
sg4185
g43485
sg7059
(dp57460
sg9852
(dp57461
sg7809
(dp57462
sg10104
(dp57463
sg10653
(dp57464
ssg6549
(dp57465
VAmino Acids, Peptides, and Proteins
p57466
g47400
sVAntiinfectives for Systemic Use
p57467
(dp57468
sVLipopeptides
p57469
g33706
sVGlycopeptides
p57470
g38504
sg3798
g40945
sg6777
(dp57471
sVCarbohydrates
p57472
(dp57473
sVGlycopeptide Antibacterials
p57474
(dp57475
sVPeptides
p57476
g47202
sVLipids
p57477
g14286
sVGlycoconjugates
p57478
(dp57479
sVAnti-Bacterial Agents
p57480
g38374
sVAntibacterials for Systemic Use
p57481
g32572
sVAnti-Infective Agents
p57482
g54653
ssg6552
(dp57483
VIons
p57484
g49108
sVBoron Compounds
p57485
g42046
sVAcids
p57486
g40566
sVAcids, Noncarboxylic
p57487
g54191
sg297
g14776
sVElectrolytes
p57488
g52408
sVAntiinfectives and Antiseptics for Local Oral Treatment
p57489
(dp57490
sVAnions
p57491
(dp57492
sVStomatological Preparations
p57493
(dp57494
sg258
g14425
sVAlimentary Tract and Metabolism
p57495
g23855
ssg6555
(dp57496
g3090
g36712
sg9846
(dp57497
sg9630
(dp57498
sg9426
(dp57499
sg2940
g35722
ssg6558
(dp57500
g10200
(dp57501
sg6567
(dp57502
sg10185
(dp57503
sg10767
(dp57504
sg5415
g50918
sg657
g18322
sg4581
g46217
sg2553
g32875
sg9561
(dp57505
sg5085
g49044
sg5286
g50195
sg3312
g38139
sg8826
(dp57506
sg3825
g41020
sg4770
g47441
ssg6561
(dp57507
g1266
g23214
sg9348
(dp57508
sg8076
(dp57509
sg10653
(dp57510
sg4905
g48196
ssg6564
(dp57511
g11952
(dp57512
sg7971
(dp57513
sg6360
g56716
sg10323
(dp57514
sg6180
g55408
sg2886
g35316
sg11274
(dp57515
sg8106
(dp57516
sg2007
g28858
sg4515
g45882
sg402
g15826
sg2817
g34542
sg11046
(dp57517
sg11160
(dp57518
ssg6567
(dp57519
g1992
g28831
sg6558
g57502
sg5820
g53333
sVCompounds used in a research, industrial, or household setting
p57520
(dp57521
sg5673
g52412
sg6270
g55898
sVPharmaceutical Preparations
p57522
g53858
sVGastrointestinal Agents
p57523
(dp57524
sg1116
g22222
sg8109
(dp57525
sg3042
g36478
sg4938
g48457
sg558
g17337
sg4362
g44718
sVAlimentary Tract and Metabolism
p57526
g23808
sg7557
(dp57527
sg6132
g55144
sg1155
g22554
sg11907
(dp57528
sg162
g13556
sg9651
(dp57529
sg7992
(dp57530
sVP-glycoprotein/ABCB1 Inhibitors
p57531
(dp57532
sg2721
g33831
sg11949
(dp57533
ssg6570
(dp57534
g4050
g42507
sg2292
g31226
sg3468
g39007
sg1122
g22259
sg4065
g42714
sg6942
(dp57535
sg4167
g43373
sg10641
(dp57536
sVCentral Nervous System Agents
p57537
(dp57538
sg1950
g28717
sg12030
(dp57539
sg5049
g48860
sg5385
g50776
sg1416
g24470
sg6264
g55874
sg9876
(dp57540
sVAlimentary Tract and Metabolism
p57541
g23861
sg4149
g43175
sg2187
g30562
ssg6573
(dp57542
g687
g18537
ssg6576
(dp57543
g9471
(dp57544
sg9588
(dp57545
sg7527
(dp57546
sg5193
g49632
ssg6579
(dp57547
VAgents Causing Muscle Toxicity
p57548
g55378
sVAmino Acids, Peptides, and Proteins
p57549
g47346
sVCentral Nervous System Depressants
p57550
(dp57551
sVAmino Acids
p57552
g43101
sg6513
g57324
sVDrugs that are Mainly Renally Excreted
p57553
g43841
sVGABA Agents
p57554
g16206
sg10224
(dp57555
sVMusculo-Skeletal System
p57556
g31515
sVAminobutyrates
p57557
g56745
sVGABA Agonists
p57558
g13096
sVgamma-Aminobutyric Acid
p57559
g31884
sg11607
(dp57560
sVCentral Nervous System Agents
p57561
(dp57562
sVNeurotransmitter Agents
p57563
(dp57564
sVButyrates
p57565
(dp57566
sVMuscle Relaxants, Centrally Acting Agents
p57567
g37385
sVMuscle Relaxants
p57568
(dp57569
sg4575
g46186
ssg6582
(dp57570
g11283
(dp57571
sg7464
(dp57572
sg10635
(dp57573
sg10818
(dp57574
sg19588
g32466
sg5427
g50997
sg4635
g46476
sg42
g12574
sg4788
g47562
sg4803
g47628
sg4647
g46569
sg7650
(dp57575
sg8418
(dp57576
sg10674
(dp57577
sg6303
g56242
sg72
g12791
sg7671
(dp57578
sg8430
(dp57579
sg6186
g55496
sg426
g16071
sg888
g20437
sg891
g20541
sg4683
g46927
sg2088
g29902
sg10713
(dp57580
sg2433
g32160
sg9960
(dp57581
sg9963
(dp57582
sg915
g20691
sg3177
g37295
sg4716
g47074
sg2391
g31711
sg9996
(dp57583
sg1719
g26826
sg11805
(dp57584
sg8514
(dp57585
sg9264
(dp57586
sg4746
g47271
sg11445
(dp57587
sg963
g20979
sg3279
g37928
sg11544
(dp57588
sg171
g13696
sg10794
(dp57589
sg2523
g32730
sg4056
g42577
sg5589
g51915
sg7164
(dp57590
sg1770
g27050
sg5598
g52011
sg7041
(dp57591
sg3708
g40376
sg1104
g22104
sg8580
(dp57592
sg11595
(dp57593
sg9339
(dp57594
sg7707
(dp57595
sg1809
g27425
sg4035
g42421
sg10857
(dp57596
sg1803
g27377
sg8601
(dp57597
sg255
g14418
sg11619
(dp57598
sg7713
(dp57599
sg5652
g52367
sg6411
g56883
sg4653
g46670
sg375
g15435
sg9099
(dp57600
sg11649
(dp57601
sg4623
g46376
sg11655
(dp57602
sg11667
(dp57603
sg9402
(dp57604
sg5694
g52531
sg4101
g42962
sg12534
g52619
sg5739
g52864
sg2784
g34356
sg8673
(dp57605
sg6318
g56353
sg9462
(dp57606
sg1635
g26034
sg3393
g38544
sg1134
g22316
sg4260
g44103
sg8487
(dp57607
sg3408
g38693
sg8703
(dp57608
sg8463
(dp57609
sg4959
g48527
sg537
g17022
sg7971
(dp57610
sg2688
g33623
sg23
g12213
sg4974
g48610
sg1008
g21271
sg14872
g15709
sg1947
g28669
sg6819
(dp57611
sg10239
(dp57612
sg1281
g23365
sg3447
g38918
sg1092
g21965
sg8724
(dp57613
sg3531
g39264
sg8028
(dp57614
sg9519
(dp57615
sg450
g16331
sg11811
(dp57616
sg14791
(dp57617
sg5829
g53355
sg2013
g28939
sg1059
g21745
sg168
g13637
sg3087
g36653
sg2658
g33362
sg7275
(dp57618
sg6261
g55845
sg10005
(dp57619
sg5781
g53102
sg7284
(dp57620
sg9561
(dp57621
sg10977
(dp57622
sg10335
(dp57623
sg5877
g53675
sg2067
g29670
sg9702
(dp57624
sg3156
g37189
sg534
g16981
sg1707
g26761
sg4458
g45479
sg6639
(dp57625
sg546
g17167
sg10593
(dp57626
sg10959
(dp57627
sg9012
(dp57628
sg7320
(dp57629
sg11136
(dp57630
sg3036
g36429
sg6024
g54435
sg1413
g24455
sg7569
(dp57631
sg1578
g25626
sg11439
(dp57632
sg69
g12748
sg570
g17473
sg3570
g39465
sg141
g13334
sg6687
(dp57633
sg9465
(dp57634
sg11910
(dp57635
sg11916
(dp57636
sg3363
g38409
sg1260
g23141
sg336
g15083
sg612
g17911
sg8187
(dp57637
sg8019
(dp57638
sg657
g18366
sg11955
(dp57639
sg4425
g44922
sg516
g16856
sg8163
(dp57640
sg1434
g24641
sg10470
(dp57641
sg5250
g49964
sg11265
(dp57642
sg6759
(dp57643
sg8295
(dp57644
sg6045
g54697
sg3684
g40225
sg687
g18549
sg10494
(dp57645
sg5487
g51360
sg4488
g45781
sg1491
g25063
sg10740
(dp57646
sg3711
g40427
sg2109
g30112
sg714
g19006
sg8277
(dp57647
sg5316
g50435
sg11319
(dp57648
sg6102
g55068
sg11727
(dp57649
sg2277
g31116
sg10854
(dp57650
sg1548
g25364
sg8862
(dp57651
sg9819
(dp57652
sg11352
(dp57653
sg5181
g49581
sg12126
(dp57654
sg10596
(dp57655
sg6381
g56768
sg10602
(dp57656
sg6156
g55214
sg9060
(dp57657
sg5394
g50824
sg9111
(dp57658
sg9864
(dp57659
sg5580
g51858
ssg6585
(dp57660
VPregnanes
p57661
(dp57662
sg4914
g48296
sVSteroids, Fluorinated
p57663
(dp57664
sVCardiovascular Agents
p57665
g26611
sVSteroids
p57666
g56411
sVCorticosteroids, Dermatological Preparations
p57667
g51329
sVCorticosteroids, Potent (Group III)
p57668
g56440
sVPregnadienes
p57669
(dp57670
sVDermatologicals
p57671
g17268
sVAnti-Inflammatory Agents
p57672
(dp57673
sVCorticosteroid Hormone Receptor Agonists
p57674
(dp57675
sVPregnadienetriols
p57676
(dp57677
sVImmunosuppressive Agents
p57678
(dp57679
sVBetamethasone
p57680
g39970
sVVasoconstrictor Agents
p57681
g35891
sVAdrenal Cortex Hormones
p57682
g30015
sVFused-Ring Compounds
p57683
g14856
sVCorticosteroids
p57684
(dp57685
ssg6588
(dp57686
g6393
g56824
sg2553
g32888
sg3699
g40318
sg5226
g49778
sg4725
g47137
ssg6591
(dp57687
g1782
g27140
sg11733
(dp57688
sg2046
g29115
sg3141
g37065
sg2895
g35423
sg11358
(dp57689
sg1761
g26979
sg11604
(dp57690
sg10218
(dp57691
sg11067
(dp57692
sg5082
g49021
sg1656
g26155
ssg6594
(dp57693
VMiscellaneous Anti-infectives
p57694
g54186
sVPhenols
p57695
(dp57696
sVBenzene Derivatives
p57697
(dp57698
ssg6597
(dp57699
g3126
g36957
sg1149
g22495
sg10428
(dp57700
ssg6600
(dp57701
g6183
g55467
sg135
g13246
sg6204
g55567
sg4788
g47569
sg4803
g47639
sg7650
(dp57702
sg10011
(dp57703
sg4656
g46806
sg8418
(dp57704
sg6231
g55734
sg7671
(dp57705
sg1914
g28405
sg9192
(dp57706
sg11451
(dp57707
sg891
g20547
sg2088
g29912
sg6267
g55880
sg10347
(dp57708
sg4710
g47004
sg4716
g47069
sg2391
g31748
sg9261
(dp57709
sg3207
g37472
sg7005
(dp57710
sg963
g20990
sg3279
g37934
sg972
g21116
sg9282
(dp57711
sg171
g13701
sg1761
g26986
sg5589
g51925
sg4005
g42163
sg1782
g27142
sg4341
g44601
sg11604
(dp57712
sg279
g14491
sg9426
(dp57713
sg3408
g38702
sg72
g12797
sg10953
(dp57714
sg10200
(dp57715
sg8760
(dp57716
sg11184
(dp57717
sg4974
g48618
sg1941
g28578
sg11775
(dp57718
sg9519
(dp57719
sg11805
(dp57720
sg978
g21154
sg7074
(dp57721
sg879
g20342
sg11052
(dp57722
sg3087
g36674
sg4260
g44111
sg11079
(dp57723
sg10977
(dp57724
sg8079
(dp57725
sg9702
(dp57726
sg11862
(dp57727
sg1311
g23521
sg2109
g30122
sg6024
g54445
sg3963
g41866
sg1332
g23652
sg1578
g25634
sg10383
(dp57728
sg7662
(dp57729
sg2436
g32173
sg9657
(dp57730
sg3291
g37998
sg10878
(dp57731
sg336
g15095
sg8922
(dp57732
sg8019
(dp57733
sg4425
g44930
sg5250
g49974
sg12000
(dp57734
sg8238
(dp57735
sg7470
(dp57736
sg9909
(dp57737
sg10494
(dp57738
sg2991
g35964
sg10740
(dp57739
sg3711
g40434
sg2250
g30856
sg3981
g42029
sg4062
g42624
sg8493
(dp57740
sg6162
g55257
sg5181
g49579
sg3090
g36692
sg9846
(dp57741
sg5394
g50832
sg10611
(dp57742
sg819
g19747
ssg6603
(dp57743
g8463
(dp57744
sg1092
g21968
ssg6606
(dp57745
g6204
g55569
sg8079
(dp57746
ssg6609
(dp57747
g6408
g56855
sg5574
g51795
sg7716
(dp57748
sg3546
g39388
sg3900
g41494
sg10899
(dp57749
sg5817
g53317
sg339
g15161
sg10416
(dp57750
sg621
g17960
ssg6612
(dp57751
VAmino Acids, Peptides, and Proteins
p57752
g47381
sVGlobulins
p57753
g19178
sVAntibodies
p57754
(dp57755
sVBlood Proteins
p57756
g39856
sVMyelosuppressive Agents
p57757
(dp57758
sVAntibodies, Monoclonal
p57759
(dp57760
sVImmunosuppressive Agents
p57761
(dp57762
sVAntineoplastic Agents, Immunological
p57763
(dp57764
sVImmunoglobulins
p57765
g41524
sVCD20-directed Antibody Interactions
p57766
(dp57767
sVAntirheumatic Agents
p57768
g24228
sVSerum Globulins
p57769
g49656
sVImmunologic Factors
p57770
g42379
sg519
g16898
sVBiologics for Rheumatoid Arthritis Treatment
p57771
g47866
sVProteins
p57772
g52770
sVAntineoplastic Agents
p57773
(dp57774
sVCD20-directed Cytolytic Antibody
p57775
g56252
sVImmunoproteins
p57776
g57449
ssg6615
(dp57777
g6180
g55423
sg8373
(dp57778
sg2346
g31381
sg10629
(dp57779
sg7944
(dp57780
sg2403
g31844
sg6186
g55501
sg1059
g21758
sg690
g18648
sg5427
g51007
sg816
g19691
sg6318
g56363
sg8394
(dp57781
sg3531
g39271
sg7821
(dp57782
sg10662
(dp57783
sg4656
g46786
sg1869
g27828
sg10674
(dp57784
sg6069
g54842
sg3885
g41447
sg9924
(dp57785
sg7983
(dp57786
sg11451
(dp57787
sg8433
(dp57788
sg1674
g26338
sg5499
g51423
sg3156
g37199
sg8448
(dp57789
sg909
g20641
sg10347
(dp57790
sg8460
(dp57791
sg9966
(dp57792
sg3177
g37315
sg10728
(dp57793
sg6966
(dp57794
sg7377
(dp57795
sg9231
(dp57796
sg8487
(dp57797
sg8139
(dp57798
sg11337
(dp57799
sg945
g20892
sg9981
(dp57800
sg19588
g32482
sg10005
(dp57801
sg6303
g56218
sg2493
g32616
sg3975
g41944
sg6999
(dp57802
sg7764
(dp57803
sg3978
g41993
sg3222
g37602
sg6315
g56300
sg3231
g37654
sg4773
g47490
sg9465
(dp57804
sg3240
g37714
sg11562
(dp57805
sg10815
(dp57806
sg7029
(dp57807
sg2676
g33551
sg10056
(dp57808
sg7041
(dp57809
sg3381
g38475
sg7533
(dp57810
sg11022
(dp57811
sg10323
(dp57812
sg9417
(dp57813
sg1035
g21461
sg1371
g24100
sg7707
(dp57814
sg240
g14192
sg10857
(dp57815
sg8595
(dp57816
sg9918
(dp57817
sg5289
g50277
sg1050
g21676
sg11619
(dp57818
sg9375
(dp57819
sg1626
g25964
sg4857
g47885
sg4863
g47947
sg282
g14556
sg6156
g55221
sg9111
(dp57820
sg11655
(dp57821
sg12042
(dp57822
sg11667
(dp57823
sg9879
(dp57824
sg8655
(dp57825
sg4449
g45387
sg5694
g52543
sg6348
g56646
sg1947
g28683
sg1881
g27956
sg4920
g48345
sg9432
(dp57826
sg3570
g39480
sg2841
g34840
sg1899
g28067
sg10179
(dp57827
sg9198
(dp57828
sg3399
g38635
sg1911
g28361
sg8463
(dp57829
sg4959
g48540
sg7941
(dp57830
sg2688
g33643
sg4164
g43313
sg147
g13453
sg387
g15641
sg6729
(dp57831
sg10227
(dp57832
sg7191
(dp57833
sg2304
g31263
sg414
g15965
sg9684
(dp57834
sg5793
g53212
sg5796
g53253
sg11016
(dp57835
sg9393
(dp57836
sg5805
g53282
sg11793
(dp57837
sg2481
g32411
sg2007
g28880
sg8493
(dp57838
sg2013
g28947
sg1239
g22954
sg1047
g21609
sg10308
(dp57839
sg11052
(dp57840
sg1248
g23027
sg2034
g29024
sg2658
g33368
sg11721
(dp57841
sg7275
(dp57842
sg8874
(dp57843
sg11940
(dp57844
sg2817
g34555
sg8820
(dp57845
sg7329
(dp57846
sg7299
(dp57847
sg9588
(dp57848
sg10350
(dp57849
sg8580
(dp57850
sg2910
g35540
sg8097
(dp57851
sg1707
g26776
sg2427
g32023
sg2838
g34796
sg3546
g39391
sg1503
g25184
sg3021
g36221
sg8106
(dp57852
sg3963
g41874
sg696
g18737
sg5127
g49234
sg10383
(dp57853
sg3114
g36870
sg11439
(dp57854
sg4173
g43407
sg11160
(dp57855
sg4827
g47780
sg573
g17552
sg4344
g44657
sg6678
(dp57856
sg2733
g33925
sg5169
g49520
sg15016
(dp57857
sg10410
(dp57858
sg5295
g50340
sg4419
g44898
sg4479
g45719
sg1188
g22773
sg9663
(dp57859
sg5193
g49616
sg609
g17814
sg11979
(dp57860
sg621
g17966
sg630
g18027
sg2196
g30618
sg11955
(dp57861
sg516
g16870
sg528
g16932
sg11229
(dp57862
sg6012
g54372
sg5235
g49838
sg654
g18276
sg4452
g45428
sg1434
g24655
sg8211
(dp57863
sg9711
(dp57864
sg9828
(dp57865
sg6759
(dp57866
sg11265
(dp57867
sg684
g18499
sg405
g15900
sg12126
(dp57868
sg6639
(dp57869
sg687
g18557
sg11274
(dp57870
sg3696
g40285
sg9507
(dp57871
sg10497
(dp57872
sg7485
(dp57873
sg10959
(dp57874
sg9009
(dp57875
sg9759
(dp57876
sg3732
g40526
sg12063
(dp57877
sg2265
g31012
sg5256
g50068
sg723
g19097
sg10533
(dp57878
sg735
g19141
sg4539
g46048
sg10854
(dp57879
sg8298
(dp57880
sg4542
g46092
sg1539
g25291
sg1092
g21973
sg2289
g31200
sg12066
(dp57881
sg10557
(dp57882
sg8862
(dp57883
sg5316
g50447
sg10098
(dp57884
sg771
g19289
sg7416
(dp57885
sg9084
(dp57886
sg1464
g24876
sg2664
g33447
sg780
g19359
sg819
g19757
sg11790
(dp57887
sg10305
(dp57888
sg5580
g51869
ssg6618
(dp57889
g7161
(dp57890
sg3297
g38032
sg7521
(dp57891
ssg6621
(dp57892
g3846
g41123
sg8916
(dp57893
sg2946
g35818
sg5832
g53418
sg8241
(dp57894
ssg6624
(dp57895
g4446
g45343
sg1767
g27039
sg6735
(dp57896
sg11403
(dp57897
sg9144
(dp57898
sg4341
g44606
sg978
g21168
sg4890
g48127
sg5235
g49843
sg7641
(dp57899
sg3597
g39639
sg879
g20356
sg4656
g46808
sg4062
g42636
sg5472
g51321
sg9687
(dp57900
sg20252
(dp57901
sg4287
g44387
sg5460
g51218
sg6267
g55895
sg4887
g48091
sg9216
(dp57902
sg5457
g51211
sg11862
(dp57903
sg6447
g57027
sg5574
g51820
sg7314
(dp57904
sg10164
(dp57905
sg6885
(dp57906
sg5238
g49904
sg5934
g54111
sg9486
(dp57907
sg10383
(dp57908
sg7698
(dp57909
sg10200
(dp57910
sg966
g21050
sg9117
(dp57911
sg3231
g37658
sg5094
g49099
sg1941
g28592
sg11976
(dp57912
sg2706
g33775
sg204
g13962
sg3624
g39891
ssg6627
(dp57913
g8019
(dp57914
sg4260
g44116
sg4425
g44935
sg5181
g49586
sg4788
g47576
sg2088
g29926
sg336
g15106
sg10011
(dp57915
ssg6630
(dp57916
g5022
g48748
sVImmunosuppressive Agents
p57917
(dp57918
sVImmunologic Factors
p57919
g42381
sg1221
g22884
sVSerum Globulins
p57920
g49659
sg408
g15910
sVImmunoglobulins
p57921
g41528
sVBiological Products
p57922
(dp57923
sg6957
(dp57924
sg11430
(dp57925
sVFluids and Secretions
p57926
g40896
sVAntibodies
p57927
(dp57928
sVSelective Immunosuppressants
p57929
g23560
sVProteins
p57930
g52773
sg5232
g49805
sVGlobulins
p57931
g19182
sVAmino Acids, Peptides, and Proteins
p57932
g47386
sg9483
(dp57933
sVImmunoglobulin G
p57934
g44806
sVAntineoplastic and Immunomodulating Agents
p57935
g39789
sVBlood Proteins
p57936
g39860
sVComplex Mixtures
p57937
(dp57938
sVSerum
p57939
g54286
sVMiscellaneous Therapeutic Agents
p57940
(dp57941
sVImmunoproteins
p57942
g57452
ssg6633
(dp57943
g11733
(dp57944
sg3249
g37765
sg12057
(dp57945
sg5556
g51730
sg10272
(dp57946
sg8658
(dp57947
ssg6636
(dp57948
g8454
(dp57949
sg12060
(dp57950
sg5595
g51992
ssg6639
(dp57951
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p57952
(dp57953
sVCytochrome P-450 CYP2D6 Substrates
p57954
g52173
sVSerotonin Agents
p57955
(dp57956
sVNeurotransmitter Agents
p57957
(dp57958
sVHypotensive Agents
p57959
g34168
sVCentral Nervous System Agents
p57960
(dp57961
sVDrugs Used in Addictive Disorders
p57962
g24712
sVPeripheral Nervous System Agents
p57963
g57625
sVDrugs that are Mainly Renally Excreted
p57964
g43845
sVCytochrome P-450 CYP1A2 Substrates
p57965
g45605
sVAntihypertensive Agents
p57966
g20296
sVImidazolines
p57967
g44248
sVSerotonin 5-HT2 Receptor Agonists
p57968
(dp57969
sVQTc Prolonging Agents
p57970
g57869
sVImidazoles
p57971
(dp57972
sVDrugs Used in Opioid Dependence
p57973
g17931
sVAdrenergic Agents
p57974
g41699
sVCentral Nervous System Depressants
p57975
(dp57976
sVCardiovascular Agents
p57977
g26625
sVMATE inhibitors
p57978
(dp57979
sVAdrenergic Agonists
p57980
(dp57981
sVAgents that produce hypertension
p57982
(dp57983
sVSerotonin Receptor Agonists
p57984
(dp57985
sVModerate Risk QTc-Prolonging Agents
p57986
(dp57987
sVAdrenergic alpha-2 Receptor Agonists
p57988
(dp57989
sVAdrenergic alpha-Agonists
p57990
(dp57991
sVAntidepressive Agents
p57992
g15549
sVAgents producing tachycardia
p57993
g50780
sVSensory System Agents
p57994
(dp57995
sVMATE 1 Inhibitors
p57996
(dp57997
sVNervous System
p57998
(dp57999
ssg6642
(dp58000
g3018
g36148
sg1704
g26721
sg633
g18085
sg828
g19874
sg5919
g53986
sg7056
(dp58001
sg933
g20831
sg8259
(dp58002
sg9252
(dp58003
sg4488
g45763
sg1635
g26056
sg9372
(dp58004
sg1668
g26262
sg168
g13653
sg2583
g33079
ssg6645
(dp58005
VUrologicals
p58006
(dp58007
sVGenito Urinary System and Sex Hormones
p58008
(dp58009
sVDrugs Used in Erectile Dysfunction
p58010
g20787
sVCytochrome P-450 CYP3A Substrates
p58011
g45006
sVCYP3A Substrates (Sensitive)
p58012
(dp58013
sVVasodilating Agents
p58014
g23708
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58015
g29255
sg8517
(dp58016
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p58017
(dp58018
sVCytochrome P-450 CYP3A4 Substrates
p58019
(dp58020
sVPhosphodiesterase 5 Inhibitors
p58021
(dp58022
ssg6648
(dp58023
g9906
(dp58024
ssg6651
(dp58025
g10794
(dp58026
ssg6654
(dp58027
VAgents Causing Muscle Toxicity
p58028
g55388
sVDideoxynucleosides
p58029
g48720
sVAntivirals for Systemic Use
p58030
(dp58031
sVNucleic Acid Synthesis Inhibitors
p58032
g48740
sVUGT1A1 Substrates
p58033
g12317
sVNoxae
p58034
(dp58035
sVCarbohydrates
p58036
(dp58037
sVPyrimidines
p58038
g47705
sVDirect Acting Antivirals
p58039
g38071
sVAnti-HIV Agents
p58040
(dp58041
sVBCRP/ABCG2 Substrates
p58042
g42084
sVEnzyme Inhibitors
p58043
(dp58044
sVThymidine
p58045
(dp58046
sVReverse Transcriptase Inhibitors
p58047
g28962
sVAnti-Infective Agents
p58048
g54572
sVAntiinfectives for Systemic Use
p58049
(dp58050
sVCytochrome P-450 CYP2C8 Substrates
p58051
(dp58052
sVDeoxyribonucleosides
p58053
g33061
sVMyelosuppressive Agents
p58054
(dp58055
sVUGT1A1 Inducers
p58056
g39244
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58057
g29258
sVCytochrome P-450 CYP2C9 Substrates
p58058
g29824
sVCytochrome P-450 CYP3A Substrates
p58059
g45007
sVGlycosides
p58060
(dp58061
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p58062
g38164
sVToxic Actions
p58063
g49401
sVOAT3/SLC22A8 Substrates
p58064
g13135
sVNucleic Acids, Nucleotides, and Nucleosides
p58065
g47128
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p58066
g14472
sVP-glycoprotein/ABCB1 Substrates
p58067
g35028
sVCytochrome P-450 CYP2A6 Substrates
p58068
g35132
sVUGT2B7 substrates
p58069
g28639
sVPyrimidine Nucleosides
p58070
(dp58071
sVCytochrome P-450 CYP3A4 Substrates
p58072
(dp58073
sVOAT1/SLC22A6 Substrates
p58074
(dp58075
sVAnti-Retroviral Agents
p58076
(dp58077
sVNucleosides
p58078
g49469
sVAntimetabolites
p58079
(dp58080
sVNucleoside Reverse Transcriptase Inhibitors
p58081
g38842
sVImmunosuppressive Agents
p58082
(dp58083
sVOAT3/SLC22A8 Inhibitors
p58084
(dp58085
sVAntiviral Agents
p58086
g30474
ssg6657
(dp58087
g537
g17044
sg4458
g45495
sg11595
(dp58088
sg10596
(dp58089
sg1281
g23391
sg1434
g24695
sg1008
g21293
sg915
g20716
sg8295
(dp58090
ssg6660
(dp58091
g2901
g35480
ssg6663
(dp58092
g1014
g21333
sg6093
g54991
ssg6666
(dp58093
g11940
(dp58094
sg14822
g41829
sg2133
g30310
sg3543
g39354
sg816
g19695
ssg6669
(dp58095
g1503
g25175
sg10347
(dp58096
sg1152
g22546
ssg6672
(dp58097
g12274
g27560
sg5433
g51065
ssg6675
(dp58098
g4860
g47920
ssg6678
(dp58099
VAnalgesics
p58100
g26480
sVNeurotransmitter Agents
p58101
(dp58102
sVHypotensive Agents
p58103
g34179
sVCentral Nervous System Agents
p58104
(dp58105
sVPotential QTc-Prolonging Agents
p58106
(dp58107
sVCytochrome P-450 CYP1A2 Substrates
p58108
g45611
sVAutonomic Agents
p58109
(dp58110
sVNeuromuscular Agents
p58111
g20234
sVImidazolines
p58112
g44246
sVQTc Prolonging Agents
p58113
g57856
sVImidazoles
p58114
(dp58115
sVMusculo-Skeletal System
p58116
g31544
sVAdrenergic Agents
p58117
g41710
sVCentral Nervous System Depressants
p58118
(dp58119
sVAnticonvulsants
p58120
(dp58121
sVCentral alpha-2 Adrenergic Agonist
p58122
g57056
sVMuscle Relaxants, Centrally Acting Agents
p58123
g37394
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p58124
g36466
sVAdrenergic Agonists
p58125
(dp58126
sVAdrenergic alpha-2 Receptor Agonists
p58127
(dp58128
sVAdrenergic alpha-Agonists
p58129
(dp58130
sVBradycardia-Causing Agents
p58131
(dp58132
sVMuscle Relaxants
p58133
(dp58134
sVAgents producing tachycardia
p58135
g50784
sVSensory System Agents
p58136
(dp58137
ssg6681
(dp58138
g8598
(dp58139
sg8601
(dp58140
ssg6684
(dp58141
g11532
(dp58142
sVAdrenergic Agents
p58143
g41714
sVAdrenergic alpha-1 Receptor Antagonists
p58144
g14139
sVDrugs that are Mainly Renally Excreted
p58145
g43848
sVAntihypertensive Agents
p58146
g20305
sVSympatholytic (Adrenergic Blocking) Agents
p58147
g44227
sVNeurotransmitter Agents
p58148
(dp58149
sVHypotensive Agents
p58150
g34180
sVPeripheral Vasodilators
p58151
g46225
sVVasodilating Agents
p58152
g23719
sVAdrenergic Antagonists
p58153
g52290
sVAdrenergic alpha-Antagonists
p58154
(dp58155
sVAgents that produce hypertension
p58156
(dp58157
sVPeripheral alpha-1 blockers
p58158
g32711
sVCardiovascular Agents
p58159
g26640
sVImidazoles
p58160
(dp58161
sVAntidotes
p58162
(dp58163
sg9456
(dp58164
ssg6687
(dp58165
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p58166
(dp58167
sVAnticholinergic Agents
p58168
g24505
sVCytochrome P-450 CYP2D6 Inhibitors
p58169
(dp58170
sVCytochrome P-450 CYP3A Substrates
p58171
g45010
sVNeurotransmitter Agents
p58172
(dp58173
sVHydroxy Acids
p58174
g18165
sVCytochrome P-450 CYP3A4 Inhibitors
p58175
(dp58176
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p58177
g43774
sVCytochrome P-450 Enzyme Inhibitors
p58178
(dp58179
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p58180
g18423
sVMuscarinic Antagonists
p58181
g48882
sVDrugs for Urinary Frequency and Incontinence
p58182
g28989
sVUrologicals
p58183
(dp58184
sVAutonomic Agents
p58185
(dp58186
sVAcids, Carbocyclic
p58187
g41574
sVPeripheral Nervous System Agents
p58188
g57633
sVUrological Agents
p58189
g38278
sVParasympatholytics
p58190
g35942
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58191
g29262
sVCytochrome P-450 CYP2C8 Inhibitors
p58192
g55034
sVCytochrome P-450 CYP3A4 Substrates
p58193
(dp58194
sVCytochrome P-450 CYP3A5 Substrates
p58195
(dp58196
sVGenito Urinary System and Sex Hormones
p58197
(dp58198
sVCytochrome P-450 CYP3A Inhibitors
p58199
(dp58200
sVCholinergic Agents
p58201
g28729
sVAgents producing tachycardia
p58202
g50785
ssg6690
(dp58203
g11631
(dp58204
ssg6693
(dp58205
g11268
(dp58206
ssg6696
(dp58207
g9081
(dp58208
ssg6699
(dp58209
VBSEP/ABCB11 Substrates
p58210
(dp58211
sVCytochrome P-450 CYP3A4 Inhibitors
p58212
(dp58213
sVUGT1A1 Substrates
p58214
g12288
sVUGT2B7 substrates
p58215
g28624
sVBCRP/ABCG2 Inhibitors
p58216
g12525
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p58217
g43763
sVCytochrome P-450 Enzyme Inhibitors
p58218
(dp58219
sVUGT1A3 substrates
p58220
g31804
sVLipid Modifying Agents, Plain
p58221
(dp58222
sVOATP1B1/SLCO1B1 Substrates
p58223
(dp58224
sVHypolipidemic Agents
p58225
(dp58226
sVLipid Modifying Agents
p58227
g40540
sVP-glycoprotein/ABCB1 Substrates
p58228
g35009
sg12084
(dp58229
sg2859
g35145
sg8268
(dp58230
sVToxic Actions
p58231
g49384
sVAnticholesteremic Agents
p58232
g50593
sVCytochrome P-450 CYP3A Inhibitors
p58233
(dp58234
sVNoxae
p58235
(dp58236
sVBCRP/ABCG2 Substrates
p58237
g42071
sVAzetines
p58238
(dp58239
sVLipid Regulating Agents
p58240
(dp58241
ssg6702
(dp58242
g4653
g46755
sg4155
g43258
sg9198
(dp58243
sg183
g13864
sg1140
g22374
sg6045
g54726
sg12534
g52701
ssg6705
(dp58244
g3531
g39289
ssg6708
(dp58245
g6090
g54976
sg4263
g44192
sg10779
(dp58246
ssg6711
(dp58247
g10713
(dp58248
ssg6714
(dp58249
VGastric Acid Lowering Agents
p58250
(dp58251
sVImmunologic Factors
p58252
g42391
sVAlkalies
p58253
(dp58254
sVAntacids
p58255
g42405
sg6888
(dp58256
sg5040
g48833
sVMetal divalent cations
p58257
(dp58258
sVElectrolytes
p58259
g52420
sg699
g18798
sVGastrointestinal Agents
p58260
(dp58261
sVHydroxides
p58262
g19065
sVAntacids and Adsorbents
p58263
(dp58264
sVAcids
p58265
g40577
sVAdjuvants, Immunologic
p58266
g39436
sVAlimentary Tract and Metabolism
p58267
g23780
sg3540
g39301
sVIons
p58268
g49120
sVAluminum and magnesium containing antacids
p58269
g26964
sVAcids, Noncarboxylic
p58270
g54202
sVDrugs for Acid Related Disorders
p58271
g55167
sVAnions
p58272
(dp58273
sVMetal cations
p58274
g40810
ssg6717
(dp58275
g9774
(dp58276
sg1614
g25902
sg6045
g54718
sg9693
(dp58277
sg13750
g24409
sg1800
g27341
sg4653
g46738
sg2388
g31686
sg6345
g56608
sg2226
g30787
sg11997
(dp58278
sg12534
g52684
ssg6720
(dp58279
g969
g21100
sg11535
(dp58280
ssg6723
(dp58281
g8781
(dp58282
sg7905
(dp58283
sg11967
(dp58284
ssg6726
(dp58285
VCarbon Compounds, Inorganic
p58286
g39296
sVDrugs that are Mainly Renally Excreted
p58287
g43825
sVCentral Nervous System Depressants
p58288
(dp58289
sg10773
(dp58290
sVCarbonates
p58291
(dp58292
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p58293
(dp58294
sVAntidepressive Agents
p58295
g15503
sVAcids
p58296
g40579
sVAcids, Noncarboxylic
p58297
g54204
sVAlkalies
p58298
(dp58299
sVCentral Nervous System Agents
p58300
(dp58301
sVMood Stabilizer
p58302
(dp58303
sVNarrow Therapeutic Index Drugs
p58304
g50568
sVAnions
p58305
(dp58306
sVCarbonic Acid
p58307
g48829
sVEnzyme Inhibitors
p58308
(dp58309
sVPsychotropic Drugs
p58310
(dp58311
sVElectrolytes
p58312
g52421
sVTranquilizing Agents
p58313
g55284
sVAntimanic Agents
p58314
(dp58315
sVIons
p58316
g49121
ssg6729
(dp58317
VAntipruritics
p58318
(dp58319
sVAntihistamines for Topical Use
p58320
g39012
sVHistamine H1 Antagonists
p58321
g40757
sVCytochrome P-450 CYP2D6 Inhibitors
p58322
(dp58323
sVNeurotransmitter Agents
p58324
(dp58325
sVAnti-Allergic Agents
p58326
g50651
sVCentral Nervous System Depressants
p58327
(dp58328
sVHistamine Agents
p58329
(dp58330
sVAminoalkyl Ethers
p58331
g19320
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p58332
g53084
sVPyrrolidines
p58333
(dp58334
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p58335
(dp58336
sVHistamine Antagonists
p58337
g43414
sVAntihistamines for Systemic Use
p58338
g12977
sVCytochrome P-450 Enzyme Inhibitors
p58339
(dp58340
sVDermatologicals
p58341
g17251
sVQTc Prolonging Agents
p58342
g57831
sVHighest Risk QTc-Prolonging Agents
p58343
g35875
ssg6732
(dp58344
g4014
g42209
ssg6735
(dp58345
VOphthalmologicals
p58346
g35246
sVGenito Urinary System and Sex Hormones
p58347
(dp58348
sVGynecological Antiinfectives and Antiseptics
p58349
(dp58350
sVSulfonamides
p58351
(dp58352
sVHypotensive Agents
p58353
g34187
sg11808
(dp58354
sVSulfur Compounds
p58355
(dp58356
sVAmides
p58357
g44343
sVSensory Organs
p58358
g40734
sVEnzyme Inhibitors
p58359
(dp58360
sVSulfones
p58361
(dp58362
sVAntiglaucoma Preparations and Miotics
p58363
g36545
sg8046
(dp58364
sVDiuretics
p58365
g57896
ssg6738
(dp58366
g6315
g56293
ssg6741
(dp58367
g2844
g34881
sg5622
g52236
sg1038
g21480
sg7854
(dp58368
sg4845
g47850
sg5457
g51193
sg7161
(dp58369
sg6903
(dp58370
sg8418
(dp58371
sg1461
g24791
sg285
g14615
sg10494
(dp58372
sg10779
(dp58373
sg1683
g26382
sg4752
g47290
sg5511
g51461
sg6090
g54945
sg11301
(dp58374
sg7521
(dp58375
sg7800
(dp58376
sg9441
(dp58377
sg6024
g54421
sg9102
(dp58378
sg3867
g41335
sg3297
g38025
sg10554
(dp58379
sg5589
g51900
sg11934
(dp58380
sg10047
(dp58381
sg7059
(dp58382
sg5793
g53204
ssg6744
(dp58383
g9519
(dp58384
sg11805
(dp58385
sg4788
g47550
sg4803
g47619
sg5250
g49947
sg7650
(dp58386
sg10011
(dp58387
sg8418
(dp58388
sg10977
(dp58389
sg4260
g44094
sg1914
g28393
sg7671
(dp58390
sg891
g20534
sg10494
(dp58391
sg10740
(dp58392
sg3711
g40413
sg9702
(dp58393
sg4716
g47051
sg2109
g30093
sg2391
g31700
sg6024
g54424
sg1578
g25612
sg3408
g38677
sg72
g12781
sg963
g20969
sg3279
g37918
sg171
g13688
sg4974
g48600
sg5589
g51903
sg5394
g50815
ssg6747
(dp58394
g6726
g58299
sg5415
g50919
sg7920
(dp58395
sg1842
g27655
sg7548
(dp58396
sg4557
g46139
sg8649
(dp58397
sg6714
g58254
ssg6750
(dp58398
g6207
g55594
sg42
g12570
sg8514
(dp58399
sg7464
(dp58400
sg10635
(dp58401
sg2358
g31457
sg12421
g12424
sg3117
g36899
sg828
g19840
sg11283
(dp58402
sg4788
g47552
sg4803
g47622
sg7650
(dp58403
sg1869
g27812
sg10674
(dp58404
sg8421
(dp58405
sg69
g12759
sg72
g12785
sg2403
g31833
sg7671
(dp58406
sg11016
(dp58407
sg5922
g54013
sg888
g20399
sg891
g20536
sg3048
g36504
sg6468
g57079
sg6939
(dp58408
sg2427
g31984
sg10818
(dp58409
sg2433
g32146
sg5133
g49268
sg9960
(dp58410
sg9963
(dp58411
sg8460
(dp58412
sg915
g20685
sg6726
g58301
sg10728
(dp58413
sg6966
(dp58414
sg6792
(dp58415
sg4716
g47055
sg5535
g51643
sg8874
(dp58416
sg7299
(dp58417
sg9996
(dp58418
sg9252
(dp58419
sg10737
(dp58420
sg9981
(dp58421
sg4635
g46463
sg3204
g37427
sg19588
g32459
sg6186
g55481
sg11445
(dp58422
sg7065
(dp58423
sg963
g20973
sg6999
(dp58424
sg10056
(dp58425
sg3978
g41968
sg11544
(dp58426
sg171
g13694
sg10794
(dp58427
sg9465
(dp58428
sg2088
g29891
sg183
g13772
sg11112
(dp58429
sg10356
(dp58430
sg204
g13944
sg1770
g27042
sg1008
g21267
sg7041
(dp58431
sg10062
(dp58432
sg5739
g52874
sg7053
(dp58433
sg7533
(dp58434
sg2559
g32927
sg1104
g22098
sg1092
g21963
sg8580
(dp58435
sg11595
(dp58436
sg9339
(dp58437
sg7707
(dp58438
sg240
g14175
sg4035
g42411
sg12066
(dp58439
sg1947
g28661
sg8598
(dp58440
sg3156
g37184
sg11619
(dp58441
sg7713
(dp58442
sg2583
g33085
sg10977
(dp58443
sg6921
(dp58444
sg6411
g56872
sg1059
g21737
sg9417
(dp58445
sg282
g14529
sg6156
g55212
sg3111
g36829
sg294
g14726
sg11655
(dp58446
sg4596
g46238
sg5970
g54229
sg8655
(dp58447
sg11931
(dp58448
sg5691
g52481
sg5694
g52522
sg4101
g42958
sg12534
g52670
sg1425
g24532
sg2784
g34373
sg10497
(dp58449
sg6318
g56331
sg9462
(dp58450
sg3381
g38465
sg1401
g24298
sg1890
g28001
sg8463
(dp58451
sg3393
g38534
sg345
g15209
sg7941
(dp58452
sg1134
g22314
sg2658
g33346
sg8487
(dp58453
sg1908
g28273
sg3408
g38681
sg8703
(dp58454
sg7959
(dp58455
sg11727
(dp58456
sg4959
g48514
sg537
g17018
sg7971
(dp58457
sg2688
g33609
sg4155
g43194
sg8721
(dp58458
sg7176
(dp58459
sg4974
g48602
sg8724
(dp58460
sg387
g15604
sg14872
g15699
sg2538
g32811
sg5256
g50035
sg5769
g53033
sg10239
(dp58461
sg7197
(dp58462
sg1281
g23361
sg3447
g38905
sg1194
g22807
sg2730
g33880
sg780
g19340
sg2523
g32726
sg4746
g47264
sg426
g16057
sg465
g16443
sg10266
(dp58463
sg9393
(dp58464
sg11793
(dp58465
sg2430
g32088
sg8028
(dp58466
sg9519
(dp58467
sg450
g16325
sg10017
(dp58468
sg11811
(dp58469
sg6570
g57538
sg10308
(dp58470
sg6579
g57562
sg168
g13615
sg6303
g56192
sg3087
g36648
sg5853
g53531
sg4260
g44096
sg7272
(dp58471
sg7275
(dp58472
sg1263
g23194
sg6261
g55839
sg5064
g48914
sg8067
(dp58473
sg7284
(dp58474
sg2199
g30673
sg9561
(dp58475
sg9564
(dp58476
sg5877
g53697
sg4287
g44366
sg2067
g29619
sg7329
(dp58477
sg7335
(dp58478
sg9588
(dp58479
sg10350
(dp58480
sg5781
g53098
sg7389
(dp58481
sg2910
g35515
sg534
g16970
sg1707
g26752
sg4458
g45475
sg6639
g57961
sg546
g17153
sg10959
(dp58482
sg7317
(dp58483
sg11136
(dp58484
sg11139
(dp58485
sg1413
g24444
sg696
g18697
sg7569
(dp58486
sg1578
g25618
sg7428
(dp58487
sg11154
(dp58488
sg564
g17393
sg1809
g27421
sg4653
g46724
sg5145
g49360
sg4344
g44639
sg6678
g58105
sg3570
g39456
sg582
g17611
sg603
g17776
sg5169
g49495
sg11910
(dp58489
sg9144
(dp58490
sg1188
g22762
sg3363
g38403
sg336
g15071
sg612
g17848
sg9372
(dp58491
sg8832
(dp58492
sg8187
(dp58493
sg6525
g57339
sg11097
(dp58494
sg8019
(dp58495
sg8097
(dp58496
sg630
g18004
sg657
g18348
sg4425
g44913
sg8205
(dp58497
sg516
g16851
sg7422
(dp58498
sg11229
(dp58499
sg9702
(dp58500
sg3651
g40103
sg8163
(dp58501
sg5235
g49814
sg11979
(dp58502
sg1434
g24629
sg10470
(dp58503
sg9711
(dp58504
sg5247
g49929
sg5250
g49952
sg11265
(dp58505
sg4266
g44211
sg8295
(dp58506
sg6045
g54712
sg11277
(dp58507
sg7944
(dp58508
sg3516
g39148
sg687
g18534
sg12018
(dp58509
sg5487
g51353
sg702
g18815
sg1491
g25050
sg1113
g22159
sg10740
(dp58510
sg3711
g40419
sg7497
(dp58511
sg2109
g30099
sg714
g19025
sg3018
g36125
sg2391
g31736
sg10518
(dp58512
sg2265
g30993
sg5316
g50429
sg11319
(dp58513
sg7734
(dp58514
sg486
g16632
sg9864
(dp58515
sg2814
g34506
sg9420
(dp58516
sg3279
g37922
sg10854
(dp58517
sg414
g15939
sg2013
g28933
sg12111
(dp58518
sg9822
(dp58519
sg5181
g49567
sg5067
g48937
sg12126
(dp58520
sg10596
(dp58521
sg11805
(dp58522
sg2664
g33418
sg6381
g56762
sg10602
(dp58523
sg7593
(dp58524
sg9060
(dp58525
sg5394
g50820
sg11790
(dp58526
sg9111
(dp58527
sg5652
g52375
ssg6753
(dp58528
g1548
g25360
sg10263
(dp58529
sg10557
(dp58530
sg2616
g33165
sg5829
g53352
sg10761
(dp58531
sg3708
g40372
sg4452
g45451
ssg6756
(dp58532
g4266
g44224
sg8721
(dp58533
sg10356
(dp58534
ssg6759
(dp58535
VQuinolines
p58536
(dp58537
sVCytochrome P-450 CYP2D6 Substrates
p58538
g52187
sVAntiarrhythmic agents
p58539
(dp58540
sVNeurotransmitter Agents
p58541
(dp58542
sVHypotensive Agents
p58543
g34193
sVAmino Alcohols
p58544
g32670
sVPotential QTc-Prolonging Agents
p58545
(dp58546
sVAdrenergic Antagonists
p58547
g52270
sVPeripheral Nervous System Agents
p58548
g57643
sVSympatholytics
p58549
g56847
sVAmines
p58550
g42731
sVAntihypertensive Agents
p58551
g20311
sVQTc Prolonging Agents
p58552
g57866
sVAntiglaucoma Preparations and Miotics
p58553
g36549
sVAdrenergic Agents
p58554
g41694
sVQuinolones
p58555
g23988
sVAgents causing hyperkalemia
p58556
g43631
sVCardiovascular Agents
p58557
g26657
sVAdrenergic beta-Antagonists
p58558
g15353
sVPhenoxypropanolamines
p58559
g20869
sVSensory Organs
p58560
g40713
sVBeta Blocking Agents, Non-Selective
p58561
g38744
sVPropanolamines
p58562
g37501
sVAutonomic Agents
p58563
(dp58564
sVHeterocyclic Compounds, Fused-Ring
p58565
g56096
sVOphthalmologicals
p58566
g35221
sVBradycardia-Causing Agents
p58567
(dp58568
sVPropanols
p58569
g56545
sVAlcohols
p58570
(dp58571
ssg6762
(dp58572
g9372
(dp58573
ssg6765
(dp58574
VCytochrome P-450 CYP3A4 Inhibitors
p58575
(dp58576
sVPhosphorus Acids
p58577
(dp58578
sVImmunosuppressive Agents
p58579
(dp58580
sVCytochrome P-450 CYP3A Substrates
p58581
g45017
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p58582
(dp58583
sVCytochrome P-450 CYP2B6 Substrates
p58584
g33008
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p58585
g43783
sVCytochrome P-450 Enzyme Inhibitors
p58586
(dp58587
sVPhosphoric Acids
p58588
(dp58589
sg267
g14452
sVAntineoplastic Agents, Alkylating
p58590
(dp58591
sVDrugs that are Mainly Renally Excreted
p58592
g43851
sVCytochrome P-450 CYP2C8 Substrates
p58593
(dp58594
sg2031
g28991
sVMyelosuppressive Agents
p58595
(dp58596
sVElectrolytes
p58597
g52429
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58598
g29273
sVCytochrome P-450 CYP2C9 Substrates
p58599
g29803
sVCytochrome P-450 CYP3A4 Inducers
p58600
g18965
sVAntineoplastic Agents
p58601
(dp58602
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p58603
g44462
sVAnions
p58604
(dp58605
sVToxic Actions
p58606
g49386
sg117
g13090
sVAcids
p58607
g40591
sVCytochrome P-450 CYP2A6 Substrates
p58608
g35124
sVAlkylating Drugs
p58609
(dp58610
sVCytochrome P-450 Enzyme Inducers
p58611
g28234
sVCytochrome P-450 CYP3A Inducers
p58612
(dp58613
sVCytochrome P-450 CYP2C18 Substrates
p58614
g20940
sg4131
g43124
sVNoxae
p58615
(dp58616
sVCytochrome P-450 CYP3A4 Substrates
p58617
(dp58618
sVIons
p58619
g49128
sVCardiotoxic antineoplastic agents
p58620
(dp58621
sVCytochrome P-450 CYP3A5 Substrates
p58622
(dp58623
sVCytochrome P-450 CYP2C8 Inducers
p58624
(dp58625
sVCytochrome P-450 CYP3A Inhibitors
p58626
(dp58627
sg1032
g21371
sVAcids, Noncarboxylic
p58628
g54214
sVAlkylating Activity
p58629
g46191
sVMethemoglobinemia Associated Agents
p58630
g25574
sVHydrocarbons, Halogenated
p58631
(dp58632
sVPhosphorus Compounds
p58633
g36721
sVAntineoplastic and Immunomodulating Agents
p58634
g39812
sVOxazines
p58635
(dp58636
sVPhosphoramides
p58637
g22264
sVOrganophosphorus Compounds
p58638
(dp58639
ssg6768
(dp58640
g6867
(dp58641
sg5571
g51766
sg2355
g31426
sg5313
g50390
sg9231
(dp58642
sg6192
g55535
sg10374
(dp58643
sg10179
(dp58644
sg11961
(dp58645
sg132
g13216
sg9060
(dp58646
sg9591
(dp58647
sg8190
(dp58648
ssg6771
(dp58649
g10539
(dp58650
ssg6774
(dp58651
g11733
(dp58652
ssg6777
(dp58653
g6549
g57471
ssg6780
(dp58654
g10539
(dp58655
ssg6783
(dp58656
VHydroxycorticosteroids
p58657
g55779
sVCytochrome P-450 CYP3A Substrates
p58658
g45018
sVHydrocortisone and derivatives
p58659
g14159
sVHormones
p58660
g55692
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p58661
g44465
sV17-Hydroxycorticosteroids
p58662
(dp58663
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58664
g29274
sVFused-Ring Compounds
p58665
g14878
sVCytochrome P-450 CYP3A4 Inducers
p58666
g18968
sg11970
(dp58667
sVAdrenal Cortex Hormones
p58668
g30022
sVAdministration, Topical
p58669
(dp58670
sVCytochrome P-450 Enzyme Inducers
p58671
g28229
sVCytochrome P-450 CYP3A Inducers
p58672
(dp58673
sVCytochrome P-450 CYP3A4 Substrates
p58674
(dp58675
sVPregnanes
p58676
(dp58677
sVCytochrome P-450 CYP3A5 Substrates
p58678
(dp58679
sVPregnenediones
p58680
g29964
sV11-Hydroxycorticosteroids
p58681
g52908
sVCytochrome P-450 CYP2C8 Inducers
p58682
(dp58683
sVSteroids
p58684
g56415
sVImmunosuppressive Agents
p58685
(dp58686
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p58687
(dp58688
sVAnti-Inflammatory Agents
p58689
(dp58690
sVPregnenes
p58691
g28750
sVHormones, Hormone Substitutes, and Hormone Antagonists
p58692
g53185
sVCorticosteroids
p58693
(dp58694
sVCytochrome P-450 CYP3A7 Substrates
p58695
(dp58696
ssg6786
(dp58697
g6150
g55192
ssg6789
(dp58698
g7980
(dp58699
sg447
g16292
ssg6792
(dp58700
VCentral Nervous System Depressants
p58701
(dp58702
sVCytochrome P-450 CYP1A2 Substrates
p58703
g45639
sVHeterocyclic Compounds, Fused-Ring
p58704
g56148
sVThiazoles
p58705
g49139
sVAnticonvulsants
p58706
(dp58707
sVNeurotransmitter Agents
p58708
(dp58709
sVBenzothiazoles
p58710
g55104
sVBCRP/ABCG2 Substrates
p58711
g42074
sVCentral Nervous System Agents
p58712
g58415
sVExcitatory Amino Acid Antagonists
p58713
(dp58714
sVExcitatory Amino Acid Agents
p58715
g14799
sVCompounds used in a research, industrial, or household setting
p58716
(dp58717
sVProtective Agents
p58718
(dp58719
sVMiscellaneous Central Nervous System Agents
p58720
(dp58721
sVNervous System
p58722
(dp58723
sVNeuroprotective Agents
p58724
(dp58725
sVSulfur Compounds
p58726
(dp58727
ssg6795
(dp58728
g4446
g45350
sg2346
g31379
sg6735
g58362
sg9117
(dp58729
sg11961
(dp58730
sg7188
(dp58731
sg7884
(dp58732
sg978
g21162
sg4830
g47819
sg7641
(dp58733
sg9486
(dp58734
sg3597
g39648
sg879
g20350
sg4656
g46784
sg10884
(dp58735
sg6051
g54788
sg10377
(dp58736
sg20252
(dp58737
sg9687
(dp58738
sg6867
(dp58739
sg3519
g39211
sg2355
g31437
sg9081
(dp58740
sg2088
g29928
sg5685
g52460
sg7314
(dp58741
sg11475
(dp58742
sg6348
g56644
sg11862
(dp58743
sg5574
g51800
sg5313
g50398
sg5919
g53970
sg6435
g56981
sg10164
(dp58744
sg2391
g31726
sg2115
g30203
sg6885
(dp58745
sg2274
g31084
sg5934
g54088
sg7947
(dp58746
sg4062
g42632
sg132
g13227
sg5127
g49232
sg10383
(dp58747
sg2667
g33530
sg9180
(dp58748
sg11166
(dp58749
sg5571
g51778
sg3231
g37652
sg1941
g28587
sg5370
g50678
sg1650
g26110
sg2706
g33755
sg6336
g56532
sg5235
g49836
sg10692
(dp58750
sg5460
g51225
sg3624
g39898
ssg6798
(dp58751
VCytochrome P-450 CYP3A4 Inhibitors
p58752
(dp58753
sVAntifungal Agents
p58754
(dp58755
sg9888
(dp58756
sVEnzyme Inhibitors
p58757
(dp58758
sVCytochrome P-450 Enzyme Inhibitors
p58759
(dp58760
sVAnti-Infective Agents
p58761
g54666
sg3501
g39085
sg5565
g51760
sg867
g20195
sVGynecological Antiinfectives and Antiseptics
p58762
(dp58763
sVCytochrome P-450 CYP2E1 Inhibitors
p58764
g46844
sVAntifungals for Topical Use
p58765
g39233
sg9945
(dp58766
sg11856
(dp58767
sVAntifungals for Dermatological Use
p58768
g30078
sVDermatologicals
p58769
g17213
sg144
g13396
sg1725
g26876
sVHormone Antagonists
p58770
g24272
sg10971
(dp58771
sVGenito Urinary System and Sex Hormones
p58772
(dp58773
sVCytochrome P-450 CYP3A Inhibitors
p58774
(dp58775
sVP-glycoprotein/ABCB1 Inhibitors
p58776
(dp58777
sVHormones, Hormone Substitutes, and Hormone Antagonists
p58778
g53187
sg1002
g21233
sg10254
(dp58779
ssg6801
(dp58780
g11793
(dp58781
sg11265
(dp58782
sg9393
(dp58783
ssg6804
(dp58784
VAmino Acids, Peptides, and Proteins
p58785
g47349
sVAntibodies
p58786
(dp58787
sg10071
(dp58788
sVAntibodies, Monoclonal
p58789
(dp58790
sVProteins
p58791
g52754
sVImmunoglobulins
p58792
g41526
sVImmunosuppressive Agents
p58793
(dp58794
sVDrugs for Obstructive Airway Diseases
p58795
g42516
sVSerum Globulins
p58796
g49657
sVGlobulins
p58797
g19180
sVBlood Proteins
p58798
g39858
sg5148
g49372
sVImmunoproteins
p58799
g57450
ssg6807
(dp58800
VAgents Causing Muscle Toxicity
p58801
g55391
sVCytochrome P-450 CYP3A4 Inhibitors
p58802
(dp58803
sVCytochrome P-450 CYP3A Substrates
p58804
g44967
sVCycloparaffins
p58805
g43666
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p58806
g43735
sVCytochrome P-450 Enzyme Inhibitors
p58807
(dp58808
sVAntimitotic Agents
p58809
(dp58810
sVTerpenes
p58811
(dp58812
sVTaxane Derivatives
p58813
(dp58814
sVMyelosuppressive Agents
p58815
(dp58816
sVTubulin Modulators
p58817
g33859
sVMicrotubule Inhibition
p58818
g12889
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58819
g29199
sVAntineoplastic Agents
p58820
(dp58821
sVCyclodecanes
p58822
(dp58823
sVDiterpenes
p58824
g48894
sVP-glycoprotein/ABCB1 Substrates
p58825
g34926
sVMicrotubule Inhibitors
p58826
g36410
sVCytochrome P-450 CYP3A4 Substrates
p58827
(dp58828
sVMitosis Modulators
p58829
g33591
sVCardiotoxic antineoplastic agents
p58830
(dp58831
sVCytochrome P-450 CYP3A5 Substrates
p58832
(dp58833
sVOATP1B3 substrates
p58834
g28518
sVCytochrome P-450 CYP3A Inhibitors
p58835
(dp58836
sVImmunosuppressive Agents
p58837
(dp58838
sVBCRP/ABCG2 Substrates
p58839
g42094
sVTaxoids
p58840
g35470
sVAntineoplastic and Immunomodulating Agents
p58841
g39736
sVCytochrome P-450 CYP3A7 Substrates
p58842
(dp58843
ssg6810
(dp58844
g11379
(dp58845
ssg6813
(dp58846
g723
g19083
sg7533
(dp58847
sg3279
g37939
sg1263
g23191
sg5796
g53241
ssg6816
(dp58848
g8421
(dp58849
sg10512
(dp58850
sg9822
(dp58851
sg7335
(dp58852
ssg6819
(dp58853
g2349
g31415
sVCytochrome P-450 CYP2D6 Substrates
p58854
g52114
sVCytochrome P-450 CYP3A Substrates
p58855
g45033
sVNeurotransmitter Agents
p58856
(dp58857
sVOCT2 Inhibitors
p58858
g42469
sVCytochrome P-450 CYP2B6 Substrates
p58859
g33010
sVCytochrome P-450 Enzyme Inhibitors
p58860
(dp58861
sg2010
g28913
sVDrugs Used in Addictive Disorders
p58862
g24714
sVPeripheral Nervous System Agents
p58863
g57611
sVCytochrome P-450 CYP2E1 Inducers
p58864
g27610
sVCytochrome P-450 CYP2C8 Substrates
p58865
(dp58866
sVCytochrome P-450 CYP1A2 Substrates
p58867
g45572
sg9453
(dp58868
sVAutonomic Agents
p58869
(dp58870
sVCytochrome P-450 CYP2E1 Inhibitors
p58871
g46847
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p58872
g14789
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p58873
g29297
sVCytochrome P-450 CYP2C9 Substrates
p58874
g29717
sVOCT1 inhibitors
p58875
(dp58876
sg11688
(dp58877
sVCytochrome P-450 CYP1A2 Inducers
p58878
(dp58879
sg924
g20782
sVSolanaceous Alkaloids
p58880
(dp58881
sVPyridines
p58882
(dp58883
sVCytochrome P-450 CYP2A6 Substrates
p58884
g35126
sg9474
(dp58885
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p58886
(dp58887
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p58888
g17442
sVCytochrome P-450 CYP3A4 Substrates
p58889
(dp58890
sg7167
(dp58891
sVNervous System
p58892
(dp58893
sg2775
g34328
sg7368
(dp58894
sg10482
(dp58895
sVCholinergic Agents
p58896
g28734
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p58897
g26885
sVCholinergic Agonists
p58898
g40988
sVAgents producing tachycardia
p58899
g50747
sVAlkaloids
p58900
g19409
sVCytochrome P-450 Enzyme Inducers
p58901
g28177
sVCytochrome P-450 CYP2A6 Inhibitors
p58902
g48580
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p58903
(dp58904
ssg6822
(dp58905
g11832
(dp58906
sg3312
g38153
ssg6825
(dp58907
g5415
g50934
sg1326
g23610
sg831
g19932
sg4449
g45363
sg8964
(dp58908
sg11022
(dp58909
sg1626
g25940
sg3504
g39097
sg7530
(dp58910
sg6051
g54776
sg10320
(dp58911
sg10521
(dp58912
sg9099
(dp58913
sg3900
g41507
sg6069
g54820
sg5499
g51411
sg3156
g37211
sg10713
(dp58914
sg10884
(dp58915
sg11874
(dp58916
sg10593
(dp58917
sg8487
(dp58918
sg6645
g58007
sg561
g17379
sg570
g17477
sg10554
(dp58919
sg6687
g58184
sg10041
(dp58920
sg4401
g44862
sg7170
(dp58921
sg9828
(dp58922
sg420
g16026
ssg6828
(dp58923
g4263
g44185
sg10839
(dp58924
sg9198
(dp58925
sg10179
(dp58926
sg7821
(dp58927
sg7563
(dp58928
sg147
g13483
ssg6831
(dp58929
g4155
g43249
sg1434
g24679
sg8277
(dp58930
sg2199
g30708
sg5067
g48962
sg183
g13850
sg10854
(dp58931
sg5133
g49297
sg7272
(dp58932
sg10308
(dp58933
ssg6834
(dp58934
g8760
(dp58935
sg2736
g33970
sg2466
g32353
sg10290
(dp58936
sg10587
(dp58937
sg9909
(dp58938
sg4002
g42123
sg11781
(dp58939
sg14338
g13518
ssg6837
(dp58940
g10515
(dp58941
sg723
g19070
sg11649
(dp58942
sg4623
g46402
sg5427
g50979
sg10857
(dp58943
sg4488
g45771
sg11667
(dp58944
sg9402
(dp58945
sg255
g14412
sg11439
(dp58946
sg5796
g53232
ssg6840
(dp58947
g8373
(dp58948
sg6639
g57979
sg8472
(dp58949
sg11241
(dp58950
sg3753
g40611
sg2481
g32432
sg5646
g52334
sg9444
(dp58951
sg11508
(dp58952
sg8211
(dp58953
sg9180
(dp58954
sg1098
g22019
ssg6843
(dp58955
VStyrene
p58956
(dp58957
sVChelating Agents
p58958
(dp58959
sVCompounds used in a research, industrial, or household setting
p58960
(dp58961
sg11463
(dp58962
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p58963
g37166
sg7095
(dp58964
sVSulfur Compounds
p58965
(dp58966
sVIon Exchange Resins
p58967
g23412
sVBenzene Derivatives
p58968
(dp58969
sVPolymers
p58970
g22238
sVAcids
p58971
g40589
sVSequestering Agents
p58972
g57201
sVLaboratory Chemicals
p58973
(dp58974
sVStyrenes
p58975
(dp58976
sVBenzylidene Compounds
p58977
g43128
sVBiomedical and Dental Materials
p58978
g44730
sVPlastics
p58979
(dp58980
sg11889
(dp58981
sg10215
(dp58982
sg10584
(dp58983
sVAcids, Noncarboxylic
p58984
g54212
sVSulfur Acids
p58985
(dp58986
sVMacromolecular Substances
p58987
g33846
ssg6846
(dp58988
g5409
g50901
ssg6849
(dp58989
g23
g12245
sg2418
g31929
sg2559
g32980
sg14791
(dp58990
sg6819
g58904
sg7320
(dp58991
sg3240
g37739
sg288
g14700
sg5235
g49864
sg3363
g38429
sg10356
(dp58992
sg564
g17428
sg2286
g31168
sg141
g13367
sg4266
g44206
ssg6852
(dp58993
g8019
(dp58994
sg4911
g48282
sg8763
(dp58995
sg1941
g28612
sg1278
g23331
sg9918
(dp58996
sg4425
g44944
sg318
g14931
sg3846
g41114
sg8439
(dp58997
sg978
g21190
sg8916
(dp58998
sg2946
g35837
sg5250
g49998
sg7650
(dp58999
sg879
g20378
sg7653
(dp59000
sg8418
(dp59001
sg477
g16619
sg354
g15279
sg4062
g42655
sg8238
(dp59002
sg9192
(dp59003
sg3141
g37087
sg7458
(dp59004
sg5271
g50163
sg10494
(dp59005
sg13070
g21877
sg9081
(dp59006
sg8079
(dp59007
sg10740
(dp59008
sg3711
g40455
sg9759
(dp59009
sg12051
(dp59010
sg5199
g49709
sg11862
(dp59011
sg10728
(dp59012
sg4710
g47007
sg9231
(dp59013
sg4716
g47091
sg2109
g30161
sg11241
(dp59014
sg6024
g54474
sg1176
g22673
sg1578
g25661
sg165
g13584
sg9180
(dp59015
sg4005
g42187
sg10230
(dp59016
sg972
g21119
sg6204
g55571
sg8472
(dp59017
sg10794
(dp59018
sg7671
(dp59019
sg7188
(dp59020
sg2046
g29142
sg10611
(dp59021
sg5256
g50059
sg6654
g58085
sg5589
g51954
sg336
g15124
sg11775
(dp59022
sg9372
(dp59023
sg8922
(dp59024
sg1371
g24130
sg11385
(dp59025
ssg6855
(dp59026
g1059
g21747
sg8598
(dp59027
sg801
g19537
ssg6858
(dp59028
g2733
g33917
sg11283
(dp59029
sg4263
g44179
sg11976
(dp59030
sg3867
g41348
sg7563
(dp59031
sg5094
g49075
sg10779
(dp59032
ssg6861
(dp59033
g2886
g35329
ssg6864
(dp59034
g11319
(dp59035
sg2067
g29644
sg4623
g46388
sg9402
(dp59036
sg255
g14394
sg612
g17881
sg11445
(dp59037
ssg6867
(dp59038
VDrugs that are Mainly Renally Excreted
p59039
g43984
sVCytochrome P-450 CYP2C8 Substrates
p59040
(dp59041
sVUrea
p59042
g58641
sVOral Hypoglycemics
p59043
g35995
sVSulfonylurea Compounds
p59044
(dp59045
sVDiagnostic Agents
p59046
(dp59047
sVSulfones
p59048
g58739
sg1749
g26958
sVSulfonylureas
p59049
(dp59050
sVHypoglycemia-Associated Agents
p59051
g17702
sVSulfur Compounds
p59052
(dp59053
sVCytochrome P-450 CYP2C18 Substrates
p59054
g20933
sVOAT1/SLC22A6 inhibitors
p59055
(dp59056
sVCytochrome P-450 CYP2C9 Substrates
p59057
g29805
sVBlood Glucose Lowering Agents
p59058
(dp59059
sVAlimentary Tract and Metabolism
p59060
g23917
sVDrugs Used in Diabetes
p59061
(dp59062
ssg6870
(dp59063
g465
g16465
sg10266
(dp59064
sg12421
g12414
sg7065
(dp59065
sg11283
(dp59066
sg11979
(dp59067
sg10308
(dp59068
sg168
g13609
sg8721
(dp59069
sg9111
(dp59070
sg4266
g44201
sg6468
g57093
sg2427
g32010
sg8655
(dp59071
sg10497
(dp59072
sg2910
g35538
sg11112
(dp59073
sg9417
(dp59074
sg3381
g38453
sg1890
g27989
sg7941
(dp59075
sg9981
(dp59076
sg1908
g28291
sg11154
(dp59077
sg564
g17402
sg4344
g44625
sg8874
(dp59078
sg3978
g41986
sg7359
(dp59079
sg7176
(dp59080
sg5169
g49510
sg387
g15627
sg7533
(dp59081
sg7197
(dp59082
sg10356
(dp59083
sg7593
(dp59084
sg10056
(dp59085
sg6525
g57335
sg6921
(dp59086
ssg6873
(dp59087
g8670
(dp59088
sg5532
g51621
sg9540
(dp59089
sg5577
g51823
sg3099
g36738
sg7977
(dp59090
sg11751
(dp59091
sg11826
(dp59092
sg8274
(dp59093
sg11085
(dp59094
sg11664
(dp59095
sg5382
g50719
sg3183
g37337
sg5073
g48972
sg12186
g42904
sg372
g15397
sg10512
(dp59096
ssg6876
(dp59097
g8673
(dp59098
sg2277
g31130
sg9111
(dp59099
sg11916
(dp59100
sg10335
(dp59101
sg9492
(dp59102
sg6381
g56778
ssg6879
(dp59103
g11874
(dp59104
ssg6882
(dp59105
VCytochrome P-450 CYP2D6 Inhibitors
p59106
(dp59107
sVSecologanin Tryptamine Alkaloids
p59108
g51343
sVCytochrome P-450 CYP3A Substrates
p59109
g45029
sVCytochrome P-450 Enzyme Inhibitors
p59110
(dp59111
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p59112
g18388
sVAntimitotic Agents
p59113
(dp59114
sVMyelosuppressive Agents
p59115
(dp59116
sVTubulin Modulators
p59117
g33855
sVAntineoplastic Agents, Phytogenic
p59118
g55827
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59119
g29292
sVVinca Alkaloids
p59120
g13056
sVAntineoplastic Agents
p59121
(dp59122
sVIndoles
p59123
(dp59124
sVP-glycoprotein/ABCB1 Substrates
p59125
g34910
sVIndole Alkaloids
p59126
(dp59127
sVCytochrome P-450 CYP3A4 Substrates
p59128
(dp59129
sVMitosis Modulators
p59130
g33587
sVCardiotoxic antineoplastic agents
p59131
(dp59132
sVHeterocyclic Compounds, Fused-Ring
p59133
g56032
sVImmunosuppressive Agents
p59134
(dp59135
sVNeurotoxic agents
p59136
(dp59137
sVAntineoplastic and Immunomodulating Agents
p59138
g39724
sVAlkaloids
p59139
g19438
ssg6885
(dp59140
VCardiovascular Agents
p59141
g26633
sVGenito Urinary System and Sex Hormones
p59142
(dp59143
sVGynecological Antiinfectives and Antiseptics
p59144
(dp59145
sVAntihypertensive Agents
p59146
g20300
sVVasodilating Agents
p59147
g23712
sVHypotensive Agents
p59148
g34174
sg10848
(dp59149
sg8901
(dp59150
sVSulfur Compounds
p59151
(dp59152
sVThiazides
p59153
(dp59154
sVAmides
p59155
g44336
sVBenzothiadiazines
p59156
g44813
sg6297
g56024
sg5310
g50369
sVSulfones
p59157
g58745
sVHeterocyclic Compounds, Fused-Ring
p59158
g56117
sVHyperglycemia-Associated Agents
p59159
(dp59160
sVSulfonamides
p59161
(dp59162
sVDiuretics
p59163
g57906
ssg6888
(dp59164
g1146
g22473
sg10548
(dp59165
sg11745
(dp59166
sg12072
(dp59167
sg10314
(dp59168
sg9948
(dp59169
sg10692
(dp59170
sg1113
g22218
sg1239
g22931
sg2667
g33493
sg5157
g49439
sg4902
g48161
sg6714
g58256
sg4302
g44453
ssg6891
(dp59171
g11664
(dp59172
sg9000
(dp59173
sg7680
(dp59174
ssg6894
(dp59175
g2814
g34509
ssg6897
(dp59176
g3930
g41673
ssg6900
(dp59177
g5793
g53210
ssg6903
(dp59178
VFibrin Modulating Agents
p59179
g22863
sVAnticoagulants
p59180
g58370
sg2364
g31559
sVAgents causing angioedema
p59181
(dp59182
sg10812
(dp59183
sVBiological Factors
p59184
g38102
sVEndopeptidases
p59185
(dp59186
sVFibrinolytic Agents
p59187
g26308
sg3159
g37225
sVEnzymes and Coenzymes
p59188
(dp59189
sVPeptide Hydrolases
p59190
g42948
sVBlood and Blood Forming Organs
p59191
g53912
sVCardiovascular Agents
p59192
g26529
sVEnzymes
p59193
(dp59194
sVProteins
p59195
g52740
sVSensory Organs
p59196
g40675
sVAmino Acids, Peptides, and Proteins
p59197
g47316
sVHematologic Agents
p59198
(dp59199
sVOphthalmologicals
p59200
g35174
sg2904
g35490
sVBlood Proteins
p59201
g39849
sVHydrolases
p59202
(dp59203
sg5763
g52952
ssg6906
(dp59204
VCytochrome P-450 CYP3A Substrates
p59205
g45265
sVHypotensive Agents
p59206
g34204
sVDrugs that are Mainly Renally Excreted
p59207
g44050
sVVasodilators Used in Cardiac Diseases
p59208
(dp59209
sVCardiac Therapy
p59210
(dp59211
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59212
g29586
sVSugar Alcohols
p59213
g34050
sg4893
g48129
sVCarbohydrates
p59214
(dp59215
sVCardiovascular Agents
p59216
g26669
sg9975
(dp59217
sVVasodilation
p59218
(dp59219
sVNitrate Vasodilator
p59220
g50500
sVVasodilating Agents
p59221
g23703
sVOrganic Nitrates
p59222
(dp59223
sg7755
(dp59224
sVCytochrome P-450 CYP3A4 Substrates
p59225
(dp59226
sVAntianginal Agents
p59227
(dp59228
sVNitrates and Nitrites
p59229
(dp59230
sVMethemoglobinemia Associated Agents
p59231
g25571
sg11373
(dp59232
sVAlcohols
p59233
(dp59234
ssg6909
(dp59235
g4479
g45689
sg7377
(dp59236
sg690
g18612
sg4539
g46025
sg8448
(dp59237
sg1539
g25307
sg3021
g36189
ssg6912
(dp59238
g2763
g34246
sg6333
g56465
sg1650
g26124
ssg6915
(dp59239
g10365
(dp59240
sg2769
g34293
ssg6918
(dp59241
g645
g18132
sg2256
g30919
sg141
g13343
sg10230
(dp59242
sg11874
(dp59243
sg6474
g57162
sg7719
(dp59244
sg10074
(dp59245
sg6471
g57136
sg1038
g21478
sg10974
(dp59246
sg7020
(dp59247
sg1356
g23959
sg10245
(dp59248
sg4320
g44502
ssg6921
(dp59249
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p59250
(dp59251
sVPsychoanaleptics
p59252
g59086
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p59253
(dp59254
sVSerotonin Agents
p59255
(dp59256
sVNeurotransmitter Agents
p59257
(dp59258
sVCentral Nervous System Agents
p59259
g58444
sVDopamine Agents
p59260
g14266
sVPsychostimulants, Agents Used for Adhd and Nootropics
p59261
g53758
sVCentral Nervous System Stimulation
p59262
g30768
sVPiperidines
p59263
(dp59264
sg6420
g56913
sVMembrane Transport Modulators
p59265
g54148
sVCentrally Acting Sympathomimetics
p59266
(dp59267
sVCentral Nervous System Stimulants
p59268
g51448
sVCentral Nervous System Depressants
p59269
(dp59270
sVNeurotransmitter Uptake Inhibitors
p59271
g52398
sVAgents that produce hypertension
p59272
(dp59273
sVPhenylacetates
p59274
g34426
sVSerotonin Modulators
p59275
(dp59276
sVDopamine Uptake Inhibitors
p59277
(dp59278
sVMethylphenidate and isomer
p59279
g22298
sVAntidepressive Agents
p59280
g15537
sVNervous System
p59281
(dp59282
ssg6924
(dp59283
g1914
g28390
sg11319
(dp59284
sg2067
g29666
sg612
g17907
sg11445
(dp59285
sg5598
g52015
ssg6927
(dp59286
g7533
(dp59287
ssg6930
(dp59288
g10839
(dp59289
ssg6933
(dp59290
VAntiinfectives for Systemic Use
p59291
(dp59292
sVDrugs that are Mainly Renally Excreted
p59293
g43889
sVHeterocyclic Compounds, Fused-Ring
p59294
g56134
sVbeta-Lactams
p59295
(dp59296
sVLactams
p59297
g22267
sVCarbapenems
p59298
(dp59299
sVAmides
p59300
g44328
sVSulfur Compounds
p59301
(dp59302
sVAnti-Bacterial Agents
p59303
g38357
sVAntibacterials for Systemic Use
p59304
g32554
sVAnti-Infective Agents
p59305
g54626
sVPenem Antibacterial
p59306
g26891
ssg6936
(dp59307
g11832
(dp59308
ssg6939
(dp59309
g8016
(dp59310
sVFatty Acids
p59311
(dp59312
sVGABA Agents
p59313
g16214
sg9882
(dp59314
sVCytochrome P-450 CYP3A Substrates
p59315
g45035
sVNeurotransmitter Agents
p59316
(dp59317
sg120
g13097
sVCentral Nervous System Agents
p59318
g58408
sg5034
g48822
sVGABA Modulators
p59319
g39055
sVDrugs that are Mainly Renally Excreted
p59320
g43865
sVCytochrome P-450 CYP3A4 Substrates
p59321
(dp59322
sVHypnotics and Sedatives
p59323
(dp59324
sVAmides
p59325
g44295
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59326
g29299
sg12033
(dp59327
sVPsycholeptics
p59328
g33240
sVCentral Nervous System Depressants
p59329
(dp59330
sVFatty Acids, Volatile
p59331
(dp59332
sVAnticonvulsants
p59333
(dp59334
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p59335
g40815
sg2673
g33539
sVCytochrome P-450 CYP3A5 Substrates
p59336
(dp59337
sVBenzodiazepine hypnotics and sedatives
p59338
g17663
sVAcids, Acyclic
p59339
g25457
sVNervous System
p59340
(dp59341
sVCytochrome P-450 CYP3A7 Substrates
p59342
(dp59343
sVLipids
p59344
g14314
ssg6942
(dp59345
g3174
g37269
sg6729
g58334
sg8622
(dp59346
sg10548
(dp59347
sg2403
g31840
sg5865
g53614
sg30
g12384
sg5922
g54018
sg10581
(dp59348
sg10314
(dp59349
sg7944
(dp59350
sg6240
g55762
sg9096
(dp59351
sg2739
g34013
sg6570
g57535
sg11277
(dp59352
sg5145
g49366
sg1869
g27826
ssg6945
(dp59353
g8871
(dp59354
ssg6948
(dp59355
g11175
(dp59356
sg6990
(dp59357
sg11760
(dp59358
sg9741
(dp59359
sg3777
g40821
sg11379
(dp59360
ssg6951
(dp59361
g1152
g22544
sg9918
(dp59362
sg2928
g35633
sg10275
(dp59363
sg10914
(dp59364
sg11229
(dp59365
sg7707
(dp59366
sg4830
g47810
sg1239
g22952
sg10890
(dp59367
sg2424
g31955
sg10347
(dp59368
sg5208
g49742
sg5316
g50445
sg1503
g25182
sg3753
g40622
sg11337
(dp59369
sg8562
(dp59370
sg10170
(dp59371
sg9261
(dp59372
sg10950
(dp59373
sg4542
g46086
sg2667
g33511
sg11838
(dp59374
sg2688
g33641
sg3222
g37600
sg10878
(dp59375
sg12126
(dp59376
sg4782
g47533
ssg6954
(dp59377
g10410
(dp59378
ssg6957
(dp59379
g6630
g57924
ssg6960
(dp59380
g696
g18776
ssg6963
(dp59381
g5532
g51623
ssg6966
(dp59382
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p59383
(dp59384
sVSerotonin Agents
p59385
(dp59386
sVCytochrome P-450 CYP3A Substrates
p59387
g45039
sVNeurotransmitter Agents
p59388
(dp59389
sVSerotonin Receptor Antagonists
p59390
g35677
sVCentral Nervous System Agents
p59391
g58414
sVDopamine Agents
p59392
g14249
sVCYP3A Substrates (Sensitive)
p59393
(dp59394
sVAdrenergic Antagonists
p59395
g52284
sVPsychotropic Drugs
p59396
(dp59397
sVSerotonin 5-HT1 Receptor Antagonists
p59398
g14428
sVHyperglycemia-Associated Agents
p59399
(dp59400
sVIndole Derivatives
p59401
(dp59402
sVAntipsychotic Agents
p59403
(dp59404
sVThiazoles
p59405
g49133
sVDopamine Antagonists
p59406
g53745
sVAdrenergic alpha-2 Receptor Antagonists
p59407
g46950
sVAdrenergic alpha-Antagonists
p59408
(dp59409
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59410
g29303
sVQTc Prolonging Agents
p59411
g57794
sVSerotonin 5-HT2 Receptor Antagonists
p59412
(dp59413
sVSulfur Compounds
p59414
(dp59415
sVAdrenergic Agents
p59416
g41709
sVCentral Nervous System Depressants
p59417
(dp59418
sVPotential QTc-Prolonging Agents
p59419
(dp59420
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p59421
(dp59422
sVAgents that produce hypertension
p59423
(dp59424
sVCytochrome P-450 CYP3A4 Substrates
p59425
(dp59426
sVIsoindoles
p59427
g17596
sVDopamine D2 Receptor Antagonists
p59428
g49419
sVHeterocyclic Compounds, Fused-Ring
p59429
g56049
sVAntidepressive Agents
p59430
g15504
sVPsycholeptics
p59431
g33246
sVTranquilizing Agents
p59432
g55299
sVNeurotoxic agents
p59433
(dp59434
sVNervous System
p59435
(dp59436
sVAntipsychotic Agents (Second Generation [Atypical])
p59437
g52060
ssg6969
(dp59438
g8583
(dp59439
sg9441
(dp59440
ssg6972
(dp59441
g7971
(dp59442
ssg6975
(dp59443
g6204
g55576
sg4005
g42176
sg972
g21124
ssg6978
(dp59444
g7014
(dp59445
ssg6981
(dp59446
VAmidines
p59447
(dp59448
sVDrugs that are Mainly Renally Excreted
p59449
g43867
sVMATE 2 Substrates
p59450
g44487
sVMATE 1 Substrates
p59451
g23500
sVOCT1 substrates
p59452
g13078
sVGuanidines
p59453
(dp59454
sVMATE substrates
p59455
(dp59456
sVOCT2 Inhibitors
p59457
g42481
sVOCT2 Substrates
p59458
g14949
sVOral Hypoglycemics
p59459
g36002
sVOCT2 substrates with narrow therapeutic index
p59460
g29691
sVBlood Glucose Lowering Agents
p59461
(dp59462
sVAlimentary Tract and Metabolism
p59463
g23786
sVDrugs Used in Diabetes
p59464
(dp59465
sVBiguanides
p59466
g25209
ssg6984
(dp59467
g6333
g56478
sg11385
(dp59468
sg12123
(dp59469
sg888
g20472
ssg6987
(dp59470
g687
g18569
sg8580
(dp59471
sg1260
g23157
ssg6990
(dp59472
VGastrointestinal Agents
p59473
(dp59474
sg9777
(dp59475
sg1377
g24140
sg6948
g59357
sg11148
(dp59476
sg3102
g36749
sg9753
(dp59477
sg2328
g31325
sg8967
(dp59478
sVComplex Mixtures
p59479
(dp59480
sg10827
(dp59481
sVAlimentary Tract and Metabolism
p59482
g23788
sg9600
(dp59483
ssg6993
(dp59484
g10377
(dp59485
sg11334
(dp59486
sg10368
(dp59487
sg10509
(dp59488
sg7815
(dp59489
ssg6996
(dp59490
g4101
g42979
sg1809
g27440
sg42
g12590
sg1281
g23387
sg9864
(dp59491
sg10602
(dp59492
ssg6999
(dp59493
g1005
g21253
sVDrugs that are Mainly Renally Excreted
p59494
g43868
sVCentral Nervous System Depressants
p59495
(dp59496
sg3873
g41372
sVAmines
p59497
g42680
sVUGT1A3 substrates
p59498
g31817
sVPolyamines
p59499
g40553
sVAcids, Acyclic
p59500
g25483
sVAnticonvulsants
p59501
(dp59502
sVMembrane Transport Modulators
p59503
g54131
sVCentral Nervous System Agents
p59504
g58424
sVUGT1A9 Substrates
p59505
g24021
sVPotential QTc-Prolonging Agents
p59506
(dp59507
sVUGT1A4 substrates
p59508
g41045
sVUGT1A1 Substrates
p59509
g12325
sVAniline Compounds
p59510
g23437
sg5349
g50543
sVNervous System
p59511
(dp59512
sVQTc Prolonging Agents
p59513
g57802
ssg7002
(dp59514
g7662
(dp59515
ssg7005
(dp59516
VAntiinfectives for Systemic Use
p59517
(dp59518
sVDrugs that are Mainly Renally Excreted
p59519
g43869
sVHeterocyclic Compounds, Fused-Ring
p59520
g56056
sg4359
g44713
sVbeta-Lactams
p59521
(dp59522
sVNephrotoxic agents
p59523
g57710
sVLactams
p59524
g22288
sVOAT1/SLC22A6 inhibitors
p59525
(dp59526
sVAmides
p59527
g44300
sg459
g16423
sVSulfur Compounds
p59528
(dp59529
sg5982
g54277
sVAnti-Bacterial Agents
p59530
g38326
sVAntibacterials for Systemic Use
p59531
g32533
sg5091
g49070
sVAnti-Infective Agents
p59532
g54576
ssg7008
(dp59533
g837
g19985
sg1674
g26356
sg11799
(dp59534
sg11541
(dp59535
sg48
g12655
sg9411
(dp59536
sg477
g16615
sg4521
g45981
sg4863
g47963
sg4068
g42791
sg8808
(dp59537
sg5880
g53723
sg2079
g29867
sg3609
g39710
sg918
g20758
sg1785
g27183
sg87
g12944
sg2451
g32211
sg5727
g52807
sg6654
g58080
sg10950
(dp59538
sg474
g16580
sg1275
g23307
sg10698
(dp59539
sg11208
(dp59540
sg3576
g39594
sg12090
(dp59541
sg3015
g36109
sg1173
g22631
sg6015
g54400
sg11775
(dp59542
sg7809
(dp59543
sg8985
(dp59544
ssg7011
(dp59545
g3141
g37051
sg2046
g29101
ssg7014
(dp59546
VAntiplatelet agents
p59547
g46304
sg5802
g53260
sVAlkaloids
p59548
g19447
sVCompounds used in a research, industrial, or household setting
p59549
(dp59550
sVEnzyme Inhibitors
p59551
(dp59552
sVAntioxidants
p59553
g54808
sVDrugs for Obstructive Airway Diseases
p59554
g42530
sVDrugs that are Mainly Renally Excreted
p59555
g43850
sVCytochrome P-450 CYP1A2 Substrates
p59556
g45614
sg1203
g22848
sVXanthine derivatives
p59557
g28826
sVProtective Agents
p59558
(dp59559
sVPurinones
p59560
g48140
sVFree Radical Scavengers
p59561
g45828
sg675
g18469
sVPhosphodiesterase 5 Inhibitors
p59562
(dp59563
sVCardiovascular Agents
p59564
g26648
sg6978
g59445
sVRadiation-Protective Agents
p59565
(dp59566
sVVasodilating Agents
p59567
g23728
sVPurines
p59568
(dp59569
sVHematologic Agents
p59570
(dp59571
sVHeterocyclic Compounds, Fused-Ring
p59572
g56126
sVPhosphodiesterase Inhibitors
p59573
(dp59574
sVPeripheral Vasodilators
p59575
g46226
ssg7017
(dp59576
g3087
g36672
sg12003
(dp59577
sg5394
g50835
sg171
g13697
sg6024
g54467
sg969
g21090
sg10494
(dp59578
sg2658
g33392
sg11769
(dp59579
sg5589
g51947
sg3711
g40457
sg1578
g25663
sg11535
(dp59580
sg7824
(dp59581
sg8418
(dp59582
ssg7020
(dp59583
VDrugs that are Mainly Renally Excreted
p59584
g43871
sVAutacoids
p59585
(dp59586
sVFatty Acids
p59587
(dp59588
sVAlprostadil
p59589
(dp59590
sVMiscellaneous GI Drugs
p59591
g23549
sVFatty Acids, Unsaturated
p59592
g59247
sVInflammation Mediators
p59593
g23631
sVDrugs for Constipation
p59594
g53338
sVProstaglandins E
p59595
(dp59596
sVLaxatives
p59597
g17357
sVBiological Factors
p59598
g38124
sVMembrane Transport Modulators
p59599
g54135
sg8301
(dp59600
sVFatty Acids, Monounsaturated
p59601
g27672
sVAlimentary Tract and Metabolism
p59602
g23797
sVEicosanoids
p59603
g37791
sVLipids
p59604
g14350
ssg7023
(dp59605
g5469
g51297
ssg7026
(dp59606
g1947
g28706
sg2844
g34877
sg9819
(dp59607
sg9696
(dp59608
sg7065
(dp59609
sg4638
g46547
sg6102
g55088
sg12421
g12466
sg3321
g38237
sg4449
g45381
sg7800
(dp59610
sg7014
g59574
sg7197
(dp59611
sg7170
(dp59612
sg5793
g53227
ssg7029
(dp59613
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p59614
(dp59615
sVCytochrome P-450 CYP2D6 Inhibitors
p59616
(dp59617
sVCytochrome P-450 CYP2D6 Substrates
p59618
g52129
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p59619
(dp59620
sVSerotonin Agents
p59621
(dp59622
sVCytochrome P-450 CYP3A Substrates
p59623
g45046
sVNeurotransmitter Agents
p59624
(dp59625
sVHistamine Agents
p59626
(dp59627
sVOCT2 Inhibitors
p59628
g42494
sVCytochrome P-450 Enzyme Inhibitors
p59629
(dp59630
sVAntipruritics
p59631
(dp59632
sVPheniramine
p59633
g51384
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59634
g29311
sVAntihistamines for Systemic Use
p59635
g12980
sVQTc Prolonging Agents
p59636
g57807
sVOCT1 inhibitors
p59637
(dp59638
sVCentral Nervous System Depressants
p59639
(dp59640
sVSubstituted Alkylamines
p59641
g40976
sVPyridines
p59642
(dp59643
sVDermatologicals
p59644
g17220
sVHistamine H1 Antagonists
p59645
g40795
sVCytochrome P-450 CYP3A4 Substrates
p59646
(dp59647
sVModerate Risk QTc-Prolonging Agents
p59648
(dp59649
sVCytochrome P-450 CYP3A5 Substrates
p59650
(dp59651
sVSerotonin Modulators
p59652
(dp59653
sVAntidepressive Agents
p59654
g15516
sVAnti-Allergic Agents
p59655
g50653
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p59656
g53070
sVHistamine Antagonists
p59657
g43456
sVPropylamine Derivatives
p59658
g50808
sVCytochrome P-450 CYP3A7 Substrates
p59659
(dp59660
ssg7032
(dp59661
g1599
g25744
ssg7035
(dp59662
g11862
(dp59663
sg4062
g42659
sg9687
(dp59664
sg1941
g28616
sg4341
g44616
sg978
g21194
sg879
g20382
ssg7038
(dp59665
g9540
(dp59666
ssg7041
(dp59667
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p59668
g52099
sVNMDA Receptor Antagonists
p59669
g43499
sVCytochrome P-450 CYP3A4 Inhibitors
p59670
(dp59671
sVAnti-Parkinson Drugs
p59672
g16162
sVCytochrome P-450 CYP2D6 Inhibitors
p59673
(dp59674
sVCytochrome P-450 CYP3A Substrates
p59675
g45047
sVNeurotransmitter Agents
p59676
(dp59677
sg1788
g27211
sVCentral Nervous System Agents
p59678
g58431
sVPotential QTc-Prolonging Agents
p59679
(dp59680
sVEnzyme Inhibitors
p59681
(dp59682
sVCytochrome P-450 Enzyme Inhibitors
p59683
(dp59684
sVMuscarinic Antagonists
p59685
g48888
sVAnticholinergic Agents
p59686
g24513
sVCytochrome P-450 CYP3A4 Substrates
p59687
(dp59688
sVAmines
p59689
g42688
sVCentrally-mediated Muscle Relaxation
p59690
(dp59691
sVPeripheral Nervous System Agents
p59692
g57591
sVParasympatholytics
p59693
g35950
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59694
g29313
sVEthylamines
p59695
g20604
sVQTc Prolonging Agents
p59696
g57809
sVMusculo-Skeletal System
p59697
g31554
sVCentral Nervous System Depressants
p59698
(dp59699
sVHistamine Antagonists
p59700
g43457
sVBenzene Derivatives
p59701
(dp59702
sVCytochrome P-450 CYP1A2 Inhibitors
p59703
g15054
sVAnti-Dyskinesia Agents
p59704
g50491
sVCytochrome P-450 CYP2B6 Inhibitors
p59705
g45943
sVMuscle Relaxants, Centrally Acting Agents
p59706
g37397
sg8946
(dp59707
sVHistamine H1 Antagonists
p59708
g40796
sVBenzhydryl Compounds
p59709
(dp59710
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p59711
g49349
sVAutonomic Agents
p59712
(dp59713
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p59714
g13748
sVCytochrome P-450 CYP3A Inhibitors
p59715
(dp59716
sVCholinergic Agents
p59717
g28739
sVMuscle Relaxants
p59718
(dp59719
sVAgents producing tachycardia
p59720
g50755
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p59721
(dp59722
sVChemically-Induced Disorders
p59723
g21251
sVNervous System
p59724
(dp59725
ssg7044
(dp59726
VGlucans
p59727
g51754
sVMacromolecular Substances
p59728
g33850
sVPolymers
p59729
g22242
sVCarbohydrates
p59730
(dp59731
sVPolysaccharides
p59732
g41774
sVPhosphate Binder
p59733
g21952
sVOligosaccharides
p59734
g33108
sVCompounds used in a research, industrial, or household setting
p59735
(dp59736
sVDisaccharides
p59737
(dp59738
sVBiomedical and Dental Materials
p59739
g44736
sVOrganometallic Compounds
p59740
(dp59741
sVBiopolymers
p59742
(dp59743
sVIron Compounds
p59744
g36408
sVParenteral Iron Replacement
p59745
g41683
ssg7047
(dp59746
g10833
(dp59747
sg10326
(dp59748
sg9126
(dp59749
sg7815
(dp59750
sg3912
g41591
sg3576
g39554
sg7884
(dp59751
sg8622
(dp59752
sg11427
(dp59753
sg279
g14485
sg11052
(dp59754
sg5847
g53492
sg5871
g53641
sg6231
g55719
sg11061
(dp59755
sg9663
(dp59756
sg9192
(dp59757
sg11451
(dp59758
sg8985
(dp59759
sg9198
(dp59760
sg13070
g21869
sg8049
(dp59761
sg3132
g36976
sg10377
(dp59762
sg2991
g35958
sg2808
g34468
sg9954
(dp59763
sg8454
(dp59764
sg2250
g30849
sg9432
(dp59765
sg10509
(dp59766
sg318
g14898
sg4299
g44422
sg5520
g51531
sg4707
g46973
sg819
g19721
sg2652
g33296
sg6435
g56949
sg10368
(dp59767
sg7524
(dp59768
sg1527
g25247
sg2274
g31054
sg7947
(dp59769
sg6654
g58031
sg11508
(dp59770
sg8298
(dp59771
sg8493
(dp59772
sg11334
(dp59773
sg573
g17508
sg11166
(dp59774
sg1332
g23644
sg11208
(dp59775
sg3795
g40920
sg4164
g43276
sg12051
(dp59776
sg1101
g22039
sg7500
(dp59777
sg6075
g54849
sg1863
g27751
sg438
g16167
sg7881
(dp59778
sg4953
g48480
sg8922
(dp59779
sg11385
(dp59780
ssg7050
(dp59781
g11760
(dp59782
sg3777
g40835
ssg7053
(dp59783
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p59784
g52076
sVCytochrome P-450 CYP3A4 Inhibitors
p59785
(dp59786
sVCytochrome P-450 CYP2D6 Substrates
p59787
g52132
sVUGT1A1 Substrates
p59788
g12261
sVAnalgesics
p59789
g26444
sVCentral Nervous System Agents
p59790
g58433
sVUGT1A9 Substrates
p59791
g23993
sVAnilides
p59792
(dp59793
sVCytochrome P-450 Enzyme Inhibitors
p59794
(dp59795
sVMethemoglobinemia Associated Agents
p59796
g25554
sVDrugs that are Mainly Renally Excreted
p59797
g43833
sVCytochrome P-450 CYP1A2 Substrates
p59798
g45582
sVAmines
p59799
g42689
sVAmides
p59800
g44308
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59801
g29221
sVAniline Compounds
p59802
g23414
sVCytochrome P-450 CYP3A4 Inducers
p59803
g18906
sVCytochrome P-450 CYP3A Substrates
p59804
g44982
sVUGT1A6 substrate
p59805
g38508
sVP-glycoprotein/ABCB1 Substrates
p59806
g34945
sVAntipyretics
p59807
(dp59808
sVCytochrome P-450 CYP2A6 Substrates
p59809
g35117
sVAcetaminophen and Prodrugs
p59810
(dp59811
sVCytochrome P-450 Enzyme Inducers
p59812
g28149
sVCytochrome P-450 CYP3A Inducers
p59813
(dp59814
sVCytochrome P-450 CYP3A4 Substrates
p59815
(dp59816
sVAnalgesics, Non-Narcotic
p59817
g56888
sVCytochrome P-450 CYP3A Inhibitors
p59818
(dp59819
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p59820
(dp59821
sVCytochrome P-450 CYP2E1 Substrates
p59822
(dp59823
sVP-glycoprotein/ABCB1 Inhibitors
p59824
(dp59825
sVSensory System Agents
p59826
(dp59827
sVNervous System
p59828
(dp59829
sVMiscellaneous Analgesics and Antipyretics
p59830
g43120
ssg7056
(dp59831
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p59832
(dp59833
sVSerotonin-1b and Serotonin-1d Receptor Agonist
p59834
(dp59835
sVSerotonin Agents
p59836
(dp59837
sVAnalgesics
p59838
g26445
sVNeurotransmitter Agents
p59839
(dp59840
sVSelective Serotonin Agonists
p59841
(dp59842
sVIndoles
p59843
(dp59844
sVAmines
p59845
g42690
sVBiogenic Monoamines
p59846
(dp59847
sVMonoamine Oxidase A Substrates
p59848
(dp59849
sVCentral Nervous System Depressants
p59850
(dp59851
sVAntimigraine Preparations
p59852
g32374
sVCardiovascular Agents
p59853
g26578
sVVasoconstrictor Agents
p59854
g35890
sVBiogenic Amines
p59855
g58001
sVSerotonin 1b Receptor Agonists
p59856
(dp59857
sVSelective Serotonin 5-HT1 Receptor Agonists
p59858
g52796
sVAgents that produce hypertension
p59859
(dp59860
sVSerotonin 5-HT1 Receptor Agonists
p59861
g34586
sVHeterocyclic Compounds, Fused-Ring
p59862
g56066
sVSerotonin Modulators
p59863
(dp59864
sVAntidepressive Agents
p59865
g15519
sVTriptans
p59866
g33826
sVSerotonin 1d Receptor Agonists
p59867
(dp59868
sVSerotonin Receptor Agonists
p59869
(dp59870
sVNervous System
p59871
(dp59872
ssg7059
(dp59873
VAmino Acids, Peptides, and Proteins
p59874
g47362
sVAntiplatelet agents
p59875
g46305
sVAntibodies
p59876
(dp59877
sVBlood and Blood Forming Organs
p59878
g53931
sVImmunoglobulin Fab Fragments
p59879
(dp59880
sVAntibodies, Monoclonal
p59881
(dp59882
sVAntibodies, Monoclonal, Humanized
p59883
(dp59884
sVAnticoagulants
p59885
g58382
sVImmunoglobulins
p59886
g41540
sVProteins
p59887
g52760
sVFibrinolytic Agents
p59888
g26303
sVPlatelet Aggregation Inhibitors Excl. Heparin
p59889
(dp59890
sVPeptides
p59891
g47183
sVSerum Globulins
p59892
g49668
sVImmunoglobulin Fragments
p59893
g21348
sVPeptide Fragments
p59894
(dp59895
sVHematologic Agents
p59896
(dp59897
sVBlood Proteins
p59898
g39875
sVGlobulins
p59899
g19200
sVMiscellaneous Therapeutic Agents
p59900
(dp59901
sVImmunoproteins
p59902
g57460
ssg7062
(dp59903
g16906
(dp59904
sg2829
g34625
ssg7065
(dp59905
VPsychoanaleptics
p59906
g59065
sVCytochrome P-450 CYP2D6 Substrates
p59907
g52191
sVCytochrome P-450 CYP3A Substrates
p59908
g45049
sVNeurotransmitter Agents
p59909
(dp59910
sVCaffeine
p59911
g12477
sVCentral Nervous System Agents
p59912
g58423
sVPsychostimulants, Agents Used for Adhd and Nootropics
p59913
g53756
sVTests for Gastric Secretion
p59914
(dp59915
sVEnzyme Inhibitors
p59916
(dp59917
sVCentral Nervous System Stimulation
p59918
g30765
sVCytochrome P-450 Enzyme Inhibitors
p59919
(dp59920
sVDiagnostic Agents
p59921
(dp59922
sVAnorexigenic Agents & Respiratory and CNS Stimulants
p59923
g38242
sVPurinergic Agents
p59924
(dp59925
sVCytochrome P-450 CYP2C8 Substrates
p59926
(dp59927
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p59928
g49340
sVApnea
p59929
(dp59930
sVPurinergic Antagonists
p59931
(dp59932
sVPurinergic P1 Receptor Antagonists
p59933
(dp59934
sVXanthine derivatives
p59935
g28824
sVDrugs for Obstructive Airway Diseases
p59936
g42504
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p59937
g29317
sVCentral Nervous System Stimulants
p59938
g51444
sVCytochrome P-450 CYP2C9 Substrates
p59939
g29738
sVCaffeine and Caffeine Containing Products
p59940
g26420
sVCytochrome P-450 CYP1A2 Inhibitors
p59941
g15034
sVPhosphodiesterase Inhibitors
p59942
g59609
sVP-glycoprotein/ABCB1 Substrates
p59943
g34950
sVCytochrome P-450 CYP1A2 Substrates
p59944
g45584
sVTricarboxylic Acids
p59945
(dp59946
sVHeterocyclic Compounds, Fused-Ring
p59947
g56144
sVCytochrome P-450 CYP3A4 Substrates
p59948
(dp59949
sVPurinones
p59950
g48137
sVPurines
p59951
(dp59952
sVRespiratory and CNS Stimulants
p59953
(dp59954
sVCytochrome P-450 CYP3A5 Substrates
p59955
(dp59956
sVAcids, Acyclic
p59957
g25481
sVP-glycoprotein/ABCB1 Inhibitors
p59958
(dp59959
sVAlkaloids
p59960
g19436
sVNervous System
p59961
(dp59962
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p59963
g27737
sVCytochrome P-450 CYP3A7 Substrates
p59964
(dp59965
ssg7068
(dp59966
g1782
g27172
sg2373
g31582
sg11592
(dp59967
sg7353
(dp59968
sg1911
g28357
sg9903
(dp59969
sg12063
(dp59970
sg1452
g24727
sg1656
g26157
sg4113
g43030
sg3087
g36660
sg3090
g36694
sg7545
(dp59971
sg7668
(dp59972
sg8430
(dp59973
sg7470
(dp59974
sg2424
g31954
sg5895
g53801
sg14838
g39975
sg6279
g55945
sg3657
g40171
sg9426
(dp59975
sg2391
g31718
sg9261
(dp59976
sg3207
g37476
sg7662
(dp59977
sg2940
g35701
sg9630
(dp59978
sg10878
(dp59979
sg5766
g52971
sg10122
(dp59980
sg2316
g31295
ssg7071
(dp59981
g11820
(dp59982
sg12111
(dp59983
sg4467
g45538
sg10794
(dp59984
sg4926
g48381
sg1401
g24300
sg4650
g46605
sg11619
(dp59985
sg6579
g57566
sg10797
(dp59986
sg4959
g48519
ssg7074
(dp59987
VAntiinfectives for Systemic Use
p59988
(dp59989
sVHeterocyclic Compounds, Fused-Ring
p59990
g56105
sVOphthalmologicals
p59991
g35224
sVbeta-Lactams
p59992
(dp59993
sVNephrotoxic agents
p59994
g57721
sVLactams
p59995
g22269
sVAmides
p59996
g44330
sVThiazines
p59997
g16421
sVSensory Organs
p59998
g40715
sVAnti-Bacterial Agents
p59999
g38359
sVAntibacterials for Systemic Use
p60000
g32557
sg5643
g52314
sVCephalosporins
p60001
g49069
sVAnti-Infective Agents
p60002
g54632
sVSulfur Compounds
p60003
(dp60004
ssg7077
(dp60005
VAngiotensin II Antagonists and Diuretics
p60006
g30407
sVAngiotensin II Antagonists and Calcium Channel Blockers
p60007
g42306
sVAngiotensin Receptor Antagonists
p60008
(dp60009
sVAngiotensin II receptor blockers (ARBs) and diuretics
p60010
g18117
sVAgents causing hyperkalemia
p60011
g43585
sVHypotensive Agents
p60012
g34130
sVAgents causing angioedema
p60013
(dp60014
sVOATP1B1/SLCO1B1 Inhibitors
p60015
(dp60016
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p60017
(dp60018
sVCytochrome P-450 CYP2C9 Inhibitors
p60019
g18192
sVCytochrome P-450 Enzyme Inhibitors
p60020
(dp60021
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p60022
(dp60023
sVAntihypertensive Agents
p60024
g20267
sVAngiotensin II Type 1 Receptor Blockers
p60025
(dp60026
sVCytochrome P-450 CYP2C9 Substrates
p60027
g29730
sVOATP1B1/SLCO1B1 Substrates
p60028
(dp60029
sVCardiovascular Agents
p60030
g26559
sVAngiotensin 2 Receptor Blocker
p60031
(dp60032
sVAgents Acting on the Renin-Angiotensin System
p60033
g25346
sVOATP1B3 substrates
p60034
g28532
sVAngiotensin II receptor blockers (ARBs), plain
p60035
g22613
sVAngiotensin II Type 2 Receptor Blockers
p60036
(dp60037
sVAngiotensin II Antagonists, Plain
p60038
(dp60039
ssg7080
(dp60040
g6867
g59047
sg12421
g12436
sg7065
g59922
sg7197
(dp60041
sg657
g18302
sg9561
(dp60042
sg11781
(dp60043
ssg7083
(dp60044
g135
g13242
ssg7086
(dp60045
g7299
(dp60046
sg6966
g59402
ssg7089
(dp60047
g9819
(dp60048
sg7197
(dp60049
sg12421
g12450
sg6102
g55066
sg7065
g59934
ssg7092
(dp60050
g9471
(dp60051
sg3246
g37759
sg5334
g50529
ssg7095
(dp60052
g6246
g55792
sg6843
g58964
ssg7098
(dp60053
g4341
g44602
ssg7101
(dp60054
g4014
g42228
sg8097
(dp60055
sg6090
g54947
sg2739
g34005
sg2403
g31842
sg8205
(dp60056
sg30
g12376
sg444
g16252
sg3858
g41217
sg11460
(dp60057
sg16906
(dp60058
sg828
g19864
sg11979
(dp60059
sg4452
g45426
sg10470
(dp60060
sg6033
g54517
sg9954
(dp60061
sg4023
g42336
sg2784
g34361
sg8421
(dp60062
sg2034
g29022
sg10596
(dp60063
sg9663
(dp60064
sg5472
g51314
sg282
g14554
sg8430
(dp60065
sg11451
(dp60066
sg7884
(dp60067
sg9819
(dp60068
sg11079
(dp60069
sg10062
(dp60070
sg888
g20449
sg9564
(dp60071
sg4077
g42832
sg2664
g33445
sg2358
g31477
sg2814
g34520
sg7335
(dp60072
sg4449
g45385
sg915
g20706
sg7389
(dp60073
sg3174
g37263
sg9417
(dp60074
sg11595
(dp60075
sg6966
g59422
sg2829
g34647
sg10521
(dp60076
sg9432
(dp60077
sg3027
g36358
sg6645
g58018
sg8820
(dp60078
sg1461
g24836
sg6102
g55076
sg3963
g41872
sg7941
(dp60079
sg11097
(dp60080
sg3627
g39932
sg9981
(dp60081
sg8514
(dp60082
sg8703
(dp60083
sg3867
g41356
sg9918
(dp60084
sg11625
(dp60085
sg3132
g37013
sg1668
g26253
sg6435
g56977
sg9273
(dp60086
sg966
g21045
sg9822
(dp60087
sg6315
g56298
sg11910
(dp60088
sg10056
(dp60089
sg387
g15692
sg4911
g48264
sg5865
g53608
sg1857
g27706
sg9096
(dp60090
sg7524
(dp60091
sg9102
(dp60092
sg2676
g33561
sg7170
(dp60093
sg8724
(dp60094
sg8028
(dp60095
sg9105
(dp60096
ssg7104
(dp60097
g10557
(dp60098
sg9225
(dp60099
sg9357
(dp60100
sg12274
g27519
sg2832
g34695
sg816
g19667
sg1470
g24899
sg849
g20072
sg507
g16761
sg5433
g51036
sg4680
g46874
sg10209
(dp60101
sg2127
g30270
sg3117
g36901
sg3543
g39324
sg11940
(dp60102
sg14822
g41808
sg2133
g30293
sg3783
g40872
sg2901
g35486
ssg7107
(dp60103
g1704
g26713
sg8721
(dp60104
sg5919
g53976
sg7056
g59849
sg933
g20823
sg8259
(dp60105
sg1635
g26049
sg5598
g52025
ssg7110
(dp60106
g219
g14090
sg5463
g51251
sg11403
(dp60107
sg2355
g31443
sg7962
(dp60108
sg4821
g47757
sg2397
g31794
sg3858
g41221
sg9324
(dp60109
sg8796
(dp60110
sg4365
g44767
sg4890
g48125
sg7407
(dp60111
sg6033
g54521
sg9033
(dp60112
sg4278
g44278
sg11976
(dp60113
sg1659
g26216
sg10149
(dp60114
sg1062
g21815
sg2598
g33132
sg8808
(dp60115
sg6867
g59062
sg3519
g39217
sg11961
(dp60116
sg10338
(dp60117
sg339
g15169
sg5889
g53776
sg8457
(dp60118
sg2253
g30909
sg9216
(dp60119
sg5514
g51518
sg6447
g57025
sg5313
g50400
sg6981
g59465
sg4053
g42563
sg5112
g49173
sg9081
(dp60120
sg132
g13236
sg10416
(dp60121
sg4338
g44583
sg7698
(dp60122
sg8088
(dp60123
sg5571
g51784
sg5094
g49097
sg10581
(dp60124
sg6015
g54387
sg11367
(dp60125
sg2172
g30515
sg1185
g22730
sg801
g19555
sg11259
(dp60126
ssg7113
(dp60127
g7650
(dp60128
sg4788
g47595
sg7671
(dp60129
ssg7116
(dp60130
g9657
(dp60131
ssg7119
(dp60132
g4023
g42328
sg5268
g50130
sg3027
g36349
sg600
g17725
sg6882
g59114
sg11601
(dp60133
sg11370
(dp60134
sg5454
g51145
sg6807
g58810
ssg7122
(dp60135
g5415
g50931
sg7920
(dp60136
sg7548
(dp60137
sg4557
g46161
sg11769
(dp60138
sg8649
(dp60139
sg5511
g51481
sg6714
g58264
ssg7125
(dp60140
g426
g16099
sg2403
g31851
sg9144
(dp60141
sg5235
g49850
sg183
g13828
sg657
g18336
sg888
g20470
sg11619
(dp60142
sg1869
g27835
sg8421
(dp60143
sg7272
(dp60144
sg5064
g48909
sg7284
(dp60145
sg9561
(dp60146
sg702
g18827
sg4287
g44391
sg6939
g59334
sg6792
g58707
sg7329
(dp60147
sg7335
(dp60148
sg8460
(dp60149
sg10728
(dp60150
sg10518
(dp60151
sg5853
g53549
sg7317
(dp60152
sg7734
(dp60153
sg10737
(dp60154
sg10539
(dp60155
sg7944
(dp60156
sg5133
g49289
sg5145
g49357
sg4959
g48547
sg6999
g59502
sg6678
g58121
sg582
g17631
sg4155
g43232
sg9822
(dp60157
sg10350
(dp60158
sg5067
g48953
sg5256
g50079
sg2538
g32805
sg204
g13970
sg2730
g33872
sg1401
g24320
sg7152
(dp60159
ssg7128
(dp60160
g14791
(dp60161
sg141
g13356
sg1260
g23155
sg6819
g58881
sg8580
(dp60162
sg4035
g42439
sg687
g18567
ssg7131
(dp60163
g6504
g57265
sg8142
(dp60164
sg2043
g29070
sg4476
g45658
sg11316
(dp60165
sg8949
(dp60166
sg10041
(dp60167
sg4236
g43710
sg543
g17101
ssg7134
(dp60168
g4356
g44707
ssg7137
(dp60169
g3627
g39940
sg8421
(dp60170
sg8763
(dp60171
sg4062
g42642
sg11934
(dp60172
sg9822
(dp60173
sg444
g16259
sg11301
(dp60174
sg888
g20447
sg6333
g56491
sg1110
g22129
sg1941
g28598
sg4746
g47276
sg7335
(dp60175
sg11460
(dp60176
ssg7140
(dp60177
g11523
(dp60178
ssg7143
(dp60179
g4746
g47267
ssg7146
(dp60180
g8142
(dp60181
sg543
g17085
sg4236
g43701
ssg7149
(dp60182
g6312
g56269
sg9963
(dp60183
sg3573
g39539
sg4863
g47954
sg5268
g50140
sg1674
g26346
sg9339
(dp60184
sg10239
(dp60185
sg3249
g37775
sg4377
g44790
sg10272
(dp60186
sg351
g15264
sg9552
(dp60187
sg1209
g22869
sg11145
(dp60188
sg3963
g41885
sg10041
(dp60189
sg1917
g28454
sg1599
g25725
sg1611
g25819
ssg7152
(dp60190
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p60191
(dp60192
sVCentral Nervous System Depressants
p60193
(dp60194
sVCytochrome P-450 CYP3A4 Substrates
p60195
(dp60196
sVAntidepressive Agents
p60197
g15531
sVAnticonvulsants
p60198
g60159
sVCytochrome P-450 CYP3A Substrates
p60199
g45055
sVTerpenes
p60200
(dp60201
sg10500
(dp60202
sVBCRP/ABCG2 Inhibitors
p60203
g12543
sVNervous System
p60204
(dp60205
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60206
g29328
sVAgents producing tachycardia
p60207
g50766
sVAgents that produce hypertension
p60208
(dp60209
sVSerotonin Agents
p60210
(dp60211
sVCytochrome P-450 CYP2C9 Substrates
p60212
g29751
sg11943
(dp60213
sg9534
(dp60214
sg2820
g34590
ssg7155
(dp60215
VAntiinfectives for Systemic Use
p60216
(dp60217
sVAmines
p60218
g42686
sVAnti-Infective Agents, Urinary
p60219
g25224
sVPolyamines
p60220
g40558
sVBenzoates
p60221
g30402
sVHydroxy Acids
p60222
g18170
sVBenzene Derivatives
p60223
(dp60224
sVAcids, Carbocyclic
p60225
g41582
sVCycloparaffins
p60226
g43677
sVUrinary Acidifying Agents
p60227
g56022
sVAmides
p60228
g44306
sVAnti-Bacterial Agents
p60229
g38334
sVAntibacterials for Systemic Use
p60230
g32539
sVAnti-Infective Agents
p60231
g54585
sVAdamantane
p60232
(dp60233
sVRenal Agents
p60234
g24770
sVKeto Acids
p60235
g30321
ssg7158
(dp60236
g11145
(dp60237
ssg7161
(dp60238
VFibrin Modulating Agents
p60239
g22859
sVHematologic Agents
p60240
(dp60241
sVBlood and Blood Forming Organs
p60242
g53911
sVCardiovascular Agents
p60243
g26591
sVPolysaccharides
p60244
g41782
sVAnticoagulants
p60245
g58369
sVCarbohydrates
p60246
(dp60247
sVAgents causing hyperkalemia
p60248
g43594
sVFibrinolytic Agents
p60249
g26307
sg6618
g57890
sVGlycosaminoglycans
p60250
g26084
sVHeparin and similars
p60251
(dp60252
ssg7164
(dp60253
VAgents Causing Muscle Toxicity
p60254
g55379
sVAmino Acids, Cyclic
p60255
g27283
sVCOMT Substrates
p60256
g43558
sVNeurotransmitter Agents
p60257
(dp60258
sVHypotensive Agents
p60259
g34160
sVCentral Alpha-agonists
p60260
(dp60261
sVPhenols
p60262
(dp60263
sVPeripheral Nervous System Agents
p60264
g57590
sVSympatholytics
p60265
g56844
sVDrugs that are Mainly Renally Excreted
p60266
g43882
sVAmino Acids
p60267
g43104
sVAmines
p60268
g42748
sVAntihypertensive Agents
p60269
g20293
sVDihydroxyphenylalanine
p60270
g41628
sVTyrosine
p60271
(dp60272
sVAmino Acids, Aromatic
p60273
(dp60274
sVAdrenergic Agents
p60275
g41698
sVCardiovascular Agents
p60276
g26613
sVBenzene Derivatives
p60277
(dp60278
sVCentral alpha-2 Adrenergic Agonist
p60279
g57057
sVCatecholamines
p60280
g19117
sVAdrenergic Agonists
p60281
(dp60282
sVAutonomic Agents
p60283
(dp60284
sVAmino Acids, Peptides, and Proteins
p60285
g47376
sVCatechols
p60286
(dp60287
sVAdrenergic alpha-2 Receptor Agonists
p60288
(dp60289
sVAmino Acids, Essential
p60290
g35283
sVAdrenergic alpha-Agonists
p60291
(dp60292
sVBradycardia-Causing Agents
p60293
(dp60294
sVPhenylalanine
p60295
(dp60296
ssg7167
(dp60297
g6819
g58891
sg14791
(dp60298
ssg7170
(dp60299
VCytochrome P-450 CYP3A Substrates
p60300
g44980
sVCYP3A Substrates (Sensitive)
p60301
(dp60302
sVEnzyme Inhibitors
p60303
(dp60304
sVDrugs that are Mainly Renally Excreted
p60305
g43831
sVCytochrome P-450 CYP3A4 Substrates
p60306
(dp60307
sVAntihypertensive Agents
p60308
g20271
sVUrological Agents
p60309
g38291
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60310
g29219
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p60311
g60093
sg10152
(dp60312
sVCardiovascular Agents
p60313
g26617
sg10107
(dp60314
sg927
g20790
sVPyridines
p60315
(dp60316
sVVasodilating Agents
p60317
g23729
sVCytochrome P-450 CYP3A5 Substrates
p60318
(dp60319
sVUrologicals
p60320
g58921
sVHeterocyclic Compounds, Fused-Ring
p60321
g56090
sVGenito Urinary System and Sex Hormones
p60322
(dp60323
sg7578
(dp60324
sg7026
g59612
sg1602
g25752
ssg7173
(dp60325
g5853
g53562
sg8205
(dp60326
sg582
g17641
sg5472
g51316
sg828
g19885
sg5064
g48906
sg2430
g32116
sg7284
(dp60327
sg426
g16115
sg12018
(dp60328
sg4827
g47778
sg7191
(dp60329
sg5769
g53050
sg9420
(dp60330
sg3204
g37456
sg1938
g28541
sg5691
g52503
sg6303
g56235
sg9111
(dp60331
sg10737
(dp60332
ssg7176
(dp60333
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p60334
(dp60335
sVCytochrome P-450 CYP2D6 Inhibitors
p60336
(dp60337
sVCytochrome P-450 CYP2D6 Substrates
p60338
g52154
sVNeurotransmitter Agents
p60339
(dp60340
sVCentral Nervous System Agents
p60341
g58459
sVDopamine Agents
p60342
g14260
sVPsychostimulants, Agents Used for Adhd and Nootropics
p60343
g53755
sVSympathomimetics
p60344
g48810
sVCentral Nervous System Stimulation
p60345
g30764
sVAmphetamines
p60346
(dp60347
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p60348
g18426
sVCytochrome P-450 Enzyme Inhibitors
p60349
(dp60350
sVNeurotransmitter Uptake Inhibitors
p60351
g52395
sVAmines
p60352
g42706
sVMembrane Transport Modulators
p60353
g54145
sVCentrally Acting Sympathomimetics
p60354
(dp60355
sVEthylamines
p60356
g20603
sVCentral Nervous System Stimulants
p60357
g51441
sVPsychoanaleptics
p60358
g59080
sVAgents that produce hypertension
p60359
(dp60360
sVDopamine Uptake Inhibitors
p60361
(dp60362
sVAgents producing tachycardia
p60363
g50769
sVPhenethylamines
p60364
(dp60365
sVNervous System
p60366
(dp60367
ssg7179
(dp60368
g9693
(dp60369
sg9918
(dp60370
sg4653
g46759
sg10797
(dp60371
sg1656
g26188
sg2196
g30644
sg8421
(dp60372
sg2787
g34411
sg7272
(dp60373
sg9198
(dp60374
sg6783
g58683
sg888
g20508
sg7335
(dp60375
sg6045
g54728
sg12534
g52705
sg4911
g48277
sg9609
(dp60376
sg6765
g58625
sg1140
g22430
sg5133
g49301
sg3432
g38823
sg4155
g43254
sg1371
g24127
sg13091
g21424
sg7188
(dp60377
sg183
g13856
sg5766
g53004
sg4023
g42356
sg12123
(dp60378
ssg7182
(dp60379
g8373
(dp60380
sg690
g18658
sg3105
g36802
sg1326
g23614
sg30
g12402
sg3846
g41150
sg5256
g50108
sg3858
g41249
sg816
g19699
sg11283
(dp60381
sg7821
(dp60382
sg8265
(dp60383
sg5454
g51174
sg4653
g46740
sg1650
g26126
sg11151
(dp60384
sg288
g14702
sg3141
g37085
sg8022
(dp60385
sg2046
g29140
sg8445
(dp60386
sg6468
g57122
sg8448
(dp60387
sg2358
g31492
sg8454
(dp60388
sg9960
(dp60389
sg102
g13025
sg6807
g58836
sg9966
(dp60390
sg3174
g37282
sg6279
g55973
sg10728
(dp60391
sg7377
(dp60392
sg9231
(dp60393
sg2460
g32298
sg8874
(dp60394
sg11337
(dp60395
sg10758
(dp60396
sg8211
(dp60397
sg9144
(dp60398
sg8514
(dp60399
sg6186
g55522
sg9267
(dp60400
sg6303
g56239
sg147
g13493
sg12045
(dp60401
sg9273
(dp60402
sg7764
(dp60403
sg3222
g37621
sg6315
g56310
sg11550
(dp60404
sg9906
(dp60405
sg6765
g58627
sg9462
(dp60406
sg9081
(dp60407
sg4782
g47519
sg10356
(dp60408
sg204
g13984
sg8724
(dp60409
sg7041
g59716
sg7053
g59819
sg4017
g42297
sg6216
g55642
sg11592
(dp60410
sg7353
(dp60411
sg11601
(dp60412
sg9366
(dp60413
sg1050
g21699
sg12063
(dp60414
sg8787
(dp60415
sg8625
(dp60416
sg282
g14587
sg10122
(dp60417
sg9099
(dp60418
sg7884
(dp60419
sg5313
g50410
sg10899
(dp60420
sg3132
g37024
sg4077
g42849
sg11667
(dp60421
sg9663
(dp60422
sg5694
g52568
sg5208
g49728
sg12534
g52686
sg5739
g52886
sg9417
(dp60423
sg8673
(dp60424
sg1881
g27974
sg4920
g48362
sg5853
g53565
sg9432
(dp60425
sg6435
g56996
sg1899
g28090
sg9444
(dp60426
sg9198
(dp60427
sg7947
(dp60428
sg1908
g28321
sg8703
(dp60429
sg1911
g28379
sg11733
(dp60430
sg10179
(dp60431
sg2688
g33685
sg4164
g43357
sg7191
(dp60432
sg402
g15824
sg11451
(dp60433
sg8190
(dp60434
sg11385
(dp60435
sg426
g16121
sg8433
(dp60436
sg10266
(dp60437
sg9918
(dp60438
sg3912
g41620
sg2481
g32438
sg456
g16381
sg9528
(dp60439
sg5832
g53446
sg1239
g22977
sg1047
g21633
sg10308
(dp60440
sg11052
(dp60441
sg4023
g42358
sg8055
(dp60442
sg2034
g29041
sg11838
(dp60443
sg8721
(dp60444
sg3516
g39183
sg5865
g53628
sg11079
(dp60445
sg6699
g58234
sg9564
(dp60446
sg10335
(dp60447
sg5877
g53703
sg11940
(dp60448
sg78
g12875
sg8820
(dp60449
sg11097
(dp60450
sg7299
(dp60451
sg9591
(dp60452
sg4299
g44432
sg2910
g35562
sg339
g15188
sg2838
g34812
sg3546
g39406
sg1503
g25200
sg9954
(dp60453
sg11136
(dp60454
sg6504
g57279
sg8856
(dp60455
sg3963
g41897
sg696
g18775
sg5127
g49250
sg4887
g48102
sg10416
(dp60456
sg11160
(dp60457
sg573
g17581
sg11166
(dp60458
sg4344
g44676
sg2142
g30373
sg11016
(dp60459
sg3570
g39509
sg9963
(dp60460
sg141
g13369
sg6687
g58200
sg28215
g35382
sg2895
g35458
sg10878
(dp60461
sg11931
(dp60462
sg609
g17802
sg7593
(dp60463
sg621
g17982
sg3633
g40048
sg2196
g30646
sg2427
g32068
sg7428
(dp60464
sg2943
g35787
sg3657
g40190
sg4452
g45453
sg1434
g24687
sg10470
(dp60465
sg6033
g54544
sg6045
g54719
sg12126
(dp60466
sg8241
(dp60467
sg4479
g45727
sg4488
g45777
sg1113
g22205
sg10365
(dp60468
sg9009
(dp60469
sg6798
g58775
sg6090
g54974
sg3021
g36229
sg10518
(dp60470
sg3024
g36322
sg2769
g34309
sg11316
(dp60471
sg11241
(dp60472
sg1140
g22432
sg2832
g34741
sg4539
g46056
sg2739
g34029
sg8298
(dp60473
sg11625
(dp60474
sg3783
g40890
sg4596
g46268
sg10557
(dp60475
sg5289
g50313
sg771
g19263
sg5370
g50692
sg9084
(dp60476
sg9096
(dp60477
sg3651
g40136
sg7596
(dp60478
sg9060
(dp60479
sg819
g19779
ssg7185
(dp60480
g2466
g32340
ssg7188
(dp60481
g5610
g52101
sg11019
(dp60482
sVOAT1/SLC22A6 inhibitors
p60483
(dp60484
sVMusculo-Skeletal System
p60485
g31549
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p60486
(dp60487
sVOCT2 Inhibitors
p60488
g42492
sVCompounds used in a research, industrial, or household setting
p60489
(dp60490
sVCytochrome P-450 CYP2C9 Inhibitors
p60491
g18210
sVCytochrome P-450 Enzyme Inhibitors
p60492
(dp60493
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p60494
(dp60495
sVRenal Agents
p60496
g24767
sVDrugs that are Mainly Renally Excreted
p60497
g43885
sVGynecological Antiinfectives and Antiseptics
p60498
(dp60499
sVSulfonamides
p60500
(dp60501
sVAmides
p60502
g44346
sVSulfur Compounds
p60503
(dp60504
sVSulfones
p60505
g58731
sVCytochrome P-450 CYP3A4 Inducers
p60506
g18927
sVOCT1 inhibitors
p60507
(dp60508
sVPharmaceutical Preparations
p60509
g53872
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p60510
g44464
sVPharmaceutic Aids
p60511
(dp60512
sVUGT1A1 Inhibitors
p60513
(dp60514
sVCytochrome P-450 Enzyme Inducers
p60515
g28174
sVCytochrome P-450 CYP3A Inducers
p60516
(dp60517
sVCytochrome P-450 CYP2C19 Inhibitors
p60518
(dp60519
sVOAT3/SLC22A8 Inhibitors
p60520
g59020
sVGenito Urinary System and Sex Hormones
p60521
(dp60522
sVCytochrome P-450 CYP2C8 Inducers
p60523
g60377
sg3234
g37681
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p60524
(dp60525
sg10485
(dp60526
sVAntirheumatic Agents
p60527
g24249
ssg7191
(dp60528
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p60529
(dp60530
sVCytochrome P-450 CYP2D6 Substrates
p60531
g52157
sVAntiarrhythmic agents
p60532
(dp60533
sVCytochrome P-450 CYP3A Substrates
p60534
g45058
sVAgents causing hyperkalemia
p60535
g43600
sVHypotensive Agents
p60536
g34156
sVCytochrome P-450 CYP3A4 Inhibitors
p60537
(dp60538
sVCytochrome P-450 CYP3A7 Inhibitors
p60539
(dp60540
sVCalcium Channel Blockers
p60541
g41322
sVHeterocyclic Compounds, Fused-Ring
p60542
g56093
sVVasoprotectives
p60543
g41396
sVCytochrome P-450 Enzyme Inhibitors
p60544
(dp60545
sg11724
(dp60546
sVCytochrome P-450 CYP2C8 Substrates
p60547
(dp60548
sg1467
g24884
sVAntihypertensive Agents
p60549
g20288
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p60550
g16835
sg10341
(dp60551
sVCytochrome P-450 CYP2C9 Substrates
p60552
g29761
sVQTc Prolonging Agents
p60553
g57833
sVCardiovascular Agents
p60554
g26600
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60555
g29332
sVCytochrome P-450 CYP2C8 Inhibitors
p60556
g55021
sg7869
(dp60557
sVP-glycoprotein/ABCB1 Substrates
p60558
g34989
sVVasodilating Agents
p60559
g23723
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p60560
(dp60561
sVMembrane Transport Modulators
p60562
g54147
sVCytochrome P-450 CYP3A5 Substrates
p60563
(dp60564
sVCytochrome P-450 CYP3A Inhibitors (strong)
p60565
g13411
sVCytochrome P-450 CYP3A4 Substrates
p60566
(dp60567
sg8307
(dp60568
sVCalcium-Regulating Hormones and Agents
p60569
(dp60570
sVModerate Risk QTc-Prolonging Agents
p60571
(dp60572
sVBenzazepines
p60573
g60329
sg5361
g50600
sVCytochrome P-450 CYP3A Inhibitors
p60574
g60432
sVBradycardia-Causing Agents
p60575
(dp60576
sg2169
g30490
sVP-glycoprotein/ABCB1 Inhibitors
p60577
(dp60578
sVCytochrome P-450 CYP3A7 Substrates
p60579
(dp60580
sVCytochrome P-450 CYP3A5 Inhibitors
p60581
g55348
ssg7194
(dp60582
g8601
(dp60583
ssg7197
(dp60584
VPsychoanaleptics
p60585
g59082
sVCytochrome P-450 CYP2D6 Substrates
p60586
g52158
sVCytochrome P-450 CYP3A Substrates
p60587
g45059
sVNeurotransmitter Agents
p60588
(dp60589
sg36
g12488
sVCentral Nervous System Agents
p60590
g58462
sVPsychostimulants, Agents Used for Adhd and Nootropics
p60591
g53757
sg10449
(dp60592
sVEnzyme Inhibitors
p60593
(dp60594
sVCentral Nervous System Stimulation
p60595
g30766
sVCytochrome P-450 Enzyme Inhibitors
p60596
(dp60597
sVDiagnostic Agents
p60598
g60041
sg3324
g38241
sVPurinergic Agents
p60599
(dp60600
sVCytochrome P-450 CYP2C8 Substrates
p60601
(dp60602
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p60603
g49347
sg9489
(dp60604
sVPurinergic Antagonists
p60605
(dp60606
sVPurinergic P1 Receptor Antagonists
p60607
g60049
sVXanthine derivatives
p60608
g28825
sVDrugs for Obstructive Airway Diseases
p60609
g42528
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60610
g29333
sVCentral Nervous System Stimulants
p60611
g51445
sVCytochrome P-450 CYP2C9 Substrates
p60612
g29763
sg1689
g26419
sVCytochrome P-450 CYP1A2 Inhibitors
p60613
g15048
sVPhosphodiesterase Inhibitors
p60614
g59611
sVP-glycoprotein/ABCB1 Substrates
p60615
g34990
sVCytochrome P-450 CYP1A2 Substrates
p60616
g45597
sVTricarboxylic Acids
p60617
(dp60618
sVHeterocyclic Compounds, Fused-Ring
p60619
g56094
sVCytochrome P-450 CYP3A4 Substrates
p60620
(dp60621
sVPurinones
p60622
g48138
sVPurines
p60623
(dp60624
sVRespiratory and CNS Stimulants
p60625
(dp60626
sVCytochrome P-450 CYP3A5 Substrates
p60627
(dp60628
sVAcids, Acyclic
p60629
g25493
sVP-glycoprotein/ABCB1 Inhibitors
p60630
(dp60631
sVAlkaloids
p60632
g19420
sVNervous System
p60633
(dp60634
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p60635
g27740
sVCytochrome P-450 CYP3A7 Substrates
p60636
(dp60637
ssg7200
(dp60638
g5847
g53516
ssg7203
(dp60639
g4770
g47470
sg10764
(dp60640
ssg7206
(dp60641
g4479
g45733
sg7464
(dp60642
sg2358
g31500
sg12421
g12498
sg4635
g46529
sg5433
g51082
sg828
g19899
sg4653
g46765
sg11016
(dp60643
sg888
g20523
sg6939
g59343
sg8448
(dp60644
sg10818
(dp60645
sg9960
(dp60646
sg6807
g58843
sg915
g20748
sg7377
(dp60647
sg2460
g32312
sg3858
g41255
sg147
g13511
sg9273
(dp60648
sg966
g21070
sg3978
g42024
sg3240
g37749
sg1857
g27729
sg5112
g49191
sg7029
g59660
sg8724
(dp60649
sg1791
g27276
sg11595
(dp60650
sg7065
g59965
sg11601
(dp60651
sg12274
g27585
sg282
g14601
sg11655
(dp60652
sg4077
g42854
sg4680
g46915
sg5694
g52580
sg12534
g52711
sg9417
(dp60653
sg4920
g48364
sg9432
(dp60654
sg9414
(dp60655
sg10179
(dp60656
sg2667
g33533
sg2688
g33702
sg5766
g53024
sg7197
g60637
sg3447
g38978
sg6537
g57427
sg426
g16133
sg9198
(dp60657
sg9918
(dp60658
sg9084
(dp60659
sg3912
g41623
sg10041
(dp60660
sg1239
g22989
sg1947
g28708
sg11079
(dp60661
sg507
g16804
sg9564
(dp60662
sg5877
g53715
sg2814
g34538
sg7299
(dp60663
sg9609
(dp60664
sg543
g17132
sg9954
(dp60665
sg6504
g57289
sg3963
g41906
sg7569
(dp60666
sg11439
(dp60667
sg573
g17591
sg3570
g39521
sg438
g16198
sg9693
(dp60668
sg2199
g30721
sg8205
(dp60669
sg516
g16896
sg16906
(dp60670
sg4452
g45461
sg1434
g24699
sg6033
g54550
sg6045
g54730
sg7191
g60580
sg690
g18664
sg6783
g58696
sg849
g20118
sg2664
g33485
sg1491
g25130
sg3009
g36063
sg3021
g36235
sg3027
g36398
sg11316
(dp60671
sg2832
g34753
sg4539
g46062
sg11790
(dp60672
sg10557
(dp60673
sg5289
g50323
sg12126
(dp60674
sg6075
g54901
ssg7209
(dp60675
g11952
(dp60676
sg5463
g51268
sg1776
g27114
sg6360
g56731
sg7407
(dp60677
sg8088
(dp60678
sg5514
g51519
ssg7212
(dp60679
g8625
(dp60680
ssg7215
(dp60681
g3699
g40336
ssg7218
(dp60682
g12015
(dp60683
sg9705
(dp60684
ssg7221
(dp60685
VAmino Acids, Peptides, and Proteins
p60686
g47366
sVPeptide Hormones
p60687
g20202
sg984
g21198
sg7221
(dp60688
sg5625
g52255
sVThyroid Products
p60689
g28976
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p60690
(dp60691
sVPeptides
p60692
g47185
sg1485
g25029
sVBone Density Conservation Agents
p60693
g40351
sVHormones
p60694
g55676
sVHormones, Hormone Substitutes, and Hormone Antagonists
p60695
g53161
sVCalcium Homeostasis
p60696
g22843
sVCalcium-Regulating Hormones and Agents
p60697
(dp60698
ssg7224
(dp60699
g5409
g50882
ssg7227
(dp60700
g10578
(dp60701
sg10890
(dp60702
sg2928
g35619
ssg7230
(dp60703
g8097
(dp60704
sg9417
(dp60705
sg3381
g38463
sg5169
g49492
sg387
g15600
sg7941
(dp60706
sg11979
(dp60707
sg2427
g31980
sg8028
(dp60708
sg9981
(dp60709
sg10056
(dp60710
ssg7233
(dp60711
g7305
(dp60712
ssg7236
(dp60713
g7197
g60626
sg12421
g12483
sg11154
(dp60714
sg7065
g59954
ssg7239
(dp60715
g2481
g32385
sg11427
(dp60716
sg5250
g49954
sg279
g14516
sg9192
(dp60717
sg8985
(dp60718
sg10326
(dp60719
sg2991
g35955
sg7500
(dp60720
sg4710
g47010
sg11874
(dp60721
sg2769
g34279
sg10365
(dp60722
sg1332
g23671
sg6654
g58075
sg3576
g39588
sg1275
g23273
sg10230
(dp60723
sg5595
g51977
sg972
g21110
sg11241
(dp60724
sg4005
g42150
sg8922
(dp60725
sg11781
(dp60726
sg2250
g30846
ssg7242
(dp60727
g11781
(dp60728
ssg7245
(dp60729
g4002
g42135
ssg7248
(dp60730
g8472
(dp60731
ssg7251
(dp60732
g6180
g55413
sg10323
(dp60733
sg4515
g45886
sg11274
(dp60734
sg2007
g28862
sg8106
(dp60735
ssg7254
(dp60736
g645
g18140
sg1629
g25979
sg1578
g25620
sg4737
g47222
sg10296
(dp60737
sg3711
g40421
ssg7257
(dp60738
g9612
(dp60739
ssg7260
(dp60740
g10122
(dp60741
sg8448
(dp60742
ssg7263
(dp60743
g4014
g42219
sg6765
g58591
sg1365
g24062
sg4917
g48314
sg10839
(dp60744
sg11313
(dp60745
sg6009
g54352
sg13091
g21370
sg10374
(dp60746
sg3258
g37831
sg7848
(dp60747
sg8190
(dp60748
ssg7266
(dp60749
g561
g17380
ssg7269
(dp60750
g1164
g22579
sg9309
(dp60751
sg7629
(dp60752
sg4725
g47142
sg4737
g47226
sg12108
(dp60753
ssg7272
(dp60754
g4809
g47694
sVAnticholinergic Agents
p60755
g24477
sg441
g16208
sg9336
(dp60756
sVNeurotransmitter Agents
p60757
(dp60758
sVCentral Nervous System Agents
p60759
g58471
sg3492
g39050
sg846
g20040
sg471
g16521
sVCytochrome P-450 CYP3A4 Inducers (strong)
p60760
g23076
sg8424
(dp60761
sVCytochrome P-450 CYP2B6 Inducers
p60762
g39117
sg5481
g51341
sg2796
g34433
sg1488
g25033
sg3528
g39241
sVCytochrome P-450 CYP2C9 Substrates
p60763
g29774
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p60764
g25141
sVCytochrome P-450 CYP3A4 Inducers
p60765
g18938
sg1299
g23465
sg5904
g53884
sVCentral Nervous System Depressants
p60766
(dp60767
sg8841
(dp60768
sVAnticonvulsants
p60769
g60144
sg10527
(dp60770
sVCytochrome P-450 Enzyme Inducers
p60771
g28192
sVCytochrome P-450 CYP3A Inducers
p60772
(dp60773
sg2631
g33234
sVCytochrome P-450 CYP3A Inducers (strong)
p60774
g22451
sg12099
(dp60775
sg6831
g58932
sg11178
(dp60776
sVCytochrome P-450 CYP2C8 Inducers
p60777
g60373
sVCytochrome P-450 CYP2C19 Inducers
p60778
g25532
sg3999
g42121
sg8511
(dp60779
sVNervous System
p60780
(dp60781
ssg7275
(dp60782
g9699
(dp60783
sVNeurotransmitter Agents
p60784
(dp60785
sVHistamine Agents
p60786
(dp60787
sVCentral Nervous System Agents
p60788
g58472
sVPeripheral Nervous System Agents
p60789
g57618
sg8628
(dp60790
sg1074
g21862
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60791
g29329
sVQTc Prolonging Agents
p60792
g57842
sVCytochrome P-450 CYP3A Substrates
p60793
g45056
sVCentral Nervous System Depressants
p60794
(dp60795
sg3390
g38523
sVP-glycoprotein/ABCB1 Substrates
p60796
g35005
sg11142
(dp60797
sVSensory Organs
p60798
g40717
sVHistamine H1 Antagonists
p60799
g40772
sVCytochrome P-450 CYP3A4 Substrates
p60800
(dp60801
sVNasal Preparations
p60802
(dp60803
sVHeterocyclic Compounds, Fused-Ring
p60804
g56106
sVOphthalmologicals
p60805
g35226
sg8331
(dp60806
sVAnti-Allergic Agents
p60807
g50647
sVAnti-Inflammatory Agents
p60808
(dp60809
sVHistamine Antagonists
p60810
g43430
sg8178
(dp60811
sVSensory System Agents
p60812
(dp60813
sg4191
g43489
ssg7278
(dp60814
g4806
g47680
sg6906
g59209
sg3318
g38177
ssg7281
(dp60815
g5247
g49931
sg9165
(dp60816
sg3156
g37193
sg8487
(dp60817
sg8067
(dp60818
ssg7284
(dp60819
VGABA Agents
p60820
g16210
sVCytochrome P-450 CYP3A Substrates
p60821
g45063
sVNeurotransmitter Agents
p60822
(dp60823
sVAnti-Anxiety Agents
p60824
g35648
sVCentral Nervous System Agents
p60825
g58474
sVBenzodiazepinones
p60826
(dp60827
sVPsychotropic Drugs
p60828
(dp60829
sVGABA Modulators
p60830
g39052
sVPeripheral Nervous System Agents
p60831
g57620
sVDrugs that are Mainly Renally Excreted
p60832
g43893
sVCytochrome P-450 CYP3A4 Substrates
p60833
(dp60834
sVAutonomic Agents
p60835
(dp60836
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60837
g29340
sVPsycholeptics
p60838
g33236
sVCentral Nervous System Depressants
p60839
(dp60840
sVAntiemetics
p60841
(dp60842
sVGastrointestinal Agents
p60843
(dp60844
sVAnticonvulsants
p60845
g60145
sVMuscle Relaxants, Centrally Acting Agents
p60846
g37387
sVBenzazepines
p60847
g60327
sVHypnotics and Sedatives
p60848
(dp60849
sVHeterocyclic Compounds, Fused-Ring
p60850
g56108
sVBenzodiazepine hypnotics and sedatives
p60851
g17658
sVMuscle Relaxants
p60852
(dp60853
sVBenzodiazepines and benzodiazepine derivatives
p60854
(dp60855
sVNervous System
p60856
(dp60857
sVTranquilizing Agents
p60858
g55293
ssg7287
(dp60859
g3753
g40607
ssg7290
(dp60860
g630
g18023
sg11790
(dp60861
sg7422
(dp60862
sg240
g14189
sg6318
g56358
sg831
g19924
sg11979
(dp60863
sg10470
(dp60864
sg9711
(dp60865
sg10884
(dp60866
sg6408
g56857
sg6051
g54786
sg8805
(dp60867
sg3900
g41502
sg8433
(dp60868
sg6069
g54837
sg6468
g57099
sg9987
(dp60869
sg11097
(dp60870
sg7299
(dp60871
sg7305
(dp60872
sg8097
(dp60873
sg9417
(dp60874
sg1707
g26784
sg6966
g59409
sg7716
(dp60875
sg12066
(dp60876
sg3036
g36440
sg7941
(dp60877
sg3978
g41991
sg9981
(dp60878
sg8514
(dp60879
sg2664
g33442
sg6303
g56215
sg570
g17489
sg4344
g44655
sg696
g18731
sg11016
(dp60880
sg6684
g58155
sg6315
g56296
sg5169
g49518
sg387
g15637
sg5289
g50274
sg10041
(dp60881
sg9918
(dp60882
sg414
g15961
sg8187
(dp60883
sg780
g19355
ssg7293
(dp60884
g11523
(dp60885
sg8241
(dp60886
ssg7296
(dp60887
g1605
g25772
sg3363
g38413
ssg7299
(dp60888
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p60889
(dp60890
sVCytochrome P-450 CYP3A4 Inhibitors
p60891
(dp60892
sVAdrenergic alpha-1 Receptor Antagonists
p60893
g14123
sVAnticholinergic Agents
p60894
g24499
sVCytochrome P-450 CYP2D6 Inhibitors
p60895
(dp60896
sVSerotonin Agents
p60897
(dp60898
sVCytochrome P-450 CYP3A Substrates
p60899
g45070
sVNeurotransmitter Agents
p60900
(dp60901
sVSerotonin Receptor Antagonists
p60902
g35674
sVCentral Nervous System Agents
p60903
g58417
sVDopamine Agents
p60904
g14257
sVAdrenergic Antagonists
p60905
g52302
sVPsychotropic Drugs
p60906
(dp60907
sVSerotonin 5-HT1 Receptor Antagonists
p60908
g14438
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p60909
g18406
sVMuscarinic Antagonists
p60910
g48868
sVHighest Risk QTc-Prolonging Agents
p60911
g35867
sVCytochrome P-450 CYP1A2 Substrates
p60912
g45603
sg7086
g60046
sVAntipsychotic Agents
p60913
(dp60914
sg5274
g50167
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p60915
g29348
sVSulfur Compounds
p60916
(dp60917
sVAdrenergic alpha-Antagonists
p60918
g60871
sVDopamine Antagonists
p60919
g53744
sVQTc Prolonging Agents
p60920
g57847
sVHyperglycemia-Associated Agents
p60921
(dp60922
sVSerotonin 5-HT2 Receptor Antagonists
p60923
(dp60924
sVCentral Nervous System Depressants
p60925
(dp60926
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p60927
(dp60928
sVHistamine H1 Antagonists
p60929
g40776
sVAgents that produce hypertension
p60930
(dp60931
sVCytochrome P-450 CYP3A4 Substrates
p60932
(dp60933
sVSerotonin 5-HT1 Receptor Agonists
p60934
g34593
sVDopamine D2 Receptor Antagonists
p60935
g49417
sVCytochrome P-450 CYP3A5 Substrates
p60936
(dp60937
sVAntidepressive Agents
p60938
g15545
sVPsycholeptics
p60939
g33252
sVCytochrome P-450 CYP3A Inhibitors
p60940
g60451
sVTranquilizing Agents
p60941
g55297
sVNeurotoxic agents
p60942
(dp60943
sVHistamine Antagonists
p60944
g43436
sVSerotonin Receptor Agonists
p60945
(dp60946
sVNervous System
p60947
(dp60948
sVAntipsychotic Agents (Second Generation [Atypical])
p60949
g52065
sVCytochrome P-450 CYP3A7 Substrates
p60950
g60663
ssg7302
(dp60951
g528
g16948
sg147
g13499
sg8013
(dp60952
ssg7305
(dp60953
VAdrenergic Agents
p60954
g41706
sg7233
g60712
sVNeurotransmitter Agents
p60955
(dp60956
sVAdrenergic alpha-1 Receptor Antagonists
p60957
g14124
sVAmines
p60958
g42717
sVPeripheral alpha-1 blockers
p60959
g32718
sVAntihypertensive Agents
p60960
g20294
sVEthylamines
p60961
g20594
sVHypotensive Agents
p60962
g34165
sVVasodilating Agents
p60963
g23701
sVOCT2 Inhibitors
p60964
g42476
sVAdrenergic Antagonists
p60965
g52280
sVAdrenergic alpha-Antagonists
p60966
g60872
sVAgents that produce hypertension
p60967
(dp60968
sVPeripheral Vasodilators
p60969
g46227
sVCardiovascular Agents
p60970
g26621
sVOCT1 inhibitors
p60971
(dp60972
ssg7308
(dp60973
g9897
(dp60974
sg4200
g43528
sg9132
(dp60975
sg2754
g34069
sg447
g16274
sg9705
(dp60976
sg8772
(dp60977
sg9300
(dp60978
sg6213
g55603
sg6216
g55631
sg9348
(dp60979
sg11646
(dp60980
sg669
g18439
sg10104
(dp60981
sg3147
g37148
sg12015
(dp60982
sg11286
(dp60983
sg1266
g23227
sg1482
g25001
sg9741
(dp60984
sg8076
(dp60985
sg6612
g57755
sg4977
g48648
sg6804
g58787
sg7512
(dp60986
sg6630
g57928
sg9612
(dp60987
sg4713
g47026
sg10431
(dp60988
sg1737
g26905
sg3801
g40951
sg9627
(dp60989
sg3882
g41405
sg4551
g46102
sg3573
g39526
sg11349
(dp60990
sg11550
(dp60991
sg3588
g39614
sg7980
(dp60992
sg1563
g25503
sg4905
g48175
sg8910
(dp60993
sg4185
g43464
sg7059
g59877
sg9852
(dp60994
sg7809
(dp60995
sg10653
(dp60996
ssg7311
(dp60997
g8322
(dp60998
sg9918
(dp60999
sg969
g21075
sg5334
g50509
sg2505
g32653
sg11535
(dp61000
ssg7314
(dp61001
VSulfones
p61002
g58741
sVCardiovascular Agents
p61003
g26629
sVGenito Urinary System and Sex Hormones
p61004
(dp61005
sVGynecological Antiinfectives and Antiseptics
p61006
(dp61007
sVSodium Chloride Symporter Inhibitors
p61008
g55911
sVHypotensive Agents
p61009
g34170
sVSulfonamides
p61010
(dp61011
sVThiazides
p61012
(dp61013
sVAmides
p61014
g44353
sVBenzothiadiazines
p61015
g44811
sVSulfur Compounds
p61016
(dp61017
sVIncreased Diuresis
p61018
g40996
sVMembrane Transport Modulators
p61019
g54156
sVHeterocyclic Compounds, Fused-Ring
p61020
g56109
sVHyperglycemia-Associated Agents
p61021
(dp61022
sVNatriuretic Agents
p61023
g40493
sVDiuretics
p61024
g57904
ssg7317
(dp61025
VAcetates
p61026
(dp61027
sVHydrocarbons, Acyclic
p61028
g19584
sVAcetamides
p61029
(dp61030
sVFatty Acids
p61031
(dp61032
sVAnti-epileptic Agent
p61033
(dp61034
sVCytochrome P-450 CYP3A Substrates
p61035
g45088
sVCentral Nervous System Agents
p61036
g58483
sg8400
(dp61037
sVLipids
p61038
g14325
sVMiscellaneous Anticonvulsants
p61039
g53478
sVAmides
p61040
g44335
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61041
g29367
sVCytochrome P-450 CYP2C9 Substrates
p61042
g29784
sVDecreased Central Nervous System Disorganized Electrical Activity
p61043
g23469
sVCytochrome P-450 CYP2C19 Substrates
p61044
g53893
sVCentral Nervous System Depressants
p61045
(dp61046
sVFatty Acids, Volatile
p61047
(dp61048
sVCardiovascular Agents
p61049
g26668
sVAnticonvulsants
p61050
g60152
sVMembrane Transport Modulators
p61051
g54157
sVCytochrome P-450 CYP3A4 Substrates
p61052
(dp61053
sVSodium Channel Blockers
p61054
(dp61055
sVVoltage-Gated Sodium Channel Blockers
p61056
g40905
sVAcids, Acyclic
p61057
g25471
sVBradycardia-Causing Agents
p61058
(dp61059
sVNervous System
p61060
(dp61061
ssg7320
(dp61062
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p61063
(dp61064
sVCytochrome P-450 CYP2D6 Substrates
p61065
g52175
sVBronchodilator Agents
p61066
(dp61067
sg2760
g34218
sVSympathomimetics
p61068
g48813
sg11247
(dp61069
sVAlpha-and Beta-adrenergic Agonists
p61070
g26138
sVHyperglycemia-Associated Agents
p61071
(dp61072
sVVasoconstrictor Agents
p61073
g35881
sVAmines
p61074
g42720
sVPeripheral Nervous System Agents
p61075
g57629
sVRespiratory System Agents
p61076
(dp61077
sVEthylamines
p61078
g20598
sVNasal Preparations
p61079
(dp61080
sVAdrenergic beta-Agonists
p61081
g42997
sVCardiovascular Agents
p61082
g26631
sVSympathomimetic (Adrenergic) Agents
p61083
(dp61084
sg6111
g55107
sVAdrenergic Agonists
p61085
(dp61086
sVAgents that produce hypertension
p61087
(dp61088
sVAnti-Asthmatic Agents
p61089
g36524
sVPropanolamines
p61090
g37506
sVAutonomic Agents
p61091
(dp61092
sVAdrenergic alpha-2 Receptor Agonists
p61093
(dp61094
sVAmino Alcohols
p61095
g32681
sVAdrenergic alpha-Agonists
p61096
(dp61097
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p61098
g58991
sVPropanols
p61099
g56551
sVAgents producing tachycardia
p61100
g50782
sVAdrenergic alpha-1 Receptor Agonists
p61101
(dp61102
sg12141
(dp61103
sVAlcohols
p61104
(dp61105
sg9114
(dp61106
ssg7323
(dp61107
g11370
(dp61108
ssg7326
(dp61109
g8421
(dp61110
sg1371
g24113
sg9198
(dp61111
sg888
g20499
sg6333
g56480
sg6336
g56525
sg7335
(dp61112
sg8724
(dp61113
sg4299
g44437
sg11385
(dp61114
ssg7329
(dp61115
VNMDA Receptor Antagonists
p61116
g43497
sVAnti-epileptic Agent
p61117
(dp61118
sVCytochrome P-450 CYP3A Substrates
p61119
g45064
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p61120
g46424
sVCentral Nervous System Agents
p61121
g58477
sVPotential QTc-Prolonging Agents
p61122
(dp61123
sVCytochrome P-450 CYP2C9 Inhibitors
p61124
g18225
sVCytochrome P-450 Enzyme Inhibitors
p61125
(dp61126
sVCarbamates
p61127
g45519
sVCytochrome P-450 CYP3A4 Inducers (weak)
p61128
g19515
sVPhenylcarbamates
p61129
(dp61130
sVPropylene Glycols
p61131
g55825
sVExcitatory Amino Acid Antagonists
p61132
(dp61133
sVExcitatory Amino Acid Agents
p61134
g14800
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61135
g29343
sVQTc Prolonging Agents
p61136
g57846
sVCytochrome P-450 CYP3A4 Inducers
p61137
g18943
sVDecreased Central Nervous System Disorganized Electrical Activity
p61138
g23475
sVCentral Nervous System Depressants
p61139
(dp61140
sVNeurotransmitter Agents
p61141
(dp61142
sVAnticonvulsants
p61143
g60147
sVCytochrome P-450 Enzyme Inducers
p61144
g28201
sVCytochrome P-450 CYP3A Inducers
p61145
(dp61146
sVCytochrome P-450 CYP2C19 Inhibitors
p61147
(dp61148
sVCytochrome P-450 CYP3A4 Substrates
p61149
(dp61150
sVGlycols
p61151
g55149
sVAcids, Acyclic
p61152
g25459
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p61153
(dp61154
sVNervous System
p61155
(dp61156
sVAlcohols
p61157
(dp61158
ssg7332
(dp61159
g1776
g27109
ssg7335
(dp61160
VAgents Causing Muscle Toxicity
p61161
g55385
sVCytochrome P-450 CYP2D6 Inducers (moderate)
p61162
(dp61163
sVInducers of Drug Clearance
p61164
g44537
sVAnti-epileptic Agent
p61165
(dp61166
sVCytochrome P-450 CYP3A Substrates
p61167
g45065
sVMembrane Transport Modulators
p61168
g54153
sVCentral Nervous System Agents
p61169
g58478
sVCytochrome P-450 CYP2D6 Inducers
p61170
(dp61171
sVCytochrome P-450 CYP3A7 Inducers
p61172
g39043
sVCytochrome P-450 CYP2C9 Inhibitors
p61173
g18226
sVCytochrome P-450 CYP1A2 Inducers
p61174
(dp61175
sVCytochrome P-450 CYP2C9 Inducers
p61176
g20044
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p61177
g16527
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p61178
(dp61179
sVPhenytoin and Prodrugs
p61180
g35602
sVPhenytoin
p61181
(dp61182
sVCytochrome P-450 CYP2C8 Substrates
p61183
(dp61184
sVCytochrome P-450 CYP3A4 Inducers (strong)
p61185
g23086
sVCytochrome P-450 CYP2C8 Inducers (strong)
p61186
(dp61187
sVCytochrome P-450 CYP2B6 Inducers
p61188
g39119
sVVoltage-Gated Sodium Channel Blockers
p61189
g40911
sVCytochrome P450 1A2 Inducers
p61190
(dp61191
sVCytochrome P-450 Enzyme Inhibitors
p61192
(dp61193
sVEnzyme Inducing Antiepileptic Drugs
p61194
g25038
sVUGT1A1 Inducers
p61195
g39247
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61196
g29344
sVCytochrome P450 2D6 Inducers
p61197
g44686
sVCytochrome P-450 CYP2C9 Substrates
p61198
g29780
sVImidazoles
p61199
(dp61200
sVCytochrome P-450 CYP3A4 Inducers
p61201
g18953
sVDecreased Central Nervous System Disorganized Electrical Activity
p61202
g23476
sVCytochrome P-450 CYP2C19 Substrates
p61203
g53887
sVCentral Nervous System Depressants
p61204
(dp61205
sVCytochrome P-450 CYP3A5 Inducers
p61206
g41746
sVCardiovascular Agents
p61207
g26619
sVCytochrome P450 2C19 Inducers
p61208
g57047
sVP-glycoprotein/ABCB1 Substrates
p61209
g35030
sVAnticonvulsants
p61210
g60148
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p61211
g49153
sVCytochrome P-450 CYP2B6 Inducers (strong)
p61212
(dp61213
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p61214
g37408
sVCytochrome P-450 CYP2C19 Substrates (moderate)
p61215
(dp61216
sVHydantoins
p61217
(dp61218
sVCytochrome P450 3A Inducers
p61219
(dp61220
sVThyroxine-binding globulin substrates
p61221
g60175
sVCytochrome P-450 Enzyme Inducers
p61222
g28212
sVCytochrome P-450 CYP3A Inducers
p61223
(dp61224
sVCytochrome P-450 CYP2C18 Substrates
p61225
g20937
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p61226
g60072
sVCytochrome P-450 CYP3A Inducers (strong)
p61227
g22453
sVCytochrome P-450 CYP3A4 Substrates
p61228
(dp61229
sVCytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index
p61230
g36542
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p61231
(dp61232
sVNarrow Therapeutic Index Drugs
p61233
g50562
sVSodium Channel Blockers
p61234
(dp61235
sVUGT1A6 Inhibitors
p61236
g58852
sVCytochrome P450 2C9 Inducers
p61237
g61112
sVUGT1A9 Inhibitors
p61238
(dp61239
sVImidazolidines
p61240
g46001
sVCytochrome P-450 CYP2C8 Inducers
p61241
g60375
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p61242
g47504
sVMethemoglobinemia Associated Agents
p61243
g25568
sVCytochrome P-450 CYP3A7 Inducers (weak)
p61244
g25713
sVChemically-Induced Disorders
p61245
g21232
sVNervous System
p61246
(dp61247
sVCytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index
p61248
(dp61249
ssg7338
(dp61250
g1326
g23608
sg3846
g41141
sg5433
g51062
sg7821
(dp61251
sg1650
g26119
sg10797
(dp61252
sg11451
(dp61253
sg8433
(dp61254
sg888
g20489
sg2427
g32052
sg4887
g48097
sg9960
(dp61255
sg9966
(dp61256
sg6279
g55960
sg10728
(dp61257
sg9231
(dp61258
sg7734
(dp61259
sg945
g20906
sg132
g13229
sg6303
g56231
sg2538
g32819
sg10056
(dp61260
sg4017
g42293
sg11592
(dp61261
sg8916
(dp61262
sg12274
g27556
sg1050
g21685
sg10899
(dp61263
sg3132
g37017
sg288
g14690
sg10356
(dp61264
sg9417
(dp61265
sg1899
g28076
sg10179
(dp61266
sg1908
g28310
sg2688
g33672
sg4164
g43345
sg8724
(dp61267
sg387
g15669
sg7188
g60519
sg5256
g50093
sg6537
g57414
sg426
g16109
sg9198
(dp61268
sg10266
(dp61269
sg5832
g53439
sg10308
(dp61270
sg8049
(dp61271
sg2784
g34369
sg8721
(dp61272
sg11079
(dp61273
sg5877
g53693
sg4287
g44368
sg8820
(dp61274
sg7329
g61148
sg2910
g35553
sg8097
(dp61275
sg3543
g39349
sg8856
(dp61276
sg696
g18760
sg7944
(dp61277
sg564
g17420
sg573
g17570
sg2895
g35448
sg3072
g36599
sg6525
g57353
sg11955
(dp61278
sg5370
g50688
sg2943
g35777
sg5235
g49854
sg2946
g35829
sg5250
g49996
sg1461
g24838
sg8241
(dp61279
sg1113
g22196
sg9009
(dp61280
sg12045
(dp61281
sg10518
(dp61282
sg1140
g22420
sg2832
g34726
sg8298
(dp61283
sg771
g19297
sg8949
(dp61284
sg12126
(dp61285
sg7593
(dp61286
sg11241
(dp61287
sg7563
(dp61288
sg7608
(dp61289
ssg7341
(dp61290
g1791
g27237
sg5556
g51719
sg3249
g37767
sg1581
g25698
sg12057
(dp61291
sg2826
g34602
sg10272
(dp61292
sg1917
g28464
sg8658
(dp61293
ssg7344
(dp61294
VDecreased Blood Pressure
p61295
(dp61296
sVHeterocyclic Compounds, Fused-Ring
p61297
g56046
sVAngiotensin Receptor Antagonists
p61298
(dp61299
sVAngiotensin II receptor blockers (ARBs), plain
p61300
g22618
sVAgents causing hyperkalemia
p61301
g43580
sVHypotensive Agents
p61302
g34116
sVAgents causing angioedema
p61303
(dp61304
sVOxazoles
p61305
g33225
sVAngiotensin II Type 1 Receptor Blockers
p61306
(dp61307
sVAngiotensin II receptor blockers (ARBs) and diuretics
p61308
g18122
sVAngiotensin 2 Receptor Blocker
p61309
(dp61310
sVAgents Acting on the Renin-Angiotensin System
p61311
g25337
ssg7347
(dp61312
g5463
g51266
sg11367
(dp61313
sg7407
(dp61314
sg8088
(dp61315
sg801
g19525
sg5514
g51500
ssg7350
(dp61316
g1041
g21502
sg8322
(dp61317
ssg7353
(dp61318
VCytochrome P-450 CYP3A4 Inhibitors
p61319
(dp61320
sVAntifungal Agents
p61321
(dp61322
sVPolyene Antifungal
p61323
g36946
sVOATP1B1/SLCO1B1 Inhibitors
p61324
(dp61325
sVCompounds used in a research, industrial, or household setting
p61326
(dp61327
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p61328
g43742
sVCytochrome P-450 Enzyme Inhibitors
p61329
(dp61330
sVAnti-Infective Agents
p61331
g54591
sVAntifungal Agents (Vaginal)
p61332
g39083
sVGynecological Antiinfectives and Antiseptics
p61333
(dp61334
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p61335
g59968
sVLactones
p61336
(dp61337
sVAntifungals for Topical Use
p61338
g39226
sVPolyenes
p61339
g51393
sVOATP1B3 inhibitors
p61340
(dp61341
sVAntifungals for Dermatological Use
p61342
g30071
sVAnti-Bacterial Agents
p61343
g38338
sVDermatologicals
p61344
g17228
sVMembrane Transport Modulators
p61345
g54137
sVPolyketides
p61346
g48470
sVAlimentary Tract and Metabolism
p61347
g23813
sg1932
g28508
sVGenito Urinary System and Sex Hormones
p61348
(dp61349
sVIntestinal Antiinfectives
p61350
(dp61351
sVCytochrome P-450 CYP3A Inhibitors
p61352
g60411
ssg7356
(dp61353
g11286
(dp61354
ssg7359
(dp61355
VDrugs that are Mainly Renally Excreted
p61356
g43903
sVPsychoanaleptics
p61357
g59079
sVPsychostimulants, Agents Used for Adhd and Nootropics
p61358
g53753
sVQuinones
p61359
(dp61360
sVProtective Agents
p61361
(dp61362
sg45
g12612
sVCoenzymes
p61363
g31644
sVCompounds used in a research, industrial, or household setting
p61364
(dp61365
sVEnzymes and Coenzymes
p61366
(dp61367
sVNervous System
p61368
(dp61369
sVAntioxidants
p61370
g54805
ssg7362
(dp61371
g10833
(dp61372
sg9918
(dp61373
sg11595
(dp61374
sg8595
(dp61375
sg11979
(dp61376
sg12000
(dp61377
sg1461
g24853
sg10596
(dp61378
sg7881
(dp61379
sg294
g14762
sg888
g20505
sg2427
g32065
sg2079
g29869
sg915
g20733
sg8097
(dp61380
sg9417
(dp61381
sg6726
g58294
sg7941
(dp61382
sg3399
g38657
sg8760
(dp61383
sg1101
g22081
sg11196
(dp61384
sg7470
(dp61385
sg10056
(dp61386
sg1611
g25832
ssg7365
(dp61387
g5934
g54105
sg11133
(dp61388
sg8751
(dp61389
sg7641
(dp61390
ssg7368
(dp61391
g6819
g58894
sg14791
(dp61392
ssg7371
(dp61393
g9879
(dp61394
sg6186
g55507
sg828
g19872
sg11415
(dp61395
sg7641
(dp61396
sg4650
g46626
sg1650
g26117
sg10797
(dp61397
sg8418
(dp61398
sg4929
g48430
sg6246
g55797
sg891
g20555
sg10701
(dp61399
sg7824
(dp61400
sg9216
(dp61401
sg3930
g41656
sg5268
g50133
sg9231
(dp61402
sg9750
(dp61403
sg9996
(dp61404
sg10758
(dp61405
sg11805
(dp61406
sg138
g13293
sg147
g13463
sg11535
(dp61407
sg171
g13711
sg10794
(dp61408
sg3990
g42105
sg3246
g37756
sg195
g13895
sg5589
g51937
sg7155
g60224
sg1770
g27052
sg7041
g59702
sg834
g19957
sg7812
(dp61409
sg6273
g55902
sg8166
(dp61410
sg4890
g48112
sg255
g14396
sg2583
g33075
sg4062
g42639
sg375
g15457
sg3111
g36825
sg4623
g46390
sg4638
g46536
sg288
g14674
sg9081
(dp61411
sg9402
(dp61412
sg4902
g48152
sg11820
(dp61413
sg6447
g57031
sg4926
g48402
sg10179
(dp61414
sg3399
g38641
sg11712
(dp61415
sg3408
g38712
sg8463
(dp61416
sg4974
g48625
sg1941
g28595
sg11769
(dp61417
sg1092
g21985
sg9828
(dp61418
sg11793
(dp61419
sg5028
g48789
sg450
g16345
sg978
g21172
sg10296
(dp61420
sg1041
g21509
sg879
g20360
sg168
g13651
sg3087
g36666
sg2658
g33374
sg7164
g60278
sg6594
g57698
sg10977
(dp61421
sg9591
(dp61422
sg11862
(dp61423
sg6024
g54457
sg969
g21083
sg5934
g54094
sg1578
g25648
sg564
g17412
sg5025
g48772
sg7698
(dp61424
sg11172
(dp61425
sg141
g13354
sg2895
g35439
sg603
g17764
sg1635
g26054
sg5757
g52929
sg3639
g40073
sg528
g16936
sg9366
(dp61426
sg5370
g50680
sg8964
(dp61427
sg12003
(dp61428
sg9726
(dp61429
sg1473
g24970
sg10494
(dp61430
sg4488
g45762
sg4491
g45794
sg3711
g40445
sg9009
(dp61431
sg9765
(dp61432
sg10512
(dp61433
sg3018
g36146
sg9393
(dp61434
sg9810
(dp61435
sg6843
g58969
sg3072
g36597
sg9252
(dp61436
sg7593
(dp61437
sg7596
(dp61438
sg5394
g50840
sg11649
(dp61439
ssg7374
(dp61440
g10263
(dp61441
sg657
g18358
sg5805
g53301
sg402
g15860
sg1035
g21454
sg11595
(dp61442
sg4827
g47769
sg10005
(dp61443
sg5235
g49866
sg5829
g53375
sg4452
g45455
sg4647
g46588
sg5289
g50315
sg1857
g27723
sg6759
g58568
sg11619
(dp61444
sg684
g18521
sg1869
g27844
sg6678
g58132
sg4056
g42598
sg1059
g21782
sg7164
g60294
sg375
g15477
sg2403
g31859
sg8433
(dp61445
sg9561
(dp61446
sg3696
g40309
sg2616
g33196
sg3531
g39260
sg8820
(dp61447
sg909
g20662
sg9591
(dp61448
sg8460
(dp61449
sg7317
g61059
sg3177
g37301
sg2262
g30982
sg12063
(dp61450
sg10557
(dp61451
sg1890
g27999
sg10164
(dp61452
sg9987
(dp61453
sg3036
g36457
sg3444
g38890
sg1719
g26852
sg9486
(dp61454
sg10761
(dp61455
sg7944
(dp61456
sg3114
g36887
sg1911
g28381
sg11160
(dp61457
sg1920
g28482
sg4959
g48557
sg1548
g25399
sg7764
(dp61458
sg8862
(dp61459
sg10098
(dp61460
sg6315
g56312
sg11910
(dp61461
sg10350
(dp61462
sg10410
(dp61463
sg7533
(dp61464
sg4419
g44888
sg3240
g37741
sg10227
(dp61465
sg915
g20738
sg7191
g60576
sg2304
g31254
sg1044
g21564
sg8595
(dp61466
sg609
g17836
sg3708
g40396
sg9012
(dp61467
sg9111
(dp61468
sg5580
g51885
ssg7377
(dp61469
VBSEP/ABCB11 Substrates
p61470
(dp61471
sVCytochrome P-450 CYP3A4 Inhibitors
p61472
(dp61473
sVCytochrome P-450 CYP3A Substrates
p61474
g45040
sVCytochrome P-450 CYP3A7 Inhibitors
p61475
(dp61476
sVAntibacterials for Systemic Use
p61477
g32529
sVAnti-Acne Preparations
p61478
(dp61479
sVOATP1B1/SLCO1B1 Inhibitors
p61480
(dp61481
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p61482
(dp61483
sVEnzyme Inhibitors
p61484
(dp61485
sVCytochrome P-450 Enzyme Inhibitors
p61486
(dp61487
sVAnti-Infective Agents
p61488
g54570
sVAntiinfectives for Systemic Use
p61489
(dp61490
sVMacrolide Antimicrobial
p61491
g59236
sVLactones
p61492
(dp61493
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61494
g29304
sVErythromycins
p61495
g45818
sVMacrolides, Lincosamides and Streptogramins
p61496
g33213
sVAnti-Bacterial Agents
p61497
g38321
sVMacrolides
p61498
g16905
sVOATP1B1/SLCO1B1 Substrates
p61499
(dp61500
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p61501
g24773
sVGastrointestinal Agents
p61502
(dp61503
sVOATP1B3 inhibitors
p61504
(dp61505
sVP-glycoprotein/ABCB1 Substrates
p61506
g34927
sVDermatologicals
p61507
g17206
sVErythromycin and similars
p61508
g49198
sVProtein Synthesis Inhibitors
p61509
g45552
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p61510
(dp61511
sVBSEP/ABCB11 Inhibitors
p61512
(dp61513
sVCytochrome P-450 CYP3A5 Substrates
p61514
(dp61515
sVCytochrome P-450 CYP3A4 Substrates
p61516
(dp61517
sVQTc Prolonging Agents
p61518
g57795
sVModerate Risk QTc-Prolonging Agents
p61519
(dp61520
sVAnti-Acne Preparations for Topical Use
p61521
(dp61522
sVOphthalmologicals
p61523
g35182
sVOATP1B3 substrates
p61524
g28520
sVCytochrome P-450 CYP3A Inhibitors
p61525
g60392
sVP-glycoprotein/ABCB1 Inhibitors
p61526
(dp61527
sVAntiinfectives for Treatment of Acne
p61528
(dp61529
sVCytochrome P-450 CYP3A7 Substrates
p61530
g60647
sVCytochrome P-450 CYP3A5 Inhibitors
p61531
g55343
ssg7380
(dp61532
g6228
g55716
ssg7383
(dp61533
g3099
g36740
ssg7386
(dp61534
g4014
g42254
sg1875
g27903
sg1629
g26003
sg6843
g58986
sg6246
g55818
sg9561
(dp61535
sg9810
(dp61536
sg657
g18364
sg9006
(dp61537
sg5025
g48783
sg10554
(dp61538
sg8832
(dp61539
ssg7389
(dp61540
VAnesthetics, General
p61541
g24706
sVCytochrome P-450 CYP3A Substrates
p61542
g45067
sVCentral Nervous System Agents
p61543
g58481
sVCycloparaffins
p61544
g43667
sg8775
(dp61545
sVCytochrome P-450 CYP2B6 Substrates
p61546
g33017
sVCytochrome P-450 CYP2B6 Inducers
p61547
g39120
sVCytochrome P-450 CYP3A4 Inducers (weak)
p61548
g19518
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61549
g29345
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p61550
g60073
sVCytochrome P-450 CYP3A4 Inducers
p61551
g18945
sVCyclohexanes
p61552
g33286
sVCytochrome P-450 CYP2C19 Substrates
p61553
g53889
sVCentral Nervous System Depressants
p61554
(dp61555
sVAnesthetics
p61556
g51607
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p61557
g26813
sVCytochrome P-450 Enzyme Inducers
p61558
g28203
sVCytochrome P-450 CYP3A Inducers
p61559
(dp61560
sVCytochrome P-450 CYP2C9 Substrates
p61561
g29781
sVCytochrome P-450 CYP3A4 Substrates
p61562
(dp61563
sVAntidepressive Agents
p61564
g15546
sVAgents producing tachycardia
p61565
g50779
sVPsychotropic Drugs
p61566
(dp61567
sVNervous System
p61568
(dp61569
ssg7392
(dp61570
g3573
g39540
ssg7395
(dp61571
VDrugs that are Mainly Renally Excreted
p61572
g43904
sVGlycosides
p61573
(dp61574
sVGastrointestinal Agents
p61575
(dp61576
sg1068
g21843
sVCarbohydrates
p61577
(dp61578
sVMetal divalent cations
p61579
(dp61580
sg7686
(dp61581
sVDrugs for Acid Related Disorders
p61582
g55175
sVAluminium Compounds
p61583
g18796
sg11517
(dp61584
sg5730
g52825
sVMetal cations
p61585
g40807
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p61586
(dp61587
sVOrganometallic Compounds
p61588
(dp61589
sVSulfur Compounds
p61590
(dp61591
sVAlimentary Tract and Metabolism
p61592
g23899
sVAnti-Ulcer Agents
p61593
(dp61594
ssg7398
(dp61595
g2553
g32907
sg10767
(dp61596
sg5415
g50947
sg3825
g41023
sg657
g18372
sg9561
(dp61597
ssg7401
(dp61598
g10245
(dp61599
ssg7404
(dp61600
g4911
g48294
sg4155
g43263
sg183
g13872
ssg7407
(dp61601
VAmino Acids, Peptides, and Proteins
p61602
g47340
sVRecombinant Proteins
p61603
(dp61604
sVGlucagon-like peptide-1 (GLP-1) analogues
p61605
g61314
sVPeptide Hormones
p61606
g20207
sVGastrointestinal Hormones
p61607
g40981
sVGlucagon-like Peptide-1 (GLP-1) Agonists
p61608
g44481
sVProteins
p61609
g52749
sVProglucagon
p61610
g47543
sVPeptides
p61611
g47175
sVPancreatic Hormones
p61612
(dp61613
sVGLP-1 Agonists
p61614
(dp61615
sg252
g14359
sVHormones
p61616
g55668
sVHormones, Hormone Substitutes, and Hormone Antagonists
p61617
g53152
sVIncretins
p61618
g20130
sVBlood Glucose Lowering Agents
p61619
(dp61620
sVAlimentary Tract and Metabolism
p61621
g23818
sVDrugs Used in Diabetes
p61622
g60111
sVProtein Precursors
p61623
g60677
ssg7410
(dp61624
g8373
(dp61625
sg690
g18590
sg3105
g36756
sg1326
g23579
sg30
g12350
sg3846
g41091
sg5256
g50023
sg3858
g41189
sg816
g19623
sg11283
(dp61626
sg7821
(dp61627
sg8265
(dp61628
sg5454
g51132
sg4653
g46649
sg1650
g26090
sg11151
(dp61629
sg3141
g37050
sg8022
(dp61630
sg2046
g29099
sg8445
(dp61631
sg6468
g57065
sg8448
(dp61632
sg2358
g31446
sg8454
(dp61633
sg9960
(dp61634
sg102
g12987
sg6807
g58803
sg9966
(dp61635
sg3174
g37246
sg6279
g55919
sg10728
(dp61636
sg7377
g61473
sg9231
(dp61637
sg2460
g32252
sg8874
(dp61638
sg11337
(dp61639
sg10758
(dp61640
sg8211
(dp61641
sg9144
(dp61642
sg8514
(dp61643
sg6186
g55472
sg9267
(dp61644
sg6303
g56178
sg147
g13427
sg12045
(dp61645
sg7764
(dp61646
sg3222
g37581
sg6315
g56274
sg11550
(dp61647
sg9906
(dp61648
sg6765
g58576
sg9462
(dp61649
sg4782
g47523
sg10356
(dp61650
sg204
g13940
sg8724
(dp61651
sg7041
g59671
sg7053
g59786
sg4017
g42265
sg6216
g55623
sg11592
(dp61652
sg7353
g61320
sg11601
(dp61653
sg9366
(dp61654
sg1050
g21645
sg12063
(dp61655
sg8787
(dp61656
sg8625
(dp61657
sg282
g14521
sg10122
(dp61658
sg9099
(dp61659
sg7884
(dp61660
sg5313
g50376
sg10899
(dp61661
sg3132
g36974
sg4077
g42816
sg11667
(dp61662
sg9663
(dp61663
sg5694
g52513
sg5208
g49732
sg12534
g52598
sg5739
g52851
sg8673
(dp61664
sg1881
g27927
sg4920
g48317
sg5853
g53521
sg9432
(dp61665
sg6435
g56947
sg1899
g28030
sg9444
(dp61666
sg9198
(dp61667
sg7947
(dp61668
sg1908
g28260
sg8703
(dp61669
sg1911
g28335
sg11733
(dp61670
sg10179
(dp61671
sg2688
g33680
sg4164
g43286
sg7191
g60538
sg402
g15822
sg11451
(dp61672
sg8190
(dp61673
sg11385
(dp61674
sg426
g16047
sg8433
(dp61675
sg10266
(dp61676
sg9918
(dp61677
sg3912
g41589
sg2481
g32381
sg456
g16369
sg9528
(dp61678
sg5832
g53386
sg1239
g22921
sg1047
g21571
sg10308
(dp61679
sg11052
(dp61680
sg4023
g42312
sg8055
(dp61681
sg2034
g28998
sg11838
(dp61682
sg8721
(dp61683
sg3516
g39142
sg5865
g53588
sg11079
(dp61684
sg6699
g58213
sg9564
(dp61685
sg10335
(dp61686
sg5877
g53662
sg11940
(dp61687
sg78
g12829
sg8820
(dp61688
sg11097
(dp61689
sg7299
g60892
sg9591
(dp61690
sg4299
g44420
sg2910
g35499
sg339
g15141
sg2838
g34770
sg3546
g39374
sg1503
g25158
sg9954
(dp61691
sg11136
(dp61692
sg6504
g57242
sg8856
(dp61693
sg3963
g41842
sg696
g18675
sg5127
g49208
sg4887
g48072
sg10416
(dp61694
sg11160
(dp61695
sg573
g17506
sg11166
(dp61696
sg4344
g44623
sg2142
g30329
sg11016
(dp61697
sg3570
g39444
sg9963
(dp61698
sg141
g13316
sg6687
g58176
sg28215
g35336
sg2895
g35397
sg10878
(dp61699
sg11931
(dp61700
sg609
g17800
sg621
g17935
sg3633
g40041
sg2196
g30638
sg2427
g31963
sg7428
(dp61701
sg2943
g35740
sg3657
g40155
sg4452
g45400
sg1434
g24613
sg10470
(dp61702
sg6033
g54492
sg6045
g54691
sg12126
(dp61703
sg8241
(dp61704
sg4479
g45669
sg4488
g45741
sg1113
g22155
sg10365
(dp61705
sg9009
(dp61706
sg6798
g58753
sg6090
g54921
sg3021
g36168
sg10518
(dp61707
sg3024
g36256
sg2769
g34270
sg11316
(dp61708
sg11241
(dp61709
sg1140
g22352
sg4539
g46008
sg2739
g33983
sg8298
(dp61710
sg11625
(dp61711
sg3783
g40855
sg10557
(dp61712
sg5289
g50237
sg771
g19261
sg5370
g50657
sg9084
(dp61713
sg9096
(dp61714
sg3651
g40097
sg7596
(dp61715
sg4596
g46232
sg819
g19719
ssg7413
(dp61716
g11910
(dp61717
sg2262
g30951
sg7164
g60261
sg375
g15431
sg3444
g38860
ssg7416
(dp61718
VIndoles
p61719
(dp61720
sVHistone Deacetylase Inhibitors
p61721
g40562
sVQTc Prolonging Agents
p61722
g57885
sVHeterocyclic Compounds, Fused-Ring
p61723
g56164
sVAmines
p61724
g42743
sVCytochrome P-450 CYP2D6 Inhibitors
p61725
(dp61726
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p61727
g41083
sVCytochrome P-450 CYP3A Substrates
p61728
g45166
sVHydroxy Acids
p61729
g18144
sg8853
(dp61730
sVP-glycoprotein/ABCB1 Substrates
p61731
g35085
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61732
g29458
sVImmunosuppressive Agents
p61733
(dp61734
sVAntineoplastic and Immunomodulating Agents
p61735
g39825
sVCytochrome P450 2D6 Inhibitors
p61736
(dp61737
sVEnzyme Inhibitors
p61738
(dp61739
sVHydroxylamines
p61740
g26073
sVCytochrome P-450 Enzyme Inhibitors
p61741
(dp61742
sVCytochrome P-450 CYP3A4 Substrates
p61743
(dp61744
sVAntineoplastic Agents
p61745
(dp61746
sVModerate Risk QTc-Prolonging Agents
p61747
(dp61748
ssg7419
(dp61749
g9153
(dp61750
sg6090
g54926
sg30
g12348
sg129
g13198
sg48
g12619
sg11427
(dp61751
sg3333
g38256
sg9411
(dp61752
sg858
g20152
sg11151
(dp61753
sg6171
g55322
sg2397
g31778
sg10701
(dp61754
sg9216
(dp61755
sg3609
g39679
sg3174
g37244
sg10725
(dp61756
sg4707
g46979
sg9261
(dp61757
sg3204
g37420
sg19588
g32485
sg3207
g37482
sg5577
g51825
sg3981
g42040
sg1761
g27006
sg10047
(dp61758
sg4008
g42197
sg7044
g59731
sg1782
g27126
sg10833
(dp61759
sg4890
g48115
sg8595
(dp61760
sg11604
(dp61761
sg4845
g47852
sg87
g12899
sg4521
g45952
sg11631
(dp61762
sg4068
g42759
sg10122
(dp61763
sg7881
(dp61764
sg3183
g37339
sg5691
g52474
sg6447
g57023
sg9414
(dp61765
sg11826
(dp61766
sg10698
(dp61767
sg6489
g57214
sg7161
g60247
sg372
g15399
sg10200
(dp61768
sg7977
(dp61769
sg11751
(dp61770
sg8010
(dp61771
sg9918
(dp61772
sg7815
(dp61773
sg11799
(dp61774
sg9528
(dp61775
sg474
g16548
sg9540
(dp61776
sg11061
(dp61777
sg11838
(dp61778
sg3015
g36075
sg5865
g53586
sg10326
(dp61779
sg11085
(dp61780
sg4287
g44362
sg5085
g49033
sg21710
g54031
sg5889
g53766
sg5073
g48974
sg10368
(dp61781
sg1527
g25259
sg6240
g55764
sg7662
(dp61782
sg7698
(dp61783
sg3576
g39558
sg9657
(dp61784
sg28215
g35341
sg1101
g22043
sg10878
(dp61785
sg357
g15296
sg11934
(dp61786
sg7395
g61578
sg4953
g48489
sg11208
(dp61787
sg6549
g57473
sg5520
g51538
sg3318
g38169
sg7470
(dp61788
sg8985
(dp61789
sg6150
g55179
sg7500
(dp61790
sg10509
(dp61791
sg8670
(dp61792
sg6906
g59215
sg11301
(dp61793
sg7521
(dp61794
sg2739
g33981
sg11334
(dp61795
sg3297
g38027
sg1275
g23271
sg10554
(dp61796
sg3264
g37863
sg12090
(dp61797
sg4581
g46206
sg8274
(dp61798
sg6654
g58037
sg9096
(dp61799
sg5382
g50721
ssg7422
(dp61800
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p61801
(dp61802
sVSerotonin Agents
p61803
(dp61804
sVCytochrome P-450 CYP3A Substrates
p61805
g45076
sVNeurotransmitter Agents
p61806
(dp61807
sVDopamine Agonists
p61808
g56750
sVCentral Nervous System Agents
p61809
g58498
sVDopamine Agents
p61810
g14226
sVAdrenergic Antagonists
p61811
g52265
sVSympatholytic (Adrenergic Blocking) Agents
p61812
g44226
sVNootropic Agents
p61813
g42801
sVErgot Alkaloids and Derivatives
p61814
g49009
sVErgot-derivative Dopamine Receptor Agonists
p61815
g35984
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61816
g29355
sVAdrenergic alpha-Antagonists
p61817
g60862
sVAdrenergic Agents
p61818
g41687
sVCentral Nervous System Depressants
p61819
(dp61820
sVCardiovascular Agents
p61821
g26623
sVVasodilating Agents
p61822
g23705
sVAgents that produce hypertension
p61823
(dp61824
sVCytochrome P-450 CYP3A4 Substrates
p61825
(dp61826
sVHeterocyclic Compounds, Fused-Ring
p61827
g56132
sVSerotonin Modulators
p61828
(dp61829
sVAntidepressive Agents
p61830
g15563
sg9666
(dp61831
sVErgotamines
p61832
(dp61833
sVAlkaloids
p61834
g19396
sVPeripheral Vasodilators
p61835
g46223
ssg7425
(dp61836
g12274
g27503
sg1470
g24893
sg507
g16758
sg5433
g51022
sg849
g20068
sg3117
g36897
sg3543
g39314
sg14822
g41805
sg2133
g30278
ssg7428
(dp61837
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p61838
g52087
sVCytochrome P-450 CYP3A4 Inhibitors
p61839
g61701
sVCytochrome P-450 CYP2D6 Substrates
p61840
g52178
sVUGT1A1 Substrates
p61841
g12268
sVAnalgesics
p61842
g26484
sVCentral Nervous System Agents
p61843
g58487
sVUGT1A9 Substrates
p61844
g23995
sVAnilides
p61845
(dp61846
sVCytochrome P-450 Enzyme Inhibitors
p61847
(dp61848
sVMethemoglobinemia Associated Agents
p61849
g25559
sVDrugs that are Mainly Renally Excreted
p61850
g43907
sVCytochrome P-450 CYP1A2 Substrates
p61851
g45619
sVAmines
p61852
g42722
sVAmides
p61853
g44345
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61854
g29357
sVAniline Compounds
p61855
g23417
sVCytochrome P-450 CYP3A4 Inducers
p61856
g18961
sVCytochrome P-450 CYP3A Substrates
p61857
g45078
sVUGT1A6 substrate
p61858
g38512
sVP-glycoprotein/ABCB1 Substrates
p61859
g35050
sVAntipyretics
p61860
(dp61861
sVCytochrome P-450 CYP2A6 Substrates
p61862
g35121
sVAcetaminophen and Prodrugs
p61863
(dp61864
sVCytochrome P-450 Enzyme Inducers
p61865
g28221
sVCytochrome P-450 CYP3A Inducers
p61866
(dp61867
sVCytochrome P-450 CYP3A4 Substrates
p61868
(dp61869
sVAnalgesics, Non-Narcotic
p61870
g56891
sVCytochrome P-450 CYP3A Inhibitors
p61871
g60464
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p61872
(dp61873
sVCytochrome P-450 CYP2E1 Substrates
p61874
(dp61875
sVP-glycoprotein/ABCB1 Inhibitors
p61876
(dp61877
sVSensory System Agents
p61878
(dp61879
sVNervous System
p61880
(dp61881
sVMiscellaneous Analgesics and Antipyretics
p61882
g43121
ssg7431
(dp61883
VImmunosuppressive Agents
p61884
(dp61885
sVCytochrome P-450 CYP3A Substrates
p61886
g45079
sVAntifungal Agents
p61887
(dp61888
sVAgents causing angioedema
p61889
(dp61890
sVDecreased Immunologic Activity
p61891
g59904
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p61892
(dp61893
sVKinase Inhibitor
p61894
g24600
sVOATP1B1/SLCO1B1 Inhibitors
p61895
(dp61896
sVAnti-Infective Agents
p61897
g54647
sVmTOR Inhibitors
p61898
g35161
sVHyperglycemia-Associated Agents
p61899
(dp61900
sVP-glycoprotein/ABCB1 Inducers
p61901
(dp61902
sVMyelosuppressive Agents
p61903
(dp61904
sVmTOR Inhibitor Immunosuppressant
p61905
(dp61906
sVLactones
p61907
(dp61908
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p61909
g29358
sVAnti-Bacterial Agents
p61910
g38375
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p61911
g60058
sVImmunologic Factors
p61912
g42372
sg2829
g34626
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p61913
g49150
sVSelective Immunosuppressants
p61914
g23568
sVP-glycoprotein/ABCB1 Substrates
p61915
g35051
sVSensory Organs
p61916
g40727
sVMacrolides
p61917
g16907
sVProtein Kinase Inhibitors
p61918
(dp61919
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p61920
(dp61921
sVCytochrome P-450 CYP3A4 Substrates
p61922
(dp61923
sVNarrow Therapeutic Index Drugs
p61924
g50548
sVCytochrome P-450 CYP3A5 Substrates
p61925
(dp61926
sVOphthalmologicals
p61927
g35249
sVCYP3A Substrates (Sensitive)
p61928
(dp61929
sVAntibiotics, Antineoplastic
p61930
g30415
sVP-glycoprotein/ABCB1 Inhibitors
p61931
(dp61932
sVAntineoplastic and Immunomodulating Agents
p61933
g39801
sVPolyketides
p61934
g48465
sVCytochrome P-450 CYP3A7 Substrates
p61935
g60670
ssg7434
(dp61936
g2985
g35912
sg9870
(dp61937
ssg7437
(dp61938
g2283
g31151
sg10878
(dp61939
ssg7440
(dp61940
g6291
g56009
sg7740
(dp61941
sg3072
g36585
sg5007
g48702
sg7077
g60018
sg3696
g40275
sg6000
g54300
sg7596
(dp61942
sg9009
(dp61943
ssg7443
(dp61944
g2805
g34455
ssg7446
(dp61945
g3105
g36766
sg1326
g23588
sg30
g12358
sg6192
g55551
sg12421
g12434
sg9144
(dp61946
sg816
g19644
sg6318
g56342
sg48
g12628
sg9165
(dp61947
sg10797
(dp61948
sg3141
g37057
sg6186
g55487
sg10818
(dp61949
sg4887
g48082
sg102
g13001
sg6807
g58808
sg3174
g37254
sg6279
g55935
sg9225
(dp61950
sg9231
(dp61951
sg132
g13232
sg138
g13277
sg9267
(dp61952
sg6303
g56201
sg147
g13441
sg9273
(dp61953
sg3222
g37592
sg6315
g56287
sg5169
g49505
sg3240
g37703
sg7077
g60021
sg6333
g56457
sg10356
(dp61954
sg204
g13950
sg5739
g52860
sg7053
g59795
sg8166
(dp61955
sg7353
g61330
sg12066
(dp61956
sg9366
(dp61957
sg3318
g38174
sg10662
(dp61958
sg87
g12905
sg4653
g46668
sg282
g14541
sg603
g17785
sg9417
(dp61959
sg9432
(dp61960
sg9444
(dp61961
sg6504
g57251
sg14791
(dp61962
sg3432
g38788
sg387
g15619
sg402
g15836
sg3447
g38914
sg6537
g57392
sg414
g15948
sg426
g16069
sg9198
(dp61963
sg2430
g32097
sg444
g16240
sg2481
g32395
sg456
g16403
sg9528
(dp61964
sg168
g13627
sg2658
g33353
sg8721
(dp61965
sg3516
g39153
sg2736
g33941
sg9564
(dp61966
sg78
g12838
sg9588
(dp61967
sg9591
(dp61968
sg2910
g35521
sg534
g16977
sg9618
(dp61969
sg3546
g39382
sg3021
g36183
sg3036
g36427
sg7944
(dp61970
sg564
g17399
sg11439
(dp61971
sg573
g17528
sg3570
g39463
sg582
g17619
sg6687
g58179
sg1188
g22766
sg9663
(dp61972
sg609
g17808
sg621
g17950
sg3627
g39921
sg3633
g40061
sg3651
g40108
sg3657
g40165
sg6765
g58587
sg690
g18606
sg3696
g40278
sg10740
(dp61973
sg6798
g58760
sg486
g16641
sg9393
(dp61974
sg3783
g40864
sg771
g19276
sg789
g19483
sg11283
(dp61975
sg7464
(dp61976
sg3846
g41116
sg3858
g41204
sg6882
g59111
sg4788
g47560
sg834
g19947
sg9906
(dp61977
sg6819
g58861
sg11016
(dp61978
sg888
g20435
sg3912
g41603
sg9954
(dp61979
sg9960
(dp61980
sg9963
(dp61981
sg15016
(dp61982
sg9966
(dp61983
sg7377
g61487
sg11337
(dp61984
sg945
g20886
sg10170
(dp61985
sg10005
(dp61986
sg5469
g51282
sg3978
g41976
sg11523
(dp61987
sg7029
g59630
sg10056
(dp61988
sg7041
g59684
sg1014
g21335
sg4017
g42271
sg4023
g42324
sg7707
(dp61989
sg7065
g59920
sg1044
g21538
sg1050
g21657
sg1062
g21798
sg10122
(dp61990
sg3111
g36840
sg4077
g42823
sg4782
g47525
sg6348
g56628
sg11820
(dp61991
sg9462
(dp61992
sg6435
g56961
sg3753
g40624
sg10179
(dp61993
sg8760
(dp61994
sg7176
g60350
sg4164
g43295
sg6729
g58340
sg7188
g60493
sg7191
g60545
sg7197
g60597
sg465
g16455
sg10266
(dp61995
sg10017
(dp61996
sg1239
g22936
sg1047
g21592
sg10308
(dp61997
sg1248
g23057
sg4263
g44149
sg10335
(dp61998
sg4287
g44372
sg7329
g61126
sg7335
g61193
sg4299
g44446
sg10365
(dp61999
sg1503
g25170
sg7569
(dp62000
sg10416
(dp62001
sg4344
g44647
sg7884
(dp62002
sg1371
g24085
sg8019
(dp62003
sg4425
g44918
sg2427
g32001
sg4437
g45303
sg7428
g61848
sg4452
g45417
sg1434
g24637
sg8211
(dp62004
sg1461
g24811
sg4479
g45683
sg10593
(dp62005
sg4488
g45748
sg1491
g25059
sg10512
(dp62006
sg10518
(dp62007
sg10521
(dp62008
sg4539
g46020
sg2739
g33991
sg4542
g46088
sg10557
(dp62009
sg10563
(dp62010
sg8949
(dp62011
sg7593
(dp62012
sg11241
(dp62013
sg4596
g46243
sg7608
(dp62014
sg819
g19735
sg9249
(dp62015
sg4635
g46472
sg4647
g46567
sg4650
g46610
sg7650
(dp62016
sg1650
g26098
sg9507
(dp62017
sg10701
(dp62018
sg3543
g39322
sg10728
(dp62019
sg4716
g47060
sg10752
(dp62020
sg7734
(dp62021
sg10758
(dp62022
sg10761
(dp62023
sg7764
(dp62024
sg10794
(dp62025
sg10815
(dp62026
sg10839
(dp62027
sg4830
g47789
sg12274
g27517
sg4857
g47896
sg4863
g47932
sg10899
(dp62028
sg288
g14655
sg4680
g46870
sg1881
g27943
sg4920
g48329
sg11151
(dp62029
sg4926
g48385
sg1899
g28048
sg7941
(dp62030
sg7947
(dp62031
sg1908
g28283
sg10950
(dp62032
sg1911
g28351
sg6048
g54740
sg4974
g48608
sg5256
g50047
sg11385
(dp62033
sg8022
(dp62034
sg5028
g48805
sg2013
g28945
sg8049
(dp62035
sg8055
(dp62036
sg2034
g29008
sg5064
g48928
sg11079
(dp62037
sg11097
(dp62038
sg8097
(dp62039
sg339
g15157
sg2109
g30110
sg11136
(dp62040
sg5127
g49219
sg11160
(dp62041
sg69
g12752
sg11166
(dp62042
sg2142
g30343
sg141
g13332
sg9465
(dp62043
sg5295
g50353
sg336
g15079
sg6525
g57344
sg8190
(dp62044
sg2196
g30607
sg8205
(dp62045
sg10470
(dp62046
sg11229
(dp62047
sg2211
g30750
sg5235
g49824
sg5250
g49962
sg8241
(dp62048
sg9687
(dp62049
sg822
g19824
sg1113
g22171
sg8265
(dp62050
sg2265
g31000
sg5313
g50392
sg5316
g50431
sg11316
(dp62051
sg1140
g22358
sg5238
g49900
sg8298
(dp62052
sg2289
g31212
sg5289
g50257
sg7416
g61742
sg5370
g50662
sg7563
(dp62053
sg8373
(dp62054
sg2346
g31358
sg1674
g26322
sg2358
g31468
sg5433
g51034
sg7821
(dp62055
sg5454
g51142
sg8421
(dp62056
sg11451
(dp62057
sg8433
(dp62058
sg11460
(dp62059
sg2046
g29107
sg8445
(dp62060
sg5499
g51407
sg2088
g29900
sg8448
(dp62061
sg8454
(dp62062
sg7485
(dp62063
sg2460
g32266
sg5535
g51651
sg450
g16329
sg8514
(dp62064
sg5556
g51713
sg11550
(dp62065
sg2616
g33171
sg2538
g32823
sg2676
g33563
sg8724
(dp62066
sg2559
g32940
sg11592
(dp62067
sg11601
(dp62068
sg8916
(dp62069
sg5652
g52373
sg3024
g36266
sg8625
(dp62070
sg9099
(dp62071
sg11655
(dp62072
sg11052
(dp62073
sg3132
g36996
sg11667
(dp62074
sg8655
(dp62075
sg5694
g52529
sg5208
g49734
sg12534
g52617
sg8673
(dp62076
sg9357
(dp62077
sg8703
(dp62078
sg11733
(dp62079
sg2688
g33617
sg5757
g52920
sg2703
g33738
sg2730
g33891
sg5793
g53207
sg9918
(dp62080
sg5805
g53271
sg11793
(dp62081
sg1425
g24539
sg5832
g53401
sg8787
(dp62082
sg2784
g34354
sg5853
g53537
sg11838
(dp62083
sg5865
g53595
sg6699
g58219
sg5877
g53672
sg11940
(dp62084
sg8820
(dp62085
sg2838
g34786
sg8856
(dp62086
sg696
g18709
sg8874
(dp62087
sg28215
g35350
sg2895
g35417
sg10878
(dp62088
sg11931
(dp62089
sg2913
g35589
sg11955
(dp62090
sg2943
g35750
sg11979
(dp62091
sg2946
g35808
sg6033
g54504
sg6093
g54993
sg6045
g54696
sg9084
(dp62092
sg9525
(dp62093
sg12018
(dp62094
sg6468
g57085
sg5526
g51570
sg9009
(dp62095
sg12045
(dp62096
sg6090
g54936
sg12063
(dp62097
sg2769
g34285
sg7596
(dp62098
sg2832
g34689
sg6000
g54303
sg6123
g55128
sg3072
g36589
sg5181
g49573
sg12126
(dp62099
sg6075
g54872
sg9096
(dp62100
sg1185
g22712
ssg7449
(dp62101
g8850
(dp62102
ssg7452
(dp62103
g10557
(dp62104
sg9225
(dp62105
sg1470
g24897
sg3783
g40865
ssg7455
(dp62106
g12015
(dp62107
sg9705
(dp62108
ssg7458
(dp62109
VAgents Causing Muscle Toxicity
p62110
g55370
sVBSEP/ABCB11 Substrates
p62111
(dp62112
sVHypolipidemic Agents
p62113
(dp62114
sVAnticholesteremic Agents
p62115
g50592
sVOATP1B3 substrates
p62116
g28535
sVLipid Modifying Agents
p62117
g40537
sVToxic Actions
p62118
g49375
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p62119
g25227
sVNoxae
p62120
(dp62121
sVOAT3/SLC22A8 Inhibitors
p62122
g59004
sVBCRP/ABCG2 Substrates
p62123
g42067
sVBCRP/ABCG2 Inhibitors
p62124
g12521
sVOAT3/SLC22A8 Substrates
p62125
g13116
sVP-glycoprotein/ABCB1 Substrates
p62126
g34961
sVLipid Modifying Agents, Plain
p62127
(dp62128
sVOAT1/SLC22A6 inhibitors
p62129
(dp62130
sVEnzyme Inhibitors
p62131
(dp62132
sVOATP1B1/SLCO1B1 Substrates
p62133
(dp62134
sVLipid Regulating Agents
p62135
(dp62136
ssg7461
(dp62137
g5727
g52805
sg11958
(dp62138
ssg7464
(dp62139
VAnalgesics and Anesthetics
p62140
g49750
sVCytochrome P-450 CYP2D6 Inhibitors
p62141
(dp62142
sVCytochrome P-450 CYP2D6 Substrates
p62143
g52107
sVAntiarrhythmic agents
p62144
(dp62145
sVCytochrome P-450 CYP3A Substrates
p62146
g45028
sVCentral Nervous System Agents
p62147
g58400
sVAnesthetics, Local
p62148
g53469
sVAnilides
p62149
(dp62150
sVOtologicals
p62151
(dp62152
sVLocal Anesthesia
p62153
g14960
sVCytochrome P-450 Enzyme Inhibitors
p62154
g61976
sVThroat Preparations
p62155
(dp62156
sVPeripheral Nervous System Agents
p62157
g57572
sVCytochrome P-450 CYP2C8 Substrates
p62158
(dp62159
sVCytochrome P-450 CYP1A2 Substrates
p62160
g45563
sVAmines
p62161
g42661
sVAntipruritics and Local Anesthetics
p62162
g31865
sVCardiac Therapy
p62163
(dp62164
sVAmides
p62165
g44292
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p62166
g16813
sVAniline Compounds
p62167
g23423
sVVasoprotectives
p62168
g41376
sVCytochrome P-450 CYP2C9 Substrates
p62169
g29703
sVCardiovascular Agents
p62170
g26517
sVAnesthetics
p62171
g51598
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62172
g29288
sVAgents that reduce seizure threshold
p62173
g45834
sVCytochrome P-450 CYP1A2 Inhibitors
p62174
g15007
sVDermatologicals
p62175
g17178
sVAnesthetics for Topical Use
p62176
g43179
sVCytochrome P-450 CYP2A6 Substrates
p62177
g35118
sVCytochrome P-450 CYP2C18 Substrates
p62178
g20926
sVMembrane Transport Modulators
p62179
g54117
sVNeuraxial Anesthetics
p62180
g32590
sVCytochrome P-450 CYP3A4 Substrates
p62181
(dp62182
sVSodium Channel Blockers
p62183
(dp62184
sVOphthalmologicals
p62185
g35166
sVAntiarrhythmics, Class I
p62186
(dp62187
sVVoltage-Gated Sodium Channel Blockers
p62188
g40903
sVCytochrome P-450 CYP3A5 Substrates
p62189
(dp62190
sVAmide Local Anesthetic
p62191
(dp62192
sVMethemoglobinemia Associated Agents
p62193
g25555
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p62194
g53058
sVP-glycoprotein/ABCB1 Inhibitors
p62195
(dp62196
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p62197
(dp62198
sVAntiarrhythmics, Class Ib
p62199
g50588
sVSensory System Agents
p62200
(dp62201
sVNervous System
p62202
(dp62203
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p62204
g27734
sVCytochrome P-450 CYP3A7 Substrates
p62205
g60642
sVCytochrome P-450 CYP2B6 Substrates
p62206
g33000
ssg7467
(dp62207
g10200
(dp62208
sg21710
g54029
sg3699
g40325
sg3105
g36776
sg8529
(dp62209
sg5556
g51722
sg8022
(dp62210
sg8439
(dp62211
sg7680
(dp62212
sg9660
(dp62213
sg10272
(dp62214
sg8340
(dp62215
sg6150
g55191
sg1581
g25688
sg11664
(dp62216
sg2826
g34606
sg10245
(dp62217
sg12186
g42923
sg5511
g51475
ssg7470
(dp62218
VAmino Acids, Peptides, and Proteins
p62219
g47405
sVAntiinfectives for Systemic Use
p62220
(dp62221
sVAgents that produce neuromuscular block (indirect)
p62222
g37984
sVNephrotoxic agents
p62223
g57736
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p62224
g61385
sVDrugs that are Mainly Renally Excreted
p62225
g43910
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p62226
g59974
sVCarbohydrates
p62227
g61788
sg3384
g38505
sVIntestinal Antiinfectives
p62228
(dp62229
sg10137
(dp62230
sVPeptides
p62231
g47205
sVGlycoconjugates
p62232
(dp62233
sVAnti-Bacterial Agents
p62234
g38382
sVAntibacterials for Systemic Use
p62235
g32579
sVAnti-Infective Agents
p62236
g54663
sVAlimentary Tract and Metabolism
p62237
g23915
sVNarrow Therapeutic Index Drugs
p62238
g50556
sg11547
(dp62239
ssg7473
(dp62240
g4977
g48656
ssg7476
(dp62241
g7563
(dp62242
sg4263
g44160
ssg7479
(dp62243
g4911
g48252
sg12123
(dp62244
sg1656
g26174
ssg7482
(dp62245
g8088
(dp62246
sg5463
g51249
sg402
g15844
sg8808
(dp62247
sg4821
g47752
sg6015
g54385
sg4053
g42558
sg8796
(dp62248
sg4365
g44762
sg10338
(dp62249
sg7407
g61613
sg4338
g44578
sg11160
(dp62250
sg2253
g30904
sg1776
g27096
sg5514
g51508
ssg7485
(dp62251
VAntiarrhythmics, Class I
p62252
(dp62253
sVVoltage-Gated Sodium Channel Blockers
p62254
g40908
sVPiperidines
p62255
(dp62256
sVCardiovascular Agents
p62257
g26541
sVCytochrome P-450 CYP2D6 Substrates
p62258
g52119
sVAntiarrhythmic agents
p62259
(dp62260
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p62261
g36633
sVCardiac Therapy
p62262
(dp62263
sVAntiarrhythmics, Class Ic
p62264
g20872
sVSodium Channel Blockers
p62265
(dp62266
sVMembrane Transport Modulators
p62267
g54127
sVCytochrome P-450 CYP2C9 Inhibitors
p62268
g18242
sVCytochrome P-450 Enzyme Inhibitors
p62269
g62063
sVQTc Prolonging Agents
p62270
g57873
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p62271
(dp62272
sVNarrow Therapeutic Index Drugs
p62273
g50560
sVModerate Risk QTc-Prolonging Agents
p62274
(dp62275
ssg7488
(dp62276
g10725
(dp62277
sg1881
g27941
ssg7491
(dp62278
g3627
g39930
sg438
g16189
sg2373
g31591
sg444
g16250
sg816
g19664
sg7353
g61341
sg11601
(dp62279
sg690
g18631
sg7377
g61505
sg3132
g37009
sg1062
g21810
sg11451
(dp62280
sg4479
g45704
sg11079
(dp62281
sg11460
(dp62282
sg11052
(dp62283
sg2844
g34893
sg6468
g57101
sg5514
g51499
sg4911
g48244
sg3021
g36205
sg2829
g34649
sg4920
g48348
sg2652
g33311
sg2460
g32280
sg2391
g31724
sg2274
g31071
sg9834
(dp62284
sg4539
g46034
sg4467
g45543
sg9180
(dp62285
sg573
g17558
sg11166
(dp62286
sg2142
g30359
sg1371
g24079
sg9663
(dp62287
sg7800
(dp62288
sg11940
(dp62289
sg819
g19751
ssg7494
(dp62290
g13750
g24376
sg4653
g46692
sg7545
(dp62291
sg4113
g43041
sg1614
g25869
sg5766
g52979
sg6345
g56583
sg6045
g54704
sg12534
g52639
ssg7497
(dp62292
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p62293
(dp62294
sVCytochrome P-450 CYP2D6 Substrates
p62295
g52195
sVSerotonin Agents
p62296
(dp62297
sVCytochrome P-450 CYP3A Substrates
p62298
g45087
sVSerotonin Receptor Antagonists
p62299
g35680
sVCentral Nervous System Agents
p62300
g58511
sVPsychotropic Drugs
p62301
(dp62302
sVAntipsychotic Agents
p62303
(dp62304
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62305
g29366
sVPsycholeptics
p62306
g33250
sVSerotonin 5-HT2 Receptor Antagonists
p62307
(dp62308
sVCentral Nervous System Depressants
p62309
(dp62310
sVHistamine H1 Antagonists
p62311
g40785
sVAgents that produce hypertension
p62312
(dp62313
sVCytochrome P-450 CYP3A4 Substrates
p62314
(dp62315
sVSerotonin 5-HT1 Receptor Agonists
p62316
g34587
sVAntidepressive Agents
p62317
g15574
sVTranquilizing Agents
p62318
g55301
sVNeurotoxic agents
p62319
(dp62320
sVHistamine Antagonists
p62321
g43446
sVSerotonin Receptor Agonists
p62322
(dp62323
sVNervous System
p62324
(dp62325
sVAntipsychotic Agents (Second Generation [Atypical])
p62326
g52064
ssg7500
(dp62327
VAgents Causing Muscle Toxicity
p62328
g55399
sVDideoxynucleosides
p62329
g48722
sVAntivirals for Systemic Use
p62330
g59777
sVNucleic Acid Synthesis Inhibitors
p62331
g48736
sVCarbohydrates
p62332
g61790
sVPyrimidines
p62333
g47712
sVDirect Acting Antivirals
p62334
g38081
sVAnti-HIV Agents
p62335
(dp62336
sVBCRP/ABCG2 Substrates
p62337
g42088
sVEnzyme Inhibitors
p62338
(dp62339
sVReverse Transcriptase Inhibitors
p62340
g28959
sVAnti-Infective Agents
p62341
g54582
sVAntiinfectives for Systemic Use
p62342
(dp62343
sVDrugs that are Mainly Renally Excreted
p62344
g43912
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p62345
g14470
sVDeoxyribonucleosides
p62346
g33060
sVRibonucleosides
p62347
(dp62348
sVCytidine
p62349
(dp62350
sVDeoxycytidine
p62351
g12702
sVOCT2 substrates with narrow therapeutic index
p62352
g29688
sVGlycosides
p62353
(dp62354
sVOCT2 Substrates
p62355
g14945
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p62356
g38163
sVOCT1 substrates
p62357
g13074
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p62358
(dp62359
sVNucleic Acids, Nucleotides, and Nucleosides
p62360
g47131
sVP-glycoprotein/ABCB1 Substrates
p62361
g34937
sVPyrimidine Nucleosides
p62362
(dp62363
sVAnti-Retroviral Agents
p62364
(dp62365
sVOAT1/SLC22A6 Substrates
p62366
g60720
sVNucleosides
p62367
g49463
sVNucleoside Reverse Transcriptase Inhibitors
p62368
g38845
sVAntiviral Agents
p62369
g30473
sg993
g21205
ssg7503
(dp62370
g4713
g47039
ssg7506
(dp62371
g11175
(dp62372
ssg7509
(dp62373
g3882
g41423
ssg7512
(dp62374
VAmino Acids, Peptides, and Proteins
p62375
g47409
sVGlobulins
p62376
g19181
sVAntibodies
p62377
g60986
sVGastrointestinal Agents
p62378
(dp62379
sVAntibodies, Monoclonal
p62380
(dp62381
sVImmunoglobulins
p62382
g41527
sVProteins
p62383
g52788
sVSerum Globulins
p62384
g49658
sVAntineoplastic and Immunomodulating Agents
p62385
g39818
sVBlood Proteins
p62386
g39859
sVAntineoplastic Agents
p62387
(dp62388
sVImmunoproteins
p62389
g57451
ssg7515
(dp62390
g9750
(dp62391
sg1176
g22660
sg1278
g23318
sg7653
(dp62392
ssg7518
(dp62393
g3027
g36362
sg6807
g58823
ssg7521
(dp62394
VFibrin Modulating Agents
p62395
g22864
sVHematologic Agents
p62396
(dp62397
sVBlood and Blood Forming Organs
p62398
g53916
sVCardiovascular Agents
p62399
g26673
sVPolysaccharides
p62400
g41785
sVAnticoagulants
p62401
g58375
sVCarbohydrates
p62402
g61794
sVAgents causing hyperkalemia
p62403
g43591
sVHeparin (Low Molecular Weight)
p62404
g57891
sVHeparins
p62405
(dp62406
sVGlycosaminoglycans
p62407
g26080
sVHeparin and similars
p62408
(dp62409
sVHeparin Group
p62410
g34338
ssg7524
(dp62411
VAntiinfectives for Systemic Use
p62412
(dp62413
sVDirect Acting Antivirals
p62414
g38069
sVAntivirals for Systemic Use
p62415
g59768
sVHIV Fusion Inhibitors
p62416
g52911
sVCytochrome P-450 CYP3A Substrates
p62417
g45169
sVAnti-Infective Agents
p62418
g54679
sg9933
(dp62419
sVAntiviral Agents
p62420
g30460
sVViral Fusion Protein Inhibitors
p62421
g37229
sVCycloparaffins
p62422
g43669
sVCYP3A Substrates (Sensitive)
p62423
(dp62424
sVAnti-HIV Agents
p62425
(dp62426
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62427
g29461
sVTriazoles
p62428
g47837
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p62429
g60091
sVCytochrome P-450 CYP3A4 Substrates
p62430
(dp62431
sVAnti-Retroviral Agents
p62432
(dp62433
sg3129
g36969
sVCyclohexanes
p62434
g33281
ssg7527
(dp62435
VAntiparasitic Products, Insecticides and Repellents
p62436
g30575
sg6456
g57050
sVToxic Actions
p62437
g49379
sVAgents that reduce seizure threshold
p62438
g45858
sVInsecticides
p62439
g40090
sVHydrocarbons, Halogenated
p62440
(dp62441
sVCompounds used in a research, industrial, or household setting
p62442
(dp62443
sVPesticides
p62444
(dp62445
sVEctoparasiticides, Incl. Scabicides
p62446
g57546
sVEctoparasiticides, Incl. Scabicides, Insecticides and Repellents
p62447
g44412
sVHydrocarbons, Chlorinated
p62448
(dp62449
sVAgrochemicals
p62450
(dp62451
ssg7530
(dp62452
VCalcium Compounds
p62453
g51124
sVElectrolyte Solutions
p62454
g20027
sVCalcium Salts
p62455
g54683
sVReplacement Preparations
p62456
g27633
sVElectrolytes
p62457
g52414
sVMineral Supplements
p62458
g38296
sVPhosphate Binder
p62459
g21942
sVChlorine Compounds
p62460
g33265
sVI.V. Solution Additives
p62461
g37232
sVHydrochloric Acid
p62462
(dp62463
sVBlood and Blood Forming Organs
p62464
g53927
sVChlorides
p62465
g27979
sVIons
p62466
g49114
sVAcids
p62467
g40569
sg3948
g41787
sVUrologicals
p62468
g58910
sVAlimentary Tract and Metabolism
p62469
g23822
sVBlood Coagulation Factors
p62470
(dp62471
sVBlood Substitutes and Perfusion Solutions
p62472
g49446
sVGenito Urinary System and Sex Hormones
p62473
(dp62474
sVAcids, Noncarboxylic
p62475
g54194
sVAnions
p62476
(dp62477
sVHemodialysis Solution
p62478
g36613
sVAcidifiers
p62479
(dp62480
ssg7533
(dp62481
VPsychoanaleptics
p62482
g59081
sVCytochrome P-450 CYP2D6 Substrates
p62483
g52126
sVCytochrome P-450 CYP3A Substrates
p62484
g44976
sVNeurotransmitter Agents
p62485
(dp62486
sVCentral Nervous System Agents
p62487
g58434
sVPotential QTc-Prolonging Agents
p62488
(dp62489
sVEnzyme Inhibitors
p62490
(dp62491
sVParasympathomemetic (Cholinergic) Agents
p62492
(dp62493
sVPiperidines
p62494
(dp62495
sVCholinergic Agents
p62496
g28731
sg6927
g59287
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62497
g29214
sVCytochrome P-450 CYP2C9 Substrates
p62498
g29728
sVQTc Prolonging Agents
p62499
g57810
sVCentral Nervous System Depressants
p62500
(dp62501
sVIndenes
p62502
g58847
sVMuscle Relaxants, Centrally Acting Agents
p62503
g37395
sVAnti-Dementia Drugs
p62504
g49311
sVCytochrome P-450 CYP3A4 Substrates
p62505
(dp62506
sVNootropic Agents
p62507
g42802
sVBradycardia-Causing Agents
p62508
g61464
sVCholinesterase Inhibitors
p62509
(dp62510
sVMuscle Relaxants
p62511
(dp62512
sVNervous System
p62513
(dp62514
ssg7536
(dp62515
g534
g16998
sg11955
(dp62516
sg5370
g50685
sg8856
(dp62517
sg789
g19475
sg1047
g21616
sg2730
g33884
sg7563
(dp62518
ssg7539
(dp62519
g14822
g41825
sg2133
g30304
sg2127
g30242
sg507
g16786
sg849
g20098
ssg7542
(dp62520
g690
g18642
sg9918
(dp62521
sg6318
g56379
sg7821
(dp62522
sg5454
g51165
sg7377
g61513
sg4479
g45713
sg11079
(dp62523
sg3132
g37029
sg2088
g29936
sg3543
g39316
sg4911
g48266
sg3024
g36316
sg5313
g50405
sg9231
(dp62524
sg3027
g36371
sg3021
g36215
sg2832
g34680
sg4539
g46042
sg5469
g51291
sg147
g13479
sg11166
(dp62525
sg11733
(dp62526
sg165
g13586
sg5289
g50298
sg6336
g56534
sg11241
(dp62527
sg11385
(dp62528
ssg7545
(dp62529
VOphthalmological and Otological Preparations
p62530
(dp62531
sVCytochrome P-450 CYP3A Substrates
p62532
g44989
sVStomatological Preparations
p62533
(dp62534
sVVasoprotectives
p62535
g41386
sVProdrugs
p62536
g52310
sVHormones
p62537
g55670
sVCorticosteroids for Systemic Use
p62538
g48836
sVHyperglycemia-Associated Agents
p62539
(dp62540
sVCorticosteroids for Systemic Use, Plain
p62541
g31757
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p62542
g59971
sVCorticosteroids Acting Locally
p62543
g54811
sVOtologicals
p62544
(dp62545
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p62546
(dp62547
sVPregnadienetriols
p62548
(dp62549
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p62550
g16825
sVCorticosteroids for Local Oral Treatment
p62551
g62291
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62552
g29230
sVFused-Ring Compounds
p62553
g14835
sg11997
(dp62554
sVCytochrome P-450 CYP3A4 Inducers
p62555
g18909
sVAntineoplastic Agents
p62556
(dp62557
sVAdrenal Cortex Hormones
p62558
g30018
sg4113
g43059
sVCorticosteroids, Weak (Group I)
p62559
(dp62560
sg3393
g38575
sVAdrenals
p62561
g37365
sVP-glycoprotein/ABCB1 Substrates
p62562
g34958
sVAntineoplastic Agents, Hormonal
p62563
(dp62564
sVDermatologicals
p62565
g17233
sVCytochrome P-450 Enzyme Inducers
p62566
g28154
sVCytochrome P-450 CYP3A Inducers
p62567
(dp62568
sg7545
(dp62569
sVPregnadienes
p62570
(dp62571
sVCytochrome P-450 CYP3A4 Substrates
p62572
(dp62573
sVAntidotes
p62574
(dp62575
sVAlimentary Tract and Metabolism
p62576
g23823
sVNasal Preparations
p62577
(dp62578
sVPregnanes
p62579
(dp62580
sVOphthalmologicals
p62581
g35201
sVSteroids
p62582
g56413
sg14872
g15749
sVImmunosuppressive Agents
p62583
(dp62584
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p62585
(dp62586
sVAnti-Inflammatory Agents
p62587
(dp62588
sVCorticosteroid Hormone Receptor Agonists
p62589
(dp62590
sVCorticosteroids, Dermatological Preparations
p62591
g51332
sVHormones, Hormone Substitutes, and Hormone Antagonists
p62592
g53155
sVCorticosteroids
p62593
(dp62594
sVIntestinal Antiinflammatory Agents
p62595
(dp62596
sVSensory Organs
p62597
g40695
ssg7548
(dp62598
VGastric Acid Lowering Agents
p62599
(dp62600
sVAlkalies
p62601
g58396
sVAntacids
p62602
g42400
sVIrrigating Solutions
p62603
g41366
sVCarbonic Acid
p62604
g48831
sVElectrolyte Solutions
p62605
g20030
sVUrinary Alkalinisers
p62606
g56836
sg8052
(dp62607
sVElectrolytes
p62608
g52425
sg11871
(dp62609
sVI.V. Solution Additives
p62610
g37235
sVBlood and Blood Forming Organs
p62611
g53929
sVAntacids and Adsorbents
p62612
g60137
sVSalt Solutions
p62613
g22248
sVAcids
p62614
g40583
sVSodium Compounds
p62615
g37414
sVCarbon Compounds, Inorganic
p62616
g39298
sVIons
p62617
g49124
sVBlood Substitutes and Perfusion Solutions
p62618
g49443
sVAcids, Noncarboxylic
p62619
g54208
sVAnions
p62620
(dp62621
sg3075
g36616
sg4404
g44864
ssg7551
(dp62622
g4287
g44399
sg21710
g54044
ssg7554
(dp62623
g1515
g25216
sVAntifungals for Dermatological Use
p62624
g30080
sVDermatologicals
p62625
g17231
sVAntifungals for Topical Use
p62626
g39235
ssg7557
(dp62627
g2784
g34376
sg10185
(dp62628
sg6567
g57527
sg357
g15322
sg7977
(dp62629
sg11139
(dp62630
sg4737
g47236
sg5286
g50217
sg5073
g48994
sg9348
(dp62631
sg1149
g22521
ssg7560
(dp62632
g5463
g51253
sg11760
(dp62633
sg9741
(dp62634
sg7407
g61604
sg1866
g27784
sg9108
(dp62635
sg9540
(dp62636
ssg7563
(dp62637
VAntiplatelet agents
p62638
g46307
sVFibrin Modulating Agents
p62639
g22852
sVThiophenes
p62640
g59031
sVDecreased Platelet Aggregation
p62641
(dp62642
sVCytochrome P-450 CYP2D6 Inhibitors
p62643
(dp62644
sVCytochrome P-450 CYP2D6 Substrates
p62645
g52152
sVPurinergic P2Y Receptor Antagonists
p62646
(dp62647
sVCytochrome P-450 CYP3A Substrates
p62648
g45170
sVNeurotransmitter Agents
p62649
(dp62650
sVPurinergic P2 Receptor Antagonists
p62651
g39032
sVEnzyme Inhibitors
p62652
(dp62653
sVCytochrome P-450 CYP2C9 Inhibitors
p62654
g18260
sVCytochrome P-450 Enzyme Inhibitors
p62655
g62053
sVThienopyridines
p62656
g62242
sVPurinergic Agents
p62657
(dp62658
sVDrugs that are Mainly Renally Excreted
p62659
g43993
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p62660
g49342
sVPurinergic Antagonists
p62661
(dp62662
sVCytochrome P-450 CYP2C19 Inhibitors (moderate)
p62663
g56916
sVCytochrome P-450 CYP2E1 Inhibitors
p62664
g46850
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62665
g29462
sVSulfur Compounds
p62666
(dp62667
sVBlood and Blood Forming Organs
p62668
g53936
sVCardiovascular Agents
p62669
g26592
sVCytochrome P-450 CYP1A2 Inhibitors
p62670
g15039
sVCytochrome P-450 CYP2C8 Inhibitors
p62671
g55047
sVCytochrome P-450 CYP2B6 Inhibitors
p62672
g45942
sVPyridines
p62673
(dp62674
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p62675
g44527
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p62676
g62518
sVCytochrome P-450 CYP2C19 Inhibitors
p62677
g61288
sVCytochrome P-450 CYP3A4 Substrates
p62678
(dp62679
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p62680
(dp62681
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p62682
g58928
sVHematologic Agents
p62683
(dp62684
sVHeterocyclic Compounds, Fused-Ring
p62685
g56130
sVCytochrome P-450 CYP2C9 Inhibitors (weak)
p62686
g41914
sVPlatelet Aggregation Inhibitors Excl. Heparin
p62687
(dp62688
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p62689
g53081
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p62690
g24200
sVChemically-Induced Disorders
p62691
g21250
ssg7566
(dp62692
g1791
g27267
sg30
g12398
sg9339
(dp62693
sg2895
g35453
sg1800
g27335
sg6393
g56826
sg4653
g46733
sg6045
g54716
sg5865
g53624
sg690
g18652
sg5685
g52443
sg12534
g52679
sg3174
g37278
sg7377
g61522
sg3393
g38585
sg3021
g36225
sg351
g15255
sg11712
(dp62694
sg4539
g46052
sg2739
g34025
sg2667
g33528
sg14872
g15759
sg4479
g45723
sg3990
g42103
sg10239
(dp62695
sg9096
(dp62696
sg1611
g25830
ssg7569
(dp62697
VAnalgesics and Anesthetics
p62698
g49753
sVCytochrome P-450 CYP2D6 Inhibitors
p62699
(dp62700
sVCytochrome P-450 CYP2D6 Substrates
p62701
g52176
sVAntiarrhythmic agents
p62702
(dp62703
sVCytochrome P-450 CYP3A Substrates
p62704
g45068
sVCentral Nervous System Agents
p62705
g58486
sVAnesthetics, Local
p62706
g53473
sVAnilides
p62707
(dp62708
sVOtologicals
p62709
(dp62710
sVLocal Anesthesia
p62711
g14963
sVCytochrome P-450 Enzyme Inhibitors
p62712
g62000
sVThroat Preparations
p62713
(dp62714
sVPeripheral Nervous System Agents
p62715
g57631
sVCytochrome P-450 CYP2C8 Substrates
p62716
(dp62717
sVCytochrome P-450 CYP1A2 Substrates
p62718
g45608
sVAmines
p62719
g42721
sVAntipruritics and Local Anesthetics
p62720
g31870
sVCardiac Therapy
p62721
(dp62722
sVAmides
p62723
g44337
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p62724
g16833
sVAniline Compounds
p62725
g23433
sVVasoprotectives
p62726
g41392
sVCytochrome P-450 CYP2C9 Substrates
p62727
g29787
sVCardiovascular Agents
p62728
g26635
sVAnesthetics
p62729
g51609
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62730
g29346
sVAgents that reduce seizure threshold
p62731
g45861
sVCytochrome P-450 CYP1A2 Inhibitors
p62732
g15028
sVDermatologicals
p62733
g17288
sVAnesthetics for Topical Use
p62734
g43183
sVCytochrome P-450 CYP2A6 Substrates
p62735
g35131
sVCytochrome P-450 CYP2C18 Substrates
p62736
g20943
sVMembrane Transport Modulators
p62737
g54158
sVNeuraxial Anesthetics
p62738
g32594
sVCytochrome P-450 CYP3A4 Substrates
p62739
(dp62740
sVSodium Channel Blockers
p62741
(dp62742
sVOphthalmologicals
p62743
g35235
sVAntiarrhythmics, Class I
p62744
(dp62745
sVVoltage-Gated Sodium Channel Blockers
p62746
g40909
sVCytochrome P-450 CYP3A5 Substrates
p62747
(dp62748
sVAmide Local Anesthetic
p62749
(dp62750
sVMethemoglobinemia Associated Agents
p62751
g25577
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p62752
g53079
sVP-glycoprotein/ABCB1 Inhibitors
p62753
(dp62754
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p62755
(dp62756
sVAntiarrhythmics, Class Ib
p62757
g50590
sVSensory System Agents
p62758
(dp62759
sVNervous System
p62760
(dp62761
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p62762
g27738
sVCytochrome P-450 CYP3A7 Substrates
p62763
g60666
sVCytochrome P-450 CYP2B6 Substrates
p62764
g33026
ssg7572
(dp62765
g6090
g54972
sg1947
g28702
sg2844
g34879
sg4263
g44191
sg1038
g21490
sg10494
(dp62766
sg6024
g54472
sg5589
g51952
sg7800
(dp62767
sg7059
g59890
sg5946
g54173
sg7563
g62688
sg10779
(dp62768
sg8418
(dp62769
ssg7575
(dp62770
g6333
g56496
sg8421
(dp62771
sg9822
(dp62772
sg7335
g61163
ssg7578
(dp62773
g7170
g60324
ssg7581
(dp62774
g11760
(dp62775
sg3777
g40827
sg4884
g48069
ssg7584
(dp62776
g702
g18813
ssg7587
(dp62777
g1746
g26947
ssg7590
(dp62778
g654
g18271
ssg7593
(dp62779
VPsychoanaleptics
p62780
g59084
sVCytochrome P-450 CYP3A Substrates
p62781
g45097
sVCentral Nervous System Agents
p62782
g58524
sVPsychostimulants, Agents Used for Adhd and Nootropics
p62783
g53759
sVCytochrome P-450 CYP3A5 Inducers (weak)
p62784
(dp62785
sVCytochrome P-450 CYP2B6 Inducers (weak)
p62786
(dp62787
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p62788
g17458
sVCytochrome P-450 CYP2C9 Inhibitors
p62789
g18258
sVCentral Nervous System Stimulation
p62790
g30767
sVCytochrome P-450 CYP2C9 Inducers
p62791
g20059
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p62792
g16536
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p62793
(dp62794
sVCytochrome P-450 CYP2B6 Inducers
p62795
g39134
sVCytochrome P-450 CYP3A4 Inducers (weak)
p62796
g19508
sVCytochrome P-450 Enzyme Inhibitors
p62797
g62012
sVCentrally Acting Sympathomimetics
p62798
(dp62799
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62800
g29377
sVCentral Nervous System Stimulants
p62801
g51446
sVCytochrome P-450 CYP3A4 Inducers
p62802
g18987
sVCytochrome P-450 CYP3A5 Inducers
p62803
g41759
sVCytochrome P-450 CYP1A2 Inducers
p62804
(dp62805
sVBenzene Derivatives
p62806
g61437
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p62807
(dp62808
sVCytochrome P-450 CYP3A5 Inhibitors (weak)
p62809
g27591
sVCytochrome P-450 CYP2B6 Inhibitors
p62810
g45941
sVCytochrome P-450 CYP2B6 Inhibitors (weak)
p62811
g51690
sVCytochrome P-450 Enzyme Inducers
p62812
g28251
sVCytochrome P-450 CYP3A Inducers
p62813
(dp62814
sg4740
g47248
sVCytochrome P-450 CYP2C19 Inhibitors
p62815
g61286
sVBenzhydryl Compounds
p62816
(dp62817
sVCytochrome P-450 CYP3A4 Substrates
p62818
(dp62819
sVIncreased Sympathetic Activity
p62820
(dp62821
sg11682
(dp62822
sVCytochrome P-450 CYP3A Inhibitors
p62823
g60463
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p62824
(dp62825
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p62826
(dp62827
sVChemically-Induced Disorders
p62828
g21248
sVNervous System
p62829
(dp62830
sg7605
(dp62831
sVCytochrome P-450 CYP3A5 Inhibitors
p62832
g55350
ssg7596
(dp62833
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p62834
(dp62835
sVCytochrome P-450 CYP3A Inhibitors
p62836
g60478
sVAngiotensin Receptor Antagonists
p62837
(dp62838
sVAngiotensin II receptor blockers (ARBs) and diuretics
p62839
g18120
sVAgents causing hyperkalemia
p62840
g43648
sVHypotensive Agents
p62841
g34215
sVCytochrome P-450 CYP3A4 Inhibitors
p62842
g61715
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p62843
g61942
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p62844
g43795
sVCytochrome P-450 Enzyme Inhibitors
p62845
g62098
sVCytochrome P-450 CYP2C8 Substrates
p62846
(dp62847
sVUGT1A3 substrates
p62848
g31820
sVAntihypertensive Agents
p62849
g20325
sVBiphenyl Compounds
p62850
g24991
sVSpiro Compounds
p62851
g30062
sVCytochrome P-450 CYP2C9 Substrates
p62852
g29825
sVCardiovascular Agents
p62853
g26691
sVBenzene Derivatives
p62854
g61438
sVCytochrome P-450 CYP2C8 Inhibitors
p62855
g55044
sVTetrazoles
p62856
g19113
sg4536
g46003
sVAngiotensin 2 Receptor Blocker
p62857
(dp62858
sVAgents Acting on the Renin-Angiotensin System
p62859
g25347
sVAngiotensin II receptor blockers (ARBs), plain
p62860
g22616
sVAngiotensin II Type 2 Receptor Blockers
p62861
(dp62862
ssg7599
(dp62863
g2928
g35627
ssg7602
(dp62864
g4272
g44243
sg3000
g36026
ssg7605
(dp62865
g1605
g25786
sg7593
g62831
ssg7608
(dp62866
g759
g19238
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p62867
g23127
sVAmines
p62868
g42751
sVP-glycoprotein/ABCB1 Substrates
p62869
g35091
sg6021
g54415
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p62870
(dp62871
sVCytochrome P-450 CYP3A Substrates
p62872
g45099
sVCytochrome P-450 CYP2C8 Inhibitors
p62873
g55050
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p62874
(dp62875
sVBCRP/ABCG2 Inhibitors
p62876
g12558
sVCytochrome P-450 CYP2C9 Inhibitors
p62877
g18261
sVAmides
p62878
g44358
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p62879
g29379
sVAntineoplastic and Immunomodulating Agents
p62880
g39829
sVAniline Compounds
p62881
g23446
sVCytochrome P-450 CYP2C19 Inhibitors
p62882
g61289
sVCytochrome P-450 CYP2C9 Substrates
p62883
g29828
sVCytochrome P-450 Enzyme Inhibitors
p62884
g62014
sVCytochrome P-450 CYP3A4 Substrates
p62885
(dp62886
sVAntineoplastic Agents
p62887
(dp62888
ssg7611
(dp62889
g8670
(dp62890
sg5577
g51845
sg357
g15335
sg7977
(dp62891
sg8274
(dp62892
sg9540
(dp62893
sg5382
g50736
sg3183
g37355
sg11718
(dp62894
sg5073
g49004
sg9267
(dp62895
sg3333
g38267
sg372
g15416
ssg7614
(dp62896
g10890
(dp62897
sg2928
g35608
ssg7617
(dp62898
g2346
g31350
sg3105
g36759
sg7464
g62142
sg1326
g23593
sg10818
(dp62899
sg3846
g41095
sg6192
g55542
sg4635
g46456
sg816
g19628
sg6882
g59107
sg6318
g56322
sg465
g16433
sg7821
(dp62900
sg9165
(dp62901
sg1650
g26121
sg11151
(dp62902
sg288
g14642
sg11451
(dp62903
sg8022
(dp62904
sg5499
g51396
sg2088
g29882
sg2427
g31968
sg9954
(dp62905
sg4887
g48074
sg9960
(dp62906
sg102
g12989
sg9966
(dp62907
sg6279
g55921
sg9231
(dp62908
sg2460
g32255
sg5535
g51639
sg8874
(dp62909
sg11337
(dp62910
sg945
g20878
sg789
g19459
sg10761
(dp62911
sg5556
g51704
sg6186
g55475
sg6303
g56183
sg147
g13417
sg9273
(dp62912
sg3978
g41956
sg3222
g37586
sg6315
g56277
sg3240
g37688
sg2616
g33151
sg10815
(dp62913
sg10356
(dp62914
sg7029
g59617
sg2676
g33543
sg10056
(dp62915
sg7041
g59674
sg4017
g42266
sg2559
g32919
sg9417
(dp62916
sg11592
(dp62917
sg7707
(dp62918
sg12066
(dp62919
sg1044
g21524
sg10662
(dp62920
sg9462
(dp62921
sg2265
g30987
sg9099
(dp62922
sg3111
g36835
sg10899
(dp62923
sg3132
g36978
sg4077
g42811
sg8655
(dp62924
sg5694
g52515
sg2784
g34342
sg1881
g27929
sg9432
(dp62925
sg10179
(dp62926
sg9198
(dp62927
sg1908
g28263
sg10950
(dp62928
sg11733
(dp62929
sg7941
(dp62930
sg2688
g33600
sg7176
g60337
sg4164
g43280
sg387
g15588
sg6729
g58323
sg2703
g33723
sg3447
g38897
sg6537
g57382
sg4647
g46558
sg11283
(dp62931
sg6093
g54983
sg11016
(dp62932
sg10266
(dp62933
sg9918
(dp62934
sg5805
g53263
sg11793
(dp62935
sg1425
g24524
sg5028
g48791
sg450
g16311
sg5832
g53390
sg1047
g21574
sg10308
(dp62936
sg1248
g23033
sg5853
g53523
sg2658
g33339
sg8721
(dp62937
sg10005
(dp62938
sg11079
(dp62939
sg5877
g53664
sg11940
(dp62940
sg8820
(dp62941
sg7299
g60896
sg2910
g35501
sg8097
(dp62942
sg10593
(dp62943
sg10365
(dp62944
sg3036
g36415
sg8856
(dp62945
sg696
g18682
sg7569
g62700
sg5127
g49210
sg564
g17385
sg573
g17510
sg3570
g39446
sg6687
g58170
sg5169
g49482
sg1188
g22756
sg6075
g54852
sg9663
(dp62946
sg2913
g35577
sg8190
(dp62947
sg5454
g51134
sg2196
g30594
sg11955
(dp62948
sg4437
g45287
sg11979
(dp62949
sg4452
g45402
sg1434
g24616
sg5289
g50240
sg8241
(dp62950
sg822
g19798
sg3696
g40261
sg6468
g57068
sg1491
g25042
sg5526
g51562
sg6090
g54923
sg8433
(dp62951
sg10518
(dp62952
sg3024
g36278
sg10521
(dp62953
sg2769
g34274
sg5316
g50423
sg486
g16628
sg1140
g22354
sg9393
(dp62954
sg8298
(dp62955
sg4542
g46072
sg414
g15927
sg7563
g62644
sg7416
g61726
sg8949
(dp62956
sg12126
(dp62957
sg1014
g21323
sg11241
(dp62958
sg1185
g22706
ssg7620
(dp62959
g87
g12920
sg1785
g27209
sg4863
g47944
sg1674
g26335
sg1173
g22647
sg918
g20778
ssg7623
(dp62960
g11349
(dp62961
sg2754
g34055
sg1563
g25509
sg1737
g26911
sg8772
(dp62962
sg3801
g40961
sg8910
(dp62963
sg4185
g43472
sg6612
g57764
sg11646
(dp62964
sg10104
(dp62965
ssg7626
(dp62966
VAmino Acids, Peptides, and Proteins
p62967
g47310
sVAmino Acids
p62968
g43115
sVAmino Acids, Cyclic
p62969
g27282
sVAntihypertensive Agents
p62970
g20244
sg8952
(dp62971
sg3735
g40530
sg8613
(dp62972
sVEnzyme Inhibitors
p62973
(dp62974
sVTyrosine
p62975
(dp62976
sVAmino Acids, Aromatic
p62977
(dp62978
ssg7629
(dp62979
VSunscreen Agents
p62980
(dp62981
sVIons
p62982
g49112
sVHousehold Products
p62983
g60752
sVBasic Ointments and Protectants
p62984
g41765
sVMetal divalent cations
p62985
(dp62986
sVZinc Compounds
p62987
(dp62988
sVSunscreening Agents
p62989
g57238
sVDermatologicals
p62990
g17211
sVOxides
p62991
g27677
sVRadiation-Protective Agents
p62992
(dp62993
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p62994
g16816
sVCompounds used in a research, industrial, or household setting
p62995
(dp62996
sVAnions
p62997
(dp62998
sVBasic Powders and Demulcents
p62999
g31648
sVProtective Agents
p63000
(dp63001
sVMetal cations
p63002
g40804
sVVasoprotectives
p63003
g41379
sVCopper Absorption Inhibitor
p63004
(dp63005
sVElectrolytes
p63006
g52411
sVOxygen Compounds
p63007
g46961
sVCosmetics
p63008
g34261
ssg7632
(dp63009
g1704
g26705
sg633
g18071
sg5919
g53961
sg7056
g59842
sg933
g20811
sg8259
(dp63010
sg1668
g26241
ssg7635
(dp63011
g11334
(dp63012
sg10368
(dp63013
sg10509
(dp63014
sg7815
(dp63015
ssg7638
(dp63016
g7812
(dp63017
sg4929
g48433
sg3657
g40161
sg3024
g36259
sg6273
g55905
sg1113
g22163
sg5334
g50525
sg10692
(dp63018
sg2706
g33761
sg10314
(dp63019
sg3246
g37761
sg10296
(dp63020
sg10578
(dp63021
sg5283
g50186
sg5685
g52441
sg11067
(dp63022
sg4902
g48159
sg2928
g35624
sg10548
(dp63023
ssg7641
(dp63024
VKetones
p63025
g50971
sVImides
p63026
(dp63027
sVHypotensive Agents
p63028
g34104
sVHyperglycemia-Associated Agents
p63029
(dp63030
sVPhthalimides
p63031
g20184
sg75
g12824
sVAntihypertensive Agents
p63032
g20246
sVAcids, Carbocyclic
p63033
g41548
sVAmides
p63034
g44288
sVSulfur Compounds
p63035
(dp63036
sVSulfones
p63037
g58733
sVNatriuretic Agents
p63038
g40481
sVSodium Chloride Symporter Inhibitors
p63039
g55915
sVCardiovascular Agents
p63040
g26524
sVBenzene Derivatives
p63041
g61396
sVNon Potassium Sparing Diuretics
p63042
g14977
sg9642
(dp63043
sVMembrane Transport Modulators
p63044
g54119
sVIsoindoles
p63045
g17600
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p63046
g25431
sVHeterocyclic Compounds, Fused-Ring
p63047
g56033
sVPhthalic Acids
p63048
g61390
sVSulfonamides
p63049
(dp63050
sVIncreased Diuresis
p63051
g41000
sg5787
g53198
sVDiuretics
p63052
g57899
ssg7644
(dp63053
g8670
(dp63054
sg3099
g36742
sg8529
(dp63055
sg5577
g51829
sg7977
(dp63056
sg11751
(dp63057
sg7680
(dp63058
sg11826
(dp63059
sg8274
(dp63060
sg11664
(dp63061
sg5382
g50732
sg3183
g37351
sg3699
g40340
sg12186
g42913
sg372
g15412
sg9000
(dp63062
ssg7647
(dp63063
g11775
(dp63064
ssg7650
(dp63065
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p63066
g50952
sVOAT1/SLC22A6 inhibitors
p63067
(dp63068
sVAnalgesics
p63069
g26426
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p63070
g58386
sVNon COX-2 selective NSAIDS
p63071
(dp63072
sVCentral Nervous System Agents
p63073
g58403
sVAntiinflammatory and Antirheumatic Products
p63074
g56807
sVThiazines
p63075
g16410
sVEnzyme Inhibitors
p63076
(dp63077
sVCytochrome P-450 Enzyme Inhibitors
p63078
g62016
sVPeripheral Nervous System Agents
p63079
g57575
sVDrugs that are Mainly Renally Excreted
p63080
g43928
sVCytochrome P-450 CYP2C8 Substrates
p63081
(dp63082
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p63083
g23105
sVAnalgesics, Non-Narcotic
p63084
g56893
sVNephrotoxic agents
p63085
g57702
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p63086
(dp63087
sVSulfur Compounds
p63088
(dp63089
sVCytochrome P-450 CYP2C9 Substrates
p63090
g29712
sVMusculo-Skeletal System
p63091
g31514
sVTopical Products for Joint and Muscular Pain
p63092
g13934
sVAgents causing hyperkalemia
p63093
g43570
sVCytochrome P-450 CYP2C8 Inhibitors
p63094
g55000
sVOther Nonsteroidal Antiimflammatory Agents
p63095
(dp63096
sVSensory Organs
p63097
g40673
sVAgents that produce hypertension
p63098
(dp63099
sVNonsteroidal Anti-inflammatory Compounds
p63100
(dp63101
sVOphthalmologicals
p63102
g35172
sVOAT3/SLC22A8 Inhibitors
p63103
g58999
sVAnti-Inflammatory Agents
p63104
(dp63105
sVCyclooxygenase Inhibitors
p63106
g32781
sg7113
g60128
sVAntirheumatic Agents
p63107
g24213
sVSensory System Agents
p63108
(dp63109
sVAnti-Inflammatory Agents, Non-Steroidal
p63110
(dp63111
ssg7653
(dp63112
VAntiinfectives for Systemic Use
p63113
(dp63114
sg7515
g62392
sVHeterocyclic Compounds, Fused-Ring
p63115
g56036
sVOphthalmologicals
p63116
g35173
sVbeta-Lactams
p63117
(dp63118
sVOAT1/SLC22A6 inhibitors
p63119
(dp63120
sg4410
g44868
sVOAT3/SLC22A8 Substrates
p63121
g13110
sVOAT3/SLC22A8 Inhibitors
p63122
g59000
sVLactams
p63123
g22271
sVSulfur Compounds
p63124
(dp63125
sVAmides
p63126
g44290
sVSensory Organs
p63127
g40674
sVAnti-Bacterial Agents
p63128
g38316
sVAntibacterials for Systemic Use
p63129
g32523
sVPenicillin G
p63130
g34326
sVOATP1B1/SLCO1B1 Substrates
p63131
(dp63132
sVAnti-Infective Agents
p63133
g54560
sVPenicillins
p63134
g52898
sVBeta-Lactam Antibacterials
p63135
g46296
ssg7656
(dp63136
g645
g18130
sg7719
(dp63137
sg1038
g21476
sg4341
g44589
sg10290
(dp63138
sg2943
g35733
sg1812
g27468
sg4650
g46601
sg11619
(dp63139
sg10797
(dp63140
sg4320
g44499
sg1869
g27804
sg2256
g30916
sg5256
g50026
sg8241
(dp63141
sg2058
g29173
sg891
g20530
sg2418
g31894
sg6939
g59312
sg9702
(dp63142
sg11820
(dp63143
sg9810
(dp63144
sg10728
(dp63145
sg4467
g45529
sg11874
(dp63146
sg7317
g61032
sg4926
g48374
sg6471
g57134
sg10245
(dp63147
sg6474
g57153
sg10977
(dp63148
sg3408
g38669
sg8493
(dp63149
sg10974
(dp63150
sg5025
g48751
sg14338
g13522
sg1356
g23956
sg4959
g48530
sg10230
(dp63151
sg12111
(dp63152
sg141
g13318
sg10218
(dp63153
sg10794
(dp63154
sg10074
(dp63155
sg6048
g54735
sg7020
g59588
sg2715
g33786
sg9462
(dp63156
sg6537
g57380
sg1401
g24291
sg11385
(dp63157
ssg7659
(dp63158
g8322
(dp63159
sg11136
(dp63160
ssg7662
(dp63161
VAntiinfectives for Systemic Use
p63162
(dp63163
sVProtein Synthesis Inhibitors
p63164
g45556
sVAgents that produce neuromuscular block (indirect)
p63165
g37976
sg7002
g59515
sVAntimycobacterials
p63166
g22569
sVNephrotoxic agents
p63167
g57729
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p63168
g59977
sVAminoglycoside Antibacterials
p63169
g52731
sVDrugs for Treatment of Tuberculosis
p63170
(dp63171
sVGlycosides
p63172
(dp63173
sVCarbohydrates
p63174
g61782
sVIntestinal Antiinfectives
p63175
(dp63176
sVOAT1/SLC22A6 inhibitors
p63177
(dp63178
sVEnzyme Inhibitors
p63179
(dp63180
sVAnti-Bacterial Agents
p63181
g38368
sVAntibacterials for Systemic Use
p63182
g32567
sVAnti-Infective Agents
p63183
g54645
sVAlimentary Tract and Metabolism
p63184
g23889
sVNarrow Therapeutic Index Drugs
p63185
g50575
ssg7665
(dp63186
g771
g19281
sg1767
g27033
sg4881
g48061
ssg7668
(dp63187
VCytochrome P-450 CYP3A Substrates
p63188
g45106
sVPregnadienediols
p63189
(dp63190
sVHormones
p63191
g55656
sVCorticosteroids for Systemic Use
p63192
g48846
sVHyperglycemia-Associated Agents
p63193
(dp63194
sVDrugs that are Mainly Renally Excreted
p63195
g43930
sVCorticosteroids for Systemic Use, Plain
p63196
g31770
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p63197
g59972
sVCorticosteroids Acting Locally
p63198
g54813
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p63199
(dp63200
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63201
g29386
sVGlucocorticoids
p63202
g21927
sVFused-Ring Compounds
p63203
g14814
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p63204
g25142
sVCytochrome P-450 CYP3A4 Inducers
p63205
g18882
sVAntineoplastic Agents
p63206
(dp63207
sVCytochrome P-450 CYP3A5 Inducers
p63208
g41740
sVAdrenal Cortex Hormones
p63209
g30019
sVAdrenals
p63210
g37366
sVP-glycoprotein/ABCB1 Substrates
p63211
g34918
sVAntineoplastic Agents, Hormonal
p63212
(dp63213
sVCytochrome P-450 Enzyme Inducers
p63214
g28121
sVCytochrome P-450 CYP3A Inducers
p63215
(dp63216
sVPregnadienes
p63217
(dp63218
sVCytochrome P-450 CYP3A4 Substrates
p63219
(dp63220
sVAlimentary Tract and Metabolism
p63221
g23845
sVPregnanes
p63222
(dp63223
sVSteroids
p63224
g56427
sVImmunosuppressive Agents
p63225
(dp63226
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p63227
(dp63228
sVCytochrome P-450 CYP2C19 Inducers
p63229
g25533
sVAnti-Inflammatory Agents
p63230
(dp63231
sVCorticosteroid Hormone Receptor Agonists
p63232
(dp63233
sVP-glycoprotein/ABCB1 Inhibitors
p63234
(dp63235
sVHormones, Hormone Substitutes, and Hormone Antagonists
p63236
g53134
sVCorticosteroids
p63237
(dp63238
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p63239
(dp63240
sVIntestinal Antiinflammatory Agents
p63241
(dp63242
ssg7671
(dp63243
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p63244
g50955
sVAnalgesics
p63245
g26460
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p63246
g58390
sVNon COX-2 selective NSAIDS
p63247
(dp63248
sVCentral Nervous System Agents
p63249
g58406
sVAntiinflammatory and Antirheumatic Products
p63250
g56811
sVThiazines
p63251
g16413
sVEnzyme Inhibitors
p63252
(dp63253
sVPeripheral Nervous System Agents
p63254
g57578
sVAnalgesics, Non-Narcotic
p63255
g56898
sVNephrotoxic agents
p63256
g57705
sVSulfur Compounds
p63257
(dp63258
sVCytochrome P-450 CYP2C9 Substrates
p63259
g29760
sVMusculo-Skeletal System
p63260
g31520
sVAgents causing hyperkalemia
p63261
g43574
sVOther Nonsteroidal Antiimflammatory Agents
p63262
(dp63263
sVAgents that produce hypertension
p63264
(dp63265
sVOAT3/SLC22A8 Inhibitors
p63266
g59019
sVAnti-Inflammatory Agents
p63267
(dp63268
sVCyclooxygenase Inhibitors
p63269
g32786
sVOxicams
p63270
g60129
sVAntirheumatic Agents
p63271
g24221
sVSensory System Agents
p63272
(dp63273
sVAnti-Inflammatory Agents, Non-Steroidal
p63274
(dp63275
ssg7674
(dp63276
g4377
g44782
sg1917
g28440
sg9618
(dp63277
sg1791
g27239
sg1611
g25809
ssg7677
(dp63278
g1890
g28015
sg7329
g61130
sg9996
(dp63279
ssg7680
(dp63280
VDrugs that are Mainly Renally Excreted
p63281
g43931
sg8619
(dp63282
sVBlood and Blood Forming Organs
p63283
g53917
sVHeterocyclic Compounds, Fused-Ring
p63284
g56042
sVIron Preparations
p63285
(dp63286
sVFood
p63287
g62212
sg6288
g55993
sg8235
(dp63288
sVDiet, Food, and Nutrition
p63289
g22902
sg6891
g59174
sVFood and Beverages
p63290
(dp63291
sVAntianemic Preparations
p63292
g63058
sg17
g12174
sg6087
g54916
sg4554
g46125
ssg7683
(dp63293
g8622
(dp63294
sg318
g14925
sg12051
(dp63295
ssg7686
(dp63296
g7395
g61581
ssg7689
(dp63297
VAmino Acids, Peptides, and Proteins
p63298
g47322
sg6510
g57318
sVPeptide Hormones
p63299
g20213
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p63300
(dp63301
sg8634
(dp63302
sVPituitary Hormones, Anterior
p63303
g24146
sg1335
g23676
sVPeptides
p63304
g47165
sVPituitary Hormones
p63305
g15918
sVHormones
p63306
g55659
sVHormones, Hormone Substitutes, and Hormone Antagonists
p63307
g53166
sg2025
g28979
ssg7692
(dp63308
VAmino Acids, Peptides, and Proteins
p63309
g47360
sVAmino Acids
p63310
g43116
sVAmino Acids, Cyclic
p63311
g27288
sVAmino Acids, Essential
p63312
g35286
sg9885
(dp63313
sVAntidiarrheals
p63314
(dp63315
sVAmino Acids, Aromatic
p63316
(dp63317
ssg7695
(dp63318
g4164
g43311
sg8298
(dp63319
sg5370
g50674
sg8820
(dp63320
sg1050
g21674
sg9765
(dp63321
ssg7698
(dp63322
VCytochrome P-450 CYP2D6 Substrates
p63323
g52179
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p63324
g39026
sVCytochrome P-450 CYP3A Substrates
p63325
g45075
sVHypotensive Agents
p63326
g34178
sVUGT1A9 Substrates
p63327
g24020
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p63328
g49341
sVBlood Glucose Lowering Agents
p63329
(dp63330
sVCytochrome P-450 CYP1A2 Substrates
p63331
g45610
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63332
g29353
sVOral Hypoglycemics
p63333
g36005
sVCytochrome P-450 CYP2C9 Substrates
p63334
g29789
sVCarbohydrates
p63335
g61783
sVDrugs Used in Diabetes
p63336
g60122
sVDiuretics
p63337
g57909
sVGlycosides
p63338
(dp63339
sVBenzene Derivatives
p63340
g61424
sVCytochrome P-450 CYP1A2 Inhibitors
p63341
g15037
sVP-glycoprotein/ABCB1 Substrates
p63342
g35036
sVSodium-Glucose Transport Proteins, antagonists & inhibitors
p63343
(dp63344
sVCytochrome P-450 CYP2A6 Substrates
p63345
g35134
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p63346
(dp63347
sVCytochrome P-450 CYP3A4 Substrates
p63348
(dp63349
sVAlimentary Tract and Metabolism
p63350
g23892
sVUGT2B7 substrates
p63351
g28642
sVSodium-Glucose Transporter 2 Inhibitors
p63352
g46283
ssg7701
(dp63353
g2346
g31404
sg6735
g58352
sg9144
(dp63354
sg7884
(dp63355
sg978
g21188
sg4830
g47812
sg7641
g63050
sg879
g20376
sg4656
g46788
sg10884
(dp63356
sg6051
g54790
sg9687
(dp63357
sg5235
g49840
sg20252
(dp63358
sg2088
g29922
sg5685
g52464
sg7314
g61011
sg6348
g56648
sg11862
(dp63359
sg5574
g51802
sg5919
g53974
sg6435
g56979
sg10164
(dp63360
sg2391
g31728
sg6885
g59162
sg5934
g54107
sg9486
(dp63361
sg4062
g42653
sg10383
(dp63362
sg11166
(dp63363
sg3231
g37675
sg1941
g28610
sg7188
g60501
sg2706
g33753
sg6336
g56541
sg9081
(dp63364
sg10692
(dp63365
sg204
g13960
ssg7704
(dp63366
g9963
(dp63367
sg11079
(dp63368
sg3963
g41876
ssg7707
(dp63369
VAgents Causing Muscle Toxicity
p63370
g55389
sVAntiparasitic Products, Insecticides and Repellents
p63371
g30568
sVAgents that produce neuromuscular block (indirect)
p63372
g37954
sVAntimalarials
p63373
g14097
sVQuinolines
p63374
(dp63375
sVCytochrome P-450 CYP2D6 Inhibitors
p63376
g62918
sVCytochrome P-450 CYP2D6 Substrates
p63377
g52135
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p63378
g41062
sVAnalgesics
p63379
g26448
sVCentral Nervous System Agents
p63380
g58438
sVCytochrome P-450 Enzyme Inhibitors
p63381
g61989
sVAnti-Infective Agents
p63382
g54590
sVPeripheral Nervous System Agents
p63383
g57595
sVDrugs that are Mainly Renally Excreted
p63384
g43875
sVCytochrome P-450 CYP2C8 Substrates
p63385
(dp63386
sVAnalgesics, Non-Narcotic
p63387
g56904
sVAmebicides
p63388
(dp63389
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63390
g29316
sVAntiprotozoals
p63391
g59366
sVQTc Prolonging Agents
p63392
g57814
sVCytochrome P-450 CYP3A Substrates
p63393
g45048
sVAntinematodal Agents
p63394
(dp63395
sVAgents that reduce seizure threshold
p63396
g45863
sVChloroquine
p63397
(dp63398
sVAminoquinolines
p63399
g55117
sVP-glycoprotein/ABCB1 Substrates
p63400
g34949
sVAntiparasitic Agents
p63401
g40647
sg8127
(dp63402
sVHeterocyclic Compounds, Fused-Ring
p63403
g56119
sVCytochrome P-450 CYP3A4 Substrates
p63404
(dp63405
sVModerate Risk QTc-Prolonging Agents
p63406
(dp63407
sVCytochrome P-450 CYP3A5 Substrates
p63408
(dp63409
sValpha-Galactosidase, antagonists & inhibitors
p63410
g37628
sVMethemoglobinemia Associated Agents
p63411
g25569
sVAnti-Inflammatory Agents
p63412
(dp63413
sVP-glycoprotein/ABCB1 Inhibitors
p63414
(dp63415
sVAntirheumatic Agents
p63416
g24237
sVSensory System Agents
p63417
(dp63418
ssg7710
(dp63419
g11820
(dp63420
sg8217
(dp63421
sg3105
g36780
sg4977
g48660
sg7458
g62128
sg8022
(dp63422
sg4926
g48394
sg6033
g54515
sg3858
g41215
sg6699
g58222
sg2943
g35761
sg9081
(dp63423
sg4491
g45797
sg8928
(dp63424
sg6537
g57400
sg11625
(dp63425
sg4650
g46618
sg7809
(dp63426
sg10797
(dp63427
ssg7713
(dp63428
VDrugs that are Mainly Renally Excreted
p63429
g43877
sVNitrogen Compounds
p63430
g38997
sVMorphinans
p63431
g57233
sVHeterocyclic Compounds, Fused-Ring
p63432
g56072
sVAmines
p63433
g42694
sVMiscellaneous GI Drugs
p63434
g23548
sVOnium Compounds
p63435
g22261
sVOpiate Alkaloids
p63436
(dp63437
sVDrugs for Constipation
p63438
g53334
sVOpioid Antagonists
p63439
(dp63440
sVSensory System Agents
p63441
(dp63442
sVPeripheral Opioid Receptor Antagonists
p63443
g12733
sVPeripheral Nervous System Agents
p63444
g57599
sVAlkaloids
p63445
g19403
sVNaloxone
p63446
(dp63447
sVPhenanthrenes
p63448
g32832
sVCentral Nervous System Agents
p63449
g58442
sVAlimentary Tract and Metabolism
p63450
g23820
sVAmmonium Compounds
p63451
g30558
ssg7716
(dp63452
VAdrenergic Agents
p63453
g41713
sVNeurotransmitter Agents
p63454
(dp63455
sVAdrenergic alpha-1 Receptor Antagonists
p63456
g14128
sVCytochrome P-450 CYP2C19 Substrates
p63457
g53892
sVAntihypertensive Agents
p63458
g20256
sVCytochrome P-450 CYP3A Substrates
p63459
g45110
sVCytochrome P-450 CYP2D6 Substrates
p63460
g52120
sVHypotensive Agents
p63461
g34117
sVHeterocyclic Compounds, Fused-Ring
p63462
g56053
sVQuinazolines
p63463
g57748
sVAdrenergic Antagonists
p63464
g52287
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63465
g29391
sVP-glycoprotein/ABCB1 Inhibitors
p63466
(dp63467
sVAdrenergic alpha-Antagonists
p63468
g60875
sVAntiadrenergic Agents, Peripherally Acting
p63469
g55754
sVPeripheral alpha-1 blockers
p63470
g32712
sVCardiovascular Agents
p63471
g26543
sVCytochrome P-450 CYP3A4 Substrates
p63472
(dp63473
sVCytochrome P-450 CYP2C9 Substrates
p63474
g29723
sVOCT1 inhibitors
p63475
(dp63476
ssg7719
(dp63477
VGlycols
p63478
g55147
sVPharmaceutical Preparations
p63479
g53857
sVProstaglandins F, Synthetic
p63480
g54801
sVAutacoids
p63481
(dp63482
sVAbortifacient Agents, Nonsteroidal
p63483
(dp63484
sVGenito Urinary System and Sex Hormones
p63485
(dp63486
sVFatty Acids, Unsaturated
p63487
g59244
sVProstaglandins, Synthetic
p63488
g28022
sVInflammation Mediators
p63489
g23627
sVUterotonic agents
p63490
g38829
sVPropylene Glycols
p63491
g55824
sVLipids
p63492
g14306
sVTromethamine
p63493
g47980
sVBiological Factors
p63494
g38106
sVReproductive Control Agents
p63495
g18837
sVAbortifacient Agents
p63496
g37798
sVProstaglandins
p63497
g19497
sVAlcohols
p63498
(dp63499
sVEicosanoids
p63500
g37787
sVFatty Acids
p63501
g63137
ssg7722
(dp63502
g10878
(dp63503
ssg7725
(dp63504
g10569
(dp63505
sg2118
g30216
ssg7728
(dp63506
g4398
g44831
sg8826
(dp63507
ssg7731
(dp63508
g8721
(dp63509
sg2559
g32968
sg1263
g23192
sg168
g13657
sg288
g14682
sg2418
g31919
sg10356
(dp63510
sg564
g17416
sg4266
g44209
sg3930
g41668
ssg7734
(dp63511
VUGT1A1 Substrates
p63512
g12314
sVAnti-epileptic Agent
p63513
(dp63514
sVCentral Nervous System Agents
p63515
g58514
sVCytochrome P-450 CYP2C19 Inhibitors
p63516
g61259
sVCytochrome P-450 Enzyme Inhibitors
p63517
g62021
sVMiscellaneous Anticonvulsants
p63518
g53479
sVP-glycoprotein/ABCB1 Inducers
p63519
(dp63520
sVCytochrome P-450 CYP3A4 Inducers (strong)
p63521
g23084
sVCarbamazepine
p63522
g20473
sVEnzyme Inducing Antiepileptic Drugs
p63523
g25035
sVUGT1A1 Inducers
p63524
g39245
sVCytochrome P-450 CYP3A4 Inducers
p63525
g18894
sVDecreased Central Nervous System Disorganized Electrical Activity
p63526
g23470
sVCentral Nervous System Depressants
p63527
(dp63528
sVCytochrome P-450 CYP3A5 Inducers
p63529
g41750
sVCardiovascular Agents
p63530
g26544
sVCarboxamide Derivatives
p63531
(dp63532
sVAnticonvulsants
p63533
g60153
sVCytochrome P-450 Enzyme Inducers
p63534
g28135
sVCytochrome P-450 CYP3A Inducers
p63535
(dp63536
sVMembrane Transport Modulators
p63537
g54128
sVCytochrome P-450 CYP3A Inducers (strong)
p63538
g22458
sVSodium Channel Blockers
p63539
(dp63540
sVVoltage-Gated Sodium Channel Blockers
p63541
g40906
sVHeterocyclic Compounds, Fused-Ring
p63542
g56074
sVDibenzazepines
p63543
g48670
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p63544
(dp63545
sVChemically-Induced Disorders
p63546
g21240
sVNervous System
p63547
(dp63548
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p63549
(dp63550
ssg7737
(dp63551
g4377
g44785
sg2736
g33967
sg10272
(dp63552
sg9552
(dp63553
sg3249
g37780
ssg7740
(dp63554
VCardiovascular Agents
p63555
g26519
sVBSEP/ABCB11 Substrates
p63556
(dp63557
sVAngiotensin II Antagonists and Calcium Channel Blockers
p63558
g42304
sVAntihypertensive Agents
p63559
g20258
sVOATP1B3 substrates
p63560
g28512
sVAngiotensin Receptor Antagonists
p63561
(dp63562
sVAngiotensin II receptor blockers (ARBs) and diuretics
p63563
g18113
sVAgents causing hyperkalemia
p63564
g43564
sVHypotensive Agents
p63565
g34098
sVTetrazoles
p63566
g19110
sVAngiotensin II Antagonists, Plain
p63567
(dp63568
sVAngiotensin II receptor blockers (ARBs) and calcium channel blockers
p63569
g61941
sVAngiotensin II receptor blockers (ARBs), plain
p63570
g22609
sVAngiotensin 2 Receptor Blocker
p63571
(dp63572
sVOATP1B1/SLCO1B1 Substrates
p63573
(dp63574
sVImidazoles
p63575
(dp63576
sVAgents Acting on the Renin-Angiotensin System
p63577
g25340
ssg7743
(dp63578
g10767
(dp63579
sg5415
g50929
sg657
g18320
sg9561
(dp63580
ssg7746
(dp63581
g8823
(dp63582
sg4860
g47912
sg11361
(dp63583
sg11268
(dp63584
ssg7749
(dp63585
g2553
g32889
ssg7752
(dp63586
g1776
g27088
ssg7755
(dp63587
g6906
g59224
sg5535
g51666
sg1149
g22491
sg2283
g31154
sg486
g16659
ssg7758
(dp63588
g10674
(dp63589
sg3570
g39498
sg630
g18039
sg486
g16661
sg2265
g31018
sg282
g14572
sg8805
(dp63590
sg8187
(dp63591
sg5535
g51668
sg1425
g24560
sg1707
g26755
sg240
g14202
sg6318
g56334
sg1194
g22810
sg9711
(dp63592
sg414
g15977
sg5694
g52558
ssg7761
(dp63593
g13750
g24401
sg2373
g31616
sg9693
(dp63594
sg9774
(dp63595
sg11922
(dp63596
sg3117
g36931
sg9903
(dp63597
sg1800
g27333
sg2226
g30776
sg4653
g46729
sg2388
g31680
sg6585
g57662
sg11997
(dp63598
sg1383
g24150
sg7545
g62580
sg7668
g63223
sg8430
(dp63599
sg1614
g25894
sg6783
g58677
sg8445
(dp63600
sg4620
g46350
sg14838
g40011
sg5895
g53833
sg6045
g54714
sg12534
g52675
sg11886
(dp63601
sg9609
(dp63602
sg9225
(dp63603
sg4113
g43070
sg966
g21052
sg9030
(dp63604
sg3393
g38581
sg4875
g48013
sg2832
g34735
sg5238
g49884
sg8694
(dp63605
sg3783
g40876
sg3219
g37560
sg10209
(dp63606
sg1245
g22997
sg14872
g15755
sg5766
g52998
sg12132
(dp63607
sg6345
g56603
sg14829
g56683
ssg7764
(dp63608
VDihydropyridine Derivatives
p63609
g56699
sVBSEP/ABCB11 Substrates
p63610
(dp63611
sVCytochrome P-450 CYP3A4 Inhibitors
p63612
g61646
sVAntiarrhythmic agents
p63613
(dp63614
sVCytochrome P-450 CYP3A Substrates
p63615
g45117
sVAgents causing hyperkalemia
p63616
g43584
sVHypotensive Agents
p63617
g34126
sVCalcium Channel Blockers
p63618
g41320
sVPotential QTc-Prolonging Agents
p63619
(dp63620
sVCytochrome P-450 Enzyme Inhibitors
p63621
g62024
sVCalcium Channel Blockers (Dihydropyridine)
p63622
g20121
sVDrugs that are Mainly Renally Excreted
p63623
g43940
sVAntihypertensive Agents
p63624
g20263
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63625
g29398
sVQTc Prolonging Agents
p63626
g57803
sVCardiovascular Agents
p63627
g26553
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p63628
(dp63629
sVPyridines
p63630
(dp63631
sVVasodilating Agents
p63632
g23718
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p63633
(dp63634
sVMembrane Transport Modulators
p63635
g54132
sVCytochrome P-450 CYP3A4 Substrates
p63636
(dp63637
sVCalcium-Regulating Hormones and Agents
p63638
(dp63639
sVCytochrome P-450 CYP3A Inhibitors
p63640
g60403
sVBradycardia-Causing Agents
p63641
g61458
sVP-glycoprotein/ABCB1 Inhibitors
p63642
(dp63643
sVDihydropyridines
p63644
(dp63645
ssg7767
(dp63646
g5556
g51742
ssg7770
(dp63647
g1266
g23241
sg9540
(dp63648
ssg7773
(dp63649
g8928
(dp63650
ssg7776
(dp63651
g3321
g38222
sg4638
g46538
ssg7779
(dp63652
g2805
g34463
sg2112
g30186
ssg7782
(dp63653
g8763
(dp63654
ssg7785
(dp63655
g9153
(dp63656
sg2397
g31781
sg12060
(dp63657
sg5595
g51994
sg8454
(dp63658
sg4008
g42198
ssg7788
(dp63659
g5133
g49283
sg5067
g48947
ssg7791
(dp63660
g13750
g24418
sg2373
g31628
sg1245
g23017
sg11922
(dp63661
sg9903
(dp63662
sg1800
g27349
sg2226
g30798
sg4653
g46751
sg6585
g57675
sg11997
(dp63663
sg5766
g53014
sg7545
g62590
sg7668
g63233
sg8430
(dp63664
sg1614
g25911
sg14838
g40022
sg4089
g42883
sg5895
g53844
sg6045
g54724
sg12534
g52697
sg4113
g43081
sg9030
(dp63665
sg3393
g38598
sg4875
g48031
sg3219
g37570
sg14872
g15774
sg1383
g24171
sg6345
g56616
sg14829
g56693
ssg7794
(dp63666
g8598
(dp63667
sg8601
(dp63668
ssg7797
(dp63669
g10758
(dp63670
ssg7800
(dp63671
VAntiplatelet agents
p63672
g46303
sVBSEP/ABCB11 Substrates
p63673
(dp63674
sVHematologic Agents
p63675
(dp63676
sVBlood and Blood Forming Organs
p63677
g53940
sVCardiovascular Agents
p63678
g26565
sVPyrimidines
p63679
g47704
sVPhosphodiesterase Inhibitors
p63680
g59610
sVPlatelet Aggregation Inhibitors Excl. Heparin
p63681
g62767
sVAnticoagulants
p63682
g58376
sVDecreased Platelet Aggregation
p63683
(dp63684
sVHypotensive Agents
p63685
g34133
sVP-glycoprotein/ABCB1 Substrates
p63686
g34942
sVVasodilating Agents
p63687
g23727
sVOATP1B1/SLCO1B1 Inhibitors
p63688
(dp63689
sVP-glycoprotein/ABCB1 Inhibitors
p63690
(dp63691
sVOATP1B3 inhibitors
p63692
g62288
sVEnzyme Inhibitors
p63693
(dp63694
sVMiscellaneous Vasodilatating Agents
p63695
(dp63696
sVPhosphodiesterase 5 Inhibitors
p63697
(dp63698
ssg7803
(dp63699
g10230
(dp63700
ssg7806
(dp63701
g12111
(dp63702
sg1938
g28552
sg6792
g58721
sg4173
g43405
sg11292
(dp63703
sg6525
g57363
sg2289
g31210
sg8832
(dp63704
ssg7809
(dp63705
VAmino Acids, Peptides, and Proteins
p63706
g47357
sVPCSK9 Inhibitor
p63707
g53854
sVAntibodies
p63708
g60995
sVAnticholesteremic Agents
p63709
g50598
sVAntibodies, Monoclonal
p63710
(dp63711
sVAntimetabolites
p63712
g59543
sVToxic Actions
p63713
g49380
sVLipid Modifying Agents
p63714
g40551
sVProteins
p63715
g52746
sVImmunoglobulins
p63716
g41542
sVNoxae
p63717
(dp63718
sVHypolipidemic Agents
p63719
(dp63720
sVSerum Globulins
p63721
g49670
sVLipid Modifying Agents, Plain
p63722
g63426
sVBlood Proteins
p63723
g39877
sVLipid Regulating Agents
p63724
(dp63725
sVGlobulins
p63726
g19202
sVProprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors
p63727
(dp63728
sVImmunoproteins
p63729
g57462
ssg7812
(dp63730
VAnti-Infective Agents
p63731
g54622
sVPhenols
p63732
(dp63733
sg6429
g56922
sVBenzene Derivatives
p63734
g61409
sVDermatologicals
p63735
g17258
sVHydrocarbons, Halogenated
p63736
(dp63737
sVAnti-Infective Agents, Local
p63738
g63017
sVPhenol and Derivatives
p63739
(dp63740
sVAntiseptics and Disinfectants
p63741
g23736
sg957
g20953
sVHydrocarbons, Chlorinated
p63742
(dp63743
ssg7815
(dp63744
VPyrimidines
p63745
g47690
sVAntivirals for Systemic Use
p63746
g59750
sVCarbohydrates
p63747
g61773
sVDirect Acting Antivirals
p63748
g38042
sVHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
p63749
g63015
sVAntiviral Agents
p63750
g30425
sVAnti-Infective Agents
p63751
g54625
sVNucleotides
p63752
g49314
sVAntiinfectives for Systemic Use
p63753
(dp63754
sVDrugs that are Mainly Renally Excreted
p63755
g43888
sVRibonucleotides
p63756
g46852
sVUracil Nucleotides
p63757
(dp63758
sVGlycosides
p63759
(dp63760
sVRibonucleosides
p63761
(dp63762
sVAntivirals for treatment of HCV infections
p63763
g31034
sVNucleic Acids, Nucleotides, and Nucleosides
p63764
g47112
sVP-glycoprotein/ABCB1 Substrates
p63765
g34944
sVPyrimidine Nucleosides
p63766
(dp63767
sVRNA Replicase Inhibitors
p63768
g59489
sVPyrimidine Nucleotides
p63769
g48568
sVNucleosides
p63770
g49454
sVUridine Monophosphate
p63771
(dp63772
sVBCRP/ABCG2 Substrates
p63773
g42048
ssg7818
(dp63774
g4557
g46135
sg3099
g36734
sg7920
(dp63775
sg8649
(dp63776
sg9660
(dp63777
ssg7821
(dp63778
VBSEP/ABCB11 Substrates
p63779
(dp63780
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p63781
(dp63782
sVCytochrome P-450 CYP2D6 Inhibitors
p63783
g62900
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p63784
g41065
sVCytochrome P-450 CYP3A Substrates
p63785
g45174
sVAgents causing hyperkalemia
p63786
g43569
sVAntifungal Agents
p63787
(dp63788
sVCytochrome P-450 CYP3A4 Inhibitors
p63789
g61627
sVCytochrome P-450 CYP3A7 Inhibitors
p63790
(dp63791
sVBSEP/ABCB11 Inhibitors
p63792
g62522
sVOATP1B1/SLCO1B1 Inhibitors
p63793
(dp63794
sVCytochrome P-450 CYP2C9 Inhibitors
p63795
g18178
sVCytochrome P-450 Enzyme Inhibitors
p63796
g62055
sVAnti-Infective Agents
p63797
g54558
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p63798
(dp63799
sVAntiinfectives for Systemic Use
p63800
(dp63801
sVCytochrome P-450 CYP3A7 Inhibitors (strong)
p63802
(dp63803
sVImidazole and Triazole Derivatives
p63804
g51759
sVAzole Antifungals
p63805
g20192
sVEnzyme Inhibitors
p63806
(dp63807
sVGynecological Antiinfectives and Antiseptics
p63808
(dp63809
sg11622
(dp63810
sVAntifungals for Topical Use
p63811
g39230
sVSteroid Synthesis Inhibitors
p63812
(dp63813
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p63814
g29469
sVQTc Prolonging Agents
p63815
g57782
sVCytochrome P450 3A5 Inhibitors
p63816
g42993
sVCytochrome P450 3A4 Inhibitors
p63817
g13033
sVGenito Urinary System and Sex Hormones
p63818
(dp63819
sVPotential QTc-Prolonging Agents
p63820
(dp63821
sVAntifungals for Dermatological Use
p63822
g30075
sVCytochrome P-450 CYP1A2 Inhibitors
p63823
g14987
sVCytochrome P-450 CYP2C8 Inhibitors
p63824
g54999
sVCytochrome P-450 CYP2B6 Inhibitors
p63825
g45924
sVP-glycoprotein/ABCB1 Substrates
p63826
g34912
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p63827
(dp63828
sVUGT1A1 Inhibitors
p63829
(dp63830
sg8115
(dp63831
sVCytochrome P-450 CYP3A5 Inhibitors
p63832
g55335
sVCytochrome P-450 CYP2C19 Inhibitors
p63833
g61251
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p63834
g23102
sVCytochrome P-450 CYP3A Inhibitors (strong)
p63835
g13383
sVCytochrome P-450 CYP3A4 Substrates
p63836
(dp63837
sVUGT2B7 Inhibitors
p63838
g53577
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p63839
g58927
sVHormone Antagonists
p63840
g24260
sVAntimycotics for Systemic Use
p63841
(dp63842
sV14-alpha Demethylase Inhibitors
p63843
(dp63844
sVDermatologicals
p63845
g17184
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p63846
(dp63847
sVCytochrome P-450 CYP3A Inhibitors
p63848
g60382
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p63849
(dp63850
sVImidazole Derivatives
p63851
(dp63852
sVP-glycoprotein/ABCB1 Inhibitors
p63853
(dp63854
sVHormones, Hormone Substitutes, and Hormone Antagonists
p63855
g53148
sVChemically-Induced Disorders
p63856
g21221
sVCytochrome P-450 CYP2A6 Inhibitors
p63857
g48579
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p63858
g27741
ssg7824
(dp63859
VNitrogen Compounds
p63860
g39009
sVSalicylic Acid and Derivatives
p63861
g36816
sVAnalgesics
p63862
g26432
sVHydroxy Acids
p63863
g18153
sVOCT2 Inhibitors
p63864
g42472
sVDrugs that are Mainly Renally Excreted
p63865
g43932
sVSalicylates
p63866
g27628
sVAmines
p63867
g42668
sVAcids, Carbocyclic
p63868
g41557
sVOCT2 substrates with narrow therapeutic index
p63869
g29687
sVEthanolamines
p63870
(dp63871
sVOCT1 substrates
p63872
g13073
sVOCT1 inhibitors
p63873
(dp63874
sVPharmaceutical Preparations
p63875
g53862
sVOCT2 Substrates
p63876
g14943
sVPhenols
p63877
(dp63878
sVBenzene Derivatives
p63879
g61400
sVOnium Compounds
p63880
g22258
sVAmino Alcohols
p63881
g32675
sVBenzoates
p63882
g30388
sVTrimethyl Ammonium Compounds
p63883
g16042
sVHydroxybenzoates
p63884
g59581
sVNervous System
p63885
(dp63886
sVQuaternary Ammonium Compounds
p63887
g43372
sVAlcohols
p63888
(dp63889
sVAmmonium Compounds
p63890
g30561
ssg7827
(dp63891
g10365
(dp63892
sg2769
g34277
ssg7830
(dp63893
g8019
(dp63894
sg10629
(dp63895
sg4425
g44938
sg5619
g52216
sg5622
g52240
sg5229
g49793
sg16906
g61890
sg7854
(dp63896
sg11619
(dp63897
sg6903
g59182
sg8418
(dp63898
sg10149
(dp63899
sg3426
g38767
sg4278
g44262
sg213
g14046
sg10494
(dp63900
sg339
g15147
sg12114
(dp63901
sg9009
(dp63902
sg8457
(dp63903
sg7344
g61304
sg7962
(dp63904
sg12060
(dp63905
sg4467
g45533
sg7971
(dp63906
sg10740
(dp63907
sg2109
g30095
sg336
g15112
sg9783
(dp63908
sg6024
g54426
sg6000
g54296
sg10416
(dp63909
sg9273
(dp63910
sg2835
g34761
sg3072
g36582
sg10581
(dp63911
sg8226
(dp63912
sg7077
g60014
sg5589
g51905
sg2172
g30498
sg5199
g49682
sg5595
g51975
sg11259
(dp63913
ssg7833
(dp63914
g3699
g40341
ssg7836
(dp63915
g4023
g42319
sg8205
(dp63916
sg2358
g31459
sg3858
g41197
sg16906
g61929
sg828
g19842
sg4449
g45373
sg4452
g45410
sg10470
(dp63917
sg6033
g54498
sg2784
g34348
sg3132
g36990
sg2034
g29039
sg5472
g51309
sg282
g14533
sg8430
(dp63918
sg11451
(dp63919
sg7884
(dp63920
sg9564
(dp63921
sg2664
g33420
sg9954
(dp63922
sg2814
g34508
sg6090
g54931
sg6966
g59394
sg2829
g34660
sg10521
(dp63923
sg9432
(dp63924
sg6435
g56955
sg6645
g58013
sg3963
g41852
sg11097
(dp63925
sg8514
(dp63926
sg3867
g41346
sg11625
(dp63927
sg1668
g26243
sg966
g21036
sg6315
g56284
sg1857
g27698
sg9663
(dp63928
sg7524
g62424
sg2676
g33554
sg7170
g60302
sg8724
(dp63929
sg9105
(dp63930
ssg7839
(dp63931
g1791
g27226
sg30
g12352
sg9339
(dp63932
sg2895
g35406
sg1800
g27304
sg6393
g56830
sg4653
g46744
sg6045
g54721
sg5865
g53590
sg690
g18598
sg5685
g52455
sg12534
g52690
sg3174
g37248
sg7377
g61479
sg3393
g38536
sg3021
g36175
sg351
g15262
sg11712
(dp63933
sg4539
g46013
sg2739
g33985
sg2667
g33491
sg14872
g15701
sg4479
g45675
sg3990
g42112
sg10239
(dp63934
sg9096
(dp63935
sg1611
g25800
ssg7842
(dp63936
g10659
(dp63937
sVKeratolytic Agents
p63938
(dp63939
sVComplex Mixtures
p63940
(dp63941
sg11880
(dp63942
sVDermatologicals
p63943
g17299
ssg7845
(dp63944
VSequestering Agents
p63945
g57203
sVDrugs that are Mainly Renally Excreted
p63946
g43950
sg3414
g38738
sVUGT1A6 substrate
p63947
g38510
sVChelating Agents
p63948
(dp63949
sVIron Chelating Agents
p63950
(dp63951
sVPyridines
p63952
(dp63953
sVCompounds used in a research, industrial, or household setting
p63954
(dp63955
sVIron Chelating Activity
p63956
(dp63957
sVHeavy Metal Antagonists
p63958
g30318
ssg7848
(dp63959
VAmino Acids, Cyclic
p63960
g27289
sVImmunosuppressive Agents
p63961
(dp63962
sVImmunologic Factors
p63963
g42374
sVNitrogen Mustard Compounds
p63964
g14455
sVAntineoplastic Agents, Alkylating
p63965
g60747
sVAmino Acids
p63966
g43099
sVMustard Compounds
p63967
g28993
sVMyelosuppressive Agents
p63968
(dp63969
sVMyeloablative Agonists
p63970
(dp63971
sVAntineoplastic Agents
p63972
(dp63973
sVAmino Acids, Aromatic
p63974
(dp63975
sVP-glycoprotein/ABCB1 Substrates
p63976
g34914
sVAlkylating Drugs
p63977
(dp63978
sVNitrogen Mustard Analogues
p63979
g43126
sVAmino Acids, Peptides, and Proteins
p63980
g47342
sVToxic Actions
p63981
g49383
sVAmino Acids, Essential
p63982
g35287
sVNoxae
p63983
(dp63984
sVAlkylating Activity
p63985
g46197
sVPhenylalanine
p63986
(dp63987
sVHydrocarbons, Halogenated
p63988
(dp63989
sVAntineoplastic and Immunomodulating Agents
p63990
g39757
ssg7851
(dp63991
g5409
g50886
sg402
g15834
ssg7854
(dp63992
VAmino Acids, Peptides, and Proteins
p63993
g47343
sVFibrin Modulating Agents
p63994
g22855
sVHematologic Agents
p63995
(dp63996
sVBlood and Blood Forming Organs
p63997
g53910
sVCardiovascular Agents
p63998
g26574
sVEndopeptidases
p63999
(dp64000
sVEnzymes
p64001
(dp64002
sVAnticoagulants
p64003
g58368
sVProteins
p64004
g52751
sVAgents causing angioedema
p64005
g63896
sVFibrinolytic Agents
p64006
g26301
sVBiological Factors
p64007
g38095
sVEnzymes and Coenzymes
p64008
(dp64009
sVBlood Proteins
p64010
g39847
sVSerine Endopeptidases
p64011
g35489
sVHydrolases
p64012
(dp64013
sVPeptide Hydrolases
p64014
g42947
sVSerine Proteases
p64015
g31558
sVPlasminogen Activators
p64016
g52951
ssg7857
(dp64017
g8673
(dp64018
sg2277
g31121
sg1890
g28012
sg9111
(dp64019
sg7533
g62493
sg11916
(dp64020
sg10335
(dp64021
sg9492
(dp64022
sg6381
g56766
ssg7860
(dp64023
g2142
g30349
ssg7863
(dp64024
g9252
(dp64025
sg7626
g62976
sg3018
g36130
sg375
g15449
sg7164
g60272
ssg7866
(dp64026
g9810
(dp64027
sg11751
(dp64028
sg501
g16728
sg5226
g49776
sg11826
(dp64029
sg5025
g48761
ssg7869
(dp64030
g2460
g32273
sg9198
(dp64031
sg7191
g60557
sg7821
g63803
sg1047
g21600
sg573
g17538
ssg7872
(dp64032
g4398
g44826
sg8826
(dp64033
sg5448
g51121
ssg7875
(dp64034
g6312
g56260
ssg7878
(dp64035
VAntiinfectives for Systemic Use
p64036
(dp64037
sg10398
(dp64038
sVAgents that produce neuromuscular block (indirect)
p64039
g37979
sVProtein Synthesis Inhibitors
p64040
g45560
sVTetracyclines
p64041
(dp64042
sVEnzyme Inhibitors
p64043
(dp64044
sVAnti-Bacterial Agents
p64045
g38330
sVAntibacterials for Systemic Use
p64046
g32535
sVNaphthacenes
p64047
g40473
sVAnti-Infective Agents
p64048
g54584
ssg7881
(dp64049
g5016
g48717
sVAntivirals for Systemic Use
p64050
g59778
sVNucleic Acid Synthesis Inhibitors
p64051
g48731
sVCarbohydrates
p64052
g61764
sVPyrimidines
p64053
g47697
sVDirect Acting Antivirals
p64054
g38083
sVAnti-HIV Agents
p64055
(dp64056
sVEnzyme Inhibitors
p64057
(dp64058
sVReverse Transcriptase Inhibitors
p64059
g28956
sVDeoxyribonucleosides
p64060
g33056
sVAntiinfectives for Systemic Use
p64061
(dp64062
sVDrugs that are Mainly Renally Excreted
p64063
g43953
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p64064
g14464
sVAnti-Infective Agents
p64065
g54597
sg8640
(dp64066
sg57
g12698
sVGlycosides
p64067
(dp64068
sg3315
g38160
sVRibonucleosides
p64069
(dp64070
sVNucleic Acids, Nucleotides, and Nucleosides
p64071
g47119
sVPyrimidine Nucleosides
p64072
(dp64073
sVAnti-Retroviral Agents
p64074
(dp64075
sVNucleosides
p64076
g49460
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p64077
g61379
sVNucleoside Reverse Transcriptase Inhibitors
p64078
g38837
sVAntiviral Agents
p64079
g30475
ssg7884
(dp64080
VCytochrome P-450 CYP3A4 Inhibitors
p64081
g61660
sVAntivirals for Systemic Use
p64082
g59751
sVCytochrome P-450 CYP3A Substrates
p64083
g44984
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p64084
(dp64085
sVDirect Acting Antivirals
p64086
g38045
sVCYP3A Substrates (Sensitive)
p64087
g63920
sVAnti-HIV Agents
p64088
(dp64089
sVEnzyme Inhibitors
p64090
(dp64091
sVCytochrome P-450 Enzyme Inhibitors
p64092
g62002
sVAnti-Infective Agents
p64093
g54598
sVHyperglycemia-Associated Agents
p64094
(dp64095
sVAntiinfectives for Systemic Use
p64096
(dp64097
sVCarbamates
p64098
g45511
sVGynecological Antiinfectives and Antiseptics
p64099
(dp64100
sVAmides
p64101
g44309
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64102
g29223
sVSulfur Compounds
p64103
(dp64104
sVHIV Protease Inhibitors
p64105
(dp64106
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p64107
g60067
sVSulfonamides
p64108
g63355
sVSulfones
p64109
g58732
sVProtease Inhibitors
p64110
g51088
sVCytochrome P450 2D6 Inhibitors
p64111
(dp64112
sVCytochrome P-450 CYP3A Inhibitors (strong)
p64113
g13382
sVCytochrome P-450 CYP3A4 Substrates
p64114
(dp64115
sVAnti-Retroviral Agents
p64116
(dp64117
sVFurans
p64118
(dp64119
sVGenito Urinary System and Sex Hormones
p64120
(dp64121
sVAcids, Acyclic
p64122
g25451
sVCytochrome P-450 CYP3A Inhibitors
p64123
g60419
sVAntiviral Agents
p64124
g30429
sVOATP1B1/SLCO1B1 Inhibitors
p64125
(dp64126
sVCytochrome P450 3A Inhibitors
p64127
g54268
sVP-glycoprotein/ABCB1 Inhibitors
p64128
(dp64129
ssg7887
(dp64130
g11940
(dp64131
sg816
g19658
ssg7890
(dp64132
g3072
g36594
sg5229
g49797
sg7077
g60026
sg6000
g54308
sg9009
(dp64133
sg7344
g61307
ssg7893
(dp64134
g4377
g44801
sg2736
g33951
ssg7896
(dp64135
VAntimuscarinics Antispasmodics
p64136
g31223
sVAgents to Treat Airway Disease
p64137
g32641
sVAnticholinergic Agents
p64138
g24494
sVDrugs that are Mainly Renally Excreted
p64139
g43956
sVAzabicyclo Compounds
p64140
(dp64141
sVMuscarinic Antagonists
p64142
g48875
sVAza Compounds
p64143
(dp64144
sVAgents producing tachycardia
p64145
g50762
sVAlkaloids
p64146
g19418
sVCholinesterase substrates
p64147
g41635
sVDrugs for Obstructive Airway Diseases
p64148
g42526
sVAdrenergics, Inhalants
p64149
g43170
ssg7899
(dp64150
g10839
(dp64151
sg4014
g42226
sg13091
g21383
sg3609
g39694
sg7848
g63971
ssg7902
(dp64152
g2703
g33725
ssg7905
(dp64153
VAmino Acids, Peptides, and Proteins
p64154
g47411
sVAntiinfectives for Systemic Use
p64155
(dp64156
sVEchinocandin Antifungal
p64157
g40665
sVLipopeptides
p64158
g33713
sVAntimycotics for Systemic Use
p64159
(dp64160
sVCOMT Substrates
p64161
g43560
sVPeptides, Cyclic
p64162
(dp64163
sVAntifungal Agents
p64164
(dp64165
sVPeptides
p64166
g47209
sVLipids
p64167
g14331
sVAnti-Infective Agents
p64168
g54669
sVEchinocandins
p64169
g58283
ssg7908
(dp64170
g10200
(dp64171
sg21710
g54024
ssg7911
(dp64172
g10701
(dp64173
sg7593
g62785
sg888
g20403
ssg7914
(dp64174
g11061
(dp64175
sg6654
g58046
sg1275
g23292
sg8985
(dp64176
ssg7917
(dp64177
g438
g16187
sg2652
g33332
sg2460
g32309
sg1371
g24134
sg2274
g31096
sg11166
(dp64178
sg11385
(dp64179
ssg7920
(dp64180
VPolyvalent cation containing laxatives, antacids, oral supplements
p64181
g63775
sVGastric Acid Lowering Agents
p64182
(dp64183
sVAlkalies
p64184
g58395
sVAntacids
p64185
g42399
sVCarbonic Acid
p64186
g48830
sVCalcium Compounds
p64187
g51125
sVCalcium Salts
p64188
g54684
sVReplacement Preparations
p64189
g27634
sVElectrolytes
p64190
g52423
sVMineral Supplements
p64191
g38298
sVPhosphate Binder
p64192
g21943
sVMinerals
p64193
g52584
sVGastrointestinal Agents
p64194
(dp64195
sVCarbonates
p64196
(dp64197
sVIons
p64198
g49122
sVAntacids and Adsorbents
p64199
g60136
sVAcids
p64200
g40581
sVAlimentary Tract and Metabolism
p64201
g23839
sVCarbon Compounds, Inorganic
p64202
g39297
sVBlood Coagulation Factors
p64203
(dp64204
sVAcids, Noncarboxylic
p64205
g54206
sVDrugs for Acid Related Disorders
p64206
g55169
sVAnions
p64207
(dp64208
ssg7923
(dp64209
g4437
g45289
sg8724
(dp64210
sg8703
(dp64211
ssg7926
(dp64212
g3363
g38433
sg1605
g25778
sg10113
(dp64213
sg4287
g44402
sg801
g19543
ssg7929
(dp64214
g10245
(dp64215
ssg7932
(dp64216
g12126
(dp64217
sg2688
g33660
sg9918
(dp64218
ssg7935
(dp64219
g10062
(dp64220
sg1980
g28799
sg8433
(dp64221
sg3105
g36789
sg7845
g63953
sg9924
(dp64222
sg819
g19764
sg3846
g41132
sg9249
(dp64223
sg8394
(dp64224
sg4017
g42288
sg8916
(dp64225
sg2946
g35827
sg5832
g53430
sg11265
(dp64226
sg11052
(dp64227
sg684
g18505
sg3885
g41452
sg9552
(dp64228
sg4263
g44177
sg8241
(dp64229
sg5973
g54244
sg285
g14628
sg9687
(dp64230
sg8022
(dp64231
sg4638
g46545
sg3696
g40295
sg1857
g27711
sg5652
g52360
sg9954
(dp64232
sg1683
g26388
sg3975
g41934
sg11292
(dp64233
sg6075
g54882
sg9696
(dp64234
sg7764
g63631
sg12078
(dp64235
sg10179
(dp64236
sg3978
g42003
sg14791
(dp64237
sg10353
(dp64238
sg10539
(dp64239
sg7563
g62674
sg10557
(dp64240
sg8139
(dp64241
sg7170
g60316
sg3432
g38810
sg1188
g22779
sg5646
g52319
sg6819
g58883
sg9492
(dp64242
sg9684
(dp64243
sg7029
g59643
sg4401
g44859
sg9855
(dp64244
sg4452
g45438
ssg7938
(dp64245
g3543
g39346
ssg7941
(dp64246
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p64247
(dp64248
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p64249
g29606
sVAdrenergic alpha-1 Receptor Antagonists
p64250
g14131
sVAnticholinergic Agents
p64251
g24495
sVCytochrome P-450 CYP2D6 Inhibitors
p64252
g62930
sVCytochrome P-450 CYP2D6 Substrates
p64253
g52149
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p64254
(dp64255
sVSerotonin Agents
p64256
(dp64257
sVCytochrome P-450 CYP3A Substrates
p64258
g45134
sVNeurotransmitter Agents
p64259
(dp64260
sVAntidepressive Agents, Tricyclic
p64261
g60706
sVSerotonin Receptor Antagonists
p64262
g35679
sVHistamine Agents
p64263
(dp64264
sVCentral Nervous System Agents
p64265
g58452
sVPotential QTc-Prolonging Agents
p64266
(dp64267
sVAdrenergic Antagonists
p64268
g52288
sVPsychotropic Drugs
p64269
(dp64270
sVDopamine Antagonists
p64271
g53747
sVSerotonin 5-HT1 Receptor Antagonists
p64272
g14433
sVCytochrome P-450 Enzyme Inhibitors
p64273
g62030
sVHistamine H2 Antagonists
p64274
g12706
sVAcid Reducers
p64275
g43807
sVDrugs that are Mainly Renally Excreted
p64276
g43960
sVCytochrome P-450 CYP1A2 Substrates
p64277
g45593
sVPsychoanaleptics
p64278
g59075
sVNon-Selective Monoamine Reuptake Inhibitors
p64279
(dp64280
sVAntipruritics and Local Anesthetics
p64281
g31869
sVDibenzoxepins
p64282
g21860
sVHypnotics and Sedatives
p64283
(dp64284
sVMuscarinic Antagonists
p64285
g48876
sg4815
g47721
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64286
g29415
sVAdrenergic alpha-Antagonists
p64287
g60877
sVCytochrome P-450 CYP2C9 Substrates
p64288
g29750
sVQTc Prolonging Agents
p64289
g57830
sVSerotonin 5-HT2 Receptor Antagonists
p64290
(dp64291
sVNeurotoxic agents
p64292
(dp64293
sVCytochrome P-450 CYP2C19 Substrates
p64294
g53895
sVCentral Nervous System Depressants
p64295
(dp64296
sVHistamine Antagonists
p64297
g43450
sVSleep Aids, Pharmaceutical
p64298
(dp64299
sVAgents that reduce seizure threshold
p64300
g45860
sVP-glycoprotein/ABCB1 Substrates
p64301
g34977
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p64302
g37405
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p64303
g36471
sVDermatologicals
p64304
g17242
sVHistamine H1 Antagonists
p64305
g40789
sVAgents that produce hypertension
p64306
(dp64307
sVCytochrome P-450 CYP3A4 Substrates
p64308
(dp64309
sVNarrow Therapeutic Index Drugs
p64310
g50570
sVHeterocyclic Compounds, Fused-Ring
p64311
g56085
sVSerotonin Modulators
p64312
(dp64313
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p64314
g61382
sVAntidepressive Agents
p64315
g15529
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p64316
g47501
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p64317
g36629
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p64318
g53078
sVTertiary amine tricyclic antidepressants
p64319
g31316
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p64320
(dp64321
sVAgents producing tachycardia
p64322
g50765
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p64323
g60079
sVNervous System
p64324
(dp64325
ssg7944
(dp64326
VCytochrome P-450 CYP2C19 Substrates
p64327
g53896
sVCentral Nervous System Depressants
p64328
(dp64329
sVImides
p64330
(dp64331
sVAntiarrhythmic agents
p64332
(dp64333
sVAnti-epileptic Agent
p64334
(dp64335
sVPyrrolidinones
p64336
g30234
sVAgents causing hyperkalemia
p64337
g43618
sVQTc Prolonging Agents
p64338
g57780
sVBradycardia-Causing Agents
p64339
g61456
sVSuccinimide Derivatives
p64340
g28848
sVCentral Nervous System Agents
p64341
g58508
sVCalcium Channel Blockers
p64342
g41317
sVPotential QTc-Prolonging Agents
p64343
(dp64344
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p64345
(dp64346
sVPyrrolidines
p64347
g59350
sVAnticonvulsants
p64348
g60156
sVCytochrome P-450 CYP2C19 Inhibitors
p64349
g61277
sVCytochrome P-450 Enzyme Inhibitors
p64350
g61970
sVNervous System
p64351
(dp64352
sVDecreased Central Nervous System Disorganized Electrical Activity
p64353
g23474
ssg7947
(dp64354
VCytochrome P-450 CYP3A4 Inhibitors
p64355
g61668
sVAntivirals for Systemic Use
p64356
g59769
sVCytochrome P-450 CYP3A Substrates
p64357
g45135
sg10851
(dp64358
sVDirect Acting Antivirals
p64359
g38070
sg5436
g51100
sg8397
(dp64360
sVEnzyme Inhibitors
p64361
(dp64362
sVCytochrome P-450 Enzyme Inhibitors
p64363
g62031
sVAnti-Infective Agents
p64364
g54611
sVHyperglycemia-Associated Agents
p64365
(dp64366
sVAntiinfectives for Systemic Use
p64367
(dp64368
sg8520
(dp64369
sVAmides
p64370
g44327
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64371
g29416
sVSulfur Compounds
p64372
(dp64373
sg11673
(dp64374
sVSulfones
p64375
g58746
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p64376
(dp64377
sVCytochrome P-450 CYP3A4 Substrates
p64378
(dp64379
sVAcids, Acyclic
p64380
g25488
sVCytochrome P-450 CYP3A Inhibitors
p64381
g60428
sVAntiviral Agents
p64382
g30462
sVP-glycoprotein/ABCB1 Inhibitors
p64383
(dp64384
sg10443
(dp64385
ssg7950
(dp64386
g2787
g34418
sg5268
g50142
ssg7953
(dp64387
g9414
(dp64388
sg4581
g46215
sg11751
(dp64389
sg7044
g59738
sg11826
(dp64390
ssg7956
(dp64391
g1581
g25695
ssg7959
(dp64392
VNeurotransmitter Agents
p64393
(dp64394
sVAnti-Parkinson Drugs
p64395
g16158
sg5319
g50489
sVCentral Nervous System Agents
p64396
g58455
sVCholinergic Agents
p64397
g28727
sg10110
(dp64398
sVAgents producing tachycardia
p64399
g50767
sg4248
g43802
sVNervous System
p64400
(dp64401
sVMuscarinic Antagonists
p64402
g48878
sVAnticholinergic Agents
p64403
g24500
ssg7962
(dp64404
VDrugs that are Mainly Renally Excreted
p64405
g43835
sVCytochrome P-450 CYP2C8 Substrates
p64406
(dp64407
sVProtease Inhibitors
p64408
g51095
sVOAT3/SLC22A8 Substrates
p64409
g13102
sVCytochrome P-450 CYP3A Substrates
p64410
g44983
sVTriazoles
p64411
g47839
sVDPP-IV Inhibitors
p64412
(dp64413
sVAgents causing angioedema
p64414
g63904
sVHypoglycemia-Associated Agents
p64415
g17676
sVP-glycoprotein/ABCB1 Substrates
p64416
g34948
sVHormones, Hormone Substitutes, and Hormone Antagonists
p64417
g53151
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64418
g29222
sVOral Hypoglycemics
p64419
g35989
sVHormones
p64420
g55667
sVEnzyme Inhibitors
p64421
(dp64422
sVIncretins
p64423
g20128
sVCytochrome P-450 CYP3A4 Substrates
p64424
(dp64425
sVBlood Glucose Lowering Agents
p64426
(dp64427
sVAlimentary Tract and Metabolism
p64428
g23810
sVDrugs Used in Diabetes
p64429
g60108
ssg7965
(dp64430
g4725
g47143
ssg7968
(dp64431
g7155
g60233
sg9726
(dp64432
sg6525
g57355
sg10854
(dp64433
ssg7971
(dp64434
VAnalgesics
p64435
g26457
sVAgents causing angioedema
p64436
g63906
sVNeuropeptides
p64437
g57513
sVCentral Nervous System Agents
p64438
g58457
sg10647
(dp64439
sVOligopeptides
p64440
(dp64441
sVBiological Factors
p64442
g38117
sg5046
g48849
sVPeripheral Nervous System Agents
p64443
g57610
sVDrugs that are Mainly Renally Excreted
p64444
g43962
sVAutacoids
p64445
(dp64446
sVAnalgesics, Non-Narcotic
p64447
g56907
sVImmunologic Factors
p64448
g42386
sVBlood and Blood Forming Organs
p64449
g53935
sVProteins
p64450
g52758
sVInflammation Mediators
p64451
g23623
sVNerve Tissue Proteins
p64452
(dp64453
sg5823
g53342
sg11835
(dp64454
sVAmino Acids, Peptides, and Proteins
p64455
g47356
sg6972
g59442
sVIntercellular Signaling Peptides and Proteins
p64456
g25415
sVPeptides
p64457
g47181
sVAnti-Inflammatory Agents
p64458
(dp64459
sVAntirheumatic Agents
p64460
g24243
sVSensory System Agents
p64461
(dp64462
ssg7974
(dp64463
g7053
g59808
sg3516
g39171
sg7428
g61861
sg10494
(dp64464
sg6024
g54462
sg5589
g51942
sg3651
g40125
sg4596
g46256
sg8418
(dp64465
ssg7977
(dp64466
VHematinics
p64467
g59090
sVCarbohydrates
p64468
g61769
sVBiological Factors
p64469
g38119
sVGlycoconjugates
p64470
(dp64471
sVAntianemic Preparations
p64472
g63056
sVColony-Stimulating Factors
p64473
g47973
sVGlycols
p64474
g55145
sVBlood and Blood Forming Organs
p64475
g53943
sVHematopoietic Cell Growth Factors
p64476
(dp64477
sVPolymers
p64478
g22239
sVProteins
p64479
g52781
sVPeptides
p64480
g47182
sVIncreased Erythroid Cell Production
p64481
(dp64482
sVBiomedical and Dental Materials
p64483
g44731
sVEthylene Glycols
p64484
g62629
sVAmino Acids, Peptides, and Proteins
p64485
g47361
sVIntercellular Signaling Peptides and Proteins
p64486
g25416
sVPegylated agents
p64487
g13558
sVErythropoiesis-Stimulating Agents
p64488
g13885
sVMacromolecular Substances
p64489
g33847
sVGlycoproteins
p64490
(dp64491
sVAlcohols
p64492
(dp64493
sVCytokines
p64494
g62891
sVCompounds used in a research, industrial, or household setting
p64495
(dp64496
ssg7980
(dp64497
VAmino Acids, Peptides, and Proteins
p64498
g47398
sVAntibodies
p64499
g60992
sg9645
(dp64500
sVAntibodies, Monoclonal
p64501
(dp64502
sVAntibodies, Monoclonal, Humanized
p64503
(dp64504
sVProteins
p64505
g52759
sVImmunologic Factors
p64506
g42395
sVImmunoglobulins
p64507
g41535
sVImmunosuppressive Agents
p64508
(dp64509
sg6789
g58699
sVSerum Globulins
p64510
g49665
sg8973
(dp64511
sVAntineoplastic and Immunomodulating Agents
p64512
g39773
sVBlood Proteins
p64513
g39871
sVGlobulins
p64514
g19195
sVInterleukin Inhibitors
p64515
g49764
sVImmunoproteins
p64516
g57458
ssg7983
(dp64517
VPiperidines
p64518
(dp64519
sVHistamine H1 Antagonists
p64520
g40773
sVCytochrome P-450 CYP2D6 Substrates
p64521
g52113
sVCytochrome P-450 CYP3A Substrates
p64522
g45179
sVHistamine H1 Antagonists, Non-Sedating
p64523
g38525
sg5118
g49194
sVPotential QTc-Prolonging Agents
p64524
(dp64525
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64526
g29475
sVHistamine Antagonists
p64527
g43431
sVAntihistamines for Systemic Use
p64528
g12964
sVCytochrome P-450 CYP2C9 Substrates
p64529
g29716
sVQTc Prolonging Agents
p64530
g57786
sVCytochrome P-450 CYP3A4 Substrates
p64531
(dp64532
sg825
g19830
sg5097
g49101
ssg7986
(dp64533
g4620
g46328
sg1245
g23012
sg9132
(dp64534
sg6192
g55544
sg6882
g59135
sg9300
(dp64535
sg6213
g55612
sg6216
g55644
sg1800
g27297
sg7848
g63962
sg5454
g51176
sg4653
g46742
sg9411
(dp64536
sg858
g20150
sg11151
(dp64537
sg10680
(dp64538
sg7668
g63226
sg8430
(dp64539
sg888
g20511
sg11952
(dp64540
sg10701
(dp64541
sg2388
g31688
sg9963
(dp64542
sg6807
g58838
sg3609
g39666
sg2451
g32217
sg2391
g31741
sg9903
(dp64543
sg10752
(dp64544
sg2466
g32359
sg3801
g40965
sg9267
(dp64545
sg9273
(dp64546
sg3219
g37543
sg11550
(dp64547
sg10794
(dp64548
sg13091
g21426
sg11562
(dp64549
sg6345
g56610
sg4002
g42131
sg10104
(dp64550
sg14829
g56687
sg10653
(dp64551
sg4014
g42247
sg1791
g27269
sg837
g19992
sg10839
(dp64552
sg11601
(dp64553
sg4905
g48184
sg2226
g30791
sg3930
g41662
sg3321
g38226
sg9375
(dp64554
sg4113
g43075
sg87
g12897
sg11922
(dp64555
sg4521
g45950
sg7545
g62584
sg8625
(dp64556
sg4068
g42793
sg8076
(dp64557
sg1614
g25905
sg9135
(dp64558
sg14838
g39956
sg3027
g36385
sg4089
g42875
sg6804
g58794
sg12534
g52688
sg4917
g48305
sg9414
(dp64559
sg9444
(dp64560
sg3258
g37811
sg8694
(dp64561
sg6171
g55320
sg11718
(dp64562
sg6489
g57212
sg474
g16546
sg1920
g28480
sg1149
g22498
sg12015
(dp64563
sg10179
(dp64564
sg6504
g57281
sg8760
(dp64565
sg7980
g64509
sg48
g12617
sg1173
g22645
sg5766
g53008
sg2715
g33821
sg4185
g43475
sg11775
(dp64566
sg8751
(dp64567
sg2373
g31567
sg4197
g43507
sg4200
g43537
sg11079
(dp64568
sg2754
g34087
sg11799
(dp64569
sg447
g16290
sg456
g16383
sg9528
(dp64570
sg9348
(dp64571
sg4356
g44700
sg6585
g57679
sg4023
g42360
sg477
g16591
sg2034
g29043
sg1674
g26315
sg3015
g36073
sg1266
g23244
sg3519
g39205
sg5880
g53727
sg6612
g57762
sg5895
g53788
sg2079
g29873
sg11886
(dp64572
sg9609
(dp64573
sg9612
(dp64574
sg2829
g34662
sg9618
(dp64575
sg3393
g38592
sg11133
(dp64576
sg11136
(dp64577
sg10698
(dp64578
sg8856
(dp64579
sg3963
g41899
sg9030
(dp64580
sg6654
g58083
sg5127
g49252
sg9180
(dp64581
sg3573
g39536
sg1365
g24046
sg10410
(dp64582
sg28215
g35339
sg11913
(dp64583
sg2895
g35460
sg1383
g24175
sg4875
g48035
sg10431
(dp64584
sg8190
(dp64585
sg13750
g24412
sg3633
g40050
sg14872
g15768
sg9693
(dp64586
sg6630
g57918
sg6009
g54337
sg9705
(dp64587
sg16906
g61885
sg5250
g50004
sg6045
g54720
sg6765
g58580
sg4476
g45661
sg9525
(dp64588
sg6783
g58686
sg9909
(dp64589
sg11286
(dp64590
sg2418
g31931
sg5652
g52358
sg11997
(dp64591
sg9774
(dp64592
sg2196
g30648
sg11313
(dp64593
sg4542
g46076
sg10374
(dp64594
sg1275
g23269
sg4863
g47926
sg3264
g37865
sg12090
(dp64595
sg771
g19305
sg5364
g50604
sg7416
g61734
sg9084
(dp64596
sg12132
(dp64597
sg11241
(dp64598
sg1599
g25738
sg9105
(dp64599
ssg7989
(dp64600
g4620
g46357
sg5409
g50903
sg2346
g31406
sg9132
(dp64601
sg3846
g41152
sg9249
(dp64602
sg5433
g51074
sg9903
(dp64603
sg1800
g27345
sg2226
g30793
sg5454
g51178
sg7668
g63228
sg8430
(dp64604
sg9198
(dp64605
sg10701
(dp64606
sg8448
(dp64607
sg10272
(dp64608
sg5133
g49303
sg9966
(dp64609
sg9225
(dp64610
sg1113
g22207
sg816
g19701
sg147
g13495
sg3219
g37566
sg13091
g21363
sg11523
(dp64611
sg6345
g56612
sg3258
g37813
sg14829
g56689
sg7053
g59821
sg4023
g42362
sg12274
g27571
sg7545
g62586
sg1062
g21835
sg1614
g25907
sg4680
g46904
sg14838
g40018
sg3027
g36387
sg4089
g42877
sg1104
g22094
sg4113
g43077
sg9444
(dp64612
sg8694
(dp64613
sg8703
(dp64614
sg2688
g33691
sg14872
g15770
sg7188
g60525
sg5766
g53010
sg9492
(dp64615
sg2373
g31624
sg9918
(dp64616
sg5832
g53448
sg2787
g34401
sg3516
g39185
sg11079
(dp64617
sg11940
(dp64618
sg78
g12877
sg5895
g53840
sg11952
(dp64619
sg9609
(dp64620
sg543
g17122
sg3393
g38594
sg6504
g57283
sg11886
(dp64621
sg3651
g40138
sg1668
g26289
sg696
g18782
sg13750
g24414
sg5757
g52945
sg9693
(dp64622
sg7428
g61873
sg2943
g35742
sg1434
g24689
sg405
g15889
sg6765
g58583
sg6783
g58688
sg5526
g51593
sg3024
g36326
sg9030
(dp64623
sg11316
(dp64624
sg1140
g22434
sg2832
g34747
sg10539
(dp64625
sg10113
(dp64626
sg10557
(dp64627
sg1098
g22010
sg5364
g50634
sg12126
(dp64628
sg10596
(dp64629
sg12132
(dp64630
sg4596
g46270
ssg7992
(dp64631
g10185
(dp64632
sg2283
g31147
sg5286
g50227
sg6567
g57530
sg10878
(dp64633
ssg7995
(dp64634
g6630
g57923
sg8322
(dp64635
sg9918
(dp64636
sg5334
g50523
sg1266
g23248
sg4170
g43384
sg6015
g54405
sg969
g21092
sg2805
g34449
sg8076
(dp64637
sg10653
(dp64638
sg2505
g32658
sg8808
(dp64639
sg11535
(dp64640
ssg7998
(dp64641
g8373
(dp64642
sg10266
(dp64643
sg9918
(dp64644
sg5370
g50693
sg1140
g22438
sg8949
(dp64645
sg8211
(dp64646
ssg8001
(dp64647
g6069
g54822
ssg8004
(dp64648
g8019
(dp64649
sg4425
g44951
sg9519
(dp64650
sg11805
(dp64651
sg4788
g47600
sg4803
g47667
sg5250
g50017
sg7650
g63111
sg10011
(dp64652
sg8418
(dp64653
sg3087
g36678
sg10977
(dp64654
sg4260
g44134
sg1914
g28431
sg7671
g63275
sg3279
g37951
sg891
g20571
sg10494
(dp64655
sg2088
g29958
sg10740
(dp64656
sg3711
g40462
sg9702
(dp64657
sg4716
g47100
sg2109
g30172
sg2391
g31753
sg6024
g54482
sg1578
g25669
sg3408
g38732
sg72
g12819
sg963
g21025
sg5394
g50855
sg171
g13729
sg4974
g48644
sg5181
g49600
sg5589
g51962
sg336
g15136
sg6162
g55275
ssg8007
(dp64658
g933
g20856
sg1704
g26744
sg633
g18107
ssg8010
(dp64659
VGlucans
p64660
g51755
sVPolysaccharides
p64661
g41778
sVPolymers
p64662
g22241
sVCarbohydrates
p64663
g61771
sg4878
g48046
sVDrugs for Constipation
p64664
g53340
sVLaxatives
p64665
g17358
sVCompounds used in a research, industrial, or household setting
p64666
(dp64667
sVMacromolecular Substances
p64668
g33849
sVBiomedical and Dental Materials
p64669
g44734
sVEENT Drugs, Miscellaneous
p64670
g40849
sVBiopolymers
p64671
(dp64672
sVAlimentary Tract and Metabolism
p64673
g23852
sg12054
(dp64674
ssg8013
(dp64675
VEstrogen Antagonists
p64676
g43657
sg5220
g49771
sVUGT1A1 Substrates
p64677
g12341
sVCytochrome P-450 CYP3A Substrates
p64678
g45220
sVHormone Antagonists and Related Agents
p64679
(dp64680
sVSelective Estrogen Receptor Modulators
p64681
g43683
sg9363
(dp64682
sg1818
g27583
sVHormones
p64683
g55674
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64684
g29529
sVFused-Ring Compounds
p64685
g14851
sVAntineoplastic Agents
p64686
(dp64687
sVAntineoplastic Agents, Hormonal
p64688
(dp64689
sVCytochrome P-450 CYP3A4 Substrates
p64690
(dp64691
sVGonadal Hormones
p64692
g33582
sVHormone Antagonists
p64693
g24288
sVSteroids
p64694
g56437
sVGonadal Steroid Hormones
p64695
(dp64696
sVAnti-Estrogens
p64697
g60952
sVAntineoplastic and Immunomodulating Agents
p64698
g39774
sVEstranes
p64699
g50806
sVHormones, Hormone Substitutes, and Hormone Antagonists
p64700
g53146
sVEstrenes
p64701
(dp64702
sVEndocrine Therapy
p64703
g19576
ssg8016
(dp64704
g891
g20526
sg8241
(dp64705
sg9126
(dp64706
sg7317
g61027
sg14338
g13516
sg4341
g44586
sg10290
(dp64707
sg1812
g27462
sg6939
g59310
sg8493
(dp64708
sg2418
g31888
sg1869
g27801
ssg8019
(dp64709
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p64710
g50949
sVUGT1A1 Substrates
p64711
g12259
sVOAT1/SLC22A6 inhibitors
p64712
(dp64713
sVAnalgesics
p64714
g26482
sVAgents causing hyperkalemia
p64715
g43623
sVCOX-1 Inhibitors
p64716
g55556
sVAntiinflammatory Products for Vaginal Administration
p64717
g27408
sVCentral Nervous System Agents
p64718
g58495
sVUGT1A9 Substrates
p64719
g23992
sVAntiinflammatory and Antirheumatic Products
p64720
g56805
sVEnzyme Inhibitors
p64721
(dp64722
sVCytochrome P-450 Enzyme Inhibitors
p64723
g62003
sVThroat Preparations
p64724
(dp64725
sVPeripheral Nervous System Agents
p64726
g57638
sVDrugs that are Mainly Renally Excreted
p64727
g43905
sVCytochrome P-450 CYP2C8 Substrates
p64728
(dp64729
sVNonsteroidal Anti-inflammatory Compounds
p64730
(dp64731
sVAnalgesics, Non-Narcotic
p64732
g56887
sVUGT1A3 substrates
p64733
g31796
sVNephrotoxic agents
p64734
g57733
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p64735
(dp64736
sVAcids, Carbocyclic
p64737
g41545
sVPhenylpropionates
p64738
(dp64739
sVCytochrome P-450 CYP2C9 Substrates
p64740
g29792
sVTopical Products for Joint and Muscular Pain
p64741
g13920
sVCOX-2 Inhibitors
p64742
g57914
sVOpioids
p64743
g32229
sVP-glycoprotein/ABCB1 Substrates
p64744
g35046
sVAgents causing angioedema
p64745
g63894
sVOther Nonsteroidal Antiimflammatory Agents
p64746
(dp64747
sVPropionates
p64748
g36485
sVNon COX-2 selective NSAIDS
p64749
(dp64750
sVAgents that produce hypertension
p64751
(dp64752
sVUGT2B7 substrates
p64753
g28618
sVOAT3/SLC22A8 Inhibitors
p64754
g58994
sVAnti-Inflammatory Agents
p64755
(dp64756
sVCyclooxygenase Inhibitors
p64757
g32774
sVP-glycoprotein/ABCB1 Inhibitors
p64758
(dp64759
sVAntirheumatic Agents
p64760
g24203
sVSensory System Agents
p64761
(dp64762
sVAnti-Inflammatory Agents, Non-Steroidal
p64763
g64649
sVNervous System
p64764
(dp64765
ssg8022
(dp64766
VAgents Causing Muscle Toxicity
p64767
g55377
sg11586
(dp64768
sVCytochrome P-450 CYP3A4 Inhibitors
p64769
g61630
sVVitamins
p64770
g12172
sVCytochrome P-450 CYP2D6 Inhibitors
p64771
g62904
sVFood and Beverages
p64772
(dp64773
sVDiet, Food, and Nutrition
p64774
g22900
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p64775
g43733
sVCytochrome P-450 Enzyme Inhibitors
p64776
g62034
sVPhysiological Phenomena
p64777
g21716
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p64778
g18397
sVHyperglycemia-Associated Agents
p64779
(dp64780
sVMicronutrients
p64781
(dp64782
sg11697
(dp64783
sVFood
p64784
g62210
sVCytochrome P-450 CYP2E1 Inhibitors
p64785
g46832
sg7710
g63422
sVVitamin B Complex
p64786
g54910
sVHypolipidemic Agents
p64787
(dp64788
sVCardiovascular Agents
p64789
g26537
sg3738
g40538
sVPyridines
p64790
g64231
sVVasodilating Agents
p64791
g23694
sg5331
g50504
sg5340
g50536
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p64792
g26872
sVGrowth Substances
p64793
g46123
sVToxic Actions
p64794
g49389
sg159
g13551
sVCytochrome P-450 CYP3A Inhibitors
p64795
g60385
sVNoxae
p64796
(dp64797
sg4593
g46224
sVLipid Regulating Agents
p64798
(dp64799
ssg8025
(dp64800
g6333
g56446
ssg8028
(dp64801
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p64802
(dp64803
sVCytochrome P-450 CYP2D6 Substrates
p64804
g52151
sVUGT1A1 Substrates
p64805
g12321
sVSerotonin Agents
p64806
(dp64807
sVMusculo-Skeletal System
p64808
g31505
sVAntidepressive Agents, Tricyclic
p64809
g60708
sVSerotonin Receptor Antagonists
p64810
g35683
sVCentral Nervous System Agents
p64811
g58466
sVPeripheral Nervous System Agents
p64812
g57614
sVCytochrome P-450 CYP1A2 Substrates
p64813
g45594
sVCentrally-mediated Muscle Relaxation
p64814
(dp64815
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64816
g29236
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p64817
g60095
sVSerotonin 5-HT2 Receptor Antagonists
p64818
(dp64819
sVCytochrome P-450 CYP3A Substrates
p64820
g44994
sVMuscle Relaxants
p64821
(dp64822
sVCentral Nervous System Depressants
p64823
(dp64824
sVUGT1A1 substrates with narrow therapeutic index
p64825
g41795
sVAgents that reduce seizure threshold
p64826
g45876
sVMuscle Relaxants, Centrally Acting Agents
p64827
g37391
sVBenzocycloheptenes
p64828
g49195
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p64829
g36469
sVAgents that produce hypertension
p64830
(dp64831
sVCytochrome P-450 CYP3A4 Substrates
p64832
(dp64833
sVNarrow Therapeutic Index Drugs
p64834
g50573
sVSerotonin Modulators
p64835
(dp64836
sVAntidepressive Agents
p64837
g15532
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p64838
g36637
sVNeurotoxic agents
p64839
(dp64840
sVDibenzocycloheptenes
p64841
g49102
sVTranquilizing Agents
p64842
g55302
ssg8031
(dp64843
VDrugs that are Mainly Renally Excreted
p64844
g43963
sVCentral Nervous System Depressants
p64845
(dp64846
sVNeurotransmitter Agents
p64847
(dp64848
sVGastrointestinal Agents
p64849
(dp64850
sg9429
(dp64851
sVAntidepressive Agents
p64852
g15541
sVLaxatives
p64853
g17336
sVSerotonin Agents
p64854
(dp64855
sVCytochrome P-450 CYP3A Substrates
p64856
g45140
sVMiscellaneous GI Drugs
p64857
g23547
sVP-glycoprotein/ABCB1 Substrates
p64858
g34932
sVDrugs for Constipation
p64859
g53336
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64860
g29420
sVHeterocyclic Compounds, Fused-Ring
p64861
g56055
sVSerotonin Receptor Agonists
p64862
(dp64863
sVCytochrome P-450 CYP3A4 Substrates
p64864
(dp64865
sVAlimentary Tract and Metabolism
p64866
g23858
ssg8034
(dp64867
g10245
(dp64868
ssg8037
(dp64869
g10011
(dp64870
ssg8040
(dp64871
g528
g16924
sg5028
g48796
sg147
g13433
sg834
g19945
sg9366
(dp64872
ssg8043
(dp64873
g10218
(dp64874
ssg8046
(dp64875
g4446
g45354
sg9117
(dp64876
sg6735
g58364
sg9144
(dp64877
sg2706
g33773
sg5235
g49826
sg4287
g44376
sg204
g13952
sg4887
g48084
sg3597
g39652
sg5460
g51229
sg3624
g39905
ssg8049
(dp64878
VAntivirals for Systemic Use
p64879
g59761
sVNucleic Acid Synthesis Inhibitors
p64880
g48727
sVCytochrome P-450 CYP3A Substrates
p64881
g45141
sVDirect Acting Antivirals
p64882
g38058
sVEnzyme Inhibitors
p64883
(dp64884
sVCytochrome P-450 CYP2C9 Inhibitors
p64885
g18219
sVCytochrome P-450 Enzyme Inhibitors
p64886
g62035
sVAnti-Infective Agents
p64887
g54600
sVCytochrome P-450 CYP2C9 Inducers
p64888
g20037
sVNonnucleoside Reverse Transcriptase Inhibitors
p64889
g34334
sVAntiinfectives for Systemic Use
p64890
(dp64891
sVP-glycoprotein/ABCB1 Inducers
p64892
(dp64893
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p64894
g16519
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p64895
(dp64896
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p64897
g29421
sVCytochrome P-450 CYP2C9 Substrates
p64898
g29743
sVReverse Transcriptase Inhibitors
p64899
g28968
sVCytochrome P-450 CYP3A4 Inducers
p64900
g18935
sVCytochrome P-450 CYP2C19 Substrates
p64901
g53882
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p64902
(dp64903
sVHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
p64904
g45991
sVCytochrome P-450 Enzyme Inducers
p64905
g28188
sVCytochrome P-450 CYP3A Inducers
p64906
(dp64907
sVCytochrome P-450 CYP2C19 Inhibitors
p64908
g61271
sVCytochrome P-450 CYP3A4 Substrates
p64909
(dp64910
sVAnti-Retroviral Agents
p64911
(dp64912
sVNon-Nucleoside Reverse Transcriptase Inhibitors
p64913
g15491
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p64914
(dp64915
sVAntiviral Agents
p64916
g30442
ssg8052
(dp64917
g7548
g62607
ssg8055
(dp64918
VEstrogen Antagonists
p64919
g43652
sVNitriles
p64920
g34036
sVHormone Antagonists and Related Agents
p64921
(dp64922
sVCytochrome P-450 CYP3A4 Inhibitors
p64923
g61681
sVCytochrome P-450 CYP2C9 Inhibitors
p64924
g18220
sVEnzyme Inhibitors
p64925
(dp64926
sVTriazoles
p64927
g47835
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p64928
(dp64929
sg2223
g30772
sVCytochrome P-450 Enzyme Inhibitors
p64930
g62036
sVSteroid Synthesis Inhibitors
p64931
(dp64932
sVAntineoplastic Agents
p64933
(dp64934
sVCytochrome P-450 CYP1A2 Inhibitors
p64935
g15004
sVAntineoplastic Agents, Hormonal
p64936
(dp64937
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p64938
(dp64939
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p64940
g49328
sVHormone Antagonists
p64941
g24266
sVCardiotoxic antineoplastic agents
p64942
(dp64943
sVCytochrome P-450 CYP3A Inhibitors
p64944
g60442
sVAntineoplastic and Immunomodulating Agents
p64945
g39786
sVHormones, Hormone Substitutes, and Hormone Antagonists
p64946
g53164
sVEndocrine Therapy
p64947
g19560
ssg8058
(dp64948
g1461
g24808
ssg8061
(dp64949
g9687
(dp64950
sg4062
g42620
sg1941
g28574
sg4341
g44599
ssg8064
(dp64951
g10230
(dp64952
sg7020
g59596
sg11874
(dp64953
ssg8067
(dp64954
VDrugs that are Mainly Renally Excreted
p64955
g43966
sVNeurotransmitter Agents
p64956
(dp64957
sVHeterocyclic Compounds, Fused-Ring
p64958
g56107
sVAnti-Parkinson Drugs
p64959
g16149
sVOCT1 substrates
p64960
g13067
sg5223
g49773
sVThiazoles
p64961
g49135
sVHypotensive Agents
p64962
g34161
sVAnti-Dyskinesia Agents
p64963
g50483
sVDopamine Agonists
p64964
g56753
sg6105
g55103
sVCentral Nervous System Agents
p64965
g58473
sVDopamine Agents
p64966
g14238
sVAnti-Parkinson Agents (Dopamine Agonist)
p64967
g25593
sVOCT2 Substrates
p64968
g14940
sVSulfur Compounds
p64969
(dp64970
sVNonergot-derivative Dopamine Receptor Agonists
p64971
g60818
sVOCT2 substrates with narrow therapeutic index
p64972
g29684
sVNervous System
p64973
(dp64974
sVAntioxidants
p64975
g54806
ssg8070
(dp64976
g6432
g56935
sg126
g13171
ssg8073
(dp64977
g762
g19245
sg4170
g43383
sg6228
g55709
sg2007
g28873
ssg8076
(dp64978
VTumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors
p64979
g57509
sVSerum Globulins
p64980
g49655
sVBiologics for Rheumatoid Arthritis Treatment
p64981
g47863
sVTumor Necrosis Factor Receptor Blocking Activity
p64982
g18473
sVImmunoglobulins
p64983
g41523
sVTumor Necrosis Factor Blocker
p64984
g52437
sVAntibodies
p64985
g60985
sVAgents reducing cytokine levels
p64986
(dp64987
sVProteins
p64988
g52769
sVDisease-modifying Antirheumatic Agents
p64989
g57190
sVGlobulins
p64990
g19177
sVAmino Acids, Peptides, and Proteins
p64991
g47359
sVAntibodies, Monoclonal
p64992
(dp64993
sVAntibodies, Monoclonal, Humanized
p64994
(dp64995
sVImmunosuppressive Agents
p64996
g64557
sVAnti-Inflammatory Agents
p64997
(dp64998
sVBiological Products
p64999
g64637
sVAntineoplastic and Immunomodulating Agents
p65000
g39763
sVAntirheumatic Agents
p65001
g24225
sVBlood Proteins
p65002
g39855
sVComplex Mixtures
p65003
(dp65004
sVImmunoproteins
p65005
g57448
ssg8079
(dp65006
VAntiinfectives for Systemic Use
p65007
(dp65008
sVBSEP/ABCB11 Substrates
p65009
(dp65010
sVHeterocyclic Compounds, Fused-Ring
p65011
g56112
sVDrugs that are Mainly Renally Excreted
p65012
g43967
sVbeta-Lactams
p65013
(dp65014
sVNephrotoxic agents
p65015
g57725
sg6606
g57746
sVOAT3/SLC22A8 Substrates
p65016
g13122
sVOAT3/SLC22A8 Inhibitors
p65017
g59007
sVLactams
p65018
g22276
sVAmides
p65019
g44331
sVThiazines
p65020
g16419
sVSulfur Compounds
p65021
(dp65022
sVAnti-Bacterial Agents
p65023
g38363
sVAntibacterials for Systemic Use
p65024
g32561
sVSecond-Generation Cephalosporins
p65025
g52315
sVCephalosporins
p65026
g49067
sVAnti-Infective Agents
p65027
g54639
ssg8082
(dp65028
g1164
g22589
sg1746
g26946
sg9309
(dp65029
sg7629
g62993
sg4725
g47141
sg7014
g59566
sg12108
(dp65030
ssg8085
(dp65031
g5571
g51768
sg5313
g50382
sg11961
(dp65032
sg6867
g59045
sg2355
g31428
sg132
g13217
ssg8088
(dp65033
VAmino Acids, Peptides, and Proteins
p65034
g47384
sVProtein Precursors
p65035
g60678
sVGlucagon-like peptide-1 (GLP-1) analogues
p65036
g61315
sVIncretin Mimetics
p65037
g16679
sVGastrointestinal Hormones
p65038
g40979
sVGlucagon-like Peptide-1 (GLP-1) Agonists
p65039
g44482
sVProteins
p65040
g52771
sVHypoglycemia-Associated Agents
p65041
g17711
sVPeptide Hormones
p65042
g20217
sVProglucagon
p65043
g47541
sVPeptides
p65044
g47196
sVPancreatic Hormones
p65045
g62246
sVGLP-1 Agonists
p65046
(dp65047
sVGlucagon-Like Peptides
p65048
g14358
sVHormones
p65049
g55680
sVHormones, Hormone Substitutes, and Hormone Antagonists
p65050
g53170
sVIncretins
p65051
g20134
sVBlood Glucose Lowering Agents
p65052
(dp65053
sVAlimentary Tract and Metabolism
p65054
g23894
sVDrugs Used in Diabetes
p65055
g60123
sg11058
(dp65056
ssg8091
(dp65057
g5256
g50091
sg10728
(dp65058
ssg8094
(dp65059
g4398
g44832
sg6162
g55281
ssg8097
(dp65060
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p65061
(dp65062
sg2064
g29603
sVAdrenergic alpha-1 Receptor Antagonists
p65063
g14125
sVAnticholinergic Agents
p65064
g24487
sVCytochrome P-450 CYP2D6 Inhibitors
p65065
g62942
sg5616
g52171
sg11028
(dp65066
sg10842
(dp65067
sVAnalgesics
p65068
g26473
sg3081
g36621
sg7230
g60704
sg2937
g35675
sVCentral Nervous System Agents
p65069
g58496
sVAdrenergic Antagonists
p65070
g52281
sVPsychotropic Drugs
p65071
(dp65072
sg2571
g33018
sVCytochrome P-450 Enzyme Inhibitors
p65073
g62039
sg666
g18411
sg10770
(dp65074
sVDrugs that are Mainly Renally Excreted
p65075
g44041
sg10887
(dp65076
sg4473
g45604
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p65077
g23116
sg6417
g56905
sg9732
(dp65078
sg3951
g41791
sVMuscarinic Antagonists
p65079
g48870
sg27
g12302
sVMembrane Transport Modulators
p65080
g54161
sg3039
g36465
sVAdrenergic alpha-Antagonists
p65081
g60873
sVCytochrome P-450 CYP2C9 Substrates
p65082
g29782
sVQTc Prolonging Agents
p65083
g57851
sg9654
(dp65084
sVCytochrome P-450 CYP3A Substrates
p65085
g45249
sVCytochrome P-450 CYP2C19 Substrates
p65086
g53890
sVCentral Nervous System Depressants
p65087
(dp65088
sVNeurotransmitter Agents
p65089
(dp65090
sg4182
g43440
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p65091
g29567
sVAgents that reduce seizure threshold
p65092
g45852
sg5109
g49143
sVCytochrome P-450 CYP2C8 Inhibitors
p65093
g55035
sVP-glycoprotein/ABCB1 Substrates
p65094
g35017
sg9624
(dp65095
sg1716
g26807
sg2463
g32314
sg5658
g52390
sg3768
g40779
sVAgents that produce hypertension
p65096
(dp65097
sVCytochrome P-450 CYP2C19 Inhibitors
p65098
g61275
sVCytochrome P-450 CYP3A4 Substrates
p65099
(dp65100
sg3195
g37399
sVNarrow Therapeutic Index Drugs
p65101
g50546
sVModerate Risk QTc-Prolonging Agents
p65102
(dp65103
sVCytochrome P-450 CYP3A5 Substrates
p65104
(dp65105
sg9075
(dp65106
sg7362
g61380
sg384
g15548
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p65107
(dp65108
sg2319
g31314
sVNeurotoxic agents
p65109
(dp65110
sVAgents producing tachycardia
p65111
g50787
sVSensory System Agents
p65112
(dp65113
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p65114
g60055
ssg8100
(dp65115
g7812
g63733
sg195
g13892
sg450
g16343
sg828
g19870
sg11415
(dp65116
sg10296
(dp65117
sg255
g14372
sg1041
g21517
sg4650
g46624
sg168
g13649
sg2583
g33071
sg3087
g36651
sg12003
(dp65118
sg7164
g60263
sg375
g15433
sg3111
g36822
sg4623
g46386
sg10797
(dp65119
sg4488
g45746
sg7824
g63878
sg9402
(dp65120
sg3711
g40443
sg11769
(dp65121
sg4902
g48149
sg11820
(dp65122
sg3018
g36144
sg4926
g48400
sg9996
(dp65123
sg9252
(dp65124
sg2658
g33351
sg138
g13275
sg969
g21081
sg11535
(dp65125
sg141
g13330
sg6594
g57696
sg171
g13709
sg10758
(dp65126
sg1578
g25646
sg603
g17761
sg1635
g26032
sg5394
g50838
sg9828
(dp65127
sg11649
(dp65128
ssg8103
(dp65129
g8670
(dp65130
sg5577
g51833
sg357
g15310
sg7977
g64477
sg3183
g37335
sg8274
(dp65131
sg9540
(dp65132
sg5382
g50717
sg8769
(dp65133
sg5073
g48986
sg3333
g38254
sg372
g15395
ssg8106
(dp65134
VAmino Acids, Peptides, and Proteins
p65135
g47388
sVPeptides
p65136
g47198
sVOligopeptides
p65137
(dp65138
sVAdrenal Cortex Hormones
p65139
g30039
sVAntineoplastic and Immunomodulating Agents
p65140
g39793
sVPeptide Hormones
p65141
g20220
sVGonadotropin Releasing Hormone Receptor Agonist
p65142
(dp65143
sVHypothalamic Hormones
p65144
(dp65145
sVProteins
p65146
g52775
sVNerve Tissue Proteins
p65147
(dp65148
sVNeuropeptides
p65149
g57516
sVPituitary Hormone-Releasing Hormones
p65150
g40152
sVPotential QTc-Prolonging Agents
p65151
(dp65152
sVHormones and Related Agents
p65153
g57371
sVGonadotropin Releasing Hormone Receptor Agonists
p65154
g60735
sVHormones
p65155
g55683
sVHormones, Hormone Substitutes, and Hormone Antagonists
p65156
g53173
sVGonadotropin-releasing hormone agonist
p65157
(dp65158
sVHyperglycemia-Associated Agents
p65159
(dp65160
sVQTc Prolonging Agents
p65161
g57852
sVEndocrine Therapy
p65162
g19559
ssg8109
(dp65163
g10200
(dp65164
sg10185
(dp65165
sg6567
g57525
sg21710
g54034
sg7188
g60512
sg10119
(dp65166
sg5286
g50210
sg10764
(dp65167
ssg8112
(dp65168
g8595
(dp65169
ssg8115
(dp65170
g7821
g63831
sg8820
(dp65171
ssg8118
(dp65172
g7884
g64119
sg6435
g56991
sg10365
(dp65173
sg1110
g22122
sg2769
g34307
ssg8121
(dp65174
g8880
(dp65175
sg8241
(dp65176
sg6156
g55234
sg1473
g24975
sg11523
(dp65177
sg2088
g29932
sg10959
(dp65178
sg6162
g55269
ssg8124
(dp65179
g2784
g34367
sg5739
g52876
sg546
g17147
sg10635
(dp65180
sg5781
g53115
sg6261
g55852
sg2523
g32746
sg5877
g53691
sg2316
g31306
sg9960
(dp65181
sg7713
g63440
sg9864
(dp65182
sg5487
g51367
ssg8127
(dp65183
g5316
g50459
sg7707
g63402
ssg8130
(dp65184
g9117
(dp65185
sg6186
g55491
sg30
g12394
sg12421
g12476
sg3117
g36905
sg816
g19654
sg42
g12578
sg9165
(dp65186
sg10797
(dp65187
sg2133
g30309
sg3141
g37081
sg9198
(dp65188
sg10818
(dp65189
sg6807
g58828
sg3174
g37275
sg6279
g55962
sg3177
g37317
sg9225
(dp65190
sg9231
(dp65191
sg9234
(dp65192
sg9981
(dp65193
sg3204
g37433
sg147
g13481
sg9273
(dp65194
sg3219
g37558
sg3222
g37615
sg6315
g56307
sg6318
g56381
sg3231
g37667
sg7533
g62506
sg13091
g21414
sg3240
g37727
sg6333
g56489
sg6336
g56536
sg195
g13911
sg6345
g56598
sg7170
g60307
sg14829
g56681
sg7053
g59816
sg7962
g64425
sg240
g14204
sg7884
g64115
sg12066
(dp65195
sg3318
g38200
sg3321
g38239
sg10662
(dp65196
sg9462
(dp65197
sg1626
g25966
sg6411
g56881
sg7545
g62573
sg282
g14578
sg285
g14634
sg1614
g25889
sg294
g14734
sg14838
g40006
sg9663
(dp65198
sg6447
g57039
sg9432
(dp65199
sg3393
g38579
sg339
g15180
sg8028
g64833
sg6504
g57271
sg14791
(dp65200
sg387
g15671
sg14872
g15753
sg3444
g38881
sg3447
g38951
sg6537
g57416
sg426
g16077
sg2373
g31611
sg2430
g32114
sg444
g16263
sg456
g16405
sg9528
(dp65201
sg3867
g41358
sg3516
g39179
sg507
g16791
sg9564
(dp65202
sg78
g12869
sg9588
(dp65203
sg9591
(dp65204
sg2910
g35555
sg11886
(dp65205
sg9609
(dp65206
sg543
g17112
sg9618
(dp65207
sg10959
(dp65208
sg6645
g58020
sg3021
g36219
sg3963
g41889
sg6654
g58073
sg11439
(dp65209
sg9180
(dp65210
sg570
g17494
sg573
g17573
sg3570
g39500
sg582
g17639
sg6687
g58194
sg8472
(dp65211
sg3597
g39650
sg600
g17748
sg3363
g38422
sg621
g17978
sg3627
g39943
sg3633
g40063
sg9693
(dp65212
sg3651
g40132
sg9324
(dp65213
sg9711
(dp65214
sg9828
(dp65215
sg8295
(dp65216
sg6765
g58618
sg690
g18646
sg6783
g58675
sg3696
g40300
sg702
g18829
sg9987
(dp65217
sg3975
g41946
sg9774
(dp65218
sg723
g19099
sg11625
(dp65219
sg3783
g40884
sg9819
(dp65220
sg9822
(dp65221
sg771
g19300
sg10758
(dp65222
sg2664
g33467
sg10305
(dp65223
sg4620
g46346
sg11283
(dp65224
sg138
g13303
sg7464
g62182
sg819
g19773
sg3846
g41145
sg3858
g41239
sg3861
g41288
sg6882
g59129
sg828
g19881
sg831
g19907
sg4788
g47589
sg9903
(dp65225
sg3885
g41458
sg5805
g53273
sg6819
g58890
sg11016
(dp65226
sg888
g20493
sg6939
g59322
sg9954
(dp65227
sg9960
(dp65228
sg9963
(dp65229
sg915
g20724
sg6966
g59426
sg7377
g61517
sg933
g20839
sg11337
(dp65230
sg10170
(dp65231
sg966
g21056
sg3978
g42008
sg11523
(dp65232
sg5646
g52347
sg9081
(dp65233
sg7029
g59647
sg4005
g42183
sg1008
g21297
sg7041
g59688
sg4014
g42237
sg4023
g42353
sg714
g19027
sg1035
g21463
sg7707
g63405
sg7065
g59949
sg2262
g30972
sg10308
(dp65234
sg1062
g21829
sg6156
g55236
sg4077
g42843
sg4089
g42865
sg4101
g42977
sg11820
(dp65235
sg4113
g43063
sg6435
g56987
sg345
g15238
sg10179
(dp65236
sg1134
g22340
sg7152
g60196
sg7275
g60801
sg537
g17048
sg10209
(dp65237
sg4164
g43352
sg7191
g60567
sg7197
g60621
sg780
g19371
sg465
g16485
sg10266
(dp65238
sg9084
(dp65239
sg10275
(dp65240
sg4236
g43717
sg1047
g21621
sg1059
g21773
sg4257
g44084
sg4263
g44183
sg7284
g60834
sg4278
g44273
sg4287
g44398
sg7329
g61150
sg7335
g61229
sg10350
(dp65241
sg7389
g61563
sg1503
g25191
sg7569
g62740
sg11151
(dp65242
sg7299
g60933
sg10416
(dp65243
sg4827
g47762
sg10389
(dp65244
sg9096
(dp65245
sg7698
g63349
sg1365
g24059
sg1371
g24121
sg1383
g24154
sg1863
g27777
sg4299
g44444
sg13750
g24396
sg7422
g61826
sg4437
g45305
sg7428
g61869
sg16906
g61923
sg8163
(dp65246
sg4449
g45389
sg4452
g45444
sg1434
g24675
sg10470
(dp65247
sg684
g18513
sg1461
g24840
sg4476
g45648
sg4479
g45717
sg1473
g24979
sg1491
g25102
sg5970
g54239
sg7497
g62315
sg7317
g61053
sg10521
(dp65248
sg10539
(dp65249
sg2739
g34021
sg1539
g25319
sg10557
(dp65250
sg10563
(dp65251
sg12090
(dp65252
sg8949
(dp65253
sg10596
(dp65254
sg10602
(dp65255
sg7593
g62819
sg4596
g46264
sg1599
g25746
sg7608
g62886
sg9105
(dp65256
sg1611
g25824
sg4635
g46503
sg4638
g46549
sg4650
g46631
sg4653
g46722
sg1650
g26123
sg1656
g26183
sg10674
(dp65257
sg7668
g63220
sg1668
g26278
sg1470
g24925
sg10701
(dp65258
sg2388
g31678
sg3543
g39351
sg4344
g44669
sg7716
g63473
sg10740
(dp65259
sg10752
(dp65260
sg9834
(dp65261
sg10761
(dp65262
sg4746
g47273
sg10779
(dp65263
sg7764
g63637
sg10737
(dp65264
sg4782
g47535
sg5112
g49177
sg11259
(dp65265
sg1791
g27262
sg9417
(dp65266
sg10839
(dp65267
sg1803
g27395
sg1809
g27429
sg4830
g47822
sg12274
g27558
sg10884
(dp65268
sg10899
(dp65269
sg4881
g48052
sg288
g14692
sg4680
g46893
sg4773
g47476
sg4911
g48270
sg1881
g27964
sg4920
g48356
sg10149
(dp65270
sg1890
g27988
sg4926
g48408
sg1899
g28079
sg7941
g64309
sg7947
g64379
sg1908
g28312
sg10950
(dp65271
sg1911
g28372
sg1920
g28497
sg4959
g48552
sg11022
(dp65272
sg5028
g48807
sg8031
g64865
sg2007
g28896
sg8049
g64910
sg1947
g28696
sg2034
g29035
sg11721
(dp65273
sg2043
g29083
sg5064
g48904
sg11079
(dp65274
sg10263
(dp65275
sg5094
g49092
sg11952
(dp65276
sg2094
g29997
sg8448
(dp65277
sg2109
g30154
sg2115
g30205
sg10272
(dp65278
sg2127
g30239
sg5127
g49244
sg69
g12736
sg5145
g49369
sg11166
(dp65279
sg2142
g30369
sg2943
g35781
sg9966
(dp65280
sg2172
g30523
sg5199
g49703
sg438
g16194
sg2196
g30636
sg2199
g30683
sg8205
(dp65281
sg516
g16886
sg528
g16943
sg11229
(dp65282
sg2211
g30752
sg5235
g49856
sg8241
(dp65283
sg822
g19826
sg849
g20104
sg1113
g22198
sg2250
g30874
sg11997
(dp65284
sg5313
g50407
sg5316
g50463
sg11316
(dp65285
sg1140
g22424
sg8298
(dp65286
sg14822
g41810
sg5289
g50302
sg5364
g50628
sg7416
g61744
sg11358
(dp65287
sg11370
(dp65288
sg7524
g62431
sg7563
g62679
sg2346
g31398
sg2403
g31854
sg10377
(dp65289
sg2358
g31487
sg5433
g51064
sg8388
(dp65290
sg7821
g63837
sg1800
g27331
sg2226
g30780
sg5454
g51167
sg5460
g51227
sg1869
g27841
sg8421
(dp65291
sg5472
g51318
sg7983
g64532
sg8430
(dp65292
sg11451
(dp65293
sg8433
(dp65294
sg11460
(dp65295
sg4446
g45352
sg2046
g29135
sg5499
g51431
sg2088
g29940
sg2427
g32054
sg2433
g32158
sg8454
(dp65296
sg8457
(dp65297
sg8460
(dp65298
sg2460
g32293
sg8514
(dp65299
sg5556
g51738
sg2493
g32618
sg11544
(dp65300
sg11112
(dp65301
sg2616
g33189
sg2676
g33565
sg8724
(dp65302
sg2559
g32974
sg11592
(dp65303
sg11595
(dp65304
sg11601
(dp65305
sg8916
(dp65306
sg11619
(dp65307
sg3024
g36319
sg8625
(dp65308
sg9099
(dp65309
sg9111
(dp65310
sg11655
(dp65311
sg11052
(dp65312
sg3132
g37020
sg1857
g27716
sg9030
(dp65313
sg8655
(dp65314
sg5691
g52486
sg8658
(dp65315
sg5694
g52560
sg5208
g49744
sg12534
g52668
sg9357
(dp65316
sg2652
g33322
sg9414
(dp65317
sg9471
(dp65318
sg8694
(dp65319
sg11508
(dp65320
sg8703
(dp65321
sg2667
g33526
sg11733
(dp65322
sg2688
g33676
sg10056
(dp65323
sg1245
g23001
sg2703
g33740
sg8013
g64691
sg5766
g52993
sg5769
g53041
sg2715
g33815
sg1281
g23371
sg11775
(dp65324
sg2730
g33893
sg8751
(dp65325
sg5796
g53255
sg4539
g46046
sg10062
(dp65326
sg9918
(dp65327
sg9924
(dp65328
sg3912
g41616
sg1425
g24562
sg2763
g34244
sg10041
(dp65329
sg5829
g53369
sg5832
g53407
sg8781
(dp65330
sg8787
(dp65331
sg2784
g34358
sg5853
g53560
sg11838
(dp65332
sg5865
g53621
sg5877
g53679
sg11940
(dp65333
sg8820
(dp65334
sg2814
g34526
sg5895
g53828
sg4458
g45498
sg2829
g34654
sg1548
g25389
sg2850
g35113
sg696
g18762
sg11097
(dp65335
sg8874
(dp65336
sg11910
(dp65337
sg28215
g35376
sg11913
(dp65338
sg11922
(dp65339
sg11931
(dp65340
sg8097
g65100
sg11955
(dp65341
sg11961
(dp65342
sg11976
(dp65343
sg11979
(dp65344
sg2946
g35833
sg8964
(dp65345
sg6033
g54536
sg6045
g54711
sg6048
g54759
sg6051
g54793
sg12018
(dp65346
sg6069
g54844
sg6468
g57115
sg5526
g51588
sg3546
g39401
sg9009
(dp65347
sg3009
g36057
sg6090
g54959
sg6906
g59226
sg11475
(dp65348
sg12063
(dp65349
sg3027
g36375
sg6102
g55092
sg2832
g34730
sg9420
(dp65350
sg11790
(dp65351
sg9060
(dp65352
sg1098
g22031
sg5181
g49590
sg12126
(dp65353
sg6075
g54892
sg12132
(dp65354
sg9102
(dp65355
sg1185
g22720
sg12123
(dp65356
sg3624
g39903
ssg8133
(dp65357
g5973
g54241
ssg8136
(dp65358
g4770
g47444
sg10764
(dp65359
ssg8139
(dp65360
VDrugs that are Mainly Renally Excreted
p65361
g43976
sVNeurotransmitter Agents
p65362
(dp65363
sVHistamine Antagonists
p65364
g43451
sVHistamine H1 Antagonists, Non-Sedating
p65365
g38521
sVHistamine Agents
p65366
(dp65367
sVPotential QTc-Prolonging Agents
p65368
(dp65369
sVPyridines
p65370
g64241
sVHistamine H1 Antagonists
p65371
g40790
sVAntihistamines for Systemic Use
p65372
g12975
sVQTc Prolonging Agents
p65373
g57798
ssg8142
(dp65374
g7146
g60181
sVSex Hormones and Modulators of the Genital System
p65375
g19615
sVGenito Urinary System and Sex Hormones
p65376
(dp65377
sVAndrostanes
p65378
(dp65379
sVSteroids
p65380
g56431
sVAndrostenes
p65381
g60164
sVSteroids, Fluorinated
p65382
(dp65383
sg3582
g39606
sVAndrogens
p65384
(dp65385
sVHormones
p65386
g55687
sVHormones, Hormone Substitutes, and Hormone Antagonists
p65387
g53177
sVAnabolic Agents
p65388
g33535
sVFused-Ring Compounds
p65389
g14869
sVAndrostenols
p65390
g16959
ssg8145
(dp65391
g5271
g50154
ssg8148
(dp65392
g11145
(dp65393
sg4647
g46586
sg2262
g30978
sg7164
g60292
sg375
g15475
sg11649
(dp65394
sg11652
(dp65395
sg4488
g45774
sg2067
g29665
sg11097
(dp65396
sg11319
(dp65397
sg6639
g57991
sg7320
g61097
sg9264
(dp65398
sg11445
(dp65399
sg6678
g58130
sg23
g12243
sg6507
g57297
sg11910
(dp65400
sg5598
g52048
sg3444
g38886
sg9093
(dp65401
sg612
g17905
sg210
g13997
ssg8151
(dp65402
g4143
g43144
ssg8154
(dp65403
g8448
(dp65404
sg9432
(dp65405
sg2460
g32302
sg9198
(dp65406
sg6468
g57120
sg7821
g63847
sg1047
g21631
sg8454
(dp65407
sg573
g17579
ssg8157
(dp65408
g6180
g55438
sg10323
(dp65409
sg4515
g45912
sg11274
(dp65410
sg2007
g28902
sg8106
g65145
sg402
g15858
sg2817
g34570
sg609
g17834
sg11160
(dp65411
ssg8160
(dp65412
g4014
g42211
sg11820
(dp65413
sg2553
g32873
sg4017
g42278
sg3105
g36804
sg837
g19989
sg7458
g62121
sg10839
(dp65414
sg10275
(dp65415
sg6009
g54347
sg3858
g41251
sg8190
(dp65416
sg8928
(dp65417
sg8601
(dp65418
sg7848
g63984
sg4650
g46637
sg6699
g58236
sg10797
(dp65419
sg2451
g32215
sg477
g16617
sg6765
g58616
sg4521
g45983
sg9552
(dp65420
sg4863
g47967
sg4068
g42757
sg8808
(dp65421
sg8022
g64797
sg6033
g54546
sg3015
g36111
sg1674
g26360
sg2805
g34445
sg5880
g53725
sg4491
g45812
sg2112
g30181
sg11541
(dp65422
sg4902
g48155
sg3609
g39713
sg918
g20764
sg1785
g27189
sg87
g12948
sg9612
(dp65423
sg4917
g48303
sg11313
(dp65424
sg11268
(dp65425
sg4926
g48415
sg12078
(dp65426
sg10374
(dp65427
sg3258
g37824
sg6654
g58035
sg2466
g32324
sg10950
(dp65428
sg3576
g39598
sg474
g16582
sg1275
g23309
sg1152
g22534
sg10698
(dp65429
sg7809
g63718
sg1365
g24044
sg12090
(dp65430
sg48
g12657
sg1173
g22651
sg6015
g54402
sg13091
g21357
sg9081
(dp65431
sg4200
g43534
sg11775
(dp65432
sg11208
(dp65433
sg8985
(dp65434
sg1611
g25834
ssg8163
(dp65435
VNMDA Receptor Antagonists
p65436
g43495
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p65437
(dp65438
sVAnticholinergic Agents
p65439
g24467
sVCytochrome P-450 CYP2D6 Substrates
p65440
g52183
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p65441
(dp65442
sVSerotonin Agents
p65443
(dp65444
sVAnalgesics
p65445
g26485
sVOpiate Agonists
p65446
g46447
sVCentral Nervous System Agents
p65447
g58501
sVCycloparaffins
p65448
g43660
sVCytochrome P-450 CYP2B6 Substrates
p65449
g33004
sVNarcotics
p65450
(dp65451
sVMuscarinic Antagonists
p65452
g48858
sVDrugs that are Mainly Renally Excreted
p65453
g43908
sVAmines
p65454
g42730
sg882
g20384
sVPeripheral Nervous System Agents
p65455
g57640
sVUGT1A1 Substrates
p65456
g12271
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p65457
g29359
sVSerotonin 5-HT2 Receptor Antagonists
p65458
(dp65459
sVCytochrome P-450 CYP3A Substrates
p65460
g45080
sVCyclohexanes
p65461
g33285
sVCentral Nervous System Depressants
p65462
(dp65463
sVOpioids
p65464
g32232
sVAgents that reduce seizure threshold
p65465
g45839
sVSerotonin Receptor Antagonists
p65466
g35663
sVP-glycoprotein/ABCB1 Substrates
p65467
g35041
sVCyclohexanols
p65468
g22349
sVCytochrome P-450 CYP3A4 Substrates
p65469
g65246
sVSerotonin Modulators
p65470
(dp65471
sVAntidepressive Agents
p65472
g15564
sVOpioid Agonist
p65473
(dp65474
sVAgents producing tachycardia
p65475
g50788
sVSensory System Agents
p65476
(dp65477
sVNervous System
p65478
(dp65479
sVAlcohols
p65480
(dp65481
ssg8166
(dp65482
VUGT1A3 substrates
p65483
g31815
sVAgents causing hyperkalemia
p65484
g43589
sVCardiovascular Agents
p65485
g26636
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p65486
g46320
sVBenzene Derivatives
p65487
g61410
sVAngiotensin Receptor Antagonists
p65488
(dp65489
sVAntihypertensive Agents
p65490
g20274
sVAngiotensin II Antagonists and Diuretics
p65491
g30406
sVHypotensive Agents
p65492
g34176
sVCytochrome P-450 CYP2C8 Inhibitors
p65493
g55013
sVHeterocyclic Compounds, Fused-Ring
p65494
g56068
sVP-glycoprotein/ABCB1 Inhibitors
p65495
(dp65496
sVCytochrome P-450 CYP2C9 Substrates
p65497
g29737
sVAngiotensin 2 Receptor Blocker
p65498
(dp65499
sVCytochrome P-450 Enzyme Inhibitors
p65500
g61955
sVAgents Acting on the Renin-Angiotensin System
p65501
g25333
ssg8169
(dp65502
g4806
g47673
sg6906
g59230
sg3318
g38204
ssg8172
(dp65503
g8694
(dp65504
ssg8175
(dp65505
g1782
g27170
sg6279
g55979
sg3657
g40192
sg1146
g22477
sg3024
g36332
sg3141
g37092
sg11592
(dp65506
sg10878
(dp65507
sg354
g15283
sg2046
g29148
sg6552
g57490
sg4782
g47529
sg1239
g22983
sg5208
g49738
ssg8178
(dp65508
g6012
g54370
sg5928
g54067
sg7275
g60811
sg11955
(dp65509
sg1452
g24754
ssg8181
(dp65510
g10200
(dp65511
sg2199
g30717
sg294
g14772
sg396
g15805
sg3144
g37129
sg11415
(dp65512
sg9006
(dp65513
sg11379
(dp65514
ssg8184
(dp65515
g6630
g57938
sg969
g21102
sg8322
(dp65516
sg9918
(dp65517
sg5334
g50517
sg1266
g23254
sg4170
g43389
sg6015
g54409
sg6990
g59480
sg8598
(dp65518
sg2805
g34459
sg8076
g65004
sg7842
g63941
sg10653
(dp65519
sg5835
g53461
sg1059
g21787
sg2505
g32663
sg8808
(dp65520
sg11535
(dp65521
ssg8187
(dp65522
VUGT1A4 substrates
p65523
g41053
sVAdrenergic alpha-1 Receptor Antagonists
p65524
g14147
sVNeurotransmitter Agents
p65525
(dp65526
sVCentral Nervous System Agents
p65527
g58493
sVDopamine Agents
p65528
g14269
sVAdrenergic Antagonists
p65529
g52304
sVPsychotropic Drugs
p65530
(dp65531
sVPeripheral Nervous System Agents
p65532
g57637
sVCytochrome P-450 CYP1A2 Substrates
p65533
g45617
sVAutonomic Agents
p65534
(dp65535
sg10491
(dp65536
sVAntipsychotic Agents
p65537
(dp65538
sVDopamine Antagonists
p65539
g53751
sVSulfur Compounds
p65540
(dp65541
sVAdrenergic alpha-Antagonists
p65542
g60883
sVPsycholeptics
p65543
g33262
sVCentral Nervous System Depressants
p65544
(dp65545
sVAntiemetics
p65546
(dp65547
sVGastrointestinal Agents
p65548
(dp65549
sVP-glycoprotein/ABCB1 Substrates
p65550
g35045
sVAgents that produce hypertension
p65551
(dp65552
sVAntipsychotic Agents (First Generation [Typical])
p65553
g63591
sVDopamine D2 Receptor Antagonists
p65554
g49426
sVHeterocyclic Compounds, Fused-Ring
p65555
g56129
sVPhenothiazines
p65556
(dp65557
sVP-glycoprotein/ABCB1 Inhibitors
p65558
(dp65559
sVNeurotoxic agents
p65560
(dp65561
sVNervous System
p65562
(dp65563
sVTranquilizing Agents
p65564
g55309
ssg8190
(dp65565
VToxic Actions
p65566
g49394
sVCytochrome P-450 CYP3A4 Inhibitors
p65567
g61673
sVUrea
p65568
g58648
sVMyelosuppressive Agents
p65569
(dp65570
sVCytochrome P-450 CYP2D6 Inhibitors
p65571
g62947
sg4794
g47604
sVNoxae
p65572
g65416
sVCytochrome P-450 CYP3A Inhibitors
p65573
g60434
sVImmunosuppressive Agents
p65574
g64585
sVAlkylating Activity
p65575
g46198
sg4836
g47831
sVAlkylating Drugs
p65576
(dp65577
sVAntineoplastic and Immunomodulating Agents
p65578
g39777
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p65579
g43777
sg11043
(dp65580
sVCytochrome P-450 Enzyme Inhibitors
p65581
g62044
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p65582
g18432
sVAntineoplastic Agents
p65583
(dp65584
sVAntineoplastic Agents, Alkylating
p65585
g60748
ssg8193
(dp65586
VAgents Causing Muscle Toxicity
p65587
g55393
sVBisphosphonates
p65588
(dp65589
sVMusculo-Skeletal System
p65590
g31502
sVDrugs for Treatment of Bone Diseases
p65591
g14274
sVBone Density Conservation Agents
p65592
g40350
sVOrganophosphonates
p65593
(dp65594
sVDrugs Affecting Bone Structure and Mineralization
p65595
g16506
sVOrganophosphorus Compounds
p65596
(dp65597
ssg8196
(dp65598
g11832
(dp65599
sg6765
g58578
sg10839
(dp65600
sg12060
(dp65601
sg13091
g21353
sg3312
g38135
sg8826
(dp65602
ssg8199
(dp65603
g9741
(dp65604
ssg8202
(dp65605
g5847
g53493
ssg8205
(dp65606
VAgents Causing Muscle Toxicity
p65607
g55394
sVGABA Agents
p65608
g16202
sVCytochrome P-450 CYP3A Substrates
p65609
g45155
sVNeurotransmitter Agents
p65610
(dp65611
sVAnti-Anxiety Agents
p65612
g35643
sVCentral Nervous System Agents
p65613
g58497
sVCYP3A Substrates (Sensitive)
p65614
g63916
sVPsychotropic Drugs
p65615
(dp65616
sVTriazolobenzodiazepines
p65617
(dp65618
sVGABA Modulators
p65619
g39048
sVCytochrome P-450 Enzyme Inhibitors
p65620
g62045
sVDrugs that are Mainly Renally Excreted
p65621
g43980
sVHypnotics and Sedatives
p65622
(dp65623
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p65624
g23096
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p65625
g29444
sVAdjuvants, Anesthesia
p65626
g55875
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p65627
g60056
sVCentral Nervous System Depressants
p65628
(dp65629
sVCytochrome P-450 CYP2C8 Inhibitors
p65630
g55036
sVPsycholeptics
p65631
g33229
sVHeterocyclic Compounds, Fused-Ring
p65632
g56131
sVCytochrome P-450 CYP3A4 Substrates
p65633
g65281
sVBenzazepines
p65634
g60326
sVBenzodiazepine hypnotics and sedatives
p65635
g17656
sVCytochrome P-450 CYP3A5 Substrates
p65636
(dp65637
sVBenzodiazepines and benzodiazepine derivatives
p65638
(dp65639
sVNervous System
p65640
(dp65641
sVTranquilizing Agents
p65642
g55287
sVCytochrome P-450 CYP3A7 Substrates
p65643
g60669
ssg8208
(dp65644
g8823
(dp65645
sg2079
g29839
ssg8211
(dp65646
VAgents Causing Muscle Toxicity
p65647
g55396
sVCytochrome P-450 CYP3A4 Inhibitors
p65648
g61641
sVQuinolines
p65649
(dp65650
sVOphthalmological and Otological Preparations
p65651
(dp65652
sVCytochrome P-450 CYP3A7 Inhibitors
p65653
(dp65654
sVMATE 2 Inhibitors
p65655
g52716
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p65656
g43781
sVEnzyme Inhibitors
p65657
(dp65658
sVCytochrome P-450 Enzyme Inhibitors
p65659
g62004
sVAnti-Infective Agents
p65660
g54657
sVQuinolone Antimicrobial
p65661
(dp65662
sVAntiinfectives for Systemic Use
p65663
(dp65664
sVDrugs that are Mainly Renally Excreted
p65665
g43909
sVMATE substrates
p65666
(dp65667
sVOtologicals
p65668
(dp65669
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p65670
(dp65671
sVAnti-Bacterial Agents
p65672
g38376
sVQTc Prolonging Agents
p65673
g57863
sVQuinolones
p65674
g23987
sVCiprofloxacin and isotope
p65675
g35598
sVMATE 1 Substrates
p65676
g23505
sVCytochrome P-450 CYP1A2 Inhibitors
p65677
g14999
sVP-glycoprotein/ABCB1 Substrates
p65678
g35055
sVFluoroquinolones
p65679
g50495
sVCytochrome P-450 CYP3A5 Inhibitors
p65680
g55334
sVAntibacterials for Systemic Use
p65681
g32575
sVModerate Risk QTc-Prolonging Agents
p65682
(dp65683
sVMATE inhibitors
p65684
g58953
sVHeterocyclic Compounds, Fused-Ring
p65685
g56111
sVOphthalmologicals
p65686
g35251
sVCytochrome P-450 CYP3A Inhibitors
p65687
g60397
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p65688
g30491
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p65689
g64646
sVTopoisomerase II Inhibitors
p65690
g40638
sVChemically-Induced Disorders
p65691
g21222
sVMATE 1 Inhibitors
p65692
(dp65693
sVTopoisomerase Inhibitors
p65694
g32857
sVSensory Organs
p65695
g40738
ssg8214
(dp65696
g2199
g30671
ssg8217
(dp65697
VHypolipidemic Agents
p65698
(dp65699
sVAnion Exchange Resins
p65700
g29051
sVBile-acid Binding Activity
p65701
g52827
sVAmines
p65702
g42729
sVLipid Modifying Agents
p65703
g40544
sVPolyamines
p65704
g40554
sVPolymers
p65705
g22235
sVSequestering Agents
p65706
g57199
sVBile Acid Sequestrants
p65707
(dp65708
sVCompounds used in a research, industrial, or household setting
p65709
(dp65710
sVMacromolecular Substances
p65711
g33844
sVLipid Regulating Agents
p65712
(dp65713
sVLipid Modifying Agents, Plain
p65714
g63421
ssg8220
(dp65715
g9525
(dp65716
sg5235
g49818
sg4266
g44215
sg780
g19343
sg11541
(dp65717
ssg8223
(dp65718
g3861
g41267
sg12274
g27501
sg3543
g39312
sg5433
g51020
ssg8226
(dp65719
VAngiotensin-Converting Enzyme Inhibitors
p65720
(dp65721
sVACE Inhibitors and Diuretics
p65722
(dp65723
sVACE Inhibitors and Calcium Channel Blockers
p65724
(dp65725
sVLipid Modifying Agents
p65726
g40548
sVProtease Inhibitors
p65727
g51104
sVAntihypertensive Agents
p65728
g20285
sVAgents causing hyperkalemia
p65729
g43598
sVHypotensive Agents
p65730
g34153
sVAgents causing angioedema
p65731
g63912
sVHeterocyclic Compounds, Fused-Ring
p65732
g56092
sVCholinesterase Inhibitors
p65733
(dp65734
sVEnzyme Inhibitors
p65735
(dp65736
sVCardiovascular Agents
p65737
g26596
sVAgents Acting on the Renin-Angiotensin System
p65738
g25345
ssg8229
(dp65739
g2664
g33452
ssg8232
(dp65740
g294
g14732
sg1809
g27427
sg42
g12576
sg1281
g23369
sg4101
g42964
sg10602
(dp65741
ssg8235
(dp65742
g7680
g63288
ssg8238
(dp65743
VAntiinfectives for Systemic Use
p65744
(dp65745
sVCephacetrile
p65746
(dp65747
sVHeterocyclic Compounds, Fused-Ring
p65748
g56142
sVThird-Generation Cephalosporins
p65749
g44710
sVbeta-Lactams
p65750
(dp65751
sVAgents that reduce seizure threshold
p65752
g45844
sVOAT3/SLC22A8 Inhibitors
p65753
g59002
sVLactams
p65754
g22274
sVOAT1/SLC22A6 inhibitors
p65755
(dp65756
sVAmides
p65757
g44352
sVThiazines
p65758
g16412
sVSulfur Compounds
p65759
(dp65760
sVAnti-Bacterial Agents
p65761
g38381
sVAntibacterials for Systemic Use
p65762
g32578
sVCephalosporins
p65763
g49064
sVAnti-Infective Agents
p65764
g54662
sVNephrotoxic agents
p65765
g57735
ssg8241
(dp65766
VAcetates
p65767
g64705
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p65768
(dp65769
sV2-Pyridinylmethylsulfinylbenzimidazoles
p65770
(dp65771
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p65772
g50954
sVCytochrome P-450 CYP3A Substrates
p65773
g45158
sVFatty Acids
p65774
g63141
sVCytochrome P-450 CYP3A4 Inhibitors
p65775
g61704
sVBCRP/ABCG2 Inhibitors
p65776
g12520
sVAntiinflammatory and Antirheumatic Products
p65777
g56810
sg10422
(dp65778
sVLipids
p65779
g14308
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p65780
g43784
sVCytochrome P-450 CYP2C9 Inhibitors
p65781
g18239
sVGastrointestinal Agents
p65782
(dp65783
sVCytochrome P-450 Enzyme Inhibitors
p65784
g62048
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p65785
g18394
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p65786
(dp65787
sVAcid Reducers
p65788
g43805
sVDrugs that are Mainly Renally Excreted
p65789
g43983
sVCytochrome P-450 CYP2D6 Inhibitors
p65790
g62950
sVEnzyme Inhibitors
p65791
(dp65792
sVHeterocyclic Compounds, Fused-Ring
p65793
g56143
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p65794
(dp65795
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p65796
g29448
sVSulfur Compounds
p65797
(dp65798
sVMusculo-Skeletal System
p65799
g31519
sVSulfoxides
p65800
g56734
sVAnti-Ulcer Agents
p65801
(dp65802
sVCytochrome P-450 CYP2C19 Substrates
p65803
g53885
sVFatty Acids, Volatile
p65804
(dp65805
sVCytochrome P-450 CYP1A2 Inducers
p65806
(dp65807
sVHydroxy Acids
p65808
g18151
sVCytochrome P-450 CYP2C8 Inhibitors
p65809
g55040
sVPyridines
p65810
g64229
sVGastric Acid Lowering Agents
p65811
(dp65812
sVProton-pump Inhibitors
p65813
g31275
sVCytochrome P-450 Enzyme Inducers
p65814
g28227
sVCytochrome P-450 CYP2C19 Inhibitors
p65815
g61279
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p65816
g17441
sVCytochrome P-450 CYP3A4 Substrates
p65817
g65283
sVAlimentary Tract and Metabolism
p65818
g23913
sVBenzimidazoles
p65819
(dp65820
sVPyrazolones
p65821
g60886
sVAcids, Acyclic
p65822
g25449
sVCytochrome P-450 CYP3A Inhibitors
p65823
g60467
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p65824
(dp65825
sVProton Pump Inhibitors
p65826
g57894
sVDrugs for Acid Related Disorders
p65827
g55163
sVTopical Products for Joint and Muscular Pain
p65828
g13923
sVPyrazoles
p65829
g65176
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p65830
(dp65831
ssg8244
(dp65832
g1626
g25933
sg9783
(dp65833
sg1365
g24055
sg11022
(dp65834
ssg8247
(dp65835
g9309
(dp65836
sg1812
g27473
sg7629
g62988
sg12108
(dp65837
sg1164
g22583
ssg8250
(dp65838
g1185
g22745
sg1062
g21833
ssg8253
(dp65839
g8277
(dp65840
ssg8256
(dp65841
g2553
g32884
sg4770
g47448
sg10767
(dp65842
sg5415
g50923
sg1164
g22582
sg9309
(dp65843
sg7629
g62986
sg9561
(dp65844
sg1812
g27464
sg12108
(dp65845
sg657
g18304
sg7395
g61580
sg11382
(dp65846
sg3825
g41012
sg1842
g27650
sg6714
g58258
ssg8259
(dp65847
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p65848
(dp65849
sg8370
(dp65850
sVSerotonin Agents
p65851
(dp65852
sVAnalgesics
p65853
g26489
sVAntimigraine Preparations
p65854
g32376
sg7632
g63010
sVIndoles
p65855
(dp65856
sVCytochrome P-450 CYP1A2 Substrates
p65857
g45625
sVAmines
p65858
g42733
sVBiogenic Monoamines
p65859
(dp65860
sg7107
g60105
sVCentral Nervous System Depressants
p65861
(dp65862
sVNeurotransmitter Agents
p65863
(dp65864
sVBiogenic Amines
p65865
g58002
sVOxazoles
p65866
g33223
sg9990
(dp65867
sg5721
g52797
sVAgents that produce hypertension
p65868
(dp65869
sVSerotonin 5-HT1 Receptor Agonists
p65870
g34588
sVHeterocyclic Compounds, Fused-Ring
p65871
g56146
sVSerotonin Modulators
p65872
(dp65873
sVAntidepressive Agents
p65874
g15571
sg2718
g33827
sg8352
(dp65875
sVSerotonin Receptor Agonists
p65876
(dp65877
sVNervous System
p65878
(dp65879
ssg8262
(dp65880
g6726
g58315
sg10728
(dp65881
sg888
g20417
sg5256
g50050
sg11196
(dp65882
sg4959
g48528
ssg8265
(dp65883
VArteriolar Vasodilation
p65884
g34044
sVCytochrome P-450 CYP3A4 Inhibitors
p65885
g61628
sg3957
g41799
sVCardiovascular Agents
p65886
g26666
sVArteriolar Vasodilator
p65887
(dp65888
sg1419
g24515
sVDrugs that are Mainly Renally Excreted
p65889
g43986
sVAntihypertensive Agents
p65890
g20316
sVCytochrome P-450 CYP3A Inhibitors
p65891
g60383
sVHypotensive Agents
p65892
g34202
sVDirect Vasodilators
p65893
(dp65894
sVArteriolar Smooth Muscle, Agents Acting On
p65895
(dp65896
sVVasodilating Agents
p65897
g23715
sg6096
g54996
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p65898
g43787
sVPyridazines
p65899
g32865
sVCytochrome P-450 Enzyme Inhibitors
p65900
g62050
sg11583
(dp65901
ssg8268
(dp65902
g6699
g58230
ssg8271
(dp65903
g10335
(dp65904
sg8673
(dp65905
sg6381
g56780
ssg8274
(dp65906
VAmino Acids, Peptides, and Proteins
p65907
g47417
sVHematologic Agents
p65908
(dp65909
sVBlood and Blood Forming Organs
p65910
g53938
sVPeptides
p65911
g47214
sVErythropoietin
p65912
g51843
sVColony-Stimulating Factors
p65913
g47974
sVHematopoietic Cell Growth Factors
p65914
g65131
sVHematinics
p65915
g59093
sVCarbohydrates
p65916
g61798
sVProteins
p65917
g52792
sVIntercellular Signaling Peptides and Proteins
p65918
g25418
sVIncreased Erythroid Cell Production
p65919
(dp65920
sVErythropoiesis-Stimulating Agents
p65921
g13886
sVBiological Factors
p65922
g38123
sVGlycoconjugates
p65923
(dp65924
sVAntianemic Preparations
p65925
g63060
sVGlycoproteins
p65926
(dp65927
sVCytokines
p65928
g62892
ssg8277
(dp65929
VNicotinic Antagonists
p65930
g58930
sVAndrostanols
p65931
(dp65932
sVSteroids
p65933
g56406
sVAnticholinergic Agents
p65934
g24491
sVOCT1 substrates
p65935
g13062
sVNeuromuscular Agents
p65936
g20236
sVAndrostanes
p65937
(dp65938
sVMusculo-Skeletal System
p65939
g31533
sg9288
(dp65940
sVCentral Nervous System Depressants
p65941
(dp65942
sg8253
g65840
sVPeripheral Nervous System Agents
p65943
g57647
sVMuscle Relaxants, Peripherally Acting Agents
p65944
g46189
sg10908
(dp65945
sVMuscle Relaxants
p65946
(dp65947
sVAgents producing tachycardia
p65948
g50795
sVFused-Ring Compounds
p65949
g14882
sVMuscarinic Antagonists
p65950
g48873
sVOCT1 inhibitors
p65951
(dp65952
ssg8280
(dp65953
g1266
g23230
ssg8283
(dp65954
g6726
g58303
sg10728
(dp65955
sg888
g20519
sg5256
g50085
sg11196
(dp65956
sg10350
(dp65957
ssg8286
(dp65958
g5313
g50384
ssg8289
(dp65959
g4596
g46259
sg7053
g59811
sg7428
g61864
sg3651
g40127
sg3516
g39174
ssg8292
(dp65960
g10122
(dp65961
ssg8295
(dp65962
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p65963
(dp65964
sVCytochrome P-450 CYP2D6 Substrates
p65965
g52189
sVUGT1A1 Substrates
p65966
g12280
sVAnalgesics
p65967
g26488
sVHypotensive Agents
p65968
g34195
sVOpiate Agonists
p65969
g46451
sVCentral Nervous System Agents
p65970
g58506
sVNarcotics
p65971
(dp65972
sVPeripheral Nervous System Agents
p65973
g57644
sVCytochrome P-450 CYP2C8 Substrates
p65974
(dp65975
sVOpioids
p65976
g32233
sVUGT1A3 substrates
p65977
g31802
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p65978
g29272
sVCytochrome P-450 CYP3A Substrates
p65979
g45016
sVNatural Opium Alkaloids
p65980
g23488
sVCentral Nervous System Depressants
p65981
(dp65982
sVAnesthetics
p65983
g51602
sVOpiate Alkaloids
p65984
(dp65985
sVP-glycoprotein/ABCB1 Substrates
p65986
g35058
sVHigh-risk opioids
p65987
g58090
sVNeuraxial Anesthetics
p65988
g32597
sVCytochrome P-450 CYP3A4 Substrates
p65989
g65216
sVHeterocyclic Compounds, Fused-Ring
p65990
g56138
sVOpioid Agonist
p65991
(dp65992
sVUGT2B7 substrates
p65993
g28626
sVAlkaloids
p65994
g19404
sVSensory System Agents
p65995
(dp65996
sVPhenanthrenes
p65997
g32833
sVNervous System
p65998
(dp65999
ssg8298
(dp66000
VBSEP/ABCB11 Substrates
p66001
(dp66002
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p66003
(dp66004
sVAntivirals for Systemic Use
p66005
g59771
sVNucleic Acid Synthesis Inhibitors
p66006
g48741
sVCytochrome P-450 CYP2D6 Inhibitors
p66007
g62955
sVCytochrome P-450 CYP3A Substrates
p66008
g45163
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p66009
g46423
sVCytochrome P-450 CYP3A4 Inhibitors
p66010
g61710
sVDirect Acting Antivirals
p66011
g38073
sVEnzyme Inhibitors
p66012
(dp66013
sVCytochrome P450 3A4 Inhibitors
p66014
g13048
sVAntiviral Agents
p66015
g30465
sVCytochrome P-450 CYP2C9 Inhibitors
p66016
g18252
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p66017
g12677
sVCytochrome P-450 Enzyme Inhibitors
p66018
g62052
sVAnti-Infective Agents
p66019
g54670
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p66020
g18421
sVReverse Transcriptase Inhibitors
p66021
g28965
sg2778
g34335
sVAntiinfectives for Systemic Use
p66022
(dp66023
sVAnti-Retroviral Agents
p66024
(dp66025
sVCytochrome P-450 CYP2B6 Inducers
p66026
g39126
sVCytochrome P-450 CYP2C19 Inhibitors (moderate)
p66027
g56917
sVUGT1A1 Inducers
p66028
g39243
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66029
g29454
sVCytochrome P450 2C9 Inhibitors
p66030
g63319
sVQTc Prolonging Agents
p66031
g57880
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p66032
g25150
sVCytochrome P-450 CYP3A4 Inducers
p66033
g18976
sVOCT1 inhibitors
p66034
(dp66035
sVOxazines
p66036
(dp66037
sVCentral Nervous System Depressants
p66038
(dp66039
sVCytochrome P-450 CYP3A5 Inducers
p66040
g41751
sVCytochrome P-450 CYP3A7 Inducers
p66041
g39042
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p66042
(dp66043
sVCytochrome P-450 CYP1A2 Inhibitors
p66044
g15033
sVCytochrome P-450 CYP2C8 Inhibitors
p66045
g55045
sVCytochrome P-450 CYP2B6 Inhibitors
p66046
g45936
sg4527
g45992
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p66047
(dp66048
sVCytochrome P450 3A Inducers
p66049
(dp66050
sVCytochrome P-450 Enzyme Inducers
p66051
g28239
sVCytochrome P-450 CYP3A Inducers
p66052
(dp66053
sVInducers of Drug Clearance
p66054
g44536
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p66055
g44549
sVCytochrome P-450 CYP2C19 Inhibitors
p66056
g61283
sVCytochrome P-450 CYP3A Inhibitors (strong)
p66057
g13407
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p66058
g49339
sVModerate Risk QTc-Prolonging Agents
p66059
(dp66060
sVCytochrome P-450 CYP3A4 Substrates
p66061
g65286
sVHeterocyclic Compounds, Fused-Ring
p66062
g56158
sg381
g15492
sVCytochrome P-450 CYP3A Inhibitors
p66063
g60473
sVCytochrome P-450 CYP2C19 Inducers
p66064
g25543
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p66065
(dp66066
sVCytochrome P-450 CYP3A7 Inducers (moderate)
p66067
g28102
sVChemically-Induced Disorders
p66068
g21242
sVCytochrome P450 2C19 Inhibitors
p66069
(dp66070
sVCytochrome P-450 CYP2B6 Substrates
p66071
g33030
ssg8301
(dp66072
g7020
g59600
sg10758
(dp66073
ssg8304
(dp66074
g4197
g43517
sg9696
(dp66075
sg11649
(dp66076
sg1635
g26063
sg6102
g55094
sg8595
(dp66077
sg6381
g56787
sg255
g14406
sg5598
g52042
sg213
g14061
ssg8307
(dp66078
g7191
g60568
sg5289
g50304
ssg8310
(dp66079
g6033
g54512
sg5526
g51590
sg5268
g50146
sg9618
(dp66080
sg9339
(dp66081
sg2703
g33729
sg3858
g41212
sg3240
g37729
sg1719
g26844
sg10701
(dp66082
sg10239
(dp66083
sg10170
(dp66084
sg1581
g25701
sg4803
g47654
sg8742
(dp66085
sg9165
(dp66086
sg963
g21009
ssg8313
(dp66087
VAgents Causing Muscle Toxicity
p66088
g55363
sVBSEP/ABCB11 Substrates
p66089
(dp66090
sVQuinolines
p66091
(dp66092
sVOtologicals
p66093
(dp66094
sVOAT1/SLC22A6 inhibitors
p66095
(dp66096
sg2481
g32413
sVEnzyme Inhibitors
p66097
(dp66098
sVCytochrome P-450 Enzyme Inhibitors
p66099
g61982
sVAnti-Infective Agents
p66100
g54568
sVQuinolone Antimicrobial
p66101
(dp66102
sVRenal Agents
p66103
g24771
sVAntiinfectives for Systemic Use
p66104
(dp66105
sVAnti-Bacterial Agents
p66106
g38319
sVQTc Prolonging Agents
p66107
g57857
sVQuinolones
p66108
g23990
sVAnti-Infective Agents, Urinary
p66109
g25225
sVCytochrome P-450 CYP1A2 Inhibitors
p66110
g15017
sVFluoroquinolones
p66111
g50496
sVSensory Organs
p66112
g40679
sVAntibacterials for Systemic Use
p66113
g32527
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p66114
g49333
sVModerate Risk QTc-Prolonging Agents
p66115
(dp66116
sVHeterocyclic Compounds, Fused-Ring
p66117
g56045
sVOphthalmologicals
p66118
g35180
sVTopoisomerase II Inhibitors
p66119
g40641
sVChemically-Induced Disorders
p66120
g21234
sVTopoisomerase Inhibitors
p66121
g32861
ssg8316
(dp66122
g2835
g34755
sg3426
g38751
sg10629
(dp66123
sg8226
g65721
sg5619
g52209
sg12114
(dp66124
sg12060
(dp66125
sg9783
(dp66126
sg5199
g49693
sg5595
g51983
sg213
g14030
ssg8319
(dp66127
g5199
g49707
sg1857
g27719
sg7344
g61296
ssg8322
(dp66128
VContact Laxatives
p66129
g61317
sVPharmaceutical Preparations
p66130
g53870
sVGastrointestinal Agents
p66131
(dp66132
sVAnthracenes
p66133
g53580
sVDrugs for Constipation
p66134
g53335
sVAnthraquinones
p66135
g63159
sg11796
(dp66136
sVBiological Products
p66137
g64635
sVPlant Preparations
p66138
g60998
sVLaxatives
p66139
g17352
sVHerbs and Natural Products
p66140
g19490
sVComplex Mixtures
p66141
g65516
sVQuinones
p66142
(dp66143
sVAlimentary Tract and Metabolism
p66144
g23935
ssg8325
(dp66145
VAmino Acids, Peptides, and Proteins
p66146
g47404
sVHematologic Agents
p66147
(dp66148
sg5613
g52104
sg8883
(dp66149
sVProteins
p66150
g52784
sg10992
(dp66151
sg3888
g41468
sg3669
g40199
ssg8328
(dp66152
g2346
g31402
sg5415
g50940
sg1326
g23612
sg30
g12400
sg7719
g63486
sg3117
g36934
sg5433
g51070
sg831
g19911
sg834
g19969
sg7821
g63819
sg4656
g46799
sg6228
g55706
sg3900
g41487
sg963
g21011
sg20252
(dp66153
sg8445
(dp66154
sg5499
g51435
sg2424
g31952
sg3543
g39356
sg10713
(dp66155
sg5157
g49430
sg3174
g37280
sg6279
g55969
sg3657
g40186
sg5685
g52446
sg8487
(dp66156
sg2391
g31739
sg14822
g41833
sg762
g19247
sg9144
(dp66157
sg816
g19673
sg14338
g13524
sg9225
(dp66158
sg3231
g37673
sg6336
g56539
sg9081
(dp66159
sg204
g13978
sg7170
g60323
sg3156
g37205
sg4803
g47656
sg11592
(dp66160
sg7353
g61349
sg4830
g47824
sg4401
g44856
sg12274
g27567
sg9366
(dp66161
sg10884
(dp66162
sg1626
g25950
sg7530
g62474
sg4062
g42650
sg10890
(dp66163
sg9099
(dp66164
sg9402
(dp66165
sg6348
g56657
sg6435
g56993
sg10164
(dp66166
sg9486
(dp66167
sg2832
g34739
sg4170
g43380
sg1941
g28606
sg7188
g60522
sg2706
g33749
sg9828
(dp66168
sg420
g16011
sg11022
(dp66169
sg10275
(dp66170
sg5028
g48793
sg978
g21184
sg10041
(dp66171
sg4236
g43720
sg1239
g22975
sg879
g20372
sg3504
g39091
sg10320
(dp66172
sg10548
(dp66173
sg5865
g53626
sg507
g16797
sg10314
(dp66174
sg11940
(dp66175
sg11097
(dp66176
sg2088
g29944
sg11862
(dp66177
sg5574
g51816
sg543
g17118
sg11874
(dp66178
sg10593
(dp66179
sg7314
g61005
sg6645
g58009
sg6474
g57175
sg6885
g59143
sg10578
(dp66180
sg561
g17369
sg10383
(dp66181
sg2133
g30312
sg570
g17497
sg11166
(dp66182
sg7884
g64121
sg8142
g65377
sg6687
g58198
sg2895
g35456
sg10878
(dp66183
sg5973
g54246
sg11931
(dp66184
sg6735
g58348
sg2928
g35614
sg10290
(dp66185
sg5235
g49862
sg4449
g45365
sg8964
(dp66186
sg6051
g54795
sg1470
g24932
sg3861
g41294
sg849
g20110
sg6069
g54824
sg5919
g54000
sg5283
g50179
sg12042
(dp66187
sg6798
g58773
sg10521
(dp66188
sg12072
(dp66189
sg12045
(dp66190
sg2739
g34027
sg3783
g40887
sg10554
(dp66191
sg10230
(dp66192
sg8334
(dp66193
sg9096
(dp66194
sg10692
(dp66195
sg2127
g30244
sg6162
g55255
ssg8331
(dp66196
g4440
g45318
sg10662
(dp66197
sg5928
g54053
sg7275
g60806
sg1452
g24748
ssg8334
(dp66198
VHeterocyclic Compounds, Fused-Ring
p66199
g56163
sVQuinolines
p66200
(dp66201
sVGenito Urinary System and Sex Hormones
p66202
g66193
sg981
g21196
sVNeurotransmitter Agents
p66203
(dp66204
sg6378
g56749
sg243
g14262
sg10734
(dp66205
sVMiscellaneous Therapeutic Agents
p66206
(dp66207
ssg8337
(dp66208
g6102
g55099
sg3849
g41169
ssg8340
(dp66209
VVitamins
p66210
g12177
sVOAT1/SLC22A6 inhibitors
p66211
(dp66212
sVDiet, Food, and Nutrition
p66213
g22905
sVBiological Factors
p66214
g38111
sVFood and Beverages
p66215
(dp66216
sg10101
(dp66217
sVPhysiological Phenomena
p66218
g21720
sVMicronutrients
p66219
(dp66220
sVFood
p66221
g62215
sVPigments, Biological
p66222
g21851
sVPteridines
p66223
(dp66224
sVRadiation-Sensitizing Agents
p66225
(dp66226
sVEnzymes and Coenzymes
p66227
(dp66228
sVVitamin B Complex
p66229
g54914
sVDermatologicals
p66230
g17212
sVSensory Organs
p66231
g40682
sVAlimentary Tract and Metabolism
p66232
g23789
sVGrowth Substances
p66233
g46128
sVHeterocyclic Compounds, Fused-Ring
p66234
g56054
sVOphthalmologicals
p66235
g35184
sg2376
g31643
sVPhotosensitizing Agents
p66236
g21315
ssg8343
(dp66237
g2466
g32362
ssg8346
(dp66238
g8808
(dp66239
sg6015
g54406
sg4053
g42543
sg4365
g44746
sg10338
(dp66240
sg4338
g44562
sg2253
g30886
ssg8349
(dp66241
g3087
g36680
sg7668
g63242
sg2373
g31640
sg7545
g62596
sg4113
g43089
sg8430
(dp66242
sg2391
g31755
sg5766
g53017
sg14838
g40033
sg5895
g53851
sg1452
g24758
sg9903
(dp66243
ssg8352
(dp66244
g1704
g26738
sg633
g18102
sg5919
g54004
sg7056
g59868
sg933
g20850
sg8259
g65875
sg1668
g26293
ssg8355
(dp66245
g8421
(dp66246
sg5394
g50846
sg9822
(dp66247
sg4974
g48634
sg5757
g52947
sg10179
(dp66248
sg7335
g61239
sg9591
(dp66249
sg10512
(dp66250
ssg8358
(dp66251
g9834
(dp66252
sg9180
(dp66253
sg6699
g58239
ssg8361
(dp66254
g10557
(dp66255
sg7764
g63645
sg8433
(dp66256
sg3696
g40313
sg1857
g27727
sg4452
g45459
sg684
g18525
ssg8364
(dp66257
g4620
g46344
sg5409
g50896
sg2346
g31392
sg9132
(dp66258
sg3846
g41138
sg9249
(dp66259
sg5433
g51060
sg9903
(dp66260
sg6216
g55638
sg1800
g27329
sg2226
g30803
sg5454
g51163
sg4653
g46716
sg1656
g26180
sg8421
(dp66261
sg7668
g63216
sg8430
(dp66262
sg9198
(dp66263
sg888
g20483
sg10701
(dp66264
sg8448
(dp66265
sg10272
(dp66266
sg5133
g49292
sg9966
(dp66267
sg9225
(dp66268
sg1113
g22194
sg9231
(dp66269
sg7734
g63536
sg816
g19683
sg147
g13477
sg3219
g37556
sg11550
(dp66270
sg13091
g21409
sg11523
(dp66271
sg183
g13838
sg6333
g56485
sg6336
g56530
sg2538
g32815
sg6345
g56596
sg3258
g37820
sg14829
g56679
sg7053
g59814
sg4023
g42351
sg12274
g27554
sg7545
g62568
sg1062
g21827
sg1614
g25887
sg4680
g46891
sg14838
g40000
sg9030
(dp66272
sg4089
g42887
sg12534
g52662
sg4911
g48262
sg1104
g22108
sg4113
g43057
sg9444
(dp66273
sg8694
(dp66274
sg8703
(dp66275
sg2688
g33669
sg4155
g43240
sg4164
g43339
sg5757
g52939
sg7188
g60517
sg5766
g52991
sg9492
(dp66276
sg405
g15895
sg6537
g57411
sg2730
g33886
sg2373
g31605
sg9918
(dp66277
sg9528
(dp66278
sg5832
g53436
sg8049
g64907
sg5853
g53574
sg2787
g34408
sg7272
g60773
sg3516
g39177
sg11079
(dp66279
sg11940
(dp66280
sg4287
g44395
sg7329
g61146
sg78
g12865
sg5895
g53823
sg7389
g61560
sg11952
(dp66281
sg9609
(dp66282
sg543
g17108
sg10362
(dp66283
sg3393
g38573
sg6504
g57269
sg11886
(dp66284
sg3651
g40130
sg7335
g61224
sg3432
g38815
sg1668
g26272
sg696
g18754
sg8472
(dp66285
sg1371
g24117
sg28215
g35373
sg11922
(dp66286
sg13750
g24394
sg14872
g15747
sg9693
(dp66287
sg7428
g61867
sg2943
g35773
sg1434
g24670
sg6045
g54710
sg6765
g58613
sg1461
g24833
sg9618
(dp66288
sg6783
g58673
sg5526
g51586
sg3024
g36312
sg3027
g36370
sg11316
(dp66289
sg1140
g22416
sg2832
g34724
sg11775
(dp66290
sg10539
(dp66291
sg8298
g66053
sg10113
(dp66292
sg10557
(dp66293
sg1098
g22023
sg9822
(dp66294
sg5364
g50626
sg5067
g48956
sg12126
(dp66295
sg10596
(dp66296
sg6075
g54888
sg12132
(dp66297
sg7593
g62814
sg4596
g46262
sg12123
(dp66298
ssg8367
(dp66299
g2886
g35291
ssg8370
(dp66300
g1704
g26698
sg633
g18063
sg5919
g53953
sg7056
g59835
sg933
g20799
sg8259
g65850
sg1668
g26231
ssg8373
(dp66301
VAgents Causing Muscle Toxicity
p66302
g55355
sVCytochrome P-450 CYP3A4 Inhibitors
p66303
g61625
sVQuinolines
p66304
(dp66305
sVOphthalmological and Otological Preparations
p66306
(dp66307
sVCytochrome P-450 CYP3A7 Inhibitors
p66308
(dp66309
sVMATE 2 Inhibitors
p66310
g52714
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p66311
g43730
sVEnzyme Inhibitors
p66312
(dp66313
sVCytochrome P-450 Enzyme Inhibitors
p66314
g62054
sVAnti-Infective Agents
p66315
g54554
sVQuinolone Antimicrobial
p66316
(dp66317
sVAntiinfectives for Systemic Use
p66318
(dp66319
sVDrugs that are Mainly Renally Excreted
p66320
g43994
sVMATE substrates
p66321
(dp66322
sVOtologicals
p66323
(dp66324
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p66325
(dp66326
sVAnti-Bacterial Agents
p66327
g38311
sVQTc Prolonging Agents
p66328
g57778
sVQuinolones
p66329
g23980
sg2919
g35597
sVMATE 1 Substrates
p66330
g23493
sVCytochrome P-450 CYP1A2 Inhibitors
p66331
g14984
sVP-glycoprotein/ABCB1 Substrates
p66332
g34901
sVFluoroquinolones
p66333
g50493
sVCytochrome P-450 CYP3A5 Inhibitors
p66334
g55331
sVAntibacterials for Systemic Use
p66335
g32519
sVModerate Risk QTc-Prolonging Agents
p66336
(dp66337
sVMATE inhibitors
p66338
g58948
sVHeterocyclic Compounds, Fused-Ring
p66339
g56026
sVOphthalmologicals
p66340
g35165
sVCytochrome P-450 CYP3A Inhibitors
p66341
g60380
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p66342
g30487
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p66343
g64642
sVTopoisomerase II Inhibitors
p66344
g40631
sVChemically-Induced Disorders
p66345
g21214
sVMATE 1 Inhibitors
p66346
(dp66347
sVTopoisomerase Inhibitors
p66348
g32847
sVSensory Organs
p66349
g40669
ssg8376
(dp66350
g1776
g27084
ssg8379
(dp66351
g8484
(dp66352
sg12186
g42901
sg8439
(dp66353
ssg8382
(dp66354
g9111
(dp66355
ssg8385
(dp66356
g465
g16466
sg345
g15226
sg4344
g44651
ssg8388
(dp66357
VCytochrome P-450 CYP2C8 Substrates
p66358
(dp66359
sVAntihypertensive Agents
p66360
g20245
sVCytochrome P-450 CYP3A Substrates
p66361
g45173
sVHypotensive Agents
p66362
g34101
sVEnzyme Activators
p66363
g19314
sVBCRP/ABCG2 Substrates
p66364
g42055
sg5814
g53308
sVVasodilating Agents
p66365
g23685
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66366
g29468
sg9408
(dp66367
sVCytochrome P-450 CYP3A4 Substrates
p66368
g65290
sVAntihypertensives for Pulmonary Arterial Hypertension
p66369
g25750
sg10401
(dp66370
ssg8391
(dp66371
g7668
g63190
sg4875
g48018
sg1800
g27302
ssg8394
(dp66372
VAntipruritics
p66373
(dp66374
sVAntihistamines for Topical Use
p66375
g39013
sVHistamine H1 Antagonists
p66376
g40765
sVAnti-Allergic Agents
p66377
g50646
sVHistamine Agents
p66378
(dp66379
sVDermatologicals
p66380
g17182
sVPyridines
p66381
g64224
sVPotential QTc-Prolonging Agents
p66382
(dp66383
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p66384
(dp66385
sVHistamine Antagonists
p66386
g43422
sVAntihistamines for Systemic Use
p66387
g12958
sVQTc Prolonging Agents
p66388
g57781
ssg8397
(dp66389
g10833
(dp66390
sg9153
(dp66391
sg7884
g64089
sg6435
g56957
sg11427
(dp66392
sg279
g14502
sg11052
(dp66393
sg5847
g53496
sg8622
(dp66394
sg7881
g64056
sg8985
(dp66395
sg9198
(dp66396
sg3132
g36992
sg9954
(dp66397
sg7500
g62336
sg12051
(dp66398
sg5520
g51546
sg9432
(dp66399
sg2460
g32262
sg318
g14906
sg7524
g62426
sg1527
g25269
sg7947
g64360
sg6654
g58041
sg9267
(dp66400
sg573
g17523
sg3576
g39561
sg10326
(dp66401
sg1101
g22049
sg6075
g54858
sg9663
(dp66402
sg11451
(dp66403
sg4953
g48497
sg819
g19731
ssg8400
(dp66404
g4014
g42217
sg7317
g61037
sg8832
(dp66405
sg1629
g25975
sg9006
(dp66406
ssg8403
(dp66407
g10335
(dp66408
sg8673
(dp66409
sg11916
(dp66410
ssg8406
(dp66411
VAmino Acids, Peptides, and Proteins
p66412
g47314
sg1698
g26512
sVGastrointestinal Agents
p66413
(dp66414
sVMiscellaneous GI Drugs
p66415
g23551
sg894
g20575
sg774
g19315
sVDrugs for Constipation
p66416
g53339
sVLaxatives
p66417
g17342
sg2931
g35639
sVAlimentary Tract and Metabolism
p66418
g23760
ssg8409
(dp66419
g1260
g23135
sg3684
g40218
sg687
g18539
sg8580
(dp66420
sg1803
g27367
sg4035
g42413
sg10593
(dp66421
ssg8412
(dp66422
g834
g19948
ssg8415
(dp66423
g717
g19049
sg2058
g29179
ssg8418
(dp66424
VAntiplatelet agents
p66425
g46310
sVSalicylic Acid and Derivatives
p66426
g36815
sVUGT1A6 substrate
p66427
g38519
sVAnticoagulants
p66428
g58371
sVAnalgesics
p66429
g26428
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p66430
g58388
sVAgents causing angioedema
p66431
g63898
sVNon COX-2 selective NSAIDS
p66432
(dp66433
sVAntiinflammatory and Antirheumatic Products
p66434
g56809
sVBlood and Blood Forming Organs
p66435
g53913
sVStomatological Preparations
p66436
(dp66437
sVPeripheral Nervous System Agents
p66438
g57576
sVDrugs that are Mainly Renally Excreted
p66439
g43998
sVP-glycoprotein/ABCB1 Inducers
p66440
(dp66441
sVSalicylates
p66442
g27627
sVNonsteroidal Anti-inflammatory Compounds
p66443
(dp66444
sVAnalgesics, Non-Narcotic
p66445
g56895
sVNephrotoxic agents
p66446
g57704
sVDecreased Platelet Aggregation
p66447
(dp66448
sVAcids, Carbocyclic
p66449
g41551
sVOAT1/SLC22A6 inhibitors
p66450
(dp66451
sVCytochrome P-450 CYP2C9 Substrates
p66452
g29714
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p66453
g25140
sVMusculo-Skeletal System
p66454
g31516
sVAgents causing hyperkalemia
p66455
g43572
sVCardiovascular Agents
p66456
g26530
sVBenzene Derivatives
p66457
g61398
sVDecreased Prostaglandin Production
p66458
(dp66459
sVP-glycoprotein/ABCB1 Substrates
p66460
g34916
sVAntipyretics
p66461
g64465
sVCytochrome P-450 Enzyme Inducers
p66462
g28119
sVAgents that produce hypertension
p66463
(dp66464
sVHydroxybenzoates
p66465
g59582
sVAlimentary Tract and Metabolism
p66466
g23764
sVHematologic Agents
p66467
(dp66468
sVPlatelet Aggregation Inhibitors Excl. Heparin
p66469
g62769
sVOAT3/SLC22A8 Inhibitors
p66470
g59001
sVCytochrome P-450 CYP2C19 Inducers
p66471
g25530
sVAnti-Inflammatory Agents
p66472
(dp66473
sVCyclooxygenase Inhibitors
p66474
g32783
sVSensory System Agents
p66475
(dp66476
sVAnti-Inflammatory Agents, Non-Steroidal
p66477
g64653
ssg8421
(dp66478
VAgents Causing Muscle Toxicity
p66479
g55360
sg7575
g62771
sVInducers of Drug Clearance
p66480
g44533
sVAnti-epileptic Agent
p66481
(dp66482
sVCytochrome P-450 CYP3A Substrates
p66483
g45177
sVMembrane Transport Modulators
p66484
g54120
sVCentral Nervous System Agents
p66485
g58405
sg7335
g61182
sVCytochrome P-450 CYP2D6 Inducers
p66486
(dp66487
sVCytochrome P-450 CYP3A7 Inducers
p66488
g39036
sVCytochrome P-450 CYP2C9 Inhibitors
p66489
g18181
sVCytochrome P-450 CYP1A2 Inducers
p66490
(dp66491
sVCytochrome P-450 CYP2C9 Inducers
p66492
g20038
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p66493
g16520
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p66494
(dp66495
sg2922
g35600
sg8421
(dp66496
sVCytochrome P-450 CYP2C8 Substrates
p66497
(dp66498
sVCytochrome P-450 CYP3A4 Inducers (strong)
p66499
g23074
sVCytochrome P-450 CYP2C8 Inducers (strong)
p66500
(dp66501
sVCytochrome P-450 CYP2B6 Inducers
p66502
g39116
sg3789
g40899
sg11841
(dp66503
sVCytochrome P-450 Enzyme Inhibitors
p66504
g62056
sVEnzyme Inducing Antiepileptic Drugs
p66505
g25032
sVUGT1A1 Inducers
p66506
g39239
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66507
g29473
sg4347
g44685
sVCytochrome P-450 CYP2C9 Substrates
p66508
g29715
sVImidazoles
p66509
(dp66510
sVCytochrome P-450 CYP3A4 Inducers
p66511
g18881
sVDecreased Central Nervous System Disorganized Electrical Activity
p66512
g23463
sVCytochrome P-450 CYP2C19 Substrates
p66513
g53883
sVCentral Nervous System Depressants
p66514
(dp66515
sVCytochrome P-450 CYP3A5 Inducers
p66516
g41739
sVCardiovascular Agents
p66517
g26531
sg6453
g57045
sVP-glycoprotein/ABCB1 Substrates
p66518
g34917
sVAnticonvulsants
p66519
g60143
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p66520
g49144
sVCytochrome P-450 CYP2B6 Inducers (strong)
p66521
(dp66522
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p66523
g37400
sg8499
(dp66524
sg8502
(dp66525
sg8505
(dp66526
sg7137
g60170
sVCytochrome P-450 Enzyme Inducers
p66527
g28120
sVCytochrome P-450 CYP3A Inducers
p66528
g66261
sVCytochrome P-450 CYP2C18 Substrates
p66529
g20931
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p66530
g60062
sVCytochrome P-450 CYP3A Inducers (strong)
p66531
g22450
sVCytochrome P-450 CYP3A4 Substrates
p66532
g65291
sg3063
g36541
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p66533
(dp66534
sVNarrow Therapeutic Index Drugs
p66535
g50567
sg10194
(dp66536
sg6816
g58849
sg7326
g61110
sg8355
g66246
sg4533
g45996
sVCytochrome P-450 CYP2C8 Inducers
p66537
g60372
sg4776
g47496
sVMethemoglobinemia Associated Agents
p66538
g25564
sVCytochrome P-450 CYP3A7 Inducers (weak)
p66539
g25711
sVChemically-Induced Disorders
p66540
g21226
sVNervous System
p66541
(dp66542
sVCytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index
p66543
(dp66544
ssg8424
(dp66545
g4911
g48268
sg8421
g66501
sg7272
g60761
sg183
g13794
sg4155
g43209
sg7335
g61187
sg5133
g49274
ssg8427
(dp66546
g6186
g55519
sg5427
g50983
sg6318
g56349
sg3708
g40391
sg4653
g46679
sg10674
(dp66547
sg11445
(dp66548
sg6819
g58870
sg4683
g46937
sg3156
g37191
sg10713
(dp66549
sg3177
g37290
sg8487
(dp66550
sg1719
g26848
sg9264
(dp66551
sg10005
(dp66552
sg6303
g56209
sg4056
g42593
sg8724
(dp66553
sg7041
g59713
sg4647
g46583
sg8580
(dp66554
sg1803
g27373
sg4035
g42417
sg10857
(dp66555
sg255
g14376
sg375
g15465
sg9099
(dp66556
sg9111
(dp66557
sg4623
g46373
sg11667
(dp66558
sg9402
(dp66559
sg5694
g52536
sg12534
g52627
sg8673
(dp66560
sg1134
g22324
sg8703
(dp66561
sg8463
(dp66562
sg7164
g60284
sg23
g12237
sg5598
g52044
sg14872
g15715
sg8430
(dp66563
sg1092
g21967
sg426
g16079
sg3531
g39284
sg5829
g53371
sg2013
g28925
sg168
g13665
sg1947
g28675
sg2658
g33358
sg1260
g23139
sg7284
g60836
sg10335
(dp66564
sg2067
g29631
sg534
g16985
sg1707
g26764
sg10593
(dp66565
sg10959
(dp66566
sg9012
(dp66567
sg7320
g61092
sg3036
g36434
sg14791
(dp66568
sg11439
(dp66569
sg570
g17479
sg6678
g58110
sg3570
g39472
sg6687
g58186
sg9465
(dp66570
sg11910
(dp66571
sg11916
(dp66572
sg3363
g38425
sg1635
g26038
sg612
g17861
sg8187
g65535
sg11955
(dp66573
sg516
g16864
sg6759
g58564
sg11265
(dp66574
sg6045
g54700
sg3684
g40222
sg687
g18543
sg4488
g45769
sg3393
g38549
sg11319
(dp66575
sg6102
g55065
sg2277
g31103
sg1548
g25393
sg8862
(dp66576
sg9819
(dp66577
sg11352
(dp66578
sg6381
g56789
sg6156
g55216
sg11649
(dp66579
sg5580
g51881
ssg8430
(dp66580
VBSEP/ABCB11 Substrates
p66581
(dp66582
sVImmunosuppressive Agents
p66583
g64539
sVCytochrome P-450 CYP3A Substrates
p66584
g45180
sVBronchodilator Agents
p66585
(dp66586
sg7836
g63918
sVHormones
p66587
g55657
sVCorticosteroids for Systemic Use
p66588
g48838
sVDrugs for Obstructive Airway Diseases
p66589
g42508
sVDrugs that are Mainly Renally Excreted
p66590
g44000
sVAutonomic Agents
p66591
g66563
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p66592
g59973
sg6060
g54812
sVPeripheral Nervous System Agents
p66593
g57579
sVRespiratory System Agents
p66594
(dp66595
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66596
g29476
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p66597
g60065
sVFused-Ring Compounds
p66598
g14815
sVCytochrome P-450 CYP3A4 Inducers
p66599
g18883
sg2091
g29963
sVCytochrome P-450 CYP3A5 Inducers
p66600
g41741
sVAdrenal Cortex Hormones
p66601
g30020
sVAdrenals
p66602
g37367
sVDermatologicals
p66603
g17192
sVCytochrome P-450 Enzyme Inducers
p66604
g28122
sVCytochrome P-450 CYP3A Inducers
p66605
g66262
sVAnti-Asthmatic Agents
p66606
g36533
sVCytochrome P-450 CYP3A4 Substrates
p66607
g65292
sVAlimentary Tract and Metabolism
p66608
g23771
sVNasal Preparations
p66609
(dp66610
sVPregnanes
p66611
g63599
sVAgents to Treat Airway Disease
p66612
g32636
sVSteroids
p66613
g56414
sg6327
g56439
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p66614
g64604
sVAnti-Inflammatory Agents
p66615
(dp66616
sVCorticosteroid Hormone Receptor Agonists
p66617
g63664
sg1959
g28749
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p66618
(dp66619
sVCorticosteroids, Dermatological Preparations
p66620
g51333
sVHormones, Hormone Substitutes, and Hormone Antagonists
p66621
g53135
sVCorticosteroids
p66622
(dp66623
sg8349
g66242
ssg8433
(dp66624
g6354
g56700
sVBSEP/ABCB11 Substrates
p66625
(dp66626
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p66627
(dp66628
sVAdrenergic alpha-1 Receptor Antagonists
p66629
g14118
sVAnticholinergic Agents
p66630
g24480
sVCytochrome P-450 CYP2D6 Inhibitors
p66631
g62951
sVAntiarrhythmic agents
p66632
(dp66633
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p66634
g41068
sVCytochrome P-450 CYP3A Substrates
p66635
g45182
sVAgents causing hyperkalemia
p66636
g43576
sVHypotensive Agents
p66637
g34110
sVCytochrome P-450 CYP3A4 Inhibitors
p66638
g61675
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p66639
(dp66640
sVCalcium Channel Blockers
p66641
g41310
sVPotential QTc-Prolonging Agents
p66642
(dp66643
sVAdrenergic Antagonists
p66644
g52275
sVCytochrome P-450 CYP2C9 Inhibitors
p66645
g18184
sg1824
g27590
sVCytochrome P-450 Enzyme Inhibitors
p66646
g62058
sg852
g20122
sVMuscarinic Antagonists
p66647
g48866
sVCytochrome P-450 CYP2C8 Substrates
p66648
(dp66649
sg9639
(dp66650
sVCytochrome P-450 CYP2B6 Inducers
p66651
g39118
sVAntihypertensive Agents
p66652
g20251
sVMembrane Transport Modulators
p66653
g54122
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66654
g29478
sVAdrenergic alpha-Antagonists
p66655
g60868
sVQTc Prolonging Agents
p66656
g57788
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p66657
g28839
sVCardiovascular Agents
p66658
g26580
sg9237
(dp66659
sVCytochrome P-450 CYP2C8 Inhibitors
p66660
g55023
sVP-glycoprotein/ABCB1 Substrates
p66661
g34921
sVPyridines
p66662
g64221
sVVasodilating Agents
p66663
g23714
sVCytochrome P-450 Enzyme Inducers
p66664
g28124
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p66665
(dp66666
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p66667
g44543
sVCytochrome P-450 CYP2C19 Inhibitors
p66668
g61254
sVCytochrome P-450 CYP3A4 Substrates
p66669
g65294
sVCalcium-Regulating Hormones and Agents
p66670
(dp66671
sg105
g13031
sVCytochrome P-450 CYP3A Inhibitors
p66672
g60436
sVBradycardia-Causing Agents
p66673
g61445
sVOATP1B1/SLCO1B1 Inhibitors
p66674
(dp66675
sVP-glycoprotein/ABCB1 Inhibitors
p66676
(dp66677
sVAgents producing tachycardia
p66678
g50748
sg8361
g66256
sVCytochrome P-450 CYP3A5 Inhibitors
p66679
g55332
ssg8436
(dp66680
g8874
(dp66681
sg2787
g34399
sg6315
g56290
sg2112
g30179
sg8820
(dp66682
sg2910
g35531
ssg8439
(dp66683
VFolic Acid and Derivatives
p66684
g66353
sVVitamins
p66685
g12173
sVCoenzymes
p66686
g31645
sVBiological Factors
p66687
g38091
sVFood and Beverages
p66688
(dp66689
sVPhysiological Phenomena
p66690
g21717
sVPterins
p66691
(dp66692
sVFolate Analog
p66693
g42605
sVFood
p66694
g62211
sVPigments, Biological
p66695
g21849
sVPteridines
p66696
(dp66697
sVProtective Agents
p66698
(dp66699
sVFolic Acid
p66700
g42925
sVVitamin B Complex
p66701
g54911
sVTetrahydrofolates
p66702
g48367
sVOAT3/SLC22A8 Substrates
p66703
g13152
sVMicronutrients
p66704
(dp66705
sVEnzymes and Coenzymes
p66706
(dp66707
sVAntidotes
p66708
(dp66709
sVGrowth Substances
p66710
g46124
sVHeterocyclic Compounds, Fused-Ring
p66711
g56101
sVDetoxifying Agents for Antineoplastic Treatment
p66712
(dp66713
sVOAT3/SLC22A8 Inhibitors
p66714
g58997
sVDiet, Food, and Nutrition
p66715
g22901
sVFormyltetrahydrofolates
p66716
g25790
sVCompounds used in a research, industrial, or household setting
p66717
(dp66718
ssg8442
(dp66719
g10320
(dp66720
sg420
g16012
ssg8445
(dp66721
VHormone Antagonists
p66722
g24269
sVPregnanes
p66723
g63600
sVCytochrome P-450 CYP3A4 Inhibitors
p66724
g61631
sVCytochrome P-450 CYP3A Inhibitors
p66725
g60386
sVSex Hormones and Modulators of the Genital System
p66726
g19606
sVGenito Urinary System and Sex Hormones
p66727
g66154
sg5667
g52403
sg4215
g43654
sVPregnadienes
p66728
(dp66729
sVAndrogens
p66730
(dp66731
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p66732
(dp66733
sVHormones, Hormone Substitutes, and Hormone Antagonists
p66734
g53138
sVCytochrome P-450 Enzyme Inhibitors
p66735
g62060
sVSteroids
p66736
g56416
sVFused-Ring Compounds
p66737
g14816
sVHyperglycemia-Associated Agents
p66738
(dp66739
ssg8448
(dp66740
VBSEP/ABCB11 Substrates
p66741
(dp66742
sVCytochrome P-450 CYP3A4 Inhibitors
p66743
g61632
sVCytochrome P-450 CYP3A Substrates
p66744
g45148
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p66745
(dp66746
sVEnzyme Inhibitors
p66747
(dp66748
sVCytochrome P-450 Enzyme Inhibitors
p66749
g62061
sVAnti-Infective Agents
p66750
g54566
sg7260
g60742
sVAntiinfectives for Systemic Use
p66751
(dp66752
sVMacrolide Antimicrobial
p66753
g59237
sVLactones
p66754
(dp66755
sVP-glycoprotein/ABCB1 Inhibitors
p66756
(dp66757
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66758
g29429
sVMacrolides, Lincosamides and Streptogramins
p66759
g33217
sVAnti-Bacterial Agents
p66760
g38318
sVMacrolides
p66761
g16909
sVQTc Prolonging Agents
p66762
g57789
sVCytochrome P-450 CYP3A4 Inducers
p66763
g18887
sVProtein Synthesis Inhibitors
p66764
g45551
sVCytochrome P450 3A4 Inhibitors
p66765
g13040
sVP-glycoprotein/ABCB1 Substrates
p66766
g34924
sVErythromycin and similars
p66767
g49199
sVCytochrome P-450 Enzyme Inducers
p66768
g28127
sVCytochrome P-450 CYP3A Inducers
p66769
g66265
sVAntibacterials for Systemic Use
p66770
g32526
sVCytochrome P-450 CYP3A Inhibitors (strong)
p66771
g13393
sVCytochrome P-450 CYP3A4 Substrates
p66772
g65277
sVAlimentary Tract and Metabolism
p66773
g23775
sVModerate Risk QTc-Prolonging Agents
p66774
(dp66775
sVCytochrome P-450 CYP3A5 Substrates
p66776
(dp66777
sg8154
g65404
sVCytochrome P-450 CYP3A Inhibitors
p66778
g60387
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p66779
g64607
sVDrugs for Acid Related Disorders
p66780
g55168
sVCytochrome P450 3A Inhibitors
p66781
g54271
sVPolyketides
p66782
g48471
sVChemically-Induced Disorders
p66783
g21230
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p66784
(dp66785
sVCytochrome P-450 CYP3A7 Substrates
p66786
g60644
sVCytochrome P-450 CYP3A5 Inhibitors
p66787
g55339
ssg8451
(dp66788
g4197
g43512
sg2559
g32953
sg1326
g23599
sg9309
(dp66789
sg7629
g63001
sg8439
g66699
sg8595
(dp66790
sg255
g14384
sg1059
g21756
sg1947
g28681
sg10680
(dp66791
sg1263
g23197
sg11649
(dp66792
sg1746
g26952
sg3144
g37112
sg5085
g49042
sg6792
g58719
sg9006
(dp66793
sg8826
(dp66794
sg12108
(dp66795
sg1875
g27910
sg9696
(dp66796
sg1890
g28010
sg3393
g38558
sg9987
(dp66797
sg4725
g47146
sg6102
g55074
sg4398
g44841
sg5727
g52815
sg753
g19227
sg8484
(dp66798
sg11172
(dp66799
sg7359
g61362
sg1164
g22597
sg1938
g28548
sg14872
g15725
sg6381
g56784
sg1635
g26059
sg7014
g59559
sg9372
(dp66800
sg5598
g52021
sg213
g14063
ssg8454
(dp66801
VCytochrome P-450 CYP3A4 Inhibitors
p66802
g61633
sVAntivirals for Systemic Use
p66803
g59764
sg3309
g38129
sVAmino Acids, Cyclic
p66804
g27290
sVCytochrome P-450 CYP3A Substrates
p66805
g45186
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p66806
(dp66807
sVDirect Acting Antivirals
p66808
g38061
sVProtease Inhibitors
p66809
g51094
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p66810
(dp66811
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p66812
g43772
sVCytochrome P-450 Enzyme Inhibitors
p66813
g62062
sVAntiinfectives for Systemic Use
p66814
(dp66815
sVAmino Acids
p66816
g43106
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66817
g29484
sg4104
g42992
sg8676
(dp66818
sVAntivirals for treatment of HCV infections
p66819
g31042
sVCytochrome P-450 CYP3A5 Inhibitors
p66820
g55341
sVCytochrome P-450 CYP3A Inhibitors (strong)
p66821
g13395
sVCytochrome P-450 CYP3A4 Substrates
p66822
g65296
sVAmino Acids, Peptides, and Proteins
p66823
g47323
sVCytochrome P-450 CYP3A5 Substrates
p66824
(dp66825
sg6636
g57949
sVAcids, Acyclic
p66826
g25460
sVCytochrome P-450 CYP3A Inhibitors
p66827
g60388
sVImines
p66828
g63658
sVAntiviral Agents
p66829
g30449
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p66830
g65407
sVP-glycoprotein/ABCB1 Inhibitors
p66831
(dp66832
ssg8457
(dp66833
VCytochrome P-450 CYP3A Substrates
p66834
g45187
sg11802
(dp66835
sVAgents causing angioedema
p66836
g63903
sVCycloparaffins
p66837
g43665
sVProtease Inhibitors
p66838
g51084
sVHormones
p66839
g55660
sVEnzyme Inhibitors
p66840
(dp66841
sVBlood Glucose Lowering Agents
p66842
(dp66843
sVDrugs that are Mainly Renally Excreted
p66844
g44003
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66845
g29485
sVOral Hypoglycemics
p66846
g35998
sVDrugs Used in Diabetes
p66847
g60118
sVOligopeptides
p66848
(dp66849
sVOAT3/SLC22A8 Substrates
p66850
g13099
sVPeptides
p66851
g47166
sg855
g20133
sVCytochrome P-450 CYP3A4 Substrates
p66852
g65297
sVAlimentary Tract and Metabolism
p66853
g23778
sVAmino Acids, Peptides, and Proteins
p66854
g47324
sVCytochrome P-450 CYP3A5 Substrates
p66855
(dp66856
sVHypoglycemia-Associated Agents
p66857
g17695
sVHormones, Hormone Substitutes, and Hormone Antagonists
p66858
g53139
ssg8460
(dp66859
VCytochrome P-450 CYP2C19 Substrates
p66860
g53888
sVCentral Nervous System Depressants
p66861
(dp66862
sVCytochrome P-450 CYP3A4 Substrates
p66863
g65298
sVCytochrome P-450 CYP2C8 Substrates
p66864
(dp66865
sVAntiarrhythmic agents
p66866
(dp66867
sVAnti-epileptic Agent
p66868
(dp66869
sVCytochrome P-450 CYP3A Substrates
p66870
g45188
sVAgents causing hyperkalemia
p66871
g43579
sVBradycardia-Causing Agents
p66872
g61449
sVCentral Nervous System Agents
p66873
g58412
sVCalcium Channel Blockers
p66874
g41314
sVPotential QTc-Prolonging Agents
p66875
(dp66876
sg2628
g33224
sVNervous System
p66877
(dp66878
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66879
g29486
sVAnticonvulsants
p66880
g60149
sg10791
(dp66881
sVCytochrome P-450 CYP2C9 Substrates
p66882
g29721
sVQTc Prolonging Agents
p66883
g57791
sVCytochrome P-450 CYP2E1 Substrates
p66884
(dp66885
sVDecreased Central Nervous System Disorganized Electrical Activity
p66886
g23478
ssg8463
(dp66887
VNeurotransmitter Agents
p66888
(dp66889
sVHistamine Agents
p66890
(dp66891
sVCentral Nervous System Agents
p66892
g58451
sVPeripheral Nervous System Agents
p66893
g57609
sVAutonomic Agents
p66894
g66562
sVDiphenhydramine
p66895
g57744
sVAmines
p66896
g42704
sVEthylamines
p66897
g20601
sVQTc Prolonging Agents
p66898
g57829
sVPurines
p66899
(dp66900
sVPharmaceutical Preparations
p66901
g53867
sVCentral Nervous System Depressants
p66902
(dp66903
sVAntiemetics
p66904
(dp66905
sVGastrointestinal Agents
p66906
(dp66907
sVBenzene Derivatives
p66908
g61416
sVHistamine H1 Antagonists
p66909
g40786
sVBenzhydryl Compounds
p66910
(dp66911
sVPurinones
p66912
g48139
sVModerate Risk QTc-Prolonging Agents
p66913
(dp66914
sVHeterocyclic Compounds, Fused-Ring
p66915
g56103
sVHistamine Antagonists
p66916
g43447
sVAlkaloids
p66917
g19435
ssg8466
(dp66918
g9918
(dp66919
sg9924
(dp66920
sg5433
g51051
sg12274
g27540
sg7716
g63476
sg6408
g56861
sg5289
g50279
sg3885
g41449
sg8625
(dp66921
sg9192
(dp66922
sg6819
g58876
sg294
g14746
sg5271
g50165
sg13070
g21899
sg4680
g46884
sg7824
g63874
sg2427
g32027
sg9954
(dp66923
sg7305
g60972
sg339
g15171
sg8277
g65952
sg9432
(dp66924
sg2832
g34709
sg3399
g38637
sg10854
(dp66925
sg8298
g66035
sg10416
(dp66926
sg573
g17554
sg4263
g44166
sg10230
(dp66927
sg2688
g33648
sg14791
(dp66928
sg4164
g43317
sg7188
g60508
sg12126
(dp66929
sg6075
g54878
sg11241
(dp66930
sg7029
g59638
sg8922
(dp66931
ssg8469
(dp66932
g9492
(dp66933
ssg8472
(dp66934
g2352
g31420
sVAntiandrogens
p66935
(dp66936
sVBCRP/ABCG2 Inducers
p66937
g24518
sVCytochrome P-450 CYP3A Substrates
p66938
g45011
sVHormone Antagonists and Related Agents
p66939
(dp66940
sVOCT2 Inhibitors
p66941
g42490
sg7248
g60731
sVCytochrome P-450 CYP2C9 Inducers
p66942
g20053
sVDrugs that are Mainly Renally Excreted
p66943
g43849
sVCytochrome P-450 CYP2C8 Substrates
p66944
(dp66945
sVCytochrome P-450 CYP3A4 Inducers (strong)
p66946
g23079
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p66947
g29263
sVImidazoles
p66948
(dp66949
sVCytochrome P-450 CYP3A4 Inducers
p66950
g18956
sVAntineoplastic Agents
p66951
(dp66952
sVMATE 2 Inhibitors
p66953
g52715
sVP-glycoprotein/ABCB1 Inducers
p66954
(dp66955
sVHydantoins
p66956
(dp66957
sVCytochrome P-450 Enzyme Inducers
p66958
g28214
sVCytochrome P-450 CYP3A Inducers
p66959
g66285
sVCytochrome P-450 CYP3A Inducers (strong)
p66960
g22462
sVCytochrome P-450 CYP3A4 Substrates
p66961
g65211
sVMATE inhibitors
p66962
g58949
sVImidazolidines
p66963
g45998
sVCytochrome P-450 CYP2C9 Inducers (weak)
p66964
g13880
sVOAT3/SLC22A8 Inhibitors
p66965
g59017
sVCytochrome P-450 CYP2C19 Inducers
p66966
g25541
sg2709
g33777
sVAntineoplastic and Immunomodulating Agents
p66967
g39803
sVEndocrine Therapy
p66968
g19565
ssg8475
(dp66969
g4341
g44608
sg10290
(dp66970
sg1812
g27466
sg4650
g46622
sg11619
(dp66971
sg10797
(dp66972
sg1869
g27833
sg5256
g50076
sg8241
g65805
sg2058
g29181
sg891
g20538
sg2418
g31915
sg6939
g59332
sg9702
(dp66973
sg11820
(dp66974
sg10728
(dp66975
sg4467
g45540
sg7317
g61048
sg4926
g48398
sg10977
(dp66976
sg3408
g38686
sg8493
(dp66977
sg5025
g48755
sg14338
g13520
sg4959
g48521
sg9810
(dp66978
sg12111
(dp66979
sg10794
(dp66980
sg6048
g54750
sg9462
(dp66981
sg1401
g24302
sg11385
(dp66982
ssg8478
(dp66983
g5289
g50255
sg5619
g52210
sg12114
(dp66984
sg8226
g65725
sg3696
g40282
sg4452
g45430
sg5199
g49697
sg3426
g38757
sg213
g14034
ssg8481
(dp66985
g8598
(dp66986
sg8601
(dp66987
ssg8484
(dp66988
g8379
g66352
sg4059
g42604
sVPigments, Biological
p66989
g21845
sVHeterocyclic Compounds, Fused-Ring
p66990
g56058
sVVitamins
p66991
g12168
sVFolic Acid Analogues
p66992
(dp66993
sg4095
g42936
sVPterins
p66994
(dp66995
sg4923
g48366
sVDetoxifying Agents for Antineoplastic Treatment
p66996
(dp66997
sg11589
(dp66998
sVPteridines
p66999
(dp67000
sVProtective Agents
p67001
g66798
sVCoenzymes
p67002
g31642
sVBiological Factors
p67003
g38125
sVEnzymes and Coenzymes
p67004
(dp67005
sVAntidotes
p67006
(dp67007
sVVitamin B Complex
p67008
g54909
sg1608
g25789
sVCompounds used in a research, industrial, or household setting
p67009
(dp67010
ssg8487
(dp67011
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p67012
(dp67013
sVAnti-Parkinson Drugs
p67014
g16155
sVIsoquinolines
p67015
g44957
sVNeurotransmitter Agents
p67016
(dp67017
sVHypotensive Agents
p67018
g34119
sVOpiate Agonists
p67019
g46445
sVCentral Nervous System Agents
p67020
g58453
sVDopamine Agents
p67021
g14251
sVPotential QTc-Prolonging Agents
p67022
(dp67023
sVPeripheral Nervous System Agents
p67024
g57607
sVAutonomic Agents
p67025
g66550
sVNonergot-derivative Dopamine Receptor Agonists
p67026
g60817
sg3678
g40209
sVSerotonin Agents
p67027
(dp67028
sVQTc Prolonging Agents
p67029
g57797
sVCentral Nervous System Depressants
p67030
(dp67031
sVGastrointestinal Agents
p67032
(dp67033
sVGenito Urinary System and Sex Hormones
p67034
g66156
sVDrugs Used in Erectile Dysfunction
p67035
g20786
sVDopamine Agonists
p67036
g56748
sVSerotonin Receptor Antagonists
p67037
g35673
sVUrologicals
p67038
g58918
sg11169
(dp67039
sVHeterocyclic Compounds, Fused-Ring
p67040
g56086
sVAntidepressive Agents
p67041
g15506
sg9477
(dp67042
sVAnti-Parkinson Agents (Dopamine Agonist)
p67043
g25590
sVAlkaloids
p67044
g19428
sVNervous System
p67045
(dp67046
ssg8490
(dp67047
g282
g14552
sg1194
g22817
ssg8493
(dp67048
VAcetates
p67049
g64708
sVAntivirals for Systemic Use
p67050
g59772
sVNucleic Acid Synthesis Inhibitors
p67051
g48742
sVFatty Acids
p67052
g63149
sVOAT1/SLC22A6 inhibitors
p67053
(dp67054
sVDirect Acting Antivirals
p67055
g38074
sVPotential QTc-Prolonging Agents
p67056
(dp67057
sVLipids
p67058
g14335
sVEnzyme Inhibitors
p67059
(dp67060
sVReverse Transcriptase Inhibitors
p67061
g28966
sVAnti-Infective Agents
p67062
g54583
sVAntiinfectives for Systemic Use
p67063
(dp67064
sVNephrotoxic agents
p67065
g57740
sVOrganophosphonates
p67066
(dp67067
sVQTc Prolonging Agents
p67068
g57838
sVFatty Acids, Volatile
p67069
g66977
sg2982
g35909
sVAnti-Retroviral Agents
p67070
(dp67071
sg12039
(dp67072
sVAcids, Acyclic
p67073
g25479
sVAntiviral Agents
p67074
g30466
sg3714
g40468
sg9195
(dp67075
sVOrganophosphorus Compounds
p67076
(dp67077
ssg8496
(dp67078
g1140
g22408
ssg8499
(dp67079
g8421
g66524
sg7335
g61216
ssg8502
(dp67080
g8421
g66525
sg9822
(dp67081
sg8472
g66957
sg6333
g56482
sg4746
g47266
sg7335
g61218
ssg8505
(dp67082
g8421
g66526
sg3432
g38812
sg1098
g22017
sg4164
g43336
sg9198
(dp67083
sg6336
g56527
sg8298
g66050
sg7335
g61220
ssg8508
(dp67084
g9225
(dp67085
sg10209
(dp67086
ssg8511
(dp67087
g4155
g43196
sg7272
g60779
sg183
g13774
ssg8514
(dp67088
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p67089
(dp67090
sVCytochrome P-450 CYP3A4 Inhibitors
p67091
g61643
sVAdrenergic alpha-1 Receptor Antagonists
p67092
g14107
sVSerotonin Agents
p67093
(dp67094
sVAnalgesics
p67095
g26438
sVAntimigraine Preparations
p67096
g32377
sVDopamine Agonists
p67097
g56747
sVCentral Nervous System Agents
p67098
g58399
sVDopamine Agents
p67099
g14253
sVCYP3A Substrates (Sensitive)
p67100
g63926
sVAdrenergic Antagonists
p67101
g52293
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p67102
g43738
sg11613
(dp67103
sVCytochrome P-450 Enzyme Inhibitors
p67104
g62064
sVPeripheral Nervous System Agents
p67105
g57585
sVVasoconstrictor Agents
p67106
g35886
sVAnalgesics, Non-Narcotic
p67107
g56906
sg4269
g44228
sg5076
g49011
sg2994
g35986
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67108
g29489
sVAdrenergic alpha-Antagonists
p67109
g60879
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p67110
g60082
sVCytochrome P-450 CYP3A Substrates
p67111
g45190
sVCentral Nervous System Depressants
p67112
(dp67113
sVNeurotransmitter Agents
p67114
(dp67115
sVCardiovascular Agents
p67116
g26547
sVAgents that produce hypertension
p67117
(dp67118
sVCytochrome P-450 CYP3A4 Substrates
p67119
g65299
sVNarrow Therapeutic Index Drugs
p67120
g50547
sVSerotonin 5-HT1 Receptor Agonists
p67121
g34584
sVHeterocyclic Compounds, Fused-Ring
p67122
g56028
sVSerotonin Modulators
p67123
(dp67124
sVAntidepressive Agents
p67125
g15510
sVCytochrome P-450 CYP3A Inhibitors
p67126
g60399
sVSerotonin 5-HT2 Receptor Agonists
p67127
(dp67128
sVP-glycoprotein/ABCB1 Inhibitors
p67129
(dp67130
sg12135
(dp67131
sVAlkaloids
p67132
g19434
sVSensory System Agents
p67133
(dp67134
sVSerotonin Receptor Agonists
p67135
(dp67136
sVNervous System
p67137
(dp67138
ssg8517
(dp67139
g6645
g58016
ssg8520
(dp67140
g10833
(dp67141
sg10326
(dp67142
sg7884
g64117
sg11427
(dp67143
sg279
g14514
sg8049
g64912
sg5847
g53514
sg8622
(dp67144
sg7881
g64075
sg8985
(dp67145
sg9198
(dp67146
sg11052
(dp67147
sg3132
g37004
sg9954
(dp67148
sg7500
g62365
sg12051
(dp67149
sg5520
g51552
sg9432
(dp67150
sg6435
g56989
sg318
g14924
sg7524
g62433
sg1527
g25277
sg7947
g64369
sg6654
g58077
sg8298
g66025
sg8493
g67071
sg573
g17540
sg3576
g39584
sg4164
g43304
sg1101
g22077
sg6075
g54894
sg9663
(dp67151
sg11451
(dp67152
sg4953
g48503
sg819
g19745
ssg8523
(dp67153
g1980
g28809
sg7221
g60698
sg5235
g49858
sg4452
g45446
sg657
g18312
sg1059
g21775
sg684
g18515
sg7191
g60570
sg11619
(dp67154
sg8433
g66671
sg9561
(dp67155
sg3696
g40302
sg9987
(dp67156
sg10272
(dp67157
sg10350
(dp67158
sg3177
g37303
sg4935
g48454
sg5556
g51740
sg10557
(dp67159
sg7764
g63639
sg2703
g33742
sg5289
g50306
sg1857
g27718
sg2826
g34608
ssg8526
(dp67160
g8373
g66337
sg690
g18650
sg5805
g53295
sg1674
g26350
sg8580
(dp67161
sg8298
g66060
sg2481
g32430
sg2007
g28898
sg6318
g56384
sg7485
g62275
sg1434
g24677
sg8211
g65683
sg9375
(dp67162
sg12063
(dp67163
sg10674
(dp67164
sg4857
g47901
sg11721
(dp67165
sg4863
g47957
sg6639
g57987
sg10005
(dp67166
sg6156
g55239
sg4479
g45721
sg11655
(dp67167
sg9432
(dp67168
sg684
g18517
sg8448
g66775
sg10347
(dp67169
sg5694
g52562
sg9966
(dp67170
sg7707
g63407
sg6348
g56654
sg8097
g65103
sg9417
(dp67171
sg1707
g26792
sg7377
g61520
sg4920
g48358
sg9231
(dp67172
sg10959
(dp67173
sg8463
g66914
sg3021
g36223
sg696
g18766
sg945
g20908
sg4539
g46050
sg19588
g32504
sg1911
g28375
sg1539
g25324
sg10323
(dp67174
sg10557
(dp67175
sg3570
g39502
sg8862
(dp67176
sg5316
g50465
sg3222
g37617
sg4164
g43350
sg15016
g66116
sg5295
g50358
sg7416
g61748
sg3240
g37732
sg7191
g60572
sg1464
g24882
sg4773
g47494
sg1881
g27968
sg7029
g59649
sg9879
(dp67177
sg1092
g21993
sg5580
g51871
sg10056
(dp67178
sg10305
(dp67179
sg5127
g49246
ssg8529
(dp67180
VIron Bivalent, Oral Preparations
p67181
g56702
sVMicronutrients
p67182
(dp67183
sVBlood and Blood Forming Organs
p67184
g53915
sVPhysiological Phenomena
p67185
g21714
sVIron Preparations
p67186
(dp67187
sVFood
p67188
g62209
sVIron Compounds
p67189
g36402
sVTrace Elements
p67190
(dp67191
sVDiet, Food, and Nutrition
p67192
g22898
sVFood and Beverages
p67193
(dp67194
sVAntianemic Preparations
p67195
g63055
sVOrganometallic Compounds
p67196
(dp67197
sVMinerals
p67198
g52585
sVGrowth Substances
p67199
g46122
ssg8532
(dp67200
g6678
g58128
sg23
g12239
sg6507
g57294
sg7164
g60289
sg6639
g57989
sg375
g15471
sg11910
(dp67201
sg7320
g61094
sg11652
(dp67202
sg11145
(dp67203
sg3444
g38884
sg4488
g45772
sg9264
(dp67204
sg11097
(dp67205
sg2262
g30976
sg210
g13991
sg9093
(dp67206
ssg8535
(dp67207
g8772
(dp67208
sg8910
(dp67209
ssg8538
(dp67210
g1452
g24746
ssg8541
(dp67211
g11160
(dp67212
sg402
g15856
sg609
g17832
ssg8544
(dp67213
g9225
(dp67214
sg9357
(dp67215
sg4236
g43722
sg11316
(dp67216
sg1470
g24934
sg3861
g41296
sg5433
g51072
sg4680
g46902
sg10209
(dp67217
sg3543
g39358
sg2286
g31169
sg2832
g34671
sg8013
g64696
sg12274
g27569
sg543
g17120
ssg8547
(dp67218
g11475
(dp67219
ssg8550
(dp67220
g2763
g34252
sg6333
g56499
sg1650
g26128
ssg8553
(dp67221
g1767
g27014
sg6267
g55885
ssg8556
(dp67222
g9627
(dp67223
ssg8559
(dp67224
VAntiinfectives for Systemic Use
p67225
(dp67226
sg4965
g48575
sg10683
(dp67227
sVImmunoglobulins
p67228
g41538
sVSerum Globulins
p67229
g49667
sg5997
g54287
ssg8562
(dp67230
VAntiparasitic Agents
p67231
g40655
sVAntiparasitic Products, Insecticides and Repellents
p67232
g30582
sVAnti-Infective Agents
p67233
g54668
sVSulfur Compounds
p67234
(dp67235
sVAntiprotozoals
p67236
g59370
ssg8565
(dp67237
g23
g12251
sg6507
g57310
sg11910
(dp67238
sg210
g14021
sg11649
(dp67239
sg7320
g61102
sg11652
(dp67240
sg4488
g45784
sg4647
g46594
sg9264
(dp67241
sg11097
(dp67242
sg5598
g52053
sg9093
(dp67243
ssg8568
(dp67244
g5511
g51495
ssg8571
(dp67245
g891
g20528
sg7317
g61030
sg2418
g31892
sg9126
(dp67246
sg1869
g27802
ssg8574
(dp67247
g2553
g32871
sg4770
g47439
sg10767
(dp67248
sg5415
g50916
sg8241
g65812
sg7920
g64183
sg11241
(dp67249
sg10365
(dp67250
sg3846
g41093
sg2769
g34272
sg7548
g62600
sg4557
g46137
sg8649
(dp67251
sg8916
(dp67252
sg2946
g35810
sg5832
g53432
sg10764
(dp67253
sg9759
(dp67254
sg1842
g27647
sg6714
g58251
sg9579
(dp67255
ssg8577
(dp67256
VAgents Causing Muscle Toxicity
p67257
g55402
sVAmino Acids, Peptides, and Proteins
p67258
g47415
sVPeptides, Cyclic
p67259
(dp67260
sVLipopeptides
p67261
g33708
sVAntiinfectives for Systemic Use
p67262
(dp67263
sg4572
g46184
sVPeptides
p67264
g47212
sVLipids
p67265
g14343
sVAnti-Bacterial Agents
p67266
g38387
sVAntibacterials for Systemic Use
p67267
g32583
sVAnti-Infective Agents
p67268
g54672
sVDrugs that are Mainly Renally Excreted
p67269
g43856
sg153
g13547
ssg8580
(dp67270
g10446
(dp67271
sVAnticholinergic Agents
p67272
g24462
sVAntiarrhythmic agents
p67273
(dp67274
sVBronchodilator Agents
p67275
(dp67276
sVCentral Nervous System Agents
p67277
g58435
sg8409
g66420
sVMuscarinic Antagonists
p67278
g48855
sVAutonomic Agents
p67279
g66554
sg9189
(dp67280
sg2988
g35945
sVPeripheral Nervous System Agents
p67281
g57592
sg10905
(dp67282
sVRespiratory System Agents
p67283
(dp67284
sVAdjuvants, Anesthesia
p67285
g55870
sVQTc Prolonging Agents
p67286
g57850
sg4110
g43011
sVNeurotransmitter Agents
p67287
(dp67288
sVCardiovascular Agents
p67289
g26572
sg12069
(dp67290
sg7128
g60162
sg6987
g59471
sVMydriatics
p67291
g49201
sVSensory Organs
p67292
g40690
sVDrugs for Functional Gastrointestinal Disorders
p67293
(dp67294
sVAgents that produce hypertension
p67295
(dp67296
sVAnti-Asthmatic Agents
p67297
g36512
sVAlimentary Tract and Metabolism
p67298
g23809
sg8526
g67161
sVAntimuscarinics Antispasmodics
p67299
g31222
sg4767
g47432
sVOphthalmologicals
p67300
g35196
sVCholinergic Agents
p67301
g28712
sg5184
g49602
sVAgents producing tachycardia
p67302
g50756
sg783
g19395
ssg8583
(dp67303
VCompounds used in a research, industrial, or household setting
p67304
(dp67305
sVHematologic Agents
p67306
(dp67307
sg6969
g59439
sVAcids, Acyclic
p67308
g25475
sVDigestives, Incl. Enzymes
p67309
(dp67310
sg11406
(dp67311
sVUrinary Acidifying Agents
p67312
g56020
sg6483
g57202
sVCalculi Dissolution Agent
p67313
g12687
sg9399
(dp67314
sVTricarboxylic Acids
p67315
(dp67316
sg9306
(dp67317
sg201
g13937
sg5292
g50327
sg6396
g56837
sVAlimentary Tract and Metabolism
p67318
g23812
sVCitrates
p67319
g17794
ssg8586
(dp67320
g8019
g64750
sg4425
g44940
sg9519
(dp67321
sg4803
g47650
sg5250
g49950
sg7650
g63072
sg8418
g66433
sg3087
g36646
sg3279
g37920
sg1914
g28395
sg7671
g63248
sg10977
(dp67322
sg10494
(dp67323
sg10740
(dp67324
sg3711
g40417
sg9702
(dp67325
sg4716
g47053
sg2109
g30097
sg2391
g31702
sg6024
g54428
sg1578
g25616
sg3408
g38679
sg72
g12783
sg963
g21005
sg5394
g50818
sg171
g13692
sg5589
g51907
sg336
g15118
sg6162
g55271
ssg8589
(dp67326
g2418
g31932
ssg8592
(dp67327
g534
g16971
sg714
g18998
sg8703
(dp67328
ssg8595
(dp67329
VBSEP/ABCB11 Substrates
p67330
(dp67331
sVAntiarrhythmic agents
p67332
(dp67333
sg5088
g49061
sVCarbohydrates
p67334
g61760
sVAgents causing hyperkalemia
p67335
g43620
sg5628
g52257
sVPotential QTc-Prolonging Agents
p67336
(dp67337
sVOATP1B1/SLCO1B1 Inhibitors
p67338
(dp67339
sVCompounds used in a research, industrial, or household setting
p67340
(dp67341
sVDrugs that are Mainly Renally Excreted
p67342
g44008
sVP-glycoprotein/ABCB1 Inducers
p67343
(dp67344
sg9495
(dp67345
sVCardiac Therapy
p67346
(dp67347
sVProtective Agents
p67348
g66790
sVFused-Ring Compounds
p67349
g14831
sVGlycosides
p67350
(dp67351
sg6282
g55987
sVCardiovascular Agents
p67352
g26645
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p67353
g49151
sVQTc Prolonging Agents
p67354
g57816
sVP-glycoprotein/ABCB1 Substrates
p67355
g34951
sg1344
g23734
sVCardiotonic Agents
p67356
g66077
sVOATP1B1/SLCO1B1 Substrates
p67357
(dp67358
sVNarrow Therapeutic Index Drugs
p67359
g50549
sg8112
g65169
sVBSEP/ABCB11 Substrates with Narrow Therapeutic Index
p67360
g49474
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p67361
g61375
sVBradycardia-Causing Agents
p67362
g61466
sg3993
g42116
sVP-glycoprotein/ABCB1 Inhibitors
p67363
(dp67364
ssg8598
(dp67365
VAgents that produce neuromuscular block (indirect)
p67366
g37958
sVGanglion Blockers
p67367
g31417
sg2280
g31134
sVMusculo-Skeletal System
p67368
g31525
sVNeurotransmitter Agents
p67369
(dp67370
sVCentral Nervous System Agents
p67371
g58440
sVBotulinum Toxins
p67372
g26013
sVBiological Factors
p67373
g38093
sVEndopeptidases
p67374
(dp67375
sVBodily Secretions
p67376
g30841
sVToxins, Biological
p67377
g51387
sVEnzymes and Coenzymes
p67378
(dp67379
sVPeptide Hydrolases
p67380
g42950
sVFluids and Secretions
p67381
g40897
sVCentral Nervous System Depressants
p67382
(dp67383
sVNeurotoxins
p67384
g66986
sVEnzymes
p67385
(dp67386
sVAnti-Dyskinesia Agents
p67387
g50481
sVProteins
p67388
g52782
sVMuscle Relaxants, Peripherally Acting Agents
p67389
g46187
sVBacterial Toxins
p67390
(dp67391
sVMembrane Transport Modulators
p67392
g54138
sVAmino Acids, Peptides, and Proteins
p67393
g47399
sVAcetylcholine Release Inhibitors
p67394
g58139
sVMetalloendopeptidases
p67395
(dp67396
sVVenoms
p67397
g59027
sVCholinergic Agents
p67398
g28715
sVMetalloproteases
p67399
g63667
sVMuscle Relaxants
p67400
(dp67401
sVComplex Mixtures
p67402
g65518
sVHydrolases
p67403
(dp67404
sVOther Miscellaneous Therapeutic Agents
p67405
g28773
sVBacterial Proteins
p67406
g54323
ssg8601
(dp67407
VAgents that produce neuromuscular block (indirect)
p67408
g37959
sVGanglion Blockers
p67409
g31418
sVMusculo-Skeletal System
p67410
g31512
sVNeurotransmitter Agents
p67411
(dp67412
sg1632
g26014
sVBiological Factors
p67413
g38094
sg1437
g24701
sVPeripheral Nervous System Agents
p67414
g57597
sg11637
(dp67415
sg873
g20238
sg5493
g51386
sVEnzymes and Coenzymes
p67416
(dp67417
sg4098
g42949
sVCentral Nervous System Depressants
p67418
(dp67419
sg8481
g66987
sVEnzymes
p67420
(dp67421
sVProteins
p67422
g52750
sVMuscle Relaxants, Peripherally Acting Agents
p67423
g46188
sg9798
(dp67424
sVMembrane Transport Modulators
p67425
g54139
sVAmino Acids, Peptides, and Proteins
p67426
g47341
sVToxic Actions
p67427
g49382
sg6681
g58140
sVNoxae
p67428
g65418
sg11919
(dp67429
sVCholinergic Agents
p67430
g28716
sg7794
g63668
sg7194
g60583
sVMuscle Relaxants
p67431
(dp67432
sVHydrolases
p67433
(dp67434
sVOther Miscellaneous Therapeutic Agents
p67435
g28774
sg6003
g54324
ssg8604
(dp67436
g1782
g27130
sg13750
g24350
sg6552
g57494
sg11592
(dp67437
sg5448
g51118
sg1239
g22927
sg4653
g46654
sg8418
g66437
sg6045
g54693
sg11832
(dp67438
sg354
g15277
sg7545
g62534
sg2046
g29097
sg3141
g37048
sg1614
g25844
sg10494
(dp67439
sg4488
g45779
sg8826
(dp67440
sg5208
g49730
sg12534
g52603
sg6279
g55931
sg3657
g40157
sg3024
g36324
sg6024
g54433
sg1146
g22479
sg10878
(dp67441
sg5766
g52957
sg4113
g43018
sg4782
g47521
sg5589
g51913
sg6345
g56565
sg4398
g44839
sg6162
g55261
ssg8607
(dp67442
g2844
g34897
sg11874
(dp67443
sg7800
g63696
ssg8610
(dp67444
g2895
g35413
ssg8613
(dp67445
g7626
g62972
ssg8616
(dp67446
VAntiinfectives for Systemic Use
p67447
(dp67448
sVDrugs that are Mainly Renally Excreted
p67449
g44021
sVAminopenicillins
p67450
g35278
sVOphthalmologicals
p67451
g35199
sVbeta-Lactams
p67452
(dp67453
sVPenicillins With Extended Spectrum
p67454
g57008
sVLactams
p67455
g22295
sVSulfur Compounds
p67456
(dp67457
sVPenicillin G
p67458
g34322
sVAmides
p67459
g44307
sVSensory Organs
p67460
g40693
sVAnti-Bacterial Agents
p67461
g38336
sVAntibacterials for Systemic Use
p67462
g32542
sVHeterocyclic Compounds, Fused-Ring
p67463
g56091
sVAnti-Infective Agents
p67464
g54586
sVPenicillins
p67465
g52894
sVBeta-Lactam Antibacterials
p67466
g46291
ssg8619
(dp67467
g3105
g36772
sg8529
g67183
sg5556
g51717
sg8022
g64782
sg8439
g66705
sg7680
g63282
sg8340
g66220
sg11664
(dp67468
sg1581
g25686
sg2826
g34600
sg10272
(dp67469
sg12186
g42919
sg3699
g40316
ssg8622
(dp67470
VAgents Causing Muscle Toxicity
p67471
g55369
sVAntiinfectives for Systemic Use
p67472
(dp67473
sVAnti-Infective Agents
p67474
g54594
sVUGT1A1 Substrates
p67475
g12283
sVPyrrolidinones
p67476
g30229
sVAntiviral Agents
p67477
g30430
sVHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor
p67478
g14710
sVDirect Acting Antivirals
p67479
g38046
sVAnti-HIV Agents
p67480
g66394
sVAntivirals for Systemic Use
p67481
g59752
sVPyrrolidines
p67482
g59346
sVEnzyme Inhibitors
p67483
(dp67484
sVHIV Integrase Inhibitors
p67485
g56737
sVAnti-Retroviral Agents
p67486
g67144
sVIntegrase Inhibitors
p67487
g63294
ssg8625
(dp67488
g7212
g60680
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p67489
g52081
sVCytochrome P-450 CYP3A4 Inhibitors
p67490
g61657
sVCytochrome P-450 CYP3A Substrates
p67491
g45200
sVBCRP/ABCG2 Inhibitors
p67492
g12519
sVKinase Inhibitor
p67493
g24587
sVEnzyme Inhibitors
p67494
(dp67495
sVCytochrome P-450 Enzyme Inhibitors
p67496
g62070
sVKinase Inhibitors
p67497
g47872
sVMyelosuppressive Agents
p67498
(dp67499
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67500
g29504
sVCytochrome P450 3A Inhibitors
p67501
g54265
sVAntineoplastic Agents
p67502
(dp67503
sVOCT1 inhibitors
p67504
g66921
sVP-glycoprotein/ABCB1 Substrates
p67505
g34959
sVCytochrome P-450 CYP3A4 Substrates
p67506
g65308
sVProtein Kinase Inhibitors
p67507
(dp67508
sVCytochrome P-450 CYP3A Inhibitors
p67509
g60416
sVImmunosuppressive Agents
p67510
g64556
sVBCRP/ABCG2 Substrates
p67511
g42063
sVP-glycoprotein/ABCB1 Inhibitors
p67512
(dp67513
sVAntineoplastic and Immunomodulating Agents
p67514
g39761
ssg8628
(dp67515
g4440
g45316
sg5928
g54051
sg7275
g60790
sg1452
g24725
ssg8631
(dp67516
g6180
g55420
sg10323
(dp67517
sg4515
g45891
sg11274
(dp67518
sg2007
g28871
sg8106
g65143
ssg8634
(dp67519
g11952
(dp67520
sg5409
g50889
sg6360
g56706
sg7689
g63302
sg10002
(dp67521
sg4143
g43146
ssg8637
(dp67522
g8484
g67000
sg8439
g66697
sg8340
g66224
sg6267
g55884
sg11775
(dp67523
sg12186
g42907
ssg8640
(dp67524
g87
g12918
sg10833
(dp67525
sg4521
g45962
sg3015
g36089
sg12090
(dp67526
sg7881
g64066
sg10326
(dp67527
sg1101
g22064
sg11427
(dp67528
sg474
g16560
sg7500
g62350
ssg8643
(dp67529
g8217
g65708
sg501
g16742
sg4491
g45795
sg8928
(dp67530
ssg8646
(dp67531
g10350
(dp67532
sg4917
g48312
ssg8649
(dp67533
VPolyvalent cation containing laxatives, antacids, oral supplements
p67534
g63776
sVGastric Acid Lowering Agents
p67535
g67251
sVAlkalies
p67536
g58397
sVAntacids
p67537
g42403
sVCarbonic Acid
p67538
g48832
sVCalcium Compounds
p67539
g51127
sVCalcium Salts
p67540
g54686
sVReplacement Preparations
p67541
g27639
sVElectrolytes
p67542
g52422
sVMineral Supplements
p67543
g38302
sVPhosphate Binder
p67544
g21949
sVMinerals
p67545
g52587
sVGastrointestinal Agents
p67546
(dp67547
sVCarbonates
p67548
(dp67549
sVIons
p67550
g49117
sVAntacids and Adsorbents
p67551
g60139
sVAcids
p67552
g40573
sVAlimentary Tract and Metabolism
p67553
g23832
sVCarbon Compounds, Inorganic
p67554
g39300
sVBlood Coagulation Factors
p67555
(dp67556
sVAcids, Noncarboxylic
p67557
g54198
sVDrugs for Acid Related Disorders
p67558
g55165
sVAnions
p67559
(dp67560
ssg8652
(dp67561
g4017
g42279
sg12078
(dp67562
ssg8655
(dp67563
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p67564
(dp67565
sVAntidepressive Agents, Second-Generation
p67566
g49759
sVCytochrome P-450 CYP2D6 Inhibitors
p67567
g62924
sVCytochrome P-450 CYP2D6 Substrates
p67568
g52145
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p67569
(dp67570
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p67571
g41073
sVCytochrome P-450 CYP3A Substrates
p67572
g45206
sVNeurotransmitter Agents
p67573
(dp67574
sVCentral Nervous System Agents
p67575
g58447
sVCycloparaffins
p67576
g43664
sVPotential QTc-Prolonging Agents
p67577
(dp67578
sVPsychotropic Drugs
p67579
(dp67580
sVLipids
p67581
g14316
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p67582
g12670
sVCytochrome P-450 Enzyme Inhibitors
p67583
g62075
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p67584
g18405
sVDrugs that are Mainly Renally Excreted
p67585
g44013
sVNeurotransmitter Uptake Inhibitors
p67586
g52388
sVAmines
p67587
g42702
sg5421
g50962
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67588
g29511
sVEthylamines
p67589
g20593
sg1422
g24517
sVCytochrome P-450 CYP2C9 Substrates
p67590
g29746
sVQTc Prolonging Agents
p67591
g57825
sg6084
g54906
sVCyclohexanes
p67592
g33287
sVCentral Nervous System Depressants
p67593
(dp67594
sVAgents that reduce seizure threshold
p67595
g45849
sg4665
g46814
sVCytochrome P-450 CYP2B6 Inhibitors
p67596
g45930
sVP-glycoprotein/ABCB1 Substrates
p67597
g34967
sg1137
g22348
sVMembrane Transport Modulators
p67598
g54142
sVCytochrome P-450 CYP3A4 Substrates
p67599
g65314
sVSerotonin Modulators
p67600
(dp67601
sVAntidepressive Agents
p67602
g15526
sVPsychoanaleptics
p67603
g59071
sVHypoglycemia-Associated Agents
p67604
g17693
sg2637
g33272
sVP-glycoprotein/ABCB1 Inhibitors
p67605
(dp67606
sVAgents producing tachycardia
p67607
g50763
sVSerotonin Agents
p67608
(dp67609
sVPhenethylamines
p67610
(dp67611
sVNervous System
p67612
(dp67613
sVAlcohols
p67614
(dp67615
ssg8658
(dp67616
VLipids
p67617
g14307
sVCholestenes
p67618
g57947
sVUGT1A4 substrates
p67619
g41052
sVSecosteroids
p67620
g44477
sVSteroids
p67621
g56430
sVMembrane Lipids
p67622
g47729
sVCytochrome P-450 CYP3A Substrates
p67623
g45208
sVSterols
p67624
(dp67625
sVVitamin D and Analogues
p67626
g40204
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p67627
(dp67628
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67629
g29513
sVBone Density Conservation Agents
p67630
g40358
sVCholestanes
p67631
g19152
sVVitamins (Fat Soluble)
p67632
g61293
sVFused-Ring Compounds
p67633
g14841
sVCytochrome P-450 CYP3A4 Substrates
p67634
g65315
sVCalcium Homeostasis
p67635
g22845
sVVitamins
p67636
g12185
sVAnti-Parathyroid Agents
p67637
(dp67638
ssg8661
(dp67639
g3495
g39072
ssg8664
(dp67640
g6216
g55629
ssg8667
(dp67641
g10854
(dp67642
ssg8670
(dp67643
VAmino Acids, Peptides, and Proteins
p67644
g47410
sVHematologic Agents
p67645
(dp67646
sVBlood and Blood Forming Organs
p67647
g53923
sVPeptides
p67648
g47208
sVErythropoietin
p67649
g51830
sVColony-Stimulating Factors
p67650
g47971
sVHematopoietic Cell Growth Factors
p67651
g65130
sVHematinics
p67652
g59088
sVCarbohydrates
p67653
g61792
sVProteins
p67654
g52789
sVIntercellular Signaling Peptides and Proteins
p67655
g25411
sVIncreased Erythroid Cell Production
p67656
(dp67657
sVErythropoiesis-Stimulating Agents
p67658
g13883
sVBiological Factors
p67659
g38105
sVGlycoconjugates
p67660
(dp67661
sVAntianemic Preparations
p67662
g63054
sVGlycoproteins
p67663
(dp67664
sVCytokines
p67665
g62890
sVErythropoietin, genetics
p67666
(dp67667
ssg8673
(dp67668
VCytochrome P-450 CYP3A4 Inhibitors
p67669
g61664
sVParasympathomimetics
p67670
g59098
sVNeurotransmitter Agents
p67671
(dp67672
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p67673
g43750
sVMuscarinic Agonists
p67674
g66409
sVCytochrome P-450 Enzyme Inhibitors
p67675
g62076
sVParasympathomemetic (Cholinergic) Agents
p67676
g64018
sVPeripheral Nervous System Agents
p67677
g57605
sVPilocarpine
p67678
(dp67679
sVAutonomic Agents
p67680
g66560
sVMiotics
p67681
(dp67682
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p67683
g45821
sVCholinergic Receptor Agonist
p67684
g65905
sVSensory Organs
p67685
g40701
sVAntiglaucoma Preparations and Miotics
p67686
g36556
sVCytochrome P-450 CYP2A6 Inhibitors
p67687
g48586
sVOphthalmologicals
p67688
g35207
sVCytochrome P-450 CYP3A Inhibitors
p67689
g60424
sVCholinergic Agents
p67690
g28724
sVCholinergic Agonists
p67691
g40986
sVAlkaloids
p67692
g19425
sVNervous System
p67693
(dp67694
ssg8676
(dp67695
g2274
g31077
sg8454
g66818
sg2652
g33315
sg11166
(dp67696
ssg8679
(dp67697
g396
g15788
ssg8682
(dp67698
g10794
(dp67699
ssg8685
(dp67700
g2199
g30698
sg294
g14754
sg1434
g24666
sg10635
(dp67701
ssg8688
(dp67702
g2058
g29177
ssg8691
(dp67703
g1059
g21767
ssg8694
(dp67704
VHydroxycorticosteroids
p67705
g55780
sVCytochrome P-450 CYP3A Substrates
p67706
g45215
sVHormones
p67707
g55672
sVOtologicals
p67708
(dp67709
sVCorticosteroids for Systemic Use
p67710
g48842
sVHyperglycemia-Associated Agents
p67711
(dp67712
sVCorticosteroids for Systemic Use, Plain
p67713
g31763
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p67714
(dp67715
sVOphthalmological and Otological Preparations
p67716
(dp67717
sV17-Hydroxycorticosteroids
p67718
(dp67719
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67720
g29521
sVPregnenes
p67721
g28753
sVFused-Ring Compounds
p67722
g14846
sVCytochrome P-450 CYP3A4 Inducers
p67723
g18921
sVPregnenediones
p67724
g29967
sVAdrenal Cortex Hormones
p67725
g30044
sVAdrenals
p67726
g37375
sVCytochrome P-450 Enzyme Inducers
p67727
g28164
sVCytochrome P-450 CYP3A Inducers
p67728
g66274
sVCytochrome P-450 CYP3A4 Substrates
p67729
g65319
sVPregnanes
p67730
g63605
sVOphthalmologicals
p67731
g35210
sV11-Hydroxycorticosteroids
p67732
g52906
sVSteroids
p67733
g56425
sVImmunosuppressive Agents
p67734
g64561
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p67735
g64613
sVAnti-Inflammatory Agents
p67736
(dp67737
sg8172
g65504
sVHormones, Hormone Substitutes, and Hormone Antagonists
p67738
g53157
sVCorticosteroids
p67739
(dp67740
sVSensory Organs
p67741
g40704
ssg8697
(dp67742
g8796
(dp67743
sg8808
(dp67744
sg4821
g47745
sg6015
g54394
sg4053
g42551
sg4365
g44755
sg10338
(dp67745
sg4338
g44571
sg2253
g30897
ssg8700
(dp67746
g8670
g67657
sg5577
g51838
sg7977
g64482
sg8274
g65920
sg5382
g50726
sg3183
g37344
sg372
g15405
ssg8703
(dp67747
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p67748
g52091
sVCytochrome P-450 CYP3A4 Inhibitors
p67749
g61669
sVCytochrome P-450 CYP3A Substrates
p67750
g45217
sVNeurotransmitter Agents
p67751
(dp67752
sVCentral Nervous System Agents
p67753
g58454
sVMiscellaneous Antiemetics
p67754
g67328
sVOxazines
p67755
(dp67756
sVCytochrome P-450 Enzyme Inhibitors
p67757
g62078
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p67758
g16529
sVCytochrome P-450 CYP2C9 Inducers
p67759
g20048
sVAutonomic Agents
p67760
g66561
sVMorpholines
p67761
g35903
sVAprepitant and Prodrugs
p67762
g34429
sVPeripheral Nervous System Agents
p67763
g57608
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67764
g29523
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p67765
g60083
sVSubstance P/Neurokinin-1 Receptor Antagonist
p67766
g27487
sVCytochrome P-450 CYP3A4 Inducers
p67767
g18922
sVAntiemetics
p67768
(dp67769
sVGastrointestinal Agents
p67770
(dp67771
sVNeurokinin-1 Receptor Antagonists
p67772
g64211
sVCytochrome P-450 Enzyme Inducers
p67773
g28165
sVCytochrome P-450 CYP3A Inducers
p67774
g66275
sVNeurokinin 1 Antagonists
p67775
g50533
sVCytochrome P-450 CYP3A4 Substrates
p67776
g65321
sVCytochrome P-450 CYP3A Inhibitors
p67777
g60429
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p67778
g64614
ssg8706
(dp67779
g528
g16941
sg5028
g48798
sg147
g13425
sg834
g19941
sg9366
(dp67780
ssg8709
(dp67781
g9225
(dp67782
sg10209
(dp67783
sg12274
g27525
sg816
g19689
sg1470
g24903
sg849
g20076
sg507
g16765
sg5433
g51041
sg4680
g46898
sg11940
(dp67784
sg2127
g30266
sg3117
g36929
sg3543
g39328
sg14822
g41831
sg2133
g30284
sg3783
g40868
sg2901
g35484
ssg8712
(dp67785
g5832
g53426
sg8241
g65831
sg2769
g34320
sg3141
g37094
sg3846
g41159
sg11241
(dp67786
sg2481
g32447
sg10365
(dp67787
sg7395
g61587
sg6474
g57182
sg2046
g29150
sg8916
(dp67788
sg2946
g35845
sg8448
g66785
sg10275
(dp67789
sg1239
g22985
sg9759
(dp67790
sg4872
g48006
sg1872
g27877
sg9579
(dp67791
ssg8715
(dp67792
g4806
g47672
ssg8718
(dp67793
g690
g18644
sg7464
g62190
sg2358
g31489
sg12421
g12485
sg4635
g46511
sg5433
g51068
sg828
g19879
sg831
g19909
sg10149
(dp67794
sg11016
(dp67795
sg888
g20501
sg10701
(dp67796
sg4680
g46896
sg6939
g59337
sg8448
g66777
sg10818
(dp67797
sg8454
g66825
sg8457
g66856
sg10347
(dp67798
sg6807
g58833
sg915
g20729
sg918
g20757
sg10728
(dp67799
sg7377
g61515
sg9234
(dp67800
sg10752
(dp67801
sg2460
g32295
sg10758
(dp67802
sg3858
g41246
sg3867
g41331
sg3861
g41292
sg816
g19687
sg147
g13489
sg9273
(dp67803
sg966
g21060
sg3978
g42010
sg42
g12600
sg13091
g21420
sg3240
g37736
sg11112
(dp67804
sg6333
g56493
sg9081
(dp67805
sg5112
g49182
sg7029
g59651
sg7170
g60319
sg8724
(dp67806
sg1791
g27258
sg11595
(dp67807
sg7707
g63409
sg1809
g27450
sg11601
(dp67808
sg12274
g27564
sg282
g14574
sg285
g14610
sg9099
(dp67809
sg11655
(dp67810
sg4077
g42847
sg1857
g27721
sg5694
g52566
sg1785
g27181
sg4920
g48360
sg2652
g33324
sg9414
(dp67811
sg6471
g57141
sg10179
(dp67812
sg2667
g33524
sg6504
g57276
sg10209
(dp67813
sg387
g15679
sg5766
g53000
sg2715
g33818
sg7197
g60628
sg3447
g38960
sg6537
g57420
sg780
g19375
sg4539
g46044
sg426
g16111
sg9198
(dp67814
sg3912
g41618
sg2763
g34249
sg10041
(dp67815
sg1239
g22973
sg10308
(dp67816
sg1947
g28694
sg2034
g29037
sg4263
g44189
sg11079
(dp67817
sg507
g16795
sg9564
(dp67818
sg5877
g53701
sg11940
(dp67819
sg2814
g34530
sg7299
g60937
sg9588
(dp67820
sg9432
(dp67821
sg8097
g65105
sg9609
(dp67822
sg543
g17116
sg3546
g39410
sg9954
(dp67823
sg2688
g33683
sg2850
g35109
sg7569
g62748
sg11439
(dp67824
sg7065
g59956
sg9960
(dp67825
sg3570
g39507
sg6687
g58196
sg11910
(dp67826
sg2172
g30528
sg621
g17980
sg438
g16169
sg3633
g40042
sg9693
(dp67827
sg11955
(dp67828
sg2199
g30710
sg8205
g65637
sg516
g16894
sg16906
g61926
sg2943
g35783
sg5235
g49860
sg4449
g45379
sg4452
g45449
sg1434
g24681
sg6033
g54541
sg684
g18519
sg7191
g60564
sg4479
g45715
sg1473
g24981
sg6783
g58679
sg849
g20108
sg3696
g40307
sg2664
g33471
sg1491
g25111
sg5289
g50308
sg3009
g36043
sg5256
g50103
sg3021
g36217
sg6765
g58623
sg5316
g50467
sg3027
g36382
sg11316
(dp67829
sg2832
g34737
sg10539
(dp67830
sg11790
(dp67831
sg3963
g41893
sg10557
(dp67832
sg9084
(dp67833
sg12126
(dp67834
sg6075
g54896
sg10602
(dp67835
sg9105
(dp67836
ssg8721
(dp67837
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p67838
(dp67839
sVCytochrome P-450 CYP3A4 Inhibitors
p67840
g61683
sVCytochrome P-450 CYP2D6 Inhibitors
p67841
g62937
sVSerotonin Agents
p67842
(dp67843
sVHypotensive Agents
p67844
g34151
sVCentral Nervous System Agents
p67845
g58458
sVHydrazines
p67846
(dp67847
sVPsychotropic Drugs
p67848
(dp67849
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p67850
(dp67851
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p67852
g43761
sVEnzyme Inhibitors
p67853
(dp67854
sVCytochrome P-450 Enzyme Inhibitors
p67855
g61965
sVMonoamine Oxidase Inhibitors, Non-Selective
p67856
g58533
sVCytochrome P-450 CYP2E1 Inducers
p67857
g27609
sVDrugs that are Mainly Renally Excreted
p67858
g43842
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p67859
g23109
sVPsychoanaleptics
p67860
g59069
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p67861
g14788
sVMonoamine Oxidase A Substrates
p67862
g60104
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p67863
g24776
sVCentral Nervous System Depressants
p67864
(dp67865
sVAgents that reduce seizure threshold
p67866
g45867
sVCytochrome P-450 CYP2C8 Inhibitors
p67867
g55028
sVMonoamine Oxidase Inhibitors
p67868
g63509
sVCytochrome P-450 Enzyme Inducers
p67869
g28194
sVCytochrome P-450 CYP3A5 Inhibitors
p67870
g55336
sVAgents that produce hypertension
p67871
(dp67872
sVCytochrome P-450 CYP2C19 Inhibitors
p67873
g61272
sVCytochrome P-450 CYP3A7 Inhibitors
p67874
(dp67875
sVSerotonin Modulators
p67876
(dp67877
sVAntidepressive Agents
p67878
g15533
sVCytochrome P-450 CYP3A Inhibitors
p67879
g60444
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p67880
(dp67881
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p67882
g53068
sVNervous System
p67883
(dp67884
ssg8724
(dp67885
VCytochrome P-450 CYP3A4 Inhibitors
p67886
g61651
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p67887
g49911
sVCytochrome P-450 CYP3A Substrates
p67888
g45194
sVNeurotransmitter Agents
p67889
(dp67890
sVCytochrome P-450 CYP3A7 Inhibitors
p67891
(dp67892
sVCYP3A Substrates (Sensitive)
p67893
g63929
sVCytochrome P450 3A4 Inhibitors
p67894
g13053
sVOxazines
p67895
(dp67896
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p67897
(dp67898
sVCytochrome P-450 CYP2C9 Inducers
p67899
g20060
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p67900
g16537
sVCytochrome P-450 Enzyme Inhibitors
p67901
g62066
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p67902
g24786
sVAutonomic Agents
p67903
g66553
sVMorpholines
p67904
g35907
sg2793
g34428
sVPeripheral Nervous System Agents
p67905
g57613
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67906
g29496
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p67907
g60094
sg1815
g27486
sVAntiemetics and Antinauseants
p67908
g41645
sVAntiemetics
p67909
(dp67910
sVGastrointestinal Agents
p67911
(dp67912
sg7923
g64210
sVCytochrome P450 2C9 Inducers
p67913
g61113
sVCentral Nervous System Agents
p67914
g58460
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p67915
(dp67916
sg5337
g50532
sVCytochrome P450 3A4 Inducers
p67917
g53781
sVCytochrome P-450 CYP2C19 Inhibitors
p67918
g61267
sVCytochrome P-450 CYP3A4 Substrates
p67919
g65302
sVAlimentary Tract and Metabolism
p67920
g23804
sVCytochrome P-450 CYP3A5 Substrates
p67921
g67806
sVCytochrome P-450 CYP3A Inhibitors
p67922
g60409
sVCytochrome P-450 Enzyme Inducers
p67923
g28172
sVCytochrome P-450 CYP3A7 Substrates
p67924
g60649
sVCytochrome P-450 CYP3A5 Inhibitors
p67925
g55352
ssg8727
(dp67926
g9444
(dp67927
sg3399
g38617
sg5271
g50158
sg5646
g52330
ssg8730
(dp67928
g11745
(dp67929
ssg8733
(dp67930
g5457
g51198
ssg8736
(dp67931
g11760
(dp67932
sg3777
g40831
ssg8739
(dp67933
g1371
g24133
ssg8742
(dp67934
VCarbamates
p67935
g45517
sg1479
g24994
sVAcids, Acyclic
p67936
g25494
sVAntifungals for Dermatological Use
p67937
g30072
sVAntifungal Agents
p67938
(dp67939
sVDermatologicals
p67940
g17256
sVAntifungals for Topical Use
p67941
g39227
sVSulfur Compounds
p67942
(dp67943
sVAnti-Infective Agents
p67944
g54620
sVNaphthalenes
p67945
g66085
ssg8745
(dp67946
g11733
(dp67947
ssg8748
(dp67948
g5457
g51202
sg12421
g12472
sg8583
g67316
sg11196
(dp67949
sg9660
(dp67950
sg7197
g60618
sg3825
g41035
sg7065
g59946
sg5511
g51494
ssg8751
(dp67951
VCytochrome P-450 CYP3A Substrates
p67952
g45224
sg11031
(dp67953
sg3855
g41182
sVDrugs that are Mainly Renally Excreted
p67954
g44025
sg864
g20183
sVCytochrome P-450 CYP1A2 Substrates
p67955
g45640
sg9381
(dp67956
sVMyelosuppressive Agents
p67957
(dp67958
sVAcids, Carbocyclic
p67959
g41584
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p67960
g29535
sVImmunologic Factors
p67961
g42394
sVCentral Nervous System Depressants
p67962
(dp67963
sVP-glycoprotein/ABCB1 Substrates
p67964
g34992
sg9246
(dp67965
sVPiperidines
p67966
(dp67967
sVCytochrome P-450 CYP3A4 Substrates
p67968
g65325
sVGrowth Substances
p67969
g46132
sg579
g17597
sVHeterocyclic Compounds, Fused-Ring
p67970
g56050
sg9648
(dp67971
sg7365
g61389
sg180
g13758
sVImmunosuppressive Agents
p67972
g64567
sVAntineoplastic Agents
p67973
(dp67974
sVAntineoplastic and Immunomodulating Agents
p67975
g39738
ssg8754
(dp67976
g2256
g30932
sg1356
g23974
sg11874
(dp67977
ssg8757
(dp67978
g2553
g32909
ssg8760
(dp67979
VNitrogen Compounds
p67980
g39004
sVOCT2 Inhibitors
p67981
g42488
sVCompounds used in a research, industrial, or household setting
p67982
(dp67983
sVCross-Linking Reagents
p67984
(dp67985
sVCytochrome P-450 CYP2C9 Inhibitors
p67986
g18208
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p67987
g12679
sVCytochrome P-450 Enzyme Inhibitors
p67988
g61994
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p67989
(dp67990
sVDrugs that are Mainly Renally Excreted
p67991
g43884
sVPlatinum Compounds
p67992
(dp67993
sVMyelosuppressive Agents
p67994
(dp67995
sVNephrotoxic agents
p67996
g57716
sVRadiation-Sensitizing Agents
p67997
(dp67998
sVOCT2 substrates with narrow therapeutic index
p67999
g29695
sVChlorine Compounds
p68000
g33269
sVAntineoplastic Agents
p68001
(dp68002
sVOCT2 Substrates
p68003
g14952
sVCytochrome P-450 CYP2B6 Inhibitors
p68004
g45937
sVP-glycoprotein/ABCB1 Substrates
p68005
g35032
sVLaboratory Chemicals
p68006
(dp68007
sVIndicators and Reagents
p68008
g58935
sVCardiotoxic antineoplastic agents
p68009
(dp68010
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p68011
g61383
sVImmunosuppressive Agents
p68012
g64565
sVBCRP/ABCG2 Substrates
p68013
g42093
sVCholinesterase Inhibitors
p68014
(dp68015
sVAntineoplastic and Immunomodulating Agents
p68016
g39772
ssg8763
(dp68017
VDrugs that are Mainly Renally Excreted
p68018
g44026
sVP-glycoprotein/ABCB1 Inducers
p68019
(dp68020
sVOATP1B3 substrates
p68021
g28510
sg5061
g48898
sVUGT1A1 Substrates
p68022
g12267
sg7782
g63654
sVOAT3/SLC22A8 Inhibitors
p68023
g58995
sVThyroxine-binding globulin substrates
p68024
g60171
sVAgents used to treat hypothyroidism
p68025
g23677
sg9942
(dp68026
sVHormones
p68027
g55675
sVHormones, Hormone Substitutes, and Hormone Antagonists
p68028
g53160
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p68029
(dp68030
sVOATP1B1/SLCO1B1 Substrates
p68031
(dp68032
sVThyroid Products
p68033
g28974
ssg8766
(dp68034
g5085
g49031
ssg8769
(dp68035
VAmino Acids, Peptides, and Proteins
p68036
g47412
sg3567
g39439
sVHematologic Agents
p68037
(dp68038
sVAntineoplastic and Immunomodulating Agents
p68039
g39819
sVColony-Stimulating Factors
p68040
g47977
sVHematopoietic Cell Growth Factors
p68041
g65133
sg1269
g23259
sVProteins
p68042
g52790
sg1368
g24065
sVPeptides
p68043
g47210
sVBiological Factors
p68044
g38088
sVGlycoconjugates
p68045
(dp68046
sVGlycoproteins
p68047
(dp68048
ssg8772
(dp68049
VAmino Acids, Peptides, and Proteins
p68050
g47367
sVGlobulins
p68051
g19165
sVAntibodies
p68052
g60977
sVProgrammed Death Receptor-1-directed Antibody Interactions
p68053
g67208
sVAntibodies, Monoclonal
p68054
(dp68055
sVAntineoplastic Agents, Immunological
p68056
g62962
sVImmunoglobulins
p68057
g41513
sVProteins
p68058
g52763
sVProgrammed Death Receptor-1 Blocking Antibody
p68059
g21208
sVAntineoplastic and Immunomodulating Agents
p68060
g39782
sVSerum Globulins
p68061
g49646
sVBlood Proteins
p68062
g39843
sg2220
g30770
sVAntineoplastic Agents
p68063
(dp68064
sVImmunoproteins
p68065
g57441
ssg8775
(dp68066
g7593
g62787
sg7389
g61545
sg12123
(dp68067
ssg8778
(dp68068
VAnticholinergic Agents
p68069
g24502
sVAgents producing tachycardia
p68070
g50798
sVHydroxy Acids
p68071
g18161
sVAcids, Carbocyclic
p68072
g41549
sVMuscarinic Antagonists
p68073
g48880
sVSynthetic Anticholinergics, Quaternary Ammonium Compounds
p68074
(dp68075
sVDrugs for Functional Gastrointestinal Disorders
p68076
(dp68077
sVPhenylacetates
p68078
g34425
sVAlimentary Tract and Metabolism
p68079
g23859
sVDiphenylacetic Acids
p68080
g52592
ssg8781
(dp68081
VAmino Acids, Peptides, and Proteins
p68082
g47368
sVAntiinfectives for Systemic Use
p68083
(dp68084
sVCytochrome P-450 CYP3A4 Substrates
p68085
g65330
sVLipopeptides
p68086
g33714
sVOATP1B3 substrates
p68087
g28515
sVAntimycotics for Systemic Use
p68088
(dp68089
sVOAT1/SLC22A6 inhibitors
p68090
(dp68091
sVCytochrome P-450 CYP3A Substrates
p68092
g45233
sVAntifungal Agents
p68093
(dp68094
sVOATP1B1/SLCO1B1 Inhibitors
p68095
(dp68096
sVPeptides
p68097
g47186
sg3762
g40664
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68098
g29546
sVLipids
p68099
g14298
sVPeptides, Cyclic
p68100
(dp68101
sVEnzyme Inhibitors
p68102
(dp68103
sVP-glycoprotein/ABCB1 Inhibitors
p68104
(dp68105
sVOATP1B1/SLCO1B1 Substrates
p68106
(dp68107
sVAnti-Infective Agents
p68108
g54592
sg6723
g58282
ssg8784
(dp68109
g10236
(dp68110
ssg8787
(dp68111
VCytochrome P-450 CYP3A4 Inhibitors
p68112
g61656
sVCytochrome P450 3A4 Inhibitors
p68113
g13036
sVP-glycoprotein/ABCB1 Inhibitors
p68114
(dp68115
sVBreast Cancer Resistance Protein Inhibitors
p68116
g12728
sVCytochrome P-450 CYP2D6 Substrates
p68117
g52140
sVCytochrome P-450 CYP3A Substrates
p68118
g45234
sVCytochrome P-450 CYP3A Inhibitors
p68119
g60415
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68120
g29547
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p68121
(dp68122
sVNeurokinin 1 Antagonists
p68123
g50531
sVCytochrome P-450 CYP2C9 Substrates
p68124
g29741
sVCytochrome P-450 Enzyme Inhibitors
p68125
g62082
sVCytochrome P-450 CYP3A4 Substrates
p68126
g65331
sVSubstance P/Neurokinin-1 Receptor Antagonist
p68127
g27485
ssg8790
(dp68128
g1686
g26413
sg10077
(dp68129
sg8871
(dp68130
ssg8793
(dp68131
g8373
g66317
sg4857
g47887
sg2838
g34790
sg9507
(dp68132
sg2481
g32399
sg8211
g65662
sg5295
g50344
sg15016
g66102
ssg8796
(dp68133
VAmino Acids, Peptides, and Proteins
p68134
g47374
sVInsulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting
p68135
g32631
sVCytochrome P-450 CYP1A2 Inducers
p68136
(dp68137
sVPeptide Hormones
p68138
g20205
sVInsulins and Analogues for Inhalation
p68139
g34047
sVHypoglycemia-Associated Agents
p68140
g17673
sVInsulins and Analogues for Injection, Fast-Acting
p68141
(dp68142
sVInsulin, Short-Acting
p68143
g13878
sVInsulins and Analogues
p68144
(dp68145
sVPeptides
p68146
g47172
sVCytochrome P-450 Enzyme Inducers
p68147
g28112
sVInsulin
p68148
g67743
sVHormones
p68149
g55665
sVHormones, Hormone Substitutes, and Hormone Antagonists
p68150
g53163
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p68151
g17436
sVPancreatic Hormones
p68152
g62248
sVBlood Glucose Lowering Agents
p68153
(dp68154
sVAlimentary Tract and Metabolism
p68155
g23862
sVDrugs Used in Diabetes
p68156
g60110
ssg8799
(dp68157
g8019
g64731
sg4425
g44926
sg9519
(dp68158
sg11805
(dp68159
sg4788
g47587
sg4803
g47635
sg5250
g49968
sg7650
g63101
sg10011
(dp68160
sg8418
g66444
sg10977
(dp68161
sg4260
g44106
sg1914
g28401
sg891
g20543
sg10494
(dp68162
sg2088
g29906
sg4716
g47065
sg6024
g54441
sg3408
g38697
sg72
g12793
sg963
g20986
sg3279
g37930
sg4974
g48614
sg5589
g51921
sg336
g15089
sg5394
g50828
ssg8802
(dp68163
g1563
g25514
ssg8805
(dp68164
VCentral Nervous System Depressants
p68165
(dp68166
sVPhenothiazines With Piperidine Structure
p68167
(dp68168
sVAdrenergic alpha-1 Receptor Antagonists
p68169
g14116
sVPsycholeptics
p68170
g33235
sVAntipsychotic Agents
p68171
(dp68172
sVPhenothiazines
p68173
(dp68174
sVAdrenergic Antagonists
p68175
g52274
sVDopamine Antagonists
p68176
g53742
sVNeurotoxic agents
p68177
(dp68178
sVAdrenergic alpha-Antagonists
p68179
g60867
sVAgents that produce hypertension
p68180
(dp68181
sVAntipsychotic Agents (First Generation [Typical])
p68182
g63590
sVHeterocyclic Compounds, Fused-Ring
p68183
g56061
sVNervous System
p68184
(dp68185
sVSulfur Compounds
p68186
(dp68187
ssg8808
(dp68188
VInsulins and Analogues
p68189
(dp68190
sVHormones
p68191
g55678
sVBlood Glucose Lowering Agents
p68192
(dp68193
sVPeptide Hormones
p68194
g20211
sVInsulin, Long-Acting
p68195
(dp68196
sVPancreatic Hormones
p68197
g62247
sVDrugs Used in Diabetes
p68198
g60115
sVHypolipidemic Agents
p68199
(dp68200
sVCytochrome P-450 CYP1A2 Inducers
p68201
(dp68202
sVPeptides
p68203
g47192
sVCytochrome P-450 Enzyme Inducers
p68204
g28196
sVInsulin
p68205
g67744
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p68206
g17443
sVAlimentary Tract and Metabolism
p68207
g23868
sVAmino Acids, Peptides, and Proteins
p68208
g47377
sVToxic Actions
p68209
g49388
sVAntimetabolites
p68210
g59537
sVNoxae
p68211
g65421
sVInsulins and Analogues for Injection, Long-Acting
p68212
g39629
sVHypoglycemia-Associated Agents
p68213
g17687
sVBiological Products
p68214
g64639
sVInsulin Analog
p68215
g66239
sVHormones, Hormone Substitutes, and Hormone Antagonists
p68216
g53165
sVComplex Mixtures
p68217
g65520
sVLipid Regulating Agents
p68218
(dp68219
ssg8811
(dp68220
g11916
(dp68221
ssg8814
(dp68222
g8874
(dp68223
sg10815
(dp68224
sg10356
(dp68225
sg138
g13287
sg10308
(dp68226
sg2289
g31196
sg2910
g35535
ssg8817
(dp68227
g11475
(dp68228
ssg8820
(dp68229
VAgents Causing Muscle Toxicity
p68230
g55384
sVBSEP/ABCB11 Substrates
p68231
(dp68232
sVCytochrome P-450 CYP3A4 Inhibitors
p68233
g61688
sVCytochrome P-450 CYP2D6 Inhibitors
p68234
g62941
sVCytochrome P-450 CYP2D6 Substrates
p68235
g52169
sVAntiarrhythmic agents
p68236
(dp68237
sVCytochrome P-450 CYP3A Substrates
p68238
g45240
sVAgents causing hyperkalemia
p68239
g43611
sVHypotensive Agents
p68240
g34162
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p68241
(dp68242
sVCalcium Channel Blockers
p68243
g41313
sVEnzyme Inhibitors
p68244
(dp68245
sVOCT2 Inhibitors
p68246
g42473
sVCytochrome P450 3A4 Inhibitors
p68247
g13044
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p68248
(dp68249
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p68250
g43767
sVCytochrome P-450 CYP2C9 Inhibitors
p68251
g18224
sVCytochrome P-450 Enzyme Inhibitors
p68252
g62085
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p68253
g18404
sVHighest Risk QTc-Prolonging Agents
p68254
g35866
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p68255
g24783
sVCytochrome P-450 CYP2C8 Substrates
p68256
(dp68257
sVCytochrome P-450 CYP1A2 Substrates
p68258
g45602
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p68259
g36634
sVBenzofurans
p68260
g66682
sVCardiac Therapy
p68261
(dp68262
sVMembrane Transport Modulators
p68263
g54152
sVCytochrome P450 1A2 Inhibitors
p68264
g16807
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68265
g29554
sVSodium Channel Blockers
p68266
(dp68267
sVCytochrome P450 2D6 Inhibitors
p68268
(dp68269
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p68270
g60078
sVQTc Prolonging Agents
p68271
g57845
sVVasodilating Agents
p68272
g23698
sVCytochrome P-450 CYP2C19 Substrates
p68273
g53886
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p68274
g46418
sVCardiovascular Agents
p68275
g26538
sVAgents that reduce seizure threshold
p68276
g45848
sVCytochrome P-450 CYP1A2 Inhibitors
p68277
g15014
sVP-glycoprotein/ABCB1 Inducers
p68278
(dp68279
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p68280
g37404
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p68281
g36474
sVCytochrome P-450 CYP2A6 Inhibitors (moderate)
p68282
g65171
sVCytochrome P-450 CYP3A5 Inhibitors
p68283
g55340
sVCytochrome P450 2C9 Inhibitors
p68284
g63320
sVCytochrome P-450 CYP2C19 Inhibitors
p68285
g61274
sVCytochrome P-450 CYP3A4 Substrates
p68286
g65334
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p68287
g49332
sVNarrow Therapeutic Index Drugs
p68288
g50561
sVHeterocyclic Compounds, Fused-Ring
p68289
g56114
sValpha-Galactosidase, antagonists & inhibitors
p68290
g37629
sVBSEP/ABCB11 Substrates with Narrow Therapeutic Index
p68291
g49475
sVCytochrome P-450 CYP3A7 Inhibitors
p68292
(dp68293
sVPotassium Channel Blockers
p68294
g44770
sVCytochrome P-450 CYP3A Inhibitors
p68295
g60449
sVBradycardia-Causing Agents
p68296
g61447
sVP-glycoprotein/ABCB1 Inhibitors
p68297
(dp68298
sVAntiarrhythmics, Class III
p68299
(dp68300
sVChemically-Induced Disorders
p68301
g21231
sVCytochrome P-450 CYP2A6 Inhibitors
p68302
g48583
sVCytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index
p68303
(dp68304
ssg8823
(dp68305
g10623
(dp68306
sVAmino Acids, Peptides, and Proteins
p68307
g47383
sVAmino Acids
p68308
g43107
sg8208
g65645
sg5760
g52949
sg7746
g63582
sg6078
g54903
sg906
g20609
sVAlimentary Tract and Metabolism
p68309
g23876
ssg8826
(dp68310
g8196
g65602
sg1620
g25926
sVOsmotic Laxatives
p68311
g57506
sVCompounds used in a research, industrial, or household setting
p68312
(dp68313
sVStomatological Preparations
p68314
g67440
sg7872
g64033
sVElectrolytes
p68315
g52419
sg3150
g37163
sVMineral Supplements
p68316
g38305
sVProtective Agents
p68317
g66794
sVDental Agents
p68318
(dp68319
sVAcids
p68320
g40576
sg7728
g63507
sVLaxatives
p68321
g17354
sVBiomedical and Dental Materials
p68322
g44727
sVAlimentary Tract and Metabolism
p68323
g23877
sVIons
p68324
g49119
sg8907
(dp68325
sVAcids, Noncarboxylic
p68326
g54201
sg10803
(dp68327
sg3096
g36725
sVAnions
p68328
(dp68329
sg11577
(dp68330
ssg8829
(dp68331
g10839
(dp68332
ssg8832
(dp68333
VHydrocarbons, Acyclic
p68334
g19591
sVNervous System
p68335
(dp68336
sg453
g16366
sVAcids
p68337
g40578
sVAcids, Noncarboxylic
p68338
g54203
sVCentral Nervous System Agents
p68339
g58492
sVSulfur Acids
p68340
g61539
sVAlcohol Deterrents
p68341
g15815
sVAlkanes
p68342
g66405
sVSulfonic Acids
p68343
g56742
sVMiscellaneous Central Nervous System Agents
p68344
g63704
sVAlkanesulfonic Acids
p68345
g32766
sVDrugs Used in Addictive Disorders
p68346
g24719
sVDrugs Used in Alcohol Dependence
p68347
(dp68348
sVSulfur Compounds
p68349
(dp68350
ssg8835
(dp68351
g1782
g27150
sg10833
(dp68352
sg28215
g35363
sg6090
g54951
sg2739
g34011
sg7815
g63760
sg9528
(dp68353
sg30
g12382
sg11799
(dp68354
sg10725
(dp68355
sg6489
g57216
sg4890
g48110
sg8595
g67351
sg11604
(dp68356
sg48
g12642
sg11427
(dp68357
sg9411
(dp68358
sg87
g12926
sg11151
(dp68359
sg11061
(dp68360
sg11631
(dp68361
sg11838
(dp68362
sg4068
g42773
sg5865
g53612
sg7881
g64068
sg8985
(dp68363
sg10326
(dp68364
sg10701
(dp68365
sg5691
g52479
sg10509
(dp68366
sg3609
g39681
sg3174
g37267
sg6447
g57029
sg5520
g51529
sg10368
(dp68367
sg4521
g45969
sg9216
(dp68368
sg7500
g62354
sg10698
(dp68369
sg6654
g58061
sg9261
(dp68370
sg3204
g37425
sg19588
g32491
sg3207
g37480
sg11334
(dp68371
sg474
g16568
sg7662
g63173
sg1275
g23290
sg7698
g63339
sg3264
g37867
sg3576
g39576
sg1527
g25245
sg11184
(dp68372
sg12090
(dp68373
sg3981
g42032
sg9657
(dp68374
sg3015
g36096
sg1101
g22067
sg10878
(dp68375
sg1761
g26992
sg6240
g55766
sg9096
(dp68376
sg7395
g61574
sg4953
g48478
sg11208
(dp68377
sg858
g20158
ssg8838
(dp68378
g1719
g26838
sg8862
(dp68379
sg5580
g51874
ssg8841
(dp68380
g8796
g68137
sg4821
g47734
sg4365
g44741
sg5832
g53424
sg8421
g66491
sg2787
g34396
sg7272
g60768
sg8241
g65807
sg6819
g58879
sg8808
g68202
sg9198
(dp68381
sg888
g20409
sg10338
(dp68382
sg78
g12859
sg7335
g61175
sg2253
g30881
sg4911
g48242
sg4053
g42538
sg1140
g22402
sg5133
g49287
sg4338
g44559
sg14791
(dp68383
sg4155
g43229
sg3222
g37604
sg9822
(dp68384
sg141
g13352
sg10794
(dp68385
sg6015
g54391
sg183
g13824
sg6048
g54752
sg10596
(dp68386
sg11370
(dp68387
sg7593
g62805
sg5598
g52008
ssg8844
(dp68388
g6216
g55632
ssg8847
(dp68389
g2730
g33870
sg2538
g32803
sg7734
g63532
sg888
g20468
ssg8850
(dp68390
VAntiinfectives for Systemic Use
p68391
(dp68392
sVPenicillins With Extended Spectrum
p68393
g57007
sVAnti-Infective Agents
p68394
g54640
sVHeterocyclic Compounds, Fused-Ring
p68395
g56149
sVAnti-Infective Agents, Urinary
p68396
g25221
sVbeta-Lactams
p68397
(dp68398
sVLactams
p68399
g22283
sVAmides
p68400
g44334
sVSulfur Compounds
p68401
(dp68402
sVAnti-Bacterial Agents
p68403
g38364
sVAntibacterials for Systemic Use
p68404
g32563
sg7449
g62102
sVPenicillins
p68405
g52895
sVRenal Agents
p68406
g24765
sVBeta-Lactam Antibacterials
p68407
g46292
ssg8853
(dp68408
g7416
g61730
ssg8856
(dp68409
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p68410
g52089
sVCytochrome P-450 CYP3A4 Inhibitors
p68411
g61693
sVCytochrome P-450 CYP2D6 Inhibitors
p68412
g62945
sVSulfhydryl Compounds
p68413
g54327
sVCytochrome P-450 CYP2C9 Inhibitors
p68414
g18228
sVCytochrome P-450 Enzyme Inhibitors
p68415
g62086
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p68416
g18416
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p68417
(dp68418
sVDrugs that are Mainly Renally Excreted
p68419
g44038
sVThyroid Hormone Synthesis Inhibitors
p68420
g41057
sVMyelosuppressive Agents
p68421
(dp68422
sVCytochrome P-450 CYP2E1 Inhibitors
p68423
g46840
sVThyroid Products
p68424
g28977
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p68425
(dp68426
sVSulfur Compounds
p68427
(dp68428
sVImidazoles
p68429
(dp68430
sVAntithyroid agents
p68431
(dp68432
sVCytochrome P-450 CYP1A2 Inhibitors
p68433
g15031
sVCytochrome P-450 CYP2B6 Inhibitors
p68434
g45934
sVThyroid Hormone Synthesis Inhibitor
p68435
g41008
sg12087
(dp68436
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p68437
g62517
sVCytochrome P-450 CYP2C19 Inhibitors
p68438
g61276
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p68439
g49338
sVHormone Antagonists
p68440
g24276
sg5874
g53657
sVCytochrome P-450 CYP3A Inhibitors
p68441
g60455
sVImmunosuppressive Agents
p68442
g64579
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p68443
(dp68444
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p68445
(dp68446
sVHormones, Hormone Substitutes, and Hormone Antagonists
p68447
g53174
sVCytochrome P-450 CYP2A6 Inhibitors
p68448
g48587
ssg8859
(dp68449
g9612
(dp68450
ssg8862
(dp68451
VCytochrome P-450 CYP2D6 Substrates
p68452
g52199
sVAntiarrhythmic agents
p68453
(dp68454
sVOphthalmologicals
p68455
g35268
sVAgents causing hyperkalemia
p68456
g43643
sVHypotensive Agents
p68457
g34210
sVAdrenergic Antagonists
p68458
g52297
sVPeripheral Nervous System Agents
p68459
g57651
sVSympatholytics
p68460
g56843
sVCytochrome P-450 CYP1A2 Substrates
p68461
g45637
sVAmines
p68462
g42741
sVAdrenergic beta-1 Receptor Antagonists
p68463
g46816
sVAntihypertensive Agents
p68464
g20320
sVNeurotransmitter Agents
p68465
(dp68466
sVBeta Blocking Agents, Selective
p68467
g51455
sVQTc Prolonging Agents
p68468
g57883
sVModerate Risk QTc-Prolonging Agents
p68469
g67176
sVAdrenergic Agents
p68470
g41722
sg8838
g68379
sVCardiovascular Agents
p68471
g26682
sVAdrenergic beta-Antagonists
p68472
g15364
sVPhenoxypropanolamines
p68473
g20861
sVSensory Organs
p68474
g40751
sVPropanolamines
p68475
g37510
sVAutonomic Agents
p68476
g66576
sVAmino Alcohols
p68477
g32683
sVAntiglaucoma Preparations and Miotics
p68478
g36559
sVBradycardia-Causing Agents
p68479
g61459
sVPropanols
p68480
g56554
sVBeta-Blockers (Beta1 Selective)
p68481
g57434
sVAlcohols
p68482
(dp68483
ssg8865
(dp68484
g4017
g42291
sg11955
(dp68485
sg6819
g58887
sg2736
g33963
sg5877
g53690
sg14791
(dp68486
sg2427
g32046
sg1539
g25309
sg9960
(dp68487
sg1185
g22740
ssg8868
(dp68488
g1911
g28369
sg2316
g31307
sg12063
(dp68489
ssg8871
(dp68490
VHeterocyclic Compounds, Fused-Ring
p68491
g56162
sVOphthalmologicals
p68492
g35237
sg6945
g59354
sVRadiation-Sensitizing Agents
p68493
(dp68494
sVPigments, Biological
p68495
g21856
sVDermatologicals
p68496
g17291
sVPhotoabsorption
p68497
(dp68498
sg1575
g25600
sVBiological Factors
p68499
g38115
sVPhotosensitizing Activity
p68500
g38982
sVEENT Drugs, Miscellaneous
p68501
g40850
sg2382
g31653
sVPorphyrins
p68502
g68130
sVPhotosensitizing Agents
p68503
g21318
sVSensory Organs
p68504
g40726
ssg8874
(dp68505
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p68506
g52094
sVAntidepressive Agents, Second-Generation
p68507
g49755
sVCytochrome P-450 CYP3A4 Inhibitors
p68508
g61638
sVAnticholinergic Agents
p68509
g24503
sVCytochrome P-450 CYP2D6 Inhibitors
p68510
g62909
sVCytochrome P-450 CYP2D6 Substrates
p68511
g52170
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p68512
(dp68513
sVSerotonin Agents
p68514
(dp68515
sVCytochrome P-450 CYP3A Substrates
p68516
g45244
sVNeurotransmitter Agents
p68517
(dp68518
sVCentral Nervous System Agents
p68519
g58416
sVPsychotropic Drugs
p68520
(dp68521
sVCytochrome P-450 Enzyme Inhibitors
p68522
g62087
sVMuscarinic Antagonists
p68523
g48881
sVSelective Serotonin Reuptake Inhibitors
p68524
g39074
sVHighest Risk QTc-Prolonging Agents
p68525
g35869
sVNeurotransmitter Uptake Inhibitors
p68526
g52394
sVAmines
p68527
g42724
sVCitalopram
p68528
(dp68529
sVBenzofurans
p68530
g66681
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p68531
(dp68532
sVPropylamines
p68533
g68223
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68534
g29561
sVQTc Prolonging Agents
p68535
g57843
sVCytochrome P-450 CYP2C19 Substrates
p68536
g53894
sVCentral Nervous System Depressants
p68537
(dp68538
sVPsychoanaleptics
p68539
g59078
sVMembrane Transport Modulators
p68540
g54160
sVCytochrome P-450 CYP3A4 Substrates
p68541
g65336
sVHeterocyclic Compounds, Fused-Ring
p68542
g56124
sVSerotonin Modulators
p68543
(dp68544
sVAntidepressive Agents
p68545
g15556
sVCytochrome P-450 CYP3A Inhibitors
p68546
g60394
sVHypoglycemia-Associated Agents
p68547
g17690
sVNitriles
p68548
g34037
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p68549
g53072
sVNervous System
p68550
(dp68551
ssg8877
(dp68552
g285
g14635
sg3867
g41360
sg4752
g47301
sg9441
(dp68553
sg10047
(dp68554
ssg8880
(dp68555
VHeterocyclic Compounds, Fused-Ring
p68556
g56125
sVPoly(ADP-ribose) Polymerase Inhibitors
p68557
g30813
sVPyrazoles
p68558
g65175
sVAntineoplastic and Immunomodulating Agents
p68559
g39802
sVEnzyme Inhibitors
p68560
(dp68561
sVAntineoplastic Agents
p68562
(dp68563
ssg8883
(dp68564
g8325
g66149
ssg8886
(dp68565
g2703
g33724
ssg8889
(dp68566
g1782
g27168
sg6279
g55971
sg3657
g40188
sg9426
(dp68567
sg10122
(dp68568
sg7470
g62229
sg11592
(dp68569
sg9261
(dp68570
sg10878
(dp68571
sg7353
g61351
sg2940
g35703
sg2424
g31950
sg3207
g37484
sg7662
g63176
sg9630
(dp68572
sg1656
g26190
sg3090
g36702
ssg8892
(dp68573
g8097
g65110
sg630
g18052
sg11790
(dp68574
sg30
g12404
sg240
g14215
sg6882
g59137
sg6318
g56397
sg11601
(dp68575
sg11979
(dp68576
sg11769
(dp68577
sg9711
(dp68578
sg405
g15908
sg10674
(dp68579
sg2940
g35715
sg2265
g31028
sg282
g14595
sg5865
g53630
sg8985
(dp68580
sg11016
(dp68581
sg11079
(dp68582
sg1113
g22212
sg1425
g24574
sg9096
(dp68583
sg5694
g52574
sg5511
g51477
sg3174
g37283
sg9417
(dp68584
sg1707
g26798
sg6966
g59434
sg2427
g32074
sg3381
g38498
sg12066
(dp68585
sg3027
g36393
sg5535
g51678
sg486
g16673
sg7941
g64293
sg7497
g62320
sg6240
g55770
sg9981
(dp68586
sg2739
g34031
sg8028
g64840
sg822
g19818
sg696
g18786
sg3570
g39515
sg11541
(dp68587
sg3576
g39602
sg5169
g49524
sg10056
(dp68588
sg387
g15688
sg13091
g21438
sg8805
g68178
sg2664
g33477
sg10815
(dp68589
sg7299
g60943
sg1194
g22833
sg414
g15989
sg8187
g65561
sg9630
(dp68590
sg780
g19386
ssg8895
(dp68591
g11334
(dp68592
sg10368
(dp68593
sg10509
(dp68594
sg7815
g63772
ssg8898
(dp68595
g10314
(dp68596
sg10548
(dp68597
ssg8901
(dp68598
g6312
g56271
sg8265
g65896
sg10587
(dp68599
sg6885
g59150
ssg8904
(dp68600
g10275
(dp68601
ssg8907
(dp68602
g8826
g68325
ssg8910
(dp68603
VAmino Acids, Peptides, and Proteins
p68604
g47395
sVGlobulins
p68605
g19198
sVAntibodies
p68606
g60993
sg8535
g67209
sVAntibodies, Monoclonal
p68607
(dp68608
sVAntibodies, Monoclonal, Humanized
p68609
(dp68610
sg7623
g62963
sVImmunoglobulins
p68611
g41537
sVProteins
p68612
g52780
sg4383
g44807
sg996
g21209
sVAntineoplastic and Immunomodulating Agents
p68613
g39806
sVSerum Globulins
p68614
g49666
sVBlood Proteins
p68615
g39873
sg3564
g39433
sVAntineoplastic Agents
p68616
(dp68617
sVImmunoproteins
p68618
g57459
ssg8913
(dp68619
g3609
g39684
sg4068
g42795
ssg8916
(dp68620
V2-Pyridinylmethylsulfinylbenzimidazoles
p68621
(dp68622
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p68623
g50951
sVMusculo-Skeletal System
p68624
g31552
sVAntiinflammatory and Antirheumatic Products
p68625
g56818
sVOmeprazole
p68626
g53393
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p68627
g49909
sVEnzyme Inhibitors
p68628
(dp68629
sVCytochrome P-450 Enzyme Inhibitors
p68630
g62069
sVGastric Acid Lowering Agents
p68631
g67252
sVCytochrome P450 2C19 Inhibitors
p68632
(dp68633
sVSulfoxides
p68634
g56735
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68635
g29501
sVSulfur Compounds
p68636
(dp68637
sVAcid Reducers
p68638
g43809
sVCytochrome P-450 CYP3A Substrates
p68639
g45198
sVAnti-Ulcer Agents
p68640
(dp68641
sVCytochrome P-450 CYP2C19 Substrates
p68642
g53897
sVGastrointestinal Agents
p68643
(dp68644
sVP-glycoprotein/ABCB1 Substrates
p68645
g34952
sVPyridines
p68646
g64225
sVProton-pump Inhibitors
p68647
g31272
sVPropionates
p68648
g36491
sVCytochrome P-450 CYP2C19 Inhibitors
p68649
g61262
sVHeterocyclic Compounds, Fused-Ring
p68650
g56071
sVCytochrome P-450 CYP3A4 Substrates
p68651
g65306
sVAlimentary Tract and Metabolism
p68652
g23817
sVBenzimidazoles
p68653
(dp68654
sVOAT3/SLC22A8 Inhibitors
p68655
g58998
sVProton Pump Inhibitors
p68656
g57893
sVDrugs for Acid Related Disorders
p68657
g55162
sVP-glycoprotein/ABCB1 Inhibitors
p68658
(dp68659
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p68660
g67788
ssg8919
(dp68661
g8373
g66347
sg6639
g57997
sg11241
(dp68662
sg3753
g40628
sg2481
g32428
sg5646
g52345
sg9444
(dp68663
sg11508
(dp68664
sg8211
g65693
sg1098
g22029
ssg8922
(dp68665
VAntivirals for Systemic Use
p68666
g59779
sVNucleic Acid Synthesis Inhibitors
p68667
g48746
sVOAT1/SLC22A6 inhibitors
p68668
(dp68669
sVGuanine
p68670
(dp68671
sVDirect Acting Antivirals
p68672
g38085
sVAcyclovir and prodrug
p68673
g32995
sVHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor
p68674
(dp68675
sVAntiinfectives for Systemic Use
p68676
(dp68677
sVDrugs that are Mainly Renally Excreted
p68678
g44040
sVHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
p68679
g50120
sVCytochrome P-450 CYP1A2 Substrates
p68680
g45616
sVNephrotoxic agents
p68681
g57732
sVAnti-Infective Agents
p68682
g54615
sVPurinones
p68683
g48141
sVOCT1 inhibitors
p68684
g66931
sVMATE 1 Substrates
p68685
g23508
sVOCT1 substrates
p68686
g13086
sVOAT3/SLC22A8 Substrates
p68687
g13140
sVMATE substrates
p68688
(dp68689
sVDermatologicals
p68690
g17300
sVHerpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
p68691
(dp68692
sVNucleosides and Nucleotides
p68693
g39104
sVNucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors
p68694
g51697
sVSensory Organs
p68695
g40733
sVPurines
p68696
(dp68697
sVOAT1/SLC22A6 Substrates
p68698
g60725
sVMATE 2 Substrates
p68699
g44493
sVHeterocyclic Compounds, Fused-Ring
p68700
g56128
sVOphthalmologicals
p68701
g35245
sVOAT3/SLC22A8 Inhibitors
p68702
g59024
sVAntiviral Agents
p68703
g30469
ssg8925
(dp68704
g11952
(dp68705
sg6360
g56729
ssg8928
(dp68706
VHydrocarbons, Acyclic
p68707
g19587
sVHypolipidemic Agents
p68708
(dp68709
sVAnticholesteremic Agents
p68710
g50595
sVBile-acid Binding Activity
p68711
g52828
sVAmines
p68712
g42693
sVLipid Modifying Agents
p68713
g40534
sVToxic Actions
p68714
g49381
sg7773
g63650
sVNoxae
p68715
g65417
sVBile Acid Sequestrants
p68716
g67530
sVLipid Modifying Agents, Plain
p68717
g63424
sVAlkenes
p68718
g30760
sg4695
g46955
sVLipid Regulating Agents
p68719
(dp68720
ssg8931
(dp68721
g16906
g61906
sg2829
g34636
ssg8934
(dp68722
g4977
g48655
sg7809
g63728
ssg8937
(dp68723
g9855
(dp68724
sg9324
(dp68725
sg5112
g49160
ssg8940
(dp68726
g507
g16768
sg14822
g41813
sg2127
g30258
sg849
g20080
sg3543
g39334
sg2133
g30288
ssg8943
(dp68727
g4170
g43381
ssg8946
(dp68728
g7041
g59707
sg6186
g55513
ssg8949
(dp68729
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p68730
(dp68731
sVCytochrome P-450 CYP2D6 Inhibitors
p68732
g62956
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p68733
g41084
sVCytochrome P-450 CYP3A Substrates
p68734
g45094
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p68735
g46419
sVEnzyme Inhibitors
p68736
(dp68737
sVCytochrome P-450 CYP2C9 Inhibitors
p68738
g18255
sVCytochrome P-450 Enzyme Inhibitors
p68739
g62011
sVAndrostanes
p68740
(dp68741
sVCytochrome P-450 CYP2C19 Inhibitors (moderate)
p68742
g56915
sVSteroid Synthesis Inhibitors
p68743
(dp68744
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68745
g29374
sg9957
(dp68746
sVFused-Ring Compounds
p68747
g14891
sVAntineoplastic Agents
p68748
(dp68749
sVHormone Antagonists and Related Agents
p68750
(dp68751
sVCytochrome P-450 CYP1A2 Inhibitors
p68752
g15035
sVCytochrome P-450 CYP2C8 Inhibitors
p68753
g55048
sVAndrostenes
p68754
g60166
sVCytochrome P450 2D6 Inhibitors
p68755
(dp68756
sVCytochrome P-450 CYP2C19 Inhibitors
p68757
g61284
sVCytochrome P-450 CYP3A4 Substrates
p68758
g65253
sVHormone Antagonists
p68759
g24283
sVSteroids
p68760
g56432
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p68761
g64645
sVAntineoplastic and Immunomodulating Agents
p68762
g39826
sVHormones, Hormone Substitutes, and Hormone Antagonists
p68763
g53144
sVChemically-Induced Disorders
p68764
g21246
sVEndocrine Therapy
p68765
g19567
ssg8952
(dp68766
g7626
g62971
ssg8955
(dp68767
g3978
g41999
sg6468
g57107
ssg8958
(dp68768
g1785
g27197
sg4863
g47929
sg10362
(dp68769
sg1674
g26319
sg48
g12623
sg918
g20770
sg147
g13509
sg1434
g24631
ssg8961
(dp68770
g837
g19993
ssg8964
(dp68771
VDrugs for Urinary Frequency and Incontinence
p68772
g28985
sVDrugs that are Mainly Renally Excreted
p68773
g44045
sVNeurotransmitter Agents
p68774
(dp68775
sVAnticholinergic Agents
p68776
g24463
sVBenzene Derivatives
p68777
g61427
sVCytochrome P-450 CYP2D6 Substrates
p68778
g52185
sVCytochrome P-450 CYP3A Substrates
p68779
g45254
sVGenito Urinary System and Sex Hormones
p68780
g66186
sVP-glycoprotein/ABCB1 Substrates
p68781
g35049
sVUrological Agents
p68782
g38283
sVCholinergic Agents
p68783
g28713
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68784
g29573
sVAgents producing tachycardia
p68785
g50790
sVCytochrome P-450 CYP3A4 Substrates
p68786
g65345
sVMuscarinic Antagonists
p68787
g48856
sVUrologicals
p68788
g58908
ssg8967
(dp68789
g6990
g59478
ssg8970
(dp68790
g6291
g56007
sg7740
g63568
sg5007
g48700
sg6000
g54321
sg7077
g60039
ssg8973
(dp68791
g7980
g64511
sg447
g16296
ssg8976
(dp68792
g6180
g55417
sg1470
g24910
sg3105
g36770
sg4620
g46334
sg3117
g36913
sg5433
g51048
sg6318
g56345
sg7641
g63030
sg1800
g27310
sg4653
g46672
sg4656
g46774
sg7668
g63194
sg11451
(dp68793
sg8022
g64780
sg11952
(dp68794
sg20252
(dp68795
sg8445
g66739
sg3543
g39339
sg9954
(dp68796
sg10347
(dp68797
sg9225
(dp68798
sg6966
g59400
sg6303
g56205
sg9273
(dp68799
sg3231
g37638
sg6345
g56575
sg9903
(dp68800
sg10323
(dp68801
sg4341
g44597
sg7884
g64095
sg12066
(dp68802
sg12274
g27537
sg4062
g42614
sg7545
g62540
sg1614
g25858
sg3132
g37000
sg14838
g39972
sg4089
g42897
sg5694
g52533
sg12534
g52610
sg9357
(dp68803
sg4113
g43027
sg9432
(dp68804
sg6435
g56964
sg10164
(dp68805
sg9198
(dp68806
sg9486
(dp68807
sg6504
g57254
sg10209
(dp68808
sg1941
g28568
sg7947
g64366
sg5766
g52966
sg402
g15838
sg780
g19347
sg2373
g31578
sg2007
g28866
sg978
g21148
sg879
g20336
sg11052
(dp68809
sg507
g16773
sg2817
g34550
sg7299
g60922
sg5895
g53798
sg11886
(dp68810
sg5574
g51788
sg2829
g34633
sg8106
g65160
sg7314
g61022
sg3393
g38546
sg7320
g61072
sg6885
g59160
sg3963
g41860
sg696
g18713
sg5934
g54079
sg23
g12207
sg2127
g30237
sg10383
(dp68811
sg8694
g67712
sg11160
(dp68812
sg2133
g30282
sg573
g17534
sg11016
(dp68813
sg3570
g39467
sg1371
g24087
sg11922
(dp68814
sg609
g17810
sg11862
(dp68815
sg13750
g24364
sg14872
g15711
sg2196
g30620
sg16906
g61900
sg6045
g54698
sg9687
(dp68816
sg11274
(dp68817
sg822
g19828
sg849
g20085
sg4488
g45750
sg2832
g34706
sg11790
(dp68818
sg3783
g40867
sg5364
g50607
sg2664
g33449
sg12132
(dp68819
sg819
g19741
ssg8979
(dp68820
g9828
(dp68821
ssg8982
(dp68822
g6504
g57256
sg8142
g65379
sg2043
g29064
sg8277
g65938
sg4476
g45653
sg11316
(dp68823
sg8949
g68741
sg4236
g43703
sg10041
(dp68824
sg6123
g55126
sg102
g13009
sg543
g17089
ssg8985
(dp68825
VAgents Causing Muscle Toxicity
p68826
g55398
sVDideoxynucleosides
p68827
g48718
sVAntivirals for Systemic Use
p68828
g59759
sVNucleic Acid Synthesis Inhibitors
p68829
g48732
sVCarbohydrates
p68830
g61789
sVPyrimidines
p68831
g47698
sVDirect Acting Antivirals
p68832
g38056
sVAnti-HIV Agents
p68833
g66395
sVEnzyme Inhibitors
p68834
(dp68835
sVThymidine
p68836
g64176
sVReverse Transcriptase Inhibitors
p68837
g28957
sVAnti-Infective Agents
p68838
g54664
sVAntiinfectives for Systemic Use
p68839
(dp68840
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p68841
g14465
sVDeoxyribonucleosides
p68842
g33057
sVGlycosides
p68843
g68363
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p68844
g38161
sVToxic Actions
p68845
g49411
sVNucleic Acids, Nucleotides, and Nucleosides
p68846
g47120
sVPyrimidine Nucleosides
p68847
(dp68848
sVAnti-Retroviral Agents
p68849
g67145
sVOAT1/SLC22A6 Substrates
p68850
g60718
sVNucleosides
p68851
g49461
sVAntimetabolites
p68852
g59544
sVNucleoside Reverse Transcriptase Inhibitors
p68853
g38838
sVNoxae
p68854
g65434
sVAntiviral Agents
p68855
g30440
sVNeurotoxic agents
p68856
g68580
ssg8988
(dp68857
g9855
(dp68858
sg4401
g44853
sg1188
g22777
sg9696
(dp68859
ssg8991
(dp68860
g477
g16600
sg87
g12916
sg4521
g45960
sg4863
g47942
sg4068
g42766
sg12090
(dp68861
sg11799
(dp68862
sg3264
g37869
sg3015
g36087
sg1674
g26333
sg474
g16558
sg1275
g23284
sg3609
g39674
ssg8994
(dp68863
g3570
g39476
sg5694
g52539
sg1707
g26768
ssg8997
(dp68864
g9471
(dp68865
sg2142
g30353
sg3639
g40075
ssg9000
(dp68866
VBlood and Blood Forming Organs
p68867
g53921
sVHeterocyclic Compounds, Fused-Ring
p68868
g56147
sVVitamins
p68869
g12183
sVVITAMIN B12 AND FOLIC ACID
p68870
g55992
sVCorrinoids
p68871
g59173
sVAntianemic Preparations
p68872
g63062
sVVitamin B Complex
p68873
g54917
ssg9003
(dp68874
g8193
g65594
sg1980
g28804
sg735
g19138
sg11040
(dp68875
sg1332
g23648
sg2862
g35156
sg8493
g67067
sg10953
(dp68876
sg3216
g37525
ssg9006
(dp68877
VCytoprotective Agent
p68878
g38447
sVHydrocarbons, Acyclic
p68879
g19585
sVSulfhydryl Compounds
p68880
g54328
sg1218
g22882
sVAcids
p68881
g40574
sVDetoxifying Agents for Antineoplastic Treatment
p68882
(dp68883
sVAcids, Noncarboxylic
p68884
g54199
sg2526
g32767
sVSulfur Acids
p68885
g61537
sVAlkanes
p68886
g66406
sVCompounds used in a research, industrial, or household setting
p68887
(dp68888
sVExpectorants
p68889
g49259
sg9006
(dp68890
sVProtective Agents
p68891
g66793
sVCough and Cold Preparations
p68892
g65513
sVSulfur Compounds
p68893
(dp68894
sg6372
g56741
ssg9009
(dp68895
VBSEP/ABCB11 Substrates
p68896
(dp68897
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p68898
(dp68899
sVCytochrome P-450 CYP3A Inhibitors
p68900
g60469
sg10455
(dp68901
sg642
g18121
sVCytochrome P-450 CYP3A Substrates
p68902
g45263
sVAgents causing hyperkalemia
p68903
g43635
sVHypotensive Agents
p68904
g34201
sVAgents causing angioedema
p68905
g63902
sVPotential QTc-Prolonging Agents
p68906
(dp68907
sg7440
g61943
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p68908
g43786
sVCytochrome P-450 Enzyme Inhibitors
p68909
g62095
sVCytochrome P-450 CYP2C8 Substrates
p68910
(dp68911
sVUGT1A3 substrates
p68912
g31808
sVAntihypertensive Agents
p68913
g20315
sg1476
g24988
sVAntiarrhythmic agents
p68914
(dp68915
sg7890
g64133
sVOAT1/SLC22A6 inhibitors
p68916
(dp68917
sVCytochrome P-450 CYP2C9 Substrates
p68918
g29812
sVQTc Prolonging Agents
p68919
g57875
sVImidazoles
p68920
(dp68921
sVCardiovascular Agents
p68922
g26665
sVBenzene Derivatives
p68923
g61431
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68924
g29583
sVCytochrome P-450 CYP2C8 Inhibitors
p68925
g55041
sVP-glycoprotein/ABCB1 Substrates
p68926
g35068
sg729
g19114
sVCytochrome P-450 CYP2C19 Inhibitors
p68927
g61280
sg10545
(dp68928
sVCytochrome P-450 CYP3A4 Substrates
p68929
g65347
sVAgents Acting on the Renin-Angiotensin System
p68930
g25336
sVCytochrome P-450 CYP3A4 Inhibitors
p68931
g61706
sg1167
g22617
sg9690
(dp68932
sVUGT2B7 substrates
p68933
g28631
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p68934
(dp68935
sVP-glycoprotein/ABCB1 Inhibitors
p68936
(dp68937
sVUGT1A1 Substrates
p68938
g12296
ssg9012
(dp68939
VBeta Blocking Agents, Non-Selective, and Thiazides
p68940
g38993
sVCytochrome P-450 CYP2D6 Substrates
p68941
g52174
sVAntiarrhythmic agents
p68942
(dp68943
sVNeurotransmitter Agents
p68944
(dp68945
sVHypotensive Agents
p68946
g34171
sVAdrenergic Antagonists
p68947
g52286
sVPeripheral Nervous System Agents
p68948
g57628
sVSympatholytics
p68949
g56846
sVDrugs that are Mainly Renally Excreted
p68950
g43846
sVAmines
p68951
g42719
sVAntihypertensive Agents
p68952
g20297
sVAdrenergic Agents
p68953
g41711
sVAgents causing hyperkalemia
p68954
g43615
sVCardiovascular Agents
p68955
g26630
sVP-glycoprotein/ABCB1 Substrates
p68956
g35070
sVAdrenergic beta-Antagonists
p68957
g15357
sVPhenoxypropanolamines
p68958
g20863
sVBeta Blocking Agents, Non-Selective
p68959
g38742
sVPropanolamines
p68960
g37505
sVAutonomic Agents
p68961
g66567
sVBeta Blocking Agents and Thiazides
p68962
g47425
sVAmino Alcohols
p68963
g32680
sVBradycardia-Causing Agents
p68964
g61467
sVPropanols
p68965
g56550
sVAlcohols
p68966
(dp68967
ssg9015
(dp68968
g4419
g44896
sg6315
g56315
sg8820
g68300
ssg9018
(dp68969
g10890
(dp68970
sg5283
g50188
ssg9021
(dp68971
g8106
g65138
sg10149
(dp68972
sg6180
g55427
sg10323
(dp68973
sg7971
g64441
sg2886
g35306
sg11274
(dp68974
sg5199
g49695
sg2007
g28884
sg4515
g45897
sg2817
g34559
sg2172
g30517
sg11046
(dp68975
sg8457
g66849
sg819
g19739
sg11052
(dp68976
sg213
g14053
ssg9024
(dp68977
g2733
g33923
ssg9027
(dp68978
g9618
(dp68979
sg4164
g43325
sg1371
g24107
sg6336
g56523
sg7593
g62808
sg8298
g66043
sg8049
g64903
ssg9030
(dp68980
VCytochrome P-450 CYP3A Substrates
p68981
g45205
sVSteroids, Fluorinated
p68982
(dp68983
sVCorticosteroids for Systemic Use
p68984
g48839
sVDrugs for Obstructive Airway Diseases
p68985
g42517
sVRespiratory System Agents
p68986
(dp68987
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p68988
g29510
sVFused-Ring Compounds
p68989
g14883
sVCytochrome P-450 CYP3A4 Inducers
p68990
g18914
sVAdrenal Cortex Hormones
p68991
g30040
sVAdrenals
p68992
g37373
sVPregnadienes
p68993
(dp68994
sVCytochrome P-450 Enzyme Inducers
p68995
g28157
sVCytochrome P-450 CYP3A Inducers
p68996
g66272
sVAnti-Asthmatic Agents
p68997
g36523
sVCytochrome P-450 CYP3A4 Substrates
p68998
g65313
sVNasal Preparations
p68999
(dp69000
sVPregnanes
p69001
g63604
sVAgents to Treat Airway Disease
p69002
g32642
sVSteroids
p69003
g56422
sVImmunosuppressive Agents
p69004
g64580
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p69005
g64623
sVAnti-Inflammatory Agents
p69006
(dp69007
sVCorticosteroid Hormone Receptor Agonists
p69008
g63665
sVCorticosteroids
p69009
(dp69010
ssg9033
(dp69011
VAmidines
p69012
(dp69013
sVDrugs that are Mainly Renally Excreted
p69014
g43858
sVMATE 2 Substrates
p69015
g44488
sVMATE 1 Substrates
p69016
g23502
sVOCT1 substrates
p69017
g13083
sVGuanidines
p69018
(dp69019
sVMATE substrates
p69020
(dp69021
sVOCT2 Inhibitors
p69022
g42467
sVOCT2 Substrates
p69023
g14953
sVOral Hypoglycemics
p69024
g35990
sVOCT2 substrates with narrow therapeutic index
p69025
g29696
sVBlood Glucose Lowering Agents
p69026
(dp69027
sVAlimentary Tract and Metabolism
p69028
g23903
sVDrugs Used in Diabetes
p69029
g60112
sVBiguanides
p69030
g25210
ssg9036
(dp69031
g2835
g34756
sg3426
g38755
sg10629
(dp69032
sg8226
g65723
sg12114
(dp69033
sg12060
(dp69034
sg9783
(dp69035
sg5199
g49699
sg5595
g51986
sg213
g14032
ssg9039
(dp69036
g11646
(dp69037
sg11349
(dp69038
ssg9042
(dp69039
g10569
(dp69040
sg2118
g30212
ssg9045
(dp69041
g6408
g56856
ssg9048
(dp69042
g4017
g42292
sg10266
(dp69043
sg1326
g23606
sg11592
(dp69044
sg1050
g21683
sg8787
g68122
sg690
g18640
sg8055
g64939
sg8433
g66666
sg4077
g42841
sg8445
g66733
sg339
g15176
sg5289
g50295
sg7299
g60928
sg12045
(dp69045
sg5694
g52555
sg6279
g55958
sg7377
g61511
sg5853
g53553
sg3021
g36213
sg7764
g63634
sg1899
g28074
sg696
g18794
sg7947
g64377
sg4539
g46040
sg10416
(dp69046
sg11166
(dp69047
sg11733
(dp69048
sg11016
(dp69049
sg3570
g39495
sg3222
g37612
sg6315
g56303
sg4479
g45711
sg7191
g60561
sg8724
g67916
ssg9051
(dp69050
g4623
g46396
sg5427
g51002
sg2664
g33463
sg6318
g56377
sg831
g19926
sg4788
g47585
sg4803
g47652
sg4647
g46581
sg9165
(dp69051
sg7650
g63099
sg10011
(dp69052
sg8418
g66464
sg1914
g28417
sg10494
(dp69053
sg1668
g26274
sg11016
(dp69054
sg6468
g57112
sg5499
g51429
sg2088
g29934
sg2427
g32050
sg915
g20718
sg6966
g59424
sg1704
g26727
sg4716
g47087
sg2391
g31734
sg933
g20837
sg3279
g37943
sg9981
(dp69055
sg8514
g67118
sg9264
(dp69056
sg11445
(dp69057
sg963
g21007
sg10056
(dp69058
sg3978
g42006
sg6315
g56305
sg171
g13715
sg10356
(dp69059
sg5598
g52039
sg2559
g32972
sg7056
g59860
sg8580
g67296
sg11595
(dp69060
sg240
g14201
sg10857
(dp69061
sg9918
(dp69062
sg255
g14402
sg2262
g30970
sg1626
g25962
sg6921
g59273
sg11649
(dp69063
sg11652
(dp69064
sg288
g14688
sg11667
(dp69065
sg9402
(dp69066
sg3363
g38420
sg5589
g51945
sg9417
(dp69067
sg3381
g38500
sg1635
g26061
sg7941
g64307
sg7152
g60209
sg3408
g38721
sg8028
g64831
sg72
g12809
sg23
g12231
sg8721
g67872
sg7176
g60360
sg4974
g48631
sg210
g14019
sg387
g15667
sg7671
g63265
sg3444
g38879
sg414
g15975
sg780
g19369
sg11022
(dp69068
sg5805
g53290
sg9519
(dp69069
sg10041
(dp69070
sg11046
(dp69071
sg168
g13663
sg3087
g36668
sg4260
g44123
sg1263
g23203
sg8805
g68181
sg11079
(dp69072
sg10977
(dp69073
sg2067
g29654
sg2814
g34522
sg9702
(dp69074
sg7305
g60968
sg8097
g65097
sg1707
g26786
sg6639
g57983
sg5919
g53992
sg2109
g30146
sg7320
g61088
sg7299
g60931
sg6024
g54465
sg696
g18758
sg11097
(dp69075
sg1578
g25655
sg11154
(dp69076
sg564
g17391
sg11439
(dp69077
sg570
g17492
sg2418
g31921
sg4344
g44667
sg6684
g58157
sg5169
g49535
sg11910
(dp69078
sg11931
(dp69079
sg336
g15120
sg612
g17893
sg8187
g65552
sg8019
g64752
sg11112
(dp69080
sg630
g18037
sg633
g18091
sg4425
g44942
sg7422
g61824
sg11979
(dp69081
sg10470
(dp69082
sg9711
(dp69083
sg5250
g49994
sg4266
g44219
sg8259
g65869
sg4488
g45766
sg10740
(dp69084
sg3711
g40451
sg7497
g62313
sg5922
g54011
sg10515
(dp69085
sg723
g19095
sg11319
(dp69086
sg11790
(dp69087
sg2289
g31208
sg12066
(dp69088
sg5394
g50844
sg5181
g49588
sg9093
(dp69089
sg5796
g53251
sg6162
g55273
sg1605
g25767
ssg9054
(dp69090
g3027
g36352
sg6807
g58814
ssg9057
(dp69091
g5739
g52881
sg1875
g27914
sg6684
g58163
sg7545
g62575
sg4113
g43065
sg8484
g67007
sg4713
g47032
sg1938
g28558
sg396
g15808
sg3144
g37123
sg8439
g66709
sg11664
(dp69092
sg10680
(dp69093
sg10815
(dp69094
sg1113
g22200
sg753
g19230
sg10236
(dp69095
ssg9060
(dp69096
VHormone Antagonists
p69097
g24287
sVUGT1A9 Substrates
p69098
g24028
sVAgents to Treat Airway Disease
p69099
g32649
sVCytochrome P-450 CYP1A2 Substrates
p69100
g45634
sVAnalgesics, Non-Narcotic
p69101
g56911
sVLeukotriene Antagonists
p69102
g32991
sVPeripheral Nervous System Agents
p69103
g57657
sVAnalgesics
p69104
g26496
sVCytochrome P-450 CYP3A Inhibitors
p69105
g60479
sVHormones, Hormone Substitutes, and Hormone Antagonists
p69106
g53195
sVCentral Nervous System Agents
p69107
g58525
sVAnti-Inflammatory Agents
p69108
(dp69109
sVEnzyme Inhibitors
p69110
(dp69111
sVUrea
p69112
g58646
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69113
g29594
sg9156
(dp69114
sVSensory System Agents
p69115
(dp69116
sg9312
(dp69117
sVCytochrome P-450 CYP2C9 Substrates
p69118
g29827
sVCytochrome P-450 CYP3A4 Substrates
p69119
g65352
sVCytochrome P-450 CYP3A Substrates
p69120
g45271
ssg9063
(dp69121
g4200
g43526
ssg9066
(dp69122
g1470
g24930
sg3117
g36932
ssg9069
(dp69123
g69
g12755
ssg9072
(dp69124
g5736
g52845
ssg9075
(dp69125
g11112
(dp69126
sg11283
(dp69127
sg10266
(dp69128
sg2559
g32977
sg633
g18097
sg2199
g30712
sg7056
g59864
sg7422
g61829
sg450
g16353
sg8163
g65471
sg11979
(dp69129
sg1434
g24683
sg10470
(dp69130
sg10308
(dp69131
sg4266
g44199
sg1263
g23187
sg8028
g64836
sg8259
g65873
sg2418
g31925
sg2427
g32063
sg8655
g67601
sg11931
(dp69132
sg6468
g57117
sg3930
g41678
sg2910
g35559
sg8097
g65106
sg9417
(dp69133
sg11595
(dp69134
sg1704
g26733
sg3381
g38492
sg5919
g53997
sg933
g20845
sg345
g15240
sg7941
g64313
sg11097
(dp69135
sg9981
(dp69136
sg1908
g28317
sg8514
g67124
sg564
g17423
sg1668
g26286
sg4344
g44673
sg8874
g68544
sg3978
g42012
sg8721
g67877
sg5169
g49543
sg387
g15681
sg10497
(dp69137
sg915
g20731
sg10596
(dp69138
sg10815
(dp69139
sg10356
(dp69140
sg7029
g59653
sg10056
(dp69141
sg6921
g59276
ssg9078
(dp69142
g11160
(dp69143
ssg9081
(dp69144
VAgents Causing Muscle Toxicity
p69145
g55365
sVBSEP/ABCB11 Substrates
p69146
(dp69147
sVPyrimidines
p69148
g47714
sVNoxae
p69149
g65431
sVCytochrome P-450 CYP3A Substrates
p69150
g45045
sVDPP-IV Inhibitors
p69151
(dp69152
sVOATP1B1/SLCO1B1 Inhibitors
p69153
(dp69154
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p69155
(dp69156
sVEnzyme Inhibitors
p69157
(dp69158
sg6399
g56839
sVBlood Glucose Lowering Agents
p69159
(dp69160
sVLipid Modifying Agents
p69161
g40549
sVGynecological Antiinfectives and Antiseptics
p69162
(dp69163
sVAmides
p69164
g44305
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69165
g29310
sVLipid Modifying Agents, Plain
p69166
g63423
sVCytochrome P-450 CYP2C9 Substrates
p69167
g29733
sVOATP1B1/SLCO1B1 Substrates
p69168
(dp69169
sVSulfonamides
p69170
g63364
sVDrugs Used in Diabetes
p69171
g60120
sVSulfur Compounds
p69172
(dp69173
sVHypolipidemic Agents
p69174
(dp69175
sVBenzene Derivatives
p69176
g61411
sVHydroxymethylglutaryl-CoA Reductase Inhibitors
p69177
g25231
sVOAT3/SLC22A8 Substrates
p69178
g13120
sVCytochrome P-450 CYP3A5 Inhibitors
p69179
g55349
sVSulfones
p69180
g58740
sVCytochrome P-450 CYP3A4 Substrates
p69181
g65233
sVAlimentary Tract and Metabolism
p69182
g23798
sVToxic Actions
p69183
g49407
sVAnticholesteremic Agents
p69184
g50594
sVCytochrome P-450 CYP3A5 Substrates
p69185
g67805
sVGenito Urinary System and Sex Hormones
p69186
g66159
sVCytochrome P-450 CYP3A Inhibitors
p69187
g60407
sg6696
g58208
sVOAT3/SLC22A8 Inhibitors
p69188
g59006
sVBCRP/ABCG2 Substrates
p69189
g42073
sVHydrocarbons, Halogenated
p69190
(dp69191
sVLipid Regulating Agents
p69192
(dp69193
ssg9084
(dp69194
VCytochrome P-450 CYP3A4 Inhibitors
p69195
g61713
sVCytochrome P-450 CYP3A Inhibitors
p69196
g60476
sVCytochrome P-450 CYP3A Substrates
p69197
g45061
sVBCRP/ABCG2 Inhibitors
p69198
g12555
sVKinase Inhibitor
p69199
g24603
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p69200
g43791
sVEnzyme Inhibitors
p69201
(dp69202
sVCytochrome P-450 Enzyme Inhibitors
p69203
g62092
sVBlood Glucose Lowering Agents
p69204
(dp69205
sVIndoles
p69206
(dp69207
sVAngiogenesis Inhibitors
p69208
(dp69209
sVTyrosine Kinase Inhibitors
p69210
g30833
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69211
g29335
sVProtein Kinase Inhibitors
p69212
(dp69213
sVQTc Prolonging Agents
p69214
g57886
sVAntineoplastic Agents
p69215
(dp69216
sVP-glycoprotein/ABCB1 Substrates
p69217
g35060
sVCytochrome P-450 CYP3A5 Substrates
p69218
g67833
sVCytochrome P-450 CYP3A4 Substrates
p69219
g65239
sVGrowth Substances
p69220
g46126
sVHeterocyclic Compounds, Fused-Ring
p69221
g56140
sVAngiogenesis Modulating Agents
p69222
(dp69223
sVPotential QTc-Prolonging Agents
p69224
(dp69225
sVGrowth Inhibitors
p69226
g13755
sVImmunosuppressive Agents
p69227
g64596
sVHypoglycemia-Associated Agents
p69228
g17683
sVP-glycoprotein/ABCB1 Inhibitors
p69229
(dp69230
sVAntineoplastic and Immunomodulating Agents
p69231
g39827
sVCytochrome P-450 CYP3A7 Substrates
p69232
g60659
ssg9087
(dp69233
g11862
(dp69234
sg2346
g31371
sg2739
g33998
sg2928
g35616
sg30
g12366
sg11592
(dp69235
sg10884
(dp69236
sg9144
(dp69237
sg2895
g35427
sg10290
(dp69238
sg978
g21152
sg5235
g49829
sg7821
g63809
sg1239
g22947
sg10878
(dp69239
sg879
g20340
sg4656
g46776
sg6735
g58350
sg6051
g54778
sg10890
(dp69240
sg5865
g53602
sg5283
g50181
sg7884
g64100
sg7314
g61007
sg14338
g13534
sg10314
(dp69241
sg20252
(dp69242
sg9081
g69163
sg2424
g31947
sg5685
g52448
sg10275
(dp69243
sg6798
g58763
sg5157
g49432
sg2088
g29910
sg3174
g37260
sg6279
g55943
sg3657
g40169
sg5574
g51792
sg3024
g36282
sg6435
g56969
sg10164
(dp69244
sg2391
g31716
sg12072
(dp69245
sg6885
g59145
sg9486
(dp69246
sg4062
g42622
sg10578
(dp69247
sg10383
(dp69248
sg12045
(dp69249
sg11166
(dp69250
sg10548
(dp69251
sg7353
g61334
sg3231
g37643
sg1941
g28576
sg7188
g60499
sg2706
g33751
sg5973
g54248
sg6336
g56511
sg4830
g47803
sg9096
(dp69252
sg10692
(dp69253
sg204
g13954
sg6348
g56638
ssg9090
(dp69254
g2886
g35325
sg11046
(dp69255
ssg9093
(dp69256
VAdrenergic Agents
p69257
g41707
sVAdrenergic alpha-2 Receptor Agonists
p69258
g67206
sVCardiovascular Agents
p69259
g26689
sVOphthalmologicals
p69260
g35271
sVAdrenergic alpha-Agonists
p69261
g65401
sVVasoconstrictor Agents
p69262
g35892
sVSensory Organs
p69263
g40753
sVNeurotransmitter Agents
p69264
(dp69265
sVRespiratory System Agents
p69266
(dp69267
sVDecongestants and Antiallergics
p69268
(dp69269
sVNasal Decongestants
p69270
g55109
sVSympathomimetics Used as Decongestants
p69271
(dp69272
sVSympathomimetics, Plain
p69273
g14450
sVAdrenergic Agonists
p69274
(dp69275
sVAgents producing tachycardia
p69276
g50801
sVAgents that produce hypertension
p69277
g69089
sVAdrenergic alpha-1 Receptor Agonists
p69278
g67243
sVImidazoles
p69279
(dp69280
sVNasal Preparations
p69281
(dp69282
ssg9096
(dp69283
VAgents that produce neuromuscular block (indirect)
p69284
g37977
sVCarbohydrates
p69285
g61799
sVCytochrome P-450 CYP3A4 Inhibitors
p69286
g61714
sVAnti-Acne Preparations
p69287
g63935
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p69288
g43794
sVEnzyme Inhibitors
p69289
(dp69290
sVCytochrome P-450 Enzyme Inhibitors
p69291
g62100
sVAnti-Infective Agents
p69292
g54677
sVAntiinfectives for Systemic Use
p69293
(dp69294
sVLincosamides
p69295
g26222
sVGynecological Antiinfectives and Antiseptics
p69296
g69252
sVLincomycin
p69297
g14779
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69298
g29352
sVMacrolides, Lincosamides and Streptogramins
p69299
g33215
sVDecreased Sebaceous Gland Activity
p69300
g42862
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p69301
g60090
sVCytochrome P-450 CYP3A Substrates
p69302
g45074
sVProtein Synthesis Inhibitors
p69303
g45559
sVGlycosides
p69304
g68376
sVPyrrolidines
p69305
g59351
sVAnti-Bacterial Agents
p69306
g38390
sVDermatologicals
p69307
g17329
sVLincomycins
p69308
(dp69309
sVAntibacterials for Systemic Use
p69310
g32585
sVCytochrome P-450 CYP3A4 Substrates
p69311
g65245
sVNarrow Therapeutic Index Drugs
p69312
g50583
sVAnti-Acne Preparations for Topical Use
p69313
g62696
sVGenito Urinary System and Sex Hormones
p69314
g66194
sVCytochrome P-450 CYP3A Inhibitors
p69315
g60477
sVNeurotoxic agents
p69316
g68583
sVLincosamide Antibacterial
p69317
g28761
sVAntiinfectives for Treatment of Acne
p69318
(dp69319
ssg9099
(dp69320
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p69321
(dp69322
sVAnticholinergic Agents
p69323
g24479
sVCytochrome P-450 CYP2D6 Inhibitors
p69324
g62922
sVCytochrome P-450 CYP3A Substrates
p69325
g45201
sVNeurotransmitter Agents
p69326
(dp69327
sVHydroxy Acids
p69328
g18152
sVCytochrome P-450 CYP3A4 Inhibitors
p69329
g61659
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p69330
g43746
sVCytochrome P-450 Enzyme Inhibitors
p69331
g62071
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p69332
g18395
sVMuscarinic Antagonists
p69333
g48865
sVDrugs for Urinary Frequency and Incontinence
p69334
g28984
sVUrologicals
p69335
g58913
sVAutonomic Agents
p69336
g66556
sVAcids, Carbocyclic
p69337
g41554
sVPeripheral Nervous System Agents
p69338
g57600
sVUrological Agents
p69339
g38281
sVParasympatholytics
p69340
g35944
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69341
g29505
sVCytochrome P-450 CYP2C8 Inhibitors
p69342
g55015
sVCytochrome P-450 CYP3A4 Substrates
p69343
g65309
sVCytochrome P-450 CYP3A5 Substrates
p69344
g67809
sVGenito Urinary System and Sex Hormones
p69345
g66164
sVCytochrome P-450 CYP3A Inhibitors
p69346
g60418
sVCholinergic Agents
p69347
g28721
sVAgents producing tachycardia
p69348
g50758
ssg9102
(dp69349
VCytochrome P-450 CYP2C19 Substrates
p69350
g53904
sVHematologic Agents
p69351
(dp69352
sVBlood and Blood Forming Organs
p69353
g53941
sVHeterocyclic Compounds, Fused-Ring
p69354
g56170
sV4-Hydroxycoumarins
p69355
g43265
sVAnticoagulants
p69356
g58378
sVCytochrome P-450 CYP3A Substrates
p69357
g45276
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p69358
g47503
sVVitamin K Antagonists
p69359
g51684
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p69360
g37407
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p69361
g36475
sVCoumarins
p69362
g54846
sVCytochrome P-450 CYP1A2 Substrates
p69363
g45643
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69364
g29599
sVPyrans
p69365
(dp69366
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p69367
g60092
sVCytochrome P-450 CYP2C9 Substrates
p69368
g29826
sVBenzopyrans
p69369
g31327
sVCytochrome P-450 CYP3A4 Substrates
p69370
g65355
sVNarrow Therapeutic Index Drugs
p69371
g50585
ssg9105
(dp69372
VKinase Inhibitor
p69373
g24604
sVCytochrome P-450 CYP3A5 Substrates
p69374
g67836
sVMyelosuppressive Agents
p69375
(dp69376
sVCytochrome P-450 CYP2D6 Substrates
p69377
g52205
sVCytochrome P-450 CYP3A Substrates
p69378
g45100
sVImmunosuppressive Agents
p69379
g64599
sVTyrosine Kinase Inhibitors
p69380
g30834
sVCYP3A Substrates (Sensitive)
p69381
g63930
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69382
g29380
sVProtein Kinase Inhibitors
p69383
(dp69384
sVAntineoplastic and Immunomodulating Agents
p69385
g39830
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p69386
g60096
sVCytochrome P-450 CYP3A4 Substrates
p69387
g65256
sVAntineoplastic Agents
p69388
(dp69389
ssg9108
(dp69390
VRecombinant Proteins
p69391
g62635
sVEnzymes
p69392
(dp69393
sVEnzyme Replacement Therapy
p69394
g46824
sVGaucher Disease
p69395
g21956
sVGlycoside Hydrolases
p69396
g18668
sg10134
(dp69397
sVGlucosidases
p69398
g57052
sVEnzymes and Coenzymes
p69399
(dp69400
sVHydrolases
p69401
(dp69402
sVAlimentary Tract and Metabolism
p69403
g23947
ssg9111
(dp69404
VPsychoanaleptics
p69405
g59070
sVCytochrome P-450 CYP2D6 Substrates
p69406
g52142
sg8382
g66355
sVParasympathomimetics
p69407
g59099
sVNeurotransmitter Agents
p69408
(dp69409
sVCentral Nervous System Agents
p69410
g58527
sVPotential QTc-Prolonging Agents
p69411
(dp69412
sVEnzyme Inhibitors
p69413
(dp69414
sVParasympathomemetic (Cholinergic) Agents
p69415
g64019
sVPeripheral Nervous System Agents
p69416
g57658
sVDrugs that are Mainly Renally Excreted
p69417
g44059
sVAutonomic Agents
p69418
g66557
sVCholinergic Agents
p69419
g28722
sVNootropic Agents
p69420
g42800
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69421
g29506
sVQTc Prolonging Agents
p69422
g57820
sVCytochrome P-450 CYP3A Substrates
p69423
g45202
sVAnti-Dementia Drugs
p69424
g49310
sVHeterocyclic Compounds, Fused-Ring
p69425
g56076
sVCytochrome P-450 CYP3A4 Substrates
p69426
g65310
sVBenzazepines
p69427
g60331
sVBradycardia-Causing Agents
p69428
g61468
sVCholinesterase Inhibitors
p69429
(dp69430
sVAlkaloids
p69431
g19411
sVNervous System
p69432
(dp69433
ssg9114
(dp69434
g23
g12257
sg7320
g61106
sg2067
g29679
sg612
g17923
sg11445
(dp69435
sg11319
(dp69436
ssg9117
(dp69437
VDrugs that are Mainly Renally Excreted
p69438
g43818
sVCardiovascular Agents
p69439
g26514
sVOphthalmologicals
p69440
g35164
sVAntihypertensive Agents
p69441
g20241
sVCytochrome P-450 CYP3A Substrates
p69442
g44961
sVDiuretics
p69443
g57911
sVAmides
p69444
g44281
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69445
g29190
sVSensory Organs
p69446
g40668
sVSulfones
p69447
g58729
sVEnzyme Inhibitors
p69448
(dp69449
sVCytochrome P-450 CYP2C9 Substrates
p69450
g29701
sVCytochrome P-450 CYP3A4 Substrates
p69451
g65185
sVCarbonic Anhydrase Inhibitors
p69452
g64876
sVSulfur Compounds
p69453
(dp69454
sVAntiglaucoma Preparations and Miotics
p69455
g36544
ssg9120
(dp69456
g11820
(dp69457
sg4650
g46638
sg4926
g48417
sg10797
(dp69458
ssg9123
(dp69459
g4827
g47764
ssg9126
(dp69460
VAcetates
p69461
g64706
sVAntiinfectives for Systemic Use
p69462
(dp69463
sVAntivirals for Systemic Use
p69464
g59749
sVAcetamides
p69465
g67246
sVDrugs that are Mainly Renally Excreted
p69466
g43819
sVOAT3/SLC22A8 Substrates
p69467
g13101
sVAntiviral Agents
p69468
g30424
sVDirect Acting Antivirals
p69469
g38041
sVAmides
p69470
g44283
sg10956
(dp69471
sVAnti-Infective Agents
p69472
g54556
ssg9129
(dp69473
g1782
g27144
sg13750
g24346
sg8373
g66324
sg7464
g62152
sg9774
(dp69474
sg10818
(dp69475
sg11592
(dp69476
sg4635
g46469
sg10290
(dp69477
sg2940
g35705
sg11604
(dp69478
sg9903
(dp69479
sg8211
g65669
sg4653
g46686
sg6045
g54702
sg7545
g62545
sg10890
(dp69480
sg3141
g37067
sg1614
g25840
sg2046
g29117
sg14838
g39979
sg5895
g53805
sg15016
g66094
sg1491
g25056
sg6279
g55923
sg4113
g43034
sg11727
(dp69481
sg7569
g62710
sg8694
g67709
sg14338
g13530
sg9630
(dp69482
sg2895
g35435
sg5766
g52963
sg1761
g26990
sg3447
g38911
sg6345
g56562
sg12534
g52633
sg14829
g56661
ssg9132
(dp69483
VInterleukin Inhibitors
p69484
g49763
sg3642
g40086
sVSerum Globulins
p69485
g49644
sVBiologics for Rheumatoid Arthritis Treatment
p69486
g47861
sVCytochrome P-450 CYP3A4 Inducers (weak)
p69487
g19511
sVImmunoglobulins
p69488
g41511
sg5262
g50123
sVCytochrome P-450 CYP3A4 Inducers
p69489
g18870
sVAntibodies
p69490
g60975
sVAgents reducing cytokine levels
p69491
(dp69492
sVProteins
p69493
g52735
sVDisease-modifying Antirheumatic Agents
p69494
g57188
sVCytochrome P-450 Enzyme Inducers
p69495
g28107
sVCytochrome P-450 CYP3A Inducers
p69496
g66258
sVGlobulins
p69497
g19162
sVAmino Acids, Peptides, and Proteins
p69498
g47309
sVAntibodies, Monoclonal
p69499
(dp69500
sVImmunosuppressive Agents
p69501
g64534
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p69502
g64601
sVAntineoplastic and Immunomodulating Agents
p69503
g39720
sVAntirheumatic Agents
p69504
g24206
sVBlood Proteins
p69505
g39840
sVImmunoproteins
p69506
g57439
ssg9135
(dp69507
VAmino Acids, Peptides, and Proteins
p69508
g47347
sVProtein Synthesis Inhibitors
p69509
g45550
sVPeptides, Cyclic
p69510
(dp69511
sVHeterocyclic Compounds, Fused-Ring
p69512
g56034
sVMyelosuppressive Agents
p69513
(dp69514
sg9993
(dp69515
sVImmunosuppressive Agents
p69516
g64558
sVAntibiotics, Antineoplastic
p69517
g30413
sVP-glycoprotein/ABCB1 Substrates
p69518
g34905
sVBCRP/ABCG2 Substrates
p69519
g42050
sVAntineoplastic Agents
p69520
(dp69521
sVP-glycoprotein/ABCB1 Inhibitors
p69522
(dp69523
sVPeptides
p69524
g47176
sVCytotoxic Antibiotics and Related Substances
p69525
g50172
sVAntineoplastic and Immunomodulating Agents
p69526
g39721
sVEnzyme Inhibitors
p69527
(dp69528
sVNucleic Acid Synthesis Inhibitors
p69529
g48734
sVAnti-Infective Agents
p69530
g54599
sg9330
(dp69531
ssg9138
(dp69532
g2886
g35292
sg11046
(dp69533
ssg9141
(dp69534
g9417
(dp69535
ssg9144
(dp69536
VCytochrome P-450 CYP3A4 Inhibitors
p69537
g61642
sVOAT1/SLC22A6 inhibitors
p69538
(dp69539
sVCentral Nervous System Agents
p69540
g58490
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p69541
g43737
sVEnzyme Inhibitors
p69542
(dp69543
sVCytochrome P-450 Enzyme Inhibitors
p69544
g61946
sVCarbonic Anhydrase Inhibitors
p69545
g64877
sVGynecological Antiinfectives and Antiseptics
p69546
g69237
sVThiadiazoles
p69547
g39220
sVSulfur Compounds
p69548
(dp69549
sVSulfonamides
p69550
g63354
sVDiuretics
p69551
g57898
sVCentral Nervous System Depressants
p69552
(dp69553
sVCardiovascular Agents
p69554
g26643
sVThiazoles
p69555
g49132
sVAnticonvulsants
p69556
g60141
sVSensory Organs
p69557
g40670
sVAntiglaucoma Preparations and Miotics
p69558
g36548
sVOphthalmologicals
p69559
g35222
sVGenito Urinary System and Sex Hormones
p69560
g66157
sg2514
g32705
sVNatriuretic Agents
p69561
g40479
sVCytochrome P-450 CYP3A Inhibitors
p69562
g60398
ssg9147
(dp69563
g603
g17759
ssg9150
(dp69564
g702
g18818
ssg9153
(dp69565
VPiperidines
p69566
(dp69567
sVGlucosylceramide Synthase Inhibitors
p69568
(dp69569
sg9228
(dp69570
sVVarious Alimentary Tract and Metabolism Products
p69571
g43554
sVCarbohydrates
p69572
g61750
sVImino Sugars
p69573
g19105
sVImines
p69574
g63656
sVGaucher Disease
p69575
g21955
sVGlucosylceramide Synthase Inhibitor
p69576
g25280
sVAnti-HIV Agents
p69577
g66391
sVAlkaloids
p69578
g19392
sVEnzyme Inhibitors
p69579
(dp69580
sVAnti-Infective Agents
p69581
g54555
sVImino Pyranoses
p69582
g53344
sVAlimentary Tract and Metabolism
p69583
g23750
sVMiscellaneous Therapeutic Agents
p69584
(dp69585
ssg9156
(dp69586
g9060
g69114
sg11955
(dp69587
ssg9159
(dp69588
g10200
(dp69589
sg21710
g54040
sg3699
g40338
sg3105
g36761
sg8529
g67194
sg5556
g51710
sg8022
g64773
sg8439
g66689
sg7680
g63291
sg9660
(dp69590
sg10272
(dp69591
sg8340
g66216
sg6150
g55185
sg1581
g25680
sg11664
(dp69592
sg2826
g34613
sg10245
(dp69593
sg12186
g42911
sg5511
g51468
ssg9162
(dp69594
g2142
g30341
sg1461
g24797
sg11172
(dp69595
sg3639
g40080
sg7527
g62445
sg9471
(dp69596
sg5193
g49624
ssg9165
(dp69597
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p69598
(dp69599
sVAnti-Parkinson Drugs
p69600
g16144
sVCytochrome P-450 CYP2D6 Inhibitors
p69601
g62901
sVCytochrome P-450 CYP2D6 Substrates
p69602
g52110
sVSerotonin Agents
p69603
(dp69604
sVCytochrome P-450 CYP3A Substrates
p69605
g44963
sVNeurotransmitter Agents
p69606
(dp69607
sVHypotensive Agents
p69608
g34106
sVDopamine Agents
p69609
g14232
sVCytochrome P-450 Enzyme Inhibitors
p69610
g61947
sVNonergot-derivative Dopamine Receptor Agonists
p69611
g60816
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69612
g29193
sVSulfur Compounds
p69613
(dp69614
sVCentral Nervous System Depressants
p69615
(dp69616
sVDopamine Agonists
p69617
g56755
sVAgents that produce hypertension
p69618
g69051
sVCytochrome P-450 CYP3A4 Substrates
p69619
g65186
sVNaphthalenes
p69620
g66086
sVSerotonin 5-HT1 Receptor Agonists
p69621
g34594
sVAntidepressive Agents
p69622
g15496
sVAnti-Parkinson Agents (Dopamine Agonist)
p69623
g25596
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p69624
g53066
sVSerotonin Receptor Agonists
p69625
(dp69626
sVNervous System
p69627
(dp69628
ssg9168
(dp69629
g4806
g47678
sg9918
(dp69630
sg9924
(dp69631
sg9696
(dp69632
sg10818
(dp69633
sg4635
g46483
sg4827
g47771
sg8595
g67347
sg4647
g46573
sg255
g14380
sg5250
g49978
sg3318
g38181
sg3885
g41444
sg5805
g53276
sg11649
(dp69634
sg4488
g45755
sg1491
g25073
sg2067
g29634
sg7485
g62263
sg6906
g59211
sg11319
(dp69635
sg1881
g27949
sg11874
(dp69636
sg7464
g62164
sg8820
g68262
sg7569
g62722
sg3399
g38628
sg5334
g50519
sg138
g13285
sg19588
g32473
sg11445
(dp69637
sg6315
g56292
sg4419
g44890
sg3447
g38927
sg1635
g26044
sg612
g17865
sg5598
g52017
ssg9171
(dp69638
g8373
g66319
sg690
g18610
sg9126
g69463
sg10377
(dp69639
sg30
g12362
sg135
g13239
sg6204
g55560
sg7821
g63801
sg11427
(dp69640
sg279
g14480
sg4872
g47983
sg7653
g63114
sg6231
g55729
sg354
g15271
sg9192
(dp69641
sg3141
g37061
sg6240
g55757
sg9198
(dp69642
sg5871
g53638
sg2046
g29111
sg8448
g66752
sg9954
(dp69643
sg8454
g66815
sg2436
g32165
sg15016
g66105
sg3174
g37258
sg6279
g55939
sg5520
g51526
sg4707
g46970
sg7377
g61490
sg4710
g46996
sg9750
(dp69644
sg126
g13156
sg3849
g41162
sg3207
g37465
sg7005
g59518
sg7500
g62343
sg11541
(dp69645
sg972
g21108
sg9282
(dp69646
sg7878
g64037
sg9630
(dp69647
sg1761
g26973
sg4782
g47509
sg8559
g67226
sg1110
g22119
sg7155
g60217
sg4005
g42155
sg3267
g37884
sg8616
g67448
sg1782
g27136
sg10833
(dp69648
sg4017
g42276
sg1278
g23316
sg1101
g22057
sg11592
(dp69649
sg7884
g64097
sg8781
g68084
sg4830
g47797
sg11604
(dp69650
sg1047
g21598
sg1050
g21663
sg4857
g47876
sg8622
g67473
sg7881
g64062
sg4881
g48049
sg8049
g64891
sg3132
g37002
sg9432
(dp69651
sg13070
g21885
sg6432
g56925
sg9663
(dp69652
sg4773
g47474
sg318
g14914
sg11685
(dp69653
sg6348
g56635
sg4911
g48221
sg11967
(dp69654
sg11694
(dp69655
sg9426
(dp69656
sg4920
g48335
sg2652
g33308
sg6435
g56966
sg1872
g27849
sg12078
(dp69657
sg1899
g28054
sg7947
g64368
sg11508
(dp69658
sg2667
g33499
sg11733
(dp69659
sg11208
(dp69660
sg11184
(dp69661
sg4164
g43302
sg1173
g22623
sg11451
(dp69662
sg11385
(dp69663
sg9507
(dp69664
sg7815
g63754
sg3912
g41605
sg10275
(dp69665
sg10914
(dp69666
sg12051
(dp69667
sg2481
g32402
sg1539
g25289
sg1239
g22942
sg7074
g59989
sg11052
(dp69668
sg5847
g53505
sg11061
(dp69669
sg11838
(dp69670
sg5865
g53599
sg10326
(dp69671
sg5082
g49018
sg8079
g65008
sg4299
g44418
sg2808
g34466
sg1311
g23511
sg2838
g34792
sg8850
g68392
sg1503
g25174
sg3021
g36187
sg1527
g25241
sg1332
g23638
sg9627
(dp69672
sg6183
g55447
sg7662
g63163
sg573
g17536
sg11166
(dp69673
sg3576
g39568
sg9657
(dp69674
sg5295
g50331
sg3291
g37992
sg2895
g35419
sg10878
(dp69675
sg6075
g54868
sg1863
g27747
sg4953
g48475
sg8922
g68677
sg5208
g49718
sg6549
g57468
sg438
g16165
sg11229
(dp69676
sg10725
(dp69677
sg6933
g59292
sg2940
g35693
sg8211
g65664
sg10479
(dp69678
sg12000
(dp69679
sg12003
(dp69680
sg9726
(dp69681
sg8238
g65745
sg7470
g62221
sg8985
g68840
sg4479
g45687
sg1482
g24999
sg2991
g35953
sg2418
g31903
sg2460
g32271
sg2250
g30844
sg10509
(dp69682
sg10368
(dp69683
sg5736
g52831
sg2274
g31066
sg1176
g22658
sg7905
g64156
sg4539
g46024
sg2739
g33995
sg8298
g66023
sg8493
g67064
sg11334
(dp69684
sg3795
g40916
sg8577
g67263
sg10611
(dp69685
sg3090
g36685
sg6654
g58050
sg9096
g69294
sg7524
g62413
sg12123
(dp69686
sg10305
(dp69687
sg819
g19743
ssg9174
(dp69688
g5739
g52862
sg5487
g51357
sg6261
g55842
ssg9177
(dp69689
g9987
(dp69690
ssg9180
(dp69691
VMATE 2 Substrates with a Narrow Therapeutic Index
p69692
g24339
sVOAT1/SLC22A6 inhibitors
p69693
(dp69694
sVCytochrome P-450 CYP3A Substrates
p69695
g45009
sVBCRP/ABCG2 Inhibitors
p69696
g12545
sVOCT2 Inhibitors
p69697
g42485
sVDrugs that are Mainly Renally Excreted
p69698
g43847
sVMATE substrates
p69699
(dp69700
sVAmides
p69701
g44339
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69702
g29260
sVSulfur Compounds
p69703
(dp69704
sVOATP1B3 inhibitors
p69705
g62285
sVSulfones
p69706
g58748
sg4692
g46953
sVMATE 2 Inhibitors
p69707
g52718
sVSelective Immunosuppressants
p69708
g23573
sVOAT3/SLC22A8 Substrates
p69709
g13137
sVP-glycoprotein/ABCB1 Substrates
p69710
g35033
sVCytochrome P-450 CYP3A4 Substrates
p69711
g65210
sg3069
g36571
sVMATE 2 Substrates
p69712
g44492
sVMATE inhibitors
p69713
g58954
sVImmunosuppressive Agents
p69714
g64581
sVOAT3/SLC22A8 Inhibitors
p69715
g59015
sVBCRP/ABCG2 Substrates
p69716
g42087
sVAntineoplastic and Immunomodulating Agents
p69717
g39798
sVAzetines
p69718
g66253
ssg9183
(dp69719
g9765
(dp69720
ssg9186
(dp69721
g11175
(dp69722
ssg9189
(dp69723
g687
g18545
sg8580
g67280
ssg9192
(dp69724
VAntivirals for Systemic Use
p69725
g59757
sVNucleic Acid Synthesis Inhibitors
p69726
g48730
sVOAT1/SLC22A6 inhibitors
p69727
(dp69728
sg9999
(dp69729
sVDirect Acting Antivirals
p69730
g38054
sg2565
g32996
sg10665
(dp69731
sVAntiinfectives for Systemic Use
p69732
g69641
sVDrugs that are Mainly Renally Excreted
p69733
g43823
sg5259
g50121
sVCytochrome P-450 CYP1A2 Substrates
p69734
g45571
sVNephrotoxic agents
p69735
g57706
sVAnti-Infective Agents
p69736
g54563
sg4899
g48135
sVOCT1 inhibitors
p69737
g66922
sVMATE 1 Substrates
p69738
g23496
sVOCT1 substrates
p69739
g13082
sVOAT3/SLC22A8 Substrates
p69740
g13114
sVMATE substrates
p69741
(dp69742
sVDermatologicals
p69743
g17191
sg9843
(dp69744
sVNucleosides and Nucleotides
p69745
g39106
sg5550
g51696
sVSensory Organs
p69746
g40676
sVPurines
p69747
(dp69748
sVOAT1/SLC22A6 Substrates
p69749
g60717
sVMATE 2 Substrates
p69750
g44486
sVHeterocyclic Compounds, Fused-Ring
p69751
g56039
sVOphthalmologicals
p69752
g35175
sVOAT3/SLC22A8 Inhibitors
p69753
g59003
sVAntiviral Agents
p69754
g30438
ssg9195
(dp69755
g8493
g67075
ssg9198
(dp69756
VAgents Causing Muscle Toxicity
p69757
g55361
sVBSEP/ABCB11 Substrates
p69758
(dp69759
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p69760
(dp69761
sVAntivirals for Systemic Use
p69762
g59760
sVBreast Cancer Resistance Protein Inhibitors
p69763
g12722
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p69764
g46317
sVCytochrome P-450 CYP2D6 Substrates
p69765
g52150
sVCytochrome P-450 CYP2C19 Inducers
p69766
g25534
sVCytochrome P-450 CYP3A Substrates
p69767
g44965
sVCytochrome P450 2D6 Inhibitors
p69768
(dp69769
sVCytochrome P-450 CYP3A4 Inhibitors
p69770
g61667
sVBCRP/ABCG2 Inhibitors
p69771
g12522
sVDirect Acting Antivirals
p69772
g38057
sVEnzyme Inhibitors
p69773
(dp69774
sVAnti-HIV Agents
p69775
g66396
sVBCRP/ABCG2 Substrates
p69776
g42068
sVCytochrome P-450 CYP3A7 Inhibitors
p69777
(dp69778
sVCytochrome P-450 CYP2C9 Inducers
p69779
g20042
sVAnti-Infective Agents
p69780
g54565
sVCytochrome P-450 Enzyme Inhibitors
p69781
g61963
sVHyperglycemia-Associated Agents
p69782
g68806
sVAntiinfectives for Systemic Use
p69783
g69642
sVCytochrome P-450 CYP3A7 Inhibitors (strong)
p69784
g64031
sVAnti-Retroviral Agents
p69785
g67146
sVCytochrome P-450 CYP2D6 Inhibitors
p69786
g62927
sVCytochrome P-450 CYP2B6 Inducers
p69787
g39125
sg10686
(dp69788
sVCytochrome P450 1A2 Inducers
p69789
(dp69790
sVCytochrome P-450 CYP2E1 Inhibitors
p69791
g46841
sVCytochrome P450 3A4 Inhibitors
p69792
g13039
sVUGT1A1 Inducers
p69793
g39240
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69794
g29197
sVSulfur Compounds
p69795
(dp69796
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p69797
g41078
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p69798
g16523
sVP-glycoprotein/ABCB1 Inhibitors
p69799
(dp69800
sVCytochrome P450 3A Inducers
p69801
g67083
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p69802
g25143
sVCytochrome P-450 CYP3A4 Inducers
p69803
g18884
sVCytochrome P-450 CYP1A2 Inhibitors
p69804
g15008
sVOATP1B1/SLCO1B1 Inhibitors
p69805
(dp69806
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p69807
g44467
sVCytochrome P-450 CYP3A5 Inducers
p69808
g41742
sVCytochrome P-450 CYP1A2 Inducers
p69809
g68381
sVCytochrome P450 2C19 Inducers
p69810
g57046
sVP-glycoprotein/ABCB1 Substrates
p69811
g34978
sVThiazoles
p69812
g49136
sVAntivirals for treatment of HCV infections
p69813
g31037
sVCytochrome P-450 CYP2C8 Inhibitors
p69814
g55003
sVCytochrome P-450 CYP2B6 Inhibitors
p69815
g45929
sVP-glycoprotein/ABCB1 Inducers
p69816
(dp69817
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p69818
(dp69819
sVProtease Inhibitors
p69820
g51092
sVHIV Protease Inhibitors
p69821
(dp69822
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p69823
g26863
sVCytochrome P-450 Enzyme Inducers
p69824
g28163
sVCytochrome P-450 CYP3A Inducers
p69825
g66263
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p69826
g44548
sVCytochrome P-450 CYP2C19 Inhibitors
p69827
g61268
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p69828
g17444
sVCytochrome P-450 CYP3A Inhibitors (strong)
p69829
g13390
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p69830
g49330
sVQTc Prolonging Agents
p69831
g57828
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p69832
g58925
sVCytochrome P-450 CYP3A4 Substrates
p69833
g65188
sVCytochrome P450 2C9 Inducers
p69834
g61111
sVCytochrome P-450 CYP3A5 Substrates
p69835
g67814
sVCytochrome P-450 CYP3A5 Inhibitors
p69836
g55345
sVPotential QTc-Prolonging Agents
p69837
(dp69838
sVAcids, Acyclic
p69839
g25452
sVCytochrome P-450 CYP2C8 Inducers
p69840
g60374
sVCytochrome P-450 CYP3A Inhibitors
p69841
g60427
sVCytochrome P-450 CYP3A7 Inducers
p69842
g39040
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p69843
(dp69844
sVAntiviral Agents
p69845
g30441
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p69846
g65406
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p69847
(dp69848
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p69849
g64605
sVCytochrome P450 3A Inhibitors
p69850
g54269
sVCytochrome P-450 CYP3A7 Inducers (strength unknown)
p69851
g58243
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p69852
(dp69853
sVChemically-Induced Disorders
p69854
g21228
sVCytochrome P-450 CYP3A7 Substrates
p69855
g60657
sVCytochrome P-450 CYP2B6 Substrates
p69856
g33011
ssg9201
(dp69857
g3036
g36436
ssg9204
(dp69858
g630
g18015
sg1425
g24547
sg240
g14183
sg6318
g56351
sg9711
(dp69859
sg10674
(dp69860
sg282
g14548
sg8805
g68172
sg11016
(dp69861
sg822
g19806
sg7299
g60914
sg5694
g52538
sg1707
g26766
sg6966
g59404
sg405
g15887
sg2265
g31004
sg12066
(dp69862
sg5535
g51656
sg486
g16647
sg696
g18723
sg11790
(dp69863
sg7497
g62304
sg6303
g56211
sg3570
g39474
sg5169
g49514
sg10350
(dp69864
sg2664
g33437
sg10815
(dp69865
sg1194
g22814
sg414
g15955
sg8187
g65538
sg780
g19351
ssg9207
(dp69866
g4911
g48228
sg12123
(dp69867
sg1656
g26159
ssg9210
(dp69868
g6246
g55783
sg4491
g45789
sg6843
g58957
ssg9213
(dp69869
g6048
g54747
sg5370
g50673
ssg9216
(dp69870
VDrugs that are Mainly Renally Excreted
p69871
g43824
sVGlycosides
p69872
g68368
sVBenzene Derivatives
p69873
g61401
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p69874
g39022
sVCarbohydrates
p69875
g61755
sVHypotensive Agents
p69876
g34115
sVSodium-Glucose Transporter 2 Inhibitors
p69877
g46284
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p69878
(dp69879
sVOral Hypoglycemics
p69880
g36007
sVBlood Glucose Lowering Agents
p69881
(dp69882
sVAlimentary Tract and Metabolism
p69883
g23779
sVDrugs Used in Diabetes
p69884
g60119
sVDiuretics
p69885
g57902
ssg9219
(dp69886
g11358
(dp69887
ssg9222
(dp69888
g4017
g42283
sg3105
g36784
sg3858
g41223
sg8928
g68709
sg4650
g46620
sg10797
(dp69889
sg7458
g62114
sg8022
g64788
sg6033
g54523
sg6699
g58226
sg4077
g42836
sg4491
g45800
sg11268
(dp69890
sg4902
g48147
sg11820
(dp69891
sg8217
g65699
sg4926
g48396
sg12078
(dp69892
sg6015
g54389
sg9081
g69175
sg6537
g57404
sg7809
g63720
sg8808
g68200
ssg9225
(dp69893
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p69894
(dp69895
sVSteroids
p69896
g56412
sVSex Hormones and Modulators of the Genital System
p69897
g19610
sg4659
g46810
sVCytochrome P-450 CYP3A Substrates
p69898
g44969
sg11814
(dp69899
sVHormones
p69900
g55661
sVCytochrome P-450 CYP2C9 Inhibitors
p69901
g18186
sVCytochrome P-450 Enzyme Inhibitors
p69902
g61950
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p69903
(dp69904
sVContraceptive Agents, Male
p69905
g62105
sVHormonal Contraceptives for Systemic Use
p69906
g60099
sVDrugs that are Mainly Renally Excreted
p69907
g43826
sVCorpus Luteum Hormones
p69908
g33291
sVProgesterone and Derivatives
p69909
g39659
sVProgesterone Congeners
p69910
(dp69911
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69912
g29203
sVContraceptives, Oral
p69913
(dp69914
sVFused-Ring Compounds
p69915
g14820
sVHyperglycemia-Associated Agents
p69916
g68798
sVCytochrome P-450 CYP3A4 Inducers
p69917
g18891
sVAntineoplastic Agents
p69918
(dp69919
sVPregnenediones
p69920
g29968
sVAdrenal Cortex Hormones
p69921
g30017
sVReproductive Control Agents
p69922
g18840
sVProgestins
p69923
g43093
sVCytochrome P-450 CYP2C8 Inhibitors
p69924
g55007
sVCombination Contraceptives (with Estrogen and derivatives)
p69925
g31048
sVAntineoplastic Agents, Hormonal
p69926
(dp69927
sVCytochrome P-450 Enzyme Inducers
p69928
g28223
sVCytochrome P-450 CYP3A Inducers
p69929
g66268
sVContraceptives, Oral, Synthetic
p69930
(dp69931
sVCytochrome P-450 CYP3A4 Substrates
p69932
g65190
sVGonadal Hormones
p69933
g33572
sVPregnanes
p69934
g63603
sVHydroxyprogesterones
p69935
g67085
sVContraceptive Agents, Female
p69936
g67782
sVGenito Urinary System and Sex Hormones
p69937
g66158
sVGonadal Steroid Hormones
p69938
g67214
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p69939
g64610
sVProgestin Contraceptives
p69940
g51700
sVHormones and Related Agents
p69941
g57369
sVPregnenes
p69942
g28754
sVAntineoplastic and Immunomodulating Agents
p69943
g39737
sVHormones, Hormone Substitutes, and Hormone Antagonists
p69944
g53141
sVEndocrine Therapy
p69945
g19572
ssg9228
(dp69946
g5889
g53764
sg9153
g69570
sg2397
g31776
ssg9231
(dp69947
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p69948
g52088
sg11397
(dp69949
sVCytochrome P-450 CYP2D6 Inhibitors
p69950
g62908
sVOAT1/SLC22A6 inhibitors
p69951
(dp69952
sVCytochrome P-450 CYP3A Substrates
p69953
g44970
sVCytochrome P-450 CYP3A4 Inhibitors
p69954
g61637
sg6852
g59013
sVBSEP/ABCB11 Inhibitors
p69955
g62524
sVOCT2 Inhibitors
p69956
g42478
sg10650
(dp69957
sVCytochrome P-450 CYP2C9 Inhibitors
p69958
g18187
sg51
g12674
sVCytochrome P-450 Enzyme Inhibitors
p69959
g61951
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p69960
(dp69961
sVCytochrome P-450 CYP3A4 Substrates
p69962
g65191
sVEnzyme Inhibitors
p69963
(dp69964
sg798
g19510
sg2241
g30826
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69965
g29204
sVQTc Prolonging Agents
p69966
g57796
sVCytochrome P-450 CYP3A4 Inducers
p69967
g18893
sVAntineoplastic Agents
p69968
(dp69969
sVBenzene Derivatives
p69970
g61402
sVCytochrome P-450 CYP1A2 Inhibitors
p69971
g15024
sVCytochrome P-450 CYP2C8 Inhibitors
p69972
g55008
sg4518
g45933
sVP-glycoprotein/ABCB1 Substrates
p69973
g34928
sg5541
g51686
sVUrea
p69974
g58642
sVCytochrome P-450 Enzyme Inducers
p69975
g28133
sVCytochrome P-450 CYP3A Inducers
p69976
g66269
sVCytochrome P-450 CYP2C19 Inhibitors
p69977
g61258
sg11739
(dp69978
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p69979
g49337
sVModerate Risk QTc-Prolonging Agents
p69980
g67172
sVHeterocyclic Compounds, Fused-Ring
p69981
g56051
sg1428
g24592
sVCytochrome P-450 CYP3A Inhibitors
p69982
g60393
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p69983
(dp69984
sVBCRP/ABCG2 Substrates
p69985
g42078
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p69986
g53076
sVAntineoplastic and Immunomodulating Agents
p69987
g39739
ssg9234
(dp69988
VHeterocyclic Compounds, Fused-Ring
p69989
g56052
sVCytochrome P-450 CYP3A Substrates
p69990
g44971
sVP-glycoprotein/ABCB1 Substrates
p69991
g34929
sVDioxoles
p69992
(dp69993
sVP-glycoprotein/ABCB1 Inhibitors
p69994
(dp69995
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p69996
g29205
sVCytochrome P-450 CYP3A5 Substrates
p69997
g67800
sVCytochrome P-450 CYP3A4 Substrates
p69998
g65192
ssg9237
(dp69999
g10557
(dp70000
sg7764
g63629
sg8433
g66659
sg3696
g40288
sg1857
g27709
sg4452
g45434
sg684
g18503
ssg9240
(dp70001
g11838
(dp70002
ssg9243
(dp70003
g945
g20900
sg9966
(dp70004
ssg9246
(dp70005
g11133
(dp70006
sg8751
g67965
ssg9249
(dp70007
VDrugs that are Mainly Renally Excreted
p70008
g43926
sVPyrimidines
p70009
g47692
sVProtein Kinase Inhibitors
p70010
(dp70011
sVMAP Kinase Kinase 1, antagonists & inhibitors
p70012
g32703
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p70013
g46321
sVMAP Kinase Kinase 2, antagonists & inhibitors
p70014
g50702
sVCytochrome P-450 CYP2C8 Inhibitors
p70015
g54998
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p70016
g64602
sVPyridines
p70017
g64223
sVKinase Inhibitor
p70018
g24583
sVCytochrome P-450 Enzyme Inducers
p70019
g28109
sVCytochrome P-450 CYP3A Inducers
p70020
g66259
sVAntineoplastic and Immunomodulating Agents
p70021
g39723
sVEnzyme Inhibitors
p70022
(dp70023
sVCytochrome P-450 Enzyme Inhibitors
p70024
g62015
sVCytochrome P-450 CYP3A4 Inducers
p70025
g18872
sVAntineoplastic Agents
p70026
(dp70027
ssg9252
(dp70028
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p70029
(dp70030
sVAnti-Parkinson Drugs
p70031
g16156
sVAmino Acids, Cyclic
p70032
g27286
sVNeurotransmitter Agents
p70033
(dp70034
sVHypotensive Agents
p70035
g34120
sVCentral Nervous System Agents
p70036
g58419
sVDopamine Agents
p70037
g14255
sg10476
(dp70038
sg7863
g64025
sVAmino Acids
p70039
g43111
sVAmines
p70040
g42676
sVBiogenic Monoamines
p70041
(dp70042
sg3918
g41627
sVAmino Acids, Aromatic
p70043
(dp70044
sVCentral Nervous System Depressants
p70045
(dp70046
sVPhenols
p70047
g65124
sVBenzene Derivatives
p70048
g61436
sVBiogenic Amines
p70049
g58003
sVAnti-Dyskinesia Agents
p70050
g50487
sVCatecholamines
p70051
g19122
sg11520
(dp70052
sVAmino Acids, Peptides, and Proteins
p70053
g47326
sVCatechols
p70054
(dp70055
sg2880
g35285
sg10038
(dp70056
sVAnti-Parkinson Agents (Dopamine Agonist)
p70057
g25591
sVNervous System
p70058
(dp70059
ssg9255
(dp70060
g4014
g42235
sg6765
g58610
sg1365
g24050
sg4917
g48308
sg10839
(dp70061
sg11313
(dp70062
sg6009
g54343
sg13091
g21405
sg2466
g32348
sg10374
(dp70063
sg10275
(dp70064
sg3258
g37817
sg7848
g63978
sg3930
g41652
sg8190
g65577
ssg9258
(dp70065
g477
g16608
sg4068
g42778
sg11799
(dp70066
sg5880
g53729
sg3609
g39696
sg9411
(dp70067
ssg9261
(dp70068
VAgents that produce neuromuscular block (indirect)
p70069
g37975
sVNephrotoxic agents
p70070
g57709
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p70071
g59976
sVAminoglycoside Antibacterials
p70072
g52730
sVCarbohydrates
p70073
g61757
sVAmebicides
p70074
(dp70075
sVIntestinal Antiinfectives
p70076
g68570
sVAntiparasitic Agents
p70077
g40657
sVAnti-Bacterial Agents
p70078
g38324
sVAntiprotozoals
p70079
g59372
sVAnti-Infective Agents
p70080
g54575
sVGlycosides
p70081
g68370
sVAlimentary Tract and Metabolism
p70082
g23853
sVNarrow Therapeutic Index Drugs
p70083
g50572
ssg9264
(dp70084
VNeurotransmitter Agents
p70085
(dp70086
sVSympathomimetics
p70087
g48816
sVSympathomimetics, Plain
p70088
g14446
sVPeripheral Nervous System Agents
p70089
g57586
sVVasoconstrictor Agents
p70090
g35887
sVAutonomic Agents
p70091
g66551
sVRespiratory System Agents
p70092
(dp70093
sVImidazoles
p70094
(dp70095
sVAdrenergic Agents
p70096
g41717
sVCardiovascular Agents
p70097
g26548
sg10932
(dp70098
sVDecongestants and Antiallergics
p70099
(dp70100
sVNasal Decongestants
p70101
g55110
sVSympathomimetics Used as Decongestants
p70102
(dp70103
sVAdrenergic Agonists
p70104
(dp70105
sVAgents that produce hypertension
p70106
g69056
sVNasal Preparations
p70107
(dp70108
sVAdrenergic alpha-2 Receptor Agonists
p70109
g67204
sg10023
(dp70110
sVOphthalmologicals
p70111
g35186
sVAdrenergic alpha-Agonists
p70112
g65398
sVAgents producing tachycardia
p70113
g50751
sVAdrenergic alpha-1 Receptor Agonists
p70114
g67241
sVSensory Organs
p70115
g40684
ssg9267
(dp70116
VCytochrome P-450 CYP3A4 Inhibitors
p70117
g61644
sg3123
g36950
sVHypotensive Agents
p70118
g34123
sVAnti-HIV Agents
p70119
g66400
sVBiological Factors
p70120
g38097
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p70121
g43739
sVCytochrome P-450 Enzyme Inhibitors
p70122
g61952
sVAnti-Infective Agents
p70123
g54577
sg6042
g54688
sVDrugs that are Mainly Renally Excreted
p70124
g43827
sVAdjuvants, Immunologic
p70125
g39435
sVMyelosuppressive Agents
p70126
(dp70127
sg11400
(dp70128
sVCytochrome P-450 CYP2E1 Inhibitors
p70129
g46843
sVAntineoplastic Agents
p70130
(dp70131
sg3996
g42118
sVProteins
p70132
g52739
sVPeptides
p70133
g47169
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p70134
g26882
sVAmino Acids, Peptides, and Proteins
p70135
g47327
sVIntercellular Signaling Peptides and Proteins
p70136
g25424
sVCytochrome P-450 CYP3A Inhibitors
p70137
g60400
sVImmunosuppressive Agents
p70138
g64545
sg2601
g33135
sVAntineoplastic and Immunomodulating Agents
p70139
g39742
sVCytokines
p70140
g62895
ssg9270
(dp70141
g12000
(dp70142
sg11967
(dp70143
sg9135
g69511
sg9426
(dp70144
sg8577
g67260
sg2940
g35695
sg9846
(dp70145
sg9630
(dp70146
sg11079
(dp70147
sg3090
g36689
sg8781
g68101
sg7905
g64163
sg9906
(dp70148
sg609
g17826
sg11067
(dp70149
sg5946
g54177
ssg9273
(dp70150
VCytochrome P-450 CYP2D6 Inhibitors
p70151
g62912
sVCytochrome P-450 CYP3A Substrates
p70152
g44973
sVAgents causing angioedema
p70153
g63910
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p70154
(dp70155
sVKinase Inhibitor
p70156
g24599
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p70157
(dp70158
sVCytochrome P-450 Enzyme Inhibitors
p70159
g61953
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p70160
g18408
sg4950
g48472
sVHyperglycemia-Associated Agents
p70161
g68799
sVMyelosuppressive Agents
p70162
(dp70163
sVLactones
p70164
(dp70165
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70166
g29208
sVAnti-Bacterial Agents
p70167
g38327
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p70168
g60086
sVAntineoplastic Agents
p70169
(dp70170
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p70171
g49154
sVP-glycoprotein/ABCB1 Substrates
p70172
g34938
sVCytochrome P-450 CYP3A5 Inhibitors
p70173
g55346
sVMacrolides
p70174
g16912
sVProtein Kinase Inhibitors
p70175
(dp70176
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p70177
(dp70178
sVCytochrome P-450 CYP3A4 Substrates
p70179
g65194
sVNarrow Therapeutic Index Drugs
p70180
g50576
sVCytochrome P-450 CYP3A5 Substrates
p70181
g67803
sVCytochrome P-450 CYP3A Inhibitors
p70182
g60402
sVImmunosuppressive Agents
p70183
g64546
sVP-glycoprotein/ABCB1 Inhibitors
p70184
(dp70185
sVAntineoplastic and Immunomodulating Agents
p70186
g39743
sVCytochrome P-450 CYP3A7 Substrates
p70187
g60648
ssg9276
(dp70188
g2703
g33733
ssg9279
(dp70189
g11775
(dp70190
sg6474
g57173
sg7719
g63484
ssg9282
(dp70191
VAntiinfectives for Systemic Use
p70192
g69646
sVHeterocyclic Compounds, Fused-Ring
p70193
g56141
sVbeta-Lactams
p70194
(dp70195
sVNephrotoxic agents
p70196
g57711
sVLactams
p70197
g22289
sVAmides
p70198
g44302
sVThiazines
p70199
g16417
sVSulfur Compounds
p70200
(dp70201
sVAnti-Bacterial Agents
p70202
g38329
sVAntibacterials for Systemic Use
p70203
g32521
sVSecond-Generation Cephalosporins
p70204
g52316
sVCephalosporins
p70205
g49066
sVAnti-Infective Agents
p70206
g54580
ssg9285
(dp70207
g1059
g21779
ssg9288
(dp70208
g8277
g65940
ssg9291
(dp70209
VAntimuscarinics Antispasmodics
p70210
g31224
ssg9294
(dp70211
g11316
(dp70212
sg543
g17126
sg4236
g43726
ssg9297
(dp70213
g7314
g61013
sg10164
(dp70214
sg6885
g59154
sg20252
(dp70215
sg9486
(dp70216
sg10383
(dp70217
sg4656
g46802
ssg9300
(dp70218
VAmino Acids, Peptides, and Proteins
p70219
g47311
sVAntibodies
p70220
g60978
sVAntibodies, Monoclonal
p70221
(dp70222
sVSelective Immunosuppressants
p70223
g23571
sVProteins
p70224
g52736
sVImmunoglobulins
p70225
g41514
sVImmunosuppressive Agents
p70226
g64535
sVComplement Inactivating Agents
p70227
(dp70228
sVSerum Globulins
p70229
g49647
sVAntineoplastic and Immunomodulating Agents
p70230
g39725
sVBlood Proteins
p70231
g39844
sVGlobulins
p70232
g19166
sVImmunoproteins
p70233
g57442
ssg9303
(dp70234
g4467
g45536
ssg9306
(dp70235
g8583
g67317
ssg9309
(dp70236
VSunscreen Agents
p70237
(dp70238
sVIons
p70239
g49111
sVHousehold Products
p70240
g60751
sVBasic Ointments and Protectants
p70241
g41763
sVMetal divalent cations
p70242
g65843
sVZinc Compounds
p70243
g65836
sVSunscreening Agents
p70244
g57237
sVDermatologicals
p70245
g17226
sVOxides
p70246
g27676
sVRadiation-Protective Agents
p70247
g65029
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p70248
g16815
sVCompounds used in a research, industrial, or household setting
p70249
(dp70250
sVAnions
p70251
(dp70252
sVBasic Powders and Demulcents
p70253
g31647
sVProtective Agents
p70254
g66789
sVMetal cations
p70255
g40802
sVVasoprotectives
p70256
g41378
sVCopper Absorption Inhibitor
p70257
(dp70258
sVElectrolytes
p70259
g52410
sVOxygen Compounds
p70260
g46960
sVCosmetics
p70261
g34260
ssg9312
(dp70262
g9060
g69117
ssg9315
(dp70263
g11283
(dp70264
sg3204
g37460
sg7464
g62203
sg10635
(dp70265
sg2358
g31496
sg12421
g12494
sg4635
g46526
sg828
g19895
sg9165
g69628
sg1869
g27846
sg10674
(dp70266
sg8421
g66542
sg2403
g31863
sg6819
g58893
sg11016
(dp70267
sg3156
g37222
sg3516
g39193
sg6468
g57127
sg6939
g59341
sg2427
g32059
sg10818
(dp70268
sg2433
g32131
sg5133
g49308
sg9960
(dp70269
sg8460
g66878
sg915
g20746
sg10728
(dp70270
sg6966
g59436
sg5970
g54233
sg8487
g67046
sg5535
g51680
sg933
g20854
sg8874
g68551
sg7299
g60948
sg9252
g70059
sg9981
(dp70271
sg8514
g67138
sg6186
g55531
sg7359
g61369
sg6303
g56247
sg7065
g59962
sg6999
g59512
sg3978
g42020
sg11544
(dp70272
sg42
g12610
sg7533
g62514
sg2523
g32761
sg183
g13870
sg8805
g68185
sg10356
(dp70273
sg1770
g27077
sg1008
g21310
sg7041
g59725
sg10062
(dp70274
sg7053
g59829
sg10497
(dp70275
sg2559
g32986
sg7824
g63886
sg11595
(dp70276
sg240
g14219
sg4035
g42459
sg12066
(dp70277
sg11619
(dp70278
sg6921
g59282
sg6411
g56864
sg1059
g21778
sg282
g14597
sg3111
g36837
sg294
g14774
sg288
g14708
sg8655
g67613
sg603
g17787
sg5691
g52507
sg5694
g52576
sg4101
g42989
sg2538
g32825
sg5739
g52892
sg9417
(dp70279
sg8673
g67694
sg6318
g56400
sg9462
(dp70280
sg3381
g38502
sg1890
g28005
sg7941
g64325
sg7152
g60205
sg7959
g64401
sg4959
g48564
sg537
g17062
sg14791
(dp70281
sg4155
g43262
sg8721
g67884
sg7176
g60367
sg10056
(dp70282
sg387
g15694
sg1401
g24328
sg5256
g50114
sg5769
g53054
sg9492
(dp70283
sg7197
g60634
sg1281
g23406
sg3447
g38975
sg1194
g22837
sg2730
g33882
sg780
g19388
sg1908
g28332
sg426
g16129
sg465
g16503
sg10266
(dp70284
sg11790
(dp70285
sg2430
g32124
sg450
g16364
sg10017
(dp70286
sg11811
(dp70287
sg10296
(dp70288
sg10308
(dp70289
sg168
g13671
sg1248
g23059
sg5853
g53570
sg7272
g60781
sg1263
g23207
sg6261
g55867
sg5064
g48919
sg8067
g64974
sg7284
g60857
sg2199
g30719
sg9564
(dp70290
sg10335
(dp70291
sg5877
g53699
sg4287
g44404
sg7056
g59872
sg2814
g34534
sg7335
g61247
sg9588
(dp70292
sg10350
(dp70293
sg5781
g53128
sg7389
g61569
sg2910
g35569
sg11112
(dp70294
sg1707
g26800
sg4458
g45509
sg6639
g57999
sg546
g17139
sg5919
g54008
sg7317
g61061
sg11139
(dp70295
sg696
g18790
sg7569
g62761
sg1578
g25671
sg3651
g40145
sg11154
(dp70296
sg564
g17434
sg4173
g43409
sg1809
g27459
sg1668
g26297
sg5145
g49362
sg4344
g44681
sg3570
g39517
sg582
g17649
sg141
g13377
sg5169
g49555
sg11910
(dp70297
sg11916
(dp70298
sg11931
(dp70299
sg336
g15138
sg9372
(dp70300
sg8832
g68336
sg8187
g65563
sg6525
g57365
sg11097
(dp70301
sg8019
g64765
sg630
g18056
sg633
g18106
sg4425
g44953
sg8205
g65641
sg1425
g24576
sg7428
g61881
sg8163
g65479
sg5235
g49870
sg11979
(dp70302
sg1434
g24697
sg10470
(dp70303
sg9711
(dp70304
sg5247
g49933
sg11277
(dp70305
sg4266
g44223
sg8295
g65999
sg1704
g26742
sg7944
g64352
sg822
g19794
sg12018
(dp70306
sg7329
g61156
sg8259
g65879
sg5487
g51382
sg702
g18820
sg1491
g25126
sg6792
g58723
sg3711
g40464
sg7497
g62325
sg11292
(dp70307
sg3018
g36163
sg10518
(dp70308
sg2265
g31030
sg7734
g63548
sg486
g16675
sg11727
(dp70309
sg2277
g31101
sg10539
(dp70310
sg10854
(dp70311
sg414
g15991
sg2289
g31214
sg5394
g50857
sg12111
(dp70312
sg9822
(dp70313
sg5067
g48966
sg10596
(dp70314
sg2664
g33481
sg6381
g56798
sg10602
(dp70315
sg7593
g62830
sg4596
g46278
sg9855
(dp70316
sg9111
g69433
sg9864
(dp70317
ssg9318
(dp70318
g9309
g70238
sg7629
g62981
sg4725
g47136
sg12108
(dp70319
sg1164
g22575
ssg9321
(dp70320
g5847
g53490
ssg9324
(dp70321
VBSEP/ABCB11 Substrates
p70322
(dp70323
sVCytochrome P-450 CYP2C8 Substrates
p70324
(dp70325
sg1542
g25326
sg6516
g57326
sVAcids, Acyclic
p70326
g25438
sVCytochrome P-450 CYP3A Substrates
p70327
g45013
sVHypoglycemia-Associated Agents
p70328
g17678
sVPotassium Channel Antagonists
p70329
g68725
sg1953
g28741
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70330
g29269
sVOral Hypoglycemics
p70331
g36009
sVOATP1B1/SLCO1B1 Substrates
p70332
(dp70333
sVCytochrome P-450 CYP3A4 Substrates
p70334
g65213
sVBlood Glucose Lowering Agents
p70335
(dp70336
sVAlimentary Tract and Metabolism
p70337
g23848
sVDrugs Used in Diabetes
p70338
g60109
ssg9327
(dp70339
g9588
(dp70340
ssg9330
(dp70341
g9135
g69531
ssg9333
(dp70342
g2985
g35911
sg9870
(dp70343
ssg9336
(dp70344
g8421
g66482
sg10728
(dp70345
sg7272
g60756
sg2403
g31827
sg9822
(dp70346
sg10350
(dp70347
sg7317
g61034
sg702
g18808
sg7734
g63514
sg5256
g50031
sg5235
g49810
sg7944
g64335
sg7329
g61118
sg7335
g61166
sg8460
g66869
sg1401
g24294
sg4959
g48509
ssg9339
(dp70348
VAnti-Acne Preparations for Topical Use
p70349
g62693
sVAnalgesics, Non-Narcotic
p70350
g56900
sVPeripheral Nervous System Agents
p70351
g57594
sVAnalgesics
p70352
g26447
sVRetinoids for Topical Use in Acne
p70353
g48969
sVCentral Nervous System Agents
p70354
g58437
sVAnti-Inflammatory Agents
p70355
(dp70356
sVAnti-Acne Preparations
p70357
g63932
sVMisc. Skin and Mucous Membrane Agents
p70358
g60184
sVRetinoids
p70359
g48826
sVSensory System Agents
p70360
(dp70361
sVDermatologicals
p70362
g17227
sVNaphthalenes
p70363
g66081
ssg9342
(dp70364
g285
g14618
sg3867
g41341
sg4752
g47292
sg1683
g26386
sg10047
(dp70365
ssg9345
(dp70366
g834
g19939
ssg9348
(dp70367
VImmunologic Factors
p70368
g42375
sVTumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors
p70369
g57508
sVSerum Globulins
p70370
g49650
sVImmunoglobulin Fragments
p70371
g21346
sVPeptide Fragments
p70372
(dp70373
sVBiologics for Rheumatoid Arthritis Treatment
p70374
g47867
sVDrugs that are Mainly Renally Excreted
p70375
g44030
sVTumor Necrosis Factor Receptor Blocking Activity
p70376
g18472
sg10962
(dp70377
sVImmunoglobulins
p70378
g41517
sVTumor Necrosis Factor Blocker
p70379
g52436
sVGlycols
p70380
g55150
sVAntibodies
p70381
g60979
sVAntineoplastic and Immunomodulating Agents
p70382
g39784
sVAgents reducing cytokine levels
p70383
(dp70384
sVPolymers
p70385
g22223
sVProteins
p70386
g52765
sVPeptides
p70387
g47188
sVDisease-modifying Antirheumatic Agents
p70388
g57193
sVGlobulins
p70389
g19169
sVEthylene Glycols
p70390
g62631
sVAmino Acids, Peptides, and Proteins
p70391
g47370
sVPolyethylene Glycols
p70392
g22551
sVPegylated agents
p70393
g13563
sVAntibodies, Monoclonal
p70394
(dp70395
sVAntibodies, Monoclonal, Humanized
p70396
(dp70397
sVImmunosuppressive Agents
p70398
g64571
sVMacromolecular Substances
p70399
g33832
sVAntirheumatic Agents
p70400
g24215
sVAlcohols
p70401
(dp70402
sVImmunoproteins
p70403
g57443
ssg9351
(dp70404
g6180
g55411
sg10629
(dp70405
sg7944
g64344
sg2403
g31837
sg6186
g55483
sg5427
g50991
sg8394
g66383
sg7821
g63821
sg10662
(dp70406
sg4656
g46772
sg1869
g27816
sg3696
g40272
sg7983
g64525
sg8433
g66643
sg5499
g51403
sg3156
g37187
sg2427
g31986
sg909
g20624
sg8460
g66876
sg3177
g37287
sg6966
g59420
sg405
g15891
sg6678
g58107
sg8487
g67023
sg8139
g65369
sg11337
(dp70407
sg9981
(dp70408
sg12042
(dp70409
sg11979
(dp70410
sg6303
g56194
sg147
g13491
sg3975
g41920
sg6999
g59507
sg7764
g63620
sg3978
g41970
sg3231
g37636
sg9465
(dp70411
sg11562
(dp70412
sg10815
(dp70413
sg7041
g59680
sg7533
g62489
sg1035
g21456
sg1371
g24125
sg10857
(dp70414
sg8595
g67337
sg1050
g21697
sg11619
(dp70415
sg1626
g25944
sg9111
g69412
sg11667
(dp70416
sg8655
g67578
sg1947
g28663
sg3381
g38467
sg1899
g28088
sg10179
(dp70417
sg9198
g69838
sg4959
g48517
sg7941
g64267
sg387
g15606
sg10227
(dp70418
sg2304
g31257
sg9828
(dp70419
sg5796
g53243
sg9507
(dp70420
sg11022
(dp70421
sg11793
(dp70422
sg8493
g67057
sg2013
g28935
sg1239
g22929
sg1047
g21588
sg1059
g21741
sg11052
(dp70423
sg1248
g23045
sg2034
g29029
sg2658
g33349
sg2817
g34546
sg7329
g61123
sg9588
(dp70424
sg10350
(dp70425
sg2838
g34778
sg3546
g39378
sg1503
g25166
sg3963
g41895
sg10383
(dp70426
sg3114
g36853
sg11439
(dp70427
sg11160
(dp70428
sg573
g17556
sg4344
g44641
sg11016
(dp70429
sg2733
g33916
sg5169
g49498
sg10410
(dp70430
sg4419
g44892
sg1188
g22764
sg9663
(dp70431
sg5193
g49613
sg609
g17804
sg4449
g45370
sg9684
(dp70432
sg11955
(dp70433
sg11229
(dp70434
sg6012
g54365
sg5235
g49817
sg654
g18268
sg4452
g45432
sg11790
(dp70435
sg6759
g58546
sg11265
(dp70436
sg5289
g50249
sg687
g18536
sg11274
(dp70437
sg6069
g54831
sg8106
g65152
sg10497
(dp70438
sg2841
g34830
sg9009
g68907
sg9759
(dp70439
sg3732
g40517
sg2265
g30996
sg723
g19085
sg10533
(dp70440
sg735
g19133
sg10854
(dp70441
sg4542
g46074
sg2289
g31202
sg10098
(dp70442
sg9393
(dp70443
sg771
g19271
sg9084
g69225
sg819
g19729
ssg9354
(dp70444
g13070
g21881
sg3795
g40927
ssg9357
(dp70445
VEstradiol Congeners
p70446
g49769
sVCytochrome P-450 CYP3A Substrates
p70447
g45212
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p70448
g49324
sVHormones
p70449
g55671
sVCytochrome P-450 CYP2C9 Inhibitors
p70450
g18203
sVCytochrome P-450 Enzyme Inhibitors
p70451
g62077
sg6402
g56841
sVHormonal Contraceptives for Systemic Use
p70452
g60100
sVDrugs that are Mainly Renally Excreted
p70453
g44016
sVMATE substrates
p70454
(dp70455
sVCytochrome P-450 CYP1A2 Substrates
p70456
g45592
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p70457
(dp70458
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70459
g29517
sVReproductive Control Agents
p70460
g18852
sVCytochrome P-450 CYP2C9 Substrates
p70461
g29749
sVFused-Ring Compounds
p70462
g14843
sVHyperglycemia-Associated Agents
p70463
g68803
sVMATE 1 Substrates
p70464
g23494
sVAdrenal Cortex Hormones
p70465
g30036
sVCytochrome P-450 CYP1A2 Inhibitors
p70466
g15032
sVCytochrome P-450 CYP3A4 Substrates
p70467
g65316
sg2238
g30818
sVGonadal Hormones
p70468
g33573
sVMATE 2 Substrates
p70469
g44485
sg2295
g31228
sVSteroids
p70470
g56421
sVGonadal Steroid Hormones
p70471
g67215
sVEstranes
p70472
g50803
sVHormones, Hormone Substitutes, and Hormone Antagonists
p70473
g53156
sVEstrenes
p70474
(dp70475
sg5202
g49713
ssg9360
(dp70476
g2886
g35328
sg11046
(dp70477
ssg9363
(dp70478
g8013
g64682
ssg9366
(dp70479
VCytochrome P-450 CYP3A4 Inhibitors
p70480
g61654
sVSex Hormones and Modulators of the Genital System
p70481
g19601
sVUGT1A1 Substrates
p70482
g12276
sVEstrogen Antagonists
p70483
g43656
sVStilbenes
p70484
g67780
sVSelective Estrogen Receptor Modulators
p70485
g43682
sVEstrogen Agonist/Antagonist
p70486
g64872
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p70487
g43744
sVCytochrome P-450 Enzyme Inhibitors
p70488
g61957
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p70489
g23103
sVBone Density Conservation Agents
p70490
g40359
sVOATP1B1/SLCO1B1 Substrates
p70491
(dp70492
sVBenzene Derivatives
p70493
g61426
sVCytochrome P-450 CYP2C8 Inhibitors
p70494
g55014
sVCytochrome P-450 CYP2B6 Inhibitors
p70495
g45925
sVP-glycoprotein/ABCB1 Substrates
p70496
g34953
sVBenzylidene Compounds
p70497
g43132
sVEstrogen Receptor Modulators
p70498
g17594
sVHormone Antagonists
p70499
g24262
sVOATP1B3 substrates
p70500
g28514
sVGenito Urinary System and Sex Hormones
p70501
g66161
sVTamoxifen
p70502
g48667
sVCytochrome P-450 CYP3A Inhibitors
p70503
g60413
sVBCRP/ABCG2 Substrates
p70504
g42057
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p70505
(dp70506
sVHormones, Hormone Substitutes, and Hormone Antagonists
p70507
g53182
sVEstrogen Agonist-antagonists
p70508
(dp70509
ssg9369
(dp70510
g2667
g33531
ssg9372
(dp70511
VCentral Nervous System Agents
p70512
g58491
sVCompounds used in a research, industrial, or household setting
p70513
(dp70514
sVHormones
p70515
g55689
sVAntioxidants
p70516
g54809
sg6762
g58573
sVIndoles
p70517
(dp70518
sVCytochrome P-450 CYP1A2 Substrates
p70519
g45615
sVAmines
p70520
g42728
sVBiogenic Monoamines
p70521
(dp70522
sVProtective Agents
p70523
g66800
sVPsycholeptics
p70524
g33254
sg6441
g57005
sVCentral Nervous System Depressants
p70525
(dp70526
sg6285
g55989
sVBiogenic Amines
p70527
g58004
sVHormones, Hormone Substitutes, and Hormone Antagonists
p70528
g53180
sVCytochrome P-450 CYP2C9 Substrates
p70529
g29791
sVHypnotics and Sedatives
p70530
(dp70531
sVHeterocyclic Compounds, Fused-Ring
p70532
g56127
sVOAT3/SLC22A8 Inhibitors
p70533
g59023
sg585
g17653
sg9372
(dp70534
sVNervous System
p70535
g70300
ssg9375
(dp70536
VOCT2 Substrates
p70537
g14937
sg11448
(dp70538
sVMyelosuppressive Agents
p70539
(dp70540
sg3342
g38272
sVImmunosuppressive Agents
p70541
g64554
sVBCRP/ABCG2 Substrates
p70542
g42059
sVAntineoplastic and Immunomodulating Agents
p70543
g39758
sVOCT2 substrates with narrow therapeutic index
p70544
g29682
sVQTc Prolonging Agents
p70545
g57819
sVOrganometallic Compounds
p70546
(dp70547
sVAntineoplastic Agents
p70548
(dp70549
sVModerate Risk QTc-Prolonging Agents
p70550
g67162
ssg9378
(dp70551
g3627
g39924
sg8763
g68020
sg2373
g31580
sg9528
(dp70552
sg444
g16244
sg11229
(dp70553
sg816
g19652
sg16906
g61902
sg11601
(dp70554
sg5454
g51147
sg849
g20074
sg8049
g64893
sg8418
g66441
sg11151
(dp70555
sg4653
g46675
sg9198
g69817
sg11079
(dp70556
sg3861
g41277
sg507
g16763
sg888
g20466
sg10494
(dp70557
sg6468
g57090
sg8820
g68279
sg6045
g54699
sg11460
(dp70558
sg12534
g52623
sg4911
g48246
sg165
g13569
sg3024
g36273
sg9432
(dp70559
sg9954
(dp70560
sg11136
(dp70561
sg6024
g54438
sg3963
g41881
sg5238
g49888
sg7734
g63520
sg4155
g43206
sg2832
g34698
sg147
g13445
sg573
g17562
sg10557
(dp70562
sg3978
g41981
sg3432
g38792
sg8472
g66955
sg28215
g35353
sg183
g13790
sg5289
g50290
sg8595
g67344
sg5589
g51918
sg11241
(dp70563
sg11940
(dp70564
sg12123
(dp70565
ssg9381
(dp70566
g9897
(dp70567
sg2754
g34061
sg11133
(dp70568
sg9084
g69209
sg5127
g49225
sg8751
g67956
ssg9384
(dp70569
g10596
(dp70570
sg11595
(dp70571
sg915
g20727
ssg9387
(dp70572
g141
g13344
ssg9390
(dp70573
g10314
(dp70574
sg10548
(dp70575
ssg9393
(dp70576
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p70577
(dp70578
sVAntihistamines for Topical Use
p70579
g39015
sVAnticholinergic Agents
p70580
g24458
sVCytochrome P-450 CYP2D6 Inhibitors
p70581
g62954
sVCytochrome P-450 CYP2D6 Substrates
p70582
g52197
sVHistamine Agents
p70583
(dp70584
sVCentral Nervous System Agents
p70585
g58464
sVPotential QTc-Prolonging Agents
p70586
g70443
sVOCT2 Inhibitors
p70587
g42483
sVAnesthetics, Local
p70588
g53472
sVCytochrome P-450 Enzyme Inhibitors
p70589
g61974
sVMuscarinic Antagonists
p70590
g48877
sVAmines
p70591
g42740
sVAnesthetics
p70592
g51610
sVEthylamines
p70593
g20599
sVAntihistamines for Systemic Use
p70594
g12973
sVCytochrome P-450 CYP2C9 Substrates
p70595
g29818
sVQTc Prolonging Agents
p70596
g57836
sVFirst Generation Antihistamines
p70597
g29878
sVEthanolamine Derivatives
p70598
g58783
sVCentral Nervous System Depressants
p70599
(dp70600
sVAntiemetics
p70601
(dp70602
sVGastrointestinal Agents
p70603
(dp70604
sVHistamine Antagonists
p70605
g43445
sVBenzene Derivatives
p70606
g61434
sVSleep Aids, Pharmaceutical
p70607
(dp70608
sVDermatologicals
p70609
g17324
sVHistamine H1 Antagonists
p70610
g40784
sVBenzhydryl Compounds
p70611
(dp70612
sVHypnotics and Sedatives
p70613
(dp70614
sVAnti-Allergic Agents
p70615
g50650
sVAminoalkyl Ethers
p70616
g19321
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p70617
g53080
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p70618
(dp70619
sVAgents producing tachycardia
p70620
g50799
ssg9396
(dp70621
g4155
g43212
sg2199
g30685
sg183
g13798
sg6792
g58714
sg7329
g61133
sg6525
g57347
sg4959
g48536
ssg9399
(dp70622
g8583
g67314
sg4581
g46210
ssg9402
(dp70623
VAnticholinergic Agents
p70624
g24482
sVAdrenergic beta-Agonists
p70625
g43006
sVBronchodilator Agents
p70626
(dp70627
sVSympathomimetics
p70628
g48815
sVDrugs for Obstructive Airway Diseases
p70629
g42513
sVAutonomic Agents
p70630
g66559
sVTocolytic Agents
p70631
g33144
sVPeripheral Nervous System Agents
p70632
g57604
sVRespiratory System Agents
p70633
(dp70634
sVReproductive Control Agents
p70635
g18850
sVEthanolamines
p70636
(dp70637
sVAdrenergic Agents
p70638
g41704
sVNeurotransmitter Agents
p70639
(dp70640
sVPhenols
p70641
g65120
sVAdrenergics for Systemic Use
p70642
g59036
sVBenzene Derivatives
p70643
g61412
sVAgents to Treat Airway Disease
p70644
g32640
sg12105
(dp70645
sVAdrenergic Agonists
p70646
(dp70647
sVAgents that produce hypertension
p70648
g69066
sVAnti-Asthmatic Agents
p70649
g36520
sVAmines
p70650
g42701
sVCatechols
p70651
(dp70652
sVAdrenergic beta-2 Receptor Agonists
p70653
g58945
sg3792
g40913
sVAmino Alcohols
p70654
g32676
sVGenito Urinary System and Sex Hormones
p70655
g66165
sg12129
(dp70656
sVAgents producing tachycardia
p70657
g50761
sVAlcohols
p70658
(dp70659
sVAdrenergics, Inhalants
p70660
g43174
ssg9405
(dp70661
g2553
g32892
ssg9408
(dp70662
g8388
g66367
ssg9411
(dp70663
VAgents Causing Muscle Toxicity
p70664
g55359
sVImmunologic Factors
p70665
g42376
sVDeoxyribonucleosides
p70666
g33065
sVMyelosuppressive Agents
p70667
(dp70668
sVCarbohydrates
p70669
g61752
sVGlycosides
p70670
g68358
sVRibonucleosides
p70671
(dp70672
sVSelective Immunosuppressants
p70673
g23576
sVNucleic Acids, Nucleotides, and Nucleosides
p70674
g47116
sg6114
g55112
sVPurine Analogues
p70675
g70067
sg2484
g32467
sVPurines
p70676
(dp70677
sg3429
g38783
sVCardiotoxic antineoplastic agents
p70678
(dp70679
sVHeterocyclic Compounds, Fused-Ring
p70680
g56037
sVNucleosides
p70681
g49458
sVAntimetabolites
p70682
g59536
sVImmunosuppressive Agents
p70683
g64536
sVBCRP/ABCG2 Substrates
p70684
g42060
sVAntineoplastic Agents
p70685
(dp70686
sVAntineoplastic and Immunomodulating Agents
p70687
g39729
sg6480
g57196
sg2334
g31332
ssg9414
(dp70688
VUGT1A1 Substrates
p70689
g12310
sVCarbohydrates
p70690
g61765
sVUGT1A9 Substrates
p70691
g24013
sVOATP1B1/SLCO1B1 Inhibitors
p70692
(dp70693
sVCytochrome P-450 CYP2B6 Substrates
p70694
g33016
sVEnzyme Inhibitors
p70695
(dp70696
sVOligosaccharides
p70697
g33103
sVMyelosuppressive Agents
p70698
(dp70699
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70700
g29519
sVCholinesterase substrates
p70701
g41631
sVCytochrome P-450 CYP3A Substrates
p70702
g45213
sVPharmaceutical Preparations
p70703
g53864
sVPolysaccharides
p70704
g41772
sVP-glycoprotein/ABCB1 Substrates
p70705
g34975
sVDisaccharides
p70706
g64388
sVCytochrome P-450 CYP3A4 Substrates
p70707
g65317
sVCytochrome P-450 CYP3A5 Substrates
p70708
g67811
sVCamptothecin
p70709
(dp70710
sVImmunosuppressive Agents
p70711
g64559
sVBCRP/ABCG2 Substrates
p70712
g42065
sVAntineoplastic Agents
p70713
(dp70714
sVTopoisomerase I Inhibitors
p70715
g32772
sVAntineoplastic and Immunomodulating Agents
p70716
g39767
sVAlkaloids
p70717
g19429
sVCytochrome P-450 CYP3A7 Substrates
p70718
g60655
sVTopoisomerase Inhibitors
p70719
g32851
ssg9417
(dp70720
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p70721
(dp70722
sVDibenzazepines
p70723
g48669
sVAdrenergic alpha-1 Receptor Antagonists
p70724
g14126
sVAnticholinergic Agents
p70725
g24488
sVCytochrome P-450 CYP2D6 Inhibitors
p70726
g62916
sVCytochrome P-450 CYP2C19 Substrates
p70727
g53879
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p70728
(dp70729
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p70730
g41075
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p70731
g37403
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p70732
g36622
sVAntidepressive Agents, Tricyclic
p70733
g60705
sg9141
g69535
sVCentral Nervous System Agents
p70734
g58445
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p70735
(dp70736
sVOCT2 Inhibitors
p70737
g42477
sVAdrenergic Antagonists
p70738
g52282
sVPsychotropic Drugs
p70739
(dp70740
sVCytochrome P-450 CYP2B6 Substrates
p70741
g33019
sVCytochrome P-450 Enzyme Inhibitors
p70742
g61959
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p70743
g18412
sVMuscarinic Antagonists
p70744
g48871
sVDrugs that are Mainly Renally Excreted
p70745
g43837
sVCytochrome P-450 CYP1A2 Substrates
p70746
g45583
sVPsychoanaleptics
p70747
g59074
sVHypotensive Agents
p70748
g34136
sVNon-Selective Monoamine Reuptake Inhibitors
p70749
(dp70750
sVCytochrome P-450 CYP2D6 Substrates
p70751
g52134
sVCytochrome P-450 CYP2E1 Inhibitors
p70752
g46827
sVMembrane Transport Modulators
p70753
g54143
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p70754
g36472
sVAdrenergic alpha-Antagonists
p70755
g60874
sVSerotonin Agents
p70756
(dp70757
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70758
g29403
sVQTc Prolonging Agents
p70759
g57813
sVSerotonin 5-HT2 Receptor Antagonists
p70760
(dp70761
sVCytochrome P-450 CYP3A Substrates
p70762
g45122
sVAdrenergic Agents
p70763
g41708
sVCentral Nervous System Depressants
p70764
(dp70765
sVNeurotransmitter Agents
p70766
(dp70767
sVHistamine Antagonists
p70768
g43441
sVNeurotransmitter Uptake Inhibitors
p70769
g52391
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p70770
g49146
sVAgents that reduce seizure threshold
p70771
g45853
sVCytochrome P-450 CYP1A2 Inhibitors
p70772
g15043
sVSerotonin Receptor Antagonists
p70773
g35676
sVP-glycoprotein/ABCB1 Substrates
p70774
g34947
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p70775
g26808
sVAdrenergic Uptake Inhibitors
p70776
g32315
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p70777
g26877
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p70778
g44518
sVCytochrome P-450 CYP2C18 Substrates
p70779
g20939
sVAgents that produce hypertension
p70780
g69067
sVCytochrome P-450 CYP2C19 Inhibitors
p70781
g61265
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p70782
g29604
sVCytochrome P-450 CYP3A4 Substrates
p70783
g65266
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p70784
g49343
sVNarrow Therapeutic Index Drugs
p70785
g50563
sVModerate Risk QTc-Prolonging Agents
p70786
g67171
sVHeterocyclic Compounds, Fused-Ring
p70787
g56065
sVSerotonin Modulators
p70788
g69133
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p70789
g61381
sVAntidepressive Agents
p70790
g15527
sVHistamine H1 Antagonists
p70791
g40780
sVCytochrome P-450 CYP3A Inhibitors
p70792
g60423
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p70793
(dp70794
sVTertiary amine tricyclic antidepressants
p70795
g31315
sVNeurotoxic agents
p70796
g68584
sVAgents producing tachycardia
p70797
g50764
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p70798
g60074
sVNervous System
p70799
g70279
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p70800
g27731
sVCytochrome P-450 CYP3A7 Substrates
p70801
g60653
ssg9420
(dp70802
VDrugs that are Mainly Renally Excreted
p70803
g44053
sVCentral Nervous System Depressants
p70804
(dp70805
sVHypnotics and Sedatives
p70806
(dp70807
sVBenzazepines
p70808
g60330
sVBenzodiazepine hypnotics and sedatives
p70809
g17662
sVGABA Agents
p70810
g16220
sVHeterocyclic Compounds, Fused-Ring
p70811
g56156
sVCytochrome P-450 CYP3A Substrates
p70812
g45269
sVTranquilizing Agents
p70813
g55306
sVAnti-Anxiety Agents
p70814
g35658
sVCytochrome P-450 CYP2C8 Substrates
p70815
(dp70816
sVMuscle Relaxants, Centrally Acting Agents
p70817
g37390
sVCentral Nervous System Agents
p70818
g58516
sVGABA Modulators
p70819
g39058
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70820
g29592
sVCytochrome P-450 CYP2B6 Substrates
p70821
g33027
sVBenzodiazepines and benzodiazepine derivatives
p70822
(dp70823
sVCytochrome P-450 CYP2C9 Substrates
p70824
g29762
sVCytochrome P-450 CYP3A4 Substrates
p70825
g65350
sVPsychotropic Drugs
p70826
(dp70827
sVMuscle Relaxants
p70828
(dp70829
ssg9423
(dp70830
g4479
g45702
sg5415
g50938
sg11793
(dp70831
sg516
g16874
sg3846
g41129
sg2013
g28923
sg8031
g64850
sg4035
g42433
sg6318
g56371
sg8916
g68644
sg2946
g35824
sg5832
g53399
sg1041
g21506
sg609
g17818
sg8406
g66414
sg12063
(dp70832
sg11265
(dp70833
sg690
g18629
sg1656
g26170
sg6045
g54715
sg3087
g36664
sg6567
g57524
sg2658
g33372
sg12015
(dp70834
sg8241
g65783
sg495
g16694
sg6156
g55228
sg7284
g60844
sg2769
g34299
sg10365
(dp70835
sg3825
g41032
sg6303
g56226
sg9579
(dp70836
sg5286
g50207
sg8487
g67033
sg9759
(dp70837
sg5694
g52549
sg8463
g66907
sg6714
g58261
sg7512
g62379
sg534
g16994
sg10674
(dp70838
sg1707
g26782
sg2391
g31732
sg8649
g67547
sg7920
g64195
sg10959
(dp70839
sg3393
g38583
sg11268
(dp70840
sg4257
g44062
sg2841
g34848
sg6990
g59474
sg4557
g46155
sg1134
g22336
sg10185
(dp70841
sg789
g19457
sg4539
g46033
sg9393
g70604
sg8703
g67771
sg1911
g28363
sg8322
g66132
sg1842
g27645
sg5469
g51288
sg4653
g46731
sg3021
g36203
sg3570
g39486
sg10767
(dp70842
sg9465
(dp70843
sg8724
g67912
sg1776
g27099
sg14872
g15757
sg6474
g57168
sg7377
g61503
sg4581
g46201
sg2316
g31289
sg4770
g47459
sg11241
(dp70844
sg7395
g61576
sg1092
g21983
sg12534
g52677
sg8187
g65549
sg3156
g37203
sg10653
(dp70845
ssg9426
(dp70846
VAmino Acids, Peptides, and Proteins
p70847
g47350
sVAntiinfectives for Systemic Use
p70848
g69656
sVAgents that produce neuromuscular block (indirect)
p70849
g37970
sg9270
g70144
sg2694
g33707
sVNephrotoxic agents
p70850
g57713
sg7068
g59975
sVAminoglycoside Antibacterials
p70851
g52726
sg5655
g52379
sVProteins
p70852
g52755
sg8889
g68567
sVPeptides
p70853
g47178
sVLipids
p70854
g14323
sVAnti-Bacterial Agents
p70855
g38351
sVAntibacterials for Systemic Use
p70856
g32550
sVAnti-Infective Agents
p70857
g54607
sg6555
g57499
sVAlimentary Tract and Metabolism
p70858
g23838
sg4602
g46289
sg2586
g33097
ssg9429
(dp70859
g8031
g64851
ssg9432
(dp70860
VAgents Causing Muscle Toxicity
p70861
g55372
sVBSEP/ABCB11 Substrates
p70862
(dp70863
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p70864
(dp70865
sVAntivirals for Systemic Use
p70866
g59765
sVQuinolines
p70867
(dp70868
sVCytochrome P-450 CYP2D6 Inhibitors
p70869
g62925
sVIsoquinolines
p70870
g44956
sVCytochrome P-450 CYP3A Substrates
p70871
g44992
sVCytochrome P-450 CYP3A4 Inhibitors
p70872
g61665
sVBCRP/ABCG2 Inhibitors
p70873
g12514
sVDirect Acting Antivirals
p70874
g38062
sVCYP3A Substrates (Sensitive)
p70875
g63924
sVAnti-HIV Agents
p70876
g66399
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p70877
(dp70878
sVCytochrome P-450 CYP3A7 Inhibitors
p70879
(dp70880
sVCytochrome P-450 Enzyme Inhibitors
p70881
g61960
sVAnti-Infective Agents
p70882
g54608
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p70883
g18409
sVHyperglycemia-Associated Agents
p70884
g68804
sVAntiinfectives for Systemic Use
p70885
g69651
sVP-glycoprotein/ABCB1 Inducers
p70886
g70559
sVAnti-Retroviral Agents
p70887
g67150
sVEnzyme Inhibitors
p70888
(dp70889
sVP-glycoprotein/ABCB1 Inhibitors
p70890
(dp70891
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70892
g29234
sVHIV Protease Inhibitors
p70893
(dp70894
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p70895
g60077
sVQTc Prolonging Agents
p70896
g57826
sVOCT1 inhibitors
p70897
g66924
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p70898
g24784
sVCytochrome P-450 CYP2C8 Inhibitors
p70899
g55018
sVP-glycoprotein/ABCB1 Substrates
p70900
g34964
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p70901
(dp70902
sVCytochrome P-450 CYP3A5 Inhibitors
p70903
g55342
sVHeterocyclic Compounds, Fused-Ring
p70904
g56083
sVCytochrome P-450 CYP3A Inhibitors (strong)
p70905
g13402
sVCytochrome P-450 CYP3A4 Substrates
p70906
g65199
sVModerate Risk QTc-Prolonging Agents
p70907
g67168
sVCytochrome P-450 CYP3A7 Inhibitors (weak)
p70908
g31277
sVCytochrome P-450 CYP3A5 Substrates
p70909
g67821
sVProtease Inhibitors
p70910
g51097
sVCytochrome P-450 CYP3A5 Inhibitors (strong)
p70911
g65405
sVCytochrome P-450 CYP3A Inhibitors
p70912
g60425
sVAntiviral Agents
p70913
g30451
sVOATP1B1/SLCO1B1 Inhibitors
p70914
(dp70915
sVCytochrome P450 3A Inhibitors
p70916
g54266
sVChemically-Induced Disorders
p70917
g21229
sVCytochrome P-450 CYP3A7 Substrates
p70918
g60654
ssg9435
(dp70919
g5847
g53508
ssg9438
(dp70920
g10635
(dp70921
sg1809
g27444
sg42
g12594
sg7713
g63437
sg8295
g65985
sg2784
g34365
sg6261
g55850
sg5781
g53112
sg2199
g30696
sg294
g14752
sg5487
g51365
sg5877
g53688
sg9960
(dp70922
sg4101
g42975
sg10602
(dp70923
sg5739
g52871
sg4458
g45492
sg546
g17149
sg1413
g24442
sg537
g17040
sg2523
g32742
sg1281
g23389
sg1008
g21289
sg9864
(dp70924
ssg9441
(dp70925
VAnticoagulants
p70926
g58377
sVFactor Xa Inhibitors
p70927
g68553
sVDecreased Coagulation Factor Activity
p70928
g59440
sg10242
(dp70929
sg5001
g48684
ssg9444
(dp70930
g1407
g24337
sVCytochrome P-450 CYP3A4 Inhibitors
p70931
g61666
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p70932
g64612
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p70933
g43752
sVEnzyme Inhibitors
p70934
(dp70935
sVCytochrome P-450 Enzyme Inhibitors
p70936
g61961
sVDrugs that are Mainly Renally Excreted
p70937
g43840
sVMATE substrates
p70938
(dp70939
sVMyelosuppressive Agents
p70940
(dp70941
sVCytochrome P-450 CYP3A4 Inducers
p70942
g18920
sVAntineoplastic Agents
p70943
(dp70944
sVMATE 1 Substrates
p70945
g23503
sVP-glycoprotein/ABCB1 Substrates
p70946
g34981
sVCytochrome P-450 Enzyme Inducers
p70947
g28162
sVCytochrome P-450 CYP3A Inducers
p70948
g66273
sVMATE 2 Substrates
p70949
g44489
sg6840
g58951
sg11904
(dp70950
sVCytochrome P-450 CYP3A Inhibitors
p70951
g60426
sVImmunosuppressive Agents
p70952
g64560
sg8727
g67927
sVBCRP/ABCG2 Substrates
p70953
g42091
sg2532
g32771
sVAntineoplastic and Immunomodulating Agents
p70954
g39768
sVAlkaloids
p70955
g19432
sg8919
g68663
sg2547
g32854
ssg9447
(dp70956
g4017
g42289
sg3024
g36309
ssg9450
(dp70957
g3036
g36432
ssg9453
(dp70958
g6819
g58868
sg14791
(dp70959
ssg9456
(dp70960
g6684
g58164
ssg9459
(dp70961
g2256
g30914
sg7971
g64446
sg10230
(dp70962
sg11874
(dp70963
sg6474
g57160
sg7719
g63482
sg6471
g57147
sg1038
g21474
sg10974
(dp70964
sg7020
g59586
sg1356
g23954
sg10245
(dp70965
sg12186
g42921
sg4320
g44511
ssg9462
(dp70966
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p70967
(dp70968
sVCytochrome P-450 CYP3A4 Inhibitors
p70969
g61649
sVFatty Acids
p70970
g63156
sVCytochrome P-450 CYP2D6 Inhibitors
p70971
g62921
sVCytochrome P-450 CYP2D6 Substrates
p70972
g52127
sVAnalgesics
p70973
g26454
sVCentral Nervous System Agents
p70974
g58450
sVLipids
p70975
g14290
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p70976
g43751
sVCytochrome P-450 Enzyme Inhibitors
p70977
g61992
sVNarcotics
p70978
(dp70979
sVPeripheral Nervous System Agents
p70980
g57606
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p70981
g23118
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p70982
g29228
sVDiphenylpropylamine Derivatives
p70983
g36035
sVCytochrome P-450 CYP3A Substrates
p70984
g44987
sVCentral Nervous System Depressants
p70985
(dp70986
sVFatty Acids, Volatile
p70987
g66981
sVOpioids
p70988
g32243
sVAgents that reduce seizure threshold
p70989
g45855
sVCytochrome P-450 CYP2C8 Inhibitors
p70990
g55017
sVPropionates
p70991
g36486
sVCytochrome P-450 CYP3A4 Substrates
p70992
g65197
sVAcids, Acyclic
p70993
g25492
sVOpioid Agonist
p70994
(dp70995
sVCytochrome P-450 CYP3A Inhibitors
p70996
g60406
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p70997
g53075
sVSensory System Agents
p70998
(dp70999
sVNervous System
p71000
g70280
ssg9465
(dp71001
VPiperazines
p71002
(dp71003
sVCentral Nervous System Depressants
p71004
(dp71005
sVAntiemetics
p71006
(dp71007
sVGastrointestinal Agents
p71008
g70843
sVAutonomic Agents
p71009
g66570
sVHistamine H1 Antagonists
p71010
g40793
sVNeurotransmitter Agents
p71011
(dp71012
sVHistamine Agents
p71013
(dp71014
sVCentral Nervous System Agents
p71015
g58428
sVPotential QTc-Prolonging Agents
p71016
g70411
sVPiperazine Derivatives
p71017
g50705
sVPeripheral Nervous System Agents
p71018
g57634
sVHistamine Antagonists
p71019
g43453
sVAntihistamines for Systemic Use
p71020
g12976
sVCytochrome P-450 CYP2C9 Inhibitors
p71021
g18230
sVCytochrome P-450 Enzyme Inhibitors
p71022
g62043
sVQTc Prolonging Agents
p71023
g57804
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p71024
(dp71025
ssg9468
(dp71026
g1482
g25011
sg9741
(dp71027
sg1266
g23252
ssg9471
(dp71028
g3462
g38989
sVAntiparasitic Products, Insecticides and Repellents
p71029
g30578
sVCytochrome P-450 CYP3A Substrates
p71030
g45214
sg3645
g40089
sVCytochrome P-450 CYP2B6 Substrates
p71031
g33025
sg6576
g57544
sVEnzyme Inhibitors
p71032
(dp71033
sVPesticides
p71034
g69596
sVAgrochemicals
p71035
(dp71036
sVDrugs that are Mainly Renally Excreted
p71037
g44018
sVTerpenes
p71038
(dp71039
sVCytochrome P-450 CYP2B6 Inducers
p71040
g39124
sVMonoterpenes
p71041
g60051
sg8997
g68865
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71042
g29520
sVEctoparasiticides, Incl. Scabicides, Insecticides and Repellents
p71043
g44409
sg1893
g28017
sVCytochrome P-450 Enzyme Inducers
p71044
g28167
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p71045
g44547
sVCytochrome P-450 CYP3A4 Substrates
p71046
g65318
sVToxic Actions
p71047
g49399
sVCompounds used in a research, industrial, or household setting
p71048
(dp71049
ssg9474
(dp71050
VGanglion Blockers
p71051
g31416
sVCytochrome P-450 CYP2D6 Substrates
p71052
g52177
sVCytochrome P-450 CYP3A Substrates
p71053
g44996
sVNeurotransmitter Agents
p71054
(dp71055
sVOCT2 Inhibitors
p71056
g42487
sVCytochrome P-450 CYP2B6 Substrates
p71057
g33033
sVCytochrome P-450 Enzyme Inhibitors
p71058
g61962
sVDrugs Used in Nicotine Dependence
p71059
g28914
sVDrugs Used in Addictive Disorders
p71060
g24711
sVPeripheral Nervous System Agents
p71061
g57617
sVCytochrome P-450 CYP2E1 Inducers
p71062
g27612
sVCytochrome P-450 CYP2C8 Substrates
p71063
(dp71064
sVCytochrome P-450 CYP1A2 Substrates
p71065
g45596
sVNicotine, metabolism
p71066
g70959
sVAutonomic Agents
p71067
g66568
sg6819
g58885
sVCytochrome P-450 CYP2E1 Inhibitors
p71068
g46842
sVCytochrome P-450 CYP2E1 Inducers (strength unknown)
p71069
g14792
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71070
g29238
sVCytochrome P-450 CYP2C9 Substrates
p71071
g29756
sVOCT1 inhibitors
p71072
g66928
sVMiscellaneous Autonomic Drugs
p71073
(dp71074
sVCytochrome P-450 CYP1A2 Inducers
p71075
g68383
sVNicotine, antagonists & inhibitors
p71076
g20783
sVSolanaceous Alkaloids
p71077
g60161
sVPyridines
p71078
g64237
sVCytochrome P-450 CYP2A6 Substrates
p71079
g35137
sg14791
(dp71080
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p71081
g68486
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p71082
g17451
sVCytochrome P-450 CYP3A4 Substrates
p71083
g65200
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p71084
g26881
sVCholinergic Nicotinic Agonist
p71085
g60298
sVNervous System
p71086
g70281
sVSmoking Cessation Agents
p71087
g34329
sVGanglionic Stimulants
p71088
g61392
sVNicotinic Agonists
p71089
(dp71090
sVCholinergic Agents
p71091
g28728
sVCholinergic Agonists
p71092
g40987
sVAgents producing tachycardia
p71093
g50768
sVAlkaloids
p71094
g19440
sVCytochrome P-450 Enzyme Inducers
p71095
g28169
sVCytochrome P-450 CYP2A6 Inhibitors
p71096
g48589
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p71097
g58990
ssg9477
(dp71098
g8487
g67042
sg3156
g37218
ssg9480
(dp71099
g219
g14075
sg4707
g46977
sg1659
g26202
sg2598
g33119
sg6981
g59454
sg9033
g69019
sg5271
g50156
sg3444
g38888
sg10950
(dp71100
sg11241
(dp71101
sg2262
g30980
ssg9483
(dp71102
g6630
g57933
ssg9486
(dp71103
VSulfones
p71104
g58734
sVSodium Chloride Symporter Inhibitors
p71105
g55914
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p71106
g25430
sVCardiovascular Agents
p71107
g26597
sVGenito Urinary System and Sex Hormones
p71108
g66167
sVGynecological Antiinfectives and Antiseptics
p71109
g69246
sVAntihypertensive Agents
p71110
g20283
sVHypotensive Agents
p71111
g34148
sVBradycardia-Causing Agents
p71112
g61454
sVSulfonamides
p71113
g63361
sVThiazides
p71114
g70216
sVAmides
p71115
g44325
sVBenzothiadiazines
p71116
g44815
sVSulfur Compounds
p71117
(dp71118
sVIncreased Diuresis
p71119
g40999
sVMembrane Transport Modulators
p71120
g54146
sVHeterocyclic Compounds, Fused-Ring
p71121
g56104
sVHyperglycemia-Associated Agents
p71122
g68807
sVNatriuretic Agents
p71123
g40497
sVDiuretics
p71124
g57907
ssg9489
(dp71125
g7197
g60604
sg12421
g12446
sg7065
g59930
ssg9492
(dp71126
g8469
g66933
sg7857
g64022
sg9840
(dp71127
sg6876
g59102
sVNeurotransmitter Agents
p71128
(dp71129
sg7989
g64615
sg7935
g64242
sVCholinergic Agents
p71130
g28735
sVCytochrome P-450 Enzyme Inducers
p71131
g28178
sVCytochrome P-450 CYP3A Inducers
p71132
g66276
sg9912
(dp71133
sg9315
g70283
sVCytochrome P-450 CYP3A4 Inducers
p71134
g18929
ssg9495
(dp71135
g8595
g67345
ssg9498
(dp71136
g7812
g63743
sg7527
g62449
sg10362
(dp71137
ssg9501
(dp71138
g11367
(dp71139
ssg9504
(dp71140
g3981
g42035
ssg9507
(dp71141
VQuinolines
p71142
(dp71143
sg4530
g45994
sVPotential QTc-Prolonging Agents
p71144
g70420
sVCompounds used in a research, industrial, or household setting
p71145
(dp71146
sVEnzyme Inhibitors
p71147
(dp71148
sVCytochrome P-450 Enzyme Inhibitors
p71149
g62017
sVAnti-Infective Agents
p71150
g54623
sVQuinolone Antimicrobial
p71151
g68132
sVAntiinfectives for Systemic Use
p71152
g69664
sVAnti-Bacterial Agents
p71153
g38317
sVQTc Prolonging Agents
p71154
g57871
sVPharmaceutical Preparations
p71155
g53861
sVCytochrome P-450 CYP1A2 Inhibitors
p71156
g14994
sVFluoroquinolones
p71157
g50494
sVSensory Organs
p71158
g40677
sVAntibacterials for Systemic Use
p71159
g32525
sVQuinolones
p71160
g23983
sVHeterocyclic Compounds, Fused-Ring
p71161
g56040
sVOphthalmologicals
p71162
g35177
sVHypoglycemia-Associated Agents
p71163
g17688
sVSolutions
p71164
g53090
sVTopoisomerase II Inhibitors
p71165
g40634
sVPharmaceutical Solutions
p71166
g15484
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p71167
g27735
sVTopoisomerase Inhibitors
p71168
g32852
ssg9510
(dp71169
g4920
g48318
ssg9513
(dp71170
g10263
(dp71171
sg3708
g40367
sg5805
g53266
sg11652
(dp71172
sg1035
g21448
sg3114
g36847
sg4635
g46460
sg10005
(dp71173
sg5235
g49808
sg5829
g53347
sg4452
g45404
sg657
g18285
sg6759
g58540
sg11619
(dp71174
sg684
g18483
sg1869
g27806
sg4056
g42569
sg3885
g41429
sg1059
g21731
sg7944
g64333
sg9924
(dp71175
sg7464
g62145
sg687
g18530
sg2403
g31825
sg8433
g66633
sg3519
g39201
sg9561
(dp71176
sg3696
g40263
sg909
g20616
sg1857
g27688
sg1491
g25046
sg10818
(dp71177
sg9009
g68915
sg8460
g66867
sg8580
g67274
sg7485
g62260
sg3177
g37293
sg12063
(dp71178
sg10557
(dp71179
sg9012
g68943
sg8820
g68237
sg9987
(dp71180
sg7569
g62703
sg3399
g38615
sg10761
(dp71181
sg138
g13269
sg19588
g32454
sg1911
g28339
sg9918
(dp71182
sg4959
g48507
sg1548
g25352
sg7764
g63614
sg8862
g68454
sg10098
(dp71183
sg6315
g56280
sg3531
g39255
sg10350
(dp71184
sg5289
g50242
sg4419
g44884
sg3240
g37692
sg10227
(dp71185
sg7191
g60533
sg2304
g31247
sg2616
g33155
sg8595
g67333
sg3447
g38901
sg5580
g51851
ssg9516
(dp71186
g1581
g25677
ssg9519
(dp71187
g1986
g28818
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p71188
g50950
sVOAT1/SLC22A6 inhibitors
p71189
(dp71190
sVAnalgesics
p71191
g26462
sg6744
g58384
sVNon COX-2 selective NSAIDS
p71192
g67321
sVCentral Nervous System Agents
p71193
g58467
sVAntiinflammatory and Antirheumatic Products
p71194
g56806
sVEnzyme Inhibitors
p71195
(dp71196
sVPeripheral Nervous System Agents
p71197
g57615
sVNonsteroidal Anti-inflammatory Compounds
p71198
g68158
sVAnalgesics, Non-Narcotic
p71199
g56890
sVNephrotoxic agents
p71200
g57719
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p71201
(dp71202
sg2361
g31506
sVTopical Products for Joint and Muscular Pain
p71203
g13928
sVAgents causing hyperkalemia
p71204
g43603
sVAgents that produce hypertension
p71205
g69069
sVAnti-Inflammatory Agents
p71206
(dp71207
sVCyclooxygenase Inhibitors
p71208
g32776
sVAntirheumatic Agents
p71209
g24207
sVSensory System Agents
p71210
(dp71211
sVAnti-Inflammatory Agents, Non-Steroidal
p71212
g64650
ssg9522
(dp71213
g4707
g46982
ssg9525
(dp71214
VAgents Causing Muscle Toxicity
p71215
g55397
sVCytochrome P-450 CYP2C9 Inhibitors
p71216
g18215
sVCytochrome P-450 CYP1A2 Substrates
p71217
g45623
sVEnzyme Inhibitors
p71218
(dp71219
sVSelective Immunosuppressants
p71220
g23564
sVImmunologic Factors
p71221
g42373
sVIsoxazoles
p71222
g65716
sVImmunosuppressive Agents
p71223
g64588
sVBCRP/ABCG2 Substrates
p71224
g42066
sVAdjuvants
p71225
g50697
sVDisease-modifying Antirheumatic Agents
p71226
g57189
sVAntineoplastic and Immunomodulating Agents
p71227
g39813
sVAntirheumatic Agents
p71228
g24209
sVCytochrome P-450 CYP2C9 Substrates
p71229
g29769
sVCytochrome P-450 Enzyme Inhibitors
p71230
g62093
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p71231
(dp71232
ssg9528
(dp71233
VBSEP/ABCB11 Substrates
p71234
(dp71235
sVCytochrome P-450 CYP3A4 Inhibitors
p71236
g61678
sVDaunorubicin
p71237
g35344
sVImmunosuppressive Agents
p71238
g64570
sVCarbohydrates
p71239
g61775
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p71240
g43757
sVEnzyme Inhibitors
p71241
(dp71242
sVCytochrome P-450 Enzyme Inhibitors
p71243
g61964
sVP-glycoprotein/ABCB1 Inducers
p71244
g70552
sVMyelosuppressive Agents
p71245
(dp71246
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71247
g29244
sVCytotoxic Antibiotics and Related Substances
p71248
g50174
sVNaphthacenes
p71249
g40471
sVCytochrome P-450 CYP3A Substrates
p71250
g44998
sVGlycosides
p71251
g68353
sVCytochrome P-450 CYP3A5 Inducers
p71252
g41735
sVAnthracyclines and Related Substances
p71253
g51556
sVP-glycoprotein/ABCB1 Substrates
p71254
g34999
sVTopoisomerase II Inhibitors
p71255
g40637
sVAnthracyclines
p71256
g31938
sVCytochrome P-450 Enzyme Inducers
p71257
g28185
sVCytochrome P-450 CYP3A Inducers
p71258
g66278
sVCytochrome P-450 CYP3A4 Substrates
p71259
g65201
sVCardiotoxic antineoplastic agents
p71260
(dp71261
sVAnthracycline Topoisomerase Inhibitor
p71262
g43268
sVCytochrome P-450 CYP3A Inhibitors
p71263
g60439
sVAntibiotics, Antineoplastic
p71264
g30411
sVBCRP/ABCG2 Substrates
p71265
g42054
sVAntineoplastic Agents
p71266
(dp71267
sVP-glycoprotein/ABCB1 Inhibitors
p71268
(dp71269
sVAntineoplastic and Immunomodulating Agents
p71270
g39783
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p71271
(dp71272
sVTopoisomerase Inhibitors
p71273
g32856
ssg9531
(dp71274
g4479
g45679
sg3912
g41599
sg8721
g67851
sg690
g18602
sg11079
(dp71275
sg288
g14650
sg8820
g68249
sg8454
g66811
sg102
g12995
sg9432
g70878
sg7377
g61483
sg4920
g48327
sg2838
g34780
sg3021
g36179
sg1899
g28032
sg4539
g46016
sg9273
g70158
sg6504
g57248
sg2895
g35408
sg9081
g69156
sg8724
g67898
sg11385
(dp71276
ssg9534
(dp71277
g534
g16979
sg714
g19004
sg7152
g60214
ssg9537
(dp71278
g6180
g55435
sg10323
(dp71279
sg4515
g45904
sg11274
(dp71280
sg2007
g28894
sg8106
g65158
sg2817
g34566
sg1650
g26092
ssg9540
(dp71281
VHematinics
p71282
g59089
sVCarbohydrates
p71283
g61776
sVBiological Factors
p71284
g38112
sVGlycoconjugates
p71285
(dp71286
sVMembrane Proteins
p71287
g52382
sVHemostatics
p71288
g23065
sVReceptors, Immunologic
p71289
g50498
sVIncreased Platelet Production
p71290
g26225
sVColony-Stimulating Factors
p71291
g47975
sVThrombopoietin Receptor Agonist
p71292
g49014
sVRecombinant Proteins
p71293
g62636
sVBlood and Blood Forming Organs
p71294
g53930
sVHematopoietic Cell Growth Factors
p71295
g65132
sVProteins
p71296
g52753
sVPeptides
p71297
g47177
sVThrombopoietin Receptor Agonists
p71298
(dp71299
sVAmino Acids, Peptides, and Proteins
p71300
g47348
sVIntercellular Signaling Peptides and Proteins
p71301
g25419
sVIncreased Megakaryocyte Maturation
p71302
(dp71303
sVReceptors, Cell Surface
p71304
g63648
sVGlycoproteins
p71305
(dp71306
sg7038
g59666
sVCytokines
p71307
g62893
ssg9543
(dp71308
g6090
g54938
sg4263
g44153
sg12421
g12440
sg6102
g55062
sg7065
g59925
sg7197
g60600
sg19588
g32483
sg7563
g62658
sg9819
(dp71309
ssg9546
(dp71310
g288
g14666
sg2559
g32949
ssg9549
(dp71311
g969
g21077
sg11535
(dp71312
ssg9552
(dp71313
VToxic Actions
p71314
g49387
sVCytochrome P-450 CYP2C8 Substrates
p71315
(dp71316
sg5037
g48824
sVNoxae
p71317
g65420
sVPyridines
p71318
g64228
sVDermatologicals
p71319
g17271
sg7149
g60187
sg5640
g52309
sg9849
(dp71320
sg10542
(dp71321
sg1242
g22993
sg7737
g63553
ssg9555
(dp71322
g1674
g26331
sg6192
g55540
sg6882
g59116
sg837
g19981
sg7848
g63969
sg5454
g51149
sg9411
g70668
sg858
g20144
sg11151
(dp71323
sg10680
(dp71324
sg888
g20503
sg10701
(dp71325
sg6807
g58816
sg3609
g39672
sg2451
g32209
sg10752
(dp71326
sg2466
g32335
sg3801
g40955
sg9267
g70127
sg9273
g70163
sg13091
g21422
sg11562
(dp71327
sg3258
g37803
sg4014
g42221
sg48
g12636
sg10839
(dp71328
sg9375
g70540
sg10104
(dp71329
sg87
g12914
sg4521
g45958
sg8625
g67499
sg4068
g42764
sg9135
g69514
sg3027
g36354
sg4917
g48301
sg9414
g70699
sg10179
(dp71330
sg4002
g42129
sg6489
g57210
sg474
g16556
sg1920
g28475
sg9444
g70941
sg8760
g67995
sg1173
g22629
sg11775
(dp71331
sg8751
g67958
sg4197
g43503
sg2754
g34063
sg11799
(dp71332
sg456
g16377
sg9528
g71246
sg4023
g42331
sg477
g16598
sg2034
g29012
sg3015
g36085
sg5880
g53721
sg6612
g57758
sg2079
g29850
sg2829
g34635
sg9618
(dp71333
sg11133
(dp71334
sg11136
(dp71335
sg8856
g68422
sg3963
g41864
sg6654
g58055
sg1365
g24037
sg28215
g35355
sg11913
(dp71336
sg2895
g35425
sg3930
g41654
sg8190
g65570
sg3633
g40043
sg2196
g30642
sg6009
g54334
sg16906
g61904
sg5250
g49972
sg6765
g58596
sg9909
(dp71337
sg2418
g31905
sg11313
(dp71338
sg10374
(dp71339
sg4863
g47940
sg3264
g37857
sg12090
(dp71340
sg771
g19283
sg11241
(dp71341
sg9105
g69376
ssg9558
(dp71342
g6279
g55929
sg11592
(dp71343
sg5973
g54258
ssg9561
(dp71344
VAgents that produce neuromuscular block (indirect)
p71345
g37965
sVAntiarrhythmic agents
p71346
g71176
sVAnalgesics
p71347
g26468
sVAgents causing hyperkalemia
p71348
g43609
sVDrugs for Constipation
p71349
g53337
sVCalcium Channel Blockers
p71350
g41312
sg2574
g33047
sg843
g20033
sg54
g12688
sVElectrolytes
p71351
g52417
sg7080
g60042
sg8256
g65844
sVMiscellaneous Anticonvulsants
p71352
g53480
sg1839
g27636
sg2052
g29154
sVCalcium-Regulating Hormones and Agents
p71353
g67155
sg2613
g33146
sg3351
g38301
sg705
g18847
sg7743
g63580
sVOsmotic Laxatives
p71354
g57505
sg3168
g37237
sVSulfur Compounds
p71355
(dp71356
sVCentral Nervous System Depressants
p71357
(dp71358
sVBlood and Blood Forming Organs
p71359
g53918
sVCardiovascular Agents
p71360
g26616
sg5529
g51604
sVAnticonvulsants
p71361
g60146
sg3747
g40572
sVDermatologicals
p71362
g17277
sVVasodilating Agents
p71363
g23696
sg1533
g25284
sVLaxatives
p71364
g17344
sVMembrane Transport Modulators
p71365
g54151
sVCentral Nervous System Agents
p71366
g58475
sVAlimentary Tract and Metabolism
p71367
g23870
sg5103
g49116
sg5160
g49449
sg5748
g52902
sVBradycardia-Causing Agents
p71368
g61446
sg11205
(dp71369
sg5967
g54197
sg7386
g61535
sVPeripheral Nervous System Agents
p71370
g57621
sg9669
(dp71371
sg3771
g40805
sg7398
g61597
sVSensory System Agents
p71372
(dp71373
ssg9564
(dp71374
VCytochrome P-450 CYP3A4 Inhibitors
p71375
g61685
sVUGT1A4 substrates
p71376
g41049
sVGABA Agents
p71377
g16212
sVCytochrome P-450 CYP3A Substrates
p71378
g44999
sVNeurotransmitter Agents
p71379
(dp71380
sVAnti-Anxiety Agents
p71381
g35650
sVCentral Nervous System Agents
p71382
g58476
sVCYP3A Substrates (Sensitive)
p71383
g63921
sVPsychotropic Drugs
p71384
(dp71385
sVTriazolobenzodiazepines
p71386
(dp71387
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p71388
g43764
sVGABA Modulators
p71389
g39054
sVCytochrome P-450 Enzyme Inhibitors
p71390
g61966
sVDrugs that are Mainly Renally Excreted
p71391
g43843
sVHypnotics and Sedatives
p71392
(dp71393
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71394
g29247
sVAdjuvants, Anesthesia
p71395
g55872
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p71396
g60071
sVCentral Nervous System Depressants
p71397
(dp71398
sVAnesthetics
p71399
g51605
sVPsycholeptics
p71400
g33239
sVHeterocyclic Compounds, Fused-Ring
p71401
g56110
sVCytochrome P-450 CYP3A4 Substrates
p71402
g65202
sVCytochrome P-450 CYP3A5 Substrates
p71403
g67818
sVBenzodiazepine hypnotics and sedatives
p71404
g17660
sVCytochrome P-450 CYP3A Inhibitors
p71405
g60446
sVBenzodiazepines and benzodiazepine derivatives
p71406
(dp71407
sVNervous System
p71408
g70290
sVTranquilizing Agents
p71409
g55296
sVCytochrome P-450 CYP3A7 Substrates
p71410
g60662
ssg9567
(dp71411
g11886
(dp71412
sg9609
(dp71413
sg9693
(dp71414
sg6783
g58663
sg5766
g52976
sg8694
g67719
ssg9570
(dp71415
g2373
g31586
sg11955
(dp71416
sg10635
(dp71417
sg4623
g46378
sg8580
g67284
sg1803
g27381
sg5427
g50993
sg10857
(dp71418
sg11415
(dp71419
sg9903
(dp71420
sg1434
g24649
sg255
g14382
sg5457
g51197
sg1452
g24729
sg1947
g28677
sg1260
g23145
sg687
g18553
sg2199
g30687
sg11652
(dp71421
sg3144
g37108
sg4488
g45743
sg11667
(dp71422
sg14838
g39981
sg9402
g70634
sg294
g14738
sg4683
g46929
sg5895
g53807
sg9030
g68987
sg5922
g54015
sg7320
g61077
sg5928
g54062
sg6102
g55070
sg3147
g37150
sg9264
g70093
sg11439
(dp71423
sg3882
g41414
sg23
g12215
sg9819
(dp71424
sg210
g14005
sg5370
g50670
sg6048
g54744
sg8430
g66595
sg9093
g69267
sg9852
(dp71425
sg5598
g52019
ssg9573
(dp71426
g4920
g48339
ssg9576
(dp71427
g285
g14611
sg3867
g41339
sg4752
g47288
sg1683
g26380
sg10047
(dp71428
ssg9579
(dp71429
VAgents Causing Muscle Toxicity
p71430
g55383
sVGastrointestinal Agents
p71431
g70836
sVGastric Acid Lowering Agents
p71432
g67255
sVDrugs for Acid Related Disorders
p71433
g55164
sVThiazoles
p71434
g49138
sVNeurotransmitter Agents
p71435
(dp71436
sVP-glycoprotein/ABCB1 Substrates
p71437
g35011
sVHistamine Agents
p71438
(dp71439
sVHistamine H2 Antagonists
p71440
g12709
sVCholinesterase Inhibitors
p71441
(dp71442
sVSulfur Compounds
p71443
(dp71444
sVHistamine Antagonists
p71445
g43434
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p71446
g67791
sVAcid Reducers
p71447
g43816
sVAlimentary Tract and Metabolism
p71448
g23880
sVAnti-Ulcer Agents
p71449
(dp71450
ssg9582
(dp71451
g4053
g42564
ssg9585
(dp71452
g9540
g71303
sg10512
(dp71453
ssg9588
(dp71454
VAntiparasitic Products, Insecticides and Repellents
p71455
g30571
sg9327
g70340
sVBSEP/ABCB11 Substrates
p71456
(dp71457
sg4698
g46957
sg6159
g55246
sVCentral Nervous System Agents
p71458
g58479
sVPotential QTc-Prolonging Agents
p71459
g70424
sVDrugs Used in Alcohol Dependence
p71460
(dp71461
sVEnzyme Inhibitors
p71462
(dp71463
sVEctoparasiticides, Incl. Scabicides
p71464
g57545
sVCytochrome P-450 Enzyme Inhibitors
p71465
g61967
sVCarbamates
p71466
g45520
sVDrugs Used in Addictive Disorders
p71467
g24717
sg663
g18379
sVCytochrome P-450 CYP3A4 Substrates
p71468
g65203
sVThiocarbamates
p71469
g24993
sg3897
g41481
sg4482
g45737
sVCytochrome P-450 CYP2E1 Inhibitors
p71470
g46836
sVElectrolytes
p71471
g52418
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71472
g29248
sVSulfur Compounds
p71473
(dp71474
sVEctoparasiticides, Incl. Scabicides, Insecticides and Repellents
p71475
g44410
sVCytochrome P-450 CYP3A Substrates
p71476
g45000
sg12036
(dp71477
sVAgents that reduce seizure threshold
p71478
g45850
sVAcids
p71479
g40575
sg5430
g51011
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p71480
g26883
sVQTc Prolonging Agents
p71481
g57848
sVIons
p71482
g49118
sVCytochrome P-450 CYP3A5 Substrates
p71483
g67820
sVAcids, Acyclic
p71484
g25461
sVAcids, Noncarboxylic
p71485
g54200
sg6144
g55159
sg399
g15814
sVAnions
p71486
(dp71487
sVNervous System
p71488
g70292
ssg9591
(dp71489
VCytochrome P-450 CYP3A4 Inhibitors
p71490
g61690
sVCytochrome P-450 CYP3A Substrates
p71491
g45001
sVBCRP/ABCG2 Inhibitors
p71492
g12531
sVUGT1A9 Substrates
p71493
g24007
sVKinase Inhibitor
p71494
g24590
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p71495
g43769
sVCytochrome P-450 CYP2C9 Inhibitors
p71496
g18227
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p71497
g12671
sVCytochrome P-450 Enzyme Inhibitors
p71498
g61968
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p71499
(dp71500
sVUrea
p71501
g58647
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p71502
g23114
sVTyrosine Kinase Inhibitors
p71503
g30825
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71504
g29249
sVAntineoplastic Agents
p71505
(dp71506
sVBenzene Derivatives
p71507
g61422
sVCytochrome P-450 CYP2C8 Inhibitors
p71508
g55031
sVCytochrome P-450 CYP2B6 Inhibitors
p71509
g45931
sVP-glycoprotein/ABCB1 Substrates
p71510
g35014
sVUGT1A1 Inhibitors
p71511
(dp71512
sVCytochrome P-450 CYP3A4 Substrates
p71513
g65204
sVProtein Kinase Inhibitors
p71514
(dp71515
sVCytochrome P-450 CYP3A Inhibitors
p71516
g60452
sVBradycardia-Causing Agents
p71517
g61448
sVP-glycoprotein/ABCB1 Inhibitors
p71518
(dp71519
sVAntineoplastic and Immunomodulating Agents
p71520
g39788
sVUGT1A9 Inhibitors
p71521
g66249
ssg9594
(dp71522
g1371
g24106
ssg9597
(dp71523
g6180
g55425
sg2346
g31384
sg1674
g26340
sg9135
g69521
sg6192
g55553
sg9249
g70027
sg3117
g36915
sg6882
g59122
sg6216
g55646
sg7848
g63973
sg5454
g51157
sg4653
g46698
sg1650
g26112
sg9411
g70686
sg858
g20172
sg11151
(dp71524
sg6171
g55329
sg7668
g63207
sg147
g13459
sg1470
g24912
sg10701
(dp71525
sg10362
(dp71526
sg1686
g26415
sg6807
g58821
sg3609
g39715
sg918
g20777
sg10728
(dp71527
sg8751
g67974
sg9231
g69969
sg10752
(dp71528
sg2466
g32339
sg9834
(dp71529
sg9267
g70131
sg2493
g32620
sg9273
g70170
sg2763
g34240
sg13091
g21388
sg11562
(dp71530
sg5646
g52349
sg6333
g56472
sg4002
g42143
sg3261
g37844
sg8013
g64687
sg4014
g42256
sg1791
g27248
sg48
g12640
sg10323
(dp71531
sg10839
(dp71532
sg10077
(dp71533
sg11601
(dp71534
sg9375
g70549
sg4113
g43046
sg87
g12924
sg4521
g45967
sg7545
g62557
sg8625
g67503
sg4068
g42771
sg10899
(dp71535
sg11313
(dp71536
sg11931
(dp71537
sg12534
g52645
sg1785
g27207
sg4917
g48311
sg9414
g70714
sg9444
g70944
sg3258
g37829
sg6489
g57225
sg474
g16566
sg1149
g22500
sg10179
(dp71538
sg10209
(dp71539
sg8760
g68002
sg14872
g15730
sg5256
g50071
sg402
g15846
sg4185
g43483
sg11775
(dp71540
sg8190
g65584
sg5793
g53214
sg6093
g54988
sg2754
g34067
sg11799
(dp71541
sg5817
g53328
sg2007
g28882
sg8772
g68064
sg456
g16407
sg9528
g71267
sg4236
g43707
sg11646
(dp71542
sg1917
g28466
sg477
g16606
sg8055
g64934
sg2034
g29026
sg2043
g29085
sg3015
g36113
sg4551
g46115
sg5880
g53734
sg78
g12856
sg6612
g57774
sg2817
g34557
sg9591
g71506
sg840
g20024
sg6009
g54350
sg2829
g34664
sg9618
(dp71543
sg3546
g39393
sg3393
g38562
sg11133
(dp71544
sg11136
(dp71545
sg2115
g30207
sg1737
g26929
sg5127
g49236
sg3126
g36967
sg10389
(dp71546
sg11349
(dp71547
sg2079
g29854
sg1365
g24061
sg8880
g68563
sg10953
(dp71548
sg8472
g66952
sg3588
g39623
sg1371
g24103
sg28215
g35387
sg11913
(dp71549
sg2451
g32226
sg8910
g68617
sg3930
g41676
sg10428
(dp71550
sg609
g17816
sg621
g17968
sg3633
g40065
sg3801
g40972
sg2196
g30622
sg528
g16934
sg2094
g29999
sg2211
g30754
sg9225
g69919
sg654
g18278
sg669
g18456
sg6045
g54705
sg6765
g58602
sg11274
(dp71551
sg1473
g24966
sg9909
(dp71552
sg5652
g52377
sg10104
(dp71553
sg7512
g62388
sg3027
g36361
sg1140
g22396
sg10374
(dp71554
sg3783
g40874
sg1275
g23288
sg4863
g47949
sg3264
g37880
sg10563
(dp71555
sg1098
g22034
sg12090
(dp71556
sg771
g19291
sg1563
g25524
sg7416
g61746
sg8949
g68749
sg9084
g69216
sg1014
g21331
sg1599
g25748
sg7608
g62888
sg9105
g69389
ssg9600
(dp71557
g6990
g59483
ssg9603
(dp71558
g10794
(dp71559
sg1650
g26113
sg5370
g50676
sg3639
g40084
ssg9606
(dp71560
g9870
(dp71561
sg7530
g62463
sg10320
(dp71562
sg9780
(dp71563
sg2985
g35922
sg11382
(dp71564
sg420
g15999
ssg9609
(dp71565
VHydroxycorticosteroids
p71566
g55777
sVCytochrome P-450 CYP3A Substrates
p71567
g45003
sVHydrocortisone and derivatives
p71568
g14157
sVHormones
p71569
g55682
sV17-Hydroxycorticosteroids
p71570
g71413
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71571
g29252
sVFused-Ring Compounds
p71572
g14863
sVCytochrome P-450 CYP3A4 Inducers
p71573
g18947
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p71574
g44460
sVAdrenal Cortex Hormones
p71575
g30035
sVCytochrome P-450 Enzyme Inducers
p71576
g28205
sVCytochrome P-450 CYP3A Inducers
p71577
g66282
sVCytochrome P-450 CYP3A4 Substrates
p71578
g65206
sVPregnanes
p71579
g63602
sVCytochrome P-450 CYP3A5 Substrates
p71580
g67822
sVPregnenediones
p71581
g29960
sV11-Hydroxycorticosteroids
p71582
g52905
sVCytochrome P-450 CYP2C8 Inducers
p71583
g60376
sVSteroids
p71584
g56420
sVImmunosuppressive Agents
p71585
g64573
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p71586
g64620
sVAnti-Inflammatory Agents
p71587
(dp71588
sVPregnenes
p71589
g28746
sVHormones, Hormone Substitutes, and Hormone Antagonists
p71590
g53172
sVCorticosteroids
p71591
(dp71592
sVCytochrome P-450 CYP3A7 Substrates
p71593
g60664
ssg9612
(dp71594
VAmino Acids, Peptides, and Proteins
p71595
g47387
sVGlobulins
p71596
g19183
sVAntibodies
p71597
g60987
sVProteins
p71598
g52774
sVAgents reducing cytokine levels
p71599
(dp71600
sVSelective Immunosuppressants
p71601
g23561
sVNoxae
p71602
g65423
sVImmunologic Factors
p71603
g42382
sVImmunosuppressive Agents
p71604
g64574
sVToxic Actions
p71605
g49393
sg8859
g68450
sg7257
g60739
sVDisease-modifying Antirheumatic Agents
p71606
g57186
sVSerum Globulins
p71607
g49660
sVAntineoplastic and Immunomodulating Agents
p71608
g39790
sVAntirheumatic Agents
p71609
g24231
sVBiologics for Rheumatoid Arthritis Treatment
p71610
g47859
sg10719
(dp71611
sVBlood Proteins
p71612
g39861
sVImmunoproteins
p71613
g57453
ssg9615
(dp71614
g5511
g51463
ssg9618
(dp71615
VHydrocarbons, Acyclic
p71616
g19583
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p71617
(dp71618
sVCytochrome P-450 CYP3A Substrates
p71619
g45004
sVCycloparaffins
p71620
g43668
sVCompounds used in a research, industrial, or household setting
p71621
(dp71622
sVRetinoids
p71623
g48825
sVAlkenes
p71624
g30758
sVCytochrome P-450 Enzyme Inhibitors
p71625
g61969
sVTerpenes
p71626
(dp71627
sVMyelosuppressive Agents
p71628
g71333
sVCarotenoids
p71629
g63277
sVPigments, Biological
p71630
g21847
sVPolyenes
p71631
g51391
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71632
g29253
sVCytochrome P-450 CYP2C9 Substrates
p71633
g29783
sVCytochrome P-450 CYP3A4 Inducers
p71634
g18967
sVAntineoplastic Agents
p71635
g71543
sVCyclohexanes
p71636
g33280
sVCytochrome P-450 CYP3A4 Inducers (moderate)
p71637
g68979
sVCytochrome P-450 CYP2C8 Inhibitors
p71638
g55032
sVCytochrome P-450 Enzyme Inducers
p71639
g28206
sVCytochrome P-450 CYP3A Inducers
p71640
g66288
sVCyclohexenes
p71641
(dp71642
sVCytochrome P-450 CYP3A4 Substrates
p71643
g65207
sg8310
g66080
sVImmunosuppressive Agents
p71644
g64575
sVAntineoplastic and Immunomodulating Agents
p71645
g39754
sg4011
g42206
sVBiological Factors
p71646
g38108
ssg9621
(dp71647
g5472
g51306
ssg9624
(dp71648
g2196
g30630
sg11403
(dp71649
sg10377
(dp71650
sg7821
g63830
sg5250
g49989
sg10797
(dp71651
sg3000
g36020
sg11052
(dp71652
sg10977
(dp71653
sg9954
(dp71654
sg9591
g71512
sg10512
(dp71655
sg8097
g65095
sg10728
(dp71656
sg2652
g33320
sg2274
g31082
sg5127
g49242
sg3408
g38714
sg10179
(dp71657
sg5757
g52936
sg7188
g60514
sg5256
g50087
sg819
g19766
sg621
g17974
ssg9627
(dp71658
VAmino Acids, Peptides, and Proteins
p71659
g47391
sVAntiinfectives for Systemic Use
p71660
g69672
sVAntibodies
p71661
g60989
sVSpecific Immunoglobulins
p71662
(dp71663
sVAntibodies, Monoclonal
p71664
(dp71665
sVAntibodies, Monoclonal, Humanized
p71666
(dp71667
sVImmunoglobulins
p71668
g41531
sVProteins
p71669
g52776
sVImmune Sera and Immunoglobulins
p71670
g48574
sVAntiviral Agents
p71671
g30463
sVImmunoproteins
p71672
g57455
sg8556
g67223
sVSerum Globulins
p71673
g49662
sVBlood Proteins
p71674
g39865
sVAnti-Infective Agents
p71675
g54642
sVGlobulins
p71676
g19188
sg5850
g53518
ssg9630
(dp71677
VAmino Acids, Peptides, and Proteins
p71678
g47332
sVAntiinfectives for Systemic Use
p71679
g69647
sVPeptides, Cyclic
p71680
g70146
sVLipopeptides
p71681
g33710
sVOphthalmologicals
p71682
g35189
sVOphthalmological and Otological Preparations
p71683
(dp71684
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p71685
g59978
sVIntestinal Antiinfectives
p71686
g68572
sVOtologicals
p71687
g69482
sVProteins
p71688
g52745
sVSensory Organs
p71689
g40686
sVPolymyxin-class Antibacterial
p71690
g51750
sVPeptides
p71691
g47171
sVNeurotoxic agents
p71692
g68590
sVAnti-Bacterial Agents
p71693
g38331
sVAntibacterials for Systemic Use
p71694
g32536
sVAnti-Infective Agents
p71695
g54581
sVPore Forming Cytotoxic Proteins
p71696
g57498
sVAlimentary Tract and Metabolism
p71697
g23795
sVPolymyxins
p71698
g46288
sVAntimicrobial Cationic Peptides
p71699
g33096
ssg9633
(dp71700
g10578
(dp71701
ssg9636
(dp71702
g6231
g55743
ssg9639
(dp71703
g4164
g43364
sg8433
g66650
sg1899
g28056
sg8916
g68633
sg5832
g53454
sg8298
g66070
sg1050
g21687
ssg9642
(dp71704
g3231
g37669
sg5934
g54097
sg5574
g51809
sg7641
g63043
ssg9645
(dp71705
g7980
g64500
sg447
g16280
ssg9648
(dp71706
g11832
(dp71707
sg9897
(dp71708
sg2754
g34082
sg11133
(dp71709
sg9084
g69223
sg8751
g67971
ssg9651
(dp71710
g1041
g21511
sg10185
(dp71711
sg5286
g50225
sg6567
g57529
sg4581
g46203
ssg9654
(dp71712
g630
g18029
sg240
g14194
sg6318
g56365
sg8163
g65459
sg11979
(dp71713
sg9711
(dp71714
sg10662
(dp71715
sg10308
(dp71716
sg11016
(dp71717
sg6468
g57103
sg2427
g32025
sg7299
g60924
sg2910
g35542
sg8097
g65084
sg9417
g70761
sg6966
g59413
sg2841
g34842
sg7941
g64291
sg7497
g62308
sg9981
(dp71718
sg11790
(dp71719
sg8028
g64819
sg6303
g56220
sg4344
g44659
sg696
g18725
sg3978
g41995
sg5169
g49522
sg387
g15643
sg2664
g33451
sg1194
g22821
sg414
g15967
sg10056
(dp71720
sg780
g19363
ssg9657
(dp71721
VAntiinfectives for Systemic Use
p71722
g69674
sVAgents that produce neuromuscular block (indirect)
p71723
g37980
sVOphthalmologicals
p71724
g35239
sg7116
g60131
sVNephrotoxic agents
p71725
g57730
sVAminoglycoside Antibacterials
p71726
g52728
sVGlycosides
p71727
g68374
sVKanamycin
p71728
g37474
sVSensory Organs
p71729
g40729
sVAnti-Bacterial Agents
p71730
g38371
sVAntibacterials for Systemic Use
p71731
g32568
sVAnti-Infective Agents
p71732
g54649
sVCarbohydrates
p71733
g61784
sVNarrow Therapeutic Index Drugs
p71734
g50580
ssg9660
(dp71735
g1734
g26898
sg10782
(dp71736
sg8748
g67950
sg7818
g63777
sg10671
(dp71737
sVAcids, Acyclic
p71738
g25489
sVMineral Supplements
p71739
g38300
sg7467
g62213
sg4644
g46555
sg1233
g22903
sg606
g17795
sVPhosphate Binder
p71740
g21950
sg9159
g69590
sg5451
g51126
sg1053
g21718
sg6039
g54685
sVAlimentary Tract and Metabolism
p71741
g23896
sVCompounds used in a research, industrial, or household setting
p71742
(dp71743
ssg9663
(dp71744
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p71745
g52096
sVCytochrome P-450 CYP3A4 Inhibitors
p71746
g61663
sVAntivirals for Systemic Use
p71747
g59756
sVNucleic Acid Synthesis Inhibitors
p71748
g48735
sVCytochrome P-450 CYP2D6 Inhibitors
p71749
g62946
sVCytochrome P-450 CYP3A Substrates
p71750
g44990
sVPyrimidines
p71751
g47715
sVBCRP/ABCG2 Inhibitors
p71752
g12556
sVDirect Acting Antivirals
p71753
g38053
sVCYP3A Substrates (Sensitive)
p71754
g63928
sVAnti-HIV Agents
p71755
g66402
sVEnzyme Inhibitors
p71756
(dp71757
sVCytochrome P-450 Enzyme Inhibitors
p71758
g61972
sVAnti-Infective Agents
p71759
g54602
sVReverse Transcriptase Inhibitors
p71760
g28963
sVNonnucleoside Reverse Transcriptase Inhibitors
p71761
g34333
sVAntiinfectives for Systemic Use
p71762
g69652
sVAnti-Retroviral Agents
p71763
g67151
sVNitriles
p71764
g34040
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71765
g29232
sVOATP1B3 inhibitors
p71766
g62287
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p71767
g60064
sVQTc Prolonging Agents
p71768
g57859
sVOATP1B1/SLCO1B1 Inhibitors
p71769
(dp71770
sVCytochrome P-450 CYP2B6 Inhibitors
p71771
g45940
sVHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
p71772
g45990
sVCytochrome P-450 CYP3A4 Substrates
p71773
g65198
sVNon-Nucleoside Reverse Transcriptase Inhibitors
p71774
g15490
sVPotential QTc-Prolonging Agents
p71775
g70431
sVCytochrome P-450 CYP3A Inhibitors
p71776
g60422
sVAntiviral Agents
p71777
g30437
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p71778
g53083
sVP-glycoprotein/ABCB1 Inhibitors
p71779
(dp71780
sVCytochrome P-450 CYP2B6 Inhibitors (strong)
p71781
(dp71782
ssg9666
(dp71783
g7422
g61831
ssg9669
(dp71784
g9870
(dp71785
sg6552
g57492
sg5415
g50944
sg10839
(dp71786
sg9309
g70252
sg7629
g62998
sg657
g18368
sg3312
g38151
sg11832
(dp71787
sg7530
g62477
sg10320
(dp71788
sg1842
g27662
sg9561
g71371
sg2985
g35938
sg8649
g67560
sg9588
g71487
sg8826
g68329
sg6714
g58273
sg6726
g58306
sg1875
g27908
sg7920
g64208
sg9780
(dp71789
sg7548
g62621
sg4557
g46172
sg10764
(dp71790
sg4770
g47468
sg10767
(dp71791
sg1164
g22594
sg13091
g21396
sg396
g15785
sg10587
(dp71792
sg6765
g58605
sg12108
(dp71793
sg4398
g44837
sg11382
(dp71794
sg420
g16028
ssg9672
(dp71795
g5853
g53568
sg8205
g65639
sg582
g17647
sg828
g19893
sg5064
g48924
sg2358
g31494
sg7284
g60855
sg426
g16127
sg12018
(dp71796
sg9564
g71407
sg5769
g53052
sg9420
g70823
sg3204
g37458
sg2430
g32122
sg5691
g52505
sg6303
g56245
sg10737
(dp71797
ssg9675
(dp71798
g11283
(dp71799
sg7464
g62201
sg10635
(dp71800
sg10818
(dp71801
sg4635
g46524
sg42
g12606
sg4788
g47598
sg4803
g47665
sg7650
g63109
sg8418
g66476
sg72
g12817
sg7671
g63273
sg888
g20521
sg891
g20569
sg3516
g39191
sg2088
g29956
sg2433
g32156
sg9960
(dp71802
sg9963
(dp71803
sg915
g20744
sg10740
(dp71804
sg2391
g31751
sg450
g16362
sg8514
g67134
sg19588
g32517
sg963
g21023
sg3279
g37949
sg11544
(dp71805
sg171
g13727
sg10794
(dp71806
sg2523
g32757
sg5589
g51960
sg1770
g27074
sg1008
g21306
sg7053
g59827
sg11595
(dp71807
sg9339
g70361
sg7707
g63418
sg1809
g27455
sg11619
(dp71808
sg7713
g63442
sg5652
g52371
sg6411
g56879
sg294
g14770
sg4101
g42986
sg5739
g52889
sg2784
g34386
sg9462
g70999
sg3408
g38730
sg4959
g48550
sg537
g17058
sg7971
g64462
sg2688
g33700
sg4974
g48642
sg10239
(dp71809
sg1281
g23402
sg3447
g38973
sg9519
g71211
sg11805
(dp71810
sg1059
g21785
sg3087
g36676
sg4260
g44132
sg7275
g60813
sg6261
g55864
sg5781
g53125
sg9561
g71373
sg10977
(dp71811
sg5877
g53712
sg9702
(dp71812
sg8097
g65113
sg4458
g45506
sg6639
g57995
sg546
g17169
sg2109
g30170
sg11136
(dp71813
sg6024
g54480
sg1413
g24447
sg7569
g62759
sg1578
g25673
sg3651
g40143
sg6678
g58137
sg141
g13375
sg11910
(dp71814
sg336
g15134
sg8019
g64762
sg657
g18374
sg4425
g44950
sg7428
g61879
sg8163
g65477
sg1434
g24673
sg10470
(dp71815
sg5250
g50015
sg8295
g65996
sg10494
(dp71816
sg5487
g51379
sg1491
g25124
sg4716
g47098
sg3711
g40466
sg714
g19037
sg5316
g50476
sg11727
(dp71817
sg10854
(dp71818
sg9060
g69116
sg5181
g49598
sg12126
(dp71819
sg10596
(dp71820
sg6381
g56796
sg10602
(dp71821
sg4596
g46276
sg5394
g50853
sg9864
(dp71822
ssg9678
(dp71823
g4491
g45798
ssg9681
(dp71824
g969
g21104
sg11535
(dp71825
ssg9684
(dp71826
VCentral Nervous System Depressants
p71827
(dp71828
sVHistamine Antagonists
p71829
g43458
sVNeurotransmitter Agents
p71830
(dp71831
sVAnti-Allergic Agents
p71832
g50654
sVHistamine Agents
p71833
(dp71834
sVPotential QTc-Prolonging Agents
p71835
g70432
sVPyridines
p71836
g64243
sVHistamine H1 Antagonists
p71837
g40797
sVAntihistamines for Systemic Use
p71838
g12981
sVQTc Prolonging Agents
p71839
g57834
ssg9687
(dp71840
VHypotensive Agents
p71841
g34198
sVCytochrome P-450 CYP2C9 Inhibitors
p71842
g18240
sVCytochrome P-450 Enzyme Inhibitors
p71843
g62049
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p71844
(dp71845
sVHyperglycemia-Associated Agents
p71846
g68816
sVCytochrome P-450 CYP2C8 Substrates
p71847
(dp71848
sg8061
g64950
sVAntihypertensive Agents
p71849
g20312
sVSulfur Compounds
p71850
(dp71851
sVSulfones
p71852
g58738
sVOATP1B1/SLCO1B1 Substrates
p71853
(dp71854
sVSulfonamides
p71855
g63357
sg1695
g26508
sVDiuretics
p71856
g57900
sVCardiovascular Agents
p71857
g26659
sg327
g14973
sVPyridines
p71858
g64230
sVMembrane Transport Modulators
p71859
g54162
sVCytochrome P-450 CYP2C9 Substrates
p71860
g29804
sVNatriuretic Agents
p71861
g40486
sg11772
(dp71862
sg7035
g59664
ssg9690
(dp71863
g3072
g36607
sg9009
g68932
sg6000
g54319
sg7077
g60037
sg7596
g62862
ssg9693
(dp71864
VHydroxycorticosteroids
p71865
g55778
sVCytochrome P-450 CYP3A Substrates
p71866
g45012
sVHydrocortisone and derivatives
p71867
g14158
sVHormones
p71868
g55690
sVCorticosteroids, Dermatological Preparations
p71869
g51327
sV17-Hydroxycorticosteroids
p71870
g71414
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71871
g29267
sVFused-Ring Compounds
p71872
g14874
sVCytochrome P-450 CYP3A4 Inducers
p71873
g18960
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p71874
g44461
sVAdrenal Cortex Hormones
p71875
g30003
sg10176
(dp71876
sVDermatologicals
p71877
g17303
sVCytochrome P-450 Enzyme Inducers
p71878
g28220
sVCytochrome P-450 CYP3A Inducers
p71879
g66287
sVCytochrome P-450 CYP3A4 Substrates
p71880
g65212
sVPregnanes
p71881
g63594
sVCytochrome P-450 CYP3A5 Substrates
p71882
g67827
sVPregnenediones
p71883
g29962
sV11-Hydroxycorticosteroids
p71884
g52907
sVCytochrome P-450 CYP2C8 Inducers
p71885
g60369
sVSteroids
p71886
g56405
sVImmunosuppressive Agents
p71887
g64586
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p71888
g64622
sVPregnenes
p71889
g28748
sVCorticosteroids, Moderately Potent (Group II)
p71890
g58277
sVHormones, Hormone Substitutes, and Hormone Antagonists
p71891
g53181
sVCorticosteroids
p71892
(dp71893
sVCytochrome P-450 CYP3A7 Substrates
p71894
g60668
ssg9696
(dp71895
VDrugs that are Mainly Renally Excreted
p71896
g43853
sVHematologic Agents
p71897
(dp71898
sVCardiotonic Agents
p71899
g66075
sVCardiovascular Agents
p71900
g26674
sVAmines
p71901
g42737
sVCardiac Stimulants Excl. Cardiac Glycosides
p71902
g29157
sVAminopyridines
p71903
g68859
sVPhosphodiesterase 3 Inhibitors
p71904
g39029
sVPyridines
p71905
g64234
sVCardiac Therapy
p71906
g69632
sVProtective Agents
p71907
g66796
sVVasodilating Agents
p71908
g23693
sVCompounds used in a research, industrial, or household setting
p71909
(dp71910
sVPhosphodiesterase Inhibitors
p71911
g59608
sVEnzyme Inhibitors
p71912
(dp71913
sg1179
g22696
sVPhosphodiesterase 5 Inhibitors
p71914
(dp71915
ssg9699
(dp71916
g2733
g33905
sg11652
(dp71917
sg7275
g60783
ssg9702
(dp71918
VFatty Acids
p71919
g63142
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p71920
g50958
sVAnalgesics
p71921
g26471
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p71922
g58393
sVNon COX-2 selective NSAIDS
p71923
g67325
sVCentral Nervous System Agents
p71924
g58500
sVAntiinflammatory and Antirheumatic Products
p71925
g56815
sVFatty Acids, Volatile
p71926
g66973
sVLipids
p71927
g14317
sVPeripheral Nervous System Agents
p71928
g57624
sVAnalgesics, Non-Narcotic
p71929
g56902
sVNephrotoxic agents
p71930
g57726
sVMusculo-Skeletal System
p71931
g31507
sVAgents causing hyperkalemia
p71932
g43612
sg1197
g22841
sVOther Nonsteroidal Antiimflammatory Agents
p71933
(dp71934
sVPropionates
p71935
g36494
sVAgents that produce hypertension
p71936
g69074
sVAcids, Acyclic
p71937
g25478
sVAnti-Inflammatory Agents
p71938
(dp71939
sVAntirheumatic Agents
p71940
g24229
sVSensory System Agents
p71941
g71812
sVAnti-Inflammatory Agents, Non-Steroidal
p71942
g64657
sVPhotosensitizing Agents
p71943
g21316
ssg9705
(dp71944
VAmino Acids, Peptides, and Proteins
p71945
g47402
sg7455
g62108
sVAntibodies
p71946
g60976
sVImmunomodulatory Agents
p71947
g22796
sVAntibodies, Monoclonal
p71948
(dp71949
sVAntibodies, Monoclonal, Humanized
p71950
(dp71951
sVProteins
p71952
g52783
sVImmunologic Factors
p71953
g42371
sVImmunoglobulins
p71954
g41512
sVImmunosuppressive Agents
p71955
g64587
sVSelective Immunosuppressants
p71956
g23567
sg7218
g60684
sVSerum Globulins
p71957
g49645
sVAntineoplastic and Immunomodulating Agents
p71958
g39811
sVBlood Proteins
p71959
g39842
sVGlobulins
p71960
g19164
sVImmunoproteins
p71961
g57440
ssg9708
(dp71962
g9564
g71387
sg2358
g31462
sg8205
g65618
sg828
g19846
ssg9711
(dp71963
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p71964
(dp71965
sVAdrenergic alpha-1 Receptor Antagonists
p71966
g14112
sVCytochrome P-450 CYP2D6 Substrates
p71967
g52186
sVSerotonin Agents
p71968
(dp71969
sVCytochrome P-450 CYP3A Substrates
p71970
g45014
sVNeurotransmitter Agents
p71971
(dp71972
sVSerotonin Receptor Antagonists
p71973
g35665
sVCentral Nervous System Agents
p71974
g58504
sVDopamine Agents
p71975
g14230
sVAdrenergic Antagonists
p71976
g52269
sVPsychotropic Drugs
p71977
(dp71978
sVHighest Risk QTc-Prolonging Agents
p71979
g35859
sVAntipsychotic Agents
p71980
g69859
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p71981
g29270
sVSulfur Compounds
p71982
(dp71983
sVAdrenergic alpha-Antagonists
p71984
g60865
sVDopamine Antagonists
p71985
g53740
sVQTc Prolonging Agents
p71986
g57864
sVSerotonin 5-HT2 Receptor Antagonists
p71987
g71714
sVCentral Nervous System Depressants
p71988
(dp71989
sVThioxanthene Derivatives
p71990
g53948
sVHistamine H1 Antagonists
p71991
g40767
sVAgents that produce hypertension
p71992
g69083
sVAntipsychotic Agents (First Generation [Typical])
p71993
g63592
sVCytochrome P-450 CYP3A4 Substrates
p71994
g65214
sVDopamine D2 Receptor Antagonists
p71995
g49414
sVHeterocyclic Compounds, Fused-Ring
p71996
g56137
sVThioxanthenes
p71997
g55152
sVAntidepressive Agents
p71998
g15568
sVPsycholeptics
p71999
g33231
sVXanthenes
p72000
g48678
sVNeurotoxic agents
p72001
g68578
sVHistamine Antagonists
p72002
g43425
sVNervous System
p72003
g70304
sVTranquilizing Agents
p72004
g55290
ssg9714
(dp72005
g2277
g31128
sg753
g19228
ssg9717
(dp72006
g11301
(dp72007
sg7521
g62409
sg11934
(dp72008
sg3297
g38035
sg4845
g47857
sg7161
g60252
ssg9720
(dp72009
g10335
(dp72010
sg8673
g67679
ssg9723
(dp72011
g102
g13007
sg6123
g55120
sg8277
g65932
ssg9726
(dp72012
VAntiinfectives for Systemic Use
p72013
g69681
sVAmines
p72014
g42732
sVAnti-Infective Agents, Urinary
p72015
g25219
sg3741
g40555
sVBenzoates
p72016
g30386
sVHydroxy Acids
p72017
g18150
sVBenzene Derivatives
p72018
g61429
sVAcids, Carbocyclic
p72019
g41553
sVCycloparaffins
p72020
g43662
sg6294
g56021
sVAmides
p72021
g44351
sVAnti-Bacterial Agents
p72022
g38380
sVAntibacterials for Systemic Use
p72023
g32577
sVAnti-Infective Agents
p72024
g54661
sg7968
g64432
sVRenal Agents
p72025
g24763
sg2139
g30322
ssg9729
(dp72026
g10347
(dp72027
sg2424
g31948
sg1152
g22530
ssg9732
(dp72028
g8097
g65078
sg9417
g70750
sg3381
g38473
sg5169
g49512
sg387
g15629
sg10497
(dp72029
sg7941
g64280
sg11979
(dp72030
sg2427
g32012
sg9981
(dp72031
sg10056
(dp72032
ssg9735
(dp72033
g5256
g50064
sg10728
(dp72034
sg10797
(dp72035
ssg9738
(dp72036
g11100
(dp72037
ssg9741
(dp72038
VAmino Acids, Peptides, and Proteins
p72039
g47407
sVGlobulins
p72040
g19176
sVAntibodies
p72041
g60984
sVProteins
p72042
g52787
sVRecombinant Proteins
p72043
g62634
sVEnzymes
p72044
(dp72045
sg4671
g46823
sg10893
(dp72046
sVImmunoglobulins
p72047
g41522
sg9468
g71027
sVEsterases
p72048
g59359
sg3726
g40501
sVEnzymes and Coenzymes
p72049
(dp72050
sVSerum Globulins
p72051
g49654
sVBlood Proteins
p72052
g39854
sVHydrolases
p72053
(dp72054
sVAlimentary Tract and Metabolism
p72055
g23919
sg8199
g65604
sVImmunoproteins
p72056
g57447
ssg9744
(dp72057
g2787
g34409
ssg9747
(dp72058
g9225
g69914
sg12274
g27531
sg816
g19662
sg1470
g24907
sg849
g20082
sg507
g16770
sg5433
g51044
sg11940
(dp72059
sg2127
g30260
sg3117
g36908
sg3543
g39336
sg14822
g41818
sg2133
g30290
sg3783
g40870
ssg9750
(dp72060
VAntiinfectives for Systemic Use
p72061
g69644
sVBeta-Lactamase Sensitive Penicillins
p72062
g62391
sg11634
(dp72063
sVpara-Aminobenzoates
p72064
g30550
sVHeterocyclic Compounds, Fused-Ring
p72065
g56113
sVAminobenzoates
p72066
g46181
sVBenzene Derivatives
p72067
g61403
sVDrugs that are Mainly Renally Excreted
p72068
g43852
sVBenzoates
p72069
g30392
sVAcids, Carbocyclic
p72070
g41558
sVbeta-Lactams
p72071
(dp72072
sVAmides
p72073
g44299
sVLactams
p72074
g22277
sVAnti-Bacterial Agents
p72075
g38323
sVAntibacterials for Systemic Use
p72076
g32531
sVPenicillin G
p72077
g34324
sVAnti-Infective Agents
p72078
g54571
sVSulfur Compounds
p72079
(dp72080
sVPenicillins
p72081
g52897
sVBeta-Lactam Antibacterials
p72082
g46294
ssg9753
(dp72083
g2343
g31343
sg5622
g52245
sg8598
g67379
sg8601
g67417
sg1866
g27796
sg7854
g64009
sg6903
g59189
sg3891
g41474
sg8439
g66707
sg9741
g72050
sg6990
g59477
sg8340
g66228
sg19588
g32479
sg3777
g40838
sg2118
g30222
sg1149
g22511
sg8484
g67005
sg7359
g61367
sg10569
(dp72084
sg11175
(dp72085
sg9108
g69400
sg11760
(dp72086
sg11379
(dp72087
sg3126
g36962
ssg9756
(dp72088
g11334
(dp72089
sg10368
(dp72090
sg10509
(dp72091
sg7815
g63758
ssg9759
(dp72092
VGastrointestinal Agents
p72093
g70837
sg8574
g67254
sVPotential QTc-Prolonging Agents
p72094
g70439
sg5106
g49140
sVNeurotransmitter Agents
p72095
(dp72096
sVOAT3/SLC22A8 Substrates
p72097
g13123
sVOAT3/SLC22A8 Inhibitors
p72098
g59009
sg10644
(dp72099
sg60
g12712
sg6147
g55166
sVOCT2 Inhibitors
p72100
g42474
sVSulfur Compounds
p72101
(dp72102
sVHistamine Antagonists
p72103
g43437
sVQTc Prolonging Agents
p72104
g57876
sg8712
g67790
sg4251
g43814
sVAlimentary Tract and Metabolism
p72105
g23924
sg9969
(dp72106
ssg9762
(dp72107
g10410
(dp72108
ssg9765
(dp72109
g9183
g69720
sVBenzene Derivatives
p72110
g61432
sVVarious Alimentary Tract and Metabolism Products
p72111
g43556
sVBenzoates
p72112
g30390
sVKetones
p72113
g50973
sVAcids, Carbocyclic
p72114
g41561
sVCycloparaffins
p72115
g43676
sg6528
g57367
sVOther Miscellaneous Therapeutic Agents
p72116
g28779
sVEnzyme Inhibitors
p72117
(dp72118
sVCytochrome P450 2C9 Inhibitors
p72119
g63321
sVAlimentary Tract and Metabolism
p72120
g23926
sVCyclohexanes
p72121
g33289
sg3012
g36066
ssg9768
(dp72122
g10587
(dp72123
ssg9771
(dp72124
g11733
(dp72125
ssg9774
(dp72126
VPregnanes
p72127
g63595
sVCytochrome P-450 CYP3A4 Substrates
p72128
g65218
sVAdrenal Cortex Hormones
p72129
g30005
sVOtologicals
p72130
g69474
sVSteroids
p72131
g56407
sVCorticosteroids, Dermatological Preparations
p72132
g51336
sVCytochrome P-450 CYP3A Substrates
p72133
g45020
sVHormones
p72134
g55694
sVImmunosuppressive Agents
p72135
g64592
sVPregnadienes
p72136
(dp72137
sVDermatologicals
p72138
g17320
sVAnti-Inflammatory Agents
p72139
(dp72140
sVPregnadienetriols
p72141
(dp72142
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72143
g29278
sVSensory Organs
p72144
g40744
sVCorticosteroids, Moderately Potent (Group II)
p72145
g58276
sVHormones, Hormone Substitutes, and Hormone Antagonists
p72146
g53188
sVFused-Ring Compounds
p72147
g14881
sVCorticosteroids
p72148
(dp72149
sVSteroids, Fluorinated
p72150
(dp72151
ssg9777
(dp72152
g2343
g31340
sg3891
g41471
sg10569
(dp72153
sg11175
(dp72154
sg5622
g52234
sg7854
g64002
sg6990
g59475
sg11760
(dp72155
sg9741
g72045
sg4884
g48066
sg6903
g59194
sg8601
g67421
sg19588
g32496
sg11379
(dp72156
sg3777
g40823
sg1866
g27789
sg2118
g30214
sg9108
g69393
sg1149
g22489
sg3126
g36953
sg8598
g67386
ssg9780
(dp72157
VPotassium Compounds
p72158
g32193
sVAgents causing hyperkalemia
p72159
g43638
sVElectrolyte Solutions
p72160
g20029
sVDrugs that are Mainly Renally Excreted
p72161
g43854
sVReplacement Preparations
p72162
g27635
sg498
g16724
sVElectrolytes
p72163
g52424
sVMineral Supplements
p72164
g38299
sVChlorine Compounds
p72165
g33267
sVMinerals
p72166
g52586
sVI.V. Solution Additives
p72167
g37234
sVHydrochloric Acid
p72168
g71563
sVBlood and Blood Forming Organs
p72169
g53926
sVChlorides
p72170
g27981
sVAcids
p72171
g40582
sVAlimentary Tract and Metabolism
p72172
g23929
sVIons
p72173
g49123
sVBlood Substitutes and Perfusion Solutions
p72174
g49445
sVAcids, Noncarboxylic
p72175
g54207
sVPotassium Salt
p72176
g30480
sVAnions
p72177
g71789
sVHemodialysis Solution
p72178
g36614
ssg9783
(dp72179
VAngiotensin-Converting Enzyme Inhibitors
p72180
g66126
sVTetrahydroisoquinolines
p72181
g65833
sVACE Inhibitors and Diuretics
p72182
g69035
sVCardiovascular Agents
p72183
g26676
sVAntihypertensive Agents
p72184
g20317
sVAgents causing hyperkalemia
p72185
g43639
sVHypotensive Agents
p72186
g34207
sVAgents causing angioedema
p72187
g63908
sVOAT3/SLC22A8 Substrates
p72188
g13132
sVProtease Inhibitors
p72189
g51099
sVIsoquinolines
p72190
g44958
sVEnzyme Inhibitors
p72191
(dp72192
sVHeterocyclic Compounds, Fused-Ring
p72193
g56154
sVAgents Acting on the Renin-Angiotensin System
p72194
g25339
ssg9786
(dp72195
g13750
g24389
sg2373
g31609
sg3117
g36921
sg9903
(dp72196
sg1800
g27324
sg2226
g30778
sg4653
g46702
sg2388
g31673
sg6585
g57670
sg11997
(dp72197
sg7545
g62571
sg7668
g63218
sg1614
g25882
sg8445
g66729
sg14838
g40004
sg5895
g53826
sg6045
g54706
sg12534
g52648
sg9774
g72137
sg4113
g43061
sg9030
g68994
sg3393
g38577
sg4875
g48026
sg3783
g40881
sg3219
g37552
sg5364
g50622
sg14872
g15751
sg12132
(dp72198
sg6345
g56592
sg14829
g56675
ssg9789
(dp72199
g3399
g38644
sg3885
g41454
sg9924
(dp72200
sg9918
(dp72201
ssg9792
(dp72202
g1842
g27663
ssg9795
(dp72203
g4629
g46442
ssg9798
(dp72204
g8598
g67391
sg8601
g67424
ssg9801
(dp72205
g1770
g27062
ssg9804
(dp72206
g9225
g69931
sg816
g19685
sg507
g16789
sg849
g20102
sg11940
(dp72207
sg2127
g30262
sg3117
g36927
sg14822
g41827
sg2133
g30306
ssg9807
(dp72208
g5526
g51591
ssg9810
(dp72209
VFatty Acids
p72210
g63144
sVChelating Agents
p72211
(dp72212
sVFatty Acids, Volatile
p72213
g66978
sVCompounds used in a research, industrial, or household setting
p72214
(dp72215
sVCalcium Salts
p72216
g54682
sVPhosphate-removing Agents
p72217
g64027
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p72218
g37165
sVSulfonic Acids
p72219
g56740
sVPhosphate Binder
p72220
g21941
sVMinerals
p72221
g52582
sVSulfur Compounds
p72222
(dp72223
sVAcids
p72224
g40588
sVBenzene Derivatives
p72225
g61435
sVArylsulfonic Acids
p72226
(dp72227
sVSequestering Agents
p72228
g57198
sVAlimentary Tract and Metabolism
p72229
g23934
sVBlood Coagulation Factors
p72230
(dp72231
sVAcids, Acyclic
p72232
g25465
sVAcids, Noncarboxylic
p72233
g54211
sVSulfur Acids
p72234
g61536
sVArylsulfonates
p72235
g57436
sVLipids
p72236
g14297
ssg9813
(dp72237
g4014
g42245
sg1791
g27265
sg1674
g26354
sg2754
g34078
sg6882
g59132
sg11601
(dp72238
sg5454
g51170
sg9411
g70679
sg87
g12940
sg6765
g58621
sg6171
g55314
sg4863
g47961
sg10701
(dp72239
sg6807
g58831
sg3609
g39690
sg858
g20138
sg8055
g64943
sg3027
g36379
sg11136
(dp72240
sg2466
g32355
sg10374
(dp72241
sg11775
(dp72242
sg11151
(dp72243
sg6489
g57208
sg147
g13487
sg3264
g37850
sg8760
g68010
sg12090
(dp72244
sg771
g19302
sg28215
g35378
sg13091
g21418
sg9528
g71261
sg4185
g43477
sg4002
g42125
ssg9816
(dp72245
g1707
g26790
sg8241
g65820
sg282
g14585
sg3072
g36604
sg3846
g41148
sg600
g17729
sg8916
g68654
sg2946
g35835
sg5832
g53444
sg516
g16892
sg1683
g26378
sg11370
(dp72246
ssg9819
(dp72247
VCytochrome P-450 CYP2D6 Substrates
p72248
g52192
sVCytochrome P-450 CYP3A Substrates
p72249
g45022
sVBronchodilator Agents
p72250
(dp72251
sVRespiratory Smooth Muscle Relaxants
p72252
g17926
sVXanthines and Adrenergics
p72253
g22915
sVEnzyme Inhibitors
p72254
(dp72255
sVPeripheral Nervous System Agents
p72256
g57652
sVPurinergic Agents
p72257
g71309
sVCytochrome P-450 CYP2C8 Substrates
p72258
(dp72259
sVCytochrome P-450 CYP1A2 Substrates
p72260
g45638
sVAutonomic Agents
p72261
g66577
sVPurinergic P1 Receptor Antagonists
p72262
g60048
sVXanthine derivatives
p72263
g28822
sVDrugs for Obstructive Airway Diseases
p72264
g42524
sVRespiratory System Agents
p72265
g71424
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72266
g29281
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p72267
g60068
sVPurinones
p72268
g48134
sVPurines
p72269
(dp72270
sVPhosphodiesterase 5 Inhibitors
p72271
(dp72272
sVNeurotransmitter Agents
p72273
(dp72274
sVCardiovascular Agents
p72275
g26639
sVAgents that reduce seizure threshold
p72276
g45866
sVPhosphodiesterase Inhibitors
p72277
g59607
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p72278
g36467
sVVasodilating Agents
p72279
g23720
sVAnti-Asthmatic Agents
p72280
g36530
sVCytochrome P-450 CYP3A4 Substrates
p72281
g65220
sVNarrow Therapeutic Index Drugs
p72282
g50577
sVPurinergic Antagonists
p72283
(dp72284
sVHeterocyclic Compounds, Fused-Ring
p72285
g56161
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p72286
g36625
sVAlkaloids
p72287
g19441
ssg9822
(dp72288
VCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p72289
g47499
sVPhenytoin and Prodrugs
p72290
g35601
sVAnti-epileptic Agent
p72291
g70346
sVCytochrome P-450 CYP3A Substrates
p72292
g45023
sVMembrane Transport Modulators
p72293
g54165
sVCentral Nervous System Agents
p72294
g58519
sVProdrugs
p72295
g52311
sVCytochrome P-450 CYP2D6 Inducers
p72296
(dp72297
sVCardiovascular Agents
p72298
g26684
sVCytochrome P-450 CYP2C9 Inducers
p72299
g20052
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p72300
g16533
sVCytochrome P-450 CYP2C8 Substrates
p72301
(dp72302
sVCytochrome P-450 CYP3A4 Inducers (strong)
p72303
g23077
sVCytochrome P-450 CYP2B6 Inducers
p72304
g39129
sVEnzyme Inducing Antiepileptic Drugs
p72305
g25034
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72306
g29282
sVSodium Channel Blockers
p72307
(dp72308
sVCytochrome P-450 CYP2C9 Substrates
p72309
g29820
sVImidazoles
p72310
(dp72311
sVCytochrome P-450 CYP3A4 Inducers
p72312
g18980
sVDecreased Central Nervous System Disorganized Electrical Activity
p72313
g23467
sVCytochrome P-450 CYP2C19 Substrates
p72314
g53900
sVCentral Nervous System Depressants
p72315
(dp72316
sVCytochrome P-450 CYP1A2 Inducers
p72317
g68384
sVAnticonvulsants
p72318
g60157
sVCytochrome P-450 CYP2B6 Inducers (strong)
p72319
(dp72320
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p72321
g37402
sVUGT1A6 Inhibitors
p72322
g58851
sVHydantoins
p72323
g67081
sVThyroxine-binding globulin substrates
p72324
g60173
sVCytochrome P-450 Enzyme Inducers
p72325
g28243
sVCytochrome P-450 CYP3A Inducers
p72326
g66294
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p72327
g60087
sVCytochrome P-450 CYP3A Inducers (strong)
p72328
g22461
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p72329
g17453
sVCytochrome P-450 CYP3A4 Substrates
p72330
g65221
sVNarrow Therapeutic Index Drugs
p72331
g50578
sVImidazolidines
p72332
g45997
sVCytochrome P-450 CYP2D6 Inducers (moderate)
p72333
g62772
sVUGT1A9 Inhibitors
p72334
g66247
sVNervous System
p72335
g70313
sVCytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index
p72336
(dp72337
ssg9825
(dp72338
g11775
(dp72339
sg8484
g66993
sg2079
g29871
sg2451
g32213
ssg9828
(dp72340
VAnticholinergic Agents
p72341
g24512
sVCytochrome P-450 CYP2D6 Substrates
p72342
g52159
sg11529
(dp72343
sVCytochrome P-450 CYP3A Substrates
p72344
g45015
sVNeurotransmitter Agents
p72345
(dp72346
sVPotential QTc-Prolonging Agents
p72347
g70419
sVMuscarinic Antagonists
p72348
g48887
sVDrugs for Urinary Frequency and Incontinence
p72349
g28988
sVDrugs that are Mainly Renally Excreted
p72350
g43857
sVUrologicals
p72351
g58922
sVAmines
p72352
g42709
sVUrological Agents
p72353
g38290
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72354
g29271
sg8979
g68821
sVCytochrome P-450 CYP2C9 Substrates
p72355
g29765
sVQTc Prolonging Agents
p72356
g57865
sVPhenols
p72357
g65127
sVBenzene Derivatives
p72358
g61418
sVCresols
p72359
(dp72360
sVBenzhydryl Compounds
p72361
(dp72362
sVCytochrome P-450 CYP3A4 Substrates
p72363
g65215
sVPropanolamines
p72364
g37515
sVAmino Alcohols
p72365
g32690
sVGenito Urinary System and Sex Hormones
p72366
g66168
sVCholinergic Agents
p72367
g28738
sVPropanols
p72368
g56557
sVAgents producing tachycardia
p72369
g50771
sVAlcohols
p72370
(dp72371
ssg9831
(dp72372
g10236
(dp72373
ssg9834
(dp72374
g4854
g47871
sg8358
g66252
sVProtein Kinase Inhibitors
p72375
(dp72376
sVOATP1B3 substrates
p72377
g28527
sVMAP Kinase Kinase 1, antagonists & inhibitors
p72378
g32702
sVCytochrome P-450 CYP3A Substrates
p72379
g45113
sVP-glycoprotein/ABCB1 Substrates
p72380
g35086
sVKinase Inhibitor
p72381
g24596
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72382
g29394
sVAntineoplastic and Immunomodulating Agents
p72383
g39741
sVOATP1B3 inhibitors
p72384
g62284
sVOATP1B1/SLCO1B1 Substrates
p72385
(dp72386
sVCytochrome P-450 CYP3A4 Substrates
p72387
g65261
sVAntineoplastic Agents
p72388
g71529
ssg9837
(dp72389
g7053
g59823
sg9918
(dp72390
sg2403
g31861
sg7428
g61875
sg3516
g39187
sg3651
g40139
sg1113
g22209
sg4596
g46272
sg69
g12769
sg8460
g66885
ssg9840
(dp72391
g5409
g50906
sg10839
(dp72392
sg12114
(dp72393
sg6318
g56392
sg3426
g38771
sg2658
g33394
sg9111
g69430
sg9579
g71442
sg11268
(dp72394
sg2769
g34283
sg1890
g27993
sg10365
(dp72395
sg11727
(dp72396
sg2277
g31106
sg3399
g38661
sg11067
(dp72397
sg141
g13371
sg11337
(dp72398
sg753
g19215
sg8760
g68015
sg7533
g62510
sg8226
g65734
sg9492
g71127
sg5193
g49621
sg6525
g57359
ssg9843
(dp72399
g6231
g55740
sg8922
g68692
sg9192
g69744
ssg9846
(dp72400
VAmino Acids, Peptides, and Proteins
p72401
g47419
sVMembrane Proteins
p72402
g52381
sVAgents that produce neuromuscular block (indirect)
p72403
g37972
sVLipopeptides
p72404
g33709
sVNephrotoxic agents
p72405
g57741
sVProteins
p72406
g52785
sVPeptides
p72407
g47216
sVLipids
p72408
g14309
sVPore Forming Cytotoxic Proteins
p72409
g57497
sg5559
g51749
sVPeptides, Cyclic
p72410
g70145
sVPolymyxins
p72411
g46287
sVAntimicrobial Cationic Peptides
p72412
g33095
ssg9849
(dp72413
g9552
g71320
sg11745
(dp72414
sg5268
g50144
sg3990
g42114
sg4377
g44796
sg1791
g27274
sg7842
g63939
sg5835
g53459
sg3711
g40460
sg6393
g56833
sg1578
g25667
sg11712
(dp72415
ssg9852
(dp72416
VAmino Acids, Peptides, and Proteins
p72417
g47420
sVGlobulins
p72418
g19201
sVAntibodies
p72419
g60994
sVInterleukin-5 Antagonist
p72420
(dp72421
sVAntibodies, Monoclonal
p72422
(dp72423
sVImmunoglobulins
p72424
g41541
sVProteins
p72425
g52793
sg2367
g31561
sVRespiratory System Agents
p72426
g71425
sVSerum Globulins
p72427
g49669
sg462
g16428
sVAnti-Asthmatic Agents
p72428
g36534
sVBlood Proteins
p72429
g39876
sVDrugs for Obstructive Airway Diseases
p72430
g42531
sVInterleukin-5 Antagonists
p72431
g49371
sVImmunoproteins
p72432
g57461
ssg9855
(dp72433
VDrugs that are Mainly Renally Excreted
p72434
g43859
sVOCT2 Substrates
p72435
g14955
sVCardiovascular Agents
p72436
g26692
sVAmines
p72437
g42750
sg8988
g68858
sg8937
g68724
sg4368
g44769
sVPyridines
p72438
g64244
sVMembrane Transport Modulators
p72439
g54166
sVOCT2 substrates with narrow therapeutic index
p72440
g29698
sVNervous System
p72441
g70316
sVOther Miscellaneous Therapeutic Agents
p72442
g28768
ssg9858
(dp72443
g13750
g24425
sg2373
g31638
sg4620
g46364
sg9528
g71272
sg9903
(dp72444
sg1800
g27355
sg8421
g66534
sg7668
g63240
sg1614
g25919
sg14838
g40031
sg4089
g42871
sg7335
g61232
sg5895
g53849
sg11886
(dp72445
sg1140
g22443
sg7734
g63550
sg3219
g37576
sg6504
g57287
sg5364
g50640
sg28215
g35393
sg11922
(dp72446
sg12132
(dp72447
sg6345
g56622
ssg9861
(dp72448
g3174
g37284
sg690
g18662
sg2739
g34034
sg5865
g53633
sg30
g12408
sg4479
g45731
sg2895
g35465
sg9096
g69319
sg4539
g46060
sg5685
g52466
sg3021
g36233
sg7377
g61529
ssg9864
(dp72449
VOpiate Partial Agonists
p72450
g28789
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p72451
(dp72452
sVCentral Nervous System Depressants
p72453
(dp72454
sVNervous System
p72455
g70317
sVHeterocyclic Compounds, Fused-Ring
p72456
g56172
sVOpioids
p72457
g32247
sVSemi-synthetic Opioids
p72458
g59491
sVMixed Agonist / Antagonist Opioids
p72459
(dp72460
sVOpioid Antagonists
p72461
g65182
sVOpiate Alkaloids
p72462
g70924
sVCentral Nervous System Agents
p72463
g58515
sVOpioid Agonist/Antagonist
p72464
(dp72465
sVPeripheral Nervous System Agents
p72466
g57659
sVAlkaloids
p72467
g19451
sVSensory System Agents
p72468
g71822
sVPhenanthrenes
p72469
g32844
sVMorphinans
p72470
g57231
sVNarcotics
p72471
(dp72472
sVAnalgesics
p72473
g26504
sVMorphinan Derivatives
p72474
g32624
ssg9867
(dp72475
g4017
g42301
sg3105
g36808
sg3858
g41257
sg2943
g35794
sg8928
g68720
sg501
g16749
sg4650
g46642
sg10797
(dp72476
sg10113
(dp72477
sg8808
g68219
sg8022
g64799
sg6033
g54552
sg6699
g58241
sg4077
g42856
sg4491
g45815
sg11268
(dp72478
sg4902
g48170
sg11820
(dp72479
sg8217
g65713
sg4926
g48426
sg12078
(dp72480
sg6015
g54411
sg9081
g69193
sg6537
g57429
sg7809
g63725
sg7458
g62136
ssg9870
(dp72481
VSodium
p72482
g70343
sVDiluents
p72483
g61937
sVElectrolyte Solutions
p72484
g20026
sVReplacement Preparations
p72485
g27631
sVElectrolytes
p72486
g52407
sVMineral Supplements
p72487
g38294
sVChlorine Compounds
p72488
g33264
sVI.V. Solution Additives
p72489
g37231
sVRespiratory Agents, Miscellaneous
p72490
(dp72491
sVHydrochloric Acid
p72492
g71561
sVBlood and Blood Forming Organs
p72493
g53907
sVChlorides
p72494
g27978
sVSalt Solutions
p72495
g22245
sVAcids
p72496
g40564
sVSodium Compounds
p72497
g37413
sVEENT Drugs, Miscellaneous
p72498
g40843
sVAlimentary Tract and Metabolism
p72499
g23854
sVIons
p72500
g49107
sVBlood Substitutes and Perfusion Solutions
p72501
g49451
sVAcids, Noncarboxylic
p72502
g54190
sVIrrigating Solutions
p72503
g41369
sVOther Miscellaneous Therapeutic Agents
p72504
g28767
sVAnions
p72505
g71785
sVMiscellaneous Therapeutic Agents
p72506
(dp72507
ssg9873
(dp72508
g5847
g53498
ssg9876
(dp72509
g3177
g37311
sg2658
g33379
sg3684
g40236
sg495
g16718
sg516
g16882
sg8580
g67294
sg10593
(dp72510
sg687
g18573
sg6570
g57540
sg8778
g68077
ssg9879
(dp72511
VCentral Nervous System Depressants
p72512
(dp72513
sVNeurotransmitter Agents
p72514
(dp72515
sVHistamine H1 Antagonists
p72516
g40762
sVBenzene Derivatives
p72517
g61394
sVOAT3/SLC22A8 Substrates
p72518
g13113
sVHistamine H1 Antagonists, Non-Sedating
p72519
g38526
sVAnti-Allergic Agents
p72520
g50644
sVP-glycoprotein/ABCB1 Substrates
p72521
g34902
sVHistamine Agents
p72522
(dp72523
sVPiperidines
p72524
(dp72525
sVP-glycoprotein/ABCB1 Inhibitors
p72526
(dp72527
sVHistamine Antagonists
p72528
g43419
sVAntihistamines for Systemic Use
p72529
g12963
sVBenzhydryl Compounds
p72530
(dp72531
sVOATP1B1/SLCO1B1 Substrates
p72532
(dp72533
sVQTc Prolonging Agents
p72534
g57824
sVModerate Risk QTc-Prolonging Agents
p72535
g67177
ssg9882
(dp72536
g10062
(dp72537
sg6939
g59314
sg5970
g54223
ssg9885
(dp72538
g7692
g63313
ssg9888
(dp72539
g2196
g30600
sg7884
g64085
sg7821
g63828
sg10470
(dp72540
sg1047
g21584
sg11052
(dp72541
sg11451
(dp72542
sg6435
g56952
sg9198
g69819
sg3132
g36986
sg6468
g57077
sg8448
g66746
sg9954
(dp72543
sg8454
g66807
sg6798
g58756
sg4299
g44434
sg5739
g52856
sg10518
(dp72544
sg12063
(dp72545
sg4920
g48321
sg9432
g70902
sg2460
g32259
sg1503
g25164
sg1140
g22360
sg1899
g28038
sg8298
g66048
sg1911
g28367
sg573
g17516
sg4164
g43334
sg819
g19725
ssg9891
(dp72546
g8373
g66309
sg9198
g69778
sg10266
(dp72547
sg3912
g41596
sg2895
g35403
sg7821
g63791
sg8211
g65654
sg1047
g21586
sg7191
g60540
sg8721
g67875
sg690
g18594
sg9432
g70880
sg11940
(dp72548
sg9954
(dp72549
sg102
g12993
sg3021
g36172
sg7377
g61476
sg4920
g48323
sg2838
g34776
sg2460
g32291
sg8820
g68293
sg1899
g28040
sg816
g19636
sg4539
g46010
sg2832
g34732
sg573
g17577
sg4479
g45672
sg5289
g50311
sg11241
(dp72550
sg8724
g67892
sg11385
(dp72551
ssg9894
(dp72552
g8796
g68145
sg8808
g68190
sg4821
g47741
sg6015
g54377
sg4053
g42546
sg4365
g44750
sg10338
(dp72553
sg4338
g44566
sg2253
g30892
ssg9897
(dp72554
VOphthalmics
p72555
(dp72556
sVSerum Globulins
p72557
g49642
sVVascular Endothelial Growth Factor Inhibitors
p72558
g45463
sVAntineovascularisation Agents
p72559
g31651
sVEENT Drugs, Miscellaneous
p72560
g40844
sVAngiogenesis Inhibitors
p72561
g70567
sVImmunoglobulins
p72562
g41509
sVGrowth Substances
p72563
g46131
sVAntibodies
p72564
g60974
sVProteins
p72565
g52762
sVSensory Organs
p72566
g40714
sVGlobulins
p72567
g19160
sVOphthalmologicals
p72568
g35223
sVAmino Acids, Peptides, and Proteins
p72569
g47364
sVAntibodies, Monoclonal
p72570
(dp72571
sVAngiogenesis Modulating Agents
p72572
g71708
sVAntibodies, Monoclonal, Humanized
p72573
(dp72574
sVGrowth Inhibitors
p72575
g13759
sVVascular Endothelial Growth Factor Inhibitor
p72576
g36639
sVOcular Vascular Disorder Agents
p72577
g25598
sVBlood Proteins
p72578
g39838
sVImmunoproteins
p72579
g57438
ssg9900
(dp72580
g534
g16973
sg630
g18009
sg10266
(dp72581
sg2559
g32930
sg426
g16061
sg8205
g65616
sg2358
g31461
sg1425
g24535
sg240
g14181
sg11811
(dp72582
sg828
g19844
sg465
g16448
sg11979
(dp72583
sg12018
(dp72584
sg10737
(dp72585
sg9711
g71978
sg6966
g59397
sg10308
(dp72586
sg9417
g70740
sg4266
g44217
sg10674
(dp72587
sg5853
g53534
sg11619
(dp72588
sg2265
g30998
sg8721
g67849
sg282
g14535
sg7284
g60829
sg11016
(dp72589
sg11655
(dp72590
sg888
g20405
sg9564
g71385
sg6468
g57082
sg2427
g31990
sg2430
g32092
sg8655
g67580
sg7299
g60907
sg5691
g52483
sg4344
g44645
sg5694
g52525
sg8874
g68521
sg7389
g61567
sg2910
g35517
sg8097
g65072
sg714
g19000
sg1707
g26759
sg10728
(dp72591
sg6318
g56337
sg12066
(dp72592
sg3381
g38469
sg6726
g58311
sg5535
g51646
sg10350
(dp72593
sg486
g16635
sg345
g15213
sg7941
g64270
sg7497
g62302
sg3978
g41974
sg9981
(dp72594
sg1908
g28277
sg3204
g37429
sg564
g17395
sg2664
g33424
sg6303
g56197
sg4959
g48562
sg696
g18701
sg3570
g39459
sg582
g17615
sg5169
g49553
sg10056
(dp72595
sg387
g15610
sg10497
(dp72596
sg5256
g50042
sg5769
g53037
sg9420
g70827
sg10356
(dp72597
sg1194
g22835
sg11112
(dp72598
sg414
g15944
sg11283
(dp72599
sg8187
g65531
sg11790
(dp72600
sg780
g19345
ssg9903
(dp72601
VAgents Causing Muscle Toxicity
p72602
g55367
sVOphthalmological and Otological Preparations
p72603
(dp72604
sVImmunosuppressive Agents
p72605
g64543
sVCytochrome P-450 CYP3A Substrates
p72606
g45031
sVSteroids, Fluorinated
p72607
(dp72608
sVVasoprotectives
p72609
g41381
sVHormones
p72610
g55654
sVCorticosteroids for Systemic Use
p72611
g48840
sVDrugs for Obstructive Airway Diseases
p72612
g42506
sVHyperglycemia-Associated Agents
p72613
g68800
sVCorticosteroids for Systemic Use, Plain
p72614
g31760
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p72615
g59969
sVCorticosteroids Acting Locally
p72616
g54814
sVOtologicals
p72617
g69479
sVRespiratory System Agents
p72618
g71420
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p72619
(dp72620
sVPregnadienetriols
p72621
(dp72622
sVGlucocorticoids
p72623
g21939
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72624
g29294
sVBetamethasone
p72625
g39963
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p72626
g16819
sVFused-Ring Compounds
p72627
g14809
sVCytochrome P-450 CYP3A4 Inducers
p72628
g18874
sVCytochrome P-450 CYP3A5 Inducers
p72629
g41736
sVAdrenal Cortex Hormones
p72630
g30010
sVAdrenals
p72631
g37362
sVP-glycoprotein/ABCB1 Substrates
p72632
g34943
sVDermatologicals
p72633
g17223
sVCytochrome P-450 Enzyme Inducers
p72634
g28113
sVCytochrome P-450 CYP3A Inducers
p72635
g66260
sVAnti-Asthmatic Agents
p72636
g36515
sVPregnadienes
p72637
g72196
sVCytochrome P-450 CYP3A4 Substrates
p72638
g65225
sVAlimentary Tract and Metabolism
p72639
g23758
sVNasal Preparations
p72640
(dp72641
sVPregnanes
p72642
g63597
sVOphthalmologicals
p72643
g35170
sVSteroids
p72644
g56410
sVCorticosteroids, Potent (Group III)
p72645
g56441
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p72646
g64603
sVAnti-Inflammatory Agents
p72647
(dp72648
sVCorticosteroid Hormone Receptor Agonists
p72649
g63662
sVCorticosteroids, Dermatological Preparations
p72650
g51328
sVHormones, Hormone Substitutes, and Hormone Antagonists
p72651
g53142
sVCorticosteroids
p72652
(dp72653
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p72654
g72444
sVIntestinal Antiinflammatory Agents
p72655
g66243
sVSensory Organs
p72656
g40671
ssg9906
(dp72657
VAmino Acids, Peptides, and Proteins
p72658
g47336
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p72659
g52074
sVCytochrome P-450 CYP3A4 Inhibitors
p72660
g61648
sVPeptides, Cyclic
p72661
g70148
sg6648
g58024
sVCytochrome P-450 CYP3A Inhibitors
p72662
g60405
sg2121
g30227
sVPeptides
p72663
g47161
sVAnti-Bacterial Agents
p72664
g38314
sVCytochrome P-450 Enzyme Inhibitors
p72665
g61977
sVAnti-Infective Agents
p72666
g54588
ssg9909
(dp72667
VDrugs that are Mainly Renally Excreted
p72668
g43985
sVPlatinum Compounds
p72669
(dp72670
sVAntineoplastic and Immunomodulating Agents
p72671
g39815
sVMyelosuppressive Agents
p72672
g71337
sVIndicators and Reagents
p72673
g58938
sVNephrotoxic agents
p72674
g57737
sVImmunosuppressive Agents
p72675
g64589
sVBCRP/ABCG2 Substrates
p72676
g42070
sVLaboratory Chemicals
p72677
(dp72678
sVCompounds used in a research, industrial, or household setting
p72679
(dp72680
sVCross-Linking Reagents
p72681
(dp72682
sVOrganometallic Compounds
p72683
(dp72684
sVAntineoplastic Agents
p72685
g71552
ssg9912
(dp72686
g2427
g31998
sg8373
g66313
sg9153
g69580
sg10629
(dp72687
sg6186
g55485
sg30
g12356
sg690
g18604
sg6192
g55549
sg9249
g70023
sg3858
g41231
sg3867
g41354
sg2346
g31355
sg4788
g47558
sg4803
g47626
sg7821
g63807
sg11427
(dp72688
sg10266
(dp72689
sg7650
g63077
sg10011
(dp72690
sg10797
(dp72691
sg5460
g51223
sg858
g20166
sg10149
(dp72692
sg1914
g28399
sg2397
g31789
sg7671
g63253
sg3141
g37055
sg6240
g55768
sg9198
g69774
sg10701
(dp72693
sg2088
g29896
sg8448
g66748
sg12114
(dp72694
sg1683
g26395
sg4887
g48080
sg8457
g66841
sg9963
(dp72695
sg15016
g66098
sg3609
g39670
sg6726
g58309
sg6279
g55928
sg5520
g51548
sg10728
(dp72696
sg4707
g46991
sg7377
g61485
sg9231
g69964
sg4716
g47057
sg10752
(dp72697
sg2466
g32329
sg12421
g12430
sg10170
(dp72698
sg2481
g32393
sg3207
g37486
sg3048
g36509
sg7065
g59917
sg963
g20977
sg2835
g34765
sg3279
g37926
sg7878
g64044
sg7533
g62491
sg7500
g62339
sg1761
g26996
sg831
g19928
sg819
g19733
sg10356
(dp72699
sg6345
g56571
sg204
g13948
sg2676
g33559
sg5595
g51979
sg7041
g59682
sg11259
(dp72700
sg1782
g27132
sg10833
(dp72701
sg28215
g35348
sg2559
g32934
sg5619
g52220
sg11592
(dp72702
sg7962
g64422
sg6033
g54530
sg4341
g44595
sg7884
g64091
sg11604
(dp72703
sg1050
g21651
sg2583
g33091
sg4521
g45954
sg4857
g47889
sg10113
(dp72704
sg8625
g67495
sg285
g14630
sg7881
g64058
sg3111
g36833
sg1614
g25852
sg10899
(dp72705
sg8049
g64884
sg4077
g42821
sg9081
g69158
sg9663
g71757
sg4752
g47299
sg318
g14910
sg4911
g48290
sg1947
g28667
sg2460
g32264
sg3504
g39095
sg1890
g27991
sg6435
g56959
sg9414
g70696
sg2172
g30506
sg2034
g29006
sg1899
g28042
sg10179
(dp72706
sg7947
g64362
sg6102
g55059
sg3408
g38689
sg6489
g57222
sg72
g12789
sg474
g16550
sg1920
g28484
sg5199
g49686
sg7563
g62653
sg11733
(dp72707
sg9444
g70935
sg7170
g60304
sg8721
g67854
sg2277
g31125
sg4974
g48606
sg10218
(dp72708
sg3015
g36077
sg8226
g65736
sg5727
g52817
sg2706
g33767
sg7626
g62974
sg9492
g71133
sg7197
g60594
sg11451
(dp72709
sg11775
(dp72710
sg213
g14057
sg1908
g28275
sg9144
g69543
sg465
g16452
sg4197
g43516
sg9918
(dp72711
sg13750
g24358
sg9528
g71242
sg9519
g71196
sg5817
g53324
sg10017
(dp72712
sg8493
g67060
sg10041
(dp72713
sg5832
g53397
sg2667
g33495
sg8781
g68103
sg1047
g21590
sg10308
(dp72714
sg11052
(dp72715
sg477
g16594
sg8055
g64926
sg11061
(dp72716
sg4260
g44101
sg2043
g29080
sg1263
g23205
sg2046
g29105
sg5865
g53593
sg753
g19225
sg10326
(dp72717
sg11079
(dp72718
sg10047
(dp72719
sg10977
(dp72720
sg4278
g44270
sg78
g12836
sg8820
g68245
sg5889
g53770
sg9588
g71463
sg2079
g29843
sg9432
g70889
sg6075
g54856
sg4446
g45348
sg3021
g36181
sg339
g15155
sg2838
g34784
sg3546
g39380
sg2109
g30108
sg9954
(dp72721
sg11136
(dp72722
sg1527
g25271
sg3963
g41856
sg1332
g23666
sg1578
g25622
sg11151
(dp72723
sg564
g17397
sg10416
(dp72724
sg7662
g63180
sg10389
(dp72725
sg573
g17521
sg11166
(dp72726
sg3576
g39563
sg8880
g68561
sg603
g17774
sg1371
g24081
sg5295
g50346
sg1101
g22051
sg2895
g35412
sg3597
g39646
sg4164
g43289
sg1863
g27773
sg5193
g49630
sg336
g15077
sg7014
g59552
sg8916
g68629
sg4953
g48499
sg1401
g24305
sg9135
g69528
sg621
g17948
sg8019
g64722
sg3174
g37252
sg3633
g40058
sg6735
g58360
sg11955
(dp72727
sg4425
g44916
sg2094
g29994
sg11229
(dp72728
sg4449
g45383
sg2946
g35806
sg2112
g30185
sg8211
g65658
sg5250
g49960
sg7800
g63694
sg4266
g44221
sg2451
g32219
sg12000
(dp72729
sg7458
g62132
sg8241
g65792
sg9525
g71219
sg8985
g68835
sg4479
g45681
sg1473
g24951
sg2844
g34895
sg9507
g71148
sg2991
g35973
sg2418
g31899
sg5526
g51568
sg10740
(dp72730
sg3711
g40423
sg6798
g58758
sg12051
(dp72731
sg1503
g25168
sg9765
g72118
sg12060
(dp72732
sg3024
g36306
sg9696
g71913
sg5256
g50039
sg9783
g72192
sg3753
g40620
sg1140
g22407
sg12045
(dp72733
sg6537
g57390
sg4539
g46018
sg2739
g33989
sg8298
g66013
sg4542
g46079
sg8622
g67484
sg9471
g71033
sg3264
g37877
sg10563
(dp72734
sg9117
g69449
sg9819
g72255
sg5181
g49569
sg10581
(dp72735
sg7416
g61739
sg8949
g68737
sg3426
g38775
sg9084
g69202
sg6654
g58044
sg9096
g69290
sg11241
(dp72736
sg9060
g69111
sg5394
g50822
sg9111
g69414
sg3624
g39900
ssg9915
(dp72737
g9918
(dp72738
sg2805
g34461
sg11085
(dp72739
sg6150
g55187
sg8010
g64672
sg7044
g59743
ssg9918
(dp72740
VCytochrome P-450 CYP2D6 Inhibitors
p72741
g62934
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p72742
g46426
sVOATP1B1/SLCO1B1 Inhibitors
p72743
(dp72744
sVEnzyme Inhibitors
p72745
g72711
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p72746
g12665
sVBiopolymers
p72747
g72738
sVAntiprotozoals
p72748
g59362
sVOCT1 inhibitors
p72749
g66919
sVAdrenergic Agents
p72750
g41719
sVNeurotransmitter Agents
p72751
(dp72752
sVCardiovascular Agents
p72753
g26606
sVPolysaccharides
p72754
g41771
sVAntiarrhythmics, Class Ia
p72755
g72201
sVCytochrome P-450 CYP3A Inducers
p72756
g66277
sVBiomedical and Dental Materials
p72757
g44716
sVCytochrome P-450 CYP2D6 Inhibitors (strong)
p72758
g13739
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p72759
g47498
sVPlant Extracts
p72760
(dp72761
sVChemically-Induced Disorders
p72762
g21216
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p72763
g52077
sVAgents that produce neuromuscular block (indirect)
p72764
g37961
sVAntimalarials
p72765
g14104
sVAdrenergic alpha-1 Receptor Antagonists
p72766
g14145
sVCytochrome P-450 CYP2D6 Substrates
p72767
g52111
sVOCT2 Inhibitors
p72768
g42466
sVAdrenergic Antagonists
p72769
g52301
sVCompounds used in a research, industrial, or household setting
p72770
(dp72771
sVCytochrome P-450 CYP2C8 Inducers (weak)
p72772
g35847
sVCardiac Therapy
p72773
g69630
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p72774
g60084
sVPolymers
p72775
g22220
sVCytochrome P-450 CYP1A2 Inhibitors
p72776
g14996
sVCinchona Alkaloids
p72777
g64218
sVCytochrome P-450 Enzyme Inducers
p72778
g28183
sVSodium Channel Blockers
p72779
(dp72780
sVCytochrome P-450 CYP2C8 Inducers
p72781
g60370
sVCytochrome P-450 CYP3A Inhibitors
p72782
g60438
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p72783
g64616
sVCholinergic Agents
p72784
g28719
sVBiological Products
p72785
g64636
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p72786
g64644
sVMacromolecular Substances
p72787
g33829
sVCytochrome P-450 CYP3A7 Substrates
p72788
g60658
sVQuinolines
p72789
(dp72790
sVAntiarrhythmic agents
p72791
g71182
sVAgents that produce hypertension
p72792
g69062
sVMuscarinic Antagonists
p72793
g48863
sVQuinuclidines
p72794
g48892
sVDrugs that are Mainly Renally Excreted
p72795
g44027
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72796
g29539
sVAdrenergic alpha-Antagonists
p72797
g60882
sVCytochrome P-450 CYP2C9 Substrates
p72798
g29740
sVQTc Prolonging Agents
p72799
g57817
sVCytochrome P-450 CYP3A Substrates
p72800
g45228
sVPharmaceutical Preparations
p72801
g53859
sVAntiarrhythmics, Class I
p72802
(dp72803
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p72804
g49145
sVP-glycoprotein/ABCB1 Substrates
p72805
g34996
sVMembrane Transport Modulators
p72806
g54150
sVCytochrome P-450 CYP3A4 Substrates
p72807
g65327
sVHeterocyclic Compounds, Fused-Ring
p72808
g56088
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p72809
g61373
sVP-glycoprotein/ABCB1 Inhibitors
p72810
(dp72811
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p72812
g24189
sVComplex Mixtures
p72813
g65517
sVCytochrome P-450 CYP3A4 Inhibitors
p72814
g61677
sVAnticholinergic Agents
p72815
g24496
sVCarbohydrates
p72816
g61772
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p72817
(dp72818
sVCytochrome P-450 CYP2C9 Inhibitors
p72819
g18214
sVCytochrome P-450 Enzyme Inhibitors
p72820
g62080
sVAnti-Infective Agents
p72821
g54561
sVHighest Risk QTc-Prolonging Agents
p72822
g35861
sVCytochrome P-450 CYP3A4 Inducers
p72823
g18933
sVAgents that reduce seizure threshold
p72824
g45842
sVCytochrome P-450 CYP2C8 Inhibitors
p72825
g55025
sVCytochrome P-450 CYP2B6 Inhibitors
p72826
g45923
sVAntiparasitic Agents
p72827
g40643
sVCytochrome P450 2D6 Inhibitors
p72828
(dp72829
sVBSEP/ABCB11 Inhibitors
p72830
g62521
sVNarrow Therapeutic Index Drugs
p72831
g50552
sVPlant Preparations
p72832
g60999
sVVoltage-Gated Sodium Channel Blockers
p72833
g40910
sg1230
g22891
sVOAT3/SLC22A8 Inhibitors
p72834
g58996
sVCytochrome P-450 CYP2E1 Substrates
p72835
g72390
sVAgents producing tachycardia
p72836
g50745
sVAlkaloids
p72837
g19405
ssg9921
(dp72838
g9963
(dp72839
sg11079
(dp72840
sg3963
g41862
ssg9924
(dp72841
VAnticholinergic Agents
p72842
g24459
sVAntiarrhythmic agents
p72843
g71175
sVCytochrome P-450 CYP3A Substrates
p72844
g45229
sVOCT2 Inhibitors
p72845
g42462
sVBlood Glucose Lowering Agents
p72846
(dp72847
sVMuscarinic Antagonists
p72848
g48852
sVHighest Risk QTc-Prolonging Agents
p72849
g35857
sVDrugs that are Mainly Renally Excreted
p72850
g44028
sVCytochrome P-450 CYP1A2 Substrates
p72851
g45570
sVCardiac Therapy
p72852
g69631
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72853
g29540
sVQTc Prolonging Agents
p72854
g57785
sVOCT1 inhibitors
p72855
g66920
sVCardiovascular Agents
p72856
g26533
sVPyridines
p72857
g64222
sVAntiarrhythmics, Class Ia
p72858
g72200
sVMembrane Transport Modulators
p72859
g54121
sVCytochrome P-450 CYP3A4 Substrates
p72860
g65328
sVSodium Channel Blockers
p72861
(dp72862
sVAntiarrhythmics, Class I
p72863
(dp72864
sVVoltage-Gated Sodium Channel Blockers
p72865
g40901
sVHypoglycemia-Associated Agents
p72866
g17674
sVAgents producing tachycardia
p72867
g50774
ssg9927
(dp72868
g8019
g64736
sg6162
g55250
sg3408
g38704
sg8241
g65795
sg4425
g44931
sg4716
g47071
sg2109
g30124
sg9519
g71202
sg10977
(dp72869
sg4803
g47641
sg10740
(dp72870
sg336
g15097
sg5250
g49976
sg7650
g63087
sg963
g20992
ssg9930
(dp72871
g4629
g46432
sg4770
g47451
sg10764
(dp72872
ssg9933
(dp72873
g7524
g62419
ssg9936
(dp72874
g1611
g25810
ssg9939
(dp72875
g8805
g68168
sg414
g15951
sg822
g19810
ssg9942
(dp72876
g8763
g68026
ssg9945
(dp72877
g6279
g55949
sg10563
(dp72878
sg3024
g36288
sg8055
g64932
sg11592
(dp72879
sg1503
g25178
sg8949
g68744
sg1899
g28059
sg831
g19904
sg10041
(dp72880
sg7821
g63813
sg1047
g21605
sg1050
g21672
sg6798
g58766
sg12045
(dp72881
sg2043
g29074
ssg9948
(dp72882
VDermatologicals
p72883
g17196
sVSolvents
p72884
g36481
sVPropanols
p72885
g56546
sVMiscellaneous Local Anti-infectives
p72886
g59169
sVAntiseptics and Disinfectants
p72887
g23742
sVAlcohols
p72888
(dp72889
sVCompounds used in a research, industrial, or household setting
p72890
(dp72891
ssg9951
(dp72892
g11439
(dp72893
ssg9954
(dp72894
VAgents Causing Muscle Toxicity
p72895
g55362
sVBSEP/ABCB11 Substrates
p72896
(dp72897
sVCytochrome P-450 CYP3A4 Inhibitors
p72898
g61691
sVAntivirals for Systemic Use
p72899
g59763
sVCytochrome P-450 CYP2D6 Inhibitors
p72900
g62905
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p72901
g41072
sVCytochrome P-450 CYP3A Substrates
p72902
g45036
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p72903
g72543
sVCytochrome P-450 CYP3A7 Inhibitors
p72904
g72549
sVDirect Acting Antivirals
p72905
g38060
sVCYP3A Substrates (Sensitive)
p72906
g63922
sVAnti-HIV Agents
p72907
g66397
sVEnzyme Inhibitors
p72908
g72721
sVCytochrome P-450 CYP3A5 Inhibitors (weak)
p72909
g27592
sVCytochrome P-450 Enzyme Inhibitors
p72910
g61979
sVAnti-Infective Agents
p72911
g54567
sVHyperglycemia-Associated Agents
p72912
g68796
sVAntiinfectives for Systemic Use
p72913
g69643
sVP-glycoprotein/ABCB1 Inducers
p72914
g70560
sVAnti-Retroviral Agents
p72915
g67148
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72916
g29300
sVHIV Protease Inhibitors
p72917
(dp72918
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p72919
g60061
sVOCT1 inhibitors
p72920
g66923
sVCytochrome P450 3A4 Inhibitors
p72921
g13041
sVP-glycoprotein/ABCB1 Substrates
p72922
g34925
sVPyridines
p72923
g64232
sVUGT1A1 Inhibitors
p72924
g71654
sVCytochrome P-450 CYP3A5 Inhibitors
p72925
g55344
sVCytochrome P-450 CYP3A Inhibitors (strong)
p72926
g13394
sVCytochrome P-450 CYP3A4 Substrates
p72927
g65227
sg2310
g31278
sVCytochrome P-450 CYP3A5 Substrates
p72928
g67823
sVProtease Inhibitors
p72929
g51093
sVCytochrome P-450 CYP3A Inhibitors
p72930
g60453
sVAntiviral Agents
p72931
g30448
sVOATP1B1/SLCO1B1 Inhibitors
p72932
(dp72933
sVP-glycoprotein/ABCB1 Inhibitors
p72934
(dp72935
sVCytochrome P-450 CYP3A7 Substrates
p72936
g60665
ssg9957
(dp72937
g8949
g68746
ssg9960
(dp72938
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p72939
g52085
sVOpiate Partial Agonists
p72940
g28788
sVCytochrome P-450 CYP3A4 Inhibitors
p72941
g61634
sVOripavine Derivatives
p72942
g26861
sVCytochrome P-450 CYP2D6 Inhibitors
p72943
g62906
sVCytochrome P-450 CYP2D6 Substrates
p72944
g52116
sVUGT1A1 Substrates
p72945
g12297
sVAnalgesics
p72946
g26433
sVNarcotics
p72947
(dp72948
sVOpiate Agonists
p72949
g46450
sVBCRP/ABCG2 Inhibitors
p72950
g12530
sVUGT1A9 Substrates
p72951
g24006
sVCytochrome P-450 Enzyme Inhibitors
p72952
g61980
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p72953
g18407
sVPeripheral Nervous System Agents
p72954
g57581
sVCytochrome P-450 CYP2C8 Substrates
p72955
(dp72956
sVCytochrome P-450 CYP3A4 Substrates
p72957
g65228
sVDrugs Used in Addictive Disorders
p72958
g24718
sVMixed Agonist / Antagonist Opioids
p72959
(dp72960
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p72961
g29301
sVMorphinans
p72962
g57232
sVCytochrome P-450 CYP2C9 Substrates
p72963
g29720
sVCytochrome P-450 CYP3A Substrates
p72964
g45037
sVDrugs Used in Opioid Dependence
p72965
g17930
sVCentral Nervous System Depressants
p72966
(dp72967
sVOpioids
p72968
g32239
sVOpiate Alkaloids
p72969
g70922
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p72970
g68487
sVCytochrome P-450 CYP2C18 Substrates
p72971
g20938
sVOpioid Antagonists
p72972
g65181
sVCytochrome P-450 CYP2C19 Inhibitors
p72973
g61255
sVHeterocyclic Compounds, Fused-Ring
p72974
g56044
sVCentral Nervous System Agents
p72975
g58410
sVNervous System
p72976
g70269
sVCytochrome P-450 CYP3A5 Substrates
p72977
g67825
sVCytochrome P-450 CYP3A Inhibitors
p72978
g60389
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p72979
(dp72980
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p72981
(dp72982
sVP-glycoprotein/ABCB1 Inhibitors
p72983
(dp72984
sVAlkaloids
p72985
g19421
sVSensory System Agents
p72986
g71802
sVPhenanthrenes
p72987
g32839
sVCytochrome P-450 CYP2A6 Inhibitors
p72988
g48584
sVCytochrome P-450 CYP3A7 Substrates
p72989
g60646
ssg9963
(dp72990
VCytochrome P-450 CYP3A4 Inhibitors
p72991
g61698
sVImmunologic Factors
p72992
g42380
sVCytochrome P-450 CYP3A Substrates
p72993
g45038
sVCentral Nervous System Agents
p72994
g58411
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p72995
g43773
sVEnzyme Inhibitors
p72996
g72695
sVCytochrome P-450 Enzyme Inhibitors
p72997
g61981
sVPeripheral Nervous System Agents
p72998
g57582
sVCalcineurin Inhibitors
p72999
g72839
sVAnalgesics, Non-Narcotic
p73000
g56903
sg10221
(dp73001
sVLactones
p73002
(dp73003
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73004
g29302
sVAnti-Bacterial Agents
p73005
g38370
sVAnalgesics
p73006
g26434
sVDermatologicals
p73007
g17200
sVMisc. Skin and Mucous Membrane Agents
p73008
g60183
sVPolyketides
p73009
g48468
sVCytochrome P-450 CYP3A4 Substrates
p73010
g65229
sVCytochrome P-450 CYP3A Inhibitors
p73011
g60460
sVImmunosuppressive Agents
p73012
g64542
sVAgents for Dermatitis, Excluding Corticosteroids
p73013
g47506
sVCalcineurin Inhibitor Immunosuppressant
p73014
g63367
sVAnti-Inflammatory Agents
p73015
(dp73016
sVSensory System Agents
p73017
g71803
ssg9966
(dp73018
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p73019
g52086
sVBSEP/ABCB11 Substrates
p73020
(dp73021
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p73022
(dp73023
sVCytochrome P-450 CYP2D6 Inhibitors
p73024
g62907
sVCytochrome P-450 CYP2D6 Substrates
p73025
g52118
sVCytochrome P-450 CYP3A Substrates
p73026
g45153
sVNeurotransmitter Agents
p73027
(dp73028
sVCytochrome P-450 CYP3A4 Inhibitors
p73029
g61635
sVHistamine Agents
p73030
(dp73031
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p73032
(dp73033
sVCytochrome P-450 Enzyme Inhibitors
p73034
g61983
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p73035
g18410
sVAntipruritics
p73036
(dp73037
sVPiperidines
p73038
(dp73039
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73040
g29439
sVAntihistamines for Systemic Use
p73041
g12966
sVQTc Prolonging Agents
p73042
g57792
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p73043
g25147
sVCytochrome P-450 CYP3A4 Inducers
p73044
g18890
sVDibenzocycloheptenes
p73045
g49103
sVCentral Nervous System Depressants
p73046
(dp73047
sVHistamine H1 Antagonists, Non-Sedating
p73048
g38529
sVCytochrome P-450 CYP2C8 Inhibitors
p73049
g55006
sVCytochrome P-450 CYP2C8 Substrates
p73050
(dp73051
sVCyproheptadine
p73052
g70004
sVBenzocycloheptenes
p73053
g49196
sVDermatologicals
p73054
g17201
sVCytochrome P-450 Enzyme Inducers
p73055
g28130
sVCytochrome P-450 CYP3A Inducers
p73056
g66267
sVHistamine H1 Antagonists
p73057
g40778
sVCytochrome P-450 CYP2C19 Inhibitors
p73058
g61256
sVCytochrome P-450 CYP3A4 Substrates
p73059
g65280
sVModerate Risk QTc-Prolonging Agents
p73060
g67170
sVCytochrome P-450 CYP3A Inhibitors
p73061
g60390
sVAnti-Allergic Agents
p73062
g50648
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p73063
g64609
sVCytochrome P-450 CYP2C19 Inducers
p73064
g25538
sVP-glycoprotein/ABCB1 Inhibitors
p73065
(dp73066
sVHistamine Antagonists
p73067
g43439
ssg9969
(dp73068
g8241
g65802
sg2769
g34296
sg495
g16722
sg10365
(dp73069
sg3846
g41125
sg6474
g57166
sg8916
g68641
sg2946
g35820
sg5832
g53420
sg11241
(dp73070
sg7395
g61594
sg9759
g72106
sg9579
g71450
ssg9972
(dp73071
g3099
g36736
sg8529
g67187
sg11751
(dp73072
sg7680
g63286
sg11826
(dp73073
sg3699
g40321
ssg9975
(dp73074
g6906
g59217
sg3318
g38191
sg10587
(dp73075
ssg9978
(dp73076
g4377
g44780
ssg9981
(dp73077
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p73078
(dp73079
sVAdrenergic alpha-1 Receptor Antagonists
p73080
g14133
sVPsychoanaleptics
p73081
g59076
sVCytochrome P-450 CYP2D6 Substrates
p73082
g52204
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p73083
(dp73084
sVSerotonin Agents
p73085
(dp73086
sVCytochrome P-450 CYP3A Substrates
p73087
g44972
sVMembrane Transport Modulators
p73088
g54130
sVAntidepressive Agents, Tricyclic
p73089
g60709
sVSerotonin Receptor Antagonists
p73090
g35681
sVCentral Nervous System Agents
p73091
g58421
sVPotential QTc-Prolonging Agents
p73092
g70408
sVAdrenergic Antagonists
p73093
g52291
sVPsychotropic Drugs
p73094
g72594
sVCytochrome P-450 CYP2B6 Substrates
p73095
g33028
sVSerotonin 5-HT1 Receptor Antagonists
p73096
g14439
sVNeurotransmitter Uptake Inhibitors
p73097
g52392
sVNon-Selective Monoamine Reuptake Inhibitors
p73098
g72031
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73099
g29206
sVAdrenergic alpha-Antagonists
p73100
g60878
sVCytochrome P-450 CYP2C9 Substrates
p73101
g29754
sVQTc Prolonging Agents
p73102
g57800
sVSerotonin 5-HT2 Receptor Antagonists
p73103
g71718
sVAdrenergic Agents
p73104
g41715
sVCentral Nervous System Depressants
p73105
(dp73106
sVNeurotransmitter Agents
p73107
(dp73108
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p73109
g29609
sVAgents that reduce seizure threshold
p73110
g45862
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p73111
g49149
sVP-glycoprotein/ABCB1 Substrates
p73112
g35089
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p73113
g26810
sVAdrenergic Uptake Inhibitors
p73114
g32319
sVHistamine H1 Antagonists
p73115
g40783
sVAgents that produce hypertension
p73116
g69055
sVCytochrome P-450 CYP3A4 Substrates
p73117
g65193
sVNarrow Therapeutic Index Drugs
p73118
g50571
sVHeterocyclic Compounds, Fused-Ring
p73119
g56041
sVSerotonin Modulators
p73120
g69136
sVAntidepressive Agents
p73121
g15508
sVDibenzazepines
p73122
g48671
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p73123
g36635
sVTertiary amine tricyclic antidepressants
p73124
g31318
sVNeurotoxic agents
p73125
g68586
sVHistamine Antagonists
p73126
g43444
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p73127
g60081
sVNervous System
p73128
g70271
ssg9984
(dp73129
g11175
(dp73130
ssg9987
(dp73131
VAdrenergic alpha-1 Receptor Antagonists
p73132
g14121
sVCytochrome P-450 CYP2D6 Substrates
p73133
g52194
sVAntiarrhythmic agents
p73134
g71180
sVCytochrome P-450 CYP3A Substrates
p73135
g45019
sVAgents causing hyperkalemia
p73136
g43593
sVHypotensive Agents
p73137
g34200
sVCalcium Channel Blockers
p73138
g41316
sVAdrenergic Antagonists
p73139
g52278
sVCompounds used in a research, industrial, or household setting
p73140
(dp73141
sVAntioxidants
p73142
g54807
sVIndoles
p73143
(dp73144
sg9177
g69690
sVCytochrome P-450 CYP1A2 Substrates
p73145
g45628
sVAmines
p73146
g42674
sVAdrenergic beta-1 Receptor Antagonists
p73147
g46819
sVAntihypertensive Agents
p73148
g20314
sVUGT1A1 Substrates
p73149
g12311
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73150
g29276
sVAdrenergic alpha-Antagonists
p73151
g60869
sVProtective Agents
p73152
g66797
sVCytochrome P-450 CYP2C9 Substrates
p73153
g29725
sVCarbazoles
p73154
g29832
sVAlpha and Beta Blocking Agents
p73155
g33276
sVAdrenergic Agents
p73156
g41688
sVNeurotransmitter Agents
p73157
(dp73158
sVCardiovascular Agents
p73159
g26664
sVAdrenergic beta-Antagonists
p73160
g15354
sVVasodilating Agents
p73161
g23710
sVMembrane Transport Modulators
p73162
g54163
sVCytochrome P-450 CYP3A4 Substrates
p73163
g65217
sVCalcium-Regulating Hormones and Agents
p73164
g67156
sVPropanolamines
p73165
g37504
sVHeterocyclic Compounds, Fused-Ring
p73166
g56152
sVAmino Alcohols
p73167
g32679
sVBradycardia-Causing Agents
p73168
g61453
sVPropanols
p73169
g56549
sVP-glycoprotein/ABCB1 Inhibitors
p73170
(dp73171
sVAlcohols
p73172
(dp73173
ssg9990
(dp73174
g1704
g26723
sg633
g18087
sg5919
g53988
sg7056
g59857
sg933
g20833
sg8259
g65867
sg1668
g26264
ssg9993
(dp73175
g9135
g69515
ssg9996
(dp73176
VCatechols
p73177
(dp73178
sVCentral Nervous System Depressants
p73179
(dp73180
sVGuaiacol
p73181
g54180
sVPhenols
p73182
g65123
sVBenzene Derivatives
p73183
g61404
sVAcids, Acyclic
p73184
g25443
sVPhenyl Ethers
p73185
g40597
sg11271
(dp73186
sg2208
g30727
sVMusculo-Skeletal System
p73187
g31536
sVMethyl Ethers
p73188
(dp73189
sVMuscle Relaxants, Centrally Acting Agents
p73190
g37389
sVCentral Nervous System Agents
p73191
g58418
sVPhenylcarbamates
p73192
g63279
sVGuaifenesin
p73193
(dp73194
sVPeripheral Nervous System Agents
p73195
g57583
sVMuscle Relaxants
p73196
(dp73197
sVCarbamates
p73198
g45514
sVEthers
p73199
g27598
ssg9999
(dp73200
g6231
g55722
sg2079
g29841
sg3795
g40934
sg9192
g69729
sg13070
g21875
sg2808
g34482
sg8922
g68671
ssg10002
(dp73201
VAmino Acids, Peptides, and Proteins
p73202
g47328
sg1551
g25421
sVPituitary and Hypothalamic Hormones and Analogues
p73203
g57319
sVProteins
p73204
g52743
sVAnterior Pituitary Lobe Hormones and Analogues
p73205
g67521
sg11559
(dp73206
sVHypoglycemia-Associated Agents
p73207
g17705
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p73208
(dp73209
sVPeptides
p73210
g47168
sVBiological Factors
p73211
g38113
sVBlood Proteins
p73212
g39866
sVBlood Glucose Lowering Agents
p73213
(dp73214
sg10776
(dp73215
sVGrowth Substances
p73216
g46130
ssg10005
(dp73217
VCytochrome P-450 CYP2D6 Inhibitors
p73218
g62938
sVCytochrome P-450 CYP2D6 Substrates
p73219
g52123
sVAntiarrhythmic agents
p73220
g71173
sVAgents causing hyperkalemia
p73221
g43566
sVHypotensive Agents
p73222
g34122
sVAdrenergic Antagonists
p73223
g52294
sVSympathomimetics
p73224
g48814
sVCytochrome P-450 Enzyme Inhibitors
p73225
g61986
sVPeripheral Nervous System Agents
p73226
g57619
sVAmines
p73227
g42678
sVAdrenergic beta-1 Receptor Antagonists
p73228
g46820
sVAntihypertensive Agents
p73229
g20260
sVPropanols
p73230
g56552
sVBeta Blocking Agents, Selective
p73231
g51453
sVQTc Prolonging Agents
p73232
g57801
sVModerate Risk QTc-Prolonging Agents
p73233
g67166
sVAdrenergic Agents
p73234
g41718
sVNeurotransmitter Agents
p73235
(dp73236
sVCardiovascular Agents
p73237
g26549
sVP-glycoprotein/ABCB1 Substrates
p73238
g34935
sVAdrenergic beta-Antagonists
p73239
g15362
sVPhenoxypropanolamines
p73240
g20868
sVPropanolamines
p73241
g37508
sVAutonomic Agents
p73242
g66552
sVBeta Blocking Agents and Thiazides
p73243
g47429
sVAmino Alcohols
p73244
g32686
sVBradycardia-Causing Agents
p73245
g61443
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p73246
g53069
sVBeta-Blockers (Beta1 Selective)
p73247
g57433
sVAlcohols
p73248
(dp73249
sVBeta Blocking Agents, Selective, and Thiazides
p73250
g52071
ssg10008
(dp73251
g5532
g51632
sg4272
g44241
sg3099
g36744
sg8529
g67197
sg11751
(dp73252
sg10587
(dp73253
sg11826
(dp73254
sg11085
(dp73255
sg3699
g40343
sg2424
g31943
sg9909
g72684
sg7395
g61589
sg7044
g59741
sg9375
g70547
sg3000
g36028
ssg10011
(dp73256
VAntiinflammatory and Antirheumatic Products, Non-Steroids
p73257
g50953
sVKetones
p73258
g50968
sVMusculo-Skeletal System
p73259
g31522
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p73260
g58387
sVAntiinflammatory and Antirheumatic Products
p73261
g56808
sg8037
g64870
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p73262
g24335
sVEnzyme Inhibitors
p73263
g72690
sVCytochrome P-450 CYP1A2 Substrates
p73264
g45569
sVNonsteroidal Anti-inflammatory Compounds
p73265
g68160
sVAnalgesics, Non-Narcotic
p73266
g56894
sVNephrotoxic agents
p73267
g57703
sVCytochrome P-450 CYP2C9 Substrates
p73268
g29713
sVAnalgesics
p73269
g26427
sVCOX-2 Inhibitors
p73270
g57915
sVAgents causing hyperkalemia
p73271
g43571
sVOther Nonsteroidal Antiimflammatory Agents
p73272
(dp73273
sVAgents that produce hypertension
p73274
g69052
sVAnti-Inflammatory Agents
p73275
(dp73276
sVCyclooxygenase Inhibitors
p73277
g32782
sVAntirheumatic Agents
p73278
g24214
sVAnti-Inflammatory Agents, Non-Steroidal
p73279
g64652
ssg10014
(dp73280
g13750
g24399
sg2373
g31614
sg11955
(dp73281
sg4620
g46348
sg6012
g54375
sg210
g14025
sg9903
g72641
sg4653
g46727
sg1452
g24741
sg6045
g54713
sg7545
g62578
sg7275
g60803
sg8430
g66610
sg1614
g25892
sg11652
(dp73282
sg4488
g45786
sg14838
g40009
sg2067
g29629
sg5895
g53831
sg3981
g42044
sg12534
g52673
sg11319
(dp73283
sg4113
g43068
sg9030
g69000
sg7320
g61080
sg5928
g54071
sg9264
g70108
sg11445
(dp73284
sg1260
g23161
sg6504
g57273
sg23
g12219
sg10218
(dp73285
sg5766
g52996
sg9093
g69282
sg6345
g56601
sg612
g17859
sg5598
g52055
ssg10017
(dp73286
VCytochrome P-450 CYP2C8 Inhibitors
p73287
g55026
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p73288
g23099
sVAnti-Parkinson Drugs
p73289
g16142
sVOxazoles
p73290
g33222
sVAnti-Dyskinesia Agents
p73291
g50480
sVCytochrome P-450 CYP2C19 Inducers
p73292
g25528
sVCentral Nervous System Agents
p73293
g58468
sVDopamine Agents
p73294
g14258
sVCOMT Inhibitors
p73295
(dp73296
sVNervous System
p73297
g70286
sVCytochrome P-450 Enzyme Inducers
p73298
g28184
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p73299
g24193
sVEnzyme Inhibitors
p73300
g72712
sVCytochrome P-450 Enzyme Inhibitors
p73301
g61996
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p73302
g25138
ssg10020
(dp73303
g1041
g21504
sg5085
g49052
ssg10023
(dp73304
g1605
g25763
sg3363
g38427
sg7593
g62821
sg9264
g70110
ssg10026
(dp73305
g9897
g72571
sg9132
g69500
sg2754
g34080
sg447
g16278
sg9705
g71949
sg8772
g68055
sg9300
g70222
sg10653
(dp73306
sg9348
g70395
sg11646
(dp73307
sg669
g18442
sg10104
(dp73308
sg3147
g37139
sg12015
(dp73309
sg11286
(dp73310
sg8076
g64993
sg6612
g57760
sg4977
g48651
sg6804
g58790
sg7512
g62381
sg4713
g47028
sg1737
g26907
sg3801
g40957
sg9627
g71665
sg3882
g41408
sg4551
g46104
sg3573
g39531
sg11349
(dp73311
sg11550
(dp73312
sg3588
g39615
sg7980
g64502
sg1563
g25505
sg4905
g48177
sg8910
g68608
sg4185
g43466
sg7059
g59882
sg9852
g72423
sg7809
g63711
sg6213
g55606
ssg10029
(dp73313
g888
g20506
ssg10032
(dp73314
g5757
g52943
sg7845
g63951
ssg10035
(dp73315
g11160
(dp73316
sg402
g15830
sg609
g17806
ssg10038
(dp73317
g3018
g36160
sg7164
g60296
sg375
g15479
sg5112
g49188
sg9252
g70056
sg7848
g63987
ssg10041
(dp73318
VCytochrome P-450 CYP3A Substrates
p73319
g45230
sVAdrenergic Antagonists
p73320
g52279
sVEnzyme Inhibitors
p73321
g72713
sVUrologicals
p73322
g58920
sVAndrostanes
p73323
g68824
sVUrological Agents
p73324
g38286
sVSteroid Synthesis Inhibitors
p73325
g72880
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73326
g29543
sVAdrenergic alpha-Antagonists
p73327
g60881
sVFused-Ring Compounds
p73328
g14854
sVAzasteroids
p73329
g49105
sVAndrostenes
p73330
g60167
sVDermatologicals
p73331
g17263
sVMisc. Skin and Mucous Membrane Agents
p73332
g60189
sVAgents that produce hypertension
p73333
g69070
sVCytochrome P-450 CYP3A4 Substrates
p73334
g65329
sVHormone Antagonists
p73335
g24286
sVCytochrome P-450 CYP3A5 Substrates
p73336
g67815
sVGenito Urinary System and Sex Hormones
p73337
g66171
sVSteroids
p73338
g56409
sVDrugs Used in Benign Prostatic Hypertrophy
p73339
(dp73340
sVHormones, Hormone Substitutes, and Hormone Antagonists
p73341
g53162
sV5-alpha Reductase Inhibitors
p73342
(dp73343
sVCytochrome P-450 CYP3A7 Substrates
p73344
g60660
ssg10044
(dp73345
g5238
g49896
sg966
g21066
sg1767
g27027
sg6267
g55886
ssg10047
(dp73346
VFibrin Modulating Agents
p73347
g22858
sVDrugs that are Mainly Renally Excreted
p73348
g43873
sVHematologic Agents
p73349
(dp73350
sVBlood and Blood Forming Organs
p73351
g53944
sVCardiovascular Agents
p73352
g26588
sVPolysaccharides
p73353
g41780
sVSerine Proteinase Inhibitors
p73354
g71428
sVAnticoagulants
p73355
g58381
sVCarbohydrates
p73356
g61758
sVAntithrombins
p73357
g70365
sVFibrinolytic Agents
p73358
g26302
sVProtease Inhibitors
p73359
g51105
sVEnzyme Inhibitors
p73360
g72719
sVOligosaccharides
p73361
g33106
sVFactor Xa Inhibitors
p73362
g68554
ssg10050
(dp73363
g669
g18440
ssg10053
(dp73364
g13750
g24423
sg2373
g31636
sg9693
g71893
sg9774
g72149
sg11922
(dp73365
sg9903
g72653
sg1800
g27353
sg2226
g30807
sg4653
g46763
sg2388
g31696
sg6585
g57685
sg11997
(dp73366
sg1383
g24184
sg7545
g62594
sg7668
g63238
sg8430
g66623
sg1614
g25917
sg6783
g58694
sg11952
(dp73367
sg4620
g46362
sg14838
g40029
sg4089
g42893
sg5895
g53848
sg6045
g54729
sg12534
g52709
sg11886
(dp73368
sg9609
g71592
sg4113
g43087
sg9030
g69010
sg3393
g38602
sg4875
g48042
sg8694
g67740
sg3219
g37574
sg6504
g57285
sg1245
g23024
sg5364
g50638
sg14872
g15778
sg5766
g53022
sg4476
g45664
sg12132
(dp73369
sg6345
g56620
sg14829
g56696
ssg10056
(dp73370
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p73371
(dp73372
sVNeurotransmitter Uptake Inhibitors
p73373
g52397
sVCytochrome P-450 CYP2D6 Inhibitors
p73374
g62915
sVCytochrome P-450 CYP2D6 Substrates
p73375
g52155
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p73376
(dp73377
sVSerotonin Agents
p73378
(dp73379
sVCytochrome P-450 CYP3A Substrates
p73380
g45219
sVMembrane Transport Modulators
p73381
g54136
sVAntidepressive Agents, Tricyclic
p73382
g60710
sVSerotonin Receptor Antagonists
p73383
g35688
sVCentral Nervous System Agents
p73384
g58425
sVPsychotropic Drugs
p73385
g72595
sVCytochrome P-450 CYP2B6 Substrates
p73386
g33043
sVCytochrome P-450 Enzyme Inhibitors
p73387
g61988
sVDrugs that are Mainly Renally Excreted
p73388
g43874
sVCytochrome P-450 CYP1A2 Substrates
p73389
g45580
sVPsychoanaleptics
p73390
g59085
sVHypotensive Agents
p73391
g34152
sVNon-Selective Monoamine Reuptake Inhibitors
p73392
g72032
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73393
g29527
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p73394
g29610
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p73395
g60089
sVQTc Prolonging Agents
p73396
g57808
sVSerotonin 5-HT2 Receptor Antagonists
p73397
g71720
sVCytochrome P-450 CYP2C19 Substrates
p73398
g53905
sVCentral Nervous System Depressants
p73399
(dp73400
sVNeurotransmitter Agents
p73401
(dp73402
sVAgents that reduce seizure threshold
p73403
g45875
sVTertiary amine tricyclic antidepressants
p73404
g31319
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p73405
g37409
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p73406
g36476
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p73407
g44525
sVAgents that produce hypertension
p73408
g69058
sVCytochrome P-450 CYP2C19 Inhibitors
p73409
g61260
sVCytochrome P-450 CYP3A4 Substrates
p73410
g65323
sVNarrow Therapeutic Index Drugs
p73411
g50586
sVModerate Risk QTc-Prolonging Agents
p73412
g67178
sVHeterocyclic Compounds, Fused-Ring
p73413
g56102
sVSerotonin Modulators
p73414
g69141
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p73415
g61386
sVAntidepressive Agents
p73416
g15517
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p73417
g26812
sVDibenzazepines
p73418
g48672
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p73419
g36636
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p73420
g53087
sVP-glycoprotein/ABCB1 Inhibitors
p73421
(dp73422
sVNeurotoxic agents
p73423
g68588
sVNervous System
p73424
g70282
ssg10059
(dp73425
g10353
(dp73426
ssg10062
(dp73427
VCytochrome P-450 CYP2D6 Substrates
p73428
g52131
sVGABA Agents
p73429
g16200
sVHypnotics (Nonbenzodiazepine)
p73430
g72537
sVCytochrome P-450 CYP3A Substrates
p73431
g45227
sVNeurotransmitter Agents
p73432
(dp73433
sVGABA Agonists
p73434
g13094
sVCentral Nervous System Agents
p73435
g58432
sVGABA-A Receptor Agonists
p73436
g48820
sVCytochrome P-450 CYP1A2 Substrates
p73437
g45581
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73438
g29538
sVCentral Nervous System Depression
p73439
(dp73440
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p73441
g60070
sVCytochrome P-450 CYP2C19 Substrates
p73442
g53877
sVCentral Nervous System Depressants
p73443
(dp73444
sVSleep Aids, Pharmaceutical
p73445
(dp73446
sVPyridines
p73447
g64220
sVCytochrome P-450 CYP2C9 Substrates
p73448
g29735
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p73449
g40812
sVCytochrome P-450 CYP3A4 Substrates
p73450
g65326
sVHypnotics and Sedatives
p73451
(dp73452
sVgamma-Aminobutyric Acid-ergic Agonist
p73453
g57323
sVBenzodiazepine hypnotics and sedatives
p73454
g17655
sVPsycholeptics
p73455
g33227
sVNervous System
p73456
g70274
ssg10065
(dp73457
g1776
g27083
ssg10068
(dp73458
g9864
g72465
sg10635
(dp73459
ssg10071
(dp73460
g9852
g72421
sg6804
g58788
ssg10074
(dp73461
VProstaglandins
p73462
g19498
sVFatty Acids
p73463
g63155
sVProstaglandin analogs reducing intraocular pressure (IOP)
p73464
g19250
sVFatty Acids, Unsaturated
p73465
g59245
sVAntihypertensive Agents
p73466
g20265
sVProstaglandins, Synthetic
p73467
g28023
sVInflammation Mediators
p73468
g23628
sVOphthalmics
p73469
(dp73470
sVProstaglandins F, Synthetic
p73471
g54802
sVLipids
p73472
g14346
sVOphthalmologicals
p73473
g35190
sVEicosanoids
p73474
g37788
sVAntiglaucoma Preparations and Miotics
p73475
g36563
ssg10077
(dp73476
g11973
(dp73477
sVPigments, Biological
p73478
g21848
sVHeterocyclic Compounds, Fused-Ring
p73479
g56067
sg3450
g38981
sg6462
g57054
sg3954
g41797
sVDermatologicals
p73480
g17261
sg11109
(dp73481
sVBiological Factors
p73482
g38090
sVAntineoplastic and Immunomodulating Agents
p73483
g39753
sVRadiation-Sensitizing Agents
p73484
(dp73485
sVPorphyrins
p73486
g68129
sVAntineoplastic Agents
p73487
g71533
sVPhotosensitizing Agents
p73488
g21312
sVSensitizers Used in Photodynamic/radiation Therapy
p73489
g33206
ssg10080
(dp73490
g1947
g28657
sg687
g18532
sg1260
g23151
sg11955
(dp73491
sg23
g12197
sg8430
g66586
sg1803
g27387
sg8580
g67276
sg7320
g61067
sg4623
g46384
sg5427
g50987
sg6102
g55055
sg10857
(dp73492
sg4488
g45742
sg11667
(dp73493
sg9402
g70627
sg255
g14364
sg11439
(dp73494
sg4683
g46920
sg9819
g72251
ssg10083
(dp73495
g10635
(dp73496
sg11595
(dp73497
sg450
g16351
sg1809
g27423
sg42
g12572
sg8163
g65451
sg1434
g24625
sg8295
g65972
sg5781
g53100
sg2199
g30679
sg294
g14728
sg5877
g53668
sg9960
g72948
sg915
g20689
sg4101
g42960
sg10602
(dp73498
sg4458
g45477
sg9462
g70979
sg1413
g24453
sg537
g17020
sg2523
g32728
sg10596
(dp73499
sg1281
g23363
sg1008
g21269
sg9864
g72472
ssg10086
(dp73500
g3885
g41462
sg9924
g72864
sg5805
g53297
sg10818
(dp73501
sg7464
g62187
sg4635
g46508
sg7569
g62745
sg3399
g38651
sg1491
g25107
sg3447
g38956
sg7485
g62253
sg138
g13307
sg9918
g72803
ssg10089
(dp73502
g10890
(dp73503
sg2928
g35629
ssg10092
(dp73504
g10245
(dp73505
sg2805
g34454
sg969
g21096
sg2505
g32661
sg11535
(dp73506
ssg10095
(dp73507
g11832
(dp73508
ssg10098
(dp73509
VBeta Blocking Agents, Non-Selective, and Thiazides
p73510
g38992
sVCytochrome P-450 CYP2D6 Substrates
p73511
g52200
sVAntiarrhythmic agents
p73512
g71183
sVAgents causing hyperkalemia
p73513
g43644
sVHypotensive Agents
p73514
g34211
sVAmino Alcohols
p73515
g32688
sVPotential QTc-Prolonging Agents
p73516
g70442
sVAdrenergic Antagonists
p73517
g52298
sVOxazines
p73518
(dp73519
sVBeta Blocking Agents, Non-Selective
p73520
g38741
sVDrugs that are Mainly Renally Excreted
p73521
g44055
sVAmines
p73522
g42742
sVAntihypertensive Agents
p73523
g20321
sg3522
g39219
sVSulfur Compounds
p73524
(dp73525
sVQTc Prolonging Agents
p73526
g57884
sVCytochrome P-450 CYP2C19 Substrates
p73527
g53899
sVCardiovascular Agents
p73528
g26683
sVThiazoles
p73529
g49141
sVP-glycoprotein/ABCB1 Substrates
p73530
g35083
sVAdrenergic beta-Antagonists
p73531
g15365
sVEENT Drugs, Miscellaneous
p73532
g40846
sVPropanolamines
p73533
g37511
sVAntiglaucoma Preparations and Miotics
p73534
g36561
sVBeta Blocking Agents and Thiazides
p73535
g47424
sVOphthalmologicals
p73536
g35269
sVBradycardia-Causing Agents
p73537
g61460
sVPropanols
p73538
g56555
sg2979
g35902
sVAlcohols
p73539
(dp73540
ssg10101
(dp73541
g8340
g66217
ssg10104
(dp73542
VAmino Acids, Peptides, and Proteins
p73543
g47345
sVGlobulins
p73544
g19203
sVAntibodies
p73545
g60981
sVProteins
p73546
g52752
sVMyelosuppressive Agents
p73547
g71329
sVAntibodies, Monoclonal
p73548
g73308
sVHypotensive Agents
p73549
g34203
sVAntineoplastic Agents, Immunological
p73550
g62965
sVImmunoglobulins
p73551
g41519
sg11457
(dp73552
sVSerum Globulins
p73553
g49671
sVImmunosuppressive Agents
p73554
g64550
sVAntineoplastic and Immunomodulating Agents
p73555
g39759
sg5688
g52469
sVBlood Proteins
p73556
g39878
sVAntineoplastic Agents
p73557
g71553
sg6309
g56253
sVImmunoproteins
p73558
g57463
ssg10107
(dp73559
g2346
g31366
sg633
g18073
sg12114
(dp73560
sg6882
g59124
sg2943
g35754
sg11601
(dp73561
sg5250
g49966
sg3426
g38761
sg5454
g51159
sg4260
g44119
sg11655
(dp73562
sg8259
g65856
sg7056
g59844
sg840
g20007
sg1704
g26719
sg5919
g53984
sg9987
g73144
sg933
g20829
sg1140
g22376
sg2466
g32333
sg1668
g26245
sg3231
g37663
sg7416
g61720
sg9084
g69207
sg9372
g70518
sg7170
g60314
ssg10110
(dp73563
g9153
g69567
sg9879
g72525
sg516
g16880
sg11595
(dp73564
sg2397
g31774
sg7983
g64519
sg702
g18801
sg7485
g62256
sg915
g20695
sg12063
(dp73565
sg2841
g34836
sg11133
(dp73566
sg945
g20889
sg1908
g28328
sg11154
(dp73567
sg1911
g28355
sg7959
g64398
sg6312
g56257
sg2733
g33901
sg7533
g62495
sg9966
g73039
sg10596
(dp73568
sg4008
g42192
sg8751
g67967
sg6921
g59264
ssg10113
(dp73569
VMiscellaneous GI Drugs
p73570
g23546
sg4563
g46176
sg3369
g38441
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p73571
g64626
sVLactones
p73572
(dp73573
sVEnzyme Inhibitors
p73574
g72704
sVCytochrome P-450 Enzyme Inducers
p73575
g28240
sVCytochrome P-450 CYP3A Inducers
p73576
g66292
sVAnti-Obesity Agents
p73577
g64213
sVAntiobesity Preparations, Excl. Diet Products
p73578
g39832
sVCytochrome P-450 CYP3A4 Inducers
p73579
g18977
sVAlimentary Tract and Metabolism
p73580
g23769
sg3423
g38748
sVLipid Regulating Agents
p73581
g72477
ssg10116
(dp73582
g1041
g21507
ssg10119
(dp73583
VLipids
p73584
g14349
sVPharmaceutical Preparations
p73585
g53874
sg12075
(dp73586
sVPharmaceutic Aids
p73587
g65166
sg393
g15782
sVAlimentary Tract and Metabolism
p73588
g23796
sg6027
g54484
sVFatty Alcohols
p73589
g54907
sVAntiemetics and Antinauseants
p73590
g41643
sVAlcohols
p73591
(dp73592
sVCompounds used in a research, industrial, or household setting
p73593
(dp73594
ssg10122
(dp73595
VCytochrome P-450 CYP3A4 Inhibitors
p73596
g61658
sVOther Macrolides
p73597
g60741
sVP-glycoprotein/ABCB1 Substrates
p73598
g34960
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p73599
g59980
sVCarbohydrates
p73600
g61763
sVCytochrome P-450 CYP3A Inhibitors
p73601
g60417
sVIntestinal Antiinfectives
p73602
g68568
sVLactones
p73603
(dp73604
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p73605
g43745
sVP-glycoprotein/ABCB1 Inhibitors
p73606
(dp73607
sg8292
g65961
sVAnti-Bacterial Agents
p73608
g38342
sVPolyketides
p73609
g48467
sVMacrolides
p73610
g16903
sVCytochrome P-450 Enzyme Inhibitors
p73611
g61990
sVAnti-Infective Agents
p73612
g54596
sVAlimentary Tract and Metabolism
p73613
g23825
ssg10125
(dp73614
g10635
(dp73615
sg5781
g53104
sg2523
g32732
sg5877
g53680
sg2316
g31297
sg9960
g72960
sg9864
g72460
ssg10128
(dp73616
g10587
(dp73617
ssg10131
(dp73618
g5316
g50442
sg9261
g70075
sg7707
g63389
sg10878
(dp73619
ssg10134
(dp73620
g9108
g69397
ssg10137
(dp73621
g6549
g57475
sg7470
g62230
ssg10140
(dp73622
g3627
g39928
sg13750
g24371
sg8763
g68030
sg14872
g15719
sg7221
g60691
sg444
g16248
sg5409
g50891
sg9903
g72620
sg837
g19997
sg11046
(dp73623
sg4653
g46747
sg6045
g54722
sg11922
(dp73624
sg7545
g62547
sg7668
g63200
sg4515
g45893
sg1614
g25864
sg11460
(dp73625
sg7689
g63301
sg14838
g39983
sg4089
g42879
sg12042
(dp73626
sg5895
g53809
sg8658
g67628
sg12534
g52693
sg11952
(dp73627
sg4935
g48445
sg4113
g43036
sg3393
g38553
sg609
g17812
sg8856
g68426
sg8694
g67715
sg2283
g31160
sg10002
g73209
sg11160
(dp73628
sg4143
g43150
sg1776
g27094
sg6360
g56712
sg2703
g33731
sg5766
g52969
sg402
g15842
sg6345
g56579
ssg10143
(dp73629
g10335
(dp73630
sg8673
g67682
sg6381
g56773
ssg10146
(dp73631
g10479
(dp73632
sg8238
g65747
sg6183
g55455
sg10611
(dp73633
ssg10149
(dp73634
VCytochrome P-450 CYP3A Substrates
p73635
g45132
sVDPP-IV Inhibitors
p73636
(dp73637
sVAgents causing angioedema
p73638
g63899
sVCycloparaffins
p73639
g43661
sVProtease Inhibitors
p73640
g51090
sVHormones
p73641
g55655
sVEnzyme Inhibitors
p73642
g72692
sVBlood Glucose Lowering Agents
p73643
(dp73644
sVDrugs that are Mainly Renally Excreted
p73645
g43999
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73646
g29413
sVOral Hypoglycemics
p73647
g35994
sVDrugs Used in Diabetes
p73648
g60114
sVOligopeptides
p73649
g68972
sVOAT3/SLC22A8 Substrates
p73650
g13112
sVPeptides
p73651
g47163
sVIncretins
p73652
g20127
sVCytochrome P-450 CYP3A4 Substrates
p73653
g65270
sVAlimentary Tract and Metabolism
p73654
g23765
sVAmino Acids, Peptides, and Proteins
p73655
g47317
sVCytochrome P-450 CYP3A5 Substrates
p73656
g67794
sVHypoglycemia-Associated Agents
p73657
g17700
sVHormones, Hormone Substitutes, and Hormone Antagonists
p73658
g53133
ssg10152
(dp73659
g2844
g34899
sg9819
g72272
sg9696
g71915
sg6645
g58022
sg4449
g45393
sg7800
g63698
sg7014
g59563
sg7170
g60312
sg5793
g53216
ssg10155
(dp73660
g4629
g46441
ssg10158
(dp73661
g9810
g72227
sg5025
g48773
ssg10161
(dp73662
g10833
(dp73663
sg7815
g63762
sg48
g12645
sg11427
(dp73664
sg9411
g70672
sg87
g12930
sg4521
g45971
sg3015
g36098
sg7881
g64070
sg10326
(dp73665
sg7500
g62348
sg10509
(dp73666
sg3609
g39686
sg6090
g54954
sg10725
(dp73667
sg10368
(dp73668
sg19588
g32494
sg11334
(dp73669
sg474
g16570
sg3264
g37859
sg3576
g39574
sg12090
(dp73670
sg1101
g22071
sg11208
(dp73671
ssg10164
(dp73672
g6795
g58744
sg6276
g55912
sg1554
g25428
sg1701
g26587
sVGenito Urinary System and Sex Hormones
p73673
g66166
sVGynecological Antiinfectives and Antiseptics
p73674
g69244
sg876
g20281
sg2757
g34147
sg7374
g61452
sg7701
g63360
sg9297
g70214
sg4284
g44318
sg4389
g44812
sg11670
(dp73675
sg3816
g40997
sg5940
g54144
sVHeterocyclic Compounds, Fused-Ring
p73676
g56084
sVHyperglycemia-Associated Agents
p73677
g68805
sg3723
g40494
sg6624
g57905
ssg10167
(dp73678
g6393
g56827
ssg10170
(dp73679
VAntiparasitic Products, Insecticides and Repellents
p73680
g30579
sVAntimalarials
p73681
g14100
sVP-glycoprotein/ABCB1 Inhibitors
p73682
(dp73683
sVCytochrome P-450 CYP3A Substrates
p73684
g45042
sVMiscellaneous Antiprotozoals
p73685
g32707
sVCytochrome P-450 Enzyme Inhibitors
p73686
g61985
sVNaphthalenes
p73687
g66084
sVAntiparasitic Agents
p73688
g40656
sVEnzyme Inhibitors
p73689
g72698
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73690
g29306
sVNaphthoquinones
p73691
g48463
sVCytochrome P-450 CYP2C9 Inhibitors
p73692
g18189
sVAntiprotozoals
p73693
g59371
sVCytochrome P-450 CYP3A4 Substrates
p73694
g65231
sVAnti-Infective Agents
p73695
g54574
sVQuinones
p73696
(dp73697
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p73698
(dp73699
ssg10173
(dp73700
g11751
(dp73701
sg11826
(dp73702
ssg10176
(dp73703
g9693
g71876
sg6783
g58670
ssg10179
(dp73704
VCytochrome P-450 CYP3A4 Inhibitors
p73705
g61671
sVVitamins
p73706
g12176
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p73707
g46322
sVCytochrome P-450 CYP3A Substrates
p73708
g45054
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p73709
g28840
sVBCRP/ABCG2 Inhibitors
p73710
g12542
sVUGT1A9 Substrates
p73711
g24016
sVEnzyme Inhibitors
p73712
g72706
sVOATP1B1/SLCO1B1 Inhibitors
p73713
(dp73714
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p73715
g43753
sVCytochrome P-450 CYP2C9 Inhibitors
p73716
g18206
sVCytochrome P-450 Enzyme Inhibitors
p73717
g61993
sVDrugs that are Mainly Renally Excreted
p73718
g43881
sVCytochrome P-450 CYP2C8 Substrates
p73719
(dp73720
sVCytochrome P-450 CYP1A2 Substrates
p73721
g45595
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p73722
g23121
sVCytochrome P-450 CYP2D6 Inhibitors
p73723
g62926
sVMyelosuppressive Agents
p73724
g71330
sVTyrosine Kinase Inhibitors
p73725
g30829
sg1956
g28743
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73726
g29327
sVUrea
p73727
g58644
sVQTc Prolonging Agents
p73728
g57827
sVAntineoplastic Agents
p73729
g71538
sVBenzene Derivatives
p73730
g61414
sVPotential QTc-Prolonging Agents
p73731
g70417
sVCytochrome P-450 CYP2C8 Inhibitors
p73732
g55019
sVCytochrome P-450 CYP2B6 Inhibitors
p73733
g45935
sVP-glycoprotein/ABCB1 Substrates
p73734
g35015
sVPyridines
p73735
g64236
sVUGT1A1 Inhibitors
p73736
g71657
sVNicotinic Acids
p73737
g50502
sVCytochrome P-450 CYP2C19 Inhibitors
p73738
g61266
sVProtein Kinase Inhibitors
p73739
(dp73740
sVCytochrome P-450 CYP3A4 Substrates
p73741
g65236
sg6828
g58926
sVCytochrome P-450 CYP3A5 Substrates
p73742
g67812
sVKinase Inhibitor
p73743
g24595
sVCytochrome P-450 CYP3A Inhibitors
p73744
g60431
sVImmunosuppressive Agents
p73745
g64564
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p73746
(dp73747
sVBCRP/ABCG2 Substrates
p73748
g42082
sVVitamin B Complex
p73749
g54913
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p73750
g53082
sVP-glycoprotein/ABCB1 Inhibitors
p73751
(dp73752
sVMiscellaneous Therapeutic Agents
p73753
(dp73754
sVAntineoplastic and Immunomodulating Agents
p73755
g39771
sVUGT1A9 Inhibitors
p73756
g66248
sVCytochrome P-450 CYP3A7 Substrates
p73757
g60656
ssg10182
(dp73758
g8142
g65385
sg4236
g43714
sg11316
(dp73759
sg8445
g66731
sg6123
g55134
sg2286
g31173
sg102
g13015
sg543
g17104
ssg10185
(dp73760
VOsmotic Activity
p73761
g28830
sVOsmotic Laxatives
p73762
g57503
sVDrugs for Constipation
p73763
g53331
sVCompounds used in a research, industrial, or household setting
p73764
(dp73765
sVElectrolytes
p73766
g52415
sVPharmaceutical Vehicles
p73767
g55897
sVPharmaceutical Preparations
p73768
g53860
sVGastrointestinal Agents
p73769
g70841
sVPolymers
p73770
g22225
sVPharmaceutic Aids
p73771
g65165
sVSolvents
p73772
g36479
sVSurface-Active Agents
p73773
g48456
sVLaxatives
p73774
g17341
sVBiomedical and Dental Materials
p73775
g44719
sVAlimentary Tract and Metabolism
p73776
g23907
sVEthylene Glycols
p73777
g62628
sVGlycols
p73778
g55143
sVPolyethylene Glycols
p73779
g22552
sVExcipients
p73780
(dp73781
sVPegylated agents
p73782
g13559
sVStimulation Large Intestine Fluid/Electrolyte Secretion
p73783
g71711
sVDrug Delivery Systems
p73784
g64632
sVP-glycoprotein/ABCB1 Inhibitors
p73785
(dp73786
sVMacromolecular Substances
p73787
g33834
sVAlcohols
p73788
(dp73789
ssg10188
(dp73790
g3144
g37117
ssg10191
(dp73791
g1791
g27260
sg9618
g71642
sg4377
g44798
sg19588
g32502
sg1917
g28462
sg1611
g25822
ssg10194
(dp73792
g9918
g72780
sg9924
g72862
sg10818
(dp73793
sg4635
g46505
sg8421
g66536
sg3885
g41460
sg5805
g53293
sg888
g20445
sg1491
g25104
sg8820
g68267
sg7335
g61235
sg10350
(dp73794
sg7317
g61055
sg7485
g62266
sg1881
g27966
sg7464
g62184
sg6267
g55893
sg7734
g63540
sg7569
g62742
sg3399
g38632
sg138
g13305
sg9822
g72308
sg1767
g27037
sg2538
g32828
sg3447
g38953
sg2730
g33864
ssg10197
(dp73795
g12421
g12481
sg7065
g59952
sg8463
g66900
sg279
g14506
sg9411
g70677
sg477
g16609
sg6231
g55745
sg9192
g69748
sg2991
g35979
sg13070
g21912
sg5880
g53736
sg4683
g46947
sg2808
g34491
sg339
g15184
sg7197
g60624
sg2250
g30876
sg2079
g29861
sg3609
g39701
sg6090
g54961
sg10725
(dp73796
sg6102
g55079
sg5727
g52823
sg19588
g32477
sg10416
(dp73797
sg3576
g39586
sg10698
(dp73798
sg3795
g40943
sg9819
g72270
sg4068
g42782
sg5871
g53655
sg1863
g27781
sg7014
g59569
sg1092
g21975
sg8922
g68697
ssg10200
(dp73799
VFood Additives
p73800
(dp73801
sg4203
g43551
sVOsmotic Activity
p73802
g28829
sVCarbohydrates
p73803
g61768
sVAgents causing hyperkalemia
p73804
g43596
sVHypotensive Agents
p73805
g34166
sVDrugs for Constipation
p73806
g53330
sVIrrigating Solutions
p73807
g41364
sVDiet, Food, and Nutrition
p73808
g22894
sVCompounds used in a research, industrial, or household setting
p73809
(dp73810
sVFood and Beverages
p73811
g69589
sVCardiovascular Agents
p73812
g26593
sVPhysiological Phenomena
p73813
g21709
sVDrugs that are Mainly Renally Excreted
p73814
g43883
sVFood
p73815
g62208
sVNephrotoxic agents
p73816
g57715
sVSugar Alcohols
p73817
g34049
sVNatriuretic Agents
p73818
g40499
sVOsmotic Laxatives
p73819
g57501
sVDiuretics
p73820
g57910
sVPharmaceutical Preparations
p73821
g53869
sg636
g18109
sg7908
g64171
sVBlood and Blood Forming Organs
p73822
g53934
sg2130
g30272
sVPharmaceutic Aids
p73823
g65164
sVP-glycoprotein/ABCB1 Substrates
p73824
g34980
sg234
g14154
sVExpectorants
p73825
g49256
sVAlimentary Tract and Metabolism
p73826
g23846
sg11340
(dp73827
sVFood Ingredients
p73828
g26895
sVBlood Substitutes and Perfusion Solutions
p73829
g49442
sVIncreased Diuresis
p73830
g40993
sVLaxatives
p73831
g17353
sVCough and Cold Preparations
p73832
g65511
sVAlcohols
p73833
(dp73834
ssg10203
(dp73835
g1908
g28315
ssg10206
(dp73836
g6090
g54964
sg2844
g34870
sg10779
(dp73837
sg9696
g71898
sg5622
g52227
sg6192
g55537
sg8583
g67307
sg1038
g21470
sg11046
(dp73838
sg7854
g63996
sg4845
g47843
sg7161
g60241
sg6903
g59199
sg8418
g66468
sg1947
g28698
sg11832
(dp73839
sg1461
g24848
sg4263
g44187
sg8325
g66148
sg285
g14613
sg2058
g29169
sg10494
(dp73840
sg11085
(dp73841
sg11664
(dp73842
sg372
g15385
sg3183
g37325
sg1683
g26374
sg11769
(dp73843
sg4752
g47283
sg12186
g42938
sg5511
g51488
sg5382
g50709
sg8670
g67646
sg11301
(dp73844
sg11934
(dp73845
sg11874
(dp73846
sg3099
g36730
sg10047
g73350
sg6024
g54470
sg11826
(dp73847
sg3297
g38018
sg8769
g68038
sg7059
g59897
sg3867
g41327
sg5946
g54171
sg10554
(dp73848
sg5532
g51618
sg5577
g51841
sg2886
g35322
sg11751
(dp73849
sg8274
g65909
sg6150
g55197
sg1581
g25705
sg5589
g51950
sg717
g19044
sg7800
g63676
sg7014
g59571
sg9102
g69352
sg7563
g62684
sg5793
g53222
sg5400
g50864
sg7521
g62397
ssg10209
(dp73850
VEstrogen Antagonists
p73851
g43655
sVCytochrome P-450 CYP3A Substrates
p73852
g45057
sVHormones
p73853
g55673
sVHormonal Contraceptives for Systemic Use
p73854
g60101
sg2649
g33292
sg2049
g29152
sg11049
(dp73855
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p73856
g29330
sVFused-Ring Compounds
p73857
g14849
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p73858
g25152
sVAntineoplastic Agents
p73859
g71539
sVPregnanes
p73860
g63606
sVPregnenediones
p73861
g29961
sVAdrenal Cortex Hormones
p73862
g30051
sVProgestins
p73863
g43092
sVCombination Contraceptives (with Estrogen and derivatives)
p73864
g31047
sVCytochrome P-450 Enzyme Inducers
p73865
g28210
sVProgestin Contraceptives
p73866
g51699
sVHyperglycemia-Associated Agents
p73867
g68808
sVCytochrome P-450 CYP3A4 Substrates
p73868
g65237
sVGonadal Hormones
p73869
g33579
sVHormone Antagonists
p73870
g24279
sg8508
g67086
sVCytochrome P-450 CYP3A5 Substrates
p73871
g67813
sVContraceptive Agents, Female
p73872
g67783
sVSteroids
p73873
g56426
sVGonadal Steroid Hormones
p73874
g67217
sVCytochrome P-450 CYP2C19 Inducers
p73875
g25545
sg3603
g39660
sVPregnenes
p73876
g28747
sVHormones, Hormone Substitutes, and Hormone Antagonists
p73877
g53158
ssg10212
(dp73878
g1866
g27787
ssg10215
(dp73879
g6246
g55813
sg6843
g58982
ssg10218
(dp73880
VProtein Synthesis Inhibitors
p73881
g45558
sVPyrans
p73882
(dp73883
sVAntibiotics for Topical Use
p73884
g57691
sVFatty Acids
p73885
g63153
sg8043
g64874
sVEthers, Cyclic
p73886
g47722
sg10218
(dp73887
sVDermatologicals
p73888
g17250
sg10860
(dp73889
sVLipids
p73890
g14344
sVAnti-Bacterial Agents
p73891
g38356
sVEnzyme Inhibitors
p73892
g72708
sVAnti-Infective Agents
p73893
g54618
sg11898
(dp73894
sVEthers
p73895
g27596
sVNasal Preparations
p73896
g73285
ssg10221
(dp73897
g9963
g73001
ssg10224
(dp73898
g6579
g57555
ssg10227
(dp73899
VBeta Blocking Agents, Non-Selective, and Thiazides
p73900
g38994
sVCytochrome P-450 CYP2D6 Substrates
p73901
g52156
sVAntiarrhythmic agents
p73902
g71185
sVAgents causing hyperkalemia
p73903
g43599
sVHypotensive Agents
p73904
g34154
sVAmino Alcohols
p73905
g32693
sVPotential QTc-Prolonging Agents
p73906
g70418
sVAdrenergic Antagonists
p73907
g52300
sVOxazines
p73908
(dp73909
sVBeta Blocking Agents, Non-Selective
p73910
g38743
sVDrugs that are Mainly Renally Excreted
p73911
g43886
sVAmines
p73912
g42708
sVAntihypertensive Agents
p73913
g20286
sVThiadiazoles
p73914
g39221
sVSulfur Compounds
p73915
(dp73916
sVQTc Prolonging Agents
p73917
g57832
sVCytochrome P-450 CYP2C19 Substrates
p73918
g53891
sVCardiovascular Agents
p73919
g26598
sVThiazoles
p73920
g49137
sVP-glycoprotein/ABCB1 Substrates
p73921
g34988
sVAdrenergic beta-Antagonists
p73922
g15368
sVEENT Drugs, Miscellaneous
p73923
g40847
sVPropanolamines
p73924
g37513
sVAntiglaucoma Preparations and Miotics
p73925
g36564
sVBeta Blocking Agents and Thiazides
p73926
g47426
sVOphthalmologicals
p73927
g35216
sVBradycardia-Causing Agents
p73928
g61465
sVPropanols
p73929
g56556
sVMorpholines
p73930
g35904
sVAlcohols
p73931
(dp73932
ssg10230
(dp73933
VProstaglandins
p73934
g19495
sVAutacoids
p73935
g70962
sVFatty Acids
p73936
g63151
sVGenito Urinary System and Sex Hormones
p73937
g66192
sVFatty Acids, Unsaturated
p73938
g59242
sVOAT1/SLC22A6 inhibitors
p73939
(dp73940
sVProstaglandins, Synthetic
p73941
g28020
sVOAT3/SLC22A8 Substrates
p73942
g13139
sVInflammation Mediators
p73943
g23624
sVUterotonic agents
p73944
g38828
sVOAT3/SLC22A8 Inhibitors
p73945
g59016
sVOAT1/SLC22A6 Substrates
p73946
g60723
sVProstaglandins E
p73947
g64952
sVOCT2 Inhibitors
p73948
g42486
sVBiological Factors
p73949
g38116
sVReproductive Control Agents
p73950
g18860
sg7803
g63700
sVOATP1B1/SLCO1B1 Substrates
p73951
(dp73952
sVOCT1 inhibitors
p73953
g66927
sVEicosanoids
p73954
g37784
sVLipids
p73955
g14321
ssg10233
(dp73956
g4788
g47592
sg9903
g72648
sg1800
g27347
sg2226
g30796
sg4653
g46749
sg10011
g73276
sg8418
g66473
sg1914
g28425
sg7668
g63231
sg7671
g63268
sg8430
g66616
sg891
g20563
sg2388
g31692
sg9963
g73016
sg10740
(dp73957
sg2391
g31746
sg963
g21015
sg3219
g37568
sg3279
g37945
sg171
g13723
sg10794
(dp73958
sg5589
g51957
sg6345
g56614
sg14829
g56691
sg4803
g47659
sg9339
g70356
sg7707
g63413
sg3321
g38229
sg4875
g48029
sg1383
g24169
sg7650
g63105
sg7545
g62588
sg1614
g25909
sg14838
g40020
sg4089
g42881
sg12534
g52695
sg4113
g43079
sg8694
g67737
sg3408
g38726
sg72
g12811
sg7971
g64459
sg4974
g48638
sg1245
g23015
sg5766
g53012
sg10239
(dp73959
sg2373
g31626
sg9519
g71207
sg11805
(dp73960
sg6585
g57673
sg3087
g36655
sg4260
g44128
sg7275
g60809
sg1266
g23246
sg11079
(dp73961
sg10977
(dp73962
sg8076
g64998
sg9702
g71939
sg5895
g53842
sg2088
g29949
sg11886
(dp73963
sg9609
g71588
sg3393
g38596
sg5928
g54058
sg6024
g54477
sg1578
g25628
sg11922
(dp73964
sg336
g15126
sg5364
g50636
sg8019
g64756
sg13750
g24416
sg14872
g15772
sg4425
g44946
sg5250
g50009
sg6045
g54723
sg6783
g58690
sg10494
(dp73965
sg5652
g52363
sg4716
g47093
sg3711
g40429
sg11997
(dp73966
sg2109
g30163
sg9774
g72140
sg5316
g50471
sg9030
g69007
sg10353
(dp73967
sg6162
g55264
sg5181
g49594
sg12132
(dp73968
sg9060
g69109
sg5394
g50849
ssg10236
(dp73969
VDrugs that are Mainly Renally Excreted
p73970
g43844
sg9831
g72373
sVSulfhydryl Compounds
p73971
g54329
sVAntidotes
p73972
g69095
sVChelating Agents
p73973
(dp73974
sVSequestering Agents
p73975
g57204
sVCompounds used in a research, industrial, or household setting
p73976
(dp73977
sg8784
g68110
sVHeavy Metal Antagonists
p73978
g30319
sVSulfur Compounds
p73979
(dp73980
ssg10239
(dp73981
VAnti-Acne Preparations for Topical Use
p73982
g62695
sVAnalgesics, Non-Narcotic
p73983
g56910
sVPeripheral Nervous System Agents
p73984
g57612
sVAnalgesics
p73985
g26461
sVRetinoids for Topical Use in Acne
p73986
g48968
sVCentral Nervous System Agents
p73987
g58461
sVAnti-Inflammatory Agents
p73988
g73959
sVAnti-Acne Preparations
p73989
g63934
sVMisc. Skin and Mucous Membrane Agents
p73990
g60185
sVRetinoids
p73991
g48827
sVSensory System Agents
p73992
g71809
sVDermatologicals
p73993
g17255
sVNaphthalenes
p73994
g66083
ssg10242
(dp73995
g9441
g70929
ssg10245
(dp73996
VPharmaceutical Preparations
p73997
g53875
sVPhysiological Phenomena
p73998
g21725
sVAutacoids
p73999
g70965
sVFatty Acids
p74000
g63147
sVFatty Acids, Unsaturated
p74001
g59248
sVOils
p74002
g73505
sg7929
g64215
sVInflammation Mediators
p74003
g23633
sg8034
g64868
sg12024
(dp74004
sVFood
p74005
g62217
sg4731
g47156
sVDiet, Food, and Nutrition
p74006
g22910
sVBiological Factors
p74007
g38110
sVFood and Beverages
p74008
g69593
sVNootropic Agents
p74009
g42799
sg7401
g61599
sVEicosanoids
p74010
g37792
sVLipids
p74011
g14329
ssg10248
(dp74012
g465
g16483
ssg10251
(dp74013
g834
g19972
sg9366
g70509
ssg10254
(dp74014
g6279
g55984
sg3024
g36339
sg10275
(dp74015
sg11592
(dp74016
sg7821
g63852
sg1239
g22987
sg6798
g58779
sg12045
(dp74017
ssg10257
(dp74018
g9870
g72507
sg10179
g73754
sg11301
(dp74019
sg9153
g69585
sg4197
g43521
sg10296
(dp74020
sg10323
(dp74021
sg1326
g23620
sg609
g17839
sg8334
g66207
sg6630
g57941
sg11040
(dp74022
sg2985
g35939
sg2817
g34580
sg11934
(dp74023
sg1113
g22216
sg19588
g32513
sg4398
g44849
sg7059
g59901
sg11292
(dp74024
sg10554
(dp74025
ssg10260
(dp74026
g3264
g37846
ssg10263
(dp74027
VCytochrome P-450 CYP2D6 Substrates
p74028
g52161
sVAntiarrhythmic agents
p74029
g71171
sVCytochrome P-450 CYP3A Substrates
p74030
g45145
sVAgents causing hyperkalemia
p74031
g43601
sVHypotensive Agents
p74032
g34158
sg6753
g58529
sVAdrenergic Antagonists
p74033
g52262
sVAmines
p74034
g42710
sVAntihypertensive Agents
p74035
g20291
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74036
g29425
sg5505
g51450
sVAdrenergic beta-1 Receptor Agonists
p74037
(dp74038
sg10404
(dp74039
sVAdrenergic Agents
p74040
g41686
sVNeurotransmitter Agents
p74041
(dp74042
sVCardiovascular Agents
p74043
g26604
sg366
g15346
sVVasodilating Agents
p74044
g23681
sVAdrenergic Agonists
p74045
(dp74046
sVCytochrome P-450 CYP3A4 Substrates
p74047
g65275
sg2331
g31329
sVAgents Acting on the Renin-Angiotensin System
p74048
g25328
sg4764
g47423
sg10947
(dp74049
sVHeterocyclic Compounds, Fused-Ring
p74050
g56098
sg2508
g32665
sVBradycardia-Causing Agents
p74051
g61441
sVAdrenergic beta-Agonists
p74052
g42995
sg6540
g57431
sVAlcohols
p74053
(dp74054
sg5604
g52068
ssg10266
(dp74055
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p74056
(dp74057
sVBSEP/ABCB11 Substrates
p74058
(dp74059
sVCytochrome P-450 CYP3A4 Inhibitors
p74060
g61676
sVCytochrome P-450 CYP2D6 Inhibitors
p74061
g62933
sVAntidepressive Agents, Second-Generation
p74062
g49756
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p74063
g41060
sVCytochrome P-450 CYP3A Substrates
p74064
g45060
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p74065
g46416
sVAnti-Anxiety Agents
p74066
g35642
sVCentral Nervous System Agents
p74067
g58463
sVEnzyme Inhibitors
p74068
g72689
sVHydroxylamines
p74069
g26072
sVNeurotransmitter Uptake Inhibitors
p74070
g52385
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p74071
g43756
sVCytochrome P-450 CYP2C9 Inhibitors
p74072
g18213
sVCytochrome P-450 Enzyme Inhibitors
p74073
g61995
sVSelective Serotonin Reuptake Inhibitors
p74074
g39076
sVDrugs that are Mainly Renally Excreted
p74075
g43887
sVCytochrome P-450 CYP1A2 Substrates
p74076
g45599
sVAmines
p74077
g42711
sVCytochrome P-450 CYP2D6 Substrates
p74078
g52162
sVPsychotropic Drugs
p74079
g72581
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74080
g29334
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p74081
(dp74082
sVPsychoanaleptics
p74083
g59064
sVP-glycoprotein/ABCB1 Inhibitors
p74084
(dp74085
sVCentral Nervous System Depressants
p74086
(dp74087
sVNeurotransmitter Agents
p74088
(dp74089
sVCytochrome P-450 CYP1A2 Inhibitors
p74090
g14986
sVCytochrome P-450 CYP2C8 Inhibitors
p74091
g55024
sVCytochrome P-450 CYP2B6 Inhibitors
p74092
g45917
sg3396
g38606
sVCytochrome P-450 CYP2B6 Inhibitors (weak)
p74093
g51688
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p74094
g44522
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p74095
g69043
sVMembrane Transport Modulators
p74096
g54149
sVCytochrome P-450 CYP2C19 Inhibitors
p74097
g61269
sVCytochrome P-450 CYP3A4 Substrates
p74098
g65238
sVCytochrome P-450 CYP3A7 Inhibitors
p74099
g72547
sVSerotonin Modulators
p74100
g69128
sVAntidepressive Agents
p74101
g15540
sVCytochrome P-450 CYP3A Inhibitors
p74102
g60437
sVHypoglycemia-Associated Agents
p74103
g17672
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p74104
g30488
sVCytochrome P-450 CYP1A2 Inhibitors (strong)
p74105
g64643
sVSerotonin Agents
p74106
(dp74107
sVChemically-Induced Disorders
p74108
g21215
sVNervous System
p74109
g70284
sVTranquilizing Agents
p74110
g55285
sVCytochrome P-450 CYP3A5 Inhibitors
p74111
g55333
ssg10269
(dp74112
g8373
g66305
sg9918
g72790
sg2928
g35612
sg2481
g32383
sg8211
g65650
sg6759
g58537
sg1947
g28651
sg4857
g47891
sg10890
(dp74113
sg9507
g71143
sg723
g19074
sg9432
g70868
sg4773
g47479
sg4299
g44426
sg2838
g34772
sg5928
g54064
sg11727
(dp74114
sg10758
(dp74115
sg10578
(dp74116
sg7707
g63375
sg11790
(dp74117
sg4542
g46070
sg11337
(dp74118
sg15016
g66092
sg2688
g33598
sg5316
g50421
sg3222
g37584
sg8334
g66201
sg5295
g50348
sg12126
(dp74119
sg1599
g25731
sg5796
g53236
ssg10272
(dp74120
VVitamins
p74121
g12182
sVMembrane Lipids
p74122
g47728
sVCytochrome P-450 CYP3A Substrates
p74123
g45149
sVDiet, Food, and Nutrition
p74124
g22904
sVLipids
p74125
g14288
sVFood and Beverages
p74126
g69591
sVAntipsoriatics for Topical Use
p74127
g22991
sVPhysiological Phenomena
p74128
g21719
sVVitamin D and Analogues
p74129
g40203
sVMicronutrients
p74130
g67469
sVVitamins (Fat Soluble)
p74131
g61292
sVFood
p74132
g62214
sVCalcium-Regulating Hormones and Agents
p74133
g67157
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74134
g29432
sVBone Density Conservation Agents
p74135
g40354
sg10272
(dp74136
sVFused-Ring Compounds
p74137
g14819
sVCytochrome P-450 CYP3A4 Inducers
p74138
g18888
sVCholestenes
p74139
g57946
sVSecosteroids
p74140
g44476
sVAntipsoriatics
p74141
g63552
sVCytochrome P-450 Enzyme Inducers
p74142
g28128
sVCytochrome P-450 CYP3A Inducers
p74143
g66266
sVCholestanes
p74144
g19151
sVMembrane Transport Modulators
p74145
g54126
sVCytochrome P-450 CYP3A4 Substrates
p74146
g65278
sVAlimentary Tract and Metabolism
p74147
g23777
sVGrowth Substances
p74148
g46121
sVSteroids
p74149
g56424
sVSterols
p74150
(dp74151
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p74152
g64608
sg10608
(dp74153
sVMisc. Skin and Mucous Membrane Agents
p74154
g60186
ssg10275
(dp74155
VAntiparasitic Products, Insecticides and Repellents
p74156
g30566
sVBSEP/ABCB11 Substrates
p74157
(dp74158
sVCytochrome P-450 CYP3A Substrates
p74159
g45062
sVAnti-Infective Agents
p74160
g54627
sVAntiinfectives for Systemic Use
p74161
g69665
sVDrugs that are Mainly Renally Excreted
p74162
g43890
sVGynecological Antiinfectives and Antiseptics
p74163
g69243
sVNitroimidazole Derivatives
p74164
(dp74165
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74166
g29336
sVAnti-Bacterial Agents
p74167
g38358
sVAntiprotozoals
p74168
g59363
sVImidazoles
p74169
(dp74170
sVNitro Compounds
p74171
g51521
sVAntiparasitic Agents
p74172
g40644
sVAlkylating Drugs
p74173
g70064
sVAntibacterials for Systemic Use
p74174
g32555
sVNitroimidazole Antimicrobial
p74175
g20950
sVCytochrome P-450 CYP3A4 Substrates
p74176
g65240
sVAlimentary Tract and Metabolism
p74177
g23857
sg8904
g68601
sVToxic Actions
p74178
g49377
sVGenito Urinary System and Sex Hormones
p74179
g66170
sVNoxae
p74180
g65415
sVDrugs for Acid Related Disorders
p74181
g55161
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p74182
g67789
sVImidazole Derivatives
p74183
g74015
sVNitroimidazoles
p74184
g44870
ssg10278
(dp74185
g9540
g71299
sg10512
(dp74186
ssg10281
(dp74187
g2316
g31300
ssg10284
(dp74188
g6933
g59299
sg11685
(dp74189
sg5736
g52839
ssg10287
(dp74190
g1365
g24049
sg10518
(dp74191
sg3432
g38785
sg9234
g69993
ssg10290
(dp74192
VAcetates
p74193
g64707
sVIndicators and Reagents
p74194
g58936
sVFatty Acids, Volatile
p74195
g66970
sVFatty Acids
p74196
g63138
sVGenito Urinary System and Sex Hormones
p74197
g66185
sVAcids, Acyclic
p74198
g25484
sVSensory Organs
p74199
g40737
sVOtologicals
p74200
g69477
sVLaboratory Chemicals
p74201
(dp74202
sVGynecological Antiinfectives and Antiseptics
p74203
g69238
sVOrganic Acids
p74204
g24256
sVCompounds used in a research, industrial, or household setting
p74205
(dp74206
sVAnti-Bacterial Agents
p74207
g38369
sVAnti-Infective Agents
p74208
g54656
sVLipids
p74209
g14294
ssg10293
(dp74210
g11718
(dp74211
ssg10296
(dp74212
VAnti-Infective Agents, Local
p74213
g63020
sVAnesthetics, Local
p74214
g53468
sVCompounds used in a research, industrial, or household setting
p74215
(dp74216
sVSclerosing Solutions
p74217
g60737
sVCardiovascular Agents
p74218
g26609
sVVasoprotectives
p74219
g41382
sVAnti-Infective Agents
p74220
g54631
sVSclerosing Agents for Local Injection
p74221
g51274
sVThroat Preparations
p74222
(dp74223
sVAnesthetics
p74224
g51601
sg2619
g33204
sVPhenol and Derivatives
p74225
(dp74226
sVPharmaceutical Preparations
p74227
g53856
sVPhenols
p74228
g65117
sVBenzene Derivatives
p74229
g61420
sVDermatologicals
p74230
g17264
sVAntiseptics and Disinfectants
p74231
g23741
sVPharmaceutical Solutions
p74232
g15486
sVSolutions
p74233
g53091
sVHistamine Antagonists
p74234
g43424
sVAntivaricose Therapy
p74235
g30542
sVNervous System
p74236
g70288
sVMiscellaneous Therapeutic Agents
p74237
g74020
ssg10299
(dp74238
g5757
g52918
sg7845
g63957
ssg10302
(dp74239
g5457
g51206
sg5511
g51469
ssg10305
(dp74240
VAntiinfectives for Systemic Use
p74241
g69687
sVNitro Compounds
p74242
g51523
sVImidazoles
p74243
(dp74244
sVAntimycobacterials
p74245
g22572
sVCytochrome P-450 CYP3A Substrates
p74246
g45025
sVDrugs for Treatment of Tuberculosis
p74247
(dp74248
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74249
g29285
sVQTc Prolonging Agents
p74250
g57888
sVCytochrome P-450 CYP3A4 Substrates
p74251
g65223
sVModerate Risk QTc-Prolonging Agents
p74252
g67179
ssg10308
(dp74253
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p74254
(dp74255
sVAntidepressive Agents, Second-Generation
p74256
g49760
sVCytochrome P-450 CYP3A4 Inhibitors
p74257
g61679
sVNeurotransmitter Uptake Inhibitors
p74258
g52387
sVAnticholinergic Agents
p74259
g24472
sVCytochrome P-450 CYP2D6 Inhibitors
p74260
g62936
sVCytochrome P-450 CYP2D6 Substrates
p74261
g52167
sVSerotonin Agents
p74262
(dp74263
sVCytochrome P-450 CYP3A Substrates
p74264
g45050
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p74265
g46425
sVSerotonin Receptor Antagonists
p74266
g35667
sVCentral Nervous System Agents
p74267
g58470
sVEnzyme Inhibitors
p74268
g72714
sVPsychotropic Drugs
p74269
g72586
sVCytochrome P-450 CYP2B6 Substrates
p74270
g33006
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p74271
g43759
sVCytochrome P-450 CYP2C9 Inhibitors
p74272
g18218
sVCytochrome P-450 Enzyme Inhibitors
p74273
g61997
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p74274
(dp74275
sVSelective Serotonin Reuptake Inhibitors
p74276
g39079
sVHighest Risk QTc-Prolonging Agents
p74277
g35860
sVCytochrome P-450 CYP1A2 Substrates
p74278
g45601
sVAmines
p74279
g42715
sVPropylamines
p74280
g68226
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74281
g29319
sVCytochrome P-450 CYP2C9 Substrates
p74282
g29771
sVQTc Prolonging Agents
p74283
g57839
sVSerotonin 5-HT2 Receptor Antagonists
p74284
g71716
sVCytochrome P-450 CYP2C19 Substrates
p74285
g53881
sVCentral Nervous System Depressants
p74286
(dp74287
sVNeurotransmitter Agents
p74288
(dp74289
sVAgents that reduce seizure threshold
p74290
g45841
sVPsychoanaleptics
p74291
g59068
sVVasodilating Agents
p74292
g23688
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p74293
g44524
sVMembrane Transport Modulators
p74294
g54141
sVCytochrome P-450 CYP2C19 Inhibitors
p74295
g61270
sVCytochrome P-450 CYP3A4 Substrates
p74296
g65234
sVNicotinic Antagonists
p74297
g58933
sVCytochrome P-450 CYP3A5 Substrates
p74298
g67816
sVSerotonin Modulators
p74299
g69131
sVAntidepressive Agents
p74300
g15542
sg174
g13747
sVCytochrome P-450 CYP3A Inhibitors
p74301
g60440
sVHypoglycemia-Associated Agents
p74302
g17682
sVP-glycoprotein/ABCB1 Inhibitors
p74303
(dp74304
sVChemically-Induced Disorders
p74305
g21224
sVNervous System
p74306
g70289
ssg10311
(dp74307
g2142
g30348
sg1461
g24800
sg11172
(dp74308
sg3639
g40082
sg7527
g62451
sg9471
g71036
sg5193
g49639
ssg10314
(dp74309
VHydrocarbons, Acyclic
p74310
g19586
sVIrrigating Solutions
p74311
g41370
sVAnti-Infective Agents, Local
p74312
g63019
sVMiscellaneous Local Anti-infectives
p74313
g59168
sVAlkenes
p74314
g30759
sVAnti-Infective Agents
p74315
g54638
sVAntifungal Agents (Vaginal)
p74316
g39087
sVThroat Preparations
p74317
(dp74318
sVGynecological Antiinfectives and Antiseptics
p74319
g69241
sg10896
(dp74320
sg9390
g70574
sg11466
(dp74321
sg1065
g21840
sVMedicated Dressings
p74322
g20582
sVPyrrolidines
p74323
g59349
sVPolymers
p74324
g22229
sVDermatologicals
p74325
g17278
sVPyrrolidinones
p74326
g30233
sVSensory Organs
p74327
g40718
sVAntiseptics and Disinfectants
p74328
g23739
sVBiomedical and Dental Materials
p74329
g44723
sVMedicated Dressings With Antiinfectives
p74330
g43164
sVPlastics
p74331
(dp74332
sVIodine Compounds
p74333
(dp74334
sVOphthalmologicals
p74335
g35228
sVGenito Urinary System and Sex Hormones
p74336
g66174
sg1272
g23261
sg8898
g68596
sVPolyenes
p74337
g51389
sVMacromolecular Substances
p74338
g33838
sVCompounds used in a research, industrial, or household setting
p74339
(dp74340
ssg10317
(dp74341
g4542
g46066
sg5316
g50453
sg7707
g63398
ssg10320
(dp74342
VHydrochloric Acid
p74343
g71562
sVDrugs that are Mainly Renally Excreted
p74344
g43892
sVNitrogen Compounds
p74345
g38998
sVAgents causing hyperkalemia
p74346
g43607
sVBlood Substitutes and Perfusion Solutions
p74347
g49444
sVChlorides
p74348
g27980
sVGenito Urinary System and Sex Hormones
p74349
g66172
sVAcidifying Agents
p74350
g66720
sVAcids
p74351
g40570
sVAcids, Noncarboxylic
p74352
g54195
sVElectrolytes
p74353
g52416
sVIons
p74354
g49115
sVUrinary Acidifying Agents
p74355
g56019
sVBlood and Blood Forming Organs
p74356
g53914
sVUrologicals
p74357
g58911
sVAnions
p74358
g71788
sVElectrolyte Solutions
p74359
g20028
sVChlorine Compounds
p74360
g33266
sVAcidifiers
p74361
(dp74362
sVI.V. Solution Additives
p74363
g37233
sVAmmonium Compounds
p74364
g30552
ssg10323
(dp74365
VNeuropeptides
p74366
g57514
sVPituitary Hormone-Releasing Hormones
p74367
g40149
sVGonadotropin Releasing Hormone Receptor Agonists
p74368
g60733
sVHormones
p74369
g55666
sVHyperglycemia-Associated Agents
p74370
g68801
sVDrugs that are Mainly Renally Excreted
p74371
g43947
sVPeptide Hormones
p74372
g20201
sVGonadotropin Releasing Hormone Receptor Agonist
p74373
g67517
sVQTc Prolonging Agents
p74374
g57812
sVAntineoplastic Agents
p74375
g71531
sVOligopeptides
p74376
g68973
sVAdrenal Cortex Hormones
p74377
g30004
sVProteins
p74378
g52748
sVAntineoplastic Agents, Hormonal
p74379
(dp74380
sVNerve Tissue Proteins
p74381
(dp74382
sVGonadotropin-releasing hormone agonist
p74383
g71279
sVModerate Risk QTc-Prolonging Agents
p74384
g67174
sVAmino Acids, Peptides, and Proteins
p74385
g47337
sVGonadotropins and Antigonadotropins
p74386
(dp74387
sVHypothalamic Hormones
p74388
g65409
sVPeptides
p74389
g47173
sVHormones and Related Agents
p74390
g57370
sVAntineoplastic and Immunomodulating Agents
p74391
g39751
sVHormones, Hormone Substitutes, and Hormone Antagonists
p74392
g53149
sVMiscellaneous Therapeutic Agents
p74393
g74021
sVEndocrine Therapy
p74394
g19563
ssg10326
(dp74395
VAgents Causing Muscle Toxicity
p74396
g55381
sVDideoxynucleosides
p74397
g48719
sVAntivirals for Systemic Use
p74398
g59748
sVNucleic Acid Synthesis Inhibitors
p74399
g48733
sVCarbohydrates
p74400
g61779
sVPyrimidines
p74401
g47709
sVDirect Acting Antivirals
p74402
g38040
sVAnti-HIV Agents
p74403
g66401
sVBCRP/ABCG2 Substrates
p74404
g42052
sVEnzyme Inhibitors
p74405
g72717
sVReverse Transcriptase Inhibitors
p74406
g28958
sVAnti-Infective Agents
p74407
g54636
sVAntiinfectives for Systemic Use
p74408
g69671
sVDrugs that are Mainly Renally Excreted
p74409
g43894
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p74410
g14466
sVDeoxyribonucleosides
p74411
g33058
sVRibonucleosides
p74412
g73665
sVCytidine
p74413
g67527
sVDeoxycytidine
p74414
g12699
sVOCT2 substrates with narrow therapeutic index
p74415
g29685
sVGlycosides
p74416
g68364
sVOCT2 Substrates
p74417
g14941
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p74418
g38162
sVOCT1 substrates
p74419
g13068
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p74420
(dp74421
sVNucleic Acids, Nucleotides, and Nucleosides
p74422
g47121
sVP-glycoprotein/ABCB1 Substrates
p74423
g34985
sVPyrimidine Nucleosides
p74424
(dp74425
sVAnti-Retroviral Agents
p74426
g67142
sVOAT1/SLC22A6 Substrates
p74427
g60719
sVNucleosides
p74428
g49462
sVNucleoside Reverse Transcriptase Inhibitors
p74429
g38839
sVAntiviral Agents
p74430
g30422
sVZalcitabine
p74431
g21206
ssg10329
(dp74432
g6882
g59127
sg5454
g51184
sg11601
(dp74433
sg1140
g22444
ssg10332
(dp74434
g5472
g51307
ssg10335
(dp74435
VCytochrome P-450 CYP3A4 Inhibitors
p74436
g61686
sVParasympathomimetics
p74437
g59101
sVNeurotransmitter Agents
p74438
(dp74439
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p74440
g43765
sg8403
g66408
sVCytochrome P-450 Enzyme Inhibitors
p74441
g61998
sVParasympathomemetic (Cholinergic) Agents
p74442
g64021
sVPeripheral Nervous System Agents
p74443
g57623
sg9720
g72010
sVAutonomic Agents
p74444
g66564
sg10143
g73630
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p74445
g45824
sg8271
g65904
sVSensory Organs
p74446
g40719
sVAntiglaucoma Preparations and Miotics
p74447
g36552
sVCytochrome P-450 CYP2A6 Inhibitors
p74448
g48581
sVOphthalmologicals
p74449
g35229
sVCytochrome P-450 CYP3A Inhibitors
p74450
g60447
sVCholinergic Agents
p74451
g28723
sg3813
g40990
sVAlkaloids
p74452
g19414
sVNervous System
p74453
g70291
ssg10338
(dp74454
VAmino Acids, Peptides, and Proteins
p74455
g47380
sVInsulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting
p74456
g32628
sVCytochrome P-450 CYP1A2 Inducers
p74457
g68382
sVPeptide Hormones
p74458
g20214
sVInsulin Analog
p74459
g66240
sVHypoglycemia-Associated Agents
p74460
g17692
sVInsulins and Analogues for Injection, Fast-Acting
p74461
(dp74462
sVInsulin, Short-Acting
p74463
g13877
sVInsulins and Analogues
p74464
g72553
sVPeptides
p74465
g47194
sVCytochrome P-450 Enzyme Inducers
p74466
g28198
sVInsulin
p74467
g67745
sVHormones
p74468
g55679
sVHormones, Hormone Substitutes, and Hormone Antagonists
p74469
g53167
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p74470
g17445
sVPancreatic Hormones
p74471
g62249
sVBlood Glucose Lowering Agents
p74472
(dp74473
sVAlimentary Tract and Metabolism
p74474
g23872
sVDrugs Used in Diabetes
p74475
g60117
ssg10341
(dp74476
g5289
g50283
sg8373
g66326
sg10266
g74082
sg11241
(dp74477
sg1899
g28063
sg7191
g60551
sg8211
g65671
ssg10344
(dp74478
g11940
(dp74479
sg816
g19679
ssg10347
(dp74480
VAmidines
p74481
(dp74482
sVAntiparasitic Products, Insecticides and Repellents
p74483
g30572
sVCytochrome P-450 CYP2C8 Substrates
p74484
(dp74485
sg11691
(dp74486
sVCytochrome P-450 CYP3A5 Substrates
p74487
g67798
sVTrypanocidal Agents
p74488
g58096
sVCytochrome P-450 CYP2D6 Substrates
p74489
g52117
sVAgents Against Leishmaniasis and Trypanosomiasis
p74490
g72027
sVCytochrome P-450 CYP3A Substrates
p74491
g45108
sVAgents causing hyperkalemia
p74492
g43578
sVAntifungal Agents
p74493
(dp74494
sVHypoglycemia-Associated Agents
p74495
g17694
sVAntiparasitic Agents
p74496
g40651
sVMiscellaneous Antiprotozoals
p74497
g32708
sVNephrotoxic agents
p74498
g57708
sVAntiprotozoals
p74499
g59368
sVModerate Risk QTc-Prolonging Agents
p74500
g67169
sVAnti-Infective Agents
p74501
g54648
sVBlood Glucose Lowering Agents
p74502
(dp74503
sVQTc Prolonging Agents
p74504
g57790
sVHyperglycemia-Associated Agents
p74505
g68797
ssg10350
(dp74506
VUGT1A4 substrates
p74507
g41047
sVAnticholinergic Agents
p74508
g24486
sVAntiarrhythmic agents
p74509
g71184
sVAnti-epileptic Agent
p74510
g70347
sVCytochrome P-450 CYP3A Substrates
p74511
g45066
sVAgents causing hyperkalemia
p74512
g43619
sVCentral Nervous System Agents
p74513
g58480
sVCalcium Channel Blockers
p74514
g41321
sVPotential QTc-Prolonging Agents
p74515
g70425
sVOCT2 Inhibitors
p74516
g42491
sVPsychotropic Drugs
p74517
g72593
sVMiscellaneous Anticonvulsants
p74518
g53483
sVMuscarinic Antagonists
p74519
g48869
sVTriazines
p74520
g67532
sVDrugs that are Mainly Renally Excreted
p74521
g43898
sVUGT1A3 substrates
p74522
g31818
sVAntipsychotic Agents
p74523
g69864
sVUGT1A1 Substrates
p74524
g12329
sVUGT1A1 Inducers
p74525
g39249
sVQTc Prolonging Agents
p74526
g57849
sVDecreased Central Nervous System Disorganized Electrical Activity
p74527
g23468
sVCentral Nervous System Depressants
p74528
(dp74529
sVCardiovascular Agents
p74530
g26620
sVAnticonvulsants
p74531
g60158
sVP-glycoprotein/ABCB1 Substrates
p74532
g34984
sVMood Stabilizer
p74533
g65957
sVMembrane Transport Modulators
p74534
g54154
sVCytochrome P-450 CYP3A4 Substrates
p74535
g65241
sVCalcium-Regulating Hormones and Agents
p74536
g67158
sVSodium Channel Blockers
p74537
g73794
sVBradycardia-Causing Agents
p74538
g61462
sVAgents producing tachycardia
p74539
g50778
sVNervous System
p74540
g70293
sVTranquilizing Agents
p74541
g55305
ssg10353
(dp74542
VAnti-Inflammatory Agents
p74543
g73967
sVNicotinic Acids
p74544
g50503
sg5991
g54283
sVPyridines
p74545
g64238
sg10059
g73426
ssg10356
(dp74546
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p74547
(dp74548
sVCytochrome P-450 CYP3A4 Inhibitors
p74549
g61650
sVCytochrome P-450 CYP2D6 Inhibitors
p74550
g62914
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p74551
g41086
sVAnti-Anxiety Agents
p74552
g35659
sVCentral Nervous System Agents
p74553
g58430
sVEnzyme Inhibitors
p74554
g72699
sVPsychotropic Drugs
p74555
g72597
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p74556
g43741
sVCytochrome P-450 CYP2C9 Inhibitors
p74557
g18194
sVCytochrome P-450 Enzyme Inhibitors
p74558
g61954
sVMonoamine Oxidase Inhibitors, Non-Selective
p74559
g58534
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p74560
(dp74561
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p74562
g49348
sVAmines
p74563
g42685
sVHypotensive Agents
p74564
g34132
sVCytochrome P-450 CYP2E1 Inhibitors
p74565
g46848
sVPropylamines
p74566
g68225
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p74567
g45825
sVPsychoanaleptics
p74568
g59083
sVCentral Nervous System Depressants
p74569
(dp74570
sVAgents that reduce seizure threshold
p74571
g45874
sVCytochrome P-450 CYP1A2 Inhibitors
p74572
g15049
sVMonoamine Oxidase Inhibitors
p74573
g63510
sVAgents that produce hypertension
p74574
g69059
sVCytochrome P-450 CYP2C19 Inhibitors
p74575
g61264
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p74576
g26886
sVNervous System
p74577
g70273
sVSerotonin Modulators
p74578
g69140
sVAntidepressive Agents
p74579
g15515
sVMonoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
p74580
g58992
sVCytochrome P-450 CYP3A Inhibitors
p74581
g60408
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p74582
(dp74583
sVSerotonin Agents
p74584
(dp74585
sVCytochrome P-450 CYP2A6 Inhibitors
p74586
g48590
sVTranquilizing Agents
p74587
g55307
ssg10359
(dp74588
g5766
g52985
sg3393
g38567
sg14872
g15736
sg7545
g62560
sg4113
g43049
ssg10362
(dp74589
VCytochrome P-450 CYP3A4 Inducers (strong)
p74590
g23078
sVP-glycoprotein/ABCB1 Inhibitors
p74591
(dp74592
sg9498
g71137
sVAntineoplastic Agents, Hormonal
p74593
(dp74594
sg12006
(dp74595
sVCytochrome P-450 Enzyme Inducers
p74596
g28228
sVCytochrome P-450 CYP3A Inducers
p74597
g66283
sVAntineoplastic and Immunomodulating Agents
p74598
g39792
sVCytochrome P-450 CYP3A Inducers (strong)
p74599
g22457
sVCytochrome P450 3A4 Inducers
p74600
g53779
sVThyroxine-binding globulin inducers
p74601
g68769
sVCytochrome P-450 CYP3A4 Inducers
p74602
g18948
sVAntineoplastic Agents
p74603
g71526
ssg10365
(dp74604
VAgents Causing Muscle Toxicity
p74605
g55387
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p74606
g52084
sVCytochrome P-450 CYP3A4 Inhibitors
p74607
g61705
sVGastric Acid Lowering Agents
p74608
g67250
sVCytochrome P-450 CYP2D6 Inhibitors
p74609
g62944
sVOAT1/SLC22A6 inhibitors
p74610
(dp74611
sVRadioisotopes
p74612
g63892
sVOAT1/SLC22A6 Substrates
p74613
g60722
sVOCT2 Inhibitors
p74614
g42479
sVCholinesterase Inhibitors
p74615
g72395
sVCytochrome P-450 Enzyme Inhibitors
p74616
g61999
sVHistamine H2 Antagonists
p74617
g12705
sVAcid Reducers
p74618
g43806
sVDrugs that are Mainly Renally Excreted
p74619
g43900
sVCytochrome P-450 CYP1A2 Substrates
p74620
g45606
sVElements, Radioactive
p74621
g59240
sVOCT2 substrates with narrow therapeutic index
p74622
g29690
sVAnti-Ulcer Agents
p74623
g73069
sVIsotopes
p74624
g23490
sVOCT2 Substrates
p74625
g14947
sVGastrointestinal Agents
p74626
g70835
sVOCT1 substrates
p74627
g13076
sVCytochrome P-450 CYP1A2 Inhibitors
p74628
g15025
sVOAT3/SLC22A8 Substrates
p74629
g13130
sVP-glycoprotein/ABCB1 Substrates
p74630
g35022
sVAlimentary Tract and Metabolism
p74631
g23923
sVFurans
p74632
g65173
sVCytochrome P-450 CYP3A Inhibitors
p74633
g60468
sVDrugs for Acid Related Disorders
p74634
g55170
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p74635
g53077
sVP-glycoprotein/ABCB1 Inhibitors
p74636
(dp74637
sVHistamine Antagonists
p74638
g43435
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p74639
g30534
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p74640
g67787
ssg10368
(dp74641
VPyrimidines
p74642
g47703
sg7047
g59767
sVCarbohydrates
p74643
g61781
sg3303
g38068
sg7635
g63013
sg2160
g30459
sVAnti-Infective Agents
p74644
g54641
sg5139
g49316
sVAntiinfectives for Systemic Use
p74645
g69683
sVDrugs that are Mainly Renally Excreted
p74646
g43901
sg4677
g46853
sg9756
g72090
sVGlycosides
p74647
g68367
sg10161
g73668
sg2268
g31036
sg4722
g47126
sVP-glycoprotein/ABCB1 Substrates
p74648
g35023
sg11715
(dp74649
sg6993
g59487
sg4962
g48569
sg5163
g49467
sg8895
g68593
sVBCRP/ABCG2 Substrates
p74650
g42079
ssg10371
(dp74651
g1461
g24825
ssg10374
(dp74652
VDrugs that are Mainly Renally Excreted
p74653
g43918
sVCardiotoxic antineoplastic agents
p74654
g72241
sVCytochrome P-450 CYP1A2 Substrates
p74655
g45607
sVNitrosourea Compounds
p74656
g47830
sVMyelosuppressive Agents
p74657
g71339
sVToxic Actions
p74658
g49398
sVNoxae
p74659
g65427
sVImmunosuppressive Agents
p74660
g64594
sVUrea
p74661
g58643
sVAlkylating Activity
p74662
g46196
sVAlkylating Drugs
p74663
g70063
sVAntineoplastic and Immunomodulating Agents
p74664
g39731
sVNitroso Compounds
p74665
(dp74666
sVNitrosoureas
p74667
g47603
sVAntineoplastic Agents
p74668
g71554
sVAntineoplastic Agents, Alkylating
p74669
g60746
ssg10377
(dp74670
VAntiinfectives for Systemic Use
p74671
g69639
sVCytochrome P-450 CYP2C8 Substrates
p74672
(dp74673
sVAntivirals for Systemic Use
p74674
g59762
sVRNA Replicase Inhibitors
p74675
g59485
sVBreast Cancer Resistance Protein Inhibitors
p74676
g12718
sVPyrimidines
p74677
g47696
sVCytochrome P-450 CYP2D6 Substrates
p74678
g52108
sVAntivirals for treatment of HCV infections
p74679
g31040
sVPyrimidinones
p74680
(dp74681
sVP-glycoprotein/ABCB1 Substrates
p74682
g34904
sVAntiviral Agents
p74683
g30444
sVBCRP/ABCG2 Inhibitors
p74684
g12504
sVDirect Acting Antivirals
p74685
g38059
sVUGT1A1 Inhibitors
p74686
g71650
sVAmides
p74687
g44284
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74688
g29465
sVSulfur Compounds
p74689
(dp74690
sVSulfones
p74691
g58736
sg6126
g55140
sVCytochrome P-450 CYP3A4 Substrates
p74692
g65289
sVCytochrome P-450 CYP3A Substrates
p74693
g45171
ssg10380
(dp74694
g4143
g43147
ssg10383
(dp74695
VOAT1/SLC22A6 inhibitors
p74696
(dp74697
sVHypotensive Agents
p74698
g34177
sVPotential QTc-Prolonging Agents
p74699
g70426
sVHyperglycemia-Associated Agents
p74700
g68811
sVGynecological Antiinfectives and Antiseptics
p74701
g69248
sVAntihypertensive Agents
p74702
g20303
sg11469
(dp74703
sVAmides
p74704
g44338
sVSulfur Compounds
p74705
(dp74706
sVSulfones
p74707
g58747
sVQTc Prolonging Agents
p74708
g57853
sVSulfonamides
p74709
g63362
sVSodium Chloride Symporter Inhibitors
p74710
g55916
sVCardiovascular Agents
p74711
g26637
sVNon Potassium Sparing Diuretics
p74712
g14978
sVMembrane Transport Modulators
p74713
g54116
sVLow-Ceiling Diuretics and Potassium-Sparing Agents
p74714
g25432
sVHeterocyclic Compounds, Fused-Ring
p74715
g56120
sVGenito Urinary System and Sex Hormones
p74716
g66181
sVNatriuretic Agents
p74717
g40498
sVThiazides
p74718
g70217
sVBenzothiadiazines
p74719
g44816
sVIncreased Diuresis
p74720
g41001
sVNephrotoxic agents
p74721
g57728
sVDiuretics
p74722
g57908
ssg10386
(dp74723
g4629
g46439
ssg10389
(dp74724
VHeterocyclic Compounds, Fused-Ring
p74725
g56122
sVCytochrome P-450 CYP3A Substrates
p74726
g45073
sVP-glycoprotein/ABCB1 Substrates
p74727
g35034
sg4548
g46095
sVKinase Inhibitor
p74728
g24588
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74729
g29351
sVAntineoplastic and Immunomodulating Agents
p74730
g39799
sVTyrosine Kinase Inhibitors
p74731
g30823
sVEnzyme Inhibitors
p74732
g72725
sVProtein Kinase Inhibitors
p74733
(dp74734
sVCytochrome P-450 CYP3A4 Substrates
p74735
g65244
sVAntineoplastic Agents
p74736
g71546
ssg10392
(dp74737
g11805
(dp74738
ssg10395
(dp74739
g2343
g31347
ssg10398
(dp74740
g7878
g64038
ssg10401
(dp74741
g8388
g66370
ssg10404
(dp74742
g10263
g74039
sg9402
g70637
sg171
g13705
sg4623
g46381
sg828
g19866
sg3036
g36442
sg10857
(dp74743
sg3531
g39273
sg6381
g56776
sg7824
g63871
sg4647
g46575
sg255
g14414
sg11439
(dp74744
sg11667
(dp74745
sg5598
g52023
sg4683
g46933
ssg10407
(dp74746
g537
g17052
sg4101
g42983
sg4458
g45502
sg12063
(dp74747
sg10596
(dp74748
sg11595
(dp74749
sg294
g14764
sg450
g16356
sg1413
g24438
sg42
g12602
sg8163
g65474
sg1281
g23397
sg10602
(dp74750
sg1434
g24694
sg1911
g28377
sg1809
g27452
sg1008
g21301
sg915
g20736
sg8295
g65992
sg9462
g70995
ssg10410
(dp74751
VGlycols
p74752
g55146
sVAmino Alcohols
p74753
g32691
sVPotential QTc-Prolonging Agents
p74754
g70430
sg591
g17666
sg1323
g23565
sVImmunologic Factors
p74755
g42390
sVImmunosuppressive Agents
p74756
g64582
sVBradycardia-Causing Agents
p74757
g61463
sg6252
g55823
sg1191
g22793
sVAntineoplastic and Immunomodulating Agents
p74758
g39804
sVQTc Prolonging Agents
p74759
g57858
sg9762
g72108
sVAlcohols
p74760
(dp74761
sg6954
g59378
sVAmines
p74762
g42675
ssg10413
(dp74763
g2199
g30714
ssg10416
(dp74764
VCytochrome P-450 CYP3A4 Inhibitors
p74765
g61694
sVCytochrome P-450 CYP3A Substrates
p74766
g45071
sVDPP-IV Inhibitors
p74767
(dp74768
sVAgents causing angioedema
p74769
g63909
sVProtease Inhibitors
p74770
g51101
sVOCT2 Inhibitors
p74771
g42484
sVHormones
p74772
g55685
sVEnzyme Inhibitors
p74773
g72724
sVCytochrome P-450 Enzyme Inhibitors
p74774
g62001
sVBlood Glucose Lowering Agents
p74775
(dp74776
sVQuinazolines
p74777
g57750
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74778
g29349
sVOral Hypoglycemics
p74779
g36004
sVOCT2 substrates with narrow therapeutic index
p74780
g29694
sVDrugs Used in Diabetes
p74781
g60121
sVOCT1 inhibitors
p74782
g66926
sVOCT2 Substrates
p74783
g14951
sVP-glycoprotein/ABCB1 Substrates
p74784
g35031
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p74785
g69046
sVIncretins
p74786
g20132
sVCytochrome P-450 CYP3A4 Substrates
p74787
g65243
sVAlimentary Tract and Metabolism
p74788
g23887
sVPurines
p74789
g73797
sVHeterocyclic Compounds, Fused-Ring
p74790
g56121
sVCytochrome P-450 CYP3A Inhibitors
p74791
g60456
sVP-glycoprotein/ABCB1 Inhibitors
p74792
(dp74793
sVHormones, Hormone Substitutes, and Hormone Antagonists
p74794
g53175
ssg10419
(dp74795
g4257
g44077
sg5469
g51296
sg165
g13582
ssg10422
(dp74796
g8241
g65778
ssg10425
(dp74797
g2346
g31410
sg7464
g62196
sg10818
(dp74798
sg3846
g41156
sg12421
g12492
sg3117
g36940
sg3240
g37745
sg6318
g56395
sg11283
(dp74799
sg4803
g47662
sg7821
g63854
sg5454
g51180
sg279
g14504
sg1650
g26132
sg11151
(dp74800
sg7668
g63235
sg5472
g51311
sg11451
(dp74801
sg3900
g41498
sg8433
g66677
sg10701
(dp74802
sg5499
g51437
sg8448
g66757
sg9954
g72935
sg8454
g66832
sg9960
g72984
sg9432
g70891
sg915
g20741
sg7707
g63415
sg6279
g55978
sg10557
(dp74803
sg7377
g61527
sg9234
g69995
sg5535
g51676
sg10752
(dp74804
sg11337
(dp74805
sg2460
g32282
sg945
g20912
sg10170
g73683
sg2481
g32442
sg8514
g67130
sg816
g19708
sg2493
g32614
sg963
g21019
sg9273
g70185
sg2835
g34763
sg7764
g63643
sg3222
g37624
sg6315
g56314
sg2523
g32754
sg10365
g74637
sg5646
g52343
sg6333
g56501
sg1857
g27725
sg10815
(dp74806
sg7800
g63691
sg4002
g42137
sg2676
g33556
sg5595
g51996
sg10056
g73422
sg4911
g48287
sg7053
g59825
sg5832
g53452
sg11592
(dp74807
sg11595
(dp74808
sg8166
g65496
sg7065
g59959
sg4035
g42454
sg8781
g68105
sg8595
g67364
sg8916
g68659
sg1050
g21703
sg12063
(dp74809
sg6408
g56860
sg8787
g68115
sg8625
g67513
sg282
g14593
sg10122
g73607
sg5313
g50413
sg10899
(dp74810
sg3132
g37031
sg4077
g42852
sg8655
g67606
sg5694
g52572
sg7716
g63467
sg12534
g52699
sg11820
(dp74811
sg1881
g27976
sg3381
g38496
sg2652
g33330
sg6435
g57002
sg4437
g45301
sg4926
g48419
sg10179
g73752
sg7947
g64384
sg10185
g73786
sg1908
g28326
sg4452
g45457
sg3021
g36231
sg1770
g27070
sg2688
g33693
sg3432
g38826
sg147
g13503
sg387
g15686
sg7191
g60578
sg7197
g60631
sg3447
g38967
sg1194
g22831
sg6537
g57425
sg3858
g41253
sg780
g19384
sg11385
(dp74812
sg9198
g69800
sg10266
g74085
sg9918
g72811
sg5805
g53304
sg2430
g32120
sg339
g15190
sg9987
g73171
sg5817
g53320
sg1911
g28383
sg456
g16391
sg9528
g71269
sg5829
g53378
sg6567
g57532
sg1239
g22981
sg1047
g21635
sg10308
g74304
sg11052
(dp74813
sg2559
g32982
sg2034
g29047
sg9135
g69523
sg3516
g39189
sg5781
g53122
sg11079
(dp74814
sg5877
g53709
sg11940
(dp74815
sg5085
g49057
sg8820
g68298
sg2814
g34532
sg9591
g71519
sg840
g20018
sg2910
g35567
sg2829
g34666
sg10362
g74592
sg3546
g39408
sg2109
g30167
sg2844
g34891
sg11136
(dp74816
sg3963
g41903
sg7569
g62754
sg3651
g40141
sg10416
g74793
sg4653
g46753
sg573
g17550
sg11166
(dp74817
sg543
g17128
sg2142
g30377
sg7884
g64129
sg3570
g39513
sg5169
g49549
sg5094
g49090
sg28215
g35389
sg9966
g73066
sg11601
(dp74818
sg9663
g71780
sg336
g15130
sg9879
g72527
sg5199
g49711
sg8187
g65559
sg621
g17984
sg8019
g64759
sg438
g16181
sg630
g18050
sg2196
g30652
sg11955
(dp74819
sg4425
g44948
sg528
g16950
sg2427
g32072
sg11229
(dp74820
sg7428
g61877
sg16906
g61932
sg11976
(dp74821
sg5235
g49868
sg4449
g45376
sg2946
g35843
sg1434
g24693
sg10470
(dp74822
sg5250
g50012
sg6033
g54548
sg684
g18523
sg6045
g54725
sg12126
(dp74823
sg10596
(dp74824
sg4479
g45729
sg3696
g40311
sg6468
g57125
sg1491
g25119
sg5286
g50229
sg10740
(dp74825
sg9009
g68937
sg6798
g58777
sg1503
g25202
sg6090
g54978
sg714
g19031
sg11097
(dp74826
sg3732
g40521
sg3024
g36330
sg2769
g34315
sg5316
g50473
sg3027
g36391
sg11316
(dp74827
sg486
g16671
sg2832
g34749
sg2274
g31073
sg4539
g46058
sg4542
g46083
sg1539
g25295
sg11625
(dp74828
sg1548
g25403
sg5289
g50321
sg3072
g36611
sg10758
(dp74829
sg9084
g69230
sg690
g18660
sg11370
(dp74830
sg4635
g46518
sg4596
g46274
sg4023
g42364
sg10611
(dp74831
sg819
g19789
ssg10428
(dp74832
VAsparagine-specific Enzyme
p74833
g57700
sVAsparaginase
p74834
g36954
sVAntineoplastic Agents
p74835
g71550
sVThyroxine-binding globulin inhibitors
p74836
(dp74837
ssg10431
(dp74838
VAmino Acids, Peptides, and Proteins
p74839
g47396
sVAntibodies
p74840
g60988
sVInterleukin Inhibitors
p74841
g49765
sg11493
(dp74842
sVProteins
p74843
g52756
sVImmunoglobulins
p74844
g41530
sVImmunosuppressive Agents
p74845
g64584
sg2883
g35289
sVSerum Globulins
p74846
g49661
sVAntineoplastic and Immunomodulating Agents
p74847
g39808
sVGlobulins
p74848
g19185
sVBlood Proteins
p74849
g39863
sVImmunoproteins
p74850
g57454
ssg10434
(dp74851
g10680
(dp74852
sg561
g17376
sg3144
g37116
ssg10437
(dp74853
g11694
(dp74854
ssg10440
(dp74855
g4806
g47682
sg6906
g59223
sg3318
g38198
ssg10443
(dp74856
g8193
g65597
sg12060
(dp74857
sg6765
g58639
sg10839
(dp74858
sg13091
g21446
sg735
g19143
sg1980
g28811
sg2991
g35981
sg11040
(dp74859
sg1746
g26956
sg1332
g23673
sg7947
g64385
sg2862
g35159
sg5193
g49635
sg8493
g67077
sg10953
(dp74860
sg279
g14518
sg3216
g37530
ssg10446
(dp74861
g5454
g51130
sg4479
g45667
sg10266
g74059
sg3708
g40363
sg11961
(dp74862
sg10275
g74158
sg8580
g67271
sg4803
g47609
sg3858
g41187
sg9528
g71235
sg8595
g67331
sg5238
g49874
sg4452
g45398
sg7821
g63780
sg11151
(dp74863
sg5250
g49936
sg6699
g58211
sg9954
g72897
sg11052
(dp74864
sg7377
g61471
sg3132
g36972
sg8430
g66582
sg11451
(dp74865
sg5007
g48689
sg8433
g66626
sg3519
g39198
sg6033
g54490
sg7740
g63557
sg573
g17504
sg2844
g34868
sg4077
g42807
sg6468
g57063
sg11601
(dp74866
sg8079
g65010
sg8448
g66742
sg10740
(dp74867
sg9009
g68897
sg9588
g71457
sg15016
g66090
sg9966
g73021
sg11820
(dp74868
sg1881
g27925
sg3021
g36166
sg3024
g36240
sg5313
g50374
sg9432
g70863
sg3027
g36344
sg2109
g30084
sg8820
g68232
sg4926
g48372
sg6291
g55997
sg9198
g69759
sg816
g19621
sg4539
g46006
sg690
g18588
sg8298
g66002
sg5469
g51277
sg963
g20958
sg11523
(dp74869
sg10557
(dp74870
sg7764
g63611
sg165
g13567
sg4164
g43272
sg3072
g36574
sg28215
g35334
sg9324
g70323
sg5289
g50235
sg9081
g69147
sg1110
g22121
sg7800
g63674
sg6537
g57378
sg11940
(dp74871
sg1185
g22702
sg11781
(dp74872
sg7458
g62112
sg819
g19717
ssg10449
(dp74873
g7197
g60592
sg12421
g12428
sg7065
g59915
ssg10452
(dp74874
g11832
(dp74875
sg11472
(dp74876
ssg10455
(dp74877
g7740
g63562
sg3072
g36576
sg5007
g48694
sg5229
g49795
sg8166
g65489
sg7077
g60009
sg6291
g56002
sg6000
g54291
sg7596
g62838
sg9009
g68901
sg7344
g61299
ssg10458
(dp74878
g4911
g48209
sg1656
g26148
ssg10461
(dp74879
g4002
g42132
ssg10464
(dp74880
g9417
g70736
sg9918
g72818
sg282
g14531
sg3027
g36378
sg11595
(dp74881
sg11079
(dp74882
sg3963
g41850
sg16906
g61893
sg915
g20687
sg9273
g70155
ssg10467
(dp74883
g9588
g71461
sg8832
g68348
sg5487
g51355
sg546
g17154
sg6261
g55841
ssg10470
(dp74884
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p74885
(dp74886
sVCytochrome P-450 CYP3A4 Inhibitors
p74887
g61702
sVAdrenergic alpha-1 Receptor Antagonists
p74888
g14111
sVSerotonin Agents
p74889
(dp74890
sVAnalgesics
p74891
g26486
sVAntimigraine Preparations
p74892
g32378
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p74893
g72540
sg3435
g38831
sVCentral Nervous System Agents
p74894
g58503
sVCYP3A Substrates (Sensitive)
p74895
g63917
sVAdrenergic Antagonists
p74896
g52268
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p74897
g43778
sVErgotamine Derivative
p74898
(dp74899
sVCytochrome P-450 Enzyme Inhibitors
p74900
g62046
sVPeripheral Nervous System Agents
p74901
g57641
sVVasoconstrictor Agents
p74902
g35885
sVAnalgesics, Non-Narcotic
p74903
g56892
sVSympatholytic (Adrenergic Blocking) Agents
p74904
g44229
sVErgot Alkaloids and Derivatives
p74905
g49012
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p74906
g29362
sVAdrenergic alpha-Antagonists
p74907
g60864
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p74908
g60060
sVCytochrome P-450 CYP3A Substrates
p74909
g45083
sVAdrenergic Agents
p74910
g41693
sVCentral Nervous System Depressants
p74911
(dp74912
sVNeurotransmitter Agents
p74913
(dp74914
sVCardiovascular Agents
p74915
g26655
sVReproductive Control Agents
p74916
g18842
sVAgents that produce hypertension
p74917
g69082
sVCytochrome P-450 CYP3A Inhibitors (strong)
p74918
g13384
sVCytochrome P-450 CYP3A4 Substrates
p74919
g65247
sVNarrow Therapeutic Index Drugs
p74920
g50551
sVSerotonin 5-HT1 Receptor Agonists
p74921
g34592
sVHeterocyclic Compounds, Fused-Ring
p74922
g56136
sVSerotonin Modulators
p74923
g69130
sVAntidepressive Agents
p74924
g15567
sVCytochrome P-450 CYP3A Inhibitors
p74925
g60465
sVSerotonin 5-HT2 Receptor Agonists
p74926
(dp74927
sVP-glycoprotein/ABCB1 Inhibitors
p74928
g74822
sVErgotamines
p74929
(dp74930
sVAlkaloids
p74931
g19401
sVSensory System Agents
p74932
g71815
sVSerotonin Receptor Agonists
p74933
(dp74934
sVNervous System
p74935
g70303
ssg10473
(dp74936
g11775
(dp74937
sg8484
g66995
sg12186
g42915
sg8439
g66692
ssg10476
(dp74938
g9252
g70038
sg3018
g36128
ssg10479
(dp74939
VAntiinfectives for Systemic Use
p74940
g69678
sg5406
g50878
sVHeterocyclic Compounds, Fused-Ring
p74941
g56139
sVThird-Generation Cephalosporins
p74942
g44709
sVbeta-Lactams
p74943
(dp74944
sg10146
g73632
sVLactams
p74945
g22273
sVAmides
p74946
g44349
sVThiazines
p74947
g16409
sVSulfur Compounds
p74948
(dp74949
sVAnti-Bacterial Agents
p74950
g38377
sVAntibacterials for Systemic Use
p74951
g32576
sVCephalosporins
p74952
g49063
sVAnti-Infective Agents
p74953
g54658
ssg10482
(dp74954
g6819
g58895
sg14791
g71090
ssg10485
(dp74955
g5727
g52809
sg7188
g60526
sg11523
(dp74956
ssg10488
(dp74957
g4845
g47848
ssg10491
(dp74958
g10674
(dp74959
sg1425
g24545
sg5535
g51654
sg8187
g65536
sg486
g16645
ssg10494
(dp74960
VAntiplatelet agents
p74961
g46300
sg3108
g36812
sg3387
g38514
sg6741
g58372
sVAnalgesics
p74962
g26430
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p74963
g58391
sVAgents causing angioedema
p74964
g63900
sVNon COX-2 selective NSAIDS
p74965
g67323
sVAntiinflammatory and Antirheumatic Products
p74966
g56813
sVBlood and Blood Forming Organs
p74967
g53919
sVStomatological Preparations
p74968
g67439
sVPeripheral Nervous System Agents
p74969
g57645
sVDrugs that are Mainly Renally Excreted
p74970
g43911
sVP-glycoprotein/ABCB1 Inducers
p74971
g70557
sg1836
g27624
sVNonsteroidal Anti-inflammatory Compounds
p74972
g68162
sVAnalgesics, Non-Narcotic
p74973
g56899
sVNephrotoxic agents
p74974
g57738
sVDecreased Platelet Aggregation
p74975
(dp74976
sVAcids, Carbocyclic
p74977
g41556
sVOAT1/SLC22A6 inhibitors
p74978
(dp74979
sVCytochrome P-450 CYP2C9 Substrates
p74980
g29807
sVCytochrome P-450 CYP2C19 Inducers (unknown strength)
p74981
g25144
sVMusculo-Skeletal System
p74982
g31526
sVAgents causing hyperkalemia
p74983
g43633
sVCardiovascular Agents
p74984
g26661
sVBenzene Derivatives
p74985
g61430
sg11127
(dp74986
sVP-glycoprotein/ABCB1 Substrates
p74987
g35065
sg7974
g64464
sVCytochrome P-450 Enzyme Inducers
p74988
g28230
sVAgents that produce hypertension
p74989
g69053
sVHydroxybenzoates
p74990
g59578
sVAlimentary Tract and Metabolism
p74991
g23770
sVHematologic Agents
p74992
g73840
sVPlatelet Aggregation Inhibitors Excl. Heparin
p74993
g62766
sVOAT3/SLC22A8 Inhibitors
p74994
g59005
sVCytochrome P-450 CYP2C19 Inducers
p74995
g25535
sVAnti-Inflammatory Agents
p74996
g73965
sVCyclooxygenase Inhibitors
p74997
g32787
sVSensory System Agents
p74998
g71816
sVAnti-Inflammatory Agents, Non-Steroidal
p74999
g64655
ssg10497
(dp75000
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p75001
(dp75002
sVAntidepressive Agents, Second-Generation
p75003
g49757
sVAnticholinergic Agents
p75004
g24508
sVPsychoanaleptics
p75005
g59072
sVCytochrome P-450 CYP2D6 Substrates
p75006
g52133
sVSerotonin Agents
p75007
(dp75008
sVNeurotransmitter Agents
p75009
(dp75010
sVCentral Nervous System Agents
p75011
g58449
sVPotential QTc-Prolonging Agents
p75012
g70438
sVPsychotropic Drugs
p75013
g72596
sVMuscarinic Antagonists
p75014
g48885
sVDrugs that are Mainly Renally Excreted
p75015
g43942
sVCytochrome P-450 CYP1A2 Substrates
p75016
g45579
sVAnthracenes
p75017
g53581
sVNon-Selective Monoamine Reuptake Inhibitors
p75018
g72029
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p75019
g29605
sVQTc Prolonging Agents
p75020
g57872
sVAdrenergic Agents
p75021
g41726
sVCentral Nervous System Depressants
p75022
(dp75023
sVHistamine Antagonists
p75024
g43433
sVAgents that reduce seizure threshold
p75025
g45869
sVAdrenergic Uptake Inhibitors
p75026
g32318
sVNeurotransmitter Uptake Inhibitors
p75027
g52396
sVHistamine H1 Antagonists
p75028
g40775
sVMembrane Transport Modulators
p75029
g54133
sVSerotonin Modulators
p75030
g69137
sVAntidepressive Agents
p75031
g15513
sVAntidepressive Agents, Tetracyclic
p75032
g44819
sVAgents producing tachycardia
p75033
g50753
sVNervous System
p75034
g70275
ssg10500
(dp75035
g6639
g57969
sg11931
(dp75036
sg7152
g60202
sg8514
g67128
sg10470
g74927
sg11097
(dp75037
ssg10503
(dp75038
g6318
g56388
ssg10506
(dp75039
g8658
g67638
sg2703
g33744
ssg10509
(dp75040
VPyrimidines
p75041
g47702
sVAntivirals for Systemic Use
p75042
g59766
sVCarbohydrates
p75043
g61791
sVDirect Acting Antivirals
p75044
g38063
sVHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
p75045
g63014
sVAntiviral Agents
p75046
g30452
sVAnti-Infective Agents
p75047
g54667
sVNucleotides
p75048
g49319
sVAntiinfectives for Systemic Use
p75049
g69682
sVDrugs that are Mainly Renally Excreted
p75050
g43913
sVRibonucleotides
p75051
g46856
sVUracil Nucleotides
p75052
g72091
sVGlycosides
p75053
g68366
sVRibonucleosides
p75054
g73666
sVAntivirals for treatment of HCV infections
p75055
g31044
sVNucleic Acids, Nucleotides, and Nucleosides
p75056
g47123
sVP-glycoprotein/ABCB1 Substrates
p75057
g35069
sVPyrimidine Nucleosides
p75058
(dp75059
sVRNA Replicase Inhibitors
p75060
g59488
sVPyrimidine Nucleotides
p75061
g48572
sVNucleosides
p75062
g49464
sVUridine Monophosphate
p75063
g68594
sVBCRP/ABCG2 Substrates
p75064
g42075
ssg10512
(dp75065
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p75066
(dp75067
sVBreast Cancer Resistance Protein Inhibitors
p75068
g12729
sVUGT1A1 Substrates
p75069
g12307
sVHematinics
p75070
g59096
sVUGT2B7 Inhibitors
p75071
g53578
sVBCRP/ABCG2 Inhibitors
p75072
g12557
sVOATP1B1/SLCO1B1 Inhibitors
p75073
(dp75074
sVCytochrome P-450 Enzyme Inhibitors
p75075
g62006
sVHemostatics
p75076
g23071
sVCytochrome P-450 CYP2C8 Substrates
p75077
(dp75078
sVCytochrome P-450 CYP1A2 Substrates
p75079
g45629
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p75080
g23115
sg1665
g26226
sVUGT1A3 substrates
p75081
g31810
sVAcids, Carbocyclic
p75082
g41562
sg5079
g49015
sg1029
g21350
sVBlood and Blood Forming Organs
p75083
g53922
sVBenzene Derivatives
p75084
g61433
sVCytochrome P-450 CYP2C8 Inhibitors
p75085
g55043
sVUGT1A6 Inhibitors
p75086
g58850
sVUGT1A1 Inhibitors
p75087
g71655
sg10278
g74186
sg12096
(dp75088
sVUGT1A3 Inhibitors
p75089
g19236
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p75090
(dp75091
sVUGT1A9 Inhibitors
p75092
g66250
sg9585
g71453
ssg10515
(dp75093
VAdrenergic beta-Agonists
p75094
g43005
sVAdrenergic beta-2 Receptor Agonists
p75095
g58941
sVAmines
p75096
g42736
sVDrugs that are Mainly Renally Excreted
p75097
g43914
sVEthylamines
p75098
g20589
sVPropanols
p75099
g56547
sVAdrenergic Agonists
p75100
(dp75101
sVAgents producing tachycardia
p75102
g50793
sVAgents that produce hypertension
p75103
g69085
sVPhenethylamines
p75104
(dp75105
sVAlcohols
p75106
(dp75107
sVPropanolamines
p75108
g37502
sVAmino Alcohols
p75109
g32677
ssg10518
(dp75110
VDrugs that are Mainly Renally Excreted
p75111
g43915
sVCentral Nervous System Depressants
p75112
(dp75113
sVCytochrome P-450 CYP1A2 Substrates
p75114
g45630
sVCytochrome P-450 CYP2D6 Inhibitors
p75115
g62952
sVDioxoles
p75116
g74191
sVMiscellaneous Anticonvulsants
p75117
g53477
sVAnticonvulsants
p75118
g60151
sVCytochrome P-450 CYP1A2 Inhibitors
p75119
g15022
sVCytochrome P-450 CYP3A Inhibitors
p75120
g60470
sVCytochrome P-450 CYP3A4 Inhibitors
p75121
g61707
sVCytochrome P-450 Enzyme Inhibitors
p75122
g62007
sVCentral Nervous System Agents
p75123
g58512
sVCytochrome P-450 CYP2C9 Inhibitors
p75124
g18245
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p75125
g44517
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p75126
g53074
sVCytochrome P-450 CYP2C19 Inhibitors
p75127
g61282
sVCytochrome P-450 CYP3A Inhibitors (strong)
p75128
g13399
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p75129
g49336
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p75130
g72544
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p75131
(dp75132
sVNervous System
p75133
g70308
ssg10521
(dp75134
VDrugs for Urinary Frequency and Incontinence
p75135
g28982
sVNeurotransmitter Agents
p75136
(dp75137
sVHeterocyclic Compounds, Fused-Ring
p75138
g56153
sVAnticholinergic Agents
p75139
g24490
sVCytochrome P-450 CYP2D6 Inhibitors
p75140
g62953
sVCYP3A Substrates (Sensitive)
p75141
g63923
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p75142
g41076
sVCytochrome P-450 CYP3A Substrates
p75143
g45089
sVCytochrome P-450 CYP2D6 Substrates
p75144
g52196
sVGenito Urinary System and Sex Hormones
p75145
g66188
sVUrological Agents
p75146
g38289
sVCholinergic Agents
p75147
g28725
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75148
g29368
sVAgents producing tachycardia
p75149
g50794
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p75150
g60076
sVCytochrome P-450 Enzyme Inhibitors
p75151
g62008
sVCytochrome P-450 CYP3A4 Substrates
p75152
g65248
sVMuscarinic Antagonists
p75153
g48872
sVUrologicals
p75154
g58912
ssg10524
(dp75155
g3657
g40177
ssg10527
(dp75156
g4911
g48256
sg8421
g66522
sg7272
g60770
sg9822
g72320
sg183
g13832
sg888
g20475
sg6075
g54880
sg7335
g61213
sg4155
g43236
ssg10530
(dp75157
g102
g13013
sg6123
g55129
ssg10533
(dp75158
VDrugs that are Mainly Renally Excreted
p75159
g43916
sVCentral Nervous System Depressants
p75160
(dp75161
sVNeurotransmitter Agents
p75162
(dp75163
sVHistamine Antagonists
p75164
g43443
sVHistamine H1 Antagonists, Non-Sedating
p75165
g38528
sg5670
g52405
sVHistamine Agents
p75166
(dp75167
sVPotential QTc-Prolonging Agents
p75168
g70440
sg5379
g50704
sVHistamine H1 Antagonists
p75169
g40782
sVAntihistamines for Systemic Use
p75170
g12971
sVQTc Prolonging Agents
p75171
g57878
sVPiperazines
p75172
(dp75173
ssg10536
(dp75174
g6246
g55805
sg4491
g45805
sg6843
g58976
ssg10539
(dp75175
VCentral Nervous System Depressants
p75176
(dp75177
sVCytochrome P-450 CYP1A2 Substrates
p75178
g45633
sVCytochrome P-450 CYP3A5 Substrates
p75179
g67830
sg6771
g58650
sVMiscellaneous Anticonvulsants
p75180
g53481
sVAnticonvulsants
p75181
g60155
sVCytochrome P-450 CYP3A Substrates
p75182
g45090
sg6780
g58655
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p75183
g64625
sVPyridines
p75184
g64239
sg4374
g44774
sVNervous System
p75185
g70310
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75186
g29369
sVCytochrome P-450 CYP2B6 Substrates
p75187
g33029
sVCytochrome P-450 Enzyme Inducers
p75188
g28238
sVCytochrome P-450 CYP3A4 Substrates
p75189
g65249
sVCytochrome P-450 CYP3A4 Inducers
p75190
g18975
sVCytochrome P-450 CYP3A Inducers
p75191
g66291
ssg10542
(dp75192
g9552
g71321
sg1611
g25821
ssg10545
(dp75193
g7740
g63572
sg3072
g36587
sg5007
g48705
sg5229
g49802
sg8166
g65499
sg7077
g60032
sg6291
g56012
sg6000
g54314
sg7596
g62858
sg9009
g68928
sg7344
g61310
ssg10548
(dp75194
VHydrocarbons, Acyclic
p75195
g19582
sVIrrigating Solutions
p75196
g41365
sVAnti-Infective Agents, Local
p75197
g63023
sVMiscellaneous Local Anti-infectives
p75198
g59165
sVAlkenes
p75199
g30757
sVAnti-Infective Agents
p75200
g54613
sVAntifungal Agents (Vaginal)
p75201
g39084
sVThroat Preparations
p75202
(dp75203
sVGynecological Antiinfectives and Antiseptics
p75204
g69251
sVPolyvinyls
p75205
(dp75206
sVIodine Products
p75207
g70575
sVPovidone
p75208
(dp75209
sVVinyl Compounds
p75210
g21841
sVMedicated Dressings
p75211
g20580
sVPyrrolidines
p75212
g59347
sVPolymers
p75213
g22226
sVDermatologicals
p75214
g17272
sVPyrrolidinones
p75215
g30230
sVSensory Organs
p75216
g40705
sVAntiseptics and Disinfectants
p75217
g23745
sVBiomedical and Dental Materials
p75218
g44720
sVMedicated Dressings With Antiinfectives
p75219
g43163
sVPlastics
p75220
(dp75221
sVIodine Compounds
p75222
(dp75223
sVOphthalmologicals
p75224
g35212
sVGenito Urinary System and Sex Hormones
p75225
g66173
sVMedicated Shampoos
p75226
g23262
sVIodophors
p75227
g68597
sVPolyenes
p75228
g51390
sVMacromolecular Substances
p75229
g33835
sVCompounds used in a research, industrial, or household setting
p75230
(dp75231
ssg10551
(dp75232
g10758
(dp75233
sg3432
g38819
ssg10554
(dp75234
VHematologic Agents
p75235
g73848
sVPolysaccharides
p75236
g41784
sVGenito Urinary System and Sex Hormones
p75237
g66191
sVAnticoagulants
p75238
g58379
sVCarbohydrates
p75239
g61796
sVAcids
p75240
g40587
sVAcids, Noncarboxylic
p75241
g54210
sVSulfur Acids
p75242
g61538
sVSulfuric Acids
p75243
g25283
sVVasoprotectives
p75244
g41394
sVSulfur Compounds
p75245
(dp75246
sVGlycosaminoglycans
p75247
g26085
sVAntivaricose Therapy
p75248
g30543
sVUrologicals
p75249
g58919
sVMiscellaneous Therapeutic Agents
p75250
g74025
ssg10557
(dp75251
VDihydropyridine Derivatives
p75252
g56698
sVBSEP/ABCB11 Substrates
p75253
g74870
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p75254
(dp75255
sVCytochrome P-450 CYP2D6 Substrates
p75256
g52198
sVAntiarrhythmic agents
p75257
g71179
sVCytochrome P-450 CYP3A Substrates
p75258
g45091
sVAgents causing hyperkalemia
p75259
g43614
sVHypotensive Agents
p75260
g34169
sVCytochrome P-450 CYP3A4 Inhibitors
p75261
g61712
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p75262
g64627
sVCalcium Channel Blockers
p75263
g41319
sVBeta blocking agents and calcium channel blockers
p75264
g58530
sVAdrenergic Antagonists
p75265
g52283
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p75266
g43790
sVCardiovascular Agents
p75267
g26627
sVCytochrome P-450 CYP2C9 Inducers
p75268
g20050
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p75269
g16531
sVCalcium Channel Blockers (Dihydropyridine)
p75270
g20120
sVCytochrome P-450 Enzyme Inhibitors
p75271
g62009
sVContraceptive Agents, Male
p75272
g62104
sVHormonal Contraceptives for Systemic Use
p75273
g60098
sVDrugs that are Mainly Renally Excreted
p75274
g43920
sVP-glycoprotein/ABCB1 Inducers
p75275
g70562
sVCytochrome P-450 CYP1A2 Substrates
p75276
g45635
sVCytochrome P-450 CYP2B6 Inducers
p75277
g39127
sVTocolytic Agents
p75278
g33143
sVCytochrome P-450 CYP2E1 Inhibitors
p75279
g46845
sVMembrane Transport Modulators
p75280
g54164
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75281
g29371
sVReproductive Control Agents
p75282
g18861
sVQTc Prolonging Agents
p75283
g57882
sVCytochrome P-450 CYP3A4 Inducers
p75284
g18978
sVAdrenal Cortex Hormones
p75285
g30038
sVSelective Calcium Channel Blockers With Mainly Vascular Effects
p75286
g70000
sVCytochrome P-450 CYP2C8 Inhibitors
p75287
g55046
sVP-glycoprotein/ABCB1 Substrates
p75288
g35020
sVPyridines
p75289
g64240
sVAdrenergic beta-Antagonists
p75290
g15356
sVVasodilating Agents
p75291
g23717
sVCytochrome P-450 CYP2A6 Substrates
p75292
g35135
sVCytochrome P-450 Enzyme Inducers
p75293
g28241
sVCytochrome P-450 CYP3A Inducers
p75294
g66293
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p75295
g44550
sVCytochrome P-450 CYP3A4 Substrates
p75296
g65250
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p75297
g26884
sVCalcium-Regulating Hormones and Agents
p75298
g67159
sVModerate Risk QTc-Prolonging Agents
p75299
g67175
sVCalcium Channel Blockers and Diuretics
p75300
g32371
sVCytochrome P-450 CYP3A5 Substrates
p75301
g67832
sVCytochrome P-450 CYP3A Inhibitors
p75302
g60475
sVBradycardia-Causing Agents
p75303
g61451
sVOATP1B1/SLCO1B1 Inhibitors
p75304
(dp75305
sVP-glycoprotein/ABCB1 Inhibitors
p75306
g74803
sVDihydropyridines
p75307
g66255
sVCytochrome P-450 CYP3A7 Substrates
p75308
g60673
ssg10560
(dp75309
g4806
g47670
sg6906
g59228
sg3696
g40305
sg3318
g38202
sg1881
g27972
ssg10563
(dp75310
VAgents Causing Muscle Toxicity
p75311
g55401
sVAromatase Inhibitors
p75312
g30773
sVEstrogen Antagonists
p75313
g43653
sVCytochrome P-450 CYP3A4 Substrates
p75314
g65251
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p75315
g45822
sVNitriles
p75316
g34038
sVTriazoles
p75317
g47836
sVCytochrome P-450 CYP3A Substrates
p75318
g45092
sVHormone Antagonists and Related Agents
p75319
(dp75320
sVHormones, Hormone Substitutes, and Hormone Antagonists
p75321
g53191
sVCytochrome P-450 CYP2A6 Substrates
p75322
g35136
sVSteroid Synthesis Inhibitors
p75323
g72878
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75324
g29372
sVAntineoplastic and Immunomodulating Agents
p75325
g39823
sVEnzyme Inhibitors
p75326
g72734
sVCytochrome P-450 Enzyme Inhibitors
p75327
g62010
sVCytochrome P-450 CYP2A6 Inhibitors
p75328
g48588
sVAntineoplastic Agents
p75329
g71555
sVHormone Antagonists
p75330
g24282
sVEndocrine Therapy
p75331
g19561
ssg10566
(dp75332
g5487
g51369
sg7713
g63447
sg546
g17159
sg6261
g55854
ssg10569
(dp75333
VAmino Acids, Peptides, and Proteins
p75334
g47414
sg9042
g69040
sVEnzymes
p75335
g72153
sg7725
g63505
sVProteins
p75336
g52778
sVGlycoside Hydrolases
p75337
g18671
sg1224
g22886
sVEnzymes and Coenzymes
p75338
g72084
sVHydrolases
p75339
(dp75340
sVAlimentary Tract and Metabolism
p75341
g23936
ssg10572
(dp75342
g6393
g56834
ssg10575
(dp75343
g6489
g57218
sg11151
(dp75344
ssg10578
(dp75345
g5958
g54185
sg11250
(dp75346
sg6300
g56118
sg10269
g74116
sg8328
g66180
sg9087
g69247
sg7227
g60701
sVDermatologicals
p75347
g17290
sg7638
g63021
sg1347
g23740
sg9633
g71701
sg6036
g54643
ssg10581
(dp75348
VPyrrolidines
p75349
g59348
sVNitriles
p75350
g34039
sVDPP-IV Inhibitors
p75351
(dp75352
sVAgents causing angioedema
p75353
g63911
sVCycloparaffins
p75354
g43673
sVProtease Inhibitors
p75355
g51103
sVOral Hypoglycemics
p75356
g36008
sVEnzyme Inhibitors
p75357
g72735
sVBlood Glucose Lowering Agents
p75358
(dp75359
sVAlimentary Tract and Metabolism
p75360
g23938
sVDrugs Used in Diabetes
p75361
g60124
sVGlucagon-Like Peptide 1
p75362
(dp75363
ssg10584
(dp75364
g501
g16736
sg6246
g55815
sg6843
g58983
ssg10587
(dp75365
VNitrogen Compounds
p75366
g39006
sVHypotensive Agents
p75367
g34213
sVDirect Vasodilators
p75368
(dp75369
sVCompounds used in a research, industrial, or household setting
p75370
(dp75371
sVMethemoglobinemia Associated Agents
p75372
g25584
sVFerric Compounds
p75373
g53487
sVDrugs that are Mainly Renally Excreted
p75374
g43922
sg11742
(dp75375
sVAntihypertensive Agents
p75376
g20324
sg10128
g73617
sVElectrolytes
p75377
g52428
sg9768
g72123
sVVasodilation
p75378
(dp75379
sVCardiovascular Agents
p75380
g26687
sVNitric Oxide Donors
p75381
g73075
sVIndicators and Reagents
p75382
g58937
sVIron Compounds
p75383
g36404
sVAcids
p75384
g40590
sVLaboratory Chemicals
p75385
(dp75386
sVVasodilating Agents
p75387
g23722
sVOrganometallic Compounds
p75388
g73253
sVIons
p75389
g49127
sg2145
g30379
sVAcids, Noncarboxylic
p75390
g54213
sVArteriolar Smooth Muscle, Agents Acting On
p75391
g68599
sVAnions
p75392
g71792
ssg10590
(dp75393
g2787
g34417
sg5526
g51596
ssg10593
(dp75394
VAnticholinergic Agents
p75395
g24492
sVCytochrome P-450 CYP2D6 Inhibitors
p75396
g62943
sVNeurotransmitter Agents
p75397
(dp75398
sVHydroxy Acids
p75399
g18157
sVCytochrome P-450 Enzyme Inhibitors
p75400
g62005
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p75401
g18413
sVMuscarinic Antagonists
p75402
g48874
sVDrugs for Urinary Frequency and Incontinence
p75403
g28983
sVAutonomic Agents
p75404
g66565
sVAza Compounds
p75405
(dp75406
sVAcids, Carbocyclic
p75407
g41564
sVPeripheral Nervous System Agents
p75408
g57626
sVUrological Agents
p75409
g38280
sVParasympatholytics
p75410
g35947
sVDiphenylacetic Acids
p75411
g52591
sVTropanes
p75412
g66421
sVAzabicyclo Compounds
p75413
(dp75414
sVDrugs for Functional Gastrointestinal Disorders
p75415
g72510
sVUrologicals
p75416
g58917
sVPhenylacetates
p75417
g34423
sVAlimentary Tract and Metabolism
p75418
g23881
sVGenito Urinary System and Sex Hormones
p75419
g66179
sVCholinergic Agents
p75420
g28733
sVAgents producing tachycardia
p75421
g50781
sVAlkaloids
p75422
g19427
ssg10596
(dp75423
VNMDA Receptor Antagonists
p75424
g43494
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p75425
(dp75426
sVCytochrome P-450 CYP2D6 Substrates
p75427
g52202
sVSerotonin Agents
p75428
(dp75429
sVAnalgesics
p75430
g26499
sVOpiate Agonists
p75431
g46444
sVCentral Nervous System Agents
p75432
g58521
sVCytochrome P-450 CYP2B6 Substrates
p75433
g33037
sVNarcotics
p75434
g73499
sVPeripheral Nervous System Agents
p75435
g57655
sVDrugs that are Mainly Renally Excreted
p75436
g43923
sVPiperidines
p75437
g73568
sVPhenylpiperidine Derivatives
p75438
g70570
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75439
g29375
sVAdjuvants, Anesthesia
p75440
g55873
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p75441
g60063
sVCytochrome P-450 CYP3A4 Inducers
p75442
g18984
sVCytochrome P-450 CYP3A Substrates
p75443
g45095
sVCentral Nervous System Depressants
p75444
(dp75445
sVCytochrome P-450 CYP1A2 Inducers
p75446
g68386
sVOpioids
p75447
g32245
sVAgents that reduce seizure threshold
p75448
g45872
sVCytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index
p75449
g26809
sVCytochrome P-450 Enzyme Inducers
p75450
g28248
sVCytochrome P-450 CYP3A Inducers
p75451
g66296
sVSensory System Agents
p75452
g71820
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p75453
g17456
sVCytochrome P-450 CYP3A4 Substrates
p75454
g65254
sVNarrow Therapeutic Index Drugs
p75455
g50554
sVSerotonin Modulators
p75456
g69138
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p75457
g61378
sVAntidepressive Agents
p75458
g15576
sVOpioid Agonist
p75459
g74748
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p75460
g36630
sVAdjuvants
p75461
g50699
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p75462
g64629
sVP-glycoprotein/ABCB1 Inhibitors
p75463
g74824
sVHigh-risk opioids
p75464
g58089
sVNervous System
p75465
g70314
sg11325
(dp75466
ssg10599
(dp75467
g3543
g39330
ssg10602
(dp75468
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p75469
(dp75470
sVCytochrome P-450 CYP2D6 Substrates
p75471
g52203
sVAnalgesics
p75472
g26501
sVOpiate Agonists
p75473
g46449
sVCentral Nervous System Agents
p75474
g58523
sVNarcotics
p75475
g73498
sVPeripheral Nervous System Agents
p75476
g57656
sg8232
g65741
sVCytochrome P-450 CYP3A4 Substrates
p75477
g65255
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75478
g29376
sVCytochrome P-450 CYP3A Substrates
p75479
g45096
sg1302
g23487
sVCentral Nervous System Depressants
p75480
(dp75481
sVOpioids
p75482
g32246
sg6996
g59492
sg11322
(dp75483
sVOpiate Alkaloids
p75484
g70923
sVHeterocyclic Compounds, Fused-Ring
p75485
g56169
sVMorphinans
p75486
g57230
sVCytochrome P-450 CYP3A5 Substrates
p75487
g67835
sVOpioid Agonist
p75488
g74750
sVAlkaloids
p75489
g19446
sVSensory System Agents
p75490
g71821
sVPhenanthrenes
p75491
g32841
sVNervous System
p75492
g70315
ssg10605
(dp75493
g4365
g44744
sg8808
g68196
sg6015
g54383
sg4053
g42541
ssg10608
(dp75494
g10272
g74153
ssg10611
(dp75495
VAntiinfectives for Systemic Use
p75496
g69685
sVCefotaxime
p75497
g50879
sVHeterocyclic Compounds, Fused-Ring
p75498
g56166
sVThird-Generation Cephalosporins
p75499
g44714
sVDrugs that are Mainly Renally Excreted
p75500
g43860
sVbeta-Lactams
p75501
(dp75502
sVCephacetrile
p75503
g73633
sVOAT3/SLC22A8 Inhibitors
p75504
g59021
sVLactams
p75505
g22291
sVOAT1/SLC22A6 inhibitors
p75506
(dp75507
sVAmides
p75508
g44303
sVP-glycoprotein/ABCB1 Inhibitors
p75509
g74831
sVSulfur Compounds
p75510
(dp75511
sVAnti-Bacterial Agents
p75512
g38389
sVAntibacterials for Systemic Use
p75513
g32586
sVThiazines
p75514
g16426
sVCephalosporins
p75515
g49071
sVAnti-Infective Agents
p75516
g54675
sVNephrotoxic agents
p75517
g57742
ssg10614
(dp75518
g2886
g35318
sg11046
(dp75519
sg6360
g56727
sg4143
g43158
ssg10617
(dp75520
g4338
g44564
sg4821
g47738
sg2253
g30889
sg10338
g74462
sg8796
g68142
ssg10620
(dp75521
g6474
g57178
ssg10623
(dp75522
g8823
g68306
sg2079
g29835
ssg10626
(dp75523
g1581
g25675
ssg10629
(dp75524
VAngiotensin-Converting Enzyme Inhibitors
p75525
g66123
sVACE Inhibitors and Diuretics
p75526
g69032
sVCardiovascular Agents
p75527
g26516
sVProtease Inhibitors
p75528
g51085
sVAntihypertensive Agents
p75529
g20242
sVAgents causing hyperkalemia
p75530
g43563
sVHypotensive Agents
p75531
g34097
sVAgents causing angioedema
p75532
g63895
sVPotential QTc-Prolonging Agents
p75533
g70405
sVIsoquinolines
p75534
g44959
sVEnzyme Inhibitors
p75535
g72687
sVHeterocyclic Compounds, Fused-Ring
p75536
g56027
sVQTc Prolonging Agents
p75537
g57779
sVAgents Acting on the Renin-Angiotensin System
p75538
g25329
ssg10632
(dp75539
g5256
g50028
sg10728
(dp75540
sg10797
(dp75541
ssg10635
(dp75542
VOpiate Partial Agonists
p75543
g28784
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p75544
(dp75545
sVCentral Nervous System Depressants
p75546
(dp75547
sVNervous System
p75548
g70265
sVHeterocyclic Compounds, Fused-Ring
p75549
g56030
sVOpioids
p75550
g32236
sVAnalgesics
p75551
g26423
sVOpioid Antagonists
p75552
g65180
sVOpiate Alkaloids
p75553
g70921
sVAntitussive Agents
p75554
g67701
sVCentral Nervous System Agents
p75555
g58401
sVRespiratory System Agents
p75556
g71417
sg10068
g73459
sVPeripheral Nervous System Agents
p75557
g57573
sVAlkaloids
p75558
g19394
sVSensory System Agents
p75559
g71800
sVPhenanthrenes
p75560
g32831
sVMorphinans
p75561
g57229
sVNarcotics
p75562
g73496
sVMixed Agonist / Antagonist Opioids
p75563
g73615
sg2496
g32625
ssg10638
(dp75564
g10758
(dp75565
ssg10641
(dp75566
g3204
g37422
sg9879
g72515
sg6186
g55478
sg2358
g31453
sg19588
g32457
sg12421
g12420
sg828
g19836
sg465
g16441
sg4647
g46561
sg4173
g43400
sg9165
g69607
sg9918
g72752
sg10674
(dp75567
sg6303
g56188
sg6819
g58857
sg1668
g26260
sg3900
g41490
sg11016
(dp75568
sg8139
g65363
sg3048
g36499
sg4488
g45759
sg5499
g51401
sg6939
g59317
sg2427
g32033
sg1425
g24530
sg5133
g49266
sg9966
g73028
sg1704
g26703
sg10728
(dp75569
sg6966
g59389
sg7716
g63455
sg8487
g67017
sg5535
g51641
sg933
g20827
sg3570
g39454
sg1719
g26832
sg945
g20880
sg6684
g58149
sg9981
g73108
sg450
g16321
sg8514
g67115
sg9264
g70086
sg10005
g73236
sg11445
(dp75570
sg3975
g41925
sg10056
g73402
sg3978
g41988
sg6318
g56327
sg2265
g30991
sg9465
g71012
sg3240
g37718
sg183
g13768
sg4056
g42571
sg10815
(dp75571
sg7164
g60258
sg7029
g59625
sg5598
g52001
sg7041
g59677
sg10062
g73433
sg10737
(dp75572
sg11241
(dp75573
sg7056
g59840
sg8580
g67288
sg2013
g28929
sg1803
g27365
sg240
g14171
sg4035
g42409
sg10857
(dp75574
sg1044
g21530
sg8598
g67370
sg8601
g67412
sg255
g14390
sg2262
g30947
sg10662
(dp75575
sg10884
(dp75576
sg1626
g25935
sg10521
g75137
sg375
g15427
sg282
g14527
sg9099
g69327
sg11649
(dp75577
sg4623
g46368
sg9402
g70640
sg8655
g67574
sg11931
(dp75578
sg5691
g52476
sg5694
g52520
sg9417
g70767
sg8673
g67672
sg10497
g75010
sg3381
g38461
sg1401
g24318
sg1890
g27997
sg8463
g66889
sg345
g15207
sg7941
g64260
sg1134
g22310
sg1908
g28271
sg8703
g67752
sg7959
g64394
sg4959
g48535
sg14791
g71055
sg6507
g57302
sg7176
g60340
sg8724
g67890
sg387
g15651
sg6729
g58325
sg3444
g38857
sg5256
g50061
sg5769
g53030
sg2304
g31237
sg9492
g71129
sg7197
g60589
sg1194
g22803
sg414
g15933
sg9684
g71831
sg9828
g72346
sg780
g19336
sg10263
g74042
sg10266
g74089
sg11022
(dp75579
sg2430
g32084
sg8031
g64848
sg5829
g53364
sg6570
g57536
sg10308
g74289
sg6579
g57564
sg168
g13647
sg1248
g23036
sg5853
g53528
sg2658
g33343
sg7272
g60758
sg7275
g60785
sg495
g16702
sg8067
g64957
sg7284
g60823
sg8874
g68518
sg9564
g71380
sg10335
g74439
sg9579
g71436
sg2067
g29617
sg7329
g61142
sg7299
g60901
sg6468
g57096
sg7305
g60956
sg2910
g35511
sg8097
g65090
sg1707
g26750
sg3531
g39257
sg6639
g57958
sg5919
g53959
sg10959
(dp75580
sg9012
g68945
sg3036
g36446
sg696
g18691
sg2814
g34504
sg11154
(dp75581
sg11439
(dp75582
sg4155
g43190
sg7065
g59910
sg570
g17467
sg4344
g44633
sg6678
g58102
sg2733
g33907
sg582
g17607
sg6687
g58173
sg5169
g49529
sg11910
(dp75583
sg4419
g44879
sg11916
(dp75584
sg1188
g22758
sg3363
g38401
sg1260
g23133
sg5193
g49619
sg1635
g26021
sg612
g17846
sg1938
g28544
sg8187
g65526
sg6525
g57337
sg11097
(dp75585
sg11112
(dp75586
sg630
g18000
sg11955
(dp75587
sg2199
g30670
sg8205
g65611
sg516
g16849
sg7422
g61807
sg4437
g45293
sg6012
g54357
sg210
g14003
sg11979
(dp75588
sg10470
g74914
sg9711
g71972
sg5247
g49922
sg6759
g58542
sg11265
(dp75589
sg405
g15883
sg6051
g54771
sg3684
g40216
sg687
g18561
sg11277
(dp75590
sg12018
(dp75591
sg6069
g54827
sg8259
g65864
sg702
g18817
sg4263
g44144
sg6792
g58709
sg2841
g34824
sg4440
g45321
sg9759
g72096
sg11292
(dp75592
sg11721
(dp75593
sg6090
g54928
sg714
g18995
sg3018
g36122
sg3156
g37179
sg9987
g73158
sg633
g18083
sg8964
g68775
sg11319
(dp75594
sg486
g16630
sg6102
g55082
sg10533
g75163
sg2277
g31112
sg7533
g62486
sg10854
(dp75595
sg753
g19219
sg1092
g21959
sg2289
g31190
sg1548
g25381
sg8862
g68466
sg9819
g72274
sg11352
(dp75596
sg8334
g66204
sg9252
g70034
sg5067
g48935
sg10593
g75398
sg1464
g24866
sg9093
g69265
sg6381
g56760
sg6921
g59258
sg6156
g55209
sg7563
g62650
sg11790
(dp75597
sg9111
g69409
sg5580
g51866
ssg10644
(dp75598
g11955
(dp75599
sg11793
(dp75600
sg9879
g72523
sg6012
g54363
sg8394
g66379
sg11979
(dp75601
sg2013
g28931
sg10662
(dp75602
sg11265
(dp75603
sg1248
g23042
sg11721
(dp75604
sg7275
g60787
sg9579
g71439
sg4440
g45329
sg9759
g72099
sg11292
(dp75605
sg9966
g73031
sg3732
g40515
sg405
g15881
sg2841
g34828
sg2733
g33919
sg10533
g75167
sg945
g20882
sg9393
g70584
sg8463
g66891
sg3975
g41931
sg4344
g44637
sg7941
g64264
sg8139
g65367
sg9465
g71014
sg6729
g58330
sg1188
g22760
sg1464
g24870
sg10815
(dp75606
sg11241
(dp75607
sg7029
g59627
sg1092
g21961
sg9684
g71834
ssg10647
(dp75608
g7971
g64439
sg9300
g70228
ssg10650
(dp75609
g2844
g34889
sg3858
g41199
sg816
g19638
sg7821
g63794
sg5454
g51139
sg10797
(dp75610
sg11451
(dp75611
sg8433
g66675
sg11460
(dp75612
sg3144
g37099
sg9954
g72933
sg5514
g51506
sg7377
g61481
sg9231
g69957
sg10740
(dp75613
sg2391
g31705
sg5433
g51027
sg165
g13590
sg10794
(dp75614
sg7077
g60016
sg9081
g69154
sg7800
g63689
sg7353
g61325
sg8595
g67339
sg12274
g27508
sg4650
g46607
sg1062
g21796
sg2652
g33304
sg3132
g37027
sg4077
g42819
sg4680
g46865
sg4911
g48285
sg4920
g48325
sg9432
g70915
sg6435
g56999
sg9414
g70693
sg10179
g73714
sg9198
g69806
sg11733
(dp75615
sg2688
g33613
sg6537
g57387
sg2373
g31572
sg9918
g72744
sg444
g16236
sg8781
g68096
sg11052
(dp75616
sg11079
(dp75617
sg11940
(dp75618
sg2829
g34629
sg2109
g30104
sg3021
g36177
sg6504
g57246
sg3963
g41854
sg5127
g49217
sg573
g17587
sg11166
(dp75619
sg2142
g30335
sg7884
g64126
sg1371
g24076
sg4479
g45677
sg11601
(dp75620
sg9663
g71770
sg3627
g39917
sg438
g16183
sg2196
g30604
sg16906
g61896
sg2943
g35744
sg2946
g35802
sg5250
g49958
sg6033
g54500
sg4467
g45535
sg12126
(dp75621
sg690
g18600
sg1473
g24949
sg3861
g41270
sg2460
g32304
sg10512
g75074
sg3024
g36328
sg2832
g34684
sg2274
g31060
sg6000
g54298
sg4539
g46015
sg10557
g75305
sg11361
(dp75622
sg5289
g50318
sg2316
g31302
sg1185
g22710
sg819
g19783
ssg10653
(dp75623
VAgents Causing Muscle Toxicity
p75624
g55356
sVTumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors
p75625
g57510
sVSerum Globulins
p75626
g49672
sVBiologics for Rheumatoid Arthritis Treatment
p75627
g47864
sVTumor Necrosis Factor Receptor Blocking Activity
p75628
g18474
sVImmunoglobulins
p75629
g41543
sVTumor Necrosis Factor Blocker
p75630
g52438
sVAntibodies
p75631
g60996
sVGastrointestinal Agents
p75632
g70845
sVAgents reducing cytokine levels
p75633
(dp75634
sVProteins
p75635
g52747
sVDermatologicals
p75636
g17183
sVDisease-modifying Antirheumatic Agents
p75637
g57191
sVGlobulins
p75638
g19204
sVAmino Acids, Peptides, and Proteins
p75639
g47335
sVAntibodies, Monoclonal
p75640
g73306
sVImmunosuppressive Agents
p75641
g64551
sVBiological Products
p75642
g64638
sVAntineoplastic and Immunomodulating Agents
p75643
g39726
sVAntirheumatic Agents
p75644
g24211
sVBlood Proteins
p75645
g39880
sVComplex Mixtures
p75646
g65519
sVImmunoproteins
p75647
g57464
ssg10656
(dp75648
g48
g12624
ssg10659
(dp75649
g5835
g53457
sg7842
g63937
ssg10662
(dp75650
VCytochrome P-450 CYP2D6 Inhibitors
p75651
g62920
sVCytochrome P-450 CYP2D6 Substrates
p75652
g52137
sVSerotonin Agents
p75653
(dp75654
sVCytochrome P-450 CYP3A Substrates
p75655
g44986
sVNeurotransmitter Agents
p75656
g75575
sVSerotonin Receptor Antagonists
p75657
g35666
sVHistamine Agents
p75658
g75602
sVOphthalmics
p75659
(dp75660
sVPotential QTc-Prolonging Agents
p75661
g70406
sVCytochrome P-450 CYP2B6 Substrates
p75662
g33005
sVCytochrome P-450 Enzyme Inhibitors
p75663
g61958
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p75664
g18392
sVHistamine H2 Antagonists
p75665
g12714
sVAcid Reducers
p75666
g43815
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75667
g29227
sVAntihistamines for Systemic Use
p75668
g12960
sVQTc Prolonging Agents
p75669
g57783
sVSerotonin 5-HT2 Receptor Antagonists
p75670
g71715
sVCentral Nervous System Depressants
p75671
(dp75672
sVP-glycoprotein/ABCB1 Substrates
p75673
g34915
sVDecongestants and Antiallergics
p75674
(dp75675
sVSensory Organs
p75676
g40672
sVHistamine H1 Antagonists
p75677
g40768
sVCytochrome P-450 CYP3A4 Substrates
p75678
g65196
sVHeterocyclic Compounds, Fused-Ring
p75679
g56035
sVOphthalmologicals
p75680
g35171
sVAntidepressive Agents
p75681
g15523
sVDecreased Histamine Release
p75682
g66197
sVHistamine Antagonists
p75683
g43426
sVHistamine H1 Inhibitors
p75684
g43490
ssg10665
(dp75685
g6231
g55727
sg8922
g68675
sg1863
g27771
sg2808
g34472
sg9192
g69731
ssg10668
(dp75686
g4155
g43203
sg183
g13786
ssg10671
(dp75687
g10200
g73801
sg21710
g54026
sg5511
g51459
sg9660
g71737
ssg10674
(dp75688
VCytochrome P-450 CYP2D6 Substrates
p75689
g52141
sVCytochrome P-450 CYP3A Substrates
p75690
g45105
sVNeurotransmitter Agents
p75691
g75567
sVCentral Nervous System Agents
p75692
g58404
sVDopamine Agents
p75693
g14234
sVPsychotropic Drugs
p75694
g72587
sVPeripheral Nervous System Agents
p75695
g57577
sVAutonomic Agents
p75696
g66547
sVPhenothiazines With Piperazine Structure
p75697
g74959
sVAntipsychotic Agents
p75698
g69860
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75699
g29385
sVSulfur Compounds
p75700
(dp75701
sVDopamine Antagonists
p75702
g53741
sVQTc Prolonging Agents
p75703
g57784
sVCentral Nervous System Depressants
p75704
(dp75705
sVAntiemetics
p75706
(dp75707
sVGastrointestinal Agents
p75708
g70838
sVPsycholeptics
p75709
g33232
sVAntipsychotic Agents (First Generation [Typical])
p75710
g63589
sVCytochrome P-450 CYP3A4 Substrates
p75711
g65257
sVModerate Risk QTc-Prolonging Agents
p75712
g67164
sVDopamine D2 Receptor Antagonists
p75713
g49415
sVHeterocyclic Compounds, Fused-Ring
p75714
g56038
sVPhenothiazines
p75715
(dp75716
sg2166
g30484
sVNeurotoxic agents
p75717
g68579
sVNervous System
p75718
g70266
sVTranquilizing Agents
p75719
g55292
ssg10677
(dp75720
g534
g16983
sg4377
g44778
sg1791
g27252
sg1209
g22871
sg9618
g71627
sg3027
g36380
sg5334
g50511
sg11358
(dp75721
sg9471
g71039
sg3246
g37754
sg714
g19008
sg1581
g25694
sg7152
g60201
sg19588
g32469
sg1917
g28435
sg6807
g58812
sg1611
g25808
ssg10680
(dp75722
VAgents Causing Muscle Toxicity
p75723
g55373
sVAmino Acids, Peptides, and Proteins
p75724
g47318
sVAmino Acids
p75725
g43103
sg1878
g27920
sVMyelosuppressive Agents
p75726
g71324
sVProtective Agents
p75727
g66791
sVHeavy Metal Antagonists
p75728
g30316
sVMusculo-Skeletal System
p75729
g31538
sVChelating Agents
p75730
(dp75731
sVImmunosuppressive Agents
p75732
g64538
sVAntirheumatic Agents
p75733
g24236
sVAntiinflammatory and Antirheumatic Products
p75734
g56817
sVCompounds used in a research, industrial, or household setting
p75735
(dp75736
sg930
g20792
sVAmino Acids, Sulfur
p75737
g74852
sVOATP1B1/SLCO1B1 Substrates
p75738
(dp75739
sVAntidotes
p75740
g69093
sVSulfur Compounds
p75741
(dp75742
sVSequestering Agents
p75743
g57200
ssg10683
(dp75744
g1482
g25003
sg9627
g71663
sg8559
g67227
ssg10686
(dp75745
g9198
g69788
ssg10689
(dp75746
g3258
g37809
sg11313
(dp75747
ssg10692
(dp75748
VAnti-Infective Agents, Local
p75749
g63018
sVSulfanilamides
p75750
g45280
sVSulfadiazine
p75751
g47827
sVAmines
p75752
g42735
sVGenito Urinary System and Sex Hormones
p75753
g66195
sVGynecological Antiinfectives and Antiseptics
p75754
g69253
sVAniline Compounds
p75755
g23443
sVSulfonamide Antibacterial
p75756
g52722
sVDermatologicals
p75757
g17330
sVAmides
p75758
g44356
sVMiscellaneous Local Anti-infectives
p75759
g59170
sVAnti-Bacterial Agents
p75760
g38391
sVSulfones
p75761
g58750
sVAnti-Infective Agents
p75762
g54678
sVSulfonamides
p75763
g63365
sVSulfur Compounds
p75764
(dp75765
ssg10695
(dp75766
g3018
g36136
sg1704
g26711
sg633
g18079
sg828
g19858
sg5919
g53965
sg7056
g59847
sg933
g20819
sg8259
g65860
sg9252
g70042
sg4488
g45754
sg1635
g26042
sg9372
g70522
sg1668
g26249
sg168
g13635
sg2583
g33083
ssg10698
(dp75767
VDrugs that are Mainly Renally Excreted
p75768
g43855
sVGlycosides
p75769
g68369
sVCytochrome P-450 CYP1A2 Substrates
p75770
g45636
sVHeterocyclic Compounds, Fused-Ring
p75771
g56160
sVNucleosides
p75772
g49468
sVAntimetabolites
p75773
g59539
sVToxic Actions
p75774
g49403
sVSulfhydryl Compounds
p75775
g54326
sVNoxae
p75776
g65429
sVCarbohydrates
p75777
g61767
sVImmunosuppressive Agents
p75778
g64578
sVNucleic Acids, Nucleotides, and Nucleosides
p75779
g47127
sg960
g20955
sVPurine Antimetabolite
p75780
g57195
sVSulfur Compounds
p75781
(dp75782
sVAntineoplastic and Immunomodulating Agents
p75783
g39734
sVAntirheumatic Agents
p75784
g24244
sVNucleic Acid Synthesis Inhibitors
p75785
g48739
sVThiopurine Analogs
p75786
g40252
sVImmunologic Factors
p75787
g42387
sVPurines
p75788
g73798
ssg10701
(dp75789
VUGT1A1 Substrates
p75790
g12290
sVCarbohydrates
p75791
g61754
sVCytochrome P-450 CYP3A5 Inducers
p75792
g41744
sVEnzyme Inhibitors
p75793
g72693
sVCytochrome P-450 Enzyme Inhibitors
p75794
g62018
sVCytochrome P-450 CYP1A2 Substrates
p75795
g45573
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p75796
g23110
sVMyelosuppressive Agents
p75797
g71325
sVBenzyl Compounds
p75798
g30836
sVAntineoplastic Agents, Phytogenic
p75799
g55828
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75800
g29387
sVLignans
p75801
g23460
sVCytochrome P-450 CYP3A4 Inducers
p75802
g18886
sVCytochrome P-450 CYP3A Substrates
p75803
g45107
sVGlycosides
p75804
g68365
sg7911
g64173
sVBenzene Derivatives
p75805
g61399
sVPodophyllotoxin
p75806
g50134
sVCytochrome P-450 CYP2C8 Inhibitors
p75807
g55005
sVP-glycoprotein/ABCB1 Substrates
p75808
g34922
sg3756
g40636
sVCytochrome P-450 Enzyme Inducers
p75809
g28126
sVCytochrome P-450 CYP3A Inducers
p75810
g66264
sVCytochrome P-450 CYP3A4 Substrates
p75811
g65258
sVNaphthalenes
p75812
g66082
sVCardiotoxic antineoplastic agents
p75813
g72239
sVCytochrome P-450 CYP3A5 Substrates
p75814
g67796
sg4407
g44866
sVImmunosuppressive Agents
p75815
g64541
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p75816
g64606
sVBCRP/ABCG2 Substrates
p75817
g42072
sVAntineoplastic Agents
p75818
g71525
sVP-glycoprotein/ABCB1 Inhibitors
p75819
g74802
sVAntineoplastic and Immunomodulating Agents
p75820
g39735
sVTetrahydronaphthalenes
p75821
g42204
sg3828
g41039
sVTopoisomerase Inhibitors
p75822
g32855
ssg10704
(dp75823
g2388
g31666
sg9774
g72142
sg2373
g31588
sg7545
g62549
sg4113
g43038
sg3393
g38555
sg14872
g15721
sg9903
g72622
sg4875
g48033
sg4653
g46689
sg12132
(dp75824
sg14838
g39985
sg2226
g30800
sg5895
g53811
sg11997
(dp75825
sg12534
g52636
sg6585
g57677
sg6045
g54703
ssg10707
(dp75826
g5973
g54259
ssg10710
(dp75827
g11760
(dp75828
sg3777
g40833
ssg10713
(dp75829
VDrugs for Urinary Frequency and Incontinence
p75830
g28987
sVDrugs that are Mainly Renally Excreted
p75831
g43933
sVHeterocyclic Compounds, Fused-Ring
p75832
g56116
sVAnticholinergic Agents
p75833
g24483
sg3831
g41043
sVGenito Urinary System and Sex Hormones
p75834
g66155
sVPeripheral Nervous System Agents
p75835
g57580
sVUrological Agents
p75836
g38288
sVParasympatholytics
p75837
g35949
sVChromones
p75838
g40984
sg6711
g58248
sVPyrans
p75839
(dp75840
sVAgents producing tachycardia
p75841
g50750
sVBenzopyrans
p75842
g31330
sVUrologicals
p75843
g58914
sVMuscarinic Antagonists
p75844
g48867
sVAutonomic Agents
p75845
g66549
ssg10716
(dp75846
g1866
g27798
sg19588
g32480
ssg10719
(dp75847
g9612
g71611
sg4200
g43546
ssg10722
(dp75848
g3627
g39934
sg3018
g36140
sg444
g16253
sg7164
g60274
sg375
g15451
sg7626
g62978
sg5112
g49175
sg11460
(dp75849
sg9252
g70044
sg2316
g31312
sg7692
g63317
sg7848
g63975
ssg10725
(dp75850
VAntiinfectives for Systemic Use
p75851
g69677
sVDrugs that are Mainly Renally Excreted
p75852
g43934
sVGlycosides
p75853
g68355
sVAnti-Infective Agents
p75854
g54655
sVHeterocyclic Compounds, Fused-Ring
p75855
g56048
sVAmines
p75856
g42671
sVPurine Nucleosides
p75857
g38780
sg6519
g57328
sVCarbohydrates
p75858
g61756
sVRibonucleosides
p75859
g73667
sVNucleic Acids, Nucleotides, and Nucleosides
p75860
g47114
sVAntiviral Agents
p75861
g30428
sVAmides
p75862
g44297
sVAnilides
p75863
(dp75864
sVAniline Compounds
p75865
g23431
sg7488
g62277
sVAdjuvants, Immunologic
p75866
g39431
sVImmunologic Factors
p75867
g42370
sVPurines
p75868
g73796
sVNucleosides
p75869
g49456
ssg10728
(dp75870
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p75871
(dp75872
sVCytochrome P-450 CYP3A4 Inhibitors
p75873
g61636
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p75874
g47497
sVFatty Acids
p75875
g63145
sg10632
g75540
sVGABA Agents
p75876
g16218
sVAnti-epileptic Agent
p75877
g70345
sVCytochrome P-450 CYP3A Substrates
p75878
g45109
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p75879
g46415
sVCentral Nervous System Agents
p75880
g58413
sVOAT1/SLC22A6 inhibitors
p75881
(dp75882
sVEnzyme Inhibitors
p75883
g72696
sg3834
g41048
sVPsychotropic Drugs
p75884
g72591
sVCytochrome P-450 CYP2B6 Substrates
p75885
g33020
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p75886
g43779
sVCytochrome P-450 CYP2C9 Inhibitors
p75887
g18236
sVCytochrome P-450 Enzyme Inhibitors
p75888
g62019
sVMethemoglobinemia Associated Agents
p75889
g25572
sVAntimanic Agents
p75890
g65881
sVHighest Risk QTc-Prolonging Agents
p75891
g35868
sVMiscellaneous Anticonvulsants
p75892
g53476
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p75893
g23117
sVUGT1A3 substrates
p75894
g31811
sg12012
(dp75895
sVOAT3/SLC22A8 Inhibitors
p75896
g59012
sVNeurotransmitter Agents
p75897
g75569
sVUGT1A1 Substrates
p75898
g12305
sg9735
g72034
sg3744
g40561
sVCytochrome P-450 CYP2C9 Substrates
p75899
g29722
sVQTc Prolonging Agents
p75900
g57793
sg912
g20671
sVAntineoplastic Agents
p75901
g71527
sg3060
g36539
sVCentral Nervous System Depressants
p75902
(dp75903
sVFatty Acids, Volatile
p75904
g66975
sVUGT1A1 substrates with narrow therapeutic index
p75905
g41792
sVAnticonvulsants
p75906
g60150
sVCytochrome P-450 CYP1A2 Inhibitors
p75907
g15021
sVCytochrome P-450 CYP2C8 Inhibitors
p75908
g55038
sVOAT3/SLC22A8 Substrates
p75909
g13127
sg8283
g65955
sVUGT1A1 Inhibitors
p75910
g71656
sVCytochrome P-450 CYP2A6 Substrates
p75911
g35130
sVCytochrome P-450 Enzyme Inducers
p75912
g28131
sg8091
g65058
sVCytochrome P-450 CYP2C19 Inhibitors
p75913
g61257
sVCytochrome P-450 CYP2A6 Inducers
p75914
g39424
sVUGT1A6 substrate
p75915
g38509
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p75916
g49335
sVNarrow Therapeutic Index Drugs
p75917
g50565
sVUGT1A9 Substrates
p75918
g24011
sg12048
(dp75919
sVCytochrome P-450 CYP3A5 Substrates
p75920
g67799
sg5745
g52900
sVAcids, Acyclic
p75921
g25466
sVCytochrome P-450 CYP3A Inhibitors
p75922
g60391
sVUGT2B7 substrates
p75923
g28633
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p75924
(dp75925
sVDecreased Central Nervous System Disorganized Electrical Activity
p75926
g23464
sVNervous System
p75927
g70270
sVTranquilizing Agents
p75928
g55298
sVLipids
p75929
g14322
ssg10731
(dp75930
g23
g12225
sg11649
(dp75931
sg7320
g61084
sg4488
g45761
sg11667
(dp75932
sg2067
g29627
sg11439
(dp75933
sg612
g17857
sg11445
(dp75934
sg5598
g52029
sg11319
(dp75935
ssg10734
(dp75936
g11097
(dp75937
sg8334
g66205
sg11931
(dp75938
ssg10737
(dp75939
VDrugs that are Mainly Renally Excreted
p75940
g43941
sVCentral Nervous System Depressants
p75941
(dp75942
sVBenzazepines
p75943
g60332
sVGABA Agents
p75944
g16201
sVAnticonvulsants
p75945
g60154
sVCytochrome P-450 CYP3A Substrates
p75946
g45118
sVNeurotransmitter Agents
p75947
g75572
sVAnti-Anxiety Agents
p75948
g35641
sVPsychotropic Drugs
p75949
g72585
sVCentral Nervous System Agents
p75950
g58420
sVGABA Modulators
p75951
g39047
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75952
g29399
sVBenzodiazepines and benzodiazepine derivatives
p75953
g71797
sVHeterocyclic Compounds, Fused-Ring
p75954
g56059
sVCytochrome P-450 CYP3A4 Substrates
p75955
g65264
sVTranquilizing Agents
p75956
g55289
ssg10740
(dp75957
VBSEP/ABCB11 Substrates
p75958
g74867
sVAcetic Acid Derivatives and Related Substances
p75959
g28816
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p75960
g50957
sVUGT1A1 Substrates
p75961
g12295
sVOAT1/SLC22A6 inhibitors
p75962
(dp75963
sVAnalgesics
p75964
g26436
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p75965
g58392
sVAgents causing angioedema
p75966
g63907
sVNon COX-2 selective NSAIDS
p75967
g67324
sVCentral Nervous System Agents
p75968
g58510
sVUGT1A9 Substrates
p75969
g24012
sVAntiinflammatory and Antirheumatic Products
p75970
g56814
sVOATP1B1/SLCO1B1 Inhibitors
p75971
g75613
sVCytochrome P-450 CYP2B6 Substrates
p75972
g33023
sVEnzyme Inhibitors
p75973
g72730
sVCytochrome P-450 Enzyme Inhibitors
p75974
g61973
sVPeripheral Nervous System Agents
p75975
g57646
sVCytochrome P-450 CYP2C8 Substrates
p75976
(dp75977
sVCytochrome P-450 CYP1A2 Substrates
p75978
g45576
sVAnalgesics, Non-Narcotic
p75979
g56901
sVUGT1A3 substrates
p75980
g31813
sVNephrotoxic agents
p75981
g57739
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p75982
g72870
sVAcids, Carbocyclic
p75983
g41559
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p75984
g29392
sVEthylamines
p75985
g20596
sVCytochrome P-450 CYP2C9 Substrates
p75986
g29810
sVCytochrome P-450 CYP3A Substrates
p75987
g45111
sVTopical Products for Joint and Muscular Pain
p75988
g13931
sVAgents causing hyperkalemia
p75989
g43581
sVDecreased Prostaglandin Production
p75990
(dp75991
sVCytochrome P-450 CYP2E1 Inhibitors
p75992
g46838
sVDermatologicals
p75993
g17208
sVOther Nonsteroidal Antiimflammatory Agents
p75994
(dp75995
sVSensory Organs
p75996
g40681
sVCytochrome P-450 CYP2C18 Substrates
p75997
g20941
sVAgents that produce hypertension
p75998
g69084
sVCyclooxygenase-2 (COX-2) Inhibitors
p75999
g55699
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p76000
g26878
sVPhenylacetates
p76001
g34421
sVAmines
p76002
g42673
sVCytochrome P-450 CYP3A4 Substrates
p76003
g65259
sVMusculo-Skeletal System
p76004
g31528
sVOphthalmologicals
p76005
g35183
sVUGT2B7 substrates
p76006
g28635
sVOAT3/SLC22A8 Inhibitors
p76007
g59008
sVAnti-Inflammatory Agents
p76008
g73957
sVCyclooxygenase Inhibitors
p76009
g32788
sVP-glycoprotein/ABCB1 Inhibitors
p76010
g74825
sVAntirheumatic Agents
p76011
g24227
sVSensory System Agents
p76012
g71804
sVAnti-Inflammatory Agents, Non-Steroidal
p76013
g64656
ssg10743
(dp76014
g1041
g21512
sg9828
g72360
ssg10746
(dp76015
g4806
g47675
sg6906
g59219
sg3318
g38193
sg10587
g75379
ssg10749
(dp76016
g11316
(dp76017
sg543
g17099
ssg10752
(dp76018
VCytochrome P-450 CYP2C8 Substrates
p76019
(dp76020
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p76021
g23120
sVMyelosuppressive Agents
p76022
g71326
sVCytochrome P-450 CYP2D6 Substrates
p76023
g52121
sVCytochrome P-450 CYP3A Substrates
p76024
g45112
sVCytochrome P-450 CYP2C8 Inhibitors
p76025
g55009
sVImmunosuppressive Agents
p76026
g64544
sVP-glycoprotein/ABCB1 Substrates
p76027
g34930
sVBCRP/ABCG2 Substrates
p76028
g42081
sVBCRP/ABCG2 Inhibitors
p76029
g12540
sVKinase Inhibitor
p76030
g24594
sVP-glycoprotein/ABCB1 Inhibitors
p76031
g74804
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76032
g29393
sVProtein Kinase Inhibitors
p76033
(dp76034
sVAntineoplastic and Immunomodulating Agents
p76035
g39740
sVTyrosine Kinase Inhibitors
p76036
g30828
sVEnzyme Inhibitors
p76037
g72697
sVCytochrome P-450 CYP3A5 Substrates
p76038
g67801
sVCytochrome P-450 Enzyme Inhibitors
p76039
g62020
sVCytochrome P-450 CYP3A4 Substrates
p76040
g65260
sVAntineoplastic Agents
p76041
g71528
ssg10755
(dp76042
g8760
g68007
sg6843
g58974
sg2736
g33959
sg6246
g55803
sg10587
g75386
sg14338
g13532
sg10290
g74202
sg4491
g45804
sg2466
g32346
sg9909
g72678
sg4002
g42134
sg11781
(dp76043
sg5511
g51483
ssg10758
(dp76044
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p76045
g52090
sVCytochrome P-450 CYP3A4 Inhibitors
p76046
g61640
sVQuinolines
p76047
g74115
sg10638
g75565
sVCytochrome P-450 CYP3A Substrates
p76048
g45024
sVCytochrome P-450 Enzyme Inhibitors
p76049
g62022
sVAmines
p76050
g42744
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76051
g29283
sVAniline Compounds
p76052
g23434
sVCytochrome P450 3A Inhibitors
p76053
g54270
sVCytochrome P450 3A4 Inhibitors
p76054
g13046
sVPhenols
p76055
g65126
sVBenzene Derivatives
p76056
g61405
sVMembrane Transport Modulators
p76057
g54129
sVHeterocyclic Compounds, Fused-Ring
p76058
g56165
sVChloride Channel Agonists
p76059
g66073
sVCytochrome P-450 CYP3A4 Substrates
p76060
g65222
sVCystic Fibrosis Transmembrane Conductance Regulator
p76061
g75233
sg7797
g63670
sVCytochrome P-450 CYP3A5 Substrates
p76062
g67802
sVCytochrome P-450 CYP3A Inhibitors
p76063
g60396
sVP-glycoprotein/ABCB1 Inhibitors
p76064
g74829
ssg10761
(dp76065
VCytochrome P-450 CYP2D6 Inhibitors
p76066
g62911
sVCytochrome P-450 CYP2D6 Substrates
p76067
g52122
sVAntiarrhythmic agents
p76068
g71181
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p76069
g41079
sVCytochrome P-450 CYP3A Substrates
p76070
g45114
sVAgents causing hyperkalemia
p76071
g43582
sVHypotensive Agents
p76072
g34121
sVBeta blocking agents and calcium channel blockers
p76073
g58531
sVOCT2 Inhibitors
p76074
g42482
sVAdrenergic Antagonists
p76075
g52292
sVCytochrome P-450 Enzyme Inhibitors
p76076
g62023
sVDrugs that are Mainly Renally Excreted
p76077
g43938
sVAmines
p76078
g42677
sVAdrenergic beta-1 Receptor Antagonists
p76079
g46818
sVAntihypertensive Agents
p76080
g20259
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76081
g29395
sVBeta Blocking Agents, Selective
p76082
g51452
sVAdrenergic Agents
p76083
g41716
sVCardiovascular Agents
p76084
g26546
sVP-glycoprotein/ABCB1 Substrates
p76085
g34933
sVAdrenergic beta-Antagonists
p76086
g15360
sVCytochrome P-450 CYP3A4 Substrates
p76087
g65262
sVPropanolamines
p76088
g37507
sVBeta Blocking Agents and Thiazides
p76089
g47428
sVAmino Alcohols
p76090
g32684
sVBradycardia-Causing Agents
p76091
g61455
sVBeta-Blockers (Beta1 Selective)
p76092
g57432
sVAlcohols
p76093
(dp76094
sVBeta Blocking Agents, Selective, and Thiazides
p76095
g52070
ssg10764
(dp76096
VDrugs that are Mainly Renally Excreted
p76097
g43863
sg8136
g65359
sVGastric Acid Lowering Agents
p76098
g67253
sVIons
p76099
g49125
sVPharmaceutic Aids
p76100
g65167
sVMinerals
p76101
g52588
sVAcids
p76102
g40585
sVAluminum and magnesium containing antacids
p76103
g26965
sVAcids, Noncarboxylic
p76104
g54209
sVAntacids
p76105
g42404
sVOxides
p76106
g27679
sVDrugs for Acid Related Disorders
p76107
g55172
sVAnions
p76108
g71790
sg7203
g60640
sVElectrolytes
p76109
g52426
sVAlimentary Tract and Metabolism
p76110
g23791
sVOxygen Compounds
p76111
g46963
sg9930
g72872
ssg10767
(dp76112
VAgents that produce neuromuscular block (indirect)
p76113
g37978
sVGastric Acid Lowering Agents
p76114
g67248
sVOsmotic Laxatives
p76115
g57504
sVAntacids
p76116
g42397
sVMagnesium Compounds
p76117
g33045
sVCalculi Dissolution Agent
p76118
g12685
sVMetal divalent cations
p76119
g65842
sVElectrolytes
p76120
g52427
sVOxides
p76121
g27675
sVMineral Supplements
p76122
g38297
sVMagnesium Salts
p76123
g63579
sVMinerals
p76124
g52583
sVOxygen Compounds
p76125
g46959
sVGastrointestinal Agents
p76126
g70842
sVLaxatives
p76127
g17355
sVDrugs for Constipation
p76128
g53332
sVAlimentary Tract and Metabolism
p76129
g23895
sVIons
p76130
g49126
sVAluminum and magnesium containing antacids
p76131
g26961
sVDrugs for Acid Related Disorders
p76132
g55173
sVAnions
p76133
g71791
sVMetal cations
p76134
g40800
sVLaxatives, magnesium containing
p76135
g61596
ssg10770
(dp76136
g8097
g65074
sg282
g14576
sg11910
(dp76137
sg3027
g36373
sg387
g15623
sg11595
(dp76138
sg11079
(dp76139
sg888
g20415
sg16906
g61921
sg3963
g41887
sg915
g20722
sg9273
g70178
ssg10773
(dp76140
g6726
g58290
sg11196
(dp76141
ssg10776
(dp76142
g4143
g43160
sg10002
g73215
ssg10779
(dp76143
VAntiplatelet agents
p76144
g46309
sVDrugs that are Mainly Renally Excreted
p76145
g43939
sVHematologic Agents
p76146
g73837
sVBlood and Blood Forming Organs
p76147
g53909
sVPlatelet Aggregation Inhibitors Excl. Heparin
p76148
g62768
sVAnticoagulants
p76149
g58373
sVCytochrome P-450 CYP3A Substrates
p76150
g45116
sVDecreased Platelet Aggregation
p76151
(dp76152
sVThiophenes
p76153
g59032
sVP2Y12 Platelet Inhibitor
p76154
g58246
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76155
g29397
sVCytochrome P-450 CYP2B6 Substrates
p76156
g33032
sVPurinergic P2Y Receptor Antagonists
p76157
(dp76158
sVCytochrome P-450 CYP2C9 Substrates
p76159
g29726
sVCytochrome P-450 CYP3A4 Substrates
p76160
g65263
sVPiperazines
p76161
(dp76162
sVSulfur Compounds
p76163
(dp76164
ssg10782
(dp76165
g9810
g72231
sg7530
g62471
sg7920
g64204
sg129
g13192
sg9660
g71736
sg4557
g46166
sg8649
g67556
sg5025
g48778
sg5400
g50862
ssg10785
(dp76166
g10548
g75221
sg6843
g58980
sg6246
g55809
sg10314
g74332
sg4491
g45810
sg2901
g35473
ssg10788
(dp76167
g9897
g72574
sg11349
(dp76168
sg4713
g47030
sg8076
g64995
sg2754
g34084
sg447
g16282
sg1737
g26909
sg3147
g37141
sg3801
g40959
sg9627
g71667
sg8910
g68610
sg6213
g55607
sg4185
g43468
sg7059
g59884
sg9348
g70397
sg9705
g71951
sg11646
(dp76169
sg7980
g64504
ssg10791
(dp76170
g8460
g66881
ssg10794
(dp76171
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p76172
(dp76173
sVFatty Acids
p76174
g63154
sVAnalgesics
p76175
g26441
sVHydroxy Acids
p76176
g18166
sVBCRP/ABCG2 Inhibitors
p76177
g12553
sVButyrates
p76178
g59984
sVOATP1B1/SLCO1B1 Inhibitors
p76179
g75614
sVLipids
p76180
g14345
sVCytochrome P-450 Enzyme Inhibitors
p76181
g62025
sVPeripheral Nervous System Agents
p76182
g57589
sVAmines
p76183
g42682
sVAniline Compounds
p76184
g23441
sVImmunologic Factors
p76185
g42385
sVToluene
p76186
g71559
sVFatty Acids, Volatile
p76187
g66980
sVCytochrome P-450 CYP1A2 Inducers
p76188
g68385
sVImmunomodulatory Agents
p76189
g22795
sVBenzene Derivatives
p76190
g61408
sg8682
g67699
sVCytochrome P-450 CYP2C8 Inhibitors
p76191
g55010
sVSelective Immunosuppressants
p76192
g23575
sg11709
(dp76193
sg6651
g58026
sVCytochrome P-450 Enzyme Inducers
p76194
g28140
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p76195
g17454
sVCentral Nervous System Agents
p76196
g58427
sVAnalgesics, Non-Narcotic
p76197
g56908
sVAcids, Acyclic
p76198
g25486
sVImmunosuppressive Agents
p76199
g64548
sVOAT3/SLC22A8 Inhibitors
p76200
g59018
sVBCRP/ABCG2 Substrates
p76201
g42098
sVAnti-Inflammatory Agents
p76202
g73958
sVAntineoplastic and Immunomodulating Agents
p76203
g39745
sVAntirheumatic Agents
p76204
g24247
sVSensory System Agents
p76205
g71806
ssg10797
(dp76206
VAgents Causing Muscle Toxicity
p76207
g55358
sVFatty Acids
p76208
g63140
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p76209
g46318
sVUGT1A1 Substrates
p76210
g12279
sVCytochrome P-450 CYP3A Substrates
p76211
g44964
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p76212
g28841
sVHypolipidemic Agents
p76213
g69889
sVFribic Acid Derivatives
p76214
g56920
sVCytochrome P-450 CYP2C9 Inhibitors
p76215
g18180
sVButyrates
p76216
g59986
sVOATP1B1/SLCO1B1 Inhibitors
p76217
g75610
sVLipids
p76218
g14301
sVEnzyme Inhibitors
p76219
g72691
sVCytochrome P-450 Enzyme Inhibitors
p76220
g61948
sVEthers
p76221
g27602
sVDrugs that are Mainly Renally Excreted
p76222
g43821
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p76223
g49326
sVLipid Modifying Agents
p76224
g40536
sVPentanoic Acids
p76225
g72035
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76226
g29194
sVLipid Modifying Agents, Plain
p76227
g63427
sVIsobutyrates
p76228
g25238
sVCytochrome P-450 CYP2C8 Inducers (strength unknown)
p76229
g44469
sVFatty Acids, Volatile
p76230
g66972
sVPhenols
p76231
g65119
sVBenzene Derivatives
p76232
g61397
sVCytochrome P-450 CYP1A2 Inhibitors
p76233
g15001
sVCytochrome P-450 CYP2C8 Inhibitors
p76234
g55001
sVPhenyl Ethers
p76235
g40601
sVUGT1A1 Inhibitors
p76236
g71651
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p76237
g44526
sVCytochrome P-450 Enzyme Inducers
p76238
g28118
sVCytochrome P-450 CYP2C19 Inhibitors
p76239
g61252
sVCytochrome P-450 CYP3A4 Substrates
p76240
g65187
sg756
g19235
sVToxic Actions
p76241
g49385
sg6138
g55155
sVAcids, Acyclic
p76242
g25454
sVCytochrome P-450 CYP2C8 Inducers
p76243
g60371
sVNoxae
p76244
g65419
sVFibric Acids
p76245
g69458
sVValerates
p76246
g75541
sg10926
(dp76247
sVChemically-Induced Disorders
p76248
g21225
sVLipid Regulating Agents
p76249
g72476
ssg10800
(dp76250
g6213
g55614
ssg10803
(dp76251
g11832
(dp76252
sg6765
g58589
sg10839
(dp76253
sg13091
g21367
sg3312
g38155
sg8826
g68327
ssg10806
(dp76254
g354
g15281
sg3141
g37088
sg2046
g29144
sg5082
g49023
sg7878
g64042
sg4782
g47514
sg5208
g49723
ssg10809
(dp76255
g3708
g40398
sg11790
(dp76256
ssg10812
(dp76257
g6903
g59183
ssg10815
(dp76258
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p76259
(dp76260
sVAntihistamines for Topical Use
p76261
g39014
sVAnticholinergic Agents
p76262
g24511
sVCytochrome P-450 CYP2D6 Inhibitors
p76263
g62913
sVCytochrome P-450 CYP2D6 Substrates
p76264
g52128
sVSerotonin Agents
p76265
(dp76266
sVNeurotransmitter Agents
p76267
g75571
sVHistamine Agents
p76268
g75606
sVPotential QTc-Prolonging Agents
p76269
g70413
sVCytochrome P-450 CYP2B6 Substrates
p76270
g33040
sVCytochrome P-450 CYP2C9 Inhibitors
p76271
g18193
sVCytochrome P-450 Enzyme Inhibitors
p76272
g62026
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p76273
(dp76274
sVAcid Reducers
p76275
g43810
sVDrugs that are Mainly Renally Excreted
p76276
g43943
sg11628
(dp76277
sVAmines
p76278
g42684
sVAntipsychotic Agents
p76279
g69865
sVHistamine H2 Antagonists
p76280
g12711
sg8814
g68224
sVDopamine Antagonists
p76281
g53750
sVSulfur Compounds
p76282
(dp76283
sVAntihistamines for Systemic Use
p76284
g12979
sVQTc Prolonging Agents
p76285
g57806
sVNeurotoxic agents
p76286
g68589
sVCentral Nervous System Depressants
p76287
(dp76288
sVHistamine Antagonists
p76289
g43454
sVAgents that reduce seizure threshold
p76290
g45873
sVDermatologicals
p76291
g17218
sVMuscarinic Antagonists
p76292
g48886
sVHistamine H1 Antagonists
p76293
g40794
sg3774
g40814
sg9057
g69094
sg11343
(dp76294
sVDopamine D2 Receptor Antagonists
p76295
g49425
sVHeterocyclic Compounds, Fused-Ring
p76296
g56063
sVSerotonin Modulators
p76297
g69139
sVAntidepressive Agents
p76298
g15514
sVAnti-Allergic Agents
p76299
g50652
sg11757
(dp76300
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p76301
g53085
sVP-glycoprotein/ABCB1 Inhibitors
p76302
g74806
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p76303
(dp76304
sVAgents producing tachycardia
p76305
g50754
ssg10818
(dp76306
VAnalgesics and Anesthetics
p76307
g49751
sVCytochrome P-450 CYP2D6 Inhibitors
p76308
g62899
sVCytochrome P-450 CYP2D6 Substrates
p76309
g52109
sVAntiarrhythmic agents
p76310
g71177
sVCytochrome P-450 CYP3A Substrates
p76311
g44966
sVCentral Nervous System Agents
p76312
g58409
sVAnesthetics, Local
p76313
g53471
sVAnilides
p76314
(dp76315
sVOtologicals
p76316
g69475
sVLocal Anesthesia
p76317
g14961
sVCytochrome P-450 Enzyme Inhibitors
p76318
g61949
sVThroat Preparations
p76319
(dp76320
sVPeripheral Nervous System Agents
p76321
g57574
sVCytochrome P-450 CYP2C8 Substrates
p76322
(dp76323
sVCytochrome P-450 CYP1A2 Substrates
p76324
g45564
sVAmines
p76325
g42663
sVAntipruritics and Local Anesthetics
p76326
g31866
sVCardiac Therapy
p76327
g69633
sVAmides
p76328
g44285
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p76329
g16814
sVAniline Compounds
p76330
g23416
sVVasoprotectives
p76331
g41377
sVCytochrome P-450 CYP2C9 Substrates
p76332
g29705
sVCardiovascular Agents
p76333
g26662
sVAnesthetics
p76334
g51606
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76335
g29198
sVAgents that reduce seizure threshold
p76336
g45835
sVCytochrome P-450 CYP1A2 Inhibitors
p76337
g14990
sVDermatologicals
p76338
g17198
sVAnesthetics for Topical Use
p76339
g43180
sVCytochrome P-450 CYP2A6 Substrates
p76340
g35128
sVCytochrome P-450 CYP2C18 Substrates
p76341
g20936
sVMembrane Transport Modulators
p76342
g54118
sVNeuraxial Anesthetics
p76343
g32591
sVCytochrome P-450 CYP3A4 Substrates
p76344
g65189
sVSodium Channel Blockers
p76345
g73793
sVOphthalmologicals
p76346
g35167
sVAntiarrhythmics, Class I
p76347
g73501
sVVoltage-Gated Sodium Channel Blockers
p76348
g40904
sVCytochrome P-450 CYP3A5 Substrates
p76349
g67797
sVAmide Local Anesthetic
p76350
(dp76351
sVMethemoglobinemia Associated Agents
p76352
g25556
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p76353
g53060
sVP-glycoprotein/ABCB1 Inhibitors
p76354
g74798
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p76355
(dp76356
sVAntiarrhythmics, Class Ib
p76357
g50589
sVSensory System Agents
p76358
g71801
sVNervous System
p76359
g70268
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p76360
g27742
sVCytochrome P-450 CYP3A7 Substrates
p76361
g60645
sVCytochrome P-450 CYP2B6 Substrates
p76362
g33001
ssg10821
(dp76363
g3024
g36333
sg6186
g55528
sg8856
g68446
sg6525
g57361
sg9663
g71782
sg9366
g70506
sg1047
g21639
sg7563
g62681
sg7041
g59722
ssg10824
(dp76364
g5169
g49502
sg1194
g22811
ssg10827
(dp76365
g2343
g31345
sg3891
g41476
sg10569
g75340
sg11175
(dp76366
sg5622
g52249
sg6990
g59481
sg11760
(dp76367
sg9741
g72054
sg8598
g67404
sg8601
g67434
sg3126
g36965
sg11379
(dp76368
sg3777
g40840
sg7854
g64013
sg2118
g30224
sg9108
g69402
sg1149
g22517
sg6903
g59203
ssg10830
(dp76369
g3264
g37881
ssg10833
(dp76370
VDideoxynucleosides
p76371
g48716
sVAntivirals for Systemic Use
p76372
g59747
sVNucleic Acid Synthesis Inhibitors
p76373
g48724
sVCarbohydrates
p76374
g61759
sVPyrimidines
p76375
g47689
sVDirect Acting Antivirals
p76376
g38039
sVAnti-HIV Agents
p76377
g66390
sVEnzyme Inhibitors
p76378
g72701
sVReverse Transcriptase Inhibitors
p76379
g28952
sVDeoxyribonucleosides
p76380
g33052
sVAntiinfectives for Systemic Use
p76381
g69648
sVDrugs that are Mainly Renally Excreted
p76382
g43946
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p76383
g14461
sVAnti-Infective Agents
p76384
g54587
sVCytidine
p76385
g67525
sVDeoxycytidine
p76386
g12697
sVGlycosides
p76387
g68352
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p76388
g38157
sVRibonucleosides
p76389
g73663
sVNucleic Acids, Nucleotides, and Nucleosides
p76390
g47111
sVPyrimidine Nucleosides
p76391
(dp76392
sVAnti-Retroviral Agents
p76393
g67141
sVNucleosides
p76394
g49453
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p76395
g61372
sVNucleoside Reverse Transcriptase Inhibitors
p76396
g38834
sVAntiviral Agents
p76397
g30421
ssg10836
(dp76398
g2763
g34222
sg3783
g40860
sg1650
g26091
sg8472
g66936
sg6333
g56459
ssg10839
(dp76399
VPhosphorus Acids
p76400
g65600
sVNoxae
p76401
g65414
sVImmunologic Factors
p76402
g42369
sg4044
g42498
sVCytochrome P-450 Enzyme Inhibitors
p76403
g62027
sVPhosphoric Acids
p76404
g76253
sVAntineoplastic Agents, Alkylating
p76405
g60744
sVMyelosuppressive Agents
p76406
g71328
sVElectrolytes
p76407
g52409
sg6930
g59289
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76408
g29404
sg7899
g64151
sg8829
g68332
sVCytochrome P-450 CYP3A Substrates
p76409
g45123
sVAnions
p76410
g71786
sVToxic Actions
p76411
g49376
sVCytochrome P-450 CYP2B6 Inhibitors
p76412
g45920
sVAcids
p76413
g40567
sg3552
g39416
sVAlkylating Drugs
p76414
g70061
sVCytochrome P-450 CYP3A4 Substrates
p76415
g65267
sVCytochrome P-450 CYP2B6 Inhibitors (moderate)
p76416
g58924
sVIons
p76417
g49110
sVImmunosuppressive Agents
p76418
g64552
sVAcids, Noncarboxylic
p76419
g54192
sVAlkylating Activity
p76420
g46193
sVAntineoplastic Agents
p76421
g71532
sVCholinesterase Inhibitors
p76422
g72392
sVPhosphorus Compounds
p76423
g36722
sVAntineoplastic and Immunomodulating Agents
p76424
g39752
sg1125
g22263
sVOrganophosphorus Compounds
p76425
g74858
ssg10842
(dp76426
g7497
g62297
sg11112
(dp76427
sg630
g17998
sg10266
g74107
sg2559
g32921
sg633
g18065
sg2199
g30666
sg7056
g59837
sg7422
g61804
sg8031
g64855
sg240
g14167
sg6318
g56360
sg8163
g65444
sg1044
g21528
sg11979
(dp76428
sg1434
g24621
sg10470
g74890
sg9711
g71969
sg9165
g69604
sg10308
g74263
sg4266
g44213
sg1704
g26700
sg6921
g59256
sg1263
g23199
sg6156
g55206
sg11016
(dp76429
sg12066
(dp76430
sg8028
g64807
sg11655
(dp76431
sg11283
(dp76432
sg8259
g65852
sg450
g16317
sg6468
g57073
sg3156
g37197
sg2427
g32020
sg8487
g67028
sg8655
g67609
sg11931
(dp76433
sg915
g20679
sg3930
g41660
sg2910
g35507
sg8097
g65067
sg9417
g70757
sg11595
(dp76434
sg6966
g59386
sg6639
g57956
sg3381
g38459
sg5919
g53956
sg10959
(dp76435
sg933
g20803
sg345
g15203
sg2841
g34822
sg7941
g64257
sg11097
(dp76436
sg1134
g22328
sg9981
g73086
sg7152
g60211
sg8514
g67094
sg564
g17389
sg6303
g56186
sg1668
g26235
sg2418
g31896
sg4344
g44629
sg696
g18733
sg8874
g68515
sg3978
g41960
sg8721
g67843
sg5169
g49488
sg10056
g73379
sg387
g15594
sg10497
g75008
sg10596
g75429
sg10662
g75654
sg2664
g33410
sg10815
g76266
sg10356
g74585
sg7299
g60898
sg1194
g22801
sg7029
g59622
sg414
g15931
sg11790
(dp76437
sg780
g19332
sg1908
g28267
ssg10845
(dp76438
g11592
(dp76439
sg11967
(dp76440
sg16906
g61888
sg7821
g63788
sg1047
g21582
sg8781
g68094
sg1050
g21649
sg2787
g34405
sg5973
g54251
sg5526
g51566
sg3711
g40415
sg6798
g58755
sg10347
g74494
sg6279
g55926
sg3657
g40159
sg3024
g36254
sg1503
g25162
sg1899
g28036
sg1578
g25614
sg12045
(dp76441
sg7353
g61322
sg11745
(dp76442
sg1173
g22639
sg10878
(dp76443
sg3246
g37758
sg7905
g64165
sg8742
g67939
sg2913
g35581
ssg10848
(dp76444
g6312
g56265
sg8265
g65894
sg10587
g75369
sg6885
g59149
ssg10851
(dp76445
g7947
g64358
ssg10854
(dp76446
VNMDA Receptor Antagonists
p76447
g43496
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p76448
(dp76449
sVAnticholinergic Agents
p76450
g24498
sVAnalgesics
p76451
g26495
sVNeurotransmitter Agents
p76452
g75595
sVCentral Nervous System Agents
p76453
g58517
sVDopamine Agents
p76454
g14224
sVPotential QTc-Prolonging Agents
p76455
g70441
sVOCT2 Inhibitors
p76456
g42461
sVOCT2 Substrates
p76457
g14950
sVAnti-Infective Agents
p76458
g54624
sVPeripheral Nervous System Agents
p76459
g57650
sVAnti-Parkinson Drugs
p76460
g16157
sVDrugs that are Mainly Renally Excreted
p76461
g43917
sVAnalgesics, Non-Narcotic
p76462
g56889
sVOCT2 substrates with narrow therapeutic index
p76463
g29693
sVQTc Prolonging Agents
p76464
g57879
sg8667
g67642
sVOCT1 inhibitors
p76465
g66925
sg3180
g37320
sVOCT1 substrates
p76466
g13079
sVAnti-Dyskinesia Agents
p76467
g50488
sg4224
g43679
sVAdamantane
p76468
g64433
sVNicotinic Antagonists
p76469
g58931
sVCycloparaffins
p76470
g43671
sVAntiviral Agents
p76471
g30464
sVSensory System Agents
p76472
g71818
sg207
g13986
sVNervous System
p76473
g70311
ssg10857
(dp76474
VAdrenergic beta-Agonists
p76475
g43002
sVNeurotransmitter Agents
p76476
g75574
sVPotential QTc-Prolonging Agents
p76477
g70414
sVDrugs for Obstructive Airway Diseases
p76478
g42505
sVAmines
p76479
g42691
sVCytochrome P-450 CYP2D6 Substrates
p76480
g52136
sVPeripheral Nervous System Agents
p76481
g57596
sVRespiratory System Agents
p76482
g71418
sVCytochrome P-450 CYP2C9 Substrates
p76483
g29739
sVQTc Prolonging Agents
p76484
g57815
sVEthanolamines
p76485
g74743
sVAdrenergic Agents
p76486
g41690
sVBronchodilator Agents
p76487
g73492
sVAgents to Treat Airway Disease
p76488
g32635
sVCytochrome P-450 CYP2A6 Substrates
p76489
g35122
sVAdrenergic Agonists
p76490
(dp76491
sVAgents that produce hypertension
p76492
g69061
sVAnti-Asthmatic Agents
p76493
g36514
sVAutonomic Agents
p76494
g66555
sVAdrenergic beta-2 Receptor Agonists
p76495
g58943
sVAmino Alcohols
p76496
g32667
sVSelective Beta 2-adrenergic Agonists
p76497
(dp76498
sVAgents producing tachycardia
p76499
g50757
sVAlcohols
p76500
(dp76501
sVAdrenergics, Inhalants
p76502
g43171
ssg10860
(dp76503
g10218
g73889
ssg10863
(dp76504
g6150
g55180
ssg10866
(dp76505
g2886
g35294
sg11046
(dp76506
ssg10869
(dp76507
g1629
g25977
sg1326
g23586
sg4629
g46437
sg7629
g62996
sg5448
g51116
sg10680
g75736
sg9507
g71146
sg6246
g55787
sg8439
g66718
sg3144
g37101
sg9948
g72891
sg5511
g51466
sg8217
g65710
sg5286
g50199
sg5532
g51636
sg9987
g73141
sg4725
g47151
sg2466
g32326
sg4737
g47220
sg14338
g13539
sg11535
(dp76508
sg8484
g67010
sg10119
g73594
sg10296
g74216
sg4002
g42139
sg5598
g52006
sg7044
g59736
sg213
g14055
sg4806
g47685
sg2553
g32879
sg2559
g32988
sg9309
g70250
sg8583
g67305
sg7353
g61327
sg8595
g67341
sg7845
g63955
sg255
g14370
sg9660
g71743
sg11649
(dp76509
sg1875
g27906
sg1113
g22165
sg1890
g28008
sg9471
g71049
sg4398
g44835
sg1149
g22505
sg10200
g73810
sg8760
g67983
sg1164
g22592
sg7977
g64496
sg5757
g52917
sg7188
g60490
sg1947
g28665
sg11781
(dp76510
sg8010
g64667
sg645
g18139
sg501
g16745
sg4197
g43514
sg9918
g72771
sg6567
g57521
sg1059
g21789
sg2784
g34350
sg10185
g73765
sg10548
g75231
sg1263
g23201
sg2736
g33936
sg11085
(dp76511
sg10314
g74340
sg2805
g34451
sg5085
g49038
sg21710
g54038
sg5073
g49006
sg8826
g68313
sg2901
g35479
sg10236
g73977
sg9618
g71622
sg3393
g38538
sg969
g21094
sg5025
g48757
sg2142
g30337
sg11172
(dp76512
sg7359
g61365
sg10878
(dp76513
sg5193
g49626
sg1635
g26030
sg7014
g59550
sg9372
g70514
sg1938
g28550
sg14872
g15703
sg3639
g40077
sg10290
g74206
sg5235
g49820
sg2112
g30183
sg1461
g24795
sg1746
g26949
sg9909
g72680
sg4491
g45791
sg6792
g58717
sg9006
g68888
sg12108
(dp76514
sg4302
g44458
sg9696
g71910
sg7527
g62443
sg6102
g55057
sg753
g19223
sg9810
g72215
sg6843
g58961
sg357
g15337
sg10587
g75371
sg6150
g55183
sg6381
g56803
ssg10872
(dp76515
g1266
g23218
sg9348
g70373
sg5463
g51243
sg5847
g53499
sg7059
g59895
ssg10875
(dp76516
g1776
g27091
ssg10878
(dp76517
VAgents Causing Muscle Toxicity
p76518
g55392
sVCytochrome P-450 CYP3A4 Inhibitors
p76519
g61699
sVCarbohydrates
p76520
g61785
sVStomatological Preparations
p76521
g67441
sVAntifungal Agents
p76522
g76443
sVPolyene Antifungal
p76523
g36948
sg7437
g61939
sVCompounds used in a research, industrial, or household setting
p76524
g76513
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p76525
g43775
sVCytochrome P-450 Enzyme Inhibitors
p76526
g62088
sVAnti-Infective Agents
p76527
g54650
sVAntiinfectives for Systemic Use
p76528
g69675
sVHypotensive Agents
p76529
g34183
sg11640
(dp76530
sVGynecological Antiinfectives and Antiseptics
p76531
g69239
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p76532
g59979
sg10131
g73619
sVLactones
p76533
(dp76534
sVPolyenes
p76535
g51392
sg7722
g63503
sVAnti-Bacterial Agents
p76536
g38373
sVAntiprotozoals
p76537
g59375
sVPharmaceutical Preparations
p76538
g53873
sVGlycosides
p76539
g68375
sg1107
g22116
sVAgents that reduce seizure threshold
p76540
g45870
sVAntiparasitic Agents
p76541
g40660
sg1341
g23732
sVBiomedical and Dental Materials
p76542
g44732
sVPolyketides
p76543
g48469
sVAlimentary Tract and Metabolism
p76544
g23819
sVNarrow Therapeutic Index Drugs
p76545
g50582
sVAntimycotics for Systemic Use
p76546
(dp76547
sVGenito Urinary System and Sex Hormones
p76548
g66183
sVIntestinal Antiinfectives
p76549
g68571
sVCytochrome P-450 CYP3A Inhibitors
p76550
g60461
sVBiomimetic Materials
p76551
g36619
sVDrug Delivery Systems
p76552
g64633
sVAntiinfectives and Antiseptics for Local Oral Treatment
p76553
g65507
sVNephrotoxic agents
p76554
g57731
ssg10881
(dp76555
g2388
g31660
ssg10884
(dp76556
VAdrenergic alpha-1 Receptor Antagonists
p76557
g14113
sVCytochrome P-450 CYP2D6 Substrates
p76558
g52138
sVCytochrome P-450 CYP3A Substrates
p76559
g45125
sVNeurotransmitter Agents
p76560
g75576
sVHypotensive Agents
p76561
g34141
sVAdrenergic Antagonists
p76562
g52271
sVDrugs that are Mainly Renally Excreted
p76563
g43951
sVUrologicals
p76564
g58915
sVGynecological Antiinfectives and Antiseptics
p76565
g69236
sVUrological Agents
p76566
g38292
sg2412
g31881
sVAmides
p76567
g44311
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76568
g29406
sVSulfur Compounds
p76569
(dp76570
sVAdrenergic alpha-Antagonists
p76571
g60866
sVSulfones
p76572
g58735
sVSulfonamides
p76573
g63356
sVAdrenergic Agents
p76574
g41695
sVCytochrome P-450 CYP3A4 Substrates
p76575
g65268
sVGenito Urinary System and Sex Hormones
p76576
g66162
sVPeripheral alpha-1 blockers
p76577
g32719
sVDrugs Used in Benign Prostatic Hypertrophy
p76578
(dp76579
ssg10887
(dp76580
g7464
g62159
sg1674
g26327
sg10818
g76323
sg3846
g41110
sg5427
g50985
sg4635
g46478
sg5433
g51039
sg8388
g66359
sg4788
g47564
sg4803
g47632
sg7650
g63082
sg8421
g66498
sg6819
g58866
sg8433
g66649
sg888
g20421
sg10377
g74673
sg2088
g29904
sg3543
g39326
sg9960
g72956
sg10347
g74485
sg8460
g66865
sg9966
g73051
sg918
g20753
sg5970
g54227
sg10740
g75977
sg933
g20815
sg10752
g76020
sg12421
g12442
sg3858
g41208
sg963
g20982
sg13091
g21373
sg6333
g56462
sg1008
g21273
sg5739
g52867
sg1791
g27235
sg2559
g32942
sg7962
g64407
sg7707
g63386
sg7065
g59927
sg4830
g47800
sg12274
g27523
sg4863
g47937
sg285
g14606
sg4077
g42828
sg4680
g46877
sg1785
g27177
sg345
g15220
sg10179
g73720
sg1911
g28353
sg2667
g33501
sg537
g17024
sg2688
g33629
sg14791
g71064
sg4974
g48612
sg9324
g70325
sg7191
g60548
sg2715
g33798
sg7197
g60602
sg3447
g38920
sg6537
g57396
sg426
g16075
sg465
g16461
sg1425
g24541
sg5832
g53405
sg9552
g71316
sg11721
(dp76581
sg2199
g30681
sg5877
g53677
sg8820
g68257
sg7335
g61184
sg8097
g65076
sg4458
g45481
sg543
g17083
sg3546
g39384
sg2109
g30114
sg696
g18719
sg7569
g62717
sg6654
g58052
sg5127
g49222
sg9819
g72259
sg8472
g66945
sg1371
g24089
sg336
g15087
sg621
g17954
sg8019
g64729
sg11112
(dp76582
sg11955
(dp76583
sg4425
g44925
sg516
g16860
sg2094
g29975
sg11229
(dp76584
sg2943
g35756
sg1434
g24645
sg6033
g54508
sg8295
g65975
sg6765
g58594
sg1461
g24804
sg9687
g71848
sg6867
g59041
sg1491
g25065
sg5526
g51574
sg5289
g50263
sg9009
g68911
sg3975
g41929
sg10512
g75078
sg12063
(dp76585
sg5316
g50438
sg3027
g36351
sg11316
(dp76586
sg9420
g70816
sg1062
g21802
sg1098
g22003
sg9822
g72302
sg5364
g50609
sg4911
g48223
sg5370
g50665
sg12126
(dp76587
sg7596
g62847
sg1185
g22718
ssg10890
(dp76588
VAntiparasitic Products, Insecticides and Repellents
p76589
g30569
sg7614
g62897
sVHeterocyclic Compounds, Fused-Ring
p76590
g56075
sVQuinoline Derivatives
p76591
g60702
sVGenito Urinary System and Sex Hormones
p76592
g66163
sVGynecological Antiinfectives and Antiseptics
p76593
g69240
sVCell-mediated Immunity
p76594
g23558
sVOtologicals
p76595
g69480
sVSensory Organs
p76596
g40696
sVDermatologicals
p76597
g17234
sVStandardized Chemical Allergen
p76598
g44803
sVMedicated Dressings
p76599
g20584
sVIncreased Histamine Release
p76600
g55115
sg9018
g68970
sg10089
g73503
sg99
g12983
sVAntiseptics and Disinfectants
p76601
g23737
sVAntiprotozoals
p76602
g59367
sVAnti-Infective Agents
p76603
g54595
sVMedicated Dressings With Antiinfectives
p76604
g43166
sVQuinolines
p76605
g74113
ssg10893
(dp76606
g9741
g72046
ssg10896
(dp76607
g10314
g74320
sg10548
g75206
ssg10899
(dp76608
VCytochrome P-450 CYP3A4 Inhibitors
p76609
g61661
sVCytochrome P-450 CYP2D6 Inhibitors
p76610
g62923
sVCytochrome P-450 CYP2D6 Substrates
p76611
g52143
sVCytochrome P-450 CYP3A Substrates
p76612
g45126
sVBCRP/ABCG2 Inhibitors
p76613
g12523
sVKinase Inhibitor
p76614
g24589
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p76615
g43747
sVEnzyme Inhibitors
p76616
g72705
sVCytochrome P-450 Enzyme Inhibitors
p76617
g62028
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p76618
g18398
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p76619
(dp76620
sVTyrosine Kinase Inhibitors
p76621
g30824
sVCytochrome P-450 CYP2C9 Inhibitors
p76622
g18200
sVQuinazolines
p76623
g57749
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76624
g29407
sVAntineoplastic Agents
p76625
g71535
sVP-glycoprotein/ABCB1 Substrates
p76626
g34962
sVCytochrome P-450 CYP2C19 Inhibitors
p76627
g61263
sVProtein Kinase Inhibitors
p76628
(dp76629
sVCytochrome P-450 CYP3A4 Substrates
p76630
g65269
sVHeterocyclic Compounds, Fused-Ring
p76631
g56077
sVCytochrome P-450 CYP3A Inhibitors
p76632
g60420
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p76633
(dp76634
sVBCRP/ABCG2 Substrates
p76635
g42069
sVP-glycoprotein/ABCB1 Inhibitors
p76636
g74810
sVAntineoplastic and Immunomodulating Agents
p76637
g39764
ssg10902
(dp76638
g195
g13907
sg11415
(dp76639
sg9996
g73189
ssg10905
(dp76640
g4521
g45964
sg1260
g23143
sg3684
g40228
sg687
g18551
sg6156
g55218
sg8580
g67282
sg7896
g64144
sg1803
g27379
sg4035
g42423
sg10593
g75406
sg5970
g54231
sg10959
(dp76641
sg474
g16562
sg4005
g42165
ssg10908
(dp76642
g8277
g65945
ssg10911
(dp76643
g10263
g74038
sg11649
(dp76644
sg4488
g45756
sg5427
g51005
ssg10914
(dp76645
VAntiinfectives for Systemic Use
p76646
g69666
sVAntiparasitic Products, Insecticides and Repellents
p76647
g30567
sVImidazoles
p76648
(dp76649
sVNitro Compounds
p76650
g51522
sVAntiparasitic Agents
p76651
g40645
sVNitroimidazole Derivatives
p76652
(dp76653
sVAntibacterials for Systemic Use
p76654
g32556
sVAntiprotozoals
p76655
g59364
sVNitroimidazole Antimicrobial
p76656
g20951
sVAnti-Infective Agents
p76657
g54628
sVNitroimidazoles
p76658
g44871
ssg10917
(dp76659
g2841
g34856
ssg10920
(dp76660
g426
g16125
sg6207
g55596
sg6186
g55525
sg11811
(dp76661
sg8598
g67401
sg8601
g67432
sg11619
(dp76662
sg6579
g57569
sg5064
g48922
sg7284
g60853
sg12018
(dp76663
sg1104
g22114
sg8277
g65947
sg9996
g73197
sg9420
g70829
sg8028
g64822
sg4746
g47278
sg69
g12767
sg4959
g48560
sg6678
g58134
sg2688
g33695
sg582
g17645
sg7533
g62512
sg12126
(dp76664
sg7041
g59719
ssg10923
(dp76665
g1185
g22731
sg1062
g21817
ssg10926
(dp76666
g11820
(dp76667
sg4926
g48421
sg10797
g76247
sg1062
g21823
ssg10929
(dp76668
g10062
g73446
sg11793
(dp76669
sg1188
g22770
sg7941
g64299
sg11979
(dp76670
sg9393
g70608
ssg10932
(dp76671
g9264
g70098
ssg10935
(dp76672
g543
g17102
ssg10938
(dp76673
g8019
g64747
sg4260
g44121
sg1914
g28411
sg3408
g38716
sg4425
g44939
sg4974
g48629
sg4716
g47084
sg2109
g30141
sg7671
g63263
sg10977
(dp76674
sg3279
g37941
sg4788
g47583
sg4803
g47647
sg10740
g75995
sg336
g15114
sg9702
g71934
sg5250
g49991
sg7650
g63096
sg10011
g73273
sg963
g21001
sg5394
g50842
ssg10941
(dp76675
g4860
g47913
ssg10944
(dp76676
g501
g16743
ssg10947
(dp76677
g1461
g24857
sg10263
g74049
sg4707
g46989
sg10218
g73883
sg2736
g33965
sg3132
g37015
sg10713
g75840
sg9102
g69366
sg1452
g24736
ssg10950
(dp76678
VAmidines
p76679
(dp76680
sVAntiparasitic Products, Insecticides and Repellents
p76681
g30580
sVAntimalarials
p76682
g14101
sVCytochrome P-450 CYP2D6 Inhibitors
p76683
g62928
sVAntimetabolites
p76684
g59538
sVCytochrome P-450 CYP2C19 Substrates
p76685
g53898
sVGuanidines
p76686
g71100
sVCytochrome P-450 CYP3A Substrates
p76687
g45136
sVNoxae
p76688
g65428
sVToxic Actions
p76689
g49402
sVAntiparasitic Agents
p76690
g40658
sVFolic Acid Antagonists
p76691
(dp76692
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76693
g29417
sVCytochrome P-450 CYP2C9 Substrates
p76694
g29752
sVAntiprotozoals
p76695
g59373
sVCytochrome P-450 CYP3A4 Substrates
p76696
g65271
sVAnti-Infective Agents
p76697
g54612
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p76698
g18420
sVCytochrome P-450 Enzyme Inhibitors
p76699
g62032
sVBiguanides
p76700
g25211
ssg10953
(dp76701
VAgents Causing Muscle Toxicity
p76702
g55374
sVBisphosphonates
p76703
(dp76704
sVNephrotoxic agents
p76705
g57714
sVMusculo-Skeletal System
p76706
g31542
sVDrugs for Treatment of Bone Diseases
p76707
g14281
sVBone Density Conservation Agents
p76708
g40357
sVOrganophosphonates
p76709
g68876
sVDrugs Affecting Bone Structure and Mineralization
p76710
g16513
sVAntineoplastic Agents
p76711
g71548
sVOrganophosphorus Compounds
p76712
g74860
ssg10956
(dp76713
g4707
g46985
sg9126
g69471
ssg10959
(dp76714
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p76715
(dp76716
sVSerotonin Agents
p76717
g76435
sVCytochrome P-450 CYP3A Substrates
p76718
g45005
sVNeurotransmitter Agents
p76719
g75580
sVSerotonin Receptor Antagonists
p76720
g35678
sVCentral Nervous System Agents
p76721
g58482
sVPeripheral Nervous System Agents
p76722
g57627
sVAutonomic Agents
p76723
g66566
sVAza Compounds
p76724
g76641
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76725
g29254
sVQTc Prolonging Agents
p76726
g57874
sVAntiemetics and Antinauseants
p76727
g41644
sVCentral Nervous System Depressants
p76728
(dp76729
sVAntiemetics
p76730
(dp76731
sVGastrointestinal Agents
p76732
g70839
sVAzabicyclo Compounds
p76733
(dp76734
sVSerotonin 5-HT3 Receptor Antagonists
p76735
(dp76736
sVPyrazoles
p76737
g65178
sVCytochrome P-450 CYP3A4 Substrates
p76738
g65208
sVAlimentary Tract and Metabolism
p76739
g23882
sVModerate Risk QTc-Prolonging Agents
p76740
g67173
sVHeterocyclic Compounds, Fused-Ring
p76741
g56089
sVAntidepressive Agents
p76742
g15551
sVIndazoles
p76743
g33781
sVSerotonin 3 Receptor Antagonists
p76744
g15342
ssg10962
(dp76745
g7059
g59880
sg9348
g70377
ssg10965
(dp76746
g3018
g36157
sg141
g13364
sg7164
g60287
sg375
g15469
sg11649
(dp76747
sg1635
g26067
sg4623
g46400
sg9996
g73178
sg828
g19883
sg9252
g70055
sg11415
(dp76748
sg168
g13667
sg9402
g70652
sg255
g14410
sg4488
g45770
sg2583
g33069
ssg10968
(dp76749
g4515
g45908
sg762
g19243
sg4170
g43378
sg6228
g55703
sg10323
g74387
ssg10971
(dp76750
g6279
g55967
sg11592
(dp76751
sg1503
g25198
sg1899
g28086
sg7821
g63844
sg1047
g21629
sg1050
g21695
sg6798
g58771
sg12045
(dp76752
ssg10974
(dp76753
VLipids
p76754
g14332
sVProstaglandins
p76755
g19501
sVCardiovascular Agents
p76756
g26582
sVFatty Acids
p76757
g63150
sVProstaglandin analogs reducing intraocular pressure (IOP)
p76758
g19252
sVFatty Acids, Unsaturated
p76759
g59246
sVAntihypertensive Agents
p76760
g20278
sVSensory Organs
p76761
g40698
sVProstaglandins, Synthetic
p76762
g28025
sVInflammation Mediators
p76763
g23630
sVProstaglandins F, Synthetic
p76764
g54800
sVBiological Factors
p76765
g38101
sVAutacoids
p76766
g70964
sVOphthalmologicals
p76767
g35203
sVEicosanoids
p76768
g37790
sVAntiglaucoma Preparations and Miotics
p76769
g36551
ssg10977
(dp76770
VFatty Acids
p76771
g63148
sVAntiinflammatory and Antirheumatic Products, Non-Steroids
p76772
g50956
sVUGT1A1 Substrates
p76773
g12289
sVOAT1/SLC22A6 inhibitors
p76774
(dp76775
sVAnalgesics
p76776
g26469
sVAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p76777
g58389
sVNon COX-2 selective NSAIDS
p76778
g67322
sVCentral Nervous System Agents
p76779
g58443
sVUGT1A9 Substrates
p76780
g24002
sVAntiinflammatory and Antirheumatic Products
p76781
g56812
sVFatty Acids, Volatile
p76782
g66976
sVLipids
p76783
g14315
sVEnzyme Inhibitors
p76784
g72720
sVThroat Preparations
p76785
(dp76786
sVPeripheral Nervous System Agents
p76787
g57622
sVDrugs that are Mainly Renally Excreted
p76788
g44032
sVNonsteroidal Anti-inflammatory Compounds
p76789
g68161
sVAnalgesics, Non-Narcotic
p76790
g56896
sVUGT1A3 substrates
p76791
g31805
sVNephrotoxic agents
p76792
g57724
sVAntiinflammatory Preparations, Non-Steroids for Topical Use
p76793
g72869
sVBiphenyl Compounds
p76794
g24987
sVCytochrome P-450 CYP2C9 Substrates
p76795
g29778
sVMusculo-Skeletal System
p76796
g31517
sVTopical Products for Joint and Muscular Pain
p76797
g13929
sVAgents causing hyperkalemia
p76798
g43610
sVBenzene Derivatives
p76799
g61421
sVUGT1A1 Inhibitors
p76800
g71653
sVOther Nonsteroidal Antiimflammatory Agents
p76801
g76674
sVPropionates
p76802
g36489
sVSensory Organs
p76803
g40716
sVAgents that produce hypertension
p76804
g69073
sVOphthalmologicals
p76805
g35225
sVAcids, Acyclic
p76806
g25476
sVUGT2B7 substrates
p76807
g28629
sVAnti-Inflammatory Agents
p76808
g73962
sVCyclooxygenase Inhibitors
p76809
g32784
sVAntirheumatic Agents
p76810
g24218
sVSensory System Agents
p76811
g71811
sVAnti-Inflammatory Agents, Non-Steroidal
p76812
g64654
ssg10980
(dp76813
g8484
g66997
sg4197
g43509
sg1746
g26944
sg8439
g66713
sg9006
g68883
sg1866
g27793
sg3495
g39068
ssg10983
(dp76814
g426
g16123
sg9198
g69844
sg12274
g27527
sg11955
(dp76815
sg1326
g23616
sg11079
(dp76816
sg11592
(dp76817
sg5433
g51024
sg2943
g35790
sg7821
g63850
sg1050
g21701
sg5250
g50006
sg1650
g26127
sg8049
g64915
sg5256
g50111
sg1461
g24855
sg8721
g67881
sg8433
g66640
sg10899
g76634
sg888
g20513
sg288
g14704
sg5877
g53705
sg4887
g48104
sg3543
g39360
sg8820
g68242
sg7329
g61154
sg9009
g68935
sg9960
g72980
sg9966
g73033
sg8097
g65108
sg6279
g55975
sg10728
g75925
sg9231
g69984
sg7734
g63545
sg8856
g68444
sg2832
g34743
sg10179
g73747
sg132
g13220
sg1908
g28323
sg7944
g64346
sg564
g17430
sg573
g17583
sg696
g18778
sg2688
g33687
sg8241
g65825
sg3072
g36609
sg9417
g70794
sg7188
g60487
sg12126
(dp76818
sg10356
g74583
sg7593
g62825
sg11241
(dp76819
sg7608
g62875
ssg10986
(dp76820
g11940
(dp76821
sg816
g19677
ssg10989
(dp76822
g5085
g49059
sg1326
g23618
ssg10992
(dp76823
g8325
g66151
ssg10995
(dp76824
g4773
g47484
ssg10998
(dp76825
g6213
g55604
ssg11001
(dp76826
g1626
g25958
sg6051
g54798
sg11022
(dp76827
sg3900
g41500
sg6069
g54835
sg10041
g73340
sg831
g19922
sg10884
g76579
ssg11004
(dp76828
g11379
(dp76829
sg3144
g37127
ssg11007
(dp76830
g5889
g53771
ssg11010
(dp76831
g10263
g74046
sg4623
g46394
sg5427
g50999
sg10857
g76491
sg10515
g75101
sg4647
g46579
sg255
g14400
sg2262
g30968
sg7164
g60282
sg375
g15463
sg11649
(dp76832
sg11652
(dp76833
sg4488
g45765
sg11667
(dp76834
sg9402
g70647
sg2067
g29652
sg11097
(dp76835
sg5499
g51427
sg11319
(dp76836
sg6639
g57981
sg723
g19091
sg7320
g61086
sg11145
(dp76837
sg9264
g70105
sg11439
(dp76838
sg11445
(dp76839
sg6678
g58126
sg23
g12229
sg6507
g57308
sg11910
(dp76840
sg5598
g52037
sg3444
g38877
sg9093
g69275
sg612
g17891
sg210
g14015
sg5796
g53248
ssg11013
(dp76841
g4200
g43531
ssg11016
(dp76842
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p76843
(dp76844
sVCytochrome P-450 CYP3A4 Inhibitors
p76845
g61697
sVPyrimidinones
p76846
(dp76847
sVAdrenergic alpha-1 Receptor Antagonists
p76848
g14138
sVCytochrome P-450 CYP2D6 Inhibitors
p76849
g62932
sVCytochrome P-450 CYP2D6 Substrates
p76850
g52115
sVSerotonin Agents
p76851
g76429
sVCytochrome P-450 CYP3A Substrates
p76852
g45034
sVNeurotransmitter Agents
p76853
g75568
sVPyrimidines
p76854
g47699
sVCentral Nervous System Agents
p76855
g58407
sVDopamine Agents
p76856
g14240
sVPotential QTc-Prolonging Agents
p76857
g70429
sVAdrenergic Antagonists
p76858
g52296
sVPsychotropic Drugs
p76859
g72589
sVSerotonin 5-HT1 Receptor Antagonists
p76860
g14431
sVCytochrome P-450 Enzyme Inhibitors
p76861
g61978
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p76862
g18424
sVHyperglycemia-Associated Agents
p76863
g68813
sVAntipsychotic Agents
p76864
g69861
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76865
g29298
sVAdrenergic alpha-Antagonists
p76866
g60880
sVDopamine Antagonists
p76867
g53743
sVQTc Prolonging Agents
p76868
g57835
sVSerotonin 5-HT2 Receptor Antagonists
p76869
g71717
sVCentral Nervous System Depressants
p76870
(dp76871
sVAgents that reduce seizure threshold
p76872
g45846
sVSerotonin Receptor Antagonists
p76873
g35669
sVP-glycoprotein/ABCB1 Substrates
p76874
g34995
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p76875
g69049
sVHistamine H1 Antagonists
p76876
g40774
sVAgents that produce hypertension
p76877
g69054
sVCytochrome P-450 CYP3A4 Substrates
p76878
g65226
sVDopamine D2 Receptor Antagonists
p76879
g49416
sVCytochrome P-450 CYP3A5 Substrates
p76880
g67795
sVAntidepressive Agents
p76881
g15497
sVPsycholeptics
p76882
g33237
sVCytochrome P-450 CYP3A Inhibitors
p76883
g60459
sVTranquilizing Agents
p76884
g55294
sVNeurotoxic agents
p76885
g68581
sVHistamine Antagonists
p76886
g43432
sVNervous System
p76887
g70267
sVAntipsychotic Agents (Second Generation [Atypical])
p76888
g52061
sVCytochrome P-450 CYP3A7 Substrates
p76889
g60643
ssg11019
(dp76890
g4023
g42314
sg11958
(dp76891
sg7188
g60482
sg11523
(dp76892
sg5727
g52804
sg4803
g47611
sg1866
g27786
sg5250
g49938
sg963
g20960
ssg11022
(dp76893
VDrugs for Urinary Frequency and Incontinence
p76894
g28981
sVTetrahydroisoquinolines
p76895
g65834
sVNeurotransmitter Agents
p76896
g75579
sVHeterocyclic Compounds, Fused-Ring
p76897
g56100
sVAnticholinergic Agents
p76898
g24473
sVUrologicals
p76899
g58909
sVCytochrome P-450 CYP2D6 Substrates
p76900
g52163
sVPotential QTc-Prolonging Agents
p76901
g70421
sVIsoquinolines
p76902
g44955
sVCytochrome P-450 CYP3A Substrates
p76903
g45139
sVGenito Urinary System and Sex Hormones
p76904
g66169
sVUrological Agents
p76905
g38277
sVCholinergic Agents
p76906
g28710
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76907
g29419
sVDrugs Used in Benign Prostatic Hypertrophy
p76908
g76827
sVAgents producing tachycardia
p76909
g50773
sVAgents that produce hypertension
p76910
g69068
sVQTc Prolonging Agents
p76911
g57811
sVCytochrome P-450 CYP3A4 Substrates
p76912
g65272
sVMuscarinic Antagonists
p76913
g48851
sVQuinuclidines
p76914
g48890
ssg11025
(dp76915
g4272
g44233
sg3000
g36014
ssg11028
(dp76916
g8097
g65066
sg9417
g70729
sg8874
g68513
sg11283
(dp76917
sg3381
g38457
sg5169
g49486
sg387
g15592
sg2199
g30664
sg345
g15201
sg450
g16315
sg7941
g64255
sg7029
g59620
sg8163
g65442
sg6468
g57071
sg11979
(dp76918
sg2427
g31972
sg8655
g67570
sg9981
g73084
sg10056
g73377
sg6921
g59254
sg2910
g35505
ssg11031
(dp76919
g2403
g31849
sg11133
(dp76920
sg5934
g54076
sg7641
g63027
sg7944
g64331
sg8751
g67953
ssg11034
(dp76921
g3048
g36507
sg4017
g42267
sg8721
g67847
sg2583
g33088
ssg11037
(dp76922
g717
g19055
sg4959
g48522
ssg11040
(dp76923
g11217
(dp76924
sVMusculo-Skeletal System
p76925
g31524
sVDrugs for Treatment of Bone Diseases
p76926
g14276
sVBone Density Conservation Agents
p76927
g40353
sg9003
g68875
sVDrugs Affecting Bone Structure and Mineralization
p76928
g16508
sVMiscellaneous Therapeutic Agents
p76929
g74022
sVOrganophosphorus Compounds
p76930
g74859
ssg11043
(dp76931
g10374
g74666
sg8190
g65580
ssg11046
(dp76932
VVasopressins
p76933
g69533
sVNeuropeptides
p76934
g57517
sVAntidiuretic Agents
p76935
g76506
sVHormones
p76936
g55677
sg6249
g55821
sVCoagulants
p76937
(dp76938
sVDrugs that are Mainly Renally Excreted
p76939
g43964
sVPeptide Hormones
p76940
g20208
sg1077
g21864
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p76941
g73623
sVNatriuretic Agents
p76942
g40482
sVPituitary Hormones, Posterior
p76943
(dp76944
sVOligopeptides
p76945
g68975
sVCardiovascular Agents
p76946
g26610
sVPosterior Pituitary Lobe Hormones
p76947
g12164
sVHemostatics
p76948
g23069
sVProteins
p76949
g52764
sVHematologic Agents
p76950
g73838
sVNerve Tissue Proteins
p76951
(dp76952
sVPituitary Hormones
p76953
g15920
sVAgents that produce hypertension
p76954
g69071
sVPituitary
p76955
g75519
sg3420
g38746
sVAmino Acids, Peptides, and Proteins
p76956
g47369
sg1710
g26804
sVPituitary and Hypothalamic Hormones and Analogues
p76957
g57320
sVPeptides
p76958
g47187
sVArginine Vasopressin
p76959
g69255
sVHormones, Hormone Substitutes, and Hormone Antagonists
p76960
g53153
sVVasopressin and Analogues
p76961
g70477
ssg11049
(dp76962
g9225
g69911
sg10209
g73855
ssg11052
(dp76963
VBSEP/ABCB11 Substrates
p76964
g74864
sVCytochrome P-450 CYP3A4 Inhibitors
p76965
g61680
sVAntivirals for Systemic Use
p76966
g59754
sVCytochrome P-450 CYP3A Substrates
p76967
g45204
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p76968
g72541
sVDirect Acting Antivirals
p76969
g38048
sVPotential QTc-Prolonging Agents
p76970
g70423
sVAnti-HIV Agents
p76971
g66393
sVEnzyme Inhibitors
p76972
g72715
sVCytochrome P-450 Enzyme Inhibitors
p76973
g62073
sVAnti-Infective Agents
p76974
g54633
sVOligopeptides
p76975
g68976
sVHyperglycemia-Associated Agents
p76976
g68809
sVAntiinfectives for Systemic Use
p76977
g69668
sVAnti-Retroviral Agents
p76978
g67147
sVNephrotoxic agents
p76979
g57722
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p76980
g29508
sVOATP1B3 inhibitors
p76981
g62283
sVHIV Protease Inhibitors
p76982
(dp76983
sVCytochrome P-450 CYP2C9 Substrates
p76984
g29772
sVQTc Prolonging Agents
p76985
g57840
sVCytochrome P450 3A4 Inhibitors
p76986
g13037
sVCytochrome P-450 CYP2C8 Inhibitors
p76987
g55027
sVP-glycoprotein/ABCB1 Substrates
p76988
g35003
sVPyridines
p76989
g64227
sVUGT1A1 Inhibitors
p76990
g71652
sVPeptides
p76991
g47189
sg1020
g21341
sVCytochrome P-450 CYP3A Inhibitors (strong)
p76992
g13386
sVCytochrome P-450 CYP3A4 Substrates
p76993
g65312
sVAmino Acids, Peptides, and Proteins
p76994
g47372
sVProtease Inhibitors
p76995
g51089
sVCytochrome P-450 CYP3A Inhibitors
p76996
g60441
sVAntiviral Agents
p76997
g30432
sVOATP1B1/SLCO1B1 Inhibitors
p76998
g75616
sg5976
g54273
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p76999
g24201
sVP-glycoprotein/ABCB1 Inhibitors
p77000
g74813
ssg11055
(dp77001
g11874
(dp77002
ssg11058
(dp77003
g8088
g65056
sg801
g19549
sg10581
g75363
ssg11061
(dp77004
VAntiinfectives for Systemic Use
p77005
g69669
sVGlycosides
p77006
g68360
sVAntivirals for Systemic Use
p77007
g59755
sg2577
g33053
sVNucleosides
p77008
g49459
sVPyrimidines
p77009
g47710
sg11121
(dp77010
sg3438
g38835
sVCarbohydrates
p77011
g61777
sVNucleic Acids, Nucleotides, and Nucleosides
p77012
g47117
sg276
g14462
sVAntiviral Agents
p77013
g30436
sVDirect Acting Antivirals
p77014
g38052
sg3507
g39103
sVPyrimidine Nucleosides
p77015
(dp77016
sVEnzyme Inhibitors
p77017
g72716
sg5019
g48729
sVAnti-Infective Agents
p77018
g54634
sg7914
g64175
ssg11064
(dp77019
g5511
g51485
ssg11067
(dp77020
VAmino Acids, Peptides, and Proteins
p77021
g47413
sVPeptides, Cyclic
p77022
g70149
sVAntibiotics for Topical Use
p77023
g57692
sVOphthalmologicals
p77024
g35266
sVDermatologicals
p77025
g17325
sVCholinesterase Inhibitors
p77026
g72397
sVPeptides
p77027
g47211
sVAnti-Infective Agents, Local
p77028
g63022
sVSensory Organs
p77029
g40749
sVAnti-Bacterial Agents
p77030
g38386
sVAnti-Infective Agents
p77031
g54630
sVThroat Preparations
p77032
(dp77033
ssg11070
(dp77034
g6090
g54940
sg4263
g44157
sg12421
g12448
sg6102
g55084
sg7065
g59932
sg7197
g60606
sg7563
g62662
sg9819
g72284
ssg11073
(dp77035
g1482
g25004
ssg11076
(dp77036
g6090
g54942
sg2844
g34883
sg4263
g44159
sg6024
g54447
sg10494
g74976
sg5589
g51927
sg7800
g63684
sg5946
g54174
sg7563
g62642
sg10779
g76152
sg8418
g66448
ssg11079
(dp77037
VAgents Causing Muscle Toxicity
p77038
g55382
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p77039
g52082
sVAgents that produce neuromuscular block (indirect)
p77040
g37964
sVCytochrome P-450 CYP2D6 Inhibitors
p77041
g62939
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p77042
g41069
sVCytochrome P-450 CYP3A Substrates
p77043
g45144
sVAgents causing hyperkalemia
p77044
g43608
sVCytochrome P-450 CYP3A4 Inhibitors
p77045
g61684
sVBCRP/ABCG2 Inhibitors
p77046
g12505
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p77047
g74882
sVCytochrome P-450 CYP2C19 Inhibitors
p77048
g61273
sVOATP1B1/SLCO1B1 Inhibitors
p77049
g75617
sVCytochrome P-450 CYP3A7 Inducers
p77050
g39041
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p77051
g71275
sVCytochrome P-450 CYP2C9 Inhibitors
p77052
g18222
sVCytochrome P-450 Enzyme Inhibitors
p77053
g62037
sVAnti-Infective Agents
p77054
g54637
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p77055
(dp77056
sg9921
g72840
sVPeptides, Cyclic
p77057
g70147
sVEnzyme Inhibitors
p77058
g72718
sVNephrotoxic agents
p77059
g57723
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77060
g29424
sVOAT1/SLC22A6 inhibitors
p77061
(dp77062
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p77063
g60069
sVCytochrome P-450 CYP3A4 Inducers
p77064
g18940
sg7704
g63368
sVCytochrome P-450 CYP3A5 Inducers
p77065
g41743
sVImmunologic Factors
p77066
g42378
sVOATP1B3 inhibitors
p77067
g62281
sVAgents that reduce seizure threshold
p77068
g45847
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p77069
g49148
sVCytochrome P-450 CYP2C8 Inhibitors
p77070
g55029
sVP-glycoprotein/ABCB1 Inducers
p77071
g70556
sVDermatologicals
p77072
g17276
sg1902
g28101
sVPeptides
p77073
g47193
sVCytochrome P-450 Enzyme Inducers
p77074
g28197
sVCytochrome P-450 CYP3A Inducers
p77075
g66279
sVAgents that produce hypertension
p77076
g69072
sVBSEP/ABCB11 Inhibitors
p77077
g62523
sg363
g15344
sVCytochrome P-450 CYP3A4 Substrates
p77078
g65274
sVNarrow Therapeutic Index Drugs
p77079
g50557
sVAmino Acids, Peptides, and Proteins
p77080
g47379
sVCytochrome P-450 CYP3A5 Substrates
p77081
g67817
sVOphthalmologicals
p77082
g35227
sVCytochrome P-450 CYP3A Inhibitors
p77083
g60445
sVImmunosuppressive Agents
p77084
g64568
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p77085
g76816
sVAnti-Inflammatory Agents
p77086
g73961
sVP-glycoprotein/ABCB1 Substrates
p77087
g35008
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p77088
g64617
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p77089
g76139
sVNeurotoxic agents
p77090
g68582
sVCytochrome P-450 CYP3A5 Inducers (moderate)
p77091
(dp77092
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p77093
g24191
sVAntirheumatic Agents
p77094
g24223
sVP-glycoprotein/ABCB1 Inhibitors
p77095
g74814
sVCytochrome P-450 CYP3A7 Substrates
p77096
g60661
sVCytochrome P-450 CYP3A5 Inhibitors
p77097
g55337
ssg11082
(dp77098
g3111
g36831
sg603
g17779
sg10017
g73296
ssg11085
(dp77099
VHematologic Agents
p77100
g73841
sVGlucans
p77101
g51752
sVPhosphate Binder
p77102
g21948
sVSupplements
p77103
g41789
sVHematinics
p77104
g59094
sVCarbohydrates
p77105
g61780
sVPolysaccharides
p77106
g41776
sVIron Compounds
p77107
g36406
sVPolymers
p77108
g22230
sVCompounds used in a research, industrial, or household setting
p77109
g76511
sVMacromolecular Substances
p77110
g33839
sg11610
(dp77111
sVBiomedical and Dental Materials
p77112
g44722
sVOrganometallic Compounds
p77113
g73255
sVBiopolymers
p77114
g72739
sVFerric Compounds
p77115
g53485
sVParenteral Iron Replacement
p77116
g41681
ssg11088
(dp77117
g1920
g28473
ssg11091
(dp77118
g426
g16087
sg12111
(dp77119
sg11595
(dp77120
sg915
g20702
ssg11094
(dp77121
g7812
g63740
sg4902
g48162
sg10296
g74226
ssg11097
(dp77122
VCytochrome P-450 CYP3A4 Inhibitors
p77123
g61689
sVAdrenergic alpha-1 Receptor Antagonists
p77124
g14122
sVAnti-Parkinson Drugs
p77125
g16152
sVSerotonin Agents
p77126
g76436
sVCytochrome P-450 CYP3A Substrates
p77127
g45243
sVNeurotransmitter Agents
p77128
g75585
sVDopamine Agonists
p77129
g56754
sVCentral Nervous System Agents
p77130
g58494
sVDopamine Agents
p77131
g14244
sVCYP3A Substrates (Sensitive)
p77132
g63925
sVAdrenergic Antagonists
p77133
g52289
sVErgolines
p77134
g24606
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p77135
g43768
sVCytochrome P-450 Enzyme Inhibitors
p77136
g62038
sVBlood Glucose Lowering Agents
p77137
(dp77138
sVProlactine Inhibitors
p77139
g75937
sVErgot Alkaloids and Derivatives
p77140
g49008
sVErgot-derivative Dopamine Receptor Agonists
p77141
g35983
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77142
g29560
sVAdrenergic alpha-Antagonists
p77143
g60870
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p77144
g60080
sVCentral Nervous System Depressants
p77145
(dp77146
sVGenito Urinary System and Sex Hormones
p77147
g66176
sVHypotensive Agents
p77148
g34163
sVAnti-Dyskinesia Agents
p77149
g50484
sVP-glycoprotein/ABCB1 Substrates
p77150
g35012
sVHormones, Hormone Substitutes, and Hormone Antagonists
p77151
g53168
sVAdrenergic Agonists
p77152
g76835
sVAgents that produce hypertension
p77153
g69075
sVCytochrome P-450 CYP3A4 Substrates
p77154
g65335
sVHormone Antagonists
p77155
g24271
sVAdrenergic alpha-2 Receptor Agonists
p77156
g67205
sVHeterocyclic Compounds, Fused-Ring
p77157
g56115
sVSerotonin Modulators
p77158
g69135
sVAdrenergic alpha-Agonists
p77159
g65396
sVAntidepressive Agents
p77160
g15544
sVCytochrome P-450 CYP3A Inhibitors
p77161
g60450
sVSerotonin 5-HT2 Receptor Agonists
p77162
g75037
sVAnti-Parkinson Agents (Dopamine Agonist)
p77163
g25594
sVP-glycoprotein/ABCB1 Inhibitors
p77164
g74826
sVErgotamines
p77165
(dp77166
sVAgents producing tachycardia
p77167
g50777
sVAlkaloids
p77168
g19419
sVAdrenergic alpha-1 Receptor Agonists
p77169
g67242
sVSerotonin Receptor Agonists
p77170
(dp77171
sVNervous System
p77172
g70301
ssg11100
(dp77173
VMusculo-Skeletal System
p77174
g31529
sg9738
g72037
sVDrugs for Treatment of Bone Diseases
p77175
g14280
sVBone Density Conservation Agents
p77176
g40356
sVDrugs Affecting Bone Structure and Mineralization
p77177
g16512
sVSulfur Compounds
p77178
(dp77179
ssg11103
(dp77180
g4398
g44846
sg8826
g68319
sg4488
g45767
ssg11106
(dp77181
g2736
g33968
ssg11109
(dp77182
g10077
g73481
sg2736
g33949
sg8871
g68498
ssg11112
(dp77183
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p77184
(dp77185
sVPsychoanaleptics
p77186
g59073
sVCytochrome P-450 CYP2D6 Substrates
p77187
g52181
sVSerotonin Agents
p77188
g76427
sVCytochrome P-450 CYP3A Substrates
p77189
g45193
sVNeurotransmitter Agents
p77190
g75586
sVAnti-Anxiety Agents
p77191
g35653
sVSerotonin Receptor Antagonists
p77192
g35661
sVCentral Nervous System Agents
p77193
g58429
sVPsychotropic Drugs
p77194
g72598
sVCytochrome P-450 CYP2B6 Substrates
p77195
g33042
sVSerotonin 5-HT1 Receptor Antagonists
p77196
g14427
sVPiperazines
p77197
(dp77198
sVDrugs that are Mainly Renally Excreted
p77199
g43969
sVCytochrome P-450 CYP2C8 Substrates
p77200
g76582
sVNeurotransmitter Uptake Inhibitors
p77201
g52384
sVMembrane Transport Modulators
p77202
g54134
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77203
g29493
sVCytochrome P-450 CYP2C9 Substrates
p77204
g29793
sVCytochrome P-450 CYP2C19 Substrates
p77205
g53903
sVCentral Nervous System Depressants
p77206
(dp77207
sVSerotonin 5-HT3 Receptor Antagonists
p77208
(dp77209
sVCytochrome P-450 CYP2A6 Substrates
p77210
g35116
sVAgents that produce hypertension
p77211
g69080
sVCytochrome P-450 CYP3A4 Substrates
p77212
g65301
sVSerotonin 5-HT1 Receptor Agonists
p77213
g34583
sVCytochrome P-450 CYP3A5 Substrates
p77214
g67804
sVSerotonin Modulators
p77215
g69126
sVAntidepressive Agents
p77216
g15559
sVSerotonin Receptor Agonists
p77217
(dp77218
sVNervous System
p77219
g70294
sVTranquilizing Agents
p77220
g55308
ssg11115
(dp77221
g48
g12643
ssg11118
(dp77222
g87
g12928
sg1785
g27204
sg4863
g47951
sg1674
g26342
sg837
g20002
sg918
g20775
ssg11121
(dp77223
g11061
g77010
sg10326
g74421
sg5871
g53645
sg2991
g35962
sg11427
(dp77224
sg7500
g62359
sg279
g14489
sg2250
g30854
ssg11124
(dp77225
g1917
g28450
sg1791
g27270
ssg11127
(dp77226
g10740
g75991
sg2109
g30136
sg6024
g54459
sg10494
g74986
sg5589
g51939
sg8418
g66459
ssg11130
(dp77227
g4725
g47138
ssg11133
(dp77228
VDrugs that are Mainly Renally Excreted
p77229
g43970
sVPhthalimides
p77230
g20182
sVImides
p77231
g76920
sVAngiogenesis Inhibitors
p77232
g70568
sVMyelosuppressive Agents
p77233
g71334
sVAngiogenesis Modulating Agents
p77234
g71709
sVIsoindoles
p77235
g17598
sVThalidomide Analog
p77236
g70006
sVImmunologic Factors
p77237
g42383
sVGrowth Inhibitors
p77238
g13757
sVImmunosuppressive Agents
p77239
g64576
sVP-glycoprotein/ABCB1 Substrates
p77240
g35024
sVAcids, Carbocyclic
p77241
g41566
sVPiperidones
p77242
g41181
sVPhthalic Acids
p77243
g61388
sVPiperidines
p77244
g73566
sVAntineoplastic and Immunomodulating Agents
p77245
g39794
sVHeterocyclic Compounds, Fused-Ring
p77246
g56151
sVAntineoplastic Agents
p77247
g71544
sVGrowth Substances
p77248
g46120
ssg11136
(dp77249
VCytochrome P-450 CYP3A4 Inhibitors
p77250
g61692
sVAnalgesics
p77251
g26477
sVCentral Nervous System Agents
p77252
g58484
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p77253
g43770
sVEnzyme Inhibitors
p77254
g72722
sVCytochrome P-450 Enzyme Inhibitors
p77255
g62040
sVPeripheral Nervous System Agents
p77256
g57630
sVP-glycoprotein/ABCB1 Inducers
p77257
g70561
sVMyelosuppressive Agents
p77258
g71335
sg5862
g53582
sg7659
g63160
sVCytotoxic Antibiotics and Related Substances
p77259
g50173
sVAntineoplastic Agents
p77260
g71545
sVAnthracyclines and Related Substances
p77261
g51555
sVP-glycoprotein/ABCB1 Substrates
p77262
g35025
sVTopoisomerase II Inhibitors
p77263
g40635
sVQuinones
p77264
(dp77265
sVCardiotoxic antineoplastic agents
p77266
g72240
sVCytochrome P-450 CYP3A Inhibitors
p77267
g60454
sVImmunosuppressive Agents
p77268
g64577
sVBCRP/ABCG2 Substrates
p77269
g42080
sVP-glycoprotein/ABCB1 Inhibitors
p77270
g74816
sVAntineoplastic and Immunomodulating Agents
p77271
g39795
sVSensory System Agents
p77272
g71813
sVTopoisomerase Inhibitors
p77273
g32853
ssg11139
(dp77274
VGlycols
p77275
g55148
sVDrugs that are Mainly Renally Excreted
p77276
g43971
sVCentral Nervous System Depressants
p77277
(dp77278
sVNervous System
p77279
g70295
sVCentral Nervous System Agents
p77280
g58485
sVMiscellaneous Anxiolytics Sedatives and Hypnotics
p77281
g40813
sVPsycholeptics
p77282
g33249
sVHypnotics and Sedatives
p77283
(dp77284
sVAlcohols
p77285
(dp77286
sVEthylene Glycols
p77287
g62630
ssg11142
(dp77288
g2733
g33913
sg7275
g60797
sg11955
(dp77289
sg1464
g24872
sg5928
g54056
sg11652
(dp77290
sg6012
g54367
sg210
g14007
sg9093
g69269
sg9264
g70100
sg4440
g45325
sg10662
g75675
sg5598
g52031
sg1452
g24733
ssg11145
(dp77291
VAdrenergic Agents
p77292
g41689
sVCentral Nervous System Depressants
p77293
(dp77294
sVAdrenergic alpha-2 Receptor Agonists
p77295
g67203
sVCardiovascular Agents
p77296
g26651
sVOphthalmologicals
p77297
g35234
sVAdrenergic alpha-Agonists
p77298
g65393
sVSympathomimetics in Glaucoma Therapy
p77299
g51325
sVSensory Organs
p77300
g40724
sVHypotensive Agents
p77301
g34189
sVDermatologicals
p77302
g17305
sVMisc. Skin and Mucous Membrane Agents
p77303
g60188
sVAdrenergic Agonists
p77304
g76837
sg7158
g60237
sVHeterocyclic Compounds, Fused-Ring
p77305
g56133
sVAntiglaucoma Preparations and Miotics
p77306
g36547
ssg11148
(dp77307
g11268
(dp77308
sg8583
g67310
sg6990
g59476
ssg11151
(dp77309
VBSEP/ABCB11 Substrates
p77310
g74863
sVCytochrome P-450 CYP3A4 Inhibitors
p77311
g61629
sVDaunorubicin
p77312
g35351
sVCytochrome P-450 CYP2D6 Inhibitors
p77313
g62902
sVCytochrome P-450 CYP2D6 Substrates
p77314
g52112
sVImmunosuppressive Agents
p77315
g64537
sVCarbohydrates
p77316
g61753
sVCytotoxic Antibiotics and Related Substances
p77317
g50170
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p77318
g43732
sVEnzyme Inhibitors
p77319
g72723
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p77320
g12666
sVCytochrome P-450 Enzyme Inhibitors
p77321
g62029
sVP-glycoprotein/ABCB1 Inducers
p77322
g70555
sVMyelosuppressive Agents
p77323
g71323
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77324
g29347
sVAnthracyclines
p77325
g31939
sVNaphthacenes
p77326
g40470
sVCytochrome P-450 CYP3A Substrates
p77327
g45069
sVGlycosides
p77328
g68359
sVAnthracyclines and Related Substances
p77329
g51554
sVCytochrome P-450 CYP2B6 Inhibitors
p77330
g45927
sVP-glycoprotein/ABCB1 Substrates
p77331
g34974
sVTopoisomerase II Inhibitors
p77332
g40630
sVDoxorubicin
p77333
g75344
sVCytochrome P-450 CYP3A4 Substrates
p77334
g65242
sVCardiotoxic antineoplastic agents
p77335
g72243
sVAnthracycline Topoisomerase Inhibitor
p77336
g43269
sVCytochrome P-450 CYP3A Inhibitors
p77337
g60384
sVAntibiotics, Antineoplastic
p77338
g30409
sVBCRP/ABCG2 Substrates
p77339
g42062
sVAntineoplastic Agents
p77340
g71524
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p77341
g53067
sVP-glycoprotein/ABCB1 Inhibitors
p77342
g74800
sVAntineoplastic and Immunomodulating Agents
p77343
g39730
sVTopoisomerase Inhibitors
p77344
g32846
ssg11154
(dp77345
VPiperidines
p77346
g73567
sVDrugs that are Mainly Renally Excreted
p77347
g43973
sg12150
(dp77348
sVNeurotransmitter Agents
p77349
g75581
sVHeterocyclic Compounds, Fused-Ring
p77350
g56099
sg1131
g22299
sVPsychoanaleptics
p77351
g59077
sg7236
g60714
sVAgents that reduce seizure threshold
p77352
g45864
sVAgents that produce hypertension
p77353
g69076
sVAcids, Carbocyclic
p77354
g41570
sVCentral Nervous System Agents
p77355
g58488
sVDopamine Agents
p77356
g14256
sg5886
g53754
sVMembrane Transport Modulators
p77357
g54159
sg11409
(dp77358
sVNeurotransmitter Uptake Inhibitors
p77359
g52393
sVCentral Nervous System Stimulants
p77360
g51440
sg2217
g30763
sVNervous System
p77361
g70296
sVPhenylacetates
p77362
g34424
ssg11157
(dp77363
g2133
g30307
sg2832
g34728
ssg11160
(dp77364
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p77365
g52092
sVCytochrome P-450 CYP3A4 Inhibitors
p77366
g61695
sVCytochrome P-450 CYP3A Inhibitors
p77367
g60457
sVNeuropeptides
p77368
g57518
sVPotential QTc-Prolonging Agents
p77369
g70428
sVNerve Tissue Proteins
p77370
(dp77371
sg10035
g73316
sVHormones
p77372
g55686
sVCytochrome P-450 Enzyme Inhibitors
p77373
g62041
sVHyperglycemia-Associated Agents
p77374
g68812
sVPeptide Hormones
p77375
g20225
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p77376
g73628
sg7482
g62250
sVQTc Prolonging Agents
p77377
g57855
sVProteins
p77378
g52777
sg9078
g69143
sVPeptides
p77379
g47162
sVAmino Acids, Peptides, and Proteins
p77380
g47392
sVPituitary and Hypothalamic Hormones and Analogues
p77381
g57321
sg8541
g67212
sVHypothalamic Hormones
p77382
g65411
sVBradycardia-Causing Agents
p77383
g61457
sVHypoglycemia-Associated Agents
p77384
g17707
sg5985
g54279
sVHormones, Hormone Substitutes, and Hormone Antagonists
p77385
g53176
ssg11163
(dp77386
VAntihistamines for Systemic Use
p77387
g12974
sVHistamine H1 Antagonists
p77388
g40787
sVHistamine Antagonists
p77389
g43448
sVAminoalkyl Ethers
p77390
g19322
ssg11166
(dp77391
VCytochrome P-450 CYP3A4 Inhibitors
p77392
g61696
sVAntivirals for Systemic Use
p77393
g59774
sVCytochrome P-450 CYP3A Substrates
p77394
g45152
sVBCRP/ABCG2 Inhibitors
p77395
g12548
sVDirect Acting Antivirals
p77396
g38076
sVProtease Inhibitors
p77397
g51102
sVHCV NS3/4A Protease Inhibitors
p77398
g67696
sVBCRP/ABCG2 Substrates
p77399
g42089
sVNS3/4A Protease Inhibitors
p77400
g38130
sVEnzyme Inhibitors
p77401
g72726
sVCytochrome P-450 Enzyme Inhibitors
p77402
g62042
sVAnti-Infective Agents
p77403
g54646
sVAntiinfectives for Systemic Use
p77404
g69673
sVGynecological Antiinfectives and Antiseptics
p77405
g69250
sVAmides
p77406
g44340
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77407
g29436
sVSulfur Compounds
p77408
(dp77409
sVOATP1B3 inhibitors
p77410
g62286
sVSulfones
p77411
g58749
sVOATP1B1/SLCO1B1 Substrates
p77412
(dp77413
sVSulfonamides
p77414
g63363
sVCytochrome P-450 CYP1A2 Inhibitors
p77415
g15036
sVCytochrome P450 3A4 Inhibitors
p77416
g13050
sVAntivirals for treatment of HCV infections
p77417
g31045
sVP-glycoprotein/ABCB1 Substrates
p77418
g35035
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p77419
g69047
sVBSEP/ABCB11 Inhibitors
p77420
g62525
sVCytochrome P-450 CYP3A4 Substrates
p77421
g65279
sVHeterocyclic Compounds, Fused-Ring
p77422
g56123
sVOATP1B3 substrates
p77423
g28530
sVGenito Urinary System and Sex Hormones
p77424
g66182
sVCytochrome P-450 CYP3A Inhibitors
p77425
g60458
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p77426
(dp77427
sVAntiviral Agents
p77428
g30468
sg6522
g57330
sVOATP1B1/SLCO1B1 Inhibitors
p77429
g75619
sVP-glycoprotein/ABCB1 Inhibitors
p77430
g74817
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p77431
g64178
sVCytochrome P-450 CYP1A2 Inhibitors (moderate)
p77432
g27744
ssg11169
(dp77433
g8487
g67039
sg3156
g37213
ssg11172
(dp77434
g2190
g30584
sVBenzene Derivatives
p77435
g61425
sg114
g13088
sVBenzoates
p77436
g30396
sVAcids, Carbocyclic
p77437
g41573
sVToxic Actions
p77438
g49404
sVAmides
p77439
g44341
sVCompounds used in a research, industrial, or household setting
p77440
g76512
sg9162
g69595
sVProtective Agents
p77441
g66799
sg11202
(dp77442
sg4293
g44411
sVBenzamides and benzamide derivatives
p77443
g15377
sg10311
g74308
ssg11175
(dp77444
g9984
g73130
sg9186
g69722
sg492
g16685
sVEnzymes
p77445
g72154
sg7506
g62372
sVEsterases
p77446
g59356
sVCarboxylic Ester Hydrolases
p77447
g36748
sVEnzymes and Coenzymes
p77448
g72085
sVHydrolases
p77449
g76366
sVAlimentary Tract and Metabolism
p77450
g23847
ssg11178
(dp77451
g87
g12946
sg1785
g27185
sg7272
g60776
sg4863
g47965
sg10377
g74681
sg1674
g26358
sg11451
(dp77452
sg11016
g76847
sg1173
g22637
sg5067
g48964
sg1332
g23650
sg4278
g44258
sg183
g13854
sg837
g19987
sg5133
g49299
sg4155
g43252
sg11259
(dp77453
sg918
g20760
ssg11181
(dp77454
g3267
g37889
ssg11184
(dp77455
VAntiinfectives for Systemic Use
p77456
g69661
sVGlycosides
p77457
g68372
sVNephrotoxic agents
p77458
g57717
sVAminoglycoside Antibacterials
p77459
g52727
sVKanamycin
p77460
g37473
sVAnti-Bacterial Agents
p77461
g38355
sVAntibacterials for Systemic Use
p77462
g32553
sVAnti-Infective Agents
p77463
g54617
sVNarrow Therapeutic Index Drugs
p77464
g50581
ssg11187
(dp77465
g438
g16174
sg2652
g33327
sg11451
(dp77466
sg1371
g24128
sg2274
g31091
sg2460
g32300
sg10512
g75091
sg11166
g77427
sg11385
(dp77467
ssg11190
(dp77468
g11301
(dp77469
sg7521
g62406
sg11934
(dp77470
ssg11193
(dp77471
g11940
(dp77472
sg816
g19704
ssg11196
(dp77473
VDrugs that are Mainly Renally Excreted
p77474
g43977
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p77475
g61384
sVAcids, Acyclic
p77476
g25491
sVMood Stabilizer
p77477
g65956
sVTricarboxylic Acids
p77478
g67949
sVNarrow Therapeutic Index Drugs
p77479
g50559
sVLithium Compounds
p77480
g76141
sVAntimanic Agents
p77481
g65882
ssg11199
(dp77482
g6474
g57179
ssg11202
(dp77483
g11172
g77442
ssg11205
(dp77484
g5532
g51630
sg657
g18360
sg9561
g71369
ssg11208
(dp77485
VAntiinfectives for Systemic Use
p77486
g69660
sVDrugs that are Mainly Renally Excreted
p77487
g43978
sVGlycosides
p77488
g68377
sVAntivirals for Systemic Use
p77489
g59775
sVNucleosides
p77490
g49472
sVAntimetabolites
p77491
g59540
sVRibonucleosides
p77492
g73671
sVNucleic Acids, Nucleotides, and Nucleosides
p77493
g47133
sVAntivirals for treatment of HCV infections
p77494
g31043
sVNoxae
p77495
g65433
sVAntiviral Agents
p77496
g30477
sVToxic Actions
p77497
g49410
sVDirect Acting Antivirals
p77498
g38077
sg6387
g56820
sVNucleosides and Nucleotides
p77499
g39107
sVAnti-Infective Agents
p77500
g54652
sVCarbohydrates
p77501
g61787
ssg11211
(dp77502
g5463
g51238
sg11367
(dp77503
sg7407
g61615
sg8088
g65047
sg801
g19557
sg5514
g51509
ssg11214
(dp77504
g11283
(dp77505
sg10635
g75545
sg2664
g33404
sg42
g12562
sg9165
g69599
sg11016
g76844
sg888
g20389
sg2418
g31890
sg3156
g37174
sg2427
g31961
sg9960
g72982
sg915
g20675
sg3930
g41650
sg10728
g75872
sg6966
g59384
sg1704
g26696
sg8487
g67013
sg933
g20797
sg9252
g70030
sg789
g19455
sg8514
g67090
sg6303
g56176
sg3978
g41951
sg6318
g56318
sg10497
g75002
sg2523
g32723
sg10815
g76260
sg10356
g74548
sg7029
g59615
sg1008
g21256
sg4017
g42263
sg2559
g32916
sg7056
g59833
sg11595
(dp77506
sg240
g14162
sg12066
(dp77507
sg1044
g21522
sg780
g19325
sg6156
g55204
sg1605
g25759
sg294
g14716
sg11655
(dp77508
sg288
g14638
sg8655
g67565
sg3363
g38397
sg4101
g42953
sg9417
g70722
sg9462
g70968
sg3381
g38451
sg345
g15196
sg7941
g64248
sg1134
g22302
sg7152
g60192
sg8028
g64803
sg537
g17007
sg23
g12193
sg8721
g67839
sg7176
g60335
sg10056
g73372
sg387
g15581
sg5256
g50021
sg1281
g23355
sg1194
g22799
sg414
g15924
sg6921
g59251
sg1908
g28256
sg9198
g69848
sg10266
g74057
sg9393
g70578
sg11793
(dp77509
sg450
g16309
sg10308
g74255
sg168
g13607
sg2658
g33396
sg1263
g23175
sg6261
g55835
sg5781
g53095
sg5877
g53707
sg2814
g34496
sg7299
g60890
sg2910
g35533
sg8097
g65062
sg4458
g45466
sg6639
g57953
sg5919
g53951
sg10959
g76716
sg7320
g61064
sg1413
g24430
sg564
g17383
sg1809
g27414
sg1668
g26229
sg4344
g44621
sg8874
g68532
sg5169
g49478
sg11931
(dp77510
sg11112
g77185
sg630
g17993
sg633
g18061
sg2199
g30659
sg7422
g61802
sg8163
g65438
sg11979
(dp77511
sg1434
g24611
sg10470
g74886
sg9711
g71965
sg4266
g44195
sg8295
g65964
sg8259
g65849
sg5487
g51349
sg6468
g57061
sg7497
g62294
sg3018
g36118
sg10854
g76449
sg10596
g75426
sg2316
g31285
sg10602
g75470
sg9981
g73079
sg11790
(dp77512
sg9864
g72452
ssg11217
(dp77513
g8193
g65589
sg2862
g35150
sg735
g19129
sg1980
g28794
sg11040
g76924
sg10953
g76704
sg3216
g37519
ssg11220
(dp77514
g11781
(dp77515
ssg11223
(dp77516
g11910
(dp77517
sg2262
g30943
sg3444
g38853
ssg11226
(dp77518
g4629
g46430
ssg11229
(dp77519
VAgents Causing Muscle Toxicity
p77520
g55395
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p77521
(dp77522
sVCytochrome P-450 CYP3A Substrates
p77523
g45156
sVAgents causing hyperkalemia
p77524
g43626
sVPyrimidines
p77525
g47691
sVCentral Nervous System Agents
p77526
g58499
sVPotential QTc-Prolonging Agents
p77527
g70434
sVOCT2 Inhibitors
p77528
g42464
sVFolic Acid Antagonists
p77529
(dp77530
sVEnzyme Inhibitors
p77531
g72728
sVCytochrome P-450 Enzyme Inhibitors
p77532
g62047
sVAnti-Infective Agents
p77533
g54654
sVRenal Agents
p77534
g24766
sVAntiinfectives for Systemic Use
p77535
g69676
sVDrugs that are Mainly Renally Excreted
p77536
g43981
sVCytochrome P-450 CYP2C8 Substrates
p77537
g76584
sg2799
g34435
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77538
g29445
sVAntiprotozoals
p77539
g59365
sVQTc Prolonging Agents
p77540
g57862
sVCytochrome P-450 CYP2C8 Inhibitors
p77541
g55037
sVAnti-Infective Agents, Urinary
p77542
g25222
sVAnti-Dyskinesia Agents
p77543
g50479
sVP-glycoprotein/ABCB1 Inducers
p77544
g70553
sVAntiparasitic Agents
p77545
g40646
sVCytochrome P-450 CYP2C9 Substrates
p77546
g29798
sVAntibacterials for Systemic Use
p77547
g32573
sVCytochrome P-450 CYP3A4 Substrates
p77548
g65282
sVAntimycobacterials
p77549
g22562
sVDrugs for Treatment of Tuberculosis
p77550
(dp77551
sVP-glycoprotein/ABCB1 Inhibitors
p77552
g74820
sVChemically-Induced Disorders
p77553
g21219
ssg11232
(dp77554
g6333
g56451
sg6336
g56508
ssg11235
(dp77555
g11793
(dp77556
sg516
g16872
sg4035
g42431
sg6318
g56369
sg2013
g28921
sg11265
(dp77557
sg6045
g54707
sg10674
g75707
sg2658
g33370
sg6156
g55226
sg7284
g60842
sg11655
(dp77558
sg5694
g52547
sg12534
g52651
sg534
g16992
sg1707
g26780
sg10959
g76731
sg3393
g38564
sg1134
g22334
sg9393
g70602
sg8703
g67769
sg8463
g66905
sg6303
g56224
sg4653
g46705
sg3570
g39484
sg9465
g71007
sg8187
g65547
sg14872
g15732
sg1092
g21981
sg8724
g67910
ssg11238
(dp77559
g2736
g33938
sg8760
g67985
sg9909
g72682
sg2466
g32327
ssg11241
(dp77560
VAgents Causing Muscle Toxicity
p77561
g55404
sVAmidines
p77562
(dp77563
sVCytochrome P-450 CYP3A4 Inhibitors
p77564
g61709
sVGastric Acid Lowering Agents
p77565
g67249
sVCytochrome P-450 CYP2D6 Inhibitors
p77566
g62958
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p77567
g41087
sVNeurotransmitter Agents
p77568
g75573
sVMATE 1 Inhibitors
p77569
g68662
sVHistamine Agents
p77570
g75607
sVCytochrome P-450 CYP3A7 Inhibitors
p77571
g72550
sVOAT1/SLC22A6 Substrates
p77572
g60724
sVBSEP/ABCB11 Inhibitors
p77573
g62527
sVOCT2 Inhibitors
p77574
g42480
sVMATE 2 Inhibitors
p77575
g52717
sVCytochrome P-450 CYP2C9 Inhibitors
p77576
g18259
sVCytochrome P-450 Enzyme Inhibitors
p77577
g62013
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p77578
g18431
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p77579
(dp77580
sVAcid Reducers
p77581
g43812
sVDrugs that are Mainly Renally Excreted
p77582
g43924
sVMATE substrates
p77583
(dp77584
sVEnzyme Inhibitors
p77585
g72736
sVDrugs for Acid Related Disorders
p77586
g55174
sVOAT3/SLC22A8 Inhibitors
p77587
g59014
sVCytochrome P-450 CYP2E1 Inhibitors
p77588
g46849
sVHistamine H2 Antagonists
p77589
g12710
sVCytochrome P-450 CYP3A7 Inhibitors (moderate)
p77590
g74477
sVOAT1/SLC22A6 inhibitors
p77591
(dp77592
sVOCT2 substrates with narrow therapeutic index
p77593
g29697
sVImidazoles
p77594
(dp77595
sVAnti-Ulcer Agents
p77596
g73070
sVMATE 1 Substrates
p77597
g23497
sVGastrointestinal Agents
p77598
g70844
sVDrugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
p77599
g67786
sVOCT1 substrates
p77600
g13085
sVCytochrome P-450 CYP1A2 Inhibitors
p77601
g15051
sVCytochrome P-450 CYP2C8 Inhibitors
p77602
g55049
sVOAT3/SLC22A8 Substrates
p77603
g13131
sVP-glycoprotein/ABCB1 Inducers
p77604
g70563
sVP-glycoprotein/ABCB1 Substrates
p77605
g35088
sVCytochrome P-450 CYP3A5 Inhibitors
p77606
g55351
sVCytochrome P-450 CYP2C19 Inhibitors
p77607
g61287
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p77608
g26887
sVAlimentary Tract and Metabolism
p77609
g23944
sVMATE 2 Substrates
p77610
g44490
sVMATE inhibitors
p77611
g58950
sVMyelosuppressive Agents
p77612
g71341
sVOCT2 Substrates
p77613
g14954
sVGuanidines
p77614
g71101
sVCytochrome P-450 CYP3A Inhibitors
p77615
g60472
sVImmunosuppressive Agents
p77616
g64598
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p77617
g76819
sVAdjuvants
p77618
g50700
sVCytochrome P-450 CYP3A5 Inhibitors (moderate)
p77619
g30489
sVHistamine Antagonists
p77620
g43455
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p77621
g24197
sVCytochrome P-450 CYP1A2 Inhibitors (weak)
p77622
g30535
sVChemically-Induced Disorders
p77623
g21249
sVCytochrome P-450 CYP3A4 Inhibitors (weak)
p77624
g52097
sVOCT1 inhibitors
p77625
g66930
ssg11244
(dp77626
g2676
g33541
sg9153
g69569
ssg11247
(dp77627
g23
g12203
sg7176
g60347
sg1605
g25782
sg7320
g61069
sg3363
g38407
sg168
g13625
ssg11250
(dp77628
g1782
g27138
sg8019
g64725
sg7464
g62156
sg4425
g44920
sg10818
g76320
sg4635
g46474
sg10296
g74223
sg10314
g74318
sg4929
g48435
sg6273
g55907
sg2928
g35637
sg10977
g76786
sg1491
g25061
sg7569
g62714
sg10578
g75346
sg3408
g38691
sg11067
g77033
sg10548
g75203
sg3447
g38916
sg336
g15081
sg1770
g27048
sg6162
g55277
ssg11253
(dp77629
g219
g14086
sg6867
g59059
sg5463
g51245
sg9924
g72847
sg11403
(dp77630
sg11961
(dp77631
sg7962
g64427
sg4821
g47754
sg2397
g31791
sg9324
g70336
sg8796
g68154
sg4365
g44764
sg4890
g48122
sg4830
g47793
sg7407
g61620
sg9033
g69027
sg4278
g44275
sg11976
(dp77632
sg1659
g26213
sg9084
g69205
sg3885
g41435
sg1062
g21800
sg2598
g33129
sg8808
g68193
sg5313
g50386
sg3519
g39214
sg2355
g31440
sg10338
g74473
sg4287
g44379
sg339
g15159
sg5889
g53773
sg8457
g66843
sg2253
g30906
sg9216
g69882
sg5514
g51515
sg6447
g57017
sg11097
g77138
sg10149
g73644
sg6981
g59462
sg4053
g42560
sg5112
g49166
sg10347
g74503
sg9081
g69160
sg132
g13233
sg10002
g73214
sg10416
g74776
sg4338
g44580
sg816
g19646
sg7698
g63330
sg2688
g33621
sg8088
g65053
sg5571
g51781
sg5094
g49094
sg10581
g75359
sg6015
g54381
sg12126
(dp77633
sg11367
(dp77634
sg2172
g30508
sg11940
(dp77635
sg1185
g22714
sg6348
g56631
sg801
g19551
sg11259
(dp77636
ssg11256
(dp77637
g8856
g68432
sg396
g15790
sg837
g19983
ssg11259
(dp77638
VDrugs that are Mainly Renally Excreted
p77639
g43945
sVPyrimidines
p77640
g47717
sVCytochrome P-450 CYP2D6 Substrates
p77641
g52130
sVCytochrome P-450 CYP3A Substrates
p77642
g45121
sVPyrimidinones
p77643
g77453
sVDPP-IV Inhibitors
p77644
(dp77645
sVAgents causing angioedema
p77646
g63913
sVHormones, Hormone Substitutes, and Hormone Antagonists
p77647
g53147
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77648
g29402
sVOral Hypoglycemics
p77649
g36010
sVHormones
p77650
g55664
sVEnzyme Inhibitors
p77651
g72700
sVIncretins
p77652
g20135
sVCytochrome P-450 CYP3A4 Substrates
p77653
g65265
sVBlood Glucose Lowering Agents
p77654
g77636
sVAlimentary Tract and Metabolism
p77655
g23805
sVDrugs Used in Diabetes
p77656
g60126
ssg11262
(dp77657
g219
g14076
sg8373
g66322
sg9357
g70455
sg1659
g26204
sg9192
g69742
sg11241
g77584
sg5646
g52322
sg2598
g33121
sg6981
g59456
sg13070
g21889
sg2481
g32406
sg9033
g69021
sg9444
g70939
sg3399
g38624
sg8211
g65667
sg5271
g50160
sg4005
g42159
sg8922
g68689
sg9180
g69700
ssg11265
(dp77658
VCentral Nervous System Depressants
p77659
(dp77660
sVAntiemetics
p77661
g77557
sVGastrointestinal Agents
p77662
g70833
sVAutonomic Agents
p77663
g66574
sVPotential QTc-Prolonging Agents
p77664
g70436
sVHistamine H1 Antagonists
p77665
g40769
sVPeripheral Nervous System Agents
p77666
g57642
sVNeurotransmitter Agents
p77667
g75589
sVHistamine Agents
p77668
g75603
sVAminoalkyl Ethers
p77669
g19317
sVHistamine Antagonists
p77670
g43427
sVMuscarinic Antagonists
p77671
g48862
sVPyridines
p77672
g64226
sVAgents producing tachycardia
p77673
g50791
sVAntihistamines for Systemic Use
p77674
g12961
sg4896
g48131
sVQTc Prolonging Agents
p77675
g57867
sVCentral Nervous System Agents
p77676
g58505
sVEthanolamine Derivatives
p77677
g58782
sVAnticholinergic Agents
p77678
g24476
ssg11268
(dp77679
VToxic Actions
p77680
g49396
sVHypolipidemic Agents
p77681
g69890
sVGastrointestinal Agents
p77682
g70840
sVAmines
p77683
g42669
sg2472
g32368
sVQuaternary Ammonium Compounds
p77684
g43367
sVOnium Compounds
p77685
g22251
sVNoxae
p77686
g65425
sVNitrogen Compounds
p77687
g38999
sg6306
g56250
sVCholinesterase Inhibitors
p77688
g72394
sVAmino Acids and Derivatives
p77689
g63584
sVDigestives, Incl. Enzymes
p77690
g77308
sVTrimethyl Ammonium Compounds
p77691
g16043
sg4308
g44472
sVAcid Preparations
p77692
g50328
sVLipid Regulating Agents
p77693
g72478
sg6693
g58206
sVAlimentary Tract and Metabolism
p77694
g23776
sVOther Miscellaneous Therapeutic Agents
p77695
g28775
sVAmmonium Compounds
p77696
g30553
ssg11271
(dp77697
g6207
g55590
sg6186
g55494
sg9996
g73186
sg8028
g64815
sg69
g12750
sg7041
g59691
ssg11274
(dp77698
g1212
g22875
sg6564
g57515
sg3654
g40151
sVPotential QTc-Prolonging Agents
p77699
g70437
sg7251
g60734
sVHormones
p77700
g55652
sVHyperglycemia-Associated Agents
p77701
g68817
sVPeptide Hormones
p77702
g20212
sg8631
g67518
sVReproductive Control Agents
p77703
g18834
sVQTc Prolonging Agents
p77704
g57870
sVAntineoplastic Agents
p77705
g71551
sg9021
g68974
sVAdrenal Cortex Hormones
p77706
g30002
sVProteins
p77707
g52786
sVAntineoplastic Agents, Hormonal
p77708
(dp77709
sg11511
(dp77710
sVGonadotropin-releasing hormone agonist
p77711
g71280
sVAmino Acids, Peptides, and Proteins
p77712
g47406
sg8157
g65410
sVPeptides
p77713
g47206
sVHormones and Related Agents
p77714
g57372
sVAntineoplastic and Immunomodulating Agents
p77715
g39814
sVHormones, Hormone Substitutes, and Hormone Antagonists
p77716
g53131
sVEndocrine Therapy
p77717
g19566
ssg11277
(dp77718
VNeurotransmitter Agents
p77719
g75590
sVAnti-Parkinson Drugs
p77720
g16145
sVAnti-Dyskinesia Agents
p77721
g50482
sVCentral Nervous System Agents
p77722
g58507
sVCholinergic Agents
p77723
g28718
sVPyrrolidines
p77724
g59352
sVAgents producing tachycardia
p77725
g50792
sVTertiary Amines
p77726
g43803
sVNervous System
p77727
g70305
sVMuscarinic Antagonists
p77728
g48864
sVAnticholinergic Agents
p77729
g24481
ssg11280
(dp77730
g690
g18614
sg16906
g61908
sg2829
g34638
sg10113
g73573
sg11838
(dp77731
sg10122
g73604
sg7353
g61337
sg4479
g45691
sg8448
g66755
sg9963
g73003
sg3657
g40173
sg7377
g61493
sg4920
g48338
sg3021
g36191
sg3963
g41868
sg5238
g49890
sg4539
g46026
sg1539
g25305
sg9273
g70165
sg2142
g30351
sg966
g21039
sg10878
g76534
ssg11283
(dp77732
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p77733
g52073
sVSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p77734
g77505
sVCytochrome P-450 CYP3A4 Inhibitors
p77735
g61626
sVCytochrome P-450 CYP2D6 Inhibitors
p77736
g62931
sVCytochrome P-450 CYP2D6 Substrates
p77737
g52106
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p77738
g76917
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p77739
g41064
sVAnalgesics
p77740
g26422
sVCentral Nervous System Agents
p77741
g58402
sVPsychotropic Drugs
p77742
g72599
sVThiophenes
p77743
g59029
sVCytochrome P-450 Enzyme Inhibitors
p77744
g61975
sVPeripheral Nervous System Agents
p77745
g57571
sVSelective Serotonin Reuptake Inhibitors
p77746
g39075
sVDrugs that are Mainly Renally Excreted
p77747
g43861
sVCytochrome P-450 CYP1A2 Substrates
p77748
g45562
sVPsychoanaleptics
p77749
g59066
sVSerotonin and Noradrenaline Reuptake Inhibitors
p77750
g50964
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77751
g29287
sVSulfur Compounds
p77752
(dp77753
sVSerotonin Agents
p77754
g76432
sVCytochrome P-450 CYP2C9 Substrates
p77755
g29702
sVCytochrome P-450 CYP3A Substrates
p77756
g45027
sVCentral Nervous System Depressants
p77757
(dp77758
sVNeurotransmitter Uptake Inhibitors
p77759
g52386
sVMembrane Transport Modulators
p77760
g54115
sVCytochrome P-450 CYP3A4 Substrates
p77761
g65224
sVSerotonin Modulators
p77762
g69127
sVAntidepressive Agents
p77763
g15494
sVCytochrome P-450 CYP3A Inhibitors
p77764
g60381
sVHypoglycemia-Associated Agents
p77765
g17671
sVNorepinephrine Uptake Inhibitors
p77766
g33273
sVP-glycoprotein/ABCB1 Inhibitors
p77767
g74799
sVAgents producing tachycardia
p77768
g50740
sVSensory System Agents
p77769
g71799
sVNervous System
p77770
g70264
ssg11286
(dp77771
VAmino Acids, Peptides, and Proteins
p77772
g47320
sg7356
g61354
sg4560
g46174
sVAntibodies, Monoclonal
p77773
g73310
sVSelective Immunosuppressants
p77774
g23569
sVProteins
p77775
g52742
sVImmunologic Factors
p77776
g42384
sVImmunoglobulins
p77777
g41521
sVImmunosuppressive Agents
p77778
g64590
sVAntibodies
p77779
g60983
sg11850
(dp77780
sVSerum Globulins
p77781
g49653
sVAntineoplastic and Immunomodulating Agents
p77782
g39816
sVBlood Proteins
p77783
g39853
sVGlobulins
p77784
g19174
sVImmunoproteins
p77785
g57446
ssg11289
(dp77786
g1113
g22210
ssg11292
(dp77787
VCardiovascular Agents
p77788
g26667
sg2697
g33716
sVNeurotransmitter Agents
p77789
g75592
sg5937
g54113
sVPyridines
p77790
g64233
sVVasodilating Agents
p77791
g23700
sVHistamine Agents
p77792
g75605
sVHistamine Antagonists
p77793
g43438
sg7806
g63703
sVNervous System
p77794
g70307
sVMiscellaneous Therapeutic Agents
p77795
g74024
ssg11295
(dp77796
g1947
g28685
sg2559
g32956
sg546
g17145
sg1890
g28014
sg3393
g38590
sg14872
g15765
sg1263
g23209
sg4287
g44401
sg6792
g58725
sg1059
g21760
ssg11298
(dp77797
g9393
g70619
sg7464
g62198
sg11793
(dp77798
sg10818
g76356
sg1188
g22789
sg6729
g58336
sg4635
g46520
sg11727
(dp77799
sg7941
g64321
sg7569
g62756
sg8394
g66385
sg10815
g76304
sg1491
g25121
sg3447
g38969
sg11979
(dp77800
sg1770
g27072
ssg11301
(dp77801
VFibrin Modulating Agents
p77802
g22851
sVHematologic Agents
p77803
g73844
sVBlood and Blood Forming Organs
p77804
g53924
sVCardiovascular Agents
p77805
g26670
sVOphthalmologicals
p77806
g35261
sVAnticoagulants
p77807
g58374
sVCarbohydrates
p77808
g61793
sVAgents causing hyperkalemia
p77809
g43636
sVNarrow Therapeutic Index Drugs
p77810
g50564
sVSensory Organs
p77811
g40745
sg11190
g77469
sVThyroxine-binding globulin substrates
p77812
g60174
sg5412
g50911
sVVasoprotectives
p77813
g41389
sVMiscellaneous Therapeutic Agents
p77814
g74019
sVPolysaccharides
p77815
g41770
sg1647
g26079
sVAntivaricose Therapy
p77816
g30539
sg9717
g72007
sg2781
g34337
ssg11304
(dp77817
g2451
g32205
sg11229
g77530
sg3753
g40615
sg10950
g76692
sg11775
(dp77818
sg2667
g33515
sg2079
g29856
ssg11307
(dp77819
g11361
(dp77820
ssg11310
(dp77821
g4911
g48248
sg3024
g36299
ssg11313
(dp77822
VDrugs that are Mainly Renally Excreted
p77823
g43878
sVCytochrome P-450 CYP1A2 Substrates
p77824
g45631
sVMyelosuppressive Agents
p77825
g71338
sVToxic Actions
p77826
g49395
sVNoxae
p77827
g65424
sg10689
g75747
sVImmunosuppressive Agents
p77828
g64593
sVAlkylating Activity
p77829
g46194
sVAlkylating Drugs
p77830
g70062
sVAntineoplastic and Immunomodulating Agents
p77831
g39765
sg3258
g37807
sVImidazoles
p77832
(dp77833
sVAntineoplastic Agents
p77834
g71536
sVAntineoplastic Agents, Alkylating
p77835
g60745
ssg11316
(dp77836
VCytochrome P-450 CYP3A4 Inhibitors
p77837
g61708
sVGonadal Steroid Hormones
p77838
g67216
sVCytochrome P-450 CYP3A Substrates
p77839
g45162
sVHormones
p77840
g55695
sVTestosterone Congeners
p77841
g48674
sVCytochrome P-450 CYP2B6 Substrates
p77842
g33024
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p77843
g43789
sVCytochrome P-450 Enzyme Inhibitors
p77844
g62051
sVDrugs that are Mainly Renally Excreted
p77845
g43988
sVCytochrome P-450 CYP2C8 Substrates
p77846
g76586
sVCytochrome P-450 CYP2B6 Inducers
p77847
g39123
sg8982
g68823
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77848
g29453
sVCytochrome P-450 CYP2C9 Substrates
p77849
g29815
sVFused-Ring Compounds
p77850
g14884
sVCytochrome P-450 CYP3A4 Inducers
p77851
g18972
sg531
g16958
sg10749
g76017
sg7131
g60165
sVAndrogens
p77852
g73759
sVCytochrome P-450 Enzyme Inducers
p77853
g28236
sVCytochrome P-450 CYP3A Inducers
p77854
g66289
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p77855
g44546
sVCytochrome P-450 CYP3A4 Substrates
p77856
g65285
sVGonadal Hormones
p77857
g33575
sVCytochrome P-450 CYP3A5 Substrates
p77858
g67829
sVSteroids
p77859
g56423
sVCytochrome P-450 CYP3A Inhibitors
p77860
g60471
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p77861
g64624
sVBCRP/ABCG2 Substrates
p77862
g42076
sg9294
g70212
sVP-glycoprotein/ABCB1 Inhibitors
p77863
g74827
sVHormones, Hormone Substitutes, and Hormone Antagonists
p77864
g53189
sVCytochrome P-450 CYP3A7 Substrates
p77865
g60671
ssg11319
(dp77866
VAdrenergic beta-Agonists
p77867
g43000
sVOphthalmologicals
p77868
g35262
sVNeurotransmitter Agents
p77869
g75594
sVCentral Nervous System Agents
p77870
g58513
sVAdrenergic and Dopaminergic Agents
p77871
g51107
sVSympathomimetics
p77872
g48818
sVSympathomimetics, Plain
p77873
g14442
sVAlpha-and Beta-adrenergic Agonists
p77874
g26142
sVSympathomimetic (Adrenergic) Agents
p77875
g75935
sVNasal Preparations
p77876
g73283
sVAutonomic Agents
p77877
g66575
sVCardiac Stimulants Excl. Cardiac Glycosides
p77878
g29156
sVCardiac Therapy
p77879
g69635
sVEthylamines
p77880
g20595
sVCentral Nervous System Stimulants
p77881
g51443
sVCholinesterase substrates
p77882
g41632
sVDrugs for Obstructive Airway Diseases
p77883
g42518
sVCentrally Acting Antiobesity Products
p77884
g50363
sVAdrenergic Agents
p77885
g41712
sVCardiovascular Agents
p77886
g26675
sVAdrenergics for Systemic Use
p77887
g59035
sVVasoconstrictor Agents
p77888
g35883
sVIncreased Norepinephrine Activity
p77889
(dp77890
sVSensory Organs
p77891
g40746
sVEphedrine
p77892
g44407
sVAdrenergic Agonists
p77893
g76836
sVAgents that produce hypertension
p77894
g69086
sVAlimentary Tract and Metabolism
p77895
g23837
sVPropanolamines
p77896
g37503
sVAmines
p77897
g42738
sVMydriatics and Cycloplegics
p77898
g47433
sVAmino Alcohols
p77899
g32678
sVAdrenergic alpha-Agonists
p77900
g65397
sVSympathomimetics Excl. Antiglaucoma Preparations
p77901
g59284
sVPropanols
p77902
g56548
sVPeripheral Nervous System Agents
p77903
g57648
sVAgents producing tachycardia
p77904
g50796
sVAntiobesity Preparations, Excl. Diet Products
p77905
g39834
sVPhenethylamines
p77906
(dp77907
sVHerbs and Natural Products
p77908
g19491
sVAlcohols
p77909
(dp77910
sVNorepinephrine Releasing Agent
p77911
g69436
ssg11322
(dp77912
g42
g12592
sg10602
g75483
sg1809
g27442
ssg11325
(dp77913
g10596
g75466
ssg11328
(dp77914
g3126
g36958
sg1149
g22503
ssg11331
(dp77915
g5598
g52050
sg9093
g69272
sg11652
(dp77916
sg210
g14011
sg9264
g70103
ssg11334
(dp77917
VPyrimidines
p77918
g47706
sVAntivirals for Systemic Use
p77919
g59773
sVCarbohydrates
p77920
g61795
sVDirect Acting Antivirals
p77921
g38075
sVHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
p77922
g63012
sVAntiviral Agents
p77923
g30467
sVAnti-Infective Agents
p77924
g54671
sVNucleotides
p77925
g49317
sVAntiinfectives for Systemic Use
p77926
g69684
sVDrugs that are Mainly Renally Excreted
p77927
g43989
sVRibonucleotides
p77928
g46854
sVUracil Nucleotides
p77929
g72089
sVGlycosides
p77930
g68371
sVRibonucleosides
p77931
g73669
sVAntivirals for treatment of HCV infections
p77932
g31041
sVNucleic Acids, Nucleotides, and Nucleosides
p77933
g47129
sVP-glycoprotein/ABCB1 Substrates
p77934
g35079
sVPyrimidine Nucleosides
p77935
(dp77936
sVRNA Replicase Inhibitors
p77937
g59486
sVPyrimidine Nucleotides
p77938
g48570
sVNucleosides
p77939
g49470
sVUridine Monophosphate
p77940
g68592
sVBCRP/ABCG2 Substrates
p77941
g42086
ssg11337
(dp77942
VAgents Causing Muscle Toxicity
p77943
g55364
sVAntiparasitic Products, Insecticides and Repellents
p77944
g30577
sVCytochrome P-450 CYP3A4 Inhibitors
p77945
g61639
sVAntimalarials
p77946
g14098
sVQuinolines
p77947
g74118
sVCytochrome P-450 CYP2D6 Inhibitors
p77948
g62910
sVCytochrome P-450 CYP3A Substrates
p77949
g45041
sVPotential QTc-Prolonging Agents
p77950
g70407
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p77951
g43736
sVCytochrome P-450 Enzyme Inhibitors
p77952
g61984
sVAnti-Infective Agents
p77953
g54573
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p77954
g18417
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p77955
g29305
sVAntiprotozoals
p77956
g59369
sVQTc Prolonging Agents
p77957
g57799
sVAgents that reduce seizure threshold
p77958
g45865
sVP-glycoprotein/ABCB1 Substrates
p77959
g34931
sVAminoquinolines
p77960
g55118
sVAntiparasitic Agents
p77961
g40654
sVCytochrome P-450 CYP3A4 Substrates
p77962
g65230
sVHeterocyclic Compounds, Fused-Ring
p77963
g56029
sVCytochrome P-450 CYP3A Inhibitors
p77964
g60395
sVCholinesterase Inhibitors
p77965
g72398
sVMethanolquinolines
p77966
(dp77967
sVP-glycoprotein/ABCB1 Inhibitors
p77968
g74805
ssg11340
(dp77969
g10200
g73827
ssg11343
(dp77970
g10815
g76294
sg405
g15871
ssg11346
(dp77971
g3174
g37273
sg30
g12390
sg9096
g69309
sg2739
g34018
sg5865
g53618
ssg11349
(dp77972
VAmino Acids, Peptides, and Proteins
p77973
g47393
sVGlobulins
p77974
g19192
sVAntibodies
p77975
g60990
sVAntibodies, Monoclonal
p77976
g73311
sVAntibodies, Monoclonal, Humanized
p77977
g76168
sVAntineoplastic Agents, Immunological
p77978
g62961
sVImmunoglobulins
p77979
g41533
sVProteins
p77980
g52791
sg9039
g69038
sg1182
g22699
sVSerum Globulins
p77981
g49663
sVAntineoplastic and Immunomodulating Agents
p77982
g39800
sVBlood Proteins
p77983
g39869
sVAntineoplastic Agents
p77984
g71547
sVImmunoproteins
p77985
g57456
ssg11352
(dp77986
VMydriatics and Cycloplegics
p77987
g47431
sVAnticholinergic Agents
p77988
g24507
sVParasympatholytics
p77989
g35948
sVNeurotransmitter Agents
p77990
g75596
sVAcids, Carbocyclic
p77991
g41579
sVPeripheral Nervous System Agents
p77992
g57653
sVCholinergic Agents
p77993
g28730
sVMydriatics
p77994
g49202
sVSensory Organs
p77995
g40752
sVCholinesterase substrates
p77996
g41630
sVOphthalmologicals
p77997
g35270
sVPhenylacetates
p77998
g34420
sVMuscarinic Antagonists
p77999
g48884
sVAutonomic Agents
p78000
g66578
ssg11355
(dp78001
g4911
g48280
sg12000
(dp78002
sg4017
g42298
sg11229
g77551
sg4881
g48057
sg12078
(dp78003
sg11541
(dp78004
sg12003
(dp78005
sg3849
g41173
sg7662
g63171
sg4773
g47483
sg12123
(dp78006
sg10305
g74248
ssg11358
(dp78007
VTerpenes
p78008
g75721
sVAnti-Infective Agents
p78009
g54674
sVAntibiotics for Topical Use
p78010
g57689
sVCytochrome P-450 CYP3A Substrates
p78011
g45167
sVDermatologicals
p78012
g17328
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78013
g29459
sg9219
g69887
sVAnti-Bacterial Agents
p78014
g38388
sVCytochrome P-450 CYP3A4 Substrates
p78015
g65287
ssg11361
(dp78016
g11307
g77820
sVNitrogen Compounds
p78017
g39003
sVAmines
p78018
g42745
sVDrugs that are Mainly Renally Excreted
p78019
g43990
sVOnium Compounds
p78020
g22255
sVOAT3/SLC22A8 Substrates
p78021
g13144
sg2001
g28846
sVVitamin B Complex
p78022
g54912
sVVitamins
p78023
g12180
sVAmino Acids and Derivatives
p78024
g63583
sVOATP1B1/SLCO1B1 Inhibitors
p78025
g75622
sg11937
(dp78026
sVTrimethyl Ammonium Compounds
p78027
g16040
sVQuaternary Ammonium Compounds
p78028
g43370
sVAlimentary Tract and Metabolism
p78029
g23940
sVAmmonium Compounds
p78030
g30557
ssg11364
(dp78031
g11712
(dp78032
sg3990
g42108
ssg11367
(dp78033
VAmino Acids, Peptides, and Proteins
p78034
g47418
sVDrugs that are Mainly Renally Excreted
p78035
g43991
sVGlucagon-like peptide-1 (GLP-1) analogues
p78036
g61313
sVIncretin Mimetics
p78037
g16680
sVGlucagon-like Peptide-1 (GLP-1) Agonists
p78038
g44480
sVGLP-1 Agonists
p78039
g77503
sg9501
g71139
sVBlood Glucose Lowering Agents
p78040
g77634
sVAlimentary Tract and Metabolism
p78041
g23921
sVDrugs Used in Diabetes
p78042
g60125
ssg11370
(dp78043
VAntiparasitic Products, Insecticides and Repellents
p78044
g30587
sVCytochrome P-450 CYP3A Substrates
p78045
g45168
sVCarbamates
p78046
g45516
sVAnthelmintics
p78047
g45522
sVAntimitotic Agents
p78048
g60134
sVCytochrome P-450 CYP1A2 Substrates
p78049
g45642
sVHeterocyclic Compounds, Fused-Ring
p78050
g56168
sVAnti-Infective Agents
p78051
g54665
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78052
g29460
sVP-glycoprotein/ABCB1 Inhibitors
p78053
g74830
sVAntihelminthic
p78054
g32195
sVCytochrome P-450 CYP2C19 Substrates
p78055
g53902
sVCytochrome P-450 CYP1A2 Inducers
p78056
g68387
sVAntinematodal Agents
p78057
(dp78058
sg7323
g61108
sVAntiparasitic Agents
p78059
g40650
sVCytochrome P-450 Enzyme Inducers
p78060
g28231
sVCytochrome P-450 CYP1A2 Inducers (unknown strength)
p78061
g17457
sVCytochrome P-450 CYP3A4 Substrates
p78062
g65288
sg5868
g53635
sVMitosis Modulators
p78063
g33589
sVBenzimidazoles
p78064
g72246
sVAcids, Acyclic
p78065
g25437
sg1386
g24186
sVTubulin Modulators
p78066
g33857
sVBenzimidazole Derivatives
p78067
g54281
ssg11373
(dp78068
g6906
g59232
sg3318
g38207
ssg11376
(dp78069
g465
g16497
sg612
g17885
sg11445
(dp78070
sg11319
g77890
sg2067
g29647
ssg11379
(dp78071
VAmino Acids, Peptides, and Proteins
p78072
g47363
sg921
g20780
sg1158
g22557
sVExpectorants
p78073
g49260
sg2202
g30723
sVEnzymes
p78074
g72156
sVProteins
p78075
g52761
sg6810
g58845
sVEsterases
p78076
g59360
sVDecreased Respiratory Secretion Viscosity
p78077
g76829
sVEnzymes and Coenzymes
p78078
g72087
sVCough and Cold Preparations
p78079
g65514
sVHydrolases
p78080
g76368
ssg11382
(dp78081
VAgents that produce neuromuscular block (indirect)
p78082
g37985
sVElectrolyte Solutions
p78083
g20032
sVMagnesium Compounds
p78084
g33048
sVCalculi Dissolution Agent
p78085
g12690
sVMetal divalent cations
p78086
g65846
sVDrugs that are Mainly Renally Excreted
p78087
g43992
sVElectrolytes
p78088
g52431
sVMineral Supplements
p78089
g38304
sVChlorine Compounds
p78090
g33270
sVMinerals
p78091
g52589
sVI.V. Solution Additives
p78092
g37236
sVHydrochloric Acid
p78093
g71564
sVBlood and Blood Forming Organs
p78094
g53942
sVChlorides
p78095
g27983
sVAcids
p78096
g40593
sVHemodialysis Solution
p78097
g36615
sVAlimentary Tract and Metabolism
p78098
g23945
sVIons
p78099
g49130
sVBlood Substitutes and Perfusion Solutions
p78100
g49448
sVAcids, Noncarboxylic
p78101
g54215
sVAnions
p78102
g71794
sVMetal cations
p78103
g40808
ssg11385
(dp78104
VCytochrome P-450 CYP3A4 Inhibitors
p78105
g61674
sVAntivirals for Systemic Use
p78106
g59780
sg4422
g44903
sVFatty Acids
p78107
g63157
sVCytochrome P-450 CYP2D6 Substrates
p78108
g52160
sVUGT1A1 Substrates
p78109
g12343
sVCytochrome P-450 CYP3A7 Inhibitors
p78110
g72551
sVDirect Acting Antivirals
p78111
g38086
sVCytochrome P-450 CYP2C19 Inducers
p78112
g25551
sVCytochrome P-450 CYP3A5 Inhibitors (strength unknown)
p78113
g71276
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p78114
g43755
sVCytochrome P-450 CYP2C9 Inducers
p78115
g20062
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p78116
g16539
sVCytochrome P-450 Enzyme Inhibitors
p78117
g62033
sVAntiinfectives for Systemic Use
p78118
g69663
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p78119
g23128
sVCytochrome P-450 CYP2B6 Inducers
p78120
g39137
sg11844
(dp78121
sVP-glycoprotein/ABCB1 Inhibitors
p78122
g74812
sVOATP1B1/SLCO1B1 Substrates
p78123
(dp78124
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p78125
g24788
sVFatty Acids, Volatile
p78126
g66982
sVCytochrome P450 2C19 Inducers
p78127
g57048
sVP-glycoprotein/ABCB1 Substrates
p78128
g34994
sVCytochrome P-450 CYP2C8 Inhibitors
p78129
g55022
sVCytochrome P-450 CYP2C19 Inducers (moderate)
p78130
g59468
sVCytochrome P450 2C9 Inducers
p78131
g61114
sVCytochrome P-450 Enzyme Inducers
p78132
g28181
sVCytochrome P-450 CYP3A5 Inhibitors
p78133
g55353
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p78134
g44554
sVBSEP/ABCB11 Inhibitors
p78135
g62528
sVBCRP/ABCG2 Inhibitors
p78136
g12524
sVHeterocyclic Compounds, Fused-Ring
p78137
g56097
sVUGT1A3 substrates
p78138
g31822
sVOATP1B3 substrates
p78139
g28536
sVAcids, Acyclic
p78140
g25497
sVCytochrome P-450 CYP3A Inhibitors
p78141
g60435
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p78142
g77467
sVOAT3/SLC22A8 Inhibitors
p78143
g59025
sVAntiviral Agents
p78144
g30478
sVCytochrome P450 3A Inhibitors
p78145
g54274
sVOrganic Anion Transporting Polypeptide 1B3 Inhibitors
p78146
g64179
sVLipids
p78147
g14356
ssg11388
(dp78148
g11952
(dp78149
sg6360
g56721
ssg11391
(dp78150
sg11394
(dp78151
g219
g14069
sg2262
g30941
sg4707
g46968
sg1659
g26194
sg2598
g33111
sg6981
g59448
sg9033
g69013
sg5271
g50150
sg3444
g38851
sg10950
g76680
sg11241
g77563
sg10347
g74482
ssg11397
(dp78152
g3627
g39911
sg9198
g69761
sg2196
g30592
sg444
g16230
sg11229
g77522
sg4164
g43274
sg2943
g35731
sg7821
g63782
sg7191
g60530
sg1062
g21792
sg8241
g65769
sg9099
g69322
sg8433
g66628
sg11460
(dp78153
sg3696
g40258
sg4077
g42809
sg9009
g68899
sg9432
g70865
sg9966
g73023
sg10512
g75067
sg534
g16964
sg9225
g69895
sg3024
g36242
sg9618
g71618
sg9231
g69949
sg5238
g49876
sg8298
g66004
sg147
g13415
sg10557
g75255
sg2688
g33607
sg6687
g58167
sg4974
g48595
sg10794
g76173
sg8949
g68731
sg12126
(dp78154
sg6333
g56445
sg7596
g62835
sg1185
g22704
ssg11400
(dp78155
g9267
g70128
ssg11403
(dp78156
g3480
g39021
sVUGT2B7 substrates
p78157
g28628
sVP-glycoprotein/ABCB1 Substrates
p78158
g34903
sVBCRP/ABCG2 Substrates
p78159
g42049
sVUGT1A9 Substrates
p78160
g24001
sVUGT1A1 Inhibitors
p78161
g71649
sg11766
(dp78162
sg4599
g46285
sVBlood Glucose Lowering Agents
p78163
g77630
sVAlimentary Tract and Metabolism
p78164
g23752
sVDrugs Used in Diabetes
p78165
g60107
sVDiuretics
p78166
g57897
ssg11406
(dp78167
g9810
g72212
sg1875
g27885
sg10680
g75731
sg6843
g58959
sg5757
g52915
sg6246
g55785
sg8583
g67311
sg7845
g63949
sg501
g16734
sg5025
g48753
sg10236
g73974
ssg11409
(dp78168
g6921
g59267
sg7176
g60355
sg7593
g62799
sg11154
g77358
sg168
g13639
ssg11412
(dp78169
g426
g16059
sg582
g17613
sg5064
g48917
sg1938
g28546
sg7284
g60827
sg12018
(dp78170
sg5769
g53035
sg2430
g32090
ssg11415
(dp78171
VCatechols
p78172
g76748
sVPhenols
p78173
g65116
sVBenzene Derivatives
p78174
g61395
sg3750
g40598
sg10902
g76639
sg9996
g73194
sVRespiratory System Agents
p78175
g71419
sg5130
g49258
sg8181
g65512
sg5949
g54179
sg1827
g27599
ssg11418
(dp78176
g1599
g25734
ssg11421
(dp78177
g7053
g59793
sg11544
(dp78178
sg1881
g27939
sg7464
g62150
sg3516
g39151
sg10818
g76315
sg4635
g46467
sg6411
g56875
sg7428
g61846
sg2763
g34228
sg7569
g62708
sg5499
g51405
sg3651
g40106
sg3447
g38909
sg2433
g32152
sg4596
g46241
sg10725
g75864
sg1491
g25054
ssg11424
(dp78179
g2886
g35295
ssg11427
(dp78180
VAgents Causing Muscle Toxicity
p78181
g55357
sVDideoxynucleosides
p78182
g48721
sVAntivirals for Systemic Use
p78183
g59753
sVNucleic Acid Synthesis Inhibitors
p78184
g48726
sVCarbohydrates
p78185
g61751
sVPyrimidines
p78186
g47693
sVDirect Acting Antivirals
p78187
g38047
sVAnti-HIV Agents
p78188
g66392
sVBCRP/ABCG2 Substrates
p78189
g42058
sVEnzyme Inhibitors
p78190
g72688
sVReverse Transcriptase Inhibitors
p78191
g28960
sVAnti-Infective Agents
p78192
g54559
sVAntiinfectives for Systemic Use
p78193
g69640
sVDrugs that are Mainly Renally Excreted
p78194
g43997
sVNucleoside and Nucleotide Reverse Transcriptase Inhibitors
p78195
g14473
sVDeoxyribonucleosides
p78196
g33063
sVRibonucleosides
p78197
g73664
sVCytidine
p78198
g67528
sVDeoxycytidine
p78199
g12701
sVOCT2 substrates with narrow therapeutic index
p78200
g29681
sVGlycosides
p78201
g68357
sVOCT2 Substrates
p78202
g14936
sVHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p78203
g38165
sVOCT1 substrates
p78204
g13063
sVHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
p78205
g77224
sVNucleic Acids, Nucleotides, and Nucleosides
p78206
g47115
sVP-glycoprotein/ABCB1 Substrates
p78207
g34913
sVPyrimidine Nucleosides
p78208
(dp78209
sVAnti-Retroviral Agents
p78210
g67143
sVOAT1/SLC22A6 Substrates
p78211
g60716
sVNucleosides
p78212
g49457
sVNucleoside Reverse Transcriptase Inhibitors
p78213
g38843
sVAntiviral Agents
p78214
g30431
sVZalcitabine
p78215
g21204
ssg11430
(dp78216
g6630
g57925
ssg11433
(dp78217
g11694
(dp78218
ssg11436
(dp78219
g8916
g68622
sg2946
g35796
sg5832
g53388
sg8241
g65771
ssg11439
(dp78220
VAgents Causing Muscle Toxicity
p78221
g55390
sg9951
g72893
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p78222
g46323
sVAdrenergic beta-Agonists
p78223
g43007
sVCytochrome P-450 CYP3A Substrates
p78224
g45008
sVBronchodilator Agents
p78225
g73494
sVPotential QTc-Prolonging Agents
p78226
g70427
sVCytochrome P-450 Enzyme Inhibitors
p78227
g61971
sVDrugs for Obstructive Airway Diseases
p78228
g42521
sVAmines
p78229
g42723
sVPeripheral Nervous System Agents
p78230
g57632
sVRespiratory System Agents
p78231
g71423
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78232
g29259
sVEthylamines
p78233
g20600
sVQTc Prolonging Agents
p78234
g57854
sVAdrenergics, Inhalants
p78235
g43176
sVAdrenergic Agents
p78236
g41696
sVNeurotransmitter Agents
p78237
g75582
sVSympathomimetic (Adrenergic) Agents
p78238
g75933
sVCytochrome P-450 CYP2C8 Inhibitors
p78239
g55033
sVAgents to Treat Airway Disease
p78240
g32643
sVAdrenergic Agonists
p78241
g76838
sVAgents that produce hypertension
p78242
g69077
sVAnti-Asthmatic Agents
p78243
g36528
sVCytochrome P-450 CYP3A4 Substrates
p78244
g65209
sVAutonomic Agents
p78245
g66569
sVAdrenergic beta-2 Receptor Agonists
p78246
g58946
sVEthanolamines
p78247
g74744
sVCytochrome P-450 CYP3A5 Substrates
p78248
g67824
sVAmino Alcohols
p78249
g32671
sVSelective Beta 2-adrenergic Agonists
p78250
(dp78251
sVAgents producing tachycardia
p78252
g50783
sVPhenethylamines
p78253
(dp78254
sVAlcohols
p78255
(dp78256
sVCytochrome P-450 CYP3A7 Substrates
p78257
g60667
ssg11442
(dp78258
g8529
g67191
sg3699
g40332
ssg11445
(dp78259
VAdrenergic beta-Agonists
p78260
g43008
sVOphthalmologicals
p78261
g35188
sVNeurotransmitter Agents
p78262
g75570
sVCentral Nervous System Agents
p78263
g58422
sVAdrenergic and Dopaminergic Agents
p78264
g51109
sVSympathomimetics
p78265
g48817
sVSympathomimetics, Plain
p78266
g14448
sVAlpha-and Beta-adrenergic Agonists
p78267
g26141
sVSympathomimetic (Adrenergic) Agents
p78268
g75934
sVNasal Preparations
p78269
g73284
sVAutonomic Agents
p78270
g66548
sVCardiac Stimulants Excl. Cardiac Glycosides
p78271
g29162
sVCardiac Therapy
p78272
g69637
sVEthylamines
p78273
g20602
sVCentral Nervous System Stimulants
p78274
g51447
sVCholinesterase substrates
p78275
g41634
sVDrugs for Obstructive Airway Diseases
p78276
g42522
sVCentrally Acting Antiobesity Products
p78277
g50365
sVAdrenergic Agents
p78278
g41720
sVCardiovascular Agents
p78279
g26550
sVAdrenergics for Systemic Use
p78280
g59037
sVVasoconstrictor Agents
p78281
g35888
sVIncreased Norepinephrine Activity
p78282
g78070
sVSensory Organs
p78283
g40685
sVEphedrine
p78284
g44406
sVAdrenergic Agonists
p78285
g76839
sVAgents that produce hypertension
p78286
g69057
sVAlimentary Tract and Metabolism
p78287
g23793
sVPropanolamines
p78288
g37509
sVAmines
p78289
g42679
sVMydriatics and Cycloplegics
p78290
g47434
sVAmino Alcohols
p78291
g32687
sVAdrenergic alpha-Agonists
p78292
g65399
sVSympathomimetics Excl. Antiglaucoma Preparations
p78293
g59285
sVPropanols
p78294
g56553
sVPeripheral Nervous System Agents
p78295
g57587
sVAgents producing tachycardia
p78296
g50746
sVAntiobesity Preparations, Excl. Diet Products
p78297
g39836
sVPhenethylamines
p78298
(dp78299
sVHerbs and Natural Products
p78300
g19489
sVAlcohols
p78301
(dp78302
sVNorepinephrine Releasing Agent
p78303
g69435
ssg11448
(dp78304
g8760
g67993
sg9909
g72670
sg9375
g70538
ssg11451
(dp78305
VBSEP/ABCB11 Substrates
p78306
g74865
sVCytochrome P-450 CYP3A4 Inhibitors
p78307
g61672
sVAntivirals for Systemic Use
p78308
g59758
sVCytochrome P-450 CYP2C8 Inhibitors (strong)
p78309
g46316
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p78310
g41067
sVCytochrome P-450 CYP3A Substrates
p78311
g45181
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p78312
g72542
sVDirect Acting Antivirals
p78313
g38055
sVCYP3A Substrates (Sensitive)
p78314
g63919
sVAnti-HIV Agents
p78315
g66403
sVCytochrome P-450 CYP2C19 Inhibitors (weak)
p78316
g49908
sVCytochrome P-450 CYP2C9 Inhibitors
p78317
g18183
sVCytochrome P-450 CYP2C9 Inducers
p78318
g20041
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p78319
g16522
sVCytochrome P-450 Enzyme Inhibitors
p78320
g62057
sVHighest Risk QTc-Prolonging Agents
p78321
g35864
sVAntiinfectives for Systemic Use
p78322
g69662
sVAnti-Infective Agents
p78323
g54621
sVCytochrome P-450 CYP2D6 Inhibitors
p78324
g62903
sVEnzyme Inhibitors
p78325
g72709
sVNephrotoxic agents
p78326
g57707
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78327
g29477
sVOATP1B3 inhibitors
p78328
g62280
sVHIV Protease Inhibitors
p78329
(dp78330
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p78331
g60066
sVQTc Prolonging Agents
p78332
g57787
sVHyperglycemia-Associated Agents
p78333
g68793
sVPyrimidines
p78334
g47716
sVCytochrome P-450 CYP2C8 Inhibitors
p78335
g55002
sVCytochrome P-450 CYP2B6 Inhibitors
p78336
g45928
sVPyrimidinones
p78337
g77452
sg5544
g51689
sVCytochrome P-450 Enzyme Inducers
p78338
g28123
sVCytochrome P-450 CYP2C19 Inhibitors
p78339
g61253
sVCytochrome P-450 CYP3A Inhibitors (strong)
p78340
g13388
sVAnti-Retroviral Agents
p78341
g67152
sVCytochrome P-450 CYP3A4 Substrates
p78342
g65293
sVP-glycoprotein/ABCB1 Inhibitors
p78343
g74801
sg3972
g41912
sVProtease Inhibitors
p78344
g51091
sVCytochrome P-450 CYP3A Inhibitors
p78345
g60433
sVOrganic Anion Transporting Polypeptide 1B1 Inhibitors
p78346
g77466
sVAntiviral Agents
p78347
g30439
sVOATP1B1/SLCO1B1 Inhibitors
p78348
g75611
sVCytochrome P450 3A Inhibitors
p78349
g54267
sVChemically-Induced Disorders
p78350
g21227
ssg11454
(dp78351
g1782
g27124
sg8373
g66307
sg4653
g46651
sg7545
g62531
sg4113
g43014
sg2046
g29091
sg3141
g37042
sg9630
g71684
sg9903
g72604
sg2895
g35429
sg2940
g35699
sg5766
g52975
sg1761
g26984
sg8694
g67717
sg11604
(dp78352
sg14838
g39954
sg8211
g65652
sg5895
g53786
sg12534
g52600
sg6045
g54692
ssg11457
(dp78353
g6612
g57767
sg10104
g73552
ssg11460
(dp78354
VCytochrome P-450 CYP2C8 Inhibitors (moderate)
p78355
g78153
sVAmino Acids, Cyclic
p78356
g27285
sVUGT1A1 Substrates
p78357
g12293
sVCytochrome P-450 CYP3A Substrates
p78358
g45183
sVOATP1B1/SLCO1B1 Inhibitors
p78359
g75612
sVHormones
p78360
g55658
sVCytochrome P-450 Enzyme Inhibitors
p78361
g62059
sVThyroid Products
p78362
g28978
sVP-glycoprotein/ABCB1 Inducers
p78363
g70558
sVAmino Acids
p78364
g43105
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p78365
g73625
sVOATP1B3 inhibitors
p78366
g62282
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p78367
g60057
sVAmino Acids, Aromatic
p78368
g75849
sVUGT1A1 substrates with narrow therapeutic index
p78369
g41793
sVCytochrome P-450 CYP2C8 Inhibitors
p78370
g55004
sVThyroxine-binding globulin substrates
p78371
g60176
sVAgents used to treat hypothyroidism
p78372
g23678
sVCytochrome P-450 CYP3A4 Substrates
p78373
g65295
sVNarrow Therapeutic Index Drugs
p78374
g50558
sVAmino Acids, Peptides, and Proteins
p78375
g47321
sVHormones, Hormone Substitutes, and Hormone Antagonists
p78376
g53136
ssg11463
(dp78377
g6246
g55789
sg6843
g58962
ssg11466
(dp78378
g10314
g74321
sg10548
g75209
ssg11469
(dp78379
VSulfones
p78380
g58737
sVSodium Chloride Symporter Inhibitors
p78381
g55913
sVCardiovascular Agents
p78382
g26614
sVIncreased Diuresis
p78383
g40998
sVGenito Urinary System and Sex Hormones
p78384
g66153
sVGynecological Antiinfectives and Antiseptics
p78385
g69242
sVAntihypertensive Agents
p78386
g20253
sVHypotensive Agents
p78387
g34111
sVSulfonamides
p78388
g63358
sVOAT1/SLC22A6 inhibitors
p78389
(dp78390
sVThiazides
p78391
g70215
sVAmides
p78392
g44293
sVBenzothiadiazines
p78393
g44814
sVSulfur Compounds
p78394
(dp78395
sg10383
g74703
sVMembrane Transport Modulators
p78396
g54123
sVHeterocyclic Compounds, Fused-Ring
p78397
g56043
sVHyperglycemia-Associated Agents
p78398
g68795
sVNatriuretic Agents
p78399
g40487
sg4656
g46779
sVDiuretics
p78400
g57901
ssg11472
(dp78401
VDrugs that are Mainly Renally Excreted
p78402
g44001
sVAmino Alcohols
p78403
g32673
sg10452
g74876
sVDermatologicals
p78404
g17195
sg3171
g37240
sVAlcohols
p78405
(dp78406
sVAmines
p78407
g42666
ssg11475
(dp78408
g8817
g68228
sVDrugs that are Mainly Renally Excreted
p78409
g44051
sVAntihypertensive Agents
p78410
g20255
sVCytochrome P-450 CYP3A Substrates
p78411
g45266
sVEndothelin Receptor Antagonists
p78412
g50541
sVVasodilating Agents
p78413
g23699
sVAmides
p78414
g44296
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78415
g29587
sVSulfur Compounds
p78416
(dp78417
sVSulfones
p78418
g58742
sVCytochrome P-450 CYP3A4 Substrates
p78419
g65348
sVAntihypertensives for Pulmonary Arterial Hypertension
p78420
g25753
sg8547
g67219
ssg11478
(dp78421
g1611
g25816
ssg11481
(dp78422
g2886
g35304
sg11046
g76944
sg2283
g31162
sg12042
(dp78423
ssg11484
(dp78424
g6207
g55588
sg3204
g37444
sg2403
g31847
sg10635
g75547
sg2358
g31479
sg9144
g69553
sg828
g19868
sg11283
g77758
sg9165
g69616
sg1869
g27831
sg10674
g75705
sg8421
g66515
sg69
g12740
sg9879
g72513
sg11016
g76871
sg888
g20456
sg6468
g57106
sg6939
g59330
sg2427
g32031
sg1425
g24555
sg5133
g49285
sg9960
g72967
sg8460
g66862
sg915
g20710
sg1704
g26715
sg6726
g58289
sg10728
g75903
sg6966
g59418
sg6792
g58702
sg8487
g67031
sg5535
g51663
sg933
g20825
sg8874
g68538
sg7734
g63528
sg9996
g73180
sg9252
g70046
sg10737
g75942
sg9981
g73106
sg450
g16341
sg8514
g67113
sg6186
g55504
sg6303
g56222
sg6999
g59496
sg3978
g41997
sg42
g12586
sg9465
g71005
sg2523
g32737
sg183
g13820
sg8805
g68166
sg11112
g77207
sg10815
g76288
sg10356
g74570
sg7029
g59640
sg1008
g21285
sg7041
g59699
sg10062
g73444
sg7533
g62501
sg2559
g32958
sg9417
g70765
sg7056
g59851
sg11595
(dp78425
sg240
g14196
sg4035
g42429
sg12066
(dp78426
sg1044
g21548
sg8598
g67383
sg8601
g67419
sg3732
g40507
sg11619
(dp78427
sg10662
g75672
sg6921
g59270
sg1059
g21764
sg2265
g31014
sg282
g14560
sg6156
g55224
sg3111
g36820
sg294
g14748
sg11655
(dp78428
sg288
g14670
sg5970
g54218
sg8655
g67594
sg1092
g21979
sg5691
g52494
sg5694
g52545
sg4101
g42972
sg2538
g32800
sg1104
g22090
sg10497
g75023
sg6318
g56367
sg9462
g70986
sg3381
g38481
sg345
g15230
sg7941
g64296
sg204
g13964
sg1134
g22332
sg7152
g60194
sg8028
g64824
sg8463
g66903
sg4959
g48543
sg537
g17036
sg2688
g33652
sg4155
g43226
sg8721
g67865
sg4164
g43321
sg10056
g73400
sg387
g15649
sg6729
g58328
sg11145
g77294
sg3444
g38872
sg5256
g50074
sg5769
g53045
sg1281
g23383
sg7299
g60926
sg1194
g22823
sg2730
g33866
sg8751
g67963
sg780
g19365
sg1908
g28301
sg426
g16095
sg465
g16474
sg10266
g74087
sg11790
(dp78429
sg11793
(dp78430
sg2430
g32108
sg8031
g64846
sg11811
(dp78431
sg2013
g28919
sg10308
g74287
sg6579
g57551
sg168
g13645
sg1248
g23040
sg5853
g53547
sg7272
g60767
sg7275
g60795
sg1263
g23179
sg5064
g48902
sg5781
g53108
sg7284
g60840
sg9561
g71358
sg9564
g71398
sg5877
g53686
sg4287
g44389
sg7329
g61140
sg7335
g61205
sg10350
g74529
sg7389
g61555
sg2910
g35546
sg534
g16990
sg1707
g26778
sg4458
g45488
sg6639
g57976
sg5919
g53980
sg10959
g76729
sg7317
g61046
sg11139
g77278
sg1413
g24432
sg696
g18741
sg11097
g77146
sg7944
g64329
sg564
g17410
sg1809
g27436
sg1668
g26258
sg5145
g49353
sg4344
g44662
sg6678
g58119
sg3570
g39482
sg582
g17629
sg603
g17758
sg5169
g49527
sg11910
(dp78432
sg1188
g22775
sg9966
g73047
sg11931
(dp78433
sg3930
g41664
sg9372
g70526
sg8187
g65545
sg1401
g24316
sg9684
g71828
sg8097
g65088
sg630
g18031
sg2418
g31913
sg657
g18328
sg11955
(dp78434
sg2199
g30692
sg8205
g65629
sg7422
g61820
sg6012
g54355
sg8163
g65463
sg5235
g49847
sg11979
(dp78435
sg1434
g24663
sg10470
g74912
sg9711
g71989
sg5247
g49915
sg11265
g77660
sg4266
g44197
sg8295
g65982
sg405
g15885
sg2262
g30963
sg822
g19792
sg12018
(dp78436
sg8259
g65862
sg702
g18803
sg1113
g22185
sg2841
g34846
sg4746
g47261
sg7497
g62310
sg3975
g41917
sg11721
(dp78437
sg714
g19020
sg3018
g36142
sg10518
g75113
sg633
g18081
sg8277
g65942
sg486
g16655
sg10533
g75161
sg9420
g70805
sg10539
g75177
sg9393
g70600
sg8298
g66039
sg414
g15971
sg2289
g31188
sg12111
(dp78438
sg9822
g72316
sg945
g20896
sg5067
g48951
sg12126
(dp78439
sg10596
g75445
sg2664
g33454
sg10602
g75481
sg3156
g37201
sg1605
g25769
sg9864
g72454
ssg11487
(dp78440
g5847
g53507
ssg11490
(dp78441
g2142
g30357
sg5316
g50450
sg600
g17731
sg11370
g78058
sg7707
g63395
ssg11493
(dp78442
g9612
g71600
sg9132
g69492
sg1266
g23229
sg10431
g74842
sg4905
g48179
sg8076
g64987
sg10653
g75634
sg6216
g55634
sg11718
(dp78443
sg9348
g70384
sg3321
g38219
ssg11496
(dp78444
g4911
g48250
sg2787
g34398
sg6045
g54708
sg4653
g46708
sg12123
(dp78445
sg1656
g26172
sg12534
g52654
ssg11499
(dp78446
g5847
g53509
ssg11502
(dp78447
g294
g14750
sg2199
g30694
ssg11505
(dp78448
g8055
g64937
sg7668
g63213
sg1470
g24921
sg7545
g62564
sg4113
g43053
sg10323
g74380
sg10362
g74594
sg6180
g55431
sg528
g16940
sg11274
g77709
sg3117
g36924
sg2007
g28890
sg2763
g34242
sg9225
g69927
sg4653
g46712
sg4236
g43712
sg609
g17822
sg12534
g52658
sg147
g13471
sg8013
g64689
sg6045
g54709
ssg11508
(dp78449
VAntiinfectives for Systemic Use
p78450
g69658
sVAntivirals for Systemic Use
p78451
g59770
sVHeterocyclic Compounds, Fused-Ring
p78452
g56087
sVUGT1A1 Substrates
p78453
g12263
sVCytochrome P-450 CYP3A Substrates
p78454
g45216
sVAntiviral Agents
p78455
g30423
sVDirect Acting Antivirals
p78456
g38072
sVMATE inhibitors
p78457
g58952
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78458
g29522
sVMATE 1 Inhibitors
p78459
g68664
sVCytochrome P-450 CYP3A4 Substrates
p78460
g65320
ssg11511
(dp78461
g11952
(dp78462
sg7971
g64453
sg6360
g56719
sg10323
g74382
sg6180
g55433
sg2886
g35313
sg11274
g77710
sg8106
g65148
sg2007
g28892
sg4515
g45884
sg402
g15828
sg2817
g34572
sg11046
g76952
sg11160
g77371
ssg11514
(dp78463
g4707
g46987
sg11751
(dp78464
sg129
g13206
sg11826
(dp78465
ssg11517
(dp78466
g7395
g61584
ssg11520
(dp78467
g9252
g70052
sg3018
g36153
ssg11523
(dp78468
VAntiplatelet agents
p78469
g46299
sVBSEP/ABCB11 Substrates
p78470
g74869
sVPreparations Increasing Uric Acid Excretion
p78471
g52102
sVAntigout Preparations
p78472
g76892
sVMusculo-Skeletal System
p78473
g31508
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p78474
g46420
sVCytochrome P-450 CYP2C9 Inhibitors
p78475
g18191
sVCytochrome P-450 Enzyme Inhibitors
p78476
g61987
sVRenal Agents
p78477
g24769
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p78478
g23122
sVCytochrome P-450 CYP2B6 Inducers
p78479
g39131
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78480
g29308
sVCytochrome P-450 CYP2C9 Substrates
p78481
g29729
sVCytochrome P-450 CYP3A4 Inducers
p78482
g18899
sVCytochrome P-450 CYP3A Substrates
p78483
g45043
sVCytochrome P-450 CYP2C8 Inhibitors
p78484
g55011
sg7140
g60178
sVPyrazoles
p78485
g65177
sVCytochrome P-450 CYP3A Inducers
p78486
g66271
sVCytochrome P-450 CYP2B6 Inducers (strength unknown)
p78487
g44551
sVCytochrome P-450 CYP3A4 Substrates
p78488
g65232
sg7293
g60885
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p78489
g64611
sVUricosuric Agents
p78490
g74956
sVCytochrome P-450 Enzyme Inducers
p78491
g28141
ssg11526
(dp78492
g9393
g70612
sg9879
g72531
sg6186
g55516
sg11793
(dp78493
sg7593
g62817
sg8463
g66911
sg1092
g21989
sg9828
g72362
sg7041
g59710
ssg11529
(dp78494
g9828
g72343
ssg11532
(dp78495
g6684
g58142
ssg11535
(dp78496
VPharmaceutical Preparations
p78497
g53868
sg7311
g61000
sg9549
g71312
sVSalicylates
p78498
g27629
sVPhenols
p78499
g65125
sVBenzene Derivatives
p78500
g61407
sVBenzoates
p78501
g30395
sVHydroxy Acids
p78502
g18163
sVAcids, Carbocyclic
p78503
g41571
sVHydroxybenzoates
p78504
g59580
sVBiological Products
p78505
g64640
sVCompounds used in a research, industrial, or household setting
p78506
g76508
sg10092
g73506
sVAntirheumatic Agents
p78507
g24242
sg6720
g58280
sVComplex Mixtures
p78508
g65521
sg9681
g71825
sVLipids
p78509
g14340
ssg11538
(dp78510
g6279
g55965
sg11967
(dp78511
sg11592
(dp78512
sg1173
g22625
sg1899
g28083
sg7905
g64160
sg7821
g63842
sg1047
g21627
sg8781
g68089
sg1050
g21693
sg10878
g76547
sg1503
g25196
ssg11541
(dp78513
VAmino Acids, Peptides, and Proteins
p78514
g47329
sVAntiinfectives for Systemic Use
p78515
g69645
sVAmino Acids
p78516
g43114
sVAntimycobacterials
p78517
g22565
sVAmino Acids, Neutral
p78518
g52720
sVAnti-Infective Agents, Urinary
p78519
g25218
sVToxic Actions
p78520
g49392
sVNoxae
p78521
g65422
sVAntituberculosis Agents
p78522
g47107
sVDrugs for Treatment of Tuberculosis
p78523
g78004
sVOxazoles
p78524
g33221
sVAntibiotics, Antitubercular
p78525
g20922
sVNeurotoxic agents
p78526
g68587
sVOxazolidinones
p78527
g23542
sVAnti-Bacterial Agents
p78528
g38328
sVIsoxazoles
p78529
g65717
sVAnti-Infective Agents
p78530
g54579
sVAntimetabolites
p78531
g59535
sVRenal Agents
p78532
g24762
ssg11544
(dp78533
VNeuraxial Anesthetics
p78534
g32589
sVDrugs that are Mainly Renally Excreted
p78535
g44005
sVCytochrome P-450 CYP1A2 Substrates
p78536
g45578
sVLocal Anesthesia
p78537
g14959
sVAmide Local Anesthetic
p78538
(dp78539
sVAnesthetics
p78540
g51612
sVCytochrome P-450 CYP3A Substrates
p78541
g45192
sVHypotensive Agents
p78542
g34127
sVCentral Nervous System Agents
p78543
g58426
sVCytochrome P-450 CYP2B6 Substrates
p78544
g33034
sVAmides
p78545
g44301
sVAnesthetics, Local
p78546
g53467
sVAnilides
p78547
g78178
sVAniline Compounds
p78548
g23439
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78549
g29492
sVSensory System Agents
p78550
g71805
sVCytochrome P-450 CYP3A4 Substrates
p78551
g65300
sVPeripheral Nervous System Agents
p78552
g57588
sVNervous System
p78553
g70272
sVAmines
p78554
g42681
ssg11547
(dp78555
g7470
g62239
ssg11550
(dp78556
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p78557
g52095
sVCytochrome P-450 CYP3A4 Inhibitors
p78558
g61647
sVInterleukin Inhibitors
p78559
g49762
sVInterleukin-6 Receptor Antagonist
p78560
g40087
sVSerum Globulins
p78561
g49664
sVCytochrome P-450 Enzyme Inhibitors
p78562
g62065
sVBiologics for Rheumatoid Arthritis Treatment
p78563
g47860
sVCytochrome P-450 CYP3A4 Inducers (weak)
p78564
g19509
sVImmunoglobulins
p78565
g41534
sVInterleukin 6 Receptor Antagonists
p78566
g50124
sVCytochrome P-450 CYP3A4 Inducers
p78567
g18897
sVAntibodies
p78568
g60991
sVProteins
p78569
g52744
sVDisease-modifying Antirheumatic Agents
p78570
g57187
sVCytochrome P-450 Enzyme Inducers
p78571
g28139
sVCytochrome P-450 CYP3A Inducers
p78572
g66270
sVGlobulins
p78573
g19193
sVAmino Acids, Peptides, and Proteins
p78574
g47331
sVAntibodies, Monoclonal
p78575
g73312
sVCytochrome P-450 CYP3A Inhibitors
p78576
g60404
sVImmunosuppressive Agents
p78577
g64547
sVAntineoplastic and Immunomodulating Agents
p78578
g39744
sVAntirheumatic Agents
p78579
g24248
sVBlood Proteins
p78580
g39870
sVImmunoproteins
p78581
g57457
ssg11553
(dp78582
g11745
(dp78583
ssg11556
(dp78584
g11733
(dp78585
sg3249
g37772
sg12057
(dp78586
sg5556
g51746
sg10272
g74151
sg8658
g67625
ssg11559
(dp78587
g10002
g73206
ssg11562
(dp78588
VMyelosuppressive Agents
p78589
g71327
sVImmunosuppressive Agents
p78590
g64549
sVMicrotubule Inhibitors
p78591
g36411
sVPotential QTc-Prolonging Agents
p78592
g70412
sVMicrotubule Inhibition
p78593
g12890
sVAntineoplastic and Immunomodulating Agents
p78594
g39746
sVQTc Prolonging Agents
p78595
g57805
sVAntineoplastic Agents
p78596
g71530
ssg11565
(dp78597
g8019
g64739
sg4716
g47076
sg336
g15101
sg72
g12813
sg4425
g44933
ssg11568
(dp78598
g4653
g46757
sg8430
g66619
sg9198
g69853
sg11079
g77092
sg4164
g43360
sg7593
g62827
sg8298
g66066
sg6045
g54727
sg12534
g52703
ssg11571
(dp78599
g3495
g39067
ssg11574
(dp78600
g8670
g67664
sg5577
g51844
sg357
g15331
sg7977
g64491
sg3183
g37353
sg8274
g65927
sg9540
g71306
sg5382
g50734
sg8769
g68048
sg5073
g49000
sg3333
g38265
sg372
g15414
ssg11577
(dp78601
g4398
g44844
sg8826
g68330
ssg11580
(dp78602
g9357
g70475
sg4680
g46910
sg1470
g24942
sg3861
g41302
sg5433
g51079
sg11940
(dp78603
sg12274
g27581
sg2286
g31179
sg816
g19714
sg8013
g64702
ssg11583
(dp78604
g8265
g65901
ssg11586
(dp78605
g8022
g64768
sg3105
g36754
ssg11589
(dp78606
g8484
g66998
ssg11592
(dp78607
VCytochrome P-450 CYP3A4 Inhibitors
p78608
g61652
sVCytochrome P-450 CYP2D6 Inhibitors
p78609
g62917
sVOtologicals
p78610
g69476
sVCytochrome P-450 CYP3A Substrates
p78611
g45195
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p78612
g46417
sVAntifungal Agents
p78613
g76439
sVEnzyme Inhibitors
p78614
g72702
sVVaginal Creams, Foams, and Jellies
p78615
g71343
sVStomatological Preparations
p78616
g67437
sVCytochrome P-450 CYP2C9 Inhibitors
p78617
g18196
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p78618
g12664
sVCytochrome P-450 Enzyme Inhibitors
p78619
g62067
sVAnti-Infective Agents
p78620
g54589
sVAntifungal Agents (Vaginal)
p78621
g39082
sVAntiinfectives for Systemic Use
p78622
g69649
sVImidazole and Triazole Derivatives
p78623
g51758
sVAzole Antifungals
p78624
g20189
sVGynecological Antiinfectives and Antiseptics
p78625
g69235
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p78626
g59967
sVCytochrome P-450 CYP2E1 Inhibitors
p78627
g46828
sVAntifungals for Topical Use
p78628
g39225
sVSteroid Synthesis Inhibitors
p78629
g72879
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78630
g29498
sVCytochrome P-450 CYP2A6 Inhibitors (strong)
p78631
g45823
sVImidazoles
p78632
(dp78633
sVCytochrome P-450 CYP2C9 Inhibitors (strong)
p78634
g28838
sVAntifungals for Dermatological Use
p78635
g30069
sVCytochrome P-450 CYP2B6 Inhibitors
p78636
g45921
sVDermatologicals
p78637
g17282
sVCytochrome P-450 CYP2E1 Inhibitors (strong)
p78638
g43097
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p78639
g44519
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p78640
g69044
sVCytochrome P-450 CYP2C19 Inhibitors
p78641
g61261
sVCytochrome P-450 CYP3A4 Substrates
p78642
g65303
sVAlimentary Tract and Metabolism
p78643
g23879
sVHormone Antagonists
p78644
g24261
sVAntimycotics for Systemic Use
p78645
g78512
sV14-alpha Demethylase Inhibitors
p78646
g76751
sVGenito Urinary System and Sex Hormones
p78647
g66160
sVIntestinal Antiinfectives
p78648
g68569
sVCytochrome P-450 CYP3A Inhibitors
p78649
g60410
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p78650
g76817
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p78651
g53061
sVP-glycoprotein/ABCB1 Inhibitors
p78652
g74807
sVAntiinfectives and Antiseptics for Local Oral Treatment
p78653
g65506
sVHormones, Hormone Substitutes, and Hormone Antagonists
p78654
g53150
sVChemically-Induced Disorders
p78655
g21218
sVCytochrome P-450 CYP2A6 Inhibitors
p78656
g48578
sVImidazole Derivatives
p78657
g74016
sVSensory Organs
p78658
g40721
ssg11595
(dp78659
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p78660
g77506
sVAnesthetics, General
p78661
g24705
sVSerotonin Agents
p78662
g76434
sVAnalgesics
p78663
g26446
sVOpiate Agonists
p78664
g46446
sVCentral Nervous System Agents
p78665
g58436
sVCytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index
p78666
g74881
sVNarcotics
p78667
g73497
sVPeripheral Nervous System Agents
p78668
g57593
sVDrugs that are Mainly Renally Excreted
p78669
g44007
sVPiperidines
p78670
g73564
sVOpioids
p78671
g32231
sVOpioids, Anilidopiperidine
p78672
g35900
sVFentanyl and fentanyl analogues
p78673
g42797
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78674
g29499
sVAnesthetics, Intravenous
p78675
g77120
sVAdjuvants, Anesthesia
p78676
g55871
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p78677
g60075
sVCytochrome P-450 CYP3A Substrates
p78678
g45196
sVCentral Nervous System Depressants
p78679
g78425
sVAnesthetics
p78680
g51600
sVAgents that reduce seizure threshold
p78681
g45836
sVHigh-risk opioids
p78682
g58088
sVAgents that produce hypertension
p78683
g69060
sVNeuraxial Anesthetics
p78684
g32592
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p78685
g76138
sVCytochrome P-450 CYP3A4 Substrates
p78686
g65304
sVNarrow Therapeutic Index Drugs
p78687
g50566
sVPhenylpiperidine Derivatives
p78688
g70571
sVCytochrome P-450 CYP3A5 Substrates
p78689
g67807
sVSerotonin Modulators
p78690
g69134
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p78691
g61374
sVAntidepressive Agents
p78692
g15520
sVOpioid Agonist
p78693
g74749
sVBradycardia-Causing Agents
p78694
g61442
sVAdjuvants
p78695
g50698
sVP-glycoprotein/ABCB1 Inhibitors
p78696
g74808
sVOpioid Anesthetics
p78697
g56403
sVSensory System Agents
p78698
g71807
sVNervous System
p78699
g70276
sVCytochrome P-450 CYP3A7 Substrates
p78700
g60650
ssg11598
(dp78701
g1911
g28345
sg11769
(dp78702
sg7692
g63315
sg12063
(dp78703
ssg11601
(dp78704
VAgents Causing Muscle Toxicity
p78705
g55368
sVBSEP/ABCB11 Substrates
p78706
g74866
sVCytochrome P-450 CYP3A4 Inhibitors
p78707
g61653
sg5484
g51344
sVCytochrome P-450 CYP3A Substrates
p78708
g45197
sVOATP1B1/SLCO1B1 Inhibitors
p78709
g75620
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p78710
g43743
sVCytochrome P-450 Enzyme Inhibitors
p78711
g62068
sVAntimitotic Agents
p78712
g60133
sVP-glycoprotein/ABCB1 Inducers
p78713
g70554
sVTubulin Modulators
p78714
g33856
sVAntineoplastic Agents, Phytogenic
p78715
g55829
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78716
g29500
sg108
g13058
sVOATP1B3 inhibitors
p78717
g62279
sVAntineoplastic Agents
p78718
g71534
sVIndoles
p78719
g73561
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p78720
g49152
sVP-glycoprotein/ABCB1 Substrates
p78721
g35042
sVIndole Alkaloids
p78722
g74433
sVHeterocyclic Compounds, Fused-Ring
p78723
g56070
sVCytochrome P-450 CYP3A4 Substrates
p78724
g65305
sVMitosis Modulators
p78725
g33588
sVCardiotoxic antineoplastic agents
p78726
g72238
sVCytochrome P-450 CYP3A5 Substrates
p78727
g67808
sVCytochrome P-450 CYP3A Inhibitors
p78728
g60412
sVImmunosuppressive Agents
p78729
g64553
sVBCRP/ABCG2 Substrates
p78730
g42056
sVP-glycoprotein/ABCB1 Inhibitors
p78731
g74818
sVNeurotoxic agents
p78732
g68575
sVAntineoplastic and Immunomodulating Agents
p78733
g39755
sVAlkaloids
p78734
g19400
sVCytochrome P-450 CYP3A7 Substrates
p78735
g60651
ssg11604
(dp78736
VAntiinfectives for Systemic Use
p78737
g69650
sVProtein Synthesis Inhibitors
p78738
g45545
sVAgents that produce neuromuscular block (indirect)
p78739
g37957
sVGentamicins
p78740
g43487
sVAntibiotics for Topical Use
p78741
g57690
sVOphthalmologicals
p78742
g35198
sValpha-Galactosidase, antagonists & inhibitors
p78743
g37627
sVOphthalmological and Otological Preparations
p78744
g78352
sVNephrotoxic agents
p78745
g57712
sVAminoglycoside Antibacterials
p78746
g52729
sVOtologicals
p78747
g69478
sVGlycosides
p78748
g68356
sVDermatologicals
p78749
g17229
sVOAT1/SLC22A6 inhibitors
p78750
(dp78751
sVEnzyme Inhibitors
p78752
g72703
sVSensory Organs
p78753
g40692
sVAnti-Bacterial Agents
p78754
g38340
sVAntibacterials for Systemic Use
p78755
g32544
sVAnti-Infective Agents
p78756
g54593
sVCarbohydrates
p78757
g61761
sVNarrow Therapeutic Index Drugs
p78758
g50550
ssg11607
(dp78759
g6579
g57560
ssg11610
(dp78760
g11085
g77111
ssg11613
(dp78761
g8514
g67103
sg10470
g74899
ssg11616
(dp78762
g3099
g36727
ssg11619
(dp78763
g7656
g63139
sVAntiarrhythmic agents
p78764
g71174
sg1692
g26450
sVAgents causing hyperkalemia
p78765
g43590
sg2934
g35646
sVAgents causing angioedema
p78766
g63897
sVCentral Nervous System Agents
p78767
g58441
sVCalcium Channel Blockers
p78768
g41309
sVPotential QTc-Prolonging Agents
p78769
g70415
sg7071
g59985
sg8475
g66971
sg9900
g72588
sg249
g14300
sg5841
g53482
sVPeripheral Nervous System Agents
p78770
g57598
sVDrugs that are Mainly Renally Excreted
p78771
g44009
sg4122
g43100
sg2415
g31883
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78772
g29502
sVQTc Prolonging Agents
p78773
g57818
sVCytochrome P-450 CYP3A Substrates
p78774
g45199
sg11484
g78427
sg6375
g56744
sVCardiovascular Agents
p78775
g26575
sg7125
g60142
sg3192
g37384
sVVasodilating Agents
p78776
g23692
sVMembrane Transport Modulators
p78777
g54140
sVCytochrome P-450 CYP3A4 Substrates
p78778
g65307
sg8523
g67154
sg4761
g47344
sVAcids, Acyclic
p78779
g25444
sVBradycardia-Causing Agents
p78780
g61444
sg597
g17685
sg10920
g76662
sg9675
g71808
sVNervous System
p78781
g70278
sg6168
g55291
ssg11622
(dp78782
g1248
g23061
sg11112
g77198
sg630
g18017
sg4197
g43519
sg7821
g63810
sg9465
g71003
sg3732
g40528
sg10533
g75173
sg3978
g41978
sg4449
g45391
sg11790
(dp78783
sg2013
g28917
sg2814
g34511
sg1047
g21596
sg10779
g76162
sg1881
g27970
ssg11625
(dp78784
VCytochrome P-450 CYP3A4 Inhibitors (weak)
p78785
g52079
sVCytochrome P-450 CYP3A4 Inhibitors
p78786
g61711
sVCytochrome P450 3A4 Inhibitors
p78787
g13049
sVHeterocyclic Compounds, Fused-Ring
p78788
g56159
sVLipid Modifying Agents
p78789
g40546
sVCytochrome P-450 CYP3A Substrates
p78790
g45021
sVCytochrome P-450 CYP3A Inhibitors
p78791
g60474
sVCYP3A Substrates (Sensitive)
p78792
g63927
sg3966
g41908
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78793
g29279
sVLipid Modifying Agents, Plain
p78794
g63425
sVMiscellaneous Antilipemic Agents
p78795
g50535
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p78796
g60085
sg4386
g44809
sVCytochrome P-450 CYP3A4 Substrates
p78797
g65219
sVP-glycoprotein/ABCB1 Inhibitors
p78798
g74828
ssg11628
(dp78799
g1248
g23029
sg2733
g33899
sg141
g13336
sg405
g15873
sg546
g17137
sg2841
g34834
sg6729
g58319
sg8394
g66374
sg10815
g76277
sg7029
g59632
sg9966
g73037
ssg11631
(dp78800
VDrugs that are Mainly Renally Excreted
p78801
g44010
sVGlycosides
p78802
g68361
sVPegylated agents
p78803
g13555
sVOphthalmologicals
p78804
g35264
sg6690
g58204
sVCarbohydrates
p78805
g61762
sVNucleic Acids, Nucleotides, and Nucleosides
p78806
g47118
sg6534
g57374
sVOcular Vascular Disorder Agents
p78807
g25599
sVSensory Organs
p78808
g40748
sVNucleotides
p78809
g49315
sVAntineovascularisation Agents
p78810
g31652
sg5445
g51113
ssg11634
(dp78811
g9750
g72063
ssg11637
(dp78812
g5622
g52232
sg7854
g64000
sg6903
g59186
sg8601
g67415
sg8598
g67375
ssg11640
(dp78813
g10878
g76530
ssg11643
(dp78814
g8874
g68529
sg2910
g35529
ssg11646
(dp78815
VAmino Acids, Peptides, and Proteins
p78816
g47371
sVGlobulins
p78817
g19170
sVAntibodies
p78818
g60980
sVAntibodies, Monoclonal
p78819
g73307
sVAntibodies, Monoclonal, Humanized
p78820
g76169
sVAntineoplastic Agents, Immunological
p78821
g62964
sVImmunoglobulins
p78822
g41518
sVProteins
p78823
g52766
sVHER1 Antagonists
p78824
g69037
sVEpidermal Growth Factor Receptor Antagonist
p78825
g22698
sVSerum Globulins
p78826
g49651
sVAntineoplastic and Immunomodulating Agents
p78827
g39785
sVBlood Proteins
p78828
g39848
sVAntineoplastic Agents
p78829
g71542
sVImmunoproteins
p78830
g57444
ssg11649
(dp78831
VAdrenergic beta-Agonists
p78832
g42996
sVCOMT Substrates
p78833
g43559
sVNeurotransmitter Agents
p78834
g75577
sVAdrenergic and Dopaminergic Agents
p78835
g51108
sVSympathomimetics
p78836
g48812
sVCompounds used in a research, industrial, or household setting
p78837
g76509
sVPhenols
p78838
g65128
sVPeripheral Nervous System Agents
p78839
g57601
sVDrugs that are Mainly Renally Excreted
p78840
g44011
sVAmines
p78841
g42697
sVCardiac Stimulants Excl. Cardiac Glycosides
p78842
g29158
sg3345
g38274
sVCardiac Therapy
p78843
g69634
sVEthylamines
p78844
g20591
sVProtective Agents
p78845
g66792
sVAdrenergic beta-1 Receptor Agonists
p78846
g76644
sVAdrenergic Agents
p78847
g41731
sVCardiovascular Agents
p78848
g26579
sVSympathomimetic (Adrenergic) Agents
p78849
g75931
sVBenzene Derivatives
p78850
g61439
sVCatecholamines
p78851
g19118
sVAdrenergic Agonists
p78852
g76832
sVAgents that produce hypertension
p78853
g69063
sVCardiotonic Agents
p78854
g66076
sVAutonomic Agents
p78855
g66579
sVCatechols
p78856
g76747
sVAdrenergic beta-2 Receptor Agonists
p78857
g58942
sVAdrenergic alpha-Agonists
p78858
g65394
sVAgents producing tachycardia
p78859
g50759
sVAdrenergic alpha-1 Receptor Agonists
p78860
g67239
sVPhenethylamines
p78861
(dp78862
ssg11652
(dp78863
VSensory Organs
p78864
g40697
sVAdrenergic alpha-2 Receptor Agonists
p78865
g67202
sVCardiovascular Agents
p78866
g26581
sVOphthalmologicals
p78867
g35202
sVAdrenergic alpha-Agonists
p78868
g65395
sVVasoconstrictor Agents
p78869
g35882
sVAntiarrhythmic agents
p78870
g71172
sVAntihistamine Drugs
p78871
g71917
sVRespiratory System Agents
p78872
g71421
sVDecongestants and Antiallergics
p78873
g77290
sVCalcium Channel Blockers
p78874
g41311
sVNasal Decongestants
p78875
g55108
sg11331
g77916
sVAdrenergic Agonists
p78876
g76833
sVAgents producing tachycardia
p78877
g50742
sVAgents that produce hypertension
p78878
g69064
sVAdrenergic alpha-1 Receptor Agonists
p78879
g67240
sVSympathomimetics, Plain
p78880
g14444
sVVasodilating Agents
p78881
g23695
sVNasal Preparations
p78882
g73282
ssg11655
(dp78883
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p78884
g77508
sVCytochrome P-450 CYP2D6 Substrates
p78885
g52144
sVSerotonin Agents
p78886
g76431
sVCytochrome P-450 CYP3A Substrates
p78887
g45203
sVAnti-Anxiety Agents
p78888
g35649
sVSerotonin Receptor Antagonists
p78889
g35670
sVCentral Nervous System Agents
p78890
g58446
sVPsychotropic Drugs
p78891
g72590
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p78892
g49331
sVCytochrome P-450 Enzyme Inhibitors
p78893
g62072
sVPeripheral Nervous System Agents
p78894
g57602
sVIndoles
p78895
g73562
sVCytochrome P-450 CYP1A2 Substrates
p78896
g45588
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p78897
g29507
sVCytochrome P-450 CYP2C9 Substrates
p78898
g29742
sVCarbazoles
p78899
g29831
sVImidazoles
p78900
(dp78901
sVAntiemetics and Antinauseants
p78902
g41641
sVCentral Nervous System Depressants
p78903
g78428
sVAntiemetics
p78904
g77558
sVCytochrome P-450 CYP1A2 Inhibitors
p78905
g15009
sg11877
(dp78906
sVP-glycoprotein/ABCB1 Substrates
p78907
g34963
sVHeterocyclic Compounds, Fused-Ring
p78908
g56078
sVCytochrome P-450 CYP3A4 Substrates
p78909
g65311
sVQTc Prolonging Agents
p78910
g57821
sVModerate Risk QTc-Prolonging Agents
p78911
g67167
sVCytochrome P-450 CYP3A5 Substrates
p78912
g67810
sVAntidepressive Agents
p78913
g15525
sg360
g15341
sVCytochrome P-450 CYP3A7 Substrates
p78914
g60652
ssg11658
(dp78915
g3024
g36269
sg2832
g34701
ssg11661
(dp78916
g2133
g30285
ssg11664
(dp78917
VDrugs that are Mainly Renally Excreted
p78918
g43872
sVHematologic Agents
p78919
g73842
sVBlood and Blood Forming Organs
p78920
g53920
sVHeterocyclic Compounds, Fused-Ring
p78921
g56062
sVVitamins
p78922
g12178
sVFood
p78923
g62216
sVHematinics
p78924
g59095
sVVITAMIN B12 AND FOLIC ACID
p78925
g55991
sVMicronutrients
p78926
g67468
sVVitamin B Complex
p78927
g54915
sVDiet, Food, and Nutrition
p78928
g22908
sVCorrinoids
p78929
g59172
sVFood and Beverages
p78930
g69592
sVAntianemic Preparations
p78931
g63061
sVPhysiological Phenomena
p78932
g21723
sVAntidotes
p78933
g69092
sg5175
g49558
sVGrowth Substances
p78934
g46129
ssg11667
(dp78935
VCytochrome P-450 CYP3A4 Inhibitors
p78936
g61662
sVAdrenergic beta-Agonists
p78937
g43004
sVBronchodilator Agents
p78938
g73493
sVPotential QTc-Prolonging Agents
p78939
g70416
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p78940
g43748
sVCytochrome P-450 Enzyme Inhibitors
p78941
g62074
sVDrugs for Obstructive Airway Diseases
p78942
g42512
sVDrugs that are Mainly Renally Excreted
p78943
g44012
sVAmines
p78944
g42700
sVTocolytic Agents
p78945
g33147
sVPeripheral Nervous System Agents
p78946
g57603
sVRespiratory System Agents
p78947
g71422
sVReproductive Control Agents
p78948
g18851
sVQTc Prolonging Agents
p78949
g57823
sVEthanolamines
p78950
g74745
sVAdrenergic Agents
p78951
g41703
sVSympathomimetic (Adrenergic) Agents
p78952
g75932
sVAgents to Treat Airway Disease
p78953
g32639
sVAdrenergic Agonists
p78954
g76834
sVAgents that produce hypertension
p78955
g69065
sVAnti-Asthmatic Agents
p78956
g36518
sVAutonomic Agents
p78957
g66558
sVAdrenergic beta-2 Receptor Agonists
p78958
g58944
sVAmino Alcohols
p78959
g32674
sVCytochrome P-450 CYP3A Inhibitors
p78960
g60421
sVSelective Beta 2-adrenergic Agonists
p78961
(dp78962
sVAgents producing tachycardia
p78963
g50760
sVPhenethylamines
p78964
(dp78965
sVAlcohols
p78966
(dp78967
sVAdrenergics, Inhalants
p78968
g43173
ssg11670
(dp78969
g9117
g69454
sg1629
g25989
sg2346
g31377
sg6183
g55460
sg1326
g23597
sg2355
g31433
sg3846
g41119
sg3114
g36868
sg135
g13254
sg6204
g55580
sg11283
g77753
sg4788
g47572
sg7641
g63036
sg9165
g69614
sg7650
g63089
sg1650
g26108
sg7653
g63125
sg4656
g46782
sg10674
g75701
sg10680
g75742
sg7671
g63258
sg9198
g69796
sg6246
g55794
sg3144
g37110
sg10377
g74690
sg5499
g51419
sg2088
g29919
sg4887
g48088
sg11475
g78417
sg2436
g32191
sg6966
g59415
sg2451
g32221
sg4710
g47014
sg9750
g72080
sg5535
g51660
sg126
g13175
sg132
g13224
sg9144
g69549
sg3867
g41362
sg7005
g59529
sg10779
g76164
sg972
g21129
sg5571
g51775
sg6318
g56356
sg3231
g37650
sg6336
g56516
sg9081
g69173
sg10815
g76283
sg204
g13958
sg4005
g42170
sg3267
g37897
sg8616
g67457
sg4014
g42231
sg1278
g23334
sg240
g14187
sg7884
g64104
sg4830
g47807
sg8916
g68637
sg10884
g76570
sg4062
g42629
sg4860
g47910
sg1062
g21806
sg4872
g48000
sg6432
g56938
sg5460
g51231
sg5685
g52453
sg4752
g47297
sg1872
g27869
sg11685
(dp78970
sg6348
g56641
sg1875
g27918
sg11694
(dp78971
sg2460
g32278
sg6435
g56973
sg10164
g73675
sg7947
g64373
sg2667
g33507
sg8562
g67235
sg11745
(dp78972
sg1941
g28584
sg7188
g60504
sg10227
g73916
sg2706
g33763
sg8742
g67943
sg414
g15959
sg6933
g59302
sg1425
g24551
sg978
g21160
sg5832
g53414
sg9486
g71118
sg7074
g60004
sg879
g20348
sg477
g16602
sg8832
g68350
sg2034
g29020
sg4263
g44163
sg20252
g78395
sg8805
g68187
sg8067
g64970
sg3519
g39208
sg7314
g61017
sg9561
g71356
sg9579
g71444
sg11100
g77179
sg9588
g71474
sg5094
g49083
sg8079
g65022
sg11862
(dp78973
sg7299
g60917
sg1311
g23529
sg5919
g53968
sg8850
g68402
sg2115
g30199
sg6885
g59152
sg5934
g54086
sg5127
g49230
sg10383
g74706
sg909
g20639
sg9180
g69704
sg5025
g48769
sg11166
g77409
sg2733
g33927
sg3624
g39907
sg3291
g38004
sg3597
g39654
sg5193
g49637
sg7395
g61591
sg10236
g73980
sg8187
g65541
sg4446
g45356
sg630
g18021
sg6735
g58356
sg11958
(dp78974
sg11961
(dp78975
sg5229
g49799
sg11976
(dp78976
sg5235
g49834
sg2946
g35815
sg657
g18326
sg9711
g71983
sg5574
g51798
sg405
g15906
sg10479
g74949
sg6051
g54784
sg9282
g70201
sg8238
g65760
sg8241
g65798
sg9687
g71851
sg6867
g59053
sg822
g19812
sg1746
g26954
sg6792
g58727
sg9006
g68894
sg9759
g72102
sg3000
g36030
sg2391
g31722
sg2265
g31008
sg5313
g50395
sg486
g16651
sg5736
g52842
sg2274
g31069
sg1176
g22676
sg8856
g68428
sg10554
g75246
sg9810
g72223
sg10698
g75782
sg7563
g62667
sg10098
g73525
sg6843
g58966
sg5370
g50672
sg2664
g33440
sg10692
g75765
sg1185
g22724
sg10611
g75511
sg561
g17374
ssg11673
(dp78977
g3132
g37011
sg9432
g70894
sg11451
g78330
sg6435
g56975
sg9198
g69822
sg573
g17548
sg7884
g64106
sg7947
g64374
sg9954
g72918
sg11052
g76983
sg819
g19753
ssg11676
(dp78978
g8763
g68032
sg690
g18625
sg1278
g23346
sg9879
g72533
sg7740
g63574
sg3858
g41219
sg2943
g35764
sg8595
g67358
sg9366
g70492
sg8781
g68107
sg6033
g54519
sg7653
g63132
sg7377
g61500
sg10680
g75739
sg9687
g71854
sg5007
g48707
sg4479
g45699
sg1473
g24964
sg9081
g69169
sg6699
g58224
sg4077
g42834
sg2715
g33804
sg2250
g30872
sg3024
g36293
sg5919
g53972
sg3021
g36200
sg2850
g35111
sg2274
g31075
sg11775
(dp78979
sg9834
g72386
sg6000
g54311
sg4539
g46031
sg11166
g77413
sg10230
g73952
sg6291
g56014
sg165
g13604
sg2652
g33313
sg9324
g70333
sg1176
g22688
sg7077
g60029
sg6336
g56519
sg2316
g31309
sg6537
g57402
sg5199
g49691
sg7458
g62134
sg11385
g78124
ssg11679
(dp78980
g1605
g25784
sg3363
g38414
ssg11682
(dp78981
g7593
g62822
ssg11685
(dp78982
VAntiinfectives for Systemic Use
p78983
g69653
sVDrugs that are Mainly Renally Excreted
p78984
g44015
sVHeterocyclic Compounds, Fused-Ring
p78985
g56081
sg12009
(dp78986
sVOAT3/SLC22A8 Substrates
p78987
g13125
sg1128
g22279
sg10284
g74189
sVAmides
p78988
g44319
sVSulfur Compounds
p78989
g78970
sVAnti-Bacterial Agents
p78990
g38347
sVAntibacterials for Systemic Use
p78991
g32547
sVAnti-Infective Agents
p78992
g54603
sg1731
g26892
ssg11688
(dp78993
g6819
g58877
sg14791
g71074
ssg11691
(dp78994
g10347
g74486
ssg11694
(dp78995
VAntiinfectives for Systemic Use
p78996
g69655
sVDrugs that are Mainly Renally Excreted
p78997
g44017
sg10437
g74854
sVHeterocyclic Compounds, Fused-Ring
p78998
g56082
sVbeta-Lactams
p78999
(dp79000
sVLactams
p79001
g22292
sVAmides
p79002
g44322
sVSulfur Compounds
p79003
g78971
sVAnti-Bacterial Agents
p79004
g38350
sVAntibacterials for Systemic Use
p79005
g32549
sVAnti-Infective Agents
p79006
g54606
sg11433
g78218
ssg11697
(dp79007
g3126
g36956
sg8022
g64783
sg3105
g36774
sg1149
g22493
sg10428
g74837
ssg11700
(dp79008
g5571
g51772
sg5313
g50402
sg11961
(dp79009
sg6867
g59050
sg3519
g39203
sg2355
g31430
sg132
g13218
ssg11703
(dp79010
g4830
g47816
ssg11706
(dp79011
g6447
g57034
sg7698
g63344
ssg11709
(dp79012
g10794
g76193
ssg11712
(dp79013
VNitrogen Binding Agent
p79014
(dp79015
sVAnti-Acne Preparations for Topical Use
p79016
g62694
sVBenzene Derivatives
p79017
g61415
sVBenzoates
p79018
g30394
sg11364
g78032
sVAcids, Carbocyclic
p79019
g41569
sVDermatologicals
p79020
g17244
sVAnti-Acne Preparations
p79021
g63933
sVKeratolytic Agents
p79022
g72415
ssg11715
(dp79023
g87
g12936
sg10833
g76392
sg11061
g77016
sg3015
g36103
sg12090
(dp79024
sg7881
g64073
sg10368
g74649
sg10326
g74425
sg1101
g22075
sg4521
g45975
sg7815
g63767
sg8985
g68848
sg7500
g62363
sg3264
g37871
sg6654
g58071
sg48
g12649
sg11427
g78209
sg11334
g77936
sg474
g16574
sg10509
g75059
sg1275
g23299
ssg11718
(dp79025
VAmino Acids, Peptides, and Proteins
p79026
g47354
sVIntercellular Signaling Peptides and Proteins
p79027
g25422
sg2970
g35896
sVInterleukin Inhibitors
p79028
g49767
sVAgents reducing cytokine levels
p79029
g78443
sVProteins
p79030
g52757
sVImmunosuppressive Agents
p79031
g64562
sVPeptides
p79032
g47180
sg6477
g57192
sVBiological Factors
p79033
g38114
sVAntineoplastic and Immunomodulating Agents
p79034
g39769
sVAntirheumatic Agents
p79035
g24239
sg4848
g47865
sVCytokines
p79036
g62894
sg10293
g74211
ssg11721
(dp79037
VCentral Nervous System Depressants
p79038
g78437
sVHistamine H1 Antagonists
p79039
g40771
sVCytochrome P-450 CYP3A Substrates
p79040
g45142
sVNeurotransmitter Agents
p79041
g75593
sVCytochrome P-450 CYP2C8 Substrates
p79042
g76581
sVHistamine Agents
p79043
g75604
sVAminoalkyl Ethers
p79044
g19318
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79045
g29422
sVHistamine Antagonists
p79046
g43429
sVAntihistamines for Systemic Use
p79047
g12962
sVQTc Prolonging Agents
p79048
g57841
sVCytochrome P-450 CYP3A4 Substrates
p79049
g65273
sVModerate Risk QTc-Prolonging Agents
p79050
g67165
ssg11724
(dp79051
g7191
g60546
sg5289
g50300
ssg11727
(dp79052
VAnalgesics and Anesthetics
p79053
g49752
sVQuinolines
p79054
g74114
sVOtologicals
p79055
g69481
sVCentral Nervous System Agents
p79056
g58456
sVAnesthetics, Local
p79057
g53474
sVVasoprotectives
p79058
g41391
sVPeripheral Nervous System Agents
p79059
g57649
sVStandardized Chemical Allergen
p79060
g44804
sVAntipruritics and Local Anesthetics
p79061
g31868
sVAmides
p79062
g44326
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p79063
g16832
sVAnesthetics
p79064
g51608
sVCell-mediated Immunity
p79065
g23555
sVDermatologicals
p79066
g17322
sVAnesthetics for Topical Use
p79067
g43182
sVIncreased Histamine Release
p79068
g55114
sVSensory Organs
p79069
g40747
sVHeterocyclic Compounds, Fused-Ring
p79070
g56155
sVOphthalmologicals
p79071
g35263
sVCholinesterase Inhibitors
p79072
g72396
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p79073
g77799
sVSensory System Agents
p79074
g71817
sVNervous System
p79075
g70309
ssg11730
(dp79076
g6312
g56259
sg8265
g65888
ssg11733
(dp79077
VAgents Causing Muscle Toxicity
p79078
g55375
sVCytochrome P-450 CYP3A4 Inhibitors
p79079
g61670
sVSterols
p79080
g78585
sVCytochrome P-450 CYP2D6 Inhibitors
p79081
g62929
sVCytochrome P-450 CYP2D6 Substrates
p79082
g52172
sVUGT1A1 Substrates
p79083
g12303
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p79084
g41081
sVCytochrome P-450 CYP3A Substrates
p79085
g45218
sVBCRP/ABCG2 Inhibitors
p79086
g12549
sVAntibacterials for Systemic Use
p79087
g32552
sVOATP1B1/SLCO1B1 Inhibitors
p79088
g75615
sVLipids
p79089
g14341
sVEnzyme Inhibitors
p79090
g72707
sVCytochrome P-450 Enzyme Inhibitors
p79091
g62079
sVAnti-Infective Agents
p79092
g54614
sg9771
g72125
sVAntiinfectives for Systemic Use
p79093
g69659
sg2967
g35894
sVAntibiotics for Topical Use
p79094
g57688
sg6774
g58652
sVMedicated Dressings
p79095
g20579
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79096
g29525
sVAnti-Bacterial Agents
p79097
g38354
sVFused-Ring Compounds
p79098
g14847
sVProtein Synthesis Inhibitors
p79099
g45557
sVCholestenes
p79100
g57944
sVDermatologicals
p79101
g17247
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p79102
g69048
sVCholestanes
p79103
g19147
sVBSEP/ABCB11 Inhibitors
p79104
g62526
sVCytochrome P-450 CYP3A4 Substrates
p79105
g65322
sVMedicated Dressings With Antiinfectives
p79106
g43162
sVMembrane Lipids
p79107
g47725
sVOphthalmologicals
p79108
g35213
sVSteroids
p79109
g56428
sVCytochrome P-450 CYP3A Inhibitors
p79110
g60430
sg8745
g67947
sVSensory Organs
p79111
g40706
ssg11736
(dp79112
g3264
g37878
ssg11739
(dp79113
g2346
g31396
sg2196
g30640
sg1473
g24977
sg9249
g70011
sg5817
g53326
sg2211
g30730
sg456
g16395
sg2034
g29033
sg8625
g67508
sg10389
g74734
sg10899
g76629
sg78
g12871
sg9591
g71515
sg840
g20022
sg2829
g34658
sg9231
g69978
sg3546
g39399
sg10752
g76034
sg1140
g22390
sg2115
g30189
sg10179
g73740
sg9834
g72376
sg5127
g49248
sg1920
g28493
sg2493
g32610
sg9273
g70176
sg16906
g61919
sg1098
g22006
sg1371
g24123
sg11913
(dp79114
sg5646
g52340
sg9084
g69213
sg3261
g37842
sg621
g17964
sg9105
g69384
ssg11742
(dp79115
g10587
g75375
ssg11745
(dp79116
VDrugs that are Mainly Renally Excreted
p79117
g44020
sg11553
g78583
sg8730
g67929
sVAntifungal Agents
p79118
g76442
sVDermatologicals
p79119
g17248
sVMiscellaneous Local Anti-infectives
p79120
g59166
sg4839
g47833
sVKeratolytic Agents
p79121
g72414
sVAnti-Infective Agents
p79122
g54616
sVSulfur Compounds
p79123
g78972
ssg11748
(dp79124
g11781
(dp79125
sg5085
g49053
ssg11751
(dp79126
g6873
g59091
sg7419
g61770
sg648
g18167
sg7644
g63057
sg5844
g53486
sg3945
g41773
sg7866
g64028
sg2595
g33104
sg3153
g37167
sg1086
g21945
sg3933
g41682
sg5901
g53871
sg5907
g53937
sg9972
g73072
sg3030
g36403
sg10173
g73701
sg4728
g47153
sg11514
g78464
sg7953
g64389
sg10008
g73252
sg10206
g73849
sVAcids, Acyclic
p79127
g25487
ssg11754
(dp79128
g13750
g24352
sg3219
g37537
sg1614
g25846
sg8142
g65383
sg2388
g31690
sg9774
g72151
sg9030
g68983
sg1800
g27301
sg9903
g72608
sg4875
g48015
sg1383
g24166
sg12132
(dp79129
sg14838
g39960
sg6345
g56567
sg5895
g53791
sg12534
g52630
sg4653
g46682
sg14829
g56664
sg6585
g57664
sg6045
g54701
ssg11757
(dp79130
g10674
g75716
sg405
g15879
sg8805
g68174
sg1425
g24570
sg5535
g51674
sg822
g19808
sg486
g16669
sg6318
g56390
sg10815
g76300
sg414
g15987
sg8187
g65557
ssg11760
(dp79131
g7560
g62633
sVEnzymes
p79132
g72155
sg7581
g62775
sg6018
g54413
sVEsterases
p79133
g59358
sg8736
g67932
sg10710
g75828
sg7050
g59782
sg1680
g26368
sVEnzymes and Coenzymes
p79134
g72086
sVHydrolases
p79135
g76367
sVAlimentary Tract and Metabolism
p79136
g23849
ssg11763
(dp79137
g2985
g35921
sg9870
g72491
sg3882
g41420
sg3147
g37156
sg5928
g54060
ssg11766
(dp79138
g6447
g57037
sg11403
g78162
sg9216
g69879
sg11976
(dp79139
sg4890
g48119
sg5094
g49085
sg7698
g63347
ssg11769
(dp79140
VDrugs that are Mainly Renally Excreted
p79141
g44023
sVHematologic Agents
p79142
g73843
sVPhenols
p79143
g65121
sVBenzene Derivatives
p79144
g61417
sg5013
g48714
sVAntacids and Adsorbents
p79145
g60138
sVHemostatics
p79146
g23068
sVHydroxy Acids
p79147
g18169
sVAntidiarrheals
p79148
g78702
sVAcids, Carbocyclic
p79149
g41580
sVHydroxybenzoates
p79150
g59579
sVBenzoates
p79151
g30400
sVNeurotoxic agents
p79152
g68577
sVAnti-Infective Agents
p79153
g54619
sVCoagulants
p79154
(dp79155
ssg11772
(dp79156
g11862
(dp79157
sg4062
g42657
sg9687
g71862
sg1941
g28614
sg4341
g44614
sg978
g21192
sg879
g20380
ssg11775
(dp79158
VAgents Causing Muscle Toxicity
p79159
g55400
sVNucleic Acid Synthesis Inhibitors
p79160
g48745
sVImmunologic Factors
p79161
g42393
sVNoxae
p79162
g65432
sVCytochrome P-450 CYP3A Substrates
p79163
g45223
sVBiological Factors
p79164
g38126
sVEnzyme Inhibitors
p79165
g72710
sg7647
g63064
sg10473
g74937
sVDrugs that are Mainly Renally Excreted
p79166
g44024
sVMyelosuppressive Agents
p79167
g71331
sVNephrotoxic agents
p79168
g57718
sVPigments, Biological
p79169
g21853
sg8637
g67523
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79170
g29533
sVReproductive Control Agents
p79171
g18862
sVOAT1/SLC22A6 inhibitors
p79172
(dp79173
sVAntimetabolites, Antineoplastic
p79174
g23457
sVOATP1B1/SLCO1B1 Substrates
p79175
g78979
sVCytochrome P-450 CYP3A4 Inducers
p79176
g18930
sVAntineoplastic Agents
p79177
g71540
sg11304
g77818
sVOATP1B3 substrates
p79178
g28526
sVOAT3/SLC22A8 Substrates
p79179
g13148
sVP-glycoprotein/ABCB1 Substrates
p79180
g34991
sVDermatologicals
p79181
g17257
sg11775
(dp79182
sVCytochrome P-450 CYP3A Inducers
p79183
g66290
sVCytochrome P-450 CYP3A4 Substrates
p79184
g65324
sVToxic Actions
p79185
g49409
sVCardiotoxic antineoplastic agents
p79186
g72242
sVHeterocyclic Compounds, Fused-Ring
p79187
g56095
sg9279
g70190
sVAntimetabolites
p79188
g59542
sg9825
g72339
sVImmunosuppressive Agents
p79189
g64566
sVOAT3/SLC22A8 Inhibitors
p79190
g59022
sVBCRP/ABCG2 Substrates
p79191
g42097
sVAntineoplastic and Immunomodulating Agents
p79192
g39776
sg3255
g37795
sVAntirheumatic Agents
p79193
g24251
ssg11778
(dp79194
g3846
g41157
ssg11781
(dp79195
VBSEP/ABCB11 Substrates
p79196
g74872
sVOAT1/SLC22A6 inhibitors
p79197
(dp79198
sVOAT1/SLC22A6 Substrates
p79199
g60726
sg7242
g60728
sVCompounds used in a research, industrial, or household setting
p79200
g76510
sg1056
g21728
sg2592
g33101
sVDiagnostic Agents
p79201
g60043
sg11220
g77515
sg1845
g27670
sg3909
g41586
sg2100
g30061
sg4296
g44415
sg3354
g38309
sVOAT3/SLC22A8 Substrates
p79202
g13151
sVLaboratory Chemicals
p79203
g76043
sVSensory Organs
p79204
g40712
sVIndicators and Reagents
p79205
g58939
sVHeterocyclic Compounds, Fused-Ring
p79206
g56064
sVOphthalmologicals
p79207
g35220
sVColoring Agents
p79208
g50360
sVOther Diagnostics
p79209
g79125
sVXanthenes
p79210
g48679
ssg11784
(dp79211
g3990
g42101
sg1578
g25603
sg11712
g79015
sg3711
g40406
sg6093
g54981
sg1014
g21321
ssg11787
(dp79212
g19588
g32452
ssg11790
(dp79213
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p79214
g77512
sVAdrenergic alpha-1 Receptor Antagonists
p79215
g14134
sVAnticholinergic Agents
p79216
g24471
sVCytochrome P-450 CYP2D6 Substrates
p79217
g52206
sVSerotonin Agents
p79218
g76437
sVCytochrome P-450 CYP3A Substrates
p79219
g45270
sVNeurotransmitter Agents
p79220
g75597
sVDopamine Agonists
p79221
g56752
sVSerotonin Receptor Antagonists
p79222
g35682
sVCentral Nervous System Agents
p79223
g58526
sVDopamine Agents
p79224
g14270
sVPotential QTc-Prolonging Agents
p79225
g70435
sVAdrenergic Antagonists
p79226
g52263
sVPsychotropic Drugs
p79227
g72600
sVSerotonin 5-HT1 Receptor Antagonists
p79228
g14437
sVMuscarinic Antagonists
p79229
g48861
sVHyperglycemia-Associated Agents
p79230
g68818
sVAntipsychotic Agents
p79231
g69863
sVPiperazines
p79232
g78783
sVDopamine Antagonists
p79233
g53748
sVAdrenergic alpha-Antagonists
p79234
g60861
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79235
g29593
sVQTc Prolonging Agents
p79236
g57887
sVSerotonin 5-HT1 Receptor Agonists
p79237
g34591
sVSerotonin 5-HT2 Receptor Antagonists
p79238
g71719
sVCentral Nervous System Depressants
p79239
g78429
sVHistamine Antagonists
p79240
g43415
sVHistamine H1 Antagonists
p79241
g40758
sVAgents that produce hypertension
p79242
g69087
sVCytochrome P-450 CYP3A5 Substrates
p79243
g67831
sVCytochrome P-450 CYP3A4 Substrates
p79244
g65351
sVQuinolones
p79245
g23986
sVDopamine D2 Receptor Antagonists
p79246
g49422
sVHeterocyclic Compounds, Fused-Ring
p79247
g56157
sVAntidepressive Agents
p79248
g15575
sVPsycholeptics
p79249
g33228
sVTranquilizing Agents
p79250
g55286
sg10809
g76256
sVQuinolines
p79251
g74117
sVNeurotoxic agents
p79252
g68574
sVAgents producing tachycardia
p79253
g50797
sVSerotonin Receptor Agonists
p79254
(dp79255
sVNervous System
p79256
g70285
sg5601
g52063
sVCytochrome P-450 CYP3A7 Substrates
p79257
g60672
ssg11793
(dp79258
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p79259
g77509
sg3471
g39011
sVAnticholinergic Agents
p79260
g24461
sVCytochrome P-450 CYP2D6 Inhibitors
p79261
g62935
sVCytochrome P-450 CYP2D6 Substrates
p79262
g52165
sVHistamine Agents
p79263
g75600
sVCentral Nervous System Agents
p79264
g58465
sVPotential QTc-Prolonging Agents
p79265
g70422
sVOCT2 Inhibitors
p79266
g42463
sg5838
g53470
sVCytochrome P-450 Enzyme Inhibitors
p79267
g62081
sVMuscarinic Antagonists
p79268
g48854
sVAmines
p79269
g42712
sVAnesthetics
p79270
g51599
sg903
g20588
sg96
g12957
sVCytochrome P-450 CYP2C9 Substrates
p79271
g29767
sVQTc Prolonging Agents
p79272
g57837
sg2082
g29877
sg6801
g58781
sVCentral Nervous System Depressants
p79273
g78430
sVAntiemetics
p79274
g77556
sVGastrointestinal Agents
p79275
g70831
sVHistamine Antagonists
p79276
g43418
sVBenzene Derivatives
p79277
g61419
sg10929
g76669
sVDermatologicals
p79278
g17262
sVHistamine H1 Antagonists
p79279
g40761
sg11526
g78493
sVHypnotics and Sedatives
p79280
(dp79281
sg5367
g50643
sg777
g19319
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p79282
g53059
sg11298
g77798
sVAgents producing tachycardia
p79283
g50775
ssg11796
(dp79284
g8322
g66136
sg9918
g72761
sg5334
g50521
ssg11799
(dp79285
VGlycosides
p79286
g68354
sVNucleic Acid Synthesis Inhibitors
p79287
g48725
sVMyelosuppressive Agents
p79288
g71332
sVAntimetabolites
p79289
g59534
sVNucleic Acids, Nucleotides, and Nucleosides
p79290
g47113
sVCarbohydrates
p79291
g61774
sVImmunosuppressive Agents
p79292
g64569
sVNucleoside Metabolic Inhibitor
p79293
g68862
sVPurine Analogues
p79294
g70066
sVAntineoplastic and Immunomodulating Agents
p79295
g39780
sVAntineoplastic Agents
p79296
g71541
sVNucleosides
p79297
g49455
ssg11802
(dp79298
g10149
g73637
sg7962
g64413
sg10581
g75352
sg4278
g44260
sg9081
g69152
sg339
g15145
sg2172
g30496
sg10416
g74768
sg8457
g66835
sg11259
g77645
ssg11805
(dp79299
VAnti-Inflammatory Agents, Non-Steroidal (Non-Selective)
p79300
g58385
sVNonsteroidal Anti-inflammatory Compounds
p79301
g68159
sVAnalgesics, Non-Narcotic
p79302
g56897
sVBenzene Derivatives
p79303
g61406
sVKetones
p79304
g50969
sVNephrotoxic agents
p79305
g57720
sVAnalgesics
p79306
g26463
sVAgents causing hyperkalemia
p79307
g43604
sVSensory Organs
p79308
g40683
sVCentral Nervous System Agents
p79309
g58522
sVAnti-Inflammatory Agents
p79310
g73960
sVHydrocarbons, Halogenated
p79311
(dp79312
sVCyclooxygenase Inhibitors
p79313
g32777
sVPeripheral Nervous System Agents
p79314
g57584
sVSelective Cyclooxygenase 2 Inhibitors (NSAIDs)
p79315
g24332
sVAntirheumatic Agents
p79316
g24208
sVSensory System Agents
p79317
g71810
sVAnti-Inflammatory Agents, Non-Steroidal
p79318
g64651
sg10392
g74738
sVOphthalmologicals
p79319
g35185
ssg11808
(dp79320
g2256
g30925
sg4446
g45341
sg9897
g72556
sg4860
g47908
sg6735
g58354
sg10074
g73470
sg3597
g39637
sg1356
g23966
sg6507
g57306
sg10662
g75660
sg5460
g51216
ssg11811
(dp79321
VCentral Nervous System Depressants
p79322
g78431
sVHypnotics and Sedatives
p79323
(dp79324
sVAcids, Acyclic
p79325
g25441
sVTranquilizing Agents
p79326
g55288
sVAnti-Anxiety Agents
p79327
g35644
sVMuscle Relaxants, Centrally Acting Agents
p79328
g37383
sVCentral Nervous System Agents
p79329
g58469
sVNervous System
p79330
g70287
sVPsychotropic Drugs
p79331
g72582
sVMuscle Relaxants
p79332
g76661
sVPsycholeptics
p79333
g33230
sVCarbamates
p79334
g45515
sVPeripheral Nervous System Agents
p79335
g57616
ssg11814
(dp79336
g9225
g69899
ssg11817
(dp79337
g8760
g67998
sg3015
g36091
sg10077
g73485
sg2736
g33953
sg4725
g47144
sg8340
g66226
sg1686
g26412
sg8871
g68494
ssg11820
(dp79338
VAgents Causing Muscle Toxicity
p79339
g55371
sVBSEP/ABCB11 Substrates
p79340
g74868
sVFatty Acids
p79341
g63143
sVKetones
p79342
g50966
sVCytochrome P-450 CYP3A Substrates
p79343
g45052
sVFribic Acid Derivatives
p79344
g56919
sVButyrates
p79345
g59982
sVLipids
p79346
g14320
sVCytochrome P-450 CYP2C9 Inhibitors
p79347
g18202
sVCytochrome P-450 Enzyme Inhibitors
p79348
g61991
sVEthers
p79349
g27594
sVDrugs that are Mainly Renally Excreted
p79350
g43919
sVLipid Modifying Agents
p79351
g40543
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p79352
(dp79353
sVUGT1A1 Substrates
p79354
g12260
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79355
g29324
sVLipid Modifying Agents, Plain
p79356
g63420
sVHypolipidemic Agents
p79357
g69891
sVFatty Acids, Volatile
p79358
g66974
sVPhenols
p79359
g65122
sVBenzene Derivatives
p79360
g61413
sVIsobutyrates
p79361
g25235
sVCytochrome P-450 CYP2C8 Inhibitors
p79362
g55016
sVPhenyl Ethers
p79363
g40595
sVCytochrome P-450 CYP3A4 Substrates
p79364
g65235
sVToxic Actions
p79365
g49374
sVPeroxisome Proliferator-activated Receptor alpha Agonists
p79366
g55154
sVAcids, Acyclic
p79367
g25464
sVNoxae
p79368
g65413
sVFibric Acids
p79369
g69457
sVP-glycoprotein/ABCB1 Inhibitors
p79370
g74811
sVPeroxisome Proliferator Receptor alpha Agonist
p79371
g76667
sVCytochrome P-450 CYP2C8 Inhibitors (weak)
p79372
g24188
sVBenzophenones
p79373
g53197
sVLipid Regulating Agents
p79374
g72479
ssg11823
(dp79375
g3147
g37154
ssg11826
(dp79376
VHematinics
p79377
g59092
sVCarbohydrates
p79378
g61766
sVHydroxy Acids
p79379
g18159
sVAntianemic Preparations
p79380
g63059
sVFerric Compounds
p79381
g53488
sVPolysaccharides
p79382
g41775
sVPhosphate-removing Agents
p79383
g64029
sVOligosaccharides
p79384
g33105
sVDrugs for Treatment of Hyperkalemia and Hyperphosphatemia
p79385
g37169
sVPhosphate Binder
p79386
g21946
sVParenteral Iron Replacement
p79387
g41684
sVPharmaceutical Preparations
p79388
g53866
sVBlood and Blood Forming Organs
p79389
g53933
sVIron Preparations
p79390
g73073
sVIron Compounds
p79391
g36405
sVGlucaric Acid
p79392
g73702
sVIron Trivalent, Oral Preparations
p79393
g47154
sVSugar Acids
p79394
g78465
sVDisaccharides
p79395
g64390
sVOrganometallic Compounds
p79396
g73254
sVHematologic Agents
p79397
g73847
sVAcids, Acyclic
p79398
g25480
ssg11829
(dp79399
g3504
g39089
ssg11832
(dp79400
VPhosphorus Acids
p79401
g65599
sg228
g14150
sVPreparations for Treatment of Wounds and Ulcers
p79402
g74875
sg3288
g37989
sVStomatological Preparations
p79403
g67438
sVBiological Factors
p79404
g38099
sVCalcium Compounds
p79405
g51123
sg10095
g73508
sg2040
g29054
sVElectrolytes
p79406
g52413
sg6936
g59308
sVCicatrizants
p79407
g37239
sVAcids
p79408
g40568
sVProteins
p79409
g52768
sVHematologic Agents
p79410
g73839
sVDermatologicals
p79411
g17270
sVPeptides
p79412
g47191
sg4743
g47250
sVPhosphate salts
p79413
g58906
sg11883
(dp79414
sVAlimentary Tract and Metabolism
p79415
g23864
sVGrowth Substances
p79416
g46119
sVAmino Acids, Peptides, and Proteins
p79417
g47375
sVIons
p79418
g49113
sVIntercellular Signaling Peptides and Proteins
p79419
g25412
sVAngiogenesis Modulating Agents
p79420
g71707
sVAcids, Noncarboxylic
p79421
g54193
sVPhosphoric Acids
p79422
g76252
sVPhosphorus Compounds
p79423
g36720
sVAnions
p79424
g71787
sg3453
g38984
sVBlood Proteins
p79425
g39851
ssg11835
(dp79426
g7971
g64454
ssg11838
(dp79427
VAntiinfectives for Systemic Use
p79428
g69670
sVCytochrome P-450 CYP3A4 Inhibitors
p79429
g61682
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p79430
g43760
sVCarbohydrates
p79431
g61778
sVCytochrome P-450 CYP3A Inhibitors
p79432
g60443
sg9240
g70002
sVGlycosides
p79433
g68362
sVCytochrome P-450 Enzyme Inhibitors
p79434
g62083
sVLactones
p79435
g77731
sVAntiparasitic Agents
p79436
g40649
sVMacrolides
p79437
g16901
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79438
g29550
sg4416
g44874
sVMacrolides, Lincosamides and Streptogramins
p79439
g33219
sVAnti-Bacterial Agents
p79440
g38360
sVAntibacterials for Systemic Use
p79441
g32558
sVAntiprotozoals
p79442
g59374
sVCytochrome P-450 CYP3A4 Substrates
p79443
g65332
sVAnti-Infective Agents
p79444
g54635
sVCytochrome P-450 CYP3A Substrates
p79445
g45236
sVPolyketides
p79446
g48466
ssg11841
(dp79447
g8421
g66503
sg9198
g69790
sg888
g20431
sg78
g12844
sg7335
g61191
ssg11844
(dp79448
g11385
g78121
ssg11847
(dp79449
g3684
g40226
ssg11850
(dp79450
g11286
g77780
ssg11853
(dp79451
g6090
g54966
sg7563
g62647
sg4263
g44140
sg10779
g76158
ssg11856
(dp79452
g7740
g63576
sg10275
g74170
sg11592
g78633
sg4449
g45360
sg1239
g22956
sg6639
g57972
sg8421
g66510
sg1152
g22526
sg8472
g66949
sg6333
g56469
sg5007
g48709
sg11655
g78901
sg7335
g61200
sg6798
g58767
sg10914
g76649
sg6279
g55952
sg3024
g36295
sg11313
g77833
sg8856
g68430
sg6291
g56016
sg9264
g70095
sg4746
g47257
sg3216
g37528
sg6678
g58115
sg6684
g58161
sg6507
g57313
sg9822
g72311
sg11910
(dp79453
sg9009
g68921
sg9093
g69280
sg11241
g77595
sg3258
g37826
sg210
g14023
sg10305
g74244
ssg11859
(dp79454
g1866
g27794
ssg11862
(dp79455
VAgents Causing Muscle Toxicity
p79456
g55386
sVOAT1/SLC22A6 inhibitors
p79457
(dp79458
sVHypotensive Agents
p79459
g34186
sVHyperglycemia-Associated Agents
p79460
g68815
sVDrugs that are Mainly Renally Excreted
p79461
g44033
sVGynecological Antiinfectives and Antiseptics
p79462
g69234
sVNephrotoxic agents
p79463
g57727
sVAcids, Carbocyclic
p79464
g41563
sVAmides
p79465
g44332
sVSulfur Compounds
p79466
g78973
sVSulfones
p79467
g58743
sVNatriuretic Agents
p79468
g40491
sVSodium Potassium Chloride Symporter Inhibitors
p79469
g26506
sVDiuretics
p79470
g57903
sVCardiovascular Agents
p79471
g26622
sVBenzene Derivatives
p79472
g61423
sVNon Potassium Sparing Diuretics
p79473
g14968
sVOAT3/SLC22A8 Substrates
p79474
g13126
sg5724
g52799
sg4326
g44529
sVMembrane Transport Modulators
p79475
g54155
sVAminobenzoates
p79476
g46178
sVGenito Urinary System and Sex Hormones
p79477
g66177
sVBenzoates
p79478
g30391
sVSulfonamides
p79479
g63359
sVOAT3/SLC22A8 Inhibitors
p79480
g59011
sVIncreased Diuresis at Loop of Henle
p79481
g79157
sVHigh-Ceiling Diuretics
p79482
g59663
ssg11865
(dp79483
g3144
g37114
ssg11868
(dp79484
g8055
g64922
sg10563
g75320
sg2043
g29068
sg8472
g66940
sg147
g13423
sg528
g16920
sg8949
g68751
sg2763
g34226
sg6333
g56449
sg654
g18266
sg1650
g26095
sg8013
g64680
ssg11871
(dp79485
g6726
g58292
sg4557
g46157
sg7920
g64197
sg8649
g67549
sg7548
g62609
ssg11874
(dp79486
VFatty Acids
p79487
g63146
sVOAT1/SLC22A6 inhibitors
p79488
(dp79489
sg1329
g23625
sg7239
g60721
sVBiological Factors
p79490
g38107
sg8607
g67443
sg1848
g27673
sg11055
g77002
sg9459
g70963
sg8064
g64953
sVCardiac Therapy
p79491
g69636
sVUrological Agents
p79492
g38279
sg3252
g37785
sVCardiovascular Agents
p79493
g26626
sVDrugs Used in Erectile Dysfunction
p79494
g20785
sg3186
g37359
sg1896
g28021
sVOAT3/SLC22A8 Substrates
p79495
g13128
sVVasodilating Agents
p79496
g23707
sVUrologicals
p79497
g58916
sVHematologic Agents
p79498
g73846
sVGenito Urinary System and Sex Hormones
p79499
g66178
sg6879
g59104
sg6918
g59243
sg7020
g59590
sg795
g19496
sg8754
g67977
sVLipids
p79500
g14324
ssg11877
(dp79501
g11112
g77209
sg6156
g55232
sg11655
g78906
sg1134
g22338
sg10959
g76736
sg4344
g44664
ssg11880
(dp79502
g5835
g53463
sg7842
g63942
ssg11883
(dp79503
g11832
g79414
ssg11886
(dp79504
VHydroxycorticosteroids
p79505
g55776
sVCytochrome P-450 CYP3A Substrates
p79506
g45002
sVHormones
p79507
g55684
sVCorticosteroids for Systemic Use
p79508
g48835
sVHyperglycemia-Associated Agents
p79509
g68810
sV17-Hydroxycorticosteroids
p79510
g71412
sVGlucocorticoids
p79511
g21923
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79512
g29251
sVFused-Ring Compounds
p79513
g14862
sVCytochrome P-450 CYP3A4 Inducers
p79514
g18951
sVCytochrome P-450 CYP3A5 Inducers
p79515
g41749
sVAdrenal Cortex Hormones
p79516
g30034
sVAdrenals
p79517
g37371
sVCytochrome P-450 Enzyme Inducers
p79518
g28204
sVCytochrome P-450 CYP3A Inducers
p79519
g66284
sVCytochrome P-450 CYP3A4 Substrates
p79520
g65205
sVPregnanes
p79521
g63601
sVSteroids
p79522
g56419
sVImmunosuppressive Agents
p79523
g64572
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p79524
g64621
sVAnti-Inflammatory Agents
p79525
g73963
sVPregnenes
p79526
g28745
sVHormones, Hormone Substitutes, and Hormone Antagonists
p79527
g53171
sVCorticosteroids
p79528
g73368
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p79529
g72445
ssg11889
(dp79530
g6246
g55811
sg6843
g58981
ssg11892
(dp79531
g4551
g46109
ssg11895
(dp79532
g12042
(dp79533
ssg11898
(dp79534
g10218
g73894
ssg11901
(dp79535
g1113
g22201
ssg11904
(dp79536
g9444
g70950
sg9414
g70710
ssg11907
(dp79537
g10185
g73781
sg5286
g50222
sg6567
g57528
ssg11910
(dp79538
g1440
g24704
sg11223
g77517
sVAnalgesics
p79539
g26481
sg2478
g32373
sVHypotensive Agents
p79540
g34181
sVCentral Nervous System Agents
p79541
g58489
sg7413
g61717
sVPeripheral Nervous System Agents
p79542
g57635
sVSympatholytics
p79543
g56845
sVCytochrome P-450 CYP1A2 Substrates
p79544
g45612
sVAutonomic Agents
p79545
g66571
sVSympathomimetics in Glaucoma Therapy
p79546
g51323
sVAntihypertensive Agents
p79547
g20306
sVCytochrome P-450 CYP2D6 Substrates
p79548
g52180
sVImidazolines
p79549
g44245
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79550
g29562
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p79551
g60088
sVImidazoles
p79552
g79453
sVCytochrome P-450 CYP3A Substrates
p79553
g45245
sg4506
g45831
sVAdrenergic Agents
p79554
g41725
sVCentral Nervous System Depressants
p79555
g78432
sVNeurotransmitter Agents
p79556
g75583
sVCardiovascular Agents
p79557
g26642
sVAnesthetics
p79558
g51613
sVP-glycoprotein/ABCB1 Substrates with narrow therapeutic index
p79559
g49147
sg6465
g57058
sVP-glycoprotein/ABCB1 Substrates
p79560
g35038
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p79561
g36468
sVAdrenergic Agonists
p79562
g76840
sVAgents that produce hypertension
p79563
g69078
sVCytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index
p79564
g76137
sVCytochrome P-450 CYP3A4 Substrates
p79565
g65337
sVNarrow Therapeutic Index Drugs
p79566
g50579
sVAntiglaucoma Preparations and Miotics
p79567
g36562
sVAdrenergic alpha-2 Receptor Agonists
p79568
g67201
sVCytochrome P-450 CYP3A5 Substrates
p79569
g67826
sVOphthalmologicals
p79570
g35238
sVAdrenergic alpha-Agonists
p79571
g65400
sVBradycardia-Causing Agents
p79572
g61461
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p79573
g36628
sVAgents producing tachycardia
p79574
g50786
sVAdrenergic alpha-1 Receptor Agonists
p79575
g67238
sVSensory System Agents
p79576
g71814
sVNervous System
p79577
g70297
sVSensory Organs
p79578
g40728
ssg11913
(dp79579
VDrugs that are Mainly Renally Excreted
p79580
g43948
sVProtein Kinase Inhibitors
p79581
g79114
sVMyelosuppressive Agents
p79582
g71336
sVCytochrome P-450 CYP3A Substrates
p79583
g45246
sVImmunosuppressive Agents
p79584
g64583
sVTyrosine Kinase Inhibitors
p79585
g30832
sg1758
g26970
sVKinase Inhibitor
p79586
g24601
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79587
g29564
sVAntineoplastic and Immunomodulating Agents
p79588
g39805
sVCytochrome P-450 CYP3A4 Substrates
p79589
g65338
sVAntineoplastic Agents
p79590
g71549
ssg11916
(dp79591
VNitrogen Compounds
p79592
g39002
sVNervous System
p79593
g70298
sVAutonomic Agents
p79594
g66572
sVOnium Compounds
p79595
g22254
sVAcids, Acyclic
p79596
g25440
sVParasympathomimetics
p79597
g59100
sVNeurotransmitter Agents
p79598
g75584
sg8811
g68221
sVTrimethyl Ammonium Compounds
p79599
g16039
sVCholinergic Agents
p79600
g28732
sVAmmonium Compounds
p79601
g30556
sVParasympathomemetic (Cholinergic) Agents
p79602
g64020
sVCholinergic Agonists
p79603
g40989
sVMuscarinic Agonists
p79604
g66410
sg708
g18865
sVCarbamates
p79605
g45513
sVQuaternary Ammonium Compounds
p79606
g43369
sVPeripheral Nervous System Agents
p79607
g57636
sVAmines
p79608
g42726
ssg11919
(dp79609
g8598
g67396
sg8601
g67429
ssg11922
(dp79610
VCytochrome P-450 CYP3A Substrates
p79611
g45247
sVHormones
p79612
g55669
sVHyperglycemia-Associated Agents
p79613
g68814
sVCytochrome P-450 CYP3A4 Inducers (strong)
p79614
g23082
sVCorticosteroids for Systemic Use, Plain
p79615
g31761
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p79616
g73624
sVGlucocorticoids
p79617
g21932
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79618
g29565
sVFused-Ring Compounds
p79619
g14870
sVCytochrome P-450 CYP3A4 Inducers
p79620
g18958
sVCytochrome P-450 CYP3A5 Inducers
p79621
g41757
sVAdrenal Cortex Hormones
p79622
g30006
sVCytochrome P-450 Enzyme Inducers
p79623
g28217
sVCytochrome P-450 CYP3A Inducers
p79624
g66286
sVCytochrome P-450 CYP3A Inducers (strong)
p79625
g22463
sVCytochrome P-450 CYP3A4 Substrates
p79626
g65339
sVPregnanes
p79627
g63596
sVOphthalmologicals
p79628
g35243
sVSteroids
p79629
g56408
sVImmunosuppressive Agents
p79630
g64555
sVAnti-Inflammatory Agents
p79631
g73964
sVCorticosteroid Hormone Receptor Agonists
p79632
g63661
sVHormones, Hormone Substitutes, and Hormone Antagonists
p79633
g53154
sVCorticosteroids
p79634
g73365
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p79635
g72446
sVSensory Organs
p79636
g40731
ssg11925
(dp79637
g6228
g55710
ssg11928
(dp79638
g12126
(dp79639
sg2688
g33638
sg11337
g77967
ssg11931
(dp79640
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p79641
g77510
sVCytochrome P-450 CYP3A4 Inhibitors
p79642
g61700
sVAnti-Parkinson Drugs
p79643
g16153
sVSerotonin Agents
p79644
g76433
sVCytochrome P-450 CYP3A Substrates
p79645
g45248
sVNeurotransmitter Agents
p79646
g75578
sVDopamine Agonists
p79647
g56751
sVCentral Nervous System Agents
p79648
g58448
sVDopamine Agents
p79649
g14265
sg1431
g24607
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p79650
g43776
sVCytochrome P-450 Enzyme Inhibitors
p79651
g62089
sVAntidepressive Agents
p79652
g15558
sVErgot Alkaloids and Derivatives
p79653
g49010
sVErgot-derivative Dopamine Receptor Agonists
p79654
g35985
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79655
g29566
sVSerotonin 5-HT2 Receptor Agonists
p79656
g75036
sVAntineoplastic Agents
p79657
g71537
sVCentral Nervous System Depressants
p79658
g78433
sVProlactine Inhibitors
p79659
g75938
sVAnti-Dyskinesia Agents
p79660
g50485
sVP-glycoprotein/ABCB1 Substrates
p79661
g35043
sVAgents that produce hypertension
p79662
g69079
sVCytochrome P-450 CYP3A4 Substrates
p79663
g65340
sVSerotonin 5-HT1 Receptor Agonists
p79664
g34589
sVHeterocyclic Compounds, Fused-Ring
p79665
g56080
sVSerotonin Modulators
p79666
g69132
sVGenito Urinary System and Sex Hormones
p79667
g66184
sVCytochrome P-450 CYP3A Inhibitors
p79668
g60462
sVAlkaloids
p79669
g19445
sVSerotonin Receptor Agonists
p79670
(dp79671
sVNervous System
p79672
g70299
ssg11934
(dp79673
VFibrin Modulating Agents
p79674
g22853
sVHematologic Agents
p79675
g73845
sVBlood and Blood Forming Organs
p79676
g53925
sVCardiovascular Agents
p79677
g26647
sVOphthalmologicals
p79678
g35244
sVAnticoagulants
p79679
g58380
sVCarbohydrates
p79680
g61786
sVAgents causing hyperkalemia
p79681
g43621
sVNarrow Therapeutic Index Drugs
p79682
g50584
sVSensory Organs
p79683
g40732
sVHeparins
p79684
g77470
sVThyroxine-binding globulin substrates
p79685
g60172
sVHeparins or Heparinoids for Topical Use
p79686
g50912
sVVasoprotectives
p79687
g41395
sVMiscellaneous Therapeutic Agents
p79688
g74023
sVPolysaccharides
p79689
g41779
sVGlycosaminoglycans
p79690
g26081
sVAntivaricose Therapy
p79691
g30540
sVHeparin and similars
p79692
g72008
sVHeparin Group
p79693
g34339
ssg11937
(dp79694
g12186
g42943
sg11361
g78026
ssg11940
(dp79695
VBSEP/ABCB11 Substrates
p79696
g74871
sVCytochrome P-450 CYP3A4 Inhibitors
p79697
g61687
sVSteroids
p79698
g56417
sVSex Hormones and Modulators of the Genital System
p79699
g19607
sVCytochrome P-450 CYP2D6 Inhibitors
p79700
g62940
sVLuteolytic Agents
p79701
g22874
sVCytochrome P-450 CYP3A Substrates
p79702
g45239
sVCytochrome P-450 CYP2C9 Inhibitors (moderate)
p79703
g46422
sVCytochrome P-450 CYP3A7 Inhibitors
p79704
g72548
sVOATP1B1/SLCO1B1 Inhibitors
p79705
g75618
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p79706
g43766
sVCytochrome P-450 CYP2C9 Inhibitors
p79707
g18223
sg660
g18376
sVCytochrome P-450 Enzyme Inhibitors
p79708
g62084
sVBlood Glucose Lowering Agents
p79709
g77635
sVHighest Risk QTc-Prolonging Agents
p79710
g35865
sVCytochrome P-450 CYP3A7 Inhibitors (strength unknown)
p79711
g24781
sVP-glycoprotein/ABCB1 Inducers
p79712
g70564
sVCytochrome P-450 CYP3A4 Substrates
p79713
g65333
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p79714
g23111
sg7887
g64131
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79715
g29553
sVContraceptives, Oral
p79716
g72059
sVOATP1B3 inhibitors
p79717
g62289
sVFused-Ring Compounds
p79718
g14860
sVHormonal Contraceptives for Systemic Use
p79719
g60102
sVCytochrome P-450 CYP3A4 Inducers
p79720
g18941
sVAdrenal Cortex Hormones
p79721
g30024
sVReproductive Control Agents
p79722
g18848
sVGenito Urinary System and Sex Hormones
p79723
g66175
sVCytochrome P-450 CYP2C8 Inhibitors
p79724
g55030
sg10986
g76821
sg10344
g74479
sVCytochrome P-450 Enzyme Inducers
p79725
g28218
sVCytochrome P-450 CYP3A Inducers
p79726
g66280
sVContraceptives, Oral, Synthetic
p79727
g72207
sVCytochrome P-450 CYP3A5 Substrates
p79728
g67819
sVContraceptive Agents, Female
p79729
g67784
sVQTc Prolonging Agents
p79730
g57844
sVHormone Antagonists
p79731
g24270
sVContraceptives, Postcoital
p79732
g58094
sVEstranes
p79733
g50805
sVCytochrome P-450 CYP3A Inhibitors
p79734
g60448
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p79735
g64618
sVHypoglycemia-Associated Agents
p79736
g17717
sg11193
g77472
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p79737
g53071
sVP-glycoprotein/ABCB1 Inhibitors
p79738
g74815
sVAbortifacient Agents
p79739
g37797
sVHormones, Hormone Substitutes, and Hormone Antagonists
p79740
g53179
sVEstrenes
p79741
g78603
ssg11943
(dp79742
g11112
g77218
sg11790
g79255
sg633
g18104
sg12066
(dp79743
sg5919
g54006
sg7056
g59870
sg933
g20852
sg8031
g64863
sg7497
g62323
sg8259
g65877
sg11931
g79671
sg7152
g60213
sg8514
g67136
sg10470
g74934
sg11097
g77171
sg7299
g60946
sg9165
g69626
sg1668
g26295
sg1704
g26740
sg6639
g57985
ssg11946
(dp79744
g10041
g73343
sg831
g19930
ssg11949
(dp79745
g4014
g42259
sg1629
g26010
sg10263
g74054
sg4647
g46596
sg6273
g55909
sg1104
g22112
sg3114
g36892
sg3240
g37747
sg10857
g76501
sg8163
g65481
sg1044
g21568
sg5829
g53382
sg6567
g57533
sg255
g14422
sg9828
g72371
sg6759
g58571
sg3318
g38209
sg9348
g70402
sg9402
g70659
sg2784
g34389
sg4929
g48437
sg10185
g73789
sg11667
g78967
sg4623
g46409
sg828
g19897
sg4440
g45333
sg11472
g78406
sg9948
g72889
sg5085
g49055
sg5286
g50232
sg2067
g29677
sg7329
g61158
sg5073
g49002
sg3708
g40402
sg10515
g75107
sg7824
g63889
sg6906
g59234
sg11319
g77910
sg1113
g22214
sg7719
g63499
sg4302
g44456
sg9012
g68967
sg7320
g61105
sg9987
g73173
sg11139
g77286
sg3036
g36463
sg1719
g26858
sg8655
g67615
sg23
g12255
sg10761
g76094
sg909
g20668
sg10005
g73249
sg11445
g78302
sg1149
g22519
sg10200
g73834
sg1548
g25407
sg11439
g78256
sg8862
g68483
sg10098
g73540
sg171
g13734
sg357
g15333
sg7977
g64493
sg10410
g74761
sg2895
g35463
sg10227
g73932
sg4056
g42602
sg10119
g73592
sg2304
g31267
sg2616
g33200
sg6381
g56801
sg4683
g46945
sg612
g17921
sg5580
g51891
sg5598
g52057
sg3531
g39291
sg4737
g47246
ssg11952
(dp79746
VCytochrome P-450 CYP3A Substrates
p79747
g45147
sVNeuropeptides
p79748
g57512
sVNerve Tissue Proteins
p79749
g78462
sVHormones
p79750
g55681
sVCorticosteroids for Systemic Use
p79751
g48837
sVHyperglycemia-Associated Agents
p79752
g68794
sVPeptide Hormones
p79753
g20219
sVAnterior Pituitary Lobe Hormones and Analogues
p79754
g67520
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p79755
g73627
sg11388
g78149
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79756
g29427
sVCytochrome P-450 CYP3A4 Inducers
p79757
g18946
sVAdrenal Cortex Hormones
p79758
g30023
sVProteins
p79759
g52772
sVPeptides
p79760
g47197
sVCytochrome P-450 Enzyme Inducers
p79761
g28125
sVCytochrome P-450 CYP3A Inducers
p79762
g66281
sVCytochrome P-450 CYP3A4 Substrates
p79763
g65276
sg1923
g28501
sVAmino Acids, Peptides, and Proteins
p79764
g47385
sVPituitary and Hypothalamic Hormones and Analogues
p79765
g57316
sVImmunosuppressive Agents
p79766
g64540
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p79767
g64619
sVPituitary Hormones, Anterior
p79768
g24142
sVProtein Precursors
p79769
g60676
sVHormones, Hormone Substitutes, and Hormone Antagonists
p79770
g53137
sVPituitary Hormones
p79771
g15912
sVCorticosteroids
p79772
g73367
sg8925
g68705
ssg11955
(dp79773
VPyridazines
p79774
g32866
sVCytochrome P-450 CYP2D6 Inhibitors
p79775
g62948
sVCytochrome P-450 CYP2D6 Substrates
p79776
g52182
sVCytochrome P-450 CYP3A Substrates
p79777
g45250
sVBronchodilator Agents
p79778
g73491
sVHistamine Agents
p79779
g75599
sVAnti-Asthmatic Agents
p79780
g36511
sVLipoxygenase Inhibitors
p79781
g69587
sVCytochrome P-450 CYP2C9 Inhibitors
p79782
g18233
sVCytochrome P-450 CYP2B6 Inhibitors (strength unknown)
p79783
g12663
sVCytochrome P-450 Enzyme Inhibitors
p79784
g62090
sVCytochrome P-450 CYP2D6 Inhibitors (weak)
p79785
g18384
sVCytochrome P-450 CYP2C9 Inhibitors (strength unknown)
p79786
(dp79787
sVCytochrome P-450 CYP2C8 Substrates
p79788
g76583
sVCytochrome P-450 CYP1A2 Substrates
p79789
g45618
sVAutonomic Agents
p79790
g66573
sVEnzyme Inhibitors
p79791
g72727
sVCytochrome P-450 CYP2E1 Inhibitors
p79792
g46826
sVPeripheral Nervous System Agents
p79793
g57639
sVRespiratory System Agents
p79794
g71416
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79795
g29568
sVAntihistamines for Systemic Use
p79796
g12956
sVCytochrome P-450 CYP2C9 Substrates
p79797
g29794
sVQTc Prolonging Agents
p79798
g57861
sVCentral Nervous System Depressants
p79799
g78434
sVNeurotransmitter Agents
p79800
g75587
sVHistamine H1 Antagonists, Non-Sedating
p79801
g38524
sVCytochrome P-450 CYP2B6 Inhibitors
p79802
g45918
sVDecongestants and Antiallergics
p79803
g77289
sVCytochrome P-450 CYP2A6 Inhibitors (strength unknown)
p79804
g68485
sVSensory Organs
p79805
g40735
sVHistamine H1 Antagonists
p79806
g40759
sVCytochrome P-450 CYP2C19 Inhibitors
p79807
g61278
sVCytochrome P-450 CYP3A4 Substrates
p79808
g65341
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p79809
g26866
sVNasal Preparations
p79810
g73281
sVCytochrome P-450 CYP3A5 Substrates
p79811
g67828
sVOphthalmologicals
p79812
g35247
sVPotential QTc-Prolonging Agents
p79813
g70433
sVAnti-Allergic Agents
p79814
g50642
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p79815
g76815
sVP-glycoprotein/ABCB1 Inhibitors
p79816
g74819
sVHistamine Antagonists
p79817
g43416
sVAntiallergic Agents, Excl. Corticosteroids
p79818
g65509
sVCytochrome P-450 CYP2E1 Inhibitors (weak)
p79819
g62516
sVCytochrome P-450 CYP2A6 Inhibitors
p79820
g48577
ssg11958
(dp79821
VXanthine Oxidase Inhibitors
p79822
g54183
sVAntigout Preparations
p79823
g76891
sVPreparations Inhibiting Uric Acid Production
p79824
g62138
sVThiazoles
p79825
g49134
sVMusculo-Skeletal System
p79826
g31523
sVSulfur Compounds
p79827
g78974
sVAntirheumatic Agents
p79828
g24222
ssg11961
(dp79829
VBSEP/ABCB11 Substrates
p79830
g74862
sVUrea
p79831
g58645
sVSulfonylurea Compounds
p79832
g65032
sVDrugs that are Mainly Renally Excreted
p79833
g44042
sVUGT1A1 Substrates
p79834
g12265
sVSulfonylureas
p79835
g79009
sVCytochrome P-450 CYP3A Substrates
p79836
g45251
sVHypoglycemia-Associated Agents
p79837
g17675
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79838
g29569
sVSulfur Compounds
p79839
g78975
sVOral Hypoglycemics
p79840
g35988
sVSulfones
p79841
g58730
sVCytochrome P-450 CYP2C9 Substrates
p79842
g29796
sVCytochrome P-450 CYP3A4 Substrates
p79843
g65342
sVBlood Glucose Lowering Agents
p79844
g77631
sVAlimentary Tract and Metabolism
p79845
g23901
sVDrugs Used in Diabetes
p79846
g60116
ssg11964
(dp79847
g9144
g69539
sg6204
g55574
sg4803
g47616
sg7650
g63068
sg4872
g47989
sg7653
g63120
sg4656
g46769
sg8418
g66451
sg354
g15275
sg9192
g69728
sg3141
g37044
sg20252
g78390
sg4887
g48076
sg15016
g66096
sg10728
g75882
sg9231
g69952
sg10740
g75963
sg126
g13166
sg8340
g66212
sg7005
g59526
sg963
g20965
sg3279
g37915
sg972
g21123
sg5571
g51770
sg1761
g26994
sg4782
g47516
sg5589
g51930
sg204
g13942
sg4005
g42146
sg5595
g51971
sg1278
g23326
sg4341
g44591
sg11604
g78751
sg4062
g42609
sg7458
g62130
sg2769
g34276
sg294
g14720
sg13070
g21873
sg6432
g56932
sg12186
g42927
sg318
g14918
sg5208
g49725
sg4911
g48206
sg1872
g27856
sg3408
g38674
sg3267
g37893
sg1941
g28562
sg7188
g60484
sg5256
g50037
sg11775
g79173
sg11781
g79198
sg9519
g71190
sg978
g21144
sg8781
g68091
sg879
g20332
sg4260
g44091
sg2046
g29093
sg11079
g77062
sg10977
g76775
sg11862
g79458
sg1311
g23524
sg11874
g79489
sg2838
g34774
sg10365
g74611
sg2109
g30090
sg5112
g49162
sg6024
g54450
sg1332
g23664
sg1578
g25608
sg10383
g74697
sg7662
g63178
sg1371
g24097
sg2895
g35401
sg336
g15061
sg5199
g49677
sg8922
g68669
sg8019
g64713
sg4425
g44908
sg5250
g49944
sg8238
g65756
sg6867
g59056
sg10494
g74979
sg2991
g35971
sg4716
g47048
sg3711
g40410
sg9009
g68917
sg12051
(dp79848
sg5313
g50378
sg1176
g22668
sg8493
g67054
sg1275
g23286
sg10230
g73940
sg11241
g77592
sg9180
g69694
sg5394
g50812
sg10611
g75507
ssg11967
(dp79849
VAmino Acids, Peptides, and Proteins
p79850
g47401
sVAntiinfectives for Systemic Use
p79851
g69654
sVEchinocandin Antifungal
p79852
g40666
sVAntimycotics for Systemic Use
p79853
g78511
sVPeptides, Cyclic
p79854
g70143
sVAntifungal Agents
p79855
g76440
sVPeptides
p79856
g47203
sVAnti-Infective Agents
p79857
g54605
sVEchinocandins
p79858
g58284
ssg11970
(dp79859
g6783
g58667
ssg11973
(dp79860
g10077
g73477
sg2736
g33934
ssg11976
(dp79861
VDrugs that are Mainly Renally Excreted
p79862
g44043
sVThiophenes
p79863
g59030
sVSodium-glucose co-transporter 2 (SGLT2) inhibitors
p79864
g39023
sVCytochrome P-450 CYP3A Substrates
p79865
g45252
sVAgents causing hyperkalemia
p79866
g43627
sVHypotensive Agents
p79867
g34190
sVP-glycoprotein/ABCB1 Substrates
p79868
g35052
sVUGT1A9 Substrates
p79869
g23997
sVSulfur Compounds
p79870
g78976
sVSodium-glucose Cotransporter 2 (SGLT2) Inhibitors
p79871
g79139
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79872
g29570
sVGlucosides
p79873
g41040
sVOral Hypoglycemics
p79874
g35993
sVP-glycoprotein/ABCB1 Inhibitors
p79875
g74821
sVCytochrome P-450 CYP3A4 Substrates
p79876
g65343
sVBlood Glucose Lowering Agents
p79877
g77632
sVAlimentary Tract and Metabolism
p79878
g23905
sVDrugs Used in Diabetes
p79879
g60113
sVDiuretics
p79880
g57912
ssg11979
(dp79881
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p79882
g77511
sVTricyclics and Other Norepinephrine-reuptake Inhibitors
p79883
g29607
sVAdrenergic alpha-1 Receptor Antagonists
p79884
g14110
sVAnticholinergic Agents
p79885
g24468
sVCytochrome P-450 CYP2D6 Inhibitors
p79886
g62949
sVCytochrome P-450 CYP2D6 Substrates
p79887
g52184
sVCombined Inhibitors of Serotonin/Norepinephrine Reuptake
p79888
g76918
sVSerotonin Agents
p79889
g76428
sVCytochrome P-450 CYP3A Substrates
p79890
g45253
sVNeurotransmitter Agents
p79891
g75588
sVAntidepressive Agents, Tricyclic
p79892
g60707
sVSerotonin Receptor Antagonists
p79893
g35664
sVHistamine Agents
p79894
g75601
sVCentral Nervous System Agents
p79895
g58502
sVPotential QTc-Prolonging Agents
p79896
g70410
sVAdrenergic Antagonists
p79897
g52303
sVPsychotropic Drugs
p79898
g72583
sVDopamine Antagonists
p79899
g53739
sVSerotonin 5-HT1 Receptor Antagonists
p79900
g14436
sVCytochrome P-450 Enzyme Inhibitors
p79901
g62091
sVHistamine H2 Antagonists
p79902
g12708
sVAcid Reducers
p79903
g43813
sVDrugs that are Mainly Renally Excreted
p79904
g44044
sVCytochrome P-450 CYP1A2 Substrates
p79905
g45620
sVPsychoanaleptics
p79906
g59067
sVNon-Selective Monoamine Reuptake Inhibitors
p79907
g72030
sVAntipruritics and Local Anesthetics
p79908
g31871
sVDibenzoxepins
p79909
g21861
sVHypnotics and Sedatives
p79910
(dp79911
sVMuscarinic Antagonists
p79912
g48859
sVEthers, Cyclic
p79913
g47723
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79914
g29571
sVAdrenergic alpha-Antagonists
p79915
g60863
sVCytochrome P-450 CYP2C9 Substrates
p79916
g29801
sVQTc Prolonging Agents
p79917
g57860
sVSerotonin 5-HT2 Receptor Antagonists
p79918
g71713
sVNeurotoxic agents
p79919
g68576
sVCytochrome P-450 CYP2C19 Substrates
p79920
g53880
sVCentral Nervous System Depressants
p79921
g78435
sVHistamine Antagonists
p79922
g43423
sVSleep Aids, Pharmaceutical
p79923
g76670
sVAgents that reduce seizure threshold
p79924
g45840
sVP-glycoprotein/ABCB1 Substrates
p79925
g35053
sVCytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index
p79926
g37406
sVCytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
p79927
g36473
sVDermatologicals
p79928
g17306
sVHistamine H1 Antagonists
p79929
g40766
sVAgents that produce hypertension
p79930
g69081
sVCytochrome P-450 CYP3A4 Substrates
p79931
g65344
sVNarrow Therapeutic Index Drugs
p79932
g50574
sVHeterocyclic Compounds, Fused-Ring
p79933
g56135
sVSerotonin Modulators
p79934
g69129
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p79935
g61376
sVAntidepressive Agents
p79936
g15565
sVCytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index
p79937
g47502
sVCytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
p79938
g36632
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p79939
g53065
sVTertiary amine tricyclic antidepressants
p79940
g31317
sVAntipruritics, Incl. Antihistamines, Anesthetics, Etc.
p79941
g77800
sVAgents producing tachycardia
p79942
g50789
sVCytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
p79943
g60059
sVNervous System
p79944
g70302
ssg11982
(dp79945
g6765
g58636
sg3177
g37309
sg10098
g73519
sg4164
g43319
sg8298
g66037
sg5427
g50976
sg10227
g73909
sg3114
g36857
sg8703
g67756
sg3867
g41351
sg909
g20628
sg8724
g67896
ssg11985
(dp79946
g6549
g57479
sg8670
g67661
sg6171
g55317
sg5577
g51827
sg357
g15302
sg7470
g62233
sg3183
g37349
sg8274
g65924
sg9540
g71286
sg5382
g50730
sg8769
g68046
sg7977
g64471
sg5073
g48978
sg3333
g38263
sg372
g15410
ssg11988
(dp79947
g4911
g48216
sg8421
g66487
sg2787
g34413
sg9822
g72297
sg4653
g46664
sg6333
g56453
sg7335
g61171
sg6045
g54695
sg12123
(dp79948
sg1656
g26150
sg12534
g52614
ssg11991
(dp79949
g9309
g70258
sg1812
g27482
sg7629
g63005
sg12108
(dp79950
sg1164
g22602
ssg11994
(dp79951
g4017
g42275
sg2196
g30609
sg11955
g79787
sg1674
g26324
sg11079
g77056
sg3846
g41106
sg3858
g41206
sg7188
g60495
sg9525
g71232
sg10170
g73699
sg2346
g31361
sg4452
g45420
sg7821
g63799
sg2013
g28949
sg1239
g22940
sg6033
g54506
sg10308
g74275
sg1650
g26100
sg8049
g64896
sg8421
g66495
sg9225
g69904
sg4263
g44151
sg8241
g65787
sg288
g14657
sg9687
g71845
sg5313
g50388
sg10899
g76620
sg4077
g42826
sg4488
g45775
sg7485
g62272
sg1113
g22175
sg7335
g61179
sg9591
g71500
sg6348
g56633
sg11820
g79353
sg9357
g70458
sg10518
g75132
sg8055
g64929
sg9231
g69961
sg4716
g47062
sg4926
g48390
sg1140
g22372
sg1899
g28052
sg6000
g54305
sg2913
g35593
sg8856
g68418
sg6123
g55131
sg8760
g67990
sg2832
g34693
sg147
g13443
sg573
g17532
sg2943
g35752
sg4863
g47934
sg3432
g38800
sg603
g17789
sg9465
g71025
sg771
g19278
sg5181
g49575
sg5370
g50668
sg7077
g60023
sg5289
g50260
sg6075
g54865
sg4830
g47795
sg10815
g76274
sg10356
g74561
sg7593
g62794
sg11241
g77580
sg6537
g57394
sg7608
g62871
sg1908
g28285
ssg11997
(dp79952
VPregnanes
p79953
g63598
sVCytochrome P-450 CYP3A4 Substrates
p79954
g65284
sVAdrenal Cortex Hormones
p79955
g30030
sVOphthalmologicals
p79956
g35258
sVSteroids
p79957
g56418
sVCorticosteroids, Moderately Potent (Group II)
p79958
g58278
sVCytochrome P-450 CYP3A Substrates
p79959
g45159
sVHormones
p79960
g55691
sVImmunosuppressive Agents
p79961
g64591
sVPregnadienes
p79962
g72197
sVDermatologicals
p79963
g17316
sVAnti-Inflammatory Agents
p79964
g73966
sVCorticosteroid Hormone Receptor Agonists
p79965
g63663
sVPregnadienetriols
p79966
g75825
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p79967
g29450
sVSensory Organs
p79968
g40742
sVCorticosteroids, Dermatological Preparations
p79969
g51330
sVHormones, Hormone Substitutes, and Hormone Antagonists
p79970
g53184
sVPrednisolone
p79971
g62554
sVFused-Ring Compounds
p79972
g14880
sVCorticosteroids
p79973
g73366
ssg12000
(dp79974
VAmino Acids, Peptides, and Proteins
p79975
g47403
sVAntiinfectives for Systemic Use
p79976
g69679
sVAgents that produce neuromuscular block (indirect)
p79977
g37962
sg948
g20919
sVAntimycobacterials
p79978
g22560
sVDrugs that are Mainly Renally Excreted with Narrow Therapeutic Index
p79979
g61377
sVDrugs that are Mainly Renally Excreted
p79980
g44046
sVNephrotoxic agents
p79981
g57734
sVAminoglycoside Antibacterials
p79982
g52725
sVAntituberculosis Agents
p79983
g47103
sVDrugs for Treatment of Tuberculosis
p79984
g78002
sVPeptides
p79985
g47204
sVPeptides, Cyclic
p79986
g70142
sVAnti-Bacterial Agents
p79987
g38378
sVEnzyme Inhibitors
p79988
g72729
sVAnti-Infective Agents
p79989
g54659
sVProtein Synthesis Inhibitors
p79990
g45546
sVNarrow Therapeutic Index Drugs
p79991
g50553
ssg12003
(dp79992
VAntiinfectives for Systemic Use
p79993
g69680
sg4662
g46812
sVAntituberculosis Agents
p79994
g47109
sVAntimycobacterials
p79995
g22566
sVAminobenzoates
p79996
g46179
sVBenzene Derivatives
p79997
g61428
sVBenzoates
p79998
g30383
sVHydroxy Acids
p79999
g18149
sg4395
g44822
sVDrugs for Treatment of Tuberculosis
p80000
g78005
sVAcids, Carbocyclic
p80001
g41552
sVHydroxybenzoates
p80002
g59577
sVSalicylates
p80003
g27620
sVAnti-Bacterial Agents
p80004
g38379
sVpara-Aminobenzoates
p80005
g30548
sVPhenols
p80006
g65118
sVAnti-Infective Agents
p80007
g54660
ssg12006
(dp80008
g7812
g63737
sg6765
g58632
sg10362
g74595
sg13091
g21434
sg6009
g54341
sg7527
g62441
sg11805
g79312
sg9081
g69191
sg7848
g63989
ssg12009
(dp80009
g1278
g23324
sg6933
g59296
sg135
g13244
sg6204
g55565
sg7074
g59993
sg4872
g47987
sg7653
g63118
sg10479
g74944
sg8238
g65751
sg6432
g56930
sg8079
g65014
sg9750
g72072
sg2436
g32171
sg11685
g78986
sg1311
g23519
sg4710
g47002
sg8850
g68398
sg1872
g27854
sg126
g13164
sg5736
g52836
sg1176
g22666
sg6183
g55453
sg7005
g59522
sg972
g21114
sg9282
g70195
sg3291
g37996
sg11694
g79000
sg4005
g42161
sg3267
g37888
sg8616
g67453
sg10611
g75502
ssg12012
(dp80010
g5256
g50057
sg10728
g75895
ssg12015
(dp80011
VAmino Acids, Peptides, and Proteins
p80012
g47319
sVIntegrin Receptor Antagonists
p80013
g62107
sVAntibodies
p80014
g60982
sVGastrointestinal Agents
p80015
g70834
sVIntegrin Receptor Antagonist
p80016
g60683
sVAntibodies, Monoclonal
p80017
g73309
sVSelective Immunosuppressants
p80018
g23566
sVProteins
p80019
g52741
sVImmunoglobulins
p80020
g41520
sVImmunosuppressive Agents
p80021
g64563
sVSerum Globulins
p80022
g49652
sVAntineoplastic and Immunomodulating Agents
p80023
g39733
sVBlood Proteins
p80024
g39852
sVGlobulins
p80025
g19173
sVImmunoproteins
p80026
g57445
ssg12018
(dp80027
VGABA Agents
p80028
g16211
sVCytochrome P-450 CYP3A Substrates
p80029
g45259
sVNeurotransmitter Agents
p80030
g75591
sVAnti-Anxiety Agents
p80031
g35645
sVCentral Nervous System Agents
p80032
g58509
sVBenzodiazepinones
p80033
g78170
sVPsychotropic Drugs
p80034
g72584
sVGABA Modulators
p80035
g39053
sVCytochrome P-450 Enzyme Inhibitors
p80036
g62094
sVDrugs that are Mainly Renally Excreted
p80037
g44048
sVCytochrome P-450 CYP1A2 Substrates
p80038
g45624
sVCytochrome P-450 CYP2E1 Inhibitors
p80039
g46833
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80040
g29578
sVPsycholeptics
p80041
g33238
sVCentral Nervous System Depressants
p80042
g78436
sVMuscle Relaxants, Centrally Acting Agents
p80043
g37388
sVCytochrome P-450 CYP2E1 Inhibitors (strength unknown)
p80044
g26873
sVHeterocyclic Compounds, Fused-Ring
p80045
g56145
sVCytochrome P-450 CYP3A4 Substrates
p80046
g65346
sVHypnotics and Sedatives
p80047
(dp80048
sVBenzazepines
p80049
g60328
sVBenzodiazepine hypnotics and sedatives
p80050
g17659
sVMuscle Relaxants
p80051
g76663
sVBenzodiazepines and benzodiazepine derivatives
p80052
g71796
sVNervous System
p80053
g70306
sVTranquilizing Agents
p80054
g55295
ssg12021
(dp80055
g2886
g35299
sg2058
g29188
sg1581
g25682
sg11769
g79155
sg717
g19059
sg11046
g76938
sg5400
g50875
ssg12024
(dp80056
g10245
g74004
ssg12027
(dp80057
g1239
g22948
sg10275
g74165
sg10914
g76653
sg1152
g22540
ssg12030
(dp80058
g495
g16708
sg8778
g68075
sg6570
g57539
ssg12033
(dp80059
g10062
g73440
sg6939
g59327
ssg12036
(dp80060
g9588
g71477
ssg12039
(dp80061
g8493
g67072
ssg12042
(dp80062
VAmino Acids, Peptides, and Proteins
p80063
g47408
sg11895
g79533
sVOxytocin and Analogues
p80064
g18477
sVPeptide Hormones
p80065
g20216
sVGenito Urinary System and Sex Hormones
p80066
g66187
sVPotential QTc-Prolonging Agents
p80067
g70409
sVPosterior Pituitary Lobe Hormones
p80068
g12166
sVUterotonic agents
p80069
g38832
sVSystemic Hormonal Preparations, Excl. Sex Hormones and Insulins
p80070
g73626
sg3555
g39418
sVPeptides
p80071
g47207
sg3402
g38664
sVPituitary Hormones
p80072
g15919
sVReproductive Control Agents
p80073
g18857
sVHormones
p80074
g55693
sVHormones, Hormone Substitutes, and Hormone Antagonists
p80075
g53186
sg12042
(dp80076
sVQTc Prolonging Agents
p80077
g57822
sVPituitary Hormones, Posterior
p80078
g78423
sVPituitary and Hypothalamic Hormones and Analogues
p80079
g57317
ssg12045
(dp80080
VCytochrome P-450 CYP3A4 Inhibitors
p80081
g61645
sVAntifungal Agents
p80082
g76441
sVEnzyme Inhibitors
p80083
g72733
sVCytochrome P-450 Enzyme Inhibitors
p80084
g62096
sVAnti-Infective Agents
p80085
g54578
sVAntifungal Agents (Vaginal)
p80086
g39086
sVAzole Antifungals
p80087
g20196
sVGynecological Antiinfectives and Antiseptics
p80088
g69249
sVCytochrome P-450 CYP2E1 Inhibitors
p80089
g46835
sVAntifungals for Topical Use
p80090
g39234
sVSteroid Synthesis Inhibitors
p80091
g72881
sVAntifungals for Dermatological Use
p80092
g30079
sVCytochrome P-450 CYP2C8 Inhibitors
p80093
g55042
sVDermatologicals
p80094
g17315
sVCytochrome P-450 CYP2E1 Inhibitors (strong)
p80095
g43096
sVCytochrome P-450 CYP2C19 Inhibitors (strong)
p80096
g44523
sVCytochrome P-450 CYP3A4 Inhibitors (moderate)
p80097
g69045
sVCytochrome P-450 CYP2C19 Inhibitors
p80098
g61281
sVCytochrome P-450 CYP2C8 Inhibitors (strength unknown)
p80099
g23113
sVImidazole and Triazole Derivatives
p80100
g51761
sVHormone Antagonists
p80101
g24281
sV14-alpha Demethylase Inhibitors
p80102
g76752
sVGenito Urinary System and Sex Hormones
p80103
g66190
sVCytochrome P-450 CYP3A Inhibitors
p80104
g60401
sVHormones, Hormone Substitutes, and Hormone Antagonists
p80105
g53143
sVChemically-Induced Disorders
p80106
g21243
sVImidazole Derivatives
p80107
g74017
ssg12048
(dp80108
g5256
g50101
sg10728
g75919
sg888
g20451
ssg12051
(dp80109
VAntivirals for Systemic Use
p80110
g59776
sVUGT1A1 Substrates
p80111
g12298
sVMiscellaneous Antiretrovirals*
p80112
g25435
sVUGT1A9 Substrates
p80113
g23996
sVOCT2 Inhibitors
p80114
g42475
sVAnti-HIV Agents
p80115
g66398
sVBCRP/ABCG2 Substrates
p80116
g42051
sVEnzyme Inhibitors
p80117
g72731
sVAnti-Infective Agents
p80118
g54629
sVAntiinfectives for Systemic Use
p80119
g69667
sVUGT1A3 substrates
p80120
g31809
sVOAT1/SLC22A6 inhibitors
p80121
g79848
sVMultidrug and Toxin Extrusion Transporter 1 Inhibitors
p80122
g30938
sVP-glycoprotein/ABCB1 Substrates
p80123
g34939
sVHIV Integrase Inhibitors
p80124
g56738
sVAnti-Retroviral Agents
p80125
g67149
sVIntegrase Inhibitors
p80126
g63295
sVDirect Acting Antivirals
p80127
g38080
sVHeterocyclic Compounds, Fused-Ring
p80128
g56150
sVOAT3/SLC22A8 Inhibitors
p80129
g59010
sVAntiviral Agents
p80130
g30472
sVHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor
p80131
g14712
ssg12054
(dp80132
g8010
g64674
ssg12057
(dp80133
VCholestenes
p80134
g57945
sVVitamins (Fat Soluble)
p80135
g61291
sVSecosteroids
p80136
g44474
sVSteroids
p80137
g56435
sVMembrane Lipids
p80138
g47726
sVMusculo-Skeletal System
p80139
g31531
sVSterols
p80140
g78586
sVDrugs for Treatment of Bone Diseases
p80141
g14278
sVBone Density Conservation Agents
p80142
g40360
sVCholestanes
p80143
g19149
sVDrugs Affecting Bone Structure and Mineralization
p80144
g16510
sVFused-Ring Compounds
p80145
g14893
sVVitamin D and Analogues
p80146
g40201
sVVitamins
p80147
g12188
sVAlimentary Tract and Metabolism
p80148
g23943
sVLipids
p80149
g14352
ssg12060
(dp80150
VPhosphorus Acids
p80151
g65601
sVAmino Acids, Cyclic
p80152
g27291
sVAgents causing hyperkalemia
p80153
g43616
sVHypotensive Agents
p80154
g34172
sVAgents causing angioedema
p80155
g63905
sVImines
p80156
g63657
sVProtease Inhibitors
p80157
g51096
sVEnzyme Inhibitors
p80158
g72732
sVProline
p80159
g35853
sVDrugs that are Mainly Renally Excreted
p80160
g43838
sVAmino Acids
p80161
g43109
sVAntihypertensive Agents
p80162
g20298
sg93
g12954
sVAngiotensin-Converting Enzyme Inhibitors
p80163
g66125
sVACE Inhibitors and Diuretics
p80164
g69034
sVCardiovascular Agents
p80165
g26671
sVAcids
p80166
g40580
sVAgents Acting on the Renin-Angiotensin System
p80167
g25338
sVAmino Acids, Peptides, and Proteins
p80168
g47389
sVAcids, Acyclic
p80169
g25472
sVImino Acids
p80170
g57950
sVAcids, Noncarboxylic
p80171
g54205
sVPhosphorus Compounds
p80172
g36723
sVOrganophosphorus Compounds
p80173
g74857
ssg12063
(dp80174
VCytochrome P-450 CYP3A4 Inhibitors
p80175
g61655
sVCytochrome P-450 CYP2D6 Substrates
p80176
g52166
sVAntiarrhythmic agents
p80177
g71178
sVCytochrome P-450 CYP3A Substrates
p80178
g45267
sVAgents causing hyperkalemia
p80179
g43637
sg11598
g78703
sVCalcium Channel Blockers
p80180
g41315
sVCytochrome P-450 CYP2B6 Substrates
p80181
g33007
sVCytochrome P-450 Enzyme Inhibitors
p80182
g62097
sVCytochrome P-450 CYP2C8 Substrates
p80183
g76585
sVPiperidines
p80184
g73565
sVAntidiarrheals, Intestinal Antiinflammatory/antiinfective Agents
p80185
g59970
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80186
g29588
sVQTc Prolonging Agents
p80187
g57877
sVGastrointestinal Agents
p80188
g70832
sVP-glycoprotein/ABCB1 Substrates
p80189
g34955
sVCytochrome P-450 CYP3A4 Inhibitors (strong)
p80190
g72545
sVAntipropulsives
p80191
g68489
sVCytochrome P-450 CYP3A Inhibitors (strong)
p80192
g13400
sVCytochrome P-450 CYP3A4 Substrates
p80193
g65349
sVAlimentary Tract and Metabolism
p80194
g23927
sVModerate Risk QTc-Prolonging Agents
p80195
g67163
sVOpioid Agonist
p80196
g74747
sVCytochrome P-450 CYP3A Inhibitors
p80197
g60414
sVBradycardia-Causing Agents
p80198
g61450
sVP-glycoprotein/ABCB1 Inhibitors
p80199
g74809
ssg12066
(dp80200
VSerotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
p80201
g77507
sVUGT1A4 substrates
p80202
g41050
sVAdrenergic alpha-1 Receptor Antagonists
p80203
g14129
sVCytochrome P-450 CYP2D6 Inhibitors
p80204
g62919
sVSerotonin Agents
p80205
g76430
sVCytochrome P-450 CYP3A Substrates
p80206
g44985
sVCentral Nervous System Agents
p80207
g58439
sVAdrenergic Antagonists
p80208
g52285
sVPsychotropic Drugs
p80209
g72592
sVCytochrome P-450 Enzyme Inhibitors
p80210
g61956
sVHistamine H2 Antagonists
p80211
g12707
sVHighest Risk QTc-Prolonging Agents
p80212
g35858
sVDiazepines, Oxazepines, Thiazepines and Oxepines
p80213
g40206
sVCytochrome P-450 CYP1A2 Substrates
p80214
g45585
sVAntipsychotic Agents
p80215
g69862
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80216
g29224
sVAdrenergic alpha-Antagonists
p80217
g60876
sVDopamine Antagonists
p80218
g53746
sVQTc Prolonging Agents
p80219
g57881
sVAcid Reducers
p80220
g43808
sVCentral Nervous System Depressants
p80221
g78426
sVHistamine H1 Antagonists
p80222
g40781
sVAgents that produce hypertension
p80223
g69088
sVHyperglycemia-Associated Agents
p80224
g68802
sVCytochrome P-450 CYP3A4 Substrates
p80225
g65195
sVDopamine D2 Receptor Antagonists
p80226
g49420
sVHeterocyclic Compounds, Fused-Ring
p80227
g56069
sVAntidepressive Agents
p80228
g15521
sVPsycholeptics
p80229
g33247
sVTranquilizing Agents
p80230
g55300
sVCytochrome P-450 CYP2D6 Inhibitors (strength unknown)
p80231
g53064
sVNeurotoxic agents
p80232
g68585
sVHistamine Antagonists
p80233
g43442
sVSerotonin Receptor Agonists
p80234
g79743
sVNervous System
p80235
g70277
sVAntipsychotic Agents (Second Generation [Atypical])
p80236
g52062
ssg12069
(dp80237
g1260
g23153
sg3684
g40233
sg687
g18565
sg6156
g55230
sg8580
g67290
sg7896
g64141
sg1803
g27391
sg4035
g42437
sg10593
g75414
sg10959
g76734
sg4005
g42178
ssg12072
(dp80238
VBasic Ointments and Protectants
p80239
g41764
sVGenito Urinary System and Sex Hormones
p80240
g66189
sVGynecological Antiinfectives and Antiseptics
p80241
g69245
sg12072
(dp80242
sg33
g12411
sVHydroxy Acids
p80243
g18158
sVLaxatives
p80244
g17350
sVMiscellaneous Local Anti-infectives
p80245
g59167
sg1395
g24258
sg5157
g49434
ssg12075
(dp80246
g10119
g73586
ssg12078
(dp80247
VAntiinfectives for Systemic Use
p80248
g69657
sVToxic Actions
p80249
g49397
sVHypolipidemic Agents
p80250
g69892
sVAntimycobacterials
p80251
g22564
sVNoxae
p80252
g65426
sVAntituberculosis Agents
p80253
g47105
sVDrugs for Treatment of Tuberculosis
p80254
g78003
sVIsonicotinic Acids
p80255
g67562
sVPyridines
p80256
g64235
sg6141
g55157
sVAnti-Bacterial Agents
p80257
g38353
sVFatty Acid Synthesis Inhibitors
p80258
g19158
sVAnti-Infective Agents
p80259
g54610
sVLipid Regulating Agents
p80260
g72480
ssg12081
(dp80261
g10314
g74334
sg396
g15803
sg10548
g75223
ssg12084
(dp80262
g6699
g58229
ssg12087
(dp80263
g8856
g68436
ssg12090
(dp80264
VAgents Causing Muscle Toxicity
p80265
g55403
sVPyrimidines
p80266
g47708
sVNucleic Acid Synthesis Inhibitors
p80267
g48743
sVImmunosuppressive Agents
p80268
g64595
sVImmunologic Factors
p80269
g42389
sVCytochrome P-450 CYP3A Substrates
p80270
g45093
sVAnti-Infective Agents
p80271
g54673
sVPyrimidine Analogues
p80272
g18464
sVMyelosuppressive Agents
p80273
g71340
sVNucleoside Metabolic Inhibitor
p80274
g68861
sVCytidine
p80275
g67526
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80276
g29373
sVAntimetabolites, Antineoplastic
p80277
g23451
sVCarbohydrates
p80278
g61797
sVGlycosides
p80279
g68373
sVOCT1 substrates
p80280
g13081
sVRibonucleosides
p80281
g73670
sVNucleic Acids, Nucleotides, and Nucleosides
p80282
g47130
sVP-glycoprotein/ABCB1 Substrates
p80283
g35084
sVPyrimidine Nucleosides
p80284
g79024
sVCytochrome P-450 CYP3A4 Substrates
p80285
g65252
sVToxic Actions
p80286
g49405
sVCardiotoxic antineoplastic agents
p80287
g72244
sVNucleosides
p80288
g49471
sVAntimetabolites
p80289
g59541
sVArabinonucleosides
p80290
g39608
sVNoxae
p80291
g65430
sVAntineoplastic Agents
p80292
g71556
sVAntineoplastic and Immunomodulating Agents
p80293
g39824
ssg12093
(dp80294
g5853
g53556
sg2829
g34651
sg2460
g32288
sg7416
g61737
sg6435
g56984
sg9198
g69769
sg4437
g45299
sg8949
g68756
sg7884
g64112
sg8820
g68269
sg9918
g72829
ssg12096
(dp80295
g10512
g75088
ssg12099
(dp80296
g10062
g73452
sg426
g16117
sg3204
g37452
sg11793
g79281
sg2358
g31472
sg11811
g79324
sg828
g19852
sg11979
g79911
sg183
g13846
sg7272
g60775
sg7284
g60849
sg12018
g80048
sg9564
g71393
sg8205
g65623
sg6939
g59324
sg5970
g54220
sg2430
g32101
sg5133
g49295
sg5691
g52500
sg11139
g77284
sg7941
g64284
sg9420
g70807
sg9393
g70614
sg4035
g42444
sg582
g17621
sg4155
g43245
sg5067
g48960
sg5769
g53049
sg1188
g22784
sg9372
g70531
ssg12102
(dp80297
g7359
g61360
sg11136
g77265
sg2466
g32351
sg10170
g73697
sg1581
g25699
sg8322
g66143
ssg12105
(dp80298
g9402
g70645
ssg12108
(dp80299
VSunscreen Agents
p80300
g70319
sVIons
p80301
g49129
sVHousehold Products
p80302
g60753
sVBasic Ointments and Protectants
p80303
g41768
sVMetal divalent cations
p80304
g65845
sVZinc Compounds
p80305
g65837
sVSunscreening Agents
p80306
g57239
sVDermatologicals
p80307
g17319
sVOxides
p80308
g27680
sVRadiation-Protective Agents
p80309
g65030
sVAgents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
p80310
g16829
sVCompounds used in a research, industrial, or household setting
p80311
g76514
sVAnions
p80312
g71793
sVBasic Powders and Demulcents
p80313
g31649
sVProtective Agents
p80314
g66795
sVMetal cations
p80315
g40806
sVVasoprotectives
p80316
g41388
sVCopper Absorption Inhibitor
p80317
g79950
sVElectrolytes
p80318
g52430
sVOxygen Compounds
p80319
g46964
sVCosmetics
p80320
g34263
ssg12111
(dp80321
VCentral Nervous System Depressants
p80322
g78438
sVFatty Acids, Volatile
p80323
g66979
sVFatty Acids
p80324
g63152
sVAnesthetics
p80325
g51611
sVAnesthetics, General
p80326
g24703
sVAcids, Acyclic
p80327
g25485
sVHydroxy Acids
p80328
g18164
sg5058
g48896
sVCentral Nervous System Agents
p80329
g58518
sVButyrates
p80330
g59983
sVAnesthetics, Intravenous
p80331
g77119
sVAdjuvants, Anesthesia
p80332
g55869
sVMiscellaneous Central Nervous System Agents
p80333
g63702
sVNervous System
p80334
g70312
sVLipids
p80335
g14342
ssg12114
(dp80336
VAngiotensin-Converting Enzyme Inhibitors
p80337
g66124
sVDrugs that are Mainly Renally Excreted
p80338
g43862
sVACE Inhibitors and Diuretics
p80339
g69033
sVACE Inhibitors and Calcium Channel Blockers
p80340
g66984
sVLipid Modifying Agents
p80341
g40532
sVIndoles
p80342
g73560
sVAntihypertensive Agents
p80343
g20243
sVAgents causing hyperkalemia
p80344
g43565
sVHypotensive Agents
p80345
g34099
sVAgents causing angioedema
p80346
g63901
sVHeterocyclic Compounds, Fused-Ring
p80347
g56031
sVCholinesterase Inhibitors
p80348
g72393
sVProtease Inhibitors
p80349
g51087
sVEnzyme Inhibitors
p80350
g72694
sVCardiovascular Agents
p80351
g26520
sVAgents Acting on the Renin-Angiotensin System
p80352
g25331
ssg12117
(dp80353
g6411
g56865
sg11544
g78539
sg7464
g62192
sg10818
g76351
sg4635
g46513
sg7569
g62750
sg1491
g25113
sg3447
g38962
sg2433
g32134
ssg12120
(dp80354
g2658
g33389
ssg12123
(dp80355
VCytochrome P-450 CYP3A Substrates
p80356
g45277
sVCytochrome P-450 CYP2B6 Inducers (weak)
p80357
g68067
sVCytochrome P-450 CYP2D6 Inducers
p80358
g79948
sVCytochrome P-450 CYP2C8 Inducers (weak)
p80359
g35848
sVCytochrome P-450 CYP2C9 Inducers
p80360
g20061
sVCytochrome P-450 CYP2C9 Inducers (strength unknown)
p80361
g16534
sVAntiinfectives for Systemic Use
p80362
g69686
sVP-glycoprotein/ABCB1 Inducers
p80363
g70565
sVAnti-Infective Agents
p80364
g54680
sVCytochrome P-450 CYP2B6 Inducers
p80365
g39136
sVCytochrome P-450 CYP3A4 Inducers (weak)
p80366
g19517
sVP-glycoprotein inducers
p80367
g31877
sg9207
g69867
sVAmides
p80368
g44355
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80369
g29600
sVAnti-Bacterial Agents
p80370
g38392
sVCytochrome P-450 CYP3A4 Inducers
p80371
g18989
sVCytochrome P-450 CYP2D6 Inducers (strength unknown)
p80372
g78445
sg7479
g62244
sVAntituberculosis Agents
p80373
g47106
sVCytochrome P-450 CYP2C19 Inducers (moderate)
p80374
g59469
sVLactams
p80375
g22296
sVCytochrome P-450 Enzyme Inducers
p80376
g28253
sVCytochrome P-450 CYP3A Inducers
p80377
g66298
sVHeterocyclic Compounds, Fused-Ring
p80378
g56171
sVCytochrome P-450 CYP3A4 Substrates
p80379
g65356
sVAntibiotics, Antitubercular
p80380
g20921
sVAntimycobacterials
p80381
g22571
sVCytochrome P-450 CYP2C8 Inducers
p80382
g60378
sVDrugs for Treatment of Tuberculosis
p80383
g78006
sg1350
g23747
sVCytochrome P-450 CYP2C19 Inducers
p80384
g25550
ssg12126
(dp80385
VAntiparasitic Products, Insecticides and Repellents
p80386
g30586
sVAgents that produce neuromuscular block (indirect)
p80387
g37981
sVAntimalarials
p80388
g14099
sVQuinolines
p80389
g74119
sVCytochrome P-450 CYP2D6 Inhibitors
p80390
g62957
sVCytochrome P-450 CYP2D6 Substrates
p80391
g52201
sVCytochrome P-450 CYP2D6 Inhibitors (moderate)
p80392
g41085
sVAnalgesics
p80393
g26498
sVCytochrome P-450 CYP2C8 Inhibitors (moderate)
p80394
g78154
sVCentral Nervous System Agents
p80395
g58520
sVOCT2 Inhibitors
p80396
g42493
sVOATP1B1/SLCO1B1 Inhibitors
p80397
g75621
sVCytochrome P-450 CYP3A4 Inhibitors (strength unknown)
p80398
g43793
sVCytochrome P-450 Enzyme Inhibitors
p80399
g62099
sVAnti-Infective Agents
p80400
g54676
sVBlood Glucose Lowering Agents
p80401
g77633
sVPeripheral Nervous System Agents
p80402
g57654
sg5052
g48891
sVHighest Risk QTc-Prolonging Agents
p80403
g35876
sVCytochrome P-450 CYP2C8 Substrates
p80404
g76587
sVCytochrome P-450 CYP1A2 Substrates
p80405
g45641
sVAnalgesics, Non-Narcotic
p80406
g56909
sVNeuromuscular Agents
p80407
g20237
sg5661
g52400
sg11928
g79639
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80408
g29596
sVAntiprotozoals
p80409
g59376
sVQTc Prolonging Agents
p80410
g57868
sVCytochrome P-450 CYP3A4 Inducers
p80411
g18983
sVCytochrome P-450 CYP3A Substrates
p80412
g45273
sVOCT1 inhibitors
p80413
g66929
sVCytochrome P-450 CYP2C19 Substrates
p80414
g53901
sVCentral Nervous System Depressants
p80415
g78439
sVOCT1 substrates
p80416
g13084
sVAgents that reduce seizure threshold
p80417
g45871
sVCytochrome P-450 CYP1A2 Inhibitors
p80418
g15047
sVCytochrome P-450 CYP2C8 Inhibitors
p80419
g55039
sg7932
g64217
sVMuscle Relaxants, Centrally Acting Agents
p80420
g37396
sVP-glycoprotein/ABCB1 Substrates
p80421
g35087
sVAntiparasitic Agents
p80422
g40661
sVCytochrome P-450 Enzyme Inducers
p80423
g28247
sVCytochrome P-450 CYP3A Inducers
p80424
g66295
sVCytochrome P-450 CYP2C9 Substrates
p80425
g29823
sVCytochrome P-450 CYP2C19 Inhibitors
p80426
g61285
sVHeterocyclic Compounds, Fused-Ring
p80427
g56167
sVCytochrome P-450 CYP3A4 Substrates
p80428
g65353
sVCytochrome P-450 CYP1A2 Inhibitors (unknown strength)
p80429
g49346
sVCytochrome P-450 CYP3A4 Inhibitors
p80430
g61703
sVMusculo-Skeletal System
p80431
g31550
sVCytochrome P-450 CYP3A5 Substrates
p80432
g67834
sVCytochrome P-450 CYP3A Inhibitors
p80433
g60466
sVCytochrome P-450 CYP2C19 inhibitors (unknown strength)
p80434
g76818
sVHypoglycemia-Associated Agents
p80435
g17714
sVMethemoglobinemia Associated Agents
p80436
g25586
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p80437
g64628
sVP-glycoprotein/ABCB1 Inhibitors
p80438
g74823
sVMuscle Relaxants
p80439
g76664
sg3294
g38014
sVAlkaloids
p80440
g19444
sVSensory System Agents
p80441
g71819
sVCytochrome P-450 CYP3A7 Substrates
p80442
g60674
ssg12129
(dp80443
g723
g19087
sg4623
g46405
sg5427
g50995
sg10857
g76498
sg11667
g78962
sg9402
g70656
sg11439
g78251
sg5796
g53245
ssg12132
(dp80444
VCytochrome P-450 CYP3A Substrates
p80445
g45275
sVSteroids, Fluorinated
p80446
g79129
sVHormones
p80447
g55696
sVHyperglycemia-Associated Agents
p80448
g68819
sVPregnadienetriols
p80449
g75824
sVGlucocorticoids
p80450
g21933
sVBetamethasone
p80451
g40023
sVCytochrome P-450 CYP3A4 Substrates (strength unknown)
p80452
g29598
sVFused-Ring Compounds
p80453
g14892
sVCytochrome P-450 CYP3A4 Inducers
p80454
g18986
sVCytochrome P-450 CYP3A5 Inducers
p80455
g41758
sVAdrenal Cortex Hormones
p80456
g30056
sVPregnadienes
p80457
g72198
sVCytochrome P-450 Enzyme Inducers
p80458
g28250
sVCytochrome P-450 CYP3A Inducers
p80459
g66297
sVCytochrome P-450 CYP3A4 Substrates
p80460
g65354
sVPregnanes
p80461
g63607
sVSteroids
p80462
g56434
sVImmunosuppressive Agents
p80463
g64597
sVCytochrome P-450 CYP3A4 Inducers (strength unknown)
p80464
g64630
sVAnti-Inflammatory Agents
p80465
g73968
sVHormones, Hormone Substitutes, and Hormone Antagonists
p80466
g53194
sVCorticosteroids
p80467
g73369
sVCytochrome P-450 CYP3A5 Inducers (strength unknown)
p80468
g72447
ssg12135
(dp80469
g11097
g77166
sg7422
g61833
sg8514
g67131
sg10470
g74930
ssg12138
(dp80470
g438
g16190
ssg12141
(dp80471
g23
g12253
sg2559
g32984
sg7176
g60365
sg11649
g78862
sg7320
g61103
sg5289
g50271
sg11439
g78254
sg11667
g78965
sg3363
g38437
sg10515
g75105
sg2067
g29675
sg8655
g67611
sg612
g17917
sg11445
g78299
sg168
g13679
sg11319
g77907
ssg12144
(dp80472
g8670
g67667
sg3183
g37357
sg5577
g51846
sg372
g15418
sg5382
g50738
ssg12147
(dp80473
g3027
g36396
sg8820
g68304
sg7335
g61249
sg9822
g72337
sg8421
g66544
ssg12150
(dp80474
g6921
g59278
sg7176
g60362
sg465
g16489
sg168
g13669
sg11154
g77348
ssg12153
(dp80475
g7530
g62480
sg10320
g74362
sg420
g16033
sssS'graph'
p80476
(dp80477
sS'adjlist_dict_factory'
p80478
g12159
sS'adj'
p80479
g12162
sb.